{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b-reasoning/e6_semantic_retrieval/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-04T03:23:25.532267"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "For Lockheed Martin’s non‑qualified defined‑benefit pension plans, the gross benefit obligation fell from about **$1.0 billion at year‑end 2023 to $905 million at year‑end 2024**.  Correspondingly, the actuarial losses (including unrecognized prior‑service credits) declined from **$347 million in 2023 to $303 million in 2024**【page_89】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. Minor formatting differences (e.g., 'about $1.0 billion' vs. '$1.0 billion') are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the gross benefit obligation and actuarial losses for both years as required by the multi-part question. (3) Entity accuracy is correct—Lockheed Martin (LMT), nonqualified defined benefit pension plans, and the correct fiscal years (2023 and 2024) are properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the evolution of both metrics over time, showing a decrease in both liability and actuarial losses, which aligns with the ground truth's conclusion. The citation of 'page_89' supports the source traceability. (5) Semantic equivalence is maintained—the wording differs slightly (e.g., 'fell' vs. 'decreased'), but the meaning is identical. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 329,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "- In the 2022 Form 10‑K GM reported that the weighted‑average long‑term rate of return assumed for its U.S. defined‑benefit pension‑plan assets had been lowered to **5.4 %** (down from 5.6 % at 12/31/2020) 【page_86】.  \n- By the 2024 Form 10‑K the same assumption had risen to **6.5 %** (up from 6.3 % at 12/31/2023) 【page_88】.  \n\nThe increase from roughly 5.4 % to 6.5 % reflects GM’s strategic shift toward a higher‑return asset mix—its target allocations moved from 9 % equity/68 % debt/23 % “other” in 2021 to 11 % equity/60 % debt/29 % “other” in 2024—indicating a tilt to more equity and alternative investments to boost pension funding returns and reduce funded‑status volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: it accurately reports the 5.4% long-term rate of return assumption in 2022 (down from 5.6% in 2020) and the increase to 6.5% in 2024 (up from 6.3% in 2023), matching the ground truth. These numbers are correctly attributed to the respective 10-K filings and time periods. 2) Quantitative accuracy is perfect—no errors in percentages or dates. The comparison from 5.4% to 6.5% is correctly framed as an increase, and the cited transitions align with the source data. 3) The reasoning is sound and adds value: the LLM correctly infers a strategic shift toward higher-return assets and supports this with specific target allocation changes (equity from 9% to 11%, debt from 68% to 60%, 'other' from 23% to 29%), which are consistent with a move toward equities and alternatives. While the original answer does not include these exact allocation figures, they are plausible and contextually appropriate, enhancing the explanation without contradicting the ground truth. The conclusion about reducing funded-status volatility is a reasonable extension. 4) The answer fully addresses both parts of the question: the evolution of return assumptions and the implication for strategic asset mix. It synthesizes information across years and documents correctly. The only reason for not scoring a 10 is that the original ground truth does not specify the exact asset allocation percentages (9%/68%/23% etc.), so while the added detail is logical, it slightly exceeds the confirmed data. However, this does not undermine correctness, as the core facts and interpretation remain aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 447,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron completed a business‑combination acquisition of PDC Energy in 2023, which drove a roughly 4 % rise in worldwide oil‑equivalent production (about 250 k BOED) and was excluded from the company’s internal‑control assessment that year (page 9; page 30). By 2024 the former PDC fields were described as “legacy PDC assets,” delivering a full year of production that added ≈250 k BOED (≈19 % increase) and lifted U.S. upstream earnings by $3.5 billion – including $2.2 billion of higher sales – attributable to the legacy PDC production (page 44).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of PDC Energy by Chevron and the exclusion of PDC from internal control assessment in 2023, which aligns with the ground truth. It also correctly notes the integration progress by 2024 and the contribution of legacy PDC assets. However, there are significant quantitative inaccuracies: the LLM states a $3.5 billion increase in U.S. upstream earnings with $2.2 billion attributed to higher sales, while the ground truth specifies a $2.2 billion increase in U.S. upstream earnings overall (not just sales). This misrepresents the financial impact. Additionally, the LLM claims a 'roughly 4%' rise in worldwide production from the acquisition, which is not mentioned in the ground truth; instead, the 19% increase in net oil-equivalent production is attributed to the full-year contribution of PDC in 2024. The LLM conflates this 19% with ≈250k BOED, which may be factually consistent if that volume corresponds to a 19% increase, but the 4% figure has no support and introduces confusion. (2) Number verification: $2.2 billion earnings increase is partially correct but misrepresented as part of a larger $3.5 billion figure; 19% production increase is correctly cited; 250k BOED is plausible but not in ground truth; 4% increase is incorrect and unsupported. (3) Multi-hop reasoning is partially sound: the model connects the 2023 acquisition to 2024 performance and uses appropriate terminology like 'legacy PDC assets' and integration timeline. However, it introduces unsupported figures and misattributes earnings components, indicating incomplete or inaccurate synthesis. (4) Correctness score is 6 due to core factual alignment on the acquisition and integration but significant errors in financial quantification. Quantitative accuracy is 5 due to major dollar amount misstatement. Qualitative accuracy is 7 because entity and timeline identification are correct, and reasoning structure is logical despite errors. Contextual relevance is 9 as the answer directly addresses the evolution and impacts as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 560,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "In the 2022 Form 10‑K the company reported energy‑related derivatives mainly as “regulatory hedges” with unrealized gains shown as a pre‑tax effect (e.g., a $155 million gain in 2021 and $12 million in 2020) and cash‑flow hedge gains/losses recorded in earnings and OCI (e.g., $17 million gain in 2021). By the 2024 filing the treatment had shifted to presenting the fair‑value of those derivatives on the balance sheet, broken out by current and non‑current regulatory‑hedge assets and liabilities, cash‑flow/fair‑value hedges and non‑designated hedges, with net amounts such as a $45 million asset and $554 million liability for regulatory hedges and detailed Level 1‑3 valuation disclosures. This change moves unrealized gains/losses from a separate pre‑tax effect note to net balance‑sheet amounts with a more granular classification and valuation disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core shift in Southern Company's treatment and presentation of energy-related derivatives between 2022 and 2024. It correctly identifies the 2022 disclosure practice of reporting pre-tax unrealized gains for regulatory hedges, citing specific figures ($155M gain in 2021, $12M in 2020), which aligns with the ground truth focus on unrealized gains as of December 31, 2021, and 2020. The 2024 shift to fair value presentation on the balance sheet, categorized by hedge type (regulatory, cash-flow, fair-value, non-designated), is accurately described, including the move from footnotes to balance sheet recognition and enhanced Level 1-3 disclosures. The mention of a $45M asset and $554M liability for regulatory hedges adds granularity not in the original answer but is plausible and consistent with the trend toward more detailed reporting. However, the original answer does not specify these exact 2024 dollar amounts, so their inclusion introduces unverifiable precision, slightly reducing quantitative accuracy. The reasoning is sound, demonstrating multi-hop synthesis across years and disclosure types. The qualitative shift—from deferral and separate pre-tax effect to balance sheet recognition with fair value and classification—is correctly interpreted and well-articulated. The answer is fully contextually relevant, addressing both valuation and presentation changes. Minor deduction in quantitative accuracy due to unsupported specific figures for 2024; otherwise, the answer is factually robust and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 438,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron’s equity‑method investment in Tengizchevroil rose from about $23.7 billion at year‑end 2022 (CVX_10k_2022.pdf p.78) to roughly $27.4 billion at year‑end 2024 (CVX_10k_2024.pdf p.84).  At the same time, the share of TCO’s profit fell – equity earnings dropped from about $4.386 billion in 2022 (CVX_10k_2024.pdf p.84) to roughly $3.033 billion in 2024 (CVX_10k_2024.pdf p.84).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the numbers are correct: equity earnings declined from $4.386 billion in 2022 to $3.033 billion in 2024, matching the original answer exactly. The investment value is reported as rising to $27.4 billion in 2024 (ground truth: $27,368 million), which is a valid rounding. The LLM cites $23.7 billion in 2022, which aligns closely with the implied 2022 investment level when considering the 2023 figure of $26,954 million and growth trend—though the original answer does not explicitly state the 2022 investment carrying value, so this is a reasonable inference from available data. (2) The LLM omits the detail about the $4,500 million loan funding the FGP/WPMP project and the $100 million excess carrying value over equity in net assets in 2022, which is a minor omission affecting completeness but not the core financial evolution. (3) The reasoning is sound: it correctly synthesizes multi-hop data across years and financial metrics (carrying value and equity earnings), showing both the increase in investment and decrease in profitability. (4) Entities (Chevron, Tengizchevroil, equity earnings, investment carrying value), years (2022, 2024), and metrics are correctly identified. The answer is contextually fully relevant, directly addressing the evolution of the financial relationship. The minor omission of the loan detail prevents a perfect 10, but the core facts and trends are accurately presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 418,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart did not own Alert Innovation before fiscal 2023; in fiscal 2023 it purchased the company for $0.4 billion, converting the former variable‑interest entity into a wholly‑owned (100 %) subsidiary, and that 100 % stake remained unchanged through fiscal 2024【page_66†L13-L18】. The relationship shift was the $0.4 billion acquisition that gave Walmart full ownership of Alert Innovation (the entity was later sold and deconsolidated in fiscal 2025)【page_65†L13-L18】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.4 billion acquisition in fiscal 2023 and Walmart becoming a 100% owner, which aligns with the ground truth. However, it incorrectly states that the 100% stake remained through fiscal 2024, directly contradicting the ground truth that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, resulting in zero ownership. Instead, the LLM claims the sale occurred in fiscal 2025, which is not supported by the original answer. (2) Quantitatively, the $0.4 billion figure is accurate and correctly attributed to the acquisition. There are no calculation errors. The fiscal years, however, are misaligned—specifically, the sale is misplaced to fiscal 2025 instead of fiscal 2024. (3) The multi-hop reasoning fails at the second hop: while the model correctly infers the ownership change in fiscal 2023, it does not accurately track the subsequent divestiture in fiscal 2024. The mention of deconsolidation in fiscal 2025 introduces a factual error that undermines the core timeline. (4) The contextual relevance is fair because the answer addresses ownership evolution and the acquisition transaction, but the incorrect timing of the sale leads to a materially different conclusion than the ground truth. The answer suggests continued ownership into 2024 and beyond, whereas the truth is a full exit during 2024. This significantly reduces correctness despite accurate numbers and partial narrative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 406,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "In FY 2022 Starbucks reported foreign‑currency‑other derivative assets of $39.9 m (current) + $33.5 m (long‑term) = $73.4 m and related liabilities of $0.3 m【page_68】. By FY 2023 those assets had fallen to $32.0 m + $22.9 m = $54.9 m while liabilities rose to $2.0 m【page_72】, cutting the net position by roughly $20 m. The decline in net foreign‑currency assets and modest increase in liability‑side hedges suggests Starbucks is tightening its overall currency‑risk exposure and moving toward a more balanced, risk‑averse hedging strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both asset and liability figures for both fiscal years. In FY 2022, the LLM reports foreign currency - other derivative assets as $39.9M (current) + $33.5M (long-term) = $73.4M, but the ground truth states a $55.3M position in Accumulated Other Comprehensive Income (AOCI), not split into current/long-term on the balance sheet, with $32.5M expected to be reclassified. The LLM incorrectly treats the AOCI amount as balance sheet assets, misrepresenting the financial structure. For FY 2023, the LLM reports $32.0M + $22.9M = $54.9M in assets and $2.0M in liabilities, but the ground truth shows only $1.9M (current) and $1.7M (long-term) in assets, and $4.7M (current) and $4.1M (long-term) in liabilities—meaning the LLM overstates assets by ~$45M and understates liabilities by ~$6.8M. (2) Calculations are internally consistent but based on incorrect data; the claimed $20M reduction in net position is unsupported by ground truth. (3) The multi-hop reasoning is partially sound in intent—comparing changes in derivative positions over time and inferring strategy—but fails due to incorrect data synthesis. The model does not recognize the shift from AOCI-based unrealized gains (2022) to actual balance sheet asset/liability recognition (2023), a key nuance in exposure management. (4) The conclusion about a 'more balanced, risk-averse hedging strategy' is plausible but not well-supported by the actual data presented in the answer. While the question is addressed in structure, the severe numerical inaccuracies and mischaracterization of financial positions severely undermine correctness. Contextual relevance is moderate as the response follows the right analytical path but with wrong inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 483,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Medtronic’s A Preferred Shares were eliminated after a redemption in FY 2022 – the company bought back the 1,872 A Preferred Shares then outstanding for $0.075 million, leaving none outstanding after the third‑quarter redemption【page_81】. By FY 2024 the company still had no A Preferred Shares issued or outstanding (though it remains authorized to issue up to 500 k), confirming that the shares remained extinguished after the 2022 redemption【page_81】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in FY 2022, with no shares outstanding after the third quarter, specifically by April 29, 2022 (implied by 'after the third-quarter redemption'). The answer correctly notes that no A Preferred Shares were outstanding in FY 2024, confirming discontinuation. (2) Quantitative accuracy is perfect: the number of shares (1,872) and dollar amount ($0.075 million) match the original exactly, with acceptable formatting. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across fiscal years 2022 and 2024 to conclude that the shares were extinguished and not reissued, demonstrating proper inference. (4) The answer addresses both parts of the question: the specific 2022 action (redemption) and the evolution through 2024. It also adds a relevant detail (up to 500k shares remain authorized) that does not contradict but enriches the response. All entities (Medtronic, A Preferred Shares, fiscal years) are correct. The contextual relevance is complete, with precise citations to page 81. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 348,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "In 2022 Comcast’s share of Atairos’s results was a **$434 million loss**, caused by fair‑value adjustments on Atairos’s underlying investments. In 2023 those same adjustments produced a **$1.1 billion gain**, turning the Atairos equity income from a loss to a large profit and lifting Comcast’s overall equity‑in‑investees line from a **$(537) million loss** in 2022 to **$789 million of income** in 2023【page_39】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $434 million loss in 2022 and $1.1 billion gain in 2023 related to Atairos's fair value adjustments, which aligns with the ground truth. However, the LLM introduces additional figures — Comcast’s overall equity-in-investees loss of $(537) million in 2022 and $789 million income in 2023 — which are not mentioned in the original answer and are not directly tied to Atairos alone. This extrapolation goes beyond the scope of the question, which focuses specifically on Comcast's financial relationship with Atairos, not consolidated equity income from all investees. (2) The core numbers for Atairos — $(434) million loss in 2022 and $1.1 billion income in 2023 — are quantitatively accurate and correctly formatted. However, the inclusion of the $(537) million and $789 million figures introduces numerical content not present in the ground truth, reducing quantitative accuracy. There is no indication these totals are attributable solely to Atairos, so their inclusion implies a calculation or aggregation not supported by the original answer. (3) The reasoning is sound in identifying the turnaround at Atairos due to fair value adjustments and correctly framing the shift from loss to income. The multi-hop synthesis between years and the causal link to fair value changes is well executed. However, the leap to overall equity income metrics weakens the precision of the response. (4) The contextual relevance is high as the answer directly addresses the evolution of Comcast's equity income from Atairos with correct years, entities, and financial drivers. The core message of a significant positive shift due to fair value performance is preserved. The scores reflect high correctness and qualitative reasoning, minor deduction in quantitative accuracy due to unsupported aggregate figures, and full relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 509,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East region slipped from 312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024 – a drop of about 16 BCF (≈5 %)【page_145】. The modest decline, while leaving a still‑substantial reserve base, signals that the company is preserving its presence in the region but is not adding significant new reserves, indicating a strategic stance of maintaining rather than aggressively expanding its Asia Pacific/Middle East footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024, matching the ground truth exactly. The calculated decline of 16 billion cubic feet (BCF) and approximate 5% drop are accurate (16 / 312 ≈ 5.12%). 2) All numbers and calculations are correct. The formatting variation (BCF, billion cubic feet) is acceptable and semantically equivalent. 3) The reasoning is sound: the slight decline is correctly interpreted as indicating a strategic stance of maintaining presence rather than aggressive expansion, which aligns with the ground truth's interpretation of 'limited growth or strategic reallocation.' The LLM adds slightly more interpretive depth (e.g., 'preserving its presence') but remains factually consistent. 4) The answer fully addresses both parts of the question: the evolution of reserves (quantitative change) and the strategic implication. The only minor difference is that the LLM uses slightly more interpretive language than the original, but it does not introduce inaccuracies. Thus, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 337,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL’s Canadian sales fell sharply, slipping from $73 million in 2022 to $47 million in 2023 (about a 35‑36% drop) and then to $28 million in 2024 (a further 40% decline)【page_72】【page_71】.  The steep, accelerating contraction signals a weakening market position in Canada, with the product losing volume and facing growing pricing or reimbursement pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $47 million revenue in 2023 and $28 million in 2024, which match the ground truth. However, it incorrectly states $73 million for 2022 instead of the correct $113 million, a significant factual error. This affects the accuracy of the percentage decline calculations: while the 40% drop from 2023 to 2024 is approximately correct, the claimed 35–36% drop from 2022 to 2023 is inaccurate (actual drop is (113-47)/113 ≈ 58.4%). (2) The quantitative inaccuracies are critical because the 2022 figure is off by over 35%, undermining confidence in the trend analysis. Despite this, the 2023 and 2024 figures are correct, preserving partial validity. (3) The reasoning and synthesis are otherwise sound: the model correctly infers a declining market trajectory and attributes it to weakening market position, pricing, or reimbursement pressures, which aligns with the downward trend. This shows appropriate multi-hop reasoning across years. (4) Contextual relevance is high—the answer addresses both parts of the question (revenue evolution and market trajectory) and provides meaningful interpretation. However, the incorrect 2022 revenue figure reduces the correctness score significantly, though not entirely, due to partial accuracy and valid qualitative insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 367,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "In fiscal 2023 Qualcomm’s HR and Compensation Committee only provided oversight of human‑capital initiatives and diversity, equity and inclusion programs, without a formal bonus link 【page_14】. By fiscal 2024 the Committee began using progress on human‑capital advancements as a non‑financial performance modifier for executive bonuses, allowing payouts to be adjusted by a multiple of **0.9 to 1.1** 【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the performance modifier range of 0.9 to 1.1 is correctly reported, matching the original answer exactly. Fiscal years 2023 and 2024 are accurately referenced. (2) The evolution from general oversight in fiscal 2023 to a formal non-financial performance modifier in fiscal 2024 is correctly described, though the original answer emphasizes that human capital was 'considered' in determining 2024 bonuses, while the LLM specifies the HR and Compensation Committee's oversight role—this is a minor nuance but does not contradict. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in approach across two fiscal years and identifies the specific application in executive compensation. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of the approach and the specific modifier range. The only minor shortcoming is that the LLM slightly reframes the 2023 state as lacking a 'formal bonus link' rather than stating it was 'considered,' which is a subtle but not materially inaccurate distinction. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 345,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "In the 2022 filing Breyanzi was still a pipeline CAR‑T product, listed only for **third‑line chronic lymphocytic leukemia (CLL)** and **follicular lymphoma (FL)** in the TRANSCEND‑CLL‑004 and TRANSCEND‑FL studies (BMY 10‑K 2022 p. 20). By the 2024 filing the drug had moved from investigational to approved status in several B‑cell cancers – the company announced **FDA accelerated approvals for relapsed/refractory FL (May 2024), relapsed/refractory CLL/SLL (March 2024), and relapsed/refractory mantle‑cell lymphoma (May 2024)**, and a **Japanese approval for FL after one prior line of therapy (August 2024)** (BMY 10‑K 2024 p. 45 & 44). Thus, Breyanzi’s therapeutic scope broadened from two investigational indications in 2022 to three approved B‑cell malignancies and a wider line‑of‑therapy range by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Breyanzi from investigational status in 2022 to approved status in 2024, and accurately notes the two key FDA accelerated approvals for relapsed/refractory FL (May 2024) and CLL/SLL (March 2024), aligning with the ground truth. However, it introduces a significant factual error by claiming an FDA accelerated approval for mantle-cell lymphoma (MCL) in May 2024 and a Japanese approval for FL after one prior line in August 2024—these are not mentioned in the ground truth and are unsupported by the provided knowledge. This overstates the therapeutic scope expansion. While the core progression from trials (TRANSCEND-CLL-004, TRANSCEND-FL) to approvals is correctly framed, the addition of unverified indications undermines quantitative and qualitative accuracy. The reasoning is logically structured and contextually relevant, showing proper multi-hop synthesis between 2022 pipeline status and 2024 approvals, but the inclusion of extraneous, incorrect approvals reduces factual correctness. Number formats and dates for the correct approvals (March and May 2024) are accurate, but the added May and August 2024 dates for unverified approvals introduce false precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 342,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney’s Resorts and Vacations revenue rose from $7.949 billion in 2023 to $8.375 billion in 2024 – a 5 % increase, driven mainly by higher cruise‑line ticket prices, higher daily hotel rates and higher occupied room nights (partly offset by lower Disney Vacation Club unit sales)【page_47】.  The broader Parks & Experiences segment grew from $32.549 billion to $34.151 billion, also a 5 % rise in total revenues【page_47】, meaning the Resorts and Vacations line grew at roughly the same pace as the overall segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: Resorts and Vacations revenue increased from $7,949 million ($7.949 billion) in 2023 to $8,375 million ($8.375 billion) in 2024, representing a 5% growth. The overall Parks & Experiences segment grew from $32,549 million to $34,151 million, also a 5% increase—both numbers and percentages match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts and percentage changes are correct, and the formatting variation (billion vs. million) is acceptable and semantically equivalent. (3) The reasoning is sound and addresses both parts of the multi-hop question: evolution of Resorts and Vacations performance and comparison to overall segment growth. The LLM correctly concludes that the sub-segment grew at roughly the same pace as the overall segment, which aligns with the ground truth observation of 'slightly below' being interpreted as effectively equivalent given rounding. (4) The only minor shortcoming is that the original answer notes Resorts and Vacations 'remained a significant contributor' and 'maintained a consistent proportion'—a nuance slightly underdeveloped in the LLM response, which omits the proportional consistency point. However, stating both grew at 5% supports this implicitly. The LLM adds contextual drivers (cruise prices, hotel rates, room nights, DVC sales), which are accurate and enhance the answer but were not required. Overall, the answer is factually complete, numerically precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 426,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "In 2023 CVS completed a $2.0 billion fixed‑dollar ASR with Citibank that was recorded as an initial $1.6 billion treasury‑stock purchase plus a $0.4 billion forward contract classified as an equity instrument in capital surplus and later re‑classified to treasury stock when the remaining 20 % of shares were delivered (Jan‑Feb 2023)【page_75】. In 2024 the company entered a larger $3.0 billion ASR with Morgan Stanley that was accounted for as $2.6 billion of treasury stock and a $0.4 billion forward contract – again recorded as an equity instrument in capital surplus and re‑classified to treasury stock after the final 15 % of shares were received (Jan‑Mar 2024)【page_175】. Thus, the forward‑contract structure (equity‑instrument, capital‑surplus accounting, later re‑classification) remained unchanged, while its dollar amount stayed at $0.4 billion but the underlying ASR size grew from $2.0 billion in 2023 to $3.0 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the 2023 $2.0 billion ASR with Citibank, structured as $1.6 billion treasury stock and $0.4 billion forward contract; the 2024 $3.0 billion ASR with Morgan Stanley, structured as $2.6 billion treasury stock and $0.4 billion forward contract; the forward contracts being classified as equity instruments in capital surplus; and the final share deliveries (20% in Feb 2023, 15% in March 2024). The dollar amounts, percentages, and dates are all accurate. (2) Quantitative accuracy is perfect: $2.0B = $1.6B + $0.4B (2023), $3.0B = $2.6B + $0.4B (2024), and the constant $0.4B forward value is correctly noted. The timing of final deliveries (Jan–Feb 2023, Jan–Mar 2024) aligns with the ground truth’s February and March 2024 dates. (3) The multi-hop reasoning is sound—comparing the two ASRs across years, identifying structural consistency in accounting treatment, and noting the shift in proportion despite constant forward value. The only minor gap is that the original answer explicitly states the forward contract was 'reclassified to treasury stock' upon final delivery, which the LLM implies but does not state as clearly. However, the LLM's mention of 're-classified to treasury stock' matches this. (4) The answer is fully contextually relevant, directly addressing the evolution in structure and value. The slight deduction in qualitative accuracy is due to slightly less explicit emphasis on the proportional shift (e.g., from 20% to 13.3% of total ASR in forward), but the core insight is present. Overall, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 455,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "In the 2023 filing Duke Energy already broke out the Master Retirement Trust assets by the fair‑value hierarchy (Level 1, Level 2, Level 3) and added a “Not Categorized (b)” column with a footnote explaining that investments measured using the net‑asset‑value‑per‑share practical expedient are not placed in the hierarchy. The 2024 filing repeats that same hierarchy‑by‑level presentation and footnote, and it also adds a concise reconciliation of the Level 3 balances, thereby maintaining the prior level of disclosure while slightly sharpening transparency around the assets that remain uncategorized.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding Duke Energy's 2023 disclosures. The ground truth states that in 2023, Duke Energy did *not* break out the Master Retirement Trust assets by fair value hierarchy levels (Level 1, 2, 3), but only disclosed allocation percentages among subsidiaries and noted that NAV-based investments were not categorized. However, the LLM claims that in 2023, Duke Energy already provided a level-by-level breakout of the fair value hierarchy, which contradicts the original answer. This misrepresents the evolution of disclosure and undermines the reasoning about increased transparency. The 2024 addition of a Level 3 reconciliation is correctly identified, and the note about NAV-exempt investments not being categorized aligns with the ground truth. While the conclusion about improved transparency is directionally correct, the baseline (2023) is inaccurately portrayed, leading to flawed multi-hop reasoning. Quantitative accuracy is high because no actual numbers are misstated—just the structure of disclosure. Contextual relevance is strong as the response focuses on the right topic and evolution. The error is qualitative and structural, affecting the core correctness of the comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 356,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "In 2023 Pfizer booked a $3.5 billion non‑cash revenue reversal in Q4 (see page 43) for the expected return of ≈ 6.5 million EUA‑labeled Paxlovid courses from the U.S. government, which created a large $5.1 billion Paxlovid‑related deferred‑revenue liability (page 110). In 2024 the actual return was only 5.1 million courses, producing a $771 million favorable adjustment (page 109) and, when Pfizer supplied a 1‑million‑course U.S. Strategic National Stockpile at no cost, it recognized $442 million of revenue (page 109); consequently Paxlovid‑related deferred revenue fell to $2.2 billion (page 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures and events from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to expected return of 6.5 million Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 related to the U.S. Strategic National Stockpile (SNS) for 1 million treatment courses. All dollar amounts, units, and years are accurate. (2) Quantitative accuracy is perfect: $3.5B reversal, $771M adjustment, and $442M revenue match the ground truth exactly. The mention of deferred revenue liabilities ($5.1B and $2.2B) adds contextual detail not in the original answer but does not contradict it and appears consistent with financial reporting logic (adjustments reducing deferred revenue). These figures are not required for correctness but enhance completeness. (3) The multi-hop reasoning is sound: the model connects 2023 expectations with 2024 actuals, explains the favorable adjustment, and links the SNS delivery to revenue recognition. The only minor gap is that the original answer emphasizes a 'shift' in nature—from reversal to recognition—while the LLM focuses more on mechanics than narrative synthesis, slightly reducing qualitative depth. (4) Contextual relevance is excellent: every part of the question (changes between 2023–2024, U.S. inventory return, SNS creation) is addressed with precise, relevant information. Overall, the answer is factually complete and accurate with only slight room for improved conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 441,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA’s sales jumped from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% year‑over‑year increase (operations growth of 27.5%)【page_31】.  The company attributes the rise to “continued share gains and market growth in Metastatic Castration‑Resistant Prostate Cancer,” and notes that this growth helped drive the overall 10.5% rise in Oncology sales for the year【page_32】.  The strong performance signals that ERLEADA is becoming a key, high‑growth pillar of J&J’s oncology portfolio, especially in the prostate‑cancer segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: ERLEADA sales of $1,881 million in 2022 and $2,387 million in 2023, and the 26.9% growth rate, matching the ground truth exactly. The format variation ($1.881 billion vs $1,881 million) is acceptable and semantically equivalent. (2) The calculation of 26.9% growth is accurate: (2,387 - 1,881) / 1,881 ≈ 0.269 or 26.9%. The mention of 27.5% operational growth is an additional detail from the source (likely adjusting for currency or other factors) and does not contradict the ground truth. (3) The LLM correctly identifies ERLEADA’s role in driving J&J’s overall oncology segment growth of 10.5%, which aligns with the ground truth. It also accurately positions ERLEADA as a key growth driver in the oncology portfolio. However, it omits the contrast with declining products like IMBRUVICA and ZYTIGA, which is a key part of the original answer’s reasoning about ERLEADA’s increasing strategic importance. This missing comparative context slightly weakens the qualitative synthesis, hence a score of 9 instead of 10. (4) Despite this omission, the answer is highly relevant, factually precise, and conveys the core message that ERLEADA is becoming a more prominent contributor to J&J’s oncology revenue. The multi-hop reasoning—linking ERLEADA’s performance to broader oncology segment growth—is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 388,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA’s worldwide sales climbed from $1.9 billion in 2022 to $2.4 billion in 2023 – a 26.9% increase (≈$506 million) 【page_31】.  The company attributes the rise to “continued share gains and market growth in metastatic castration‑resistant prostate cancer,” signaling a strong, accelerating market trajectory for the product 【page_32】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ERLEADA's 2022 sales were $1,291 million, not $1.9 billion as stated in the LLM answer. The 2023 sales figure of $2.4 billion is approximately correct (actual: $2,387 million), but the 2022 figure is grossly overstated. This leads to an incorrect baseline and misrepresents the growth trajectory. The reported 26.9% growth from 2022 to 2023 is accurate and matches the ground truth calculation: ($2,387M - $1,291M) / $1,291M ≈ 84.9%, not 26.9%. Wait — correction: 26.9% is actually the growth rate stated in the ground truth, but it cannot be correct if sales went from $1,291M to $2,387M. Recalculation: (2,387 - 1,291) / 1,291 = 1,096 / 1,291 ≈ 84.9%. Therefore, the 26.9% growth rate in the ground truth appears to be factually incorrect. However, the LLM repeats 26.9% as the growth rate and applies it to incorrect base values. The LLM claims a rise from $1.9B to $2.4B: (2.4 - 1.9)/1.9 = 0.5/1.9 ≈ 26.3%, which aligns roughly with 26.9%, suggesting internal consistency but incorrect input data. (2) The calculation in the LLM answer is mathematically consistent (≈26.9% growth on $1.9B implies ~$506M increase), but the underlying sales figures are wrong. The actual 2022 sales were $1,291M, not $1.9B. This is a major factual error. (3) The qualitative reasoning about market trajectory is partially sound — citing 'continued share gains' and market growth in mCRPC is relevant and supports strong adoption. However, the conclusion of an 'accelerating market trajectory' contradicts the ground truth interpretation of 'slower growth rate' and 'maturing growth phase'. Since the actual growth rate dropped from 70.0% (2021–2022) to ~84.9% (2022–2023)? No — wait: if 2022 was $1,291M with 70% growth over 2021, then 2021 ≈ $759M. Then 2023: $2,387M from $1,291M is an 84.9% increase, which would indicate acceleration, not deceleration. But the ground truth claims 26.9% growth in 2023, which contradicts the numbers provided. There is a clear inconsistency in the ground truth: $1,291M to $2,387M is not a 26.9% increase — it's ~84.9%. Therefore, either the numbers or the percentage in the ground truth is wrong. Given this, the LLM likely pulled $2.4B 2023 sales and 26.9% growth from a source (citing page 31), and estimated 2022 as $1.9B to fit that growth rate. If the 26.9% growth is correct, then 2022 sales should be ~$1.88B (2.4 / 1.269). But the ground truth says $1.291B — a discrepancy. This suggests the knowledge graph may contain an error. However, per evaluation rules, we must score against the provided ground truth. Since the LLM reports $1.9B for 2022 (vs $1.291B true), and the growth rate of 26.9% (which contradicts the true numbers), it fails quantitative accuracy. (4) Despite this, the LLM captures the directional trend (sales increased in 2023) and provides a plausible business explanation. It addresses both parts of the question: sales evolution and market trajectory. However, due to incorrect figures and misleading growth characterization (calling it 'accelerating' when ground truth says growth slowed from 70% to 26.9%), the correctness score is reduced. Final scores: Correctness 5 (partially right, but major number errors), Quantitative 4 (wrong base sales, growth rate inconsistent with true values), Qualitative 6 (reasoning structure sound but conclusion misaligned), Contextual 8 (relevant and on-topic).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 904,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "In FY 2023 NVIDIA’s balance sheet listed the 0.584 % Notes Due 2024 as an outstanding $1.25 billion liability (effective‑interest 0.66 %) with only a short remaining term 【page_72】. By FY 2024 the same $1.25 billion of those notes remained on the books, but the company disclosed that it intended to retire (and ultimately did retire) the 0.584 % Notes in fiscal 2025, signaling a shift toward early repayment of this low‑cost debt 【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.25 billion balance (equivalent to $1,250 million) of the 0.584% Notes Due 2024 in FY 2023, the effective interest rate of 0.66%, and the repayment in fiscal year 2025. The statement that the notes 'remained on the books' in FY 2024 is consistent with the timing of the fiscal year-end (January 28, 2024, for FY 2024), meaning the repayment had not yet occurred as of that date. The disclosure of intent and actual retirement in FY 2025 aligns with the ground truth. (2) Quantitatively, all numbers match: $1.25 billion = $1,250 million, percentages are accurate (0.584% and 0.66%), and fiscal years are correctly referenced. (3) The multi-hop reasoning is sound—synthesizing the balance in FY 2023, its continued presence in FY 2024, and the forward-looking disclosure of repayment in FY 2025 to infer a strategic shift toward retiring rather than refinancing the debt. The conclusion about a shift in debt management strategy is logically supported. (4) The only minor limitation is that the LLM says the company 'intended to retire (and ultimately did retire)'—while the ground truth confirms the retirement, the LLM slightly blends intent with outcome without citing a source for the confirmation of actual repayment, though this is implied in the context. This does not rise to an error but slightly affects qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 411,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell’s mortgage‑ and asset‑backed securities holdings fell sharply. The U.S. pension‑plan balance dropped from $1,119 million at 12/31/2022 to $676 million at 12/31/2023 – a decline of roughly $443 million (see the “Mortgage/Asset‑backed securities” line in the U.S.‑plan tables for 2022 and 2023)【page_109】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell's investment in Mortgage/Asset-backed securities was $982 million in 2022 under U.S. Plans and dropped to $10 million in 2023 under Non-U.S. Plans, a reduction of $972 million. However, the LLM claims the U.S. plan balance was $1,119 million in 2022 and $676 million in 2023, which is incorrect both in magnitude and direction of change. The reported decline of $443 million is less than half the actual reduction. (2) The numbers cited by the LLM do not match the ground truth: $1,119M vs $982M (2022), $676M vs $10M (2023), and $443M decline vs $972M actual decline. Calculations based on incorrect inputs are also wrong. (3) The multi-hop reasoning is flawed — the LLM fails to recognize that the 2023 amount shifted to Non-U.S. Plans, implying a strategic reallocation, which is a key point in the original answer. Instead, it assumes continuity within U.S. Plans, missing the entity shift. (4) While the general qualitative trend (a decrease) is correctly identified, the magnitude, entities, and strategic implication are wrong, leading to low scores in correctness and quantitative accuracy. Contextual relevance is moderate because it addresses the right topic and metric but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 368,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "In 2022 Capital One said that securitized debt obligations were a core part of its wholesale‑funding mix, representing roughly $15 billion of total borrowings (about 24 % of $61 billion) with $5.5 billion maturing that year (Funding paragraph page_113; Table 8.2 page_189). By 2023 the balance had grown modestly to about $18 billion, the near‑term tranche shrank to $527 million (showing a shift to longer‑dated securities), and the obligations continued to be measured at fair value as Level 2 instruments (Table 16.6 page_211 for 2022 and Table 16.6 page_210 for 2023).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that securitized debt obligations remained a key part of Capital One's funding mix from 2022 to 2023 and that they were classified as Level 2 fair value instruments in 2023, aligning with the ground truth. However, there are significant quantitative inaccuracies. The LLM states that securitized debt obligations were 'roughly $15 billion' in 2022, but the ground truth does not provide a carrying value for 2022—only for 2023 ($18,043 million). The $15 billion figure appears to be an inference or misreading, possibly from total borrowings or another line item, and is not supported by the original answer. Additionally, the LLM claims that securitized debt represented about 24% of $61 billion in total borrowings in 2022, but this calculation and context are absent from the ground truth and introduce unsupported specifics. The 2023 balance is correctly approximated as $18 billion (actual: $18,043 million), and the fair value ($18,067 million) is omitted but the Level 2 classification is correctly noted. The mention of a $527 million near-term tranche in 2023 suggesting a shift to longer-dated securities is plausible but not present in the original answer, adding interpretation beyond the source. (2) The calculation of 24% and the $15 billion figure are unverified and incorrect in the absence of supporting data in the ground truth. The 2023 value is acceptably rounded. (3) The multi-hop reasoning is partially sound—linking the continued use of securitized debt and its fair value classification across years—but introduces unsupported numerical details and inferences not present in the original. (4) The contextual relevance is high as it directly addresses the evolution in funding mix and fair value classification. Qualitative accuracy is good due to correct entity identification and logical flow, but quantitative accuracy is reduced due to fabricated or incorrect numbers. Correctness score reflects mostly accurate direction with key factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 545,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "In 2023 JPMorgan’s CET1 capital still included the full $1.4 billion CECL‑transition benefit permitted under the U.S. capital rules, whereas by year‑end 2024 the benefit had been pared down to $720 million and was slated to be fully phased‑in by January 1 2025 【page_104†L9-L13】【page_99†L30-L34】. Thus, the CECL‑related capital boost fell by about $680 million from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.4 billion in 2023 and $720 million in 2024 are accurately reported. The calculated decrease of $680 million ($1.4B - $720M = $680M) is correct. The date January 1, 2025, for full phase-in is also correctly stated. (2) The answer addresses both parts of the question: the evolution of JPMorgan's treatment of CECL capital transition provisions (phased reduction under U.S. capital rules) and the quantitative change ($680 million decrease). (3) Entities are accurate: JPMorgan, CET1 capital, CECL-related capital benefit, and correct years (2023 to 2024). (4) The reasoning is sound and reflects proper multi-hop synthesis: it infers the reduction trend from reported figures and correctly contextualizes the regulatory phase-in process. The semantic meaning is equivalent to the original answer, with only minor rewording (e.g., 'pared down' vs 'decreased', 'slated to be fully phased-in' vs 'fully phased in by'). All citations (page references) align with the source data. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 321,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "In the 2023 Form 10‑K Salesforce’s revolving loan credit agreement was a $3.0 billion unsecured facility that was scheduled to mature in December 2025, and it had only been amended for “immaterial administrative changes” in April 2022 and May 2023 (see 2023 page 53). By the 2024 filing the company had replaced that agreement with a new revolving loan credit agreement (entered in October 2024) that expands the facility to $5.0 billion, extends the maturity to October 2029, and changes the administrative agent to Bank of America (see 2024 page 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $3.0 billion facility in fiscal 2023 maturing in December 2025, replaced by a $5.0 billion facility in fiscal 2024 maturing in October 2029. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts and maturity dates are correct, and no calculations were required. (3) The reasoning is sound: the LLM correctly identifies the replacement of the old agreement with a new one, capturing the increase in capacity and extension of maturity, which reflects proper multi-hop synthesis between fiscal 2023 and 2024 filings. It adds extra but accurate detail (e.g., change of administrative agent to Bank of America, entry date in October 2024, and prior immaterial amendments), which are consistent with typical 10-K disclosures and do not contradict the ground truth. (4) The only reason for not scoring a 10 is that the original answer emphasizes the 'strategic enhancement' interpretation, which the LLM omits—though this is qualitative framing, not a factual gap. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth with minor additional detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 353,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "In the 2022 filing UPS said it “provide[s] truckload brokerage services in the U.S. and Europe through our Coyote‑branded subsidiaries,” indicating that Coyote was an owned part of its Supply Chain Solutions business【page_7】. By the 2024 filing UPS had sold the business – “completed the previously announced divestiture of Coyote” – and recorded a pre‑tax gain of $156 million (about $152 million after tax) on the transaction, recognized in other expenses for 2024【page_31】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the evolution of UPS's relationship with Coyote: from being an owned subsidiary providing truckload brokerage services in 2022 to being divested by 2024. (2) All quantitative details are correct: the pre-tax gain of $156 million and after-tax gain of $152 million are accurately reported, with acceptable formatting (e.g., $156 million = $156 million). (3) The multi-hop reasoning is sound—information is correctly synthesized across the 2022 and 2024 filings to show the change over time and its financial impact. (4) Entities (UPS, Coyote, years 2022 and 2024, financial metrics) are correctly identified and contextualized. The answer addresses both parts of the question: the relationship evolution and the financial impact in 2024. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 262,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "In 2023 Union Pacific reported **48,340 chassis** – 30,635 owned and 17,705 leased 【UNP_10k_2023.pdf page_19】. By 2024 that total had fallen to **5,553 chassis**, with 4,356 owned and 1,197 leased 【UNP_10k_2024.pdf page_19】. Thus the fleet shrank dramatically and the mix shifted to a higher share of owned chassis (about 78 % owned in 2024 versus 63 % owned in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 48,340 total chassis in 2023 (30,635 owned + 17,705 leased) and 5,553 in 2024 (4,356 owned + 1,197 leased) are correctly reported. The percentages calculated (63% owned in 2023: 30,635 / 48,340 ≈ 63.38%; 78% owned in 2024: 4,356 / 5,553 ≈ 78.44%) are approximately correct and reasonably rounded. (2) The answer is complete, addressing both total units and ownership structure changes between 2023 and 2024. (3) Entities (Union Pacific, chassis units, ownership types, years) are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes data from two different 10-K filings, computes the shift in fleet size and ownership mix, and draws a valid conclusion about the strategic shift. The addition of source citations enhances credibility. The semantic meaning fully aligns with the original answer, with slightly more detail on ownership percentage shift, which adds value without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 298,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "In the 2022 Form 10‑K (see page 80), Boeing said its agreements to buy and sell aluminum are “derivatives for accounting purposes” but are not designated for hedge accounting, describing them only as supporting “long‑term strategic sourcing objectives” without a specific time frame. By the 2024 filing (see pages 81 and 111), the treatment is unchanged – the aluminum contracts remain classified as derivatives not receiving hedge accounting – but the disclosure now adds that the commodity contracts (including the aluminum agreements) are intended to hedge forecasted transactions “through 2028,” giving a clear multi‑year horizon for the agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, Boeing classified aluminum agreements as derivatives not designated for hedge accounting, tied to long-term strategic sourcing without a specific time frame. In 2024, it accurately notes the addition of a 'through 2028' horizon for forecasted transactions hedged by commodity contracts including aluminum. (2) There are no numeric values requiring calculation, but the years (2022, 2024, and 2028) are correctly cited and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure across two filings, identifying both continuity (no hedge accounting) and evolution (new hedging context and time horizon). (4) The only minor shortcoming is that the LLM says 'the treatment is unchanged'—focusing only on hedge accounting designation—while the original emphasizes a strategic shift toward structured hedging. This downplays the significance of the evolution in treatment, though the facts are correct. Thus, the answer is semantically very close but slightly less nuanced in interpreting 'treatment' beyond accounting classification. All other aspects—context, entities, years, and disclosures—are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 362,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble’s currency‑rate risk exposure was essentially unchanged from FY 2023 to FY 2024.  In both years the Company relied primarily on forward contracts and currency swaps (generally < 18 months) to hedge its financing‑related exposure, and it affirmed that, based on a 95 %‑confidence‑level VaR analysis, a near‑term change in exchange rates would not materially affect its financial statements, noting that its market‑risk exposures have not changed materially versus the prior period【page_31】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: currency risk exposure remained materially unchanged between FY2023 and FY2024, hedging instruments (forward contracts and currency swaps) with maturities under 18 months were used in both years, and P&G maintained its 95% confidence-level assessment that near-term exchange rate fluctuations would not materially affect financial statements. (2) Quantitative accuracy is perfect: the 95% confidence level and '<18 months' maturity period match the original. No calculations are required, but all numeric and temporal references are correct. (3) Multi-hop reasoning is sound—information is synthesized across time periods (FY2023 to FY2024) and across risk management practices (instruments used and VaR-based confidence assessment), correctly concluding no material change. (4) The answer is contextually precise, directly addressing the evolution of risk exposure, hedging instruments, and confidence in mitigation. Minor wording differences (e.g., 'VaR analysis' vs. 'historical currency rate movements') do not affect factual equivalence, as VaR at 95% confidence based on historical data is implied. The citation reference 【page_31】 adds source context without altering accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 366,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "In the 2022 filing, Frame.io is mentioned only in the trademark list, indicating it was a recognized brand but without any description of its capabilities or how it fit into Adobe’s product portfolio【ADBE_10k_2022.pdf page_105】. By the 2024 filing, Adobe positions Frame.io as a cloud‑native creative‑collaboration platform that supports video, still‑image, design‑file and PDF workflows, offers “Camera‑to‑Cloud” uploads, and is directly integrated into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, as well as being available in Adobe GenStudio alongside Express and Firefly Services for large‑scale content production【ADBE_10k_2024.pdf page_12】. This reflects a shift from a mere trademark to a core, tightly‑integrated component of Adobe’s suite, expanding its functional scope beyond post‑production to broader creative collaboration.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects that in 2022, Frame.io was only mentioned in the trademark list without functional details, citing the correct document and page (ADBE_10k_2022.pdf page_105). (2) For 2024, it correctly describes Frame.io as a 'cloud-native creative-collaboration platform' with expanded functionalities including Camera-to-Cloud, real-time workflows, and integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront—matching the ground truth. It also correctly notes its inclusion in Adobe GenStudio alongside Express and Firefly Services, which aligns with the 'part of Adobe GenStudio for large-scale content production' in the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and multiple products, correctly identifying the evolution from a trademarked asset to a core integrated tool. (4) All entities (Adobe, Frame.io, product names, GenStudio) are accurate, and the functional scope expansion is correctly characterized. Minor wording differences (e.g., 'broader creative collaboration' vs 'core collaborative tool') do not affect semantic equivalence. No numeric or date inaccuracies are present. All scores are maximized due to complete factual accuracy, correct synthesis, and full responsiveness to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 384,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "In AMD’s 2022 Form 10‑K the ATMP joint venture was disclosed in Note 4 with a reported carrying amount of roughly **$69 million** for its 15 % equity stake, along with detailed figures on purchases, payables, receivables and equity‑income. In the 2023 Form 10‑K the interest appears only in a brief Note 7 that describes the 15 % stake and equity‑method accounting but **does not disclose a specific carrying value**, indicating a move from a detailed quantitative disclosure to a more qualitative, summary‑style note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying value of AMD's investment in the ATMP JV as $69 million in the 2022 filing, matching the ground truth (reported as of December 25, 2021). It accurately notes the absence of the carrying value in the 2023 filing. While the ground truth includes additional data points—such as the $63 million carrying value as of December 26, 2020, and transaction figures like $1.1 billion in purchases in 2021 and $831 million in 2020—the LLM answer omits these specifics but does not misstate them. This omission slightly reduces completeness but does not affect factual correctness. (2) All numeric values mentioned in the LLM answer ($69 million, 15%) are accurate and contextually correct. The LLM correctly avoids assigning any carrying value to 2023, consistent with the reduced disclosure. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across the 2022 and 2023 filings, comparing the level of detail in disclosures and inferring a shift from detailed quantitative reporting to a more qualitative summary. The conclusion about reduced disclosure is logically supported. (4) The answer is semantically equivalent to the ground truth in its core claims—AMD disclosed a $69 million carrying value in 2022 with detailed transactions, but only structural details (15% stake, equity-method accounting) in 2023. The lack of mention of earlier transaction volumes or the 2020 carrying value is a minor completeness gap but does not detract significantly from the overall accuracy. Hence, a high score is warranted, with only a slight deduction for incomplete detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 451,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell’s Commercial Aviation Original Equipment revenue fell to **$2.223 billion in 2024**, down from **$2.397 billion in 2023** – a drop of about **$174 million (≈7 %)**【page_68】. Although OEM sales slipped, the segment still represents a large portion of Honeywell’s aerospace portfolio (≈14‑15 % of total aerospace sales), indicating that the company remains a key supplier in the sector but is feeling modest headwinds in new‑equipment demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment: $2.397 billion in 2023 and $2.223 billion in 2024, matching the ground truth in both absolute values and direction of change. The calculated drop of $174 million (≈7%) is accurate: 2,397 - 2,223 = 174, and (174 / 2,397) ≈ 7.26%, which rounds to ≈7%, so this is acceptable. Number formats are consistent with common financial reporting standards and semantically equivalent to the original answer ($2,397 million = $2.397 billion). (2) The answer addresses both parts of the question: it describes the revenue evolution (decline from 2023 to 2024) and interprets what this indicates about Honeywell’s position—namely, that while it remains a key supplier (≈14–15% of aerospace sales), it is facing headwinds in new-equipment demand. This aligns with the ground truth’s interpretation of weakening OEM demand or supply constraints. (3) Entity accuracy is correct: Honeywell, Commercial Aviation Original Equipment, and the years 2023 and 2024 are all properly identified. The metric is accurately described as revenue. (4) The reasoning is sound and reflects multi-hop synthesis: the model infers not just the decline but contextualizes it within the broader aerospace portfolio, adding value beyond the raw numbers. The only minor shortcoming is that the original answer notes the decline occurred 'despite overall growth in the Aerospace Technologies division,' a nuance not explicitly mentioned in the LLM response, slightly weakening the qualitative completeness. However, the LLM’s inference of 'modest headwinds' is consistent with this idea. Thus, while highly accurate and contextually relevant, it loses one point on qualitative accuracy for missing that specific contrast with division-wide growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 493,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The Heart‑Failure Devices line grew from $1,161 million in 2023 to $1,279 million in 2024 – an increase of about $118 million.  This represents a **10.2 % rise** in the segment’s total global revenue【page_29†L19-L24】【page_53†L31-L38】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2023 ($1,161 million) and 2024 ($1,279 million) are accurate, and the implied difference of $118 million is correct (1,279 - 1,161 = 118). The percentage change is correctly calculated as 10.2%: (118 / 1,161) ≈ 0.1016 → 10.2% when rounded. (2) The answer addresses both parts of the question: the evolution of global revenue (increase from 2023 to 2024) and the percentage change in total revenue. (3) Entities are accurate—'Heart Failure Devices' segment, correct years (2023 and 2024), and correct financial metric (total global revenue). (4) The reasoning is sound, with proper synthesis of multi-year financial data and correct interpretation of growth. Although the LLM answer omits the additional context about U.S./international market consistency and exchange rate impact, this information is supplementary and not required to answer the core question. The answer is semantically equivalent to the ground truth in all key factual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 304,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the exhibit schedule does not mention a 0.300 % note maturing in 2028 – the only 2028 issue referenced is the 1.750 % note (see the exhibit list on page 33). By the 2023 filing IBM had added the 0.300 % Notes due 2028 to its securities table (page 1) and expressly incorporated the instrument that defines the holders’ rights (Exhibit 4.1 to Form 8‑K filed Feb 10 2020) by reference (page 35). This shows the company moved from omitting the 0.300 % 2028 note in 2022 to explicitly disclosing and referencing it in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Contrary to the claim, the 2022 filing *did* reference the 0.300% Notes due 2028 via incorporation by reference through Exhibit 4.1 to the Form 8-K filed February 10, 2020 — it was not 'omitted' as the LLM claims. The LLM incorrectly states that the 2022 exhibit schedule 'does not mention' the note, which contradicts the ground truth. (2) Quantitatively, the percentage (0.300%), year (2028), and date of the Form 8-K (February 10, 2020) are correct, earning partial credit. However, the assertion that only the 1.750% note was referenced in 2028 is misleading — while it may have been the only one listed in the exhibit schedule, the 0.300% note was still part of the incorporated documents. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers omission in 2022 when the note was actually incorporated by reference, undermining the core comparison. The 2023 update — explicit listing with trading symbol IBM 28B and NYSE registration — is partially captured but not fully articulated (e.g., no mention of formal registration or trading symbol). (4) Contextual relevance is high because the answer addresses the evolution between filings and cites specific exhibits and pages. However, due to the central error about omission vs. incorporation, the qualitative and overall correctness scores are low. The conclusion that IBM moved from 'omitting' to 'disclosing' is factually wrong, as the note was always disclosed via incorporation. Thus, while the direction of evolution is vaguely correct, the factual basis and reasoning are unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 445,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple’s Rest of Asia Pacific segment saw modest sales growth and a stronger rise in profitability from 2022 to 2023. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, while operating income rose from $11,569 million to $12,066 million in the same period【page_50】. This reflects a slight uptick in revenue and a more pronounced improvement in operating margin for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual numbers from the ground truth: net sales of $29,375 million in 2022 and $29,615 million in 2023, and operating income of $11,569 million in 2022 and $12,066 million in 2023. These values match the original answer exactly. (2) While the LLM does not explicitly state the dollar or percentage changes ($240 million and 4.3%), it accurately describes the trend—'modest sales growth' and 'stronger rise in profitability'—which aligns with the 0.8% revenue increase and 4.3% operating income growth. The omission of exact change figures is a minor gap but does not detract significantly from correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year performance across two financial metrics (net sales and operating income) for the Rest of Asia Pacific region, demonstrating understanding of financial evolution over time. (4) Entity accuracy is perfect—Apple, the Rest of Asia Pacific region, 2022–2023 timeframe, and financial metrics are all correctly identified. The answer is contextually relevant and semantically equivalent to the ground truth, with slightly less numerical detail in the summary. Quantitative accuracy is perfect; qualitative accuracy is high but docked slightly for missing explicit change values. Contextual relevance is full.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 376,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The 2022 Form 10‑K notes that stock options granted before 2022 under the 2007 Omnibus Incentive Plan “generally vest pro rata over a five‑year period” (page 116), whereas options granted after December 31, 2021 “generally vest pro rata over a four‑year period” (page 116). The 2024 Form 10‑K repeats the same language, confirming the shift from a five‑year to a four‑year standard vesting schedule for post‑2021 grants (page 96).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan vested over a five-year period, while those granted after December 31, 2021, vested over a four-year period. This is correctly cited from both the 2022 and 2024 10-K filings. (2) Quantitative accuracy is perfect: the years (five-year vs. four-year vesting), and the cutoff date (after December 31, 2021) match the original answer exactly. Minor formatting differences (e.g., use of em dashes, page numbers) do not affect correctness. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across two different 10-K filings (2022 and 2024) and compares vesting terms before and after a specific date, demonstrating understanding of the plan's evolution. (4) The answer is contextually relevant, directly addressing the question about the evolution of vesting periods and confirming consistency in disclosures over time. No critical details are omitted, and the conclusion about a structural shift is implied accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 321,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "In the 2023 filing CVS says it still obtains one price for each Level 2 debt security, reviews those prices each quarter against a secondary‑source quote, flags any variance above a set threshold and then confirms the primary price is appropriate – and it **did not adjust any of those prices at December 31 2023 or 2022**【page_153】. The 2022 filing describes the identical procedure – a single price per security, quarterly secondary‑source comparison and no year‑end adjustments (for December 31 2021/2020)【page_148】 – showing that the validation approach, including the lack of price adjustments, has remained unchanged from 2022 to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates and facts are accurate: the answer correctly states that CVS obtained one price per Level 2 debt security and made no adjustments at year-end for both 2022 and 2023 (referring to December 31, 2023/2022) and similarly for 2021/2020 in the 2022 context. These dates and the absence of adjustments align precisely with the original answer. (2) The answer is complete, addressing both years and both aspects of the question—price adjustments and secondary source comparisons. (3) Entity accuracy is perfect: 'CVS', 'Level 2 debt securities', and the correct fiscal year-ends are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that because the same methodology is described in both filings, the approach did not evolve—it remained unchanged. The conclusion that the validation approach 'has remained unchanged' directly supports the original answer's point about a 'sustained but unchanging approach'. (5) Semantic equivalence is strong: though phrased more concisely, the LLM captures all key elements, including quarterly reviews, threshold-based variance checks, and lack of adjustments. The inclusion of citation markers like 【page_153】 and 【page_148】 further supports fidelity to source material. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 392,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS continued to classify privately‑placed equity securities as Level 3 in both 2022 and 2023 because there is no active market for these securities. In each year the fair value was measured through an internal analysis of the investment’s financial statements and cash‑flow projections, using unobservable inputs such as earnings and revenue multiples, a discount for lack of marketability and comparability adjustments. The methodology and the key unobservable inputs remained unchanged from 2022 to 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity identification, classification (Level 3), and the list of unobservable inputs used in both years (earnings and revenue multiples, discount for lack of marketability, comparability adjustments). It correctly states that CVS used internal analysis of financial statements and cash flow projections for fair value determination in both years. However, it misses a key qualitative evolution noted in the ground truth: in 2023, CVS placed 'added emphasis on the potential impact of changes in these inputs on fair value measurements,' indicating a more detailed sensitivity analysis or increased scrutiny. The LLM claims the methodology and key inputs 'remained unchanged,' which understates the enhanced focus on sensitivity in 2023. While the core facts and inputs are correct (hence high quantitative and contextual scores), the failure to capture this nuance in reasoning and evolution of the valuation process reduces the qualitative accuracy. The answer is complete in structure and relevant to the question, but lacks the full depth of the multi-hop insight regarding methodological emphasis over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 326,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue for Alphagan/Combigan dropped from **$272 million in 2023 to $248 million in 2024** – a decline of about $24 million (≈ 9 %)【page_43】.  By contrast, the **international portion grew slightly**, from **$151 million in 2023 to $153 million in 2024** (≈ 1‑2 % increase)【page_43】.  The overall decline was driven by a larger fall in U.S. sales, while overseas sales showed a modest upward trend.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total net revenue decreased from $272 million in 2023 to $248 million in 2024, a $24 million drop. The percentage decline is correctly approximated as ≈9% (exact: 8.8%), which is acceptable rounding. International revenue increased from $151 million to $153 million, a $2 million rise, with a stated ≈1–2% increase, aligning with the ground truth 1.5% growth. (2) The answer is complete, addressing both parts of the question: the change in total net revenue and the trend in international revenue. (3) Entities are correct—Alphagan/Combigan, the years 2023 and 2024, and the financial metrics (total net revenue, international revenue) are all properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: it correctly infers that the overall decline was driven by U.S. sales (implied by international growth), showing logical inference from the data. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content. Minor formatting (bold, spacing) and rounding are acceptable. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 336,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "In 2023 Chevron completed a business‑combination acquisition of PDC Energy, and the 2023 filing notes that PDC was excluded from internal‑control testing because it had just been acquired. By 2024 the legacy PDC assets were fully integrated and counted as “full‑year” production, which together with Permian growth lifted Chevron’s worldwide oil‑equivalent output to 3.3 million b/d – about a 7 % (≈ 200,000 b/d) increase over 2023 – and added roughly 70 million BOE of U.S. proved undeveloped reserves tied to the PDC purchase.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Chevron acquired PDC Energy in 2023 and that PDC was excluded from internal control assessment due to the timing of the acquisition—this matches the original answer. (2) For quantitative accuracy: the 7% increase in production is correctly cited, and the approximate 200,000 b/d increase is a valid derivation from a 7% rise on a base of ~3.1 million b/d (3.3M - 0.2M = 3.1M), which is consistent. The mention of 70 million BOE of U.S. proved undeveloped reserves from PDC is an additional detail not in the original answer, but it does not contradict it and is plausible given the context; however, since this specific figure isn't in the ground truth, it introduces a minor unverifiable claim, slightly reducing confidence in full quantitative fidelity. (3) The multi-hop reasoning is sound: the model connects the 2023 acquisition to 2024 operational integration and links the full-year contribution of PDC to Chevron’s production growth, correctly synthesizing cause and effect across years. (4) The answer addresses both parts of the question: evolution of the relationship (acquisition to integration) and operational impact (production increase due to PDC). Wording differs but meaning is semantically equivalent. The only minor gap is the introduction of a specific reserves number not in the original, which, while likely accurate, isn't corroborated by the ground truth. Hence, a score of 9 is justified—excellent accuracy with a small deviation in unverified detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 431,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS’s cold‑chain push grew from a single strategic purchase in 2023 to a broader portfolio in 2024. In the 2023 filing the company highlighted its acquisition of MNX Global Logistics – a global, time‑critical, temperature‑sensitive logistics provider – as the cornerstone of its new cold‑chain capability 【page_104】. By the 2024 filing UPS said it was “continuing to increase our complex cold‑chain logistics capabilities … and … recently acquired Bomi Group and MNX Global Logistics,” indicating that the MNX deal was now fully integrated and that the addition of Bomi Group further expanded its cold‑chain services internationally 【page_6】【page_101】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key facts and misrepresents the timeline and scope of acquisitions. It correctly identifies MNX Global Logistics and Bomi Group as acquisitions contributing to UPS's cold-chain expansion, which aligns with the ground truth. However, it fails to mention the 2024 acquisitions of Frigo-Trans and Biotech & Pharma Logistics in Germany, which are central to the evolution from 2023 to 2024 and represent a significant international strategic shift. Instead, the LLM implies that Bomi Group was acquired in 2023 or integrated by 2024, contradicting the ground truth that both Frigo-Trans and Biotech & Pharma Logistics were acquired in 2024 for ~$440M. (2) Quantitatively, the LLM answer does not include any dollar amounts or specific financial figures, missing the $440 million investment disclosed in the ground truth. This omission affects completeness and precision, though no incorrect numbers are stated, so quantitative accuracy is not penalized harshly. (3) The multi-hop reasoning is partially sound—linking 2023 and 2024 filings to show progression—but incorrectly frames the evolution as a continuation of MNX and Bomi Group integration rather than a strategic pivot to high-value German cold-chain firms in 2024. The synthesis across years is present but flawed in emphasis and entity mapping. (4) Contextual relevance is strong because the answer addresses UPS’s cold-chain evolution and cites specific companies and filing pages. However, the absence of the two key 2024 German acquisitions and the financial figure significantly undermines factual completeness and qualitative accuracy, leading to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 463,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "In the 2022 Form 10‑K the only reference to non‑employee directors was that their restricted‑stock‑unit awards were granted under the Amended and Restated 2009 Praxair Long‑Term Incentive Plan (see Exhibit 10.10i) 【page_105】. By the 2024 filing the Board had added a dedicated Non‑Employee Director Deferral Program (adopted July 30 2024) 【page_96】 and, together with a second amendment to the Linde Compensation Deferral Program effective January 1 2024 【page_95】, introduced a deferral mechanism that postpones award payouts and ties them to longer‑term performance, thereby strengthening governance oversight and aligning directors’ compensation with shareholders’ long‑term interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of the Non-Employee Director Deferral Program on July 30, 2024, and notes the existence of a deferral mechanism tied to long-term performance, which aligns with the ground truth. However, it incorrectly states that in 2022, awards were granted under the 'Amended and Restated 2009 Praxair Long-Term Incentive Plan,' whereas the ground truth specifies the '2021 Linde plc Long Term Incentive Plan' as the governing framework in 2022. This is a significant entity and factual error regarding the plan name and year, undermining the accuracy of the governance structure evolution. (2) Quantitatively, the date July 30, 2024, is correct, and the reference to January 1, 2024, for the second amendment to the Compensation Deferral Program is plausible but not mentioned in the ground truth, making it a potential overreach or confusion with a related but distinct program. The ground truth does not mention a 'second amendment' or its effective date, so this detail lacks support. (3) The multi-hop reasoning is partially sound—linking the 2022 award structure to the 2024 deferral program shows an understanding of evolution in governance—but the incorrect plan name in 2022 breaks the logical chain of program succession. The synthesis would be stronger if it correctly traced the transition from the 2021 Linde plan to the 2024 deferral expansion. (4) Despite the plan name error, the LLM captures the core theme of enhanced long-term alignment and governance through deferral mechanisms, making the answer contextually relevant and semantically close to the ground truth. The conclusion about strengthened governance and shareholder alignment is justified, but the flawed premise reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 482,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "In the 2022 Form 10‑K GM reported that its non‑operating income included a $0.2 billion gain on Stellantis N.V. warrants (see 2022 page 36). By the 2024 filing, the focus had shifted to a legal commitment: GM disclosed that, under the 2017 Opel/Vauxhall sale, it had agreed to indemnify Stellantis for certain emissions, product‑liability and recall costs—subject to caps, thresholds and time limits—and could not estimate a material loss (see 2024 page 93 and page 94). This reflects a move from a modest investment gain to a significant indemnification obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $0.2 billion gain in 2022 is accurately reported, and the shift to indemnification obligations in 2024 is correctly framed. The mention of the 2017 Opel/Vauxhall sale is factually sound. (2) The LLM correctly cites specific pages from the 10-K filings (2022 p.36, 2024 pp.93-94), enhancing verifiability. (3) The multi-hop reasoning is strong: it synthesizes financial data (warrant gains) from 2022 with legal disclosures (indemnification) in 2024, correctly identifying the evolution from financial benefit to contingent liability. (4) The only minor shortcoming is that the LLM does not explicitly mention 'ongoing investigations into Opel’s historical conduct in Europe,' which is part of the ground truth and adds context to the potential liabilities. However, the core elements—indemnification for emissions, product liability, recalls, and the inability to estimate material loss—are all present and correctly contextualized. The answer captures the essential shift in the relationship. Wording differs slightly but maintains semantic equivalence. No calculation errors. Entities (GM, Stellantis, Opel/Vauxhall, 2017 sale) are correctly identified. Overall, the response is factually precise, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 377,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed energy‑related derivatives mainly through footnote tables that showed the pre‑tax earnings impact of cash‑flow and fair‑value hedges (e.g., gains/losses of $17 M, –$8 M, etc.) and of non‑designated contracts (e.g., a $‑117 M loss to natural‑gas revenue) and noted cumulative fair‑value adjustments to hedged items 【page_326】【page_327】. By the 2024 filing the disclosure had expanded to a detailed fair‑value hierarchy (Level 1‑3) and a balance‑sheet schedule that separates energy‑related derivatives by hedging designation—regulatory hedges, cash‑flow/fair‑value hedges, and non‑designated—and presents them as assets or liabilities (gross, offset and net amounts) in “Other” or “Risk Management Activities” 【page_278】【page_281】【page_283】. This shift reflects a move from primarily reporting income‑statement effects to a more granular presentation of fair‑value measurement and clear categorization of derivative exposures on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Southern Company's derivative disclosures from 2022 to 2024: in 2022, the focus was on pre-tax income effects (e.g., gains/losses from hedging instruments and non-designated contracts), while in 2024, the company shifted to a balance-sheet-oriented presentation emphasizing fair value, categorization, and gross/net presentation in 'Other' or 'Risk Management Activities'. (2) The quantitative details (e.g., $17M gain, -$8M, -$117M loss) are specific and correctly attributed to the 2022 disclosures, though the ground truth does not require exact numbers—these enhance accuracy without contradicting it. The 2024 enhancements (fair value hierarchy, Level 1-3, balance sheet schedule) are correctly described and reflect a more granular, balance-sheet-focused approach. (3) The multi-hop reasoning is sound: the model synthesizes changes across years, correctly identifying a shift in financial presentation from income statement to balance sheet focus, and supports it with specific disclosure practices. (4) Semantic equivalence is maintained: while the LLM provides more granular detail than the original answer, all core claims are consistent with the ground truth. The only minor point preventing a perfect 10 is that the original answer does not specify exact dollar figures or the fair value hierarchy levels, so including them—while plausible and likely correct—introduces slight over-specificity without confirmation in the ground truth. However, this does not constitute an error, just added detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 443,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "In 2023 Gilead owned roughly 19.9 % of Arcus and had two designees on Arcus’ board of directors (page_77). After amending the collaboration in January 2024, Gilead made a $320 million equity investment that lifted its stake to about 33 % and increased its board representation to three designees, expanding both its equity ownership and governance influence (page_77).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the initial 19.9% ownership in 2023, the $320 million investment in January 2024, and the resulting 33% ownership stake are all correctly reported. The board representation increase from two to three designees is also accurately stated. (2) The answer is complete, addressing both equity ownership and governance influence across both years as required by the question. (3) Entities are correct—GILD (Gilead) and Arcus are properly identified, and the timeline (2023 to January 2024) aligns with the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the equity investment to increased ownership and governance, correctly inferring the significance of crossing from 19.9% to 33% and expanding board seats. The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'lifted its stake to about 33%' vs 'increasing its ownership to 33%'). Minor formatting like spacing around percentages does not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 327,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "- 2022 10‑K: The 2021 Multicurrency Credit Facility was reported with a maturity of June 30 2025 and a total borrowing commitment of $6.0 billion (including a $3.5 billion sub‑limit for multicurrency borrowings)【page_49†L1-L8】【page_49†L9-L12】.  \n\n- 2023 10‑K: An amendment on June 29 2023 extended the facility’s maturity to July 1 2026 while the commitment remained $6.0 billion (still with a $3.5 billion multicurrency sub‑limit)【page_52†L1-L5】【page_52†L6-L9】.  \n\nThus, between 2022 and 2023 the maturity date was pushed out by about one year, but the borrowing capacity stayed at $6 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The maturity dates (June 30, 2025 in 2022 and July 1, 2026 in 2023) and borrowing capacity ($6.0 billion in both years) are accurately reported. The amendment date (June 29, 2023) is correctly cited, and the sub-limit detail ($3.5 billion) is consistent across years. (2) Completeness: The answer addresses both parts of the question—evolution of maturity date and borrowing capacity—across the two years. (3) Entity accuracy: The facility name (2021 Multicurrency Credit Facility), years (2022 and 2023), and financial terms are correctly identified. (4) Reasoning: The synthesis across the 2022 and 2023 10-Ks is sound, and the conclusion that the maturity was extended by about one year with no change in capacity is logically derived. (5) Semantic equivalence: Though slightly more detailed than the original answer, the LLM conveys the same core information with equivalent meaning. The inclusion of the sub-limit adds context without distorting the response. All citations are appropriately referenced. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 329,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s share of imported crude in its U.S. refineries stayed essentially unchanged – imported crude made up about 60 percent of U.S. refinery inputs in both 2023 and 2024【page_18】.  At the same time, refinery utilization fell: overall crude‑unit distillation capacity utilization dropped from 89.8 percent in 2023 to 87.9 percent in 2024, and U.S.‑specific utilization slipped from 90.8 percent in 2023 to 86.6 percent in 2024【page_18】【page_17】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Chevron's reliance on imported crude oil remained stable at approximately 60% in both 2023 and 2024, which matches the ground truth. It also correctly reports the 2023 U.S. refinery utilization (90.8%) and the 2024 decline to 86.6%), aligning with the original answer. However, the LLM introduces an additional figure—'overall crude-unit distillation capacity utilization'—which decreased from 89.8% in 2023 to 87.9% in 2024. This metric is not mentioned in the ground truth and appears to conflate U.S.-specific data with global or overall company-wide utilization, introducing inaccuracy. (2) The key numbers for U.S. refinery utilization (90.8% in 2023 and 86.6% in 2024) are correct. However, the 89.8% and 87.9% figures are inconsistent with the ground truth and not supported by the original answer, suggesting either misinterpretation of the data or reference to a different metric. This affects quantitative accuracy. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes data on imported crude share and refinery utilization across two years. It distinguishes between imported crude share (stable) and utilization (declining), which reflects correct logical interpretation. However, the inclusion of an unsupported 'overall' utilization metric weakens the reasoning fidelity. (4) Despite the extra, incorrect metric, the core answer addresses both parts of the question and conveys the main trend accurately: stable import dependency with reduced U.S. refinery utilization. Hence, the correctness score is 8 due to minor but notable quantitative inaccuracies, while qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 463,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS’s GBP cash‑flow hedge fell from a notional $663 million at year‑end 2023 to $536 million at year‑end 2024 – a drop of roughly $127 million (about 19%). This reduction shows UPS is trimming its pound‑sterling hedge, likely because forecasted GBP‑denominated cash flows have declined or the company is reallocating hedges to other currencies, reflecting a risk‑management approach that adjusts hedge sizes to match expected exposure.【page_130】【page_137】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key quantitative facts: the 2023 GBP hedge position of $663 million, the 2024 position of $536 million, the $127 million decrease, and the approximate 19% reduction (ground truth: 19.15%, which rounds to 19%—acceptable precision). These values match the ground truth exactly in amount and year, with only minor formatting differences (e.g., '663 million units' vs '$663 million') that do not affect meaning. 2) Calculations are accurate: 663 - 536 = 127 million; (127 / 663) ≈ 19.15%, correctly rounded to 'about 19%'. 3) The reasoning is sound and addresses both parts of the question: it identifies the evolution (decrease in hedge size) and interprets the strategic implication—adjusting hedges in line with expected exposure, which aligns with the ground truth's interpretation of reduced GBP risk and conservative strategy. The LLM adds a plausible nuance (reallocation to other currencies or lower GBP cash flow forecasts), which is not in the original but is reasonable and consistent with the data. 4) Entities are accurate: UPS, British Pound Sterling (GBP), years 2023 and 2024, and the concept of cash-flow hedging are all correctly identified and used. The answer synthesizes multi-hop information (two years of hedge data and strategic interpretation) correctly. The only minor shortcoming is that the original answer explicitly labels the shift as indicating a 'more conservative hedging approach,' while the LLM implies it through context. This slight omission in phrasing does not detract from the overall correctness but prevents a perfect 10. Thus, the answer is factually complete, quantitatively precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 460,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Bank of America’s money‑market holdings rose from a fair‑value of **$1.2 billion at 31 Dec 2023** to **$1.3 billion at 31 Dec 2024** – an increase of roughly $0.1 billion (≈8%). This modest uptick shows the firm is slightly expanding its allocation to highly liquid, low‑risk assets, reflecting a continued emphasis on preserving liquidity and earning a modest return on short‑term cash positions.【page_113】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the fair value of money market investments increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024, which matches the original answer exactly. (2) Quantitative accuracy is precise—both the dollar amounts and the implied $0.1 billion increase (≈8%) are correctly calculated. (3) The reasoning is sound: the modest growth is correctly interpreted as a slight expansion in short-term investment strategy, emphasizing liquidity preservation and modest returns, which is semantically equivalent to the original conclusion about liquidity management and capital deployment. (4) The answer addresses both parts of the multi-hop question: the evolution of fair value and its implication for strategy. Entity accuracy (Bank of America, money market investments, correct dates) is flawless. The citation of 'page_113' adds contextual support. No errors in synthesis, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 294,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "In the 2022 Form 10‑K the company said the physical gas‑supply contracts with sell‑back options could cover up to **26 million mmBtu** (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power). The 2024 filing reduces that maximum to **15 million mmBtu** (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power), a drop of **11 million mmBtu** across the subsidiaries.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values for 2022 and 2024 are accurate: 26 million mmBtu and 15 million mmBtu total, with correct subsidiary breakdowns (Alabama Power: 6 to 4, Georgia Power: 8 to 6, Mississippi Power: 4 to 2, Southern Power: 8 to 3 million mmBtu). (2) The calculation of an 11 million mmBtu decrease is correct (26 - 15 = 11) and properly attributed across subsidiaries. (3) The multi-hop reasoning is sound—information is synthesized across Southern Company and its subsidiaries over two years, correctly identifying the trend of consistent reduction. (4) All entities (subsidiaries and time periods) are accurately named and contextualized. The answer is semantically equivalent to the original, with clear, concise presentation of the change over time. Minor formatting differences (e.g., 'mmBtu' vs 'million mmBtu') are acceptable and do not affect meaning. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 286,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "In the 2023 filing Adobe introduced the Firefly Vector Model as a generative‑AI engine that creates fully editable vector graphics and made it available in core Creative Cloud apps—Photoshop, Illustrator, Express, Stock and even Acrobat—while also offering enterprise‑grade Firefly Services and IP indemnification. By the 2024 filing the model remains embedded in Photoshop, Illustrator, Express and Stock, but the emphasis has shifted to broader enterprise integration through Firefly Services and Custom Models, with added commercial‑safety features such as Content Credentials and the earlier video‑model reference dropped, indicating a deeper, more enterprise‑focused rollout of vector generation across Adobe’s product suite.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the timeline and scope of the Firefly Vector Model's integration. (1) According to the ground truth, in 2023 the Firefly Vector Model was integrated only into Adobe Express, not across 'core Creative Cloud apps—Photoshop, Illustrator, Express, Stock and even Acrobat' as claimed. The expansion to Illustrator occurred in 2024, not 2023. This misattribution of integration timing and breadth is a major factual error. (2) The ground truth specifies that in 2024, the model expanded to Illustrator with a focus on features like Generative Recolor, while the LLM answer incorrectly suggests broad 2023 availability and emphasizes enterprise services, Custom Models, and Content Credentials—details not present in the original answer and unsupported by the provided knowledge. (3) The LLM introduces concepts like 'video-model reference dropped' and 'commercial-safety features' that are not part of the original answer, adding speculative or extraneous information. (4) While the LLM correctly identifies Adobe Express and Illustrator as part of the product suite and notes a progression between years, it fails the core multi-hop requirement: accurately tracing the evolution from 2023 (Express-only) to 2024 (Illustrator expansion). The reasoning is thus partially sound but built on incorrect premises. (5) Quantitative accuracy is moderate: years (2023, 2024) are correct, but no numeric values (e.g., 100+ languages) from the original are mentioned, and unverified claims (enterprise rollout) lack grounding. Overall, the answer is contextually relevant to Adobe's product suite and AI integration but significantly deviates in entity accuracy and reasoning correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 471,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Biktarvy was the clear sales leader in Gilead’s HIV portfolio, generating $11.85 billion in 2023 – roughly two‑thirds of the company’s total HIV revenue of $18.2 billion that year【page_65】.  The 2024 filing continues to stress that HIV products remain a major revenue source and that Gilead must protect and grow its leading HIV franchise, indicating that Biktarvy’s commercial weight has persisted (and likely grown) and is shaping the company’s strategy to double‑down on its flagship HIV product while investing in next‑generation HIV therapies【page_18】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports Biktarvy's 2023 sales of $11.85 billion, matching the ground truth ($11,850 million), and accurately contextualizes it as a major product in GILD's HIV portfolio. The total HIV revenue of $18.2 billion in 2023 is not contradicted by the ground truth and may be accurate, though not provided in the original answer. 2) Quantitatively, the dollar amount for Biktarvy is correct (allowing for format variation: $11.85 billion = $11,850 million). However, the LLM omits any mention of the increased risks to Biktarvy’s dominance in 2024—such as generic competition and shifting treatment paradigms—which is a central part of the ground truth. Instead, it claims GILD is 'doubling down' and growing its reliance on Biktarvy, which contradicts the original answer’s emphasis on strategic vulnerability and the need for diversification. 3) The reasoning is flawed in the qualitative synthesis: while the 2024 filing may stress protecting the HIV franchise, the ground truth highlights growing risks and strategic concerns, not continued expansion. The LLM misinterprets the implication of GILD's strategy, presenting a narrative of growth and confidence rather than caution and risk mitigation. This misrepresents the evolution from 2023 to 2024. 4) Contextually, the answer addresses the commercial significance and strategy, so it is relevant, but fails to capture the critical shift in tone and risk assessment in 2024. The omission of generic threats and TAF-related risks results in a partially correct but misleading conclusion about strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 433,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018‑1A securities stayed outstanding, with the principal balance rising modestly from $496.1 million at year‑end 2022 to $496.8 million at year‑end 2023, while the coupon rate stayed fixed at 3.652 % in both periods【page_108】【page_118】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported principal amounts. The ground truth states that the 2022 principal was $500.0 million, not $496.1 million as claimed by the LLM. Additionally, while the 2023 principal of $496.8 million is correct, the LLM incorrectly states that the principal increased from 2022 to 2023, when in fact it decreased from $500.0 million to $496.8 million. The interest rate of 3.652% is correctly reported as unchanged. (2) Quantitative accuracy is severely compromised: the 2022 principal is off by $3.9 million, and the direction of change (increase vs. decrease) is wrong, which reflects a critical error in financial interpretation. (3) The reasoning is flawed because the model fails to correctly synthesize the multi-hop information across years—instead of showing a reduction in principal consistent with amortization or repayment, it falsely suggests growth, which contradicts the expected behavior of such securities and the ground truth. (4) Despite these major factual inaccuracies, the answer is contextually relevant—it addresses the right security, time frame, and metrics (principal and interest rate), and cites appropriate pages. However, the core numerical inaccuracies and incorrect trend severely undermine correctness, warranting a low score of 3 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 374,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "In 2023 UPS still owned Coyote, but market softness forced a $111 million impairment on the Coyote trade name and the company began evaluating strategic alternatives for the truck‑load brokerage business (see 2023 MD&A page 54). By September 2024 UPS completed the divestiture, booked a $156 million gain on the sale, eliminated about $976 million of Coyote revenue and $949 million of related operating expenses, and shifted its strategy away from the Coyote business (see 2024 MD&A pages 42 and 43).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $111 million impairment charge in 2023 and the September 2024 divestiture, aligning with the ground truth. However, it introduces new financial figures not present in the original answer—specifically a $156 million gain on sale, $976 million in eliminated revenue, and $949 million in operating expenses—which, while potentially accurate from the 2024 MD&A, are not part of the ground truth provided. Since the evaluation is based on matching the original answer (derived from the knowledge graph), these additions represent quantitative deviations. (2) The original answer does not mention any gain on sale or specific revenue/expense figures, focusing instead on the strategic evolution and the fact that Coyote's exit contributed to a revenue decrease. The LLM provides more granular data, but this exceeds the verified truth and introduces unverifiable (within this context) numbers. (3) The multi-hop reasoning is sound: the model correctly links 2023 impairment and strategic evaluation to the 2024 divestiture, demonstrating proper synthesis across years and strategic phases. The narrative evolution from impairment to divestiture is logically and contextually accurate. (4) The contextual relevance is perfect—it directly addresses financial impact and strategic direction as asked. The qualitative accuracy is high due to correct entity identification (UPS, Coyote), correct years, and correct interpretation of strategic shift. The correctness score is 8 because core facts are right and the reasoning is strong, but the added quantitative details not in the ground truth reduce quantitative accuracy. Overall, the answer goes beyond the verified truth with specific figures, which prevents a 9 or 10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 484,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed two Performance Share Unit (PSU) award forms for grants that began in 2019 – one tied to **Return on Capital** (exhibit *10.11k) and one tied to **Total Shareholder Return** (exhibit *10.11l)【page_107】. The 2024 filing still references the same two metric‑based PSU awards – now listed as exhibit *10.10l (Return on Capital) and exhibit *10.10m (Total Shareholder Return)【page_96】 – showing that the performance‑metric structure did not change, only the exhibit numbering was updated.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Linde plc maintained two forms of Performance Share Unit Awards for grants beginning in 2019—one based on Return on Capital and the other on Total Shareholder Return. The exhibits cited (10.11k and 10.11l in 2022; 10.10l and 10.10m in 2024) match the ground truth, with correct exhibit number updates over time. (2) There are no numeric values requiring calculation, but the years (2019, 2022, 2024) and exhibit numbers are correctly referenced. Format variations (e.g., 'exhibit *10.11k') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—comparing the structure of PSU awards across 2022 and 2024 filings and linking them to grants from 2019. The conclusion that the performance metric structure remained unchanged is logically supported by the consistent use of the same two metrics across years. (4) The answer addresses all parts of the question: the evolution (or lack thereof) of the PSU structure and the specific performance metrics used for 2019 grants. Wording differs slightly (e.g., 'only the exhibit numbering was updated' vs. 'same dual structure...without introducing new metrics'), but the meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 370,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "In 2023 Trodelvy was already an approved oncology product – the FDA (and the European Commission) had approved it for unresectable locally advanced or metastatic HR‑positive/HER2‑negative breast cancer (in addition to its original accelerated‑approval indication for triple‑negative disease)【page_7】. By 2024 Gilead reported that the FDA granted a **second** Breakthrough‑Therapy designation to Trodelvy for extensive‑stage small‑cell lung cancer, a new indication that will be pursued under an expedited regulatory pathway【page_8】. This shift from a set of approved breast‑cancer uses to a new breakthrough designation for lung cancer shows the drug’s development is expanding into additional tumor types and moving forward with accelerated regulatory support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Trodelvy's 2023 indications for HR-positive/HER2-negative breast cancer, triple-negative breast cancer, and implied prior approvals are consistent with the original answer. The 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer is correctly reported, including the context of progression after platinum-based chemotherapy (implied in both). (2) Quantitative accuracy is perfect: no numerical errors; dates (2023, 2024) and regulatory milestones are correctly stated. The mention of a 'second' Breakthrough Therapy designation is an inference not in the original answer but is plausible and not factually incorrect. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and indications, correctly inferring a strategic expansion into new oncology areas with unmet need, which matches the original answer’s conclusion. (4) The only minor shortcoming is that the original answer explicitly mentions urothelial cancer as a 2023 indication, which the LLM omits. This is a small completeness gap but does not undermine the core correctness. Otherwise, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 357,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "In the 2023 filing, Vertex AI was described as the Google Cloud developer platform that lets developers **train, tune, augment and deploy** generative‑AI models and services such as Enterprise Search and Conversations【page_6】. By the 2024 filing, Vertex AI’s role had expanded to also **test** models, **integrate Gemini—the company’s most capable multimodal model**, and offer a broader suite of model‑related services—including vector search, grounding and distillation—while supporting first‑party, third‑party and open models【page_8】. This reflects a shift from core model‑building capabilities to a more comprehensive, Gemini‑centric platform with added tools for model optimization and broader model access.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately captures the evolution of Vertex AI from 2023 to 2024: in 2023, the platform supported training, tuning, augmenting, and deploying generative AI models with services like Enterprise Search and Conversations; by 2024, it added testing, Gemini integration, and new services such as vector search, grounding, and distillation. (2) There are no numeric values to verify, but all dates (2023, 2024) and model names (Gemini) are correct. (3) The multi-hop reasoning is sound—information is correctly synthesized across two time points and filings, showing a clear progression in capabilities and strategic focus. (4) The answer is semantically equivalent to the original, with slightly enhanced wording (e.g., 'Gemini—the company’s most capable multimodal model' and 'first-party, third-party and open models') that adds context without introducing error. All parts of the question—capabilities, integration with generative AI, and evolution—are thoroughly addressed. No factual inaccuracies, omissions, or reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 315,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "In the 2022 Form 10‑K the derivative footnotes say that the net derivative amounts “exclude cash collateral of $3 million … and immaterial premium and intrinsic value associated with weather derivatives” (see 2022 p. 122‑123). The 2024 filing makes the same immaterial‑weather‑derivative exclusion but no longer references a cash‑collateral amount, stating only that “net amounts … exclude immaterial premium and intrinsic value associated with weather derivatives” (2024 p. 285). Thus the treatment of weather derivatives remains unchanged— they are still deemed immaterial and omitted from valuation— but the explicit $3 million cash‑collateral exclusion noted in 2022 is absent in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative details and misrepresents the evolution of disclosures between 2022 and 2024. (1) In the 2022 filing, the ground truth states that SO disclosed weather derivatives as immaterial without specifying amounts—however, the LLM incorrectly claims there was a $3 million cash collateral exclusion in 2022. This $3 million figure does not appear in the ground truth and contradicts it. (2) The ground truth indicates that in 2024, SO disclosed cash collateral of $17 million and $62 million at the end of 2024 and 2023, respectively—showing increased transparency. In contrast, the LLM claims that the 2024 filing 'no longer references a cash-collateral amount,' which is false; the 2024 filing actually provides more detailed collateral data than 2022. (3) The entity (SO) and years (2022, 2024) are correct, and the qualitative point that weather derivatives remain immaterial is accurate. However, the reasoning about disclosure trends is flawed: the LLM suggests a reduction in detail (removal of cash collateral disclosure), while the ground truth shows an increase in disclosure granularity over time. (4) Despite correct identification of the core concept (immateriality of weather derivatives), the reversal of the trend in cash collateral disclosure and the invention of a $3 million figure in 2022 severely undermine factual correctness. The answer fails on key multi-hop synthesis: comparing actual disclosed amounts across years and interpreting the direction of disclosure transparency. Hence, correctness is low due to major quantitative inaccuracies and flawed reasoning, though the response remains contextually relevant to the question's focus on disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 471,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "In 2023 Gilead’s filing noted that Biktarvy was protected by U.S. and EU patents through 2033 and was sold almost entirely through three large U.S. wholesalers (about 91 % of U.S. sales and 66 % of worldwide sales)【page_9】【page_6】. By 2024 the company reported that the FDA had approved an expanded indication for Biktarvy to treat patients with the M184V/I resistance mutation and had updated the label to reinforce its safety and efficacy in pregnant people, thereby broadening its therapeutic reach while the wholesale‑distribution model remained essentially unchanged (≈91 % U.S., ≈65 % worldwide)【page_8】【page_6】. This reflects a shift from a product with stable patent protection and distribution to one with new regulatory approvals that enhance its market positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Biktarvy's U.S. patent protection through 2033 in 2023, the 2024 FDA expanded indication for M184V/I resistance, and updated labeling for use in pregnant people with HIV are all accurately reported. The percentages for U.S. and worldwide sales via three large wholesalers (91% and 66%, later ≈65%) are correctly cited and consistent with the source. (2) Quantitative accuracy is perfect: all numbers (2033, 91%, 66%, ≈65%) match or are appropriately rounded versions of the original data. No calculation errors. (3) Multi-hop reasoning is sound—correctly synthesizing information across 2023 and 2024 disclosures to show a shift from patent/distribution stability to expanded regulatory positioning. The addition of distribution details (while not in the original answer) provides useful context and does not detract from correctness. (4) Semantic equivalence is strong: the core evolution—from reliance on patent protection to enhanced market positioning via broader indications—is clearly and correctly conveyed. The only minor limitation is the inclusion of EU patent and distribution details not present in the ground truth, which adds context but slightly shifts focus; however, this does not introduce inaccuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 403,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "In 2022 AMT only drew modestly on the 2021 Multicurrency Credit Facility – it recorded net borrowings of about **$850 million** under that facility (see page 44). By 2023 the company had **borrowed $3.0 billion and repaid $6.1 billion** on the same facility, and on June 29 2023 it **amended the facility** – extending its maturity to July 1 2026, reaffirming the $6.0 billion commitment and switching the pricing benchmark from LIBOR to SOFR (see page 52). This shows a sharp increase in utilization and a material amendment to the credit terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: $850 million net borrowings in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023, maturity extended to July 1, 2026, $6.0 billion commitment maintained, and the switch from LIBOR to SOFR. These match the original answer exactly in value and context. (2) Quantitative accuracy is perfect—numeric values, dates (June 29, 2023 amendment leading to July 1, 2026 maturity), and financial figures are all correct, including the EUR-to-USD conversion implicitly accepted as accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in borrowing behavior and structural amendments across two years from the same facility. The only minor omission is not explicitly mentioning the use of 2022 borrowings for 'repaying existing indebtedness and general corporate purposes,' which slightly reduces completeness. Also, the EUR repayment of 842.6 million ($919.1 million) is subsumed in the $6.1 billion total but not broken out—this detail is missing but does not invalidate the overall correctness. (4) The answer is contextually relevant, directly addressing both borrowing activity and facility amendments. Wording differs slightly (e.g., 'reaffirming' vs 'maintained'), but semantic equivalence is preserved. The conclusion about 'sharp increase in utilization' and 'material amendment' is a valid interpretation. Thus, near-perfect accuracy with only minor contextual omissions prevents a full 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 420,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "In the 2023 filing Alphabet already described Google Ad Manager as a primary channel through which advertisers buy inventory and noted that, for network‑property ads, the company evaluates whether it is the principal (recording revenue on a gross basis) or an agent (recording net revenue) – the same principal‑vs‑agent framework that drives its overall revenue reporting model【page_58】. The 2024 filing repeats this language, still listing Google Ad Manager among the key purchase platforms and applying the same gross‑basis treatment when Alphabet is the principal, showing that the platform’s integration into the revenue‑recognition model has remained consistent with no material change – it continues to be embedded in the same revenue‑reporting model used in 2023【page_57】.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, asserting that there was 'no material change' in Google Ad Manager's role in revenue recognition between 2023 and 2024, which directly contradicts the ground truth. The original answer states that there was a strategic evolution from a transactional model to a more control-based justification for gross revenue recognition, emphasizing a shift in language and reasoning around principal status — specifically citing control of inventory, responsibility to customers, and pricing discretion. The LLM answer fails to identify this evolution and instead claims consistency, missing the key multi-hop insight that the integration of Google Ad Manager became more strategically justified through enhanced control criteria in 2024. While the entities (Google Ad Manager, Alphabet, gross vs net revenue) and years are correctly identified, and there are no numerical inaccuracies (no actual numbers to verify), the qualitative reasoning is flawed. The model misinterprets the continuity of the principal-agent framework as evidence of no change, when the ground truth highlights a refinement in how that framework is applied and justified. This represents a failure in multi-hop synthesis — comparing the nature of the justification across years — leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer discusses the right topic and cites appropriate sections, but it draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 412,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "In 2023 UPS recorded a $56 million goodwill impairment on the Roadie acquisition, reflecting a write‑down of the value it had assigned to the platform. In 2024 the company’s annual goodwill‑impairment test found no impairment, but noted that Roadie (along with two other reporting units) now has only a limited excess of fair value – about $1.1 billion of goodwill across the three units – making it especially vulnerable to a 100‑basis‑point rise in cost of capital or a 10 % drop in cash‑flow forecasts; thus, while the immediate financial hit was avoided, UPS still treats Roadie as a strategic asset whose exposure to future impairment risk is closely monitored.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $56 million goodwill impairment in 2023 is correctly stated. In 2024, the absence of a new impairment is accurately reported. However, the LLM introduces a figure of '$1.1 billion of goodwill across the three units' that is not present in the original answer; while plausible, this specific aggregate amount is not confirmed by the ground truth and represents an addition not supported by the provided data. This does not contradict the original but adds unverified detail. (2) The explanation of sensitivity to a 100-basis-point rise in cost of capital or 10% drop in cash-flow forecasts is consistent with the original's emphasis on Roadie's sensitivity to cost of capital and performance forecasts, though the exact thresholds (100 bps, 10%) are more specific than the original's general statement. These specifics may reflect accurate sourcing beyond the ground truth but cannot be verified from the given answer alone. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from active impairment (2023) to ongoing risk monitoring (2024), capturing the evolution in financial exposure and strategic positioning. (4) All entities (UPS, Roadie, goodwill impairment, 2023–2024 timeline) are correct. The answer is contextually excellent, addressing both financial exposure and strategic positioning. The slight deduction in quantitative accuracy is due to the introduction of unsupported numerical specifics, but core facts and logic remain robust. Hence, a score of 9 is warranted for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 444,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "In the 2022 filing helium was only mentioned as one of the process gases in Linde’s industrial‑gases product line and was not reported as a separate business (see page 94). By the 2024 filing the company had moved helium into a distinct “global helium wholesale” activity within the “Other” segment (see page 28), and that change led to a $32 million (≈2 %) decline in Other‑segment sales and a $19 million (≈44 %) increase in its operating profit in 2024 versus the prior year (see page 28).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that helium was not a separate reporting category in 2022 and became more prominent in 2024 within the 'Other' segment, it incorrectly states that helium's reclassification led to a $32 million (≈2%) decline in sales and a $19 million (≈44%) increase in operating profit. The ground truth states that helium had a *negative* impact, contributing to a 2% underlying sales decrease due to lower volumes and *increased costs* affecting operating profit, partially offset by insurance recovery. The LLM claims a large *increase* in operating profit, which directly contradicts the negative impact in the original answer. (2) The quantitative inaccuracies are severe: the $32M sales decline might align approximately with a 2% decrease (if total 'Other' segment sales were ~$1.6B), but no such figure is confirmed, and the $19M profit increase is factually wrong—operating profit was pressured upward by costs, not improved. The 44% increase in operating profit is unsupported and incorrect. (3) The multi-hop reasoning is partially sound—LLM connects helium’s evolving role across years and segments—but draws the opposite conclusion about financial impact. It fails to synthesize the cost pressure and negative performance, instead implying improved profitability. (4) Scores reflect major factual and directional errors in financial impact (correctness: 3), poor number accuracy especially on profit (quantitative: 2), partial but flawed reasoning (qualitative: 4), and generally relevant structure and context (contextual: 7).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 445,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The long‑term credit‑protection agreements covered $8.7 billion of residential‑mortgage loans at December 31 2023 and $8.0 billion at December 31 2024 – a reduction of about $0.7 billion (≈8 %)【page_117】. The drop means a slightly smaller share of the mortgage portfolio is fully insured, but with more than $8 billion still protected the corporation’s credit‑risk exposure on residential mortgages remains limited and largely mitigated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC as $8.7 billion in 2023 and $8.0 billion in 2024, matching the ground truth exactly. The calculated decrease of $0.7 billion (≈8%) is accurate and appropriately contextualized. 2) All numeric values, dates (December 31, 2023 and 2024), and calculations are correct. The percentage decline is approximately accurate: (0.7 / 8.7) ≈ 8.05%, which rounds to 8%. 3) The multi-hop reasoning is sound: the model correctly identifies the implication of reduced coverage—namely, a smaller share of the portfolio being fully protected—and links this to credit risk exposure. It correctly notes that the protection limits credit risk, aligning with the ground truth that no allowance for credit losses is recorded on these loans. 4) While the LLM captures the core implication (reduced reliance on full protection), it slightly underemphasizes the key point in the original answer that the decline suggests a potential decrease in high-risk residential mortgage loans. Instead, it focuses on the continued mitigation of risk due to $8B still being protected. This is contextually valid but omits the forward-looking inference about portfolio composition. Overall, the answer is factually correct, well-reasoned, and highly relevant, warranting a high score with only minor room for deeper qualitative insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 394,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "In the 2023 filing Adobe framed Firefly primarily as a competitive edge – a generative‑AI tool that is natively embedded in Creative Cloud apps and marketed as “safe for commercial use” (2023 p.9‑10). By the 2024 filing the company still highlights Firefly’s AI capabilities but adds a clear focus on the growing AI‑regulatory environment, warning that the EU AI Act and similar rules could raise compliance costs, limit availability or create liability for the Firefly offering (2024 p.23). This shows a shift from emphasizing differentiation alone to balancing that advantage with heightened regulatory‑risk awareness.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Adobe's strategic positioning of Firefly in 2023 as a competitive differentiator through native integration and 'safe for commercial use' claims, citing the correct context from the 2023 filing. In 2024, it accurately notes the continued emphasis on AI capabilities but adds the new focus on regulatory risks, specifically the EU AI Act, which aligns with the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2023, 2024) and references to regulatory developments (EU AI Act adoption in 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the evolution in strategic tone from differentiation to risk-aware positioning. (4) The answer is contextually precise, directly addressing both competitive differentiation and regulatory risks as asked. Minor wording differences (e.g., 'limit availability or create liability' vs. 'impose compliance costs, delay development') are within acceptable semantic variation and do not affect factual accuracy. All key elements—competitive edge, commercial safety, regulatory shift, EU AI Act, compliance costs—are present and correctly represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 376,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "In 2023 Trodelvy generated $1.063 billion in product sales (up 56 % from 2022), and in 2024 sales rose to about $1.3 billion—a 24 % year‑over‑year increase. During 2024 the FDA granted Trodelvy a second Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, expanding its regulatory profile beyond the prior year, which reported no new FDA designation for the drug.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 product sales of $1.063 billion and the 56% year-over-year increase from 2022, which matches the ground truth. However, it introduces a new figure for 2024 sales—$1.3 billion with a 24% increase—which is not present in the original answer and cannot be verified from the provided ground truth. This is a significant quantitative addition not supported by the source. (2) The FDA granted a second Breakthrough Therapy designation in 2024 for extensive-stage small cell lung cancer, which the LLM correctly reports, including the indication and context of it being a new regulatory advancement. The original answer confirms this, so entity and qualitative accuracy on the regulatory front are strong. (3) The multi-hop reasoning is partially sound: the model connects financial performance (2023 sales) and regulatory developments (2024 FDA designation), but it fabricates 2024 sales data, undermining the quantitative integrity. There is no indication in the ground truth that 2024 sales reached $1.3 billion or grew 24%, so this is an unsupported extrapolation. (4) The contextual relevance is high because the answer addresses both financial and regulatory dimensions of Trodelvy’s trajectory. Qualitative accuracy is good due to correct entity and regulatory details, but quantitative accuracy is penalized for the invented 2024 sales figure. Correctness score reflects partial accuracy with a major factual overreach in numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 411,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "- In the 2022 Form 10‑K Chevron disclosed that it owned **36.4 % of Angola LNG Limited** and that the affiliate was carried on the balance sheet at roughly **$2.2 billion** (Investments and Advances of $2,180 million at 12/31/2021) with **$336 million of equity earnings** reported for 2021 【page_78】.  The MD&A also noted that higher upstream‑related earnings from Angola LNG helped lift income from equity affiliates in 2021 【page_42】.  \n\n- By the 2024 Form 10‑K the same 36.4 % ownership is still reported 【page_85】, but the discussion now emphasizes Angola LNG’s operational contribution: **75 million BOE of proved‑developed reserves were transferred from the Angola LNG affiliate in 2024**, and Chevron’s African capital spend of **about $0.8 billion** included offshore development projects in Angola 【page_111】.  This signals a shift from a primarily financial‑equity stake in 2022 to a more active strategic role in gas‑liquefaction and reserve development by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Chevron's 36.4% ownership in Angola LNG Limited was disclosed in the 2022 Form 10-K, but the ground truth indicates this specific stake was first clearly quantified in 2024, not 2022. The original answer notes that in 2022, Chevron only mentioned 'upstream-related earnings from Angola LNG' contributing to a $5,657 million income from equity affiliates, without specifying the ownership percentage. The LLM falsely attributes the 36.4% figure to 2022, which is a major error. Additionally, the LLM cites a $2.2 billion balance sheet value and $336 million equity earnings for 2021, but the question asks about 2022–2024, making this data off-cycle and potentially misleading. The mention of '75 million BOE of proved-developed reserves transferred' in 2024 is not supported by the ground truth, which does not mention any reserve transfer or specific volume. The $0.8 billion African capital spend is mentioned but not explicitly tied to Angola LNG in the ground truth. (2) Quantitative accuracy is low: while numbers like 36.4%, $2.2 billion, and $336 million may appear in filings, they are misattributed to the wrong years and contexts. The ground truth does not include these specific figures for 2022 or 2024, nor does it report reserve transfers. (3) Multi-hop reasoning is partially sound—the LLM attempts to show evolution from financial to strategic involvement—but it is based on incorrect data placement across years. The synthesis fails because it uses 2021 data to represent 2022 and invents operational details (reserve transfer) not in the ground truth. (4) Contextual relevance is high because the answer addresses equity investments, affiliate transactions, and strategic positioning over time, aligning with the question’s intent. However, factual correctness undermines the analysis. The core evolution described—general earnings mention in 2022 to defined stake and operational role in 2024—is plausible but misrepresented by incorrect data attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 557,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "In 2023 Meta’s balance sheet showed $18.5 billion of fixed‑rate senior unsecured notes outstanding, which included the $8.5 billion of May 2023 notes that produced about $8.46 billion of net proceeds from the issuance 【page_79】. By the end of 2024 the total face amount of those notes had risen to $29.0 billion, driven by a new $10.5 billion issuance of August 2024 notes (the August 2024 series) and lifting the fair‑value of the notes to $27.8 billion from $18.5 billion a year earlier 【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: $8.46 billion in net proceeds from the May 2023 issuance, $18.50 billion total outstanding at end of 2023, $10.50 billion issued in August 2024, and $29.0 billion total outstanding at end of 2024. All numbers match exactly or are acceptably rounded (e.g., $8.5 billion mentioned as issuance amount, with precise $8.46 billion net proceeds specified). (2) Quantitative accuracy is perfect: all dollar amounts, dates, and totals align with the ground truth. The increase from $18.5B to $29.0B is correctly implied by the $10.5B issuance in 2024, and the 2023 issuance proceeds are accurately reported. (3) The reasoning is sound and reflects multi-hop synthesis across time and issuance events. The LLM correctly links the 2023 issuance to the year-end balance and adds the 2024 issuance to explain the rise to $29.0B. It even adds contextual detail (fair value vs. face value) not in the original answer, which is accurate and enhances completeness. (4) The only minor shortcoming is that the original answer emphasizes the 'evolution' and 'continued reliance' as a strategic trend, which the LLM implies but does not explicitly interpret. However, the factual evolution is fully captured. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 404,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "In the 2023 filing Linde treated helium as a non‑critical supply and reported $614 million of “Raw materials and supplies” (which includes helium) without a separate cost line 【page_72】. By 2024 the company re‑classified helium as a dependency and disclosed a lower raw‑material inventory of $529 million 【page_62】—an $85 million reduction in the amount of raw‑material exposure tied to helium, reflecting a shift to a more strategic, dependency‑focused sourcing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) In the ground truth, helium costs were reported as percentages of total raw material expenses (4.2% in 2023, 6.8% in 2024), indicating increased cost exposure. The LLM instead cites absolute dollar amounts for 'raw materials and supplies' ($614M in 2023, $529M in 2024) and claims an $85M reduction in helium-related exposure, which contradicts the ground truth showing increased, not decreased, exposure. (2) The LLM incorrectly infers that a lower inventory value indicates reduced exposure, while the truth shows helium's cost share rose from 4.2% to 6.8%, signaling greater financial exposure. (3) The multi-hop reasoning is flawed: the model fails to connect the categorization shift (supply → depends_on) with rising proportional costs, instead misinterpreting inventory totals as helium-specific figures. (4) Entity accuracy is partially correct (LIN/Linde, years), but metric accuracy is poor—no evidence supports isolating $614M or $529M as helium-specific costs, and the claimed $85M reduction is unsupported and factually incorrect. (5) The answer is contextually relevant in discussing the classification change but draws the opposite conclusion about financial exposure. Thus, while the question's intent is addressed, core facts and logic are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 380,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s share of European customer balances that it earmarks for credit work grew modestly – from about 37 % at 12/31/2022 to roughly 39 % at 12/31/2023. At the same time, the dollar amount approved for those credit activities fell from $3.8 billion in 2022 to $3.0 billion in 2023, a decline of roughly 21 % (a $0.8 billion reduction)【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.8 billion in 2022 and $3.0 billion in 2023 are correctly reported. The percentage values (37% in 2022 and 39% in 2023) match the original answer. The $0.8 billion reduction is correct ($3.8B - $3.0B = $0.8B), and the calculated percentage change of approximately 21% is accurate ((0.8 / 3.8) ≈ 21.05%). Minor wording differences (e.g., 'earmarks for credit work' vs 'approved to fund credit activities') do not affect semantic meaning. (2) The answer addresses both parts of the question: the evolution of utilization (decline in dollar amount, slight increase in percentage share) and the percentage change in approved amount (~21% decrease). (3) Entities are correct: PayPal, European customer balances, credit activities, and the years 2022 and 2023 are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that while the proportion of balances used increased slightly, the absolute amount decreased, indicating a more conservative approach—consistent with the original conclusion. The citation reference (page_49) adds contextual support. All criteria are met with high precision and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 358,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks’ foreign‑currency‑other hedges shrank – the fair‑value of those instruments fell from $1,164 million at fiscal‑2023 year‑end to $920 million at fiscal‑2024 year‑end (page 71).  Correspondingly, the AOCI balance for foreign‑currency‑other dropped from $39.6 million to $11.5 million, and $9.5 million of the 2024 amount is expected to be re‑classified into earnings within the next 12 months (page 70).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: fair value decreased from $1,164 million in 2023 to $920 million in 2024; AOCI net gain dropped from $39.6 million to $11.5 million; and the amount expected to be reclassified into earnings within 12 months is correctly stated as $9.5 million in 2024. The 2023 reclassification amount ($55.3 million) is missing, but the 2024 figure is accurate. (2) All provided numbers match the ground truth exactly, with acceptable formatting variations (e.g., 'fiscal-2023 year-end' equivalent to '2023'). No calculation errors. (3) The reasoning is sound: the LLM correctly links the decline in fair value to a reduction in AOCI and notes the forward-looking reclassification impact, demonstrating proper multi-hop synthesis across financial metrics and time periods. (4) The answer is highly contextually relevant, directly addressing the evolution of foreign currency instruments in terms of fair value and earnings impact. The only minor omission is the absence of the 2023 reclassification amount ($55.3 million), which slightly reduces completeness but does not impair the core factual accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 371,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "In 2022 Alabama Power held $55 million of energy‑related derivative assets against $11 million of related liabilities, and Georgia Power held $75 million of assets against $8 million of liabilities【page_311】. By 2023 those asset values had collapsed to $15 million (Alabama) and $13 million (Georgia) while the liabilities surged to $110 million and $124 million, respectively【page_281】, turning each utility from a net‑asset position to a net‑liability position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: for 2022, Alabama Power's $55M in assets and $11M in liabilities, Georgia Power's $75M in assets and $8M in liabilities; for 2023, Alabama Power's $15M in assets and $110M in liabilities, Georgia Power's $13M in assets and $124M in liabilities. (2) All numbers match exactly with the original answer, including directional changes—assets decreased and liabilities increased significantly for both companies. The calculation of net position shift (from net asset to net liability) is logically sound and correctly inferred. (3) The multi-hop reasoning is accurate: the model synthesizes data across two companies and two years, correctly identifying the trend in fair value evolution and the shift in asset versus liability positions. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing but no loss of meaning. All entities (Alabama Power, Georgia Power, energy-related derivatives, years 2022 and 2023) are correctly identified and contextualized. The inclusion of page references does not affect accuracy and may indicate source transparency. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 346,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was allocated about 65 % to fixed‑income securities (and cash) and 35 % to equity securities. By year‑end 2023 the mix had shifted to roughly 80 % fixed‑income and 20 % equity, reflecting a move toward a more conservative, higher‑fixed‑income allocation (TXN 10‑K 2023, page 49).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These values are correctly reported with acceptable wording variations (e.g., 'about', 'roughly') that do not affect accuracy. (2) The answer is complete, addressing the evolution of asset allocation between the two years and specifically covering both fixed income and equity securities as required. (3) Entity accuracy is correct—the U.S. Retiree Health Care Plan is properly identified, and the time periods (2022 and 2023) are accurate. The citation to 'TXN 10-K 2023, page 49' aligns with the source context. (4) The reasoning is sound: the shift from a more balanced allocation to a higher-fixed-income, lower-equity mix is correctly interpreted as a move toward a more conservative strategy, demonstrating proper multi-hop synthesis across years and asset classes. The semantic meaning is equivalent to the original answer, with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 313,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "In 2022 Gilead’s 10‑K listed Trodelvy (sacituzumab govitecan‑hziy) as approved only for (i) unresectable locally advanced or metastatic triple‑negative breast cancer and (ii) locally advanced or metastatic urothelial cancer after prior chemotherapy (see 2022 page 6). In 2023 the company reported that Trodelvy received both FDA and European Commission approval as a monotherapy for adult patients with unresectable or metastatic hormone‑receptor‑positive, HER2‑negative (HR⁺/HER2‑) breast cancer who have received endocrine‑based therapy and at least two additional systemic therapies (see 2023 page 39), adding this new HR⁺/HER2‑ indication to its label.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies the 2022 indications for Trodelvy: unresectable locally advanced or metastatic triple-negative breast cancer and metastatic urothelial cancer after prior therapies. (2) It accurately reports the 2023 regulatory developments: both FDA and European Commission (EC) approvals for HR+/HER2- breast cancer, specifying the patient population (adults with unresectable or metastatic disease who received endocrine-based therapy and at least two additional systemic therapies). (3) The multi-hop reasoning is sound—information is correctly synthesized across the 2022 and 2023 10-K filings to show the evolution in approval status. (4) All entities (drug name, companies implied via context, indications, regulatory bodies) are correct. (5) The answer addresses both parts of the question: evolution of approval status and new indications in 2023. Minor wording differences (e.g., 'monotherapy' not in original, but semantically acceptable) do not affect factual accuracy. Number formats and dates are correct. No omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 322,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "In the 2023 Form 10‑K Meta warned that if users do not view its products as useful, reliable and trustworthy, it could impair user acquisition, retention and the ad‑driven revenue that underpins its business (2023 p. 16). By the 2024 filing the company expanded the perception risk to cover how users react to product updates, safety and age‑appropriate features, competition and even perceived inaccuracies in its community metrics, stressing that negative perception could reduce engagement, ad impressions and damage its reputation and financial performance (2024 p. 25 & 30).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of Meta's 2023 and 2024 10-K filings regarding user perception risks and includes correct page references and risk descriptions (e.g., trustworthiness in 2023, product updates and community metrics in 2024), satisfying quantitative and entity accuracy. However, it contradicts the ground truth by claiming Meta *expanded* the scope of user perception risks in 2024, whereas the original answer states that Meta *reduced* explicit mention of user perception as a risk factor and shifted focus toward operational and financial risks like acquisition integration and tax liabilities. This misrepresents the core evolution of Meta's risk disclosure. The LLM fails to capture the strategic shift away from emphasizing user perception, instead suggesting a broadening of it, which is semantically and factually incorrect. While the answer addresses user perception and cites relevant risks, it misses the central point of a de-emphasis in 2024 and omits key new risk categories highlighted in the ground truth. Thus, despite correct formatting and some accurate content, the qualitative reasoning and overall correctness are significantly flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 334,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Lockheed Martin’s aggregate notional amount of interest‑rate swaps rose from about **$500 million at year‑end 2021** (LMT 2022 10‑K, page 66) to **$1.3 billion at year‑end 2024** (LMT 2024 10‑K, page 52), essentially tripling the exposure. This growth shows the company has been expanding its use of variable‑rate swaps to convert fixed‑rate borrowings into variable‑rate positions, indicating a more aggressive, proactive approach to hedging interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of Lockheed Martin's variable interest rate swaps as $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. The statement that the amount 'tripled' is a reasonable approximation (a 160% increase from $500M to $1.3B), though slightly overstated, but this does not constitute a factual error given common usage. (2) All numeric values and years are accurate and properly cited to the relevant 10-K filings. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two different years and filings, and infers the strategic shift in interest rate risk management—specifically, converting fixed-rate borrowings to variable-rate—consistent with the ground truth. (4) The qualitative interpretation ('more aggressive, proactive approach') adds slight emphasis not in the original, but remains logically consistent with the trend and context. The core information is semantically equivalent and fully addresses both parts of the question: evolution of notional amount and strategic implication. Minor wording differences do not affect factual correctness. Thus, the answer is highly accurate with only negligible interpretive expansion, warranting a 9/10 on correctness and qualitative accuracy, full marks on quantitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 389,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "In the 2022 filing PayPal recorded a $1.170 billion provision for transaction losses and an allowance of $66 million; in the 2023 filing the provision rose to $1.192 billion while the allowance was essentially unchanged at $64 million (ending balance $282 million versus $278 million)【page_113】. The larger 2023 provision and lower realized losses ($1.313 billion vs $1.417 billion) show that PayPal strengthened its financial backing for its Seller Protection Programs between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, PayPal's allowance for transaction losses decreased from $66 million in 2022 to $64 million in 2023, which the LLM correctly states. However, the LLM introduces a 'provision for transaction losses' of $1.170 billion in 2022 and $1.192 billion in 2023, which is not mentioned in the original answer and contradicts the qualitative-to-quantitative shift described in the ground truth. The ground truth does not provide total provisions at the billion-dollar level, nor does it state that realized losses were $1.313 billion or $1.417 billion—these figures are entirely fabricated or misattributed. (2) The only correct numbers are the $66 million (2022 allowance) and $64 million (2023 allowance), which match the ground truth. All other figures (e.g., $1.170B, $1.192B, $282M ending balance) are either incorrect or not present in the original context. The claim that the 'allowance was essentially unchanged' is misleading since it decreased slightly and the ground truth emphasizes this as part of a more structured disclosure trend. (3) The multi-hop reasoning is flawed. The original answer highlights a shift from qualitative risk discussion in 2022 (mentioning historical loss rates of 0.09%–0.15% of TPV and macroeconomic risks) to more precise financial disclosures in 2023. The LLM fails to mention this key evolution and instead invents a narrative about increasing provisions and 'strengthened financial backing,' which is unsupported. The reasoning based on 'larger 2023 provision and lower realized losses' is invalid because those numbers do not appear in the ground truth. (4) The contextual relevance is moderate because the answer discusses PayPal’s Seller Protection Programs and financial provisions over 2022–2023, aligning with the question’s scope. However, due to major quantitative errors and failure to capture the actual evolution (qualitative to quantitative reporting), the correctness score is low. The answer fabricates data rather than reflecting the documented shift in disclosure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 570,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "In FY 2023 Starbucks reported foreign‑currency‑other derivative assets of $32.0 million in prepaid/current assets and $22.9 million in other long‑term assets (total $54.9 million) and related liabilities of $2.0 million (accrued) 【page_68】. By FY 2024 those assets had fallen to $1.9 million (current) and $1.7 million (long‑term) – $3.6 million total – while liabilities rose to $4.7 million (accrued) and $4.1 million (long‑term) – $8.8 million total 【page_72】. Thus assets dropped about $51 million and liabilities rose about $7 million, turning a net $53 million asset position into a net $5 million liability – a balance‑sheet swing of roughly $58 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Starbucks reported a derivative asset of $1,164 million (not $54.9 million) for 'Foreign currency - other' in fiscal year 2023. The LLM incorrectly breaks this into $32.0 million (current) and $22.9 million (long-term), which contradicts the ground truth. The only correct figures in the LLM answer are the FY2024 asset total of $3.6 million (close to truth at $1.9 million, though still off) and the FY2024 liability increase to $4.7 million (which matches). However, the LLM invents a long-term liability of $4.1 million not mentioned in the original answer and not supported by the truth. (2) Calculations are therefore flawed: the claimed $51 million drop in assets is incorrect because it's based on a false starting point ($54.9M vs actual $1,164M). The actual drop was ~$1,162 million, making the LLM's calculation off by over $1.1 billion. The net shift from a $53M asset to $5M liability is entirely fabricated due to incorrect inputs. (3) Multi-hop reasoning is partially sound in structure—comparing changes in assets and liabilities across years and assessing balance sheet impact—but fails due to reliance on incorrect data. The model attempts synthesis across years and components (current vs long-term), but the entities and values are misaligned with the ground truth. (4) Scores reflect major quantitative errors (2/10), weak qualitative reasoning due to incorrect data sourcing (4/10), high contextual relevance as it addresses the right question about changes in derivative positions (8/10), and a low overall correctness score (3/10) due to fundamental factual inaccuracies that invalidate conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 474,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "In 2022 the energy‑related derivatives that were not designated as hedges produced no material gain or loss on natural‑gas revenues and no effect on the cost of natural gas – essentially a neutral impact. By 2023 those same derivatives generated a $59 million pre‑tax gain on the cost of natural gas while the revenue impact remained neutral, turning the position from a zero effect in 2022 to a $59 million benefit in 2023【page_295】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on cost—both material and negative. However, the LLM claims a neutral impact (no gain or loss) on both revenue and cost in 2022, which directly contradicts the original answer. The only correct quantitative figure is the $59 million pre-tax gain on cost in 2023. The revenue impact in 2023 is correctly stated as neutral ($0), matching the ground truth. (2) Quantitative accuracy is low: two major figures ($117M revenue loss and $27M cost loss in 2022) are omitted and falsely reported as neutral. The $59M gain in 2023 on cost is correct. (3) The reasoning is partially sound in noting a shift from neutral/no effect in 2022 to a positive effect in 2023, but this is based on incorrect 2022 data. The multi-hop synthesis fails because it does not accurately reflect the worsening impact in 2022 before improvement in 2023. (4) Contextual relevance is high as the answer addresses the evolution of derivatives' impact on cost and revenue over the two years, using appropriate financial terminology and citing a document page. However, due to major factual errors in the 2022 figures, the overall correctness score is low despite partial alignment in structure and direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 394,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K Walmart simply listed the Deferred Compensation Matching Plan as an exhibit (marked “10.1* … effective November 8 2023 (C)”) 【page_84】, indicating it was filed herewith but not incorporated by reference. By the 2024 Form 10‑K the same plan was described as “incorporated by reference to Exhibit 10.1 … effective November 8 2023” 【page_84】, so the documentation shifted from a stand‑alone exhibit to an incorporated‑by‑reference filing, while the plan’s effective date remained November 8 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the effective date of the plan is accurately stated as November 8, 2023, in both filings, and there is no discrepancy in dates or numbers. (2) The documentation status evolution is correctly captured: in 2023, the plan was filed as a stand-alone exhibit (‘filed herewith’), while in 2024 it was ‘incorporated by reference,’ indicating integration into ongoing disclosures. This matches the ground truth’s claim of shifting from ‘newly introduced’ to ‘established.’ (3) The multi-hop reasoning across two years of 10-K filings is sound—LLM correctly identifies the change in treatment despite no change in effective date. (4) The only minor shortcoming is that the LLM does not explicitly interpret the shift as signaling the plan becoming ‘established’ or ‘integrated into long-term compensation framework,’ which the original answer infers. However, the factual basis for that inference is fully present. Wording differs but semantic meaning is equivalent. No calculation errors. Page references add precision. Thus, high scores across all categories with a 9 on correctness due to slightly less interpretive completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 344,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings note that LTIP units are “potentially dilutive” but that they **had no material dilutive effect** for the years covered (2023 and 2024, respectively). The company’s treatment is unchanged – it does not adjust net income for income allocable to limited‑partner or unit interests and **continues to accrue dividends on LTIP units when declared** – the 2024 filing merely updates the statement to include the additional year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution (or lack thereof) in the disclosure and treatment of LTIP Units between 2023 and 2024. (1) It correctly states that LTIP Units are considered 'potentially dilutive' but had no material dilutive effect in both years, aligning with the ground truth for 2023 (covering 2023, 2022, 2021) and 2024 (covering 2024, 2023, 2022). The dates and periods are factually correct. (2) Quantitatively, there are no numerical inaccuracies—no specific dollar amounts or percentages are involved, but the temporal coverage is correctly represented. The answer correctly notes the continuity in policy. (3) The reasoning is sound: it identifies that the treatment remained unchanged, including the non-adjustment of net income and the accrual of distributions when declared. The only minor omission is that the 2024 filing 'simplified' the disclosure language, which the LLM does not explicitly mention, though the substance is preserved. (4) The answer is contextually fully relevant, directly addressing both dilutive effect and accrual policy. The conclusion that the 2024 update merely extends the reporting period is consistent with the stability emphasized in the ground truth. Overall, the answer is semantically equivalent with only a slight lack of detail on the simplification of disclosure in 2024, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 384,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "In its 2023 Form 10‑K Meta reported that, after the EU‑U.S. Data‑Privacy Framework was approved and the European Commission issued an adequacy decision, the company was “implementing steps to comply with the above corrective orders following engagement with the Irish Data Protection Commission (IDPC)” 【page_10】. By the 2024 filing Meta says it is still carrying out those compliance steps but has moved to actively contest the regulator’s actions – it is appealing the IDPC’s final decision (currently stayed by an Irish High Court) and warns that a further CJEU invalidation of the EU‑U.S. DPF would create material uncertainty, reflecting a shift from straightforward implementation to a defensive, litigation‑focused approach to the framework 【page_11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of Meta's compliance evolution. (1) Correct elements: The mention of the EU-U.S. DPF adequacy decision in 2023 and Meta’s engagement with the Irish Data Protection Commission (IDPC) aligns with the original answer. The reference to ongoing compliance steps and legal appeals in 2024 is factually plausible and consistent with public knowledge. There are no numeric inaccuracies, as no specific figures (e.g., the €1.2 billion fine) are incorrectly stated—though the fine itself is omitted. (2) Quantitative accuracy is scored highly because no numbers are misstated; however, the absence of the €1.2 billion fine—a critical quantitative detail in the ground truth—represents a significant omission. (3) Qualitative accuracy suffers due to flawed reasoning and incomplete synthesis: the LLM emphasizes a shift toward a 'defensive, litigation-focused approach' and appeal efforts, which is not mentioned in the ground truth. Instead, the original answer highlights Meta’s implementation of corrective measures and introduction of a 'subscription for no ads' model under the DMA, followed by EC scrutiny in 2024. This key evolution—shifting from data transfer compliance to navigating DMA-specific business model challenges—is entirely missing in the LLM response. (4) Contextual relevance is strong because the answer addresses regulatory engagement and changes in Meta’s approach over time, but it fails to capture the actual regulatory shift from SCCs/EU-U.S. DPF compliance to DMA enforcement dynamics. The LLM substitutes this with a narrative about litigation and CJEU risks, which, while contextually relevant, misrepresents the core evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 480,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "In the 2023 filing Linde defined “green” hydrogen as being produced either by electrolysis using renewable electricity **or** by steam‑methane reforming of biomethane (2023 10‑K p. 4). By the 2024 filing the company’s description was narrowed to green hydrogen made **solely** by electrolysis that uses renewable energy and water (i.e., a non‑fossil feedstock), placing a stronger emphasis on renewable electricity as the production method (2024 10‑K p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift in Linde's definition of green hydrogen between 2023 and 2024: in 2023, green hydrogen included both electrolysis using renewable electricity and steam methane reforming (SMR) of biomethane, while in 2024, the definition was narrowed to only electrolysis using renewable energy and water as feedstock. This matches the original answer's claim about a more refined framing. (2) There are no numerical values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—comparing Linde’s disclosures across two years and synthesizing changes in terminology and emphasis. The LLM correctly infers a strategic shift toward emphasizing renewable electricity and non-fossil feedstocks. (4) The only minor omission is that the LLM answer does not explicitly mention the increased emphasis on 'carbon intensity' as a differentiating metric in 2024, which is included in the original answer and adds depth to the strategic reframing. However, the core evolution in production methods and renewable energy emphasis is fully captured. Wording differences are semantically equivalent, and the citations to the 10-K pages support accuracy. Thus, the answer is excellent but slightly less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 371,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "In the 2022 filing Southern Company Gas disclosed that it had completed the sale of Sequent on July 1 2021 for $159 million, generating a pre‑tax gain of roughly $121 million (about $92 million after tax) and incurring $85 million of additional tax expense (page_57). By the 2023 filing the wholesale‑gas‑services segment that previously included Sequent was no longer a reportable segment, reflecting that Sequent is fully divested and its revenues and earnings are no longer shown in segment results (page_302). The transaction produced a one‑time cash inflow and gain while eliminating the $188 million of 2021 wholesale‑gas‑services revenue and its associated net income from subsequent reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the timing of the sale. The ground truth states the sale occurred in 2022, but the LLM claims it was completed on July 1, 2021, which is incorrect and undermines the core timeline of the relationship evolution. This error affects the entire narrative of how the relationship changed between 2022 and 2023. The financial figures—$159 million sale price, $121 million pre-tax gain, and $85 million additional tax expense—are correctly reported and match the ground truth, supporting partial quantitative accuracy. The after-tax gain of $92 million is not mentioned in the original answer and may be inferred, but it's not part of the ground truth, so its inclusion is extraneous but not necessarily wrong. (2) The LLM correctly identifies that Sequent was fully divested by 2023 and that it was no longer part of the reportable segments, which aligns with the ground truth’s claim that Sequent was no longer in Southern Company’s portfolio. The mention of eliminating $188 million of 2021 wholesale-gas-services revenue is not in the original answer and introduces data not confirmed by the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects the divestiture to the removal of the segment in 2023 filings and infers operational and reporting consequences. However, the incorrect sale date breaks the causal link between 2022 and 2023 developments, weakening the reasoning. The model does synthesize information across years and documents, but on a flawed premise. (4) Despite the timeline error, the answer addresses both parts of the question—evolution of the relationship and financial implications—with mostly accurate financial figures and correct entity names (Southern Company Gas, Sequent, Williams not mentioned but not required). The contextual relevance is high because it directly responds to the question’s focus on change over time and financial impact. However, the incorrect date and introduction of unverified revenue figures prevent a higher score. Correctness is penalized heavily due to the critical error in timing, which distorts the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 596,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "In the 2023 Form 10‑K Walmart identified Allswell as one of its private‑brand lines (see 2023 page 7). The 2024 Form 10‑K still lists Allswell, now alongside a much larger set of private brands (see 2024 page 7), showing that the brand remains part of Walmart’s assortment and is being integrated into an expanding private‑label portfolio. This continuity and broader rollout indicate that Walmart is positioning Allswell as a stable, core element of its strategy to grow private brands for price leadership and differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Allswell was listed in both the 2023 and 2024 Form 10-K filings, confirming its introduction and continued presence. The years (2023, 2024) and document references (page 7 of each 10-K) are accurate, satisfying quantitative accuracy. (2) The answer addresses all parts of the question: the evolution of Walmart's relationship with Allswell (from inclusion in 2023 to continued presence in 2024) and the strategic implication (integration into a broader private-label portfolio as a stable, core brand). (3) Multi-hop reasoning is sound—by noting Allswell’s retention and co-listing with established brands like Equate and Great Value (implied by 'larger set'), the model correctly infers growing strategic importance. (4) While the ground truth explicitly names other brands (e.g., 'bettergoods'), the LLM captures the same semantic meaning by referencing integration into an 'expanding private-label portfolio' and positioning for 'price leadership and differentiation.' The only minor gap is not explicitly stating that Allswell moved from 'newly introduced' to 'established,' but the conclusion that it is now a 'stable, core element' conveys equivalent qualitative insight. No calculation errors or factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 372,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "In the 2022 filing TXN already treated Embedded Processing as a distinct, reportable segment (page 32) that generated roughly $3 billion of revenue – about 16‑17 % of total sales (page 33). By 2023 the MD&A stresses that “our strategic focus is on analog and embedded processing products” and notes that “higher revenue from Embedded Processing” helped offset a decline in analog sales (page 19), showing that the business is now leaning more heavily on the Embedded Processing line and its share of revenue is growing, underscoring an elevated strategic importance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in quantitative accuracy by stating that Embedded Processing generated 'roughly $3 billion' in revenue in 2022, which is not supported by the ground truth—no specific revenue figures for Embedded Processing were disclosed in 2022. This introduces a major inaccuracy. Additionally, the claim that it constituted 16–17% of total sales lacks verification from the original answer and cannot be confirmed as correct. (2) The total revenue in 2023 was stated as $17.52 billion in the ground truth, but the LLM does not mention this figure or verify the percentage contribution of Embedded Processing, missing an opportunity for accurate synthesis. While it correctly notes that Embedded Processing helped offset a decline in Analog revenue, it fabricates or infers revenue numbers not present in the source. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies that Embedded Processing remained a strategic focus and played a compensatory role in 2023, aligning with the ground truth's emphasis on its increased functional importance during a revenue downturn. It also accurately reflects TXN’s continued strategic emphasis on both Analog and Embedded Processing. The multi-hop synthesis—comparing strategic language across 2022 and 2023 filings and inferring increased reliance—is logically constructed and contextually appropriate. (4) Contextual relevance is high because the response directly addresses the evolution of strategic importance through revenue dynamics and corporate emphasis. However, the inclusion of unverified financial figures significantly undermines factual correctness, warranting a moderate overall score of 6 despite strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 477,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "In 2022 Chevron disclosed a 36.4 % equity stake in Angola LNG and that the project contributed roughly 78 k bbl of oil‑equivalent per day and 52 MMCFD of gas to its production (2022 10‑K, page 10). By 2024 the company still holds the same 36.4 % interest but reports a transfer of about 75 million BOE to proved‑developed reserves “primarily at Angola LNG” and $0.8 billion of offshore development spending in Angola (2024 10‑K, pages 85, 111, 117). This move from modest production to adding significant proved reserves and continued investment signals Chevron is deepening its commitment to Angola LNG and positioning itself as a larger, more integrated player in the global LNG market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Chevron's involvement was referenced in terms of production volumes without specifying the stake. However, the LLM claims Chevron 'disclosed a 36.4% equity stake in Angola LNG' in 2022, which contradicts the original answer that only in 2024 was the 36.4% stake explicitly stated. This misrepresents the evolution, making it appear that the stake was known and stable over time, when the key point in the ground truth is the shift from operational participation to a formally defined stake. Additionally, the LLM introduces specific production figures (78 k bbl/day, 52 MMCFD), reserves transfer (75 million BOE), and $0.8 billion spending not present in the original answer, which lacks such granular data. These numbers may be plausible but are not supported by the provided ground truth, making them hallucinated or incorrectly inferred. (2) Quantitative accuracy is low because the core percentage (36.4%) is attributed to the wrong year, and unsupported figures (production, reserves, capex) are introduced without basis in the ground truth. Even if these numbers exist in actual filings, they are not part of the verified knowledge graph answer and thus cannot be considered correct in this evaluation context. (3) The multi-hop reasoning is partially sound—the idea that increased reserves and investment indicate deeper commitment is logical—but it's built on incorrect premises. The evolution in the original answer hinges on the *explicit disclosure* of stake in 2024 versus earlier operational mentions, not on reserve additions or spending. The LLM constructs a more detailed narrative but misses the actual strategic signal: formalization of ownership rather than expansion of activity. (4) Contextual relevance is high because the answer addresses Chevron’s evolving role in Angola LNG and draws a conclusion about strategic positioning in the LNG market, aligning with the question’s intent. However, correctness and quantitative accuracy are severely compromised by factual misstatements and hallucinated data, limiting its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 579,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "In 2021 the CH‑53K heavy‑lift helicopter was a major source of RMS growth – higher production volume helped lift RMS net sales by $540 million and added about $140 million of operating profit to the Sikorsky helicopter line 【page_50】. By 2024 the program remains a key growth driver, contributing to the $1.1 billion increase in RMS product sales as its production continues to ramp up, even as other helicopter volumes (e.g., VH‑92A) fell 【page_40】【page_34】. This evolution shows the CH‑53K has become a core, high‑volume, profit‑generating platform that underpins RMS’s helicopter portfolio and overall segment performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures from the ground truth: the $540 million increase in RMS net sales and $140 million in operating profit in 2021, and the $1.1 billion contribution to product sales in 2024. These numbers match the original answer exactly and are attributed to the correct time periods and financial metrics. (2) Quantitative accuracy is perfect—no calculation errors, and the values are reported with correct magnitudes and units (e.g., $540 million vs $1.1 billion). Format variations (e.g., $1.1 billion vs $1.1B) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across 2021 and 2024 to show an evolution in the program’s status from a growth contributor to a core, high-volume platform. It correctly infers the transition from risk retirement and initial production ramp-up to mature volume production, even using context about declining volumes in other programs (e.g., VH-92A) to highlight CH-53K’s relative importance. This aligns with the ground truth’s conclusion about its role as a key growth driver. (4) The only minor shortcoming is that the LLM answer refers to the $140 million profit as being added to the 'Sikorsky helicopter line' rather than explicitly to RMS, though Sikorsky is a part of RMS and this is contextually reasonable. Additionally, the original answer explicitly mentions 'risk retirements' as a factor in 2021 profitability, which the LLM omits. These are minor omissions that do not undermine the overall correctness. The answer is contextually excellent, directly addressing the evolution of financial contribution, production status, and strategic role within RMS.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 470,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "In the 2022 filing, PayPal’s loss‑curve for revolving consumer credit was built on macro‑economic inputs such as projected unemployment trends and benchmark credit‑card charge‑off rates, applying a roughly two‑year forecast horizon. By the 2023 filing, the company expanded the macro‑economic drivers to include household disposable‑income trends (while still using retail e‑commerce sales and unemployment rates) and extended the forecast period to about 5 years (5 years 7 months), updating the models in Q2 2023 but without a material impact on the provision.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of PayPal's use of macroeconomic factors in its loss curves and correctly identifies the inclusion of household disposable income and retail e-commerce sales in 2023. However, it contains significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that unemployment rates were still used in 2023, whereas the ground truth specifies that unemployment rates were *replaced* after Q1 2023. Second, the LLM introduces a forecast horizon extension to '5 years 7 months' and a model update in Q2 2023 'without material impact'—details not present in the original answer and unsupported by the ground truth. These quantitative and qualitative errors undermine the accuracy. While the core idea of expanding macroeconomic drivers is correct, the failure to note the *replacement* of unemployment and the introduction of unsupported details (forecast length, immaterial impact) result in partial correctness. The answer is contextually relevant and addresses the question's intent, but the incorrect retention of unemployment and fabricated numerical details (forecast duration) severely limit factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 331,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks’ net gain on foreign‑currency‑denominated debt that remained in AOCI fell to **$135.2 million for FY 2024**, down from **$140.2 million for FY 2023** – a decline of roughly **$5 million** (see the “Foreign currency debt” line in the AOCI table on page 70). The modest drop, while still leaving a positive balance, suggests the company’s exposure to foreign‑currency fluctuations is relatively limited and its hedging program continues to offset most of the risk, though the net benefit was slightly lower in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change in foreign currency debt-related gains/losses. According to the ground truth, Starbucks had a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024, representing a shift from loss to large gain. However, the LLM claims a decrease from $140.2 million in 2023 to $135.2 million in 2024 — both of which are incorrect values and misrepresent the trend entirely. The LLM incorrectly states there was a net gain in 2023 when in fact there was a loss. (2) Quantitative accuracy fails because the numbers cited ($140.2M and $135.2M) do not match the ground truth ($-6.3M and $135.2M). The calculation of a $5M decline is therefore based on false inputs and is also incorrect. The only correct number is $135.2M for 2024, but it is mischaracterized as a reduction rather than a significant improvement from a loss. (3) The multi-hop reasoning is flawed: the model fails to recognize that a loss in 2023 turning into a gain in 2024 indicates increased sensitivity or exposure to currency fluctuations, not limited exposure. The conclusion that exposure is 'relatively limited' contradicts the significant reversal implied by the data. The reasoning does not align with the actual financial shift. (4) Contextual relevance is moderate because the answer addresses AOCI, foreign currency debt, and Starbucks, and references the correct type of disclosure (AOCI table), but the substance is wrong. Due to major factual and directional errors, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 447,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "At December 31 2023 Alabama Power reported $15 million and Georgia Power $13 million of energy‑related derivative assets (fair‑value) 【page_281】, while the 2022 filing did not disclose the subsidiaries separately and only gave a total of $199 million of such assets for the whole Southern Company 【page_283】.  Their derivative liabilities rose from $210 million in 2022 (total for the company) to $110 million + $124 million = $234 million for the two utilities in 2023 【page_283】【page_281】, showing an overall increase in combined liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. It incorrectly states that derivative liabilities for Alabama Power and Georgia Power rose from $210 million in 2022 to $234 million in 2023, claiming an increase. However, the ground truth shows that in 2022, Alabama Power alone had a net liability of $144 million (with no data provided for Georgia Power separately in 2022), and in 2023, the combined net liability was $206 million ($95M for Alabama Power + $111M for Georgia Power). The original answer calculates a decrease from a combined $255 million in 2022 (Alabama $144M + Georgia $111M implied from prior year trend or external data) to $206 million in 2023. The LLM fails to report Alabama Power’s 2022 net liability of $144 million and incorrectly aggregates liabilities using total company figures for Southern Company rather than the correct subsidiary-level data. (2) The LLM misrepresents the 2022 liability figure as $210 million for the entire company, which is not equivalent to the sum of the two subsidiaries’ liabilities. It also incorrectly infers an increase in liabilities when the actual trend is a decrease in combined net liability from $255M to $206M. The asset figures for 2023 ($15M and $13M) are correctly cited, but the absence of 2022 subsidiary-level breakdown does not justify using total company figures without clarification. (3) The multi-hop reasoning is flawed: the model fails to correctly identify and isolate the relevant entities (Alabama Power and Georgia Power), uses incorrect aggregate data from the parent company (Southern Company), and draws an opposite conclusion (increase vs. actual decrease). It does not compute net liabilities per entity or year correctly. (4) Despite these major errors, the answer is contextually relevant—it addresses the right topic, cites fair value of energy-related derivatives, and attempts to compare across years and entities. However, due to severe quantitative and qualitative inaccuracies, especially in core financial figures and directional trend, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 564,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart bought Alert Innovation for about $0.4 billion in fiscal 2023, bringing its stake to roughly 100 % of the company【page_45†L31-L34】. The 2024 filing reports no additional purchase or sale of Alert Innovation during that year, noting only that the entity is slated to be sold and de‑consolidated in fiscal 2025【page_44†L31-L34】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart's ownership reaching approximately 100%, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation are planned for fiscal 2025, whereas the ground truth confirms the disposition occurred in fiscal 2024. This is a critical factual error regarding timing and the evolution of the financial relationship. (2) Quantitatively, the $0.4 billion figure and 100% ownership are accurate, and no incorrect calculations are made. The dollar amount and percentage are correctly reported. (3) The multi-hop reasoning fails because the LLM does not correctly synthesize the timeline: it should conclude that Walmart moved from acquisition in 2023 to divestiture in 2024, but instead claims the sale is slated for 2025, contradicting the ground truth. This undermines the core of the question about the evolution between fiscal 2023 and 2024. (4) Contextual relevance is moderate—the answer addresses the acquisition and mentions a future disposition, but misplaces the event outside the requested timeframe, making the response misleading on the key point of evolution within a one-year span. The citation references also suggest the model relied on correct documents but misinterpreted or misreported the timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 378,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "In the 2022 Form 10‑K Trodelvy was listed as an approved product for triple‑negative breast cancer and urothelial cancer, while its use in HR⁺/HER2‑ breast cancer was still only being evaluated (2022 10‑K p. 6; p. 8). By the 2023 Form 10‑K Gilead announced that Trodelvy had obtained both FDA and European Commission approval for HR⁺/HER2‑ metastatic breast cancer (2023 10‑K p. 39). This shift from evaluation to new regulatory approvals shows Gilead’s oncology strategy of expanding the indications of existing assets to deepen its cancer franchise and capture additional market opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Trodelvy was approved for triple-negative breast cancer and urothelial cancer, with HR+/HER2- breast cancer still under evaluation—consistent with the absence of new regulatory approvals for that indication in 2022. By 2023, it accurately reports that Trodelvy received both FDA and European Commission (EC) approval for HR+/HER2- metastatic breast cancer, matching the original answer. (2) There are no numeric values requiring calculation, but the dates (2022 vs. 2023) and regulatory bodies (FDA, EC) are correctly cited. Format variations (e.g., 'European Commission' vs. 'EC') are semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings to show an evolution from investigational status to approval, demonstrating a clear understanding of regulatory progression. (4) The conclusion about Gilead’s oncology strategy—expanding indications of existing assets to strengthen its cancer franchise—is logically derived and semantically equivalent to the original answer’s claim about 'expanding therapeutic applications' and 'strengthening its position in the oncology market.' The only minor shortcoming is that the LLM does not explicitly mention 'unresectable locally advanced or metastatic' disease or the requirement of prior endocrine-based therapy and two additional systemic therapies, which are included in the ground truth. While this adds specificity, the core regulatory and strategic points are correctly conveyed. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 467,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "In 2023 Simon’s equity stake in Authentic Brands Group was steadily reduced through a series of ABG‑initiated capital transactions that cut its ownership from roughly 11.8% to about 9.6% and produced non‑cash pre‑tax gains of $36.4 million, $12.4 million and $10.3 million, plus a cash sale of a portion of its ABG interest for $157.1 million (pre‑tax gain $157.1 million)【page_72】【page_73】. By early 2024 Simon completed its exit, selling the remaining ABG interest for $1.2 billion, realizing a $414.8 million pretax gain and ending its strategic equity partnership with ABG【page_73】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The numbers reported are largely incorrect. The ground truth states non-cash pre-tax gains of $36.4 million (Q2 2023) and $145.8 million (Q3 2023) due to dilution, but the LLM reports gains of $36.4M, $12.4M, $10.3M, and a $157.1M cash sale with a $157.1M gain — none of which match the original. Most critically, the LLM claims a $1.2 billion sale in early 2024 with a $414.8M gain, which contradicts the ground truth that SPG had no active capital transactions with ABG in 2024. These figures are not supported by the original answer and represent a complete misrepresentation of the financial activity. (2) Completeness: While the question asks about the evolution between 2023 and 2024, the LLM incorrectly frames 2024 as a year of active exit and realization, whereas the ground truth emphasizes the absence of new transactions and only historical references in 2024. The strategic positioning aspect is partially addressed via mention of partnership, but the shift from active to passive engagement is misrepresented. (3) Entity Accuracy: The companies (Simon Property Group, ABG) and general timeline (2023–2024) are correct, but the nature of transactions (e.g., 'cash sale', 'exit') and associated metrics are wrong. (4) Reasoning: The multi-hop synthesis fails — instead of recognizing a reduction in active involvement from 2023 to 2024, the model invents a full exit in 2024 not present in the ground truth. This reflects flawed reasoning. (5) Semantic Equivalence: The overall message is not equivalent — the original describes a cooling of financial activity, while the LLM describes an active divestment and termination of relationship, which is unsupported. Thus, despite some correct context (e.g., dilution in 2023), the core financial claims and evolution narrative are factually wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 526,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "In the 2022 Form 10‑K Chevron disclosed Chevron Phillips Chemical Company LLC as a downstream equity affiliate, reporting $867 million of equity earnings for that year (see Note 8 in the 2022 filing [page 32]). By the 2024 filing the company’s investment in CPChem had risen to $8.571 billion and its share of CPChem’s earnings increased to $903 million (up from $608 million in 2023) (Note 15 [page 84]), and downstream affiliate capital expenditures grew to $998 million from $960 million in 2022 (Note 52 [page 52]), reflecting a larger, more actively reported financial stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness, despite addressing the right question and providing relevant context. (1) The most critical error is the mischaracterization of Chevron Phillips Chemical Company LLC's (CPChem) accounting treatment in 2022: the original answer states it was a consolidated subsidiary in 2022 (per Note 8, page 70), but the LLM incorrectly claims it was already an equity affiliate in 2022 (citing Note 8, page 32). This is a fundamental qualitative error in financial reporting classification, as consolidation vs. equity method reflects different ownership/control structures. (2) The LLM reports $867 million in equity earnings for CPChem in 2022, but the ground truth does not provide this figure, and more importantly, if CPChem were consolidated in 2022, its earnings would be fully integrated into Chevron’s income, not reported as equity earnings—further contradicting the LLM’s claim. (3) The 2024 investment value of $8,571 million matches the ground truth, which is accurate. However, the LLM cites $608 million in equity earnings for 2023 and $903 million for 2024, which are not present in the ground truth and cannot be verified; the original answer only provides investment values ($7,765M in 2023, $8,571M in 2024), not earnings. (4) The LLM introduces downstream affiliate capital expenditures ($998M in 2024) from Note 52, which is contextually relevant but not directly tied to CPChem specifically, risking conflation with other affiliates. (5) The multi-hop reasoning is partially sound—comparing investment values over time—but fails on the key point of the accounting change from consolidation to equity method, which the LLM misses entirely. Instead, it assumes equity method treatment in both years, missing the evolution in relationship. Thus, while some numbers (2024 investment value) are correct and the answer is contextually relevant, the core financial reporting evolution is misrepresented, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 552,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "By the end of 2023 Meta noted that the facilities‑consolidation actions launched in 2022 were “substantially completed” (2023 10‑K, p. 104). At the close of 2024 the company said the 2022 restructuring – including the facilities‑consolidation effort – was fully completed, and it recorded $389 million of pre‑tax restructuring charges in 2024, all attributable to facilities consolidation (2024 10‑K, p. 102).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Meta's Facilities Consolidation Strategy from 'substantially completed' in 2023 to fully completed in 2024, aligning with the ground truth's key qualitative progression. It accurately references the 2022 restructuring initiatives and correctly identifies that the 2024 completion includes facilities consolidation. However, the quantitative claim of '$389 million of pre-tax restructuring charges in 2024, all attributable to facilities consolidation' is not supported by the ground truth, which states that the 2024 disclosure included a *retrospective summary* of charges across 2022–2024, not that $389M was newly recorded in 2024. The ground truth does not specify the 2024 charge amount or attribute it entirely to facilities consolidation, making this a significant numerical inaccuracy. While the LLM correctly cites document sources and years, the addition of a specific dollar figure not present in the ground truth undermines quantitative accuracy. The reasoning is otherwise sound, with proper multi-hop synthesis between 2023 and 2024 disclosures, and the answer remains contextually relevant and focused on the question. The core status evolution is correct, but the unsupported financial figure reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 358,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin described hypersonics only as a set of existing programs within its Space and Missiles & Fire Control segments, noting “several programs … to design, develop and build hypersonic strike weapons” for the Army, Navy and Air Force (2022 p.8; 2022 p.4). By the 2024 filing the company still runs those same programs, but now highlights hypersonics as a key pillar of its Advanced Development (Skunk Works) effort and a strategic focus for future systems, while the work remains in the design‑development‑build phase across multiple business lines (2024 p.5; 2024 p.4).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its characterization of the program status evolution. While it correctly identifies that Lockheed Martin had hypersonics programs in both 2022 and 2024 and references the right business segments and military branches, it incorrectly states that by 2024 the work 'remains in the design-development-build phase.' This contradicts the ground truth, which indicates a major shift from a funding-dependent development phase in 2022 to active production of hypersonic strike weapons in 2024 under multiple programs with the Air Force and Army. The LLM answer fails to capture this critical progression from development to production, which is the central point of the evolution in strategic focus and program status. There are no numerical inaccuracies (hence high quantitative accuracy), and the entities (Lockheed Martin, military branches, business segments) are correctly identified. The contextual relevance is high as the answer addresses the right topic and timeframe, but the reasoning is flawed in synthesizing the change over time—missing the key multi-hop insight that hypersonics moved from a contingent future opportunity to an active production program. This omission undermines the qualitative accuracy and overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 374,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "In the 2022 filing Southern Company reported most of its energy‑related derivatives as hedging instruments – $175 million of assets and $165 million of liabilities were classified as regulatory hedges and $21 million of assets and $549 million of liabilities as cash‑flow/fair‑value hedges – and the non‑designated contracts produced a pre‑tax loss of $76 million (‑$11 million on natural‑gas revenue and ‑$65 million on cost)【page_290】.  By 2023 the company had re‑classified many of those contracts, with regulatory‑hedge balances falling to $43 million of assets and $315 million of liabilities and cash‑flow/fair‑value hedge balances shrinking to $3 million of assets and $419 million of liabilities, while the non‑designated derivatives now generated a $59 million pre‑tax gain on natural‑gas cost and no impact on revenue, turning the prior loss into a gain【page_290】【page_295】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and introduces specific dollar amounts and classifications not present in the original ground truth, which only discusses disclosure practices and the shift in reporting scope. The ground truth states that in 2022, Southern Company reported pre-tax effects of unrealized gains/losses from derivatives designated as regulatory hedging instruments, and in 2023 expanded disclosure to include non-designated derivatives across 2023, 2022, and 2021. However, the LLM answer fabricates detailed balance sheet figures (e.g., $175M assets, $549M liabilities) and specific pre-tax loss/gain amounts ($76M loss, $59M gain) with breakdowns by revenue and cost that are not in the original answer. These numbers may be from the filing but were not part of the verified ground truth derived from the knowledge graph, making them factually unverifiable in this context. The qualitative direction of change—increased disclosure around non-designated derivatives—is partially aligned, suggesting some correct reasoning about evolving disclosure practices. However, the emphasis on reclassification of hedge balances and reversal of losses into gains goes beyond the original answer’s focus on disclosure evolution and implies financial statement impacts not confirmed in the ground truth. The reasoning is partially sound in identifying a shift in treatment but overreaches by emphasizing quantitative financial impacts and balance sheet movements not required or confirmed by the question. Contextually, the answer addresses the right topic and timeframe, showing relevance, but fails on factual correctness due to unsupported numerical claims. Thus, the correctness score is low due to major quantitative errors, despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 485,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "In the 2022 Form 10‑K Gilead still listed Truvada (and Truvada for PrEP) among its marketed products (see 2022 page 6), but the filing gave no specific patent expiration dates or new patent filings for the drug, implying that its key patents had already expired. In the 2023 Form 10‑K the product is absent from both the marketed‑product description and the patent‑expiration table (2023 page 9), showing that Gilead no longer discloses any active IP protection for Truvada and has shifted its strategy away from pursuing or highlighting patents for that product.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects, leading to a partially correct assessment. (1) Quantitatively, there are no explicit numerical errors—the absence of specific patent dates or mentions in filings is consistent with the idea that Truvada’s key patents had expired. The reference to page numbers (2022 page 6, 2023 page 9) aligns with typical 10-K structures, though these are not verifiable without document access. (2) However, the LLM incorrectly states that Truvada is 'absent' from the marketed-product description and patent-expiration table in the 2023 10-K. This contradicts the ground truth, which indicates that Gilead *did* provide structured disclosures about Truvada’s patent expiration in 2023, suggesting it was still mentioned for transparency on IP timelines. The claim that Gilead 'no longer discloses any active IP protection' and has 'shifted strategy away from pursuing or highlighting patents' misrepresents the evolution: the truth is a shift from reactive acknowledgment of past loss (2022) to proactive disclosure of expiration timelines (2023), not a complete withdrawal of mention. (3) The multi-hop reasoning is flawed—the model infers absence from a table as evidence of strategic retreat, whereas the ground truth shows increased structured disclosure, indicating a more transparent, forward-looking IP strategy. (4) While the answer addresses the question’s focus on patent disclosures and timeframes, it draws an incorrect conclusion about Gilead’s strategy, missing the nuance of evolving from discussing past exclusivity loss to providing future expiration dates. Thus, while contextually relevant and factually plausible in parts, the answer fails to capture the actual strategic evolution, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 496,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "In the 2022 filing the Operating Partnership drew $1.05 billion from the Supplemental Facility on December 14 2021 and then repaid the entire amount on January 12 2022 with proceeds from a $500 million floating‑rate and $700 million fixed‑rate senior‑note issuance【page_73】. In the 2024 filing the partnership again tapped the facility for €750 million in early 2023 (a €750 million interest‑rate swap on January 10 2023) and fully retired that borrowing on November 17 2023 by issuing €750 million of senior unsecured bonds, after which the Supplemental Facility shows no outstanding balance and is described only as a standby source of liquidity with a $3.5‑$4.5 billion capacity (pages 70, 68‑71).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in dates and details. The ground truth states SPG borrowed $1.05 billion in January 2022, while the LLM claims the draw occurred on December 14, 2021, and repayment on January 12, 2022. This discrepancy affects quantitative accuracy. Additionally, the LLM attributes the repayment to proceeds from a $500M floating-rate and $700M fixed-rate note issuance (totaling $1.2B), which is plausible but not mentioned in the original answer—this adds detail not in the ground truth, potentially overreaching. (2) The 2024-related figures are accurate: €750 million borrowed (U.S. equivalent $815.4M is implied and reasonable), repaid on November 17, 2023, via bond issuance. The LLM correctly notes the facility is now a standby source with $3.5–$4.5 billion capacity, which adds context not in the original but aligns with the evolution narrative. (3) Multi-hop reasoning is strong: the model synthesizes data across 2022 and 2024 filings, correctly identifying repeated short-term use of the Supplemental Facility and a shift toward bond issuance for repayment, indicating strategic refinancing. (4) Despite minor date discrepancies and added details not in the ground truth, the core facts—borrowing amounts, repayment, and strategic evolution—are accurately conveyed. The answer is highly relevant and semantically aligned with the original, warranting a high correctness score with a slight deduction for date inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 413,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "In the 2022 filing MetLife reported a $12.4 bn short‑term liquidity position and $223 bn of liquid assets and warned that “we maintain a buffer of cash and other liquid assets, and may increase it. As a result, we may have less capital to devote to other uses, such as innovation, acquisitions, development and return of capital to shareholders” (page_122). The 2024 filing repeats the same language—“we maintain a buffer of cash and other liquid assets, and may increase it”—showing that the cash‑buffer remains a core element of its capital‑management framework, with any increase still limiting the amount of capital available for growth initiatives, dividends or share repurchases (page_33).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $12.4 billion short-term liquidity and $223 billion total liquid assets in 2022 are accurately reported. The LLM correctly notes the repetition of cautionary language in the 2024 filing, even if it does not explicitly cite updated liquidity figures for 2024—this omission is minor given that the focus of the question is on the evolution of the strategic narrative around cash buffers. (2) The entity identification is correct: MetLife, correct years (2022 and 2024), and relevant financial concepts (liquidity, capital allocation) are properly addressed. (3) The reasoning is sound: the LLM correctly infers that the consistent warning language across filings reflects an ongoing strategic trade-off—maintaining or increasing cash buffers may limit capital for innovation, acquisitions, and shareholder returns—thereby capturing the evolution from a strong liquidity posture in 2022 to a more cautious tone in 2024 about the opportunity cost of larger buffers. (4) While the original answer notes a 'shift in tone' by 2024, the LLM effectively supports this by showing the repeated disclosure, implying continuity in risk awareness. The only minor shortcoming is the lack of explicit mention of the 'active monitoring and adjustment' emphasis from 2022 or a direct contrast in narrative tone, but the core multi-hop synthesis—linking liquidity levels to capital allocation constraints over time—is correctly executed. Wording differs but semantic meaning matches. All criteria are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 443,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "In the 2022 filing Starbucks reported designated “Foreign currency ‑ other” derivative assets of $39.9 million in prepaid/current assets and $33.5 million in other long‑term assets (total ≈ $73.4 million) with only a $0.3 million accrued liability (page_68). By the 2023 filing those assets had fallen to $32.0 million and $22.9 million respectively (total ≈ $54.9 million) while the accrued liability increased to $2.0 million (page_72), reducing the net exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the LLM reports large derivative asset values for 2022 ($39.9M and $33.5M) and 2023 ($32.0M and $22.9M), but the ground truth states there was *no asset value* in 2022 and only a $1.9M asset in 2023. The LLM also reports liabilities of $0.3M in 2022 (correct) but $2.0M in 2023, whereas the ground truth specifies $4.7M in 2023. These numbers are significantly off. (2) The LLM claims Starbucks had designated 'Foreign currency - other' derivative *assets* in 2022, which contradicts the ground truth stating *no corresponding asset*. This misrepresents the entire exposure profile. (3) The reasoning is flawed: the LLM concludes that net exposure decreased due to falling assets and a small rise in liabilities, but the actual situation shows a major increase in both asset and liability positions, indicating rising exposure, not reduction. (4) The entities (Starbucks, 'Foreign currency - other', years 2022 and 2023) are correct, and the question about evolution in asset/liability classification is addressed in structure, so minimal contextual relevance is retained. However, the factual inaccuracies in numbers, asset existence, and direction of change make the answer substantially wrong. The multi-hop synthesis fails because the model did not correctly extract or interpret the data from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 393,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "In 2023 Coca‑Cola described FEMSA as its largest independent bottling partner, operating under standard “bottler’s agreements” that treat the bottler as an independent contractor and focus on shared‑value initiatives such as an incidence‑based concentrate‑pricing model (2023 10‑K p.7). By 2024 the Company reports an equity‑method investment in Coca‑Cola FEMSA, owning 28 % of its outstanding shares with a fair‑value of $4.5 bn versus a $1.8 bn carrying amount, reflecting a deeper strategic engagement and a substantial financial stake (2024 10‑K p.87).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of The Coca-Cola Company's relationship with Coca-Cola FEMSA from 2023 to 2024: in 2023, FEMSA was a major independent bottling partner operating under standard agreements; by 2024, it became an equity method investee with Coca-Cola holding a 28% stake. This matches the original answer’s core claim of a shift toward deeper financial and strategic alignment. (2) Quantitatively, the 28% ownership stake is correct. The LLM adds specific financial data not in the original answer—$4.5 billion fair value and $1.8 billion carrying amount—which are plausible and consistent with 2024 10-K disclosures (e.g., Coca-Cola’s 2024 10-K does report a $4.5B fair value for its Coca-Cola FEMSA investment with a $1.8B carrying amount), so this represents an enhancement rather than an error. However, the original answer does not mention these dollar figures, so their inclusion is extra detail but not a deviation. (3) The reasoning is sound: the LLM correctly synthesizes the shift from a traditional bottler relationship to an equity-based strategic partnership, interpreting the significance of the equity method accounting and ownership percentage. It references appropriate document sources (2023 and 2024 10-K pages), indicating proper multi-hop reasoning across years and reporting contexts. (4) Minor difference: the original answer notes Coca-Cola FEMSA was one of the five largest bottlers (not necessarily 'the largest'), while the LLM calls it 'the largest'—a slight overstatement but not a critical factual error given its prominence. Overall, the answer is factually correct, contextually relevant, and adds valuable detail without introducing inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 480,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "In Intel’s 2022 filing the company grouped FPGAs with its “adjacent products” – the non‑platform offerings (modems, Ethernet, silicon‑photonic, Mobileye, NSG and PSG products) that sit alongside its core CPUs and GPUs and are managed under the Programmable Solutions Group 【page_113】. By the 2024 filing Intel treats FPGAs as a standalone product class (defined simply as “field‑programmable gate array”) and discusses them in the context of its overall “shell‑ahead” manufacturing strategy, expanding capacity for its leading‑edge logic nodes and therefore scaling FPGA production as part of its broader semiconductor output 【page_102】【page_11】. This shift shows Intel moving FPGAs from a peripheral “adjacent” role toward a more central, production‑focused position in its portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, FPGAs were categorized as 'adjacent products' within Intel's structure, specifically under the Programmable Solutions Group (PSG), and were not standalone core products. This matches the original answer's description of FPGAs being part of 'adjacent products' within CCG, DCG, and IOTG, though the LLM specifies PSG more precisely. (2) The 2024 shift is accurately described: FPGAs are now treated as a standalone product class ('field-programmable gate array') and integrated into Intel's 'shell-ahead' manufacturing strategy, indicating a central production role. This reflects the ground truth's claim of a move to 'direct product definitions' and 'core product offering'. (3) The multi-hop reasoning is sound—comparing the 2022 and 2024 filings to infer a strategic shift is correctly executed. The LLM draws from the right conceptual categories (adjacent vs. core, production focus) and supports them with appropriate context (manufacturing strategy, capacity expansion). (4) Minor deduction in qualitative accuracy because the original answer emphasizes the shift across business units (CCG, DCG, IOTG), while the LLM focuses on PSG; however, this does not contradict but rather complements the ground truth. No numerical inaccuracies—dates (2022, 2024) and product classifications are correct. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 410,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "ConocoPhillips’ Lower 48 activity shifted from a net‑inflow of assets in 2022 to a net‑outflow in 2023 – the company’s investments in and advances to Lower 48 affiliates fell from **$235 million in 2022 to $118 million in 2023**【page_134】.  At the same time, the segment’s **depreciation, depletion, amortization and impairment expense rose sharply, increasing from $4.854 billion in 2022 to $5.729 billion in 2023**【page_133】.  This indicates a slowdown in new asset purchases while cost allocation to existing Lower 48 assets grew.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the depreciation, depletion, amortization, and impairment expense for the Lower 48 region as $4.854 billion in 2022 and $5.729 billion in 2023, matching the ground truth exactly in both years. The increase of $875 million is accurate and correctly implied. These numbers are reported with proper formatting variations accepted (e.g., $4.854 billion = $4,854 million). However, the LLM introduces new information not present in the original answer — specifically, that 'investments in and advances to Lower 48 affiliates' decreased from $235 million to $118 million, and that there was a shift from net-inflow to net-outflow of assets. This detail is absent from the ground truth and changes the narrative around asset acquisition. The original answer attributes 2022 activity to the Concho acquisition, indicating significant asset inflow, but does not mention any outflow or reduction in affiliate investments in 2023. (2) Quantitative accuracy is high: all key DDA&I figures are correct, and the comparison between years is valid. The introduced $235M and $118M figures, while possibly from the source document, are not part of the ground truth answer and were not required to answer the question — their inclusion distorts the focus. (3) Multi-hop reasoning is partially sound — the model correctly identifies the trend in DDA&I expenses across two years and infers ongoing utilization of assets. However, the qualitative leap to conclude a 'slowdown in new asset purchases' based on affiliate investments is not supported by the original answer, which emphasizes continued investment post-acquisition. This misrepresents the strategic intent. (4) The correctness score is 7 because core financial data is accurate and the main trend in DDA&I is correctly highlighted, but the answer adds unsupported claims about asset acquisition dynamics that contradict or overextend the ground truth. Contextual relevance remains high as the response addresses both parts of the question (acquisition and DDA), though with some misaligned emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 560,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Emerson’s 2022 transaction contributed its Open Systems International and Geological Simulation Software businesses and about $6 bn in cash to Heritage AspenTech, leaving Emerson with a **55 % equity stake** in the newly created AspenTech (2022 filing p. 56). By the 2024 filing Emerson’s holding had risen to roughly **57 %** and the company announced a cash offer to purchase the remaining shares, moving toward full ownership (2024 filing p. 25). The AspenTech deal added **≈0.6 percentage‑point** to Emerson’s gross margin in 2023 (gross margin rose to 49.0 % from 45.7 % in 2022) — the 2024 margin increase to 50.8 % was driven mainly by the Test & Measurement acquisition rather than AspenTech (2024 filing p. 26; gross‑margin table p. 22).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson contributed businesses (Open Systems International and Geological Simulation Software) to Heritage AspenTech, whereas the ground truth confirms Emerson completed a full acquisition using $6.0 billion in cash, not a merger or contribution of assets. This misrepresents the ownership structure evolution. Second, the LLM claims Emerson had a 55% stake in 2022 and increased to 57% by 2024, but the ground truth states Emerson owned 55% by 2024 (not in 2022), implying the stake was built over time — the direction and timing are inconsistent. Third, while the 0.6 percentage point gross margin boost in 2023 is correct, the LLM incorrectly attributes the 2024 gross margin increase to the Test & Measurement acquisition rather than AspenTech, contradicting the ground truth which explicitly states AspenTech contributed to a 1.8 percentage point increase in gross margin in 2024. Additionally, the LLM omits the $231 million inventory step-up amortization that reduced margins by 1.3 points — a key financial impact. (2) Quantitative accuracy is partially correct: $6 billion cash is accurate, 0.6 percentage point margin boost in 2023 is correct, and 50.8% gross margin in 2024 is correctly cited. However, the 57% ownership in 2024 contradicts the 55% in the ground truth, and the attribution of margin changes is flawed. (3) Multi-hop reasoning is weak: the model fails to correctly synthesize the acquisition’s ongoing financial impact across years and misattributes margin drivers. It also confuses the nature of the transaction (acquisition vs. asset swap). (4) Despite these issues, the answer is contextually relevant, addressing ownership and margin impacts as asked, and cites appropriate pages, suggesting plausible sourcing. However, core financial and strategic facts are misrepresented, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 525,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "The 2015 Director Stock Plan still treats any shares recovered from terminated, forfeited, cash‑settled, exchanged or tax‑withholding awards as “available again” on a one‑for‑one basis, and each share issued under the plan reduces the pool by one (share‑settled SARs are counted net of any tendered shares)【page_335】【page_312】. In the 2022 filing the company reported ≈31.5 million shares recovered and ≈32.9 million shares already covered by awards, leaving about 34.1 million shares available for future issuance (including the Director plan)【page_334】; by the 2024 filing cumulative recoveries had risen to ≈37.6 million and award‑covered shares to ≈42.3 million, cutting the remaining pool to roughly 30.7 million shares【page_311】.  Thus the recovery and issuance mechanics have not changed, but net availability under the Director plan has declined as more shares have been recovered and re‑allocated to awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key numbers are correct: ~37.6 million shares recovered by 2024 (matches 37,608,213), ~42.3 million shares covered by awards (matches 42,343,146), and ~30.7 million available (matches 30,660,961). Minor rounding is acceptable (e.g., 37.6M vs 37,608,213). The 2022 figures cited (~31.5M recovered, ~32.9M covered, ~34.1M available) are not in the ground truth but are plausible approximations consistent with the trend and do not contradict known data. (2) The mechanics of share recovery and issuance—shares recovered from forfeitures, expirations, or cash settlements are reused one-for-one, and each issuance reduces the pool by one—are correctly described and match the original answer. (3) The reasoning is sound: the LLM correctly infers that while the mechanical treatment of shares has not changed, net availability has declined due to higher issuances outpacing recoveries, which is consistent with the net reduction described in the ground truth. (4) The answer addresses all parts of the question: evolution between 2022 and 2024, share recovery, and issuance mechanics. The only minor limitation is that the exact initial authorized share count (35,395,894 as of 2015) is omitted, but this does not affect the core comparative analysis. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 394,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "In fiscal 2022 Starbucks said that product‑sales and royalty income from the Global Coffee Alliance added roughly **$216 million** to the Channel Development segment, helping drive a **16 % increase in that segment’s revenue** (see MD&A and “Other revenues increased $249 million, primarily due to higher product sales and royalty revenue in the Global Coffee Alliance ($216 million)” – page 32; “Revenue for our Channel Development segment increased $250 million… driven by higher product sales to and royalty revenue from the Global Coffee Alliance” – page 31).  \n\nBy fiscal 2023 the filing frames the alliance differently: the Global Coffee Alliance is now described as the **licensed‑model foundation of a large portion of the Channel Development business**, signaling a strategic shift toward a licensing partnership rather than a separate revenue line (see “Channel Development… A large portion of our Channel Development business operates under a licensed model of the Global Coffee Alliance with Nestlé” – page 9; Business section noting licensing through the Global Coffee Alliance – page 6).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of the Global Coffee Alliance from fiscal year 2022 to 2023, noting the shift from a revenue contributor to a foundational licensed model in Channel Development. This aligns well with the ground truth's emphasis on strategic repositioning. However, there is a discrepancy in the quantitative details: the original answer states a $250 million increase in Channel Development revenue driven by the alliance in FY2022, while the LLM cites $216 million as the alliance's direct contribution (referencing a specific line from the filing). The $250 million figure in the ground truth matches the LLM’s citation on page 31, but the $216 million (from page 32) appears to be a component of that total. The LLM incorrectly presents $216 million as the alliance’s contribution instead of clarifying it as part of the broader $250 million increase, leading to a partial mismatch. (2) The 16% revenue increase mentioned by the LLM is not present in the ground truth and lacks corroboration; this introduces an unsupported figure. While the LLM accurately reflects the FY2023 characterization of the alliance as a licensed-model foundation, consistent with the original answer, the numerical inaccuracies affect precision. (3) The multi-hop reasoning is sound in connecting fiscal year 2022 revenue drivers to fiscal year 2023 strategic framing, and the synthesis across time periods and document sections (e.g., MD&A, Business section) demonstrates good qualitative understanding. (4) Despite minor wording differences, the LLM captures the core strategic shift. However, the quantitative inaccuracy—citing $216M instead of aligning with the $250M revenue increase attributed to the alliance—lowers confidence in numerical fidelity. Thus, while the reasoning and relevance are strong, the correctness score is reduced due to significant but not fundamental numeric discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 524,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "In 2022 NEE (through NextEra Energy Resources) recorded a massive write‑off of its Mountain Valley Pipeline interest – an additional impairment in Q1 2022 “to completely write off its investment in Mountain Valley Pipeline” after a prior $1.5 billion charge in 2020 (2022 10‑K p. 97, footnote b). By 2023 the pipeline still appears in the equity‑method portfolio, but the carrying amount fell from $4.97 billion to $3.96 billion and the 2023 impairment was only $38 million versus $674 million in 2022 (2023 10‑K p. 37, “Impairment charges…Mountain Valley Pipeline” and p. 95, equity‑method investment table). This shift from a full write‑off to a residual, heavily‑impaired stake shows NEE is pulling back from the high‑risk pipeline project and concentrating its capital on core renewable assets, reflecting a more cautious, value‑driven investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) QUANTITATIVE INACCURACY: The claim that NEE 'completely wrote off its investment' in Q1 2022 is false. The ground truth states that the Mountain Valley Pipeline remained an equity method investee in both 2022 and 2023, with no indication of a full write-off. The reported carrying amounts ($4.97B to $3.96B) and impairment charges ($674M in 2022 vs $38M in 2023) are not supported by the original answer, which does not mention specific dollar values for the pipeline's carrying amount or impairments. (2) ENTITY AND TEMPORAL ERRORS: The original answer notes that in 2023, the pipeline was mentioned in 'Nonrecurring Fair Value Measurements,' but there is no mention of a prior full write-off or continued large impairments. The LLM incorrectly cites specific 10-K page numbers and footnotes not present in the ground truth. (3) REASONING FLAWS: The conclusion that NEE is 'pulling back from the high-risk pipeline project' due to a 'full write-off' followed by a residual stake is contradicted by the ground truth, which shows consistent ownership in the 32%-55% range and only a slight narrowing to 32.8%-52.6%, indicating stable, ongoing involvement. The strategic interpretation is therefore based on false premises. (4) SEMANTIC MISMATCH: While the LLM attempts to address NEE's investment strategy, its narrative of divestment and risk aversion conflicts with the ground truth's indication of continued, strategically adjusted equity participation. The answer fabricates detailed financial data and events not present in the source, severely undermining correctness. Minor contextual relevance is retained as it discusses the pipeline and investment strategy, but core facts are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 484,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "In 2022 Medtronic’s InterStim therapy was offered with the InterStim II, InterStim Micro and InterStim X neurostimulators, all indicated for over‑active bladder, urinary retention and bowel (fecal) incontinence【page_42】. By 2024 the line still includes InterStim X, but InterStim II has become a recharge‑free device and InterStim Micro is now a rechargeable system, while continuing to treat over‑active bladder, urinary retention and chronic fecal incontinence【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator models (InterStim II, Micro, X) and core indications in 2022, and notes the continued presence of InterStim X in 2024. It also correctly identifies the expansion to 'chronic fecal incontinence' in 2024. However, it introduces a significant factual error by stating that InterStim II became 'recharge-free' and InterStim Micro became 'rechargeable' in 2024 — the ground truth does not support this specific reclassification of device types. Instead, the original answer states that InterStim II and X are labeled as 'recharge-free' without mentioning Micro as rechargeable. This mischaracterization affects the accuracy of the product evolution narrative. (2) There are no numeric values requiring calculation, so quantitative accuracy is high based on correct years and consistent product names. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes information across 2022 and 2024 time points and identifies changes in labeling and indications. However, it adds unsupported detail about rechargeability that is not in the ground truth, indicating a failure in precise synthesis. (4) Contextual relevance is strong as the answer directly addresses the evolution of neurostimulator offerings and indications. The correctness score is 6 due to the mix of accurate elements and a significant factual error in device classification, which alters the understanding of product line evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 410,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "In 2022 Simon owned roughly a 10 % non‑controlling stake in Authentic Brands Group (≈10.4% after a $65.5 million sale and a $100 million purchase of ABG shares) and deepened the partnership by contributing its Eddie Bauer licensing venture to ABG and entering a long‑term Reebok licensing partnership with ABG (pages 67, 73, 74). During 2023 a series of ABG capital transactions diluted Simon’s holding to about 9.6 % and the company sold additional portions of the stake, recognizing non‑cash gains on each deemed disposal (page 73). In the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, ending the investment and the strategic relationship (page 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group held a 1.37% interest in ABG in 2022, not ~10.4% as claimed. The LLM incorrectly states that Simon owned a roughly 10% stake and later increased it to 10.4% after a $65.5 million sale and $100 million purchase — this sequence and the resulting percentage are not supported by the original answer. The original answer states Simon increased its stake in SPARC Group (a joint venture with ABG) to 50%, not in ABG itself. The LLM also fabricates details such as contributing Eddie Bauer to ABG and entering a Reebok licensing partnership, which are not mentioned in the ground truth. (2) Quantitatively, the numbers are largely incorrect: the 1.37% stake in 2022 is misrepresented as ~10%, and the 2024 transaction is described as a full sale of remaining interest for $1.2 billion, whereas the original answer states Simon sold a portion (not all) and realized a pre-tax gain of $18.8 million, then later acquired additional interests for $100 million — indicating continued investment, not an exit. The $1.2 billion figure and the claim of ending the relationship are false. (3) The multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution of Simon’s financial stake, misidentifies transactions, and invents strategic moves not present in the source. It incorrectly infers dilution to 9.6% and a complete exit in Q1 2024, contradicting the original answer’s indication of ongoing engagement via a $100 million acquisition. (4) The contextual relevance is moderate because the answer addresses the general theme of evolving financial and strategic ties between Simon and ABG, but the specific facts, figures, and direction of the relationship are incorrect. Due to major factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 509,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips’ depreciation, depletion and amortization (DD&A) expense for its Lower 48 segment rose each year – $4.07 billion in 2021, $4.85 billion in 2022 and $5.73 billion in 2023 – reflecting a steady increase in investment activity in that region【page_133】. This represents roughly a 19% jump from 2021‑2022 and an additional 18% rise from 2022‑2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the DD&A expenses are correctly reported: $4.07 billion in 2021 (matches $4,067 million), $4.85 billion in 2022 (not in original answer but consistent with progression), and $5.73 billion in 2023 (matches $5,729 million, within rounding). The percentages cited—~19% increase from 2021 to 2022 and ~18% from 2022 to 2023—are approximately correct: (4.85 - 4.07)/4.07 ≈ 19.16%, and (5.73 - 4.85)/4.85 ≈ 18.14%. (2) The answer is complete, addressing the evolution of investment activity through DD&A expenses over the full 2021–2023 period, including intermediate 2022 data not in the original but useful for trend analysis. (3) Entities—ConocoPhillips, Lower 48 region, DD&A—are correctly identified and contextualized. (4) The reasoning is sound: increasing DD&A suggests higher asset utilization or investment, which the model correctly infers as growing emphasis on the region, matching the original's conclusion. The only minor limitation is that the original does not specify 2022 values or percentage changes, so those are extrapolations, but they are mathematically accurate and enhance the narrative without introducing error. Thus, the answer exceeds the original in granularity while maintaining factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 365,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "In the 2023 Form 10‑K Verizon disclosed that its international‑bond holdings in the other post‑retirement benefit plans were valued using matrix prices with independent third‑party inputs and were split $9 million (Level 1) and $3 million (Level 2) of the $12 million total (see 2023 filing, p. 94). The 2024 filing shows the same $12 million balance but re‑classifies $10 million as Level 1 and $2 million as Level 2, reflecting a modest shift toward more observable market pricing while retaining the same matrix‑price valuation methodology (see 2024 filing, p. 93).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Verizon did not provide a breakdown of international bonds into Level 1 and Level 2 inputs; instead, they were included under a general description of using matrix pricing with third-party inputs. However, the LLM claims that in 2023, the $12 million total was split into $9 million (Level 1) and $3 million (Level 2), which contradicts the original answer and is unsupported by the ground truth. This misrepresentation introduces false quantitative data. In 2024, the LLM correctly states the $12 million total with $10 million in Level 1 and $2 million in Level 2, aligning with the ground truth. (2) The calculation of totals is consistent ($10M + $2M = $12M), but the 2023 split is entirely fabricated, making the quantitative accuracy low. There is no mention in the ground truth of a $9M/$3M split in 2023, so this is a critical error. (3) The multi-hop reasoning is partially sound in that it compares 2023 and 2024 disclosures and attempts to infer a shift in valuation transparency. However, because the premise (the 2023 breakdown) is false, the conclusion about a 'modest shift toward more observable market pricing' is based on incorrect data. The actual evolution—from general description to specific itemization—is misrepresented as a reclassification within levels, missing the key point about improved disclosure structure and transparency. (4) While the LLM addresses the right topic and time frame (Verizon’s 10-Ks for 2023 and 2024) and correctly identifies the $12M total in 2024, the core factual error in the 2023 data severely undermines correctness. The contextual relevance is high because it discusses the right companies, years, and concept (valuation approach), but the qualitative and quantitative inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 507,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Emerson first completed a business combination with Heritage AspenTech in May 2022, contributing its Open Systems International and Geological Simulation Software businesses to create “New AspenTech” and emerging with a 55 % equity stake (see page 26). The deal generated sizable goodwill and intangible assets that were reflected in Emerson’s 2022 balance sheet (see pages 61 and 82). By 2024 Emerson’s holding had risen to about 57 % and it announced a proposal to acquire the remaining shares, moving toward full ownership while AspenTech remains an integrated software segment within Emerson’s portfolio (see page 25).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson completed a business combination with AspenTech in May 2022, forming 'New AspenTech' and acquiring a 55% stake at that time. However, the ground truth indicates that in 2022, Emerson held a financial stake valued at $8,326 million, not an operational combination. The actual restructuring into 'New AspenTech' occurred in 2024, not 2022. Additionally, the LLM claims Emerson's stake increased to 57% by 2024 and that it proposed full acquisition, which contradicts the ground truth: in 2024, Emerson contributed assets and $6.0 billion in cash to form 'New AspenTech' and retained a 55% stake—no mention of 57% or a full buyout proposal. (2) Quantitative inaccuracies include: wrong year for the 55% stake (2022 vs actual 2024), incorrect stake percentage in 2024 (57% vs actual 55%), and omission of the $6.0 billion cash contribution. The $8,326 million financial stake in 2022 is entirely omitted. (3) The multi-hop reasoning is flawed: the model conflates the 2022 financial investment with the 2024 operational restructuring, reversing the timeline and misrepresenting the nature of the relationship evolution. It fails to distinguish between a balance sheet investment and a strategic integration. (4) Despite these major errors, the answer is contextually relevant—it addresses the evolution of the relationship, mentions ownership stakes, and references integration. However, the core facts, timing, and financial details are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 435,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "In the 2022 filing, Starbucks listed its interest‑rate swaps as a designated derivative with $12 million recorded as accrued liabilities and $34 million as other long‑term liabilities (about $46 million total)【page_68】. By the 2023 filing, the swaps were still designated but appeared only as other long‑term liabilities of $41.4 million, with the accrued‑liability line gone, reflecting a re‑classification and a modest reduction in the overall swap liability【page_72】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Starbucks had only a long-term liability of $34.0 million related to interest rate swaps, with no current liability mentioned. However, the LLM claims $12 million was recorded as accrued liabilities (current) and $34 million as long-term, totaling $46 million—this is incorrect. In 2023, the ground truth states liabilities were split into $0.4 million current (accrued) and $19.2 million long-term, totaling $19.6 million. The LLM incorrectly reports $41.4 million as the entire liability under long-term with no current portion, which contradicts the ground truth. (2) The numbers are largely wrong: 2022 total should be $34.0M (not $46M), and 2023 total should be $19.6M (not $41.4M). The claimed 'modest reduction' from $46M to $41.4M is factually incorrect—the actual trend is a significant decrease from $34.0M to $19.6M. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the shift in classification (from solely long-term in 2022 to both current and long-term in 2023) and misrepresents the nature of the reclassification. Instead, it claims the accrued liability disappeared, which is the opposite of the truth—accrued liability was introduced in 2023. (4) Despite incorrect facts, the answer is contextually relevant—it addresses classification changes and liability trends in interest rate swaps over the two years, which aligns with the question's focus. However, due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 438,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources recorded an impairment of roughly $0.8 billion (about $0.6 billion after‑tax) that completely wrote off its Mountain Valley Pipeline equity investment of about $0.6 billion and created a $0.2 billion liability for estimated future ARO costs【page_92】. By the 2023 filing, NEER still owned a 32.8 % equity stake in the joint‑venture and disclosed planned equity contributions in 2024 plus a $70 million‑per‑year natural‑gas transportation agreement—both reflected in the “Other (i)” line of the commitments table and the NEER (b) line of the required‑capacity schedule【page_108】【page_109】. This marks a shift from a write‑off and liability in 2022 to continued, though contingent, equity participation and future funding commitments in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of NextEra Energy Resources' (NEER) financial commitment to the Mountain Valley Pipeline from 2022 to 2023. (1) Quantitatively, it correctly states the $0.8 billion impairment charge in 2022 (matching the ground truth), breaks it down into a $0.6 billion after-tax impact and attributes the write-off to the equity investment and a $0.2 billion liability for asset retirement obligations (ARO), which aligns with typical accounting treatment even if the original answer does not specify the ARO split. This level of detail is plausible and consistent with SEC disclosures. The 2023 figures—32.8% equity stake and $70 million annual transportation obligation—are exactly correct. (2) The answer notes 'planned equity contributions in 2024,' which is slightly more specific than the original answer but supported by the context of continued commitment and is referenced with proper document citations (pages 108–109). (3) The reasoning correctly synthesizes a multi-hop narrative: from a full write-off in 2022 due to low completion probability, to maintaining ownership and new commitments in 2023, indicating a shift in outlook or strategy. This reflects sound qualitative understanding. (4) All entities (NextEra Energy Resources, NEER, Mountain Valley Pipeline, joint venture) and years (2022 to 2023) are accurate. The only minor deviation is the introduction of ARO liability detail not present in the ground truth, but this does not contradict it and may reflect deeper document insight. Overall, the answer is factually correct, complete, and contextually precise—just shy of perfect due to slight over-elaboration on the impairment breakdown without explicit confirmation in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The captive insurance company’s solvency‑capital portfolio of marketable equity and debt securities rose from **$1.643 billion at 12/31/2023** to **$1.883 billion at 12/31/2024** – an increase of about **$240 million** – while continuing to be used to reinsure the group‑annuity contracts for European and Canadian pension plans【page_80】【page_81】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.643 billion (2023) and $1.883 billion (2024) are accurately reported, with the correct increase of $240 million ($1,883M - $1,643M = $240M), and the dates (12/31/2023 and 12/31/2024) align with fiscal year-ends. Minor formatting differences ($1,643 million vs $1.643 billion) are semantically equivalent and acceptable. (2) The answer is complete, addressing the evolution of Coca-Cola’s investment in equity and debt securities through its captive insurance company over the two years, including the purpose (reinsuring group annuity contracts for European and Canadian pension plans), which adds context consistent with the filings. (3) Entity accuracy is correct: The Coca-Cola Company, its captive insurance company, equity and debt securities, and the relevant financial instruments and time periods are all properly identified. (4) The multi-hop reasoning is sound—synthesizing data from two years and calculating the change—while correctly linking the securities to solvency capital and pension reinsurance. The citations (page_80, page_81) further support contextual grounding. Overall, the answer is factually precise, comprehensive, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 363,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "The 2022 Form 10‑K contains no discussion of an Intel 4 node, indicating that at that time Intel 4 was still a future EUV‑lithography process and not in volume production (see 2022 filing, e.g., page 24). By the 2024 Form 10‑K, Intel 4 is described as its first EUV node that moved to high‑volume manufacturing in Ireland in 2024, powers the first high‑volume client product (the Intel Core Ultra processor launched in 2023), and is expected to represent an increasing portion of processor output in 2025, making it a central element of Intel’s product roadmap (see 2024 pages 6 & 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2022, Intel 4 was not yet discussed in the 10-K, indicating it was not in volume production, which matches the ground truth's mention of 'higher period charges related to the ramp-up'—consistent with early-stage development. By 2024, the LLM correctly states that Intel 4 moved to high-volume manufacturing in Ireland and powers the high-volume Intel Core Ultra processor, matching the original answer. It adds a forward-looking detail (expected to represent an increasing portion of output in 2025), which is consistent and enhances completeness. The only minor gap is that the LLM does not explicitly mention 'strategic positioning' evolution from investment phase to product integration, though this is implied. All dates, product names (Intel Core Ultra), locations (Ireland), and technological details (first EUV node) are correct. The reasoning is sound, synthesizing across two years of filings to show progression. Quantitative and entity accuracy are perfect. Minor deduction in qualitative accuracy due to slightly less explicit framing of the strategic evolution, but overall excellent multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 343,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Emerson first formed its strategic tie‑up with AspenTech in fiscal 2022 by contributing two stand‑alone industrial‑software businesses (Open Systems International and its Geological Simulation Software unit) and about $6 billion in cash to Heritage AspenTech, creating “New AspenTech” in which Emerson received a 55 % fully‑diluted ownership stake (2024 10‑K p.26). By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer to purchase the remaining shares, moving the relationship from a majority‑owned affiliate toward full ownership, and the AspenTech acquisition has been integrated into Emerson’s consolidated financials, contributing to margin improvement and higher SG&A expense (2024 10‑K p.22‑25).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative details. The ground truth states that Emerson merged its industrial software business with AspenTech in 2024 and retained a 55% stake; however, the LLM claims the 55% stake was established in 2022, which is incorrect—the partnership in 2022 did not involve ownership. Additionally, the LLM incorrectly states that Emerson's stake increased to 57% by 2024 and that a $240-per-share offer was made for the remaining shares—this level of detail (including the exact share price and ownership increase) is not supported by the original answer and introduces unsupported specifics. The $6 billion cash contribution is also not mentioned in the ground truth, making it a fabricated figure. (2) While the original answer notes AspenTech’s financial integration and impact on gross margins (0.6 percentage points in 2023) and SG&A in 2024, the LLM vaguely references margin improvement and higher SG&A without specifying the 0.6-point impact, missing a key measurable outcome. (3) The qualitative reasoning correctly identifies the evolution from strategic partner to majority-owned entity and financial integration, capturing the multi-hop progression in relationship structure. However, the incorrect dating of the ownership shift to 2022 undermines the timeline accuracy. (4) Contextually, the response is highly relevant and addresses both ownership structure and financial integration as asked. Despite incorrect numbers and timeline placement, it captures the directional shift and integration effects at a high level, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 448,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "In the 2022 Form 10‑K Intel only introduced “Intel 4” as a new name in its process‑node roadmap (see 2022 10‑K p.115), without detailing production status or performance. By the 2024 filing Intel describes Intel 4 as its first EUV lithography node that has been ramped to high‑volume manufacturing in Ireland, is already shipping in the Intel Core Ultra processor (2023), and delivers roughly 20 % higher performance‑per‑watt and significant density scaling versus Intel 7 (2024 10‑K p.6‑10).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Intel introduced 'Intel 4' in 2022 as a renamed node without production details (2022 10-K reference), and by 2024 it was in high-volume manufacturing in Ireland using EUV lithography. The 20% performance-per-watt improvement over Intel 7 is correctly stated, as is its use in the Intel Core Ultra processor shipping in 2023. (2) Quantitative accuracy is perfect: the 20% performance-per-watt gain matches the ground truth; the timeline (2022 naming, 2023 product shipment, 2024 production scale) is consistent. (3) Multi-hop reasoning is sound—information is correctly synthesized across two years of 10-K filings, showing evolution from roadmap item to production node. (4) Entity accuracy is strong: correct references to Intel 4, Intel 7, EUV lithography, Intel Core Ultra, and geographic manufacturing site (Ireland). The answer directly addresses the question’s focus on manufacturing readiness and performance improvements from 2022 to 2024. Minor formatting differences (e.g., '20 %' vs '20%') do not affect meaning. All criteria for a top score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 331,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "In the 2022 filing, InterStim Micro was mentioned only as one of the pelvic‑health neurostimulators (alongside InterStim X and InterStim II) used to treat overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence. By the 2024 filing, InterStim Micro is singled out as a **rechargeable** neurostimulator within the InterStim therapy suite—while InterStim X and InterStim II are described as recharge‑free—and is highlighted as a key driver of the continued acceptance and growth of Medtronic’s Pelvic Health therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely matches the ground truth. (1) All key facts are correct: InterStim Micro was part of a broader portfolio in 2022 alongside InterStim X and II, and by 2024 it was specifically positioned as the rechargeable option, with the others described as recharge-free. The conditions treated (overactive bladder, urinary retention, fecal incontinence) are accurately reflected, with only minor rewording (e.g., 'non-obstructive urinary retention' vs 'urinary retention' — semantically equivalent in context). (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points (2022 vs 2024 filings) and identifies the evolution in strategic positioning — from being one of several devices to being explicitly differentiated by its rechargeable feature. The conclusion that it became a 'key driver' of growth aligns with the original answer's emphasis on 'continued global growth and adoption'. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'global' growth, though 'continued acceptance and growth' captures the essence. This slight omission prevents a perfect 10, but the answer remains highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 401,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "In the 2022 filing the notes (see 2022‑page 115/116) state that LTIP units are “potentially dilutive securities” but that “no securities had a material dilutive effect for the years ended December 31, 2021, 2020 and 2019.” The 2024 filing repeats the same disclaimer (see 2024‑page 114) and updates the periods to “the years ended December 31, 2024, 2023 and 2022,” again concluding that LTIP units had no material dilutive impact. Thus, the disclosure has been refreshed to cover the most recent years, but the assessment that LTIP units are not materially dilutive has remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and periods are correct: the 2022 filing references dilutive impact for 2021, 2020, and 2019; the 2024 filing updates this to 2024, 2023, and 2022. These match the original answer exactly. (2) The LLM correctly identifies that LTIP units were described as potentially dilutive in 2022 and that no material dilutive effect was reported across the relevant years in both filings. (3) The reasoning is sound: it captures the evolution of disclosure by noting the updated time periods and consistent conclusion on materiality. (4) The only minor shortcoming is that the LLM does not explicitly note the reduction in detail regarding the exchangeability of LTIP units into common stock—a point emphasized in the ground truth. While the LLM mentions LTIP units as 'potentially dilutive securities,' it omits the specific removal of the exchangeability language in the 2024 filing, which is a nuance in qualitative detail. However, the core facts, multi-hop comparison across years, and conclusion are correct. Thus, the answer is highly accurate with only a slight omission in descriptive depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 336,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "In the 2022 filing MetLife reported that its board had authorized a $3 billion share‑repurchase program and that about $1.5 billion remained available at year‑end 2021, with no explicit emphasis on cash‑buffer constraints for those buybacks. By the 2024 filing the company’s risk discussion stresses that it “maintains a buffer of cash and other liquid assets, and may increase it,” noting that a larger buffer can limit the capital it can devote to repurchases and that liquidity and regulatory considerations now guide its buy‑back decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $3 billion authorization and $1.5 billion remaining as of year-end 2021 are accurately reported, with proper context that this was disclosed in the 2022 filing. The format variations (e.g., $3 billion vs $3.0 billion) are acceptable and semantically equivalent. (2) The answer correctly identifies the shift in MetLife’s approach: from a clear repurchase capacity in 2022 with no explicit mention of cash-buffer constraints, to a more cautious stance in 2024 where increased liquidity buffers may limit repurchases. (3) The multi-hop reasoning is sound—synthesizing information across 2022 and 2024 filings to show an evolution in capital management strategy. The LLM correctly infers a strategic shift based on explicit statements about liquidity buffers and regulatory considerations in the 2024 filing. (4) The only minor shortcoming is that the LLM does not explicitly state that the $1.5 billion remaining was as of December 31, 2021 (though it says 'year-end 2021', which is equivalent), and slightly less emphasis on 'internal capital considerations' mentioned in the original. However, the core facts, timeline, and strategic evolution are accurately conveyed. Wording differs slightly but meaning is preserved. Thus, the answer is factually correct, complete, and contextually appropriate with excellent quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 403,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "Starbucks’ foreign‑currency‑other derivative assets fell from $73.4 million at October 2 2022 (‑ $39.9 million in prepaid‑expenses/current assets and $33.5 million in other long‑term assets) to $54.9 million at October 1 2023 (‑ $32.0 million current and $22.9 million long‑term)【page_68】.  The corresponding liability rose from $0.3 million in accrued liabilities in FY 2022 to $2.0 million in FY 2023, still recorded as accrued liabilities【page_72】.  The balance‑sheet classification stayed under “Designated Derivative Instruments,” with assets split between prepaid‑expenses (current) and other long‑term assets and the liability shown as an accrued‑liability line item.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both asset and liability figures for both fiscal years. According to the ground truth, in FY 2022, Starbucks reported $103.9 million in foreign currency - other derivative assets recognized in OCI before reclassifications, with $22.0 million reclassified from AOCI to earnings — none of which is reflected in the LLM answer. Instead, the LLM claims $73.4 million in total derivative assets at October 2, 2022, split into $39.9 million current (negative value shown incorrectly as '-') and $33.5 million long-term, which contradicts the ground truth and misrepresents the data. The ground truth does not provide a full balance sheet breakout for FY 2022 assets, only OCI recognition, so the LLM's detailed split appears fabricated or misattributed. For FY 2023, the LLM reports $54.9 million in total assets ($32.0 million current and $22.9 million long-term), but the ground truth states only $1.9 million in prepaid expenses and $1.7 million in other long-term assets — a total of $3.6 million, not $54.9 million. This is a massive overstatement. On liabilities, the LLM claims $0.3 million in FY 2022 and $2.0 million in FY 2023, both in accrued liabilities, but the ground truth reports $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities as of October 1, 2023 — meaning the LLM underreports total liabilities by over 75%. (2) Calculations and comparisons are therefore fundamentally flawed. The claimed 'reduction' from $73.4M to $54.9M is incorrect, as the actual reduction is from $103.9M (OCI-reported) to $3.6M on the balance sheet, representing a much steeper decline. The LLM fails to mention the shift in classification context — from OCI focus in 2022 to specific balance sheet line items in 2023. (3) Multi-hop reasoning is weak: the model fails to synthesize the correct evolution — from OCI-recognized amounts in 2022 to explicit balance sheet line items in 2023 — and instead imposes a false continuity of balance sheet presentation in both years. It also invents precise splits not present in the ground truth for 2022. (4) Contextual relevance is moderate because the answer addresses derivative assets/liabilities and balance sheet classification, but the severe numerical inaccuracies and incorrect reasoning undermine its usefulness. The mention of 'Designated Derivative Instruments' and classification buckets shows some understanding of financial structure, but it's applied to incorrect data. Overall, the answer is mostly incorrect due to wrong numbers, missing key disclosures (OCI treatment), and failure to reflect the true magnitude of reduction and reclassification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 714,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "In fiscal 2022 P&G’s cash‑management approach was built around strong operating cash flow, with excess cash earmarked first for dividends, share‑repurchases and acquisitions and any restructuring outlays (about $250‑$500 million of before‑tax costs) largely settled in cash (≈ 65 %). By fiscal 2024 the same liquidity‑focused framework remained, but restructuring spending rose sharply to $659 million (including $216 million of non‑cash translation losses) and roughly 64 % of those charges were cash‑funded, while corporate‑level results swung from a $485 million profit and rising corporate sales in 2022 to a $1.43 billion loss and lower corporate sales in 2024, forcing the cash‑management strategy to balance higher cash outflows for restructuring against the need to preserve liquidity, dividends and repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of P&G's cash management strategy in relation to restructuring and financial performance between fiscal 2022 and 2024. It accurately notes that restructuring costs were within the $250–$500 million range in fiscal 2022 and increased to $659 million in fiscal 2024, including $216 million in non-cash foreign currency translation losses. The cash funding percentage (~65% in 2022, ~64% in 2024) is reasonably estimated and consistent with the ground truth implication that most restructuring charges were cash-funded. However, the LLM states corporate net earnings were $485 million in 2022 (correct), but claims a $1.43 billion loss in 2024, whereas the ground truth specifies a $1.0 billion decrease in corporate net earnings (not necessarily a $1.43B loss), primarily due to a $1.4B impairment charge. This misrepresents the magnitude and nature of the earnings decline, introducing a minor factual inaccuracy. (2) Quantitative accuracy is mostly strong: $659M total restructuring cost and $216M non-cash component are correct; the $250–$500M 2022 range is properly cited. The $1.43B loss figure is not directly supported by the ground truth, which states a $1.0B decrease in corporate net earnings — a significant but different metric. The 64–65% cash funding is inferential but plausible. (3) Multi-hop reasoning is sound: the model connects restructuring costs, cash flow implications, corporate earnings trends, and strategic priorities (dividends, repurchases) across years. It correctly infers that increased restructuring pressures impacted cash management despite a consistent liquidity focus. The mention of Enterprise Markets like Nigeria is missing, which is a minor omission affecting completeness. (4) Scores reflect high factual alignment with minor quantitative overprecision and a small misstatement on earnings impact. The answer remains contextually excellent, directly addressing the question’s focus on strategy evolution, financial performance, and restructuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 551,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse as a subscription‑based development platform and operating system for building virtual‑world simulations—used by industrial enterprises to create digital twins, real‑time 3‑D product configurators and to test autonomous robots and vehicles on‑premises or in the cloud (2022 p.6, p.9, p.11). By the 2023 filing the company had shifted Omniverse toward a fully managed cloud service—Omniverse Cloud on Microsoft Azure—targeting industrial‑metaverse workloads and embedding it more tightly into its enterprise AI and data‑center offerings (2023 p.36).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in describing the evolution of NVIDIA's Omniverse between 2022 and 2023. (1) Correct elements: The 2022 description aligns with the ground truth—Omniverse was indeed presented as a platform for digital twins, 3D configurators, and simulation for autonomous systems, available for enterprise and cloud/on-prem use. The mention of industrial enterprise use and integration with simulation workflows is accurate. (2) Quantitative accuracy is high—no specific numbers are misstated, and the citations to filing pages (e.g., 2022 p.6, p.9, p.11; 2023 p.36) do not contradict the ground truth (though exact page numbers are not part of the ground truth, they are not penalized if plausible). (3) However, the key inaccuracy lies in the claim that by 2023, Omniverse shifted to a 'fully managed cloud service—Omniverse Cloud on Microsoft Azure.' The ground truth does not support this specific assertion; while Omniverse expanded cloud integration and enterprise AI workflows, it was not repositioned as a fully managed service exclusively or primarily on Azure. This misrepresents the platform’s evolution. The ground truth emphasizes a broader role as a development platform and OS for virtual worlds with deeper integration into enterprise simulation and accelerated computing, not a shift to a fully managed cloud model. (4) The reasoning is partially sound—there is multi-hop synthesis between 2022 and 2023, but the conclusion overstates cloud centralization. (5) Contextual relevance is strong—the answer addresses enterprise integration and simulation technologies. However, due to the significant mischaracterization of Omniverse’s 2023 positioning, the correctness and qualitative accuracy scores are reduced. Minor omissions (e.g., surgical training, architectural walkthroughs) are less critical, but the core evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 515,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "In the 2023 filing AMT said it expected to spend **$790 million‑$820 million** in 2024 on discretionary capital projects – a spend that “includes the construction of approximately 2,500 to 3,500 communications sites globally and approximately $450 million of anticipated spend related to data‑center assets”【page_49】.  \n\nThe 2024 filing shows those site‑related commitments have moved into longer‑term liabilities: the company now reports **operating‑lease obligations of $986.9 million for 2025** (and similar amounts in later years) to retain the communications sites【page_56】, and **undiscounted asset‑retirement obligations of $4.5 billion as of Dec 31 2024** (up from $2.08 billion in 2023)【page_56】【page_86】.  \n\nThus, while the near‑term capital spend on new sites remained roughly $800 million, the firm’s future cash commitments for lease renewals and site retirements grew substantially in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, well-supported response that aligns closely with the ground truth. (1) All key numbers are correct: the $450 million anticipated spend on data center assets in 2023 is accurately cited, and the $4.5 billion undiscounted asset retirement obligation in 2024 matches the ground truth. The LLM adds precision by noting the increase from $2.08 billion in 2023 to $4.5 billion in 2024, which is factually correct and enhances the answer. The $790–820 million discretionary capital range for 2024 is correctly contextualized as including the site construction and data center spending. (2) Quantitative accuracy is excellent: all dollar amounts, years, and comparisons are correct. The LLM even provides additional verified details (e.g., $986.9 million operating lease for 2025) that are consistent with the knowledge graph and enhance completeness. (3) Reasoning is sound: the LLM correctly synthesizes information across 2023 and 2024 filings, identifying the shift from near-term capital spending to long-term obligations. It accurately characterizes the evolution in financial commitments, noting the maturation of liabilities through lease and retirement obligations. The only minor shortcoming is that the original answer emphasizes the shift from 'near-term capital allocation' to 'long-term obligation structure,' while the LLM focuses more on the numerical evolution without fully articulating the strategic shift in financial exposure—though the implication is clear. (4) The answer is fully relevant, directly addressing how AMT’s financial commitments evolved from 2023 to 2024 in terms of anticipated spending and future obligations. The inclusion of specific page references strengthens credibility. Overall, this is a factually precise, contextually rich, and logically coherent response that matches the ground truth in substance and exceeds it in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 517,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "In the 2023 Form 10‑K the company defined cash‑flow from operations and asset sales as the sum of operating cash plus “proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,” and noted that assets are divested “when they are no longer meeting these objectives or are worth considerably more to others” 【page_39】. In the 2024 filing the same concept is restated with tighter wording – “proceeds from asset sales and returns of investments” – while retaining the same strategic‑objective rationale for divestitures 【page_36】. Thus the language shifted from enumerating specific asset types to a more concise “asset sales” phrasing, but the emphasis on divesting assets that no longer meet strategic objectives remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in ExxonMobil's language between 2023 and 2024: in 2023, the company used a detailed phrase—'proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments'—while in 2024 it adopted a more concise formulation: 'proceeds from asset sales and returns of investments.' This matches the original answer's claim of a shift toward a more consolidated and generalized framing. (2) There are no numerical values to verify, but the years (2023 and 2024) and document references (page 39 and page 36) are correctly cited, supporting authenticity. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of Form 10-K filings, compares the language used, and correctly infers that the strategic rationale (divesting assets not aligned with objectives) remained consistent despite the linguistic streamlining. (4) The only minor shortcoming is that the LLM does not explicitly state the *implication* of this linguistic shift—i.e., 'suggesting a possible shift toward a more generalized narrative around asset management'—which is present in the original answer. However, the core facts, entities, and reasoning are correct, and the omission does not undermine the overall accuracy. Wording differences are semantically equivalent, and the answer fully addresses the question about evolution in language and strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 415,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast’s 2023 Form 10‑K reports that Universal Beijing Resort is reflected on the consolidated balance sheet with **$7.8 billion of assets and $7.2 billion of liabilities**【page_87】. The 2022 filing disclosed **$9.7 billion of assets and $8.1 billion of liabilities** for the same entity【page_104】. Thus, between the two periods Comcast’s exposure fell by roughly **$1.9 billion in assets and $0.9 billion in liabilities**, indicating a lower financial stake in the resort.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported figures for both years are accurate: $9.7 billion in assets and $8.1 billion in liabilities in 2022, and $7.8 billion in assets and $7.2 billion in liabilities in 2023. The calculated reductions—$1.9 billion in assets ($9.7B - $7.8B) and $0.9 billion in liabilities ($8.1B - $7.2B)—are correct. (2) The answer is complete, addressing both the financial exposure in each year and the change over time, which directly responds to the question about the evolution of Comcast's exposure. (3) Entity accuracy is correct: Comcast, Universal Beijing Resort, and the relevant fiscal years (2022 and 2023) are properly identified. (4) The reasoning is sound: the LLM correctly infers a reduced financial stake based on declining asset and liability amounts, which aligns with the multi-hop synthesis required—pulling data from two different 10-K filings and comparing them. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of key information. Minor formatting differences (e.g., use of bold, spacing in billion) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 347,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar warned that a shortfall in customer demand could leave dealers and OEM customers with excess inventory, forcing the company to defer sales, incur additional costs and see its profitability suffer (2023 p. 14) and that “if the inventory levels of our dealers and OEM customers are higher than they desire, they may postpone product purchases… and negatively impact our results” (2023 p. 16). The 2024 filing still cites demand fluctuations, but now ties the volatility more explicitly to supply‑chain constraints—stating that when demand is lower than expected the company may face excess inventories, higher costs and reduced profitability, and that “if supply is insufficient… or we are unable to adjust our production schedules… to reflect changes in customer demand” the financial results and ability to meet commitments are jeopardized (2024 p. 14; 2024 p. 13). Thus, the risk has evolved from a primarily inventory‑management concern to a broader threat that simultaneously pressures earnings and supply‑chain stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Customer Demand Volatility as a risk factor from 2023 to 2024 for Caterpillar. In 2023, the focus was on demand shortfalls leading to inventory imbalances and profitability impacts, consistent with the original answer's mention of pandemic-related uncertainties affecting demand. In 2024, the LLM correctly notes a shift toward integrating supply-chain constraints with demand volatility, citing insufficient supply and production inflexibility as risks—this matches the ground truth's emphasis on broader supply-side challenges like material shortages and labor issues. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all references to years (2023, 2024), page numbers (p. 14, p. 16), and document types (Form 10-K) are accurate and correctly attributed—thus scoring 10. (3) The multi-hop reasoning is sound: the model synthesizes risk descriptions across two years, compares shifts in language, and draws a valid conclusion about the broadening of the risk profile. The only minor shortcoming is that the LLM does not explicitly mention 'commodity price changes' or 'material price increases' as highlighted in the original answer, which slightly reduces qualitative completeness. However, it captures the essence of supply-side integration. (4) The answer is fully contextually relevant, directly addressing how the nature of the risk evolved, its impact on financial performance, and supply chain stability. Overall, this is a strong, semantically equivalent response with only a slight omission of specific risk drivers mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 484,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "In 2022 Capital One reported its net derivative assets (liabilities) at a Level 3 fair‑value balance of roughly **$58 million**, valuing them with a **discounted‑cash‑flow model that uses swap rates as the key unobservable input**【page_215】. By year‑end 2024 that balance had risen to **$69 million**, and the valuation approach remained the same discounted‑cash‑flow technique, but the swap‑rate assumption narrowed to a single **4 % rate** (versus a 3‑5 % range in the prior year)【page_217】. This reflects a modest increase in fair value while the methodology stayed consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it states that in 2022, the Level 3 fair value was $58 million, but the ground truth reports the fair value as $19 million as of December 31, 2021 (reported in the 2022 filing), not $58 million. The $58 million figure actually corresponds to the fair value as of December 31, 2023 (reported in the 2024 filing), which the LLM incorrectly assigns to 2022. Additionally, the LLM claims the 2024 balance was $69 million, which contradicts the ground truth of $58 million. (2) Regarding valuation methodology, the LLM incorrectly states that in 2022 the valuation used swap rates as 'unobservable inputs'—this is false. The ground truth indicates a shift toward using observable inputs like swap rates (3–5%, weighted average 4%), whereas the LLM mischaracterizes them as unobservable and assigns them to Level 3, which contradicts the move toward greater transparency. Furthermore, the LLM claims the methodology 'remained the same' in 2024 with only a narrowing of assumptions, but the ground truth describes a methodological shift from realized/unrealized gains/losses in net income to discounted cash flows with observable inputs, which the LLM fails to capture. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution of both value and methodology over time, misaligns years and values, and misrepresents the nature of inputs (observable vs. unobservable). It also omits key components like derivative activity (issuances, settlements, transfers) that contributed to changes in value. (4) The contextual relevance is moderate because the answer addresses fair value and methodology over time, but the severe factual and conceptual errors—especially in numbers and classification of inputs—undermine correctness. Quantitative accuracy is very low due to wrong dollar amounts and misattributed years. Qualitative accuracy is poor due to incorrect characterization of valuation methodology and lack of recognition of a key shift in approach. Correctness score is low because both core facts and reasoning are substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 573,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA’s discussion of its GPU and cloud platforms does not call out GeForce NOW, so the service was not highlighted as part of the company’s broader ecosystem (NVDA_10k_2022.pdf p.11). By the 2023 filing, GeForce NOW is listed alongside the enterprise vGPU offering as a key cloud platform that extends NVIDIA’s GPU‑accelerated graphics and AI capabilities to any device, emphasizing its integration into the full‑stack computing strategy (NVDA_10k_2023.pdf p.11; p.6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately reflects that GeForce NOW was not explicitly mentioned in NVIDIA's 2022 10-K as part of the broader ecosystem (NVDA_10k_2022.pdf p.11), which supports the original answer's implication that its positioning was less integrated at that time. By 2023, the LLM correctly notes that GeForce NOW was explicitly listed alongside enterprise vGPU offerings as a key cloud platform (NVDA_10k_2023.pdf pp.6, 11), emphasizing its role in extending GPU-accelerated graphics and AI capabilities—consistent with the ground truth's claim of deeper integration into NVIDIA’s full-stack computing and accelerated computing narrative. The answer captures the evolution in positioning: from absence in 2022 to explicit inclusion in 2023 within the broader cloud and GPU ecosystem. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (NVIDIA, GeForce NOW, vGPU, 10-K filings, years) are correct. The reasoning is sound and reflects proper multi-hop synthesis across two years of filings. The only minor shortcoming is that the LLM does not explicitly mention 'gaming as a service' or link GeForce NOW to AI training platforms like DGX Cloud as in the original answer, slightly reducing qualitative completeness. However, referencing AI capabilities and full-stack strategy provides substantial overlap. Thus, the answer is semantically equivalent in key aspects but omits a small amount of contextual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 415,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s worldwide revenue rose modestly from $1.0 billion in 2022 to $1.04 billion in 2023 (≈3% growth, with U.S. sales up 4% to $642 million and international sales up 3% to $394 million)【page_44】. The gain was driven by stronger U.S. uptake of Inlyta in combination with immune‑checkpoint inhibitors for first‑line advanced renal‑cell carcinoma, while lower volumes and net‑price pressure in some European markets partially offset the growth and emerging‑market expansion contributed to the international increase【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the revenue growth of Inlyta from $1,003 million in 2022 to $1,036 million in 2023, reporting it as $1.0 billion and $1.04 billion respectively—this is an acceptable rounding and formatting variation. The 3% growth rate is accurately stated. The breakdown into U.S. ($642M, 4% growth) and international ($394M, 3% growth) sales is consistent with the source data and adds useful detail not in the original answer, but supported by the citation (page_44). (2) Quantitatively, the numbers are accurate within reasonable rounding: $1,003M ≈ $1.0B and $1,036M ≈ $1.04B. The sum of U.S. and international sales ($642M + $394M = $1,036M) matches exactly, confirming calculation accuracy. The percentage growth (≈3%) is correct. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly identifies the driver of growth (U.S. adoption in combination therapy for RCC), the offsetting factor (European price and volume pressures), and the positive contribution from emerging markets. These elements are properly linked across geographic and therapeutic contexts. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail. The only minor shortcoming is that the original answer explicitly states the 3% growth corresponds to the increase from $1,003M to $1,036M, while the LLM implies it—though the math is correct. No factual errors; excellent contextual relevance and completeness. Hence, a high score of 9 is justified, with full marks on relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 427,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "In the 2023 filing the company said that acquired network‑location intangibles are amortized on a straight‑line basis over the shorter of the related ground‑lease term (generally up to 20 years) and that the weighted‑average remaining amortization period was about 15 years; impairment was tested at least annually (or when indicators arose) by comparing the carrying amount to undiscounted future cash‑flows and, if needed, to discounted cash‑flows or market fair value 【page_103】. In the 2024 filing the company extended the useful life of its towers to 30 years and now amortizes network‑location intangibles over the remaining tower life (useful lives now range 2‑30 years) 【page_95】【page_96】, and it now conducts a tower‑by‑tower impairment review that focuses on lease occupancy and expense‑vs‑revenue signals, measuring any loss using projected discounted cash‑flows or market information 【page_96】. This reflects a shift to longer, tower‑aligned amortization periods and a more granular, cash‑flow‑driven impairment assessment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While the 2023 weighted average amortization period of 15 years is correctly stated and aligns with the ground truth, the claim that in 2024 the company 'extended the useful life of its towers to 30 years' and now amortizes network-location intangibles over '2-30 years' is not supported by the original answer. The ground truth does not mention any change in tower useful life to 30 years or a new amortization range; it only states that amortization remained a key treatment without specifying a change in period. This is a significant factual error. Additionally, the original answer does not state that impairment testing in 2023 used a two-step process involving undiscounted cash flows followed by discounted cash flows or market value — this level of methodological detail is absent in the ground truth. (2) The $470 million increase in asset retirement obligations is mentioned in the ground truth as an indirect factor affecting valuation and useful life assumptions, but the LLM answer omits this entirely, instead fabricating specific changes in amortization periods. This omission and fabrication reduce quantitative accuracy. (3) The qualitative reasoning correctly identifies a shift toward more granular, tower-by-tower impairment reviews and a focus on lease occupancy and expense-vs-revenue triggers in 2024, which aligns with the ground truth. The synthesis of evolving impairment processes is sound and captures the essence of increased disclosure granularity. However, the reasoning is undermined by the incorrect assertion about extended amortization periods. (4) Contextual relevance is high because the answer addresses both amortization and impairment aspects across 2023 and 2024, and attempts multi-hop synthesis. However, due to key numerical and factual inaccuracies — especially the invented 30-year tower life and revised amortization range — the correctness score is limited to 6, reflecting partial accuracy with significant errors in critical financial assumptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 566,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "In the 2023 filing ExxonMobil highlighted a rapid ramp‑up in Guyana, noting four new Stabroek Block discoveries, the start‑up of the Prosperity FPSO (reaching name‑plate capacity in Jan 2024), and combined output from three FPSOs of >390 k bpd in 2023 (nearly 440 k bpd in Q4) while announcing the Yellowtail and Uaru projects (≈250 k bpd each) and a plan for six FPSOs by 2027 【page_52】. In the 2024 filing Guyana is now singled out as an “Advantaged Asset” in the upstream growth portfolio, confirming its continued prioritization in the capital program and its role as a core low‑cost, capacity‑expanding project alongside Permian and LNG 【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: four discoveries in Stabroek Block, Prosperity FPSO startup (with nameplate capacity reached in Jan 2024), production of >390 kbd in 2023 and nearly 440 kbd in Q4 2023, and the planned ~250 kbd per project for Yellowtail and Uaru. The mention of six FPSOs by 2027 is additional context not in the original answer but is factually consistent with ExxonMobil's stated plans and does not contradict the ground truth. (2) The entity identification is correct—ExxonMobil, Guyana, Stabroek Block, Prosperity FPSO, Permian, LNG—all properly referenced. (3) The reasoning correctly captures the strategic evolution: in 2023, Guyana was a high-growth upstream asset with active discoveries and production ramp-up; by 2024, it was elevated to an 'Advantaged Asset,' signaling maturity and financial importance. The LLM accurately synthesizes this multi-hop progression across years and strategic frameworks. (4) The only minor shortcoming is that the original answer emphasizes the formal reclassification of Guyana under 'Advantaged Assets' as part of 'updated earnings drivers,' a nuance slightly underemphasized in the LLM response, though the core point about strategic elevation is clearly conveyed. Wording differences are semantically equivalent. No calculation errors. Overall, the answer is factually robust, contextually precise, and fully responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 409,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "In 2022 the X1 platform already unified linear TV with internet‑based streaming, and the Flex streaming device (the predecessor of Xumo) gave customers direct access to Peacock, Disney+ and Netflix (page 7). By 2023 Comcast broadened X1’s integration to include its new NOW DTC‑streaming bundles, free channels from Xumo Play, NBC and Sky, and the ad‑supported tier of Peacock, while the re‑branded Xumo Stream Box continued to bundle Peacock, Disney+ and Netflix (page 5; page 6). This deeper, more seamless inclusion of third‑party streams shows Comcast’s strategy to keep cord‑cutters on its X1 ecosystem and lift ARPU through bundled subscriptions and commission revenue from streaming partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 integration of Disney+, Netflix, and Peacock on the X1 platform, and notes the commission revenue model, which matches the original answer. In 2023, it accurately describes the expansion to include Xumo Play, NBC, and Sky via NOW TV, though it frames this under 'NOW DTC-streaming bundles' and the 're-branded Xumo Stream Box'—slightly different phrasing but semantically consistent. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound: the answer connects platform evolution to Comcast's strategic goals of reducing cord-cutting and increasing ARPU through bundling and commission revenue, which is fully supported by the original answer. The mention of the ad-supported tier of Peacock (vs. premium tier in 2022) adds detail not contradicted by the ground truth. (4) The only minor deviation is the reference to 'Flex' as predecessor of Xumo and 'Xumo Stream Box'—details not in the original answer—but these do not undermine the core factual accuracy. Overall, the answer captures the evolution and strategic implication correctly, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 347,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "In 2023 Caterpillar sold FG Wilson‑branded electric power‑generation systems through a worldwide network of **110 distributors covering 109 countries**【page_65】. By 2024 that network had been trimmed to **108 distributors**, but it now reached **158 countries**, expanding its geographic footprint even as the number of distributors fell slightly【page_66】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers for both years are correct — 110 distributors covering 109 countries in 2023, and 108 distributors covering 158 countries in 2024. There are no calculation errors, and the slight reduction in distributor count and increase in country coverage are accurately reported. (2) Completeness: The answer addresses the evolution of Caterpillar's relationship with FG Wilson in terms of distribution network coverage for electric power generation systems across both years, including both the numerical and geographic dimensions of change. (3) Entity accuracy: The entities — Caterpillar, FG Wilson, electric power-generation systems, and the correct years (2023 and 2024) — are all correctly identified. (4) Reasoning: The LLM correctly infers a strategic shift (implied by reduced distributors but expanded reach), though it doesn't explicitly state the interpretation about 'optimizing efficiency while broadening market access' — however, the factual basis for that reasoning is fully preserved. The answer is semantically equivalent to the original, with no factual discrepancies. Minor wording differences do not affect meaning. All multi-hop elements (comparing two years, two metrics: distributor count and country coverage) are correctly synthesized from the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 382,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One’s securitization exposure rose sharply. In the 2022 filing the company reported $13.0 billion of credit‑card‑related and $2.2 billion of auto‑loan‑related securitized debt obligations – a total carrying amount of about $15.2 billion, with no separate fair‑value amount disclosed 【page_179】. By the 2024 filing the liability had grown to a carrying value of $18.0 billion and was measured at a fair value of $18.1 billion, reflecting roughly a $2.8 billion increase in exposure and a fair‑value figure essentially equal to the carrying amount 【page_220】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Capital One's securitized debt obligations from 2022 to 2024 and provides updated carrying and fair values for 2024 that are close to the ground truth ($18.0 billion vs $18,043 million and $18.1 billion vs $18,067 million). However, the 2022 carrying value of $15.2 billion (from $13.0B credit card + $2.2B auto) is not corroborated in the original answer, which does not specify exact carrying amounts for 2022—only a general description of the composition of VIE liabilities. This introduces a significant quantitative inaccuracy, as the $15.2B figure and the implied $2.8B increase are not supported by the ground truth. (2) The 2024 values are approximately correct in magnitude and can be considered acceptable with rounding ($18.043B ≈ $18.0B; $18.067B ≈ $18.1B), but the detailed 2022 breakdown appears to be an over-interpretation or hallucination based on partial data. The original answer does not disclose separate credit card and auto components for 2022, nor a total carrying amount. (3) The multi-hop reasoning is sound in structure—comparing 2022 and 2024 exposure using carrying and fair values—but relies on unsupported figures for 2022, weakening the synthesis. The conclusion about increased exposure and stable valuation is reasonable and aligns with the trend implied by the ground truth. (4) The contextual relevance is perfect—the answer directly addresses changes in exposure, carrying value, and fair value over the specified period. Due to the unsupported 2022 figures, the quantitative accuracy is reduced, but the qualitative reasoning and overall direction of the answer are correct, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 466,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "In 2023 McDonald’s said it could meet short‑term funding needs through commercial‑paper borrowings and its line‑of‑credit agreements, noting a $4.0 billion committed line of credit and that subsidiaries had about $122 million of uncommitted foreign‑currency line‑of‑credit borrowings outstanding【page_20】. By 2024 the same $4.0 billion committed facility was still available, but uncommitted foreign‑currency borrowings had fallen to roughly $7 million, showing that the company continued to rely on the line of credit for liquidity while using it far less for foreign‑currency needs as cash‑flow from financing activities shifted (cash used for financing rose because bond issuances fell)【page_21】【page_23】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies McDonald's continued reliance on line of credit agreements and commercial paper for short-term funding in both 2023 and 2024, which aligns with the ground truth. It accurately notes the $4.0 billion committed line of credit remained available in both years and reports a decline in uncommitted foreign-currency borrowings from $122 million to $7 million, indicating reduced use of foreign credit lines. However, it omits key financial figures from the ground truth: the actual cash used for financing activities in 2023 ($4.4B) and 2024 ($7.5B), the $3.1B increase, and the cash and equivalents balances of $4.6B (2023) and $1.1B (2024). These omissions significantly affect completeness and quantitative accuracy. (2) The numbers it does provide—$4.0B committed line, $122M and $7M uncommitted foreign borrowings—are factually correct and match the source context. However, the ground truth emphasizes a shift in financing strategy driven by changes in bond issuances and cash outflows, which the LLM only partially captures. The LLM correctly links reduced bond issuances to increased cash used in financing, but fails to quantify this shift or explain how prior-year liquidity (from 2023 bond issuances) funded 2024 outflows. (3) The multi-hop reasoning is partially sound: it connects line of credit usage with financing cash flow changes and recognizes evolving reliance on credit facilities. But it does not fully synthesize the evolution in cash flow management—specifically, the transition from surplus liquidity in 2023 to a cash-constrained position in 2024 due to timing of debt issuances. (4) The contextual relevance is high, as the answer focuses on the right topic and cites correct document pages. Qualitative accuracy is strong due to correct entity identification and logical flow, but quantitative accuracy is reduced due to missing core financial figures and lack of verification of key calculations (e.g., $7.5B - $4.4B = $3.1B increase). Overall, the answer is factually consistent where it speaks, but incomplete on critical metrics, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 575,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings describe the Worldwide Business Conduct Manual as a cornerstone that “reinforces” P&G’s internal‑control system by codifying the company’s commitment to integrity, embedding written policies, segregation of duties and employee development, and supporting the oversight of the Global Leadership Council, Disclosure Committee, Board and Audit Committee. In the 2024 filing the manual is again highlighted—now explicitly linked to a COSO‑based effectiveness assessment and a robust Control Self‑Assessment program—showing that P&G’s governance has remained steadfast while becoming more formally integrated and continuously monitored, underscoring a persistent, proactive focus on ethical conduct and strong internal controls.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall interpretation. It accurately identifies that the Worldwide Business Conduct Manual reinforced internal controls in both 2022 and 2024 through policies, segregation of duties, and employee development. The answer correctly notes continuity in governance oversight by bodies such as the Global Leadership Council and Disclosure Committee. Where it adds value, the LLM mentions a COSO-based effectiveness assessment and Control Self-Assessment program in 2024—details not in the original answer but plausible and consistent with enhanced governance integration. However, the original answer emphasizes a shift toward structured governance mechanisms (e.g., more specific ties to oversight frameworks), while the LLM focuses on formal integration and monitoring via COSO and self-assessments, which are not explicitly mentioned in the ground truth. This introduces plausible but unverified details, slightly reducing qualitative accuracy. There are no numeric values to assess, so quantitative accuracy is 10 by default. Contextual relevance is perfect—the response directly addresses the evolution and governance implications. The reasoning is sound and multi-hop, connecting changes in emphasis over time, though with minor overreach in specificity. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 386,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "In the 2023 filing Exxon reported Guyana as a $9.7 billion non‑U.S. long‑lived asset (the “Guyana” line in the long‑lived‑asset table) 【page_115】.  By 2024 the company’s new earnings‑driver framework explicitly groups Guyana with Permian and LNG as an “Advantaged Asset” that drives “Advantaged Volume Growth” 【page_37】, showing that Guyana has moved from being a balance‑sheet asset to a highlighted, high‑value growth project in Exxon’s strategic outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the $9,689 million (rounded to $9.7 billion) in long-lived assets in Guyana from the 2023 filing, which matches the original answer. The 2024 strategic repositioning is correctly described: Guyana is included in the 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, alongside Permian and LNG. The evolution from a balance-sheet asset to a strategic growth engine is well articulated.\n\n2) Quantitative accuracy is excellent: $9.7 billion is a valid rounding of $9,689 million. No calculations are required beyond this, and the years (2023 and 2024) are correctly attributed. The page references (though not part of the ground truth) suggest proper sourcing.\n\n3) The multi-hop reasoning is sound: the model connects the 2023 asset disclosure with the 2024 strategic framing, synthesizing information across years and disclosure types (asset tables vs. earnings driver definitions). The conclusion that Guyana's role evolved from quantitative significance to strategic emphasis is logically supported.\n\n4) The only reason for not giving a perfect 10 is minor: the original answer explicitly contrasts Guyana’s role among 'non-U.S. assets' and names LNG as a peer project, which the LLM mentions but could have emphasized slightly more for full contextual parity. However, the core meaning and strategic implication are preserved. Wording differs but is semantically equivalent and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 416,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "In 2022 Capital One highlighted securitized debt obligations as a core part of its diversified wholesale‑funding mix, reporting roughly $15 billion of such obligations outstanding (Table 8.2 shows a total of $14,994 million)【page_189】. By the end of 2024 the carrying amount of securitized debt obligations had slipped to about $14.3 billion (fair‑value table shows $14,264 million)【page_219】, indicating a modest decline in reliance while the instrument still remains a material source of funding.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the 2022 figures. The ground truth states that no specific dollar value for securitized debt obligations was disclosed by Capital One in 2022; however, the LLM claims a disclosed amount of $14,994 million (approx. $15 billion), citing 'Table 8.2' on page 189. This figure is not supported by the ground truth and represents a critical error in quantitative accuracy. In 2024, the LLM correctly reports the carrying value as $14,264 million, matching the ground truth, which shows accurate use of disclosed data. (2) The calculation and comparison between years are flawed because the 2022 number is fabricated or misattributed. The conclusion of a 'modest decline in reliance' is therefore based on incorrect premises, even though the 2024 number is accurate. (3) The multi-hop reasoning fails because the model incorrectly assumes comparable quantitative disclosures across both years. The ground truth emphasizes increased transparency in 2024 due to the first concrete quantification, whereas the LLM treats both years as having equivalent disclosures, undermining the qualitative evolution described in the original answer. (4) Despite these major factual errors, the LLM correctly identifies the conceptual role of securitized debt as a material funding source and contextualizes it within the broader funding mix, maintaining high contextual relevance. Wording and structure are otherwise coherent and address the evolution question, but the core factual foundation is compromised by the erroneous 2022 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 438,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "In FY 2022 NVIDIA described Omniverse mainly as “real‑time 3‑D design collaboration and virtual‑world simulation software that empowers artists, designers and creators” (2022 10‑K p. 11). By FY 2023 the company had repositioned Omniverse as a full‑stack development platform and operating system for industrial digitalization—offered as a software subscription for enterprise use (free for individuals) and being adopted by industrial enterprises to build digital twins, real‑time 3‑D configurators, and to test autonomous robots and vehicles (2023 10‑K p. 6; also noted as “Omniverse for industrial digitalization” p. 4). This shift marks a move from a creator‑focused collaboration tool to an enterprise‑grade platform with growing industrial adoption.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies the positioning of Omniverse in FY 2022 as a 'real-time 3D design collaboration and virtual-world simulation software' focused on creators, citing the correct context from the 2022 10-K. (2) For FY 2023, it accurately describes the evolution into a full-stack enterprise development platform and operating system for industrial digitalization, noting the subscription model for enterprises and free access for individuals—matching the ground truth. (3) The answer captures key use cases: digital twins, real-time 3D configurators, and testing autonomous robots and vehicles, which aligns with the original answer's emphasis on digitalization of physical assets and environments. (4) The strategic shift from a creator-focused tool to an enterprise-grade platform is clearly and correctly articulated, demonstrating sound multi-hop reasoning across fiscal years and document sources. (5) All entities (NVIDIA, Omniverse, fiscal years 2022 and 2023) are correct, and there are no numerical inaccuracies (no calculations required). Minor wording differences (e.g., 'full-stack development platform' vs 'robust enterprise-focused development platform') do not affect factual equivalence. The answer is complete, contextually relevant, and precisely captures the evolution in positioning and adoption.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 390,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer’s outstanding balance to Viatris fell sharply. At the end of 2022 the net amount due under the separation‑, agency‑, MSA‑ and TSA‑type agreements was $94 million, and by December 31 2023 that balance had dropped to $33 million – a reduction of roughly $61 million 【page_73】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amounts ($94 million as of December 31, 2022, and $33 million as of December 31, 2023) are accurate and correctly cited. The implied reduction of $61 million is a valid calculation (94 - 33 = 61) and is correctly stated. (2) The time periods (end of 2022 and December 31, 2023) are precise and match the original answer. (3) Entity accuracy is correct: Pfizer and Viatris are properly identified, and the reference to separation-, agency-, MSA-, and TSA-type agreements aligns with the nature of post-spinoff financial arrangements between the companies. (4) The reasoning is sound: the answer captures the evolution of the financial relationship by highlighting the significant decrease in net amounts due, which reflects a winding down of transitional obligations, consistent with the original conclusion. (5) The semantic content is equivalent to the ground truth—though the LLM adds a minor detail about agreement types and the $61 million reduction, these enhance rather than distort the meaning. No factual, numerical, or logical errors are present. The answer fully addresses the multi-hop nature of the question by comparing financial obligations across two years under multiple agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 361,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "In 2023 ExxonMobil described Guyana as an active development region – 4.6 million offshore acres, 12.6 net exploratory and development wells, the Payara field coming on‑stream on the Prosperity FPSO, continued work on Yellowtail and funding of the Uaru project (2023 p. 20). By 2024 the filing no longer lists those operational details; instead Guyana is highlighted as an “Advantaged Asset” alongside Permian and LNG in the company’s earnings‑driver definitions, signaling its re‑classification as a core growth asset rather than just a routine operating segment (2024 p. 37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitative accuracy: All numbers are correct—12.6 net exploratory and development wells in 2023 matches the original answer. The 4.6 million offshore acres, while not in the original answer, is factually consistent with ExxonMobil's Guyana operations and does not contradict the ground truth; it adds context without introducing error. (2) Completeness: The answer addresses both the 2023 operational status (Payara, Yellowtail, Uaru, well count) and the 2024 strategic reclassification into 'Advantaged Assets' under 'Advantaged Volume Growth', capturing the evolution in emphasis. (3) Entity accuracy: Correctly identifies ExxonMobil, Guyana, Permian Basin, LNG, and project names. The reference to 'Advantaged Asset' classification in 2024 is accurate and correctly contrasted with prior-year reporting. (4) Reasoning: The multi-hop synthesis is sound—connecting the shift from detailed operational reporting in 2023 to strategic categorization in 2024 demonstrates correct inference of evolving strategic emphasis. (5) Semantic equivalence: The LLM conveys the same core conclusion—that Guyana moved from an active development region to a core growth asset—using slightly different but equivalent phrasing (e.g., 'core growth asset rather than just a routine operating segment' mirrors the original's 'strategic elevation'). The only minor shortcoming is that the original explicitly names the 'Advantaged Volume Growth' earnings driver, which the LLM implies but does not quote directly—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 461,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on senior notes with maturities greater than ten years was unchanged at 3.8 % from 2022 to 2023.  The face‑value of those notes increased modestly, rising from $52.8 billion at year‑end 2022 to $53.4 billion at year‑end 2023【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8%, and the face value was $54.536 billion, not $52.8 billion. The 2023 interest rate is correctly stated as 3.8%, and the 2023 face value of $53.4 billion matches the ground truth. However, the LLM incorrectly states that the face value increased, while it actually decreased from $54.536B to $53.4B. (2) Quantitative accuracy is low: the 2022 interest rate is wrong (3.67% vs 3.8%), and the 2022 face value is off by over $1.7 billion. The direction of change in face value is also incorrect (increase vs actual decrease). (3) The reasoning is partially sound in that it compares two years and identifies stability in interest rates, but the synthesis is flawed due to incorrect input data. The model fails to accurately reflect the reduction in long-term debt, leading to an incorrect conclusion about the trend. (4) Contextual relevance is high because the answer addresses the right metrics, time frame, and debt category, and cites a relevant document page. However, due to major numerical errors and an incorrect trend characterization, the overall correctness score is limited to 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 358,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "In the 2024 filing (reflecting December 31 2023) Alabama Power’s nuclear‑decommissioning trust held $651 million of domestic‑equity assets, measured almost entirely with Level 2 inputs ($443 million) and a $208 million Level 3 component; Georgia Power’s trust held $322 million, measured with Level 2 inputs ($321 million) and only $1 million of Level 3. By comparison, the 2023 filing (reflecting December 31 2022) showed $565 million (Alabama) and $256 million (Georgia) of domestic equity, also measured with Level 2 inputs ($396 million and $255 million respectively) and modest Level 3 amounts. Thus, between the two years the trusts increased their domestic‑equity balances and continued to rely on Level 2 observable inputs (with a slightly larger Level 3 portion for Alabama), while no Level 1 inputs were used in either period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the allocation of investment levels and the years referenced. It incorrectly states that Alabama Power's 2024 filing reflects December 31, 2023, when in fact the 2024 filing reflects December 31, 2024 (not 2023), and the 2023 filing reflects December 31, 2023 (not 2022). This misalignment invalidates the entire comparison. (2) The LLM incorrectly assigns Level 2 and Level 3 inputs: according to the ground truth, Alabama Power used Level 1 and Level 2 inputs only, with $443M in Level 1 (not Level 2) and $208M in Level 2 in 2024 — but the LLM claims $443M was Level 2 and introduces a $208M Level 3 component, which is entirely incorrect. Similarly, it claims Georgia Power used Level 2 inputs for $321M and only $1M Level 3, but ground truth shows $321M in Level 1 and $1M in Level 2 — the LLM confuses Level 1 with Level 2 and invents Level 3 usage where none exists. (3) The multi-hop reasoning is fundamentally flawed: the model fails to correctly identify the shift from Level 1 and Level 2 allocations between years and instead asserts that no Level 1 inputs were used, which contradicts the ground truth that both companies primarily used Level 1 inputs and increased them. (4) The conclusion about reliance on Level 2 and Level 3 inputs is therefore incorrect and opposite to the actual trend toward higher Level 1 (more transparent, liquid) investments. While the total portfolio values ($651M, $322M, $565M, $256M) are correctly stated, their attribution to input levels and years is so distorted that the answer is largely false. Quantitative accuracy is low due to misassignment of numbers to wrong categories. Qualitative accuracy is poor due to incorrect reasoning and entity relationships. Contextual relevance is moderate because it addresses nuclear decommissioning trusts and domestic equity, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 516,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "In the 2022 filing NVIDIA framed CUDA as the “fundamental building block” of a unified architecture that powers its full‑software stacks (e.g., DRIVE, Clara, Omniverse) and supports a 3 million‑developer ecosystem across a wide range of end markets (2022 p. 9, 11). By the 2023 filing the company elevated CUDA to the “foundational programming model that runs on all NVIDIA GPUs” and placed it at the core of a full‑stack computing platform together with CUDA‑X libraries, SDKs and APIs, explicitly highlighting its integration across AI, data‑analytics, scientific computing, graphics and other vertical workloads (2023 p. 4, 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies CUDA's evolution from a 'fundamental building block' in 2022 to a 'foundational programming model' in 2023, capturing the core strategic shift. The mention of CUDA supporting full-software stacks like DRIVE, Clara, and Omniverse aligns with the expanded vertical integration described in the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the reference to a '3 million-developer ecosystem' is consistent with NVIDIA's public disclosures and does not contradict the ground truth, even if not explicitly mentioned in the original answer—this adds context without introducing error. (3) The multi-hop reasoning is sound: the answer synthesizes CUDA’s role across years and markets, correctly noting its deepened integration into AI, data analytics, scientific computing, and graphics, which maps to the ground truth’s emphasis on domain-specific verticals (healthcare, telecom, etc.). The reference to CUDA-X libraries, SDKs, and APIs reflects the broader software stack evolution. (4) The only minor gap is that the LLM answer does not explicitly state that CUDA became the 'base layer' for 'hundreds of domain-specific' libraries in 2023—a detail emphasized in the original—but it does convey the essence by referencing CUDA-X and vertical workloads. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 427,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "By the end of 2022 Pfizer still had sizable post‑spin‑off obligations to Viatris – $94 million was outstanding under the separation, distribution, agency, MSA and transitional‑service agreements. By year‑end 2023 most of the TSAs were “largely completed” and the balance due to Viatris had fallen to $33 million, showing a sharp reduction in the net amount owed.【page_73】",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $94 million owed in 2022 and the reduction to $33 million in 2023, which matches the ground truth. These figures are accurate and properly contextualized as net amounts owed under separation, distribution, agency, MSA, and TSA agreements. (2) Quantitative accuracy is perfect: both dollar amounts and the implied reduction of $61 million are correct. The years 2022 and 2023 are correctly referenced. (3) The multi-hop reasoning is mostly sound—linking the decline in obligations to the completion of TSAs post-spin-off. However, the LLM slightly misrepresents the timeline: it states that 'most of the TSAs were largely completed' by end-2023, while the ground truth specifies that TSA services were 'largely completed by end of 2022' and 'fully completed as of December 31, 2023'. The LLM understates the progress in 2022 and does not clearly reflect that the 2023 milestone was full completion. (4) Despite this minor inaccuracy in phrasing the status of TSA completion, the core financial data and trend are correct, and the answer addresses the evolution of obligations and net amounts. Hence, correctness is high but not perfect due to the slight misstatement on the status of TSA completion timing. Contextual relevance is excellent as all parts of the question are addressed with appropriate focus on transitional services and financial obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 392,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "In the 2022 filing the company warned that retail‑jurisdiction deregulation could create stranded assets and unrecovered costs and that environmental‑law compliance would add capital and operating expenses that might not be fully recoverable, but it qualified that current compliance costs were not expected to be material (page 28). The 2023 filing repeats the deregulation risk language but drops the reassuring qualifier and stresses more directly that new environmental‑regulation costs may be difficult to recover, tightening the link between deregulation pressure and potential compliance‑cost losses (page 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) It correctly identifies Duke Energy's 2022 concern about retail deregulation leading to unrecovered costs, including environmental compliance expenses, and notes the qualification that such costs were not expected to be material at the time (citing page 28). In 2023, it accurately reports that the company dropped this reassurance and emphasized greater difficulty in recovering new environmental regulation costs, directly linking deregulation pressures to compliance cost recovery challenges (citing page 26). (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or years (2022 vs. 2023). (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosure language across two years, correctly inferring an evolving relationship between deregulation and environmental cost recovery. It captures the nuanced shift from a qualified, less urgent tone in 2022 to a more direct and concerning tone in 2023, which reflects the compounding challenge described in the original answer. (4) While the LLM does not explicitly mention PURPA, QFs, or specific EPA regulations like CO2 and cooling water intake structures, it still captures the core dynamic: increasing regulatory pressure on environmental compliance costs and reduced ability to recover them under deregulation. These omissions are minor and do not undermine the central conclusion. The answer is semantically equivalent in intent and meaning, with slightly less detail on specific regulatory drivers. Hence, correctness is rated 9/10—very strong, with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 469,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.7 percentage points (page 48). By contrast, Altria’s USSTC pursued a price‑up strategy for Skoal throughout 2023, raising the list price by $0.09 per can in January, $0.10 per can in April, and another $0.09 per can in August (page 49).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decline in Skoal's retail share from 9.3% in 2023 to 7.6% in 2024, which matches the ground truth and is accurately quantified as a 1.7 percentage point drop. However, the pricing details for 2023 are incorrect. The LLM states price increases of $0.09 in January, $0.10 in April, and $0.09 in August 2023, but the ground truth indicates that the $0.11 increase (effective January 23, 2024) was announced in 2023, with no mention of the specific $0.09, $0.10, $0.09 increases in those months. Instead, the prior increases were in 2022 (January, February, May), not during 2023. Thus, the LLM fabricates or misattributes the timing and amounts of 2023 price hikes. (2) Quantitative accuracy is compromised: while the market share numbers are correct, the dollar amounts and dates of price increases are factually wrong. The cumulative price increase described in the ground truth is not reflected in the LLM answer, and the $0.10 figure does not appear in the source. (3) The multi-hop reasoning is partially sound—the model connects declining market share with a price-up strategy, which aligns with the contrast asked in the question. However, because the pricing data is inaccurate, the synthesis is based on false premises. (4) Contextual relevance is high—the answer addresses both parts of the question (market share change and pricing strategy contrast) and attempts to cite document pages. The qualitative reasoning is logical but built on incorrect data. Correctness score is 6 due to accurate market share data but significant errors in pricing details, which are central to the multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 452,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen reported $138 million of “Other short‑term interest‑bearing securities” at December 31, 2023, which fell to $135 million at December 31, 2024 – a $3 million (≈2 %) decrease【page_133】. The tiny drop indicates the company’s short‑term investment stance is essentially unchanged, emphasizing safety of principal and ample liquidity while making only modest rebalancing of its cash‑equivalent holdings【page_133】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment in 'Other short-term interest-bearing securities' decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms it remained unchanged at $138 million in both years. This is a critical factual error. The claimed $3 million (≈2%) decrease is unsupported by the original data. (2) Quantitative accuracy is low because the dollar amounts and the implied percentage change are incorrect. The calculation of a 2% drop based on $3M from $138M is mathematically plausible (~2.17%), but irrelevant since the premise is false. The correct value is stable at $138M in both years. (3) The qualitative reasoning about the company's short-term investment strategy being stable due to minimal changes is partially sound, but the conclusion is based on incorrect data. The LLM infers 'essentially unchanged' strategy, which aligns with the ground truth's interpretation of consistency, but this is undermined by the inaccurate numbers. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of investment and strategic implication—and references appropriate concepts like liquidity and principal safety. However, the core factual inaccuracy in the financial figures significantly reduces overall correctness. The citation to 'page_133' suggests a source, but contradicts the verified ground truth, indicating either misreading or hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 407,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "In the 2022 filing GD disclosed a **$360 million** Army award for Abrams main‑battle‑tank upgrades that centered on **mission‑control units and systems technical support**【page_42】. By the 2024 filing the award was a **$350 million** contract for Abrams upgrades that now adds **engineering, logistics and sustainment technical‑support services**, showing a shift toward broader lifecycle support and a modest drop in contract value【page_44】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $360 million 2022 contract for Abrams upgrades, mission-control units, and systems technical support, and the $350 million 2024 contract for upgrades plus engineering, logistics, and sustainment support. These figures match the ground truth in amount and scope. However, the LLM omits the separate $285 million contract awarded in 2024 for producing Abrams SEPv3 tanks for Romania, which is a significant part of the evolution in contract scope and value. This omission reduces completeness and affects the overall correctness. (2) Quantitatively, the two mentioned contracts are accurate in dollar amounts and years. The statement about a 'modest drop in contract value' from $360M to $350M is factually correct for those specific contracts, but misleading in the broader context since the total value of General Dynamics' Abrams-related contracts actually increased in 2024 when including the $285M production contract. Thus, while individual numbers are correct, the implied trend in total contract value is inaccurate due to incomplete data. (3) The reasoning correctly identifies a shift toward broader lifecycle support (from upgrades to include engineering and sustainment), which is valid. However, it fails to recognize the multi-hop synthesis that the evolution includes not just expanded service scope but also a new production component for international sale, indicating a strategic expansion. This limits the qualitative accuracy. (4) The answer is contextually relevant and well-structured, citing correct pages and focusing on the right company and time frame. The omission of the $285M production contract prevents a score above 7 for correctness, as it misses a key dimension of the 'evolution' asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 484,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s senior unsecured notes, junior subordinated debt and a $1.5 bn DDTL facility on its balance sheet – shown in the debt roll‑forward (page 112) and the DDTL note (page 113) – and backed by a guarantee‑reimbursement and collateral agreement with Corebridge. By 2024, after Corebridge was de‑consolidated, those borrowings disappear from AIG’s debt tables; instead AIG records equity‑method earnings of $601 million from Corebridge and recognizes a large loss on its retained Corebridge investment (about $8.5 bn, including the $439 m loss noted for 2023) in the discontinued‑operations results (pages 109‑110, 122).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures a significant transformation in AIG's relationship with Corebridge from 2023 to 2024, correctly identifying the shift from debt-based arrangements to equity-method income recognition, which aligns with the core of the question. However, there are critical quantitative and factual discrepancies. First, the $1.5 billion DDTL facility and guarantee-reimbursement agreement are not mentioned in the ground truth, nor is the specific de-consolidation date or the $601 million equity-method earnings figure present in the original answer. The original answer emphasizes that AIG began recognizing equity method income tied to stock price changes and dividends starting June 9, 2024—this timing and rationale (stock price and dividends) are missing in the LLM response, which instead cites a generic 'equity-method earnings' without explaining the trigger. Additionally, the $8.5 billion loss and $439 million 2023 loss are not referenced in the ground truth and appear to be hallucinated or misattributed. While the LLM correctly infers a structural shift (from lending to equity investment accounting), it introduces unsupported figures and omits the specific mechanism (dividends and stock price changes) and timeline (June 9, 2024) that define the income recognition change. The contextual relevance is high as it addresses borrowing arrangements and income recognition, and the qualitative reasoning shows understanding of de-consolidation effects. However, the inclusion of unverified numbers and absence of key details from the ground truth reduce quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 438,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "In the 2022 filing Tesla presented the Solar Roof as a product it was already selling directly and through channel partners and emphasized that it was “continuing to improve our installation capability and efficiency, including through collaboration with real‑estate developers and builders” (see page 6). By the 2024 filing the tone had shifted to a risk focus: the company now warns that it has “experienced…delays in launching and/or ramping production of…Solar Roof” and that its rollout is tied to the broader manufacturing‑scale and supply‑chain constraints that affect new factories (see page 17), indicating a greater reliance on securing components and scaling production capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Tesla's approach in 2022 as involving active sales and collaboration with real estate developers to improve installation efficiency, citing the correct context from the 2022 filing. In 2024, it accurately reflects the shift in tone toward production challenges, including delays in ramping production and dependence on supply chain and manufacturing scale—consistent with the 'depends in large part' dependency noted in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying a strategic shift from product development and sales emphasis to production and risk mitigation. The use of direct quotes (e.g., 'delays in launching and/or ramping production') strengthens accuracy. (4) The only minor shortcoming is that the LLM does not explicitly mention 'bottlenecks' or 'cost control' as specific production challenges highlighted in the original answer, which slightly reduces completeness in qualitative detail. However, 'supply-chain constraints' and 'manufacturing-scale' cover overlapping concepts. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor omissions in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 420,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Skoal’s retail share fell from 9.3 percent of the U.S. oral‑tobacco market in 2023 to 7.6 percent in 2024 – a drop of about 1.7 percentage points (≈18 % relative decline)【page_48】. This decline signals that Skoal is losing ground to competing brands and to the fast‑growing oral‑nicotine‑pouch segment, indicating a weakening competitive position within the oral‑tobacco category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the retail share of Skoal in 2023 (9.3%) and 2024 (7.6%), matching the ground truth exactly. The calculation of the 1.7 percentage point decline and the approximate 18% relative decline is accurate and adds helpful context not in the original answer. The conclusion about weakening competitive positioning aligns with the ground truth. 2) All numbers are correct: 9.3% → 7.6% is a 1.7 percentage point drop; (9.3 - 7.6)/9.3 ≈ 18.3%, so '≈18%' is a valid approximation. No calculation errors. 3) The multi-hop reasoning is sound—correctly synthesizing Skoal's performance over two years and inferring competitive implications. While the LLM mentions the oral-nicotine-pouch segment as a competitive pressure (not explicitly in the ground truth), this is a reasonable inference given the rise of products like on! and does not contradict the original. 4) The answer is semantically equivalent to the ground truth in all key facts and adds minor interpretive context. The only reason for not scoring 10 is that the original answer includes a direct comparison to on!'s growth (6.8% to 8.3%), which the LLM omits. This is a minor completeness gap in comparative context, but the core facts and conclusion are fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 351,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The 2023 filing already warned that Qualcomm “derives a significant portion of our revenues from a small number of customers and licensees, particularly from their sale of premium‑tier handset devices,” and that “the concentration of device share among a few companies… may result in lower prices for our products, which could have an adverse effect on our revenues and margins” (2023 10‑K p. 18). The 2024 filing repeats this risk and makes it more explicit that the trend is expected to continue, noting that “the mobile industry is experiencing… concentration of device share among a few companies, particularly at the premium tier,” and that “the corresponding purchasing power of these companies may result in lower prices for our products… and may cause our revenues and results of operations to fluctuate” (2024 10‑K p. 18‑19). Thus, the risk has not diminished; rather, Qualcomm has emphasized that the concentration is persisting and could further erode pricing power and destabilize revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies the key risk in both 2023 and 2024: concentration of device share among premium-tier companies leading to pricing pressure and revenue instability. The core facts—reliance on a small number of customers, particularly Chinese OEMs, and the resulting purchasing power that pressures Qualcomm’s pricing—are all present and correctly represented. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or the original answer, so quantitative accuracy is not applicable in a numerical sense; however, the LLM correctly cites the years (2023 and 2024) and page numbers (pp. 18, 18–19) from the 10-K filings, which supports factual grounding. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures across two years, correctly infers that the risk persists and has been more explicitly framed in 2024, and draws the logical conclusion that pricing power and revenue stability are increasingly at risk. The only minor shortcoming is that the LLM does not explicitly mention the added 2024 nuance about customers developing their own integrated circuits or switching to competitors—a detail present in the original answer that slightly strengthens the rationale for intensified risk. However, the omission does not undermine the overall correctness. (4) The answer is contextually fully relevant, directly addressing the evolution of the risk between 2023 and 2024 and its implications for Qualcomm. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 476,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity strategy keeps most of its cash in money‑market mutual funds, and the balance rose modestly – from $10.266 billion at the end of 2023 to $10.354 billion at the end of 2024, an increase of about $88 million【page_133】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased from $10.266 billion in 2023 to $10.354 billion in 2024. The ground truth confirms that the allocation remained unchanged at $10,266 million (i.e., $10.266 billion) in both years. The reported increase of $88 million is therefore inaccurate. (2) Quantitatively, the LLM misstates the 2024 amount and introduces a false change. While $10.266 billion correctly reflects the 2023 value (equivalent to $10,266 million), the 2024 figure should be identical but is instead given as $10.354 billion, which does not align with the ground truth. The cited increase of $88 million is thus based on erroneous data. (3) The reasoning is flawed because it fails to recognize the absence of change between the two years, which is the key point in the original answer. The LLM incorrectly infers a modest rise, undermining the multi-hop synthesis required to compare the two years’ disclosures. (4) Despite the factual errors, the answer is contextually relevant—it addresses Amgen’s short-term liquidity strategy and focuses on money market mutual funds as a component of available-for-sale investments. However, the core inaccuracy in numbers and trend severely limits correctness. Minor point: the use of 'billion' is acceptable and equivalent to 'thousand million', so format conversion is not the issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 393,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "In the 2022 Form 10‑K General Dynamics noted that it had pledged about **$295 million of U.S. government accounts receivable** to the Capital Construction Fund (CCF) 【page_67】. By the 2024 filing the pledged amount had risen to **$333 million at year‑end 2024** (up from $315 million at year‑end 2023) 【page_68】, indicating that the company’s participation in the CCF increased between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: $295 million pledged as of 2021 (reported in 2022 10-K), $315 million at year-end 2023, and $333 million at year-end 2024 (reported in 2024 10-K). The format variations (e.g., 'about $295 million') are acceptable and do not misrepresent the data. (2) The answer addresses the evolution of General Dynamics' participation in the CCF between 2022 and 2024, correctly showing an increasing trend in pledged receivables. (3) The multi-hop reasoning is sound—information is synthesized across multiple 10-K filings and years, correctly linking the reported figures to the trend of increasing participation. (4) The only minor shortcoming is that the LLM does not explicitly mention the significance of the increase (i.e., growing utilization of tax deferral benefits), which is included in the original answer. However, the core facts, numbers, and trend interpretation are fully correct, and the omission does not detract significantly from the overall accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 343,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "After Corebridge’s September 2022 IPO, AIG’s ownership fell below 80 % and Corebridge was tax‑deconsolidated in 2023, leaving its net operating losses and tax‑credit carryforwards with the Corebridge tax groups and still generating a $439 million gain on the retained Corebridge equity in AIG’s investment‑income line【page_255】. By 2024 AIG had fully divested and deconsolidated Corebridge, recognizing a $3.0 billion pre‑tax gain on the sale, a $545 million tax expense and, after a $7.2 billion OCI adjustment, a $4.8 billion after‑tax loss on the deconsolidation【page_110】, and the retained‑investment gain line disappeared from its net investment‑income table, indicating the Corebridge investment no longer contributed to earnings【page_122】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) While it correctly identifies the 2023 tax deconsolidation due to AIG's ownership falling below 80% after Corebridge's September 19, 2022 IPO, it incorrectly states that AIG 'fully divested' Corebridge by 2024 — the ground truth indicates AIG retained an investment and reported it under the equity method, not that it fully sold it. (2) The claimed $439 million gain on retained equity and $3.0 billion pre-tax gain, $545 million tax expense, $7.2 billion OCI adjustment, and $4.8 billion after-tax loss on deconsolidation are not supported by the original answer and contradict it; no such losses or gains of that magnitude are mentioned in the ground truth. (3) The original answer specifies that in 2024, AIG recognized equity method income (denoted as $X) from June 10 to December 31, 2024, based on dividends and stock price changes — the LLM incorrectly implies the investment no longer contributed to earnings and omits the equity method accounting entirely. (4) The LLM incorrectly frames the relationship as fully terminated, whereas the truth describes a shift to an equity-method investment relationship, not full divestiture. (5) Page citations are included but do not align with the factual claims made, suggesting potential hallucination or misinterpretation. The reasoning fails the multi-hop synthesis: it conflates deconsolidation with full divestiture and invents large financial figures absent from the ground truth. While the initial tax deconsolidation point is correct, the rest of the answer diverges factually. Quantitative accuracy is very low due to fabricated numbers. Qualitative accuracy suffers from incorrect entity relationships and accounting treatment. Contextual relevance is moderate as it addresses tax and investment themes but misrepresents the nature and outcome of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 518,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "In the 2022 Form 10‑K Tesla described a hands‑on ramp‑up of Solar Roof, saying it would grow the retrofit business with a low‑cost online ordering experience, on‑board and train new installers, partner with real‑estate developers to cut installation time and hire additional skilled electricians, while warning that the ramp depended on adequate battery‑cell supply and could be delayed by component shortages or supplier disruptions【page_34】. By the 2024 filing the Solar Roof discussion is folded into a broader “Solar Energy Systems” segment that focuses on competitive positioning and a favorable regulatory environment, and the risk‑factor sections again flag supply‑chain constraints—especially reliance on a few battery‑cell suppliers and global component shortages—without reiterating the earlier installer‑training and builder‑collaboration initiatives【page_13】【page_16】【page_18】. Thus Tesla’s approach shifted from a detailed operational scaling plan in 2022 to a more strategic market‑focus view in 2024, while the underlying supply‑chain challenges remain prominent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Tesla's 2022 strategy included onboarding and training installers, partnering with real estate developers, hiring electricians, and concerns about battery cell supply and component shortages—accurately cited from page 34. By 2024, the focus shifted to broader supply chain risks, particularly reliance on limited battery-cell suppliers and global component shortages, with no mention of installer training or developer collaborations—correctly noted from pages 13, 16, and 18. (2) There are no numerical values requiring calculation, but all dates (2022, 2024) and contextual references are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in Tesla’s operational strategy over time, identifying a shift from granular, installation-focused scaling efforts in 2022 to a more strategic, supply-chain-centric view in 2024. (4) The only minor shortcoming is that the LLM frames the 2024 shift slightly more as a 'market-focus view' due to mention of regulatory environment and competition, whereas the ground truth emphasizes systemic production scalability and cost-effectiveness under inflationary pressures. However, the core idea—that Tesla moved from localized operational initiatives to systemic supply chain dependencies—is preserved. Wording differs slightly but semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to slight nuance loss in framing the 2024 emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 451,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "- In the 2022 Form 10‑K Duke Energy said the total cost to permanently close all coal‑ash basins in North Carolina and South Carolina was “approximately $8 billion to $9 billion” (with about $3.1 billion already spent through 2021)【page_71】.  \n- In the 2023 Form 10‑K the estimate was revised to “approximately $7 billion to $8 billion” and about $4 billion had been spent through 2023【page_69】.  \n\nThe reduction of the estimated total liability by roughly $1 billion, together with the increase in actual spend, indicates Duke Energy is making progress in completing ash‑basin excavations and lowering the remaining cost under the Coal Ash Act.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The estimated cost ranges ($8B–$9B in 2022 and $7B–$8B in 2023) and the amounts spent ($3.1B through 2021 and $4B through 2023) are accurately reported, with correct timeframes and dollar figures. The $1B reduction in the estimated total liability is a valid inference from the midpoint or upper bound of the ranges and aligns with the downward trend. (2) Completeness: The answer addresses both parts of the question—how the cost estimate evolved from 2022 to 2023 and what this indicates about progress under the Coal Ash Act. (3) Entity accuracy: Duke Energy, North Carolina, South Carolina, Coal Ash Act, and the correct Form 10-K years (2022 and 2023) are properly identified. (4) Reasoning: The synthesis across two years of filings is sound; the conclusion that reduced estimates and increased spending indicate progress in basin excavations and cost refinement is logically and factually supported. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, with slightly more concise wording but no loss of key information. All multi-hop elements (comparing estimates over time, spending trends, and implications) are correctly handled.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 355,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The on! oral‑tobacco product’s retail share rose from 6.8 % in 2023 to 8.3 % in 2024 – an increase of about 1.5 percentage points. During the same period the total oral‑tobacco segment’s retail share fell from 42.5 % to 37.5 %, so on! not only grew its own share but also improved its relative position within a segment that was losing overall market share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the retail share of 'on!' increased from 6.8% in 2023 to 8.3% in 2024, and the total oral tobacco segment's share declined from 42.5% to 37.5%, as stated in the original answer. The implied increase of 1.5 percentage points is correct (8.3 - 6.8 = 1.5). (2) The answer is complete, addressing both the evolution of 'on!'s retail share and its relative market position compared to the overall segment. (3) Entities are correctly identified: the product 'on!', the time period (2023–2024), and the relevant metric (retail share) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that 'on!' gained share while the overall segment shrank, indicating relative strengthening in market position. The conclusion is logically derived and semantically equivalent to the original answer, despite slightly different phrasing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 300,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "In the 2023 filing Qualcomm already warned that “a significant portion of our licensing revenues… includes a number of Chinese OEMs” (Risk Factors, p. 18). By fiscal 2024 that exposure had grown – Chinese OEMs such as Xiaomi now account for 10 % or more of total consolidated revenue (Revenue Concentrations, p. 14) and the company notes that Chinese OEMs have increased their device‑share (Risk Factors, p. 18). The deeper concentration means Qualcomm’s results are more vulnerable to a slowdown, vertical‑integration moves or U.S./China policy actions affecting those OEMs, raising the risk to its revenue stability and cash‑flow generation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's continued reliance on Chinese OEMs from 2023 to 2024 and the associated business risks, aligning with the ground truth. However, it introduces a specific quantitative claim not present in the original answer: that Chinese OEMs such as Xiaomi account for '10% or more of total consolidated revenue' in 2024. This precise percentage is not stated in the ground truth, which only notes a 'significant portion' without quantification. Additionally, the ground truth does not mention Xiaomi specifically, making this an unsupported detail. (2) The quantitative accuracy is reduced because the 10% figure and attribution to Xiaomi are not corroborated by the original answer. While the direction of increased reliance is consistent, the introduction of unverified specifics undermines numerical precision. (3) The multi-hop reasoning is sound—LLM connects risk exposure in 2023 to ongoing trends in 2024 and infers implications for revenue stability. It correctly synthesizes the idea that increased device share and concentration among Chinese OEMs heighten vulnerability to geopolitical and market risks. (4) Despite the over-specificity in numbers, the core qualitative message—increased concentration and persistent risk—is consistent with the original. The answer is contextually relevant and well-structured, but the unsupported quantitative claim prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 397,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "By the end of 2022 Amgen’s available‑for‑sale (AFS) portfolio was $4.335 billion, made up of $1.676 billion of U.S. Treasury bills and $2.659 billion of money‑market mutual funds (no other short‑term securities) 【page_133】. In 2023 the AFS portfolio more than doubled to $10.404 billion, now consisting almost entirely of money‑market mutual funds ($10.266 billion) with a small $138 million holding of other short‑term interest‑bearing securities, while the Treasury‑bill position fell to zero 【page_133】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 available-for-sale investments. According to the ground truth, in 2022, the $4,335 million total was composed of $1,676 million in marketable securities (not U.S. Treasury bills specifically) and $2,659 million in cash and cash equivalents (not money market mutual funds). However, the LLM incorrectly states that the 2022 portfolio consisted of $1.676 billion in U.S. Treasury bills and $2.659 billion in money-market mutual funds, which misrepresents the security types entirely. The 2023 figures are accurate: $10,404 million total, with $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities, and the elimination of Treasury bills is correctly noted. (2) Quantitatively, the dollar amounts are numerically correct (allowing for billion/million formatting), but their assignment to specific security types in 2022 is wrong, leading to incorrect synthesis. The sum checks out ($1,676M + $2,659M = $4,335M), but the components are mislabeled. (3) The multi-hop reasoning is flawed because the model fails to correctly identify and distinguish the types of securities held in 2022, conflating 'marketable securities' and 'cash and cash equivalents' with 'U.S. Treasury bills' and 'money market mutual funds', which are not equivalent categories. This undermines the comparative analysis between years. (4) Despite the incorrect breakdown for 2022, the answer correctly captures the shift in 2023 and the overall growth in the portfolio, maintaining contextual relevance. However, due to the major error in entity classification and composition, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 484,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "In the 2022 filing, Shake Shack does not appear in any of the premium‑outlet tenant lists (see the 2022 Premium Outlets tables on pages 34‑35). By the 2023 filing, Shake Shack is listed as a tenant at two premium‑outlet centers—Las Vegas Outlets (page 34) and Woodbury Common Premium Outlets (page 35)—showing that the brand was added to SPG’s premium‑outlet portfolio between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims Shake Shack did not appear in any premium-outlet tenant lists in 2022, directly contradicting the ground truth, which states that Shake Shack was present at Woodbury Common Premium Outlets in 2022. This error undermines the core of the multi-hop comparison between 2022 and 2023. While the 2023 information is correct—Shake Shack is accurately reported at both Woodbury Common and Las Vegas Outlets North Premium—the claim that it was 'added' between 2022 and 2023 is false, as it was already present in 2022. The quantitative accuracy is partially correct (two locations in 2023), but the baseline (2022) is wrong. Entity names (Shake Shack, Woodbury Common, Las Vegas Outlets) and years are correctly identified, but the reasoning is flawed due to incorrect data retrieval for 2022. The answer is contextually relevant and addresses the evolution question, but the incorrect premise leads to an inaccurate conclusion about expansion. Thus, while the structure and intent are sound, the factual foundation is compromised, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 316,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "In the 2022 Form 10‑K GD reported its retirement‑annuity contracts as Level 3 assets (significant unobservable inputs) in the fair‑value hierarchy (e.g., $35 million shown in the Level 3 column)【page_93】. The 2024 Form 10‑K still classifies these contracts as Level 3 (now $22 million)【page_94】. The unchanged Level 3 classification indicates GD continues to value retirement‑annuity contracts using a methodology that relies on internal, unobservable assumptions rather than observable market prices.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that retirement annuity contracts were classified as Level 3 assets in both 2022 and 2024, with accurate dollar amounts ($35 million in 2022 and $22 million in 2024), which aligns with the ground truth. These figures are properly cited to the respective pages in the 10-K filings. (2) Quantitatively, the numbers are correct and match the ground truth; there are no calculation errors. The format variations (e.g., $35 million) are acceptable and semantically equivalent. (3) However, the LLM answer is incomplete in its qualitative reasoning. While it correctly notes the continued Level 3 classification and infers that unobservable inputs are still used, it omits a key point from the original answer: the change in disclosure practice regarding the inclusion of investments valued using net asset value (NAV) as a practical expedient in the reconciliation tables in 2024, which was not explicitly stated in 2022. This omission means the answer fails to fully capture the evolution in reporting transparency, which is a critical part of the question about how the classification 'evolved' and what it indicates about GD's valuation methodology. (4) The contextual relevance is high because the answer addresses the core of the question—classification within the fair value hierarchy and its implications. The reasoning is sound but partial, missing the nuance of improved disclosure practices. Thus, while factually accurate on the hierarchy level and values, the answer lacks completeness in multi-hop synthesis, particularly around disclosure changes, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 455,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "In 2023 Corebridge was still a consolidated subsidiary – AIG excluded 4.4 million potential dilutive shares from diluted EPS (anti‑dilutive) and booked a $439 million gain on its retained Corebridge investment as the stock price moved (see 2023 10‑K p. 242 & p. 122). By 2024 AIG had de‑consolidated Corebridge, eliminating any Corebridge‑related dilution, and now accounts for its remaining stake under the equity‑method, reporting $601 million of equity‑method income (and $1.574 billion of Corebridge pre‑tax income) while recognizing a $4.754 billion loss on the sale of Corebridge (see 2024 10‑K p. 109 & p. 110).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right topic and showing an understanding of the general shift in AIG's relationship with Corebridge. (1) Quantitative inaccuracies: The original answer states that the potential equity dilution from Blackstone’s exchange right was 24.1 million shares in 2022 and 4.4 million in 2023, but this mechanism was terminated due to Corebridge's IPO on September 19, 2022—before 2023. The LLM incorrectly implies that 4.4 million shares were still a live dilutive factor in 2023, when in fact the right had already been terminated. Additionally, the LLM cites a $439 million gain in 2023 and a $601 million equity-method income and $4.754 billion loss in 2024, but these figures are not supported by the ground truth, which does not mention specific income or loss amounts. The ground truth emphasizes structural changes in accounting treatment, not specific gains or losses. (2) The LLM introduces financial figures (e.g., $439M gain, $601M income, $4.754B loss) that are absent from the original answer and cannot be verified against the provided ground truth, suggesting potential hallucination or misattribution from external data. (3) Qualitatively, the LLM correctly identifies the shift from consolidation to equity-method accounting and the elimination of dilution risk post-deconsolidation, which aligns with the multi-hop reasoning in the original answer. However, it misrepresents the timeline—particularly the survival of dilution risk into 2023—undermining the reasoning. (4) Contextually, the answer is relevant and structured around the correct entities (AIG, Corebridge), time periods (2023–2024), and concepts (equity dilution, income recognition). But due to major numerical and timeline errors, the correctness score is low despite partial conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 499,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "In the 2022 filing Comcast reported Universal Beijing Resort’s financing as “Debt not guaranteed,” showing about $3.6 billion of resort debt (the 2021 figure) that it did not back with a guarantee. The 2024 filing shows the resort’s debt has slipped to roughly $3.4 billion (including a $3.0 billion term loan) and again notes that Comcast provides no liquidity, guarantee or other financial commitment – it simply consolidates the resort as a VIE, so its exposure is limited to its 30 % equity interest.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has significant quantitative inaccuracies. It correctly identifies that Comcast does not guarantee the debt and consolidates Universal Beijing Resort as a VIE. However, it omits key data points from the ground truth: the 2020 ($2.5B) and 2023 ($3.5B) debt figures are missing, and the 2024 figure is misstated as $3.4B 'as of December 31, 2024' — which is factually impossible in a 2024 filing released before that date. The ground truth states $3.4B was the amount as of December 31, 2024, implying a forward-looking or reported figure, but the LLM incorrectly presents it as current without clarifying the reporting lag. (2) The LLM mentions a $3.0 billion term loan not present in the original answer, introducing unverified detail. More critically, it fails to report the full consolidation impact — $7.3B in assets and $7.0B in liabilities included in Comcast’s balance sheet as of 2024 — which is a central part of the original answer and directly addresses Comcast’s financial exposure. (3) The reasoning around VIE consolidation is qualitatively sound — the model correctly infers limited exposure beyond equity interest — but misses the nuance that full consolidation means the debt *is* on Comcast’s books despite lack of guarantee, which affects financial exposure. This reflects partial multi-hop synthesis: it connects VIE status to consolidation and non-guarantee, but fails to reconcile this with the balance sheet inclusion. (4) Scores reflect mostly correct reasoning and context (hence high contextual relevance and decent qualitative accuracy), but major deductions in quantitative accuracy due to missing/misplaced numbers and introduction of unsupported specifics like the term loan. Correctness score is moderate because core trend (slight decline in debt, no guarantees) is accurate, but key details and completeness are lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 518,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "In the 2022 filing the trade‑in options were described as being available to “some customers” in the Aerospace backlog, whereas the 2023 filing narrows the language to “some Gulfstream customers.” The underlying mechanics and risk profile have not changed – the fair‑market value is set about 45 days before delivery, a guaranteed trade‑in price above market value reduces revenue, and the estimated impact on fair‑market values remains immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key changes in customer eligibility and risk exposure between 2022 and 2023. It correctly identifies the shift from 'some customers' in 2022 to 'some Gulfstream customers' in 2023, reflecting a narrowing of eligibility, which aligns with the ground truth. The answer also correctly states that the estimated impact on fair market values remains immaterial, matching the original answer. It adds specific operational detail—'fair-market value is set about 45 days before delivery' and 'guaranteed trade-in price above market value reduces revenue'—that, while not in the ground truth, are plausible and consistent with typical accounting treatment of trade-in commitments, and do not contradict the source. These additions enhance clarity without introducing inaccuracies. The only minor shortcoming is that the LLM does not explicitly mention the increased risk concentration or strategic focus on Gulfstream as a potential implication, which was noted in the original answer. However, by naming Gulfstream specifically, the model implicitly supports that focus. All entities (Aerospace segment, Gulfstream, years 2022 and 2023) are correct. No numerical inaccuracies exist—there are no explicit numbers, but the qualitative statements about materiality are correct. The reasoning is sound and synthesizes the change across years appropriately. The answer is fully contextually relevant and directly addresses both customer eligibility and risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 412,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "In the 2022 Form 10‑K Tesla listed the Semi only as a “commercial electric vehicle” among its announced future models – it was still a planned product (Item 1, “Future Consumer and Commercial Electric Vehicles”)【page_5】. By the 2024 filing the Semi had moved into “pilot production” at the Nevada factory (production‑status table) and is now described as one of the newer vehicle models—alongside the Cybertruck and next‑generation platform vehicles—that Tesla is scaling up, signaling its shift from concept to early manufacturing and a strategic role in the expanding product lineup【page_36】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects Tesla's progression of the Semi from a planned future model in 2022 to pilot production in 2024, with correct contextual details about its strategic positioning. (2) There are no numeric values requiring calculation, but the years (2022, 2024) and production status ('pilot production') are factually correct and consistent with the original answer. Format variations are not applicable here, but the response precisely matches the timeline and status changes. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different years of Tesla’s 10-K filings, identifying the evolution in both production status and strategic framing (from concept to active scaling alongside Cybertruck and next-gen platforms). (4) The answer is semantically equivalent to the ground truth, with added specificity (e.g., referencing Item 1 and page numbers, Nevada factory) that enhances accuracy without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 314,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Altria’s valuation allowance for the Cronos investment rose modestly each year – $379 million at the end of 2022, $397 million at the end of 2023 and $402 million at the end of 2024 (MO 10‑K 2024, p. 84). The incremental increase shows the company still judges that a portion of the Cronos‑related deferred tax assets is unlikely to be realized, maintaining a conservative allowance and reflecting ongoing uncertainty about future taxable income to absorb those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the valuation allowance amounts for 2022 ($379 million), 2023 ($397 million), and 2024 ($402 million), which aligns with the ground truth that the allowance increased from $379M in 2022 to $402M in 2024. The inclusion of the 2023 figure ($397M), while not in the original answer, is consistent with the upward trend and adds granularity without introducing error. (2) All numeric values are accurate and properly cited to the MO 10-K 2024, p. 84. The incremental increases are correctly represented, and no calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that the rising allowance reflects Altria’s continued uncertainty about the realizability of deferred tax assets related to the Cronos investment, particularly due to insufficient expectation of future taxable income. This matches the multi-hop logic in the ground truth—linking increasing allowances to conservative recognition and uncertainty. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., 2023 value) and equally valid interpretation. The only minor shortcoming is that it does not explicitly state that the temporary difference is not expected to reverse in the foreseeable future—a phrase in the ground truth that reinforces the rationale—but the implication is clearly conveyed through 'ongoing uncertainty about future taxable income.' Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 445,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023 Amgen re‑classified its BeiGene stake from the equity‑method to a fair‑value measurement, so the change generated a large unrealized gain that was recorded in other income (the $2.8 bn + other‑income line). By 2024 the fair‑value of the investment had fallen, producing net unrealized losses on the strategic equity investment and reducing other income to about $506 m. Thus the accounting shift turned a 2023 gain into a 2024 loss, reflecting a reversal of the valuation impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core evolution in Amgen's financial treatment and valuation of its BeiGene investment between 2023 and 2024. It accurately identifies the 2023 reclassification from equity method to fair value, resulting in a large unrealized gain recognized in other income, and the 2024 shift to net unrealized losses due to a decline in fair value. The qualitative reasoning is sound and matches the ground truth: the reversal in financial impact is correctly explained. However, the quantitative accuracy is slightly reduced because the $2.8 billion gain and $506 million other income figure, while plausible, are not present in the original answer and introduce specific numbers not supported by the ground truth. The original answer mentions gains and losses but does not specify dollar amounts. While such detail could come from external filings, since the evaluation is based on alignment with the provided ground truth (which omits exact figures), the inclusion of precise numbers introduces unsupported precision. This does not make the answer factually incorrect, but reduces confidence in strict quantitative fidelity. All entities (Amgen, BeiGene, accounting methods, financial statement impacts) and years are correct. The multi-hop synthesis—linking accounting change in 2023 to valuation reversal in 2024—is logically and accurately presented. The answer is fully contextually relevant and semantically equivalent to the original, with only the addition of unverified numerical specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 417,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "In the 2023 filing Disney+ Hotstar was presented as a stand‑alone direct‑to‑consumer service “primarily in India” that delivers general‑entertainment, family and sports programming (2023 10‑K p. 4). By the 2024 filing the company describes Disney+ Hotstar as the **regional brand** for Disney+ in India and certain other Southeast Asian markets, positioning it under the global Disney+ umbrella and making it part of the broader Disney+ product suite (including multi‑product bundles) (2024 10‑K p. 57). This reflects a shift from a India‑centric, separate service to a region‑specific branding that aligns Hotstar with Disney+ worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Disney+ Hotstar's 2023 positioning as a standalone DTC service primarily in India offering general entertainment, family, and sports content, citing the 2023 10-K. In 2024, it accurately notes the repositioning of Disney+ Hotstar as a regional brand under the global Disney+ umbrella in India and Southeast Asia, based on the 2024 10-K. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—only qualitative descriptions and branding shifts, which are correctly reported. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings and correctly infers a strategic shift from a standalone service to a regionally branded component of a unified global product. The only minor omission is that the ground truth also mentions the merger of Star+ and Disney+ in Latin America by June 2024 as part of Disney’s consolidation strategy, which the LLM answer does not include. This limits completeness slightly, but the core evolution in India/Southeast Asia—the focus of the question—is fully addressed. (4) The answer is contextually relevant, directly addressing regional branding and service structure changes. Wording differs from the original but maintains semantic equivalence. The omission of the Latin America consolidation detail prevents a perfect 10, but the response is otherwise factually correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 417,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "In the 2023 filing PayPal described its protection programs simply as a service that “protects both merchants and consumers from loss primarily due to fraud and counter‑party performance,” and said the related costs are “estimated and recorded … in transaction and credit losses during the period the payment transaction is completed” (2023 10‑K p. 77). By the 2024 filing the tone had shifted: the purchase‑ and seller‑protection programs are now highlighted as a major source of risk, with PayPal noting that it “incurs substantial losses … from disputes,” may be unable to fully recover those losses from merchants, and could even lose card‑acceptance rights or face heightened regulator‑driven charge‑back requirements, underscoring a stronger focus on risk exposure and limited loss‑recovery (2024 10‑K p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: in 2023, PayPal recorded protection program costs in 'transaction and credit losses' without treating them as a separate service, and by 2024, it emphasized increased risk exposure due to substantial losses from disputes, challenges in recovering losses from merchants (especially in fraud or insolvency cases), and potential regulatory changes affecting chargebacks. The LLM correctly identifies the shift in tone and disclosure depth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or financial metrics. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying the evolution in PayPal’s risk disclosure strategy and the qualitative shift from passive cost recording to active risk acknowledgment. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'protects both merchants and consumers', 'major source of risk'), the meaning matches the original. The only minor shortcoming is that the LLM does not explicitly mention that PayPal did not provide a separate service under these programs in 2023, which slightly reduces completeness. However, this does not detract significantly from the overall correctness. Contextual relevance is perfect—the response directly addresses the evolution in risk exposure and loss recovery mechanisms as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 435,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources was divesting portions of its solar portfolio – it sold Class B membership interests and a 90 % non‑controlling stake in a 900‑MW wind‑and‑solar portfolio (including four solar plants), retaining a controlling interest and recording non‑controlling interests of about $689 million and cash proceeds of roughly $656 million (2022 p. 79‑81). By the 2024 filing the company had shifted to consolidating a series of variable‑interest entities that own solar facilities – eight subsidiaries with 50‑67 % stakes in entities operating ~765 MW of solar (assets $1.7 billion, liabilities $520 million) and larger groups of VIEs with thousands of MW of solar (assets $23.9 billion, liabilities $1.5 billion) – so the solar assets and related liabilities now appear on NEE’s balance sheet, increasing its financial exposure while debt holders have no recourse to NEE’s general credit (2024 p. 97).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NextEra Energy's relationship with solar generation facilities from 2022 to 2024, highlighting the shift from divestiture to consolidation of VIEs and increased financial exposure. However, there are minor quantitative inaccuracies. In 2022, the original answer specifies a 100% sale of a 100 MW solar facility in Arizona and a 90% sale in a portfolio with four solar facilities. The LLM answer incorrectly refers to a '900-MW wind-and-solar portfolio' and describes it as including four solar plants — while this may be contextually plausible, the ground truth does not mention wind or total portfolio size, so this is an overreach. Additionally, the LLM cites $689 million in non-controlling interests and $656 million in cash proceeds from 2022, which are specific figures not present in the original answer, making them potentially fabricated or misattributed. (2) For 2024, the LLM correctly identifies the consolidation of eight VIEs with ~765 MW of solar capacity and mentions financials like $1.7 billion in assets and $520 million in liabilities, which aligns with the direction of the truth, though these exact numbers are not in the original answer. The mention of 'thousands of MW' and $23.9 billion in assets appears to extrapolate beyond the provided data. (3) The multi-hop reasoning is strong: the model correctly infers a strategic shift from outright ownership and divestiture to a more complex structure involving VIE consolidation and increased balance sheet exposure. It accurately links the change in ownership structure to financial exposure via consolidation, even noting the non-recourse nature of debt, which adds depth. (4) Despite some unsupported numerical details, the core qualitative narrative — a strategic pivot from divesting full or partial stakes to consolidating VIEs with greater financial exposure — is accurate and well-synthesized across years. The answer remains highly relevant and insightful, meriting a high correctness score with a deduction for overprecision on unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 562,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit plan holdings of mutual‑fund debt securities fell from $379.9 million in 2022 to $189.3 million in 2023 – a drop of roughly $190 million. In both years the securities were classified as Level 2 assets in the fair‑value hierarchy, so the valuation methodology remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. The ground truth states that ACN's Mutual Fund Debt Securities were valued at $379,989 in 2022 and $253,025 in 2023, but the LLM incorrectly reports $379.9 million (over 1,000 times higher) and $189.3 million (more than 700 times higher), which are grossly inaccurate despite the acceptable format variation of 'million'. The actual decrease is approximately $126,964, not the reported $190 million drop. (2) The calculation of the change is therefore also incorrect—while the LLM claims a drop of roughly $190 million, the true decrease is about $127 million. Additionally, the 2023 value is misrepresented: $253,025 vs. the LLM's $189.3 million. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that the valuation methodology remained in Level 2 in both years, indicating consistent use of observable market data, which aligns with the original answer. It also correctly interprets that the change reflects a reduction in exposure. However, it fails to mention that the entire amount remained in Level 2 in both years, and introduces an unverified detail about 'non-U.S. defined-benefit plan holdings', which is not present in the ground truth and cannot be confirmed. (4) The contextual relevance is moderate—the response addresses the evolution of investment and valuation methodology as asked, but with severely flawed quantitative inputs. Due to the extreme numerical errors, the correctness score is low despite some structural and qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 435,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron continued to hold a 50 % equity interest in Tengizchevroil, but the size of the investment grew modestly – the carrying value rose from about $26.5 billion at year‑end 2022 to roughly $27.0 billion at year‑end 2023【page_82】.  At the same time, the equity‑in‑earnings from TCO fell from $4.4 billion in 2022 to $3.4 billion in 2023【page_82】, while the $4.5 billion loan to TCO and the 50 % ownership percentage remained unchanged【page_78】【page_82】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value in Tengizchevroil was $23,727 million ($23.7 billion) in 2022, not $26.5 billion as stated by the model. The 2023 carrying value is reported as approximately $27.0 billion in the LLM answer, but the ground truth does not provide an exact updated carrying value—only that it was $80 million higher than its underlying equity in net assets. The equity in earnings is also incorrect: the ground truth reports $1,238 million ($1.2 billion) in 2022, while the LLM claims $4.4 billion in 2022 and $3.4 billion in 2023—overstating by more than 3x. The $4.5 billion loan is correctly identified and attributed to 2023, which is accurate. (2) Quantitative accuracy is severely compromised: the carrying values and earnings figures are completely mismatched. Even allowing for format variations, the numbers do not align with the source data. The model appears to have pulled figures from unrelated contexts or misread the filing. (3) The reasoning is partially sound in structure—comparing 2022 and 2023 values, noting consistent ownership and loan amounts—but fails on multi-hop synthesis because the underlying numbers are wrong. The conclusion about modest growth in investment is not supported by the actual data provided in the ground truth. (4) Contextual relevance is acceptable because the answer addresses the evolution of Chevron’s financial stake using the correct entities (Tengizchevroil, FGP/WPMP loan) and time frame. However, due to major quantitative errors, the overall correctness score is low—only the loan amount and ownership percentage are accurate, while all other financial metrics are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 474,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "In the 2023 filing, ABC Network is described as a core **linear network** in the Entertainment segment – a primary broadcast outlet that generates affiliate‑fee revenue and carries Disney‑owned channels such as Freeform, FX and National Geographic (see 2023 page 78). By 2024, ABC’s role has shifted to a **cross‑platform hub**: its sports schedule is branded “ESPN on ABC” (2024 page 9) and its primetime programming is made available on Hulu the day after its linear airing (2024 page 7), reflecting Disney’s strategy to use ABC as a bridge between linear broadcast, sports, and its Direct‑to‑Consumer streaming ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies ABC Network's role in 2023 as part of Disney's Linear Networks within the Entertainment segment, emphasizing affiliate fees and linear distribution. In 2024, it accurately captures the strategic shift toward integration with streaming platforms, specifically noting that ABC programming is available on Hulu the day after linear airing—matching the ground truth's key point about SVOD availability. The mention of 'ESPN on ABC' branding reinforces the deeper integration with Disney's broader sports and broadcast strategy. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2023, 2024) and page references (though not part of the ground truth evaluation) are consistent with document-based sourcing and do not contradict facts. (3) The multi-hop reasoning is sound: the model synthesizes ABC’s transition from a linear affiliate-revenue-driven network to a cross-platform content bridge feeding Hulu and Disney’s DTC ecosystem. It correctly infers strategic evolution across time and business segments. (4) Minor deduction in qualitative accuracy due to the addition of 'Freeform, FX and National Geographic' as channels carried by ABC—this detail is not in the ground truth and may conflate ABC’s role with other Disney-owned networks; ABC is a broadcast network, not a carrier of cable channels. However, this does not undermine the core correctness of the strategic positioning narrative. Overall, the answer is factually strong, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 449,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "In the 2022 filing General Dynamics highlighted the ASCOD as a core offering of its European Land Systems unit – describing it as “a highly versatile tracked combat vehicle” with the Spanish Pizarro and Austrian Ulan versions (GD 2022 10‑K, p. 11). By contrast, the 2023 10‑K’s Land‑Systems overview (GD 2023 10‑K, p. 11) no longer calls out the ASCOD, suggesting the company is de‑emphasizing that platform and likely reallocating production and R&D resources toward other tracked vehicles (e.g., Ajax, Piranha) and emerging autonomous‑vehicle initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the shift in General Dynamics' disclosure about the ASCOD vehicle between 2022 and 2023: in 2022, the vehicle was explicitly mentioned as part of the Land Systems portfolio with descriptive language about its variants, while in 2023 it was omitted from the overview. The conclusion that this indicates a de-emphasis of the platform and a likely reallocation of resources toward other vehicles like Ajax and Piranha is logically sound and consistent with the original answer. The LLM adds contextual detail (e.g., naming Pizarro and Ulan variants, referencing autonomous initiatives) not in the ground truth but supported by typical reporting patterns and plausible inference. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated). The only minor gap is that the original answer specifies the 2022 activity as 'producing and upgrading' and 2023 as 'offering', while the LLM focuses on presence vs. absence in the portfolio description—this is a slightly different framing but semantically equivalent in implication. Multi-hop reasoning is correctly applied across two years of 10-K filings. Thus, the answer is highly accurate with only a slight nuance difference in wording, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 381,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal cut the portion of European customer balances it earmarks for credit from $3.0 billion – about 39 % of the balances available for corporate use at 12/31/2023 – to $2.0 billion – roughly 26 % at 12/31/2024【page_46】. This drop in both the absolute amount and the share of balances signals a more conservative credit‑funding stance, with the company relying less on internal customer deposits and likely turning to external sources or preserving liquidity for its credit products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key quantitative figures: $3.0 billion approved in 2023 (39%) and $2.0 billion in 2024 (26%), matching the ground truth exactly. Dates (12/31/2023 and 12/31/2024) are appropriately used as reporting points, consistent with SEC filing conventions. (2) All numbers, percentages, and time periods are accurate. The decrease from $3.0B to $2.0B and the drop from 39% to 26% are correctly stated. No calculation errors. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward reduced reliance on customer balances for credit funding. It accurately characterizes this as a more conservative stance and suggests a pivot to external financing or liquidity preservation. However, it omits a key piece of multi-hop evidence from the ground truth: PayPal’s multi-year agreement to sell consumer installment receivables, with a significant increase from $5.5B in 2023 to $20.8B in 2024, which strongly supports the shift toward external funding. This omission slightly weakens the qualitative completeness of the reasoning. (4) Despite this, the LLM answer is semantically equivalent in intent and conclusion, correctly interpreting the trend and its strategic implication. The answer is fully contextually relevant, directly addressing both parts of the question—evolution between 2023 and 2024 and the strategic indication. The score of 9 reflects high accuracy with a minor gap in evidentiary completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 407,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "In the 2022 Form 10‑K the Special Use Funds were shown as a single $906 million line that “primarily represents investments accounted for under the equity method and loans not measured at fair value (Level 2),” with no detailed split of the equity component. By the 2024 filing the equity securities in those funds were disclosed separately as $6.164 billion, broken out by fair‑value hierarchy (Level 1 $2.614 bn, Level 2 $3.321 bn, Level 3 $0.229 bn), showing a much larger equity allocation and a more granular, transparent presentation of the fund’s composition.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that equity securities in the Special Use Funds were disclosed as $6.164 billion in 2024, but the ground truth reports $2,614 million for NEE and $1,028 million for FPL in Level 1 securities — not a combined $6.164 billion. The LLM incorrectly aggregates or inflates the total, possibly confusing total fund assets with equity securities alone. Additionally, the LLM introduces Level 2 ($3.321 bn) and Level 3 ($0.229 bn) values not present in the ground truth, which only specifies Level 1 amounts for NEE and FPL in 2024 and notes more granular disclosures without providing those exact figures. In 2022, the LLM mischaracterizes the $906 million as 'primarily representing investments under the equity method and loans not measured at fair value (Level 2)', but the ground truth states this amount includes equity securities with a carrying value of $906M and fair value of $907M for NEE — contradicting the claim that they are not measured at fair value. (2) Number verification: The correct 2022 figures are $906M (NEE) and $672M (FPL); the LLM omits FPL entirely and misrepresents NEE’s composition. The 2024 figures are $2,614M (NEE Level 1) and $1,028M (FPL Level 1); the LLM invents a much larger total and breaks it down into unsupported subtotals. (3) Multi-hop reasoning is partially sound — the model correctly infers increased transparency due to fair value hierarchy disclosures — but fails to accurately synthesize entity-specific data across years. It conflates NEE and FPL figures and introduces non-existent totals. (4) Despite these serious factual errors, the answer captures the qualitative trend toward greater transparency and increased equity allocation, and addresses both parts of the question (evolution of valuation/categorization and implications for transparency/investment composition), warranting moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies severely undermine factual correctness, leading to a correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 562,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "In fiscal 2022 Accenture bought about 1.96 million Class A shares through its publicly announced open‑market repurchase program and roughly 97 thousand shares in connection with employee‑related equity plans, while the Board expanded total repurchase authority to $6.129 billion (including a $3 billion addition)【page_33】. By fiscal 2023 the employee‑focused side had grown sharply, with the 2010 Employee Share Purchase Plan issuing roughly 5.71 million shares (up from 4.37 million in 2022)【page_99】, while the public program remained in place under the larger authorization, reflecting a broader scope and a shift toward greater employee‑related share utilization.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the ~1.96 million shares purchased under the public program in fiscal 2022 (matching the ground truth 1,964,612 shares) and the ~97,000 employee-related shares, it incorrectly claims that the public share repurchase program remained active in fiscal 2023 with no reduction in activity. The ground truth states there is no mention of public program purchases in 2023, indicating reduced or no activity—this key shift is misrepresented. Instead, the LLM claims the public program 'remained in place under the larger authorization,' which contradicts the original answer’s conclusion of a shift away from public repurchases. (2) The LLM introduces new data not in the ground truth: that the 2010 Employee Share Purchase Plan issued 5.71 million shares in 2023 (up from 4.37 million in 2022). This is a critical error—employee-related transactions in the original answer refer to share withholding for tax obligations, not share issuances under purchase plans. These are opposite actions (issuance vs. acquisition) and cannot be conflated. Additionally, the $6.129 billion repurchase authority and $3 billion addition are mentioned in the LLM answer but absent from the ground truth, making them unsupported. (3) The multi-hop reasoning is flawed. The question asks about evolution in 'scope and utilization' of the share purchase program, specifically contrasting public repurchases vs. employee-related acquisitions. The LLM fails to recognize that employee-related transactions in this context reduce shares outstanding (via withholding), not increase them (via issuance). It also misses the core insight: public market repurchases dropped to zero or near-zero in 2023, while employee-related acquisitions continued—indicating a strategic shift. Instead, it falsely infers increased employee utilization based on share issuances, which is the opposite of share acquisition. (4) Due to major factual and conceptual errors in both numbers and interpretation, the correctness score is low at 3. Quantitative accuracy is 4 because some 2022 numbers are approximately correct, but 2023 figures are fabricated or misapplied. Qualitative accuracy is 3 due to incorrect reasoning and entity conflation. Contextual relevance is 6 because the answer addresses the general topic and structure of the question, but with incorrect data and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 646,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron’s 50 % stake in Chevron Phillips Chemical Company LLC was treated the same way in both years – it was not consolidated into Chevron’s financial statements but was reported as a joint‑venture investment using the equity method. In the 2022 filing the company listed CPChem in Note 8 (summarized financial data) and Note 15 (investments and advances) 【page_32】, and the 2023 filing repeats that presentation and explicitly states the investment is “accounted for using the equity method” 【page_75】.  Thus, the consolidation status and accounting approach did not change between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. According to the ground truth, Chevron consolidated Chevron Phillips Chemical Company LLC (CPChem) in 2022 but switched to the equity method in 2023, marking a significant change in accounting treatment. The LLM incorrectly asserts that the accounting approach was consistent across both years and that CPChem was not consolidated in 2022. This contradicts the original answer, which states that CPChem was included as a consolidated subsidiary in 2022 via 'Note 8: Summarized Financial Data'. The LLM cites Note 8 and Note 15 in 2022 as evidence of equity-method accounting, but inclusion in summarized financial data of consolidated subsidiaries indicates consolidation, not equity-method reporting. While the 2023 statement that CPChem is 'accounted for using the equity method' is correctly noted by the LLM, it fails to recognize the shift from consolidation to equity accounting, which is the central point of the question. The 50% stake mentioned by the LLM may be factually accurate contextually, but it does not justify the erroneous conclusion that the accounting method was unchanged. The reasoning is flawed in interpreting the notes as evidence of consistent equity-method accounting, when the structure and labeling of the notes indicate a change in treatment. Thus, despite some correct references to footnotes and proper mention of the equity method in 2023, the answer misses the key evolution in consolidation status, resulting in a major factual error. Quantitative accuracy is low due to the misrepresentation of the accounting method over time, though no explicit numerical values are wrong. Qualitative accuracy is poor due to incorrect entity treatment and flawed multi-hop reasoning. Contextual relevance is moderate because the answer addresses the right company and time frame but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 508,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In the 2022 filing the Hydra‑70 rockets were noted only as a modest Army contract award – “$175 … for the production of Hydra‑70 rockets” (2022 10‑K, p. 42). By the 2023 filing the rockets are described as a market‑leading product for OTS and the segment secured new awards to dramatically scale output, expanding metal‑parts capacity from 18,000 to 86,000 rounds per month by 2025 and propellant capacity from 4 million to 16 million lb per year by 2028 (2023 10‑K, p. 12). This shows the role shifting from a single contract line‑item in 2022 to a strategic focus on large‑scale production‑capacity growth in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Hydra-70 rockets in General Dynamics' Combat Systems segment from 2022 to 2023. (1) Quantitatively, it correctly identifies the $175 million contract in 2022. It accurately reports the expansion of metal parts production capacity from 18,000 to 86,000 rounds per month by 2025, aligning with the ground truth. However, it adds a detail not present in the original answer—propellant capacity increasing from 4 million to 16 million lb per year by 2028—which, while plausible and consistent with the 2023 filing, was not included in the ground truth. This addition does not contradict but slightly exceeds the provided information. (2) The numbers and dates are correct, with proper context on capacity expansion timelines. (3) The reasoning is sound: it correctly synthesizes multi-hop information across 2022 and 2023 filings, showing a shift from a single contract to a strategic production focus. (4) The answer is contextually excellent, directly addressing contract involvement and production capacity evolution. The only minor deviation is the inclusion of propellant capacity, which was not in the ground truth, justifying a 9 instead of 10 on quantitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 351,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 Form 10‑K PayPal listed the “Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement” as Exhibit 10.07+, incorporated by reference and originally filed as a 10‑12B/A on May 14 2015 (see page 124). In the 2024 Form 10‑K the same Exhibit 10.07+ appears but without a filing‑date or form reference, and a new Exhibit 10.08+ – a “Form of Global Performance‑Based Restricted Stock Unit Award Grant Notice and Performance‑Based Restricted Stock Unit Award Agreement” (as amended and restated) – is added, indicating that PayPal has moved to a newer, performance‑based RSU agreement and changed the way the documentation is presented (see page 121).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice between 2023 and 2024. It correctly identifies that Exhibit 10.07+ (the base RSU grant notice) was present in both years and was originally incorporated by reference from the May 14, 2015 10-12B/A filing in 2023. The LLM accurately notes that in 2024, the same Exhibit 10.07+ appears but without reiterating the filing date or form reference, which aligns with typical SEC filing practices when reusing incorporated exhibits. It also correctly identifies the addition of Exhibit 10.08+ in 2024 as a new, updated performance-based RSU agreement, labeled as amended and restated, and associated with more recent disclosures. However, the LLM omits the specific linkage of the updated Exhibit 10.08+ to the April 30, 2024 10-Q filing, which is a key detail in the ground truth indicating active documentation updates. While the LLM infers a shift toward newer performance-based agreements and changes in documentation presentation, it does not explicitly confirm that the base RSU notice (10.07+) remained unchanged in substance—only that it was listed again. This misses a nuance in the synthesis: the base form was stable, while only the performance-based variant evolved. Quantitatively, all dates and exhibit numbers are correct (May 14, 2015; Exhibits 10.07+, 10.08+), and no calculations are inaccurate. The reasoning is sound for a multi-hop comparison across filings, though slightly less precise in distinguishing between documentation status (incorporated by reference vs. newly filed) and agreement type (base vs. performance-based). The answer remains highly relevant and factually aligned with the question’s focus on documentation status and associated agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 490,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "Opdivo was one of BMS’s biggest legacy oncology sellers, generating roughly $7.5 billion in net product sales in the most recent disclosed year (2021) – a level that still anchored the company’s revenue base in 2022 【page_110】.  By 2024 the drug is being repositioned as a growth platform: BMS added a sub‑cutaneous formulation (Opdivo Qvantig) and secured multiple new indications—including first‑line urothelial‑carcinoma (cisplatin + gemcitabine) in March 2024, neoadjuvant resectable NSCLC in October 2024, and the Opdivo + Yervoy combo in December 2024 – as well as approvals in Japan and the EU 【page_45】【page_44】【page_46】.  This shift shows Opdivo moving from a core revenue‑generating legacy product toward a broader, multi‑indication growth engine within BMS’s portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Opdivo as a major revenue contributor and notes its strategic evolution with new approvals, aligning with the ground truth. However, there are key quantitative inaccuracies: it cites $7.5 billion in net sales for 2021 instead of the correct $7,523 million in 2022, which misaligns the timeframe and slightly misrepresents the data. While $7.5 billion is numerically close to $7,523 million, attributing it to 2021 instead of 2022 is a factual error. (2) The LLM lists multiple new approvals in 2024, including urothelial carcinoma in March 2024 (correct), but adds neoadjuvant resectable NSCLC in October 2024 and Opdivo + Yervoy in December 2024—these are not mentioned in the ground truth and may be extraneous or speculative. The subcutaneous formulation (Opdivo Qvantig) and international approvals in Japan and EU are not part of the original answer and lack support from the provided truth. (3) The reasoning is sound in interpreting Opdivo’s strategic shift from a legacy product to a growth platform, which is a valid qualitative inference from revenue performance and new indications. The multi-hop synthesis between revenue data and regulatory developments is logical and relevant. (4) Despite over-attribution of additional approvals and using the wrong year for revenue, the core message about Opdivo’s sustained importance and expanded use is consistent with the ground truth. Hence, the answer is mostly correct but contains notable factual deviations in dates and unverified approvals, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron’s equity‑method stake in its 50 %‑owned joint venture, Chevron Phillips Chemical Company LLC, grew from a $6.843 billion carrying amount in 2022 to $7.765 billion in 2023 – a $922 million total increase, of which the 2023 increment was $608 million (versus an $867 million rise in 2022).  The investment continues to be structured around the 50 % equity ownership plus a $387 million loan that funds Chevron Phillips Chemical’s Golden Triangle Polymers Project in Orange, Texas, showing that Chevron maintained its strategic support but with a slower pace of additional project funding in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers not present in the ground truth. The carrying amounts of $6.843 billion in 2022 and $7.765 billion in 2023, along with the $922 million total increase and $608 million 2023 increment, are not mentioned or supported by the original answer. These figures appear fabricated or misattributed, as the ground truth does not provide balance sheet carrying values or year-over-year changes in equity investment. The only correct quantitative element is the $387 million loan in 2023 for the Golden Triangle Polymers Project, which matches the original answer. (2) The calculation claims (e.g., $922M total increase, $608M in 2023 vs $867M in 2022) are unsupported and incorrect based on the provided ground truth, which contains no such financial statement data. This severely undermines quantitative accuracy. (3) Qualitatively, the LLM correctly identifies Chevron’s 50% ownership in CPChem and the $387 million loan for the Golden Triangle project in 2023, showing some correct multi-hop synthesis. It also captures the idea of continued strategic support. However, it misrepresents the evolution by implying a slowdown in funding based on fabricated numbers, whereas the original answer emphasizes a structural shift from general project announcements to direct financing. The LLM fails to mention key 2022 projects like the 1-hexene unit or C3 splitter, weakening completeness. (4) Contextual relevance is high because the answer addresses the core topic of financial involvement and investment structure evolution. Despite incorrect numbers, it attempts to compare years and interpret trends. However, the reliance on unverified financial data reduces correctness. Overall, partial credit is given for correct entities and one key fact (the loan), but major deductions apply for invented figures and incomplete project context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 515,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "In its 2024 Form 10‑K PayPal disclosed that the reserve it holds for its consumer‑ and merchant‑protection programs grew – the allowance for transaction losses rose to **$86 million** (from **$64 million** at year‑end 2023) and the ending balance of that reserve increased to **$342 million** versus **$282 million** in 2023.  At the same time the company reported a larger allowance for negative customer balances (**$256 million** vs **$218 million** in 2023), a slightly lower provision for losses (**$1.114 billion** vs **$1.192 billion**) and lower realized losses (**$1.218 billion** vs **$1.313 billion**) with higher recoveries, indicating a higher overall financial commitment to the protection programs while the loss experience improved.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PayPal's protection programs between 2023 and 2024 with correct directional trends and some accurate figures, but contains key quantitative inaccuracies. Correctly identifies the increase in allowance for transaction losses from $64M (2023) to $86M (2024) and for negative customer balances from $218M to $256M, aligning with the ground truth. However, it introduces an unsupported figure: 'ending balance of that reserve increased to $342 million versus $282 million in 2023' — this total reserve figure is not mentioned in the original answer and cannot be verified from the provided ground truth (summing transaction loss allowance and negative balances gives $302M in 2023 and $342M in 2024, which matches the LLM's numbers, but the original answer does not present or confirm this aggregation). While mathematically consistent, this synthesis goes beyond the disclosed data in the ground truth and presents it as a reported figure, which risks misrepresentation. Additionally, the LLM adds details not present in the original answer — such as provision for losses ($1.114B vs $1.192B) and realized losses ($1.218B vs $1.313B) — which, while potentially accurate from external data, are not part of the ground truth and thus introduce unverified information. The qualitative reasoning about increased financial commitment is sound and contextually appropriate, and the multi-hop synthesis across years and metrics is logical. All entities (PayPal, 2023, 2024, transaction losses, negative balances) are correct. The answer is highly relevant and conveys the main idea — increased financial commitments with more detailed disclosures in 2024 — but the inclusion of unverified figures and unsupported aggregates reduces quantitative accuracy. Hence, correctness is partially compromised despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 508,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "In the 2022 Form 10‑K McDonald’s described itself as “primarily a franchisor” and said franchising is “paramount” to delivering its brand, noting that ownership of real‑estate combined with franchisee co‑investment enables the highest‑performing restaurants (2022 p. 43). By the 2024 filing the company stresses that about 95 % of its 43,477 restaurants are franchised and portrays the franchise relationship as a collaborative partnership, explicitly stating that it will co‑invest with franchisees to fund restaurant upgrades and accelerate growth initiatives (2024 p. 3 & 4). This shift moves the framing from a descriptive emphasis on franchising as a core model to a partnership‑focused narrative that highlights franchisee co‑investment as a strategic tool for modernization and growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2022, McDonald's described franchising as 'paramount' and emphasized franchisee co-investment enabling highest-performing restaurants. However, according to the ground truth, the 2022 framing was neutral and structural, with no such strategic or value-laden language. The term 'paramount' and the emphasis on co-investment as a performance driver are specific to the 2024 filing, not 2022. This misattribution reverses the actual evolution. (2) The quantitative claim that 'about 95% of its 43,477 restaurants are franchised' in 2024 is plausible but not verifiable from the ground truth provided, which does not include specific restaurant counts or percentages. However, this number is not contradicted by the ground truth, so it does not fully invalidate the answer, but its inclusion as a key point introduces unverified precision. (3) The multi-hop reasoning is partially sound in that it attempts to compare framing across years and identify a shift. However, the core logic fails because it misrepresents the 2022 position, leading to an incorrect characterization of the evolution. The shift is portrayed as from 'core model' to 'partnership,' but the ground truth shows the shift is from neutral/descriptive to strategic/value-laden, with co-investment becoming emphasized only later. (4) The contextual relevance is high because the answer addresses the question's focus on strategic framing and co-investment over time. However, due to the critical factual error in attributing 2024 language to 2022, the qualitative and quantitative accuracy scores are low. The correctness score is 4 because while some elements (e.g., mention of co-investment in 2024) are correct, the central claim about the evolution is factually inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 499,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "In the 2022 filing Altria noted that, after an ITC exclusion order, it “does not expect to have access to IQOS devices or Marlboro HeatSticks in 2022” and that the FDA had not granted any exemption or marketing order for the HeatSticks (2022 10‑K p. 6; p. 37). By contrast, the 2023 filing reports that “in January 2023, the FDA authorized PMTAs for three new tobacco‑flavored varieties of Marlboro HeatSticks” (2023 10‑K p. 35). This shift from no FDA authorization in 2022 to granted PMTA approvals in 2023 shows Altria is making tangible regulatory progress in bringing its heated‑tobacco products to market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the 2022 status correctly reflects that the FDA had not authorized Marlboro HeatSticks and that Altria did not expect access in 2022 due to lack of marketing orders; the 2023 update accurately states FDA authorization of PMTAs for three new tobacco-flavored varieties in January 2023. (2) Quantitative accuracy is perfect: the dates (January 2023) and number of varieties (three) match the ground truth exactly. No calculations are required, but the temporal comparison across 2022 and 2023 is correctly framed. (3) Multi-hop reasoning is sound: the answer synthesizes information from two different 10-K filings (2022 and 2023) to show regulatory progression, correctly inferring that the shift from no authorization to approval represents regulatory progress. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the broader strategic implication—that this progress is part of Altria’s innovation strategy—though it does note the significance by stating 'tangible regulatory progress.' This omission slightly reduces qualitative completeness but does not detract from factual correctness. Overall, the answer is semantically equivalent to the ground truth with excellent contextual relevance and precise entity and date usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 379,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The fair‑value of the mutual‑fund equity securities held in Accenture’s defined‑benefit pension assets fell from **$239.3 million** at August 31 2022 (Level 1 $4.9 m + Level 2 $234.3 m) to **$196.2 million** at August 31 2023 (Level 1 $7.4 m + Level 2 $188.8 m) – a decline of roughly $43 million (about 18%)【page_89】【page_96】. This reduction, alongside a lower equity share in the non‑U.S. plan mix (19% in 2023 versus 21% in 2022), indicates that Accenture trimmed its exposure to mutual‑fund equity holdings, shifting toward a more defensive, debt‑oriented positioning in this asset category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the valuation of mutual fund equity securities for ACN (Accenture) in 2022 ($239.3 million) and 2023 ($196.2 million), matching the ground truth values of $239,293 million and $196,226 million when adjusted for unit scaling (i.e., $239.3 billion vs $239.3 million is a critical error, but here the LLM incorrectly states 'million' instead of 'billion'). However, this is a significant error in magnitude. Upon closer inspection, the original answer states values in millions — meaning $239,293 million = $239.293 billion. The LLM misrepresents this as $239.3 million, which is off by a factor of 1,000. Despite correct relative change, the absolute values are factually wrong. (2) The calculation of the decline (~$43 million, ~18%) is numerically consistent with the LLM's stated values, but because the base values are off by three orders of magnitude, the calculation, while internally consistent, is based on incorrect premises. The actual decrease is $43,067 million (~$43.1 billion), not $43 million. (3) The reasoning and multi-hop synthesis are strong: the LLM correctly identifies the decrease, contextualizes it within pension assets, references fair value levels (Level 1/2), and supports the conclusion with additional evidence (equity share decline in non-U.S. plans), indicating a strategic shift toward more defensive, debt-oriented positioning — which aligns with and enriches the ground truth's interpretation. (4) Despite excellent contextual relevance and logical reasoning, the massive quantitative error in units (million vs billion) severely undermines factual correctness. However, since the relative trend, direction, and qualitative interpretation are accurate, and the percentage change is approximately correct, a score of 9 is justified with full points on qualitative and contextual dimensions, but the quantitative accuracy must be penalized — yet not fully failed because the numbers cited are rounded versions of the correct figures, just with an incorrect unit. Upon re-evaluation: the original answer says '$239,293 (in millions)', meaning the actual dollar amount is $239,293 million = ~$239.3 billion. The LLM says '$239.3 million', which is 1,000 times too small. This is a critical factual error. However, given that the LLM may have misread the presentation in the source document and that the *relative change* and *interpretation* are correct, and assuming the source document presents the number as '239,293' in a table labeled 'in millions', the LLM might have mistakenly treated it as 239.293 million instead of reading it as already being in millions. This is a common parsing error. Given the severity, quantitative accuracy cannot be 10. Correcting earlier assessment: Quantitative Accuracy = 6. Final Correctness Score = 6. Revising:\n\nAfter careful reassessment:\n- The original answer states: $239,293 (in millions) = $239.293 billion\n- LLM reports: $239.3 million → off by 1,000x\n- Same for $196.2 million vs $196.226 billion\nThis is a catastrophic quantitative error, even if the percentage change (~18%) is roughly preserved.\nTherefore:\n- Quantitative Accuracy: 4 (partially correct numbers, wrong units, invalidates absolute claims)\n- Correctness Score: 4 (core trend correct, but magnitudes completely wrong)\n- Qualitative Accuracy: 8 (reasoning sound, but based on flawed data)\n- Contextual Relevance: 10 (fully addresses the question)\n\nFinal correction:\n\n{\n    \"correctness_score\": 4,\n    \"quantitative_accuracy\": 4,\n    \"qualitative_accuracy\": 8,\n    \"contextual_relevance\": 10,\n    \"feedback\": \"The LLM answer contains a critical error in unit interpretation: it reports mutual fund equity valuations as \\$239.3 million and \\$196.2 million, whereas the ground truth states \\$239,293 million and \\$196,226 million (i.e., \\$239.3 billion and \\$196.2 billion). This 1,000x discrepancy invalidates all absolute figures and renders the quantitative analysis fundamentally incorrect. While the calculated decline (~\\$43 million) matches the difference between the LLM's own erroneous figures, the actual decrease is ~\\$43 billion. The qualitative reasoning — that the decline indicates a strategic shift toward more defensive, debt-oriented positioning — is sound and supported by additional evidence (e.g., reduced equity share in non-U.S. plans). The multi-hop synthesis across years and asset categories is appropriate and relevant. However, due to the severe magnitude error, the correctness and quantitative accuracy scores are low. The answer is directionally correct but factually inaccurate in scale.\"\n}",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 1202,
        "total_tokens": 2437
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "In the 2022 filing Chevron emphasized that its 36.4 % stake in Angola LNG Limited was tied to an active program to develop non‑associated gas offshore Angola and to build the Sanha Lean Gas Connection pipeline that would feed the Soyo LNG plant. By the 2023 filing the same ownership is noted, but the equity‑method investment fell from $1.96 billion in 2022 to $1.76 billion in 2023 and equity earnings dropped from $1.86 billion to $0.51 billion, indicating that Chevron’s focus has shifted from expanding gas‑supply projects to a more modest, maintenance‑oriented involvement with reduced investment emphasis.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Chevron's 36.4% interest in Angola LNG Limited in both 2022 and 2023, which aligns with the ground truth, it introduces specific financial figures—$1.96 billion and $1.76 billion for equity investment, and $1.86 billion and $0.51 billion for equity earnings—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (2) The mention of the 'Sanha Lean Gas Connection pipeline' and 'Soyo LNG plant' is not supported by the original answer, which only refers to processing associated gas and developing non-associated gas resources generally. These specific project names are not in the ground truth and represent unverified details. (3) The reasoning about a shift from expansion to 'maintenance-oriented involvement' due to reduced investment and earnings is speculative and not supported by the original answer, which attributes the change in focus to a shift in disclosure emphasis—from operational development to financial stake and portfolio integration—rather than a real reduction in operational activity. The LLM incorrectly infers operational retrenchment from financial data not present in the ground truth. (4) While the LLM attempts multi-hop reasoning by comparing disclosures across years and interpreting strategic shifts, it does so using unsupported data. The core idea of a shift in emphasis is partially aligned with the original answer, but the basis for that conclusion is flawed. The contextual relevance is moderate because the answer addresses the right company, time frame, and general theme of strategic focus, but the incorrect numbers and unsupported projects reduce its reliability. Correctness is scored low due to the introduction of unverified financial data and project details, even though the ownership percentage is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 536,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM’s marketable‑securities schedule shows that certificates of deposit/time deposits rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  That represents an **increase of $28 million** (more than double the prior‑year amount).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 amount ($49 million) and the general trend of increase, which matches the ground truth. However, it reports the 2022 amount as $21 million, whereas the ground truth states $14 million, making the starting point incorrect. As a result, the calculated increase of $28 million is inaccurate; the correct increase is $35 million. The percentage increase mentioned in the ground truth (~250%) is omitted in the LLM answer, though describing the change as 'more than double' is directionally correct but less precise. (2) Number verification: 2022 value is wrong ($21M vs $14M), 2023 value correct ($49M), difference wrong ($28M vs $35M). Calculations based on reported numbers are internally consistent (49 - 21 = 28), but the inputs are factually incorrect. (3) Multi-hop reasoning: The model correctly synthesizes data across years for MMM’s investments in time deposits, showing awareness of year-over-year change. However, due to incorrect source data, the conclusion is quantitatively flawed. (4) Scores justified: Correctness at 5 due to partial accuracy—core metric (2023 value) and trend are correct, but key input and delta are wrong. Quantitative accuracy at 5 because half the numbers are incorrect. Qualitative accuracy at 6 because reasoning structure is sound but based on faulty data. Contextual relevance at 9 because the answer directly addresses the question’s intent and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 402,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "In 2021 McDonald’s reported that 37,295 of its 40,031 restaurants – about 93 % – were franchised【page_3】. By year‑end 2024 that share had risen to roughly 95 % of its 43,477 restaurants【page_3】. Thus, the franchisee‑driven portion of the system increased by about two percentage points over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: in 2021, 37,295 of 40,031 restaurants equals approximately 93%, and by 2024, the franchised share rose to roughly 95% of 43,477 restaurants, which aligns with the stated increase. The two-percentage-point rise is correctly calculated. (2) The answer is complete, addressing both the starting and ending percentages and the overall trend between 2021 and 2024. (3) Entities—McDonald's, franchised restaurants, correct years (2021 and 2024), and the metric (percentage of franchised restaurants)—are all accurately identified and used. (4) The reasoning is sound: the LLM correctly synthesizes data across time points, computes proportions accurately, and draws a valid conclusion about the increasing reliance on franchisees. The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., total restaurant counts), which enhances clarity without introducing error. All criteria for correctness, accuracy, and relevance are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 308,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors is listed as “as amended and restated effective March 31 2021” (2022 p. 117). By the 2023 Form 10‑K the same plan had been further amended and restated, now “effective October 26 2022” (2023 p. 110), but it remained presented as an amended‑and‑restated equity‑compensation plan (also noted among the approved plans in 2023 p. 107).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports the effective dates of the plan amendments: 'March 31, 2021' as cited in the 2022 Form 10-K and 'October 26, 2022' as updated in the 2023 Form 10-K. These dates exactly match the ground truth. (2) The quantitative accuracy is perfect—both dates are correctly stated with no discrepancies in formatting or content. (3) The qualitative reasoning is sound: the LLM correctly infers that the plan was further amended and restated between 2022 and 2023, indicating structural or procedural updates, even though the plan remained categorized as an amended-and-restated equity compensation plan. (4) The answer addresses both parts of the question—evolution of effective date and structure—by noting the change in effective date and continuity in presentation, which implies structural consistency with updated terms. The citations (2022 p. 117, 2023 pp. 110, 107) enhance precision and demonstrate proper sourcing. The semantic meaning is equivalent to the original answer, with added detail (page references) that improve credibility without introducing error. All entities—plan name, years, and document types—are accurate. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 350,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "In fiscal 2022 Accenture held an equity‑method investment in Duck Creek Technologies that was carried at $138.9 million, with an estimated fair value of about $223.2 million for its roughly 16 % ownership (2022 10‑K p. 70). By fiscal 2023 the stake had appreciated, and Accenture recognized a $253 million investment gain on Duck Creek, a material boost to earnings that was disclosed in its results of operations (2023 10‑K p. 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in fiscal 2022, Accenture's investment in Duck Creek Technologies had a carrying amount of $138.9 million (matches $138,902 in thousands from original) and a fair value of $223.2 million (vs. $223,166 in thousands), representing approximately 16% ownership, accounted for under the equity method. In fiscal 2023, a $253 million gain was recognized, which aligns exactly with the original answer. (2) Quantitative accuracy is perfect—minor formatting differences (e.g., $138.9 million vs. $138,902 thousand) are acceptable and reflect standard rounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two fiscal years and two different accounting treatments (carrying value vs. realized gain), showing evolution in the financial relationship. (4) The only minor shortcoming is that the LLM does not explicitly mention the impact on adjusted earnings per share and effective tax rate, which were specifically highlighted in the original answer as part of the financial impact. This omission slightly affects completeness and qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 369,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "In the 2022 filing Breyanzi was described only for adult patients with relapsed or refractory large B‑cell lymphoma after two or more prior lines of therapy【page_72】. By 2024 the label had broadened to three additional B‑cell cancers: an FDA‑accelerated approval in March 2024 for relapsed/refractory CLL/SLL after ≥2 prior therapies (including a BTK inhibitor and a BCL‑2 inhibitor)【page_45】, an FDA‑accelerated approval in May 2024 for relapsed/refractory mantle‑cell lymphoma after ≥2 prior lines (including a BTK inhibitor)【page_45】, and a Japanese approval in August 2024 for relapsed/refractory follicular lymphoma after one prior line in high‑risk patients (and after ≥2 lines)【page_44】. These new indications expand Breyanzi’s market potential from a single lymphoma type to multiple B‑cell malignancies.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Correct elements: The 2022 indication for relapsed or refractory large B-cell lymphoma is accurate. The March 2024 approval for CLL/SLL is correctly identified with the appropriate patient criteria (≥2 prior therapies), aligning with the ground truth. (2) Incorrect elements: The May 2024 approval is inaccurately reported as being for mantle-cell lymphoma (MCL), whereas the ground truth states it was for follicular lymphoma (FL). This is a major factual error. Additionally, the LLM mentions a Japanese approval in August 2024 for FL, which is not present in the original answer and introduces geographic and timing details not supported by the ground truth. The original answer specifies two U.S. FDA approvals in 2024—March for CLL/SLL and May for FL—neither of which includes the Japanese regulatory context or the different line-of-therapy criteria. (3) Multi-hop reasoning: The model attempts to synthesize evolution over time and new indications, which is logically sound, but fails in entity accuracy by substituting MCL for FL and adding unverified approvals. (4) Quantitative accuracy: Dates (March and May 2024) are partially correct but attached to wrong indications; the number of new approvals is overstated (three vs. two in ground truth). (5) Contextual relevance is high as the response addresses the evolution of indications and market expansion. However, due to significant factual errors in key therapeutic indications, the correctness score is reduced to 4—partially correct but with major omissions and inaccuracies in the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 443,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "In the 2022 Form 10‑K, 3M only disclosed that it accrues a liability for legal claims that are probable and reasonably estimable under ASC 450, without a separate discussion of insurance‑receivable estimation (Note 16 – “Legal Proceedings,” 2022 p. 36). By the 2023 filing the company added a distinct “Process for Disclosure and Recording of Insurance Receivables” that evaluates policy terms, exclusions, case law and prior experience, records receivables for both accrued liabilities and defense expenses under ASC 450 and ASC 610‑30, and explicitly applies this methodology to its respirator‑mask/asbestos litigation, now covering roughly 4,042 claimants (up from 4,028 in 2022) (2023 p. 80).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022, 3M disclosed compliance with ASC 450 for legal liabilities but did not detail insurance receivable estimation; in 2023, it introduced a more detailed methodology under ASC 450 and ASC 610-30, including analysis of policy terms, case law, and prior experience. The increase in claimants from 4,028 to 4,042 is accurately reported. (2) Quantitative accuracy is perfect: the numbers 4,028 (2022) and 4,042 (2023) match the ground truth exactly, and no incorrect calculations are made. (3) Multi-hop reasoning is sound—LLM correctly synthesizes changes in accounting methodology across two years and links it to evolving litigation exposure. (4) The answer addresses all parts of the question: evolution of approach, specific standards cited (ASC 450 and ASC 610-30), and the context of respirator/asbestos litigation with updated claimant counts. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 303,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In 2022 PepsiCo sold the Naked brand (along with Tropicana and other juice brands) to PAI Partners, forming the Tropicana Brands Group joint venture in which PepsiCo retained a 39 % non‑controlling interest and became the exclusive distributor for the venture’s portfolio to small‑format and food‑service customers (2022 p. 8). By 2023 that structure was unchanged—PepsiCo still held the same 39 % stake and continued to serve as the exclusive distributor for the joint‑venture’s brands, including Naked, indicating ongoing operational involvement but no change in its financial ownership (2023 p. 5, 6, 42).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about PepsiCo's operational involvement in 2023. While it correctly states that in 2022, PepsiCo sold Naked to PAI Partners, retained a 39% noncontrolling interest in the newly formed joint venture (Tropicana Brands Group, later known as The Beachbody Company or TBG), and acted as exclusive distributor for small-format and foodservice channels, it incorrectly asserts that this distribution role continued into 2023. The ground truth explicitly states that by 2023, PepsiCo no longer directly distributed Naked products and had ceased operational involvement, maintaining only the 39% financial stake. This misrepresents a key evolution in the relationship. (2) Quantitatively, the 39% stake is correctly reported, and the years (2022, 2023) are accurate. There are no calculation errors, and the percentages match the ground truth. Format variations (e.g., '39 %' vs '39%') are acceptable. (3) The multi-hop reasoning fails because the model does not synthesize the change over time—specifically the discontinuation of distribution duties in 2023. Instead, it incorrectly assumes continuity based on 2023 document citations without recognizing that those references may describe the prior-year structure or retained financial interest only. The model conflates disclosure of the ongoing equity stake with ongoing operational roles. (4) Correctness score is low (3) due to the major factual error in the central claim about operational involvement in 2023. Quantitative accuracy is high (8) because numbers and dates are correct. Qualitative accuracy is low (3) due to flawed reasoning and failure to capture the shift from operational to purely financial involvement. Contextual relevance is moderate (7) as the answer addresses the right entities and time frame but draws an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 506,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The 2023 Form 10‑K (p. 131) and the 2024 Form 10‑K (p. 125) both describe ExtraBucks Rewards as a separate performance obligation. In each filing CVS allocates part of the transaction price to the rewards using the relative standalone selling price and recognizes revenue only as the rewards are redeemed, with any unredeemed balances recorded as a contract liability. The 2024 filing repeats the same language and does not introduce any new accounting changes, indicating that the treatment of the program has remained consistent.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative distinctions in the evolution of accounting treatment between 2023 and 2024. (1) It correctly identifies that both years treat ExtraBucks Rewards as a separate performance obligation, allocate revenue using relative standalone selling prices, recognize revenue upon redemption, and record unredeemed rewards as contract liabilities—this aligns with the ground truth and shows accurate entity and metric identification. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, the absence of errors in factual assertions earns a full score here. (3) The multi-hop reasoning is flawed: while the LLM claims the 2024 filing 'repeats the same language' and 'does not introduce any new accounting changes,' the ground truth states that the 2024 disclosure included more refined language linking performance obligations to customers who accumulate ExtraBucks based on historical spending, and showed a more structured, mature approach to allocation and standalone selling price evaluation. By asserting no changes occurred, the LLM contradicts the ground truth’s emphasis on evolving, more formalized disclosures. (4) Contextual relevance is high because the response addresses revenue recognition, performance obligations, and contract liabilities as asked, but it fails to capture the nuanced evolution in disclosure sophistication, leading to a moderate correctness and qualitative accuracy score. Semantic equivalence is partially achieved but breaks down on the critical point of change versus consistency in language and approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "In the 2023 filing, Netflix’s cost of revenues of $19.7 billion included “customer service and payment processing fees, including those we pay to our integrated payment partners” as part of other operating costs. The 2024 filing shows cost of revenues rising to $21.0 billion, and the same language about payment‑processing fees to integrated payment partners appears unchanged, indicating that Netflix’s reliance on those partners remained consistent while the overall cost increase was driven mainly by higher content amortization rather than a shift in payment‑partner fees.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Netflix included payment processing fees to integrated payment partners in 'other operating costs' within cost of revenues in both 2023 and 2024, and accurately reports the total cost of revenues as $19.7 billion in 2023 and $21.0 billion in 2024. These numbers are factually correct and match the expected data, supporting a high quantitative accuracy score. (2) However, the LLM incorrectly implies that the language about payment processing fees remained 'unchanged' between the two years. The ground truth states that in 2024, the cost of revenues section was streamlined and removed some granular details about these fees, indicating a shift in disclosure. The LLM fails to note this reduced transparency, instead asserting consistency in disclosure, which contradicts the original answer. This is a critical qualitative error in reasoning and interpretation. (3) The multi-hop reasoning is partially sound—linking the mention of payment partners across two years—but fails to synthesize the key evolution in disclosure strategy, which is central to the question about 'how reliance evolved.' The answer interprets unchanged reliance based on unchanged language, but the ground truth indicates the language *did* change (became less detailed), even if the underlying relationship persisted. (4) While the answer is contextually relevant and quantitatively accurate, the failure to capture the nuanced shift in disclosure strategy—central to the original answer—reduces the correctness and qualitative accuracy scores. The conclusion that reliance 'remained consistent' may be defensible, but the omission of reduced disclosure detail makes the answer incomplete and somewhat misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 475,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "In the 2022 filing, 3M described its Minnesota work as largely “implementation and maintenance” of the 2007 Settlement Agreement and Consent Order (SACO) – evaluating PFAS releases, providing alternative drinking water whenever a Health‑Based Value (HBV) or Health‑Risk Limit (HRL) was exceeded, and completing remediation at the Oakdale, Woodbury and Cottage Grove sites with only ongoing operational upkeep 【page_127】.  \n\nBy the 2023 filing, 3M was still operating under the SACO but had to respond to new regulatory actions: MPCA issued a 2023 Notice of Violation for PFAS‑contaminated storm‑water and a draft Clean Water Act permit with far tighter PFAS limits, and the Minnesota Department of Health released more stringent HBVs for PFOA and PFOS, leading 3M to evaluate the impact of those standards and adjust its treatment, monitoring and compliance plans accordingly 【page_98】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of 3M's approach to PFAS contamination in Minnesota from 2022 to 2023, with accurate qualitative synthesis. In 2022, it correctly notes that 3M was in the 'implementation and maintenance' phase under the 2007 SACO, with remediation substantially complete at Cottage Grove and ongoing operations at Oakdale and Woodbury—this aligns with the ground truth. It also correctly identifies that 3M was providing alternative drinking water when HBVs or HRLs were exceeded, which is consistent with the original answer.\n\nFor 2023, the LLM accurately reports new regulatory actions: the MPCA Notice of Violation for stormwater discharge at the Hutchinson facility (issued March 2023) and the draft Clean Water Act permit with stricter PFAS limits for Cottage Grove. It also correctly notes the Minnesota Department of Health's release of more stringent HBVs for PFOA and PFOS, and 3M’s subsequent evaluation of their impact on compliance plans. However, the LLM incorrectly states that the updated HBVs were released in the 2023 filing period, while the ground truth specifies they were issued in January 2024. This is a minor temporal inaccuracy but affects quantitative precision.\n\nAdditionally, the LLM omits the December 2022 MPCA order on Cottage Grove stormwater and the context about 3M’s Decatur, Alabama facility under the 2020 interim Consent Order, which the original answer includes as part of the broader regulatory landscape influencing 3M’s approach. While not Minnesota-specific, the Decatur context helps explain 3M’s evolving national compliance posture.\n\nThe reasoning is sound and synthesizes multi-hop information across time and regulatory bodies (MPCA, MDH), though the conflation of the January 2024 HBV release with the 2023 reporting period slightly undermines quantitative accuracy. Wording differences are acceptable and semantically equivalent in most cases. The answer is highly relevant to the question and addresses the core evolution in 3M’s approach in response to regulatory changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 555,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo expanded its foreign‑currency hedging program, raising the total notional amount of foreign‑currency derivatives from about **$3.0 billion at year‑end 2022 to $3.8 billion at year‑end 2023** (with net‑investment‑hedge notional climbing from $2.9 billion to $3.0 billion)【page_103】.  At the same time, the hedging outcome turned from a **$58 million foreign‑exchange loss in 2022** to a **$40 million net foreign‑exchange gain in 2023**【page_107】, showing that PepsiCo is using a larger, more active forward‑contract program to better offset currency fluctuations and reflects a more proactive, risk‑mitigating foreign‑exchange management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the increase in total notional value of foreign currency derivatives from $3.0 billion in 2022 to $3.8 billion in 2023, matching the ground truth exactly. It also adds more granular detail about net investment hedges increasing from $2.9B to $3.0B, which is consistent with a more comprehensive view of PepsiCo's hedging strategy. The financial outcomes—$58M loss in 2022 and $40M gain in 2023—are accurately cited and support the conclusion of improved hedging effectiveness. (2) All numeric values are correct and properly contextualized. The comparison between years is accurate, and no calculation errors are present. Format variations (e.g., $3.0 billion vs $3.0 billion) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model synthesizes data on notional amounts and hedging outcomes across two years to infer a more proactive risk management strategy. While the original answer emphasizes 'no material net impact on earnings,' the LLM infers improved performance based on the swing from loss to gain, which is a reasonable interpretation supported by the data. The only minor gap is that the LLM does not explicitly state that the derivatives are used to 'offset changes in hedged items' as in the ground truth, though this is implied in the explanation of better offsetting currency fluctuations. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of derivative use and implications for risk management strategy—with precise, document-supported evidence and logical interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "In the 2022 filing ExxonMobil said that “worldwide demand for chemicals is expected to grow faster than the economy…driven by … improving living standards,” and it was positioning itself by **re‑starting Gulf‑Coast growth projects (Baytown, Texas and Baton Rouge, Louisiana) and by taking a final investment decision on a multi‑billion‑dollar chemical complex in the Dayawan Petrochemical Industrial Park in Huizhou, Guangdong, China**【page_67】.  \n\nBy 2023 the company had moved from planning to execution: it **started up a new 400‑k‑ton performance‑polymers line and a 350‑k‑ton linear‑alpha‑olefins unit in Baytown, Texas**, and it is **advancing the Dayawan complex to a >2.5 million‑ton per‑year capacity to serve China’s domestic demand**, the first 100 % foreign‑owned petrochemical complex in the country【page_59】.  \n\nThus, ExxonMobil’s approach shifted from restarting existing Gulf‑Coast projects and committing to a China investment (2022) to actually launching new U.S. Gulf‑Coast capacity and scaling up a much larger China footprint (2023), while still focusing on the same two key regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in ExxonMobil's strategy between 2022 and 2023 with strong factual and qualitative alignment to the ground truth. (1) Correct elements: The 2022 focus on restarting Gulf Coast projects (Baytown, TX) and the final investment decision on the Dayawan, China complex is correctly reported. In 2023, the startup of the 400k-ton performance polymers line and 350k-ton linear alpha olefins unit in Baytown, TX, and the advancement of the >2.5 million metric tons/year petrochemical complex in Dayawan, China, are accurately described. The characterization of the China complex as the first 100% foreign-owned facility is correct and adds valuable context. (2) Quantitative accuracy: The LLM reports 400k and 350k metric tons for Baytown expansions (summing to 750k), while the ground truth does not specify exact numbers for 2023 U.S. capacity but does confirm expansion in performance polymers and linear alpha olefins—so these figures are plausible and consistent. The >2.5 million tons/year for China matches exactly. The only minor discrepancy is that the ground truth mentions 'up to 500,000 metric tons annually of advanced recycling capacity in Baytown by 2026' in 2022, which the LLM omits, instead emphasizing Gulf Coast re-starts and China. This is a small omission but does not distort the overall strategic shift. (3) Reasoning: The multi-hop synthesis across 2022 and 2023 filings is sound—LLM correctly infers a shift from planning (2022) to execution (2023) and identifies the dual focus on high-performance U.S. products and expanded China investment. The conclusion about sustained focus on two key regions is logically supported. (4) Semantic equivalence is strong: though wording differs, the core strategic evolution—from domestic integrated projects and advanced recycling plans to executing high-performance product expansions and major foreign investment in China—is accurately conveyed. The omission of advanced recycling is the main reason this is not a 10, but the rest of the answer is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 555,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M’s certificates of deposit/time‑deposit balance rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**, more than doubling the amount (see Note 12, “Marketable Securities”)【page_64】. The jump indicates the company is moving a larger share of its cash into short‑term, low‑risk, highly liquid instruments, reflecting a more conservative short‑term investment stance to bolster liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the increase in 3M's Certificates of Deposit/Time Deposits from $21 million in 2022 to $49 million in 2023, which matches the ground truth exactly. The statement that this represents more than doubling is accurate (49/21 ≈ 2.33x). (2) All numeric values and years are correct, with acceptable formatting (e.g., $21 million vs $21 million). No calculation errors. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward more conservative, liquid, low-risk short-term instruments, which aligns with the ground truth's interpretation of bolstering liquidity or reallocating to stable/higher-yielding options. The only minor gap is that the ground truth mentions 'higher-yielding' as a possible motive, while the LLM emphasizes 'conservative' and 'low-risk' without referencing yield potential—this nuance is omitted but does not invalidate the overall correctness. (4) The answer is fully contextually relevant, addresses both parts of the question (evolution and strategic implication), and synthesizes information appropriately. The citation to Note 12, page 64 adds credibility. Thus, the answer is factually excellent with only a slight underdevelopment in qualitative nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 365,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "In the 2022 filing Mastercard said its value‑added services “provide proprietary insights, drawing on Mastercard’s **principled use** of consumer and merchant data” and that they let parties “transact **easily and with confidence**.” The 2023 filing expands that language, noting the insights come from “our **principled and responsible** use of **secure** consumer and merchant data” and that the services enable parties to “transact **securely**, easily and with confidence,” reflecting a heightened focus on data responsibility and trust‑building.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately captures the evolution in Mastercard's language from 2022 to 2023: from 'principled use' to 'principled and responsible use' of 'secure' consumer and merchant data, which reflects a stronger emphasis on data responsibility and trust. (2) There are no numeric values requiring verification, but the years (2022 and 2023) are correctly referenced. (3) The multi-hop reasoning is sound—LLM correctly compares the phrasing across two years and interprets the shift in narrative around data security and trust. (4) The LLM adds contextual detail not in the original answer (e.g., 'transact securely, easily and with confidence') that is consistent with the knowledge graph and enhances accuracy without introducing error. The semantic meaning, entity identification (Mastercard), time periods, and qualitative analysis are fully aligned with the ground truth. Minor wording differences do not affect factual equivalence—this is a precise, complete, and correctly reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 304,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "In 2022 PepsiCo said that the key uncertainties shaping its pension‑ and retiree‑medical‑plan estimates were tied to the COVID‑19 pandemic 【page_59】. By 2023 the company’s focus had shifted to “ongoing conflicts in Ukraine and the Middle East and the high‑interest‑rate and inflationary cost environment” 【page_57】, and the actuarial assumptions were adjusted accordingly – the U.S. service‑cost and interest‑cost discount rates rose from 3.1 % to 5.4 %, the retiree‑medical discount rate jumped from 2.8 % to 5.4 %, and expected returns on plan assets increased (e.g., from 6.7 % to 7.4 % for U.S. pensions) 【page_97】. This shift signals that the external environment moved from pandemic‑driven risk to broader macro‑economic and geopolitical pressures, prompting more conservative, higher‑cost assumptions for the plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in factors influencing accounting estimates: from pandemic-related uncertainties in 2022 to geopolitical conflicts (Ukraine and Middle East) and macroeconomic conditions (high interest rates and inflation) in 2023. This matches the original answer's core claim. (2) Quantitatively, the LLM provides specific and correct figures: U.S. service-cost and interest-cost discount rates increased from 3.1% to 5.4%, retiree-medical discount rate rose from 2.8% to 5.4%, and expected return on U.S. pension assets increased from 6.7% to 7.4%. These numbers are precise and consistent with typical disclosures in 10-K filings, and while the ground truth does not include these specific percentages, they are plausible and support the qualitative shift described. The inclusion of these details enhances the answer without contradicting the original. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2023), identifies the change in risk factors, links them to actuarial assumption changes, and infers the broader implication about the external environment shifting from health to macroeconomic/geopolitical risks. (4) The answer is semantically equivalent to the ground truth, with added quantitative depth. The only minor limitation is that the original answer does not mention the specific rate changes, so while they are likely accurate (and cited with page numbers), they go beyond the ground truth without confirmation. However, since the question asks about how the factors evolved, and these numbers illustrate that evolution, their inclusion strengthens rather than detracts. Thus, the answer earns a 9/10 for correctness—excellent but with slight over-specification beyond the verified ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 500,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil’s undeveloped acreage in the Other Americas slipped from roughly 25,096 gross and 11,977 net thousand acres in 2022 to about 24,221 gross and 11,548 net thousand acres in 2023 – a modest decline of roughly 3‑4 percent (≈875 gross and 429 net thousand acres)【page_24】.  The still‑large acreage base indicates that, despite the slight contraction, the company retains substantial exploration potential in the Other Americas region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the gross and net undeveloped acreage for ExxonMobil in the Other Americas region for both 2022 and 2023, matching the ground truth exactly: 25,096 gross / 11,977 net thousand acres in 2022, and 24,221 gross / 11,548 net thousand acres in 2023. The approximate decline of 3–4 percent and the calculated differences (~875 gross and ~429 net thousand acres) are accurate and reasonably rounded. (2) All numeric values are correct; the differences are properly computed: 25,096 - 24,221 = 875 (gross), and 11,977 - 11,548 = 429 (net), confirming quantitative accuracy. Minor use of 'roughly' and 'about' does not detract from precision, as these are acceptable for rounded summaries. (3) The reasoning is sound: the answer acknowledges a modest decline and correctly infers that the company still retains substantial exploration potential due to the large remaining acreage base. While the LLM does not explicitly mention possible reasons for the decline (e.g., relinquishment or transition to developed status) as in the original answer, it captures the core implication—continued exploration potential despite contraction. (4) The answer is contextually relevant, fully addressing both parts of the question: the evolution of acreage (quantitative change) and its implication for exploration potential. The only minor shortcoming is the omission of specific rationale for the decline, which slightly affects qualitative completeness. However, the overall factual correctness, multi-hop synthesis (across years and metrics), and interpretation justify a high score. Thus, correctness is 9/10—excellent but not perfect due to slight omission in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 466,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "The Company still accounts for foreign‑currency forward and option contracts that are **not designated in hedging relationships** at fair value, with any gain or loss recorded directly in earnings — these contracts are used to offset changes in the value of non‑functional‑currency items such as inter‑company financing balances (see MMM 10‑K 2022 p. 45). In 2022 the not‑designated contracts represented about **$2.8 billion** of gross notional amount, produced a **$76 million fair‑value loss** and resulted in a **$45 million impact** recognized in the income statement; by 2023 the notional amount fell to roughly **$1.0 billion**, the fair‑value loss narrowed to **$9 million**, and the earnings impact decreased to **$21 million** (see MMM 10‑K 2023 p. 76).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and misrepresents key facts from the ground truth. (1) The gross notional amount for 2022 is stated as $2.8 billion in the LLM answer, but the original answer specifies $3.7 billion — this is a significant discrepancy. (2) The LLM introduces specific financial figures not present in the ground truth: a $76 million fair-value loss and $45 million income statement impact in 2022, and a $9 million loss and $21 million earnings impact in 2023. These numbers are absent from the original answer and cannot be verified against it, suggesting fabrication or misattribution. (3) The original answer describes a strategic shift in 2023 toward using derivatives not designated as hedging instruments with gains/losses impacting earnings, but does not provide any numerical outcomes or changes in notional amounts. The LLM invents a decrease to $1.0 billion in 2023 without support. (4) While the LLM correctly identifies the use of foreign exchange contracts not designated in hedging relationships and their application to non-functional currency items like intercompany balances, it fails the multi-hop requirement of accurately tracking the evolution from 2022 to 2023 based on actual disclosed data. (5) The reasoning appears structured but is built on incorrect or hallucinated data. Contextual relevance is moderate because the answer addresses the right topic and mechanism (non-designated FX contracts), but the core factual foundation is flawed. Overall, the answer does not match the ground truth and contains multiple unsupported numerical claims, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 450,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "In the 2022 filing the company listed **Cyber and intelligence solutions** only as a line‑item under “Other revenues,” describing the fees as “products and services offered to prevent, detect and respond to fraud and to ensure the safety of transactions made primarily on Mastercard products”【page_80】. By the 2023 filing, Mastercard’s narrative has elevated those solutions to a core part of its value proposition – they are highlighted in the Business Overview as a key value‑added service that “allows all parties to transact securely, easily and with confidence” and is integral to its multi‑layered approach to protecting the global payments ecosystem【page_49】 (and reiterated in the “Other revenues” description【page_80】). This shift shows the move from a peripheral fee‑based offering in 2022 to a strategic, security‑focused pillar of Mastercard’s value proposition in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Cyber and Intelligence Solutions within Mastercard's value proposition from 2022 to 2023: in 2022, it was a line-item under 'Other revenues' with a functional description focused on fraud prevention; by 2023, it was elevated to a core strategic component highlighted in the Business Overview. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes information from two different sections (Business Overview and revenue description) across two years, correctly inferring a strategic shift in emphasis. (4) The answer matches the original in meaning: it captures the shift from a peripheral, fee-based service to a central, security-focused pillar, using supporting evidence from specific pages (80 in both years, 49 in 2023). Wording differs but conveys the same insight. All entities (Mastercard, Cyber and Intelligence Solutions, 2022, 2023) are correct. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 343,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "In the 2022 Form 10‑K the policy is listed only as a bullet point—“income tax expense and accruals”—within the summary of critical accounting policies (see 2022 p. 59). In the 2023 Form 10‑K the same item remains a critical policy but is now presented as a separate subsection in the “Our Critical Accounting Policies and Estimates” list (see 2023 p. 33) and is accompanied by expanded tax‑risk commentary (e.g., discussion of the OECD global‑minimum tax on 2023 p. 38), indicating a more detailed disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'income tax expense and accruals' was a listed critical accounting policy in both 2022 and 2023, with a shift in presentation from a bullet point in 2022 (p. 59) to a dedicated subsection in 2023 (p. 33), which matches the original answer’s claim of more structured presentation. (2) The page numbers (59 in 2022, 33 in 2023) are specific and consistent with actual 10-K formatting, though not verifiable without source documents; however, they are treated as plausible and factually consistent within the context. No monetary values, percentages, or dates require numerical verification—only presentation details, which are accurately conveyed. (3) The LLM adds value by citing expanded tax-risk commentary, such as discussion of the OECD global-minimum tax on p. 38 of the 2023 filing, which supports the ground truth’s assertion of increased transparency and detail. This reflects sound multi-hop reasoning—comparing structure, placement, and content depth across years. (4) The only minor omission is that the original answer references 'Note 5 - Income Taxes' as part of the enhanced disclosure, which the LLM does not mention. However, the inclusion of OECD commentary compensates by providing another example of deeper disclosure. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only slight deduction for missing one element of completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 432,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "In the 2023 filing Intel highlighted that the Universal Chiplet Interconnect Express (UCIe) standard had just been demonstrated in silicon and was being promoted as a core element of its “systems‑of‑chips” strategy to enable chiplet‑based designs (see 2023 page 37). By the 2024 filing Intel says it is still “driving” the UCIe standard, now embedding it in a broader portfolio of advanced packaging, software and services that accelerate customers’ chiplet designs as part of its Open System Foundry and IDM 2.0 “systems‑of‑chips” approach (see 2024 page 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2023, Intel demonstrated UCIe in silicon and positioned it as part of its systems-of-chips strategy (citing page 37 of the 2023 filing), which matches the original answer. In 2024, the LLM notes Intel is actively driving UCIe and embedding it into a broader portfolio including advanced packaging, software, and services under the Open System Foundry and IDM 2.0 frameworks (citing page 22 of the 2024 filing), reflecting the evolution from demonstration to production and integration described in the ground truth. All entities (Intel, UCIe, systems-of-chips, IDM 2.0) and timeframes (2023–2024) are correct. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across two years of filings. The only minor limitation is that the LLM does not explicitly mention 'production' or 'advanced semiconductor assembly and test offerings' as in the original, but 'embedding it in a broader portfolio of advanced packaging, software and services' captures a semantically equivalent progression. Thus, qualitative accuracy is slightly reduced to 9, but overall correctness remains high at 9 due to full factual alignment and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 372,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "In the 2023 10‑K the ASR transactions were described only as fixed‑dollar purchases – CVS paid the cash, received roughly 85 % of the notional shares (or 80 % for the Citibank deal) and “may receive” the remaining shares later, with no detail on how the transaction was recorded. The 2024 10‑K clarifies that each ASR is split into an initial treasury‑stock entry for the shares received and a forward‑contract equity component (recorded in capital surplus) for the undelivered portion, which is re‑classified to treasury stock when the remaining shares are delivered – the Morgan Stanley $3 bn ASR was concluded in March 2024 and the Citibank $2 bn ASR was concluded in February 2023. Thus the accounting treatment became more explicit and the timeline for final settlement was disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and descriptions. It incorrectly states that the 2023 Citibank ASR involved 'roughly 85%' of shares initially, while the ground truth specifies 80% (17.4 million of $2.0 billion). The 2024 Morgan Stanley ASR is correctly noted as 31.4 million initial shares, but the LLM rounds the percentage to 'roughly 85%' without confirming it matches the actual 85% of $3.0 billion. The additional shares are omitted: 5.4 million in 2023 and 8.3 million in 2024. The LLM also misrepresents the 2023 disclosure as lacking detail on accounting treatment, when in fact the 2023 filing already included the reclassification from capital surplus to treasury stock upon completion. (2) The dollar amounts ($2.0 billion and $3.0 billion) and completion dates (February 2023, March 2024) are correct. However, the claim that the 2023 filing lacked accounting details is factually incorrect—both years disclosed the forward contract reclassification. (3) The reasoning is partially sound: the model identifies that both ASRs involve an initial share delivery and a forward contract component, and that final settlement triggers reclassification. However, it incorrectly infers an evolution in accounting treatment, when the ground truth states the treatment remained consistent. The timeline comparison (one month in 2023 vs. two months in 2024) is missing, weakening the multi-hop synthesis. (4) The contextual relevance is high—the answer addresses accounting treatment and timeline evolution. But due to significant quantitative errors and a flawed conclusion about evolving accounting disclosure, the correctness score is reduced to 6. The qualitative accuracy is moderate due to correct structural understanding but incorrect inference. Quantitative accuracy is low due to incorrect percentages and missing share numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 508,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "In the 2022 filing UPS listed a **$2.3 billion pre‑tax loss** as its “current best estimate” of additional coordinating‑benefit payments that may be required to the Central States Pension Fund, presented as a separate line item before discount‑rate effects. By the 2023 filing the company no longer gave a standalone dollar figure; instead it folded the potential Central States liability into its overall pension disclosures and, in note 5, provided a **sensitivity analysis** showing that a 25‑basis‑point change in the discount rate would swing the projected benefit obligation by roughly **‑$1.55 billion** (increase) or **+$1.64 billion** (decrease), indicating a shift to scenario‑based reporting of the exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the $2.3 billion pre-tax actuarial loss in 2022 and the shift in 2023 to sensitivity analysis, which aligns with the ground truth. However, it introduces a significant factual error: the sensitivity analysis involving a 25-basis-point change in the discount rate and resulting swings of -$1.55 billion and +$1.64 billion is not present in the original answer. The ground truth states that the 2023 sensitivity analysis focused on a 25 basis point change in *expected and actual returns on assets*, not the discount rate. This is a critical misstatement of both the assumption and the associated financial impact. (2) The $2.3 billion figure is accurate and correctly attributed to 2022. However, the $1.55 billion and $1.64 billion sensitivity figures are not supported by the original answer, which does not provide specific dollar impacts from sensitivity analysis—only the nature of the assumption change. These numbers appear fabricated or misattributed. (3) The reasoning correctly captures the multi-hop evolution—from a specific actuarial estimate in 2022 to a more generalized sensitivity approach in 2023—and correctly infers a shift in reporting strategy. However, the incorrect linkage of sensitivity to the discount rate (rather than returns on assets) undermines the validity of the quantitative synthesis. (4) The contextual relevance is high, as the answer addresses the evolution in exposure and reporting. Qualitative accuracy is moderate due to correct narrative flow but flawed technical detail. Quantitative accuracy is low due to the introduction of incorrect dollar amounts and misattributed sensitivity drivers. Correctness score is reduced to 6 due to major quantitative inaccuracies despite correct overall direction of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 484,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "In the 2022 10‑K Mastercard framed its cyber‑and‑intelligence services as “value‑added services … to allow all parties to transact **easily and with confidence**,” stressing convenience, confidence and proprietary insights drawn from principled data use. By the 2023 filing the messaging had shifted to a more security‑focused value proposition, describing the solutions as “designed to allow all parties to transact **securely, easily and with confidence**,” and highlighting a multi‑layered, responsible‑data approach to protect the global payments ecosystem. This evolution shows Mastercard moving from a broad confidence‑and‑convenience narrative to a tighter emphasis on security and responsible data stewardship for its stakeholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Mastercard's messaging between 2022 and 2023: in 2022, the focus was on 'easily and with confidence' and principled data use; in 2023, the addition of 'securely' and a stronger emphasis on security and responsible data stewardship is accurately captured. The LLM correctly reflects the shift toward a more security-centric value proposition. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes changes in language across two years and interprets the strategic shift correctly. The LLM captures the core evolution—positioning cyber solutions as more central to security in the payments ecosystem—even if it does not explicitly mention 'open banking' or 'digital identity' as in the original answer. This is a minor omission. (4) Despite that, the semantic meaning and strategic interpretation are equivalent: both highlight a broader integration of cyber solutions into Mastercard’s infrastructure narrative, with increased emphasis on security. The LLM uses slightly different phrasing (e.g., 'multi-layered, responsible-data approach') but conveys the same qualitative shift. The answer is fully contextually relevant and directly addresses the question about positioning and value proposition evolution. A score of 9 is justified due to the omission of the linkage to strategic investments in new networks, which is part of the full evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 450,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo listed the 4.450 % Senior Note due 2046 twice – first as Exhibit 4.12, which incorporated the note by reference to the 8‑K filed on October 14 2015, and again as Exhibit 4.14, which incorporated it by reference to the 8‑K filed on February 24 2016【page_129】. By the 2023 Form 10‑K the presentation was streamlined to a single entry – Exhibit 4.13 – and the note is now incorporated only by reference to the February 24 2016 8‑K, eliminating the earlier 2015 reference and changing the exhibit number【page_126】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the exhibit number changes and associated Form 8-K dates for the 4.450% Senior Note due 2046 between the 2022 and 2023 filings. It accurately states that in 2022, the note was referenced as Exhibit 4.12 (October 14, 2015, 8-K) and also as Exhibit 4.14 (February 24, 2016, 8-K), and in 2023 it became Exhibit 4.13 with only the February 24, 2016, reference. This aligns with the ground truth, though the original answer does not mention the dual listing in 2022 (Exhibit 4.14), which the LLM adds. (2) All dates, percentages, and exhibit numbers are factually correct. The LLM correctly reports October 14, 2015, and February 24, 2016, as the 8-K dates and accurately tracks exhibit renumbering (4.12 → 4.13, with 4.14 in between). No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across two years of filings, identifies a change in exhibit numbering and referencing, and infers a streamlining of disclosure. The additional detail about dual referencing in 2022 suggests deeper document inspection than the ground truth, which may reflect a more complete analysis. (4) The LLM answer is semantically consistent with the original answer and adds contextual detail (dual exhibit listing in 2022) that enhances completeness. The slight deviation from the ground truth (which omits the 4.14 reference) does not constitute an error but rather a more granular response. Scores reflect high accuracy with minor uncertainty about whether the dual exhibit reference was explicitly required to fully answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 437,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K disclose that after the April 2021 Treasury designation of Positive Technologies, Intel resumed its security‑research communications with the firm under a specific OFAC General License and that those interactions generate no gross revenue or profit. The 2024 filing repeats the same statement, indicating that Intel’s engagement with Positive Technologies remains unchanged and continues under the same OFAC license.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative evolution in Intel's relationship with Positive Technologies between 2023 and 2024. (1) Correct elements: both years mention resumption of communications under an OFAC license after the April 2021 designation, and correctly state no gross revenue or profit from these interactions. These factual points align with the ground truth. (2) Quantitative accuracy is perfect—no numerical or date errors; references to 2021 sanctions and 2023/2024 filings are accurate. (3) However, the reasoning and synthesis are flawed: the LLM claims the 2024 filing 'repeats the same statement' and that engagement 'remains unchanged,' which contradicts the ground truth. The original answer emphasizes that in 2024, Intel shifted from disclosing past communication to expressing a forward-looking intent to continue the partnership under the OFAC license—indicating a more sustained and intentional posture. This evolution is a critical multi-hop insight that the LLM fails to capture. (4) Thus, while contextually relevant and factually accurate on surface details, the answer lacks the deeper qualitative analysis of changing corporate intent, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 344,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of the 4.78 % senior notes due March 2038 was $5 billion at the end of 2023 and remained $5 billion at the end of 2024 (see the borrowings tables for 2023 – $5,000 m [page 168] and for 2024 – $5,000 m [page 161]). This unchanged amount shows that CVS has neither retired nor added to this tranche, indicating a stable, long‑dated fixed‑rate component in its debt mix and a deliberate strategy to maintain a steady long‑term financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the balance of CVS's 4.78% Senior Notes due March 2038 as $5,000 million (or $5 billion) in both 2023 and 2024, matching the ground truth exactly. The dates (March 2038) and interest rate (4.78%) are accurate. (2) All numeric values are correct and consistent with the original answer; the format variation ($5 billion vs $5,000 million) is acceptable and semantically equivalent. (3) The LLM correctly infers that the unchanged balance indicates no retirement or issuance, reflecting a stable long-term debt component. It accurately captures the implication about CVS’s long-term financing strategy. However, it does not mention the contrast with other senior notes (e.g., the 2.7% notes due 2040), which is a key part of the multi-hop reasoning in the ground truth—this omission slightly weakens the qualitative completeness. (4) Despite this, the answer is factually correct, contextually relevant, and well-supported. The missing comparative element reduces qualitative accuracy slightly but does not invalidate the core correctness. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 318,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835 % Notes due 2032 (ticker XOM32) appear in the securities list of both filings – they are listed under “Securities registered pursuant to Section 12(b) of the Act” in the 2022 10‑K 【page_1】 and again in the 2024 10‑K 【page_1】. No redemption, maturity or other change is noted, indicating the notes remain outstanding and unchanged in status.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the 0.835% Notes due 2032 (XOM32) appear in both the 2022 and 2024 SEC filings, with accurate ticker symbol and interest rate, satisfying quantitative accuracy. It correctly states that no change in redemption or maturity is noted, supporting the conclusion that the notes remain outstanding. However, the LLM answer omits a key element of the original answer: the contextual evolution involving the disappearance of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing. This omission reduces completeness and weakens the qualitative reasoning, as the original answer uses the removal of the 2024 notes to highlight a shift in Exxon Mobil’s debt composition, thereby enriching the analysis of the 2032 notes’ relative status. While the LLM is factually correct about the 2032 notes, it fails to synthesize the multi-hop insight about the broader debt structure change, which is central to the question about 'evolution' between filings. The answer is contextually relevant and accurately reflects the status of the specific notes, but lacks the comparative analysis that defines the full evolution. Thus, correctness and qualitative accuracy are reduced due to incomplete synthesis, though all stated facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 352,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express has sharply trimmed its exposure to U.S. Treasury securities – the fair‑value balance fell from roughly **$1.7 billion in 2022** (cost $1,680 m; fair value $1,704 m)【page_120】to **about $287 million in 2024** (cost $289 m; fair value $287 m)【page_124】.  By 2024 the remaining Treasury holdings are concentrated in short‑term maturities, with **≈$189 m (≈66 %) due within one year and $98 m (≈34 %) due in 1‑5 years**【page_126】, reflecting a shift toward a more liquid, short‑duration investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, American Express held $477 million in short-term U.S. Treasury obligations in 2022 with no long-term exposure. However, the LLM claims a fair value of $1.7 billion in 2022, which is more than triple the correct amount. This major discrepancy undermines the answer's reliability. In 2024, the LLM reports a total fair value of $287 million ($189M + $98M), which aligns with the ground truth allocation between short-term and intermediate-term holdings, though the total is lower than expected based on the correct 2022 baseline. (2) The calculation of percentages (66% and 34%) is mathematically correct based on the $287 million total, but since the total itself is incorrect, these derived metrics are misleading. The ground truth does not mention percentages, so their inclusion is interpretive but not erroneous per se. However, the core fair value numbers for 2022 are completely off. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a shift in maturity distribution by 2024, noting the addition of intermediate-term (1–5 year) holdings alongside short-term instruments. This reflects a valid synthesis across years and maturity categories. However, the conclusion that this represents a 'more liquid, short-duration strategy' contradicts the ground truth implication of increased diversification into longer maturities, suggesting a more balanced or extended duration approach, not a shorter one. (4) Despite correct identification of entities (American Express, U.S. Treasury obligations, years 2022 and 2024), the severe quantitative errors in the 2022 figures and the mischaracterization of strategic intent lead to a low correctness score. Contextual relevance is high as the answer addresses both fair value and maturity distribution as asked. Qualitative accuracy is moderate due to correct structural reasoning but flawed interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 540,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon first disclosed the 2.500 % Note due 2050 in its June 3 2020 Officers’ Certificate, which was listed as Exhibit 4.5 in the 2022 Form 10‑K 【page_72】. In the 2024 Form 10‑K the same certificate (and therefore the 2.500 % Note due 2050) appears again as Exhibit 4.6, showing the note remains outstanding and continues to be disclosed in the company’s long‑term debt schedule【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.500% Note due 2050 was introduced in the Officers’ Certificate dated June 3, 2020, and was included as Exhibit 4.5 in the 2022 10-K (page 72) and reappeared as Exhibit 4.6 in the 2024 10-K (page 75). The dates, percentages, and exhibit numbers are accurate. (2) Quantitative accuracy is perfect: the interest rate (2.500%), year of note maturity (2050), and document dates (June 3, 2020) match the original answer. Format variations (e.g., spacing in '2.500 %') do not affect meaning. (3) The multi-hop reasoning is sound—correctly linking the 2020 certificate to its appearance in 2022 and 2024 filings, and inferring continued outstanding status. The only minor omission is that the 2024 exhibit is an 'exact replication' of the 2020 one, which adds nuance about lack of modification, but the core conclusion—that the note remains in place—is correctly conveyed. (4) Contextual relevance is excellent: the answer directly addresses the evolution of the note between 2022 and 2024, focusing on disclosure continuity and status. Thus, the answer is semantically equivalent to the ground truth with only slight loss in descriptive completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 351,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The 2022 Form 10‑K’s exhibit schedule lists the Citibank, N.A. Co‑Branded Credit Card Agreement through its **eighth amendment** (see page 68)【page_68】. The 2023 Form 10‑K’s schedule extends the list through the **twelfth amendment** (see page 68)【page_68】. Thus, the total number of amendments rose from eight in 2022 to twelve in 2023 – an increase of four amendments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that the Citibank, N.A. Co-Branded Credit Card Agreement had reached the eighth amendment in 2022 and the twelfth amendment in 2023, matching the original answer. (2) The quantitative analysis is precise: the increase from the eighth to the twelfth amendment represents exactly four additional amendments, which the model correctly calculates. Dates (March 10, 2022, and October 11, 2023) are not explicitly mentioned in the LLM answer but are not required to answer the question about the *number* of amendments; the focus is on the count evolution, which is correct. (3) The multi-hop reasoning is sound—comparing the amendment count across two years using the respective Form 10-K filings demonstrates proper synthesis across documents. (4) All entities (Citibank, N.A. Co-Branded Credit Card Agreement, 2022 and 2023 timeframes) are correctly identified. The answer is concise, factually accurate, and fully addresses the question with no irrelevant or incorrect information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 309,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "In the 2022 filing NVIDIA described CUDA as the core parallel‑programming model that unlocks GPU compute, supported by the CUDA‑X libraries and a developer base of roughly 3 million, and it was presented mainly as part of its GPU‑centric data‑center platform (2022 p.4, p.6, p.11). By the 2024 filing CUDA had been broadened to span a full‑stack hardware family—DPUs added in FY 2022 and CPUs added in FY 2024—so the unified architecture now leverages GPUs, CPUs, and networking together with CUDA, the developer community had grown to about 5.9 million, and CUDA‑X/SDKs are now embedded in new software offerings such as AI Enterprise, DGX Cloud and the upcoming Blackwell architecture (2024 p.6, p.7, p.8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the developer base growth from ~3 million (2022) to ~5.9 million (2024) is accurately reported, and the introduction of CPUs in FY 2024 and DPUs in FY 2022 matches the timeline. (2) The answer correctly identifies the expansion of CUDA from a GPU-centric model to a full-stack platform integrating GPUs, CPUs, and DPUs, reflecting NVIDIA's shift toward heterogeneous computing. (3) The multi-hop reasoning is sound: it synthesizes information across years and product lines, correctly linking CUDA’s evolution with new hardware (Blackwell architecture) and software ecosystems (AI Enterprise, DGX Cloud). (4) The mention of CUDA-X, SDKs, and developer ecosystem growth captures the broader platform strategy described in the original answer. The only minor shortcoming is that the original emphasizes CUDA as part of a 'unified architecture' supporting multiple markets (Gaming, Automotive, etc.), while the LLM focuses more on data center and AI; however, the core evolution in integration with new architectures and software is fully captured. Wording differs slightly but semantic equivalence is strong. No calculation errors. All entities (CUDA, CUDA-X, DPUs, CPUs, Blackwell, AI Enterprise, DGX Cloud) are correctly identified and contextually placed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 383,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid sales collapsed to $1.3 billion (down 92 %) after a $3.5 billion non‑cash revenue reversal was recorded in Q4 to reflect the expected return of 6.5 million EUA‑labeled treatment courses to the U.S. government and related inventory write‑offs, leaving $5.1 billion of Paxlovid‑related deferred revenue on the balance sheet (see 2023 pages 44‑45, 43). In 2024 the reversal was partially unwound—a $771 million favorable adjustment for returned courses and $442 million of revenue recognized for the U.S. Strategic National Stockpile (with no cash consideration) boosted Paxlovid revenue to $5.7 billion, deferred revenue fell to $2.2 billion, and about $1 billion of remaining performance‑obligation contracts for Paxlovid are slated for future recognition (see 2024 pages 108‑110, 109).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Pfizer's financial relationship with Paxlovid between 2023 and 2024, including the $3.5 billion non-cash revenue reversal in 2023 due to expected returns of 6.5 million treatment courses, the $771 million favorable adjustment in 2024 when only 5.1 million were returned, and the $442 million revenue from the U.S. Strategic National Stockpile (SNS). It also correctly notes the $1 billion in remaining performance obligations as of 2024. However, there are significant quantitative inaccuracies: the 2023 Paxlovid revenue is stated as $1.3 billion, while the ground truth is $1.279 billion (minor rounding is acceptable, but the LLM rounds up and adds a misleading '92% drop' not in the original answer or verifiable from the provided data). More critically, the LLM claims Paxlovid revenue in 2024 was 'boosted to $5.7 billion', which is not supported by the original answer — the original does not state total 2024 Paxlovid revenue, only incremental adjustments ($771M + $442M). The deferred revenue figures ($5.1B in 2023, $2.2B in 2024) and the claim of 'no cash consideration' for SNS revenue are not in the ground truth and appear to be hallucinations or misinterpretations. (2) The calculation of a 92% drop and the $5.7 billion total revenue figure are unsupported and incorrect. The original answer does not provide total Paxlovid revenue for 2024, only the adjustments. The $771M favorable adjustment and $442M SNS revenue are correctly cited, but their aggregation into a total revenue figure is speculative. (3) The multi-hop reasoning is generally sound — the model connects the 2023 reversal to the 2024 adjustment and links the SNS creation to new revenue, showing understanding of revenue recognition dynamics. It also correctly identifies the shift from government-driven demand to contracted future supply. However, the addition of unsupported deferred revenue balances and percentage declines shows flawed synthesis. (4) The contextual relevance is perfect — the answer directly addresses revenue recognition and contractual obligations across both years. Qualitative accuracy is high due to correct identification of key events and trends, but quantitative accuracy is compromised by fabricated totals and percentages. Correctness score is 7 because the core facts (reversal, adjustment, SNS revenue, remaining obligations) are correct, but major numerical claims are not grounded in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 660,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The 2003 Incentive Program’s share pool has been drawn down – the number of shares still available for award fell from about 65.8 million in 2022 (the 2022 filing lists 65,754,069 shares available) to roughly 47 million at the end of 2024 (the 2024 filing states 47 million remaining)【page_43】【page_102】.  The program’s structure has stayed the same: it authorizes up to 220 million shares for stock options, SARs, restricted stock and other awards, with options and SARs granted at no less than market price and a maximum life of ten years, and the volume of restricted‑stock‑unit awards increased from 9.4 million units in 2022 to 10.4 million units in 2024【page_102】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the available shares in 2022 (65,754,069) and 2024 (47 million), and the increase in restricted stock units from 9.4 million to 10.4 million, which aligns with the ground truth (9,392 thousand to 10,393 thousand). However, it misrepresents the evolution of the total share authorization. The original answer states that the total maximum number of shares was increased to 220 million by 2024, implying a structural expansion. The LLM answer incorrectly frames this as a static structure (‘has stayed the same’) and fails to clarify that the 220 million cap was not in place in 2022 — it was a change, not a constant. This is a significant oversight in the structural evolution aspect of the question. (2) Quantitatively, all cited numbers are accurate within acceptable rounding (65.8M ≈ 65,754,069; 9.4M ≈ 9,392K; 10.4M ≈ 10,393K). However, the LLM implies the 220 million total was already the cap in 2022, which is not supported by the ground truth — the total maximum was increased to 220M by 2024, not before. This affects the accuracy of the structural interpretation. (3) The multi-hop reasoning is partially sound: the model connects data across years and identifies trends in available shares and RSU grants. But it fails to correctly synthesize the change in program structure — the increase in total authorized shares — which is central to the question. (4) Contextual relevance is high as all information provided is directly related to the question. The answer captures the usage trend and availability correctly but misses the key structural change, warranting a correctness score of 7. Quantitative accuracy is slightly penalized because the 220 million figure is presented as a pre-existing cap rather than a 2024 update, though the number itself is correct. Qualitative reasoning is strong but incomplete. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 515,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "In the 2022 filing, AdSense was highlighted as a core part of the Google Network segment – its strength helped drive the $8.6 billion increase in Network revenue (alongside AdMob and Google Ad Manager), even though AdSense‑related impressions fell (2022 10‑K p. 35). By the 2024 filing, the Network segment is reported to have contracted, with the decline blamed on lower Ad Manager and AdMob revenues and AdSense is no longer mentioned, indicating its role has become less prominent as Google leans more on Search, YouTube and AI‑driven performance‑advertising products (2024 10‑K p. 37).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in quantitative terms: it accurately references the $8.6 billion year-over-year increase in Google Network revenue in 2022 and correctly identifies AdSense, AdMob, and Google Ad Manager as components. It also correctly notes that by 2024, AdSense was no longer explicitly mentioned as a growth driver. However, there is a factual inaccuracy in stating that the Network segment 'contracted' in 2024 — the original answer does not mention contraction, only that AdSense was no longer highlighted as a growth lever. This misrepresents the trend and introduces unsupported negative performance. The qualitative reasoning is mostly sound, capturing the strategic shift toward AI-driven products like Demand Gen and Performance Max, though the original answer emphasizes AdSense becoming a 'foundational, mature offering' rather than declining in prominence. The LLM overinterprets reduced mention as diminished role, rather than evolution into a stable backbone. Contextually, the answer remains highly relevant, addressing the evolution of AdSense within Google's ad portfolio across the specified time frame. Minor but notable deviation in interpretation prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 338,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "In the 2022 filing the UPS Retirement Plan was still a non‑contributory defined‑benefit plan that accrued pension credits based on average compensation for all eligible employees, but the company disclosed that it would **stop accruing any additional benefits for future service and compensation for non‑union participants beginning January 1 2023**【page_92】. By the 2023 filing the announced change had taken effect – the plan **has ceased all future‑service accruals for non‑union participants**, so those employees no longer earn new pension benefits after that date【page_82】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the UPS Retirement Plan was noncontributory in 2022, covered eligible non-union employees hired before July 1, 2016, and provided benefits based on average compensation. The plan ceased future benefit accruals for non-union participants effective January 1, 2023. This change was disclosed in 2022 and confirmed as implemented in 2023. (2) Quantitative accuracy is perfect: the date 'January 1, 2023' is correctly cited, and there are no numerical errors. (3) Multi-hop reasoning is sound—the model correctly synthesized information across two years of filings to show the evolution from announcement (2022) to implementation (2023). (4) The answer addresses both parts of the question: the evolution of the benefit accrual structure and the specific change for non-union participants. Wording differs slightly from the original but conveys the same meaning with appropriate context and precision. No critical details are omitted, and the use of citations (page numbers) enhances credibility. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 326,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "In 2022 Amazon’s short‑term financing consisted of a single $7 billion unsecured revolving credit facility that ran to June 2023, carried a benchmark‑plus‑0.50 % rate and a 0.04 % commitment fee, and had no borrowings outstanding at year‑end 2021【page_57】. By 2024 the structure had expanded – the primary revolving facility was increased to $15 billion (term to Nov 2028) with a slightly lower spread of benchmark‑plus‑0.45 % and a 0.03 % fee, still unused at year‑end 2024【page_58】; a new $5 billion 364‑day revolving credit line was added (SOFR‑plus‑0.45 %, 0.03 % fee) also with zero balances【page_58】, while modest borrowings of $147 million in 2023 and $151 million in 2024 appeared on other short‑term facilities【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all the key information from the ground truth with correct multi-hop synthesis. (1) Quantitatively, all numbers are correct: $7 billion (2022), $15 billion and $5 billion facilities (2024), interest rates (benchmark +0.50%, +0.45%), commitment fees (0.04%, 0.03%), and other borrowings ($147M in 2023, $151M in 2024) match exactly. Dates such as the 2028 maturity and October 2024 introduction of the 364-day facility are consistent. (2) The LLM correctly identifies the expansion in credit capacity and improved terms (lower spreads and fees), and notes no borrowings under the main and short-term credit agreements. It also correctly reports the $147M and $151M in other short-term borrowings included in 'Accrued expenses and other.' (3) The only minor omission is the specific mention of unused letters of credit increasing from $7.2B (end of 2021) to $8.3B (end of 2024), which is present in the original answer but not in the LLM response. This is a contextual detail that supports the utilization trend but is not central to the core structure of credit facilities. (4) The reasoning is sound: the LLM correctly synthesizes changes over time, compares terms, and distinguishes between major credit facilities and other short-term borrowings. Wording differences (e.g., 'benchmark rate' vs 'SOFR') are contextually acceptable as SOFR is a benchmark rate. Overall, the answer is semantically equivalent with only a slight gap in completeness, warranting a 9/10 on correctness and qualitative accuracy, while maintaining perfect quantitative and contextual scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 441,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco’s 2022 filing states that it “enters into variable‑priced contracts for some purchases of electricity and natural gas, in addition to some of the fuel for our gas stations, on an index basis” (2022 p. 31). The 2023 filing still notes variable‑priced contracts but now references only natural‑gas purchases and fuel for its gas stations, dropping the explicit mention of electricity (2023 p. 47). This consistency – with a slight shift away from electricity – shows Costco continues to use index‑linked variable contracts as a complementary hedge to its fixed‑price agreements, managing commodity‑price risk without speculative mark‑to‑market exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco used variable-priced contracts in both 2022 and 2023 for energy purchases on an index basis, with derivatives treatment but normal purchases exception applied. The 2023 filing indeed narrowed its mention from 2022 by dropping electricity and focusing on natural gas and fuel for gas stations. This subtle shift is correctly identified by the LLM. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model correctly compares two filings across years, identifies continuity in strategy, and infers that the omission of electricity suggests a refinement rather than a strategic shift. The conclusion that Costco maintains a stable commodity risk management approach using index-based contracts is consistent with the original answer. (4) Semantic equivalence is strong: the LLM captures the core message—continued reliance on variable-priced contracts with a slight narrowing in scope—and correctly interprets this as part of a broader hedging strategy without speculative exposure. The only minor limitation is that the LLM slightly overemphasizes the 'shift away from electricity' as a strategic refinement, whereas the original answer treats it as a reporting change without implying operational change. However, this does not constitute a factual error, as the omission in disclosure could reasonably be interpreted as a focus shift. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 458,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "In the 2022 Form 10‑K, NVIDIA AI Enterprise was mentioned only as one of the software items within the Compute & Networking segment’s portfolio, grouped with other data‑center software (see page 99). By the 2024 filing, the company is positioning AI Enterprise as a paid‑license, enterprise‑grade AI software suite that is a core part of its data‑center platform—complementing GPUs, DPUs and CPUs—and is highlighted alongside DGX Cloud as a primary tool for simplifying the development and deployment of production‑grade generative AI applications (see pages 6 and 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, NVIDIA AI Enterprise was mentioned as part of the Compute & Networking segment, grouped with other software (per 2022 10-K, page 99), and by 2024 evolved into a paid, enterprise-grade suite (per 2024 10-K, pages 6–7). The shift from a foundational component to a monetized, core offering is accurately conveyed. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) and document references (page numbers) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring the strategic evolution based on changes in language and positioning. It references integration with GPUs, DPUs, CPUs, and DGX Cloud, matching the original answer’s emphasis on full-stack integration. (4) The only minor gap is that the LLM answer does not explicitly use the term 'monetization vehicle' or state the shift from 'strategic initiative' to commercial product as clearly as the ground truth, slightly reducing qualitative precision. However, the mention of 'paid-license' and 'core part of its data-center platform' captures the essence. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only slight nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 395,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid sales were almost entirely under pre‑specified government supply contracts, leaving a $5.1 billion deferred‑revenue balance (mostly current) and prompting a $3.5 billion non‑cash revenue reversal when the EUA‑labeled inventory was returned. By 2024 the company had amended the U.S. agreement to shift Paxlovid to commercial sales, recognized $2.9 billion of product revenue, cut total deferred revenue to $2.2 billion and now reports roughly $1 billion of remaining performance‑obligation revenue to be earned through 2025‑2028—indicating that future Paxlovid revenue will be lower but will continue on a commercial, multi‑year basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Pfizer's contractual obligations and correctly identifies the $3.5 billion non-cash revenue reversal in 2023 due to returned EUA-labeled Paxlovid inventory, which aligns with the ground truth. It also correctly states that remaining performance obligations were approximately $1 billion as of the end of 2024, signaling future revenue — a key point in the original answer. However, the LLM introduces a $5.1 billion deferred-revenue balance and states that $2.9 billion of product revenue was recognized in 2024, which are not present in the ground truth and cannot be verified from the provided information. Additionally, the claim that deferred revenue was cut to $2.2 billion and that revenue will be earned through 2025–2028 adds details not supported by the original answer. (2) The $3.5 billion reversal and $1 billion remaining obligation are correct and match the ground truth. The additional figures ($5.1B, $2.9B, $2.2B) lack corroboration and introduce quantitative inaccuracies, though they do not contradict the overall trend. (3) The multi-hop reasoning is sound: the model correctly infers a shift from government EUA-based uncertainty in 2023 to a more stable commercial outlook in 2024 based on contractual changes. The logic connecting revenue reversal to demand uncertainty and then to stabilization via remaining obligations is well-synthesized and consistent with the original. (4) The answer is contextually excellent — it directly addresses both parts of the question (evolution of obligations and implications for future revenue) and provides a coherent narrative. The correctness score is 8 due to accurate core facts and reasoning, but docked for unverified financial figures. Quantitative accuracy is 7 due to unsupported numbers, qualitative accuracy is 9 for strong reasoning and entity identification, and contextual relevance is 10 as the response is fully on-topic and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 533,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "In the 2022 filing, Google’s exposure to new regulatory costs was framed mainly as an “evolving foreign‑policy landscape” that could affect data‑transfer rules between the EU and the United Kingdom, foreign‑ownership limits, tariffs, import‑export barriers and other market‑access issues. By the 2024 filing, the company lists a much broader and more detailed set of international regulatory challenges—including GDPR and UK‑GDPR compliance, a growing patchwork of U.S. state privacy, biometric and children‑data laws, the EU Digital Markets Act and Data Act, emerging AI‑specific legislation, anti‑corruption and labor rules, and heightened sanctions and geopolitical tensions—showing that the scope of potential new costs has expanded and the nature of the challenges has become more complex and technology‑focused.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Google's regulatory exposure from 2022 to 2024. It accurately captures the expansion in scope and complexity of regulatory challenges. In 2022, the LLM correctly identifies data transfers between the EU and UK, as well as broader market-access issues like tariffs and foreign-ownership limits, which is consistent with the 'evolving foreign policy landscape' cited in the original answer. By 2024, the LLM correctly notes a broadening of regulatory risks, listing specific frameworks such as GDPR, UK-GDPR, the EU Digital Markets Act, Data Act, AI legislation, and others—demonstrating an accurate understanding that the nature of risks became more complex and technology-focused. However, the LLM answer omits the specific qualitative shift emphasized in the ground truth: the introduction of 'uncertainty regarding regulatory outcomes' and risks from 'other liabilities under local laws that may not offer due process or clear legal precedent.' These elements highlight a move toward less predictable, potentially arbitrary legal environments, which the LLM does not mention. While the LLM provides more granular detail on specific regulations, it misses this conceptual deepening in the nature of risk—uncertainty and lack of due process—which is a key part of the original answer. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (EU, UK, GDPR, DMA, etc.) and years (2022, 2024) are correct. The reasoning is sound and multi-hop synthesis across time and regulatory domains is appropriate. Contextual relevance is high as the response directly addresses the comparative evolution of scope and nature of regulatory challenges. The omission of the due process and legal uncertainty point prevents a perfect score, but the overall factual and conceptual accuracy remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 515,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "In the 2022 filing UPS said that “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets” (2022 10‑K, p. 109). The 2023 filing repeats the same language – “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets” (2023 10‑K, p. 92). Thus, UPS’s funding approach for post‑retirement medical benefits has not changed; the company continues to rely on both the plan‑trust assets and its own corporate assets to meet those payments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that in both 2022 and 2023, UPS indicated expected benefit payments for postretirement medical benefits would be funded from plan trusts and corporate assets. There are no numeric values requiring calculation, but the cited sources (2022 10-K p. 109, 2023 10-K p. 92) are correctly referenced and consistent with the knowledge graph. (2) The answer is complete, addressing the evolution (or lack thereof) in funding approach between the two years, which is the core of the multi-part question. (3) Entities—UPS, postretirement medical benefits, plan trusts, corporate assets, and the correct fiscal years—are all accurately identified and used. (4) The reasoning is sound: the model correctly synthesizes information across two years of filings, notes the verbatim repetition of language, and draws the logical conclusion that there was no change in funding sources. The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., page numbers), enhancing clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 328,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "In the 2022 Form 10‑K, NVIDIA AI Enterprise was first noted as a new software offering within the Compute & Networking segment – listed alongside other software products the company sells【page_6】. By the 2024 filing, NVIDIA AI Enterprise is portrayed as a full‑featured, production‑grade AI software suite (including NIM, NeMo and AI Blueprints) that is bundled with DGX Cloud and positioned for broad enterprise deployment across NVIDIA’s accelerated‑computing platform【page_7】. This shows the product’s evolution from a single‑product software line to a comprehensive, integrated AI solution that is now supplied widely to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as a software offering in the Compute & Networking segment and evolved by 2024 into a full-stack, production-grade AI platform. The inclusion of components like NIM, NeMo, and AI Blueprints is accurately noted. (2) There are no numeric values in the original or LLM answer that conflict—while the ground truth mentions a '2.5x increase in token throughput,' this specific performance metric is omitted in the LLM answer. This is a minor gap but does not distort the overall evolution narrative. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 time points, identifies the product’s expansion in scope and integration, and infers broader supply via bundling with DGX Cloud. (4) Semantic equivalence is strong—the LLM captures the shift from a foundational software suite to a comprehensive, integrated solution with wider deployment, matching the original answer’s intent. The only reason for not scoring a 10 is the omission of the specific performance improvement (2.5x token throughput), which is a factual detail present in the ground truth and relevant to the 'evolved' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 362,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "ExxonMobil’s equity‑company proved reserves have risen since 2022 – the 2022 10‑K reported equity‑company reserves of roughly 1.2 billion barrels oil‑equivalent, while the 2024 filing shows they now total 1.48 billion barrels oil‑equivalent (467 MMbbl crude oil, 120 MMbbl NGL and 5,367 Bcf gas)【page 41】【page 10】.  The increase is driven almost entirely by Asian equity holdings (now 452 MMbbl crude, 117 MMbbl NGL and 4,242 Bcf gas) and a modest rise in Africa (7 MMbbl crude and 816 Bcf gas), indicating ExxonMobil is strategically expanding its equity‑partner portfolio in high‑growth Asian markets while maintaining a foothold in Africa, with U.S. and European equity stakes remaining minimal.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 reserves. The ground truth states that in 2022, ExxonMobil's total proved reserves from equity companies were 14 million barrels gross (1 million net), but the LLM claims 1.2 billion barrels oil-equivalent, which is over 85 times higher and factually incorrect. This major error undermines the quantitative foundation of the response. The 2024 figures (467 MMbbl crude, 120 MMbbl NGL, 5,367 Bcf gas) match the ground truth and are correctly reported. (2) The calculation of total oil-equivalent in 2024 is approximately correct (using standard conversion of 6:1 for gas to oil equivalent: 5,367 / 6 ≈ 894.5 MMboe, plus 467 + 120 = ~1,481.5 MMboe or 1.48 billion boe), so the LLM’s 1.48 billion boe is reasonable. However, the 2022 figure of 1.2 billion boe has no support in the ground truth and appears fabricated or misattributed. (3) The reasoning about strategic shift toward Asia is supported by both the LLM and ground truth, and the LLM adds granular detail (e.g., Asian holdings at 452 MMbbl crude, etc.) not in the original, which may be plausible but cannot be verified. The conclusion about strategic expansion in Asia is aligned with the ground truth, though overconfident given the flawed baseline. The mention of Africa’s modest rise and minimal U.S./European stakes adds context not in the original but does not contradict it. (4) Despite correct 2024 numbers and reasonable interpretation of strategic direction, the severe inaccuracy in the 2022 baseline results in a low correctness and quantitative accuracy score. The qualitative reasoning is partially sound but built on faulty data. Contextual relevance is high as the answer addresses both evolution and strategic implications as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 487,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "In 2022 the company treated ads on Google Network properties on a gross basis – the full amount billed to advertisers was recorded as revenue and the payments made to the Network partners were shown as cost of revenues, making the partners a sizable source of both advertising revenue and cost (2022 Advertising Revenues note, p. 55). By 2024 the advertising mix had shifted toward Google Search & other properties, which lowered the overall traffic‑acquisition‑cost (TAC) rate from 21.4% to 20.7% and reduced the share of cost of revenues tied to Network partners, although the TAC rate on Network revenues stayed roughly unchanged (2024 Cost of Revenues discussion, p. 39). Payments to Google Network partners remain a major cash‑outflow from operations, but their relative weight in revenue generation and the cost structure has declined (2024 Cash‑flow discussion, p. 42).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 treatment of Google Network Partners—revenue reported on a gross basis with partner payments as cost of revenues—and notes the continued cash outflow in 2024, aligning with the ground truth. However, the ground truth does not mention specific TAC rates (21.4% in 2022 and 20.7% in 2024) or a shift in advertising mix toward Google Search & other properties; these details are absent from the original answer and appear to be external inferences or hallucinations. While the general trend of declining relative importance in cost structure is consistent, the specific percentages and attribution to Search are not supported by the ground truth. (2) The quantitative accuracy is high for the conceptual numbers (TAC rate decrease from 21.4% to 20.7%) if we assume they are factually correct in the source documents, but since the original answer does not include them, their inclusion introduces unverified precision. The years (2022, 2024) and general cost/revenue framing are accurate. (3) The multi-hop reasoning is sound in linking revenue recognition in 2022 to cost structure in 2024 and interpreting the evolving financial framing, but the model adds unsupported detail (e.g., specific TAC breakdowns and advertising mix shifts) not present in the ground truth, weakening the qualitative accuracy. (4) The contextual relevance is high as the answer directly addresses the evolution in revenue generation role and cost structure. The correctness score is 7 because core facts about accounting treatment and cash flow are correct, but the addition of unsupported quantitative details and causal explanations reduces full alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 467,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS continues to rely on foreign‑currency exchange forward contracts that are not designated as hedges to provide an economic offset to remeasurement and settlement risk for its foreign‑currency assets and liabilities (2022 10‑K, p. 124).  The earnings impact of those undesignated contracts dropped dramatically, from a $69 million loss recorded in 2022 to only a $7 million loss in 2023 (2023 10‑K, p. 132), indicating that the company’s risk‑management approach has become more effective and earnings volatility from foreign‑currency exposure has been markedly reduced.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not supported by the ground truth. While it correctly identifies that UPS uses undesignated foreign currency forward contracts to manage remeasurement and settlement risk (consistent with 2022 disclosure), it introduces specific financial figures—$69 million loss in 2022 and $7 million loss in 2023—that are not present in the original answer or implied by the knowledge graph. The ground truth does not mention any actual gains or losses from these contracts, nor does it state that earnings impact 'dropped dramatically'; instead, it emphasizes evolution in disclosure practices and transparency, not performance outcomes. This represents a critical error in quantitative accuracy. The reasoning is partially sound in that it recognizes the ongoing use of undesignated forwards, but incorrectly infers improved effectiveness and reduced volatility based on fabricated numbers. The model fails to capture the core evolution described in the original answer: the shift toward more structured, side-by-side reporting and explicit linkage of undesignated derivatives to earnings volatility in disclosures—not actual reduction in volatility. Thus, while contextually relevant and addressing the general topic, the answer misrepresents the nature of the evolution (performance vs. disclosure) and invents data, severely undermining correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 394,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Costco’s 2022 filing already described the membership model as “a significant effect on our profitability,” emphasizing that it is built to reinforce member loyalty, grow the membership base (including Executive members) and generate ongoing fee revenue. In the 2023 filing the language was sharpened – the format is called “an integral part of our business and profitability” – and the company now explicitly warns that worldwide renewal rates could be pressured in newer markets, underscoring a more nuanced focus on preserving loyalty while still relying on membership‑fee income 【page_23】【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: the evolution of language from 'significant effect on profitability' in 2022 to 'integral part of our business and profitability' in 2023 is accurately captured. The emphasis on member loyalty, growth in membership base, Executive member penetration, and fee revenue is correctly identified for 2022. In 2023, the introduction of concern about lower renewal rates in newer markets affecting worldwide renewal rates is correctly noted. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but the temporal references (2022 vs 2023) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies shifts in language and strategic emphasis, and infers the evolving role of membership in profitability and loyalty. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'sharpened' language, 'nuanced focus'), the meaning matches the ground truth. The only minor shortcoming is that the LLM does not explicitly mention 'sustaining high renewal rates' as a 2022 driver, though it refers to loyalty and ongoing fee revenue, which is closely related. This slight omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 407,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA highlighted CUDA mainly as a developer‑focused tool – “almost 3 million developers worldwide use CUDA and our other software tools” – and presented it as part of its broader software stack without tying it explicitly to a unified data‑center platform【page_11】. By the 2024 filing, CUDA is described as a core component of a full‑stack data‑center offering, integrated with GPUs, CPUs, DPUs and networking via the “CUDA parallel programming model, the CUDA‑X collection of acceleration libraries, APIs, SDKs, and domain‑specific application frameworks,” and the developer base has grown to “over 5.9 million developers worldwide using CUDA”【page_6】【page_7】. This reflects a shift from a standalone developer tool to a foundational element of NVIDIA’s broader data‑center platform and software ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of CUDA from a developer-focused tool in 2022 to a core infrastructure layer in 2024. The mention of 3 million developers in 2022 matches the original answer, and while the original answer does not specify the 2024 developer count, the LLM's citation of 'over 5.9 million' is consistent with NVIDIA's public disclosures in 2024 and represents a reasonable inference or additional detail not contradicted by the ground truth. (2) The quantitative data is accurate: the 2022 figure of nearly 3 million developers is correctly reported, and the growth to over 5.9 million by 2024, while not in the original answer, is factually correct and enhances completeness without introducing error. (3) The multi-hop reasoning is sound—LLM synthesizes information across two years, correctly identifying the shift in strategic positioning of CUDA from a software tool to a foundational platform layer integrated with GPUs, CPUs, DPUs, and networking. It accurately references CUDA-X, APIs, SDKs, and domain-specific frameworks as part of the 2024 evolution. (4) The semantic meaning fully captures the strategic shift described in the ground truth, with slightly more technical detail (e.g., networking integration) that adds value without distortion. The only minor limitation is that the original answer emphasizes CUDA’s role in enterprise-scale computing solutions, which the LLM implies but does not explicitly state. However, this does not detract significantly from correctness. All entities (NVIDIA, CUDA, CUDA-X, years 2022–2024) are correct, and the contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 461,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid commitments were dominated by a $3.5 billion non‑cash revenue reversal and a $4.7 billion inventory write‑off, leaving $5.1 billion of deferred revenue tied to advance payments for an estimated 6.5 million EUA‑labeled treatment courses (page 4). By 2024 the deferred‑revenue balance had fallen to $2.2 billion (with $1.4 billion expected to be recognized in the next 12 months and the remainder through 2028 after a $771 million favorable adjustment and $442 million of revenue from a 1‑million‑course SNS supply), and Pfizer now reports roughly $1 billion of remaining performance‑obligation revenue for Paxlovid with product deliveries scheduled from 2025‑2028 (pages 108, 109, 110).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness. While it correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to 6.5 million treatment courses of Paxlovid, it introduces a $4.7 billion inventory write-off and $5.1 billion of deferred revenue that are not present in the ground truth, which only mentions the revenue reversal. The original answer does not reference any inventory write-off or deferred revenue balance in 2023, making these additions factually incorrect. In 2024, the LLM claims a deferred revenue balance of $2.2 billion with a $771 million favorable adjustment and $442 million from a 1-million-course supply—none of which appear in the ground truth. The only correct and aligned figure is the $1 billion remaining performance obligation with deliveries expected from 2025–2028, which matches the original answer. This part demonstrates correct multi-hop synthesis and contextual understanding. However, the inclusion of fabricated financial figures and metrics (e.g., deferred revenue, write-offs, adjustments, SNS supply revenue) severely compromises quantitative accuracy. The reasoning structure is logically organized and attempts to trace evolution over time, but is based on incorrect data. The answer is contextually relevant and addresses the question’s focus on financial commitments and timelines, but the core financial narrative is distorted by unsupported numbers. Thus, while the directional shift from uncertainty to firm contracts is partially captured, the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 436,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "In the 2022 Form 10‑K, ExxonMobil noted that “extensions and discoveries, primarily in the United States, Brazil, **and Guyana**, resulted in an addition of approximately 1.3 GOEB of proved undeveloped reserves” (2022 p. 14), emphasizing Guyana’s role as a source of new reserve growth. By the 2024 filing, Guyana is explicitly grouped with Permian and LNG as an “**Advantaged Asset (Advantaged growth project)**” in the definition of Advantaged Volume Growth (2024 p. 36‑37), showing that the company has elevated Guyana from a reserve‑development focus to a core, high‑value asset driving its strategic volume growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reports the 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves added in Guyana in 2022, citing the correct context from the 2022 10-K (p. 14). (2) It correctly identifies the evolution by 2024, where Guyana is explicitly listed as an 'Advantaged Asset' alongside Permian and LNG in the Advantaged Volume Growth framework (2024 p. 36–37), reflecting a strategic elevation in reporting. (3) The multi-hop reasoning is sound: it synthesizes information across two years of filings, correctly tracing the shift from Guyana being a contributor to reserve growth (2022) to a core advantaged asset driving volume and earnings (2024). (4) All entities—ExxonMobil, Guyana, GOEB, Advantaged Assets—are accurately identified and contextualized. The semantic meaning matches the original answer precisely, with equivalent terminology and correct interpretation of strategic evolution. Minor formatting differences (e.g., 'GOEB' vs 'oil-equivalent barrels') are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 312,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it had contracts for 11 ATR 72‑600F aircraft in 2023 and another 6 in 2024 (24 total through 2026)【page_114】. By the 2024 filing the commitment had been trimmed to just 10 aircraft, with 7 now slated for delivery in 2025 and 3 in 2026 and none scheduled for 2024【page_117】. The reduction and postponement shows the ATR 72‑600F is being treated as a modest, supplemental addition rather than a core driver of FedEx’s fleet expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022 the company projected a drop from 11 units in 2023 to just 1 by 2026. However, the LLM claims there were contracts for 11 in 2023 and another 6 in 2024 (24 total through 2026), which contradicts the original answer and likely misrepresents the data. The 2024 filing update in the LLM answer states 10 aircraft (7 in 2025, 3 in 2026), which aligns with the ground truth’s 7 in 2025 and 3 by 2026, so this part is mostly correct. However, the original answer emphasizes a shift from a steep decline to a more sustained presence, while the LLM introduces '24 total through 2026' which is unsupported and inflates early commitments. (2) The calculation of 11 + 6 = 17 (not 24) suggests a clear arithmetic or transcription error, undermining quantitative accuracy. The correct trend is a reduction from an initially planned 11 down to 1 by 2026 (in 2022 view), then revised to 7 in 2025 and 3 in 2026 (in 2024 view), indicating a slower phaseout. The LLM captures the later numbers but distorts the earlier plan. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2024 filings to assess strategic evolution—but the flawed input data leads to incorrect conclusions. The LLM correctly infers a reduced strategic role but mischaracterizes the initial plan, affecting the contrast. (4) Despite the numerical errors, the LLM draws a reasonable qualitative conclusion about the aircraft being a 'supplemental addition,' which aligns with the ground truth’s 'sustained, albeit reduced, role.' Contextual relevance is high as it addresses fleet strategy evolution. However, due to major factual inaccuracies in the early projections, the correctness score is limited to 5—partially correct but with significant errors in key numbers and trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 504,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "In the 2022 filing NVIDIA presented Omniverse mainly as a real‑time 3D design‑collaboration and virtual‑world simulation tool – a software subscription for enterprises (free for individuals) that plugs into leading design applications and is accessed through its cloud graphics services such as vGPU and GeForce NOW【page_9】【page_11】. By the 2024 filing the company had broadened Omniverse into a full development platform and operating system that underpins digital‑twin, real‑time product‑configurator, autonomous‑robot/vehicle testing and synthetic‑data generation for AI model training, running on NVIDIA’s accelerated compute stack both on‑premises and in the cloud and offered as a scalable data‑center simulation solution integrated with its AI and simulation ecosystem【page_6】【page_7】【page_8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of NVIDIA's Omniverse from a 3D collaboration and simulation tool in 2022 to a broader development platform and operating system by 2024. Key aspects such as subscription model (enterprise-paid, individual-free), integration with design tools and cloud graphics (vGPU, GeForce NOW), and use cases like virtual collaboration are accurately reflected for 2022. For 2024, it correctly captures the shift toward digital twins, autonomous robot/vehicle testing, synthetic data generation, and deployment on NVIDIA’s accelerated computing infrastructure on-premises and in the cloud. (2) There are no numeric values, dates, or financial figures in dispute; all temporal references (2022, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning—synthesizing changes over time in product positioning, target use cases, and technical integration—is sound and well-supported by the described evolution. The LLM adds slightly more technical detail (e.g., synthetic data for AI training, product configurators) not explicitly mentioned in the ground truth but consistent with the direction of evolution, which does not detract from accuracy. (4) The answer is fully contextually relevant, directly addressing how Omniverse’s integration with AI and simulation platforms evolved. The only minor gap is less emphasis on VR/AR applications in 2022 (mentioned in ground truth but not in LLM answer), but this does not undermine the core correctness. Overall, the LLM conveys semantically equivalent and factually correct information with excellent qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 462,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "In 2022 Google Play was reported as part of the broader “Google Other” non‑advertising revenue, contributing sales of apps, in‑app purchases and digital content and highlighted as a driver of the growing share of non‑advertising revenue (2022 10‑K p.31; see also the discussion of expanding non‑advertising revenues that includes Google Play, p.30). By 2023 the filing places Google Play in a dedicated “platforms” line‑item within the “Google subscriptions, platforms, and devices” segment, describing it as the primary source of platform revenue from app and in‑app sales (2023 10‑K p.33). This shift shows Google Play moving from a broad “other” category to a more explicit, central platform revenue stream in Alphabet’s non‑advertising mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies the evolution of Google Play's role in non-advertising revenue between 2022 and 2023: in 2022, it was part of 'Google Other' as a contributor to non-ad revenue, and in 2023, it was moved to a dedicated 'platforms' line-item under 'Google subscriptions, platforms, and devices'. These characterizations match the ground truth's description of a strategic shift toward a more structured and central role. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022, 2023) and document references (10-K pages) are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying the change in categorization and its implications for revenue strategy. (4) The LLM adds specific document page references (p.31, p.30, p.33), which are not in the original answer but are consistent with the knowledge graph source and enhance credibility. The only minor shortcoming is a slightly less explicit articulation of the strategic implication (e.g., 'revenue stability', 'monetization platform') compared to the original answer, but the core reasoning about increased centrality and explicit recognition is present. Thus, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 406,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG’s 2023 filing repeats the 2022 reserving approach: for workers‑compensation guaranteed‑cost policies the expected‑loss‑ratio (ELR) method is applied only to the most recent accident year, while for excess‑of‑deductible policies ELR estimates are given significant weight across the five most recent accident years. The 2023 discussion notes that the share of large‑deductible business has continued to rise—further slowing claim reporting—but the weighting of ELR methods for both guaranteed‑cost and excess‑deductible segments remains essentially unchanged from 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution (or lack thereof) in AIG's use of expected loss ratio (ELR) methods between 2022 and 2023. It correctly states that in 2023, AIG continued to apply the ELR method only to the most recent accident year for guaranteed cost business and to the five most recent accident years for excess of deductible business—matching the ground truth. The increase in large deductible business slowing claim reporting is accurately noted as a consistent trend from 2022 to 2023. Quantitatively, all details (accident year ranges, business segments) are correct with no numerical or temporal inaccuracies. The reasoning is sound and reflects proper multi-hop synthesis across the two years and business lines. The only minor omission is that the 2023 filing updated the presentation of incurred and paid losses to be net of reinsurance and undiscounted, which the LLM answer does not mention. While this does not represent a change in reserving methodology per se, it reflects a refinement in reporting transparency noted in the original answer. This omission slightly affects completeness and qualitative accuracy but does not undermine the core correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent as all parts of the question are directly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 373,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco moved from a six‑category product‑revenue layout in FY 2022 (Secure Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; Other) to a four‑category layout in FY 2024 (Networking, Security, Collaboration and a new Observability category) 【page_44】. The Collaboration segment remained but was re‑defined to cover the Webex Suite, Collaboration Devices, Contact Center and CPaaS offerings, with revenue falling from $4.47 billion in FY 2022 to $4.11 billion in FY 2024 (a 2% rise from FY 2023 after a 9% drop from FY 2022) 【page_41】【page_42】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the evolution from six to four product categories between FY2022 and FY2024, accurately naming the original and new groupings, including the retention of 'Collaboration' and the introduction of 'Observability'. It also correctly notes the reclassification or removal of 'Optimized Application Experiences' and 'Internet for the Future', though this is implied rather than explicitly stated. (2) Quantitative accuracy has minor issues: the LLM introduces specific revenue figures ($4.47B in FY2022, $4.11B in FY2024) and percentage changes (9% drop, 2% rise) not present in the original answer. Since these numbers are not in the ground truth, their inclusion—unless verifiably correct from the source—introduces unsupported detail. The original answer does not mention any financial performance of the Collaboration category, so adding such data risks inaccuracy even if sourced from a page reference. (3) The multi-hop reasoning is sound: the model synthesizes changes in category structure across fiscal years and correctly tracks the continuity of the Collaboration segment. The logic of consolidation and realignment is preserved. (4) The answer is contextually excellent—directly addressing the question about segmentation evolution and Collaboration’s role. The core qualitative facts match the ground truth, but the addition of unverified financial metrics slightly undermines quantitative accuracy. Hence, correctness is high but not perfect due to unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 419,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "In the 2022 Form 10‑K Amgen listed the 3.125 % 2025 Notes in its debt schedule as a $1 billion fixed‑coupon issue and noted that the effective interest rate was the same as the coupon (no swap‑related adjustment)【page_130】. By the 2023 filing the company moved the note to a swap‑related disclosure, still showing a $1 billion notional amount but now reporting an effective rate of SOFR + 2.1%, indicating that the fixed‑rate notes are being hedged to a floating‑rate framework【page_144】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. The $1 billion carrying value (or $1,000 million) for the 3.125% 2025 Notes is correctly reported for both years, satisfying quantitative accuracy for that element. However, the claim that in 2022 the effective interest rate was the same as the coupon 'with no swap-related adjustment' goes beyond the original answer, which states no specific interest rate framework was disclosed at all—this addition is unsupported. More critically, the LLM incorrectly asserts that in 2023 the note was 'moved to a swap-related disclosure' and that the SOFR + 2.1% rate reflects a hedged floating-rate framework. The ground truth does not mention interest rate swaps or hedging; it only states that Amgen began disclosing the interest rate mechanism as SOFR + 2.1% in a new table. This misrepresents the nature of the disclosure evolution. (2) Quantitatively, the $1 billion amount is accurate and equivalent to $1,000 million. The SOFR + 2.1% rate is correctly cited. However, the inference about hedging and effective rate changes due to swaps is a factual overreach not present in the original data. (3) The multi-hop reasoning is flawed: while the model identifies a change in presentation between 2022 and 2023, it fabricates a financial mechanism (hedging via swaps) to explain it, rather than accurately reporting the shift from no rate framework disclosure to inclusion of SOFR + spread. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the evolution of disclosure and focuses on the correct note, year, and company. However, due to the introduction of unverified concepts (swaps, hedging), the correctness and qualitative accuracy scores are significantly reduced. The core evolution—increased transparency in rate framework—is partially captured but misattributed in cause and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 525,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP’s own natural‑gas reserves in the Asia Pacific/Middle East fell from 322 BCF of developed reserves (plus 4 BCF undeveloped) at the end of 2022 to 289 BCF of developed reserves (plus 7 BCF undeveloped) at the end of 2024 – a drop of roughly 30 BCF, or about 9 %【page_145】. At the same time, its equity‑affiliate holdings in the same region grew from about 5.75 TCF in 2022 to 5.87 TCF in 2024 (all equity‑affiliate reserves are located in this region)【page_145】, indicating that while the company’s direct reserve base is modestly contracting, it is preserving and even expanding its strategic presence through affiliate and joint‑venture assets in the Asia‑Pacific/Middle‑East market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 326 BCF in 2022 to 296 BCF in 2024. However, the LLM reports 322 BCF (developed) + 4 BCF (undeveloped) = 326 BCF total in 2022, which matches the total but misrepresents the breakdown since the original answer does not specify developed vs. undeveloped. More critically, for 2024, the LLM reports 289 BCF developed + 7 BCF undeveloped = 296 BCF total, which matches the ground truth total but again introduces unsupported detail. The 30 BCF drop and 9% decrease are approximately correct (actual drop is 30 BCF, from 326 to 296), so the magnitude is right but the component numbers are not verifiable from the ground truth. (2) The LLM introduces new data about equity-affiliate holdings increasing from 5.75 TCF to 5.87 TCF, which is not present in the original answer and cannot be verified against the ground truth. This changes the interpretation significantly by suggesting a strategic shift toward joint ventures, which the original answer does not support. (3) The reasoning is partially sound in noting a decline in reserves, but the multi-hop synthesis goes beyond the provided truth by introducing unverified affiliate data and drawing a more nuanced strategic conclusion. The original answer suggests a potential strategic shift or divestment based solely on the decline in direct reserves; the LLM adds an unsupported counter-narrative of expansion via affiliates. (4) The contextual relevance is high because the answer addresses both the evolution of reserves and the strategic implication. However, the correctness score is reduced due to factual inaccuracies in the breakdown of reserves and the introduction of unverified data. Quantitative accuracy is moderate because while the total change is correct, the component figures differ and are presented with false precision. Qualitative accuracy is fair because the core idea of a decline is correct, but the added strategic interpretation is not grounded in the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 571,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet bought back 469 million Class C shares for about $52.6 billion in 2022, but only 450 million shares in 2023 even though the cash outlay rose to roughly $52.9 billion 【page_81】. The slight drop in share count combined with a higher dollar spend reflects a continued, aggressive buy‑back program that uses excess cash to return value to shareholders and support earnings per share, despite a higher share price in 2023【page_81】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023 across Class A and Class C shares. However, the LLM claims $52.6 billion in 2022 and $52.9 billion in 2023, which is incorrect. Additionally, the LLM focuses only on Class C shares and provides share counts (469 million in 2022, 450 million in 2023), which are not present in the ground truth and contradict the total dollar figures. The ground truth does not break down repurchases by share class in dollar terms, nor does it provide exact share counts, making the LLM's specific figures unsupported. (2) The quantitative accuracy is low: the dollar amounts are wrong, and the implied increase from $52.6B to $52.9B is minimal, whereas the actual increase was from $59.3B to $62.2B—a more significant year-over-year growth. The LLM also fails to mention the additional $70.0 billion authorization in April 2023 and the $36.3 billion remaining as of year-end, which are key indicators of capital allocation strategy. (3) The reasoning is partially sound in interpreting that increased buybacks reflect a capital return strategy, but it misses the multi-hop synthesis required: combining the increased total repurchase amount with the new authorization to infer an expanding strategy. The LLM incorrectly narrows the focus to Class C only, while the original answer includes both Class A and C. (4) Contextual relevance is moderate because the answer addresses share repurchases and capital allocation, but it lacks completeness and factual grounding. The mention of supporting EPS and using excess cash is reasonable interpretation, but without the correct figures and full context, the conclusion is weakened. Overall, major factual errors in numbers and incomplete synthesis lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 509,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "In the 2022 filing AIG said it applied frequency‑severity techniques only to short‑tail classes such as U.S. Property (and similar program‑property lines) because those lines have relatively stable claim counts and loss sizes, while it deliberately avoided the method for high‑severity, variable‑mix lines like aviation (​page_273​). By the 2023 filing the company had broadened the approach – it now uses frequency‑severity (the “Average Loss” method) for any reserve category where loss‑development patterns are inconsistent or too variable, and it explicitly combines frequency‑severity with loss‑development and expected‑loss‑ratio methods for workers’ compensation, a long‑tail line (​page_202​, page_200​). This shift reflects a move from a narrow, short‑tail‑only use to a broader, complementary role across both long‑tail and volatile‑development lines, leveraging the relative stability of claim counts to improve reserve estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, AIG applied frequency/severity methods to short-tail lines like U.S. Property and avoided them for aviation due to high severity and variable claim mix—this matches the original answer exactly. In 2023, it accurately states that AIG expanded use to U.S. Workers' Compensation, a long-tail line, combining frequency/severity with other methods. The reasoning about inconsistent loss-development patterns and the strategic shift is semantically equivalent to the ground truth’s emphasis on risk-sharing and large deductible business. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across years and lines of business, noting the expansion from short-tail to long-tail applications and the complementary use with other methods. The only minor gap is that the LLM attributes the 2023 shift more broadly to 'volatile-development lines' and 'inconsistent loss-development patterns,' whereas the original emphasizes 'risk-sharing features and large deductible business' as key drivers. This nuance is downplayed but not contradicted. (4) Contextual relevance is perfect—the response directly addresses the evolution in usage, lines of business, and reasoning. Overall, the answer is factually correct, well-reasoned, and only slightly less precise in motivational nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 440,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "In 2023 Amgen recovered **$109 million** in net costs from BeiGene, down from **$199 million** in 2022; product sales to BeiGene rose to **$125 million** from **$64 million** the year before; and profit‑and‑loss‑share expenses for the initial product‑specific commercialization period fell to **$40 million** versus **$53 million** in 2022 (with amounts owed for sales increasing to $16 million from $6 million)【page_131】. This reflects a shift toward higher sales volumes but lower cost recoveries and reduced profit‑sharing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: cost recovery decreased from $199 million in 2022 to $109 million in 2023; product sales increased from $64 million to $125 million; and profit and loss sharing expenses declined from $53 million to $40 million. These values match the original answer exactly, with acceptable formatting (e.g., $109 million). (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the directional changes (increases/decreases) are accurately described. The additional detail about sales-related amounts increasing to $16 million from $6 million is not in the ground truth but does not contradict it and may reflect a deeper document insight; it doesn't detract from correctness. (3) The multi-hop reasoning is sound: the model synthesizes data across two years and three financial dimensions (cost recovery, sales, P&L sharing) and correctly infers a shift in the collaboration’s nature toward higher sales and reduced R&D cost recovery. The conclusion about maturation of the relationship is logically supported. (4) The only reason for not scoring a perfect 10 is the slight addition of a $16M/$6M detail not present in the ground truth, which, while plausible, introduces unverified granularity. However, since it doesn’t conflict with the main answer and the core multi-hop synthesis is accurate and complete, the answer remains highly correct. Contextual relevance is full—every part of the question is addressed with precise, relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 427,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves fell from 326 billion cubic feet (BCF) at year‑end 2022 to 312 BCF at year‑end 2023 and to 296 BCF at year‑end 2024. In 2022 the region recorded a modest upward revision of +6 BCF, no purchases, and production that removed 24 BCF; in 2023 revisions rose to +9 BCF, still no purchases, and production cut 25 BCF. The 2024 filing reports only the ending 296 BCF total and does not disclose separate revision, purchase or production figures, indicating the decline continued without reported new revisions or acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting (326 BCF in 2022) and ending (296 BCF in 2024) reserve volumes, which match the ground truth. However, it introduces a figure of 312 BCF at year-end 2023 that is not present in the original answer, and there is no supporting data in the ground truth to confirm this intermediate value. Additionally, the LLM claims a +6 BCF revision in 2022 and 24 BCF production in 2022, but the original answer does not provide any such breakdown for 2022—only for 2023 and 2024. The +9 BCF revision in 2023 is correct, and 25 BCF production in 2024 is also correct. However, the LLM incorrectly states that 2024 does not disclose separate figures, while the original answer explicitly attributes the change to 25 BCF subtracted due to production and no purchases. (2) The quantitative inaccuracies include the unsupported 312 BCF (2023), the fabricated 2022 revision (+6 BCF) and production (24 BCF), and the misattribution of missing 2024 data. The only correct numbers are: 326 BCF (2022), 296 BCF (2024), +9 BCF revision (2023), and 25 BCF production (2024). (3) The reasoning shows an attempt at multi-hop synthesis across years and factors (revisions, production, purchases), but invents data points not present in the source, undermining the logical chain. The conclusion that there were no purchases in 2024 aligns with the original, but the lack of transparency in 2024 data is overstated. (4) The answer is contextually relevant and structured well, addressing all aspects of the question, but suffers from significant factual overreach in the absence of data for 2022 and 2023 production and revisions. The core trend (decline from 326 to 296 BCF) is correct, but intermediate steps are not substantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 480,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "In the 2022 Form 10‑K FedEx’s purchase‑commitment table showed it intended to add 14 Boeing B767F aircraft in 2023 and another 14 in 2024 (28 total) plus 10 more in 2025 – 38 B767F overall【page_40】. By the 2024 Form 10‑K the commitment schedule had been reduced to only 14 B767F remaining – 11 slated for delivery in 2025 and 3 in 2026【page_117】. This contraction of the B767F rollout signals that FedEx is scaling back near‑term reliance on that model, re‑balancing its fleet toward newer or more efficient aircraft and aligning capacity with revised demand forecasts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a reduction to 10 by 2025. However, the LLM incorrectly states that FedEx intended to add 14 aircraft in 2023 and another 14 in 2024 (28 total), plus 10 more in 2025 (38 total), which is a complete misrepresentation of the original data. The ground truth does not mention 'adding' 14 per year, but rather a projected usage level of 14 in both 2023 and 2024. The LLM interprets the data as purchase commitments rather than projected usage, conflating two different metrics. By 2024, the revised projection was 11 for 2025 and 3 for 2026, which the LLM correctly reports, but it misattributes this to 'deliveries' rather than 'planned usage'. (2) Quantitative accuracy is severely compromised: the LLM invents a total of 38 aircraft, which is not supported by the ground truth. The ground truth shows stable usage of 14 through 2024, not increasing to 38. The only correct numbers are the 2025 (11) and 2026 (3) figures in the updated projection. (3) Multi-hop reasoning is flawed: the model fails to correctly interpret the nature of the data (projected usage vs. purchase commitments) and misrepresents the timeline and magnitude of fleet changes. It incorrectly infers an expansion followed by a contraction, while the ground truth shows a consistent plan with an accelerated reduction later. (4) Despite the factual errors, the LLM correctly identifies the strategic implication of reduced reliance on B767F and fleet rebalancing, which gives it partial credit for qualitative reasoning and contextual relevance. However, the conclusion is based on incorrect premises, limiting its validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 480,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "In the 2022 filing AIG said it applied expected‑loss‑ratio techniques almost exclusively to its aviation portfolio – using them for the most recent accident year and in combination with loss‑development methods for earlier years because aviation claims are high‑severity, have limited loss history and develop inconsistently. By the 2023 filing the firm had broadened the tool’s use, employing expected‑loss‑ratio methods not only for aviation but also for workers‑compensation and for any business written in excess of a deductible, relying on them when loss‑development patterns are erratic, losses emerge very slowly or there is little historical data, and adjusting the ratios for rate changes, inflation and other market trends. This shows a shift from a narrow, line‑specific application to a more pervasive, multi‑line reserve‑setting approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, AIG used Expected Loss Ratio Methods primarily for aviation, especially the latest accident year, in combination with loss development methods due to high severity and inconsistent development—matching the original answer. In 2023, it accurately notes the expansion to U.S. Workers' Compensation and other lines like excess-of-deductible business, reflecting broader application. The reasoning—erratic loss patterns, slow emergence, limited data, and adjustments for inflation/rate changes—is consistent with the ground truth's emphasis on long-tail characteristics and structural complexity. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; dates (2022, 2023) are correct. (3) Multi-hop reasoning is sound: the model synthesizes changes over time, identifies correct lines of business (aviation → workers' comp), and infers the strategic shift in methodology use. The only minor gap is that the original specifies 'U.S. Workers' Compensation' while LLM says 'workers-compensation' without 'U.S.', though this is a small omission. Also, the LLM adds detail about 'excess of deductible' lines not explicitly mentioned in the ground truth, which is plausible but not confirmed—this doesn't contradict, but slightly extends the known facts. (4) Despite these nuances, the core evolution—narrow to broad use, shift toward long-tail/complex lines—is correctly captured. Hence, correctness is 9 (not 10 due to slight overgeneralization), qualitative accuracy 9, and full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 464,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "In the 2022 filing Cisco already warned that the enterprise data‑center was “undergoing a fundamental transformation” and that “companies with which we have strategic alliances … may be competitors in other areas,” listing a broad set of rivals such as AWS, Arista, Broadcom, Check Point, VMware, etc. 【page_11】  \n\nBy the 2024 filing Cisco has elevated alliances to a dedicated “Strategic Alliances” section that stresses joint technology exchange, product development and new‑market creation, while its competitive landscape now includes newer entrants such as Nvidia (and drops some earlier names), reflecting the growing AI‑driven, GPU‑centric data‑center market. 【page_8】  \n\nThus, Cisco’s positioning has moved from a general acknowledgment of alliance‑related competition to a more explicit, partnership‑focused strategy, even as the competitive set has broadened to incorporate emerging data‑center players.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Cisco's 2022 positioning: acknowledgment of fundamental transformation in the enterprise data center and the complex nature of strategic alliances where partners may also be competitors, citing relevant examples like AWS, VMware, etc. (2) For 2024, it accurately reflects the evolution: the creation of a dedicated 'Strategic Alliances' section emphasizing joint development and market creation, and the inclusion of Nvidia as a new competitive entrant, which matches the ground truth's emphasis on shifting dynamics due to AI and GPU-centric infrastructure. (3) The multi-hop reasoning is sound—synthesizing changes in both alliance strategy and competitive landscape across 2022 and 2024 filings. (4) Minor deduction in qualitative accuracy due to not explicitly mentioning that some alliance partners were acquiring or aligning with competitors (a nuance in the original), but the core idea of alliance complexity is conveyed. No numeric inaccuracies; dates and entities (Cisco, Nvidia, AWS, VMware, etc.) are correct. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 337,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The 3.125 % 2025 Notes were hedged with a $1 billion swap notional and an effective rate of SOFR + 2.1% in both years – the 2022 filing shows the same $1,000 million notional and SOFR + 2.1% rate, and the 2023 filing reports identical figures, indicating no change between 2022 and 2023【page_144】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the notional amount and effective interest rate were unchanged between 2022 and 2023. The ground truth states that in 2022, the $5.2 billion principal amount was subject to new interest rate swaps after termination of prior swaps, indicating a dynamic hedging strategy. By 2023, the notional amount under swap had decreased to $1.0 billion with an effective rate of SOFR + 2.1%. The LLM incorrectly claims both years had a $1 billion notional and SOFR + 2.1% rate, contradicting the original answer. (2) Quantitative inaccuracies include the misrepresentation of the 2022 notional amount: it was $5.2 billion (not $1 billion), and the effective rate for that year is not explicitly stated as SOFR + 2.1%—that rate only appears in 2023. The LLM falsely asserts identical figures across years, which is unsupported. (3) The multi-hop reasoning failed: the model did not correctly synthesize changes over time, conflating 2023 data with 2022, and missed the evolution in hedging strategy and exposure reduction. (4) Scores reflect major factual errors in numbers and trends, poor qualitative reasoning, and partial relevance since the answer addresses the right topic (hedging of 3.125% 2025 Notes) but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 365,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "In the 2022 filing Cisco presented AppDynamics as a “key element” of its full‑stack observability strategy—listed alongside Intersight and ThousandEyes but not as a separate product line【page_5】. By the 2024 filing Cisco had reorganized its portfolio into a dedicated “Observability” category, and the Observability Suite (which now incorporates AppDynamics) drove a 27 % revenue increase, signalling that AppDynamics has been elevated to a core pillar of Cisco’s observability offerings【page_41】【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AppDynamics was positioned as a key element of Cisco's full-stack observability strategy in 2022 alongside Intersight and ThousandEyes, and by 2024, it was formally integrated into a new 'Observability' category. The 27% revenue increase cited in the 2024 filing is factually accurate and supports the claim of increased strategic emphasis. (2) Quantitative accuracy is perfect: the 27% revenue growth is correctly reported, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across 2022 and 2024 filings to show an evolution from being a component to a core pillar within a dedicated category. The only minor gap is that the original answer emphasizes the *restructuring of revenue reporting* as evidence of formal integration, which the LLM mentions implicitly via the new category but could have stated more explicitly. (4) The answer is contextually relevant, directly addressing the evolution of AppDynamics' strategic positioning within Cisco’s observability offerings from 2022 to 2024. Wording differs slightly but maintains semantic equivalence. No factual errors—only a slight nuance in emphasis prevents a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 360,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The 4.663% 2051 Notes were hedged with a $1,500 million notional swap at an effective rate of SOFR + 4.3% in both years – the same rate and the same $1.5 billion notional were reported for December 31 2022 and again for December 31 2023, so neither the rate nor the notional amount changed.【page_144】",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the notional amount and effective interest rate were the same in both 2022 and 2023. The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio, with swaps terminated and replaced at current rates — it does not specify a $1.5 billion notional or SOFR + 4.3% rate for 2022. The LLM incorrectly asserts that the $1.5 billion notional and SOFR + 4.3% rate applied in both years, which contradicts the original answer. (2) Quantitatively, the $1.5 billion notional and SOFR + 4.3% rate are correct for 2023, but their attribution to 2022 is unsupported and false. The $5.2 billion figure from 2022 is entirely omitted, which is a major quantitative omission. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2022 data describes a broader hedging context ($5.2 billion in notes, swaps terminated and reset), while 2023 data reflects a more specific disclosure of a subset (the 2051 Notes at $1.5 billion). Instead, it assumes consistency across years without evidence. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and time frame, and cites a plausible document location, but the core factual claim about stability across years is incorrect, undermining the response. The answer misrepresents the evolution of the rate and notional, which is the central focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 405,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "In the 2022 filing AIG described expected‑loss‑ratio (ELR) techniques as a tool for its long‑tail and run‑off lines—especially workers’ compensation, excess casualty and financial‑lines—applying the ELR at the product‑line level and adjusting it for overall loss‑cost trends, rate changes and other quantifiable factors. By the 2023 filing the ELR approach is still used but is given “significant weight” for business written in excess of a deductible and is now combined with paid/ incurred development, Bornhuetter‑Ferguson, Cape‑Cod and average‑loss methods; the company also segments the ELR analysis much more granularly—by state, industry subset, deductible size, whether the claim is handled by AIG or a third‑party administrator, and by market‑condition adjustments—reflecting a shift toward finer, line‑specific segmentation and broader application of the method.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, resulting in partial correctness. (1) Correct elements include the increased granularity in 2023 segmentation (state, industry subset, deductible size, claim handling entity), which aligns with the ground truth. The mention of more sophisticated use of ELR methods in 2023 and integration with other actuarial methods (e.g., Bornhuetter-Ferguson) adds relevant context. (2) However, significant inaccuracies exist: the original answer states that in 2022, AIG only referenced ELR methods in a general sensitivity analysis without specifying lines of business, whereas the LLM claims AIG applied ELR to specific lines like workers’ compensation, excess casualty, and financial lines—this contradicts the ground truth. This misrepresents the evolution, implying a more advanced 2022 baseline than actually existed. (3) The multi-hop reasoning is flawed because the LLM fails to correctly contrast the general 2022 usage with the specific 2023 application; instead, it assumes detailed segmentation was already in place in 2022. The claim that ELR was applied at the 'product-line level' in 2022 is unsupported by the original answer. (4) Despite these factual errors, the answer is contextually relevant and captures the direction of evolution (increased granularity), but the incorrect attribution of detailed 2022 practices undermines the qualitative and quantitative accuracy. Hence, the correctness score is moderate due to major factual overstatement in the earlier period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 422,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo reported that its board had authorized the issuance of the 2.850 % senior notes due 2026 as part of its existing debt program 【page_129】. By the 2024 filing the same 2.850 % senior notes remained authorized 【page_130】, but the company also listed a slate of new senior notes—4.500 % due 2029, 4.800 % due 2034 and 5.250 % due 2054—showing that PepsiCo expanded its debt‑issuance strategy in 2024 to include additional maturities and coupon rates while still retaining the 2.850 % notes 【page_129】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained the 2.850% Senior Notes due 2026 in both 2023 and 2024, and that new senior notes were introduced in 2024, which aligns with the ground truth's emphasis on an expanded debt strategy. However, the specific new notes listed in the LLM answer—4.500% due 2029, 4.800% due 2034, and 5.250% due 2054—do not match the ground truth, which cites 7.00% due 2029 and 5.50% due 2035. These discrepancies in coupon rates and maturity dates are significant and factually incorrect. (2) Quantitative accuracy is compromised because all three new note specifications (interest rates and maturities) are wrong. While the 2.850% due 2026 is correctly referenced, the new instruments introduced in 2024 are misrepresented, suggesting a failure to accurately extract or synthesize the correct financial instruments from the source. (3) The multi-hop reasoning is partially sound: the model correctly infers that retaining existing notes while issuing new ones reflects a broadening debt strategy. However, because the new notes are inaccurately reported, the synthesis is based on incorrect data, undermining the conclusion’s validity. (4) Contextual relevance is high—the answer addresses the evolution of PepsiCo’s debt strategy and attempts to compare 2023 and 2024 disclosures. The reasoning structure mirrors the ground truth, but factual errors in key numeric details reduce overall correctness. Thus, the answer is partially correct but contains significant factual inaccuracies in the quantitative components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 431,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s balance of channel‑partner financing that is subject to its guarantees fell from $1.4 billion at the end of fiscal 2022 to $1.2 billion at the end of fiscal 2024 (a drop of roughly $200 million) 【page_94†L1-L3】, while the total volume of channel‑partner financing also slipped modestly from $27.9 billion in FY 2022 to $27.1 billion in FY 2024 【page_49†L31-L34】. This reduction in guaranteed exposure shows Cisco is deliberately limiting its contingent liabilities and tightening its guarantee commitments, reflecting a prudent financial‑risk‑management strategy that seeks to protect the company from potential non‑payment losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. According to the ground truth, Cisco did not disclose specific figures for channel partner financing volume or guaranteed balances in fiscal year 2024. However, the LLM asserts that the guaranteed balance dropped to $1.2 billion and total volume fell to $27.1 billion in FY2024—numbers not present in the original disclosures. These specific values and the claimed $200 million reduction are fabricated. (2) The ground truth states that in FY2022, the volume was $27.9 billion with $1.4 billion subject to guarantees, but for FY2024, no such figures were provided. The LLM incorrectly presents quantified data for 2024 and performs calculations (e.g., $200 million drop) based on false premises. This results in severe quantitative inaccuracy. (3) The multi-hop reasoning fails because the model assumes continuity of disclosure where none exists. Instead of recognizing the absence of data as a limitation, it invents precise figures and draws a confident conclusion about Cisco’s risk management strategy. The ground truth emphasizes uncertainty due to reduced transparency, while the LLM asserts a clear strategic tightening, which is unsupported. (4) Despite this, the answer is contextually relevant—it addresses the right topic, uses correct terminology, and attempts to analyze risk management implications. However, the complete lack of factual support for its key claims severely undermines correctness and qualitative reasoning, warranting low scores in those areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 426,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "In the 2022 Form 10‑K the $1.25 billion of 2.45 % 2030 Notes were still on the balance sheet with a fixed 2.45 % coupon; although a $1 billion interest‑rate swap was in place, the company disclosed that the effective rate on those notes was essentially the same as the coupon (no material difference)【page_130】【page_131】. By the 2023 filing the notes remain outstanding (still $1.25 billion) and the same $1 billion swap now results in a floating‑rate exposure of SOFR + 1.3 % for the 2.45 % 2030 Notes【page_144】, indicating a shift from a fixed‑rate to a floating‑rate structure while the principal amount and status of the notes have not changed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several key inaccuracies that significantly affect factual correctness. (1) Quantitative inaccuracy: The original answer states the notional amount of the 2.45% 2030 Notes is $1.0 billion, but the LLM claims $1.25 billion in both 2022 and 2023, which contradicts the ground truth. This error undermines the quantitative accuracy. (2) The LLM incorrectly states that in 2022 the effective rate was 'essentially the same as the coupon' with 'no material difference,' which misrepresents the ground truth: the interest rate swap had already converted the fixed rate to a floating LIBOR-based coupon, implying a structural change, not a negligible one. (3) The transition from LIBOR to SOFR is correctly identified in 2023, and the resulting SOFR + 1.3% rate is accurately reported, which aligns with the ground truth. (4) The LLM correctly identifies that the notes remained outstanding in 2023 and that the $1 billion swap continues to apply, showing proper multi-hop synthesis across years. (5) However, the incorrect principal amount and mischaracterization of the 2022 interest rate effect lead to a partially correct but materially flawed answer. While the direction of the evolution (fixed to floating, LIBOR to SOFR) is correctly captured, the specific financial details are not fully accurate, warranting a mid-range score. Semantic equivalence is partially achieved but undermined by key numeric and descriptive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 398,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed that the $970 million of Pass‑Through Certificates issued by FedEx Express were secured by 19 Boeing aircraft and that “the payment obligations of FedEx Express in respect of the Certificates are fully and unconditionally guaranteed by FedEx”【page_94】. By the 2023 filing the company stated that “the pass‑through certificates are not direct obligations of, or guaranteed by, FedEx or FedEx Express” and that payments are made through leveraged operating leases rather than a parent guarantee【page_98】. This reflects a shift from an unconditional parent guarantee in 2022 to no guarantee in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $970 million Pass-Through Certificates issued by FedEx Express in 2022, secured by 19 Boeing aircraft, and the full guarantee by FedEx are accurately reported. The 2023 clarification that these certificates are not direct obligations nor guaranteed by FedEx or FedEx Express is also correctly stated. (2) Quantitative accuracy is perfect: the dollar amount ($970 million), number of aircraft (19), and years (2022 and 2023) match the original answer exactly. Format variations (e.g., $970M vs $970 million) are acceptable and not an issue. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years of 10-K filings to show a shift in FedEx's financial position regarding guarantees. The conclusion about a shift from unconditional guarantee to no guarantee is logically supported. (4) The only minor shortcoming is that the LLM omits the detail about the $1.8 billion net book value of the aircraft, which was present in the original answer and adds contextual depth. However, this omission does not undermine the core correctness of the financial guarantee evolution. Overall, the answer is factually correct, well-reasoned, and directly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 363,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "In 2023 Mastercard offset $12.2 billion of its $75.0 billion gross settlement exposure with risk‑mitigation arrangements (cash collateral, letters of credit, guarantees), leaving a net exposure of $62.9 billion. By year‑end 2024 the gross exposure had risen to $78.4 billion and the company increased its mitigation arrangements to $13.5 billion, resulting in a net exposure of $64.9 billion. The higher‑than‑pro‑rata increase in mitigation assets shows Mastercard is actively scaling its safeguards to match growing settlement risk, reflecting a disciplined, proactive risk‑management strategy. (2023 data – Note 22, page 112; 2024 data – Note 22, page 105)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects, with only minor rounding differences that are acceptable under semantic equivalence. The original answer reports $12,167 million (i.e., $12.167 billion) mitigated in 2023, which the LLM rounds to $12.2 billion—this is within acceptable rounding tolerance. Similarly, $75,023 million gross exposure is correctly rounded to $75.0 billion, and $78,385 million to $78.4 billion. The 2024 mitigation amount is $13,466 million ($13.466 billion), which the LLM rounds to $13.5 billion—again, reasonable. (2) Calculations are accurate: net exposure in 2023 is correctly implied as ~$62.9 billion ($75.0B - $12.1B), and 2024 net exposure as ~$64.9 billion ($78.4B - $13.5B). The LLM correctly infers net exposure even though it wasn't explicitly required. (3) Multi-hop reasoning is sound: the model synthesizes data across two years, identifies the trend of increasing gross exposure and increasing mitigation, and draws a logical conclusion about Mastercard’s risk management strategy becoming more proactive. The mention of specific instruments (cash collateral, letters of credit, guarantees) adds contextual depth not in the original but is consistent with typical risk mitigation tools and does not introduce inaccuracy. (4) The conclusion—'higher-than-pro-rata increase in mitigation assets'—while slightly stronger than the original’s 'more robust,' is still supported by the data (mitigation increased by ~10.7% vs gross exposure increase of ~4.5%), so the interpretation is valid. The citation of Note 22 and page numbers adds credibility and matches typical 10-K disclosure locations. Only a 9 instead of 10 due to minor rounding at the edges (e.g., $13.466B → $13.5B could be $13.47B for more precision), but this does not affect overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 495,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike’s balance‑sheet liabilities for foreign‑exchange forwards and options that are designated as hedging instruments rose from **$48 million in FY 2022** (accrued $37 m + deferred‑tax $11 m) to **about $115 million in FY 2024** (accrued $110 m + deferred‑tax $5 m) 【page_83 (2022)】【page_83 (2024)】. This roughly $67 million increase signals that Nike has expanded its hedging program, likely because its foreign‑currency exposure has grown and the company is taking a more aggressive stance to mitigate currency‑related risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: $37M and $11M in 2022 under accrued liabilities and deferred income taxes respectively, summing to $48M; in 2024, $110M and $5M, totaling $115M. These figures match the original answer exactly. (2) Calculations are accurate: $37M + $11M = $48M (2022 total), $110M + $5M = $115M (2024 total), and the increase of $67M ($115M - $48M) is correctly implied. Format variations (e.g., 'about $115 million') are acceptable and do not misrepresent precision. (3) Multi-hop reasoning is sound: the model synthesizes data across two fiscal years (2022 and 2024), identifies the change in liabilities, and correctly infers a strategic implication—increased hedging activity likely due to growing foreign-currency exposure. This aligns with the original answer’s conclusion about increased risk exposure or strategic shift. (4) All entities (Nike, foreign exchange forwards/options, hedging instruments, fiscal years) are accurately identified and contextualized. The answer fully addresses both parts of the question: the quantitative change and its strategic implication. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 336,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10‑K, Bounty was listed among a longer set of brands for the Baby, Feminine & Family Care segment – the major‑brands column reads “Luvs, Pampers … Always, Always Discreet, Tampax Bounty, Charmin, Puffs”【PG_10k_2022 page_19】. By the 2023 10‑K the list had been trimmed, dropping Luvs and Pampers and showing only “Always, Always Discreet, Tampax Bounty, Charmin, Puffs”【PG_10k_2023 page_18】. The shorter list puts Bounty (as part of “Tampax Bounty”) in a more prominent position, indicating that P&G is emphasizing Bounty’s visibility within the Baby, Feminine & Family Care segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly states that Bounty was explicitly listed among the key brands in the 2022 10-K, claiming it appeared in a list including 'Luvs, Pampers... Always, Always Discreet, Tampax Bounty, Charmin, Puffs' — this is false. According to the ground truth, Bounty was not highlighted as a key brand in 2022 and was only mentioned as part of the Family Care business without explicit prominence. The claim that 'Tampax Bounty' is a combined entry is also incorrect; 'Tampax' and 'Bounty' are separate brands and were never listed as a single entity in either filing. Additionally, the assertion that Luvs and Pampers were dropped from the 2023 list is misleading — while P&G may have streamlined brand disclosures, Pampers and Luvs remain core baby care brands and were not presented as part of the same list structure in either year. The reasoning that a 'shorter list' increases Bounty's prominence is speculative and based on incorrect premises. The ground truth emphasizes that Bounty went from not being named among key brands in 2022 to being explicitly named in 2023 — a factual evolution the LLM misrepresents. While the answer addresses the question's focus on brand visibility and attempts multi-hop comparison across years, the foundational facts are wrong, leading to an incorrect conclusion. Thus, despite some contextual relevance and structural attempt at reasoning, the answer fails on quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 420,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "In FY 2022 Oracle described its hardware segment – which includes Oracle Engineered Systems – as selling infrastructure products whose revenue is recognized when the hardware (and any bundled software) is delivered, while hardware‑support fees are recognized ratably over the contract term; the segment generated $3.2 billion of the $42.4 billion total revenue (about 7‑8 %). By FY 2023 the filing explicitly treats each hardware product and its associated software as a single performance‑obligation, still recognizing product revenue at the point of delivery and support revenue over time, but the hardware business now represents only roughly 6 % of total revenue, signaling a modest de‑emphasis even as Oracle commits to continued R&D investment in its Engineered Systems portfolio【page_105】【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Oracle's hardware business, including Oracle Engineered Systems, and describes the evolution in revenue recognition between fiscal 2022 and 2023. The key point about treating hardware and associated software as a combined performance obligation in FY2023 is accurately captured, with revenue recognized at the point of delivery—consistent with the original answer. The continued recognition of support revenue over time (ratably) is an added detail not in the ground truth but is factually correct and enhances accuracy. (2) Quantitatively, the LLM provides specific figures: $3.2 billion hardware revenue out of $42.4 billion total in FY2022 (~7.5%), and ~6% in FY2023. These numbers are plausible and consistent with Oracle’s reported trends. While the original answer does not include these exact percentages or dollar amounts, the LLM’s inclusion of them does not contradict the ground truth and appears to be drawn from actual filings (as noted with page references). There is no calculation error. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting treatment (revenue recognition) and strategic emphasis (continued R&D investment) across two fiscal years, correctly inferring a modest de-emphasis in relative revenue contribution despite ongoing innovation focus. (4) The mention of R&D investment in Engineered Systems in FY2023 is correctly highlighted as a new strategic emphasis not explicitly stated in FY2022, matching the original answer’s claim. The only reason for not scoring a 10 is that the original answer does not specify the $3.2B or 6% figures, so while they may be accurate, their absence in the ground truth introduces a minor risk of overprecision. However, since the LLM cites page references and the data are contextually appropriate, this is a minor concern. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth with strong reasoning and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 554,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA’s sales rose from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% increase (operational growth 27.5%, partially offset by a modest currency headwind)【page_31】. The company attributes the rise to continued share‑gain and market growth in metastatic castration‑resistant prostate cancer, indicating a strong, upward trajectory for the product【page_32】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the sales figures are accurate: $1.881 billion in 2022 and $2.387 billion in 2023, with a 26.9% growth rate, which aligns exactly with the ground truth calculation ((2,387 - 1,881) / 1,881 ≈ 26.9%). The LLM provides additional context (27.5% operational growth, currency headwind) that is consistent and plausible, without contradicting the core figure. (2) The answer addresses both parts of the question: the sales evolution (increase from 2022 to 2023) and the market trajectory (strong upward trend due to market growth and share gain). (3) Entities are correct: ERLEADA, the years 2022 and 2023, and the financial metric (sales in USD billions) are all accurately identified. (4) The reasoning is sound and reflects multi-hop synthesis—linking sales growth to underlying market dynamics in metastatic castration-resistant prostate cancer, which supports the conclusion of a positive market trajectory. (5) Despite slightly more detailed phrasing, the semantic meaning is equivalent to the ground truth. All criteria are met with high precision, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 330,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "In the 2023 filing Comcast described its relationship with independently‑owned local broadcast stations mainly as a competitive race to secure affiliations that are “necessary to ensure the effective distribution of broadcast‑network programming to a nationwide audience.” By the 2024 filing the tone shifts to a deeper dependency: the company stresses that it must negotiate retransmission‑consent (or must‑carry) terms, faces growing demands for payments, and sees programming‑cost pressure rise as media consolidation intensifies—making local stations a more critical and contested conduit for its content distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution in CMCSA's relationship with local broadcast television stations as the ground truth. It correctly identifies the shift from competition in 2023 to dependency in 2024, particularly around retransmission consent and content distribution. The use of terms like 'retransmission-consent (or must-carry)' and 'programming-cost pressure' aligns with the operational dynamics described in the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities—CMCSA, local broadcast stations, 2023–2024 timeframe—are correctly identified. The reasoning is sound and reflects multi-hop synthesis between filings across years. The only minor shortcoming is that the LLM slightly reframes the 2023 dynamic as a 'race to secure affiliations' rather than direct competition for viewers and ad revenue, which slightly nuances the original characterization. However, this does not contradict but rather complements the ground truth, and the overall semantic meaning and strategic shift are preserved. Contextual relevance is excellent, directly addressing competitive positioning and dependency in content distribution as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 342,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The company’s held‑to‑maturity securities fell sharply from **$306 million in 2023 to $38 million in 2024** – a drop of $268 million (about an 88% decline)【page_83】. This large reduction signals that Mastercard is moving away from short‑term time‑deposit (HTM) holdings and reallocating capital toward other, more flexible or potentially higher‑yielding investments (such as available‑for‑sale securities), reflecting a strategic shift in its investment approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the HTM securities values of $306 million in 2023 and $38 million in 2024, matching the ground truth exactly. The calculated drop of $268 million and the 88% decline are accurate (306 - 38 = 268; 268 / 306 ≈ 87.6%, which rounds to 88%). (2) All numeric values, dates, and calculations are factually correct, satisfying quantitative accuracy. (3) The reasoning correctly infers a strategic shift in investment approach due to the sharp reduction in HTM securities. However, there is a minor error in characterization: the LLM refers to HTM securities as 'short-term time-deposit (HTM) holdings', which is misleading—HTM securities are typically long-term, not short-term. This slightly undermines the qualitative accuracy, though the overall conclusion about capital reallocation (e.g., toward available-for-sale securities) aligns with the ground truth's implication of a move toward more liquid positions. (4) The answer fully addresses both parts of the question—quantitative evolution and strategic implication—and maintains semantic equivalence with the original answer despite minor wording differences. Contextual relevance is perfect as it directly responds to the multi-hop query with appropriate synthesis across years and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 365,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "In the 2022 filing the Always brand was placed in the Baby, Feminine & Family Care segment under the **Feminine‑Care** product category, which was broken out into the sub‑categories **Adult Incontinence** and **Menstrual Care**【page_18】. By the 2023 filing the brand is still in the same segment and product category, but the sub‑categories are now listed as **Adult Incontinence** and **Feminine Care** (a broader label that replaces “Menstrual Care”)【page_19】. This shift reflects a re‑classification of the menstrual‑care line into a more generic feminine‑care grouping while keeping Always within the same overall segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of sub-categories, reversing the actual change. According to the ground truth, in 2022, Feminine Care included Adult Incontinence and Menstrual Care (with Always under Feminine Care), and by 2023, the sub-category was refined to 'Menstrual Care' under an updated Feminine Care structure, indicating a more targeted positioning. However, the LLM claims that 'Menstrual Care' was replaced by the broader 'Feminine Care' in 2023, which is the opposite of the truth. This misrepresents the strategic shift: the actual change was toward greater specificity (toward Menstrual Care), not generalization. While the segment (Baby, Feminine & Family Care) and product category (Feminine Care) are correctly identified for both years, and the dates/entities are accurate, the reasoning and synthesis are flawed. There are no numerical values to assess, so quantitative accuracy is not applicable but scored as 10 by default. The answer is contextually relevant and addresses the question's structure, but the key qualitative inaccuracy—reversing the direction of re-categorization—makes the conclusion invalid. Thus, the correctness and qualitative accuracy scores are low despite correct entity and segment identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 358,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle’s Engineered Systems are still treated as part of its hardware segment, with revenue recognized at the point the hardware and any bundled software are delivered and ownership transfers to the customer (2022 Revenue‑Recognition discussion – p. 74; 2023 Hardware Business description – p. 43). In 2022 the filing focused on restructuring to accelerate cloud and second‑generation infrastructure and did not quantify the hardware’s share, whereas the 2023 filing states that hardware—including Engineered Systems—accounts for about 6 % of total revenue and highlights continued R&D investment to improve and expand these products, signalling a modest but strategically maintained contribution (2023 Hardware Business – p. 43; 2022 Restructuring emphasis – p. 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 6% of total revenue for hardware (including Engineered Systems) in 2023 is accurately reported, consistent with the original answer. The absence of a specific percentage in 2022 is also correctly noted. (2) The revenue recognition policy—point-in-time upon delivery of hardware and related software—is correctly cited for both years, with appropriate context from the filings. (3) The qualitative evolution is well captured: the shift from no specific disclosure in 2022 to a clear 6% contribution in 2023 is highlighted, along with Oracle’s continued R&D investment and strategic emphasis on improving hardware. The mention of restructuring in 2022 as a focus area instead of hardware quantification is accurate and contextually relevant. (4) The LLM synthesizes information across multiple sections and years (multi-hop reasoning), correctly identifying changes in disclosure practices and strategic emphasis. The only minor shortcoming is that the original answer notes Oracle projected the 6% figure for both fiscal 2023 and 2024, which the LLM omits—this slight incompleteness prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 381,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "In 2023 Comcast said it “represents the advertising‑sales efforts of certain third parties,” indicating a more informal role. By 2024 the filing notes that it now “enters into representation agreements under which we sell advertising on behalf of third parties,” formalizing the relationship. In both years the firms are used as an extension of Comcast’s sales force to sell a portion of its allocated ad inventory, with revenue recorded net of agency commissions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution in Comcast's relationship with representation firms between 2023 and 2024. It correctly identifies that in 2023 the relationship was more informal, with Comcast representing third parties' ad sales efforts, while in 2024 it shifted to formal representation agreements where Comcast sells advertising on behalf of third parties. The answer accurately notes that in both years, these firms act as an extension of Comcast’s sales force and that revenue is recorded net of agency commissions—consistent with the ground truth. The only minor shortcoming is that the LLM does not explicitly characterize the strategic shift as a move from a 'co-selling model' to a 'formalized representation structure,' which is a nuance present in the original answer that underscores the strategic deepening. However, the core facts, entities, years, and revenue treatment are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes the evolution across the two years. The answer is fully contextually relevant and captures the key transformation in strategy. Thus, the correctness score is 9 due to a small omission in strategic framing, but all critical components are present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 363,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle continues to account for its industry‑specific hardware and the related software as a single performance‑obligation, recognizing product revenue when the hardware and software are delivered to the customer and recognizing hardware‑support revenue ratably over the contract term (2022 p. 105; 2023 p. 43). However, the 2023 filing adds a stronger strategic focus—stating that hardware now accounts for roughly 6 % of total revenue and that Oracle will keep investing in R&D to improve existing hardware and launch new industry‑specific offerings—whereas the 2022 filing simply described the hardware line without emphasizing growth or investment (2022 p. 105; 2023 p. 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Oracle treats hardware and related software as a single performance obligation, with revenue recognized at delivery (point in time), and hardware support revenue recognized ratably—this is consistent across both 2022 and 2023 filings. The 2023 filing indeed introduces a more strategic emphasis on R&D investment and innovation in hardware, whereas 2022 offers a more general description. (2) Quantitatively, the claim that hardware accounts for roughly 6% of total revenue in 2023 is accurate and supported by the filings (e.g., Oracle’s 2023 10-K notes hardware revenue was ~$3.2B of ~$51.7B total revenue, which is ~6.2%). No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes revenue recognition practices across two fiscal years and identifies a shift in strategic emphasis, drawing from specific pages (2022 p.105; 2023 p.43) to support the comparison. (4) The only minor shortcoming is that the original answer highlights the 2023 clarification on 'combined performance obligations' and 'ownership transfer'—a nuance slightly underemphasized in the LLM answer, though the core idea is captured. Wording differs slightly but meaning is semantically equivalent. No irrelevant or incorrect information is present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 378,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a drop of about 13.7% (operational decline of 13.2% plus a 0.5% adverse currency effect)【page_31】. The decline was driven by competitive pressure from newer oral agents and COVID‑19‑related market dynamics that slowed new patient starts, together with a modest negative currency impact【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, representing a 13.7% decline. This matches the ground truth exactly in both absolute values and percentage change. The LLM adds additional detail not in the original answer—breaking down the 13.7% decline into a 13.2% operational decline and 0.5% adverse currency effect—which is consistent with the data source (page_31) and does not contradict the ground truth. (2) All numbers are accurate: $3.784B → $3.264B is indeed a 13.7% drop [(3.784 - 3.264)/3.784 ≈ 0.137]. The breakdown into operational and currency components is extra precision that enhances rather than detracts. (3) The reasoning is sound and multi-hop: the model correctly identifies the sales trend over two years and synthesizes contributing factors—competitive pressures from newer oral agents, pandemic-related delays in patient starts, and currency impact—across time points. The original answer mentions sustained competitive pressures and market dynamics; the LLM aligns with this and adds nuance with the currency effect, which is contextually appropriate. (4) The only reason for not scoring a 10 is that the original answer emphasizes 'continued' decline and mentions possible market saturation or treatment shifts in oncology, which the LLM omits. However, the core facts, calculations, and causal factors are correctly identified and well-supported. Thus, the answer is quantitatively perfect, contextually highly relevant, and qualitatively very strong with only minor omission of forward-looking interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 448,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "In 2023 Universal Beijing Resort carried about **$3.5 billion of debt** (including a **$3.1 billion term loan**) and was reflected on Comcast’s balance sheet with **$7.8 billion of assets and $7.2 billion of liabilities**; Comcast owned **30 % of the venture** and, because there are **no liquidity arrangements, guarantees or other commitments**, its maximum loss was limited to that 30 % equity stake【page_86】. By 31 Dec 2024 the debt had slipped to **$3.4 billion (a $3.0 billion term loan)** and the consolidated assets/liabilities fell to **$7.3 billion and $7.0 billion**, while the **30 % ownership** and the **absence of guarantees** remained unchanged, thereby slightly reducing Comcast’s financial‑risk exposure to the project【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 2023 debt of $3.5 billion (including $3.1 billion term loan), 2024 debt reduction to $3.4 billion ($3.0 billion term loan), Comcast's 30% ownership, consolidation as a VIE, and no guarantees or liquidity support. The financial risk exposure is correctly described as limited to the 30% equity stake. (2) Quantitative accuracy is perfect—numbers match exactly, including the slight reduction in debt and term loan principal. The additional balance sheet figures ($7.8B/$7.2B in 2023 and $7.3B/$7.0B in 2024) are not in the original answer but are consistent with the source document and do not contradict the ground truth; they add context without introducing error. (3) Multi-hop reasoning is sound: the model correctly synthesizes debt levels, ownership, consolidation treatment, and risk exposure across years. (4) The only minor deviation is the phrasing 'slightly reducing Comcast’s financial-risk exposure'—while technically true due to lower underlying debt, the original answer emphasizes that the *maximum* risk remains capped at the 30% equity interest, implying no structural change in risk exposure. This nuance is slightly understated but not incorrect. Overall, the answer is factually precise, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 376,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "In the 2022 filing FedEx disclosed “additional leases…generally for build‑to‑suit facilities” with undiscounted future payments of **≈ $3.4 billion**, slated to begin in 2023‑24. The 2023 filing shows the same type of leases (now also covering equipment) with undiscounted future payments of **≈ $0.9 billion**, with start dates pushed to 2025‑27【page_96】【page_98】. The roughly $2.5 billion drop and later commencement dates indicate FedEx is scaling back its build‑to‑suit lease commitments, adopting a more restrained and selective leasing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures: $3.4 billion in 2022 and $0.9 billion in 2023 for future undiscounted lease payments related to build-to-suit facilities and equipment. These values match the ground truth exactly. The drop of approximately $2.5 billion is accurately implied (3.4 - 0.9 = 2.5), though not explicitly labeled as a calculation. Commencement periods are correctly stated as 2023–2024 for 2022 and 2025–2027 for 2023. (2) All numbers, dates, and formats are accurate. The use of '≈' is appropriate given the original 'approximately' qualifier. The inclusion of equipment in the 2023 figure is correctly noted and aligns with the broader scope in the 2023 disclosure. (3) The multi-hop reasoning is sound: the model synthesizes data from two different years, compares the commitments, notes the extension in commencement dates, and infers a strategic shift—consistent with the ground truth. The conclusion about a more restrained and selective leasing strategy is a valid interpretation of the reduced commitments and delayed timelines. (4) The answer is contextually complete and relevant, addressing both the evolution of financial commitments and the implied strategic direction. The only minor shortcoming is that the original answer explicitly states this reflects a 'strategic shift toward fewer long-term build-to-suit lease commitments,' while the LLM uses slightly different phrasing ('scaling back', 'restrained and selective'), which is semantically equivalent but slightly less precise in terminology. However, this does not detract from factual correctness. Overall, the answer is highly accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 460,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard’s 2023 Form 10‑K reports that the only recent acquisition was the 2022 purchase of Dynamic Yield, and that the company completed the purchase‑accounting for that deal in 2023 (Note 2, 2023 10‑K, p. 82). The 2024 Form 10‑K still references the 2022 Dynamic Yield acquisition but shows no new activity with it; the related intangible assets (developed technologies, customer relationships and other intangibles) are now rolled into a larger portfolio of intangible assets that support its value‑added services (Note 2, 2024 10‑K, p. 79; intangible‑asset table, p. 80). This indicates that Mastercard is moving from the acquisition phase to integrating Dynamic Yield’s AI‑driven personalization capabilities into its broader data‑centric, value‑added services strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard acquired Dynamic Yield in 2022 and completed purchase accounting in 2023, with no new activity in 2024. However, it omits the specific $325 million acquisition price and the $200 million attributed to goodwill, which are key quantitative details from the ground truth. These omissions reduce quantitative accuracy slightly. (2) The dates (2022 acquisition, 2023 accounting completion, no 2024 activity) are accurate and align with the original answer. The integration into value-added services is consistent with the ground truth’s emphasis on post-acquisition stability. (3) The multi-hop reasoning is sound: the model correctly infers from the lack of new disclosures and the absorption of Dynamic Yield’s assets into broader intangibles that integration is complete. However, it misses the strategic pivot signaled by the 2024 acquisition of Recorded Future, which the ground truth explicitly ties to a shift toward cybersecurity. This limits qualitative accuracy, as the full strategic context is not captured. (4) Despite missing some financial specifics and the contrast with newer acquisitions, the LLM answer remains factually correct in its claims and highly relevant to the question about the evolution of the relationship and strategic focus. The core reasoning about integration and strategic use of AI personalization is valid and well-supported by the cited disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 401,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Severance Plan for Senior Officers is listed as Exhibit 10.29, “as amended and restated May 29 2020,” and was filed on August 26 2020 (see page 90). In the 2024 Form 10‑K the plan appears as Exhibit 10.28, “as amended and restated May 26 2022,” and the filing date is November 27 2024 (see page 79). Thus, the plan was updated from a 2020 amendment to a 2022 amendment, with the associated filing moving from 2020 to late 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 Form 10-K references the Severance Plan as 'amended and restated May 29, 2020' (Exhibit 10.29, filed August 26, 2020), and the 2024 Form 10-K references the plan as 'amended and restated May 26, 2022' (Exhibit 10.28, filed November 27, 2024). These dates, exhibit numbers, and filing details match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations required, but all dates and exhibit numbers are correct. (3) The reasoning is sound: the LLM correctly infers that the plan was updated from the 2020 version to a 2022 amendment, with the updated filing disclosed in late 2024. This demonstrates proper multi-hop synthesis across two filings. (4) The only minor shortcoming is that the LLM does not explicitly state that the *most recent amendment* occurred in 2022 and was *disclosed* in 2024, which the original answer clarifies. However, this is implied in the response. Wording differs slightly but maintains semantic equivalence. The answer is fully contextually relevant and addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 327,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The 6.375 % senior notes were valued at **$999 million** on December 31 2021 (Level 2 fair value) and fell to **$872 million** on December 31 2023【page_56 (2022 10‑K)】【page_56 (2023 10‑K)】. That $127 million (≈13 %) drop means the notes traded at an increasingly larger discount to their $800 million par amount, suggesting investors required higher yields and were viewing Netflix’s debt as comparatively riskier over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the fair value of Netflix's 6.375% Senior Notes as $999 million on December 31, 2021, and $872 million on December 31, 2023, matching the ground truth exactly. The $127 million decrease and approximate 13% drop are accurate calculations (127/999 ≈ 12.7%, rounded to 13%), so quantitative accuracy is perfect. (2) The answer correctly identifies the par amount as $800 million, which is consistent with Netflix's filings, and notes that the notes traded at a growing discount to par over time—this adds useful context not explicitly in the ground truth but factually correct and enhances the explanation. (3) The reasoning is sound: the decline in fair value despite being above par in both years indicates rising yield requirements and perceived credit risk, which aligns with the ground truth's interpretation of declining market confidence. The multi-hop synthesis across the 2022 and 2023 10-Ks (referenced via page citations) is appropriate and correctly executed. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes the general decline in market confidence, while the LLM adds the specific claim about trading at a 'larger discount to par'—while true, the par value context was not in the ground truth and slightly extends beyond it, though not inaccurately. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 398,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a 13.7 % decline (2023 vs 2022)【page_31】. The 2023 filing notes that this drop was “partially offset…by IMBRUVICA (ibrutinib) due to global competitive pressures”【page_32】, indicating that while the overall oncology segment grew, IMBRUVICA is losing market share and its position is weakening relative to competitors.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the 2022 sales figure for IMBRUVICA. The ground truth reports $4,369 million (or $4.369 billion), but the LLM states $3.784 billion, which is incorrect. The 2023 sales figure of $3.264 billion is correct. Due to the wrong base value, the calculated decline of 13.7% is inaccurate; the correct year-over-year decline is 25.2% ((4,369 - 3,264) / 4,369 ≈ 0.252). (2) The quantitative inaccuracies are critical because they misrepresent the magnitude of the sales decline, which directly affects interpretation of market performance. While $3.264 billion in 2023 is correctly cited, the erroneous 2022 figure undermines the calculation and overall financial assessment. (3) The qualitative reasoning is partially sound: the LLM correctly infers from the document that competitive pressures are affecting IMBRUVICA and that its position is weakening, which aligns with the ground truth. It also correctly contextualizes the decline within a growing oncology segment, indicating awareness of multi-hop context (product performance vs. segment trends). However, it fails to mention the comparative growth of specific competitors like DARZALEX and ERLEADA, which strengthens the ground truth's conclusion about relative market share loss. (4) The contextual relevance is high because the answer addresses both parts of the question—sales evolution and market position—and attempts to support claims with document citations. Despite incorrect numbers, the directionality (decline, competitive pressure, weakening position) is correct. However, the significant quantitative error reduces the correctness score to 5, as the core financial facts are not fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 468,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "- In FY 2022 Lowe’s inventory‑shrink reserve was **$414 million** and its LCNRV (obsolete‑inventory) reserve was **$168 million**【page_33】.  \n- By FY 2024 the shrink reserve had risen to **$427 million** and the LCNRV reserve to **$222 million**【page_34】.  \n\nThe company notes that these reserves are material to earnings – a 10 % change in the LCNRV reserve would move net earnings by about **$17 million**, and a 10 % change in the shrink reserve would move net earnings by about **$32 million** in fiscal 2024【page_34】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the shrink reserve increased from $414 million in 2022 to $427 million in 2024, and the LCNRV reserve increased from $168 million to $222 million, as confirmed in the original answer. The sensitivity impacts on net earnings—a $17 million change for a 10% LCNRV reserve change and a $32 million change for a 10% shrink reserve change in 2024—are correctly reported. (2) The answer is complete, addressing both the evolution of the two reserves over time and their implications for net earnings, satisfying both parts of the multi-part question. (3) Entity accuracy is correct: LOW (Lowe’s) is properly identified, fiscal years 2022 and 2024 are correctly referenced, and the financial terms (inventory shrink reserve, LCNRV reserve) are used appropriately. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly pulled data from different years and pages of the filing, connected the reserve changes to their earnings implications, and highlighted the materiality of these reserves to net earnings. (5) The semantic meaning is equivalent to the ground truth, with only minor rewording (e.g., 'obsolete-inventory reserve' as a parenthetical for LCNRV, which is contextually acceptable). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 383,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "In the 2022 filing AbbVie noted that Qulipta had just moved out of the “indefinite‑lived R&D” bucket and was re‑classified as a developed product right after receiving regulatory approval (together with Vuity and HArmonyCa) 【page_100】. By 2023 the drug was fully on the market, generating roughly $405 million of U.S. net revenue and about $408 million internationally (≈ $813 million total), showing a rapid shift from recent approval to substantial commercial sales 【page_42】.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qulipta's reclassification from indefinite-lived R&D to developed product rights in 2022 upon regulatory approval, and its commercialization in 2023, which aligns with the ground truth. However, there is a critical error in the financial figures: the LLM states that Qulipta generated $405 million in U.S. revenue and $408 million internationally, totaling $813 million. The ground truth specifies $405 million in the U.S. and only $3 million internationally, for a total of $408 million. The LLM incorrectly reports $408 million as international revenue instead of the total, suggesting a misreading or miscalculation. (2) Quantitative accuracy is severely compromised: the international revenue is off by over 100x ($408M vs $3M), and the total revenue is incorrectly calculated as $813M instead of $408M. While $405M U.S. revenue is correct, the international figure is completely wrong. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes information about the 2022 reclassification and 2023 commercial performance, showing understanding of the transition from development to commercialization. (4) Contextual relevance is high as the answer addresses both the status evolution and financial contribution. Due to the major numerical error affecting core financial interpretation, the correctness score is moderate at 5—partially correct but with significant factual inaccuracy in key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 407,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell’s receivable from Resideo for 90 % of its environmental costs rose from $157 million at year‑end 2022 to $187 million at year‑end 2023, with the short‑term $140 million reimbursement (the contractual cap) unchanged in both years and the long‑term portion of the receivable increasing from $474 million to $521 million (page 98). The modest increase shows Honeywell is relying slightly more on Resideo to fund its environmental liabilities, but because reimbursements are capped at $140 million annually, the company’s overall exposure to environmental‑related risk remains limited and predictable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the *obligation* of Resideo to pay 90% of Honeywell's environmental costs is capped at $140 million per year, but the LLM interprets this as an actual receivable that increased from $157M to $187M, which is not supported by the original answer. The original answer does not mention any receivables, short-term or long-term, nor does it report a rise in amounts owed or a split between short- and long-term portions. These figures ($157M, $187M, $474M, $521M) are entirely absent from the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is low because the LLM introduces specific dollar amounts and a breakdown (short-term vs. long-term receivables) that are not present in the original answer. While the $140 million cap is correctly noted, it is misrepresented as a 'reimbursement' that was 'unchanged in both years'—though the cap is accurate, the implication that it was fully utilized or that receivables are increasing contradicts the original statement of a consistent, capped obligation. (3) The multi-hop reasoning is flawed. The original answer emphasizes consistency in the indemnification arrangement between 2022 and 2023, indicating no change in risk exposure strategy. The LLM, however, infers a 'slight increase in reliance' based on non-existent receivable balances, leading to an incorrect conclusion about evolving dependency. The reasoning fails to align with the ground truth that the risk mitigation strategy 'has not changed.' (4) Contextual relevance is high because the LLM addresses the right topic—Honeywell's dependency on Resideo for environmental liabilities—and attempts to analyze risk exposure over time. However, due to major factual and quantitative errors, the overall correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 512,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target’s definition of cash equivalents has not changed – both the 2022 and 2024 10‑Ks state that cash equivalents are “highly liquid investments with an original maturity of three months or less from the time of purchase” (2022 Note 9, p. 48; 2024 Note 7, p. 52). What has shifted is the amount classified as short‑term investments: it fell from about $4.99 billion in 2022 (p. 48) to roughly $3.9 billion in 2024 (p. 52), indicating Target is holding fewer short‑term marketable securities and may be moving toward a more conservative or re‑allocated cash‑management approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Target's definition of 'original maturity' for cash equivalents remained unchanged between 2022 and 2024, with both years using the 'three months or less' threshold. This aligns with the ground truth and demonstrates accurate entity and term identification. However, the LLM introduces quantitative data about short-term investments declining from $4.99 billion to $3.9 billion, which is not present in the original answer and cannot be verified against the provided ground truth. While these figures may be accurate in context, their inclusion shifts focus to a claim about cash management strategy based on investment balances rather than the evolution in disclosure or treatment of cash equivalents. The ground truth emphasizes a qualitative shift in disclosure—specifically, a broader discussion of fair value measurements in 2024—not a change in investment amounts. Therefore, the reasoning is partially flawed: it substitutes balance changes for definitional or discursive evolution, missing the key point about enhanced financial instrument reporting. The conclusion about a 'more conservative or re-allocated cash-management approach' is speculative and not supported by the ground truth, which suggests a refinement in financial reporting framework, not necessarily strategy. Quantitative accuracy is moderate: numbers may be correctly extracted from filings but are not part of the ground truth evaluation, making their relevance questionable. Qualitative accuracy suffers due to incorrect reasoning trajectory. Contextual relevance is high as the answer addresses the right topic and timeframe, but misidentifies the nature of the evolution. Overall, the answer is factually mixed—correct on the definition, incorrect on the interpretive synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 486,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "In the 2023 Form 10‑K the 3.50 % Notes Due 2040 were reported as Level 2 liabilities with a fair‑value of about $870 million; the 2024 filing kept the same Level 2 classification but the fair‑value slipped modestly to $851 million (see the fair‑value hierarchy table)【page_67】. The notes’ net carrying amount remained $1 billion and they were still shown entirely as long‑term debt (no short‑term portion)【page_72】, indicating that NVIDIA continues to rely on these fixed‑rate senior unsecured notes as a stable source of long‑term financing, tolerating only minor fair‑value fluctuations driven by market rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. According to the ground truth, the valuation of NVDA's 3.50% Notes Due 2040 increased from $851 million in 2023 (as of January 28, 2024) to $1,000 million in 2024 (as of January 26, 2025). However, the LLM incorrectly states that the fair value was $870 million in 2023 and then 'slipped modestly to $851 million' in 2024, which reverses the actual trend and misreports the amounts. The correct direction is an increase, not a decrease. Additionally, the LLM mentions a 'net carrying amount remained $1 billion' in 2023, which contradicts the ground truth carrying value of $851 million. (2) The effective interest rate of 3.54% and remaining term of 15.2 years in 2024, which are key details in the original answer, are omitted entirely. The LLM also incorrectly frames the $851 million as a 2024 value when it is actually reported as of early 2024 (fiscal 2023), while the 2024 filing reports $1,000 million as of early 2025. (3) The reasoning about long-term debt strategy is partially sound—highlighting stable financing and classification as long-term debt is relevant—but it is based on incorrect data trends. The conclusion about 'minor fair-value fluctuations' is plausible but unsupported due to the misrepresentation of valuation movement. (4) The contextual relevance is high because the answer addresses valuation, classification, and strategic implications. However, the quantitative inaccuracies severely undermine correctness, and the qualitative reasoning is only moderately accurate due to reliance on incorrect data. Thus, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 462,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta’s worldwide net revenue grew from **$2.009 billion in 2022 to $2.288 billion in 2023**.  That represents a **year‑over‑year increase of about 13.9 %** (≈15 % on a constant‑currency basis)【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Venclexta's global revenue as $2.009 billion in 2022 and $2.288 billion in 2023, matching the ground truth values ($2,009 million and $2,288 million). The year-over-year growth rate of 13.9% is accurately calculated and reported. However, the LLM omits the 2022 growth rate of 10.4%, which was part of the original question's scope (evolution between 2022 and 2023, including growth rates for both years). (2) Quantitatively, all numbers are correct—$2.009 billion = $2,009 million and $2.288 billion = $2,288 million. The growth rate from 2022 to 2023 is correctly computed as (2,288 - 2,009) / 2,009 ≈ 13.9%. The mention of ≈15% on a constant-currency basis is additional context not in the ground truth but does not contradict it and may reflect supplementary data from the source (page_42). (3) The reasoning is sound in terms of multi-hop synthesis—revenue figures across two years are compared to derive growth. However, the failure to mention the 2022 growth rate (10.4%) represents a minor gap in completeness for the multi-year performance evolution. (4) The answer is highly relevant, accurately conveys the upward trend, and focuses on the right metric (global revenue and growth). The omission of the prior year’s growth rate prevents a perfect score, but all provided information is factually correct and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 382,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Netflix disclosed its “Amended and Restated Executive Severance and Retention Incentive Plan” (exhibit 10.7) that had been filed on September 10 2021 【page_66】. By the 2023 Form 10‑K the company had filed a new amendment (exhibit 10.16) to the same plan that will become effective on January 1 2024 (with the prior version filed as exhibit 10.15 on December 8 2023) 【page_68】. This shows Netflix moved from a plan last amended in 2021 to a fresh amendment that will take effect at the start of 2024, reflecting an updated approach to executive severance and retention incentives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates and effective periods are accurate: the 2021 filing date of September 10 for the prior plan version and the December 8, 2023 filing date for the new amendment are correctly reported. The effective date of January 1, 2024, is also accurately stated. (2) The answer addresses all parts of the question—evolution between 2022 and 2023 filings, plan amendments, and effective dates. It correctly identifies that the 2022 filing referenced a plan amended in 2021, while the 2023 filing introduced a forward-looking amendment effective in 2024. (3) Entity accuracy is perfect: Netflix is correctly identified, the plan name is accurately rendered (with proper variations in phrasing such as 'Amended and Restated' and 'as Amended and Restated effective'), and exhibit numbers (10.7, 10.15, 10.16) align with typical SEC filing structures. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects the 2022 disclosure to the 2021 amendment and then contrasts it with the 2023 filing’s new amendment effective in 2024, correctly interpreting the forward-looking nature of the update. The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., exhibit numbers and page references), enhancing clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 393,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "In the 2022 Form 10‑K the Benefit Restoration Plan is mentioned only in the retirement‑plan footnote, where it is described in a single paragraph as a supplemental “plan to provide employee salary deferrals and a company‑match for participants whose 401(k) benefits are restricted by certain IRC provisions.” By the 2024 filing the plan appears as a stand‑alone exhibit (Exhibit 10.3) titled “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025,” indicating that the company has formally revised and restated the plan’s terms. This shift from a brief narrative description to a dedicated, amended‑and‑restated document shows that Lowe’s is actively updating and formalizing its retirement‑benefit structure to better address tax‑code constraints and enhance employee retirement support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 mention of the Benefit Restoration Plan in the footnote, its purpose (supplementing 401(k) benefits limited by IRC provisions), and the 2024 filing of a stand-alone exhibit (Exhibit 10.3) titled 'as amended and restated as of January 1, 2025') are all factually consistent with the original answer. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited as the effective date of the restated plan, and the exhibit number (10.3) matches the ground truth. No numerical calculations were required, but all dates and document identifiers are precise. (3) The multi-hop reasoning is sound—comparing the 2022 and 2024 filings to infer increased formalization and strategic intent is logically supported. The LLM correctly infers that the shift from a brief footnote to a dedicated exhibit signals a more structured approach to retirement benefits. (4) The only minor shortcoming is that the LLM does not explicitly mention 'executive and high-earner compensation' as emphasized in the ground truth, slightly reducing qualitative completeness. However, the implication is present through reference to tax-code constraints. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 376,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA’s 0.584 % Notes Due 2024 increased slightly from FY 2023 to FY 2024 – the fair‑value of the liability rose from $1.185 billion at year‑end 2023 to $1.228 billion at year‑end 2024 (NVDA 10‑K 2023 p. 66; NVDA 10‑K 2024 p. 72). By the end of FY 2024 a $1.25 billion current (short‑term) portion was recognized, making the total net carrying amount $9.709 billion, whereas in FY 2023 the notes were entirely long‑term with no short‑term portion. This shows a modest increase in the liability’s value and a reclassification of $1.25 billion into short‑term as the notes approached maturity.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the ground truth states that NVDA's liability for the 0.584% Notes Due 2024 was $1,185 million in FY2023 and was fully repaid in FY2024. However, the LLM claims the fair value increased to $1.228 billion in FY2024 and that a $1.25 billion short-term portion was recognized, which contradicts the repayment. These numbers are not supported by the ground truth and misrepresent the actual financial evolution. (2) The claim of an increase in liability and reclassification to short-term debt is factually wrong—instead, the obligation was extinguished. (3) Qualitatively, the reasoning is flawed: instead of recognizing the repayment of debt, the model incorrectly infers an increase in liability and introduces a 'net carrying amount' of $9.709 billion, which is unrelated to the specific notes in question. This suggests confusion with other debt instruments or total debt figures. (4) Contextually, while the answer addresses the general topic of the notes, it fails to capture the key event—repayment—and instead fabricates a narrative of growth and reclassification. The answer does cite 10-K pages, but the data extracted is either misread or misrepresented. Multi-hop reasoning failed: the model should have synthesized that a note due in 2024 would be repaid by FY2024, especially when the ground truth explicitly states so. Overall, the answer is mostly incorrect with major factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 416,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret’s total net revenue fell from $1.541 billion in 2022 to $1.430 billion in 2023 – a drop of roughly 7 % (about 5.7 % on a constant‑currency basis)【page_43】.  In the United States, sales declined sharply from $755 million to $659 million (≈ ‑13 %); by contrast, international sales slipped only modestly from $786 million to $771 million (≈ ‑2 % at actual rates, a +1 % gain on constant currency)【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numeric values are correct: total revenue ($1.541B in 2022, $1.430B in 2023), U.S. revenue ($755M to $659M), and international revenue ($786M to $771M) match exactly. Percentages are correctly approximated: the 12.7% U.S. decline is rounded to ≈‑13%, and the 1.9% international drop is rounded to ≈‑2%, which is acceptable. The LLM adds constant-currency adjustments (‑5.7% overall, +1% international growth) not present in the original answer; however, since these are plausible and contextually relevant (and cited to a source), they do not constitute factual errors but rather additional context. (2) Calculations are accurate: the total drop from $1.541B to $1.430B is indeed ~7.2%, so 'roughly 7%' is reasonable. The U.S. decline is (755-659)/755 ≈ 12.7%, correctly stated as ≈‑13%. International decline is (786-771)/786 ≈ 1.91%, correctly rounded to ≈‑2%. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across U.S. and international markets and draws valid comparative conclusions about the relative performance. (4) The only minor shortcoming is that the original answer emphasizes the 'contraction in both regions' and the 'more pronounced decline in the U.S.', which the LLM captures qualitatively but with slightly less emphasis. However, the core facts, synthesis, and conclusions are correct. Thus, the answer earns a 9/10 for correctness—excellent but not perfect due to slight differences in emphasis and the addition of unsolicited (though not incorrect) constant-currency data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 437,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "In the 2022 Form 10‑K Netflix said it was “in compliance with all related covenants” on its senior notes, which at that time restricted the company from (i) creating liens, (ii) entering sale‑and‑lease‑back transactions, (iii) incurring or guaranteeing additional indebtedness of subsidiaries, and (iv) merging or transferring substantially all of its assets 【page_56】.  \n\nBy the 2024 filing the company still reported covenant compliance, but added that it had “repaid upon maturity the $400 million aggregate principal amount of its 5.750 % Senior Notes” 【page_54】, and the covenant language was refined to state that “certain of the Notes additionally limit the ability to enter into sale and lease‑back transactions and create, assume, incur or guarantee additional indebtedness of certain of the Company’s subsidiaries,” while the core prohibitions on liens and on consolidating, merging, or transferring substantially all assets remained 【page_54】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix was in compliance with covenants in both 2022 and 2024; the repayment of $400 million of 5.750% Senior Notes in 2024 is accurately reported; and the evolution in covenant language—specifically the narrowing of restrictions on sale-and-lease-back transactions—is correctly noted. (2) Quantitative accuracy is perfect: the $400 million repayment amount, the 5.750% interest rate, and the years (2022, 2024) are all correctly cited. No calculations were required, but factual numbers match exactly. (3) The multi-hop reasoning is sound: the model synthesizes information across two years’ filings, compares covenant language changes, and links repayment activity to debt management strategy. The only minor shortcoming is that the LLM does not explicitly mention the euro-denominated tranches totaling €5,170 million from the 2022 notes, which is part of the original answer. While not central to the covenant evolution, it adds context about the debt structure. (4) The answer is semantically equivalent in all critical aspects, with proper citation of page numbers and clear explanation of covenant changes. The omission of the euro tranche detail prevents a perfect 10, but otherwise the response is complete, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 376,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "In 2022 Honeywell still presented Safety and Retail as a distinct sub‑segment of its Safety and Productivity Solutions segment. By 2023 the company had merged that unit with its Advanced Sensing Technologies operation, creating a single “Sensing and Safety Technologies” business unit that is shown as one line‑item in the 2023 segment‑revenue table — the structural change that consolidates the safety‑related product line (2022 note on realignment 【page_68】; 2023 revenue table showing Sensing and Safety Technologies 【page_68】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that in 2022, Safety and Retail was a distinct sub-segment under Safety and Productivity Solutions, and that in 2023 it was merged with Advanced Sensing Technologies to form the new 'Sensing and Safety Technologies' unit. (2) While the original answer includes the $2,387 million revenue figure for 2022, the LLM answer omits this specific number. This is a minor omission affecting completeness but not the core correctness. All other entities—company name, segment names, timing of the change—are accurate. (3) The reasoning is sound: the LLM correctly synthesizes the structural evolution across years and identifies the merger as a key organizational shift. It also references the July 2022 realignment (implied via '2022 note on realignment') and correctly notes that the new unit appears as a line item in the 2023 filing, aligning with the delayed reporting of a change announced earlier. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the evolution of the product line approach and the structural change. The only reason for not scoring a 10 is the missing revenue figure, which is a factual component in the original answer. However, since the question does not explicitly ask for financial figures, this omission is minor. Wording differences are acceptable and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 403,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "In 2023 Visa reported that no Class B‑2 shares were outstanding and that, like the other B‑class shares, B‑2 would only become convertible into Class A common stock after the U.S.‑covered litigation is finally resolved, with only limited voting rights that allow holders to vote on a merger, a core‑business exit or other Delaware‑required matters【page_34】.  By 2024 Visa had issued roughly 49 million B‑2 shares in a May 8 exchange offer (120 million B‑2 and 48 million C shares were created) and the shares now appear in the earnings per‑share calculations【page_59】; they remain non‑convertible until the litigation restrictions lift, but any conversion‑rate adjustment to B‑2 will have “double the impact” compared with B‑1, and B‑2 holders retain the same limited voting rights to approve certain significant corporate actions【page_89】.  Thus, B‑2 moved from a non‑existent, purely prospective class in 2023 to an active, 49‑million‑share class in 2024 that is still conditional on litigation for conversion but can influence key governance votes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Class B-2 Common Stock was *not outstanding* in 2023 but had a defined role in governance and convertibility, whereas the LLM claims *no Class B-2 shares were outstanding in 2023* — this part aligns — but then incorrectly states that 49 million B-2 shares were issued in 2024 as part of an exchange offer. The ground truth explicitly states that *no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer in 2024*, indicating a reduction or elimination of the class, not an expansion. (2) The LLM cites specific numbers — '49 million B-2 shares', '120 million B-2 and 48 million C shares created' — which are not supported by the ground truth and directly contradict it; there is no mention of share creation or issuance in the original answer. (3) The multi-hop reasoning is flawed: the LLM infers that B-2 went from non-existent to active, while the correct evolution is from active (with governance and conversion rights) to non-outstanding, indicating a phase-out. The LLM reverses the trajectory. (4) The LLM incorrectly attributes ongoing governance influence in 2024, while the ground truth emphasizes a *loss* of influence due to no shares being outstanding. Although the LLM attempts to address convertibility and governance, its core facts about the direction of change, share counts, and corporate actions are factually wrong, leading to a low correctness score. Contextual relevance is moderate because it discusses the right topics (convertibility, governance, litigation), but with incorrect data and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 449,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "In 2023 Home Depot framed its strategy around an “interconnected, frictionless shopping experience,” leveraging existing digital tools and in‑store upgrades such as way‑finding signage, self‑service lockers, curb‑side pickup, electronic shelf‑label capabilities, redesigned front‑end areas, expanded self‑checkout and mobile‑app‑enabled store navigation to blend the digital and physical worlds【page_5】【page_7】【page_8】. By fiscal 2024 the company said it was “continuing to enhance…across our stores, online, on the job site, and in homes,” deepening website and mobile‑app functionality (better search, richer product content, faster checkout and more fulfillment options) while still expanding the same in‑store digital features, and it reported online sales rising to 15.1% of net sales, up 6.6% versus 2023【page_8】【page_34】. This shows a shift from mainly leveraging and extending existing tools to accelerating digital platform capabilities and tighter omnichannel integration, driving a smoother, more convenient shopping experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies The Home Depot's 2023 focus on in-store digital enhancements such as electronic shelf labels, mobile app navigation, and self-checkout, which matches the original answer. In 2024, it accurately notes the continued investment in digital platforms and in-store features while expanding functionality—specifically citing richer product content, better search, and faster checkout, which semantically aligns with the original answer’s emphasis on enhanced product content and shopability. The mention of online sales rising to 15.1% of net sales, up 6.6% versus 2023, is a precise quantitative claim that adds value not in the original answer but does not contradict it; assuming this data is correctly extracted from the source (page 34), it enhances completeness. (2) Quantitative accuracy is perfect: the percentage (15.1%) and year-over-year increase (6.6%) are clearly stated and attributed correctly. No calculations are required beyond the reported change, which is accurately described. (3) The reasoning is sound: the LLM synthesizes information across 2023 and 2024, identifying a logical evolution from integrating digital and physical experiences to deepening omnichannel capabilities and personalization through data—consistent with the ground truth’s theme of shifting toward data-driven, personalized shopping. While the original answer emphasizes 'customer product review summaries' and 'leveraging customer data' more explicitly, the LLM’s description of richer content and improved digital functionality implies a similar trajectory, capturing the essence of personalization indirectly. (4) Contextual relevance is excellent—the response directly addresses both digital and in-store capabilities across both years, fulfilling the multi-part, multi-hop nature of the question. The only minor gap is the absence of explicit mention of 'customer review summaries' or 'personalized expectations' from the 2024 strategy, which slightly reduces qualitative accuracy, but the overall synthesis remains strong. Hence, a 9/10 on correctness is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 576,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "In the 2022 Form 10‑K the Long‑Term Incentive Plan was described as offering a mix of equity awards – price‑vested stock options, restricted stock units (including performance‑based RSUs), performance‑share units and separate non‑employee director stock‑option and RSU agreements 【page_68†L1-L9】. By the 2024 Form 10‑K the plan’s equity component had been streamlined to restricted stock units (standard and cliff‑vested), performance‑based RSUs, performance‑share units and a non‑employee director RSU agreement, with no price‑vested stock‑option forms listed 【page_73†L1-L9】. This reflects a shift from a stock‑option‑heavy design in 2022 to an RSU‑focused design in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that affect the correctness score despite being contextually relevant and well-structured. (1) The ORIGINAL ANSWER states that the 2022 plan included Non-Qualified Stock Options, Price-Vested Stock Options, and other forms, and that by 2024, new forms like the Cliff-Vested Restricted Stock Unit Agreement and Performance Award Performance Share Unit Agreement were introduced—indicating an expansion. In contrast, the LLM claims the 2024 plan was 'streamlined' and 'no price-vested stock-option forms listed', suggesting a reduction or elimination of stock options, which contradicts the ground truth that the plan expanded. This misrepresents the evolution of the plan. (2) While there are no explicit numerical values (e.g., dollar amounts, percentages), the qualitative descriptors like 'streamlined' and 'shift from stock-option-heavy to RSU-focused' imply structural contraction and strategic shift not supported by the ground truth, which notes additions, not removals. The absence of mention of Non-Qualified Stock Options or Performance-Based RSUs being removed in 2024 makes the claim speculative. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2024 disclosures—but draws an incorrect conclusion about the direction of change (streamlining vs. expansion). The LLM may have misinterpreted the omission of certain terms in the 2024 description as removal, whereas the ground truth indicates new forms were added, not that old ones were dropped. (4) Contextual relevance is high because the answer addresses the evolution of equity awards and cites appropriate document sections. However, the core factual claim about the plan becoming 'RSU-focused' and eliminating price-vested options is unsupported, leading to a low correctness score despite good structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 500,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "AbbVie disclosed that Qulipta (atogepant) received FDA approval in September 2021 (see page 60).  The product generated no sales in 2021, $158 million of U.S. net revenue in 2022, and $405 million in U.S. revenue plus about $3 million internationally in 2023 – roughly $408 million total – representing more than 100 % year‑over‑year growth each year (see page 42).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: FDA approval in September 2021, $0 revenue in 2021, $158 million U.S. revenue in 2022, $405 million U.S. and $3 million international in 2023, totaling $408 million. The statement about 'more than 100% year-over-year growth' is logically sound (from $0 to $158M is infinite growth; $158M to $408M is ~158% growth). (2) The answer is complete, addressing Qulipta's approval timeline and commercial performance evolution across all three years as requested. (3) Entities are correct: AbbVie, Qulipta (atogepant), FDA, U.S. and international revenue. (4) Multi-hop reasoning is sound—synthesizing approval date, annual revenues, and growth trajectory from multiple data points into a coherent performance narrative. (5) Semantic equivalence is maintained: though more concise, the LLM conveys the same core information and implications as the original answer, including strong market adoption and positioning. Minor stylistic differences (e.g., citation of page numbers) do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 320,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "In the 2022 Form 10‑K Netflix only gave a high‑level narrative of the 2020 Stock Plan – noting that it is a “stockholder‑approved plan that provides for the grant of incentive stock options … and for the grant of non‑statutory stock options, stock‑appreciation rights, restricted stock and restricted stock units to employees, directors and consultants” and listed the plan and its option‑agreement form as exhibits (see page 60 & page 66). By the 2024 filing the same structural description is retained, but the company now couples it with detailed quantitative disclosures: a “Stock Option Activity” table showing options outstanding, granted, exercised and expired each year (page 60), tables of total intrinsic value of options exercised and the fair‑value of options and RSUs that vested (page 61), and a summary of total stock‑based compensation expense and unrecognized compensation cost (page 61). These additions highlight that no options subject to vesting were granted in 2022 and provide the specific dollar amounts of equity compensation recognized in 2023‑2024, reflecting a shift from a purely descriptive overview to a granular, activity‑focused disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Netflix's disclosure practices regarding the 2020 Stock Plan between 2022 and 2024. It accurately captures the shift from a high-level narrative in 2022 to more detailed, activity-focused disclosures in 2024. The structural description in 2022 is correctly summarized, including the types of awards permitted and the reference to exhibits. For 2024, the LLM correctly identifies the addition of quantitative disclosures such as the 'Stock Option Activity' table, intrinsic value, fair value of vested awards, and stock-based compensation expense—details not present in the 2022 filing. These enhancements reflect a move toward granular reporting, consistent with the ground truth’s claim of a shift from mere documentation to operational disclosure. However, the LLM answer emphasizes quantitative additions (tables, dollar amounts) more than the ground truth, which highlights the inclusion of vesting schedules and performance-based criteria for RSUs—specific structural elements of the plan’s implementation that the LLM does not explicitly mention. While the LLM references vesting indirectly via 'unrecognized compensation cost,' it does not directly note performance-based conditions, which is a meaningful qualitative omission. All cited page numbers and document types (Form 10-K) are plausible and contextually appropriate, though not verifiable without access to the actual filings. No incorrect numbers or dates are present, and the reasoning across years and disclosure types is sound. The answer is highly relevant and well-structured, but slightly misses the emphasis on plan mechanics (e.g., performance criteria) in favor of financial reporting metrics, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 489,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed that its agreements to buy and sell aluminum were treated as **derivative instruments that did not qualify for hedge accounting** and were used to meet **long‑term strategic sourcing objectives and non‑U.S. business requirements**【page_121】. The 2023 filing kept the same classification—still listed under “Derivative Instruments Not Receiving Hedge Accounting Treatment”—but now quantifies those non‑hedge commodity contracts ( $115 million of notional ) and shows a larger overall pool of commodity derivatives designated as cash‑flow hedges, indicating a more detailed and expanded use of derivatives while retaining the strategic sourcing purpose for aluminum【page_103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but introduces information not present in the ground truth, while missing some key aspects of the evolution described. (1) Correct elements: The 2022 classification of aluminum purchase agreements as derivative instruments not qualifying for hedge accounting and their use for strategic sourcing and non-U.S. business requirements are accurately reported. The 2023 continuation of this classification is also correct. The mention of $115 million in notional value for non-hedge commodity contracts adds specificity not contradicted by the ground truth. (2) Quantitative accuracy: The $115 million figure is plausible and format-appropriate, though not mentioned in the ground truth; no calculation errors are present. However, since this number isn't in the original answer, its relevance cannot be fully verified, slightly reducing confidence. (3) Reasoning: The LLM infers a more 'expanded use of derivatives' due to increased disclosure and quantification, but this diverges from the ground truth, which emphasizes *offsetting quantities* and *market price alignment* as the key 2023 evolution. The LLM fails to mention that the contracts now 'offset each other' and are 'priced at prevailing market prices'—the core strategic refinement. Instead, it focuses on hedge accounting distinctions and notional amounts, which shifts the emphasis. (4) The answer remains contextually relevant and factually consistent with the filings, but the multi-hop synthesis is partially misaligned: it compares classification continuity and added quantification, whereas the ground truth highlights a shift in contractual structure and risk management logic. Thus, while the answer is well-supported and plausible, it does not fully capture the specific evolution in strategic use as defined in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 494,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "In the 2023 filing BNY Mellon noted that its Directors’ Code of Conduct—applying to all directors—was posted on its website at a URL under “inv relations” ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ). The 2024 filing keeps the same universal‑director scope but updates the link to a cleaner “investor‑relations” path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ), thereby making the code more readily accessible while still pledging to disclose any amendments or waivers online.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 and 2024 URLs for the Directors' Code of Conduct, accurately noting the change in URL structure from 'inv relations' to 'investor-relations', which reflects improved accessibility. The entity (BNY Mellon), years (2023 and 2024), and document scope (applying to all directors) are correctly identified. However, the LLM omits a key qualitative addition in the 2024 filing: the introduction of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES', which was not present in 2023 and indicates an expanded compliance focus. This omission reduces completeness and qualitative accuracy. (2) Quantitatively, all details are accurate: the URLs are correctly cited (with acceptable formatting variations like spaces vs hyphens), and the description of the website path change is factually sound. No numerical errors exist. (3) The reasoning is sound in connecting the URL change to improved accessibility and recognizing the consistent application to all directors, demonstrating correct synthesis across the two years. However, the failure to mention the new insider trading section means the model did not fully synthesize the expanded scope of disclosure in 2024, weakening the multi-hop reasoning. (4) The answer is contextually relevant and well-articulated, but the missing insider trading policy update—a significant enhancement in scope—prevents a higher score. While accessibility is addressed, the evolution in content scope is underreported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 415,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023 Home Depot issued a single $750 million tranche of 4.95 % senior notes that mature in September 2026; the notes were recorded at a carrying amount of roughly $744 million as of January 29 2023 (2023 10‑K p. 60; 2023 10‑K p. 59). By 2024 the company added a much larger $1.75 billion tranche of the same 4.95 % coupon that extends to June 2034, while the original 2026 tranche’s carrying amount was essentially unchanged at about $745 million (2024 10‑K p. 63; 2024 10‑K p. 62), and the total senior‑note portfolio’s carrying value rose to $40.8 billion from $39.9 billion a year earlier (2024 10‑K p. 66). This evolution—adding a long‑dated, higher‑volume 4.95 % issuance—shows Home Depot is locking in low fixed‑rate financing and lengthening its debt maturity profile to support acquisitions and preserve long‑term liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued $750 million of 4.95% senior notes due September 30, 2026, in 2023 at a discount of $1.6 million, resulting in a carrying amount of $748.4 million (not $744 million as stated). By 2024, the carrying amount was $747 million for the 2026 notes, which aligns roughly with a slight amortization of discount. However, the LLM incorrectly claims a new $1.75 billion tranche of 4.95% notes due June 2034 was issued, which contradicts the ground truth: instead, the 2024 filing reports $980 million in 4.95% senior notes due 2052, not 2034. The LLM invents a maturity (June 2034) and amount ($1.75B) not present in the original answer. Additionally, the LLM cites a carrying amount of $745 million for the 2026 notes in 2024, which is close but not exact compared to the $747 million reported. (2) The quantitative inaccuracies are severe: the new issuance amount ($1.75B vs $980M), maturity date (2034 vs 2052), and original carrying amount ($744M vs $748.4M) are all incorrect. The total senior note portfolio increase from $39.9B to $40.8B, while possibly accurate from the 10-K, is irrelevant to the specific question about 4.95% notes and distracts from the core facts. (3) The multi-hop reasoning is flawed: the LLM correctly infers a strategy of extending maturities and locking in fixed rates, but this conclusion is based on fabricated data. The correct inference in the ground truth hinges on the introduction of a very long-term 2052 note, which the LLM misses entirely. (4) The contextual relevance is moderate because the answer addresses the structure and strategy of HD's debt, but the factual foundation is unsound. Due to major errors in key financial figures and maturities, the correctness score is low despite some plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 504,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Intel initially recorded a large upward re‑valuation of its Unisoc stake – a $471 million observable‑price adjustment in the first quarter of 2021 (part of $750 million of observable price adjustments on non‑marketable equity securities that year)【page_43】.  By 2023 those adjustments had fallen dramatically to only $17 million (down from $299 million in 2022) and the carrying amount of the investment was $1.1 billion, essentially unchanged from the prior year【page_96】【page_97】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect quantitative information. It correctly states the $471 million observable price adjustment in 2021 and the $1.1 billion net book value as of 2023, which aligns with the ground truth. However, it introduces new figures not present in the original answer—namely, that observable price adjustments were $299 million in 2022 and dropped to $17 million in 2023—which are not mentioned or supported by the ground truth. These specific annual breakdowns undermine factual accuracy. (2) The core numbers from the ground truth—$471 million in 2021 and $1.1 billion book value in 2023—are correctly reported, but the additional details about 2022 and 2023 adjustments are extraneous and unsupported, suggesting possible confusion with other data or over-extrapolation. (3) The reasoning partially captures the evolution: it acknowledges the initial revaluation and the stable carrying amount, which reflects some correct multi-hop synthesis (from 2021 to 2023). However, the claim of declining adjustments in 2022–2023 goes beyond the provided truth and misrepresents the trend, weakening the logical coherence. (4) Contextually, the answer is highly relevant and addresses the question’s focus on valuation evolution and book value. Despite incorrect specifics on intermediate years, it retains the key point of a large 2021 adjustment and stable 2023 valuation. The correctness score is reduced due to significant quantitative inaccuracies, though not enough to fail entirely because core facts are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 430,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie reported that Qulipta had already received a regulatory approval – it was re‑classified from an indefinite‑life R&D asset to a developed‑product right after the approval (see Note 7, “reclassified … upon receiving certain regulatory approvals for Vuity, **Qulipta**, and HArmonyCa”【page_100】).  By the 2023 Form 10‑K the company was announcing new milestones: the U.S. FDA approved Qulipta for chronic‑migraine prevention in April 2023 and the European Commission granted approval in August 2023, confirming its commercial launch in both the United States and Europe【page_40】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Qulipta was reclassified in 2022 upon regulatory approval, triggering the $1.0 billion reclassification of indefinite-lived R&D intangible assets to developed product rights (as noted in the 2022 10-K, Note 7, page 100). In 2023, the FDA approved Qulipta in April for chronic migraine prevention in adults, and the EC granted approval in August 2023 for migraine prevention in adults with four or more migraine days per month—both dates and indications match the original answer. (2) Quantitative accuracy is perfect: while the $1.0 billion figure is implied (not explicitly restated in the LLM answer), the reclassification event is correctly tied to regulatory approval, and the timing and nature of approvals are exact. (3) Multi-hop reasoning is sound: the LLM synthesizes information from two different years (2022 and 2023 10-Ks), correctly identifying the evolution from asset reclassification (post-approval) to commercial and regulatory milestones. (4) Semantic equivalence is maintained: though the LLM cites specific document pages and uses slightly different phrasing (e.g., 'chronic-migraine prevention' vs. 'preventive treatment of chronic migraine'), the meaning is identical. The answer fully addresses the question’s focus on regulatory and commercial development from 2022 to 2023. All entities—AbbVie, Qulipta, FDA, EC—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 409,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "In the 2022 Form 10‑K Boeing described the segment as “**BGS** sustains aerospace platforms and systems with a full spectrum of products and services, **including … upgrades and conversions**” (page 5). The 2023 filing repeats the same description—“**Global Services** sustains aerospace platforms and systems with a full spectrum of products and services, **including … upgrades and conversions**”—but drops the “BGS” abbreviation and uses the plain segment name (page 3). Thus, the strategic emphasis on upgrades and conversions has stayed unchanged, while the wording shifts slightly toward a more unified “Global Services” branding.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of the 10-K language and correctly identifies that 'upgrades and conversions' were mentioned in both the 2022 and 2023 filings with nearly identical phrasing. It also correctly notes the change from 'BGS' to 'Global Services' as the segment name, which is a valid observation about branding (quantitative and entity accuracy are high, hence 10 and 7 respectively). However, the LLM concludes that the strategic emphasis has 'stayed unchanged,' which directly contradicts the ground truth. The original answer identifies a subtle but meaningful evolution in framing: in 2023, 'upgrades and conversions' were positioned within a more structured narrative around sustaining aerospace platforms, suggesting a more integrated and strategic role. The LLM fails to detect this shift in context and strategic positioning, interpreting identical phrasing as indicating no change in emphasis. This is a critical error in qualitative reasoning and interpretation of strategic language. While the wording may be similar, the ground truth emphasizes a shift in narrative integration, which the LLM overlooks. Thus, despite correct citations, the answer misses the core analytical insight required by the question, leading to a correctness score of 4—partially correct but with significant reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 372,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel’s stake in Beijing Unisoc Technology Ltd. is recorded as a non‑marketable equity security. In its 2022 filing the company said the investment was carried at $1.1 billion as of December 25 2021 (up from $658 million a year earlier) after recognizing a $471 million observable‑price adjustment in 2021 【page_52】. By the 2023 filing the net book value remained $1.1 billion as of December 30 2023, with the same $471 million adjustment already reflected in the prior‑year valuation 【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: Intel's investment in Beijing Unisoc was carried at $1.1 billion as of December 25, 2021, and remained at $1.1 billion as of December 30, 2023. It accurately states that a $471 million observable-price adjustment was recognized in 2021, which aligns with the ground truth. The mention of the prior-year value ($658 million) is not in the original answer but is factually consistent with a $471M increase leading to $1.1B (since $658M + $471M = $1.129B, close to $1.1B, possibly due to rounding or other adjustments), so this addition does not constitute an error but provides helpful context. (2) All numeric values—$1.1 billion (both years), $471 million adjustment, and the implied prior value—are quantitatively accurate or reasonably inferred. Dates (December 25, 2021, and December 30, 2023) match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data from the 2022 and 2023 filings, correctly tracks the valuation over time, and explains the persistence of the $1.1B book value without new adjustments in 2023. The only minor gap is that the original answer emphasizes the *absence* of a 2023 adjustment as a sign of stabilization, which the LLM implies but does not explicitly interpret. (4) The answer is semantically equivalent and highly relevant, with excellent entity accuracy (correct company, correct financial terms like 'net book value' and 'observable-price adjustment'). The slight deduction in qualitative accuracy is due to the lack of explicit commentary on the significance of no new adjustment in 2023, which was part of the original insight. Overall, the answer is factually excellent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 472,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "In fiscal 2023 Home Depot added self‑service lockers to its store‑refresh program as one of several new conveniences—alongside online‑order storage areas and curbside service—to let customers pick up online orders more easily (2023 p. 8). By fiscal 2024 the lockers are described as a front‑entrance pickup point that is woven into the company’s “interconnected shopping experience,” supporting BOPIS and other omnichannel fulfillment options and becoming a core element of the digital‑physical blend (2024 p. 9 & 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the evolution of Self-Service Lockers at Home Depot between 2023 and 2024, with correct entity and year references. It correctly identifies that in 2023, lockers were introduced as part of store refreshes to improve online order pickup convenience, citing the store-refresh program and related features like curbside and online-order storage (aligned with 2023 p.8). In 2024, it accurately reflects the strategic integration of lockers into the interconnected shopping experience and omnichannel fulfillment (BOPIS), referencing their placement and role in digital-physical integration (2024 p.9–10). However, the LLM omits a key quantitative detail present in the ground truth: that approximately 50% of U.S. online orders were fulfilled through stores in 2024, which underscores the operational significance of lockers in the broader fulfillment network. This omission reduces completeness and slightly weakens the synthesis of multi-hop evidence, particularly the scale of integration. There are no errors in reasoning, entities, or dates, and the wording is semantically equivalent to the original in most aspects. The answer remains highly relevant and conveys the core evolution—shifting from a convenience feature to a core omnichannel component—even without the 50% statistic. Quantitative accuracy is perfect as no incorrect numbers are stated (the missing percentage is not misrepresented, just omitted).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 404,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "In the 2023 filing (see page 46), Costco’s note on Insurance/Self‑insurance Liabilities was brief – it said the liabilities are not discounted and are funded through self‑insurance, a captive subsidiary and reinsurance, but gave no detail on how the amounts are estimated. By the 2024 filing (see page 31), the disclosure is far more specific, stating that retained liabilities are estimated using historical claims experience, demographic and severity factors, and other actuarial assumptions, and it highlights the influence of inflation, regulatory or legal changes and other uncertainties. This reflects a clear increase in detail and specificity from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in disclosure detail from 2023 to 2024. In 2023, the description was general—mentioning self-insurance, a captive subsidiary, and reinsurance without detailing estimation methods—which aligns with the ground truth. In 2024, the LLM accurately reports the inclusion of specific estimation factors: historical claims experience, demographic and severity factors, and actuarial assumptions. It also correctly notes the discussion of external influences like inflation and regulatory changes, which reflects the increased transparency. The only minor omission is that the ground truth explicitly mentions the 2024 disclosure includes a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities—a nuance not fully articulated in the LLM response, though 'uncertainties' is mentioned. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the years (2023 and 2024) and page references (46 and 31) are correctly used as contextual anchors and match the expected data sources, earning full marks. (3) The multi-hop reasoning is sound: the model compares disclosures across two years, identifies the increase in specificity, and correctly attributes the change to enhanced disclosure of estimation methods and risk factors. The synthesis across filings is accurate and logically presented. (4) The LLM answer is semantically equivalent to the ground truth with high completeness and precision. The slight deduction in qualitative accuracy is due to the partial omission of the 'potential for significant differences between actual and recorded liabilities' point, which is a meaningful addition in the 2024 filing. Otherwise, the answer is fully relevant, factually correct, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 522,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "In 2022 the Aldevron deal produced only a modest, offsetting effect on inventory costs – the company recorded “lower incremental acquisition‑related charges associated with fair‑value adjustments to inventory in connection with the 2021 Aldevron acquisition,” which helped temper the rise in cost of sales【page_85】. By 2023 that picture had changed dramatically, as Danaher booked an $87 million charge in the second quarter for excess inventory in its Biotechnology segment, creating a much larger inventory‑related cost impact【page_46】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 characterization. The ground truth states that the Aldevron acquisition caused a $59 million increase in cost of sales in 2022 due to fair value adjustments to inventory. However, the LLM claims only a 'modest, offsetting effect' and 'lower incremental acquisition-related charges,' which contradicts the magnitude and direction implied by the $59M charge. This misrepresents both the size and impact of the adjustment. The 2023 $87 million charge for excess inventory is correctly identified in amount, timing (Q2), and segment (Biotechnology), which is accurate and relevant. (2) Quantitatively, the $87 million figure is correct, but the $59 million charge in 2022 is entirely omitted and replaced with vague, downplayed language. This is a critical error in numerical reporting. The LLM does not mention the $59M at all, failing the quantitative accuracy check for 2022. (3) The multi-hop reasoning is partially sound—linking inventory cost changes from 2022 to 2023 across acquisition and operational factors—but the incorrect characterization of the 2022 impact undermines the synthesis. The model fails to show the evolution from a specific acquisition-driven $59M charge to its absence in 2023, which is central to the question. Instead, it implies the 2022 effect was minor and ongoing, which is incorrect. (4) Contextual relevance is high—the answer addresses inventory-related costs, the Aldevron acquisition, and the shift into 2023 with the new charge. However, due to the omission and mischaracterization of the $59M 2022 charge, the correctness score is limited to 5: partially correct but with major factual gaps in one of the two key years. The qualitative accuracy is moderate because the entities and timeline are correct, but reasoning is flawed by inaccurate premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 510,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K, Costco records outstanding shop‑card balances as a “shop‑card liability,” net of estimated breakage, and includes that liability in other current liabilities (see 2024 page 48 and 2023 page 48). The accounting language and treatment are essentially unchanged, indicating that Costco consistently treats unredeemed shop‑card balances as a liability and estimates breakage based on redemption data—a prudent, conservative approach to unclaimed balances.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity identification, accounting treatment, and disclosure locations (e.g., correct citation of 2023 and 2024 10-Ks, page 48, 'shop-card liability', 'net of estimated breakage', classification in other current liabilities). All quantitative and descriptive elements (years, financial treatment, terminology) are correct and consistent with the ground truth, earning a 10 in quantitative accuracy. Contextual relevance is perfect—the response directly addresses the question's focus on treatment over time and implications for unclaimed balances. However, the qualitative accuracy is lower because the LLM emphasizes consistency in treatment ('essentially unchanged') while downplaying the evolution highlighted in the ground truth: the increased emphasis on 'estimated breakage' and refinement of methodology in 2024. The original answer notes a more formalized or refined approach emerging in 2024, suggesting progress in estimation techniques, whereas the LLM implies static practice. This omission of the nuanced evolution in disclosure emphasis and methodological sophistication results in a partially incomplete qualitative picture, though core facts are sound. Thus, the correctness score is 7—accurate on facts and entities, but less precise on the interpretive evolution of Costco’s approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 374,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "In 2022 Intel positioned Foundry Services (IFS) as a new pillar of its IDM 2.0 strategy, saying it would “build a world‑class foundry business…differentiate…through leading‑edge packaging and process technology, committed capacity in the US and Europe, and a world‑class IP portfolio” (page 9). By 2023 the vision had turned into concrete partnerships and customer wins: the IFS Accelerator Ecosystem Alliance doubled to > 40 strategic agreements, Intel announced multigenerational deals with ARM and a definitive agreement with Synopsys, expanded the RAMP‑C program to include Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, secured multiple 18A design wins and signed a commercial foundry‑services deal with Tower for advanced analog processing (pages 36‑37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: In 2022, Intel positioned IFS as part of IDM 2.0 with leading-edge technology, US/Europe capacity, and IP (correctly cited from page 9). In 2023, it secured design wins on Intel 18A and advanced packaging, expanded the IFS Accelerator Ecosystem to over 40 agreements, and entered multigenerational deals with ARM and Synopsys—details consistent with the original answer. The LLM adds specific partners in the RAMP-C program (Nvidia, IBM, Microsoft, Boeing, Northrop Grumman) and the Tower deal, which are plausible extensions of the 2023 ecosystem growth and do not contradict the ground truth. (2) Quantitative accuracy is perfect: 'over 40' agreements matches '>40'; no incorrect numbers or dates. (3) Multi-hop reasoning is sound—correctly synthesizing evolution from strategic intent (2022) to execution (2023) across partnerships, customer wins, and ecosystem growth. (4) The only minor gap is that the original answer specifies 'four design wins on Intel 18A' and 'five new design wins in advanced packaging', while the LLM mentions 'multiple 18A design wins' and does not quantify advanced packaging wins. This slight omission in specificity prevents a perfect 10, but the overall meaning and strategic progression are preserved. The added detail about Tower and RAMP-C partners enhances context without introducing errors. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 414,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Danaher reported that the Aldevron acquisition generated roughly $6.1 billion of goodwill and $9.6 billion of net cash consideration (goodwill $6,149 m; cash $9,561 m)【page_74】. The 2023 Form 10‑K shows the same amounts—about $6.1 billion of goodwill and $9.6 billion of net cash consideration—so the financial impact of the Aldevron relationship was essentially unchanged from 2022 to 2023【page_74】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, DHR recorded approximately $6.1 billion of goodwill, but the net cash consideration of $9.561 billion was reported in 2023, not in 2022. The LLM incorrectly states that both the $6.1 billion goodwill and $9.6 billion net cash consideration were reported in 2022 and remained unchanged in 2023. This contradicts the original answer, which emphasizes an evolution—specifically, an increase in financial commitment from the initial goodwill estimate in 2022 to a higher net cash consideration in 2023. (2) Quantitatively, while the LLM correctly reports the $6.1 billion goodwill and $9.561 billion cash consideration (rounded to $9.6 billion), it misattributes both figures to 2022, which is incorrect. The $9.561 billion net cash consideration was not part of the 2022 final assessment but rather a 2023 update, indicating a revised financial outlay. (3) The multi-hop reasoning is flawed: the question asks about the evolution between 2022 and 2023, but the LLM concludes there was no change, failing to recognize that the cash consideration figure was not finalized in 2022 and was instead updated in 2023. This reflects a failure to synthesize the temporal progression and revised financial assessment. (4) Contextual relevance is moderate because the answer discusses the correct companies (DHR, Aldevron), metrics (goodwill, net cash consideration), and time periods, but the core conclusion—that the financial impact was unchanged—is factually wrong. Hence, despite using correct numbers, the synthesis and interpretation are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 461,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The 2022 Form 10‑K lists the 1.800 % Global Notes as maturing on **September 5 2026**【T_10k_2022.pdf page_2】. In the 2024 Form 10‑K the company also reports a 1.800 % Global Notes series that matures on **September 14 2039** (in addition to the 2026 series)【T_10k_2024.pdf page_2】. This later maturity shows AT&T is lengthening its debt profile, moving more of its financing into longer‑dated notes to reduce near‑term refinancing risk and lock in low rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maturity dates from the 2022 and 2024 filings: September 5, 2026, and September 14, 2039, respectively. These match the ground truth exactly. The percentage (1.800%) and note class (Global Notes) are also accurate. (2) Quantitatively, all dates and percentages are correct. The implied extension of over 13 years is accurate (2039 - 2026 = 13 years), though not explicitly calculated in the answer. (3) The reasoning is sound: the LLM correctly infers that AT&T is lengthening its debt profile to reduce refinancing risk and lock in low rates. However, the LLM slightly misrepresents the situation by implying the 2039 note is an additional series rather than a replacement or refinancing of the original, which could suggest both coexist. The ground truth implies a change in maturity for the same class of notes, not the addition of a new series. This is a minor but notable nuance in entity interpretation. (4) Despite this subtlety, the core facts, dates, and strategic implication are correct and well-reasoned. The answer is contextually relevant, directly addressing both parts of the question: the change in maturity date and its implication for debt structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 346,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target said it was in compliance with its debt‑leverage covenant in both the 2023 and 2024 Form 10‑K filings and expects to remain so【page_54】【page_35】.  In 2023 the company added a new $1 billion 364‑day unsecured revolving credit facility and extended its $3 billion five‑year revolving facility to 2028, and in 2024 it renewed the $1 billion 364‑day facility (now expiring in October 2025) while keeping the $3 billion facility through 2028, providing a liquidity backstop with no balances outstanding that helped sustain covenant compliance【page_54】【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target was in compliance with its debt leverage covenant in both 2023 and 2024, maintained a $3.0 billion five-year facility expiring in 2028, and renewed its $1.0 billion 364-day facility—first entered in 2023 with a 2024 expiration, then renewed to expire in October 2025. These numeric details (dollar amounts, years) are accurate and match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar figures ($1 billion, $3 billion), expiration dates (2025, 2028), and facility types (364-day, five-year) are correctly reported. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across two years of filings, identifying both the structural changes in credit facilities and their implications for covenant compliance. It correctly infers that the renewal provided liquidity support, aiding compliance. (4) The only minor shortcoming is that the LLM mentions Target 'added' the $1 billion 364-day facility in 2023, while the original answer frames it as part of an existing structure; however, this is a nuance in phrasing and not factually incorrect, as the facility was indeed newly established in 2023. The LLM also correctly cites the role of the facilities in sustaining compliance. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 393,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "In the 2022 filing Intel described its RISE strategy as a platform for “working with customers and other stakeholders” through the newly‑created Alliance for Global Inclusion, which launched an Inclusion Index and pledged to “expand digital readiness for millions of people around the world” (2022 p. 15). By the 2023 filing Intel had moved from launching the index to publishing the third Global Inclusion Index survey—showing Intel’s own score and broader industry participation—and said it would continue to use RISE to deepen those external collaborations and scale digital‑readiness initiatives for global populations (2023 p. 18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies Intel's RISE strategy and its role in expanding digital readiness through the Alliance for Global Inclusion in 2022, citing the launch of the Inclusion Index. It also correctly notes the progression by 2023 to the publication of the third Global Inclusion Index survey, reflecting a maturation of the initiative. The mention of Intel deepening external collaborations and scaling initiatives is consistent with the evolution described in the original answer. However, the LLM answer omits key quantitative and evaluative details present in the ground truth: specifically, that the 2023 index transitioned into a formal recognition system where organizations scoring 50% or higher were recognized, and that Intel was one of only 18 out of 27 respondents to achieve this benchmark. This missing information weakens the completeness of the response, particularly in conveying the outcome-focused shift in strategy. All entities (Intel, RISE strategy, Alliance for Global Inclusion, Global Inclusion Index) and years (2022 to 2023) are correctly identified, and the reasoning reflects sound multi-hop synthesis across filings. The contextual relevance is excellent, directly addressing the evolution in approach. While no numbers are misstated, the omission of the 50% threshold and the 18-out-of-27 recognition statistic affects quantitative completeness, hence not a perfect score. Overall, the semantic meaning is close to the original, with minor but notable gaps in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 429,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson’s AspenTech unit moved from actively pursuing a purchase of Micromine (an AU $900/≈ $623 m deal announced in 2022) to terminating that agreement on August 1 2023 – a mutual decision that incurred no termination fee 【page_52】.  The termination also led AspenTech to unwind the foreign‑currency forward contracts it had entered to hedge the Micromine price, generating a $24 mark‑to‑market gain in 2023 (recorded as a foreign‑currency transaction gain) and leaving no further Micromine‑related costs or gains in 2024 【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Emerson's relationship with Micromine through AspenTech, noting the initial pursuit of acquisition and subsequent termination. It accurately reports the AU$900 million (≈$623 million) deal value, the August 1, 2023 termination date, no termination fee, and the $24 million mark-to-market gain in 2023 from unwinding foreign currency forward contracts. It also correctly states there were no further Micromine-related financial impacts in 2024. (2) All numeric values—AU$900 million, ~$623 million, $24 million gain, August 1, 2023 termination—are factually correct and match the ground truth. The reference to '2022' for the announcement is a minor contextual discrepancy (ground truth says '2023'), but the core financials and timeline of termination in 2023 remain accurate. (3) The multi-hop reasoning is sound: the model connects Emerson → AspenTech → Micromine acquisition attempt → termination → financial impact via hedging contracts → absence of 2024 exposure. It synthesizes cause-effect across corporate action and financial reporting. (4) The answer is semantically equivalent to the ground truth, with only a slight error in the announcement year (2022 vs 2023), which does not affect the correctness of the financial implications or the key timeline. Hence, high scores across all categories, with a 9 on correctness due to the minor date inconsistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 397,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot U.S. ESPP had about **17 million shares available** at the end of fiscal 2022, but that pool fell to roughly **15 million shares** by the end of fiscal 2023 – a drop of about 2 million shares【page_70】.  At the same time, the average price paid for shares bought under the plan fell from roughly **$305 per share** (the most recent average price disclosed) to **$277.19 per share** in fiscal 2023【page_70】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor differences in wording. (1) All key facts are correct: shares available decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price dropped from $305.14 to $277.19. The LLM rounds $305.14 to '$305', which is acceptable for semantic equivalence. (2) Quantitative accuracy is perfect: the 2 million share reduction and price decrease are correctly reported, with only minor rounding in the 2022 average price. (3) Multi-hop reasoning is sound—information is correctly synthesized across fiscal years and metrics (availability and pricing). (4) The answer is fully relevant and addresses both parts of the question: change in share availability and change in average purchase price. The only minor shortcoming is the slight rounding of $305.14 to $305 without indicating approximation, but this does not mislead. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 303,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "In the 2022 filing Danaher noted **no impairment triggers for 2022** and only recalled earlier triggers – Q1 2021 in Diagnostics ($10 million) and Q1/Q3 2020 in Diagnostics and Environmental & Applied Solutions ($22 million) – with no new charges. The 2023 filing, by contrast, reported **new triggers in 2023** (Q2 2023 in Biotechnology and Q4 2023 in both Biotechnology and Diagnostics) that generated a **$77 million impairment charge**, again confirming that 2022 had no impairments. The move from isolated, small‑scale Diagnostics/Environmental write‑downs to larger, multi‑segment (especially Biotechnology‑focused) impairments indicates that the risk profile of Danaher’s intangible‑asset portfolio is shifting toward its technology‑intensive, biotech intangibles.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that affect correctness. While it correctly identifies the $77 million impairment charge in 2023 and the $10 million charge in Q1 2021 (Diagnostics), it incorrectly states that the 2022 filing reported impairment triggers in Q1/Q3 2020 in Diagnostics and Environmental & Applied Solutions totaling $22 million. The ground truth does not mention any $22 million charge or impairments in 2020, nor does it reference the Environmental & Applied Solutions segment in the context of impairments. This is a significant factual error. Additionally, the LLM claims the 2022 filing noted 'no impairment triggers for 2022' — while technically consistent with the ground truth (which only references 2021 activity in the 2022 filing), the inclusion of unverified 2020 data undermines accuracy. (2) Quantitative accuracy is partially correct: the $10 million (2021) and $77 million (2023) figures are accurate and correctly attributed to Diagnostics and multi-segment activity respectively. However, the unsupported $22 million charge and references to 2020 impairments introduce false quantitative claims not present in the ground truth. Calculations are not required in this question, but comparisons of scale ('isolated' vs 'larger, multi-segment') are reasonable. (3) Multi-hop reasoning is generally sound — the model correctly contrasts the 2022 and 2023 filings and infers a shift in risk toward biotech intangibles, which aligns with the ground truth’s conclusion about growing risks in the Biotechnology segment. However, the reasoning is based partly on incorrect premises (the 2020 charges), weakening the logical foundation. (4) Contextual relevance is high: the answer addresses the evolution of impairment triggers across years and segments and draws a meaningful conclusion about shifting risks in intangible assets. Despite incorrect details, the core narrative of increasing scope and severity of impairments, especially in Biotechnology, is supported. The score is reduced due to significant factual inaccuracies in entities and numbers not present in the original data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 574,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The company’s outstanding letters of credit rose from **$362 million at January 30 2022** to **$598 million at January 28 2024** – an increase of about **$236 million (≈65 %)**【page_11】. Because these letters of credit are “primarily related to certain business transactions, including … trade contracts,” the jump signals that Home Depot’s exposure to, and participation in, trade‑contract‑related business activities grew substantially over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in outstanding letters of credit from $362 million to $598 million, matching the ground truth values. However, it references the end date as January 28, 2024, instead of 2023, which corresponds to the 2023 fiscal year-end but may misrepresent the reporting year if interpreted literally. This is a minor date labeling issue, not a factual error in the data itself, as SEC filings often report fiscal years with dates extending into the next calendar year. (2) The calculation of the $236 million increase and ~65% growth is accurate: 598 - 362 = 236; 236 / 362 ≈ 65.2%. (3) The reasoning is sound: the LLM correctly links the increase in letters of credit—specifically noting their relation to trade contracts—to greater company involvement in trade-related transactions, demonstrating proper multi-hop synthesis between financial instruments and business activity implications. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed presentation (percentage increase, exact dates). The minor discrepancy in date labeling (2024 vs. 2023) does not invalidate the correctness given fiscal year-end conventions, but prevents a perfect score. All entities (Home Depot implied, letters of credit, trade contracts) are accurate. Thus, high scores across all categories with full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 385,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 0.300 % Notes due 2028 were disclosed only by reference – the filing notes that the “instrument defining the rights of the holders of the 0.300 % Notes due 2028” is incorporated by reference to Exhibit 4.1 of a Form 8‑K filed on Feb 10 2020【page_20】. In the 2024 Form 10‑K the same notes appear in the Section 12(b) securities table as an outstanding security (“0.300 % Notes due 2028”, ticker IBM28B)【page_1】. This shift from a detailed incorporation‑by‑reference citation to a concise listing shows IBM continues to disclose the existence of the notes, but now presents them more directly in its securities register, reflecting a consistent and transparent approach to reporting its debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.300% Notes due 2028 were referenced via Exhibit 4.1 in the February 10, 2020 Form 8-K in the 2023 filing, and in the 2024 filing they appear directly in the Section 12(b) securities table with ticker IBM28B. These details match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (0.300%), dates (Feb 10, 2020), and ticker symbol (IBM28B) are all correct. (3) The multi-hop reasoning is sound—comparing the disclosure method across two years and inferring a shift in presentation from incorporation by reference to direct listing. The LLM correctly identifies this as a change in reporting style reflecting more direct disclosure. (4) The only minor shortcoming is that the LLM attributes the change to a 'consistent and transparent approach,' whereas the original answer interprets it as indicating increased market engagement or liquidity. While the LLM’s interpretation is reasonable, it slightly underemphasizes the implication of active trading on the NYSE, which suggests more than just reporting consistency. However, this is a nuanced difference in interpretation rather than a factual error. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 377,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 1.750 % Notes due 2031 were disclosed only by incorporation‑by‑reference – the filing notes that the rights of those notes are set out in 8‑K exhibits (filed Jan. 30 2019) and they do not appear in the Section 12(b) securities‑registered table. By the 2024 Form 10‑K, IBM lists the 1.750 % Notes due 2031 in the Section 12(b) table (ticker IBM31) as a security registered on the New York Stock Exchange, showing the notes have moved from a purely referenced disclosure to an explicit exchange‑registered listing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: in 2023, the 1.750% Notes due 2031 were disclosed via incorporation by reference to an exhibit filed on January 30, 2019, and were not listed in the Section 12(b) registered securities table. By 2024, the notes were explicitly included in the Section 12(b) table with ticker symbol IBM31 and registered on the New York Stock Exchange. (2) Quantitative elements—interest rate (1.750%), maturity year (2031), and filing date (January 30, 2019)—are all correct. The ticker symbol IBM31 matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure and registration status across two years, identifying the evolution from passive reference to active listing. (4) The answer addresses all parts of the question—disclosure practices and exchange registration—over the specified time frame. Wording differs slightly but meaning is preserved with high precision. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 308,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "In 2023 Eli Lilly monetized Zyprexa by selling the rights to the olanzapine portfolio, recognizing a one‑time $1.45 billion gain that was reported under “collaboration and other revenue” 【page_75】 (the sale also drove the $1.45 billion volume increase noted for outside‑U.S. sales) 【page_47】. By 2024 the same Zyprexa‑related income is shown as part of a broader, ongoing collaboration with Boehringer Ingelheim—recorded in the 2024 “collaboration and other revenue” line (which now includes the prior rights‑sale and ongoing royalties/milestones) 【page_64】—signaling a shift from a one‑off asset‑sale model to a licensing‑partnership business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.45 billion revenue from the sale of the olanzapine portfolio (including Zyprexa) in 2023 and accurately notes its classification under 'collaboration and other revenue' in both 2023 and 2024, aligning with the ground truth. The shift from direct product sales to licensing/collaboration revenue is correctly captured. (2) Quantitatively, the $1.45 billion figure is accurate, and the years (2023 and 2024) are correctly referenced. The LLM correctly interprets that the 2023 sale contributed to outside-U.S. sales volume and was a one-time gain, which matches the original answer’s implication of a direct revenue stream ending. (3) The reasoning is sound: the model synthesizes information across years and revenue categories, correctly inferring a business model shift from product sales to collaboration-based revenue. It adds contextual detail about an ongoing partnership with Boehringer Ingelheim, which is consistent with the ground truth’s mention of 'post-sale royalty or profit-sharing arrangements,' though this specific partner name is not in the original answer—this is a minor over-specification but not factually incorrect. (4) The answer is semantically equivalent to the ground truth, with slightly more detail on the collaboration mechanism. The only minor gap is that the original emphasizes Zyprexa’s removal from product sales, which the LLM implies but does not explicitly state. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 421,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023 AT&T still carried the Mobility preferred interests as a liability – the company recorded a redemption obligation of about $5.34 billion (≈ $2.67 billion in current liabilities and $2.67 billion in non‑current liabilities) and, because the interests could be settled in stock, they were counted as 72 (71) potential dilutive shares in the diluted‑EPS denominator【page_90】.  After repurchasing all of the interests in April 2023, no Mobility preferred interests remained at year‑end, the redemption liability was eliminated, and the 2024 EPS note shows the mobility interests as “‑” (i.e., zero) in the diluted‑EPS calculation, removing any dilutive effect on earnings per share【page_53】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of the Mobility Preferred Interests from 2023 to 2024, including reclassification to liability, repurchase in April 2023, elimination of redemption obligation, and removal from diluted EPS in 2024. However, there is a quantitative discrepancy in the total redemption obligation: the LLM states ~$5.34 billion, while the ground truth specifies $5,414 million (i.e., $5.414 billion) paid for repurchase including accrued distributions. The $2.67 billion split between current and noncurrent liabilities is accurate and matches the $2,670 million in the original answer. (2) The LLM introduces a new figure—72 (or 71) potential dilutive shares—that is not present in the ground truth and lacks corroboration from the context provided; this is an unsupported addition that affects quantitative accuracy. (3) The reasoning is sound: it correctly synthesizes the shift from active liability in 2023 to no remaining interests in 2024, and correctly identifies the change in diluted EPS treatment post-repurchase. It also accurately reflects the impact of ASU 2020-06 (ability to settle in stock affecting diluted EPS) even if not naming the standard explicitly. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: financial impact (liability treatment and repurchase) and effect on EPS. The only deductions are for the incorrect total repurchase amount and the unsupported share count, which prevent a top score in quantitative accuracy. Overall, the answer is factually strong with minor but notable numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 445,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 0.875% Notes due 2030 were disclosed only by reference to the instrument defining the holders’ rights (incorporated from a Form 8‑K filing – see page 20). By the 2024 Form 10‑K, IBM explicitly listed the 0.875% Notes due 2030 (ticker IBM30A) in its Section 12(b) securities table as a New York Stock Exchange‑listed security (see page 1). This shows a shift from a purely reference‑based disclosure in 2023 to a clear, direct registration and exchange listing in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: in 2023, the 0.875% Notes due 2030 were disclosed by reference to a Form 8-K (filed February 8, 2022), and in 2024, they were explicitly listed with ticker IBM30A and registered on the NYSE. (2) There are no numeric or date inaccuracies—while the LLM does not repeat the exact Form 8-K filing date, it correctly references the incorporation by reference mechanism, which aligns with the ground truth. The ticker symbol IBM30A and the NYSE listing are correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings to show an evolution in disclosure practice—from indirect reference to full registration and listing. (4) The answer addresses all parts of the question: the treatment and disclosure changes, listing status, and registration status over time. Wording differs slightly but meaning is preserved, and the inclusion of specific page references (e.g., page 20, page 1) adds contextual precision not in the original but consistent with accurate sourcing. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 341,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "In the 2023 filing the Telco LLC preferred interests were described as three non‑convertible cumulative series – Class A‑1 (4.25% initial preferred distribution) and Classes A‑2/A‑3 (6.85% initial preferred distribution), each subject to reset every seven years (the higher‑rate series resetting on Nov 1 2027) and callable at issue price after seven years, with redemption rights on certain contingent events【page_91】. The 2024 filing repeats the same three‑class structure, the same 4.25% and 6.85% rates, the same reset and call provisions, and confirms that the total outstanding Telco preferred interests remain $7.25 billion as of both year‑ends【page_87】. This continuity shows AT&T is using preferred equity as a stable, non‑dilutive financing source, preserving predictable cash‑flow obligations while retaining flexibility to redeem or call the securities under predefined conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structure of the Telco Preferred Interests with Class A-1 at 4.25% and Classes A-2/A-3 at 6.85%, and notes the seven-year reset and call provisions, which aligns with the ground truth. It also correctly states the total outstanding amount as $7.25 billion in both 2023 and 2024. However, it inaccurately implies that the $7.25 billion was outstanding in both years 'as of year-ends', while the ground truth specifies that the $7.25 billion total was reached only by 2024, with the 2023 amount being a combination of $2,000 (likely $2.0 billion) and $5.25 billion issued in April 2023, summing to $7.25 billion only after that issuance. The LLM misses the nuance that the expansion occurred during 2023 and was not present at the beginning of the year. (2) Quantitative accuracy is mostly correct: $7.25 billion total, 4.25%, 6.85%, and seven-year reset are all accurate. The only issue is the implied timing of the full $7.25 billion being outstanding in 2023, which could mislead about the evolution. The dollar amounts in thousands vs. millions/billions are not clearly resolved (e.g., $2,000 likely means $2.0 billion), but the LLM interprets them as part of the $7.25 billion total, which is acceptable. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the continuity of terms from 2023 to 2024 and infers stable financing strategy. However, it omits the key 2024 clarification that failure to pay distributions does not restrict dividends or share repurchases, which is a material change in distribution terms and indicates reduced financial covenants. This omission affects the completeness and qualitative accuracy of the response regarding AT&T's evolving approach. (4) The answer is contextually relevant and well-structured, but the missing covenant change and the slightly misleading timing of the $7.25 billion balance prevent a higher score. The conclusion about stable, non-dilutive financing is reasonable but lacks the full nuance of increased flexibility in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 554,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One kept originating multifamily commercial‑real‑estate loans for sale to the government‑sponsored enterprises, but the risk it retains through loss‑sharing agreements grew markedly.  The liability recorded for those loss‑sharing arrangements rose from **$82 million at 12/31/2022 to $137 million at 12/31/2023** (see the “Loss Sharing Agreements” note in the 2023 filing)【page_217】.  This increase shows a higher exposure to potential credit losses under the GSE loss‑sharing program, even though the overall origination strategy remained unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($82 million in 2022 and $137 million in 2023) are accurately reported with correct dates (12/31/2022 and 12/31/2023), and the increase in liability is correctly implied. Format variations (e.g., $82 million vs $82M) are acceptable and do not affect accuracy. (2) The answer addresses all parts of the question: Capital One’s continued involvement in multifamily CRE loans, the use of loss sharing agreements with GSEs, and the evolution of risk exposure as reflected in the growing liability. (3) Entities are correct—'Capital One', 'government-sponsored enterprises (GSEs)', 'loss-sharing agreements', and the relevant years (2022–2023) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers increased risk exposure from the rising liability, even though the origination strategy remained unchanged, which aligns with the ground truth’s conclusion. The citation to the 'Loss Sharing Agreements' note in the 2023 filing adds contextual support. (5) The semantic meaning is equivalent to the original answer—while wording differs, the core information about increased risk exposure due to higher liabilities under the same business model is preserved. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 381,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "In the 2022 Form 10‑K Amazon noted that its co‑branded credit‑card programs “could adversely affect our operating results if renewed on less favorable terms or terminated” and flagged exposure only to the existing payment‑card association rules 【page_13】. By the 2023 filing the same programs remain strategically important, but Amazon adds that new compliance obligations—such as required enhanced‑authentication processes and broader, evolving payment‑card regulatory requirements—could raise costs and make it harder to comply, increasing the risk that adverse changes to the programs will more materially affect operating results 【page_14】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amazon's co-branded credit card programs and their strategic significance in both 2022 and 2023, noting the risk of adverse impacts on operating results if programs are renewed on less favorable terms or terminated. It also correctly states that regulatory risks existed in 2022 related to payment card association rules. However, it misrepresents the nature of the new compliance obligations added in 2023. The ground truth specifies that Amazon emphasized *data localization rules* and cross-border data transfer risks in 2023—key regulatory developments tied to international jurisdictions. In contrast, the LLM answer cites 'enhanced-authentication processes' and 'broader, evolving payment-card regulatory requirements,' which are not mentioned in the original answer and do not align with the specific new obligations (data localization) highlighted in the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly infers increased regulatory burden and potential impact on operating results from 2022 to 2023. However, it fails to accurately synthesize the *type* of new compliance obligation, which is a critical factual component of the shift in regulatory risk. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses strategic significance, regulatory risks, and impact on operating results—all core parts of the question. But due to the incorrect characterization of the new compliance obligations, the answer is only partially factually correct, warranting a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 476,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "In the 2022 Form 10‑K PMI disclosed that Rothmans, Benson & Hedges Inc. (RBH) has been **de‑consolidated** from the company’s consolidated financial statements since the March 22, 2019 CCAA filing, with the de‑consolidation reflected in other‑comprehensive earnings (see 2022 p. 113 and the OCI table on p. 107). By the 2024 Form 10‑K RBH remains **outside the consolidation** and is treated as an equity investment; PMI now emphasizes that the investment’s **fair‑value impairment** is a critical audit matter, requiring significant judgment on discount rates, sales volumes, operating margins and the allocation of any global settlement amount (see 2024 p. 148).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2019 due to CCAA proceedings, excluded from consolidation in 2022, and treated as an equity investment by 2024 requiring fair value impairment analysis. The dates (March 22, 2019) and terminology (de-consolidated, equity investment, fair-value impairment, critical audit matter) are precise. (2) Quantitative accuracy is excellent—no numerical figures were misstated, and while the CAD 3.1 billion litigation exposure is omitted, it is not central to the core evolution of consolidation and valuation treatment. The absence of this detail does not undermine the main financial relationship trajectory. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across 2022 and 2024 filings, showing the shift from deconsolidation to equity method accounting and evolving audit considerations. (4) Semantic equivalence is strong—wording differs slightly but conveys the same meaning. The only minor shortcoming is the omission of the litigation context affecting RBH’s valuation, which slightly reduces completeness but doesn’t affect the primary financial reporting evolution. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 369,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "In 2023 Baqsimi still appeared as a product line, generating $677.6 million of total revenue ( $645.7 million U.S. + $31.9 million outside U.S.) and, after the rights were sold to Amphastar, $579 million of that amount was recorded as a net gain on the sale of the rights 【page_48】. By 2024 the drug had been removed from the core product mix – the $500 million cash received in 2023 and the additional $125 million cash payment (plus up‑to‑$450 million in sales‑based milestones) are now treated as collaboration revenue, and LLY only recognizes ongoing “net product revenue” as it manufactures Baqsimi for Amphastar under a supply agreement, sharply reducing its direct contribution to the portfolio 【page_75】【page_64】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key shift in Baqsimi's status from a direct revenue-generating product in 2023 to a divested asset in 2024, with revenue now derived via collaboration and supply arrangements. It accurately reports the 2023 total revenue of $677.6 million, broken into $645.7 million (U.S.) and $31.9 million (outside U.S.), which matches the ground truth. However, it introduces a $579 million 'net gain on sale of rights' not present in the original answer or verifiable from the context provided; this figure is likely a misinterpretation or hallucination, as the ground truth does not mention a gain amount. Additionally, the LLM cites $500 million cash received in 2023 and a $125 million payment in 2024, plus milestones—details absent from the original answer and unverifiable without external data, reducing quantitative accuracy. (2) While the core revenue numbers for 2023 are correct and properly summed, the introduction of unverified figures (e.g., $579M gain, $125M payment) undermines full quantitative precision. The absence of these numbers in the ground truth suggests they are either incorrect or inferred beyond available evidence. (3) The multi-hop reasoning is strong: the model correctly infers that Baqsimi’s removal from product revenue in 2024 reflects a strategic divestiture and that ongoing revenue comes through a supply agreement, aligning with the original answer’s conclusion about changed strategic positioning. The synthesis of revenue shift and portfolio role is logically sound. (4) The answer is highly contextually relevant, addressing both financial performance and strategic positioning across years. Despite minor factual overreach, the core narrative matches the ground truth. Correctness score is 8 due to accurate main facts but significant unverified additions; quantitative accuracy is 7 due to incorrect or unsupported figures; qualitative and contextual scores are high due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 536,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "In the 2022 filing (as of 12/31/2021) Union Pacific owned 48,962 of its 50,818 containers (≈96 % owned, 4 % leased) and 29,875 of its 44,023 chassis (≈68 % owned, 32 % leased)【page_24】. By 12/31/2024 the mix had shifted to 46,375 of 46,663 containers owned (≈99 % owned, 1 % leased) and 4,356 of 5,553 chassis owned (≈78 % owned, 22 % leased)【page_19】. Thus the owned‑to‑leased ratio rose from roughly 26 : 1 to about 161 : 1 for containers, and from about 2 : 1 to roughly 3.6 : 1 for chassis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key metrics. (1) Quantitative Accuracy: The numbers provided are incorrect. For example, the LLM claims Union Pacific owned 48,962 containers in 2022, but the ground truth states total owned *Total Highway Revenue Equipment* was 78,837 units (containers and chassis combined), with no breakdown by container/chassis ownership in the original answer. Similarly, the LLM reports leased chassis and containers separately with precise percentages, but the ground truth does not provide such granular data for 2022 or 2024 at that level of detail. Most critically, the LLM states that as of 12/31/2024, Union Pacific had 46,663 total containers and 5,553 total chassis — data not present in the original answer and inconsistent with the reported drop to 50,731 total *owned* units and 1,485 *leased* units in 2024. The original answer does not support the claim that the owned-to-leased ratio rose to 161:1; it only states that leased containers dropped from 1,856 to 288 and leased units overall fell from 16,004 to 1,485. (2) Completeness: While the LLM attempts to address the shift in ownership ratios, it introduces overly precise percentage breakdowns and equipment totals not found in the ground truth, missing the broader strategic trend emphasized in the original — a significant reduction in both owned and leased assets, especially in chassis and leased containers. (3) Entity Accuracy: The company (Union Pacific) and time periods (2022, 2024) are correct, but the specific metrics (e.g., 46,375 owned containers in 2024) are fabricated or misaligned. (4) Reasoning: The multi-hop synthesis is flawed — the LLM appears to pull detailed container/chassis splits from document pages not available in the context and constructs ratios not supported by the ground truth. It also misinterprets the timeline, referencing '2022 filing (as of 12/31/2021)' which conflates reporting year with reference date. (5) Semantic Equivalence: The conclusion about increasing ownership ratios contradicts the ground truth, which emphasizes a *reduction* in total assets and a move toward owning *fewer* assets overall, not just leasing less. The original indicates a downsizing strategy, while the LLM portrays an optimization of lease/own mix — a fundamentally different narrative. Thus, despite addressing the general topic, the answer is factually incorrect on core data points and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 661,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "In the 2022 filing Capital One listed securitized‑debt obligations of $16.973 billion, which accounted for roughly 4 % of its total funding sources [page 211]. By year‑end 2023 that balance had risen to $18.043 billion [page 210]—an increase of about $1.1 billion—showing that securitization continued to be a modest but growing component of Capital One’s overall funding mix, supplementing its primary reliance on deposits and other debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the securitized debt obligation amounts for 2022 ($16.973 billion) and 2023 ($18.043 billion), which aligns with the ground truth's 2023 figure and implies the 2022 value accurately. The $1.1 billion increase is correctly calculated (18.043 - 16.973 = 1.07 ≈ 1.1 billion). However, the 4% funding share claim is not present in the ground truth and cannot be verified from the provided information, introducing an unsupported quantitative assertion. (2) The dollar amounts are accurate and formatting is consistent; the calculation of the year-over-year increase is approximately correct. The 4% figure lacks corroboration and may be inferred incorrectly from other data, reducing quantitative accuracy slightly. (3) The LLM captures the evolution in magnitude (increase in balance) but omits the key qualitative shift noted in the ground truth: the reclassification of securitized debt obligations under Level 2 of the fair value hierarchy in 2023, indicating a methodological change in valuation and risk management. This omission represents a failure in multi-hop reasoning, as the evolution in role within the funding structure involves both quantitative and qualitative dimensions (valuation transparency, standardization), not just size. (4) The answer remains contextually relevant, addressing the evolution of securitized debt in Capital One’s funding strategy over 2022–2023 and correctly identifying it as a growing but secondary source. However, the absence of the fair value hierarchy shift—a critical signal of structural integration and risk management—limits the depth and accuracy of the qualitative assessment. Thus, while factually sound on numbers, the answer misses a key analytical point required for full correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 484,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "In 2023 LLY reported Zyprexa under the neuroscience segment as product revenue (U.S. $79.4 m; outside U.S. $1,615.4 m) and the footnote clarified that this amount “includes sale of the rights for the olanzapine portfolio.” 【page_67】 By 2024 the Zyprexa‑related amount no longer appears as product revenue; it is captured in “collaboration and other revenue,” which the 2024 note says “includes the revenue resulting from … the 2023 sales of rights for the olanzapine portfolio, including Zyprexa” and is reported as a $1.45 billion net gain on the sale of those rights. 【page_64】【page_75】 Thus the revenue shifted from being shown as ordinary product sales to a one‑time collaboration‑type gain recognized from the sale of the olanzapine (Zyprexa) rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution of LLY's Zyprexa revenue between 2023 and 2024: in 2023, revenue was reported as product sales and explicitly included the sale of rights for the olanzapine portfolio; by 2024, Zyprexa-related revenue no longer appears in product sales but is instead included in 'collaboration and other revenue' as a result of that prior sale. (2) Quantitatively, the figures are correct: $79.4 million (U.S.) and $1,615.4 million (outside U.S.) in 2023 product revenue, totaling approximately $1.695 billion in product revenue, and a $1.45 billion net gain in 2024 under collaboration revenue. While the 2023 total is not summed in the answer, the individual components are accurate and the 2024 figure matches the gain recognition. The shift from product to collaboration revenue is correctly quantified and contextualized. (3) The multi-hop reasoning is sound: the model correctly links the 2023 sale of rights to the 2024 recognition of revenue under collaboration arrangements, demonstrating synthesis across years and reporting categories. (4) All entities—LLY, Zyprexa, olanzapine portfolio, neuroscience segment, collaboration revenue—are correctly identified and used in context. The answer provides greater detail than the ground truth, including geographic revenue splits and specific financial figures, without introducing errors. Semantic equivalence is strong, and the conclusion about the shift in recognition method is precisely aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 432,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "In the 2022 filing the pension‑plan table shows Federal Government Securities measured at fair value using “Significant Other Observable Inputs (Level 2)” – i.e., a generic Level 2 fair‑value approach【page_72】. By the 2024 filing the company spells out that these securities are valued through a bid‑evaluation process with bid data from independent pricing sources, and they are still classified as Level 2 investments【page_56】. Thus, the classification remained Level 2, but the methodology shifted from a broad Level 2 input description to a specific bid‑based valuation process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Federal Government Securities were classified under Level 2 in both 2022 and 2024, and accurately describes the evolution from a generic 'Significant Other Observable Inputs (Level 2)' description in 2022 to a more specific bid-evaluation process using independent pricing sources in 2024. The dollar amount of $742 million from 2022 is missing in the LLM answer, which is a minor omission but does not affect the core reasoning. (2) All mentioned numbers and years are correct; no calculations were required. The absence of the $742 million figure reduces completeness slightly but does not introduce inaccuracy. (3) The multi-hop reasoning is sound—correctly comparing the valuation methodology across two years and synthesizing changes in disclosure specificity while maintaining consistent classification. The conclusion that the classification remained Level 2 but with a more detailed methodology is logically and factually supported. (4) The answer is contextually fully relevant, directly addressing the evolution of both valuation methodology and classification. The semantic meaning matches the ground truth, with only a minor detail (the 2022 dollar value) omitted. Hence, high scores across all dimensions with a 9 in correctness due to the partial omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 370,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Both the 2022 and 2023 10‑K disclosures say that Capital One “uses borrower credit scores … in some cases to drive product‑segmentation decisions” (2022 p. 103; 2023 p. 95). The 2023 table shows a slight shift in the score mix (e.g., domestic‑card scores > 660 fell from 69 % to 68 %), indicating the firm still relies on credit‑score data for segmentation and is fine‑tuning its models as the portfolio’s risk profile changes—an indication of a consistent, data‑driven credit‑risk modeling strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One uses credit scores for product segmentation in both 2022 and 2023, which aligns with the ground truth. However, it fails to accurately describe the evolution in data sourcing — the ground truth states that in 2022, Capital One used historical data from 2020–2021 (as shown in Table 21), and in 2023 updated to using 2022–2023 data. The LLM does not mention this shift in time periods used for modeling, which is central to the evolution. Instead, it cites a minor percentage change (69% to 68%) in borrowers with scores >660, which may be accurate but is not present in the original answer and distracts from the core evolution in data recency. (2) The quantitative accuracy is partially correct — the 68% vs 69% shift might reflect actual data in the filing, but this detail is absent from the ground truth and cannot be verified against it; more importantly, the key temporal shift (from 2020–2021 to 2022–2023 data) is not quantitatively captured. (3) The multi-hop reasoning is incomplete: the model recognizes consistent use of credit scores but misses the strategic shift toward more current data, which indicates a more dynamic risk modeling approach. This omission weakens the conclusion about strategy evolution. (4) While the LLM conveys a plausible interpretation — fine-tuning models and a data-driven strategy — it does not fully capture the proactive, recency-focused shift emphasized in the ground truth. The answer is contextually relevant and factually plausible but lacks the precise multi-hop synthesis of how the data inputs changed over time, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 456,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "In the 2022 filing AWS is mentioned mainly as a cost element and an investment focus – the MD&A notes “costs necessary to run AWS” among variable costs and says Amazon will “invest efficiently … including AWS” as part of its broader technology and infrastructure spending【page_18】 and【page_19】. By the 2023 filing AWS is elevated to a standalone operating segment alongside North America and International, and the company stresses that “we are investing in AWS, which offers a broad set of on‑demand technology services” as a core growth priority【page_3】 and【page_21】. This reflects a shift from treating AWS as a supporting cost‑center to positioning it as a distinct strategic segment that receives dedicated capital and leadership focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of AWS's strategic positioning from 2022 to 2023: in 2022, AWS was part of broader technology and infrastructure investments, mentioned in the context of costs and efficient investment; by 2023, it was elevated to a standalone operating segment alongside North America and International. These characterizations match the original answer’s core claims. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all references to years (2022, 2023) and document locations (page numbers) are correct and consistent with factual sourcing. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring a strategic shift from AWS as a cost/investment item to a core business segment. The use of terms like 'cost-center' is interpretive but reasonable and semantically aligned with the original's 'strategic investment area.' (4) The only minor shortcoming is that the LLM answer does not explicitly list the specific services AWS offers (e.g., compute, storage, database, analytics, machine learning) as detailed in the original answer, which slightly reduces completeness in qualitative detail. However, it captures the essential transformation in strategic role. Wording differs but meaning is preserved. Thus, correctness is high—9 out of 10—with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 434,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "In 2022 PMI’s Rothmans, Benson & Hedges (RBH) was already de‑consolidated under the CCAA and presented as an equity investment with no loss provision, but the filing disclosed that RBH faced large Canadian class‑action judgments and had to post CAD 226 million (≈ $177 million) in security, creating a contingent exposure. By 2024 PMI still held the equity stake, but because the allocation of a CAD 32.5 billion settlement remained unresolved, it re‑valued the investment and booked a $2.3 billion non‑cash impairment charge, signalling a much larger potential financial hit.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) between 2022 and 2024, correctly identifying the deconsolidation under CCAA, the shift to equity method accounting, and the $2.3 billion impairment in 2024. However, there are minor but notable inaccuracies in quantitative details: (1) The $177 million security amount is derived from CAD 226 million, but this figure refers to court-ordered security posted by RBH in prior years (not specifically in 2022), and the original answer does not mention this detail, so its inclusion introduces unverified information. (2) The impairment charge is stated as $2.3 billion in the LLM answer, while the ground truth specifies $2,316 million — though this is a minor rounding difference, it reduces quantitative precision. (3) The LLM implies RBH was already presented as an equity investment in 2022, while the original answer states it was deconsolidated due to restructuring, with no explicit mention of immediate equity method application — this is a subtle but important distinction in accounting treatment timing. The qualitative reasoning is strong: it correctly synthesizes the impact of the CAD 32.5 billion proposed settlement on PMI’s impairment decision, showing multi-hop understanding between litigation developments and financial statement impacts. The answer is contextually fully relevant, addressing both accounting treatment and financial exposure. While the core facts and trajectory are correct, the introduction of a specific security amount not in the ground truth and slight misrepresentation of the 2022 accounting treatment prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 463,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Biktarvy accounted for $8.6 billion of 2021 sales (≈31 % of Gilead’s $27 billion total revenue) – the single largest contributor among its HIV products【page_70】. The 2024 filing still describes HIV medicines, including Biktarvy, as a “substantial portion” of the company’s revenue but highlights heightened product risks – competitive and generic pressure, pricing‑regulation initiatives and the possibility that a shift away from tenofovir‑alafenamide (TAF)‑based regimens could erode sales【page_18】. Thus, Biktarvy’s commercial importance remains high, but its risk profile has become more pronounced.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Biktarvy as a major revenue driver for GILD and notes its continued importance through 2024, along with increasing risks. However, there is a significant error in the quantitative details: the LLM states that the $8.6 billion in Biktarvy sales were from 2021, citing the 2022 10-K, but the ground truth specifies that the $8,624 million refers to 2022 sales. This misattribution of the fiscal year undermines the accuracy of the timeline. Additionally, the LLM introduces a percentage (31%) and total revenue figure ($27 billion) not present in the original answer, which, while potentially derivable, are not confirmed in the ground truth and introduce unverified data. (2) The revenue amount is approximately correct ($8.6 billion vs. $8,624 million), but the year is wrong—this is a critical error in a time-sensitive financial context. The lack of 2024 revenue data in both answers is consistent. (3) The reasoning correctly synthesizes information across years—using 2022 data to establish revenue significance and 2024 risk disclosures to assess evolving risks—demonstrating sound multi-hop logic. The connection between TAF-based therapies and potential erosion of sales is accurately drawn from the risk factors. (4) Despite the year misassignment, the overall qualitative assessment of Biktarvy’s sustained importance and growing risk profile aligns well with the ground truth. The answer remains contextually relevant and addresses both revenue contribution and product risks as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 430,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific’s equity‑method investment in TTX grew from about **$1.6 billion** (the amount reported in the 2022 10‑K) to **$1.9 billion** at year‑end 2024, and its TTX car‑hire cost rose from **$375 million** (2021) to **$432 million** in 2024 (the 2024 filing also shows the 2022 expense was $402 million)【page_89†L1-L5】【page_68†L1-L5】. This reflects a larger financial stake in TTX and higher usage‑related expenses over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Union Pacific's investment in TTX increased from $1.6 billion (as reported in the 2022 filing, referencing 2021 value) to $1.9 billion in 2024, and car hire expenses rose from $375 million (2021) to $432 million in 2024. The LLM correctly notes the 2022 expense ($402 million), which is consistent with the upward trend and adds contextual detail not in the original answer but not contradicting it. (2) The answer is complete, addressing both financial stake (investment value) and operational relationship (car hire expenses) over the 2022–2024 period, with appropriate time-point references. (3) Entities are accurate: 'Union Pacific', 'TTX', 'equity-method investment', and 'car-hire cost' are correctly identified and aligned with the knowledge graph. (4) The reasoning is sound: the LLM synthesizes data across multiple years and filings, correctly interpreting the increasing trend as indicative of growing financial and operational involvement. The inclusion of the 2022 expense figure enhances the multi-hop analysis without introducing error. (5) Semantic equivalence is maintained—the LLM conveys the same core conclusion as the original answer, with added precision. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 373,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "In the 2022 filing Tesla said it was actively expanding Solar Roof capacity by “on‑boarding and training new installers … and hiring additional skilled electricians” to improve installation capabilities and price efficiencies (2022 p. 34), while also warning that “our suppliers may fail to deliver components … we may need to secure additional or alternate sources” (2022 p. 16). By the 2023 filing the company no longer emphasizes installer‑training programs; instead it flags possible delays in ramping Solar Roof production and focuses on broader supply‑chain risk mitigation and the need for alternate sourcing (2023 p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Tesla's 2022 focus on installer training and hiring skilled electricians, citing specific page references (2022 p. 34) and accurately contrasting this with the 2023 shift toward supply chain risk management (2023 p. 16). The removal of emphasis on installer training in 2023 is correctly noted. (2) There are no numerical values requiring calculation, but the years (2022, 2023) and page numbers are correctly cited, and no quantitative inaccuracies exist. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring a strategic shift from workforce expansion to supply chain resilience. It captures the nuanced change in tone—from growth-focused initiatives to risk mitigation—even if it doesn't explicitly mention 'cost-effective manufacturing processes' or 'collaboration with real estate developers' from the original. (4) The answer is contextually precise, directly addressing both parts of the question: installer training initiatives and supply chain risk management. The only minor omission is the lack of mention of real estate developer collaborations and cost reduction in 2022, which slightly reduces completeness but does not affect core factual correctness. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 388,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "In 2022 the Company’s U.S. bottler agreements barred bottlers from making fountain syrups; Coca‑Cola produced the syrups itself and sold them only to authorized fountain wholesalers (and a few fountain retailers) who then delivered them to restaurants and other outlets【page_8】. By 2023 the Company still manufactures the syrups but now also sells them directly to fountain retailers, while still using authorized wholesalers or bottling partners for distribution, reflecting a shift toward a more direct relationship with fountain retailers【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly states that in 2022, U.S. bottlers were not authorized to manufacture fountain syrups and that Coca-Cola manufactured and sold them to authorized fountain wholesalers and some retailers. In 2023, it accurately notes that the Company still manufactures syrups and now explicitly sells to both fountain retailers and authorized wholesalers or bottling partners. The key evolution—greater direct engagement with fountain retailers and a clarified tiered distribution model—is correctly captured. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2023) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes changes in distribution strategy across two years and correctly infers a shift toward a more direct relationship, which is supported by the source. (4) The only minor shortcoming is that the LLM says bottler agreements 'barred' bottlers from making syrups, while the original answer frames it as 'not authorized'—a slight difference in tone but not in substance. Also, the original emphasizes a 'more explicit acknowledgment of a tiered distribution model,' which the LLM captures implicitly but doesn't explicitly state. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 384,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 only by reference to the governing instrument – listed as Exhibits 4.1 and 4.2 to a Form 8‑K filed on May 22 2017 – and treated them as a debt note without explicitly showing them in the Section 12(b) securities table. By the 2024 filing, IBM now lists the same 0.950 % Notes due 2025 (ticker IBM25B) in its Section 12(b) registration table, indicating they are a listed debt security on the New York Stock Exchange, thereby moving from an exhibit‑only reference to an explicit registration and classification as a publicly‑traded note.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates (May 22, 2017), percentages (0.950%), and ticker symbol (IBM25B) are accurate. The evolution from 2022 to 2024 is correctly framed with precise references to Form 8-K exhibits and Section 12(b) registration. (2) The answer is complete, addressing both the classification (from exhibit-only to listed security) and registration details (listing on NYSE under ticker IBM25B). (3) Entity accuracy is perfect: IBM, the 0.950% Notes due 2025, Form 10-K, Form 8-K, Exhibit 4.1/4.2, Section 12(b), and NYSE are all correctly identified and contextualized. (4) The multi-hop reasoning is sound—synthesizing information across years (2022 vs 2024), document types (10-K vs 8-K), and disclosure practices (referenced vs registered) to conclude the evolution in treatment. The semantic meaning is equivalent to the original answer, with enhanced detail (e.g., mention of Section 12(b) table) that improves clarity without introducing error. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 302,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "In the 2022 Form 10‑K Gilead framed Biktarvy as a litigation‑heavy asset: it settled all ViiV‑related patent claims with a $1.25 billion one‑time charge (recorded in cost of goods sold) and agreed to pay a 3 % royalty on U.S. sales through Oct 5 2027, thereby converting a large, uncertain legal risk into a known, recurring expense while securing a broad worldwide license that differentiates Biktarvy as a next‑generation HIV regimen【page_94】. By the 2024 filing the focus has shifted to market‑level risks—state pricing reforms, 340B discounts, and generic competition—highlighting that Biktarvy’s competitive advantage now rests on its TAF‑based integrase‑inhibitor profile and the protected license, with financial exposure limited to the ongoing royalty and broader pricing pressures rather than a large settlement charge【page_18】【page_21】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides relevant context about Biktarvy's strategic positioning but introduces specific quantitative and factual details not present in the ground truth, leading to partial inaccuracy. (1) The $1.25 billion settlement and 3% royalty through Oct 5, 2027, are specific figures not mentioned in the original answer and cannot be verified against the provided ground truth, which makes the quantitative claims unsupported. (2) The ground truth emphasizes a shift in financial risk from Biktarvy’s central role in 2022 to growing concerns over reliance on TAF-based therapies and paradigm shifts by 2024, particularly due to generic competition and changing treatment preferences. The LLM reframes this around litigation resolution and pricing pressures, which, while plausible, adds unverified specifics (e.g., ViiV litigation settlement details, 340B discounts, TAF-based integrase-inhibitor profile) not present in the original. (3) The multi-hop reasoning is logically structured—showing evolution from legal to market risks—but diverges from the ground truth’s focus on therapeutic paradigm shifts and long-term differentiation. (4) While the LLM captures the general trend of increasing financial risk and competitive pressure, it substitutes the core rationale (shift away from TAF-based regimens) with unverified litigation and royalty details, reducing factual correctness. Wording and conceptual flow are strong and contextually relevant, but unsupported numbers and altered reasoning basis limit accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 417,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "In 2022 Lockheed Martin moved a large block of its defined‑benefit pension liability to an insurer – buying group‑annuity contracts that transferred about $4.3 billion of gross obligations and triggered a $1.5 billion non‑cash pension‑settlement charge 【page_82】. By 2023 the strategy shifted to a much smaller, voluntary settlement – a $414 million payment to roughly 6,500 former participants that reduced the pension trust’s obligation without a comparable large charge 【page_82】, and the company’s contributions to its defined‑contribution retirement‑savings plans rose modestly to $1.2 billion in 2023 from $1.1 billion in 2022 【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in gross defined benefit pension obligations via group annuity contracts, resulting in a $1.5 billion noncash pension settlement charge; in 2023, the company made $414 million in settlement payments to approximately 6,500 former employees. These numbers match the original answer exactly, and formatting variations (e.g., $4.3 billion vs $4.3B) are acceptable. (2) The qualitative reasoning correctly identifies the strategic shift—from large-scale insurer transfers in 2022 to direct individual settlements in 2023—demonstrating sound multi-hop synthesis across years and methods. (3) The addition of defined-contribution plan contributions increasing from $1.1B to $1.2B is contextually relevant and accurate per page 89, though not part of the original answer; this extra detail enhances context without distorting the core response. (4) The only minor shortcoming is that the original answer emphasizes the contrast in strategy more explicitly as an evolution in approach, while the LLM implies it through description. However, the semantic meaning and factual content are equivalent. No calculation errors or entity inaccuracies exist. Scores reflect high accuracy with near-perfect reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 378,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "In IBM’s 2022 filing the 2025‑maturing debt bucket included four issues – the 2.875% Notes, 0.950% Notes, 0.875% Notes and the 7.00% debentures (IBM 25A, 25B, 25C and 25) 【page_1†L31-L38】. By the 2024 filing the 0.875% Notes (IBM 25C) are no longer listed, leaving only the 2.875% Notes, the 0.950% Notes and the 7.00% debentures (IBM 25A, 25B and 25) 【page_1†L31-L38】. Thus, the 2.875% Notes due 2025 have persisted unchanged, while the lower‑coupon 0.875% Notes were removed from the 2025 maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the persistence of the 2.875% Notes due 2025 (IBM 25A) and the removal of the 0.875% Notes (IBM 25C) by 2024, which aligns with the ground truth. However, it introduces a '7.00% debentures (IBM 25)' not mentioned in the original answer, which states only three notes in 2022: 2.875%, 0.950%, and 0.875%. This is a factual overstatement not supported by the ground truth. (2) Quantitatively, the percentages (2.875%, 0.950%, 0.875%) and years (2025) are accurate. The erroneous addition of a 7.00% debenture affects quantitative accuracy slightly, but core numbers related to the 2.875% Notes are correct. (3) The reasoning correctly tracks the evolution of debt composition and infers persistence of the 2.875% Notes, but the multi-hop synthesis is flawed by including an unsupported instrument (7.00% debentures), suggesting possible confusion between different IBM debt series or misattribution from another filing. (4) Contextual relevance is high as the answer directly addresses the evolution of IBM's 2025 debt and the role of the 2.875% Notes. However, the incorrect inclusion of an extra debt instrument reduces factual precision and qualitative accuracy, preventing a higher score. The core conclusion about the 2.875% Notes remaining is correct, but the supporting details are partially inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 377,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "In the 2022 filing Gilead highlighted that “the continued growth of Biktarvy in all geographies” was a key driver of its revenue increase (2022 10‑K p. 39). By the 2024 filing the company flags that its HIV franchise—including Biktarvy—now faces heightened risk from generic and other competitive products and from any shift away from nucleoside‑based (TAF) regimens that could erode its market share (2024 10‑K p. 18; see also 2022 10‑K p. 19 and 2024 10‑K p. 21).  Thus, while Biktarvy remains strategically important as a major revenue source, its risk profile has risen as competitive pressures and potential treatment‑paradigm changes threaten its dominance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Biktarvy was a key growth driver, citing Gilead's 10-K language about 'continued growth in all geographies'—consistent with the original answer. In 2024, it accurately reflects the increased risk profile due to competitive pressures and potential shifts away from TAF-based therapies, referencing the correct risk factors in the 10-K. (2) There are no numerical inaccuracies; the answer avoids making up figures and correctly references qualitative disclosures. The absence of specific percentages (e.g., the 11% revenue increase mentioned in the ground truth) does not detract from correctness, as the LLM still correctly attributes revenue growth to Biktarvy without misrepresenting data. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings, correctly inferring a shift in strategic importance and risk profile over time. It connects Biktarvy’s reliance on TAF to broader franchise vulnerability, demonstrating proper understanding of the treatment paradigm risk. (4) The answer is contextually excellent—directly addressing the evolution of strategic importance and risk, competitive pressures, and treatment paradigm changes. The only minor shortcoming is not explicitly stating that Biktarvy’s strategic positioning has become 'precarious' or 'vulnerable' in the same terms as the ground truth, but the meaning is semantically equivalent. Thus, the answer is factually correct, well-supported, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 432,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow balance rose from **$1.449 billion at September 30, 2022** to **$1.764 billion at September 30, 2023** – a $315 million increase. During FY 2023 the company deposited **$1.0 billion** into the escrow account (see the “Deposits into the U.S. litigation escrow account” line for 2023) ; the FY 2022 deposit amount is not detailed in the excerpts (the FY 2022 ending balance of $1.449 billion reflects prior deposits, including a $467 million takedown payment noted in the 2022 filing).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the U.S. litigation escrow account balance increased from $1,449 million at the end of FY 2022 to $3,089 million at the end of FY 2023. However, the LLM reports an end balance of only $1.764 billion (i.e., $1,764 million) in FY 2023, which is $1,325 million lower than the correct value. Additionally, the LLM states that deposits in FY 2023 were $1.0 billion, but the ground truth specifies $1,500 million ($1.5 billion). The FY 2022 deposit amount is missing in the LLM answer, while the ground truth states it was $1,000 million. (2) The quantitative discrepancies are severe: the reported increase of $315 million in the LLM answer (from $1,449M to $1,764M) is less than a quarter of the actual increase of $1,640 million ($3,089M - $1,449M). The deposit figures are also incorrect—$1.0B vs $1.5B in FY2023, and no mention of the $1.0B deposit in FY2022. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the balance evolution and deposit contributions across both fiscal years. It incorrectly infers that the FY2022 ending balance reflects prior deposits including a $467M takedown, which does not align with the ground truth narrative of annual deposits increasing from $1B to $1.5B. (4) Scores are low due to major factual and numerical errors, especially in key financial figures and trends. Contextual relevance is moderate because the answer addresses the right topic and time frame, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 426,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "In the 2022 filing Coca‑Cola said that fountain syrups were **produced by its bottling partners outside the United States** using the company’s concentrates, and the company’s role was limited to supplying those concentrates (see 2022 page 35). By the 2023 filing the company reports that it **now manufactures fountain syrups in the United States and sells them directly to fountain retailers, authorized fountain wholesalers or bottling partners, and that these syrup sales are recorded in the North America operating segment** (see 2023 page 36). Thus, the company moved from relying on bottlers to make and distribute fountain syrups to taking on both manufacturing and primary distribution of the syrups within North America.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the interpretation of the 2022 and 2023 roles, reversing the actual evolution described in the ground truth. According to the original answer, in 2022 Coca-Cola manufactured fountain syrups in the U.S. and sold them directly or through partners, while in 2023 the company highlighted that outside the U.S., bottling partners were authorized to manufacture syrups from concentrates—indicating a shift toward decentralization abroad, not a change within North America. The LLM incorrectly claims that in 2022, bottling partners outside the U.S. were producing syrups and that Coca-Cola only supplied concentrates, which misrepresents the 2022 arrangement as passive when the ground truth emphasizes active U.S. manufacturing and sales. Furthermore, the LLM asserts that by 2023 Coca-Cola 'moved from relying on bottlers' to taking on manufacturing and distribution in North America, implying a shift *into* direct control, when the ground truth states there was no explicit change *within North America* and that direct U.S. control was already in place in 2022. This is a critical reversal of the timeline and operational logic. While the LLM correctly identifies that syrup sales are recorded in the North America segment and references appropriate geographic distinctions (U.S. vs. outside), its core reasoning and conclusion about evolution are factually inverted. There are no numerical values to assess, so quantitative accuracy is scored based on correct use of years (2022, 2023) and document references (page numbers), which are plausible though not verifiable here. Contextually, the answer addresses the question’s focus on manufacturing and distribution evolution, but due to the reversed causality and incorrect assignment of responsibilities across years, the qualitative accuracy is low. The model fails the multi-hop reasoning by misaligning entity roles over time, leading to an incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 529,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM listed four securities maturing in 2025 – 2.875% notes, 0.950% notes, 0.875% notes and 7.00% debentures (2022 page 1). By the 2024 filing the 0.875% notes were no longer shown, leaving only the 2.875% notes, the 0.950% notes and the 7.00% debentures (2024 page 1). Thus, the 0.950% Notes due 2025 have persisted, while the overall 2025 debt composition narrowed from four instruments to three.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual error in the number of debt instruments listed in 2022. The ground truth states there were three notes maturing in 2025 in 2022: 2.875%, 0.950%, and 0.875% Notes. However, the LLM claims there were four, including 7.00% debentures, which are not mentioned in the original answer as part of the 2025 maturities. This overstatement introduces inaccuracy. While the LLM correctly identifies that the 0.875% Notes were removed by 2024 and that the 0.950% Notes persisted, it incorrectly implies that the 7.00% debentures were part of the 2025 maturity bucket, which is not supported by the ground truth. (2) The percentages (2.875%, 0.950%, 0.875%) are accurate, but the inclusion of the 7.00% debentures as a 2025-maturing instrument is unsupported and incorrect per the original answer. No calculations are involved, so quantitative accuracy hinges on correct enumeration and attribution—where the LLM fails by adding an unverified instrument. (3) The multi-hop reasoning is partially sound: the model correctly compares 2022 and 2024 compositions and notes the disappearance of the 0.875% Notes. However, the synthesis is flawed because it introduces an entity (7.00% debentures) not present in the ground truth for 2025 maturities, undermining the validity of the comparison. (4) Contextual relevance is high because the response directly addresses the evolution of debt composition and the status of the 0.950% Notes. However, due to the incorrect count and inclusion of an unsupported debt instrument, the qualitative and quantitative accuracy scores are reduced. The core trend (narrowing of instruments, persistence of 0.950%) is correct, but the factual foundation is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 481,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships primarily as a risk‑laden, capital‑intensive investment – noting that COVID‑19 had forced a suspension of cruise‑ship sailings and that the company must “invest substantial amounts … before we know the extent to which these products will earn consumer acceptance.” By the 2024 filing the tone had shifted to an expansion strategy: Disney explicitly announced plans to add new vessels to its fleet, referenced launch costs for new ships, and even discussed a write‑down tied to the closure of the Star Wars: Galactic Starcruiser, showing that the company moved from a cautious, risk‑focused stance to actively growing its cruise‑ship business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Disney's strategic approach to cruise ships between 2022 and 2024. (1) It accurately captures the shift from a cautious, risk-focused stance in 2022—highlighting the impact of the pandemic and uncertainty around consumer acceptance—to a more proactive expansion strategy in 2024, including fleet growth and associated costs. The mention of the Star Wars: Galactic Starcruiser write-down adds relevant context about strategic risks, which is consistent with the 2024 filing's emphasis on uncertain returns. (2) There are no numeric values, dates, or financial figures in dispute; the answer avoids making up numbers and sticks to qualitative disclosures, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: it synthesizes information across two years of 10-K filings, correctly identifying a shift in tone and strategy. However, the original answer emphasizes that in 2022, cruise ships were discussed as part of broader travel and resort experiences dependent on consumer demand, whereas the LLM answer frames 2022 as already being about 'risk-laden, capital-intensive investment'—a slightly stronger characterization than the ground truth supports. This nuance is important: the original answer suggests a more passive mention in 2022, while the LLM implies a more detailed risk discussion. This minor overstatement reduces qualitative accuracy slightly. (4) Despite this, the answer is highly relevant, directly addressing the question about strategic evolution, and includes key evidence from both years. The inclusion of the Galactic Starcruiser write-down, while not in the original answer, is factually accurate and adds depth, so it does not detract from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 488,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "In the 2022 filing Lockheed Martin explained that, after the August 2021 purchase of group‑annuity contracts that transferred $4.9 billion of pension obligations, it recorded a $1.7 billion non‑cash settlement charge and noted that it had bought roughly $11.6 billion of such contracts since 2018, emphasizing that it would keep seeking pension‑risk‑transfer deals to reduce volatility【page_60】. By the 2023 filing the company reported no cash contributions to its qualified plans in 2023 (and none planned for 2024) and disclosed that its master retirement trust obtained a loan collateralized by private‑equity assets to invest in fixed‑income securities, while reiterating the intent to pursue additional risk‑transfer transactions but without a new large GAC purchase or settlement charge【page_88】【page_87】. This reflects a shift from recording a sizable one‑time settlement charge to using financing mechanisms and maintaining a “look‑for‑more‑transactions” strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the $4.9 billion pension obligation transfer in August 2021, the $1.7 billion noncash settlement charge, and the $11.6 billion total transferred since 2018. It also accurately notes no cash contributions in 2023 and none planned for 2024, which aligns with the strategic context. These numbers match the ground truth exactly, earning a perfect score on quantitative accuracy. (2) The entity identification is correct—Lockheed Martin, group annuity contracts (GACs), and the relevant timeframes (2022 and 2023 filings) are all properly referenced. (3) The reasoning is largely sound: the LLM identifies a shift in strategy from executing a major transaction (2022) to maintaining intent without new large purchases, and introduces the use of a loan from private-equity assets to fund fixed-income investments. However, it omits a critical qualitative point emphasized in the ground truth: the 2023 acknowledgment of potential residual liability if insurers default on GACs, which represents a more cautious risk framing not present in 2022. This nuance is central to the evolution in strategic intent and risk perception but is missing in the LLM response. (4) While the LLM captures the financial impact and general strategic continuity, it fails to fully convey the evolved risk awareness—specifically the possibility of retained liability—thus missing a key dimension of the strategic shift. The answer remains highly relevant and factually accurate on surface metrics, but lacks depth in capturing the full strategic re-framing. Hence, correctness and qualitative accuracy are slightly reduced, while contextual relevance and quantitative precision remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 474,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "In the 2022 Form 10‑K Tesla explained that its accounts‑receivable balances are “primarily … receivables from financial institutions and leasing companies offering various financing products to our customers,” and that collections can take up to two weeks and fluctuate with the timing of partner payments and government rebates (see 2022 page 64). By the 2023 filing, the focus has shifted to the broader financing‑partner relationship, noting that Tesla’s ability to fund and grow its vehicle‑leasing program now depends on “securing adequate financing … and managing the resulting greater levels of residual‑value and credit risk” with its partners (see 2023 page 20). This shows an evolution from routine receivable‑management details to a heightened emphasis on partner‑funded leasing‑program risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure about accounts receivable taking up to two weeks to settle is accurately represented, including the context of fluctuations due to partner payments and government rebates (2022 page 64). In 2023, the shift toward increased focus on residual value and credit risk in leasing programs is correctly identified (2023 page 20). (2) There are no numerical inaccuracies—no specific dollar amounts or percentages are misstated, and the time frame of 'up to two weeks' matches the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying a shift in emphasis from operational cash flow timing (2022) to strategic and financial risks in leasing (2023). (4) The answer is contextually fully relevant, directly addressing both parts of the question—evolution in accounts receivable management and leasing program risks. The only minor shortcoming is a slightly less explicit mention of 'compliance' risk compared to the original answer, but 'credit' and 'residual value risk' are clearly covered. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 389,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "In the 2022 filing the company’s U.S. bottler agreements barred bottlers from making fountain syrups and the company sold syrup only to “authorized fountain wholesalers (including certain authorized bottlers) and some fountain retailers,” with those wholesalers delivering the product to restaurants and other outlets (page 8, 2022). By 2023 the strategy was broadened: Coca‑Cola now manufactures the syrup and can sell it directly to fountain retailers **or** to “authorized fountain wholesalers **or bottling partners** who in turn sell and distribute the fountain syrups to fountain retailers” (page 37, 2023). Thus, bottlers moved from a limited, mostly non‑manufacturing role to being authorized distributors of syrup, while fountain wholesalers shifted from being the sole channel to sharing distribution with direct retailer sales and bottler partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor inaccuracy in emphasis regarding bottler manufacturing rights. (1) Correct elements: The 2022 model is accurately described—bottlers in the U.S. were not authorized to manufacture fountain syrups, and Coca-Cola sold directly to authorized fountain wholesalers (including some bottlers) and certain retailers. The shift in 2023 is also correctly noted: bottling partners gained a more active distribution role. The citation of page numbers and document years adds precision. (2) Quantitative accuracy is perfect—no numerical or date errors; all references to years (2022, 2023) and roles are factually sound. (3) Multi-hop reasoning is strong: the model synthesizes changes across two years and correctly identifies evolving roles of bottlers and wholesalers. However, the LLM states that bottlers became authorized distributors but does not explicitly mention the key evolution outside the U.S.—that bottlers were now typically authorized to *manufacture* fountain syrups using Coca-Cola concentrates. This is a significant qualitative omission. The LLM focuses on distribution rights but underemphasizes the manufacturing shift, which is central to the ground truth. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: changes in distribution strategy and the evolving roles of bottlers and wholesalers. Due to the omission of the manufacturing aspect, which is a core component of the 2023 change, the correctness and qualitative accuracy scores are slightly reduced, but not severely, as the distribution evolution is accurately captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 455,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "In 2023 AMD reported a $9 million receivable from the ATMP JV (​page 78​), and its equity‑method investment in the JV was about $99 million (​page 78​). By year‑end 2024 the receivable had risen to $12 million (​page 74​) and AMD also originated a new $100 million one‑year term loan to the JV, which is recorded as a related‑party receivable (​page 74​). In addition, AMD contributed an extra $17 million of equity in August 2024, raising the carrying value of its ATMP JV investment to roughly $149 million (​page 75​).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The original answer states that AMD had no direct investment or loan to the ATMP JV in 2023, but the LLM claims an equity-method investment of $99 million in 2023, which contradicts the ground truth. Additionally, the LLM reports a $17 million equity contribution in August 2024 and a total investment value of $149 million, none of which are mentioned in the original answer. These figures are entirely fabricated and not supported by the ground truth. The receivables ($9M in 2023, $12M in 2024) and the $100 million term loan in 2024 are correctly reported. (2) Completeness: While the LLM covers receivables and new lending, it incorrectly adds equity investments not present in the original, making the response misleading despite addressing the general topic. (3) Entity Accuracy: The companies (AMD, ATMP JV) and years (2023, 2024) are correct, and the $100 million loan is accurately described. However, the addition of an equity investment distorts the nature of the financial relationship. (4) Reasoning: The multi-hop reasoning fails because the model infers an equity investment and additional capital contribution without basis, leading to an incorrect characterization of AMD’s relationship with the JV as more deeply integrated via ownership, rather than just credit extension. (5) Semantic Equivalence: The core shift from transactional to financially supportive via a loan is partially captured, but the erroneous inclusion of equity investments fundamentally changes the interpretation. Thus, despite some correct numbers, the overall correctness is low due to major factual errors in financial activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 472,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "In 2022 Lockheed Martin addressed its non‑qualified pension liabilities by buying a group‑annuity contract that transferred about $4.3 billion of gross obligations to an insurer; the transaction was accounted for as a non‑cash, non‑operating pension‑settlement charge of roughly $1.5 billion to accelerate actuarial losses into earnings【page_82】. By 2023 the company had shifted to a more targeted, cash‑based approach – a voluntary Q4 offering that paid $414 million to settle benefits for roughly 6,500 former participants, directly reducing the pension obligation without a comparable large non‑cash settlement charge【page_82】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in voluntary cash settlements to about 6,500 former employees. These numbers match the original answer exactly, with acceptable formatting variations (e.g., $4.3 billion = $4.3B). (2) The answer addresses all parts of the question—evolution of approach, pension obligation settlements, and financial impacts—across both years. (3) Entities (Lockheed Martin, nonqualified defined benefit pension plans, years 2022 and 2023) and financial terms (noncash settlement charge, voluntary payments, obligation reduction) are correctly identified and used. (4) The reasoning is sound: the LLM correctly infers a strategic shift from large-scale, noncash liability transfers in 2022 to smaller, targeted, cash-based settlements in 2023, avoiding major noncash charges. This synthesis across years and transaction types demonstrates strong multi-hop understanding. The inclusion of page references (page_82) further supports fidelity to source data. No factual, numerical, or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 362,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "In 2023 AMD’s 15 % equity‑method investment in the ATMP joint venture was about **$99 million**, generating **$16 million of equity‑income** on the consolidated statement of operations【page_78】. By the end of 2024 that investment had risen to roughly **$149 million** (including a $100 million term loan to the JV) and the equity‑income recognized grew to **$33 million**【page_75】. This reflects a substantial increase in both the size of AMD’s stake and the earnings it derives from the ATMP JV.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 equity income ($16 million) and carrying value ($99 million), as well as the 2024 equity income ($33 million) and final carrying value ($149 million), which aligns with the ground truth. However, it incorrectly states that the increase in investment included a $100 million term loan, which is not mentioned in the original answer and contradicts the ground truth that AMD contributed an additional $17 million. This is a significant quantitative error. The correct calculation should be: $99M + $17M = $116M, but the final carrying value is $149M, implying other adjustments (e.g., equity income, other comprehensive income, or additional contributions not specified), but the LLM’s attribution to a $100M loan is unsupported and factually incorrect. (2) The numbers for equity income and initial/final carrying values are accurate, but the explanation of the $149M value is flawed due to the erroneous $100M loan claim. The original answer states a $17M contribution, not $100M or any loan. (3) The multi-hop reasoning is partially sound—correctly linking 2023 and 2024 values and interpreting increased investment and returns—but the synthesis is compromised by introducing an unverified financial instrument (term loan) not present in the ground truth. (4) The contextual relevance is high as it directly addresses the evolution of AMD's financial relationship with ATMP JV. Qualitative accuracy is good due to correct entity identification and trend interpretation. Quantitative accuracy is reduced due to the fabricated $100M loan. Correctness score is 7 because core financial figures (income, values) are correct, but a major factual error in explaining the investment increase prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 481,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "In 2023 Johnson & Johnson kept a 9.5 % equity stake in Kenvue after the August‑23 exchange offer – recorded in other assets at a fair‑value of $4.3 billion (about $3.9 billion at year‑end) – and the retained stake posted an unfavorable $0.4 billion fair‑value change, while the overall separation produced a $21 billion non‑cash gain (including a $2.8 billion gain on the retained Kenvue shares) 【page_41†L9-L13】【page_108†L5-L9】【page_93†L1-L3】【page_111†L9-L12】【page_109†L9-L12】. In 2024 the company completed a debt‑for‑equity exchange of its remaining 182 million Kenvue shares, eliminating any ownership and recording a $0.4 billion loss in other (income) expense 【page_41†L15-L18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: All key numbers are correct—9.5% retained stake in 2023, $4.3 billion fair value (with $3.9 billion year-end value noted), $21 billion non-cash gain (including $2.8 billion on retained shares), 182 million shares (matches 182,329,550 rounded), and $0.4 billion loss in 2024. The $0.4 billion fair-value change mentioned is consistent with the loss recorded, though phrased as an unfavorable change rather than a realized loss. (2) The answer correctly identifies the August 2023 exchange offer and the 2024 debt-for-equity exchange that eliminated ownership. (3) Multi-hop reasoning is sound: it connects the 2023 partial divestiture with retained equity and gains, then the 2024 full exit with a loss, showing evolution over time. (4) Minor point: the ground truth specifies the $2.8 billion gain is part of the $21 billion total, which the LLM captures correctly. The LLM adds detail about fair value decreasing to $3.9 billion by year-end, which is accurate but not in the original answer—this is a minor enhancement, not an error. The only slight discrepancy is framing the $0.4 billion as both an unfavorable fair-value change in 2023 and a realized loss in 2024; however, the $0.4 billion loss in 2024 is correctly attributed to the final disposal. This does not contradict the original but could be clearer in distinguishing the two events. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 420,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "AT&T’s guarantee of Southwestern Bell Telephone Co.’s obligations was disclosed in both the 2022 and the 2023 Form 10‑K. In each filing the guarantee appears under Item 4‑b as a “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” (Exhibit 4‑c), indicating that the relationship was retained and not removed or altered between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, and that the guarantee was disclosed in both years under Exhibit 4-c. The key factual elements—continuity of the guarantee, inclusion of Southwestern Bell Telephone Co., and reference to Exhibit 4-c—are accurate and consistent with the ground truth. However, there is a minor error in the LLM answer: it incorrectly states the exhibit appears under 'Item 4-b', while the ground truth specifies 'Exhibit 4-c' as the location, not an item number. This mischaracterization of the document structure slightly undermines the precision of the response. There are no numerical inaccuracies, as the question does not involve calculations or specific financial figures. The reasoning is sound in synthesizing the multi-hop requirement—comparing the guarantee's presence across two years and entities—and correctly concludes no change occurred. The answer is contextually relevant and addresses all parts of the question, though with a small factual inaccuracy in the exhibit referencing. Thus, the correctness and qualitative accuracy scores are slightly reduced, while quantitative accuracy and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 359,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "In the 2022 filing, hypersonics were described as a **major Space‑segment program** and identified as a key growth area for the company (2022 10‑K p. 8; 13). By the 2023 filing, Lockheed Martin has repositioned hypersonics within its **Advanced Development (Skunk Works) organization** and the **Missiles & Fire Control (MFC) segment**, giving it a broader, cross‑segment strategic focus and explicit responsibility for the design, development and production of hypersonic strike weapons (2023 10‑K p. 4; 5).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies in entity and strategic positioning details, leading to a partially incorrect synthesis. (1) Correctly identifies that hypersonics became more prominent in 2023 and references program responsibilities in design and development, which aligns with the ground truth. However, it incorrectly states that in 2022, hypersonics were already a 'major Space-segment program'—the original answer clarifies that in 2022, hypersonics were described only as a potential growth area dependent on government funding, not yet a major active program. (2) The LLM claims that in 2023, hypersonics were repositioned into Skunk Works and MFC with a cross-segment focus, but the ground truth only confirms placement under the Space segment in 2023, with no mention of Skunk Works or MFC in this context. These are specific entity and organizational misattributions. (3) The multi-hop reasoning is partially sound—there is an attempt to compare evolution across years and assess strategic positioning—but the synthesis is flawed due to incorrect sourcing of organizational placement. (4) Quantitative accuracy is high because there are no numerical errors (dates 2022/2023 are correct, no faulty calculations). Contextual relevance is strong as the response addresses strategic positioning and program responsibilities. However, due to key factual errors in entity assignment and premature elevation of hypersonics' status in 2022, the overall correctness is significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 422,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The escrow held **$1.4 billion** at September 30 2022 after Visa deposited **$850 million** during fiscal 2022 (V_10K 2022 p.46). By September 30 2023 the balance had risen to **$1.764 billion**, reflecting a **$1.0 billion** deposit in fiscal 2023 (V_10K 2023 p.73; restricted‑cash reconciliation shows $1,764 million on p.72).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting balance of $1.4 billion as of September 30, 2022, and correctly states that $850 million was deposited in fiscal year 2022 and $1.0 billion in fiscal year 2023, which matches the ground truth. However, it reports the ending balance as $1.764 billion instead of the correct $3.089 billion, which is a significant factual error. This suggests a misinterpretation of the restricted cash reconciliation table in the 2023 10-K (p.72), possibly confusing the escrow account with another restricted cash component. (2) Number verification: $1.4 billion (correct), $850 million deposit (correct), $1.0 billion deposit (correct), but $1.764 billion ending balance is incorrect — the correct figure is $3.089 billion. The calculation implied by the LLM — $1.4B + $1.0B = $2.4B — doesn't even match their reported $1.764B, indicating internal inconsistency. (3) Multi-hop reasoning is partially sound: the model correctly pulls deposits from two fiscal years and associates them with the correct documents, but fails to accurately extract or synthesize the final balance, breaking the chain of reasoning. It also does not explain the full evolution of the balance, which requires showing how deposits and possibly other adjustments lead to the final amount. (4) Correctness score is 5 due to half the key numbers being right (initial balance, both deposits) but the final balance — a core part of the question — being wrong. Quantitative accuracy is penalized heavily for the incorrect final balance. Qualitative accuracy is moderate because the reasoning structure is present but based on flawed data. Contextual relevance is high as the answer addresses the right entities, timeframes, and question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 479,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "In the 2022 Form 10‑K, Outdoor Garden was shown as a separate merchandising department within the Hardlines product line, posting $10.3 billion in net sales – about 6.8 % of Home Depot’s total net sales【page_56】. By the 2024 filing the company had realigned its merchandising structure, still placing Outdoor Garden in Hardlines but expanding that line to include Power and Storage & Organization; Hardlines net sales were $48.6 billion (virtually unchanged from FY 2022)【page_56】, indicating Outdoor Garden remains a stable, core component of the broader Hardlines strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Outdoor Garden was a distinct category in 2022 with $10.3 billion in net sales (matching the ground truth $10,317 million, rounded appropriately) and 6.8% of total sales, which is accurate. However, the claim that Hardlines net sales were $48.6 billion in 2024 and 'virtually unchanged from FY 2022' is not supported by the original answer and introduces unverified data not present in the ground truth. The original answer does not provide Hardlines sales figures or make performance comparisons across years beyond the reclassification. (2) The numeric values for 2022 are correct with acceptable rounding ($10.3 billion ≈ $10,317 million). The $48.6 billion figure for 2024 Hardlines sales and the assertion of stability are not in the ground truth and cannot be verified, representing a quantitative overreach. (3) The reasoning correctly captures the structural shift—Outdoor Garden moving from a separately disclosed line to being grouped under Hardlines by 2024. However, the LLM adds unsupported inference about performance stability and integration with Power and Storage & Organization, which, while plausible, goes beyond the original answer’s scope and risks misrepresenting the evidence. (4) The answer is contextually relevant and addresses the evolution in classification and strategic positioning, but the added performance claims reduce qualitative and quantitative accuracy. The core multi-hop synthesis—comparing disclosure treatment across years—is sound, but the conclusion extends beyond the provided data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 433,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD’s 2023 filing notes that with roughly 26,000 employees the company “believes we are at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment” (page 15). In 2024 the workforce grew to about 28,000 and AMD still highlights the same culture—backed by an annual engagement survey that ranked its scores among the best in the tech industry, high ERG participation, mentorship and flexible benefits (pages 13 & 14). By preserving this inclusive, high‑engagement environment as headcount expands, AMD signals that its talent‑retention strategy relies on culture and employee development to keep top talent in a fiercely competitive semiconductor market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: workforce size of 26,000 in 2023 and 28,000 in 2024 is correctly reported, and the implied 7.7% growth is accurate (2,000 / 26,000 ≈ 7.69%). No calculation errors. (2) The entity (AMD), years (2023–2024), and cultural messaging are correctly identified. (3) The multi-hop reasoning is sound—connecting workforce growth with consistent cultural emphasis and linking it to talent retention in a competitive industry. However, the LLM adds details not present in the original answer: the 'annual engagement survey,' 'ERG participation,' 'mentorship,' and 'flexible benefits' are not mentioned in the ground truth and appear to be inferred or drawn from external knowledge. While these are plausible cultural elements, they were not part of the knowledge graph-based answer, making this a minor overreach in completeness. (4) Despite this, the core reasoning—that AMD preserves its culture to retain talent during expansion—is correctly inferred and matches the original conclusion. The answer is contextually excellent and semantically equivalent in intent, though slightly augmented with unsupported specifics. Hence, a high score with minor deduction for unsupported qualitative additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 363,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "In the 2022 Form 10‑K AT&T disclosed a “Guaranty of certain obligations of … The Ohio Bell Telephone Company” (Exhibit 4‑d). The 2023 Form 10‑K repeats the same guarantee listing under Exhibit 4‑d, showing that AT&T’s role as guarantor of The Ohio Bell Telephone Company’s obligations remained unchanged – no new guarantee was added nor the existing one terminated.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that AT&T maintained its guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023, with no termination or expansion of the guarantee. The key entities (AT&T, The Ohio Bell Telephone Company), years (2022, 2023), and exhibit reference (Exhibit 4-d) are correctly identified. However, there is a minor discrepancy in the exhibit number: the original answer states Exhibit 4-c (originally filed in 2011), while the LLM claims Exhibit 4-d in both years. This inconsistency affects the qualitative accuracy, as the exhibit reference change (from 4-c to updated documentation) was a key point in the ground truth indicating updated reporting practices. The LLM incorrectly asserts the exhibit number remained the same (4-d in both years), which contradicts the original answer’s emphasis on documentation updates. Despite this, the core conclusion—that the guarantee remained stable—is correct, and the answer fully addresses the question about the evolution of the relationship. No numerical errors are present, so quantitative accuracy is perfect. Contextual relevance is strong as all parts of the question are addressed with appropriate focus on guarantee obligations and year-over-year comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 353,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "In 2023 GE recorded a $5.8 billion gain on retained and sold ownership interests, driven largely by its AerCap stake (see page 8). By 2024 that benefit had collapsed – the company reported a $5.2 billion decline in those gains, leaving only a modest gain of roughly $0.6 billion, essentially wiping out most of the 2023 upside from the AerCap relationship (see page 8).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and context but contains a critical numerical inaccuracy. The original answer states that in 2023, GE reported a $5.7 billion increase in corporate operating profit due to gains on retained and sold ownership interests (primarily from AerCap and GE HealthCare). The LLM incorrectly states this figure as $5.8 billion, which is close but not accurate. (2) The $5.2 billion decrease in gains in 2024 compared to 2023 is correctly reported by the LLM and matches the ground truth. However, the LLM makes an unsupported calculation by subtracting $5.2B from $5.8B to imply a remaining gain of ~$0.6B in 2024. This is a logical leap not present in the original answer, which only states the year-over-year decrease in gains, not the absolute level of 2024 gains. The original does not confirm that 2024 gains were $0.6B, so this inference introduces error. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies the decline in gains related to AerCap and GE HealthCare across 2023 and 2024 and links the change to the AerCap relationship. However, it over-interprets the data by quantifying the 2024 gain when the original only provides the year-over-year decrease. (4) The contextual relevance is perfect — the answer directly addresses the evolution of the financial impact of GE's relationship with AerCap in terms of gains on ownership interests. The qualitative reasoning is strong but marred by the unsupported inference. Quantitative accuracy is reduced due to the $5.7B vs $5.8B discrepancy and the erroneous $0.6B derived figure. Correctness score is 7 because core facts (direction, magnitude of decline, key drivers) are correct, but key numbers are slightly off and an unsupported calculation is introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 488,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "In the 2022 Form 10‑K Home Depot only noted that it had bought HD Supply in 2020 as a “strategic transaction” expected to drive sales, cost‑savings and synergies, without tying the subsidiary to any specific customer segment. By the 2024 filing, the company explicitly says that HD Supply is the primary channel through which it delivers MRO products and value‑added services to its professional‑customer base (multifamily, hospitality, healthcare, government housing, etc.), making it a core component of its Pro‑focused growth strategy. This reflects a shift from a generic acquisition to a targeted platform for serving pros and expanding MRO offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: HD Supply was acquired in 2020, and by 2024 it was positioned as a core part of Home Depot’s strategy for professional customers via MRO services. The 2022 filing correctly reflects a more general 'strategic transaction' characterization without specific customer segment linkage, while the 2024 shift emphasizes targeted use for pros—consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct year references (2020, 2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points (2022 vs 2024) and entities (Home Depot, HD Supply), showing evolution in strategic emphasis. The conclusion about a shift from generic integration to a Pro-focused platform is logically supported. (4) The only minor shortcoming is that the LLM omits mention of 'integration risks and challenges' explicitly noted in 2022 per the ground truth, instead characterizing it as a 'strategic transaction'—which is true but slightly less precise in tone. However, the core progression in strategic use is accurately captured. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses the evolution in strategy regarding professional customers and MRO services.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 415,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD’s 2023 Form 10‑K noted that it held roughly 7,500 U.S. patents (≈2,000 pending) and about 12,800 issued patents worldwide – ≈18,500 total patent matters – and that “numerous cross‑licensing and technology‑exchange agreements” were a core part of its IP strategy【page_15】. By the 2024 filing the U.S. patent count was unchanged at ~7,500 (pending fell slightly to ~1,900), while worldwide issued patents rose to ~13,200 and total matters to ~18,800, again emphasizing “numerous cross‑licensing and technology‑exchange agreements”【page_13】. Thus, AMD’s reliance on cross‑licensing has remained steady, but its patent portfolio grew modestly, giving it a larger pool of IP to leverage in technology‑exchange deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports AMD's total worldwide patent matters as ~18,500 in 2023 and ~18,800 in 2024, with issued patents increasing from ~12,800 to ~13,200 and pending applications remaining stable at ~5,600 (implied by total minus issued). The LLM adds U.S.-specific detail (~7,500 issued U.S. patents, ~2,000 pending in 2023, ~1,900 in 2024), which is not in the original answer but does not contradict it and may reflect additional data from the 10-K. These numbers match the ground truth within acceptable rounding and formatting variations. (2) The answer addresses all parts of the question: evolution between 2023 and 2024, patent portfolio size changes, and implications for technology exchange via cross-licensing. (3) Entities (AMD, years 2023/2024, patent counts, cross-licensing) are correct and properly contextualized. (4) The reasoning is sound: the LLM correctly infers that while reliance on cross-licensing remains steady (based on repeated language in filings), the growth in issued patents strengthens AMD’s position in such agreements. The only minor limitation is that the original answer explicitly connects the portfolio growth to enhanced leverage in cross-licensing, while the LLM implies it—this slight reduction in explanatory depth prevents a perfect 10, but the core facts and synthesis are correct. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 413,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "In 2023 Johnson & Johnson kept a minority stake in the newly independent Kenvue – about 9.5 % (≈182 million shares) recorded as a $4.3 billion equity investment and hit by a $0.4 billion fair‑value loss (see 2023 10‑K p. 108, 111, 93). The companies also entered into transition‑service and manufacturing agreements that were slated to wind down within 24 months after the IPO. By fiscal 2024 J&J eliminated that ownership through a debt‑for‑equity exchange in Q2, swapping the remaining Kenvue shares for commercial paper, recording a $0.4 billion loss and ending its equity position and related strategic relationship (see 2024 10‑K p. 69, 55).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor formatting differences. (1) Quantitatively: The 9.5% stake, $4.3 billion valuation, $0.4 billion fair-value loss in 2023, and $0.4 billion loss on disposal in 2024 are all correct. The share count of approximately 182 million aligns with the ground truth (182,329,550), and the $3.6 billion commercial paper payoff is accurately implied via the debt-for-equity exchange, though the exact dollar amount is not explicitly stated in the LLM answer. (2) Completeness: The answer covers both years, the retention and disposal mechanics, financial impacts, and strategic context including transition agreements. The only minor omission is the specific mention of May 2024 as the timing of the debt exchange, though 'Q2 2024' is a reasonable proxy. (3) Entity accuracy is correct—Johnson & Johnson, Kenvue, equity stake, commercial paper, and financial metrics are all properly identified. (4) Reasoning is sound: the multi-hop synthesis of stake retention in 2023 followed by disposal via debt settlement in 2024 is logically presented, and the conclusion that J&J fully exited Kenvue is correct. (5) Semantic equivalence is strong—wording differs but meaning matches. The answer cites specific 10-K pages, enhancing credibility. The $3.6 billion figure's absence is a small gap but does not undermine the factual core. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 412,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In the 2022 Form 10‑K, AT&T’s guarantee schedule lists Indiana Bell Telephone Co. Inc. as one of the entities whose obligations are covered by a “Guaranty of certain obligations… (Exhibit 4‑d)” 【page_141】. The 2023 Form 10‑K repeats the same language, again naming Indiana Bell in the same guarantee disclosure (Exhibit 4‑d) 【page_103】. Thus, AT&T’s relationship with Indiana Bell, as reflected in the guarantee disclosures, remained unchanged from 2022 to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Indiana Bell Telephone Co. Inc. was included in AT&T’s guarantee disclosures under Exhibit 4-d in both 2022 and 2023, with no changes in the relationship. (2) There are no numerical values requiring calculation, but the years (2022 and 2023), exhibit reference (Exhibit 4-d), and entity name (Indiana Bell Telephone Co. Inc.) are all factually correct. Page numbers (141 and 103) are provided as supporting evidence and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of Form 10-K filings to conclude that the guarantee remained unchanged. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in the guarantee relationship. All aspects of the question are covered with accurate, concise, and relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 274,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "In 2023 GE still had a senior note receivable from AerCap and paid $203 million of net cash to the leasing company while it sold its remaining AerCap equity, leaving an equity‑and‑note fair‑value balance of about $944 million at year‑end (2023 10‑K p. 51‑52). By 2024 the AerCap stake was fully divested – no cash payments to AerCap are reported and the prior gains on the AerCap investment turned negative, contributing to a $5.2 billion reduction in earnings from retained and sold ownership interests (2024 10‑K p. 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $203 million net cash payment to AerCap in 2023 and the $5.2 billion reduction in gains on retained and sold ownership interests in 2024 are accurately reported. The mention of the $944 million equity-and-note fair-value balance at year-end 2023, while not in the original answer, is consistent with the 2023 10-K and adds detail without contradicting the ground truth. (2) The timeline is correct—2023 reflects ongoing involvement with cash flows and receivables, while 2024 shows full divestment and no further cash payments. (3) The reasoning correctly captures the multi-hop transition: from operational involvement (note receivable, product leases, transition services) in 2023 to complete divestment in 2024, resulting in a negative contribution to investment gains. (4) The only minor gap is that the LLM answer states the AerCap stake was 'fully divested' by 2024, while the original answer frames it as GE holding an investment stake but with reduced gains—this is a subtle but important distinction. However, the $5.2 billion decrease in gains is correctly attributed to AerCap and GE HealthCare, and the cessation of cash flows is properly noted. The LLM slightly overstates the divestment as 'fully divested' without clarifying if a non-controlling stake remained, but the financial impact is accurately portrayed. Overall, the answer is factually sound, well-supported by cited documents, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 424,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "In 2022 Home Depot framed store appearance chiefly as a physical‑only differentiator, investing in a “store refresh package,” way‑finding signs, front‑end redesigns, self‑service lockers and associate handheld “GET phones” to make stores easier to navigate and speed checkout, all to boost the in‑store customer experience (page_10). By 2024 the company still cites store location and appearance as a competitive factor, but now positions the store as the hub of an “interconnected shopping experience,” coupling refreshed layouts with mobile‑app store maps, digital signage and seamless online‑to‑offline inventory and fulfillment tools so that the physical look and feel supports a frictionless, digitally integrated customer journey (page_8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, The Home Depot focused on physical store appearance improvements such as store refreshes, way-finding, front-end redesigns, self-service lockers, and associate handheld devices to enhance in-store experience. By 2024, the company evolved to position stores as the hub of an 'interconnected shopping experience,' integrating digital tools like mobile app store maps, digital signage, and online-to-offline inventory and fulfillment. These details are consistent with the original answer’s emphasis on a shift from physical aesthetics to a digitally integrated experience. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022, 2024) are correctly used. (3) The multi-hop reasoning is sound—correctly synthesizing changes over time in strategy, linking store appearance to broader customer experience and digital integration, and identifying the evolution in competitive positioning. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'price' and 'product availability' as co-competitive factors in 2022 as noted in the original answer, and slightly overemphasizes 'physical-only' in 2022, whereas the original answer frames appearance as part of a broader set of competitive factors even then. However, this does not materially distort the overall accurate narrative of strategic evolution. Wording differs but semantic meaning is equivalent. Thus, correctness is excellent but not perfect—justifying a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 436,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "In 2023 AMD’s only resale to the ATMP JV was modest – about $14 million – and its relationship was limited to the $1.7 billion of purchases and the related payables/receivables. By 2024 resales had surged to roughly $121 million, AMD made a $17 million equity contribution (lifting its JV investment to about $149 million) and entered a new one‑year, $100 million term‑loan agreement with the JV on Oct. 9 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. While it correctly identifies the $14 million resales in 2023 and the $121 million in 2024 (matching the ground truth), it introduces incorrect information not present in the original answer: (1) a $17 million equity contribution and an updated JV investment of $149 million, which are not mentioned in the ground truth; (2) a specific date of October 9, 2024, for the loan agreement, whereas the original only states 'October 2024'. The ground truth does confirm the $100 million term loan for general corporate purposes, which the LLM correctly includes. However, the addition of unverified equity contributions and precise dating reduces quantitative accuracy. The answer is contextually relevant, addressing the evolution of the financial relationship and correctly noting the surge in resales and new loan arrangement. The qualitative reasoning is partially sound—recognizing a deepening financial relationship—but is based on some fabricated data. Multi-hop synthesis is attempted but compromised by the inclusion of unsupported details. Overall, while the core resale figures and loan are correct, the incorrect additions lower the correctness score to 4 due to significant factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 359,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "In the 2023 filing Johnson & Johnson said it had put in place global privacy‑compliance programs and controls, required mandatory privacy training for all employees, and was monitoring the emergence of new privacy statutes and data‑localisation rules that could affect cross‑border data flows (2023 p. 22‑23). The 2024 filing builds on that foundation by adding stronger board‑level oversight through the Regulatory Compliance & Sustainability Committee, more frequent CISO updates to the board, and an explicit focus on adapting its privacy controls to the expanding suite of international privacy laws and data‑flow regulations (2024 p. 22‑23). Thus the company has moved from establishing baseline compliance to actively strengthening governance and updating its programs to meet new regulatory requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. It correctly identifies that Johnson & Johnson had established privacy compliance programs in 2023 with a focus on emerging privacy laws and data localization affecting cross-border data flows. The 2024 evolution is accurately portrayed as an expansion involving stronger governance (board-level oversight via the Regulatory Compliance & Sustainability Committee and more frequent CISO updates), which reflects a maturation from baseline compliance to enhanced governance—consistent with the ground truth's emphasis on broadened focus and anticipatory posture. The mention of 'expanding suite of international privacy laws' matches the original answer’s shift from 'other territories' to 'globally.' However, the LLM answer introduces specific structural details (mandatory employee training, CISO reporting frequency, committee name) not present in the ground truth, which comes from a knowledge graph based on actual filings but does not include those granular implementation details. While these additions are plausible and contextually appropriate, they go beyond the verified facts in the original answer, slightly reducing qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default (no errors). Contextual relevance is perfect—the response directly addresses the evolution between 2023 and 2024 in response to new laws and international data flow regulations. Overall, the semantic meaning and multi-hop reasoning (comparing two years’ disclosures to infer evolution) are sound, though minor over-specification prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 467,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "By the end of 2023 GE estimated that Bank BPH‑related borrower litigation would cost about **$2.669 billion**, and it set **$1.963 billion of valuation allowances** against the financing receivables held for sale (including **$1.712 billion** directly tied to those losses). At year‑end 2024 the loss estimate fell to **$2.461 billion** and the related allowances dropped to **$1.594 billion** (with **$1.517 billion** linked to the litigation), fully offsetting the remaining receivables. Thus, both the estimated litigation loss and the valuation allowance were reduced between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the 2023 and 2024 total estimated litigation losses ($2.669 billion and $2.461 billion), which match the ground truth. It also correctly reports the $1.712 billion and $1.517 billion portions of valuation allowances directly tied to litigation in 2023 and 2024, respectively. However, it introduces significant inaccuracies in the total valuation allowances: it claims $1.963 billion in 2023 and $1.594 billion in 2024, which do not match the ground truth values of $1,712 million and $1,517 million. The LLM appears to have added other components incorrectly (e.g., possibly conflating valuation allowances with other liabilities). (2) In 2023, the ground truth specifies $1,712 million in valuation allowances and $957 million in other liabilities, summing to $2,669 million total estimated losses. The LLM’s reported $1.963 billion in valuation allowances exceeds this and misrepresents the structure. Similarly, in 2024, the LLM reports $1.594 billion in allowances, but the correct amount is $1,517 million. These are material quantitative errors. (3) The reasoning is partially sound: the LLM correctly identifies a reduction in both estimated losses and valuation allowances and notes the full offset of receivables by 2024, which aligns with the strategic shift mentioned in the original. However, it fails to mention the $944 million in other liabilities in 2024, omitting a key component of the financial exposure. (4) The contextual relevance is high as it addresses the evolution of GE’s exposure and the trend of reduction. The qualitative accuracy is moderate because the core narrative of decreasing exposure is correct, but the financial breakdown is flawed. The correctness score is 6 due to correct directional trends and some accurate numbers, but significant errors in key financial figures undermine full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 516,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "In FY 2022 Home Depot reported that the Indoor Garden category generated about **$15.5 billion in net sales – roughly 10 % of total net sales**, highlighting its strong contribution (HD 2022 10‑K, merchandising‑department table). By FY 2024 the company still places Indoor Garden in the **Hardlines merchandising department**, but the Hardlines grouping was reshaped – “Tools” was replaced with “Power” and “Storage & Organization” – indicating a re‑organization of the merchandising structure while retaining Indoor Garden within Hardlines (HD 2024 10‑K, merchandising‑department table).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net sales of the Indoor Garden product line in 2022 as approximately $15.5 billion (ground truth: $15,546 million), which is a minor rounding difference and acceptable in format variation ($15.5 billion ≈ $15,546 million). The percentage of total revenue is reported as 'roughly 10%' by the LLM, while the ground truth specifies 10.3%; this is a small but notable approximation that slightly reduces quantitative accuracy. The 2024 merchandising department classification is correctly identified as 'Hardlines', matching the ground truth. (2) The LLM adds detail not present in the ground truth — that 'Tools' was replaced with 'Power' and 'Storage & Organization' — which may be accurate based on the 2024 10-K but goes beyond the scope of the original answer. However, this does not contradict the ground truth and adds contextual insight. (3) The multi-hop reasoning is sound: the model connects financial performance in 2022 with organizational categorization in 2024, correctly inferring a strategic shift in positioning by retention within a restructured Hardlines department. The conclusion that Indoor Garden remains in Hardlines aligns with the ground truth’s claim of reclassification into Hardlines, though the LLM does not explicitly state that it was previously standalone — a minor omission affecting completeness. (4) Scores reflect high factual accuracy, with slight deductions in quantitative precision due to rounding and percentage approximation, and in qualitative accuracy for not fully articulating the shift from standalone to integrated category. Contextual relevance is perfect as all information directly addresses the evolution of treatment and positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 472,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "In its 2022 filing, Colgate‑Palmolive said it managed commodity‑price volatility through a global mix of tools – working‑capital management, selective borrowing, selling‑price increases, sourcing strategies and limited hedging (primarily futures contracts in the Hill’s Pet Nutrition segment)【page_89】. By the 2024 filing, the company still relies on sourcing strategies and limited commodity‑hedge contracts, but now stresses price‑increase actions and broader cost‑efficiency programs in manufacturing and distribution as the primary levers to offset raw‑material price swings, reflecting a shift toward more proactive cost‑containment rather than segment‑specific hedging【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Colgate-Palmolive used sourcing strategies alongside other tools like limited hedging (specifically futures in Hill’s Pet Nutrition), working-capital management, and price increases to manage commodity price volatility. In 2024, it accurately notes a shift toward more proactive cost containment, including price increases and broader cost-efficiency programs in manufacturing and distribution, reflecting a move away from segment-specific hedging. These points are semantically equivalent to the original answer’s emphasis on increased focus on raw material cost volatility, defensive tactics, and productivity initiatives. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers an evolution in strategy—from a mix of tools with limited hedging to a greater reliance on pricing and operational efficiency. The mention of Hill’s Pet Nutrition as the primary user of futures contracts adds specificity not in the original but is consistent with filing details (per citation). (4) Minor deduction in qualitative accuracy due to omission of specific commodities named in the original (resins, essential oils, soybeans) and geopolitical/climatic disruption exposure, which adds context to the defensive shift. However, the core evolution in strategy is correctly captured. Overall, the answer is factually correct, contextually relevant, and conveys the same strategic shift as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 468,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA’s sales rose from $3.147 billion in fiscal 2023 to $3.670 billion in fiscal 2024 – a 16.6% increase year‑over‑year (2024 table) after a 17.9% rise from 2022 to 2023 (2023 table)【page_31】. The growth was driven by market expansion and continued strength in psoriasis/psoriatic‑arthritis indications and a favorable patient‑mix (2023 discussion) and by strong operational volume growth in 2024, with only a modest negative currency impact tempering the increase【page_32】【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: TREMFYA sales increased from $3.147 billion in 2023 to $3.670 billion in 2024, representing a 16.6% year-over-year growth, which matches the ground truth. The mention of market expansion, strength in psoriasis/psoriatic arthritis, favorable patient mix, and operational volume growth aligns with the original answer. The negative currency impact of 1.5% in the ground truth is paraphrased as 'modest negative currency impact,' which is semantically acceptable though slightly less precise. (2) All numeric values are accurate: $3.147 billion, $3.670 billion, and 16.6% increase are correctly stated and calculated. The additional note about 17.9% growth from 2022 to 2023 is not in the ground truth but is not incorrect—just extra context—and does not detract from accuracy. (3) The multi-hop reasoning is sound: the model synthesizes sales figures across years and attributes growth drivers from different sections (e.g., 2023 discussion and 2024 data), correctly linking performance to operational and market factors. (4) The answer is contextually fully relevant, addressing both the sales evolution and contributing factors. The only minor shortcoming is the slightly less specific reference to currency impact (‘modest’ vs. ‘1.5%’), which prevents a perfect 10 in qualitative accuracy. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 404,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "In the 2022 Form 10‑K Disney disclosed that it owned 50 % of A+E (the other 50 % held by Hearst) and listed Nielsen‑based subscriber counts for five A+E channels – A&E (69 M), HISTORY (70 M), Lifetime (69 M), LMN (52 M) and FYI (42 M) 【page_12】. The 2023 filing still shows Disney’s 50 % equity stake in A+E, but the footnote now only reports subscriber totals for A&E, HISTORY and Lifetime (about 58 M each) and no longer includes LMN or FYI, indicating a narrower scope of the partnership while the 50/50 equity‑method ownership remains unchanged 【page_6】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) QUANTITATIVE ACCURACY: The original answer states that in 2022, Disney reported A&E as having 69 million domestic subscribers as part of a partnership, but the LLM incorrectly claims Disney already had a 50% ownership stake in A+E in 2022. This contradicts the ground truth, which describes the 50% equity stake as a change occurring in 2023. The LLM also misrepresents the 2023 subscriber data: it claims A&E, HISTORY, and Lifetime each had 'about 58M' subscribers, while the ground truth states A+E's channels collectively had 58 million domestic subscribers — a significant difference in meaning. Additionally, the LLM introduces specific subscriber numbers for LMN and FYI in 2022 and claims they were dropped in 2023, which is not mentioned in the ground truth. (2) COMPLETENESS: The LLM fails to address the core structural change — the shift from a partnership to a joint ownership model — and its impact on financial reporting. It omits the key point that Disney began including A+E’s financial results under 'Equity in the income of investees' in 2023, which is central to the question. (3) ENTITY ACCURACY: While A+E, Hearst, and channel names are correctly identified, the attribution of the 50% stake to 2022 is incorrect per the ground truth. (4) REASONING: The multi-hop synthesis is flawed — the LLM assumes continuity of ownership rather than recognizing the structural change from 2022 to 2023. It focuses on changes in subscriber reporting scope (channels listed) rather than the fundamental shift in relationship and accounting treatment. (5) SEMANTIC EQUIVALENCE: The answer discusses related details but misrepresents the nature and timing of the structural change, leading to a materially different interpretation. Despite some correct elements (e.g., 50% stake mentioned, subscriber decline), the core reasoning and facts are misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 532,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023 GE reported a modest net gain of $129 million on its AerCap investment (the combined realized‑and‑unrealized gain on the AerCap shares and senior note) 【page_72】, and it sold its remaining AerCap shares that year 【page_73】. By 2024 the AerCap position had reversed – the MD&A notes that “the decrease in gains on retained and sold ownership interests of $5.2 billion, primarily related to our GE HealthCare and AerCap investments” drove earnings down 【page_8】, indicating that the prior AerCap gain was erased and turned into a loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $129 million gain in 2023 and the $5.2 billion decrease in gains in 2024, with AerCap as a key contributor—both align with the ground truth. The statement that GE sold its remaining AerCap shares in 2023 is consistent with the knowledge graph and explains the reversal in financial impact. (2) Quantitatively, all numbers are accurate: $129 million unrealized gain in 2023 and $5.2 billion drop in gains in 2024. The phrasing 'decrease in gains' matches the original, and the interpretation that this represents a reversal from gain to loss or significantly reduced gain is valid. (3) The multi-hop reasoning is sound: the model connects GE’s 2023 gain, the sale of shares, and the 2024 decline in gains to conclude a negative shift in financial impact. It correctly synthesizes information across time and entities (GE, AerCap, ownership interests). (4) The only minor shortcoming is that the LLM refers to the 2023 gain as 'combined realized-and-unrealized' while the ground truth specifies it as 'unrealized'—this is a slight overstatement, though the overall financial narrative remains correct. This does not materially misrepresent the situation but slightly reduces qualitative precision. All other aspects—context, relevance, and factual alignment—are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 370,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "In its 2022 filing Mastercard highlighted a multi‑layered security framework—using Security Operations Centers, Fusion Centers, regular testing and a robust cyber‑risk program—to protect the global payments ecosystem, but it did not call out third‑party provider risk【page_12】. By the 2024 filing the same framework now explicitly manages third‑party service‑provider risk, detailing onboarding, continuous monitoring, off‑boarding and acknowledging incidents tied to those providers【page_11】【page_39】, showing a strategic shift to broaden defenses and proactively address emerging cyber threats across its extended ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Mastercard had a multi-layered security approach but did not explicitly address third-party provider risks, and by 2024, it had explicitly integrated third-party risk management into its framework. The mention of onboarding, continuous monitoring, off-boarding, and incidents tied to third-party providers adds detail consistent with a more evolved, proactive stance. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2024), which are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two different aspects of security strategy (general framework vs. third-party focus), correctly inferring a strategic shift toward ecosystem-wide resilience. (4) The LLM answer conveys the same core evolution and strategic implication as the original answer, with slightly more operational detail (e.g., onboarding/offboarding), which enhances completeness without introducing error. The only minor gap is that the original emphasizes 'public-private partnerships' and 'experts across the organization' as part of the 2024 approach, which the LLM omits—but this is a small contextual detail that doesn't undermine the overall correctness. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 416,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "In its 2022 filing Target noted that the company’s unsecured revolving credit facility – a $3 billion line that had replaced a $2.5 billion facility – includes a debt‑leverage covenant and that Target was “in, and expect[ed] to remain, in compliance” with that covenant【page_30】. By the 2023 filing, after adding a new $1 billion 364‑day revolving facility and extending the existing $3 billion facility to 2028, Target again confirmed it “is, and expect[ed] to remain, in compliance” with the debt‑leverage covenant【page_33】. Thus, compliance has remained unchanged – the company stayed covenant‑compliant despite the credit‑facility modifications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Target was in compliance with its debt leverage covenant in both 2022 and 2023, maintained a $3.0 billion unsecured revolving credit facility, added a new $1.0 billion 364-day facility in 2023, and extended the $3.0 billion facility to 2028 (from 2026). The original answer notes the 2026 expiration pre-extension, which the LLM correctly contrasts with the 2028 extension. (2) Quantitative accuracy is perfect: all dollar amounts ($3.0 billion, $1.0 billion), timeframes (364-day, October 2028), and compliance statements are correctly reported. Format variations (e.g., $3 billion vs $3.0 billion) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes changes in credit facilities across two years and links them to ongoing covenant compliance. It accurately infers that structural changes did not affect compliance status. (4) The only minor shortcoming is that the LLM does not explicitly mention the original 2026 expiration date of the $3.0 billion facility in 2022 (though it implies change by noting the extension to 2028), which slightly reduces completeness. However, this does not impair the overall correctness. Wording such as 'in, and expect[ed] to remain, in compliance' is accurately quoted and reflects the original sentiment. The answer is contextually fully relevant and directly addresses the evolution of compliance and credit facility changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 422,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "In the 2023 filing Salesforce’s AI risk discussion was largely framed as a regulatory‑compliance issue – it warned that evolving privacy laws, cross‑border data rules and new EU AI‑related statutes (e.g., the AI Act, DSA) could limit the use of its AI services and expose the company to legal scrutiny 【page_23】 and that “countries are applying their data and consumer‑protection laws to AI, particularly generative AI” 【page_26】. By the 2024 filing the risk narrative had broadened to the operational and ethical fallout of generative and agentic AI, specifically citing Agentforce, and now lists accuracy, bias, toxicity, privacy, security, data‑provenance, copyright infringement, brand‑reputational harm, legal liability and higher compliance‑governance costs as additional, concrete risks 【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Salesforce's AI-related risks from 2023 to 2024: in 2023, the focus was on regulatory-compliance risks tied to data privacy and emerging laws like the EU AI Act and DSA, which matches the original answer's emphasis on regulatory scrutiny and cross-border data rules. In 2024, the LLM correctly notes an expansion to include operational and ethical risks tied to generative and agentic AI, specifically naming Agentforce—this is consistent with the ground truth. The listed risks (accuracy, bias, toxicity, privacy, security, data provenance, copyright infringement, reputational harm, legal liability, and higher compliance costs) are all semantically aligned with the original answer’s mention of ethical concerns, regulatory scrutiny, legal liabilities, and increased governance costs. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across two years, connects the shift from third-party integration risks to AI-specific risks, and correctly identifies Agentforce as a focal point in 2024. The only minor shortcoming is that the LLM does not explicitly mention the 2023 risk around third-party warranties (i.e., customer expectations for warranties despite not selling third-party offerings), which is a small but specific element of the original answer. However, this omission does not undermine the core accuracy regarding AI risk evolution. (4) The answer is contextually excellent, directly addressing how the nature of risks evolved, and provides document citations (page numbers) supporting its claims. Overall, this is a very strong response with only a slight gap in completeness regarding the 2023 third-party warranty nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 510,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "By fiscal 2023 Lowe’s said that “most parcel‑eligible items can be ordered by a customer and delivered within two business days at standard shipping rates” and that its gig‑network expansion was already providing same‑day delivery for some products【page_6】.  In fiscal 2024 the company refined that promise to “most parcel‑eligible items … delivered within two business days **or less** at standard shipping rates,” added the ability to deliver major appliances next‑day in almost every U.S. zip code, and continued expanding its gig‑provider network for same‑day deliveries【page_6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of Lowe's delivery capabilities: in fiscal 2023, most parcel-eligible items were delivered within two business days at standard rates, and by fiscal 2024, this improved to 'within two business days or less'—a precise semantic match. (2) The LLM correctly identifies the key improvement in 2024: next-day delivery for major appliances in nearly every U.S. zip code, which aligns with the original answer. (3) It adds context about the gig-network expansion supporting same-day delivery, which is consistent with the source (page 6) and enhances completeness without introducing inaccuracies. (4) All entities (Lowe's, fiscal years 2023 and 2024, parcel-eligible items, major appliances, U.S. zip codes) are correctly identified. (5) The reasoning is sound and synthesizes multi-hop information—comparing service levels across years and integrating geographic and speed improvements. (6) There are no numerical or temporal inaccuracies; minor phrasing differences (e.g., 'refined that promise') are semantically equivalent. The answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 340,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The 2022 Form 10‑K notes that the February 2021 sale of Dermstore “represented less than 1 percent of our consolidated revenues, operating income and net assets.” The 2023 Form 10‑K repeats the same statement, indicating the sale still accounts for under 1 % of Target’s consolidated revenues and operating income, so its financial impact remained immaterial and unchanged from 2022 to 2023.【page_21】【page_23】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dermstore's sale represented less than 1 percent of Target's consolidated revenues and operating income in both 2022 and 2023, which matches the ground truth. It accurately notes the immateriality and lack of change in financial impact year-over-year. The February 2021 sale date is correctly referenced. However, the LLM omits mention of the $335 million pretax gain from the sale, which is a key quantitative detail in the original answer, though it is not directly part of the 2022–2023 evolution. (2) All numbers and percentages are accurate: 'less than 1 percent' is correctly cited for both years, and the years (2022, 2023) and entity (Dermstore LLC, Target) are correct. The omission of the $335M gain slightly affects completeness but does not distort the answer. (3) The multi-hop reasoning is sound—LLM synthesizes consistent disclosures from both the 2022 and 2023 10-Ks to conclude no change in financial impact. This demonstrates correct cross-year comparison and understanding of materiality. (4) The answer is contextually fully relevant, directly addressing the evolution of financial impact on revenues and operating income. The omission of the pretax gain is a minor gap in completeness but does not affect the core correctness regarding the ongoing immateriality in 2022 and 2023. Hence, high scores across all categories with a 9 on correctness due to partial omission of a factual element from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 410,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "In the 2023 filing Salesforce presented Data Cloud as a core, hyperscale data engine built on the Einstein 1 platform that “leverages the power of Salesforce metadata to ingest and federate data…to power automation and analytics across multiple service offerings” and that “brings a company’s disconnected, enterprise data into Salesforce to deliver an actionable, 360‑degree view of a customer” (pages 8 & 7). By the 2024 filing the company is positioning Data Cloud as a newer, consumption‑based growth lever within its AI‑infused Customer 360 suite—highlighting its role in expanding multiple‑service adoption—but also flagging that its monetization model is still “relatively new and uncertain” and that it now faces heightened competition from AI‑focused and data‑integration rivals (page 20). This shift shows Data Cloud moving from a foundational data‑integration component to a strategic, revenue‑focused product that must contend with a more competitive, AI‑driven market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: In 2023, Data Cloud was positioned as a hyperscale, native data engine integrated across Salesforce's offerings, particularly for delivering a 360-degree customer view—this is accurately reflected with correct emphasis on integration with Marketing and Analytics via metadata and automation. By 2024, the shift toward framing Data Cloud as a consumption-based product in a competitive, uncertain market is correctly captured, including Salesforce's acknowledgment of limited pricing experience and rising competition from AI and data platforms. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying both the evolution in strategic positioning (from integration engine to revenue lever) and the introduction of competitive and monetization risks. The mention of 'AI-infused Customer 360 suite' and 'consumption-based growth lever' reflects accurate contextual understanding. (4) Minor deduction in qualitative accuracy due to slight rephrasing of 'hyperscale, trusted data engine native to Salesforce' as 'core, hyperscale data engine built on the Einstein 1 platform'—while semantically close, 'Einstein 1 platform' is an addition not present in the original ground truth and could imply a technical specificity not confirmed. However, this does not materially distort the meaning. Overall, the answer is contextually rich, factually correct, and fully addresses the evolution in role and competitive landscape.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 489,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "In the 2023 Form 10‑K Lowe’s still used forward‑interest‑rate swaps as cash‑flow hedges – the note shows a $1.29 billion notional amount of forward swaps designated as cash‑flow hedges (2023 Note 8, p. 58) and the changes in their fair value flowed through other‑comprehensive income, producing a $311 million OCI amount for the year (2023 OCI table, p. 61).  By the 2024 filing the company had removed that hedge designation – the same note lists a $0 notional amount for forward swaps (2024 Note 8, p. 58) and the OCI impact shrank to a modest $13‑$14 million loss (2024 OCI table, p. 61), while the fixed‑to‑floating swaps continued to be accounted for as fair‑value hedges with offsetting earnings effects.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. According to the ground truth, LOW had a $2.0 billion notional amount of forward interest rate swaps in 2023, not $1.29 billion as stated by the LLM. Additionally, the ground truth specifies that LOW received $247 million upon settlement of these contracts, whereas the LLM reports a $311 million OCI amount, which does not match the disclosed settlement gain or cash flow impact. The LLM also cites a $13–14 million OCI loss in 2024, but the ground truth indicates that by 2024, the company shifted to fair value hedging with no net impact on earnings due to the shortcut method, implying minimal to no OCI activity for these instruments — not a specific $13–14 million loss. While the LLM correctly identifies a shift in hedge designation (from cash flow hedges in 2023 to no such designation in 2024) and notes the continued use of fair value hedges for fixed-to-floating swaps, it misrepresents the magnitude and nature of the financial impact. The reasoning partially captures the evolution in accounting treatment but fails to accurately reflect the multi-hop synthesis of notional amounts, hedge types, and financial statement impacts as reported in the actual filings. The contextual relevance is high because the response addresses the core question about changes in hedge designation and accounting impact, but the factual foundation is flawed. Semantic equivalence is not achieved due to incorrect key figures and mischaracterization of OCI effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 424,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "In 2022 Target treated its owned‑brand business as one pillar of a broader strategy – a tool for “differentiating from our competition with our owned brands and a curated assortment of leading national brands” and for delivering affordability (2022 Form 10‑K, Item 1, p. 3). By 2023 the company made owned brands a distinct focus, stating that it will “delight with newness, style, and value by strengthening our owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” (2023 Form 10‑K, Item 1, p. 3). This evolution shows a shift from a supporting pillar to a primary growth driver with explicit objectives to grow and deepen the owned‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Target's strategy from 2022 to 2023: in 2022, owned brands were a 'pillar' among others focused on differentiation and affordability; by 2023, they became a 'distinct focus' tied to delighting customers through 'newness, style, and value.' The key strategic shift—from a supporting role to a central growth driver—is accurately captured. (2) There are no numeric values (e.g., sales figures, number of brands) in the LLM answer, but none are misrepresented either. The ground truth mentions 'over 40' brands in 2022, which the LLM omits, but since the LLM does not claim any specific number, this is a minor omission rather than an error. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying the change in strategic emphasis. It supports claims with direct quotes and proper citations (Form 10-K, Item 1), demonstrating accurate sourcing. (4) The semantic meaning matches the original answer: both describe a strategic elevation of owned brands from descriptive presence to active differentiator and growth engine. The only minor gap is the lack of explicit mention of 'driving traffic, sales, and market share growth' from the 2023 strategy, but the idea is implied in 'primary growth driver.' Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only slight room for added detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 420,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "In 2022 GM’s filing simply described its software‑enabled services as a set of after‑sale offerings – OnStar, vehicle‑connectivity, maintenance and extended‑warranty services that generate “software‑enabled services worldwide” revenue (2022 Note 1 p.60; Services description p.61). By 2023 the company is emphasizing a unified, end‑to‑end software platform that delivers over‑the‑air updates, expands Super Cruise and other digital features, and is already deployed on new EVs such as the 2024 Cadillac LYRIQ and Chevrolet Silverado EV as it rolls out across most products (2023 Business p.5). This shift from discrete services to a scalable OTA‑capable platform signals a deeper investment in a digital architecture that can be leveraged across the entire vehicle portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM's 2022 description of software-enabled services as general offerings (including OnStar and connectivity) matches the original answer's characterization of broad, non-specific involvement. In 2023, the shift to an end-to-end software platform enabling over-the-air (OTA) updates for features like Super Cruise, active safety, and infotainment is accurately described. The deployment on 2024 Cadillac LYRIQ and Chevrolet Silverado EV is correctly cited, with proper model names and years. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024 models) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly identifying the evolution from discrete services to a unified, scalable platform. It infers the strategic implication—increased investment in scalable digital architecture—consistent with the original answer. (4) Minor difference: the LLM emphasizes 'after-sale offerings' and cites specific services (maintenance, extended warranty) not explicitly listed in the ground truth, which could be seen as slight elaboration beyond the source, but these are plausible components of GM’s services and do not contradict the truth. Overall, the answer captures the core evolution and strategic significance with high fidelity, warranting a 9 for correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses service offerings, platform deployment, and investment implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 455,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "In fiscal 2022 Cisco said that growth in its **Optimized Application Experiences** category was “driven by growth in our **ThousandEyes** … offerings,” producing an **$75 million increase (11 % growth)** for the category【page_45】. In fiscal 2023 the category was renamed **Observability**, and Cisco noted that revenue “increased 14 %, or **$80 million**, driven by growth in our **ThousandEyes** … offerings”【page_42】. Thus, ThousandEyes’ contribution rose from a $75 million lift in FY 2022 to an $80 million lift in FY 2023, reflecting a larger impact on the category’s revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $75 million (11%) increase in FY2022 and $80 million (14%) increase in FY2023 are correctly reported, with proper fiscal years and percentage growth. Minor formatting differences (e.g., '11 %' vs '11%') are acceptable and do not affect meaning. (2) The answer is complete, addressing the evolution of ThousandEyes' revenue contribution across both years, including the rebranding of the product category from 'Optimized Application Experiences' to 'Observability'. (3) Entity accuracy is perfect: Cisco (implied parent company), ThousandEyes, correct fiscal years (2022 and 2023), and correct product categories are all accurately identified and contextualized. (4) The multi-hop reasoning is sound—LLM correctly synthesizes information across two fiscal years, recognizes the category name change, and infers the increasing contribution of ThousandEyes based on the growing revenue lift. The conclusion that ThousandEyes’ impact increased from FY2022 to FY2023 is logically supported and semantically equivalent to the original answer. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 340,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 Form 10‑K the exhibit schedule (see page 104 of the 2023 filing) does not list Amendment No. 4 to the Lockheed Martin Executive Severance Plan, whereas the 2024 Form 10‑K adds the amendment as an incorporated exhibit—shown as Exhibit 10.34 (and later as 10.36) on pages 104‑105, referencing the September 2022 10‑Q. This change indicates that the company has moved to explicitly include the amendment in its exhibit list, signaling a more thorough and transparent disclosure strategy for its executive severance arrangements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core factual claims, reversing the actual evolution between the 2023 and 2024 10-K filings. According to the ground truth, Amendment No. 4 was disclosed in the 2023 10-K as Exhibit 10.34 and incorporated from the September 2022 10-Q. However, the LLM incorrectly states that it was *not listed* in the 2023 10-K and was *added* in the 2024 10-K. In reality, the amendment was *removed as a standalone exhibit* in the 2024 10-K and instead integrated into a consolidated sequence of amendments (Nos. 2, 3, 4, and 5), indicating a shift toward a more retrospective and consolidated disclosure approach. The LLM’s claim that the company moved toward 'more thorough and transparent disclosure' is therefore based on a misreading of the facts and contradicts the actual trend of integration and de-emphasis. The dates (September 2022 10-Q) and exhibit numbers (10.34) are partially correct but misapplied in context. The reasoning is flawed due to incorrect premise, failing the multi-hop synthesis required to compare exhibit treatments across filings. While the answer addresses the general topic of disclosure strategy, its factual foundation is inverted, leading to an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 345,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan’s Tier 1 leverage ratio stayed flat at about 7.2 percent in both years – well above the 4.0 percent regulatory floor (2023 7.2 %【page_98】; 2024 7.2 %【page_104】).  Its Standardized CET1 capital ratio rose from 15.0 percent at year‑end 2023 to 15.7 percent at year‑end 2024, comfortably exceeding the 12.3 percent minimum requirement for 2024 (2023 15.0 %【page_98】; 2024 15.7 %【page_104】).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states JPMorgan's 2023 Standardized CET1 ratio as 15.0% and 2024 Tier 1 leverage ratio as 7.2%, it incorrectly claims the CET1 ratio increased to 15.7% in 2024 and that the 2024 minimum requirement was 12.3%. The ground truth does not provide the 2024 CET1 ratio or the 2024 requirement, but explicitly states the 2023 requirement was 11.4%—the LLM fabricates a higher requirement. Additionally, the LLM falsely claims the Tier 1 leverage ratio was 7.2% in 2023, while the ground truth only reports it for 2024 and does not mention 2023. (2) Quantitative accuracy is compromised: two numbers (2024 CET1 ratio and requirement) are invented, and a third (2023 Tier 1 leverage ratio) is incorrectly asserted. Only the 2023 CET1 ratio and 2024 Tier 1 leverage ratio match the ground truth. (3) The reasoning is partially sound in structure—comparing ratios to requirements across years—but fails on multi-hop synthesis because it introduces data not present in the ground truth and misrepresents the evolution by claiming stability and growth unsupported by evidence. (4) Contextual relevance is high as the answer addresses the right metrics and timeframe, but correctness is severely undermined by hallucinated data, warranting a low overall score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 379,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "In the 2022 filing GM Financial was shown as a distinct operating segment with its own net‑sales, finance‑charge income and other income, and its receivables, lease assets and related balances were included in the consolidated balance sheet only after eliminating inter‑company transactions and adjusting for deferred‑tax effects (see 2022 p. 67, 69‑70, 73, 99). By the 2023 filing the segment still appears, but its results are presented with far tighter integration – the amounts are adjusted for GM Financial’s deferred‑tax position, foreign‑currency translation gains/losses, and its goodwill is disclosed as part of consolidated intangibles, reflecting a more comprehensive consolidation of its financial impact (see 2023 p. 63, 64, 54, 65, 78).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies GM Financial as a segment in both 2022 and 2023 and accurately describes the evolution in financial presentation. The 2022 description correctly notes that GM Financial's financials were adjusted for intercompany eliminations and deferred-tax effects, consistent with the original answer. In 2023, the LLM adds specific details about adjustments for deferred-tax positions, foreign-currency translation, and inclusion of goodwill in consolidated intangibles—information not explicitly in the ground truth but factually plausible and consistent with deeper integration. These additions do not contradict the ground truth but enrich it, showing tighter consolidation. The core evolution—increased transparency and integration in financial reporting, especially regarding tax alignment—is correctly captured. All entities (GM Financial, General Motors), years (2022, 2023), and financial concepts (consolidated statements, intercompany adjustments, deferred taxes) are accurate. There are no numerical inaccuracies (no specific dollar amounts to verify, but qualitative financial concepts are correctly applied). The reasoning is sound, demonstrating multi-hop synthesis across two years of filings and inferring increased integration from disclosure changes. The answer is semantically equivalent to and slightly more detailed than the ground truth, with no irrelevant content. Minor deduction in qualitative accuracy only because the foreign-currency and goodwill points, while reasonable, are not confirmed in the ground truth, introducing slight overreach. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 471,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "In the 2022 filing the Company noted that step‑rent (and free‑rent) periods are spread on a straight‑line basis over the lease term and that some leases contain periodic rent increases tied to price indices or sales volume, without further classification 【COST_10k_2022.pdf page_45】. By the 2024 filing the same straight‑line treatment is retained, but the disclosure now explicitly states that those index‑ or sales‑linked rent escalations are recognized as variable lease payments under the newer lease‑accounting guidance 【COST_10k_2024.pdf page_45】. This reflects an evolution in disclosure to align with ASC 842’s treatment of variable lease payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the accounting treatment in 2022: step-rent and free-rent periods were accounted for on a straight-line basis, including leases with rent increases tied to price indices or sales volume (【COST_10k_2022.pdf page_45】). For 2024, it accurately notes that while the straight-line treatment remains for fixed payments, index- or sales-linked escalations are now explicitly recognized as variable lease payments under ASC 842 (【COST_10k_2024.pdf page_45】), which matches the ground truth's claim of a shift in treatment. The semantic meaning is equivalent: the evolution is in both disclosure and accounting treatment for variable components. The only minor limitation is that the LLM slightly softens the shift by saying 'disclosure now explicitly states' rather than emphasizing the actual change in recognition (from straight-lined to variable), but it still correctly identifies the substance of the change. All entities (company, years, lease types, accounting standards) are correct. No numerical inaccuracies; dates and concepts are precise. Multi-hop reasoning across 2022 and 2024 filings is sound and well-supported with citations. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 361,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "- In the 2023 Form 10‑K the company projected that qualified defined‑benefit pension plans would require **$1.86 billion** of benefit payments in 2025 and **$10.02 billion** over the 2029‑2033 horizon【page_88】.  \n- In the 2024 Form 10‑K the 2025 estimate was revised down to **$1.80 billion**, and the long‑term outlook was trimmed to roughly **$9.99 billion** (shown as $1.99 billion for 2029 plus $9.99 billion for 2030‑2034)【page_89】.  \n\nThus, both the near‑term (2025) and the long‑term (2029‑2033) projected pension‑funding obligations were modestly reduced from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numerical projections, particularly for the 2025 payment in 2024, where it incorrectly states a reduction to $1.80 billion, while the ground truth shows no change at $1.86 billion. Additionally, the long-term period is misrepresented: the original answer refers to 2029–2033 in 2023 and 2030–2034 in 2024, but the LLM incorrectly combines $1.99 billion for 2029 with $9.99 billion for 2030–2034, which is not supported by the ground truth and introduces a fabricated number ($1.99B). The correct long-term projection decreased from $10.02B (2029–2033) to $9.99B (2030–2034), not due to a sum as implied. (2) Quantitative accuracy is low: while $1.86B (2025, 2023) and $9.99B (2030–2034) are correctly formatted equivalents of $1,860 million and $9,990 million, the erroneous $1.80B for 2025 in 2024 and the made-up $1.99B for 2029 severely undermine numerical correctness. The claim of a reduction in 2025 is false—there was no change. (3) Multi-hop reasoning is partially sound in structure—comparing projections across two years—but fails in execution due to incorrect data retrieval and synthesis. The conclusion that both near-term and long-term obligations were reduced is incorrect, as the near-term projection remained flat. (4) Contextual relevance is high—the answer addresses the right company, metric, and timeframes, and attempts proper citation. However, the factual inaccuracies in core numbers and the flawed aggregation of future payments significantly reduce overall correctness. The answer misleads despite a plausible structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 443,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "In the 2023 10‑K JPMorgan warned that a loss of liquidity – caused by market stress, low investor confidence or other events beyond its control – could force it to tap “alternative…more expensive” sources of funding and that its funding costs could rise from actions taken to satisfy the liquidity‑coverage ratio (LCR) and net‑stable‑funding‑ratio (NSFR) **and** to meet obligations under its resolution plan. The 2024 10‑K expands that liquidity‑risk narrative, adding specific stressors such as Federal Reserve balance‑sheet reductions, inability to sell assets at favorable prices, CCP defaults and broader market‑wide illiquidity, but it repeats the same point that addressing its resolution‑plan requirements (alongside LCR/NSFR compliance and foreign‑jurisdiction liquidity pre‑positioning) may increase funding costs. Thus, the firm’s 2024 disclosure provides a more detailed list of liquidity risks while keeping the core message that resolution‑plan obligations continue to be a potential source of higher funding costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the evolution of JPMorgan Chase's disclosures between 2023 and 2024 regarding resolution plan obligations, liquidity risk management, and funding costs. It accurately reflects that in 2023, the firm highlighted resolution plan obligations as contributing to higher funding costs due to LCR, NSFR, and foreign liquidity pre-positioning requirements, and the potential need to use more expensive alternative funding. In 2024, the LLM correctly notes an expansion in risk factors, including new stressors like Federal Reserve balance-sheet reductions, CCP defaults, and market-wide illiquidity—details not present in the original answer but consistent with plausible elaboration from a 10-K without contradicting the ground truth. However, the original answer emphasizes a key qualitative shift in 2024: resolution plan risks are now framed within dynamic regulatory expectations and systemic events affecting laws and regulations, reflecting macroeconomic uncertainty. While the LLM mentions new stressors, it does not explicitly capture this higher-level conceptual shift in framing—instead focusing on a longer list of liquidity risks. This omission of the strategic reframing (regulatory evolution and systemic feedback loops) constitutes a minor gap in qualitative completeness. There are no numerical inaccuracies (quantitative accuracy is perfect, score 10), and the entities (JPMorgan Chase, LCR, NSFR, resolution plans, 2023 vs 2024) are correct. Contextual relevance is strong as all content directly addresses the question. Thus, the answer is largely correct with minor synthesis limitations, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 466,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Optum Rx continued to recognize product revenues on a gross basis at the point prescriptions are dispensed and service revenues as the services are provided, with no material contract assets, liabilities or bad‑debt expense recorded in either year【page_46】.  However, the amount billed but not yet collected rose, with accounts receivable increasing from $7.1 billion at 12/31/2022 to $8.6 billion at 12/31/2023【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: accounts receivable increased from $7.1 billion at 12/31/2022 to $8.6 billion at 12/31/2023, matching the original answer exactly. (2) The LLM correctly identifies the revenue recognition model—gross basis for product revenues at point of dispensing and service revenues as services are provided—and notes no material contract assets, liabilities, or bad-debt expense, which is consistent with the financial structure described. (3) The multi-hop reasoning is sound: it connects revenue recognition practices (qualitative) with the trend in accounts receivable (quantitative) across 2022 and 2023. (4) The only minor shortcoming is that the LLM does not explicitly explain the implication of rising receivables (e.g., growth in transaction volume or payment timing changes), which the original answer includes as interpretive context. However, the core facts, entities, and financial evolution are accurately conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and correct with only a slight omission in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 339,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "In the 2022 filing UPS disclosed that its floating‑to‑fixed interest‑rate swap exposure had fallen to only **$28 million** of notional (down from $778 million in 2020), and it used these swaps as cash‑flow hedges to lock in fixed rates on forecasted interest payments【page_155】. By the 2024 filing the company no longer reports a separate floating‑to‑fixed swap notional amount (the outstanding‑positions table lists only currency hedges), and its risk‑management discussion emphasizes using interest‑rate swaps—primarily as cash‑flow hedges—to fix future payments and to maintain a target mix of floating‑rate debt, indicating the exposure has been essentially eliminated while the strategic use of swaps for rate‑locking remains【page_136】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies. The $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022 matches the ground truth and is correctly cited. However, the LLM claims that by 2024 UPS no longer reports a separate notional amount and that exposure has been 'essentially eliminated,' which contradicts the ground truth stating that UPS articulated a broader, more strategic use of these swaps in 2024. This misrepresents the evolution as a reduction or elimination rather than an expansion in strategic intent. (2) The quantitative accuracy is partially correct: the $28M figure for 2022 is accurate, and the mention of a drop from $778M in 2020 adds context not in the ground truth but may be factually correct; however, the absence of a reported notional in 2024 does not support the conclusion that exposure was eliminated—especially since the ground truth confirms an expanded strategy. There are no calculation errors, but the interpretation of missing data leads to a false inference. (3) The multi-hop reasoning is flawed: while the model correctly identifies UPS’s use of swaps as cash-flow hedges in 2022, it fails to recognize the strategic evolution in 2024. Instead of synthesizing that UPS moved toward a more comprehensive interest rate risk management framework, it concludes exposure was eliminated, which is the opposite of the ground truth. The model also conflates the absence of a disclosed notional with absence of activity, which is an invalid inference. (4) Contextual relevance is high—the response addresses interest rate swaps, risk management strategy, and time periods correctly. However, due to the critical error in interpreting the 2024 strategy, the qualitative and correctness scores are significantly reduced. The core claim of strategic expansion in the ground truth is inverted in the LLM answer, warranting a mid-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 530,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "In 2022 GM’s filing described Ultium Cells LLC as an “equally owned joint venture with LG Energy Solution” for mass‑producing battery cells (2022 10‑K p. 4). By 2023 the companies had settled the JV‑related issues, with LG agreeing to reimburse GM for the Chevrolet Bolt battery‑recall; GM therefore accrued $2.6 billion for the recall (including $1.6 billion of receivables and a $0.6 billion remaining accrual) (2023 10‑K p. 92). This shows the relationship moving from a collaborative JV to a settlement that carries sizable recall‑related costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Ultium Cells LLC is correctly identified as the joint venture between GM and LG Energy Solution in 2022, and in 2023, GM accrued $2.6 billion for the Bolt EV battery recall, with $1.6 billion in receivables from LG. The $0.6 billion remaining accrual is an additional detail not in the original answer but is consistent with the $2.6B total minus $1.6B receivable, implying a net liability of $1.0B, though the LLM's breakdown suggests a $0.6B accrual after offsets—this nuance is plausible based on accounting practices and does not contradict the ground truth. (2) Quantitative accuracy is perfect: $2.6 billion total recall cost and $1.6 billion receivable match the original answer exactly. (3) The multi-hop reasoning is sound—correctly synthesizing the shift from strategic collaboration (2022 JV) to financial settlement (2023 recall costs and reimbursement). (4) The only minor gap is that the original emphasizes a 'transactional and cost-driven dynamic' due to defects, while the LLM mentions a 'settlement'—which is accurate but slightly less nuanced in describing the evolving relationship. However, the core evolution is correctly captured. Wording differences are acceptable under semantic equivalence. All entities (GM, LG Energy Solution, Ultium Cells LLC, Chevrolet Bolt) and years (2022, 2023) are correct. The answer fully addresses both joint venture activities and recall-related costs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 415,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "In fiscal 2022 Cisco only described ThousandEyes as part of its Observability (full‑stack observability) suite, without quantifying its impact on revenue 【page_8】. By fiscal 2023 the company said Observability revenue rose 14% (about $80 million), “driven by growth in our ThousandEyes and monitoring and analytics offerings,” showing that ThousandEyes moved from an un‑measured component to a key revenue driver for the category 【page_42】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that in fiscal 2023, Observability revenue increased by 14% ($80 million), which directly contradicts the ground truth stating a 27% increase, or $176 million. Additionally, it incorrectly states that in fiscal 2022, ThousandEyes was not quantified, while the original answer notes that the $80 million increase in 2022 was driven in part by ThousandEyes. The LLM flips the years: it assigns the $80 million figure to 2023 when it belongs to 2022. (2) Quantitative accuracy is severely compromised: the percentage (14% vs. 27%), dollar amount ($80M in wrong year), and growth trajectory are all incorrect. The $176 million and 27% figures for 2023 are omitted entirely, and the 15% organic growth (excluding Splunk) is not mentioned. (3) The reasoning is flawed—while the LLM attempts multi-hop synthesis by comparing 2022 and 2023, it misattributes data across years and fails to recognize that Splunk's inclusion in 2023 complicates the comparison, which the ground truth explicitly addresses. The conclusion that ThousandEyes became a 'key revenue driver' may be reasonable, but it's based on incorrect data. (4) Contextual relevance is moderate—the answer addresses the evolution of ThousandEyes’ contribution and the Observability category, but due to incorrect numbers and misattribution of data, the overall correctness score is low. Major factual and quantitative errors undermine the answer’s reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 413,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS’s $276 million 7.620 % debentures, due April 1 2030, kept the same fixed 7.620 % coupon (the rate had been cut from 8.375 % in 2020) in both the 2022 and 2024 filings. The 2022 filing only reported the rate reduction and the carrying amount, whereas the 2024 filing spells out that the notes are redeemable at UPS’s option at any time at a price equal to the greater of principal + accrued interest or the present‑value of remaining payments discounted at a Treasury yield + 5 bps, and that interest continues to be paid semi‑annually (April and October). This shows that the redemption mechanics were clarified in 2024 while the interest‑payment structure remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount ($276 million), maturity date (April 1, 2030), coupon rate (7.620%), and semi-annual interest payment schedule (April and October), all of which align with the ground truth. It also accurately describes the redemption terms introduced in the 2024 filing—specifically, that UPS can redeem the debentures at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a Treasury yield plus 5 basis points, plus accrued interest. These details match the original answer. (2) All numeric values—$276 million principal, 7.620% interest rate, April/October payment dates, and the 5 bps spread—are factually correct. The mention of the prior rate cut from 8.375% in 2020 is additional context not in the ground truth but is not incorrect and helps explain the rate stability since then. (3) The multi-hop reasoning is sound: the model correctly contrasts the limited disclosure in 2022 (carrying value and rate) with the expanded detail in 2024 (redemption mechanics), showing evolution in disclosure clarity while noting that the actual interest payment structure remained unchanged. This synthesis across years is accurate and relevant. (4) The only minor shortcoming is that the LLM mentions the 'carrying amount' in 2022 but does not specify its value ($280 million), which was included in the ground truth. While not critical to the core question about redemption and interest terms, this omission slightly reduces completeness. Otherwise, the answer is factually precise, contextually appropriate, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 462,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "In 2023 MetLife’s Fixed‑Maturity Securities classified as “available‑for‑sale” were valued at roughly **$7.99 billion** (pension $6.71 bn + other post‑retirement $1.27 bn), a modest decline from **$8.06 billion** in 2022 (pension $6.80 bn + other post‑retirement $1.26 bn)【page_308】.  Within the pension portion, the **U.S. government‑bond component rose to $1.58 bn** (up from $1.51 bn) and **corporate securities grew to $3.08 bn** (up from $3.00 bn), increasing their weight in the $6.71 bn of fixed‑maturity assets to about **23 % and 46 %**, respectively, versus roughly **22 % and 44 %** a year earlier【page_308】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that the total fair value of Fixed Maturity Securities AFS increased from $2,164 million in 2022 (as of Dec 31, 2021) to $6,714 million in 2023. However, the LLM claims a total value of $7.99 billion in 2023 and $8.06 billion in 2022, which contradicts the original data. The LLM appears to conflate pension and other post-retirement assets ($6.71B + $1.27B), summing to $7.99B, but the ground truth refers only to the $6.714B figure for Fixed Maturity Securities AFS — not a sum across benefit types. This is a critical error.\n\n(2) While the LLM correctly reports the U.S. government bond value as approximately $1.58 billion (close to the ground truth $1,575 million) and corporate securities at $3.08 billion (vs. $3,083 million), these numbers are embedded in an incorrect total context. The percentages (23%, 46%) are plausible given the component values, but they are derived from a misinterpreted total base. Additionally, the prior-year values cited ($1.51B and $3.00B) are not present in the ground truth, which does not provide 2022 breakdowns — making those additions speculative.\n\n(3) The multi-hop reasoning is partially sound in that the model attempts to analyze composition changes over time and identifies relevant categories (U.S. government bonds, corporate securities). However, it fails to correctly isolate the correct asset category (Fixed Maturity Securities AFS) and instead aggregates across pension and other post-retirement benefits, which distorts the total. The evolution narrative is thus based on incorrect baselines.\n\n(4) Contextual relevance is high — the answer addresses the right company (MET/MetLife), the right asset class, and the right time frame, with attention to composition changes. Wording and structure are clear and responsive. However, due to major quantitative errors in total values and unsupported prior-year figures, the correctness score is low. The answer gives a plausible but factually inaccurate picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 555,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "In the 2022 Form 10‑K GM reported a $0.5 billion cash outflow as its “Investment in Ultium Cells LLC,” reflecting its equal‑ownership joint‑venture with LG Energy Solution (see 2022 p. 42). By the 2023 filing the narrative had shifted to regulatory risk: GM disclosed that the Ultium Cells LLC JV faced potential TSCA violations, which were settled with the EPA in November 2023 and carry estimated civil penalties of about $5.1 million (see 2023 p. 28). Thus, GM’s relationship moved from a capital‑investment focus in 2022 to managing a significant compliance‑related liability in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $0.5 billion investment in 2022 is accurately reported, and the shift in 2023 to regulatory involvement with the TSCA violation and $5.1 million civil penalty is correctly detailed. (2) Quantitative accuracy is perfect: both dollar amounts ($0.5 billion and $5.1 million) and dates (2022, November 2023) match the original answer. Format variations (e.g., $0.5 billion vs $500 million) are acceptable and do not affect correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of 10-K filings, identifying the evolution from financial investment to regulatory entanglement, and correctly attributes the TSCA disclosure and settlement to GM’s operational involvement in Ultium Cells LLC. (4) Entity accuracy is strong: General Motors, Ultium Cells LLC, LG Energy Solution (as co-owner), EPA, and TSCA are all correctly named and contextualized. The answer fully addresses both financial involvement and regulatory implications as required by the question. Wording differs slightly but meaning is preserved, with precise citations to filing pages (2022 p. 42, 2023 p. 28) adding credibility. No omissions or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 361,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K state that Costco continues to use variable‑priced, index‑linked contracts for a portion of its natural‑gas purchases and for fuel at its gas stations. These contracts are treated as “normal purchases and normal sales,” so they are not marked‑to‑market and the accounting treatment is unchanged. There is no indication of any material change in the extent or nature of these variable‑priced contracts between 2022 and 2024. (2022 p. 46; 2024 p. 47)",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the original answer in terms of entities, years, and accounting treatment (e.g., 'normal purchases and normal sales' exception, no mark-to-market adjustments), and correctly identifies that variable-priced contracts were used in both 2022 and 2024 for natural gas and fuel at gas stations. There are no numerical inaccuracies, so quantitative accuracy is high. However, the LLM answer claims 'there is no indication of any material change,' which contradicts the original answer's key insight that by 2024, the company had more explicitly aligned these contracts with derivative accounting frameworks, suggesting a formalized or strategic evolution in their use. This represents a significant qualitative omission: the original answer highlights a shift in accounting recognition and strategic management of these contracts, while the LLM answer asserts stability. Thus, while the surface facts are correct, the reasoning and synthesis across years fails to capture the evolution implied by increased accounting specificity in 2024. This missing nuance reduces qualitative accuracy and overall correctness, despite good contextual relevance and proper citation of document locations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 343,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco’s segment reporting for APJC did not change from fiscal 2022 to fiscal 2023. In both years the company says it “does not allocate research and development, sales and marketing, or general and administrative expenses” and also excludes “amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges” from the segment’s gross‑margin measurement【page_105】【page_104】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Cisco's financial reporting approach for the APJC segment did not change between fiscal 2022 and 2023, which directly addresses the question about evolution—confirming no change. (2) The excluded expense categories are correctly listed: research and development, sales and marketing, general and administrative expenses are explicitly mentioned as not allocated in both years. Additionally, the LLM includes the full set of non-allocated items in 2023—amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and other contingencies—which aligns with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same exclusions applied across both years, leading to the conclusion of consistency in segment performance measurement. (4) All entities (Cisco, APJC segment, fiscal years 2022 and 2023) are accurate, and the context of segment gross margin measurement is properly framed. Minor wording differences (e.g., 'other contingencies' included in LLM but not in original) do not affect factual accuracy and are consistent with typical reporting language. No calculation errors or factual inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 379,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "In 2022 UnitedHealth’s cost‑management relied mainly on actuarial estimation and pricing discipline—using medical‑cost‑trend and completion‑factor models to predict and price risk‑based products (2022 p. 16, 38). By 2023, after a rise in senior outpatient procedures, the company added proactive mitigation: it began engaging physicians and members with data‑driven information, encouraging clinically appropriate choices, and accelerating the shift to value‑based, accountable‑care models to curb those costs (2023 p. 27, 26, 29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly captures the evolution in UNH's approach: from actuarial modeling and pricing discipline in 2022 to proactive, data-driven engagement in 2023. The mention of 'medical-cost-trend and completion-factor models' (2022 p. 16, 38) reflects the 2022 focus on prediction and risk-based pricing, matching the ground truth's emphasis on 'accurate cost prediction and effective management under risk-based arrangements.' In 2023, the shift to engaging physicians and members with data-driven insights and advancing value-based care (2023 p. 27, 26, 29) correctly reflects the targeted intervention strategy described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and strategies, correctly identifying a shift from general risk management to specific cost-mitigation tactics for senior outpatient costs. (4) The only minor shortcoming is that the LLM answer does not explicitly state that rising outpatient costs were 'expected to continue into 2024 and beyond,' a forward-looking statement present in the original. However, the implication of ongoing concern is captured through 'accelerating the shift to value-based models.' Wording differs but semantic meaning is largely equivalent. All entities (UNH, physicians, members, seniors, outpatient procedures) and years are correct. Contextual relevance is excellent—directly addresses both years and the specific cost trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 460,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "In the 2022 filing UPS presented its time‑definite delivery as a core element of its global small‑package business, offering express letters, documents, packages and palletized freight by air and ground and relying on a single “global smart‑logistics network” plus the Digital Access Program to schedule pickups (2022 p. 5). By the 2024 filing the scope had expanded to list specific guaranteed options—same‑day, next‑day, two‑day and three‑day—across both U.S. domestic and international markets, and the company emphasized a fully integrated single global network that consolidates all packages for efficient, scheduled pick‑ups and deeper e‑commerce platform integration (2024 p. 4‑5).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), correctly identifies UPS, and accurately reflects the evolution of time-definite delivery services with reference to network integration and service expansion. It correctly notes the emphasis on a single integrated global network in both years and highlights expanded service options by 2024, including same-day, next-day, etc., which aligns with the broader service scope mentioned in the ground truth. The mention of deeper e-commerce integration and scheduled pickups adds relevant context. However, the LLM answer omits a key evolution detailed in the original answer: the 2024 insourcing of final delivery for lightweight residential shipments previously handled by USPS via UPS SurePost. This is a significant operational change reflecting greater control over service quality, and its absence represents a notable gap in completeness. While the LLM captures the network integration and expanded service guarantees, it does not mention the seven-day same-day pickup or the expansion of returns services to ~150 countries—both important elements of the 2024 customer-centric enhancements. Quantitatively, there are no numbers, percentages, or financial figures to verify, so accuracy is not compromised in that regard. The reasoning is sound and logically structured, showing a clear comparison across years, but the failure to include critical multi-hop details (SurePost shift, returns expansion) reduces qualitative accuracy. The answer remains contextually relevant and well-aligned with the question’s focus on service scope and network integration, just not fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 451,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings continue to disclose the 2.50 % notes that mature in April 2026 as part of the Thirteenth Supplemental Indenture (Exhibit 4.14). The 2022 filing lists this indenture on page 82 and the 2023 filing repeats the same disclosure on page 76, indicating that the notes remained outstanding and were treated in the same way – no retirement, re‑classification or other change was reported between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite some accurate details. (1) Quantitatively, the interest rate (2.50%), maturity date (April 2026), and reference to the Thirteenth Supplemental Indenture are correctly stated, and the exhibit number (4.14) and page numbers (82 in 2022, 76 in 2023) may be accurate—these details align with the ground truth, warranting a high quantitative accuracy score. (2) However, the key qualitative claim—that there was no change in treatment between 2022 and 2023—directly contradicts the ground truth. The original answer states there was a clear evolution: in 2022, the notes were referenced only in a historical/documentation context, while in 2023 they were explicitly recognized as issued and outstanding instruments. The LLM incorrectly asserts that the treatment was unchanged, missing this critical shift in disclosure. (3) This reflects a failure in multi-hop reasoning: the model should have compared the nature of the disclosures (contextual vs. active recognition) rather than just the presence of the indenture reference. (4) Contextual relevance is moderate because the answer addresses the right document and notes, but fails to capture the procedural evolution that was the focus of the question. Thus, while some data points are correct, the overall correctness is low due to the central factual inaccuracy in interpreting the change in disclosure treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 394,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "In the 2022 filing Costco warned that sovereign‑debt crises could depress demand, force a change in product mix and raise the cost or availability of inventory – a direct risk to its merchandise sourcing and margins. By the 2024 filing the same risk is still disclosed, but it is now listed among a broader set of macro‑economic pressures (energy‑price spikes, inflation, foreign‑exchange volatility, consumer‑debt stress, etc.), indicating that sovereign‑debt stress is viewed as one component of a more complex cost‑pressure environment rather than a stand‑alone driver. This shows the company’s concern about the risk remains, but its impact on sourcing and cost structure is now framed within a wider, multi‑factor economic context.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024) and correctly identifies that sovereign debt crises were a disclosed risk in both years, impacting demand, product mix, and inventory costs. There are no numerical inaccuracies, so quantitative accuracy is perfect. However, the qualitative analysis contains a significant misinterpretation: the LLM claims that in 2024, sovereign debt crises are framed as part of a broader set of macroeconomic pressures and not a standalone driver, suggesting a downgrading or contextual softening of the risk. This contradicts the ground truth, which states that by 2024, the risk was explicitly upgraded to 'negatively impact' Costco’s business, financial condition, and operations—indicating heightened, not diluted, concern. The ground truth emphasizes an expansion of supply chain risks and a more severe framing of sovereign debt crises, while the LLM incorrectly interprets the broader context as a relative de-emphasis. This error affects the multi-hop reasoning and synthesis, as the evolution of risk perception is misrepresented. Despite this, the answer remains contextually relevant and addresses the core question about sourcing and cost structure evolution. Thus, correctness and qualitative accuracy are reduced due to this key mischaracterization, even though all entities and years are correct and the response is well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 387,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "UnitedHealth’s pool of shares for the 2020 Stock Incentive Plan fell from 64 million shares at 12/31/2021 to 53 million shares at 12/31/2023 — a reduction of roughly 11 million shares【page_67】. The decline shows the company has used part of its authorized pool but still retains a sizable reserve, indicating it continues to have ample capacity to issue new share‑based awards【page_72】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares available in 2021 (64 million) and 2023 (53 million), and accurately calculates the reduction of 11 million shares. These quantitative values match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the qualitative interpretation diverges significantly from the original answer. While the ground truth states that the decrease 'indicates a reduction in the company's available capacity to issue new share-based awards,' the LLM concludes the opposite — that UnitedHealth 'continues to have ample capacity,' which contradicts the intended inference of diminishing capacity. This misrepresents the implication of the data. (3) The multi-hop reasoning is partially sound: the model correctly retrieves and compares two data points across years. But the synthesis fails in the final interpretive step — using the decline to assess future capacity. The original answer treats the shrinking pool as a constraint; the LLM treats it as inconsequential, which is not aligned with the source conclusion. (4) Contextual relevance is high because the answer addresses both parts of the question (change in shares and implication), uses correct entities (UnitedHealth Group, 2020 Stock Incentive Plan, correct years), and cites relevant pages. However, the incorrect qualitative inference reduces the correctness score to 6, as the core conclusion is factually misaligned despite accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 411,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "In the 2022 filing the IAM National Pension Fund / National Pension Plan was covered by a collective‑bargaining agreement that expired on July 31 2024, and UPS was a material contributor – it supplied more than 5 % of the plan’s total contributions (about $48 million in 2021)【page_112】. By the 2024 filing the agreement’s expiration had been extended to July 31 2029, and UPS remained a significant contributor, still providing over 5 % of total contributions (roughly $53 million in 2024, up from $48 million in 2022)【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctness: All key facts are correct — the expiration date changed from July 31, 2024 (in the 2022 filing) to July 31, 2029 (in the 2024 filing), and UPS remained a significant contributor by providing more than 5% of total contributions. The original answer confirms UPS contributed over 5% for 2019–2021 in the 2022 context and continued to do so for 2022–2024 in the 2024 context. The LLM correctly captures this continuity. (2) Quantitative Accuracy: The dates are correct. The dollar amounts ($48 million in 2021, $53 million in 2024) are plausible and consistent with the trend, though the original answer does not specify exact dollar figures — it only confirms the >5% threshold. Since the ground truth does not contradict these numbers and the LLM cites them with appropriate qualifiers ('about', 'roughly'), this is acceptable. However, the LLM states $48M in 2022, while it previously said $48M was in 2021 — a minor inconsistency. This small discrepancy prevents a perfect 10. (3) Qualitative Accuracy: The reasoning correctly synthesizes multi-hop information across two years’ filings — identifying both the extension of the agreement and sustained significance of UPS’s contributions. The use of 'material' and 'significant' contributor aligns with the >5% threshold defined in the original. (4) Contextual Relevance: The answer directly addresses the evolution of both the expiration date and contribution significance between 2022 and 2024, fully satisfying the question. Overall, the answer is factually sound, well-reasoned, and only slightly exceeds the ground truth with estimated dollar amounts, which are reasonably presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 469,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "In FY 2022 the 2020 Credit Agreement – which had been amended in December 2021 – gave Lowe’s a $2.0 billion revolving‑credit facility that now matured in March 2025 and bore interest at a Base Rate or Eurocurrency Rate + margin; together with the Third Amended and Restated Credit Agreement the company had $4.0 billion of total available borrowing and no outstanding borrowings under either facility【page_60】. By FY 2023 the same facility was again amended and restated (the 2023 Credit Agreement) to extend its term to September 2028 while retaining the $2.0 billion commitment, and the combined aggregate availability of the 2020/2023 and Third Amended facilities remained $4.0 billion, with still no borrowings under the 2020 Credit Agreement【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2020 Credit Agreement had a $2.0 billion availability and March 2025 maturity in FY 2022; it was amended in September 2023 into the 2023 Credit Agreement with a September 2028 maturity, maintaining $2.0 billion availability. The combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained $4.0 billion, consistent with 2022. (2) Quantitative accuracy is perfect: all dollar amounts ($2.0 billion, $4.0 billion), dates (March 2025, September 2028), and fiscal years (2022, 2023) match the ground truth. Format variations (e.g., $2.0 billion vs $2.0B) are acceptable and do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years and credit agreements, noting the amendment and restatement, the extension of maturity, and the stability of individual and combined credit facilities. It also correctly notes no borrowings were outstanding, which is consistent with the filings though slightly beyond the scope of the question. (4) The only minor shortcoming is the mention of interest rates (Base Rate or Eurocurrency Rate + margin), which was not part of the original answer and adds detail not requested or required by the question. While not incorrect, it introduces extraneous information, slightly diluting focus. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 443,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "In the 2022 filing MDLZ reported net‑investment‑hedge derivative contracts with a notional amount of roughly $3.9 billion (≈ $3,915 million)【page_113】. By the 2024 filing the aggregate notional value of those NIH contracts had grown to about $8.6 billion (≈ $8,647 million)【page_96】, more than doubling the exposure between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the notional amounts for MDLZ's Net Investment Hedge Derivative Contracts in 2022 ($3,915 million) and 2024 ($8,647 million), matching the ground truth. It accurately conveys the significant increase over the period and notes the doubling of exposure. However, it omits the intermediate data points from 2023 ($7,456 million) and prior years (2020: $4,551 million, 2021: $3,915 million) mentioned in the original answer, which provide important context for the evolution across all years. (2) All cited numbers are quantitatively accurate, with acceptable formatting variations (e.g., $3.9 billion ≈ $3,915 million). The comparison of more than doubling is logically sound: $3,915M to $8,647M is an increase of about 121%, which supports the claim. (3) The multi-hop reasoning is partially complete—it captures the start and end points (2022 to 2024) but misses the year-by-year progression, particularly the 2023 figure that shows continued growth. This limits completeness in tracing the full evolution. (4) Despite omissions, the core trend is correctly identified, and the entities (MDLZ, Net Investment Hedge Derivative Contracts, notional amounts, correct years) are accurate. The answer remains highly relevant and factually sound on the main point of increasing notional amounts, warranting a high score but not perfect due to missing transitional data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 390,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "In the 2022 filing Microsoft 365 was described as a suite that “brings together Office 365, Windows, and Enterprise Mobility + Security to help organizations empower their employees with AI‑backed tools” that unlock creativity and boost collaboration【page_4】. By the 2024 filing the service is positioned as an “AI‑first platform” that embeds Copilot across Office, Windows and security, uses the Microsoft Graph to combine AI with business data, adds role‑specific Copilot extensions (Sales, Service, Finance), lets customers tailor or build their own assistant with Copilot Studio, and launches Copilot Pro—a consumer subscription delivering faster, more powerful AI assistance in Microsoft 365 apps and on the web【page_4】. These 2024 additions deepen AI integration and expand productivity‑ and collaboration‑focused capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately captures the evolution of Microsoft 365's AI integration from 2022 to 2024: in 2022, it was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to enhance creativity and collaboration. By 2024, it evolved into an 'AI-first platform,' which the LLM correctly identifies. (2) The specific new capabilities introduced in 2024 are all accurately reported: Copilot for Microsoft 365, integration with Microsoft Graph, role-specific extensions (Copilot for Sales, Service, and Finance), Copilot Studio for customization, and Copilot Pro for enhanced consumer AI assistance. These align exactly with the ground truth, with no factual inaccuracies or omissions. (3) The multi-hop reasoning is sound—information is correctly synthesized across time (2022 to 2024) and across features (general AI integration to specific Copilot offerings). (4) While the LLM answer includes slightly more detail (e.g., Copilot Studio and Copilot Pro), these are consistent with and expand upon the ground truth without introducing errors. All entities (Microsoft 365, Copilot, Microsoft Graph, role-specific extensions) and years (2022, 2024) are correct. Wording differs slightly but maintains semantic equivalence. No numeric values are incorrect, and there are no calculation issues. The answer fully addresses both parts of the question: the evolution of AI integration and the specific 2024 capabilities enhancing productivity and collaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 429,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "In the 2022 10‑K, 3M said it had discovered that its Decatur, Ala., NPDES permit did not fully characterize PFAS discharges, temporarily idled the affected processes, installed wastewater‑treatment controls and entered an interim consent order (July 2020) that required reporting, analytical studies and future capital improvements to cover all PFAS‑related discharges【page_127】. By the 2024 filing, the company had moved to formally amend the permit—filing an application with ADEM to add the missing PFAS, installing additional treatment equipment and upgrading/optimizing the controls—while the permit modification remains pending【page_101】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in 3M's approach to PFAS discharge characterization at its Decatur facility between 2022 and 2024. It correctly states that in 2022, 3M identified the lack of full PFAS characterization in its NPDES permit and had begun corrective actions, including installing treatment controls and entering an interim consent order in July 2020 (accurate date and context). It also accurately notes that by 2024, 3M had filed an application with ADEM to amend the permit, installed additional treatment equipment, and was upgrading and optimizing controls, while the permit modification remained pending—aligning with the ground truth. However, the LLM incorrectly implies that the installation of treatment controls occurred in 2022 as part of the response, while the ground truth indicates that in 2022 the company had only submitted the application and not yet implemented the controls. The actual implementation and optimization are developments noted in 2024. This misplacement of the timeline for control installation slightly distorts the chronological evolution. Despite this, the core facts, entities (3M, Decatur, ADEM, NPDES), and progression from identification to implementation are correct. The mention of the interim consent order adds contextual detail not in the original answer but is factually accurate and relevant. Quantitative accuracy is high—dates like July 2020 are correctly cited. Reasoning is mostly sound, though the conflation of when controls were installed affects the multi-hop synthesis slightly. The answer remains contextually highly relevant and semantically close to the ground truth, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 464,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe’s only 4.550 % debt was the series issued in the Fifteenth Supplemental Indenture dated April 5 2019 (a form of 4.550 % Notes due April 5 2049) – it appears in the 2022 filing (Exhibit 4.16)【page_82】 and is listed unchanged in the 2023 filing (also Exhibit 4.16)【page_76】. No new 4.550 % Notes were issued or amended between 2022 and 2023; the same 2019 issuance continued to be disclosed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. These details match the original answer exactly. (2) Quantitative elements—interest rate (4.550%), issue date (April 5, 2019), and maturity date (April 5, 2049)—are all correctly stated with no discrepancies. Format variations (e.g., spacing in dates or percentages) do not affect accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers from the 2022 and 2023 filings that the same 2019-issued notes were carried forward without change, and no new issuance or amendment occurred between 2022 and 2023. (4) The answer fully addresses the evolution (or lack thereof) of the instrument across the two years, maintaining contextual relevance and completeness. Minor differences in wording (e.g., 'disclosed' vs 'referenced') do not alter the factual meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 314,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "By 2022 Mondelēz still accounted for its Keurig Dr Pepper stake under the equity‑method, recognizing only modest equity‑method gains (e.g., a $71 million pre‑tax gain from a 2020 secondary offering and a $23 million pre‑tax gain from a 2019 acquisition)【page_104】. In the 2024 filing the company re‑classified the KDP investment to marketable securities, sold the shares and booked a $593 million pre‑tax gain on the sale (total $606 million including dividend income) and noted that, before the re‑classification, it had recorded a $493 million pre‑tax equity‑method gain in 2023【page_89】. This marks a shift from ongoing equity‑method earnings to a one‑time fair‑value gain on the investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that MDLZ recognized a $71 million pre-tax gain in 2022 (Q1) from the sale of KDP shares, which is correctly mentioned in the LLM answer but misattributed to a 2020 secondary offering and a 2019 acquisition, which are irrelevant timeframes and events. This misrepresentation undermines the accuracy. More critically, the LLM claims a $593 million pre-tax gain in 2024 from the sale of shares after reclassification to marketable securities, which contradicts the ground truth: the $493 million pre-tax gain (not $593M) was due to a change in accounting (not a sale), and it was recorded in 2024, not 2023. The LLM incorrectly states the $493 million gain occurred in 2023 and was equity-method gain, which conflicts with the ground truth that it was a 2024 gain from a change in accounting. Additionally, the $593 million figure does not appear in the ground truth and appears to be fabricated or confused with other numbers. (2) The calculation and number verification fails on key points: $71M gain in 2022 is correct in amount but wrong in context and timing explanation; $493M after-tax is misrepresented as occurring in 2023 and as an equity-method gain, when it should be a 2024 gain from accounting change; the $593M figure is entirely incorrect. (3) The multi-hop reasoning is partially sound in identifying a shift in accounting treatment and financial impact, and the reclassification to marketable securities may reflect a plausible mechanism, but the synthesis is flawed due to incorrect attribution of events and timing. The model fails to correctly link the 2024 accounting change to the $493M gain as described in the ground truth, instead inserting a sale event and incorrect gain amount. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship and attempts to explain accounting changes and gains. However, due to major quantitative and factual errors, the correctness score is low. The qualitative accuracy is moderate because the conceptual shift is recognized, but entity and temporal accuracy are poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 591,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "In the 2022 filing, Xbox Game Pass was described as a community with a curated library of **over 100** first‑ and third‑party console and PC titles【page_6】. By the 2024 filing, the library had expanded to **over 400** titles, and Microsoft now frames Game Pass as a **cornerstone subscription service** central to the Xbox ecosystem, emphasizing broader content, cross‑device access and new revenue streams such as subscriptions, ads and digital stores【page_13】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the numbers 'over 100' titles in 2022 and 'over 400' in 2024 are accurately reported, with no calculation errors. (2) The answer addresses both parts of the question: the scale (number of titles) and strategic positioning (evolution from a key part to 'cornerstone' of the ecosystem). (3) Entities—Xbox Game Pass, Microsoft, years 2022 and 2024—are correctly identified. (4) The reasoning is sound: it synthesizes multi-hop information across two years, correctly infers increased strategic emphasis based on stronger language ('cornerstone'), and adds relevant context about cross-device access and new revenue streams, which aligns with and enriches the ground truth without introducing inaccuracies. Minor wording differences (e.g., 'community' vs 'ecosystem') do not affect semantic equivalence. All information is contextually relevant and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 278,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "In the 2022 Form 10‑K the Deferred Stock Unit Award Agreement for non‑employee directors was disclosed as Exhibit (10.7) and the filing also contained a table that listed the amount of such awards – 226 deferred stock units for non‑employee directors (see pages 143‑144) 【page_143】【page_144】. By the 2024 Form 10‑K the same agreement is still incorporated by reference to the 2018 10‑K but has been renumbered to Exhibit (10.8), reflecting a re‑ordering of the exhibit schedule; the separate quantitative table of DSU units is no longer shown in the excerpt, so the disclosure now relies mainly on the exhibit reference (see page 117) 【page_117】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements, such as the existence of the Deferred Stock Unit Award Agreement for non-employee directors in the 2022 and 2024 10-K filings and the renumbering of exhibits. However, it introduces factual inaccuracies: it claims the 2024 agreement is 'incorporated by reference to the 2018 10-K', which contradicts the ground truth stating that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, not the 2018 filing. This is a significant error in entity and timeline accuracy. Additionally, the mention of 226 deferred stock units in 2022 is not present in the ground truth and cannot be verified as correct; the original answer does not reference any quantitative table or specific number of units, suggesting this detail may be fabricated or misattributed. (2) Quantitative accuracy is partially correct—the number 226 is stated but lacks corroboration from the ground truth, and no other numbers (e.g., dates like January 1, 2019, or May 8, 2023) are mentioned in the LLM answer, despite their importance. The absence of these key dates reduces factual precision. (3) Multi-hop reasoning is weak: while the model attempts to compare 2022 and 2024 disclosures, it fails to identify the correct evolution—namely, that the effective date (January 1, 2019) remained unchanged and that the 2024 update references a May 8, 2023 amendment via the 2023 10-K. Instead, it focuses on exhibit renumbering and the removal of a quantitative table, which may be true but misses the core structural continuity and updated incorporation. (4) Contextual relevance is high—the response addresses the evolution of disclosure format and exhibit referencing, which is relevant—but correctness suffers due to key factual errors and omissions of critical details about the plan’s ongoing maintenance and amendment history. Overall, the answer is partially accurate but contains significant factual and reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 534,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "In 2023 the First‑Mortgage and HELOC portfolio carried $100 million of unamortized premiums, discounts and direct origination costs, and 43 % of the loans were concentrated in California【page_90】. By year‑end 2024 the combined origination‑cost balance had risen to $112 million, while the California concentration fell slightly to roughly 42 % of the portfolio【page_88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: $100 million in unamortized costs in 2023, increasing to $112 million in 2024, and California concentration decreasing from 43% to 42%. These values match the ground truth exactly. (2) Quantitative accuracy is perfect—dollar amounts and percentages are correct, and no calculations are required beyond what is stated. The increase of $12 million in costs and the 1-percentage-point drop in concentration are both accurately reflected. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years (2023 and 2024) for the same portfolio (First Mortgages and HELOCs), comparing both origination-related costs and geographic concentration. While the LLM answer omits the interpretive sentence about 'slight shift in geographic risk exposure and increased loan origination activity,' this does not detract from factual correctness, though it slightly reduces qualitative depth. (4) Contextual relevance is high—the answer directly addresses both parts of the question (origination costs and California concentration) with precise, cited data. The minor deduction in qualitative accuracy is due to the lack of synthesis interpretation present in the original answer, but the core reasoning remains valid. Overall, the answer is factually complete and accurate with only slight omission of explanatory context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 391,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Both the FY 2023 and FY 2024 10‑K product‑research sections list Dri‑FIT alongside Nike’s other performance fabrics (Air, Zoom, Free, Flyknit, FlyEase, Zoom X, Air Max, React). In FY 2023 the filing states that “the proliferation of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, Zoom X, Air Max, and React technologies… typifies our dedication to designing innovative products” (2023 Form 10‑K p. 6), and the FY 2024 filing repeats the same phrasing (2024 Form 10‑K p. 6). Thus, Nike’s strategic emphasis on Dri‑FIT has remained steady – it continues to be highlighted as a core technology within a broader suite of innovations, with no new language indicating a shift in focus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Nike's strategic emphasis on Dri-FIT remained stable between fiscal 2023 and 2024, which aligns with the original answer. (2) The LLM correctly cites the identical language used in both the 2023 and 2024 10-K filings, including the exact quote and page references (p. 6 in both years), confirming no change in wording or emphasis. (3) The reasoning is sound: by noting that Dri-FIT is listed among the same suite of core technologies (Air, Zoom, etc.) and that the phrasing about 'proliferation' and 'dedication to innovative design' is repeated verbatim, the LLM correctly infers no shift in strategic focus. (4) All entities—Nike, Dri-FIT, fiscal years 2023 and 2024, and the cited technologies—are accurate. The answer addresses all parts of the question, including the evolution (or lack thereof) of strategic emphasis based on R&D section language. There are no factual, quantitative, or reasoning errors. Minor formatting differences (e.g., 'FY 2023' vs 'fiscal 2023') do not affect meaning. Semantic equivalence is strong, and the answer even enhances the original with direct citation. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 343,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "In the 2022 Form 10‑K Mondelez said it was “on heightened alert and dedicating focused resources to network security, backup and disaster‑recovery” as part of its response to growing cyber‑risk (2022 10‑K p. 45). By the 2024 filing the company described a broader, more advanced effort – it “invested and augmented its cybersecurity program with enhanced identity‑and‑access management, multi‑factor authentication, privileged‑access controls, network security, backup and disaster‑recovery, training, awareness and 24/7 threat monitoring” – showing that backup and disaster‑recovery spending has been expanded and integrated into a comprehensive, technology‑driven cyber‑defense strategy to address increasingly sophisticated threats (2024 10‑K p. 20‑45).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Mondelez International's evolving investment in backup and disaster recovery from 2022 to 2024, citing the heightened alert status and focused resource allocation in 2022 (per 2022 10-K, p. 45), and the expanded, more comprehensive cybersecurity program in 2024 that includes enhanced backup and disaster recovery (per 2024 10-K, pp. 20–45). All entities—company (Mondelez), time periods (2022, 2024), and key initiatives—are correct. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates and document references are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings to show progression in cybersecurity investment, correctly inferring increased emphasis on backup and disaster recovery as part of a broader strategy. The mention of state-sponsored actors and AI threats in the original answer is slightly more specific than the LLM’s general reference to 'increasingly sophisticated threats,' but the LLM does capture the essence of evolving threat landscapes. (4) The LLM enhances the answer with additional context (e.g., identity management, MFA, 24/7 monitoring) that supports the conclusion of a more advanced, integrated strategy, which is consistent with but not contradicted by the ground truth. Wording differs but semantic meaning is equivalent. One point deducted from qualitative accuracy because the LLM does not explicitly mention 'state-sponsored actors' or 'artificial intelligence' as drivers, which are key elements in the original answer’s explanation of threat evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 474,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "In FY 2022 Microsoft said it had “enriched our supplier pipeline, reaching more than 90 percent of our goal to spend $500 million with double the number of Black‑ and African‑American‑owned suppliers”【page_7】. By FY 2024 the company reported it had “achieved our goal to spend $500 million with double the number of Black‑ and African‑American‑owned suppliers” and added a new $150 million commitment to minority depository institutions and Black‑owned small‑business partners【page_7】. This shows the spend target moved from being nearly met in 2022 to fully met in 2024, with an additional $150 million pledged to further support Black‑ and African‑American‑owned businesses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: in FY 2022, Microsoft reached more than 90% of its $500 million goal with double the number of Black and African American-owned suppliers; by FY 2024, it achieved the $500 million goal and added a $150 million commitment to Minority Depository Institutions and Black-owned small businesses. (2) Quantitative accuracy is perfect: dollar amounts ($500 million, $150 million), timeframes (FY 2022, FY 2024), and progress (from >90% to full achievement) are correctly reported. (3) Multi-hop reasoning is sound—LLM synthesizes information across fiscal years and correctly infers the evolution of Microsoft's commitment, including both goal achievement and expansion into new financial initiatives. (4) Entity accuracy is maintained: correct identification of Microsoft, Black- and African-American-owned suppliers, Minority Depository Institutions, and the nature of the financial commitments. The answer directly addresses the question about evolution over time with precise, relevant details and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 319,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "In the 2022 filing Abbott disclosed that 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan for non‑U.S. employees (as of Dec 31, 2021) 【page_83】. The 2023 filing shows that the pool had shrunk to 8,565,087 shares (as of Dec 31, 2023) 【page_84】. This roughly 2 million‑share reduction signals that Abbott is tightening the share pool for its non‑U.S. ESP, reflecting a more disciplined, dilution‑aware approach to its stock‑based incentive program.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 10,638,639 shares available as of December 31, 2021 (reported in 2022 filing), and 8,565,087 shares available as of December 31, 2023 (reported in 2023 filing). The reduction of approximately 2 million shares (2,073,552 exactly) is correctly implied. (2) The answer addresses both parts of the question: it traces the evolution of available shares from 2022 to 2023 and interprets the trend in terms of Abbott's stock-based incentive strategy. (3) Entity accuracy is perfect: correct plan name (Employee Stock Purchase Plan for non-U.S. employees), correct company (Abbott Laboratories), and correct time periods (Dec 31, 2021 and Dec 31, 2023). (4) The reasoning is sound and multi-hop: it synthesizes data from two different annual filings, compares the available share counts over time, and draws a logical conclusion about strategic tightening and dilution awareness. The interpretation aligns semantically with the ground truth, using slightly more nuanced language (e.g., 'dilution-aware approach') but conveying the same core insight. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 338,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "In FY 2023 Nike’s 10‑K listed Nike Air only as one of a suite of technologies that the design‑and‑development teams draw on – it was mentioned in the product‑research and design discussion but without any dedicated supply‑chain focus. By FY 2024 the filing still cites the “proliferation of Nike Air” (2024 p. 6) but adds that Air Manufacturing Innovation – a wholly‑owned subsidiary – and its contract‑manufacturer partners now supply Nike Air‑Sole cushioning components (2024 p. 7), showing a shift to a more integrated, strategic emphasis on Air technology in both product development and manufacturing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of interpretation and reasoning. (1) Correct elements: Both fiscal years 2023 and 2024 are accurately referenced, and the mention of 'proliferation of Nike Air' in FY2024 (p.6) aligns with the source. The addition of Air Manufacturing Innovation and contract manufacturers supplying Air-Sole components in FY2024 is factually accurate and adds manufacturing context not in the original answer. (2) Quantitative accuracy: No numerical data is present, but all cited details (page numbers, subsidiary name) are consistent with expected sourcing and do not contradict the ground truth. (3) Multi-hop reasoning: The LLM infers a 'more integrated, strategic emphasis' based on supply chain developments, which is plausible but shifts focus to manufacturing integration rather than the conceptual evolution in product development strategy emphasized in the ground truth. The original answer identifies a shift in how Nike Air is positioned among other technologies—moving from an innovative differentiator to a mature, foundational technology alongside Zoom, Free, and React. This strategic repositioning within the innovation platform is missing in the LLM response. (4) The LLM introduces new information (Air Manufacturing Innovation) that, while accurate, redirects the explanation toward operational integration rather than the conceptual evolution in product development strategy asked in the question. Thus, while contextually relevant and factually plausible, the answer misses the core analytical point about Nike Air transitioning from a growth-focused innovation to a standard component of a broader platform, resulting in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 472,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "In the 2022 Form 10‑K, Osmolite is identified as one of the “nutritional products used in enteral feeding in health‑care institutions” and is listed alongside Jevity®, Glucerna®, Oxepa®, Freego®, Nepro® and Vital® within the Nutritional Products segment (see 2022 page 3). The 2023 Form 10‑K repeats the same description, again placing Osmolite in the enteral‑feeding portfolio with the same companion products (see 2023 page 4). Thus, Abbott’s positioning of Osmolite has remained unchanged – it continues to be a core component of the enteral nutrition product line, with no new product‑line strategy or repositioning evident between 2022 and 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately states that in both 2022 and 2023, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, naming the correct companion products (Jevity®, Glucerna®, Oxepa®, Freego®, Nepro®, Vital®), with minor variation in Glucerna® product specificity (the ground truth specifies Glucerna® 1.2 Cal and 1.5 Cal, while the LLM generalizes to Glucerna®—this is acceptable as Glucerna® is still factually correct and commonly referenced as a line). (2) There are no numeric values, dates, or financial figures in this question; the years 2022 and 2023 are correctly referenced as filing years. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information from two consecutive 10-K filings to assess evolution (or lack thereof) in product positioning. (4) The conclusion—that Abbott’s positioning of Osmolite remained unchanged and that it continues to be a core component of the enteral nutrition line with no repositioning or strategic shift—is fully supported by the evidence and matches the ground truth. The answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 346,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "In 2022 3M’s PFAS work in Minnesota was largely limited to fulfilling the May 2007 Settlement Agreement and Consent Order with the MPCA – remediation was essentially finished at the Oakdale and Woodbury sites and “substantially completed” at Cottage Grove, with ongoing operation‑and‑maintenance activities (page 127). By 2024 the company was also dealing with a 2021 MPCA Notice of Violation, a 2022 order to address storm‑water PFAS, new, more‑stringent health‑based values and proposed HRLs issued by the MDH in early 2024, and a July 2024 draft Clean Water Act permit that imposes tighter PFAS effluent limits and required 3M to install a new wastewater‑treatment system and comment on the revised draft (page 102) – showing a broadened and more intensive regulatory engagement. In Alabama, the 2022 filing described a voluntary remedial‑action agreement and the July 2020 interim Consent Order with ADEM that obligates 3M to provide notices, reports, analytical studies, capital improvements and remediation activities (page 127); the 2024 filing simply restates that the same interim Consent Order continues to govern the Decatur facility’s PFAS‑related wastewater and air‑emission obligations (page 102), indicating little change in the regulatory framework there.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its portrayal of 3M's evolving regulatory engagement on PFAS in Minnesota and Alabama between 2022 and 2024, with accurate qualitative trends and mostly correct dates and regulatory actions. However, there are some factual inaccuracies and omissions that affect correctness. In Minnesota, the LLM correctly notes the 2007 Settlement Agreement and that remediation was substantially completed at Cottage Grove by 2022, but incorrectly states remediation was finished at Oakdale and Woodbury—these sites are not mentioned in the ground truth, which only references Cottage Grove. This is a factual overreach. The LLM accurately identifies the July 2024 draft Clean Water Act permit (though ground truth says it was issued in 2024 but doesn't specify July; the December 2024 revised draft is omitted), and correctly notes 3M submitted comments and faced tighter effluent limits. It also correctly references updated HBVs from MDH in early 2024 (ground truth: January 2024) and proposed HRLs in October 2024. However, the LLM incorrectly cites a '2021 Notice of Violation' and a '2022 storm-water order'—these specific enforcement actions are not in the ground truth, making them unsupported additions. In Alabama, the LLM correctly states the July 2020 Interim Consent Order with ADEM was in place in 2022 and remained in effect in 2024, but incorrectly refers to a 'voluntary remedial-action agreement' not mentioned in the ground truth. The ground truth emphasizes ongoing investigations and future capital costs, which the LLM downplays by saying there was 'little change,' missing the nuance that obligations were expected to incur additional costs over multiple years. Quantitative accuracy is high: all dates and regulatory milestones are either correct or plausibly aligned (e.g., July 2024 draft permit aligns with August 2024 comment submission). The reasoning is sound in showing increased regulatory pressure in Minnesota and relative stability in Alabama, but flawed by introducing unverified enforcement actions. Contextual relevance is strong—answer directly addresses the evolution across both states and years. Overall, core facts about Minnesota’s tightening standards and Alabama’s ongoing obligations are correct, but unsupported details and site inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 620,
        "total_tokens": 2313
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola HBC AG is not listed among the equity‑method investees – the filing only refers to “equity‑method investees” in general and gives no specific stake for HBC AG【page_116】. By the 2024 Form 10‑K the company explicitly classifies its holding in Coca‑Cola HBC AG as an equity‑method investment and discloses that it now owns 22 % of the bottler’s outstanding shares【page_87】. This reflects a move to an explicit equity‑method accounting treatment and a reduced ownership percentage.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Coca-Cola HBC AG was not listed among the equity-method investees in the 2022 Form 10-K. The ground truth states it *was* among the listed equity method investees, though the ownership percentage was not disclosed. The LLM incorrectly claims it was not listed at all, which contradicts the original answer. However, the 2024 disclosure of a 22% stake is correctly reported. (2) Quantitatively, the 22% ownership figure as of 2024 is accurate and matches the ground truth. There are no calculation errors, but the claim of a 'reduced ownership percentage' is unsupported — the 2022 percentage was not disclosed, so no valid comparison can be made about reduction. This introduces a false inference. (3) The multi-hop reasoning is partially sound in comparing disclosures across years, but the synthesis fails because it misrepresents the 2022 status. The model incorrectly infers a change in classification (from non-equity to equity method), whereas the ground truth indicates consistent equity-method treatment — only the specificity of disclosure improved. (4) Contextual relevance is high as the answer addresses investment classification and stake percentage over time, but the core factual inaccuracy regarding 2022 classification severely undermines correctness. The conclusion about 'move to explicit equity-method accounting' is misleading since the relationship was already under equity-method accounting in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 414,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle’s 2022 filing makes clear that hybrid‑deployment capability is a cornerstone of its strategy, noting that “providing choice and flexibility… including on‑premise, cloud‑based and hybrid deployments” is a key growth driver and that the company backed this with $7.2 billion of R&D spending to enhance performance, security, integration and cost‑effectiveness across those models【page_6】. By the 2024 filing the same hybrid emphasis is reiterated – Oracle still markets “on‑premise, cloud‑based and hybrid deployments” as interoperable options – but the narrative now stresses deeper integration through investments in its “second‑generation cloud infrastructure” and resources allocated under the 2024 restructuring plan to develop, market, sell and deliver cloud‑based (including hybrid) offerings【page_72】【page_54】. Thus, Oracle has moved from positioning hybrid as a strategic differentiator supported by broad R&D spending to actively channeling new infrastructure and restructuring investments to embed hybrid capabilities more tightly into its product roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Oracle emphasized hybrid deployments in both fiscal 2022 and 2024, with $7.2 billion in R&D spending in 2022, which matches the original answer. The evolution from a development-focused strategy to deeper integration via infrastructure and restructuring investments in 2024 is correctly captured. (2) Quantitative accuracy is perfect: the $7.2 billion R&D figure is correctly cited and attributed to 2022. No other numerical claims are made that contradict the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across two fiscal years and identifies the shift in strategic emphasis—from broad R&D support for hybrid models in 2022 to targeted integration through second-generation cloud infrastructure and restructuring efforts in 2024. The use of specific document pages (e.g., page 72, 54) suggests proper grounding. (4) While the original answer highlights hybrid deployments becoming a 'standard deployment choice' and emphasizes 'interoperability and customer choice,' the LLM captures this conceptually by referencing 'interoperable options' and 'choice and flexibility.' The only minor gap is that the LLM does not explicitly state that hybrid is now positioned as a standard option alongside on-premise and cloud, but this is implied in the narrative. Wording differs slightly but semantic meaning is equivalent. No factual errors or omissions affect the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 415,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "In the 2023 Form 10‑K, the Mandatory Clawback Policy was presented as Exhibit 97 and was “Filed herewith” as an attached exhibit. In the 2024 Form 10‑K, the same policy (still Exhibit 97) is no longer attached directly; instead it is “Incorporated by reference” to the prior year’s Form 10‑K filing. Thus, the policy shifted from a directly filed exhibit in 2023 to a referenced exhibit in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that in 2023, the Mandatory Clawback Policy was filed directly as Exhibit 97 ('Filed herewith'), and in 2024, it was 'Incorporated by reference' from the prior year’s 10-K—matching the original answer’s description of a procedural shift. (2) There are no numerical values requiring calculation, but the years (2023, 2024), exhibit number (97), and filing methods ('Filed herewith' vs 'Incorporated by reference') are all factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in disclosure practice across two consecutive 10-K filings for the same company and policy, identifying the evolution in filing status. (4) The answer is contextually precise, directly addressing the procedural change in disclosure without implying a substantive policy change, which aligns with the original answer’s intent. Wording differs slightly but conveys identical information with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 294,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher closed its acquisition of CorEvitas, LLC in August 2023, paying $0.91 billion in cash as part of its 2023 investing activities 【page_24】. In the 2024 filing the company lists CorEvitas as part of the Laboratory Products and Biopharma Services segment, with the purchase recorded under the acquisition method (including non‑tax‑deductible goodwill) and reflected in segment assets and the amortization of acquisition‑related intangibles 【page_65】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $0.91 billion acquisition amount and the 2023 timing (specifically August) match the original answer. The mention of cash payment and placement within investing activities is consistent. (2) The integration of CorEvitas into the Laboratory Products and Biopharma Services segment in 2024 is correctly reported, confirming the evolution from acquisition to operational integration. (3) The LLM correctly identifies the accounting treatment—acquisition method, inclusion of non-tax-deductible goodwill, and amortization of intangible assets—though it does not specify the 18-year weighted average amortization period mentioned in the ground truth, which is a minor omission. (4) The broader strategic context from the original answer (e.g., $5.94B in senior notes, $3.00B stock repurchase) is not included, but these are supplementary details not directly tied to the relationship evolution or its direct financial implications. The LLM focuses on the core financial implications—acquisition cost, segment integration, and amortization—demonstrating sound multi-hop reasoning across 2023 and 2024 filings. Semantic equivalence is strong; wording differs but meaning matches. The answer is fully contextually relevant and factually precise, warranting a high correctness score with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 396,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "In the 2022 Form 10‑K RTX said that, under the 2012 Rolls‑Royce IAE agreement, flight‑hour payments due through June 2027 were included in “Other commercial aerospace commitments” and would be **capitalized as collaboration intangible assets as the payments are made** 【page_112】.  At that time the schedule showed $735 million of such payments expected in 2022 and $1,053 million in 2023.  By the 2023 filing the timing had shifted forward – the same payments are now projected to start in 2024 ($836 million) and continue through 2028 and thereafter (with no 2022‑23 amounts) 【page_101】, but the **capitalization treatment remains the same**, i.e., the payments are still recorded as collaboration intangible assets when incurred.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, there was no change in the timing or magnitude of RTX's flight hour payment obligations between 2022 and 2023 — the structure remained stable through June 2027, with no shift in payment schedules. However, the LLM claims that in the 2022 filing, $735M was expected in 2022 and $1,053M in 2023, and that by 2023 the payments were pushed to 2024–2028, which contradicts the original answer stating 'no indication of a change in the magnitude or timing.' These specific dollar amounts and the claimed forward shift in payment timing are not supported by the ground truth and appear to be hallucinated or misattributed. While the LLM correctly identifies that payments are capitalized as collaboration intangible assets and are tied to flight hours through June 2027, the erroneous financial figures and misrepresentation of a timing shift severely undermine the answer's correctness. The reasoning is partially sound in tracking disclosure treatment across years, but the synthesis is flawed due to incorrect data. Contextually, the response addresses the right question about evolution in timing and capitalization, hence moderate relevance, but the core quantitative claims are false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 364,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola only reported that it had completed the acquisition of the remaining ownership interest in fairlife in 2020, without mentioning any ongoing contingent payment [page_55]. By the 2024 Form 10‑K the company records a contingent‑consideration liability of about $6.1 billion representing the fair‑value of a milestone payment that will be payable in 2025 if fairlife meets specified financial targets through 2024 [page_111].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the contingent payment amount, stating $6.1 billion, which is grossly inaccurate and not supported by the ground truth—no specific dollar amount was mentioned in the original answer, but $6.1 billion is implausibly large for a milestone payment related to fairlife and inconsistent with Coca-Cola's disclosures. This severely undermines factual correctness. (2) Quantitative accuracy is very low because the $6.1 billion figure is incorrect; the ground truth does not specify an amount, but the LLM fabricates a highly specific and unrealistic number. Dates (2020 acquisition, 2025 payment, performance through 2024) are correct and align with the original answer. (3) The reasoning correctly identifies the evolution from no mention of contingent payments in 2022 to the acknowledgment of a future milestone payment in 2024, showing proper multi-hop synthesis across years and filings. The structure of the answer reflects an understanding of the evolving financial relationship. (4) Contextual relevance is high because the answer addresses the core question about the evolution of contingent payments and ties it to performance milestones and disclosure changes. However, the fabricated dollar amount leads to a low correctness score despite otherwise sound reasoning and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 376,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "In the 2022 filing Oracle described Oracle Cloud Services as a unified SaaS‑and‑OCI platform that “integrates the IT components… to power our Oracle Fusion SaaS Applications” and highlighted flexible on‑premise, cloud and hybrid deployment models that give customers choice and enable migration of existing workloads (2022 p. 6‑7). By the 2024 filing the company still stresses the integrated SaaS‑and‑OCI model but adds a focus on a “second‑generation cloud infrastructure” and expanded services to develop, market, sell and deliver cloud‑based offerings, underscoring deeper integration of enterprise applications with more advanced, purpose‑built infrastructure (2024 p. 54, 72).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of dates (2022 and 2024) and correctly identifies Oracle as the entity, with no numerical inaccuracies (no financial figures involved). It captures key aspects of Oracle's strategic evolution: the integration of SaaS and OCI, deployment flexibility in 2022, and the shift toward a more advanced, integrated infrastructure in 2024. However, it omits the central role of the Oracle Autonomous Database as a highlighted innovation in 2022 per the ground truth, instead focusing on integration with Fusion SaaS Applications. Additionally, while it mentions a 'second-generation cloud infrastructure,' it misses the broader strategic shift emphasized in the original answer—from promoting individual technologies to positioning Oracle Cloud Services as a holistic, customer-centric platform for enterprise transformation. The answer is contextually relevant and well-grounded in document references (page numbers cited), but lacks full completeness in capturing the conceptual evolution (e.g., 'comprehensive and integrated offerings', 'choose the best option for business needs'). The reasoning is sound but not fully aligned with the multi-hop synthesis of strategic narrative progression present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 351,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "In the 2023 Form 10‑K the Key/Specified Employee Policy is listed as Exhibit 10(r)* and is incorporated by reference to Exhibit 10(v) of the company’s 2018 Annual Report on Form 10‑K. The 2024 Form 10‑K shows the same Exhibit 10(r)* with the identical reference to the 2018 Annual Report, indicating that the policy’s documentation and method of incorporation by reference have remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying that the Key/Specified Employee Policy remained unchanged between the 2023 and 2024 filings, with both referencing the same Exhibit 10(v) from the 2018 Annual Report. The core facts—unchanged documentation and continued incorporation by reference—are accurate and align with the ground truth. However, there is a minor discrepancy: the LLM states that the exhibit is labeled as 'Exhibit 10(r)*' in both 2023 and 2024, while the original answer specifies it was incorporated by reference to 'Exhibit 10(v)' from 2018. This could imply a mismatch in exhibit labeling (10(r) vs. 10(v)), though it's possible the asterisk denotes a locally renumbered exhibit. This inconsistency slightly affects entity accuracy and raises ambiguity about exhibit identity, but does not undermine the central conclusion that the policy was carried forward without amendment. Quantitatively, all years (2018, 2023, 2024) are correct, and no calculations are required. The reasoning correctly synthesizes information across years and filings, demonstrating sound multi-hop logic. The answer is fully contextually relevant, directly addressing the evolution of the policy’s documentation and incorporation. Thus, the score is reduced slightly due to the exhibit number discrepancy, but the overall factual and semantic content remains substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 381,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The 6.700 % notes due 2028 carried an aggregate principal balance of **$285 million at the end of 2022 and the same $285 million at the end of 2023**, showing no net increase or reduction【page_84†L...】. This unchanged balance indicates RTX is maintaining the existing level of that tranche rather than issuing new debt or accelerating repayment, reflecting a steady, disciplined debt‑management stance that preserves liquidity while keeping the overall debt profile stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 was $115 million in 2022 and increased to $285 million in 2023. The LLM incorrectly states that the balance was $285 million at the end of both 2022 and 2023, which contradicts the ground truth. This error fundamentally undermines the answer’s correctness. (2) The numbers are not accurate: the 2022 figure is off by $170 million, and the change over time (a significant increase) is entirely missed. The LLM reports no change, while in reality there was a $170 million increase. This is a major quantitative error. (3) The reasoning is flawed because it fails to perform the necessary multi-hop comparison between 2022 and 2023 balances. Instead, it asserts stability, leading to an incorrect interpretation of RTX’s debt management strategy. The ground truth indicates a strategic expansion of debt exposure, while the LLM concludes a 'steady, disciplined' stance due to no change—based on false data. (4) Despite the incorrect facts, the answer is contextually relevant: it addresses the right financial instrument, company (implied), and attempts to interpret debt management strategy. However, due to the critical error in data, the qualitative and quantitative accuracy scores are low. The correctness score is 2 because the core facts are wrong, though the answer is not entirely irrelevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 407,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "In 2023 the 1.95 % 12‑year senior notes (due 7/24/2029) were carried at **$773 million** and had an **effective interest rate of 2.08 %** (see page 62). By year‑end 2024 the carrying amount had declined to **$725 million** and the effective rate had slipped slightly to **2.07 %** (see page 47). This reflects a modest reduction in both the balance and the yield of the notes over the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value in 2023 is correctly stated as $773 million and in 2024 as $725 million; the effective interest rates are correctly reported as 2.08% in 2023 and 2.07% in 2024. Minor formatting differences (e.g., spacing in percentages, use of 'million') are acceptable and do not affect meaning. (2) The answer is complete, addressing both the carrying value and effective interest rate for both years as required by the question. (3) Entity accuracy is correct: TMO's 1.95% 12-Year Senior Notes are properly identified, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound—the observation that both the balance and yield modestly declined aligns with the data and reflects correct multi-hop synthesis across the two time points. The inclusion of page references adds contextual support without detracting from accuracy. (5) The semantic meaning is equivalent to the original answer, conveying the same financial evolution and implications. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 321,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon singled out its Directors’ Code of Conduct as a stand‑alone document, giving a specific URL (…/in relations/directors‑code‑of‑conduct.pdf) and stating that any amendments or waivers would be posted on the site. By contrast, the 2024 filing only lists the Directors’ Code of Conduct together with other governance materials (Corporate Governance Guidelines, By‑laws, committee charters, etc.) and provides no separate link or amendment‑waiver language. The change reflects a shift toward presenting the directors’ code as part of an integrated governance package, which can improve overall transparency and signal a more unified, streamlined corporate‑governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key factual differences between BNY Mellon's 2022 and 2024 SEC filings regarding the presentation of the Directors' Code of Conduct. It accurately notes that in 2022, a direct URL was provided and there was explicit language about amendments and waivers, while in 2024, the Code was listed among other governance documents without a direct link or amendment/waiver disclosure. These factual details align with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable in the traditional sense; however, the years 2022 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes changes in disclosure practices across two filings. However, the interpretation diverges from the ground truth: while the original answer frames the change as potentially reducing visibility and affecting transparency negatively, the LLM interprets the consolidation as improving transparency and signaling a more unified framework. This is a significant qualitative difference in implication, making the reasoning less accurate despite correct factual input. (4) The answer is contextually relevant and factually complete in describing the change, but the interpretive conclusion contradicts the cautious, critical tone of the ground truth regarding governance accountability and stakeholder engagement. Thus, while facts are correct, the qualitative inference lowers the correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 445,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon’s short‑term facility stayed at a $5.0 billion unsecured 364‑day revolving credit line, but its maturity was pushed out by one year. In the 2023 Form 10‑K the “Short‑Term Credit Agreement” was entered into in November 2023 and was scheduled to mature in October 2024 (with one optional 364‑day extension)【page_59】. In the 2024 Form 10‑K a new agreement was signed in October 2024, still for $5.0 billion, and now matures in October 2025 (with a similar extension option)【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: facility size ($5.0 billion), maturity dates (October 2024 and October 2025), and establishment timing (November 2023 and October 2024). The shift in establishment from November to October and the one-year maturity extension are correctly noted. (2) Quantitative accuracy is perfect: dollar amounts, dates, and the 364-day structure match the original answer. The mention of an optional extension is additional but accurate context and does not contradict the ground truth. (3) Reasoning is sound: the model correctly synthesizes data from two consecutive 10-K filings, identifying the renewal pattern and procedural nature of the change. The only minor shortcoming is that the LLM does not explicitly state that the 2024 agreement 'replaced' the 2023 one, though this is implied. Also, the original answer notes the 2023 agreement replaced a November 2022 one, which the LLM omits—this is a small completeness gap but not critical to the 2023–2024 comparison. (4) The answer is semantically equivalent, well-structured, and directly addresses the question’s focus on evolution in size, maturity, and timing. The use of citation markers (e.g., 【page_59】) suggests grounding in source documents. Overall, this is a strong, factually correct response with only minor omissions in contextual continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 392,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "In 2022 AMD’s APU strategy centered on CPU‑GPU chips that “deliver visual‑processing functionality for value and mainstream PCs” and were used in gaming notebooks, emphasizing integrated graphics for general‑consumer devices (page_8). By 2024 the company had added a dedicated neural‑processing unit to the same SoC, becoming “the first company to integrate a dedicated NPU on the same SoC as an x86 CPU for AI PCs” and targeting AI‑enabled PCs and broader AI workloads (page_5). This shift widens AMD’s market from ordinary consumer PCs to AI‑PCs, creating a new, higher‑margin revenue opportunity in the fast‑growing AI PC segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AMD's APU strategy from 2022 to 2024, accurately stating that in 2022 the focus was on CPU-GPU integration for value and mainstream PCs, particularly in gaming notebooks, and that by 2024 AMD introduced a dedicated NPU on the same SoC as the x86 CPU, targeting AI PCs. This aligns with the ground truth, which notes the shift from external GPU-based AI solutions (e.g., Instinct MI200) in 2022 to integrated NPUs in client APUs by 2024. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 to 2024), identifies the strategic shift (from GPU-centric to NPU-integrated APUs), and infers the market expansion into AI PCs. The implication for revenue potential—positioning AMD for higher-margin growth in a fast-growing segment—is logically derived and consistent with the original answer’s conclusion about enhanced revenue potential through differentiation. (4) The only minor gap is that the LLM answer does not explicitly mention AMD’s prior focus on data center/cloud AI via external GPUs (e.g., Instinct MI200), instead characterizing 2022 strategy more narrowly around consumer PCs. While this omits a layer of context, it does not contradict facts and still correctly identifies the core strategic evolution. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with high qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 451,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The 2024 Form 10‑K repeats the 2023 language, stating that Irish dividend‑withholding tax (currently 25 %) applies to Medtronic dividends unless a U.S. shareholder qualifies for an exemption – either a beneficial owner whose broker’s records show a U.S. address, or a record owner who provides a valid Form 6166 or Irish Non‑Resident Form V2. If the withholding tax is imposed, it satisfies any Irish income‑tax liability, and the U.S./Ireland treaty is generally unnecessary. Thus, the treatment of Irish income‑tax liability for U.S. shareholders has not changed from 2023 to 2024【page_31】【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Irish dividend withholding tax rate is accurately stated as 25%, and the conditions for exemption—valid Form 6166 or Irish Non-Resident Form V2—are correctly identified. The treatment of the withholding tax as discharging any Irish income tax liability upon submission of required statements is properly conveyed. (2) Quantitative accuracy is perfect: the 25% rate is correct, and no calculations are required beyond accurate reporting of percentages and conditions. Format and references to forms are consistent with the original. (3) The multi-hop reasoning is sound: the LLM correctly infers that because the 2024 Form 10-K repeats the 2023 language, there is no change in treatment between the years, which aligns with the ground truth’s conclusion of a stable regulatory framework. The mention of broker records showing a U.S. address as a potential exemption path is a minor addition not explicitly in the ground truth but is consistent with common administrative practices and does not contradict the original. (4) Contextual relevance is excellent—the response directly addresses the evolution (or lack thereof) in tax treatment for U.S. shareholders receiving Medtronic dividends, focusing precisely on withholding tax and income tax liability. The only reason for not scoring a 10 is that the LLM omits explicit mention of the requirement to submit a statement to Irish Revenue when withholding applies, which is a minor but present detail in the ground truth. Overall, the answer is highly accurate, well-reasoned, and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 451,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "In the 2022 Form 10‑K the company listed a separate risk factor stating that “new lines of business, new products and services or transformational or strategic project initiatives” could expose it to new or additional risks and warned that “we may not realize some or all of the expected benefits of our transition to a platforms operating model” (2022 p. 5). By the 2024 filing that specific bullet is no longer isolated; the platforms operating model is now mentioned only within the broader forward‑looking discussion of strategic initiatives and the transition to a platforms operating model (2024 p. 3), indicating the initiative is treated as part of overall strategic risk rather than a distinct new‑product risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, the absence of numerical errors earns a perfect score by default. The core issue lies in qualitative accuracy and factual correctness. The LLM incorrectly claims that in the 2022 10-K, the company already warned about not realizing benefits from the 'transition to a platforms operating model' as a standalone risk (citing 2022 p. 5), which contradicts the ground truth: in 2022, the risk was general (new products, services, strategic initiatives), and the specific mention of the platforms operating model as a risk did not appear until 2024. The LLM reverses the evolution: it falsely asserts that the platforms operating model was a distinct risk in 2022 and then got merged into broader strategic risk in 2024, when in reality, it emerged as a new, specific risk in 2024. This is a critical factual inversion. The reasoning is therefore flawed, failing the multi-hop requirement to correctly trace the evolution of risk disclosure over time. Contextually, the answer addresses the right topic and filing years, so relevance is moderate, but the incorrect direction of change severely undermines the response. Semantic equivalence is not achieved due to this fundamental reversal of the timeline and risk framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 364,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "In the 2023 Form 10‑K Amazon listed the 3.600 % Note due 2032 in Exhibit 4.2 – the supplemental indenture that is incorporated by reference to its April 13 2022 Form 8‑K filing【page_75】. In the 2024 filing the note remains outstanding, but the company now discloses in a footnote that it has not filed the detailed instrument for certain long‑term debt (including this note) because the amount is below the 10 % of total assets threshold, and will furnish it on request【page_77】. This marks a shift from a specific exhibit reference to a more general, material‑threshold‑based disclosure.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the existence of the 3.600% Note due 2032 and its inclusion in Exhibit 4.2 in the 2023 10-K, referencing the April 13, 2022 Supplemental Indenture. However, it fundamentally misrepresents the evolution between 2023 and 2024. The ground truth states that the key change was the trustee transition from Wells Fargo Bank (prior trustee) to Computershare Trust Company (successor trustee), with the 2024 filing reflecting only Computershare as the trustee. The LLM instead claims that the change was a shift in disclosure practice due to a 10% threshold exemption, asserting Amazon stopped filing the instrument because it was below a materiality threshold. This is incorrect and contradicts the ground truth. (2) Quantitatively, the dates (April 13, 2022), interest rate (3.600%), and maturity year (2032) are accurate. However, the claim about the 10% of total assets threshold is unsupported by the ground truth and appears to be a misinterpretation or fabrication. (3) The multi-hop reasoning is flawed: the model fails to identify the actual evolution (trustee transition) and instead invents a procedural disclosure rationale not present in the original answer. It does not synthesize the correct entities (trustees) or administrative changes. (4) While the answer is contextually relevant—discussing Amazon’s debt disclosures and changes over time—it misses the core factual evolution entirely, leading to a low correctness score despite some accurate surface details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 424,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "In the 2023 filing MDL Z listed its net‑investment‑hedge derivative contracts as a **$219 million net liability** (Level 2) and recorded a **$185 million after‑tax loss** on those contracts in other comprehensive earnings, with **$148 million of the fair‑value change excluded from hedge‑effectiveness testing and shown in other income, net** (see page 95 and page 97). By the 2024 filing the same contracts were shown as a **$255 million net asset** (Level 2) in the fair‑value of derivatives table—reversing the prior liability—and the impact now appears in other income, net (still disclosed in Note 10 as amounts excluded from hedge effectiveness) (see page 95 and page 93).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed derivative assets of $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022 respectively. The LLM answer incorrectly reports a $219 million net liability and $185 million after-tax loss, which are not supported by the ground truth. There is no mention of comprehensive income or after-tax losses in the original answer. Additionally, the $148 million excluded from hedge effectiveness is fabricated and not present in the ground truth. In 2024, the LLM claims a $255 million net asset, which contradicts the original answer that does not provide updated balance sheet figures but instead notes a shift in disclosure emphasis to income statement impact. (2) Quantitative accuracy is very low: none of the key numbers ($219M net liability, $185M loss, $148M excluded amount, $255M net asset) match the ground truth. The original answer provides balance sheet values for 2023 and 2022 but does not report net liabilities or income statement losses. (3) The multi-hop reasoning is partially sound in that the LLM identifies a shift in disclosure focus toward income statement impact (specifically 'other income, net') in 2024, which aligns with the ground truth's mention of amounts excluded from hedge effectiveness appearing there. However, it invents numerical details and misrepresents the 2023 disclosures, failing to accurately synthesize the actual data. (4) Contextual relevance is moderate because the answer addresses the evolution of disclosure treatment and attempts to compare 2023 and 2024, focusing on financial statement presentation and income statement impact. However, due to severe quantitative inaccuracies and fabrication of figures, the correctness score is low despite some relevant conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 522,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "In 2023 the company focused on delivering the next‑generation SEPv3 upgrade for the M1A2 Abrams and announced the new M1E3 engineering‑change tank, which adds advanced communications, power‑generation, optics, armor and a modular systems architecture to enable faster future upgrades (page_10). By 2024 the emphasis had shifted to sustaining those capability gains while highlighting strong, growing demand from NATO members and other allies worldwide, with an expanding Abrams installed base across Europe, the Middle East, North Africa and the Indo‑Pacific (page_9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2023, General Dynamics focused on the SEPv3 upgrade and announced the M1E3, with accurate details on technological improvements (communications, power generation, optics, armor, modular architecture). In 2024, the shift toward sustaining capabilities and highlighting growing international demand across Europe, the Middle East, North Africa, and the Indo-Pacific is correctly reported. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes technological development (SEPv3 and M1E3) with strategic shifts in international demand, correctly contrasting 2023's technical focus with 2024's emphasis on global procurement momentum. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'modular systems architecture' vs 'latest systems architecture') but meaning is preserved. The only minor omission is not explicitly naming General Dynamics, though 'the company' is contextually clear. This does not detract significantly from accuracy. All parts of the question (technological development, international demand, evolution across years) are addressed thoroughly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 374,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "In the 2022 filing AMD portrayed APUs chiefly as integrated CPU‑GPU chips for “value and mainstream PCs,” stressing their role in delivering a balanced, power‑efficient platform with on‑chip security for consumer and commercial notebooks and desktops【page_7】; the narrative highlighted APUs as the core of its “All‑AMD” strategy for integrated, low‑power computing【page_8】. By the 2024 filing, APUs appear in three reportable segments—Data Center, Client, and Embedded—signaling a shift from a primarily consumer‑focused product to a cross‑segment accelerator that supports data‑center workloads, client PCs and embedded applications, reflecting a broader strategic emphasis on heterogeneous computing across multiple markets【page_69】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic evolution in AMD's positioning of APUs between 2022 and 2024 and captures the general trend of broader integration across segments. However, it contains a significant factual error: it states that in 2024, APUs appear in *three* reportable segments—Data Center, Client, and Embedded—whereas the ground truth specifies only *two*: Data Center and Client. The original answer explicitly notes that APUs were included in Data Center and Client segments in 2024, with no mention of Embedded. This misrepresentation of the number and names of segments undermines the accuracy of the synthesis. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the years 2022 and 2024 are used correctly, and no incorrect figures are presented, warranting a full score in quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategic shift from consumer-focused to broader market positioning—but fails in precise entity mapping by adding the Embedded segment without evidence. The ground truth does not support APUs being part of the Embedded segment in 2024. (4) Despite the critical error in segment count and naming, the answer is contextually relevant and captures the essence of AMD’s expanded strategic emphasis on APUs in data center and client markets. The mention of heterogeneous computing and cross-segment use aligns thematically with the ground truth. However, the incorrect segmentation reduces qualitative and overall correctness, justifying a score of 6 for correctness and qualitative accuracy, while contextual relevance remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 476,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement that, under the Irish Financial Transfers Act 1992, the Irish Minister for Finance may restrict “financial transfers” (capital movements or payments) between Ireland and other jurisdictions, and that the Minister has already restricted transfers with a number of third‑country jurisdictions – a list that is “subject to ongoing change.” The 2024 filing repeats this language verbatim, indicating no material change in the disclosure from 2023. 【page_31】【page_31】",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the disclosure content and correctly identifies that both the 2023 and 2024 Form 10-K filings contain the same language regarding the Financial Transfers Act 1992, including the Irish Minister for Finance's authority to restrict transfers and the list being 'subject to ongoing change.' This aligns with the ground truth on the regulatory framework described. However, the LLM contradicts the original answer by asserting that the 2024 filing repeats the language verbatim and shows no material change, whereas the ground truth states that by 2024, Medtronic no longer emphasized the dynamic nature of the list—indicating a shift in disclosure tone or focus. The LLM fails to detect this evolution, which is central to the question about how the disclosure 'evolved.' While the quantitative and entity accuracy (dates, act name, company) are correct, the qualitative reasoning is flawed because it misses the nuanced change in emphasis, leading to an incorrect conclusion about the lack of evolution. The answer is contextually relevant and well-sourced but incorrect in its core inference, resulting in a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 331,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In the 2023 Form 10‑K GD noted that the ultra‑long‑range G700 was still awaiting FAA certification and was expected to enter service in early 2024【page_5】. By the 2024 filing the company reported that the G700 had been certified, entered service and “began deliveries in the second quarter of 2024,” with a production ramp‑up reflected in higher work‑in‑process inventories【page_70】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the status evolution of the G700 from 2023 to 2024: in 2023, the aircraft was awaiting FAA certification with expected entry into service in early 2024; by 2024, it had been certified, entered service, and began deliveries in Q2 2024. (2) All dates and timeframes are correct—'early 2024' for certification and 'second quarter of 2024' for deliveries align with the original answer. No numerical values require calculation, but the temporal data is precise and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of disclosures to show progression from anticipated certification to actual delivery and production ramp-up, citing increased work-in-process inventories as supporting evidence. (4) The answer is contextually relevant, complete, and semantically equivalent to the ground truth, with added detail (e.g., inventory impact) that enhances accuracy without introducing error. Minor wording differences (e.g., 'began deliveries in the second quarter' vs 'had begun deliveries in the second quarter') do not affect meaning. All entities—G700, GD, FAA, 2023 and 2024 timeframes—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 357,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In 2023 PMI described its tie‑up with KT&G as a 15‑year, exclusive, worldwide collaboration (outside South Korea) that gave PMI access to KT&G’s smoke‑free devices, consumables and product‑innovation pipeline, making KT&G a strategic source of new smoke‑free offerings【page_59】. By 2024 the relationship is framed mainly as a licensing arrangement – KT&G‑licensed brands such as Fiit and Miix are now listed as part of PMI’s heated‑tobacco (HTU) portfolio and heat‑not‑burn products, showing that PMI continues to commercialize KT&G products but the partnership is presented more as product licensing than a broad strategic dependency【page_40】【page_41】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15-year exclusive worldwide collaboration (excluding South Korea) established in 2023, accurately reflecting the duration, scope, and strategic intent of the agreement. It correctly references KT&G’s smoke-free devices, consumables, and innovation pipeline as part of the partnership. In 2024, the LLM notes that KT&G-licensed brands like Fiit and Miix are included in PMI’s heated-tobacco (HTU) portfolio, which aligns with the ground truth’s claim of deeper integration into PMI’s product ecosystem. However, the LLM frames the 2024 evolution as a shift toward a 'licensing arrangement' and suggests a move away from 'broad strategic dependency,' which contradicts the ground truth’s characterization of increased strategic dependency and operational integration. This misrepresents the nature of the evolution—ground truth indicates deepening alignment, while the LLM implies a narrowing to licensing, which underplays the strategic significance. (2) All quantitative elements—15-year term, January 29, 2038 end date (implied via 2023 start), and correct product names—are factually accurate. No numerical errors. (3) The multi-hop reasoning is partially sound: the model connects 2023 collaboration terms to 2024 product inclusion, but fails to correctly infer the strategic implication of that inclusion. Instead of recognizing integration as evidence of increased dependency, it interprets it as a reduction in scope, which reflects flawed reasoning. (4) Scores reflect high factual accuracy in numbers and entities (quantitative accuracy = 10), but a moderate flaw in interpreting the strategic evolution (qualitative accuracy = 7), leading to a correctness score of 7. Contextual relevance is high as the answer directly addresses both years and both aspects of the question—strategic dependency and product commercialization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 511,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "In 2022 AMD framed its semi‑custom SoC business largely as a services‑driven revenue source – it earned non‑recurring engineering fees and product sales only when third‑party customers chose to embed the chips and when those customers’ products succeeded (2022 p. 25). By 2024 the company has repositioned semi‑custom SoCs as a core, ecosystem‑wide differentiator, embedding them across its Gaming, Data‑Center and Embedded segments and tying them to its custom‑ready chiplet platform, Infinity Architecture and open ROCm software stack to deliver integrated AI, cloud, edge and console solutions (2024 p. 5‑6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of AMD's semi-custom SoC strategy from 2022 to 2024: in 2022, revenue was tied to third-party product success and non-recurring engineering (NRE) fees, with acknowledged risks due to lack of control—this matches the original answer. By 2024, the shift to a more integrated, ecosystem-driven approach is accurately described, including integration across Gaming, Data Center, and Embedded segments. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the model synthesizes information across years and business segments, correctly identifying the strategic shift from dependency to integration. It adds specific technical and architectural details (chiplet platform, Infinity Architecture, ROCm) not in the ground truth but consistent with AMD’s known ecosystem—this enhances accuracy without introducing error. The only minor gap is that the ground truth emphasizes the inclusion of NPUs in AI PCs (e.g., x86+NPU SoCs), which the LLM answer implies via 'integrated AI' but does not explicitly mention. This omission prevents a perfect 10 but does not undermine the core correctness. (4) Contextual relevance is excellent: the answer directly addresses strategic positioning and ecosystem integration over time, fully satisfying the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 419,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "In the 2023 filing Medtronic said Irish dividend withholding tax (currently 25 %) applies unless a U.S. shareholder holds the shares through the Depository Trust Company (or qualifies under a treaty), in which case the exemption eliminates any Irish income‑tax liability on the dividend. The 2024 filing expands that exemption – record owners can also avoid withholding by furnishing a U.S. Certificate of Residence (Form 6166) or an Irish Non‑Resident Form V2 – and adds that any withholding tax that is imposed discharges the Irish income‑tax liability once the shareholder provides a statement to the Irish Revenue. Thus, the basic rule remains the same, but the 2024 disclosure adds additional documentation‑based exemptions and clarifies the discharge of Irish income tax by the withholding payment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in the description of exemption conditions. (1) Quantitatively, all numbers are accurate: the 25% withholding tax rate is correctly stated and consistent with the original answer. Dates (2023 vs 2024) are properly attributed. (2) The LLM correctly identifies that the 2024 filing added clarification on documentation (Form 6166, Form V2) and the discharge of tax liability via a statement to Irish Revenue—this matches the ground truth’s emphasis on structured exemption conditions and post-withholding procedures. (3) However, the LLM incorrectly specifies that exemption applies if shares are held through the Depository Trust Company (DTC), which is not mentioned in the original answer; instead, the ground truth refers more broadly to U.S. residents qualifying for exemption and not holding shares through an Irish branch. This is a factual deviation in entity condition, though the overall reasoning about exemption and liability discharge remains sound. (4) The answer correctly synthesizes multi-hop information across years and filings, accurately capturing the evolution in disclosure clarity. While the core facts and financial treatment are correct, the incorrect detail about DTC slightly undermines qualitative accuracy. Semantic equivalence is mostly preserved, and the answer is highly relevant to the question about evolution in tax treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 402,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "In 2023 General Dynamics saw Marine Systems revenue rise to $12.5 billion, largely from higher volume on the Columbia‑class submarine program, but its operating margin fell to 7.0 % because “supply‑chain impacts to the Virginia‑class submarine schedule and cost growth on the Arleigh Burke‑class (DDG‑51) guided‑missile destroyer program” eroded profitability【page_37】. For 2024 the company is projecting Marine Systems revenue of roughly $12.8‑$12.9 billion with an operating margin of about 7.6 %, signaling a continued strategic focus on expanding Columbia‑class production while expecting to contain the Virginia‑class and DDG‑51 cost pressures【page_37】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 Marine Systems revenue of $12.5 billion (implied from context), operating margin decline to 7.0% (consistent with 110 basis point drop to reach ~7.0%), and 2024 projected revenue of $12.8–12.9 billion with a 7.6% operating margin match the original answer. The causes—supply chain impacts on Virginia-class and cost overruns on DDG-51—are correctly identified. (2) Quantitative accuracy is perfect: all dollar figures, percentages, and ranges are correct and match the source. The 110 basis point decline is consistent with the margin falling to 7.0%, and the 2024 margin improvement to 7.6% reflects a 60 basis point recovery, which is logically sound. (3) Multi-hop reasoning is strong: the answer synthesizes financial performance (revenue and margin) across two years, links cost pressures to specific programs, and connects the strategic focus to the Columbia-class program’s growth. The mention of containing cost pressures in 2024 reflects correct inference from improved outlook. (4) The only minor omission is that the original answer explicitly notes the margin decline was from 2022 to 2023 (110 bps), while the LLM implies it without stating the prior year’s margin. However, stating the 7.0% margin in 2023 and 7.6% in 2024 still conveys the correct trend. Wording differences (e.g., 'Arleigh Burke-class' vs 'DDG-51') are semantically equivalent. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 433,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Booking Holdings’ reliance on Booking.com stayed essentially flat – online accommodation‑reservation services (which are overwhelmingly generated by Booking.com) represented about 89 % of total revenue in both 2022 and 2023. The 2023 10‑K notes “approximately 89 %, 89 % and 87 % of the Company’s revenues for the years ended December 31, 2023, 2022, and 2021, respectively, relate to online accommodation reservation services”【page_87】.  Thus, the proportion of revenue derived from accommodation reservations did not change between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Booking.com's accommodation reservations accounted for 89% of BKNG's revenue in both 2022 and 2023, which matches the ground truth. The citation from the 10-K (page 87) accurately reflects the reported figures: 89% in 2023, 89% in 2022, and 87% in 2021. All numeric values are correct and properly contextualized. (2) Quantitative accuracy is perfect: percentages (89%, 89%) and years (2022, 2023) are exact matches to the ground truth. The mention of 2021 adds context but does not detract from accuracy. (3) The reasoning is sound: the model correctly infers that the proportion did not change between 2022 and 2023, aligning with the ground truth's conclusion of sustained dependency. However, the original answer notes a 'slight increase'—which is incorrect since 89% to 89% is no change—so the LLM is actually more accurate in rejecting an increase. Thus, the LLM corrects a minor error in the ground truth. (4) The answer is semantically equivalent and highly relevant, directly addressing the evolution of financial dependency through accurate data synthesis. The only reason for not scoring 10 is that the original answer incorrectly implies a slight increase, while the LLM correctly identifies no change—so the LLM outperforms the ground truth, but per scoring guidelines, a perfect 10 requires alignment with ground truth even if it's flawed. Still, 9 reflects excellent performance with full factual and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 411,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "In the 2023 Form 10‑K PMI listed a Swiss‑franc note (1.625% due 2024) with a carrying amount of about **$299 million**【page_105】. By the 2024 filing the same line shows “‑” (no amount), indicating the note has been repaid or matured and is no longer outstanding【page_102】. This removal eliminates the company’s Swiss‑franc exposure, reducing its foreign‑currency debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $299 million Swiss Franc note obligation in 2023 and its complete removal in 2024, matching the ground truth. The note's maturity (due 2024) and carrying amount are accurately reported. The conclusion that the obligation was repaid or matured is consistent with the absence of the liability in 2024. (2) Quantitative accuracy is perfect: $299 million is correctly cited, and no incorrect figures are introduced. The use of 'about $299 million' is acceptable given typical rounding in financial disclosures. (3) The reasoning is sound—by noting the change from $299M to '-' (no amount), the model correctly infers the obligation was extinguished. It appropriately links this to reduced foreign currency exposure, aligning with the ground truth's interpretation of strategic shift. The only minor gap is not explicitly stating 'restructured' as a possibility (ground truth includes 'repaid or restructured'), but 'repaid or matured' is a reasonable inference given the note's 2024 maturity. (4) All entities (Swiss Franc note, 2023/2024 time frame, foreign currency obligations) are correctly identified and synthesized. The answer is fully relevant and conveys the same core information as the original, with only slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 361,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs listed the legacy (pre‑2015) Non‑Employee Director RSU award as Exhibit 10.8 and the current award templates as Exhibit 10.31 (standard) and Exhibit 10.32 (cash‑settled) 【page_5†L8-L13】. In the 2024 filing the legacy form was renumbered to Exhibit 10.9, the standard and cash‑settled templates were shifted to Exhibits 10.32 and 10.33, and a new amendment exhibit (10.18) was added to capture changes to non‑employee director equity award agreements 【page_246†L8-L13】【page_247†L1-L4】. These renumberings and the addition of the amendment exhibit reflect an updated and more explicitly modified set of RSU award agreements for non‑employee directors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative and exhibit details, despite capturing the general direction of change. (1) The 2023 10-K did not include Exhibits 10.31 and 10.32 for 'current award templates' as claimed—the only referenced RSU agreement was the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8. The LLM incorrectly asserts the existence of current templates in 2023, which contradicts the ground truth. (2) The renumbering of the legacy form to Exhibit 10.9 in 2024 and shifting of templates to Exhibits 10.32 and 10.33 are not supported by the ground truth, which only confirms the addition of a new Exhibit 10.18 ('Amendments to Certain Non-Employee Director Equity Award Agreements') without mentioning renumbering or new templates. (3) The core correct element is the introduction of Exhibit 10.18 in 2024, which aligns with the ground truth and indicates updated disclosures. (4) While the reasoning about more comprehensive treatment is plausible and contextually relevant, the multi-hop synthesis is flawed due to fabrication of exhibits and renumbering not present in the original data. The answer overstates the evolution by implying structural reorganization and current templates in 2023, which were not there. Quantitative accuracy is low due to incorrect exhibit numbers and implied document structure. Qualitative accuracy is moderate because the central idea of expanded disclosure via a new amendment exhibit is correct. Contextual relevance is high as the response directly addresses the evolution in treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 437,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "In 2023 PMI’s balance sheet still showed a sizable Euro‑credit facility tied to the Swedish Match acquisition – about **$6.1 billion** of borrowings (average 3.445% interest, due 2027)【page_102】. By year‑end 2024 that amount had fallen to roughly **$2.6 billion** after PMI prepaid the entire three‑year tranche of the €5.5 billion term‑loan (≈ €3 billion or $3.2 billion) on Nov 21 2024, leaving only the five‑year tranche outstanding【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key numerical aspects: it reports $6.1 billion in 2023 and $2.6 billion in 2024, which aligns with the ground truth of $6,121 million and $2,610 million (minor rounding differences are acceptable: $6.1B ≈ $6,100M and $2.6B ≈ $2,600M). The mention of the November 21, 2024 prepayment of the three-year tranche (≈€3 billion or $3.2 billion) explains the reduction and is consistent with the debt decrease. 2) Quantitative accuracy is excellent: all dollar amounts, dates (Nov 21, 2024), interest rate (3.445%), and maturity (2027) are precise and support the narrative. The calculation implied—reduction from ~$6.1B to ~$2.6B due to a ~$3.2B prepayment—is logically sound and numerically plausible. 3) The multi-hop reasoning is strong: the model connects the acquisition-related debt in 2023 to the 2024 reduction via a specific prepayment event, correctly identifying the structure of the term loan (three-year and five-year tranches) and the financial impact. It adds contextual detail (prepayment of €3B tranche) not in the original answer but consistent with the knowledge graph, enhancing explanation without introducing error. 4) The entity names (PMI, Swedish Match AB), years (2023, 2024), and financial metric (long-term debt obligations tied to acquisition) are accurate. The only minor shortcoming is that the original answer emphasizes the 'evolution' and 'reduction in financial dependency,' while the LLM focuses more on mechanics than interpretation—hence a 9 instead of 10 on qualitative accuracy. However, the core reasoning and synthesis are sound. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 456,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "In 2023 BMS’s KRAS‑inhibition strategy was still emerging, culminating in the decision to acquire Mirati to secure a KRAS‑targeted platform – the deal, announced as a subsequent event, gave BMS rights to the KRAS inhibitor Krazati (page 87). By 2024 the acquisition was completed and BMS positioned Krazati as a “best‑in‑class” KRAS‑G12C therapy, already FDA/EMA‑approved for second‑line NSCLC and now with accelerated approval for KRAS‑mutated colorectal cancer and positive Phase III KRYSTAL‑12 data in KRAS‑mutated NSCLC, reflecting a shift from pipeline‑building to an active, multi‑indication KRAS franchise (pages 93 and 71).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that BMY (BMS) acquired Mirati to gain Krazati, a KRAS G12C inhibitor, with the acquisition completed in 2024. The $4.8 billion price is omitted, which is a minor quantitative gap, but the core event and timing are correct. (2) The LLM accurately reflects Krazati’s FDA approval for second-line NSCLC and its accelerated approval for KRAS-mutated colorectal cancer with cetuximab (implied in 'accelerated approval for KRAS-mutated colorectal cancer'). The mention of EMA approval is an addition not in the original but not incorrect. The Phase III KRYSTAL-12 data supports the first-line development trajectory, consistent with the original answer’s reference to development in combination with a PD-1 inhibitor. (3) The multi-hop reasoning is sound: the answer connects the 2023 pre-acquisition state, the 2024 acquisition completion, and the resulting strategic shift in BMY’s oncology positioning. It correctly synthesizes the evolution from pipeline-building to an active multi-indication franchise. (4) The answer is contextually excellent, directly addressing the evolution of BMY’s strategic positioning around KRAS inhibition. The only minor omission is the exact acquisition cost ($4.8 billion), which slightly affects quantitative completeness but does not undermine the overall correctness. Wording differences (e.g., 'best-in-class', 'subsequent event') are acceptable and semantically consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 413,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the Restricted Partner Compensation Plan was disclosed simply as an exhibit (“The Goldman Sachs Amended and Restated Restricted Partner Compensation Plan” incorporated by reference to the 2006 Quarterly Report) and listed among other legacy compensation documents. By the 2024 filing the same cross‑reference remains, but the plan is now presented together with newly‑amended governance instruments—most notably the “Amended and Restated The Goldman Sachs Group, Inc. Clawback Policy” effective Dec 1 2023—signaling that the RPCP is now positioned within an updated compensation‑governance framework that subjects it to the firm’s recent oversight and claw‑back rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Goldman Sachs' disclosure framework by noting the introduction of the Clawback Policy and the repositioning of the Restricted Partner Compensation Plan (RPCP) within a broader governance context. However, there are key factual inaccuracies that reduce correctness. First, the original answer states that in 2023 the RPCP was listed as Exhibit 10.3 and in 2024 as Exhibit 10.4, indicating a change in exhibit numbering and placement—this detail is missing in the LLM response, which instead vaguely refers to 'incorporated by reference to the 2006 Quarterly Report' without confirming the exhibit numbers or their shifting positions. Second, the LLM incorrectly implies the RPCP was cross-referenced the same way in both years without acknowledging the exhibit renumbering and repositioning (from early to later in the list), which is a central point in the ground truth. Third, while the LLM correctly identifies the Clawback Policy as a new governance element (effective Dec 1, 2023), it mislabels it as 'Amended and Restated' and lists it as Exhibit 10.1 in the answer without naming the exhibit number—whereas the ground truth emphasizes its placement as Exhibit 10.1 in 2024, signaling prioritization. The reasoning is partially sound in linking the Clawback Policy to enhanced governance, but fails to support the claim of 'strategic repositioning' with accurate exhibit-level evidence. The answer is contextually relevant and addresses the multi-hop nature of the question (evolution over time, relation to new policies), but lacks precision in exhibit numbers, placement changes, and correct naming of documents, leading to a partially correct assessment. Quantitative accuracy is moderate: the date (Dec 1, 2023) is correct, but exhibit numbers and structural details are omitted or misrepresented. Qualitative accuracy suffers from incorrect synthesis—while the clawback policy's relevance is acknowledged, the relationship to RPCP is asserted without evidence from the exhibit list structure. Contextual relevance is high as the response stays focused on disclosure evolution and governance trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 575,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "In the 2022 filing PMI presented heat‑not‑burn as a distinct reduced‑risk platform – “Platform 1” of its IQOS brand – and described the consumables as heated‑tobacco units (HTU) that include its own HEETS line and the KT&G‑licensed Fiit and Miix brands【page_44】【page_5】. By the 2023 filing the company had folded heat‑not‑burn into the broader “Smoke‑free products” revenue category (alongside e‑vapor, oral nicotine and wellness items) and explicitly noted that its heat‑not‑burn range now includes licensed KT&G products and a new zero‑tobacco (LEVIA) consumable, signalling a more integrated, consolidated business approach【page_39】【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Philip Morris International (PMI) categorized heat-not-burn products under Reduced-Risk Products (RRPs), specifically as 'Platform 1' of IQOS, with HTUs including HEETS and licensed KT&G brands (Fiit and Miix mentioned in LLM, though not in original answer—this is a minor addition but factually plausible and not contradicted). (2) The 2023 evolution is accurately described: heat-not-burn products were integrated into the broader 'smoke-free products' category, which now includes e-vapor, oral nicotine, and wellness items. The LLM correctly notes the inclusion of licensed KT&G products and adds LEVIA as a new zero-tobacco consumable, which reflects an accurate detail from PMI's 2023 filing. (3) Multi-hop reasoning is sound—comparing categorization shifts between 2022 and 2023, synthesizing changes in product grouping and business integration. (4) The only minor gap is that the original answer emphasizes the strategic shift in categorization (from RRPs to smoke-free), while the LLM focuses more on revenue categorization and product expansion. However, the core facts—reclassification, broader integration, inclusion of licensed products—are all correct. No numerical inaccuracies; dates and entities are correct. Wording differs slightly but maintains semantic equivalence. Thus, correctness is excellent with only slight nuance missing on strategic framing, warranting a 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 413,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "In the 2023 Form 10‑K BMS disclosed that, to satisfy the SEC Consent Order, it had **created a business‑risk‑and‑disclosure group** and put in place a governance process that escalates any sales‑to‑direct‑customer compliance questions to senior management and is monitored on a regular basis (2023 p. 63). By the 2024 Form 10‑K the company reiterated that the same group remains active, now **embedded in a company‑wide policy with ongoing monitoring and a formal escalation path**, showing that the group’s role has become an institutional part of BMS’s risk‑governance framework for Consent Order compliance (2024 p. 65).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Bristol-Myers Squibb (BMS) created the business risk and disclosure group in 2023 specifically to comply with the SEC Consent Order, and that the group was still active in 2024 as part of an institutionalized governance framework. The key elements—establishment in 2023, purpose of compliance, governance process with escalation, and continued existence in 2024—are all present. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2023 and 2024) and document references (Form 10-K pages 63 and 65) are correctly cited, supporting factual precision. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings to show evolution—from creation to institutionalization—of the group’s role. The LLM captures the continuity and entrenchment of the group in company policy, which reflects the ground truth’s point about integration into ongoing compliance without reduction in scope. (4) Minor omission: the ground truth mentions the retention of an outside consultant to re-engineer accounting processes and the formal review/certification of SEC filings—details not included in the LLM answer. While the core evolution of the group’s role is accurately conveyed, this missing context slightly reduces completeness and qualitative accuracy. However, the LLM emphasizes the governance mechanism and escalation path, which are central, and correctly infers institutionalization. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 486,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP’s discussion of the pension‑plan expected return shows no change from 2023 to 2024. In both years the company states that the expected long‑term return “is based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions,” and the assumed return rate stayed at 5.25% (see 2024 page 54 and 2023 page 55). Thus the methodology linking expected return to the asset‑allocation mix remained consistent across the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that UNP's treatment of the pension plan expected return showed no change between 2023 and 2024. The ground truth indicates a clear shift in language and disclosure: in 2023, UNP cited the asset allocation mix, historical returns, and market conditions as bases for the expected return and disclosed an actual return of 6%. In 2024, the language changed to say the expected return 'depends on' the asset allocation mix only, with no mention of historical returns or market conditions, and no disclosure of the actual return. The LLM incorrectly claims the assumed return rate remained at 5.25% in both years, but the ground truth states an actual return of 6% in 2023 and no disclosed return for 2024. These are significant factual discrepancies. (2) Quantitatively, the LLM invents a 5.25% assumed return rate not present in the ground truth and misrepresents the 6% actual return from 2023 as a consistent assumed rate, which is incorrect. Page numbers cited (2024 page 54, 2023 page 55) cannot be verified but are not inherently implausible; however, the numbers they reference are wrong. (3) The multi-hop reasoning is flawed: the model fails to detect the evolution in language and disclosure practices between the two years, instead asserting consistency where there is documented change. It does not synthesize the correct qualitative shift from a comprehensive to a narrower explanation. (4) The contextual relevance is moderate because the answer addresses the right topic (pension plan expected return and asset allocation) and the correct company (UNP), but the core conclusion about consistency is false. Due to major factual and reasoning errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 478,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was mentioned only within the “Code of Ethics” section, with a URL to the PDF and a statement that any amendments would be posted on the website. By the 2023 filing, the Directors’ Code of Conduct is listed alongside the Corporate Governance Guidelines, By‑laws and committee charters as a standalone document that is freely available on BNY Mellon’s website, making it more prominently accessible and fully integrated into the company’s corporate‑governance reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of BNY Mellon's disclosure approach to the Directors' Code of Conduct between 2022 and 2023. (1) It accurately notes that in 2022, the Code was mentioned within the 'Code of Ethics' section with a URL and notice about amendments—this matches the original answer’s point about explicit posting and applicability. In 2023, the LLM correctly identifies that the Code became more prominently listed alongside other key governance documents like Corporate Governance Guidelines and committee charters, indicating improved integration and accessibility. (2) There are no numeric values, dates, or financial metrics in dispute; all time references (2022, 2023) are accurate, so quantitative accuracy is perfect. (3) The multi-hop reasoning—comparing disclosure placement across two years and inferring increased prominence and integration—is sound and supported by the evidence. However, the LLM slightly mischaracterizes the 2022 context by stating the Code was mentioned 'only within the Code of Ethics section,' whereas the original answer emphasizes it was discussed in the context of broader governance disclosures including Board Meetings and Committee Information, suggesting a wider placement than implied. This minor omission or narrowing of context prevents a top score. (4) Despite this nuance, the LLM captures the core evolution in accessibility and integration, making the answer contextually highly relevant and semantically close to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 425,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "In the 2023 filing Oracle described its database as a core enterprise product that “is delivered through the Oracle Cloud or through other IT deployment models, including cloud‑based, hybrid and on‑premise deployments” (2023 p. 7). By the 2024 filing the company is emphasizing that Oracle Engineered Systems—such as the Exadata Database Machine—are offered through “flexible deployment options, including on‑premise, as a cloud offering in OCI, and as a hybrid cloud offering in customer data centers” (2024 p. 13) and that the Autonomous Database is available “on OCI for shared or dedicated deployments and on‑premise with Oracle Exadata Cloud@Customer and OCI Dedicated Region” (2024 p. 12). This shift from a general multi‑environment statement to a concrete, engineered‑system‑centric, multi‑deployment strategy signals Oracle’s intent to accelerate cloud migration while explicitly supporting hybrid‑IT workloads through tightly integrated, flexible database offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Oracle's 2023 positioning of Oracle Database across multiple deployment models (on-premise, cloud, hybrid) and cites the 2023 filing page 7 to support this. In 2024, it accurately reflects the shift toward engineered systems like Exadata, citing flexible deployment options (on-premise, OCI, hybrid) and specific offerings such as Exadata Cloud@Customer and OCI Dedicated Region, with references to pages 12 and 13 of the 2024 filing. (2) There are no numeric values, dates, or financial figures in the question or answers that require calculation or verification; all references to years (2023, 2024) and page numbers are correct and consistent with the source context. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, identifies the evolution from general deployment flexibility to a more integrated, engineered-systems-centric approach, and infers Oracle’s strategic intent to support hybrid IT and accelerate cloud migration—this matches the core conclusion in the ground truth. (4) While the LLM answer captures the essential evolution and strategic implication, it slightly underemphasizes the performance-optimization and simplified maintenance aspects highlighted in the ground truth as key drivers of the engineered systems strategy. However, the omission is minor and does not detract from the overall correctness. Wording differs but maintains semantic equivalence. Thus, the answer is factually correct, well-supported, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 446,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The 2023 Form 10‑K notes that, under the SEC Consent Order, BMS “established a formal review and certification process of our annual and quarterly reports filed with the SEC” together with a business‑risk and disclosure group and outside consulting support【page_63】. By the 2024 filing, the company emphasizes that the same formal review remains in place but is now backed by a company‑wide policy that “includes a governance process to escalate … potential questions or concerns … and … compliance with the policy is monitored on a regular basis,” showing a more structured, ongoing compliance‑monitoring and governance framework for its SEC filings【page_65】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that in 2023, under the SEC Consent Order (referred to in the original as 'Consent agreement'), BMS established a formal review and certification process for SEC filings, including governance procedures and compliance monitoring. By 2024, it notes the continuation and strengthening of this process through integration into a company-wide policy with regular compliance monitoring—aligning with the original answer's claim of evolution from implementation to sustained enforcement. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years’ filings to show evolution in governance and compliance monitoring. It correctly infers that the 2024 process is more structured and embedded, reflecting progression. (4) Minor deduction in qualitative accuracy due to omission of the specific integration into 'sales policies' and 'inventory and sales limitations' mentioned in the original, which adds operational context slightly missing in the LLM response. However, the core evolution—formalization in 2023 to institutionalized monitoring in 2024—is accurately captured. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as it directly addresses the evolution in compliance monitoring and governance procedures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 414,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "In the 2022 filing PMI described its heat‑not‑burn offering only as “Platform 1,” a generic reduced‑risk product (see page_76) and did not separate it as a distinct market segment. By the 2023 filing the company re‑branded its heat‑not‑burn consumables as “Heated Tobacco Units (HTU),” grouping brands such as HEETS, Marlboro HeatSticks, SENTIA and TEREA under this label, and began reporting HTU shipment volumes and market‑share as a separate component of its “Smoke‑free products” portfolio (see page_40 and page_39). This shift shows a move from a broad RRP classification to a more specific, market‑positioned product category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in PMI's approach from 2022 to 2023: in 2022, heat-not-burn products were part of the broader Reduced-Risk Products (RRPs) portfolio without distinct segmentation, and by 2023, they were re-categorized under 'Smoke-free products' with a new label—Heated Tobacco Units (HTUs)—and reported with specific brands and shipment metrics. The mention of Platform 1 in 2022 and the rebranding to HTUs (including HEETS, Marlboro HeatSticks, SENTIA, TEREA) in 2023 matches the strategic shift described in the original answer. (2) There are no numeric values, dates, or financial figures in dispute; the answer references correct page numbers and product names without misstatement. (3) The multi-hop reasoning is sound: the model synthesizes changes in product categorization, branding, and reporting practices across two years, correctly inferring a strategic shift toward market positioning and commercialization. (4) The only minor omission is that the LLM answer does not mention the inclusion of licensed KT&G products, which is a component of PMI’s broader market approach noted in the ground truth. However, this does not undermine the core accuracy of the response. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original with only slight incompleteness on partnership expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 397,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "In 2023 Oracle’s strategy for its database centered on giving customers licensing choice and migration programs so they could “pivot … to the Oracle Cloud for new deployments and … expand with the Oracle Cloud for their existing workloads” (page_42). By 2024 the database was positioned as a core element of Oracle Engineered Systems—bundled with Oracle storage, OS and management software—and sold through “flexible deployment options, including on‑premise, as a cloud offering in OCI, and as a hybrid cloud offering” (page_13). This reflects a shift from license‑driven flexibility to an integrated hardware‑software platform that supports on‑premise, cloud and hybrid deployments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Oracle's 2023 strategy focused on licensing flexibility and migration to Oracle Cloud, aligning with the original answer's emphasis on deployment choice and perpetual licensing. In 2024, it accurately reflects the shift toward integration within Oracle Engineered Systems, specifically mentioning bundling with storage, OS, and management software, which matches the ground truth's reference to Exadata and integrated hardware-software systems. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes strategic evolution across two years, contrasting deployment flexibility (2023) with deeper integration into engineered systems (2024), and correctly links this to deployment options (on-premise, OCI, hybrid). The only minor shortcoming is that it does not explicitly name 'Oracle Exadata Database Machine'—a specific engineered system mentioned in the ground truth—though it refers generally to 'Oracle Engineered Systems' and bundled components, which is semantically close. (4) The answer is fully contextually relevant, directly addressing both deployment flexibility and integration with other Oracle technologies over the two years. Wording differs but meaning is preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 438,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "In the 2023 filing BMS described Krazati as a “strategic fit” in its differentiated NSCLC portfolio, noting that the KRAS‑inhibitor would be added through the planned Mirati acquisition (see page 43). By the 2024 filing BMS had completed that acquisition, paying $4.8 billion in cash (plus $205 million of equity awards) and issuing a non‑tradeable contingent‑value right worth about $1 billion (total consideration allocated ≈ $4.9 billion) to secure full rights to commercialize Krazati (see page 93). This cash purchase and CVR commitment mark the shift from a strategic‑fit concept in 2023 to full ownership and commercialization in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of BMY's (BMS's) relationship with Krazati from a 'strategic fit' in 2023 to full ownership in 2024 via the Mirati acquisition. The financial commitments in 2024 — $4.8 billion cash, $205 million in equity awards, and a $1 billion contingent value right (CVR) — are accurately reported, with the total consideration noted as approximately $4.9 billion, which is consistent with the sum of the components. (2) Quantitatively, all key figures match: the $4.8 billion acquisition price and $1 billion CVR are explicitly confirmed in the original answer. The LLM adds granularity (e.g., $205 million equity awards) not in the ground truth but plausibly from the filing and not contradictory. No calculation errors. (3) The multi-hop reasoning is sound: it connects 2023's strategic intent with 2024's execution, synthesizing information across years and documents. (4) The only minor deviation is that the original answer emphasizes Krazati’s FDA/EMA approvals and clinical development in first-line NSCLC, which the LLM omits. While not critical to the financial commitments, this context slightly enriches the strategic rationale. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only a small deduction for partial omission of clinical status details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 392,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV under the ticker BK/P, registered on the New York Stock Exchange pursuant to Section 12(b). In each filing the securities are described as “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation,” indicating that their registration and guarantee status remained unchanged between 2022 and 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV are correctly identified, with the ticker symbol BK/P, listed on the New York Stock Exchange under Section 12(b), and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric or date inaccuracies—percentages, years, and security terms match the original answer exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings (2022 and 2023) and concludes that there was no change in status or treatment, which aligns with the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the securities’ status. Wording differs slightly but conveys identical meaning, satisfying semantic equivalence. No errors in entity names, years, or financial terms. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 312,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "PMI’s short‑term credit lines expanded from roughly **$1.9 billion at 12/31/2022** to **about $2.7 billion at 12/31/2023**, while the amount actually drawn fell from **$295 million to $283 million** over the same period (PMI 2023 10‑K, p. 108). The larger unused line and slightly lower utilization indicate that PMI has built a bigger liquidity cushion and is adopting a more conservative, well‑positioned near‑term liquidity stance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: capacity increased from $1.9 billion in 2022 to $2.7 billion in 2023, and utilization decreased from $295 million to $283 million. These values exactly match the original answer, with acceptable formatting variations (e.g., 'about $2.7 billion' is reasonable given reporting conventions). (2) The answer is complete, addressing both the change in capacity and utilization, and drawing the correct implication about PMI's near-term liquidity posture. (3) Entity accuracy is correct—PMI is the focus, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the synthesis of increased capacity and decreased utilization logically supports the conclusion of a larger liquidity cushion and a more conservative liquidity stance. The mention of the source (PMI 2023 10-K, p. 108) adds credibility. (5) Semantically, the LLM conveys the same meaning as the original answer, using slightly different phrasing (e.g., 'bigger liquidity cushion' vs 'expanded its available liquidity buffer') without altering the factual or interpretive content. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 345,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "In the 2023 filing Oracle presented the Autonomous Database mainly as a managed OCI offering that could be run in the cloud, on‑premise or in hybrid Exadata Cloud@Customer models, emphasizing its role within the broader infrastructure portfolio and its flexible deployment options【page_10】. By the 2024 filing the service is positioned as a self‑driving, AI‑enabled database that automates routine admin tasks (maintenance, tuning, patching, scaling, security, backup and threat remediation) and uses policy‑ and machine‑learning‑driven optimization, while being tightly integrated with other Oracle Cloud services such as Java Cloud, APEX low‑code and Oracle Analytics Cloud, and offered with on‑demand scaling and consumption‑based pricing【page_12】. This reflects a shift from a generic managed‑service description to a more integrated, automation‑focused positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Oracle's 2023 positioning of the Autonomous Database as a managed OCI service with flexible deployment (cloud, on-premise, hybrid), which matches the original answer. In 2024, it accurately reflects the evolved positioning emphasizing AI/ML-driven automation (self-driving capabilities), integration with Java Cloud, APEX low-code, and Oracle Analytics Cloud—explicitly mentioned in the ground truth. The mention of policy- and machine-learning-driven optimization, automated maintenance, security, and threat remediation captures the enhanced automation focus in 2024. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and correctly contrasts the evolution in messaging, moving from managed service to AI-powered, integrated cloud-native platform. (4) The only minor omission is that the original answer includes specific mention of 'data lake houses' and 'real-time analysis of transactional data' as part of 2024's focus on modern application development and analytics—this nuance is missing in the LLM response. However, the core evolution in integration and automation is well captured. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 441,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "In 2023 GM reported a $0.8 billion committed‑capital contribution to Ultium Cells Holdings LLC as part of its non‑consolidated VIE battery‑cell joint venture, while noting it had no voting or similar rights to direct the venture’s activities (page 80). By 2024 the disclosed investment in Ultium Cells was $0.7 billion (page 40), but GM’s total committed capital to its battery‑cell joint ventures rose to $2.3 billion (page 79), reflecting a deeper strategic partnership to secure EV‑battery supply even though GM remains a non‑controlling partner.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.8 billion committed capital in 2023 and the $0.7 billion disclosed investment in 2024, matching the ground truth. These figures are accurately cited with correct years and dollar amounts, satisfying quantitative accuracy. The mention of Ultium Cells as a VIE where GM lacks voting control is also factually correct. However, the LLM introduces additional information not present in the ground truth—specifically, that GM’s total committed capital to *all* battery-cell joint ventures rose to $2.3 billion in 2024. While possibly true, this detail shifts focus from Ultium Cells Holdings LLC specifically to broader joint ventures, which dilutes the precision of the response regarding the *specific* financial relationship with Ultium Cells. (2) All numeric values related to Ultium Cells are correct: $0.8B commitment in 2023 and $0.7B investment in 2024. No calculation errors. Format variations are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound—comparing GM’s position in 2023 (contingent commitment, no control) to 2024 (realized investment) shows proper synthesis across years and financial disclosures. The conclusion about strategic deepening is reasonable, though the ground truth emphasizes a shift from contingent obligation to direct stake and greater influence, while the LLM emphasizes supply security without explicitly noting the strategic implication of increased influence. (4) The answer is highly contextually relevant, directly addressing capital involvement and strategic positioning. It loses minor points on qualitative accuracy for introducing extraneous data about total joint venture commitments, which may mislead about the scope of the change at Ultium Cells specifically. Overall, core facts are correct, reasoning is logical, and the answer aligns well with the question, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 521,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "The deed’s anniversary releases have become smaller. At the sixth‑anniversary release (June 21 2022) Visa freed **$3.5 billion** of as‑converted value and issued **176,655 series A preferred shares** (July 29 2022)【page_74】. At the eighth‑anniversary release (June 21 2024) the company released **$2.7 billion** of as‑converted value and issued **99,264 series A preferred shares** (July 2024)【page_75】. Thus, both the value released and the number of shares issued declined between 2022 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($3.5 billion in 2022 and $2.7 billion in 2024) and share counts (176,655 in 2022 and 99,264 in 2024) are accurately reported. The dates (June 21, 2022 and June 21, 2024 for the releases; July 29, 2022 and July 2024 for share issuances) align with the context provided in the original answer and source pages. (2) The answer is complete, addressing both parts of the question: the evolution of as-converted value released and the number of series A preferred shares issued across 2022 and 2024. (3) Entity accuracy is correct—Visa is the right company, the Litigation Management Deed is properly referenced, and the financial instruments (series A preferred shares, as-converted value) are correctly identified. (4) The reasoning is sound: the LLM correctly infers a decline in both value and shares issued, indicating a reduced financial burden, which is a valid conclusion from the data. The multi-hop synthesis—comparing two separate anniversary events across years with specific financial impacts—is accurately executed. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of key information. Minor formatting differences (e.g., 'July 2024' vs 'July 2024') are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 381,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "In 2023 3M reconsolidated the former de‑consolidated Aearo Entities after their Chapter 11 filing, recorded a $4.2 billion pre‑tax charge and raised its Combat‑Arms‑Earplugs accrual to $5 billion, and Aearo‑related respirator‑mask costs were shown as special‑item expenses in the Safety & Industrial segment 【page_101†L1-L9】【page_101†L31-L38】. By 2024 the parties had amended the CAE Settlement so that 3M elected to pay the $1 billion equity portion in cash, the litigation impact moved from special‑item charges (net litigation cost fell from $81 million in 2023 to $36 million in 2024) to an accrued liability, and the Aearo Entities’ sales were reflected as acquisition/divestiture adjustments in the Transportation & Electronics segment, lifting operating income and margins in both Safety & Industrial and Transportation & Electronics 【page_25†L31-L38】【page_30†L1-L4】【page_31†L1-L9】【page_32†L1-L9】【page_33†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the right themes. The original answer states that the reconsolidation of Aearo Entities in 2023 had an 'immaterial income statement impact,' but the LLM claims a $4.2 billion pre-tax charge and a $5 billion accrual increase, which contradicts the ground truth. These figures are not supported by the original answer and appear to be hallucinated or misattributed. Additionally, the claim that 3M elected to pay a $1 billion equity portion in cash as part of an amended CAE Settlement in 2024 is not mentioned in the ground truth and lacks corroboration. (2) The quantitative inaccuracies are severe: the $4.2B charge, $5B accrual, and $1B cash payment are all absent from the original answer. The reported drop in net litigation costs from $81M to $36M is specific but unsupported by the ground truth, which does not mention these figures. The original answer emphasizes that the reconsolidation had an immaterial impact, directly contradicting the large charges cited by the LLM. (3) The multi-hop reasoning is partially sound in structure—linking litigation, reconsolidation, and segment reporting—but flawed in execution due to incorrect data. The LLM correctly identifies that Aearo’s financials were reflected in acquisition/divestiture adjustments in the Transportation & Electronics segment in 2024, aligning with the original answer’s point about strategic financial treatment. However, the reasoning is undermined by false financial figures. (4) Contextual relevance is high because the LLM addresses litigation impact and business segment adjustments across 2023–2024, matching the question’s scope. However, correctness is low due to major factual and quantitative errors, especially the unsupported charges and accruals. The qualitative accuracy is moderate because the framework of analysis is reasonable, but the conclusions are based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 528,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "In the 2022 filing the company described Class C common stock as a limited‑voting class whose value and conversion were tied to Class A – it could only become Class A shares after the final resolution of the U.S. litigation and its voting rights were restricted to a few specified matters (see 2022 p30‑p32). By the 2024 filing, Class C shares are freely tradable with no transfer restrictions (2024 p89), still have limited voting rights (2024 p90), and are now reported separately for earnings per share, showing a basic EPS of $38.97 (diluted $38.92) in 2024 versus $33.17 (diluted $33.13) in 2023 (2024 p90). This reflects a shift from a contingent, conversion‑linked security to an unrestricted class that contributes a higher per‑share earnings figure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct qualitative insights but has significant quantitative inaccuracies. It correctly identifies that Class C Common Stock had limited voting rights in 2022 tied to litigation resolution and conversion to Class A (per 2022 p30–32), and that by 2024 it became freely tradable with no transfer restrictions (2024 p89) and continued limited voting rights (2024 p90). It also correctly notes that Class C is now reported separately for EPS, indicating a structural evolution. However, the EPS figures provided are incorrect: the LLM states Class C EPS in 2024 was $38.97 (basic) and $38.92 (diluted), but the ground truth reports $33.17 (basic) and $33.13 (diluted) for 2024. Additionally, the LLM cites a 2023 EPS of $33.17, which is not part of the original question or ground truth comparison (the focus is 2022 vs 2024). The ground truth emphasizes a comparison between Class C and Class A in 2024, showing Class C at $33.17 and Class A at $8.29 basic EPS — a key multi-hop insight the LLM omits. (2) The numbers are therefore factually wrong: $38.97 vs $33.17 is a material difference (~17.5% overstatement), and introducing 2023 data distracts from the 2022–2024 evolution asked. (3) The reasoning is partially sound: the LLM correctly infers a shift from a contingent, restricted security to a freely tradable one, showing structural evolution. However, it fails to compare Class C’s EPS performance to Class A’s in 2024 — a core part of the original answer and question. This missing comparison undermines the multi-hop synthesis required. (4) Correctness is scored 6 due to accurate structural narrative but major numerical and comparative omissions. Quantitative accuracy is 5 due to incorrect EPS values and introduction of unsupported data. Qualitative accuracy is 7 because the reasoning about governance evolution is solid. Contextual relevance is 9 — the answer stays on topic and cites relevant pages, but misses the financial performance contrast central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 547,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm’s ADAS/AD work was described mainly as a development effort – the Snapdragon automotive platform was said to support “connectivity, digital cockpit and advanced driver assistance and automated driving” and the company highlighted R&D investments in ADAS/AD technologies (see pages 11 & 14). By fiscal 2024 the company had moved into commercialization: the automotive revenue stream now explicitly lists “connectivity, digital cockpit and ADAS/AD” and grew to $2.91 billion (up from $1.51 billion in 2022) (see page 73), and Qualcomm’s strategic acquisition of Veoneer’s Arriver ADAS/AD business (reported as discontinued operations) further cemented its market presence (see page 74). This reflects a shift from pure development to revenue‑generating commercialization and strategic acquisition of ADAS/AD capabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution of Qualcomm's ADAS/AD involvement from development in fiscal 2022 to commercialization in fiscal 2024. The mention of R&D investments and Snapdragon platform support in 2022 matches the original answer's emphasis on development and strategic initiatives. By 2024, the LLM correctly identifies the shift to commercialization through explicit revenue categorization under automotive, citing the growth in automotive revenue from $1.51 billion to $2.91 billion, which reflects the inclusion of ADAS/AD as a revenue-generating segment. (2) All quantitative data is accurate: the fiscal years (2022 and 2024), the revenue figures ($1.51B and $2.91B), and the correct interpretation of growth are all factually correct and consistent with the knowledge graph. No calculation errors. (3) The multi-hop reasoning is sound—LLM synthesizes information across time (2022 vs 2024), strategic activities (R&D, product development), financial categorization (revenue streams), and strategic acquisitions (Veoneer’s Arriver business), demonstrating a clear understanding of the transition from development to commercialization. (4) Entity accuracy is excellent: Qualcomm, ADAS/AD, Snapdragon, automotive revenue, Veoneer, and fiscal years are all correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with added detail (e.g., specific revenue numbers, acquisition) that enriches but does not distort the meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 442,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "In the 2022 filing Visa described its U.S. Retrospective Responsibility Plan mainly as a single U.S. litigation‑escrow account that held cash to pay settlements or final judgments, with loss‑sharing agreements noted separately. By the 2024 filing the plan had been expanded into a multi‑tool framework that still uses the escrow but also adds a downward adjustment to the conversion rate of class B shares, make‑whole agreements tied to the class B‑1 exchange offer, indemnification obligations of Visa U.S.A. members, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement. The change shows Visa moving from a simple escrow‑only approach to a broader, layered strategy that leverages equity‑conversion, contractual reimbursements and member indemnities to more actively contain and allocate litigation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key elements of the evolution of Visa's U.S. Retrospective Responsibility Plan are correctly identified: the shift from a primarily escrow-based mechanism in 2022 to a more complex, multi-component framework in 2024. The listed mechanisms—conversion rate adjustment for Class B shares (described as 'downward adjustment to the conversion rate'), make-whole agreements, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement—are all present and correctly named or accurately paraphrased. (2) There are no numeric values, dates, or financial figures in dispute; the years 2022 and 2024 are correctly used, and no calculations are required. Format and terminology are consistent with acceptable variation (e.g., 'U.S. litigation-escrow account' vs 'U.S. litigation escrow account'). (3) The multi-hop reasoning is sound: the answer synthesizes changes across two time points and correctly infers that the expansion of mechanisms reflects a strategic shift toward a more proactive and diversified litigation risk management approach, even if the exact phrase 'proactive and diversified' isn't used—the concept is clearly conveyed through terms like 'multi-tool framework' and 'more actively contain and allocate litigation risk'. (4) One minor point preventing a perfect 10 is that the LLM slightly understates the structural formality introduced by 2024—referring to a 'multi-tool framework' rather than emphasizing the formalized 'suite of interrelated agreements' as in the original. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 494,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "- In the 2023 filing Merck’s share of the Lynparza partnership was recorded as a **$1.5 billion net intangible‑asset** related to the AstraZeneca collaboration 【page_101】.  \n- By 2024 the **alliance revenue from Lynparza grew about 9 %** year‑over‑year, reflecting stronger demand in most international markets, and the filing highlighted a **new Chinese approval (Jan 2025) for an adjuvant‑breast‑cancer indication**, signaling an expanding strategic role for the product 【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: Merck's $1.5 billion net intangible asset in Lynparza in 2023, the 9% year-over-year growth in alliance revenue in 2024, and the January 2025 China approval for adjuvant breast cancer treatment. All entities (Merck, AstraZeneca, Lynparza), timeframes (2023, 2024, Jan 2025), and financial metrics (net intangible asset, alliance revenue) are accurate. (2) Quantitative accuracy is perfect: $1.5 billion, 9% growth, and Jan 2025 date match the original answer exactly. No calculations were required, but the reported growth percentage is correctly attributed to 2024 performance. (3) The multi-hop reasoning is sound—information is synthesized across years and sources (2023 asset value, 2024 revenue trend, 2025 regulatory update)—and the conclusion about increasing strategic importance is logically supported. (4) The only minor omission is that the original answer notes the 2024 financial stake was 'not explicitly stated,' which adds nuance about disclosure transparency; the LLM answer does not mention this, but it doesn't misstate anything either. Overall, the LLM conveys semantically equivalent, factually correct, and contextually relevant information with excellent precision and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 361,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "In the 2022 filing Skoal was described as one of Altria’s two premium moist‑snuff brands (Copenhagen and Skoal) that together sat in a largely flat oral‑tobacco segment of roughly 820 million units (MO 2022 p. 6). By 2024 Skoal’s shipment volume had dropped to 147 million cans/packs (down from 163 million in 2023) and its retail share fell to 7.6% (down from 9.3% in 2023), while Copenhagen also lost share and the on! nicotine‑pouch brand grew, showing that Skoal’s market position weakened relative to its premium sibling and the fast‑growing on! competitor (MO 2024 p. 48).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Skoal's market position between 2022 and 2024. (1) Quantitatively, the LLM correctly reports Skoal's retail share decline from 9.3% in 2022 (cited as 2023 in LLM, minor misalignment) to 7.6% in 2024, which matches the ground truth. The shipment volumes (163M in 2023 to 147M in 2024) are consistent with the trend, though the original answer does not include volume data—this is an addition from the LLM but not incorrect. The LLM notes Copenhagen's decline and on!'s growth, aligning with the ground truth. (2) There is a minor discrepancy in timing: the LLM states Skoal's 9.3% share was in 2023, while the ground truth assigns it to 2022. However, the 2024 share of 7.6% is correct. This slight misattribution of the baseline year slightly affects precision but does not alter the valid conclusion of decline. (3) The reasoning is sound: the LLM correctly infers that Skoal weakened relative to both Copenhagen and on!, demonstrating proper multi-hop synthesis across brands and time. (4) Contextually, the answer fully addresses the question about Skoal’s evolving market position and competitive dynamics. The inclusion of shipment volume adds useful context not in the original but supported by filings. Overall, the answer is factually strong, with only a minor timing mislabeling preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 382,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "In FY 2022 Dynamics 365 (reported as “Dynamics products and cloud services”) generated **$4.687 billion** of Microsoft Cloud revenue, and in FY 2023 that contribution rose to **$5.437 billion**【page_93】. That represents an increase of roughly **$750 million**, or about a **16 %** year‑over‑year growth in the Dynamics 365 revenue share of the cloud business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy. The ground truth does not provide specific dollar amounts for Dynamics 365 revenue in FY2022 or FY2023—only that Dynamics 365 was a component of the $91.2B and $111.6B Microsoft Cloud revenues, respectively, and that it grew 39% in FY2022. The LLM fabricates precise figures: $4.687B in 2022 and $5.437B in 2023, with a calculated 16% growth, none of which appear in the original answer or are supported by the knowledge graph. These numbers and the $750M increase are entirely unsupported, making the quantitative claims false. While the LLM correctly identifies Dynamics 365 as part of Microsoft Cloud and addresses the evolution between FY2022 and FY2023, it fails on core factual content. The reasoning is flawed due to invented data, indicating a failure in multi-hop synthesis—instead of acknowledging partial information, it hallucinates specifics. Contextually, the answer is relevant and structured appropriately, hence moderate relevance, but the fabrication of figures severely undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 306,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck’s Balance‑Sheet Risk Management Program has not fundamentally changed – it still relies on short‑term forward‑exchange contracts as the core hedge tool. In 2023 the company used non‑designated forwards to offset re‑measured assets and liabilities and designated forwards to hedge net‑investment positions (recorded in OCI), and it also employed senior unsecured euro‑denominated notes as economic hedges of foreign‑operation investments (see 2023 filing page 95). The 2024 filing describes the same mix of instruments – forward contracts (average maturity < 6 months) for both non‑designated balance‑sheet hedges and designated net‑investment hedges, and euro‑denominated debt as economic hedges – covering the euro, Swiss franc, Japanese yen and Chinese renminbi, with added clarification on marking‑to‑market and OCI treatment but no material expansion of scope (see 2024 filing page 98).",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of Merck's foreign exchange risk management program from 2023 to 2024. (1) Correctly identifies the use of forward exchange contracts in both years and lists the correct currencies (euro, Swiss franc, Japanese yen, Chinese renminbi), which aligns with the original answer. However, it incorrectly claims no material expansion occurred, directly contradicting the ground truth that Merck introduced new instruments—specifically purchased local currency put options and collar options—in 2024. (2) The LLM mentions 'senior unsecured euro-denominated notes' and 'designated forwards for net-investment hedges' recorded in OCI, which are not mentioned in the original answer and appear to be fabricated or misattributed details not supported by the ground truth. These additions introduce factual inaccuracies. (3) The multi-hop reasoning is flawed: while the question asks about evolution in instruments and scope, the LLM concludes there was no change, missing the key development of a more structured program with expanded instruments and strategic layering of hedges over time based on cost-benefit assessments. (4) The answer also mischaracterizes the 2023 program by introducing hedge accounting distinctions (designated vs non-designated for OCI) not present in the original, which only states that 2023 forwards were not designated as hedges. This undermines qualitative accuracy. While the response is relevant to the topic and structured around the right company and time frame, the core claim of no change is factually incorrect per the ground truth, warranting a low correctness score despite partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 465,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal’s credit‑loss experience on its merchant‑financing portfolio improved markedly – the gross charge‑offs on merchant loans, advances and interest‑and‑fees receivable fell from **$42 million in 2022** to **$10 million in 2024** (see Note 12‑Merchant Receivables, page 102). At the same time, PayPal deepened its direct exposure to merchant financing, purchasing **about $1.8 billion of merchant receivables in 2024** (up from $1.7 billion in 2023 and a lower level in 2022) and growing the outstanding merchant‑loan balance to **$1.5 billion** (see Note 1‑Merchant Finance Products, page 101).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of PayPal's involvement in merchant receivables with some correct directional trends and key figures, but contains significant quantitative inaccuracies and omits critical multi-hop context. (1) Correct elements: The $1.8 billion in merchant receivables purchased in 2024 and the $1.5 billion outstanding balance as of December 31, 2024, match the ground truth. The increasing trend in direct investment is correctly conveyed. (2) Quantitative errors: The LLM claims $42 million in charge-offs in 2022 and $10 million in 2024, but the ground truth does not provide these specific charge-off figures—this data is fabricated or misattributed. Additionally, the claim that PayPal purchased $1.7 billion in 2023 is incorrect; the ground truth states $1.2 billion outstanding in 2023, not purchases. The LLM confuses outstanding balances with annual purchase volumes. (3) Missing multi-hop context: The original answer highlights a strategic shift from passive risk disclosure (e.g., 9% coverage ratio in 2021, down from 23% in 2020) to active investment, which the LLM omits entirely. This is a key part of the evolution. (4) Reasoning and synthesis: While the LLM identifies increased direct investment, it fails to contrast the earlier risk-disclosure phase with the later active financing role, weakening the qualitative analysis. The mention of PPWC and PPBL in the original answer (specific products enabling this shift) is also missing. (5) Contextual relevance is high—the answer stays on topic and references relevant financial activities. However, the inclusion of unsourced charge-off numbers and incorrect purchase amounts undermines factual reliability. Overall, partially correct but with significant factual and interpretive gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 481,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "Altria’s smokeable‑products segment still carries only $99 million of goodwill – the same amount reported in the 2022 filing (Note 4, p. 66).  Yet the segment’s earnings have risen, with operating income (OCI) climbing to $10.821 billion in 2024 from $10.670 billion in 2023 (p. 31).  Thus, while the goodwill allocation has remained flat, the segment’s operating performance has modestly improved, underscoring its continued financial importance to MO.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $99 million goodwill allocated to smokeable products in both 2022 and 2024, matching the ground truth. It accurately states the operating income increased from $10.670 billion in 2023 to $10.821 billion in 2024 (equivalent to $10,821 million in the original answer). All numeric values are factually correct, with acceptable format variation (e.g., $10.821 billion vs $10,821 million). (2) Quantitative accuracy is perfect: numbers for goodwill and operating income across years are precise and correctly attributed. No calculation errors. (3) The reasoning correctly synthesizes two key financial dimensions—goodwill (asset valuation) and operating income (performance)—across 2022 to 2024, demonstrating multi-hop understanding. The conclusion that financial importance persists despite flat goodwill aligns with the ground truth. However, the LLM does not mention the absence of updated goodwill disclosure in 2024 as a potential reporting shift, which slightly reduces completeness in qualitative reasoning. (4) The answer is highly contextually relevant, directly addressing the evolution of financial significance through both goodwill and income. The minor omission of the strategic implication about reporting focus prevents a perfect 10 on correctness, but all core facts and logic are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 377,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Microsoft’s Cloud revenue – which bundles Azure, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365 and other cloud services – rose from **$91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023**, an increase of roughly $20 billion (≈22 %).【page_93】",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies the Microsoft Cloud revenue figures for fiscal years 2022 and 2023, with only a minor discrepancy in the 2022 value: $91.4 billion (LLM) vs. $91.2 billion (ground truth). This $0.2 billion difference is small but non-trivial in a financial context. The 2023 value is exact at $111.6 billion. The calculated increase of ~$20 billion and ≈22% is reasonable given the reported numbers. (2) Quantitatively, the 2023 figure is accurate; the 2022 figure is off by $0.2 billion, which may stem from rounding or source variation but still falls within an acceptable range. The percentage increase is approximately correct: (111.6 - 91.4)/91.4 ≈ 22.1%, consistent with the stated ≈22%. However, using the ground truth $91.2B, the actual increase would be $20.4B and ≈22.4%, so the LLM's calculation is slightly affected by its input inaccuracy. (3) The reasoning is sound: the LLM correctly frames Microsoft Cloud as including the commercial portion of LinkedIn and tracks its evolution across the two fiscal years. It synthesizes the multi-hop concept that LinkedIn’s commercial revenue is embedded within Microsoft Cloud and infers growth in that segment. (4) The answer is contextually relevant, complete, and conveys the core insight of significant growth. The minor numerical variance prevents a perfect 10, but the overall factual and logical integrity is strong, warranting a 9 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 394,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "In 2023 Merck’s Lynparza (olaparib) secured its first major geographic approvals – a U.S. FDA approval in May 2023 and a Japanese MHLW approval in August 2023 for BRCAm metastatic‑castration‑resistant prostate cancer – and generated $1.199 billion of alliance revenue (the share of profits from the AstraZeneca collaboration)【page_3†L31-L38】【page_7†L31-L38】.  By 2024 that revenue had risen about 9 % (to roughly $1.3 billion) as sales grew in most international markets, and Merck announced a China NMPA approval for Lynparza (adjuvant early‑breast‑cancer indication) slated for January 2025, underscoring continued market expansion beyond the United States and Japan【page_55†L1-L9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 FDA and Japan MHLW approvals for BRCA-mutated mCRPC and the January 2025 China NMPA approval for adjuvant early breast cancer, aligning with the ground truth. It also correctly notes the 9% revenue growth in 2024 and attributes it to international demand. However, there is a quantitative inaccuracy in the revenue figures: the LLM states $1.199 billion in 2023 and 'roughly $1.3 billion' in 2024, which implies a ~9% increase but overstates the 2024 figure. A 9% increase from $1.199B would be approximately $1.307B, so 'roughly $1.3B' is acceptable as an approximation, but the lack of precision and the phrasing 'about 9%' when the ground truth states 'grew by 9%' introduces minor uncertainty. (2) The dates of approvals (May 2023 FDA, August 2023 MHLW) are plausible but not confirmed in the ground truth, which only states 'in 2023'—this adds specificity not present in the original and risks overprecision. (3) The multi-hop reasoning is sound: the model connects geographic approvals in 2023, revenue growth in 2024, and a future China approval in 2025, correctly synthesizing therapeutic expansion and commercial momentum. (4) The entity error—attributing Lynparza to Merck instead of AstraZeneca (Merck & Co. has U.S. rights under a collaboration, but AstraZeneca is the primary developer and global marketer)—is significant but not fatal to understanding. Despite this, the alliance revenue concept is correctly framed as a collaboration. Overall, the answer is factually strong with minor numerical and entity-related flaws, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 448,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "In the 2023 filing RTX recorded the Powder Metal Matter as a reduction to U.S. operating income before tax (see page 93, which notes “2023 includes the impacts of the Powder Metal Matter”) and it generated a $644 million future‑income‑tax benefit in the deferred‑tax schedule (page 98). By the 2024 filing the same line item still appears in the deferred‑tax table but the benefit had fallen to $455 million (page 98), showing that the expected future tax benefit from the Powder Metal Matter was reduced between 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $644 million in 2023 and $455 million in 2024 are accurately reported, and the decrease of $189 million is implied (644 - 455 = 189), though not explicitly stated. The percentage decrease (29.3%) is not mentioned, which is a minor omission. (2) The entity (RTX), time periods (2023 and 2024), and financial treatment (shift to future income tax benefits) are correctly identified. (3) The reasoning is sound: the LLM correctly synthesizes information across years and financial statements, noting the presence of the Powder Metal Matter in the deferred tax schedule both years and the reduction in benefit. It also correctly identifies the 2023 impact on operating income, adding contextual depth not in the ground truth but consistent with filings. (4) The answer is contextually relevant and directly addresses the evolution in financial treatment and impact on future tax benefits. The only minor shortcoming is the lack of explicit calculation of the change ($189M) and percentage (29.3%), which slightly affects completeness. However, the core facts, numbers, and multi-hop synthesis are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 348,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "In the 2022 Form 10‑K PayPal disclosed that the Paidy Credit Agreement was a **secured** revolving credit facility of roughly **$198 million (≈¥30 bn)**, with about **$100 million of borrowing capacity** still available and borrowings limited to funding loan‑receivable origination【page_50】. By the 2024 filing the agreement had been **amended (Sept 2022) to an unsecured facility of **¥90 bn (≈$574 million)**, with interest charged at **TIBOR + 0.40‑0.60 %** and a maturity set for **February 2027**【page_105】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution of the Paidy Credit Agreement from 2022 to 2024. (1) Quantitatively: The 2022 secured revolving facility of $198 million is correctly stated, and the 2024 unsecured facility of ¥90 billion (~$574 million) matches the ground truth. The interest rate (TIBOR + 0.40–0.60%) and maturity date (February 2027) are correct. The LLM approximates the 2022 outstanding amount as $100 million still available, implying $98 million outstanding, which aligns with the ground truth ($98 million outstanding as of Dec 31, 2021, referenced in the 2022 filing). (2) Minor discrepancy: The LLM states the amendment occurred in September 2022, which is not in the ground truth; however, this detail may be from the source document and does not contradict the evolution. (3) Qualitatively: The shift from secured to unsecured, increased capacity, interest rate specification, and maturity are all correctly synthesized. The financial covenant (maximum consolidated leverage ratio) mentioned in the ground truth is omitted, which prevents a perfect score. (4) Contextual relevance is excellent—the answer directly addresses how borrowing capacity and terms evolved, with proper multi-hop synthesis across 2022 and 2024 filings. Overall, the answer is factually sound, minor omission of the covenant noted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 373,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "In the 2022 filing Altria stressed that its capital resources were largely under‑pinned by the ability to issue long‑term senior unsecured notes – it had just issued $5.5 bn of such notes in early 2021 and repurchased about $4.0 bn of existing notes, describing this market access as a key component of its liquidity strategy【page_48】. By the 2024 filing the company still notes access to senior unsecured notes, but total long‑term debt had slipped to $24.9 bn (from $26.2 bn a year earlier) and it had repaid $776 m and $345 m of senior notes in Q1 2024, with only a modest $1 bn new issuance announced, indicating a smaller, more modest reliance on this financing source【page_49】【page_50】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of Altria's reliance on long-term senior unsecured notes between 2022 and 2024, despite addressing the general topic. (1) Quantitatively, the LLM claims Altria issued $5.5 billion in long-term notes in early 2021 and repurchased $4.0 billion, but this information is from a prior year and not directly relevant to the 2022–2024 timeframe in question; the ground truth focuses on 2022 and 2024 capital resources, particularly cash levels ($4.5B in 2022, $3.1B in 2024), which the LLM omits entirely. The LLM introduces long-term debt figures of $26.2B and $24.9B, which are not in the original answer and cannot be verified against the provided ground truth. (2) The LLM incorrectly infers a 'smaller, more modest reliance' on unsecured notes in 2024 based on debt repayment and limited new issuance, which contradicts the original answer’s conclusion that reduced cash reserves suggest *increased* reliance on external financing. This is a critical reasoning error. (3) While both answers agree that access to senior unsecured notes remained a feature of Altria’s capital structure, the LLM fails to synthesize the key insight from the ground truth: declining cash levels imply greater dependence on external markets. (4) The contextual relevance is high because the answer discusses the correct company, time frame, and financial instruments, but the incorrect quantitative foundation and flawed logic undermine correctness. Minor formatting like $5.5 bn is acceptable, but the substantive numbers and interpretation are misaligned. Thus, the answer is partially accurate in parts but significantly flawed in reasoning and key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 465,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "In 2023 RTX booked the Powder Metal Matter as a large charge to net sales (about $5.3 billion, offset by a $2.5 billion reduction in cost of sales) and created a $644 million deferred‑tax asset for the temporary difference 【page_37】. By the end of 2024 that deferred‑tax asset had fallen to $455 million—a $189 million decline—showing the tax effect is being realized or reversed and its contribution to future income‑tax benefits is diminishing 【page_98】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $644 million deferred-tax asset in 2023 and its decline to $455 million in 2024, matching the ground truth. The $189 million decrease is accurate ($644M - $455M = $189M), and the conclusion about diminishing future tax benefits aligns with the original answer. However, the LLM introduces additional details not present in the ground truth—specifically, the $5.3 billion charge to net sales and $2.5 billion reduction in cost of sales—which, while potentially accurate from the source document, are not part of the original answer and were not asked for in the question. (2) All numeric values related to the tax benefit ($644M and $455M) are correct and properly attributed to the right years. The calculation of the $189M decline is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in deferred-tax asset over time and infers the diminishing impact on future tax benefits, which requires connecting information across years and understanding the implication of a declining deferred-tax asset. (4) The scores reflect high accuracy in numbers and relevance, with a minor deduction in qualitative accuracy due to the inclusion of extraneous financial details not required by the question or present in the ground truth, though they do not contradict it. The core multi-hop insight—declining tax benefit—is correctly identified and explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 398,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "In 2022 PayPal’s Paidy Credit Agreement was a secured revolving facility of roughly $198 million (≈¥60 bn); about $98 million had been drawn, leaving roughly $100 million of borrowing capacity still available【page_110】. By year‑end 2024 the agreement had been expanded to ¥90 bn (≈$574 million) and the full amount was drawn down, so no borrowing capacity remained【page_45】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers are correct: $198 million borrowing capacity in 2022, $98 million drawn (leaving ~$100 million available), and expansion to ¥90.0 billion (~$574 million) in 2024 with full drawdown. Minor formatting differences (e.g., ≈$574 million vs $574 million) are acceptable. (2) Quantitative accuracy is perfect: the calculations (available capacity = total - drawn) are correct for both years, and the conversion from yen to dollars aligns with the source. (3) Multi-hop reasoning is sound—information is synthesized correctly across time (2022 vs 2024) and entities (PayPal, Paidy Credit Agreement), showing evolution in both capacity and utilization. (4) The answer fully addresses the question’s focus on borrowing capacity and actual drawdown over the specified period, with precise entity and metric identification. Contextual relevance is excellent, and the inclusion of source page references adds credibility without altering correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 297,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "The filings show that the equity relationship has not materially changed – the portion of Accenture Canada Holdings Inc. owned by current and former Accenture Leadership members continues to be reported as a non‑controlling interest of **less than 1 %** of the consolidated equity (2024 filing, p. 20) and the same exchangeable‑share mechanism remains in place: holders of Accenture Canada Holdings Inc. exchangeable shares may convert them one‑for‑one into Accenture plc Class A ordinary shares (or receive cash at market price), and the related Class X shares issued to pre‑incorporation partners are redeemable and kept in balance with the outstanding exchangeable shares (2024 filing, p. 100). No material change to these arrangements is disclosed between the 2023 and 2024 reports.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative fact — the noncontrolling interest held by current and former leadership is less than 1% — and accurately notes that this figure is reported as of the 2024 filing. It also correctly describes the exchangeable share mechanism (one-for-one conversion into Accenture plc Class A shares or cash redemption) and the linkage between exchangeable shares and Class X shares. However, the LLM concludes there was 'no material change' between 2023 and 2024, which contradicts the ground truth that the equity relationship evolved into a more formalized and structured arrangement in 2024, with explicit provisions around Class X shares and balance maintenance. The ground truth emphasizes an evolution in structure and disclosure, while the LLM interprets continuity. (2) All numbers and percentages are accurate: 'less than 1%' matches the ground truth, and no incorrect figures are introduced. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes information about ownership, exchangeable shares, and Class X shares from the 2024 filing — but fails to recognize the qualitative evolution in the equity structure from a simpler noncontrolling interest disclosure in 2023 to a more detailed, rule-based framework in 2024. This represents a missed nuance in the evolution of the relationship. (4) The answer is contextually relevant and well-supported by filing references, but the conclusion downplays the structural evolution emphasized in the ground truth, leading to a lower qualitative and overall correctness score despite strong factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 447,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "In the 2022 filing Merck said its balance‑sheet risk program “principally utilizes forward exchange contracts to offset the effects of exchange on exposures denominated in developed‑country currencies, primarily the euro, Japanese yen, British pound, Canadian dollar and Swiss franc. For exposures in developing‑country currencies, including the Chinese renminbi, the Company will enter into forward contracts … when it is deemed economical … based on a cost‑benefit analysis”【page_107】.  \n\nBy 2024 the language shifted to a broader cost‑benefit approach that now covers the main currencies it hedges – “primarily the euro, Swiss franc, Japanese yen, and Chinese renminbi” – with forward contracts still treated as non‑designated hedges marked to market through other income【page_98】.  \n\nThus, Merck moved from applying cost‑benefit analysis only to emerging‑market currencies in 2022 to applying it to its core euro, yen, franc and renminbi exposures in 2024, while continuing to use short‑term forward contracts for balance‑sheet risk mitigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in its interpretation of Merck's evolving hedging strategy. While it correctly identifies that in 2022, Merck used forward contracts for both developed and developing country currencies (including the Chinese renminbi) based on a cost-benefit analysis, it misrepresents the 2024 change. The LLM claims that by 2024, the cost-benefit analysis was 'expanded' to include core developed currencies like the euro, yen, and Swiss franc — this is incorrect. The original answer states that the *detailed discussion* of cost-benefit analysis and specific mention of the renminbi was *omitted*, suggesting a simplification or reduced emphasis, not an expansion of cost-benefit analysis to more currencies. This is a critical reasoning error. (2) Quantitatively, there are no explicit numbers (dollar amounts, percentages, dates) in the question or answers, so no numeric inaccuracies exist. Currency names are correctly listed, though the LLM incorrectly implies renminbi is now grouped with major developed market currencies in the cost-benefit framework. (3) The multi-hop reasoning is flawed: the model incorrectly infers that broader language in 2024 means expanded application of cost-benefit analysis, when the ground truth suggests the opposite — a reduction in detail and specificity, particularly regarding developing markets. The synthesis across years is therefore invalid. (4) Contextual relevance is fair — the answer addresses balance sheet risk, forward contracts, currencies, and cost-benefit considerations — but the conclusion about evolution is factually inverted. Hence, correctness is low despite accurate citation of some language and currencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 470,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The 2024 filing now quantifies a deferred‑tax asset for the Powder Metal Matter of **$455 million**, down from **$644 million** reported in the 2023 filing (see the “Deferred Tax Assets and Liabilities” table, page 98). In 2023 the company only described the matter as a large sales charge of about $5.3‑$5.4 billion (pages 36‑38) and did not disclose a tax‑benefit amount. The drop in the deferred‑tax asset implies that the expected future income‑tax benefit from the Powder Metal Matter is shrinking, indicating its ongoing financial impact on future taxes is diminishing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative changes: the deferred tax asset decreased from $644 million in 2023 to $455 million in 2024, and the $5.3 billion sales charge in 2023 is accurately referenced (with minor rounding to $5.3–$5.4 billion, which is acceptable). All numbers and years are factually correct and match the ground truth. (2) Quantitative accuracy is perfect—values are correctly cited, and the direction of change (decrease in tax benefit) is accurately interpreted. (3) The reasoning is sound: the shift from a disclosed operational loss (sales charge) in 2023 to a quantified deferred tax asset in 2024 is correctly interpreted as a change in financial treatment, and the conclusion that the future tax benefit is diminishing is logically supported. The only minor gap is that the original answer notes the broader implication—that this shift suggests a move toward resolution or long-term recovery—while the LLM focuses narrowly on the shrinking benefit without mentioning potential resolution. This slightly limits qualitative depth but does not make the answer incorrect. (4) The answer is fully contextually relevant, directly addressing the question about the change in disclosure and its implication for future income tax benefits. Overall, the LLM captures the core multi-hop insight—evolving treatment from operational loss to reduced deferred tax asset—with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 397,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "In 2022 PayPal’s merchant‑finance business was run through a program agreement with WebBank – WebBank originated the PPWC and PPBL loans, PayPal purchased the resulting receivables and sold a participation interest back to WebBank, retaining the servicing rights (2022 p. 72). By 2024 the same partner‑institution model remains, but the operation has grown dramatically: PayPal purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and held about $1.5 billion of outstanding balances net of the participation interest (2024 p. 101), reflecting a much larger merchant‑finance offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of PayPal's merchant receivables involvement from 2022 to 2024. (1) Quantitatively, all numbers are correct: $1.8 billion in receivables purchased in 2024 (vs $1.7B in 2023), $1.5 billion outstanding balance as of December 31, 2024 (up from $1.2B in 2023), and the participation interest increase from $44M to $53M is implied by the growth context though not explicitly stated in the LLM answer. The LLM correctly cites the ongoing relationship with WebBank and the structure of the program agreement. (2) The only minor omission is that the LLM does not explicitly mention the increase in participation interest sold to the partner institution ($53M in 2024 from $44M in 2023), which is part of the ground truth and reflects deeper collaboration. This detail is relevant to the question about the 'scale' and 'relationship with partner institutions' but is not entirely absent—the growth in overall activity implies it. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 filings, identifies the continuity of the WebBank partnership, and highlights the growth in scale. (4) Wording differs slightly (e.g., 'held about $1.5 billion of outstanding balances net of the participation interest' vs ground truth's 'total outstanding balance... reached $1.5 billion'), but this is semantically acceptable as the net balance aligns with derecognition of sold interests. Overall, the answer is factually correct, contextually relevant, and only slightly less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 437,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck’s Lynparza alliance revenue kept rising, posting a 9 % increase in 2024 versus the prior years (the most recent disclosed total was $989 million in 2021)【page_141】. The uptick was driven largely by stronger demand for Lynparza in most international markets under its collaboration with AstraZeneca【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the timeline—ground truth states that the $989 million revenue was for 2022, but the LLM incorrectly attributes it to 2021. This misalignment affects the validity of the year-over-year comparison. The 9% growth figure for 2024 is correctly reported, but without the correct base year, the quantitative context is misleading. (2) The revenue amount ($989 million) and growth rate (9%) are factually correct, but the incorrect attribution of the base year to 2021 instead of 2022 undermines the accuracy of the comparison. The future approval in China in January 2025 is mentioned in the ground truth as a forward-looking factor, but the LLM omits this entirely. (3) The reasoning partially captures the multi-hop nature of the question—linking alliance revenue, growth, and international demand—but fails to accurately synthesize the correct years and omits the new approvals as a contributing factor. The mention of the AstraZeneca collaboration is accurate and relevant. (4) The contextual relevance is high because the answer addresses revenue trends and drivers, but the quantitative accuracy is reduced due to the incorrect year attribution. The qualitative accuracy is moderate because core elements (growth, international demand) are correct, but key details (correct years, new approvals) are missing or wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 385,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "In the 2022 filing PayPal only noted that merchant loans and advances were part of its overall credit‑loss portfolio (see 2022 10‑K page 43, “Credit losses include … merchant … loans receivable”), without disclosing the size of the portfolio or any servicing responsibilities. By 2024 PayPal had turned merchant finance into a distinct, actively‑managed business: it purchased roughly $1.8 billion of merchant receivables in 2024, held about $1.5 billion net outstanding (page 101), services the loans and advances itself through its PPWC and PPBL products, and reports a high‑quality portfolio (≈90 % current, $10 million gross charge‑offs; page 102). This shows a marked increase in both financial exposure and operational involvement in merchant receivables from 2022 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's shift from passive risk accounting in 2022 to active purchasing and servicing of merchant receivables by 2024 is clearly articulated. The financial figures—$1.8 billion in purchases in 2024 and $1.5 billion outstanding balance—are consistent with the original answer. While the original answer references 2023 purchases ($1.7 billion), the LLM omits this comparison but does not misstate it, so the omission is minor. (2) Quantitative accuracy is excellent: $1.8 billion in purchases and $1.5 billion outstanding are correctly reported; the additional detail of $10 million gross charge-offs and ≈90% portfolio current status adds precision not in the original but is consistent with deeper 2024 disclosures and does not contradict the ground truth. (3) Reasoning is sound: the LLM correctly infers a strategic shift from 2022’s lack of disclosure on portfolio size or servicing to 2024’s active management, citing PPWC and PPBL as operational vehicles. This demonstrates proper multi-hop synthesis across years and documents. (4) The answer is contextually relevant, directly addressing both financial exposure (increased holdings and purchases) and operational role (self-servicing, dedicated products). The only minor shortcoming is the lack of explicit mention of the $1.2 billion prior balance for comparison, though the $1.5 billion figure is correct. Overall, this is a semantically equivalent, factually correct, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 427,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "In 2022 Merck’s Lynparza was already approved for several advanced cancers and, in partnership with AstraZeneca, was seeking new uses – the FDA had placed a supplemental NDA for the adjuvant early‑stage breast‑cancer (OlympiA) indication under priority review with a Q1‑2022 PDUFA date, and the EU was reviewing it for metastatic castration‑resistant prostate cancer【page_22†L13-L20】【page_23†L1-L4】. By 2024 the drug remained a co‑commercialized product, alliance revenue grew 9 % year‑over‑year on stronger international demand, and the adjuvant OlympiA indication secured Chinese NMPA approval (effective January 2025), showing expanded regulatory reach【page_55†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Merck's involvement with Lynparza from 2022 to 2024. In 2022, it accurately notes the FDA's priority review of the supplemental NDA for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer (OlympiA trial) with a Q1 2022 PDUFA date, aligning with the ground truth. It also correctly identifies the EU review for metastatic castration-resistant prostate cancer, which adds context beyond the ground truth but does not contradict it. By 2024, the LLM correctly states that alliance revenue grew by 9% year-over-year due to stronger international demand—matching the ground truth's '9% growth in 2024'. It also accurately reports the January 2025 Chinese NMPA approval for the OlympiA indication, consistent with the original answer’s mention of a January 2025 approval in China. (2) All quantitative elements are correct: the 9% revenue growth and the January 2025 approval date are precisely stated. The PDUFA date in Q1 2022 is correctly framed. No calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 to 2024), geography (U.S., EU, China), and commercialization aspects (regulatory, revenue). The mention of the AstraZeneca partnership and co-commercialization is accurate and adds useful context. The only minor shortcoming is that the original answer emphasizes 'continued global regulatory momentum' and does not mention the prostate cancer indication under EU review, which the LLM includes as additional detail—this is not incorrect but slightly shifts focus. (4) The answer is semantically equivalent to the ground truth, with excellent factual alignment, minor enrichment of context, and no material omissions or inaccuracies. Hence, a correctness score of 9 is warranted—excellent but not perfectly streamlined to the original answer’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 514,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "In the 2022 Form 10‑K Boeing said it “use[s] commodity swaps and commodity purchase contracts to hedge against … price changes” and quantified the exposure – a 10 % price swing would have moved unrealized gains or losses on those contracts by roughly **$46 million** (see 2022 p. 60). By the 2024 filing the company still relies on commodity purchase contracts, but now groups them with its **cash‑flow hedges** that cover expected sales and purchases out to **2031**, and it no longer provides a specific dollar‑impact figure, indicating a shift to a longer‑term, more integrated risk‑management horizon (see 2024 p. 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing used commodity swaps and purchase contracts in 2022, a 10% price change would impact unrealized gains/losses by $46 million (correctly cited from 2022 10-K, p.60), and by 2024 the company extended its hedging horizon to 2031 using commodity purchase contracts as part of cash-flow hedges (per 2024 10-K, p.110). The absence of a specific dollar-impact figure in 2024 is correctly noted. (2) Quantitative accuracy is perfect: the $46 million figure, 10% price change, and 2031 end date are all factually correct and match the original answer. Format variations (e.g., $46 million) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years and filings, identifying the evolution from short-term, quantified exposure to a longer-term, integrated strategy. The conclusion about a shift to a longer-term risk management horizon is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2022 strategy 'neutralized material market risk' or that the shift is aligned with 'extended production planning cycles'—contextual nuances present in the original answer. However, the core evolution in strategy, time horizon, and financial exposure is accurately conveyed. Thus, the answer is semantically equivalent with only slight omission of strategic rationale, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 417,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "In 2021 Schwab reported that all of its pledged‑asset‑line (PAL) loans were “fully collateralized by securities with fair values in excess of the borrowings,” so no allowance for credit losses was required for PALs (see 2021 Note 7). By 2024 the PAL portfolio had grown to roughly $15 billion (about 38 % of total bank loans) but remained fully collateralized, and the allowance for credit losses on PALs was still $0, while the overall allowance for credit losses on bank loans fell to just 0.05 % of year‑end balances (2024 data). Thus, exposure rose modestly, but the credit risk stayed minimal because the loans stayed over‑collateralized and no specific allowance was needed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) Quantitative inaccuracy: The claim that PALs grew to $15 billion by 2024 (about 38% of total bank loans) and that the allowance for PALs remained $0 is not supported by the ground truth, which does not specify a dollar amount for PALs or confirm zero allowance—instead, it states there was a decrease in the overall allowance due to lower projected loss rates and improved credit quality. The 0.05% allowance figure for total bank loans is mentioned, but the ground truth does not state this applies to PALs specifically. (2) The original answer emphasizes a shift in risk management approach—from reliance on full collateralization (in 2021) to a broader credit assessment including projected loss rates and credit quality (by 2024). The LLM answer incorrectly asserts that PALs 'remained fully collateralized' and 'no specific allowance was needed,' which contradicts the ground truth implication that an allowance *was* being calculated and had decreased, indicating a move beyond collateral-only assessment. (3) Multi-hop reasoning is partially sound—comparing 2021 and 2024 risk treatment—but fails to capture the conceptual evolution in risk modeling. Instead, it reinforces continued full collateralization, missing the nuance of a strategic shift in credit risk evaluation. (4) While contextually relevant and addressing the question's structure, the answer misrepresents key facts and thus scores low on quantitative and qualitative accuracy despite good framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 428,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "In the 2022 filing Boeing was still managing the 777X as a timing issue – it had revised its outlook to expect the first delivery in late 2023 and the program’s reach‑forward loss was already folded into cost‑of‑sales (2022 10‑K p.27). By the 2024 filing the company was explicitly recognizing a $4.079 billion reach‑forward loss for the 777X (and 767) in cash‑flow (2024 10‑K p.59) and a $7.634 billion forward loss in earnings (2024 10‑K p.87), while R&D spending for commercial airplanes rose by $435 million to $2.386 billion, largely driven by the 777X program (2024 10‑K p.32). This reflects a shift from schedule‑adjustment and embedded cost treatment to direct loss accounting and heightened R&D investment to advance the 777X.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Boeing's financial treatment and strategic positioning of the 777X program between 2022 and 2024, noting a shift from managing timing and embedded losses to explicit loss recognition and increased R&D investment. However, there are significant quantitative inaccuracies. The ground truth states that R&D spending increased by $435 million in 2024 compared to 2023, and by $525 million in 2023 over 2022. The LLM correctly cites the $435 million increase in 2024 but fails to mention the $525 million increase in 2023, which is a key part of the multi-year trend. Additionally, the LLM introduces specific figures like a $4.079 billion reach-forward loss in cash flow and $7.634 billion in earnings for 2024, which are not present in the original answer and go beyond the scope of the ground truth, potentially misrepresenting the source. (2) The $435 million R&D increase in 2024 is correctly reported, but the absence of the $525 million 2023 increase weakens the completeness of the financial trend. The large loss figures cited in the LLM answer, while possibly present in the 10-K, are not part of the ground truth summary and introduce unverified detail that distracts from the core narrative of strategic repositioning. (3) The reasoning is sound in interpreting a shift from cost burden to strategic investment, supported by increased R&D and explicit loss accounting. However, the failure to include the 2023 R&D increase breaks the full multi-hop synthesis across 2022–2024. The use of specific loss amounts from the 10-K may reflect deeper document knowledge but does not align with the synthesized ground truth, which focuses on the qualitative shift and R&D trends. (4) The contextual relevance is high as the answer directly addresses the question’s focus on financial treatment and strategic positioning. The qualitative accuracy is strong due to correct interpretation of the shift, but quantitative accuracy is reduced due to omission of key comparative R&D data and introduction of unsupported specific loss figures not in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 571,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab’s PAL portfolio has risen modestly – from about $14.4 billion of average loans in 2022 to roughly $14.9 billion in 2024 (≈4 % growth) and its share of total bank loans climbed from 33 % to 38 % (page 142).  The firm continues to rely on the same risk‑management framework: PALs are over‑collateralized, collateral values are monitored daily, and a “practical expedient” based on collateral‑maintenance provisions is used to estimate the allowance, which leaves the PAL segment with essentially zero allowance for credit losses (allowance shown as “‑” in 2024, page 142; methodology described on page 78).  Consistent with this approach, the overall allowance for credit losses on bank loans fell to 0.05 % of loans in 2024 (down from 0.09 % in 2023), reflecting lower projected loss rates and improved credit quality (page 142).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the use of the practical expedient due to over-collateralization, daily collateral monitoring, and the zero allowance for PALs are accurately described. The growth in the PAL portfolio and the decrease in the overall allowance ratio are correctly reported. (2) Quantitative accuracy is excellent: the $14.4B to $14.9B increase (≈4%) is consistent with the data, and the rise in PALs' share of total loans from 33% to 38% is precise. The drop in the allowance ratio from 0.09% in 2023 to 0.05% in 2024 matches the source and supports the conclusion of improved credit quality. These numbers are not in the original answer but are consistent with the trend described (portfolio growth and declining loss allowance), and their inclusion enhances precision. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk management continuity (same framework in 2022–2024), links the practical expedient to zero allowance, and explains the declining overall allowance ratio via improved credit metrics—exactly as in the ground truth. (4) The only minor limitation is that the original answer notes a 'slight decrease in 2023' in the loan portfolio, which the LLM does not explicitly mention, though it correctly infers growth from 2022 to 2024 overall. This omission slightly affects completeness but does not undermine the correctness of the trend. Semantic equivalence is maintained, and the LLM adds helpful specificity (e.g., exact percentages, page references) without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 439,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ’s net‑investment‑hedge portfolio shows that the notional amount of British‑pound‑sterling notes fell from **$45 million in 2022 to $0 (no amount) in 2023**【page_98†L1-L4】.  The elimination of the GBP‑denominated hedge indicates the company has actively reduced its exposure to the pound—either by repaying or restructuring that debt or by deciding not to hedge it—demonstrating a tighter, more deliberate foreign‑exchange risk‑management stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. In contrast, the LLM claims the amount decreased from $45 million in 2022 to $0 in 2023—reversing the actual trend and misstating the 2022 value by a factor of 15. This fundamental error invalidates the entire response. (2) Quantitative accuracy is extremely low: the reported values ($45M → $0) are incorrect on all counts. The correct values are $3M (2022) and $45M (2023), representing a $42M increase. The LLM not only gets the starting value wrong but also reports a complete elimination instead of a significant increase. (3) The reasoning is flawed due to incorrect data. The conclusion that MDLZ reduced exposure and adopted a 'tighter, more deliberate' FX risk management strategy is the opposite of what the data indicates. The actual increase from $3M to $45M suggests a strategic increase in GBP exposure, likely to hedge growing UK-related operations or financial positions. The LLM fails to correctly synthesize the multi-hop information, drawing an inverse conclusion based on fabricated numbers. (4) Contextual relevance is low but not zero—the response addresses the right topic (FX risk management strategy related to GBP notes) and attempts to interpret the implication, so it remains on-topic. However, due to severe factual and quantitative errors, the answer is substantively wrong. Correctness, quantitative, and qualitative scores are all very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 436,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 Form 10‑K the 3.125 % 2025 Notes are disclosed as a $1 billion fixed‑rate issue with a coupon of 3.125 % and, per the “effective interest rates” note, the effective rate equals the coupon (no swap hedge is mentioned)【page_130】【page_131】. By the 2024 filing the same $1 billion of 3.125 % 2025 Notes appears in the interest‑rate‑swap table, showing that Amgen has entered into a fair‑value hedge that converts the fixed 3.125 % coupon to a floating rate of SOFR + 2.1 %【page_149】. This shift indicates that Amgen is actively using swaps to manage interest‑rate risk on this debt, moving from a pure fixed‑rate exposure in 2022 to a hedged, floating‑rate profile in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fixed interest rate of 3.125% for Amgen's 2025 Notes in the 2022 filing and the shift to a floating rate of SOFR + 2.1% in the 2024 filing, which aligns with the ground truth. The $1 billion principal amount is accurate and consistent across both filings. (2) All numeric values—3.125%, SOFR + 2.1%, $1 billion—are factually correct and properly attributed to the respective years and disclosures. No calculation errors are present. (3) The reasoning correctly interprets the change not as a refinancing of the debt itself but as the application of an interest rate swap (a fair-value hedge), which effectively converts the fixed-rate obligation into a floating-rate one. This reflects sophisticated multi-hop reasoning: connecting the note's original terms in 2022 with its reappearance in a swap table in 2024, and inferring the company’s active risk management strategy. The ground truth implies a structural change in the debt, while the LLM provides a more precise and technically accurate explanation involving hedging, which is supported by typical SEC disclosure practices. (4) The LLM answer is more detailed and technically accurate than the ground truth, adding context about hedging that enhances correctness. The only reason for not scoring a 10 is that the original answer suggests a possible refinancing, while the LLM clarifies it's a hedge—though more accurate, this represents a slight interpretive divergence. Overall, the answer is factually sound, complete, and contextually superior.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 429,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "In the 2022 Form 10‑K Schwab simply noted that its commercial‑paper issuance program (together with unsecured bank lines) was a source of liquidity, but warned that “financing may not be available on acceptable terms or at all due to market conditions or disruptions in the credit markets” 【page_23】. By the 2024 filing the company still lists the commercial‑paper program, yet adds that the rapid rise in short‑term rates in 2022‑23 has pushed it to “rely on supplemental funding, such as advances under Federal Home Loan Bank facilities, repurchase‑agreement borrowings, brokered CDs, or other sources of funding” 【page_16】—showing a shift from relying primarily on commercial paper to a more diversified, higher‑cost funding mix in response to market disruptions and higher rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), entities (Schwab, commercial paper program, FHLB advances, repurchase agreements), and correctly identifies the context of rising short-term interest rates in 2022–2023 and market disruptions. It accurately reflects that in 2022, Schwab introduced the commercial paper program as a potential liquidity source with caveats about market conditions (supported by citation to page 23), and by 2024, the company was relying on supplemental funding sources. However, the LLM mischaracterizes the evolution of reliance on the commercial paper program. The original answer states that reliance on the commercial paper program *increased* by 2024 as a complement to other sources, whereas the LLM suggests a shift *away* from commercial paper toward a more diversified funding mix. This misrepresents the direction of change in reliance. While the LLM correctly notes the use of FHLB advances and repurchase agreements, it implies commercial paper became less central, when in fact it remained a growing component. There are no numerical inaccuracies (quantitative accuracy is perfect), and the citations align with the general content. The reasoning is mostly sound but contains a key error in synthesis: it fails to capture that commercial paper use increased, not decreased. Contextually, the answer is highly relevant and well-grounded in the filings. Thus, the correctness score is 7 due to a significant but not fundamental error in the interpretation of Schwab’s evolving funding strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 426,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "By 2022 Amgen had already redeemed its 3.625 % notes due 2022 ($750 million) and was left with $1.4 billion of 3.625 % notes due 2024 (see page 130). In 2023 the company hedged the entire $1.4 billion of those 2024 notes with interest‑rate swaps that converted the fixed 3.625 % coupon to a floating SOFR + 3.4 % rate (page 149), and by the end of 2024 the 3.625 % 2024 notes and the associated swaps were repaid/terminated (page 148). This evolution shows Amgen’s active debt‑management approach: retiring maturing fixed‑rate debt while using swaps to control interest‑rate exposure and maintain a balanced mix of fixed and floating‑rate obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $1.4 billion (or $1,400 million) carrying value of the 3.625% 2024 Notes in 2022 is accurate; the full repayment by 2024 is correctly stated; and the use of SOFR-based floating rates via interest rate swaps is consistent with the knowledge graph. The mention of SOFR + 3.4% is additional detail not in the original answer but does not contradict it—such specifics may come from the cited filing pages and are plausible within context. (2) The timeline is correct: the notes were outstanding in 2022, hedged in 2023, and fully repaid by 2024. (3) The reasoning is sound and reflects proper multi-hop synthesis: the LLM connects the redemption of earlier notes, the hedging activity, and the final repayment to infer a strategic debt management approach. It correctly identifies the shift from fixed to floating rate exposure, even though it frames it via swaps rather than direct issuance—this is a more granular but valid interpretation. (4) The conclusion about Amgen’s active debt management and balanced mix of fixed/floating obligations is semantically equivalent to the ground truth’s claim about strategic alignment with market conditions. The only minor gap is that the original emphasizes the replacement with floating-rate debt, while the LLM focuses on hedging and repayment without explicitly stating that new floating-rate debt replaced the old notes. However, the termination of swaps and repayment implies refinancing, and the strategic interpretation remains valid. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for not fully mirroring the 'replacement' aspect of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 489,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "In the 2022 filing Schwab explicitly said it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide” and that any remaining funding commitments were “dependent upon the occurrence of certain conditions” with an expectation to pay them between 2022 and 2025 (2022 Note 11‑12, pp. 97‑98). The 2024 filing contains no discussion of VIEs or new funding commitments (pages 18‑19, 29, 110‑120), indicating that Schwab’s stance has not changed – it still does not plan to extend support beyond contractual obligations and any prior conditional commitments remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some accurate details from the 2022 filing, including a correctly quoted statement about not providing support beyond contractual obligations and a reference to conditional funding commitments with an expectation to pay between 2022 and 2025. These elements align with the ground truth and are factually consistent, earning moderate scores for quantitative accuracy and contextual relevance. However, the core of the answer is fundamentally incorrect: it claims that the 2024 filing contains no discussion of VIEs or new funding commitments and concludes that Schwab’s stance has not changed. This contradicts the ground truth, which states that by 2024, Schwab explicitly acknowledged a shift in policy—indicating it may now choose to provide support (e.g., credit or liquidity) to its proprietary funds under stress conditions like significant valuation declines or redemptions, even without a contractual obligation. This represents a clear evolution in intent and conditions for support, which the LLM answer fails to recognize. The model appears to have misinterpreted the absence of explicit VIE discussion in certain sections as evidence of policy continuity, when in fact the shift is reflected in updated disclosures elsewhere. This is a critical failure in multi-hop reasoning: the model should have compared the qualitative evolution in tone and intent between the two years’ disclosures. As a result, the answer misses the central point of the question—how Schwab’s approach evolved—and incorrectly asserts no change. Thus, despite some accurate quoting and date references, the overall correctness and qualitative reasoning scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 455,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "In the 2022 filing MDLZ still recorded a $48 million cost for the JDE Peet’s transaction and included those costs as a non‑GAAP adjustment to operating income, indicating a drain on earnings and capital resources (2022 p.46‑57). By the 2023 filing the JDE Peet’s equity‑method investment is described as providing additional flexibility, with proceeds from JDE Peet’s share sales generating a $2.8 billion cash inflow from investing activities and the company stating that the investment does not materially affect its liquidity or capital structure (2023 p.54‑57).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The $48 million cost for the JDE Peet’s transaction in 2022 is not mentioned in the ground truth and appears to be fabricated or misattributed. More critically, the $2.8 billion cash inflow from JDE Peet’s share sales in 2023 is not reflected in the original answer and contradicts the ground truth, which emphasizes a reclassification of the investment type and improved financial flexibility—not a specific large cash inflow. The claim that the investment 'does not materially affect its liquidity or capital structure' directly contradicts the original answer, which states the investment provides 'additional financial flexibility' within MDLZ's liquidity and capital resources framework—indicating a positive impact, not a negligible one. (2) Quantitative accuracy is low: the $48M and $2.8B figures are unsupported by the ground truth, and no such numbers appear in the original answer. There is no mention of non-GAAP adjustments or page references in the ground truth, suggesting the LLM may have hallucinated specific filing details. (3) The multi-hop reasoning is partially sound—LLM attempts to compare 2022 and 2023 treatment of the investment and assess impact on liquidity—but fails in synthesis because it contradicts the core conclusion of the original answer. The shift from 'Has_Stake_In' to 'Invests_In' and its strategic implication is missed, replaced with erroneous financial figures. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship and its impact on liquidity and capital structure, aligning with the question’s intent. However, factual correctness is severely undermined by incorrect numbers and contradictory conclusions, warranting a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 494,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "In the 2022 filing the company hedged the $1 billion of 3.125 % 2025 Notes with interest‑rate swaps that referenced LIBOR at **LIBOR + 1.8 %** (see AMGN 2022 10‑K, page 132). By the end of 2024 the same notional amount was still hedged, but the swaps had been re‑based on the Secured Overnight Financing Rate, now paying **SOFR + 2.1 %** (see AMGN 2024 10‑K, page 149). Thus the hedging strategy shifted from a LIBOR‑based spread of +1.8 % to a SOFR‑based spread of +2.1 % while keeping the notional unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that the interest rate under the swap for the 3.125% 2025 Notes in 2022 was not disclosed, but the LLM claims it was LIBOR + 1.8%, which is not supported by the original answer. This is a major factual error. Additionally, the shift from LIBOR to SOFR is plausible contextually, but the original answer does not confirm the use of LIBOR or the 1.8% spread in 2022, making this detail fabricated or incorrectly inferred. (2) The notional amount of $1 billion (or $1,000 million) is correctly identified and consistent across years, which matches the ground truth. The 2024 rate of SOFR + 2.1% is accurately reported. However, the 2022 rate is entirely incorrect per the ground truth, which explicitly states it was not disclosed. (3) The multi-hop reasoning is partially sound in that the model attempts to compare the hedging strategy across 2022 and 2024 and identifies the shift in benchmark rate (LIBOR to SOFR), which aligns with broader market trends. However, the reasoning fails because it invents a specific rate (LIBOR + 1.8%) that was not disclosed, undermining the validity of the comparison. The model may have confused data from another note series or made an unsupported inference. (4) The contextual relevance is high because the answer addresses the evolution of the hedging strategy, the change in reference rate, and maintains focus on the correct note and time frame. However, due to the critical error in the 2022 interest rate, the overall correctness score is low. Quantitative accuracy is severely penalized due to the incorrect percentage, while qualitative accuracy is moderate due to correct identification of the notional and the SOFR shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 490,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart’s fair‑value of equity investments measured with Level 2 inputs fell from **$5.819 billion** at fiscal‑year‑end 2022 (January 31, 2022) to **$5.570 billion** at fiscal‑year‑end 2023 (January 31, 2023)【page_72】. This represents a decline of roughly **$249 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Walmart's fair value of equity investments using Level 2 inputs decreased from $5,819 million in FY2022 to $5,570 million in FY2023. The LLM correctly reports these values as $5.819 billion and $5.570 billion, which are numerically equivalent (format variation accepted). (2) The calculated decline of $249 million is accurate: $5,819M - $5,570M = $249M, and the LLM correctly identifies this. (3) The multi-hop reasoning is sound—comparing fair value across two fiscal years and computing the change is correctly executed. (4) Entity accuracy is perfect: Walmart, Level 2 inputs, equity investments, and fiscal years (with correct end dates: January 31, 2022 and 2023) are all correctly identified. (5) The answer addresses all parts of the question: evolution (decrease), time period (FY2022 to FY2023), and magnitude ($249 million). Contextual relevance and completeness are excellent, with appropriate citation (page_72). No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 309,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "In the 2023 Form 10‑K Apple said that “the Company **relies primarily on the innovative skills, technical competence and marketing abilities of its personnel**” (2023 10‑K p. 6). By the 2024 filing the language had shifted – marketing is no longer described as a core reliance on staff, but is listed as one of the “**principal competitive factors** … including … **marketing and distribution capability**” (2024 10‑K p. 6). Thus Apple moved from emphasizing a dependence on its employees’ marketing talent to treating marketing as one component of its broader competitive strengths.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental misrepresentation of Apple's 2024 10-K language, leading to an incorrect conclusion about the evolution of its characterization of marketing abilities. (1) The LLM claims that in the 2024 filing, Apple no longer describes marketing as a reliance on personnel but instead frames it as a 'principal competitive factor' like 'marketing and distribution capability.' This is inaccurate. The ground truth states that in the 2024 10-K, Apple continued to emphasize reliance on the same three personnel-driven factors—innovative skills, technical competence, and marketing abilities—but strengthened the language to 'depends heavily' and tied them more directly to product flow and competitiveness. The LLM incorrectly suggests a shift away from personnel-centric marketing talent toward a structural capability, which contradicts the actual filing. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored 10 by default. (3) The multi-hop reasoning fails because the model misreads the nature of the evolution: instead of recognizing a strengthening of emphasis on personnel's marketing abilities, it infers a shift in kind (from human capital to operational capability), which is not supported. (4) Contextual relevance is moderate because the answer addresses the right documents and general topic, but the core factual error undermines the analysis. The conclusion is therefore semantically divergent from the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 423,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "In 2022 Amgen still had a $1.4 billion interest‑rate‑swap hedge on its 3.625 % 2024 notes, converting the fixed‑rate debt to a floating rate of LIBOR + ≈3.2 % (SOFR‑based spread of about 3.4 %)【page_132】. By the end of 2024 the swap notional for those notes was $‑ (zero) and no interest‑rate hedge remained, showing the hedge was terminated as the notes were repaid or the exposure was no longer needed【page_149】. This indicates Amgen’s strategy of actively using swaps to hedge fixed‑rate debt while it is outstanding and unwinding the hedge when the underlying debt is retired.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the core facts mostly correct but contains key quantitative inaccuracies. It states that in 2022, Amgen had a $1.4 billion hedge on the 3.625% 2024 Notes, but the ground truth specifies that in 2022, Amgen terminated $5.2 billion in swaps covering multiple notes (including the 2024 Notes), not just $1.4 billion on the 2024 Notes alone. The $1.4 billion figure is correct for December 2023, not 2022. The LLM incorrectly attributes the full notional amount in 2022 to only the 2024 Notes and misrepresents the timing. Additionally, the LLM mentions LIBOR + ~3.2% with a SOFR-based spread of 3.4%, but the ground truth only references SOFR+3.4% in 2023, not LIBOR, and does not specify a 2022 rate. The shift from LIBOR to SOFR is contextually reasonable due to the transition, but the specific rates and timing are not fully supported. (2) The notional amount dropping to $0 by end of 2024 is correctly reported, and the conclusion that the hedge was unwound as the notes neared maturity aligns with the ground truth. However, the $5.2 billion 2022 swap termination across multiple notes is omitted, which is a significant part of the original answer. (3) The multi-hop reasoning is sound in linking the unwinding of the hedge to debt maturity and interpreting Amgen’s hedging strategy, but the synthesis misses the broader 2022 swap termination event and misattributes the $1.4 billion figure to 2022 instead of 2023. (4) Despite these quantitative errors, the qualitative interpretation of Amgen’s hedging strategy—hedging fixed-rate debt and unwinding as maturity approaches—is accurate and relevant. Contextual relevance is perfect as it directly addresses both parts of the question. Quantitative accuracy is penalized due to incorrect amounts and dates; qualitative accuracy is high due to correct logic and interpretation; overall correctness is reduced by the factual inaccuracies in numbers and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 525,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "- In the 2022 filing Schwab said it was **“retaining TD Ameritrade Institutional’s customizable portfolio‑rebalancing solution iRebal as part of our offering for independent‑advisor clients”** (2022 Integration Overview, p. 6).  \n- By the 2023 filing the language had shifted to **“incorporated TD Ameritrade Institutional’s customizable portfolio‑rebalancing solution iRebal as part of our offering for independent‑advisor clients”** (2023 Business Acquisition, p. 4).  \n\nThe move from merely retaining the tool to fully integrating it into Schwab’s platform shows a deeper embedding of iRebal into its advisor services, signaling that Schwab is strengthening its RIA value proposition with sophisticated, customizable rebalancing capabilities and thereby sharpening its competitive edge against other custodians and broker‑dealers in the independent‑advisor market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Schwab's integration of iRebal from 2022 to 2023: in 2022, Schwab was retaining iRebal, and by 2023, it had incorporated it into its offerings. The cited quotes from the filings are factually correct and properly attributed to the relevant documents and pages. (2) There are no numeric values in the question or answer that require calculation, but the years (2022 and 2023) are correctly used and contextualized. (3) The multi-hop reasoning is sound: the LLM infers from the change in language (\"retaining\" to \"incorporated\") a deeper integration of iRebal, which matches the ground truth's interpretation. It correctly links this evolution to Schwab’s competitive positioning in the RIA market. (4) While the LLM answer captures the core evolution and strategic implication, it omits a specific contextual detail present in the ground truth: the broader integration milestone of transitioning over $1.6 trillion in assets and 15 million accounts by 2023, which strengthens the narrative of integration progress. This omission slightly reduces completeness but does not affect the core correctness. The answer is semantically equivalent in its main claims and uses appropriate, precise language. Thus, the correctness score is 9 due to this minor omission, but all other dimensions—especially quantitative accuracy and contextual relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 408,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "In the 2023 Form 10‑K Apple simply listed the iMac as one of the existing desktop computers in its Mac portfolio (Item 1 – Business, page 4). By contrast, the 2024 Form 10‑K’s MD&A (Item 7) explicitly announced a new iMac in the first‑quarter product roll‑out (page 24), showing that Apple moved from merely describing the iMac as a legacy product to actively refreshing and promoting the iMac line in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in the 2023 10-K, Apple listed the iMac as part of its standard Mac portfolio (Item 1 – Business), indicating it was an existing product. For 2024, the LLM accurately notes that the iMac was mentioned in the MD&A section (Item 7) of the 10-K as part of a first-quarter product rollout (page 24), signaling a refresh. This reflects the shift in strategic emphasis described in the original answer. All entities (Apple, iMac, 10-K filings, MD&A, Item 1, Item 7) and years (2023 vs 2024) are correct. There are no numerical inaccuracies—no calculations or dollar amounts are involved, but the temporal and contextual details are precise. The reasoning is sound: the model infers increased strategic importance from the change in disclosure location and language, which is a valid interpretation supported by the filings. The only minor limitation is that the LLM does not explicitly state the broader implication—that this shift suggests greater strategic importance or innovation focus—but it strongly implies it through the contrast between 'listing' and 'announcing' the product. Thus, while slightly less explicit than the original answer in drawing the strategic conclusion, the LLM conveys semantically equivalent information with high accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 379,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "In the 2022 Form 10‑K RTX listed $1 billion of 2.820 % notes due 2051 as an outstanding long‑term liability 【page_94】. The 2024 Form 10‑K shows the same $1 billion principal balance for those notes, with no repayment or refinancing disclosed 【page_89】. This unchanged position indicates that RTX has kept the low‑coupon, 30‑year issue in its capital structure, using it as a stable, low‑cost component of its long‑term debt mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: RTX issued $1 billion of 2.820% Notes Due 2051 in 2022 and maintained the same principal balance in 2024, with no repayment or refinancing. These quantitative details match the ground truth exactly, including dollar amount ($1 billion = $1,000 million), interest rate (2.820%), and maturity year (2051). (2) Quantitative accuracy is perfect—no errors in numbers, dates, or amounts. The LLM accurately reflects that the principal remained unchanged. (3) However, the LLM answer is incomplete in terms of multi-hop reasoning. While it correctly notes the stability of the 2051 notes, it omits the broader context about RTX’s overall long-term debt increasing from $40,078 million to $41,146 million between 2022 and 2024. This omission limits the depth of the analysis regarding the evolution of the company's long-term debt structure. The ground truth emphasizes that the 2051 notes remained stable *within a growing debt portfolio*, which the LLM fails to mention. (4) Despite this gap, the answer is factually correct, well-supported by document citations, and directly addresses the core of the question—evolution of the specific note and its role in the capital structure. The reasoning is sound but not fully comprehensive. Hence, correctness and qualitative accuracy are high but not perfect due to missing synthesis of total debt growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 389,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "In the 2022 filing Schwab disclosed that the amended IDA agreement cut the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points to 15 basis points 【page_85】. By the 2023 filing the company said it had transitioned the IDA agreement (and related inter‑company loans) away from LIBOR to other appropriate benchmark rates (e.g., SOFR), completing the change with no material impact 【page_54】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the service fee reduction from 25 to 15 basis points in 2022 is accurately reported, and the 2023 transition from LIBOR to alternative benchmarks (e.g., SOFR) is correctly stated. (2) The answer addresses both parts of the question: evolution of service fees (2022) and reference rate adjustments (2023), demonstrating complete multi-hop synthesis across years and agreement terms. (3) Entities—Schwab, IDA agreement, TD Depository Institutions, LIBOR, SOFR—are correctly identified and contextualized. (4) The reasoning is sound: it traces the agreement’s evolution from fee restructuring to benchmark rate modernization, aligning with regulatory changes. The addition of 'inter-company loans' and 'no material impact' provides extra context supported by the source (page 54) without contradicting the ground truth. Semantic equivalence is maintained, with precise factual alignment. Minor wording differences (e.g., 'cut' vs 'reduced') do not affect accuracy. All scores are 10 due to full factual correctness, completeness, and proper contextualization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 325,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "In the 2023 filing the Company treated Filorga as a separate reporting unit with $221 million of goodwill, indicating it was viewed as a distinct, high‑value brand with its own cash‑flow expectations (see page 59). By the 2024 filing Filorga is only mentioned among a long list of trademarks within the broader Oral, Personal and Home Care segment (see page 79), showing the Company has folded it into its overall brand portfolio and is now valuing it on a consolidated, rather than stand‑alone, basis—suggesting a reduced strategic emphasis on Filorga as an independent asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Filorga had $221 million in goodwill in 2023 as a standalone reporting unit, and by 2024 it was no longer separately disclosed—this matches the original answer exactly. Format is consistent and precise. (2) The answer correctly identifies the change in financial treatment across years and segments, noting the shift from standalone to consolidated reporting within the Oral, Personal and Home Care segment (though the original specifies 'Europe segment' in 2023, the LLM does not misstate, just omits the segment detail). (3) The reasoning is sound: the integration into a broader portfolio suggests reduced strategic emphasis, which logically follows from the loss of standalone valuation and impairment analysis. This captures the core implication about strategic importance and valuation approach. (4) The LLM slightly simplifies the strategic implications—original mentions potential effects on divestiture, investment, or prioritization, while LLM focuses on reduced emphasis. This is a minor omission, not an error. Semantic equivalence is maintained. All entities (Filorga, years, goodwill concept) are accurate. Contextual relevance is excellent—directly addresses both strategic importance and valuation approach. One point deducted from correctness and qualitative accuracy for incomplete elaboration of strategic consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 403,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "In Apple’s 2023 Form 10‑K the iPhone was discussed only as a product line and in the segment tables (e.g., the net‑sales tables on pages 25‑26) without naming any specific model. By the 2024 Form 10‑K the company’s product description now lists “iPhone 16 Pro” as part of the iPhone family (page 4) and even calls out its launch in the fourth‑quarter product announcements (page 24). This shift from a generic iPhone reference to an explicit mention of the new iPhone 16 Pro shows Apple’s product development has progressed to a new flagship generation and its reporting strategy now provides a more detailed, forward‑looking roadmap of upcoming products.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly claims that in the 2023 10-K, Apple did not name any specific iPhone model and only discussed the iPhone as a product line. However, the ground truth states that the iPhone 16 Pro was explicitly mentioned in the 2023 10-K as part of the Fourth Quarter 2024 product lineup, which contradicts the LLM's assertion. Second, the LLM misrepresents the evolution: it frames the 2024 10-K as highlighting the 'launch' of the iPhone 16 Pro, whereas the ground truth indicates that by the 2024 10-K, the device is treated as an existing product, already part of the established lineup—implying it has moved past launch into maturity. This reverses the correct interpretation: the 2023 filing was forward-looking (planning/launch phase), while the 2024 filing is retrospective (established product). The LLM incorrectly suggests that more forward-looking detail was added in 2024, when in fact the reporting became more retrospective and integrated. There are no numerical values to verify, so quantitative accuracy is not heavily penalized on format, but the temporal and descriptive facts are wrong. The reasoning is flawed in its multi-hop logic—misidentifying the nature and direction of the shift in disclosure. While the answer addresses the general theme of evolving product disclosure, it gets the core facts and direction of change incorrect, leading to a low correctness score. Contextual relevance is moderate because it engages with the question’s framework but draws incorrect conclusions from the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 440,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "In the 2022 filing Schwab described its Economic Value‑of‑Equity (EVE) analysis as a “long‑term” stress that subjects the balance sheet to instantaneous rate shifts, using a set of static assumptions – rate‑floor scenarios, pre‑payment speeds for mortgage‑related securities, term‑structure models, non‑maturity deposit behavior and pricing assumptions – to gauge the net‑present‑value impact on assets and liabilities【page_54】.  \n\nBy 2023 the firm had refined that framework: it now runs EVE simulations that explicitly capture client‑cash‑allocation changes and, in Q4 2023, updated its deposit‑beta assumptions for a declining‑rate environment (reflecting higher margin‑loan and cash balances and greater reliance on short‑term borrowings)【page_52】. This evolution makes the EVE analysis more dynamic and better aligned with the actual balance‑sheet response to interest‑rate moves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: in 2022, EVE simulations used assumptions such as non-negative (rate-floor) investment yields, prepayment speeds, and non-maturity deposit behavior, and were described as dependent on historical and expected economic behaviors. By 2023, the company evolved its modeling to include client cash allocation changes and updated deposit beta assumptions in a declining rate environment—both explicitly mentioned in the LLM response. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, Q4 2023) are correctly cited. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in modeling assumptions over time, identifying both the static nature of 2022’s approach and the dynamic enhancements in 2023, including balance sheet dynamics like higher cash balances and short-term borrowings. (4) The LLM adds contextual detail not in the original (e.g., 'term-structure models', 'instantaneous rate shifts', 'Q4 2023') that are consistent with typical EVE frameworks and plausibly derived from the source, but not explicitly confirmed in the ground truth. This slight elaboration does not detract from accuracy but may introduce minor assumptions. Overall, the answer is semantically equivalent, complete, and factually correct, warranting a 9/10 due to minor unverified specifics (like 'Q4 2023') not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 429,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "In the 2022 filing Qualcomm portrayed itself as an enabler in the access‑point market – it supplied the Wi‑Fi, Bluetooth and other wireless‑connectivity ICs, system software and licensing that OEMs embed in their own access‑point products (see QCT’s wireless‑connectivity and networking‑chip description on page 7). By fiscal 2023 the company listed “wireless access points” as a direct QCT product offering, alongside routers and broadband‑gateway equipment (see the networking‑product lineup on page 11 and the edge‑networking discussion on page 8). That shift moves Qualcomm up the value chain, letting it compete as a hardware vendor rather than just a chip/IP supplier and expanding its portfolio from pure‑chip solutions to end‑to‑end networking equipment, thereby strengthening its competitive positioning in the broader networking market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's shift from being an enabler (chipset and IP supplier) in 2022 to a direct producer of wireless access points in 2023, accurately reflecting the strategic evolution. The mention of QCT (Qualcomm CDMA Technologies) as the division involved and the inclusion of routers and broadband gateways adds contextual precision. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic sense; all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and strategic roles, correctly inferring that moving from component supplier to full product vendor represents a move up the value chain. It accurately captures the implication for competitive positioning—enhanced ability to compete with Broadcom and Intel—though it doesn't name those competitors explicitly, which is a minor omission. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'end-to-end networking equipment' vs 'full-system solutions') but conveying the same meaning. The only reason for not scoring a 10 is the lack of explicit mention of competing with Broadcom and Intel, which is a minor detail in the broader context. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 405,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Schwab’s interest‑only portion of its adjustable‑rate mortgage portfolio edged lower – it fell from roughly 28 % of ARMs in the 2022 filing (reflecting 2021 data) to about 27 % in the 2023 filing. At the same time, the share of those interest‑only loans whose rates are not scheduled to reset for three or more years dropped from about 89 % to roughly 86 %【page_94】【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 28% to 27% for the interest-only portion of adjustable-rate mortgages (ARMs), and 89% to 86% for those not scheduled to reset for three or more years. The percentages match the original answer exactly, and no calculation errors are present. (2) The answer is complete, addressing both parts of the question: the percentage of interest-only ARMs and the portion not resetting for three+ years, across 2022 and 2023. (3) Entity accuracy is strong: Schwab is correctly identified, and the time periods (2022 and 2023 filings reflecting relevant data) are appropriately referenced. The mention of '2022 filing (reflecting 2021 data)' is a minor nuance but does not detract from correctness, as the focus is on the reported figures in the respective annual reports. (4) Reasoning is sound: the answer correctly identifies a slight decrease in both metrics, implying a minor evolution in HELOC structure, consistent with the original conclusion. The only minor shortcoming is the parenthetical clarification about the 2022 filing reflecting 2021 data, which could introduce ambiguity, but it does not contradict the core facts. Overall, the answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 364,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "In the 2022 filing Qualcomm’s QSI (Qualcomm Strategic Initiatives) segment explicitly listed XR as one of the early‑stage markets it was targeting through Qualcomm Ventures investments (“...including … XR”)【page_14】. By the 2023 filing XR is no longer highlighted as a separate investment focus but is grouped under the IoT revenue stream, which fell from $7.353 billion in 2022 to $5.940 billion in 2023, showing a contraction in XR‑related product sales even as the company’s strategic‑investment emphasis on XR persists【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that Qualcomm Ventures targeted XR in 2022 via QSI investments (citing page 14), it incorrectly claims that in 2023 XR was 'grouped under the IoT revenue stream' and that there was a contraction in XR-related product sales. The ground truth states that by 2023, XR was explicitly listed as a commercial market for product sales—indicating a shift from investment to revenue generation—not a decline. The LLM misinterprets the IoT revenue decline ($7.353B to $5.940B) as evidence of shrinking XR sales, but the original answer does not link XR revenue to this specific IoT segment drop. (2) The numbers cited ($7.353B and $5.940B) may be accurate representations of IoT revenue from the filings, but their attribution to XR is unsupported and incorrect per the ground truth. There is no quantitative data in the original answer about XR revenue amounts or trends. (3) The multi-hop reasoning is flawed: instead of recognizing the evolution from investment (2022) to direct commercialization (2023), the model infers a narrative of strategic continuity and market contraction that contradicts the ground truth. It fails to identify the key shift from indirect involvement (via investments) to direct revenue generation. (4) The contextual relevance is moderate because the answer discusses Qualcomm’s XR activities across both years and cites relevant segments, but the conclusion is factually incorrect and misleading. Due to major errors in interpretation and reasoning, the correctness score is low despite some accurate input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 446,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The 3.030 % notes due 2052 carried an aggregate principal balance of **$1.1 billion in 2022** (RTX 2022 10‑K) and the same **$1.1 billion in both 2023 and 2024** (RTX 2024 10‑K)【page_107】【page_89】.  The balance has not changed over the three‑year period, showing that RTX has neither retired nor added to this series, so the 3.030 % 2052 issue remains a stable, long‑dated component of the company’s overall long‑term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the aggregate principal balance of the 3.030% Notes Due 2052 as $1.1 billion (equivalent to $1,100 million) in both 2022 and 2024, matching the ground truth. It also correctly notes stability over the period, including 2023, which is consistent with the unchanged balance. The minor discrepancy is that the original answer specifies only 2022 and 2024, while the LLM adds 2023—this is not incorrect, but extrapolated from available data. (2) All numeric values are accurate and correctly formatted: $1.1 billion = $1,100 million. No calculations are required, and the values align with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data from the 2022 and 2024 10-K filings to infer stability in the debt balance, correctly concluding no repayments or new issuances. The conclusion about strategic consistency in long-term debt structure is semantically equivalent, though phrased as 'stable, long-dated component' instead of 'strategic consistency.' (4) The answer fully addresses both parts of the question—evolution of the balance and implications for RTX's debt structure—with high factual accuracy and relevance. The inclusion of 2023 is a slight over-specification but does not detract from correctness. Thus, full credit on quantitative accuracy and contextual relevance; minor deduction in qualitative accuracy for slight rephrasing of the implication, but reasoning remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 404,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "In the 2023 proxy, American Express said it would “evolve our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions” as part of its commercial‑payments push【page_8】. By the 2024 filing the language is unchanged on differentiation but adds that the company is “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating that the corporate‑card platform is now being leveraged to deliver a broader suite of financing and payment services【page_8】. This evolution shows a shift from simply enhancing the card offering to embedding it within a more integrated, end‑to‑end commercial‑payments strategy for business clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and accounts payable solutions is accurately cited, as is the 2024 shift toward designing innovative products including financing, banking, and payment solutions. The interpretation that this reflects a move toward a more integrated, end-to-end strategy is consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the years 2023 and 2024 are correctly attributed to the respective strategic language, satisfying temporal accuracy. (3) The multi-hop reasoning—comparing AXP’s strategic language across two years and inferring a broader strategic shift—is sound and well-supported by the cited proxy statements. The LLM correctly synthesizes information across filings to conclude that the corporate card is being embedded into a wider financial services suite. (4) The only minor shortcoming is that the LLM answer does not explicitly use the phrase 'holistic commercial needs' or 'solution-oriented approach' from the original, slightly reducing semantic completeness, but the meaning is effectively equivalent. Wording differences are acceptable under semantic equivalence, so this does not warrant a major deduction. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 427,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "In the 2023 filing the company’s “Nature of Operations” note places PCA SKIN among the Oral, Personal and Home Care trademarks and says the segment’s products are “sold primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals”【page_79】. The 2024 filing updates that language to “sold primarily to a variety of traditional **and eCommerce** retailers, wholesalers, distributors, dentists and, in some segments, skin‑health professionals,” still listing PCA SKIN as a key brand【page_79】. Thus, while PCA SKIN remains positioned within the Oral, Personal and Home Care portfolio, its distribution strategy has broadened to explicitly include e‑commerce channels in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical misinterpretation of the evolution in distribution channels between 2023 and 2024. (1) Correct elements: PCA SKIN is accurately identified as a principal trademark within Colgate-Palmolive’s Oral, Personal and Home Care segment in both years, and the citation of distribution channels including retailers, wholesalers, distributors, and dentists is factually consistent. The mention of eCommerce as a newly explicit channel in 2024 is supported by the addition of 'and eCommerce' in the 2024 filing. (2) Quantitative accuracy is perfect—no numerical data is involved, and all dates (2023, 2024) and entities (PCA SKIN, Colgate-Palmolive) are correct. (3) However, the multi-hop reasoning is flawed: the ground truth emphasizes that the key evolution in 2024 was the expansion to include sales to *skin health professionals in some geographies*, not the addition of eCommerce. While eCommerce is indeed newly highlighted in 2024, the strategic refinement in positioning PCA SKIN within specialized skincare channels—via skin health professionals—is the central development. The LLM incorrectly identifies eCommerce as the key strategic shift, missing the nuance about skin health professionals being newly emphasized in the distribution strategy. (4) This leads to a correctness score of 6: core facts are accurate, but the synthesis misidentifies the primary strategic evolution. Qualitative accuracy is low due to this reasoning error, though contextual relevance remains high as the answer addresses the question’s focus on distribution changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "In the 2022 filing BMS described Opdivo as a PD‑1 inhibitor already approved for a wide range of cancers (bladder, CRC, head‑and‑neck, RCC, HCC, lung, melanoma, MPM, stomach) and noted that the Opdivo + Yervoy regimen was approved in several indications while “several ongoing potentially registrational studies … in monotherapy and in combination with Yervoy and various anti‑cancer agents” were under way【page_71】.  By the 2023 filing the company’s strategy had moved to “broaden the use of Opdivo in earlier lines of therapy, expand into new tumors … and continue to drive adoption … both as a monotherapy and in combination with Yervoy and other anti‑cancer agents,” and it highlighted the launch of the fixed‑dose Opdivo + Yervoy combo (Opdualag) for melanoma, whose revenue jumped from $252 M in 2022 to $627 M in 2023【page_43】【page_48】.  The rapid growth of Opdualag (≈149 % YoY) helped lift the overall new‑product portfolio 77 % in 2023【page_49】, signalling that the expanded indication and combo focus is expected to reverse the modest overall revenue decline and drive a stronger Opdivo‑related revenue growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Opdivo's 2022 indications (bladder, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach cancers) and the approved use of Opdivo + Yervoy across multiple tumor types. It accurately reflects the 2023 strategic shift toward earlier lines of therapy, new tumors, and broader use in monotherapy and combination regimens. The mention of Opdualag (fixed-dose Opdivo + Yervoy) launch for melanoma and its revenue growth from $252M in 2022 to $627M in 2023 is factually correct and well-supported. (2) Quantitatively, the reported revenue figures ($252M to $627M) and implied YoY growth (~149%) are accurate. The claim that the new-product portfolio grew 77% in 2023 due to Opdualag is consistent with the cited pages and supports the revenue trajectory argument. Only minor point: the ground truth does not mention Opdualag or its revenue, so while the data is correct, it adds specificity beyond the original answer—this is a strength, not an error. (3) Multi-hop reasoning is sound: the model connects 2022 approvals and pipeline activity to 2023 strategic shifts and uses financial performance to infer implications for Opdivo’s revenue trajectory. It synthesizes across time, indications, and commercial performance. (4) The answer is semantically equivalent to the ground truth, with added detail (Opdualag revenue) that enhances precision. The conclusion about reversing revenue decline and driving growth is logically supported. One small omission: the ground truth mentions subcutaneous formulation as a strategic lever, which the LLM answer omits. This minor gap prevents a perfect 10 but does not undermine the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 470,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio slipped slightly in value – the fair‑value was $770 million at year‑end 2023 and $765 million at year‑end 2024, a $5 million decline (Table 4.1, Note 4)【page_124】.  The maturity mix stayed almost entirely short‑term: in 2023, $768 million was due within one year and $2 million in the 1‑to‑5‑year window (no holdings beyond five years)【page_120】; in 2024, $764 million was due within one year and $1 million in the 1‑to‑5‑year window, again with no longer‑dated bonds【page_126】.  Thus, the portfolio remained heavily weighted to the near‑term, with only a modest $1 million shift out of the 1‑5‑year bucket and a $5 million drop in fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2023 American Express held $549 million in foreign government bonds, not $770 million as stated in the LLM answer. The LLM incorrectly claims a decline in fair value from $770M to $765M, whereas the actual fair value increased significantly from $549M to $765M. This is a critical error in both direction and magnitude. Additionally, the LLM misrepresents the 2023 maturity distribution: it claims $768M matured within one year, but the ground truth states that *all* $549M matured in 12 months or more (i.e., *after* one year), which is the opposite of short-term. The 2024 data is partially correct: $764M maturing within one year and $1M in 1-5 years aligns with the ground truth. (2) Calculations are flawed: the LLM computes a $5M decline based on incorrect base values. The actual change is an increase of $216M ($765M - $549M), which the LLM completely misses. (3) Multi-hop reasoning fails: the question asks for evolution between 2023 and 2024 in terms of fair value and maturity distribution. The LLM incorrectly characterizes the 2023 portfolio as short-term when it was entirely long-term, failing to identify the dramatic shift from long-term in 2023 to short-term in 2024—a key insight in the ground truth. (4) Despite using correct entities (American Express, foreign government bonds, fair value, maturity buckets) and addressing the time frame, the severe numerical and directional errors undermine the answer’s validity. Contextual relevance is moderate because the structure and intent align with the question, but factual correctness is very low. Quantitative accuracy is poor due to wrong numbers and mischaracterized trends. Qualitative accuracy is low due to flawed synthesis and reasoning, though the 2024 data is mostly correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 502,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "In fiscal 2022 Walmart said roughly $4.3 billion of cash and cash equivalents could not be freely transferred to the U.S.; about $2.2 billion of that amount could be accessed only through dividends or inter‑company financing that required approval of Flipkart’s minority shareholders【page_60】. By fiscal 2024 the restricted balance had fallen to about $3.5 billion, and the company now describes the limitation more generally as arising from local laws or other restrictions and, where applicable, requiring approval of non‑controlling‑interest shareholders rather than a specific Flipkart consent【page_43】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2024 restricted cash amount as $3.5 billion, while the ground truth states $3.3 billion. This $0.2 billion discrepancy affects precision but does not alter the overall trend of a slight decrease. All other numbers are accurate — the 2022 figure of $4.3 billion and the $2.2 billion tied to Flipkart minority shareholders are correctly reported. (2) The qualitative analysis is strong: the LLM correctly identifies the shift from Flipkart-specific shareholder approval to a broader condition involving non-controlling-interest shareholders and local laws. This reflects accurate synthesis of evolving intercompany financing conditions. (3) The multi-hop reasoning is sound — the model compares two fiscal years, identifies changes in both the amount and the governing conditions of restricted cash, and infers a structural shift in financing arrangements. (4) Contextual relevance is excellent, as all parts of the question (evolution over time, amount not freely transferable, transfer conditions) are addressed with appropriate detail and sourcing. The minor numerical error prevents a top score in quantitative accuracy, but reasoning and completeness remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 357,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "In 2023 the U.S. Retiree Health Care Plan held about $210 million in fixed‑income securities (including cash) and $54 million in equity securities (≈79.5 % vs 20.5 %)【page_47】. By the 2024 filing those balances had slipped to roughly $198 million in fixed‑income and $50 million in equity (≈79.8 % vs 20.2 %)【page_46】, a modest decline in both categories that left the overall mix essentially unchanged at roughly an 80/20 split.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the asset allocations for Texas Instruments' U.S. Retiree Health Care Plan were identical in 2023 and 2024: $210 million in fixed income and $54 million in equity securities, with no change in amounts or percentages. The LLM incorrectly states that by 2024, fixed income declined to $198 million and equity to $50 million, which contradicts the ground truth. These numbers are not supported by the original data. (2) The percentages cited in the LLM answer (79.8% vs 20.2%) are miscalculated based on its own incorrect figures—$198M / $248M ≈ 79.8%, but $50M / $248M ≈ 20.2%, so the math on the fabricated numbers is correct, but the inputs are wrong. The original answer confirms that 79.5% and 20.5% are accurate for both years based on $210M and $54M of a $264M total. (3) The multi-hop reasoning fails because the model did not recognize that the asset composition was unchanged between the two years, which is the key point of the original answer. Instead, it fabricated a minor decline, undermining the correct conclusion that the allocation strategy remained stable. (4) Contextual relevance is high because the answer addresses the right plan, company, and asset categories, and attempts to compare years and compute percentages. However, the factual inaccuracies in dollar amounts and the false suggestion of a shift in allocation severely undermine correctness and quantitative accuracy. The qualitative reasoning is partially sound in structure but based on incorrect data, hence low scores on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 453,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2006 Stock Plan for Non‑Employee Directors was described as providing both a **Form of Stock‑Option Award Agreement** and a **Form of Restricted‑Unit (RSU) Agreement** (see Exhibit list on page 126). By the 2024 Form 10‑K the exhibit list references only the **Form of Stock‑Option Award Agreement** (and its omnibus amendment) with no RSU form mentioned (see Exhibit list on page 123). This change indicates that Honeywell has removed the RSU component for non‑employee directors, concentrating their equity compensation on stock‑option awards, likely to simplify the plan and align director pay more directly with share‑price performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, both the Form of Stock-Option Award Agreement and the Form of Restricted-Unit (RSU) Agreement were included in the 2006 Stock Plan for Non-Employee Directors, citing the correct context from the 10-K exhibit list. By 2024, it accurately notes that only the stock option form remains, with no mention of the RSU agreement. (2) There are no numeric values requiring calculation, but the years (2022, 2024) and exhibit references (though page numbers differ slightly—126 vs. 123) are consistent with typical variations across filings and do not affect factual accuracy. (3) The multi-hop reasoning—comparing the exhibit lists across two years to infer a change in award types—is sound and correctly executed. The conclusion that Honeywell may be shifting toward stock options over RSUs is logically supported. (4) The LLM adds a plausible interpretation (simplification and alignment with share-price performance) that goes slightly beyond the ground truth but remains reasonable and contextually appropriate, not contradicting any facts. The only minor gap is that the ground truth notes the 2024 Option Agreement is Exhibit 10.29, while the LLM does not specify exhibit numbers—this small omission prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 397,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "In fiscal 2022 Walmart sold a portion of its Flipkart holding, receiving about $3.2 billion in equity funding and cutting its ownership from roughly 83 % to 75 % (page 66). By fiscal 2024 it reversed that trend, spending roughly $3.5 billion to buy back shares and lift its stake to about 85 % (page 65), thereby increasing its financial exposure to Flipkart’s results. The 2024 filing also flags a new regulatory risk – a show‑cause notice from India’s Directorate of Enforcement over alleged foreign‑direct‑investment violations that could lead to monetary penalties or ownership restrictions on Flipkart (page 76).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states that Walmart received $3.2 billion in equity funding in 2022 and reduced its ownership in Flipkart from 83% to 75%, it falsely claims that Walmart reversed this in fiscal 2024 by spending $3.5 billion to increase its stake to 85%. This is incorrect—the ground truth does not mention any such buyback or increase in ownership. Instead, the original answer emphasizes ongoing regulatory risks, not increased financial commitment. The regulatory risk part is partially correct: the show-cause notice from July 2021 (referenced in the 2024 filing) and FDI rule violations are accurately noted, though the timing (2009–2015, pre-acquisition) is omitted. (2) Quantitative accuracy fails on key points: the $3.5 billion buyback and 85% ownership are entirely fabricated. Only the $3.2 billion and 83% to 75% reduction are correct. (3) Multi-hop reasoning is flawed: the model incorrectly infers a strategic reversal (buyback) with no evidence, misrepresenting Walmart’s evolving position from partial exit to recommitment, contrary to the ground truth of shifting from financial participation to managing legacy regulatory risks. (4) Contextual relevance is moderate—some elements (regulatory scrutiny, ownership change in 2022) are relevant, but the overall narrative is misleading due to the invented buyback, undermining the answer’s correctness. The core evolution described in the original—reduced stake and growing regulatory exposure—is distorted by the false claim of stake increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 433,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "In the 2022 filing Honeywell noted that it held $11.5 billion of U.S. cash and cash equivalents (including short‑term investments) and emphasized that safety of principal was its primary objective, with secondary focus on yield and diversification across counterparties (page 41). By year‑end 2024 the U.S. cash balance had slipped modestly to $11.0 billion, while cash held in non‑U.S. subsidiaries grew to $8.0 billion—lifting total cash to roughly $19 billion and reflecting a shift toward a more globally diversified liquidity pool, though the safety‑first, yield‑second strategy remained unchanged (page 39).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers and misrepresents the total cash holdings. The original answer states that HON had $11.5 billion in cash as of December 31, 2021 (reported in the 2022 filing), not $11.5 billion of U.S. cash in 2022. The LLM incorrectly interprets this as U.S.-held cash, when the ground truth does not specify geographic distribution for 2022. Furthermore, the LLM claims total cash rose to $19 billion by 2024 ($11.0B U.S. + $8.0B non-U.S.), which is completely incorrect—the actual total cash in 2024 was $11.0 billion, of which $8.0 billion was held in non-U.S. subsidiaries. This results in a gross overstatement of total cash. (2) Quantitative accuracy is severely compromised: the LLM invents a total cash figure of $19 billion with no basis in the ground truth. It also misattributes the $11.5 billion figure to 2022 when it refers to year-end 2021. While the $8.0 billion non-U.S. and $11.0 billion total 2024 figures are correct, the incorrect addition and geographic labeling undermine accuracy. (3) The multi-hop reasoning fails because the model does not correctly synthesize the timeline or geographic breakdown. It assumes $11.5B is U.S.-only in 2022 and constructs a false comparison with 2024, leading to an erroneous conclusion about growth in total cash and increased global diversification. The actual evolution reflects a slight decrease in total cash ($11.5B to $11.0B) and a shift in geographic allocation within that same total range, not an increase to $19B. (4) Contextual relevance is moderate because the answer addresses cash composition and strategy, but the severe quantitative and factual errors drastically reduce correctness. The strategic emphasis on safety and diversification is correctly noted, but this does not compensate for the core financial inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 502,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "In 2023 the company reported a separate “Deferred card and other fees, net” line that explicitly included deferred Membership Rewards fees, and it measured the Membership Rewards liability by applying a weighted‑average cost per point (WAC) and an Ultimate Redemption Rate (URR) – both derived from 12 months of redemptions and statistical/actuarial models of redemption trends, product type, tenure, spend and credit attributes【page_128】. By 2024 the deferred‑fees line is no longer shown; those costs are now folded into the Membership Rewards liability, and the liability model has been refined to show the dollar impact of small changes in the URR and WAC (e.g., a 25‑bp URR increase adds $197 million and a 1‑bp WAC increase adds $220 million), while still relying on the same URR‑and‑WAC assumptions based on 12‑month redemption data and actuarial modeling【page_86】. This reflects a shift from a distinct deferred‑fee presentation to a more integrated, sensitivity‑driven liability estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the shift from a standalone deferred fees line in 2023 to an integrated liability presentation in 2024, continued use of URR and WAC, and the sensitivity impacts of a 25-basis point URR increase ($197M) and a 1-basis point WAC increase ($220M) are all correctly reported. (2) Quantitative accuracy is perfect: all dollar amounts and basis point changes match the original answer exactly, and no calculation errors are present. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers an evolution in presentation and methodology between the two years, noting both the removal of the deferred fees line and the enhanced disclosure of sensitivity analysis. (4) The only minor discrepancy is that the original answer emphasizes the 2023 disclosure as focusing on 'deferred fees' without explicitly stating that URR and WAC were already in use that year; the LLM claims the 2023 model already used URR and WAC based on actuarial modeling, which may slightly overstate the sophistication described in the ground truth for 2023. However, since the LLM cites a specific page (128) and the ground truth does not contradict the use of these models in 2023, this is a reasonable interpretation. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 389,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "In the 2022 filing Adobe noted that it had just completed the October 2021 acquisition of Frame.io and was beginning to fold the cloud‑based video‑collaboration platform into its Digital Media segment as a new capability (2022 10‑K p.41‑42). By the 2024 filing, Frame.io is described as a core, cloud‑native collaboration hub that is directly integrated into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and is offered through Adobe GenStudio together with Firefly AI services—positioning it as a cross‑app, AI‑enabled engine that underpins Adobe’s broader Creative Cloud ecosystem (2024 10‑K p.12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was acquired in October 2021 (not 2022, but the answer correctly references the 2022 filing discussing the post-acquisition integration), integration began under the Digital Media segment in 2022, and by 2024 it was positioned as a core collaboration hub. The inclusion in Adobe GenStudio and integration with Premiere Pro, After Effects, Photoshop, Workfront, and Lightroom are all correctly stated. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts are cited (the $1.18B acquisition cost is omitted but not claimed, so not an error). The timeline (2022 vs 2024 filings) is accurately used. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years of filings to show evolution in strategic positioning. The shift from 'new capability' to 'core, cloud-native collaboration hub' reflects correct qualitative interpretation. (4) Minor deduction in qualitative accuracy because the answer mentions Lightroom integration, which is not in the original answer—this is a plausible addition but not confirmed in the ground truth. Also, 'AI-enabled engine' and 'Firefly AI services' are not mentioned in the original, suggesting slight over-enrichment. However, these do not contradict the truth and fit Adobe's broader strategy. Overall, the answer captures the evolution accurately and contextually, earning high marks for relevance and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "In 2022 the equity‑like private‑alternative funds were measured at Level 3 for $25.4 million in the defined‑benefit pension plan and $2.4 million in the retiree‑health plan (total ≈ $27.8 million)【page_99】. In 2023 the Level 3 amount fell slightly to $25.1 million for the pension plan while the retiree‑health portion stayed at $2.4 million (total ≈ $27.5 million)【page_98】, indicating the composition of equity‑like funds measured with significant unobservable inputs was essentially unchanged, with only a modest $0.3 million reduction.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both numbers and conclusion compared to the ground truth. The original answer states that equity-like funds under private alternative investments measured at Level 3 were $5.5 million in 2022 and increased to $25.4 million in 2023 — a fivefold increase. In contrast, the LLM claims the 2022 Level 3 value was $27.8 million (sum of $25.4M + $2.4M) and remained nearly unchanged in 2023 at $27.5 million. These figures do not match the ground truth in magnitude or trend. (2) The quantitative inaccuracies are severe: the LLM incorrectly adds values across different plans (pension and retiree health), misidentifies which funds are being discussed, and reports a total that is ~5x higher than the correct 2022 value. Furthermore, the LLM states that the Level 3 amount was $25.4 million in 2022, which contradicts the ground truth where $25.4 million is the 2023 value. This suggests a complete reversal of the timeline and misattribution of data. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of equity-like private alternative investments using Level 3 inputs over time, the LLM conflates multiple funds and plans not mentioned in the original answer, introducing entities (e.g., retiree-health plan) that were not part of the question’s scope. There is no evidence of correct synthesis across years or categories. (4) The conclusion — that the composition was 'essentially unchanged' — is directly opposite to the ground truth, which correctly identifies a significant fivefold increase. While the LLM attempts to address fair value changes using Level 3 inputs over time, its use of incorrect data sources and erroneous aggregation renders the response factually wrong. Minor contextual relevance is retained as it discusses Level 3 fair value measurements in private alternatives, but the specifics are invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 514,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "In the 2022 Form 10‑K Adobe reported that it had acquired Frame.io in October 2021 and was “beginning to integrate Frame.io into our Digital Media segment.” By the 2024 filing, Frame.io is described as a cloud‑native creative‑collaboration platform that is directly embedded in Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and Adobe GenStudio, showing that the service has moved from an initial integration to a fully‑integrated, cross‑app component of Adobe’s Digital Media portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Frame.io was acquired in October 2021, integration began in 2022, and by 2024 it was deeply embedded in Adobe's Digital Media offerings. The timeline and integration status are correctly represented. (2) Quantitative accuracy is perfect: the acquisition date (October 2021) is correctly cited, and no numerical errors are present. (3) The multi-hop reasoning is sound—comparing the 2022 and 2024 10-K filings to show evolution in integration status. The LLM correctly infers progression from 'beginning to integrate' to 'fully-integrated, cross-app component.' (4) Minor deduction in qualitative accuracy due to the phrase 'fully-integrated' not appearing in the original answer—ground truth says 'core part' and 'deeper ecosystem embedding,' which is slightly more nuanced. However, this does not constitute a factual error. All integrated applications (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio) are correctly listed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 324,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "In 2022 CVS’s medication‑management model was built around a few core clinical services—Pharmacy Advisor and Drug Savings Review—delivered through digital, phone and in‑person outreach and a digital‑connectivity platform that gave members visibility of lower‑cost alternatives (2022, page_10; 2022, page_12; 2022, page_13). By 2024 the company layered those services with a broader, data‑driven suite of tools, including the Health Engagement Engine and AI‑enabled analytics that turn prescription data into real‑time adherence interventions, the NovoLogix online pre‑authorization tool, an integrated claim‑adjudication architecture, and a new CVS Weight Management program for GLP‑1 therapies—all aimed at tighter adherence monitoring and greater cost efficiency (2024, page_10; 2024, page_11; 2024, page_9).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of evolution from 2022 to 2024, capturing the shift toward more integrated, data-driven medication management. Quantitatively, there are no errors: no specific numbers (e.g., dollar amounts, percentages, or center counts) are misstated, and all referenced years (2022, 2024) are accurate. The LLM correctly identifies key 2024 digital tools such as NovoLogix and mentions GLP-1 integration via the CVS Weight Management program, which matches the original answer. It also references AI-enabled analytics and real-time interventions, consistent with the 'enhanced analytics' and digital focus in the ground truth. However, the LLM omits mention of Oak Street Health and the expansion to 239 primary care centers across 27 states—a significant multi-hop element involving integration of value-based care into medication management. While it references 'Health Engagement Engine' and 'integrated claim-adjudication architecture' not in the original, these are plausible interpretations of CVS’s digital evolution and do not contradict known facts. The core reasoning is sound: it correctly synthesizes a shift from cost-containment (formulary management, generics) to proactive, digitally enabled care. The omission of Oak Street Health and specific clinical infrastructure reduces completeness on the multi-hop dimension, but the central narrative of digital and clinical evolution remains accurate and contextually relevant. Hence, a score of 8 is justified—strong factual alignment with minor gaps in entity completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 437,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "By 2022 Adobe was still in the early stages of weaving Frame.io into Creative Cloud – the 2022 filing notes that after the October 2021 acquisition the company was “more deeply integrating and enhancing Frame.io’s review and approval capabilities in Premiere Pro and After Effects” to create a native collaborative video‑editing platform【page_6】. By the 2024 filing Frame.io had become a core, cloud‑native collaboration hub across the entire Creative Cloud suite, now “directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom and Adobe Workfront” and available in Adobe GenStudio, with added features such as real‑time upload, frame‑accurate commenting, annotations, Camera‑to‑Cloud automatic footage ingest and support for still images, design files and PDFs【page_12】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (context for 2022 integration), and by 2024 it had evolved into a broader collaboration platform. The timeline (2022 early integration, 2024 expanded role) is correctly represented. (2) No numeric values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised; dates (2022, 2024) are accurate. (3) Multi-hop reasoning is sound: the answer synthesizes the evolution over time (2022 → 2024), identifies the correct applications integrated (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), and lists specific feature enhancements (real-time upload, frame-accurate commenting, annotations, Camera-to-Cloud, support for still images, design files, PDFs). (4) The LLM adds minor details not in the original (e.g., 'frame-accurate commenting', 'annotations', 'Adobe GenStudio') that are consistent with the direction of integration and do not contradict the ground truth; these can be seen as reasonable elaborations. The core narrative — evolution from video-specific tool to cloud-native creative collaboration hub across Creative Cloud — is fully aligned. All aspects of the question (evolution from 2022–2024 and specific collaboration enhancements) are addressed comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 387,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "In the 2023 filing the firm only pointed to “recently executed transactions” when pricing market‑based securities – for example, state‑ and municipal‑bond valuations were based on “recently executed transactions, market price quotations or pricing models” (2023 p. 98) and corporate‑bond fair values were similarly derived from recent trades (2023 p. 99). By the 2024 filing the firm had expanded that practice: the fair value of corporate loans and lending commitments is now explicitly determined using “recently executed transactions, market price quotations … and proprietary valuation models” (2024 p. 99), and non‑recurring fair‑value adjustments for loans and for other assets such as “Other assets‑Other investments” also rely on recently executed transactions (2024 p. 103). This shows a shift from using transaction data mainly for securities in 2023 to making it a primary input for loan and other‑asset fair‑value measurement in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual claims and accurately reflects a shift in the use of recently executed transactions from 2023 to 2024, with proper citation of document pages and financial instruments. Quantitatively, there are no errors—no numerical inaccuracies in dates, amounts, or references. The citations to pages (2023 p. 98, 2024 p. 99, etc.) align with the expected sourcing, and the evolution in language usage is correctly noted. However, there is a subtle but important discrepancy in the characterization of the evolution: the original answer states that in 2023, recently executed transactions were already used for corporate loans and contingent lending commitments, whereas the LLM claims they were used only for market-based securities like municipal and corporate bonds. This misrepresents the scope of 2023 usage, incorrectly narrowing it to securities only. In contrast, the ground truth indicates broader application in 2023 that included loans. The LLM then overstates the shift in 2024 by framing it as an 'expansion' or 'shift' to loans, when the actual evolution was a refinement and extension into held-for-sale loans and other investments, not a new application. Thus, while the LLM captures the directional trend and provides relevant examples, it mischaracterizes the baseline in 2023, leading to an inaccurate narrative of expansion. The reasoning is partially sound but flawed in synthesis across years. Contextually, the answer is highly relevant and well-structured, addressing the evolution question directly with supporting evidence. Semantic equivalence is mostly preserved but not fully achieved due to the misrepresentation of 2023 practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 460,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe only listed “Substance 3D Stager” among its trademarks (see 2022 page 105), with no discussion of how it fit into its product portfolio. By the 2024 filing Adobe describes Substance 3D Stager as one of several desktop apps that together form the “Adobe Substance 3D Collection” – an integrated ecosystem that includes Painter, Sampler, Designer, Modeler and a shared 3‑D assets library, positioning Stager as a core, collaborative component of the broader Substance 3D suite (see 2024 page 12). This reflects a shift from a standalone‑product reference to an explicit, integrated role within a unified 3‑D workflow ecosystem.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately reflects that in 2022, Substance 3D Stager was only mentioned as a trademark (page 105 of the 2022 10-K), with no elaboration on its role—consistent with the ground truth. By 2024, it correctly states that Adobe positioned Stager as part of the 'Adobe Substance 3D Collection' (page 12 of the 2024 10-K), integrated with Painter, Sampler, Designer, and Modeler, and highlights the shift from standalone product to integrated ecosystem component. (2) All dates (2022, 2024), document types (Form 10-K), and page numbers (105, 12) are factually accurate and correctly attributed. No numerical calculations were required, but references to filing years and pages are precise. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of filings to identify a strategic evolution in product positioning. It connects the absence of functional detail in 2022 with the explicit integration narrative in 2024, demonstrating valid cross-document inference. (4) The answer addresses all aspects of the question—evolution over time and positioning within the broader ecosystem—and uses slightly more specific details (e.g., 'shared 3D assets library', 'desktop apps') that are consistent with and enrich the ground truth without introducing inaccuracies. Wording differs but meaning is preserved and accurate. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 407,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "In the 2022 filing GE noted that deep‑decarbonisation “is likely to depend … on technologies that are not yet deployed … such as **grid‑scale batteries** or other storage solutions” (2022 p. 64), positioning batteries as a future option rather than a current core asset. The 2023 filing repeats the same view, again listing **grid‑scale batteries** among emerging technologies that “may become more important over time” (2023 p. 29), indicating that GE’s reliance on batteries has not increased – they remain a prospective, not a central, part of the company’s energy‑transition strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its interpretation of GE's strategic evolution regarding grid-scale batteries from 2022 to 2023, despite correctly citing the filings and using accurate page numbers and quotes. The original answer (ground truth) identifies a meaningful shift in language and strategic framing: in 2022, grid-scale batteries were mentioned as part of a set of emerging technologies that 'may become more important over time'—a speculative, peripheral role. By 2023, GE elevated their importance by stating decarbonization goals would 'depend in part' on such technologies, signaling increased strategic reliance and integration into the core energy transition strategy. The LLM answer incorrectly claims that the 2023 filing 'repeats the same view' and that reliance has not increased, which contradicts the ground truth. This misrepresents the qualitative shift in strategic positioning. While all cited quotes, years, and page numbers are accurate (hence full marks for quantitative accuracy), the reasoning fails to detect the nuanced but significant change in language that indicates a shift from speculative interest to strategic dependency. This is a critical failure in multi-hop qualitative reasoning, as the model must compare and interpret evolving strategic narratives across years. Contextual relevance is high because the answer addresses the right documents, timeframe, and topic, but the conclusion is substantively flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 401,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "In the 2022 Form 10‑K CVS disclosed that, for the years ended 2021 and 2020, “the Company did not have any broker quoted debt securities” when valuing its Level 3 debt securities【page_148】. The 2024 Form 10‑K repeats the same statement—now referring to 2024 and 2023—and again notes that “the Company did not have any broker quoted debt securities” for those periods【page_146】. Thus, the disclosure has only been updated to reflect the newer reporting years; the substance remains unchanged, indicating that broker‑quoted debt securities have continued to be absent and have had no impact on CVS’s fair‑value measurements or financial reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: CVS disclosed in both 2022 and 2024 that it had no broker quoted debt securities for the respective prior years (2021/2020 in 2022; 2023/2024 in 2024), and this consistency indicates no impact on fair value measurements. The quantitative accuracy is perfect—dates, years, and the absence of securities are correctly reported with proper citation to the 10-K pages. However, the LLM misses a key qualitative nuance present in the original answer: the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, which suggests a reduced emphasis over time. This evolution in tone and detail is an important part of the 'evolution' asked in the question, and its omission limits the depth of the reasoning. While the core facts and timeline are accurate, the failure to note the change in disclosure emphasis prevents a top score. The answer remains highly relevant and correctly synthesizes information across two filings, but the multi-hop reasoning is slightly incomplete without addressing the shift in narrative focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 323,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "In 2023 BlackRock’s equity securities at FVTNI consisted of $1.585 billion of equity securities/mutual‑fund holdings and $2.756 billion of equity‑method investments (≈$4.34 billion total) (page_87). By 2024 the equity‑securities/mutual‑fund component had risen to $1.950 billion and equity‑method investments to $2.783 billion (≈$4.73 billion total) (page_94), so the direct equity‑securities portion grew by about $365 million (≈23 %) while equity‑method holdings increased only $27 million (≈1 %).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2023 values. According to the ground truth, in 2023, BlackRock reported $1,211 million (not $1,585 billion) in equity securities/mutual funds and $1,895 million (not $2,756 billion) in equity method investments. The LLM's figures are off by hundreds of millions, which severely undermines quantitative accuracy. The 2024 values are correct: $1,950 million for equity securities/mutual funds and $2,783 million for equity method investments. (2) Calculations based on incorrect 2023 numbers are therefore also wrong: the LLM reports a $365 million increase in equity securities/mutual funds (correct increase is $1,950M - $1,211M = $739M), and a 23% growth rate (actual is ~61%). The equity method investment increase is reported as $27 million (correct value is $2,783M - $1,895M = $888M), with 1% growth (actual ~47%). These miscalculations stem from incorrect base values. (3) The reasoning structure is sound—LLM attempts multi-hop comparison across years and categories, correctly identifying the direction of change and attempting percentage analysis—but the synthesis is based on erroneous source data, undermining the qualitative accuracy. (4) Contextual relevance is high: the answer addresses both components of the question (equity securities/mutual funds and equity method investments) and compares them across 2023 and 2024 with proper context and citation. However, due to major numerical inaccuracies in the foundational data, the correctness score is low despite good structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 435,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "In the 2022 Form 10‑K UnitedHealth said it reviews every available‑for‑sale debt security when fair value falls below amortized cost, weighing expected cash‑flows, the issuer’s credit quality and other events; the unrealized losses it reported were $274 million (primarily from interest‑rate moves) and the allowance for credit losses on those securities was disclosed as “not material.” The 2024 filing describes the same evaluation criteria—present‑value of expected cash flows, fair‑value versus cost, and issuer credit health—and still records any credit‑related impairment as an allowance (offset to investment and other income), but again provides no material allowance amount, indicating that the treatment and the immaterial nature of the allowance have not changed.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative evolution described in the ground truth. (1) Quantitatively, the $274 million unrealized losses figure is accurate and correctly attributed to interest rate movements, and the 'not material' allowance is consistent with the original answer. However, the ground truth does not specify the exact dollar amount of unrealized losses in 2022—this figure ($274M) is correct per external data but was not present in the provided ground truth, so its inclusion introduces unverified precision. (2) The LLM correctly identifies that both 2022 and 2024 evaluations use similar criteria (expected cash flows, issuer credit, fair value vs. cost), which aligns with the ground truth. (3) However, the critical qualitative evolution—that by 2024, UnitedHealth Group explicitly structured credit-related impairments through a separate allowance account, indicating a more formalized framework—is downplayed. The LLM states the treatment 'has not changed' and that 'no material allowance amount' is provided, which contradicts the ground truth’s emphasis on a shift toward more structured recognition. This misrepresents the evolution in accounting practice. (4) While the LLM captures the immateriality of the allowance and consistent assessment factors, it fails to acknowledge the procedural shift from qualitative low-risk assessment to formal allowance accounting, which is central to the question. Thus, despite strong contextual relevance and mostly accurate entities and metrics, the answer lacks key reasoning synthesis, resulting in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 441,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "AMD’s equity‑method investment in the ATMP joint venture grew from about **$83 million at year‑end 2022 to roughly $99 million at year‑end 2023**.  In the same period the share of the JV’s earnings reported as **equity income rose from $14 million in 2022 to $16 million in 2023**【page_78】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of AMD's investment in ATMP JV increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million—both figures exactly match the original answer. Minor phrasing like 'about' and 'roughly' does not detract from accuracy as the values are clearly presented as precise. (2) The answer is complete, addressing both parts of the question: evolution of investment value (carrying value) and equity income over the two years. (3) Entity accuracy is correct—AMD, ATMP JV, and the financial metrics (carrying value, equity income) are properly identified with correct years (2022 and 2023). (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers growth in both investment value and income, indicating a strengthening financial relationship, even if not explicitly stated. The citation [page_78] suggests grounding in source material. (5) Semantically, the LLM conveys the same information as the original answer, with equivalent phrasing and no omissions or distortions. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 346,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth’s tort‑claim exposure continues to stem from medical‑malpractice and other professional‑liability suits tied to the delivery of health‑care services. In the 2022 filing the company warned that it is largely self‑insured, that many actions involve large claims and significant defense costs, and that actual losses could exceed the reserves recorded. By the 2024 filing the disclosure adds that new liability theories and the absence of damage caps are driving larger and more frequent claims, reinforcing that the potential financial impact remains uncertain and could materially exceed the amounts set aside.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of UnitedHealth Group's tort claim exposure and correctly identifies key elements from both the 2022 and 2024 filings. It accurately notes the self-insured status, the risk of losses exceeding reserves, and the increasing severity of claims due to new liability theories and lack of damage caps—details present in the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and the years (2022, 2024) and entities (UnitedHealth Group, tort claims, medical malpractice) are correctly identified. However, the LLM answer misses a key qualitative shift emphasized in the ground truth: the evolution from a focus on medical malpractice in 2022 to broader clinical quality, patient safety, and reputational risks in 2024. The original answer highlights a systemic expansion of risk beyond financial exposure to include reputational harm and business relationship impacts—nuances not captured in the LLM response. While the LLM mentions 'new liability theories' and 'larger and more frequent claims,' it does not reflect the broadening in the nature of claims (from malpractice to standards of care). This omission reduces completeness and qualitative accuracy, though the core financial and legal exposure is correctly conveyed. Contextual relevance remains high as the answer directly addresses the evolution of tort claims and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 393,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Boeing’s three‑year revolving credit facility has not changed – the 2023 filing notes a “legacy three‑year revolving credit agreement expiring in August 2025, which consists of $3.0 billion of total commitments” and that the company had $10.0 billion of unused borrowing capacity 【page_43】. The 2024 filing confirms that the same $3.0 billion three‑year facility remains in effect (still expiring August 2025) and that “we had $10.0 billion available under credit line agreements” 【page_94】. By keeping this $3 billion back‑up line unchanged while terminating the short‑term and older five‑year facilities and adding a new $4 billion five‑year facility, Boeing is preserving a stable liquidity cushion and actively reshaping its credit portfolio to maintain flexibility and optimize financing terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion legacy three-year revolving credit agreement expiring in August 2025, present in both 2023 and 2024 filings, and accurately notes the new $4.0 billion five-year facility established in 2024 expiring in May 2029. It also correctly states that Boeing terminated other credit facilities, aligning with the ground truth. The only minor omission is that the LLM does not explicitly name the terminated facilities as 'two other credit facilities' (though it refers to terminating 'short-term and older five-year facilities'), which slightly weakens completeness but does not affect factual correctness. (2) All numeric values—$3.0 billion, $4.0 billion, August 2025, May 2029—are accurate and match the ground truth. The mention of $10.0 billion in unused capacity is consistent with the filings and supports the narrative of available liquidity, though this figure is a sum across agreements and not part of the core structural evolution; its inclusion is contextually appropriate but not central. (3) The multi-hop reasoning is sound: the model synthesizes data from both 2023 and 2024 filings, recognizes the continuity of the legacy facility, identifies the addition of the new facility, and infers the strategic intent behind the changes. The conclusion about Boeing preserving a stable liquidity cushion and reshaping its credit portfolio for flexibility and optimized terms is logically supported and semantically equivalent to the ground truth’s interpretation. (4) The answer is highly relevant, directly addressing how the structure and capacity evolved and what it indicates about liquidity strategy. The slight deduction in qualitative accuracy is due to the less precise description of the terminated facilities, but overall, the response is factually robust, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 508,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "In 2023 the company reported that the 2017 performance‑based options that vested had a total grant‑date fair value of **$56 million** and that the options exercised that year delivered an **aggregate intrinsic value of $44 million**【page_101】. In 2024 the next tranche of those awards vested with a slightly lower fair‑value amount of **$52 million**, but the options exercised generated a far larger **intrinsic value of $373 million**【page_109】. Thus, the fair‑value of vested options fell modestly (‑$4 million) while the intrinsic value of exercised options surged dramatically (up $329 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The fair value of 2017 Performance-based Options that vested was $56 million in 2023 and $52 million in 2024, and the intrinsic value of options exercised was $44 million in 2023 and $373 million in 2024 — all numbers match exactly. (2) The quantitative calculations are accurate: the decrease in fair value is correctly noted as -$4 million ($56M to $52M), and the increase in intrinsic value is correctly characterized as +$329 million ($373M - $44M), even though not explicitly stated in the original, this inference is valid and precise. (3) The multi-hop reasoning is sound — the model synthesizes data across two years (2023 and 2024) for the same instrument (2017 Performance-based Options), correctly distinguishing between 'vested fair value' and 'intrinsic value of exercised options', which requires understanding of financial terminology and cross-year comparison. (4) The answer is semantically equivalent to the original, with added clarity in framing the change (e.g., 'surged dramatically') that enhances rather than distorts meaning. All entities (2017 Performance-based Options, years 2023 and 2024, financial metrics) are accurately identified and contextualized. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 372,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "In the 2022 Form 10‑K AMD said it estimated the revenue impact of its limited product‑return rights by relying on historical product‑return‑rate data (AMD 2022 10‑K, p. 45). In the 2023 filing the company refined that approach – it now uses “relevant, trended actual historical product‑return‑rate information” and explicitly adjusts those rates for any known events or current economic conditions (AMD 2023 10‑K, p. 49). The change adds a trend analysis and event‑adjustments, making the estimate more forward‑looking and reflective of present circumstances.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AMD used historical return rate data in 2022 and continued with a refined approach in 2023, citing appropriate document locations (2022 10-K p.45, 2023 10-K p.49), which aligns with the ground truth. The description of adding 'trended' analysis and adjustments for known events or economic conditions is consistent with the original answer’s mention of using 'trended actual historical product return rate information, adjusted for known information or events.' However, the LLM answer misses a key qualitative shift emphasized in the ground truth: the explicit alignment with ASC 606-10-32-8 through 14 and the use of the 'most likely amount' method under variable consideration. This is a significant omission because the question asks about evolution in methodology, and the move toward a more structured, standards-based framework (ASC 606) is central to that evolution. (2) There are no numerical values to verify, so quantitative accuracy is not applicable—no errors in dates or document references. (3) The multi-hop reasoning is partially sound: the model correctly compares two years’ disclosures and infers an enhancement in methodology. But it fails to synthesize the deeper accounting standard context (ASC 606), which represents the core of the methodological evolution. (4) While the answer is well-structured and contextually relevant, the absence of the ASC 606 and 'most likely amount' elements—critical to the true evolution—reduces qualitative accuracy significantly, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 436,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 performance‑based options fell from **1,549,080 shares outstanding at 12/31/2023** to **625,825 shares outstanding at 12/31/2024** – a net decline of roughly **923,000 shares**【page_108】.  The drop was driven almost entirely by **905,219 shares being exercised** and only **18,036 shares forfeited** during 2024, indicating that the vast majority of these options were exercised rather than forfeited.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all the key information from the ground truth. (1) Quantitatively, the starting and ending share counts (1,549,080 and 625,825) are correct, as are the breakdowns of exercised (905,219) and forfeited (18,036) shares. However, the net decline is stated as 'roughly 923,000', which is slightly inaccurate—the exact difference is 1,549,080 - 625,825 = 923,255 shares. The sum of exercise and forfeiture (905,219 + 18,036 = 923,255) matches exactly, so the error is only in the rounded summary, not in the component numbers. (2) The answer addresses both parts of the question: the evolution of shares (decrease from 2023 to 2024) and what it indicates (high exercise, low forfeiture, nearing end of lifecycle). (3) Entities—'2017 Performance-based Options', years 2023 and 2024—are correctly identified. (4) The reasoning is sound: the model correctly infers that the drop was due to exercise and forfeiture, and emphasizes that most were exercised, aligning with the ground truth's conclusion about lifecycle completion. The only minor shortcoming is the imprecise 'roughly 923,000' which slightly affects quantitative accuracy, but since all component numbers are correct and the logic holds, the overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 356,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "In the 2022 filing Optum Rx was portrayed as the “full‑spectrum” pharmacy‑care platform that operates a network of more than 67,000 retail pharmacies plus home‑delivery, specialty, infusion and direct‑to‑consumer channels, and that offers a broad suite of clinical programs, digital tools and utilization‑management services to integrate medical and pharmaceutical care through data and analytics (see page_6). By the 2024 filing the segment is framed as a “diversified pharmacy‑care services” business that is scaling rapidly—fulfilling 1.623 billion adjusted scripts in 2024 versus 1.542 billion in 2023—and is driving growth through new and existing clients, cost‑efficiency and supply‑chain initiatives, while being positioned as a core pillar of Optum’s three‑segment model that underpins UnitedHealthcare’s cost‑management and outcomes strategy (see page_32, page_4, page_3).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides relevant qualitative insights into the evolution of Optum Rx's role and strategic positioning between 2022 and 2024, correctly identifying its integration within Optum’s broader ecosystem and its function in cost management and outcomes improvement. It accurately notes the 67,000+ retail pharmacy network and service offerings (home delivery, specialty, infusion) from 2022, aligning with the ground truth. However, the quantitative accuracy is significantly compromised: the LLM introduces specific script volume figures (1.542 billion in 2023, 1.623 billion in 2024) and growth claims that are not present in the original answer or ground truth, which only provided pharmaceutical spending totals ($112B overall, $45B in specialty) for 2022 and no quantitative metrics for 2024. These fabricated numbers constitute major factual errors. Additionally, the ground truth emphasizes the shift toward a 'value-oriented and more connected approach' leveraging data, analytics, and population health—elements not fully reflected in the LLM’s description of 'diversified pharmacy-care services' and supply-chain initiatives. While the LLM captures the strategic importance of Optum Rx within UnitedHealth Group, it misses the deeper thematic evolution toward system-wide performance improvement and integration across clinical domains. The reasoning is partially sound, showing awareness of multi-year evolution, but relies on unsupported metrics. Wording differences are acceptable, but the introduction of unverified data undermines correctness. Contextually, the response stays focused and relevant to the question’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 447,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "In 2023 BlackRock’s equity securities measured at fair value through net income (FVTNI) carried a cost of $1.52 billion and a fair‑value of $1.585 billion, almost entirely Level 1 quoted securities, with only $14 million of that amount representing investments used to hedge deferred cash‑compensation plans (2023 footnote)【page_80】. By year‑end 2024 the portfolio had expanded to a cost of $1.843 billion and a fair‑value of $1.950 billion (still Level 1), and the deferred‑compensation‑plan hedge grew dramatically to $173 million, now recorded at NAV within the equity‑method investments (2024 fair‑value hierarchy)【page_92】【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect quantitative information. The ground truth states that in 2023, BlackRock reported $9 million in Equity Securities at FVTNI related to deferred cash compensation plans. However, the LLM claims this amount was $14 million, which is factually incorrect. The 2024 value of $173 million matches the ground truth and is correctly reported. Additionally, the LLM introduces aggregate portfolio values (e.g., $1.585 billion fair value in 2023, $1.950 billion in 2024) that were not part of the original question or ground truth answer, potentially conflating total equity securities with the specific subset for deferred compensation. (2) The calculation of growth from $14M to $173M is accurate within the LLM's own numbers, but since the baseline $14M is incorrect (should be $9M), the implied magnitude of change is overstated. The reclassification from FVTNI to equity-method investments at NAV is correctly identified and aligns with the ground truth’s claim of a reclassification to 'Investments related to deferred cash compensation plans' under the Equity Method. (3) The multi-hop reasoning is partially sound: the model correctly infers a reclassification based on the movement of the deferred compensation investment from one category to another across years. However, it fails to note that the specific line item disappeared from FVTNI entirely in 2024, instead emphasizing portfolio expansion and valuation changes not required by the question. (4) The contextual relevance is high because the answer focuses on the evolution of the deferred compensation investments and their reporting classification. However, the inclusion of extraneous portfolio totals and the incorrect 2023 figure reduce factual accuracy. The qualitative reasoning is mostly logical but built on a flawed data point. Thus, correctness is penalized primarily for the incorrect $14M vs $9M discrepancy, though the key conclusion about reclassification is supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 540,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Accenture’s remaining buy‑back authority fell from $3.13 billion as of August 31 2022 (​page 93) to $2.69 billion as of August 31 2024 (​page 100) – a drop of roughly $0.44 billion. This decline shows the company has been drawing down its repurchase capacity, using excess cash to buy back shares and return capital to shareholders while still keeping a sizable authorization for future purchases, reflecting a disciplined, shareholder‑focused capital‑allocation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical values for Accenture's share repurchase authorization in 2022 ($3.13 billion) and 2024 ($2.69 billion), which align with the ground truth of $3,129,296 and $2,694,281 respectively (allowing for rounding and format variation). The difference of approximately $0.44 billion is also accurate. Dates (August 31, 2022 and 2024) are plausible and consistent with fiscal year-ends. (2) Quantitative accuracy is high: all numbers are correctly rounded and the calculation of the decrease is sound. (3) However, the qualitative reasoning is flawed. While the ground truth states the decrease indicates a 'reduction in capital allocated for share repurchases' and a 'more conservative approach or strategic shift,' the LLM interprets the decline as evidence of active share buybacks and a 'disciplined, shareholder-focused strategy.' This misrepresents the implication: a declining authorization does not necessarily mean active repurchases are occurring—it may reflect reduced commitment to future repurchases. The LLM incorrectly infers positive shareholder return activity and strategic continuity, whereas the original answer suggests a pullback or strategic change. This reflects a failure in multi-hop reasoning: the model conflates reduced authorization with active capital return, when authorization is capacity, not expenditure. (4) Correctness score is 6 due to accurate numbers but incorrect interpretation. Quantitative accuracy is 9 (minor rounding acceptable). Qualitative accuracy is 5 due to flawed logic and misinterpretation of strategic implication. Contextual relevance is 8 as the answer addresses both parts of the question and stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 468,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "In the 2022 Form 10‑K the company only said that its open‑market repurchase program could “include purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares” (see 2022 p. 43) and that non‑controlling interests reflected the equity held by former leadership in that subsidiary (2022 p. 42), without specifying any repurchase limit or the precise rights of those shares. By the 2024 filing the disclosure is far more detailed: the exchangeable shares may be swapped one‑for‑one for Accenture plc Class A ordinary shares (or cash) and are tied to non‑transferable Class X shares that cannot be redeemed below the holder’s exchangeable‑share balance (2024 p. 100); the board also set a specific $2,694,281 authorization for the open‑market purchase and redemption program that includes these exchangeable shares (2024 p. 100). This reflects a shift from a generic mention of repurchases to a quantified authorization and a clear articulation of voting, dividend and redemption rights for the exchangeable‑share holders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $2,694,281 share repurchase authorization as of 2024 is accurately reported, and the absence of a specific dollar limit in 2022 is correctly noted. The fiscal years (2022 vs 2024) are properly referenced. (2) The answer addresses all parts of the question: evolution in disclosure around share repurchases and shareholder rights. It correctly contrasts the generic 2022 language with the detailed 2024 disclosures. (3) Entities are accurate—Accenture Canada Holdings Inc. exchangeable shares, Accenture plc Class A ordinary shares, and Class X shares are all correctly identified. The one-for-one exchangeability, redemption rights, and structural alignment between share classes are accurately described. (4) The reasoning is sound and reflects proper multi-hop synthesis: it infers increased transparency and structure in the treatment of exchangeable shares over time, based on specific disclosures from two different 10-K filings. Minor wording differences (e.g., 'open-market repurchase program' vs 'cash generated from operations') do not affect factual equivalence—the core evolution from general intent to specific authorization and detailed rights is preserved. Semantic meaning fully aligns with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 369,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The Medical‑Devices segment shows Electrophysiology sales of **$2,195 million in 2023** (US $1,008 m + Intl $1,187 m)【page_53】 and **$2,467 million in 2024**【page_29】.  When the impact of foreign‑exchange is removed, the revenue grew **about 14.4 %** year‑over‑year【page_29】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2023 ($2,195 million) and 2024 ($2,467 million) are accurate, and the percentage change excluding foreign exchange impact (14.4%) is correctly reported. The breakdown of 2023 revenue into US and international components adds up correctly ($1,008M + $1,187M = $2,195M), though not required for the question, showing additional consistency. (2) The percentage change including FX impact is not explicitly calculated in the LLM answer, but the question primarily asks for the change excluding FX, which is correctly provided. The implied total growth (from $2,195M to $2,467M) is (2,467 - 2,195)/2,195 ≈ 12.39%, which rounds to the ground truth's 12.3% — the LLM does not contradict this, and the focus is correctly placed on the non-FX figure. (3) The reasoning is sound: the LLM correctly identifies the relevant metric (Electrophysiology revenue), extracts values for two consecutive years, and reports the FX-excluded growth rate directly from the source. (4) All entities (Electrophysiology Devices, years 2023 and 2024, revenue in USD millions) are accurate and contextually appropriate. The answer is semantically equivalent to the ground truth, with no factual errors, omissions, or misinterpretations. Minor formatting differences (e.g., 'about 14.4%' vs exact 14.4%) do not affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 392,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "In fiscal 2022 Accenture’s equity‑method investment in Duck Creek Technologies – representing roughly 16 % of the company – was carried at $138.9 million, with an estimated fair value of $223.2 million (page 70). By fiscal 2024 the investment had appreciated enough to generate a $253 million gain (recorded in fiscal 2023) that was disclosed as affecting the effective tax rate and diluted earnings per share, showing a markedly higher valuation and a positive contribution to Accenture’s financial performance (page 40).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported carrying value of Accenture's investment in Duck Creek Technologies in fiscal 2022. The LLM states the investment was 'carried at $138.9 million' with a 'fair value of $223.2 million', but the ground truth specifies the investment was valued at $223,166 (approximately $0.223 million), not $223.2 million. This is a discrepancy of over 100,000x and fundamentally misrepresents the scale of the investment. The 16% ownership stake is correctly identified. The $253 million gain in fiscal 2024 is accurately reported and aligns with the ground truth. (2) The quantitative accuracy is severely compromised due to the incorrect valuation figure. While the $253 million gain is correct, the erroneous carrying and fair value amounts undermine confidence in the financial narrative. The claim that the gain was 'recorded in fiscal 2023' is not contradicted by the ground truth, which only specifies the gain was realized by fiscal 2024, so this may be contextually acceptable. (3) The multi-hop reasoning is partially sound: the model correctly identifies the evolution from an equity-method investment to a significant gain realization, and links the gain to financial performance (impact on tax rate and EPS). However, the massive overstatement of the initial investment value breaks the logical chain of valuation growth. (4) Contextual relevance is high—the answer addresses investment valuation changes and financial impact as required. Qualitative accuracy is moderate because the reasoning framework is correct despite the numerical error. Correctness score is 6 due to the core factual error in valuation amount, which is partially offset by correct identification of ownership percentage, gain amount, and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 490,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Union Pacific’s 2023 proxy shows a much larger and more diversified retention pool – the company reported 954,405 retention shares outstanding **and** introduced 366,046 retention units (non‑exercisable awards) into its equity‑compensation plans (see page 75). In the 2022 filing the only retention awards disclosed were traditional retention shares (e.g., 389,207 shares under the 2021 Plan and 1,218,397 shares/stock‑units under the 2013 Plan) with no separate retention‑unit component reported (see page 63). The shift to a bigger, mixed mix of shares and units in 2023 signals that Union Pacific is expanding and diversifying its executive‑retention incentives, emphasizing greater equity participation to better align executives with shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in retention shares from 389,207 in 2022 to 954,405 in 2023 and the introduction of 366,046 retention units in 2023, which aligns with the ground truth. However, it introduces an additional figure—1,218,397 shares/stock-units under the 2013 Plan—not present in the original answer or implied by the ground truth data. This number may be factually present in the filing but was not part of the provided ground truth and distracts from the focused comparison between 2022 and 2023 retention instruments under the relevant plan. This affects quantitative accuracy. (2) The core numbers from the ground truth—389,207 (2022), 954,405 (2023 retention shares), and 366,046 (2023 retention units)—are accurately reported. The LLM correctly notes the absence of retention units in 2022. However, the inclusion of the 1.2M figure from the 2013 Plan introduces extraneous data not required for answering the question and risks misleading the reader about the total scale of retention awards. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift based on the expansion and diversification of retention instruments. It synthesizes changes across years and identifies the significance of introducing non-exercisable retention units. The conclusion about aligning executives with shareholders through greater equity participation is a reasonable interpretation and adds contextual insight consistent with the ground truth’s implication of a refined long-term strategy. (4) The answer is highly contextually relevant, addressing both the compositional change and strategic implication. While the core facts are correct and the reasoning strong, the inclusion of unverified additional data (the 2013 Plan awards) reduces quantitative precision, warranting a score of 8 for correctness—core facts are right, but with a notable overreach in data inclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 521,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife’s GAAP‑based “adjusted earnings” metric was presented the same way in both years – it is a GAAP segment‑performance measure that strips out items that could distort trends, namely (i) market‑volatility effects such as net investment gains or losses, net derivative gains or losses, MRB remeasurement gains or losses and goodwill impairments, and (ii) asymmetrical or non‑economic accounting items such as in‑force reinsurance adjustments, basis‑adjustment amortizations, inflation‑indexed benefit adjustments and losses incurred at contract inception for certain single‑premium annuity business【page_170】. In the 2024 filing the company simply refined the disclosure, explicitly noting that net investment income also excludes equity‑method joint‑venture adjustments and restating the same market‑volatility and asymmetrical exclusions with more detail, but the underlying exclusions have not changed【page_150】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of MetLife's adjusted earnings exclusions between 2023 and 2024. (1) Correctly identifies that MRB remeasurements, in-force reinsurance adjustments, and amortization of intangibles are excluded, and notes the 2024 expansion to include equity-method joint-venture adjustments in net investment income — this matches the ground truth. However, it incorrectly claims that 'the underlying exclusions have not changed' and that the 2024 update was only a 'refinement in disclosure.' This contradicts the ground truth, which states that MetLife *expanded* the scope of exclusions in 2024, particularly around policyholder liability remeasurement gains/losses tied to asymmetrical accounting from in-force reinsurance — a substantive change, not just a disclosure refinement. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; the dates (2023, 2024) are correct, satisfying this dimension. (3) The multi-hop reasoning is flawed: the model fails to recognize that the adoption of LDTI in 2023 was a structural change driving new exclusions, and the 2024 changes were further refinements to the methodology — not merely presentational. The LLM downplays the evolution as disclosure-only, missing the substantive expansion. (4) Contextual relevance is high because the response addresses GAAP guidance, adjusted earnings, market volatility, and asymmetrical accounting — all key themes. However, the conclusion that there was no change in underlying exclusions directly contradicts the ground truth, resulting in a low qualitative and overall correctness score despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 476,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "In the 2022 filing Accenture’s “Industry X” approach to compressed transformations centered on using data‑driven tools—digital twins, AI, IoT, cloud/edge, 5G, advanced robotics and the metaverse—to redesign product design, engineering, sourcing, manufacturing and service (2022 p. 7). By the 2024 filing the playbook had expanded: it now adds generative AI, artificial/virtual reality, advanced automation equipment and a broader focus on capital‑project, infrastructure and end‑to‑end product‑lifecycle services, while still leveraging AI, IoT, digital twins, robotics and the metaverse (2024 p. 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key technologies mentioned in the original answer—digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, metaverse in 2022; addition of generative AI, AR/VR (referred to as artificial/virtual reality), and advanced robotics/automation equipment in 2024—are correctly identified. The expansion into capital projects (plant and asset construction, infrastructure, etc.) is accurately reflected as a broader scope in 2024. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2024), which are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes Accenture’s evolving approach across two filings, identifying both continuity (continued use of AI, digital twins, etc.) and evolution (addition of generative AI, AR/VR, automation hardware, and expanded service scope). (4) Minor phrasing differences exist—'artificial reality / virtual reality' in the original is rendered as 'artificial/virtual reality' in the LLM answer, which is semantically equivalent. The LLM also mentions 'end-to-end product-lifecycle services' not explicitly in the original, but this is a reasonable inference given the context of product design through servicing. One very minor omission: the original specifies 'commercial hardware' development, which the LLM only implies via 'automation equipment'. This slight lack of specificity prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 440,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott’s interest‑rate hedge program stayed essentially unchanged – the company reported $2.2 billion of interest‑rate hedge contracts at December 31, 2023 and the same $2.2 billion at December 31, 2024, still designating them as fair‑value hedges that convert a portion of its fixed‑rate debt to a variable rate and offset changes in the debt’s fair value due to benchmark‑rate movements【page_64†L31-L38】【page_40†L13-L19】.  Thus, between 2023 and 2024 Abbott neither expanded nor reduced the scale of its hedging of fixed‑rate debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the notional amount of interest rate hedge contracts as $2.2 billion for both 2023 and 2024, accurately reflecting the quantitative data from the original answer. It also correctly states that these contracts are designated as fair value hedges and serve to convert fixed-rate debt to variable-rate debt, which aligns with the ground truth. (2) All numeric values—$2.2 billion in both years—are factually accurate and match the original answer; there are no calculation errors. (3) However, the LLM answer omits a key qualitative point present in the original answer: the increase in the average interest rate on long-term debt from 3.6% in 2023 to 3.8% in 2024. This omission means the model fails to fully synthesize the nuance that while hedge notional amounts remained stable, underlying debt or market conditions shifted. This limits the depth of the multi-hop reasoning, as the evolution in risk profile despite stable hedges is not addressed. (4) Despite this omission, the core facts and entities (Abbott, interest rate hedges, $2.2B, fair value hedges, fixed-to-variable conversion) are correct and relevant. The answer is concise and contextually appropriate, but the missing detail about the rising interest rate reduces the completeness and qualitative accuracy slightly. Hence, correctness is high but not full.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 382,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "In the 2023 Form 10‑K MetLife defined Adjusted Earnings as “adjusted revenues less adjusted expenses, net of income tax” (p. 120) and explained that, after adopting the new LDTI standard, the calculation was updated to strip out DAC/VOBA amortization and to exclude fair‑value changes for MRBs, discount‑rate adjustments on certain guarantees, contract‑inception losses for single‑premium business and other asymmetrical accounting items; it also noted that Adjusted Earnings (and its components) are “our GAAP measures of segment performance” (p. 119). The 2024 filing keeps the same basic definition but explicitly calls Adjusted Earnings “the Company’s GAAP measure of segment performance” (p. 150) and provides a more detailed list of exclusions—market‑volatility effects, net investment and derivative gains/losses, MRB remeasurement gains/losses, goodwill impairments, discount‑rate changes and market‑value adjustments—while continuing to use the metric for senior‑management performance evaluation and resource allocation (p. 150, 152).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 update due to LDTI adoption, removal of DAC/VOBA amortization, exclusion of fair value changes for MRBs, discount rate adjustments on annuitization guarantees, and asymmetrical accounting items are all correctly identified. The 2024 refinements—continued use as the GAAP measure of segment performance, expanded and more structured exclusions (market volatility, net investment and derivative gains/losses, MRB remeasurements, goodwill impairments)—are accurately reported. (2) There are no numeric values in this question, so quantitative accuracy is not applicable in the traditional sense, but all dates (2023, 2024) and references (Form 10-K pages) are correctly cited and consistent with the source context. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across two years, links LDTI adoption to the shift in Adjusted Earnings treatment, and traces the evolution from 2023 to 2024 in terms of both definition and exclusions. (4) The only minor shortcoming is that the LLM does not explicitly mention 'inflation-indexed benefit adjustments' or 'non-economic losses from single premium annuity contracts'—specific exclusions noted in the ground truth for 2024—which slightly reduces completeness. However, it does reference 'contract-inception losses for single-premium business' and 'asymmetrical accounting items,' which are closely related. Overall, the answer is semantically equivalent with high precision, minor omissions do not undermine the core correctness. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 450,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "In 2022 Accenture’s board had authorized $3.13 million for its publicly announced open‑market share‑purchase program (and later approved an additional $3 million, bringing total outstanding authority to $6.13 million). That year the company bought about 12.2 million Class A shares – roughly $4.1 million – using open‑market purchases and share‑withholding for payroll‑tax obligations (the latter does not reduce the authorized amount). By fiscal 2024 the board approved another $4 million of authority, raising total outstanding authority to $6.69 million, and the firm purchased about 13.9 million shares (≈$4.5 million) again via open‑market buys and payroll‑tax withholding, showing higher funding and utilization while the acquisition methods remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in numbers and misrepresents the funding and utilization of Accenture's share purchase program. The original answer states that in 2022, the aggregate available authorization was $3,129,296 (approximately $3.13 million), which the LLM correctly approximates. However, the LLM incorrectly claims an additional $3 million was approved, bringing total authority to $6.13 million, and later another $4 million in 2024, totaling $6.69 million—none of which is supported by the ground truth. The original answer does not mention any increase in authorization beyond 2022 or any total funding levels in the millions beyond the initial $3.13 million. Furthermore, the LLM reports purchasing 'about 12.2 million shares – roughly $4.1 million' in 2022 and '13.9 million shares ≈$4.5 million' in 2024, which is implausible given the share price context (implying shares traded for ~$0.34 each), and these figures are not present in the ground truth. (2) The quantitative inaccuracies are severe: the original answer does not provide specific numbers of shares purchased or total dollar amounts spent, nor does it mention board approvals beyond the initial authorization. The LLM fabricates specific share counts and expenditure totals, and incorrectly calculates cumulative authorizations. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that share withholding for payroll tax obligations does not reduce authorized amounts (consistent with the original answer), it incorrectly assumes continuity in methods and growth in funding, whereas the original emphasizes a shift in focus—by 2024, purchases were primarily through withholding and held as treasury shares for employee benefits, not open-market purchases. The LLM misses this key evolution. (4) The contextual relevance is moderate because it addresses funding, authorization, and acquisition methods, but the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning is partially sound but based on fabricated data, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 568,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife continued to record Unit‑linked and FVO securities at **amortized cost** in both years – defined as the original cost reduced by repayments and adjusted for premium amortization or discount accretion (see the footnote on Schedule I, 2023 p. 320 and 2024 p. 320). In the 2024 filing the company added a **fair‑value disclosure** that classifies these securities as Level 3 assets and notes that “the sensitivity of the estimated fair value to changes in the significant unobservable inputs … is similar in nature to that described in the preceding table” (Note 13, 2024 p. 250/247), a detail that was not included in the 2023 filing. Thus, the cost‑basis treatment remained unchanged, while the 2024 filing introduced an explicit discussion of fair‑value sensitivity for Unit‑linked securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in stating that MetLife recorded Unit-linked securities at amortized cost in both 2023 and 2024. According to the ground truth, while amortized cost applied to fixed maturities in 2023, Unit-linked securities were moved into Level 3 fair value measurements in 2024, meaning they were no longer carried at amortized cost but instead valued using significant unobservable inputs. This represents a fundamental shift in valuation methodology that the LLM incorrectly downplays by claiming the 'cost-basis treatment remained unchanged.' The LLM correctly identifies that the 2024 filing introduced new fair value sensitivity disclosures related to Level 3 classification and references unobservable inputs, which aligns with the ground truth. However, it mischaracterizes the coexistence of amortized cost accounting and fair value disclosures as continuity in treatment, when in fact the 2024 approach reflects a substantive change toward a more dynamic, assumption-driven model. The citations to specific pages and notes suggest plausible sourcing, but the interpretation is flawed. Quantitatively, there are no explicit numbers to verify (e.g., dollar amounts, percentages), so the score is based on conceptual accuracy. The reasoning fails the multi-hop requirement to contrast evolving methodologies across years, instead implying consistency where there was a material change. Contextually, the response addresses the right documents and concepts (cost basis, fair value sensitivity, Level 3), making it relevant despite inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 431,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "In fiscal 2022 Broadcom’s market‑based RSUs were granted with a service and a market condition, vesting uniformly over four years and paying out 0 %‑300 % of the grant based on total shareholder return (“TSR”) versus an index group. In fiscal 2023 the company retained those four‑year TSR‑linked RSUs but also introduced a new series of market‑based RSUs that vest over five years and are tied to stock‑price performance milestones, extending the vesting horizon and adding a price‑based performance metric.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key details are correct: in fiscal 2022, market-based RSUs vested over four years with payouts from 0% to 300% based on TSR relative to an index group. In fiscal 2023, the company retained the four-year TSR-linked structure and introduced a new five-year vesting structure tied to stock price performance milestones. (2) Quantitative elements—'0%–300%', 'four years', 'five years'—are correctly reported with no calculation errors. (3) The reasoning correctly synthesizes the evolution across years, identifying both continuity (retention of four-year TSR-based RSUs) and change (addition of five-year price-target-based RSUs), demonstrating sound multi-hop understanding. (4) The answer is fully relevant, directly addressing how the structure and vesting timeline evolved. Minor wording differences (e.g., 'total shareholder return' vs 'total stockholder return', use of em-dashes) do not affect meaning. No factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 295,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "The CECL transition rule moved from a 50 % phase‑in of the $2.4 billion CECL impact in 2023 to a 75 % phase‑in by year‑end 2024, with the final $600 million to be added on January 1 2025 (2023 10‑K p. 80; 2024 10‑K p. 203). During the transition the bank was allowed to add back to regulatory capital the after‑tax “day 1” CECL adoption impact together with a 25 % portion of the cumulative “day 2” allowance increase each year, i.e., the impact was phased in at 25 % per year from 2022‑2024 (2024 10‑K p. 202).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. The ground truth states that the CECL phase-in was at 25% per year from 2022 to 2024, fully completing by December 31, 2024. However, the LLM claims a 50% phase-in in 2023 and 75% by end of 2024, with final addition on January 1, 2025 — which contradicts the uniform 25% annual phase-in over three years (2022–2024). The dollar amounts ($2.4B, $600M) are not mentioned in the original answer and appear to be fabricated or misattributed, as the ground truth does not include any specific monetary figures. (2) Quantitative accuracy is low: the 25% per year rate is correctly mentioned once, but the cumulative application is wrong (should be 25% each year starting Jan 1, 2022), and the final year should be 100% effective by Jan 1, 2025 without a remaining 'addition' — the phase-in ends Dec 31, 2024. The cited dollar figures cannot be verified against the ground truth and introduce false precision. (3) The multi-hop reasoning is partially sound — the model identifies the correct regulatory framework (CECL Transition Election), references 'day 1' and 'day 2' impacts, and correctly notes the 25% annual phase-in mechanism. However, it misapplies the timeline and adds unsupported specifics (dollar amounts, incremental percentages like 50% to 75%), indicating flawed synthesis. (4) Contextual relevance is high because the response addresses the regulatory capital treatment during the phase-in period and attempts to explain the evolution between 2023 and 2024. Despite incorrect numbers, it engages with the right concepts. Overall, the answer is partially correct in mechanism but fails on key facts and calculations, warranting a moderate-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 480,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "In its 2022 Form 10‑K Broadcom listed several Wilmington Trust‑administered indentures that issued senior notes at coupons of 3.137%–4.926% with maturities ranging from 2029 to 2037 (e.g., 3.419% due 2033, 3.469% due 2034, 3.137% due 2035, 3.187% due 2036, 4.00% due 2029, 4.15% due 2032, and 4.926% due 2037)【page_135】【page_136】. The 2023 filing still shows the April 18 2022 indenture and the 4.926% notes due 2037, but adds a supplemental July 12 2024 indenture and a new series of senior notes with higher coupons (5.05%–5.15% and 4.15%–4.80%) maturing between 2027 and 2034, reflecting a shift toward higher‑yield, later‑dated issuances while retaining Wilmington Trust as trustee【page_100】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and dates, particularly regarding the interest rates and timing of note issuances. The ground truth states that in 2022, Broadcom's senior notes under existing indentures included rates from 1.950% to 3.750%, issued under the January 2021 indenture. However, the LLM claims in 2022 Broadcom issued notes with coupons from 3.137% to 4.926%, which misrepresents both the range and origin of these notes. The 4.926% note due 2037 was indeed issued under the April 18, 2022 indenture, which is correctly noted, but the LLM incorrectly implies this was part of 2022 activity without clarifying it was issued in 2022 but reported in the 2023 filing. (2) The LLM incorrectly states that in 2023, new notes were issued with coupons of '5.05%–5.15% and 4.15%–4.80%', but the ground truth specifies only the 4.150% to 4.800% range (due 2028–2034) in October 2024, with no mention of 5.05%–5.15%. This is a major quantitative error. Additionally, the July 12, 2024 indenture is listed as a future date relative to both 2022 and 2023, so including it as part of the 2023 evolution is misleading. (3) The multi-hop reasoning is partially sound—Wilmington Trust remains the trustee, and there is a trend toward higher yields and longer maturities—but the synthesis is flawed due to incorrect attribution of dates and rates. The LLM conflates reporting year (2023 filing) with issuance year (2024), which undermines the temporal evolution. (4) Despite these errors, the answer is contextually relevant and attempts to address the evolution of the relationship, indentures, and note terms. It correctly identifies the continuation of the trustee relationship and a general shift to higher yields, which aligns with the ground truth’s conclusion, albeit with incorrect supporting data. Hence, the correctness score is low due to critical number and date inaccuracies, but not zero because of partial alignment in directionality and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 540,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One’s CECL add‑back grew from **50 % of the $2.4 billion aggregate impact in 2023 to 75 % in 2024**.  The CECL Transition Rule phases the cumulative “day‑2” impact in 25 % increments – 25 % in 2022, **50 % in 2023**, **75 % in 2024**, and 100 % (fully phased‑in) by 2025 【page_11†L1-L9】【page_202†L1-L9】.  As disclosed, the company had added back $2.4 billion as of Dec 31 2021 and had **phased‑in 75 % of that amount by Jan 1 2024**【page_202†L12-L14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One's CECL add-back was 50% of $2.4 billion in 2023 and progressed to 75% by January 1, 2024, matching the ground truth. The dollar amount ($2.4 billion) and phase-in percentages (50% in 2023, 75% in 2024) are accurate. The explanation of the 25 percentage point annual phase-in after 2021 aligns with the five-year schedule described in the original answer. (2) All numbers and dates are correct: $2.4 billion, 50%, 75%, and the progression from 2023 to 2024 are factually consistent. The mention of full phase-in by 2025 is a minor extrapolation but logically sound and consistent with the rule. (3) The multi-hop reasoning is sound—LLM synthesizes the phase-in schedule and applies it correctly to Capital One’s specific add-back amount. It references the structured annual 25% phase-in increments and correctly maps them to the relevant years. (4) The only minor deviation is that the original answer emphasizes the 25 percentage point increase during 2023–2024, while the LLM focuses more on the absolute levels (50% to 75%) without explicitly stating the change magnitude. However, this does not affect factual correctness. Overall, the answer is semantically equivalent, highly accurate, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 358,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "In the 2022 Form 10‑K Broadcom disclosed that, pending the VMware merger, any in‑the‑money VMware stock options (and RSU awards) held by non‑employee directors would be **accelerated and converted into cash and Broadcom common stock on an equal‑parts basis** (see page_97). After the merger closed, the 2023 Form 10‑K reported that this plan was carried out – the outstanding in‑the‑money VMware options and RSU awards for non‑employee directors were **accelerated and actually converted into cash and Broadcom shares, again in equal parts** (see page_66).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the treatment of VMware stock options for non-employee directors in both 2022 and 2023, correctly stating that in 2022 the plan was disclosed—acceleration and conversion into cash and Broadcom common stock on an equal-parts basis—and that in 2023 the plan was confirmed as executed. (2) There are no numerical values requiring calculation (e.g., dollar amounts or percentages), but the description of 'equal parts' cash and stock is consistent and correctly repeated across both years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two filings (2022 and 2023 10-Ks), distinguishing between the planned treatment pre-acquisition and the actualized outcome post-acquisition. (4) All entities—VMware, Broadcom, non-employee directors, stock options, RSUs, 10-K filings, and the acquisition timeline—are accurately identified and contextualized. The inclusion of page references (page_97, page_66) adds precision and traceability. Wording differs slightly from the original answer but conveys the same factual and logical content. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 341,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie only noted that Vraylar (cariprazine) was being studied as an **adjunctive treatment for major depressive disorder**, reporting top‑line Phase 3 results (page 60). By the 2024 Form 10‑K the company lists Vraylar as an **approved dopamine D3‑preferring D3/D2 partial agonist** with indications for **acute and maintenance treatment of schizophrenia, acute manic or mixed episodes of bipolar disorder, acute bipolar‑I depressive episodes, and as an adjunctive therapy for major depressive disorder** (page 6), showing a shift from a single investigational use to a multi‑indication, approved therapeutic positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Vraylar was under investigation as an adjunctive treatment for MDD based on Phase 3 trials, citing AbbVie's 2022 Form 10-K. This matches the original answer's description of one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement (though the LLM omits this granular detail, it does not misrepresent the status). (2) By 2024, the LLM accurately reports the expanded approved indications: schizophrenia, bipolar manic/mixed episodes, bipolar I depressive episodes, and adjunctive MDD treatment—fully consistent with the ground truth. The mention of Vraylar as a 'dopamine D3-preferring D3/D2 partial agonist' adds contextual pharmacological detail not in the original but is factually correct and enhances accuracy. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across two years (2022 vs 2024) from SEC filings to demonstrate evolution in therapeutic positioning. (4) Minor deduction in qualitative accuracy due to omission of trial outcome specifics (one success, one mixed result), but the overall trajectory—from investigational to multi-indication approved use—is correctly captured. Quantitative accuracy is perfect: no numerical errors, correct years, and proper entity (Vraylar, AbbVie) and document (Form 10-K) identification. Contextual relevance is excellent, directly addressing the evolution in therapeutic positioning as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 423,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "In the 2022 filing GE said that long‑term services agreements (primarily in Healthcare and Renewable Energy) were accounted for on a **straight‑line basis**, with revenue recognized as services were provided and invoiced periodically, and no detailed billing‑estimate methodology was described. By the 2024 filing the policy had changed to a **percentage‑of‑completion method**, recognizing revenue based on costs incurred relative to total expected costs and explicitly **estimating customer billings and asset utilization over the contract term**, with those estimates reviewed and adjusted regularly and revenue caught up on a cumulative basis. This marks a shift from a simple straight‑line approach to a cost‑based, estimate‑driven model that incorporates ongoing contract‑billing estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in GE's accounting policy from straight-line basis in 2022 to percentage-of-completion method in 2024, accurately reflecting the change in revenue recognition method and the associated rationale involving cost incurrence and contract billing estimates. It correctly notes the segments involved (Healthcare and Renewable Energy in 2022, with CES mentioned implicitly in 2024 context), and captures the qualitative evolution in estimation practices, including regular review and adjustment of estimates and cumulative catch-up of revenue. (2) Quantitatively, while the LLM answer does not include the specific dollar figures ($6.6 billion net liability) or the total estimated life of contract billings ($162 billion) and the derived 4.1% ratio mentioned in the ground truth, it does not misstate any numbers—it simply omits them. Since the question emphasizes evolution in policy (method and estimates), and not explicit disclosure of balances, the omission is minor rather than critical. No incorrect calculations are made. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), identifies the change in accounting method, links it to cost-based measurement and forward-looking billing estimates, and correctly infers a more sophisticated estimation process in 2024. The mention of 'asset utilization' and 'regular review' aligns with the ground truth’s emphasis on detailed, forward-looking estimation. (4) The answer is contextually fully relevant, directly addressing both parts of the question—revenue recognition method and contract billing estimates. The qualitative accuracy is high, though a perfect score would require inclusion of the key quantitative disclosures ($6.6B, $162B, 4.1%) that exemplify the enhanced estimation process in 2024. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 531,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 Form 10‑K IBM only referenced the 1.250 % Notes due 2027 in its Item 601 exhibit list, stating that the holders’ rights are defined in “Exhibit 4.3 to Form 8‑K, filed January 30, 2019”【page_33】. By the 2023 Form 10‑K the same notes are shown directly in the Section 12(b) securities‑registration table as “1.250 % Notes due 2027” with the ticker IBM 27B【page_1】, moving from a simple exhibit reference to an explicit registration listing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in the 2022 10-K, the 1.250% Notes due 2027 were referenced via Exhibit 4.3 to the Form 8-K filed on January 30, 2019, as defining the rights of holders; in the 2023 10-K, these notes are listed under Section 12(b) as a registered security with ticker IBM 27B on the NYSE. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), and filing date (January 30, 2019)—are all correct. No calculations are required, but the temporal evolution between filings is accurately captured. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different years of 10-K filings and identifies the shift in disclosure practice—from an exhibit reference to a formal registration listing. (4) The answer is contextually precise, directly addressing how the disclosure evolved, and uses appropriate terminology (e.g., 'Section 12(b)', 'ticker', 'registered securities'). Minor formatting differences (e.g., spacing in '1.250 %' vs '1.250%') do not affect meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 329,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "In both the 2022 and 2024 proxy statements AbbVie’s performance‑vested RSUs continue to vest in **one‑third increments over a three‑year performance period**. The awards are still earned **based on AbbVie’s return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech and life‑science companies**, and the 2024 filing does not introduce any new performance metrics for these RSUs【page_123】【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that performance-vested RSUs vest in one-third increments over a three-year period for both 2022 and 2024, which matches the original answer. The performance metric—ROIC relative to a peer group of pharmaceutical, biotech, and life science companies—is also accurately reported. (2) There are no numerical values requiring calculation, but the temporal references (2022 and 2024) are correctly used, and the consistency of the vesting structure across years is properly conveyed. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2022 and 2024) and correctly infers continuity in structure and metrics. However, the LLM omits a subtle but important qualitative point from the original answer: the *streamlining or simplification* of the performance metric description by 2024, particularly the removal of references to specific years tied to tranches (e.g., awards granted in 2020 and 2021 mentioned in 2022 disclosures). This indicates a minor gap in completeness regarding the *evolution* of the criteria. (4) Despite this omission, the answer remains factually correct, contextually relevant, and semantically close to the ground truth, warranting a high score. The missing nuance prevents a perfect 10, but the core facts, entities, and reasoning are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 388,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "GE’s AerCap investment moved from a large loss in 2022 to modest gains in the next two years. According to Note 19, the combined realized‑and‑unrealized result on the AerCap investment was a **$(865) million loss in 2022**, a **$129 million gain in 2023**, and a **$38 million gain in 2024**【page_68】. This trend shows the relationship shifting from a significant negative outcome to small positive earnings as GE began to unwind the position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures for GE's relationship with AerCap: an $865 million loss in 2022, a $129 million gain in 2023, and a $38 million gain in 2024. While the original answer only mentions 2022 and 2024, the LLM provides additional accurate data for 2023, which enhances completeness without contradicting the ground truth. All numeric values match the ground truth or are consistent with it—$865 million loss in 2022 and $38 million gain in 2024 are explicitly confirmed. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the progression shows a clear turnaround, as stated in the original. The inclusion of 2023 data ($129M gain) is accurate and adds context without distorting the overall narrative. (3) The multi-hop reasoning is sound: the LLM correctly interprets the shift from unrealized loss to realized/unrealized gains over time, infers a likely unwinding of the position, and supports this with a citation (Note 19, page 68). This aligns with the original’s conclusion about a significant turnaround. (4) The answer is semantically equivalent and even slightly more detailed than the ground truth. The only reason for not scoring a 10 is that the original answer focuses on 2022–2024 without specifying 2023, so the addition of $129M gain—while accurate—introduces a detail not in the ground truth, which could be seen as minor overreach if the knowledge graph didn’t support 2023 explicitly. However, since it doesn’t contradict and improves context, the score remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 433,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2026 were disclosed only by reference – the filing incorporated Exhibit 4 to a Form 8‑K (filed Nov 1 2016) that defined the instrument, but the notes did not appear in the securities‑registered table. By contrast, the 2023 Form 10‑K lists the 0.300 % Notes due 2026 in the Section 12(b) securities table (ticker IBM 26B), showing they are now directly registered and visibly presented as a listed security rather than merely referenced. This marks a shift from an incorporated‑by‑reference disclosure to explicit registration and greater visibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution in disclosure status: in 2022, the 0.300% Notes due 2026 were disclosed by reference to Exhibit 4 of the Form 8-K filed on November 1, 2016, and were not listed in the securities-registered table. In 2023, they were explicitly included in the Section 12(b) securities table with the ticker IBM 26B, indicating formal registration and increased visibility. (2) All dates (Nov 1, 2016), percentages (0.300%), years (2022, 2023, 2026), and symbols (IBM 26B) are correct and match the ground truth. (3) The multi-hop reasoning is sound—correctly synthesizing changes in disclosure practice across two years and interpreting the significance of moving from incorporation by reference to explicit listing. (4) The answer is semantically equivalent to the original, using precise financial terminology (e.g., 'Section 12(b)', 'incorporated by reference', 'directly registered') and correctly characterizing the increased transparency and formal recognition. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 319,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "In the 2022 Form 10‑K, GE presented RISE as a newly‑announced joint initiative with Safran – the “Revolutionary Innovation for Sustainable Engines” program – whose strategic goal was to achieve >20 % lower fuel burn and CO₂ emissions and to develop the next generation of sustainable engine technology. By the 2024 filing, GE describes RISE as a broader “RISE program suite” that is now a core pillar of its sustainable‑flight strategy, and the company’s R&D spend on the program has risen sharply (GE Aerospace‑funded R&D grew from $808 million in 2022 to $1.286 billion in 2024), indicating a deeper, more integrated investment focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2022 RISE Program announcement as a joint initiative with Safran aimed at reducing fuel consumption and CO2 emissions by over 20%, matching the original answer. It also accurately reflects the evolution by 2024 into a more substantial, integrated R&D effort. (2) The quantitative data provided—GE Aerospace-funded R&D increasing from $808 million in 2022 to $1.286 billion in 2024—is factually correct and supports the claim of increased investment. While the original answer does not include these specific dollar figures, their presence in the LLM response adds precision and strengthens the conclusion; thus, they do not constitute an error. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024), identifies the shift from conceptual to active development, and supports it with financial trends. (4) The term 'RISE program suite' and its characterization as a core pillar of sustainable-flight strategy match the original's emphasis on deepened strategic commitment. The only minor limitation is that the original emphasizes 'significant investments' qualitatively, while the LLM adds specific R&D spend figures—though this enhances rather than detracts from accuracy. Overall, the answer is semantically equivalent, factually correct, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 392,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "In the 2022 filing, asset securitizations were only described in a glossary entry (p. 88) and mentioned in a risk‑factor discussion of the funding plan’s reliance on the ability “to securitize and sell loans and receivables” (p. 92), indicating they were a background component of the funding mix. By the 2023 filing, the Funding Strategy section explicitly lists “asset securitizations” alongside deposits and unsecured debt as a primary source of funding, emphasizing its importance for diversification and cost‑efficiency (p. 68). This shows a shift from a peripheral, definitional reference in 2022 to a central, strategic pillar of the company’s funding approach in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, asset securitizations were mentioned in a glossary and risk factor, not as a strategic focus; by 2023, they were explicitly listed as a primary funding source alongside deposits and unsecured debt. The shift from peripheral to strategic is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all references to years (2022, 2023) and document sections (p. 88, p. 92, p. 68) are accurate and consistent with typical 10-K structures—no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying both the nature and location of disclosures (glossary vs. funding strategy section), and infers the strategic evolution. The addition of 'cost-efficiency' in the 2023 emphasis is a minor expansion beyond the original answer, which only mentions diversification and mitigation of disruption, but this is a reasonable inference from typical funding strategy language and does not contradict the ground truth. (4) The answer is contextually fully relevant, directly addressing the evolution of asset securitizations in American Express’s funding strategy. The only reason for not scoring a 10 is that the original answer emphasizes the reporting of securitized assets/liabilities in 2022, which the LLM omits—this is a minor but notable detail about accounting treatment that adds depth to the 2022 disclosure. Overall, the LLM captures the core evolution accurately and with strong evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 467,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson completed the Heritage‑AspenTech transaction in 2022, emerging with a 55 % stake in the newly formed AspenTech, which reported $656 million of sales and $12 million of earnings that year (p.26; p.77). In 2023 Emerson booked a $24 million mark‑to‑market gain on its AspenTech equity (versus a $50 million loss in 2022) and the integration of AspenTech boosted Emerson’s Software & Control segment sales by about 20% and added roughly 3 % to total net sales, reflecting both improved investment returns and deeper operational integration (p.27; p.24).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson acquired Heritage AspenTech and gained a 55% stake in 2023, not 2022. The LLM incorrectly states the acquisition occurred in 2022, which misrepresents the timeline and undermines the evolution of the relationship. Additionally, the LLM claims a $24 million mark-to-market gain in 2023 and a $50 million loss in 2022, but this information is not present in the original answer and contradicts the ground truth, which reports a $12 earnings gain in 2022 with no mention of losses or gains in 2023. The $656 million in sales is consistent in both answers (with formatting variation accepted), but the LLM misattributes it to the post-acquisition entity in 2022 rather than as part of the pre-acquisition minority investment. (2) The quantitative inaccuracies are severe: the timing of the 55% acquisition is off by a year, and the mark-to-market figures ($24M gain, $50M loss) are entirely fabricated or misextracted. The 20% sales boost and 3% contribution to total net sales are not mentioned in the ground truth, making them unsupported additions. (3) The multi-hop reasoning is flawed because the model fails to correctly sequence the evolution: it should show a shift from minority investment (2022) to controlling interest (2023), but instead presents the controlling stake as already existing in 2022. This breaks the causal and temporal logic required for accurate synthesis. (4) Despite these issues, the answer is contextually relevant—it addresses investment returns and operational integration, uses correct entity names (Emerson, AspenTech), and attempts to quantify impacts. However, the core facts are incorrect, leading to a low correctness and quantitative accuracy score. The qualitative reasoning shows structure but is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 506,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "In the 2022 filing Emerson treated the AspenTech deal as an acquisition in which it owned 55 % of the new company and recorded a $5.9 billion non‑controlling‑interest representing the 45 % held by former Heritage AspenTech shareholders; that accounting entry reduced Emerson’s additional paid‑in‑capital by $550 million【page_56】. By 2023 the relationship was reflected mainly through expense line items – SG&A rose $572 million to $4.186 billion, driven by $125 million of extra stock‑compensation expense, $50 million of which was attributable to AspenTech stock plans – and the separate non‑controlling‑interest equity adjustment was no longer highlighted, indicating Emerson’s deeper integration and larger ownership stake in AspenTech【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 transaction structure: Emerson's 55% ownership, $5.9 billion noncontrolling interest, and $550 million reduction in additional paid-in capital. These figures match the ground truth. In 2023, it accurately notes the $572 million increase in SG&A expenses compared to 2022. However, the LLM introduces specific figures not in the original answer—$125 million in extra stock compensation and $50 million attributable to AspenTech stock plans—which, while plausible, are not present in the ground truth and represent over-specificity or potential hallucination. The ground truth only states that higher SG&A was partly due to the AspenTech transaction and higher stock compensation, without breaking down amounts. (2) All core numbers from the ground truth are present and accurate: $5.9 billion noncontrolling interest, $550 million APIC reduction, 55% ownership, and $572 million SG&A increase. The additional $125M and $50M figures lack corroboration and reduce quantitative accuracy slightly. (3) The multi-hop reasoning is sound: the model connects 2022 accounting treatment (noncontrolling interest) to 2023 operational impacts (expense increases), correctly inferring deeper integration and reduced emphasis on noncontrolling interest disclosures. The conclusion about shifting focus from initial accounting to integration aligns with the ground truth’s narrative. (4) The answer is highly contextually relevant, directly addressing both years, noncontrolling interest accounting, and acquisition impacts on equity and expenses. The only deviation is the unsupported specificity in 2023 expense breakdown. Overall, the answer is factually strong with minor overprecision, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 482,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 6.22 % Debentures due 2027 were disclosed only in the exhibits section, where the filing noted that “the instrument defining the rights of the holders of the 6.22 % Debentures due 2027 is Exhibit 3 to Form 8‑K, filed on August 1 1997, and is hereby incorporated by reference” (2022 p. 31). By the 2023 filing, the same debentures appear in the cover‑page securities table as a security registered under Section 12(b) of the Exchange Act (2023 p. 1), indicating a shift to a more prominent, direct registration disclosure (while the exhibit reference remains but is not shown in the excerpts).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 6.22% Debentures due 2027 were referenced in the 2022 filing via incorporation by reference to Exhibit 3 of the August 1, 1997 Form 8-K, and this is accurately cited with the correct date and exhibit number. In 2023, the debentures are listed on the cover page as registered under Section 12(b), which matches the ground truth's emphasis on increased visibility and market-oriented disclosure. (2) Quantitative accuracy is perfect: percentages (6.22%), years (2027, 1997), and dates (August 1, 1997) are correct. Page numbers (2022 p. 31, 2023 p. 1) are consistent with typical filing structures and support the claims. (3) The multi-hop reasoning is sound—comparing disclosure treatment across two years and identifying a shift from passive reference to active registration. The LLM correctly infers a move toward greater transparency, though it does not explicitly mention the trading symbol 'IBM 27' or the New York Stock Exchange listing, which are part of the ground truth. This omission is minor and does not undermine the core conclusion. (4) The answer is contextually relevant, directly addressing the evolution in disclosure practices. The slight deduction in qualitative accuracy is due to the missing detail about the trading symbol and NYSE registration, which adds specificity to the 'market-oriented presentation' claim. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original answer with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 433,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "In the 2023 filing UnitedHealth explained that most of its premium revenue comes from risk‑based contracts in which it “assumes the economic risk of funding its customers’ health‑care and related administrative costs” and that value‑based contracts are accounted for as a single performance‑obligation premium (2023 10‑K p. 45). By the 2024 filing the company added that, while these arrangements limit exposure to rising medical costs, they also “expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers” and can make UnitedHealth liable for unpaid claims or service disruptions if a provider cannot fulfill its obligations (2024 10‑K p. 14). Consequently, UnitedHealth must now factor provider‑solvency risk into its cost‑estimation models and assume broader responsibilities for delivering and coordinating care, increasing its potential financial liability and operational oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: UnitedHealth's assumption of economic risk in 2023 under risk-based arrangements, recognition of premium revenue, and the shift in 2024 to increased exposure due to provider financial instability are all accurately represented. The LLM correctly cites page numbers from the 10-K filings (2023 p.45, 2024 p.14), which supports verifiability. (2) There are no numeric values in the question or answer that require calculation or quantitative comparison; thus, quantitative accuracy is not applicable in a numerical sense, but all references to financial exposure and risk are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the evolution in risk exposure and its implications for cost estimation and service delivery. It captures the key qualitative shift — from assuming cost risk directly to also bearing contingent liability due to provider insolvency — which reflects deeper operational and financial responsibility. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'per-patient-per-month premiums' or 'data availability for cost estimation' aspects highlighted in the original answer, which slightly reduces completeness in qualitative detail. However, the core implications — provider solvency affecting cost models and broader care delivery responsibilities — are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect: the response directly addresses both parts of the question — evolution of risk exposure and implications for cost and service responsibilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 483,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "In 2022 Emerson’s link to AspenTech was modest – it contributed two of its own industrial‑software businesses (Open Systems International and the Geological Simulation Software unit) to the newly created Heritage AspenTech, establishing an equity relationship but involving no large cash outlay (page 25). By 2023 Emerson turned that into a far larger, strategic investment, spending roughly $6 billion in cash to acquire a 55 percent ownership of AspenTech, giving it a controlling stake and deepening its involvement (page 26).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson reported a $362 million investment in AspenTech, not a contribution of two software businesses as stated by the LLM. The LLM incorrectly claims Emerson contributed Open Systems International and Geological Simulation Software in 2022 to form Heritage AspenTech, which contradicts the original answer that shows Emerson's 2022 involvement was a financial investment, not a business contribution. The $6.0 billion cash contribution and 55% ownership stake in 2023 are correctly reported, aligning with the ground truth. (2) Quantitative accuracy is partially correct: the $6 billion cash and 55% ownership are accurate, but the $362 million 2022 investment is entirely omitted and replaced with incorrect qualitative claims. No calculation errors, but key numbers are missing or misrepresented. (3) Multi-hop reasoning is flawed: the model fails to correctly trace the evolution from a financial investment in 2022 to a strategic takeover in 2023. Instead, it fabricates an early strategic move in 2022, undermining the core narrative of evolution from financial to strategic. (4) Contextual relevance is high as the answer addresses investment magnitude and strategic involvement, but factual errors severely limit correctness. The answer appears plausible and structured well, but key facts are incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 410,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "In the FY 2022 filing, Adobe Target is listed alongside Marketo Engage, Adobe Campaign and Journey Optimizer as one of the tools that “help businesses manage, test, target, personalize and orchestrate campaigns and customer journeys” (see 2022 10‑K p. 43). By FY 2023, the filing describes Adobe Target as “an AI‑ and machine‑learning‑driven personalization engine…that lets our customers create omnichannel personalized experiences and run A/B and multivariate tests at scale through AI‑powered automation” (see 2023 10‑K p. 15). This shift from a generic journey‑tool component to a highlighted AI‑centric engine signals Adobe’s strategic move to make AI‑driven personalization the core of its Experience Cloud offering.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes Adobe Target's role in FY 2022 as part of a suite of customer journey tools including Marketo Engage, Adobe Campaign, and Journey Optimizer, with functionality for testing, targeting, and personalizing content—consistent with the original answer. (2) For FY 2023, it correctly identifies the elevated positioning of Adobe Target as an 'AI- and machine-learning-driven personalization engine' with omnichannel personalization and AI-powered A/B and multivariate testing capabilities, directly quoting the 2023 10-K. (3) The multi-hop reasoning is sound: it synthesizes information across two fiscal years and correctly infers the strategic shift—from being one of several tools to a highlighted AI-centric engine—indicating Adobe’s increased focus on AI-driven personalization within Experience Cloud. (4) All entities (Adobe Target, Marketo Engage, Adobe Campaign, Journey Optimizer, fiscal years 2022 and 2023) are correctly identified. There are no numerical inaccuracies (no calculations required), and the semantic meaning fully aligns with the ground truth. The answer is concise, factually precise, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 346,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "In 2022 Emerson closed its purchase of Heritage AspenTech, paying roughly $11.2 billion and creating about $8.3 billion of goodwill (plus $2.3 billion of customer‑relationship and $1.35 billion of developed‑technology intangibles) for the AspenTech segment 【page_61】【page_82】. By 2023 Emerson had moved into the integration phase – all un‑exercised Heritage AspenTech stock options and unvested restricted‑stock units were converted into AspenTech equivalents and the post‑combination portion of the share‑based compensation was recognized as expense, reflecting ongoing operational and equity‑plan integration 【page_70】【page_36】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 acquisition of Heritage AspenTech and references a goodwill amount of $8.3 billion, which aligns closely with the ground truth's reported $8,326 million balance related to AspenTech. However, the LLM introduces additional figures—$2.3 billion for customer relationships and $1.35 billion for developed-technology intangibles—and frames the $8.3 billion as goodwill specifically, whereas the ground truth refers to it as the total acquisition-related balance, not necessarily all goodwill. This mischaracterization of the $8.3 billion as solely goodwill (rather than total asset value or total intangible assets) introduces a factual inaccuracy, though the number itself is approximately correct. (2) The LLM accurately describes the 2023 integration activities, including the conversion of unexercised stock options and unvested RSUs into AspenTech equivalents and the recognition of post-combination share-based compensation expenses. This matches the ground truth’s description of ongoing equity-plan integration and operational alignment. (3) The multi-hop reasoning is sound: the model connects the 2022 acquisition to 2023 integration efforts, synthesizing financial stake evolution with operational integration, particularly around equity plans. It correctly infers that conversion of awards and expense recognition reflect deeper integration. (4) While the core narrative of financial stake transitioning into operational integration is preserved and well-supported, the mislabeling of the $8.3 billion figure as goodwill (without clarifying it may include other intangibles) reduces quantitative accuracy. The ground truth does not mention goodwill breakdowns, so this added detail, though plausible, is not fully substantiated and slightly distorts the financial picture. Overall, the answer is factually strong, contextually relevant, and logically coherent, but with a notable quantitative overprecision that affects full factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 541,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "In the 2022 filing Adobe Experience Platform was presented mainly as a data‑centric foundation – a purpose‑built platform that “collects, connects and activates” customer data, standardizes it for AI‑driven insights, and powers “customer‑journey intelligence” across the Experience Cloud (2022 p.13; 2022 p.8). By the 2023 filing the platform had become the engine behind Adobe Journey Optimizer, enabling real‑time, cross‑channel campaign orchestration, and it is explicitly tied to Adobe Sensei AI services that deliver personalization, attribution, automated insights and other AI‑powered capabilities directly within journey execution (2023 p.15; 2023 p.8). This marks a shift from a data‑only hub to an AI‑integrated orchestration layer for end‑to‑end customer‑journey solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Experience Platform from 2022 to 2023. (1) It correctly identifies the 2022 role as a data-centric foundation enabling AI-driven insights via Adobe Sensei, aligning with the ground truth's description of data standardization and integration with AI services like automated insights and anomaly detection. In 2023, it accurately notes the platform's expanded role as the engine for Adobe Journey Optimizer, supporting real-time, cross-channel campaign orchestration—matching the ground truth's emphasis on cross-channel orchestration and real-time data profiles. The mention of AI-powered capabilities like personalization and automated insights being embedded in journey execution reflects the integration with Adobe Sensei as described. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2023) are correct, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and connects Adobe Experience Platform to Adobe Journey Optimizer and Adobe Sensei, correctly inferring a shift from data infrastructure to active orchestration. The only minor omission is the absence of 'Adobe Mix Modeler'—a specific 2023 addition leveraging cross-channel data for marketing investment optimization—which slightly reduces completeness but does not undermine the overall correctness. (4) Despite this, the LLM conveys the essential semantic shift: from a backend data layer to an AI-integrated, action-oriented orchestration platform. Wording differs but meaning aligns closely with the original answer. Hence, high scores across all dimensions with a 9/10 on correctness due to the omitted detail on Mix Modeler.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 482,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In its 2023 filing UnitedHealth warned that Medicare Advantage funding pressures would shape its 2024 benefit design, emphasizing the integration of in‑clinic, in‑home, behavioral and virtual services and an accelerated shift from fee‑for‑service to fully accountable value‑based care (2023 p.26‑27). By the 2024 filing the company had moved from planning to action—adjusting member benefits and premiums, pulling back plans in select counties, tightening medical and operating cost management, and further expanding virtual and in‑home, value‑based delivery models (2024 p.15, 20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution in UnitedHealth Group's care delivery model approach from 2023 to 2024 as the ground truth. In 2023, the company emphasized accelerating the shift to value-based care and integrating new delivery models (in-home, virtual, behavioral, etc.), which aligns with the original answer's mention of clinical engagement, technology, and new channels. The LLM correctly identifies that Medicare Advantage funding pressures were anticipated in 2023 and materialized in 2024, prompting operational changes. By 2024, the LLM notes concrete actions: adjusting benefits, pulling back in select counties, tightening cost management, and continuing expansion of value-based models—this matches the ground truth's description of strategic retrenchment involving provider networks, benefits, and county-level plan decisions. All entities (UnitedHealth Group, Medicare Advantage, value-based care) and years (2023 to 2024) are correct. There are no numerical inaccuracies (no specific numbers to verify, but references to filing pages are consistent with source-based reasoning). The reasoning is sound multi-hop synthesis across two years of filings. The only minor shortcoming is that the LLM does not explicitly mention 'reduced benchmarks and risk adjustment changes' as the specific causes of funding pressure, though it correctly attributes the 2024 adjustments to those pressures. This slight omission in causal detail prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 440,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The 2023 filing shows the same set of senior notes that were listed in 2022—including the 1.950 % Notes due 2029 (TMO 29) which appear unchanged in both years (2022 page 1; 2023 page 1). The only addition to the debt lineup in 2023 is a new 3.200 % Notes due 2026 (TMO 26B), which was not present in the 2022 list (2023 page 1 vs. 2022 page 1).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.950% Notes due 2029 (TMO 29) were present and unchanged in both 2022 and 2023, which aligns with the ground truth. It also correctly notes the addition of a new debt instrument in 2023 — the 3.200% Notes due 2026 (TMO 26B). All percentages, maturities, and trading symbols mentioned are factually accurate. (2) Quantitative accuracy is perfect: the interest rates (1.950%, 3.200%), maturity years (2029, 2026), and trading symbols (TMO 29, TMO 26B) match the ground truth. (3) However, the LLM omits mention of the 3.650% Notes due 2034, which the ground truth identifies as another new instrument issued in 2023. This is a notable omission affecting completeness and qualitative accuracy, as it understates the extent of TMO's debt portfolio expansion. The reasoning is otherwise sound, correctly comparing the two years and identifying continuity and change. (4) The answer is contextually relevant and well-structured, but the missing 2034 note reduces the completeness of the multi-hop synthesis. Hence, correctness and qualitative accuracy are slightly reduced, while quantitative accuracy and relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 333,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Thermo Fisher’s note portfolio was essentially unchanged – the 0.500 % Notes due 2028 are listed in both the 2022 and 2023 filings 【TMO_10k_2022.pdf page_1】【TMO_10k_2023.pdf page_1】 – but the 2023 filing adds a new series, the 3.650 % Notes due 2034, expanding the company’s debt mix beyond the set of notes that existed in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.500% Notes due 2028 were present in both 2022 and 2023, and accurately notes the introduction of the 3.650% Notes due 2034 in 2023. However, it omits mention of the 3.200% Notes due 2026, which were also introduced in 2023 according to the ground truth. This is a notable but not critical omission. (2) All numeric values mentioned (0.500%, 3.650%, 2028, 2034) are correct and match the ground truth. No calculations are required, but the temporal comparison is accurate. (3) The reasoning is sound in observing continuity of existing notes and the addition of new ones, supporting the idea of portfolio expansion. However, the multi-hop synthesis is slightly incomplete as it fails to reference all new note categories introduced in 2023, particularly the 3.200% Notes due 2026. (4) The answer is contextually fully relevant and conveys a correct high-level conclusion about debt diversification, though with less completeness than the original answer. Quantitative accuracy is high due to correct percentages and dates. Qualitative accuracy is slightly reduced due to missing one of two new note categories. Correctness score reflects minor but meaningful omission in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 348,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "In the 2023 annual goodwill‑impairment test the excess of fair value over carrying value for each reporting unit was roughly **140 % – 495 %** of carrying value【page_56】. In the 2024 test the same metric fell to about **70 % – 450 %**【page_52】, so both the lower and upper bounds moved lower, narrowing the overall range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the numerical ranges for both 2023 (140%–495%) and 2024 (70%–450%), matching the ground truth exactly. These percentages are accurately attributed to the correct years and context (excess of fair value over carrying value in goodwill impairment tests). 2) All numbers are correct and consistent with the original answer. The formatting (using 'about' and 'roughly') is acceptable and reflects the approximate language ('approximately') used in the ground truth. 3) The reasoning is sound: the LLM correctly identifies that both bounds decreased, indicating a narrowing of the range and a reduced cushion, which aligns with the conclusion in the original answer. However, while the original emphasizes the decline in the *lowest* excess percentage as the key takeaway, the LLM mentions both bounds moving lower—technically accurate but slightly less precise in emphasis. 4) The answer is semantically equivalent, cites correct entities (DHR, reporting units, annual goodwill impairment analyses), and correctly synthesizes multi-hop information across two years. The minor deduction in qualitative accuracy is due to slightly less focused interpretation (original highlights the decline in the lower bound as indicative of reduced cushion, which the LLM implies but does not explicitly conclude). Overall, the answer is factually correct, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 385,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In the 2022 Form 10‑K the 2022 Employee Stock Plan expressly said that “RSUs canceled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant … using a factor of two times the number of RSUs canceled or shares withheld”【page_49】. The 2023 Form 10‑K’s description of the same plan no longer repeats that language (it only notes the vesting and dividend‑equivalent rights)【page_47】, indicating that the underlying mechanics – cancelled RSUs and tax‑withheld shares still boost the share pool (effectively at the same two‑to‑one ratio) – remain unchanged, but the explicit disclosure of the factor was omitted.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements from the 2022 and 2023 Form 10-Ks: in 2022, canceled RSUs and tax-withheld shares increased the share pool by a factor of two, and in 2023, the explicit language about the 'factor of two' was omitted. The quantitative accuracy is high because the description of the 2x factor in 2022 and its absence in 2023 is factually correct, and the cited pages align with the source documents. However, the LLM draws an incorrect conclusion by stating that the 'underlying mechanics ... remain unchanged' and that the boost to the share pool 'effectively' still occurs at a two-to-one ratio. This contradicts the ground truth, which interprets the omission of the language as an actual change in how these events are accounted for in the share pool — not merely a disclosure change. The reasoning is flawed because it assumes continuity of mechanics without evidence; the absence of language in a legal plan document typically indicates a policy change, not just reduced disclosure. This misinterpretation affects the qualitative accuracy significantly, as the core of the question — how the treatment evolved — is misunderstood. While the answer is contextually relevant and includes the right entities (2022/2023 10-Ks, RSUs, tax-withheld shares, share pool), the incorrect inference undermines the correctness of the synthesis. Thus, the answer is partially correct on facts but wrong on the key interpretive point, warranting a mid-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 413,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "In the 2023 Form 10‑K Danaher still reported Aldevron as a recent acquisition, showing a net cash purchase of roughly $9.6 billion (including $6.1 billion of goodwill and $3.5 billion of other intangibles) and related $28 million transaction costs—evidence of a large financial stake. By the 2024 filing, Aldevron is no longer described only as an acquisition but is listed as part of Danaher’s Life Sciences segment, indicating that the company has fully integrated Aldevron into its core operating structure. This marks a shift from a standalone, newly‑acquired asset in 2023 to an incorporated business unit within Danaher’s segment reporting in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly identifies the ~$9.6 billion net cash consideration for Aldevron in 2023, which matches the ground truth's $9,561 million (rounded appropriately). It adds detail not in the original answer—$6.1 billion goodwill and $3.5 billion other intangibles, plus $28 million transaction costs—which are consistent with typical acquisition accounting and plausible within the context, though not explicitly confirmed in the ground truth. These additions do not contradict but enrich the response. (2) The evolution from standalone acquisition in 2023 to integration into the Life Sciences segment in 2024 is accurately described, matching the original answer’s core claim. (3) Entity accuracy is strong: Danaher, Aldevron, Life Sciences segment, and correct years (2023–2024) are all properly identified. (4) Multi-hop reasoning is sound—linking the financial stake in 2023 to the structural integration in 2024 demonstrates synthesis across filings. The only minor shortcoming is that the LLM does not explicitly reference other acquisitions (Beckman Coulter, Pall, IDT) as context for integration, slightly reducing completeness. However, this does not detract from the central point. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 380,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "In 2023 Microsoft framed Microsoft 365 as an “AI‑first” platform – a bundle of Office, Windows, Copilot and Enterprise Mobility + Security that uses Copilot for Microsoft 365 to bring AI‑driven assistance to business data and productivity tools【page_4】. By fiscal 2024 the company had woven that AI story into its performance metrics, listing Copilot for Microsoft 365 as a component of Office Commercial revenue and expanding the Microsoft 365 consumer‑subscriber metric (including Basic) while tying Microsoft 365 growth to the broader Microsoft Cloud commercial revenue metric, making the suite a core driver of its commercial business【page_42】【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Microsoft 365 as an 'AI-first' platform in 2023, integrating Office, Windows, Copilot, and Enterprise Mobility + Security, and notes the role of Copilot for Microsoft 365 in enhancing productivity with AI—matching the original answer. (2) For 2024, it accurately captures the expansion of the Microsoft 365 consumer subscriber metric to include Basic subscribers, which is a key strategic update. It also correctly links Microsoft 365 growth to broader commercial cloud metrics and identifies Copilot for Microsoft 365 as part of Office Commercial revenue—demonstrating proper synthesis across time and business segments. (3) The multi-hop reasoning is sound: it connects AI integration (product strategy) with changes in reporting metrics (business strategy), showing how Microsoft evolved its positioning by embedding AI into both product and performance tracking. (4) Minor deduction in qualitative accuracy due to slightly more expansive phrasing (e.g., 'woven that AI story into its performance metrics') which, while accurate in spirit, adds interpretive language not in the original. However, all entities (Microsoft 365, Copilot, Office Commercial, consumer subscribers, fiscal 2024) and years are correct. No numerical errors; dates and metrics are consistent with the ground truth. Semantic equivalence is strong, and the answer fully addresses both AI integration and commercial business metric evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 415,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "In the 2023 filing Microsoft introduced Copilot Pro as a consumer‑subscription service that provides “faster and more powerful AI assistance in Microsoft 365 apps and on the web.” The 2024 filing repeats that description, now framing Copilot Pro as part of its AI‑first Microsoft 365 platform, but the core positioning—AI‑enhanced assistance across the suite of Microsoft 365 applications and web‑based experiences—remains essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Copilot Pro was introduced in 2023 as a consumer subscription service offering 'faster and more powerful AI assistance in Microsoft 365 apps and on the web,' and notes that the 2024 filing retains this description while situating it within the broader AI-first Microsoft 365 platform. This captures the core evolution: consistent positioning with increased integration into Microsoft's strategic AI narrative. The answer is slightly less explicit than the original about the 'more pronounced' emphasis on differentiation and innovation in 2024, but the key point about framing within a broader ecosystem transformation is conveyed through the phrase 'part of its AI-first Microsoft 365 platform.' All entities (Microsoft, Copilot Pro, Microsoft 365, 2023, 2024) are correct. There are no numerical values requiring calculation, so quantitative accuracy is 10. The reasoning is sound and reflects multi-hop synthesis across two years of filings. The semantic meaning matches the original answer, with only minor compression of nuance in the 2024 strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 328,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan’s design did not change – it still authorizes grants of stock options, RSUs and PSUs, with RSU vesting over a five‑year period for grants made before 2022 and over a four‑year period for grants made after 2021, and the company continues to issue shares from its authorized‑but‑unissued pool (2023 description – page 103; 2024 description – page 97).  By year‑end 2024 the pool of shares left for future grants had contracted to about 47 million shares (page 96), whereas the 2023 filing showed a slightly larger, but not‑specified, balance of shares remaining for issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of approximately 47 million shares remaining as of year-end 2024 is correctly reported, matching the original answer. The absence of a specific number for 2023 is also accurately reflected, with the LLM noting that the 2023 filing showed a 'slightly larger, but not-specified' balance—this is semantically equivalent to the ground truth stating 'no specific figure was provided.' (2) The LLM adds contextual detail not in the original answer—such as vesting periods (five-year for pre-2022, four-year post-2021) and source page numbers (e.g., page 96, 97, 103)—which are consistent with typical 10-K disclosures and do not contradict the ground truth. These details enhance completeness without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers evolution in disclosure transparency and share pool depletion over time by comparing the specificity of 2024 data to the vagueness in 2023. (4) Minor deduction in qualitative accuracy due to the slight overstatement of precision with 'slightly larger' for 2023—while reasonable, the ground truth does not confirm that the 2023 pool was definitively larger, only that it was unspecified. Otherwise, entity accuracy (Danaher, 2007 Omnibus Incentive Plan, RSUs, PSUs), years (2023, 2024), and financial terms are correct. The answer is fully contextually relevant, directly addressing the evolution in structure and share availability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 416,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft revised its depreciation policy for server and network equipment by extending the estimated useful life from four years to six years, a change that took effect at the start of fiscal 2023 and was carried forward unchanged into fiscal 2024【page_40】. The adjustment was driven by Microsoft’s investments in software that improved the efficiency of operating that equipment and by broader advances in technology【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Microsoft's accounting policy—extending the estimated useful life of server and network equipment from four to six years, effective at the start of fiscal year 2023, and notes it remained unchanged in fiscal year 2024. This matches the ground truth exactly in terms of numbers, timing, and policy continuity. (2) Quantitative accuracy is perfect: the years (4 to 6), the fiscal timing (FY2023 change, FY2024 continuation), and the absence of incorrect figures are all accurate. Format and referencing (e.g., 'fiscal 2023') are consistent and acceptable. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly links the policy change to its drivers—software investments improving operational efficiency and technological advances—directly aligning with the original answer. However, the LLM omits a minor but relevant point from the ground truth: the sustained rationale tied to ongoing cloud and AI infrastructure investments in FY2024, which adds context for why the policy remained unchanged. This omission slightly weakens qualitative completeness but does not invalidate the core correctness. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of the policy (change and continuation) and the influencing factors. Overall, the answer is factually precise and semantically equivalent to the ground truth with only a minor gap in elaboration, justifying a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 423,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "In fiscal 2022 the company held $36 million of auction‑rate securities at a $33 million fair value, and they were presented in the balance sheet under **Other assets** (not as an investment)【page_70†L31-L38】. The same $33 million fair‑value amount and “Other assets” classification appear in the 2023 tables, showing the exposure was unchanged from 2022 to 2023【page_71†L31-L38】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the 2022 classification of auction rate securities. The ground truth states that in 2022, the securities were classified under 'Total' in the investment portfolio without a separate balance sheet classification, whereas the LLM incorrectly claims they were presented under 'Other assets' in 2022. This misrepresents the evolution of classification. The fair value of $33 million is correctly reported for both years. However, the LLM introduces an incorrect figure of $36 million as the carrying amount in 2022, which does not appear in the ground truth and is unsupported. (2) Quantitative accuracy is partially correct: the $33 million fair value is accurate for both years, but the erroneous $36 million value reduces precision. No calculations are required, but the reporting of an extra, incorrect number harms quantitative reliability. (3) The multi-hop reasoning is flawed because the LLM fails to correctly contrast the classification change over time—claiming 'Other assets' was used in both years directly contradicts the ground truth, which emphasizes a shift *to* 'Other assets' in 2023 from a more general investment category in 2022. This undermines the core of the question about evolution in classification. (4) Contextual relevance is high because the answer addresses fair value and balance sheet classification over the two years, which is directly responsive. However, due to the critical error in entity classification and an unsupported dollar amount, the overall correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 443,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Cisco’s net result on its available‑for‑sale debt investments moved from a **$21 million loss in fiscal 2023 to a $67 million loss in fiscal 2024**, a **$46 million increase in the loss** (see the “Available‑for‑sale debt investments” line in the gains‑losses table)【page_46】. The larger loss in 2024 signals that the fair‑value performance of this debt portfolio worsened year‑over‑year, producing greater unrealized losses (or fewer gains) for the company.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported losses of $21 million in 2023 and $67 million in 2024 are accurate, and the $46 million increase in loss is correctly calculated (67 - 21 = 46). (2) The answer addresses both parts of the question: the change in net gains/losses and the implication for investment performance. (3) Entities—Cisco, available-for-sale debt investments, fiscal years 2023 and 2024—are correctly identified. (4) The reasoning is sound: the increased loss indicates worsening fair-value performance, which aligns with the ground truth's interpretation of 'significant worsening in investment performance.' The LLM correctly synthesizes multi-hop information across fiscal years and interprets the financial implication accurately. Minor wording differences (e.g., 'worsened year-over-year' vs. 'greater unrealized losses') do not affect semantic equivalence and are factually consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 280,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco kept APJC as a separate geographic operating segment in both years – the 2023 filing states the business is “organized…into…Asia Pacific, Japan, and China (APJC)” and the 2024 notes repeat the same three‑segment structure (page 3; page 65). In fiscal 2024 Cisco added a restructuring (“Fiscal 2024 Plan”) to realign the organization and fund key priority areas, and its revenue mix moved further toward subscription‑based software and services that are recognized over the contract term (page 78; page 72), which—together with an 8 % decline in total APJC revenue (page 39)—signals a shift from one‑time product sales to a more recurring‑revenue model in the APJC region.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct information but fails to accurately address the core of the question regarding Cisco's evolution in the APJC region from 2023 to 2024 in terms of operational structure versus financial investment. (1) Correctly notes that APJC remained a geographic segment in both years, which aligns with the ground truth on operational continuity. It also correctly references a shift toward subscription-based revenue and cites an 8% decline in APJC revenue in 2024 (page 39), which is factually consistent with the filing. (2) Quantitative accuracy is high: the 8% revenue decline is correctly cited, and fiscal year references (2023, 2024) are accurate. However, the answer does not mention any financial investments—such as marketable equity securities, non-marketable equity securities, or equity method investments—which are central to the ground truth and the question. (3) The reasoning is partially sound but misdirected: while the shift to recurring revenue is relevant to Cisco’s broader strategy, it does not constitute a change in 'financial investment' as defined in the ground truth. The LLM conflates business model evolution (product to subscription) with financial investment strategy, which are distinct concepts. There is no evidence of multi-hop synthesis between operational structure and investment activity in APJC. (4) The answer is contextually relevant to Cisco’s regional operations and revenue model but misses the key evolution in financial investment strategy. As such, it provides a plausible but factually incomplete and conceptually misaligned response. The absence of any mention of equity investments—a core component of the ground truth—severely undermines the correctness score despite accurate peripheral details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 479,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Apple’s 2022 Form 10‑K still described a standard commission on App Store sales, but noted that the company was already adding “new business terms and alternative fee structures… alternative methods of distribution… alternative payment processing… and additional APIs” to comply with the EU Digital Markets Act and to address litigation and market pressures【page_13】. By the 2024 Form 10‑K the company still retains a commission, yet says that ongoing lawsuits and EU regulatory scrutiny have already prompted changes to its App Store practices and could further “limit or reshape the commission… and manage distribution of apps outside of the App Store”【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in both substance and intent. (1) It correctly identifies Apple's evolving approach to App Store commissions and regulatory compliance between 2022 and 2024. In 2022, Apple acknowledged potential changes due to legal and market pressures, including the EU's Digital Markets Act (DMA), and noted early implementation of new business terms, alternative fee structures, distribution methods, and APIs. By 2024, the company confirmed that these pressures had already led to changes and could further impact commission models and app distribution—this matches the original answer’s core claim of a shift from acknowledgment to action. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2024), regulatory frameworks (DMA), and geographic scope (EU, implied U.S. in original) are correctly cited—no factual inaccuracies. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of Form 10-K filings, connects regulatory and litigation pressures to concrete changes in App Store policies, and correctly infers a trajectory of increasing compliance-driven adjustments. The only minor shortcoming is that the LLM answer does not explicitly mention the U.S. as a region of change (noted in the original), though it references 'litigation' which may imply U.S. context. (4) The answer is semantically equivalent to the original, with slightly less emphasis on the financial impact on App Store revenue, but still captures the essential evolution in strategy. Wording differences do not detract from accuracy. Overall, this is a highly accurate, well-reasoned response that fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 499,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "In the 2022 filing (covering 2021), the U.S. Retiree Health Care Plan’s assets were about $248 million in fixed‑income securities and cash equivalents and $137 million in equity securities – roughly 64 % fixed‑income and 36 % equity 【page_48】. By the 2024 filing, the weighted‑average allocation had shifted to about 80 % fixed‑income and 20 % equity, moving the portfolio further into its target range of 75 %‑85 % fixed‑income and 15 %‑25 % equity 【page_48】. This reflects a clear move toward a higher proportion of fixed‑income holdings between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2022 allocation as $248 million in fixed-income and cash equivalents and $137 million in equity securities, matching the ground truth. It accurately calculates the approximate percentages (64% fixed-income, 36% equity) based on the provided figures, which is a valid interpretation even though the original answer did not explicitly state percentages. The 2024 allocation is correctly reported as 80% fixed-income and 20% equity, aligning with the ground truth. The mention of the target range (75%-85% fixed-income, 15%-25% equity) adds contextual accuracy and is consistent with a strategic conservative shift. (2) All numeric values are correct: $248M and $137M in 2022, 80%/20% in 2024. The percentage breakdown in 2022 is mathematically accurate (total assets ~$385M; 248/385 ≈ 64.4%, 137/385 ≈ 35.6%). No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data from 2022 and 2024 filings, correctly infers the strategic shift toward fixed income, and contextualizes it within a target allocation range. It captures the evolution in strategy even though the 2023-2024 proportions were stable, emphasizing the progressive shift. (4) The only minor omission is that the original answer notes the 2023-2024 proportions remained the same, reinforcing the stabilization of the strategy, which the LLM does not explicitly mention. However, this does not detract significantly from the overall correctness. The LLM answer is semantically equivalent and factually accurate, with excellent contextual and quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 440,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "In 2022 Texas Instruments framed embedded‑processing as a core growth pillar of its “analog‑and‑embedded‑processing” business model, stressing extra emphasis on industrial and automotive markets and reporting it as a distinct segment that posted rising revenue ($3.0 bn in 2021 vs $2.6 bn in 2020) and operating profit ($1.17 bn vs $0.74 bn)【page_21】【page_22】. By 2024 the company still treats embedded processing as one of only two reportable segments and as a key element of its four sustainable competitive advantages, but its contribution has contracted, with revenue falling 25 % YoY to $2.53 bn and operating profit dropping 65 % to $352 m【page_2】【page_30】【page_20】. This shows a consistent strategic emphasis on embedded processing within TI’s segment structure, while the business’s share of revenue and profit has shifted from growth in 2022 to a smaller, lower‑margin component by 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) Quantitative Accuracy: The revenue and profit figures cited are incorrect. The original answer (ground truth) does not provide specific revenue or profit numbers for Embedded Processing in 2022 or 2024, nor does it mention a 25% revenue decline or 65% profit drop. The LLM fabricates precise numbers (e.g., $3.0 bn in 2021, $2.53 bn in 2024, operating profit from $1.17 bn to $352 m) with false citations (e.g., 'page_21', 'page_2') that are not supported by the ground truth. These calculations and figures are entirely inaccurate. (2) Completeness: While the question asks about the evolution of strategic emphasis, competitive advantages, and segment reporting, the LLM incorrectly asserts that Embedded Processing was already a 'reportable segment' in 2022, which contradicts the ground truth stating it was not a standalone reportable segment until 2024. This is a critical error in entity and timeline accuracy. (3) Entity Accuracy: The company name is correct, and the focus on Embedded Processing is relevant, but the misrepresentation of segment status in 2022 and fabricated financials severely damage entity and metric accuracy. (4) Reasoning: The multi-hop reasoning fails because the LLM incorrectly assumes continuity in segment reporting and then interprets fabricated financial declines as evidence of strategic contraction, when the ground truth indicates a strategic elevation in 2024. The logic is internally consistent but based on false premises. (5) Semantic Equivalence: The overall message of the LLM answer—that strategic emphasis remained consistent but financial performance declined—contradicts the ground truth, which states that the strategic emphasis *increased*, marked by the elevation to a reportable segment. Thus, the semantic meaning is fundamentally different. The contextual relevance is moderate because the answer addresses the right topic and structure but with incorrect facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 542,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "In the 2022 filing Thermo Fisher reported two 2.00 % 10‑year senior‑note series: the euro‑denominated notes due 4/15/2025 carried $728 million at an effective interest rate of 2.10 % (page 86) and the notes due 10/15/2031 carried $1.2 billion at an effective rate of 2.23 % (page 88). By the 2024 filing the 2025 series had been trimmed to $663 million (down from $706 million a year earlier) with its effective rate falling slightly to 2.07 % (page 47), while the 2031 series remained unchanged at $1.2 billion and still measured at a 2.23 % effective rate (page 48). This shows a gradual reduction of the 2025 notes through amortization/redemption, while the larger 2031 issue stayed constant in both amount and valuation.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that TMO (Thermo Fisher Scientific) only has one 2.00% 10-Year Senior Note due October 15, 2031, with a principal of $1,200 million and an effective interest rate of 2.23% in 2022, unchanged in 2024. However, the LLM introduces a second series of notes due April 15, 2025, denominated in euros, which is not mentioned in the ground truth and is therefore incorrect. This euro-denominated note series and its associated values ($728M in 2022, $663M in 2024) are entirely fabricated in the context of this question. Additionally, the LLM claims the 2025 notes were reduced from $706M to $663M between 2023 and 2024, but this data is not supported by the ground truth and distracts from the actual focus on the 2031 notes. (2) While the $1.2 billion (i.e., $1,200 million) principal and 2.23% effective rate for the 2031 notes are correctly reported in both years, matching the ground truth, the inclusion of an entirely separate and incorrect debt instrument undermines the quantitative accuracy. The dates (10/15/2031) are correct, but the mention of 4/15/2025 is irrelevant and wrong. (3) The multi-hop reasoning is flawed because the model fails to focus on the specific instrument asked about — the 2.00% 10-Year Senior Notes — and instead conflates it with another maturity and currency. The conclusion that the 2031 notes remained constant is correct, but the broader synthesis is compromised by introducing non-existent data. (4) Contextual relevance is high because the answer discusses the right company (TMO/Thermo Fisher), the correct debt instrument type, and the right time frame, but the inclusion of false details about a euro-denominated series significantly reduces correctness. The core fact about the 2031 notes being unchanged is preserved, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 510,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE was highlighted in the 2022 filing as one of the Pharmaceutical segment’s key immunology products, underscoring its importance to the business 【page_7】. By 2024 its sales fell to $1.605 billion, a 12.8% decline from $1.839 billion the year before (and therefore lower than the 2022 level) 【page_31】, indicating that while REMICADE remains a core drug in J&J’s Pharmaceutical portfolio, its growth has slowed and its relative contribution is diminishing compared with newer or faster‑growing products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies REMICADE's role in Johnson & Johnson's Pharmaceutical segment in 2022 as a key immunology product, consistent with the ground truth. It accurately reports the sales decline from $1.839 billion in 2023 to $1.605 billion in 2024, and correctly calculates the 12.8% decrease. These figures match the ground truth exactly, with acceptable format variation ($1.605 billion = $1,605 million). (2) All numeric values are correct: $1.839 billion (2023), $1.605 billion (2024), and the 12.8% decline are all factually accurate and properly contextualized. The calculation of the percentage decline is implied and correct. (3) The multi-hop reasoning is sound: the model connects REMICADE’s status in 2022 to its financial performance in 2024, infers a trend of declining contribution, and contextualizes it within the broader portfolio, even though the 2022 sales figure is not explicitly stated. It correctly infers that performance in 2024 is lower than in 2022 based on the downward trend from 2023 to 2024. (4) The only minor shortcoming is that the original answer explicitly attributes the decline to potential causes like market saturation or competition, while the LLM answer implies this by referencing slower growth and diminished relative contribution compared to newer products. This is a slight omission in depth but does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually appropriate, and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 416,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE’s sales have been on a clear down‑trend – the 2022 filing shows the drug generated $3,190 million in FY 2021 (the most recent figure disclosed) and the 2024 filing shows sales of $1,839 million in FY 2023 and $1,605 million in FY 2024, a 12.8 % year‑over‑year decline and roughly a 50 % drop over the three‑year span【page_30†L31-L38】【page_31†L1-L7】.  This erosion of revenue and the fall in its share of total Immunology sales (from about 10 % to 9 %) signal that REMICADE’s market position within Johnson & Johnson’s Immunology portfolio is weakening, even though it remains one of the segment’s larger products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 sales figure ($1,605 million) and the 12.8% year-over-year decline from 2023 to 2024, which aligns with the ground truth. However, it incorrectly states that the $3,190 million figure was for FY 2021 (not 2022), while the original answer specifies $3,190 million in 2022. This misalignment in time periods affects quantitative accuracy. Additionally, the LLM introduces a $1,839 million figure for FY 2023 not present in the ground truth, which cannot be verified and appears to be an inference or error. (2) The calculation of a 'roughly 50%' drop over three years is unsupported due to the incorrect baseline year and inclusion of an unverified 2023 number. The ground truth only confirms a 14.9% decline from 2020 to 2022 and a 12.8% drop from 2023 to 2024, but does not provide 2023 data. (3) The reasoning about REMICADE's weakening market position is sound and consistent with the downward trend, and the mention of declining share in Immunology sales (10% to 9%) adds context not in the original but plausibly derived. The multi-hop synthesis across years and portfolio context is logical. (4) Despite the incorrect attribution of the $3,190M figure to 2021 instead of 2022 and the introduction of an unverified 2023 value, the core conclusion about declining sales and weakening position is supported. Hence, correctness is partially impacted by factual inaccuracies in timing and numbers, but the overall direction and qualitative assessment remain valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 420,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE’s revenue fell sharply, dropping from $3,190 million in fiscal 2021 to $1,605 million in fiscal 2024 – a roughly 50 % decline overall and a 12.8 % year‑over‑year fall from 2023 (see 2021 table 【page_30】 and 2024 table 【page_31】).  The 2021 filing notes that the product’s sales were already being “partially offset by lower sales of REMICADE… due to biosimilar competition” as biosimilar infliximab entered the U.S. and other markets 【page_31】, and the 2024 table shows an 11.4 % operational decline (plus a 1.4 % adverse currency impact) 【page_31】, indicating that continued biosimilar entry and pricing pressure have driven the ongoing sales erosion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2021 sales figure. The ground truth states REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, but the LLM incorrectly reports $3,190 million ($3.19 billion), which is significantly lower and factually wrong. The 2024 figure of $1,605 million is correct. The year-over-year decline of 12.8% from 2023 to 2024 matches the ground truth and is accurately reflected. However, the overall decline of 'roughly 50%' is based on an incorrect baseline and thus misleading. (2) The calculation of the 12.8% YoY drop is consistent with the ground truth, but the 11.4% operational decline and 1.4% currency impact cited from the 2024 table are not mentioned in the original answer and introduce unverified detail. These may be contextually relevant but are not part of the ground truth and could confuse rather than clarify. (3) The reasoning correctly identifies biosimilar competition as the primary driver of the sales decline and traces its impact from 2021 through 2024, showing sound multi-hop synthesis across years and filings. The use of document references (e.g., page numbers) suggests proper sourcing, though the numbers themselves are inconsistent with ground truth. (4) Despite accurate identification of causal factors and correct 2024 data, the major error in the 2021 sales figure undermines the quantitative foundation of the response. This leads to a significant drop in correctness and quantitative accuracy. The qualitative reasoning and contextual relevance remain strong due to proper causal explanation and focus on the right factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 449,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "In the 2022 Form 10‑K Johnson & Johnson noted that STELARA was still protected by its last U.S. patent, which would not expire until September 2023, and that the company had a new U.S. filing for a pediatric‑psoriatic‑arthritis indication while the drug was a major growth driver (U.S. sales were about $5.9 billion in fiscal 2021)【page_31】. By the 2024 filing, after the patent expiry, STELARA’s revenue had slipped to $10.36 billion in 2024 from $10.86 billion in 2023 – a 4.6 % year‑over‑year decline (operational decline of 3.4 %)【page_31】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the key evolution of STELARA between 2022 and 2024, with only minor inaccuracies affecting the quantitative precision. (1) Correct elements: The answer correctly identifies that in 2022, STELARA had a pending U.S. filing for pediatric psoriatic arthritis, aligning with the ground truth's 'filing stage' status. It accurately reports the 2024 revenue as $10.36 billion (matching the ground truth $10,361 million) and the 2023 revenue as $10.86 billion (vs. $10,858 million), and correctly calculates the 4.6% year-over-year decline. The mention of patent expiry in September 2023 is consistent with the drug's lifecycle context. (2) Quantitative verification: The reported $10.36B and $10.86B are within rounding tolerance of the ground truth ($10,361M and $10,858M). However, the LLM incorrectly attributes the $10.36B and $10.86B figures to 2024 and 2023 sales in the context of the '2024 filing', but the 2024 Form 10-K would report 2023 and 2022 financials, not 2024 sales. This is a material timing error: the $10.36B figure should be for 2023, not 2024. The ground truth states 2024 sales are $10,361M, which is inconsistent with standard 10-K reporting timelines—likely a data issue in the ground truth. However, per standard SEC filing practices, the 2024 10-K (filed in 2025) would report 2024 results, so if the LLM is referencing the '2024 filing' (i.e., 2023 results), it misattributes the year. This creates confusion in temporal alignment. (3) Multi-hop reasoning: The LLM synthesizes patent status, regulatory filings, and revenue trends across years, showing sound reasoning. It connects patent expiry (2023) to subsequent sales decline, which is logically sound. (4) The answer is contextually relevant and comprehensive, but the misattribution of sales years slightly undermines quantitative accuracy. Given that the core financial figures and trends are correct and the reasoning is strong, a score of 8 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 531,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The United States net revenue from Restasis fell from **$382 million in 2023 to $172 million in 2024**, a decline of **$210 million**. The drop represented a **55.2 % decrease in 2024** (versus 2023) and the prior year had shown a **38.5 % decrease in 2023** (versus 2022)【page_43 (2023 10‑K)】【page_43 (2024 10‑K)】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: $382 million in 2023 and $172 million in 2024, with a correct dollar decrease of $210 million. The percentage decreases are also exactly correct: 38.5% decrease in 2023 (vs. 2022) and 55.2% decrease in 2024 (vs. 2023). (2) The answer is complete, addressing both parts of the question: the change in total net revenue between 2023 and 2024, and the percentage decrease in each year. (3) Entity accuracy is correct—Restasis, United States net revenue, and the years 2022–2024 are properly referenced. (4) The multi-hop reasoning is sound: the model correctly synthesized data across two years and two filings (2023 and 2024 10-Ks), correctly interpreting year-over-year percentage changes. (5) Semantic equivalence is maintained—though the LLM rephrased the answer slightly (e.g., stating the dollar decline), all factual content matches the ground truth. Minor formatting like '55.2 %' with a space is acceptable and does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 305,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "In 2022 AMT described its master‑lease agreements as a foundation for “consistent, long‑term revenue” that “reduce the likelihood of non‑contractual churn” and that “build and augment strong strategic partnerships… while significantly reducing colocation cycle times,” positioning them as a key tool for its international expansion (2022 p. 34). By 2023 the company stresses that those same agreements have become an even more central strategic asset—still delivering reliable revenue and churn mitigation (notably the T‑Mobile MLA) but now explicitly accelerating the rollout of new sites worldwide and deepening tenant relationships to support rapid international growth (2023 p. 37; 2023 p. 35).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Master Lease Agreements (MLAs) at AMT between 2022 and 2023. (1) All entities—AMT, T-Mobile MLA, and the years 2022 and 2023—are accurately referenced. The qualitative descriptions of MLAs reducing colocation cycle times, supporting strategic partnerships, ensuring long-term revenue, and reducing non-contractual churn match the original answer. (2) There are no numeric inaccuracies; the LLM does not include the specific portfolio sizes (177,000 in 2022 and 182,000 in 2023), which are present in the ground truth. This omission affects completeness but not correctness per se, as the LLM does not misstate any numbers. (3) The multi-hop reasoning is sound: the LLM correctly infers that MLAs evolved from being foundational tools in 2022 to even more central strategic assets in 2023, with expanded roles in accelerating site rollouts and deepening tenant relationships. It appropriately cites specific pages from the filings as evidence. (4) The semantic meaning is equivalent to the original answer, though slightly less detailed regarding the explicit portfolio growth and risk mitigation (e.g., customer consolidation, regulatory changes). The emphasis on international growth and tenant retention is preserved. The answer is fully contextually relevant. The correctness score is 8 due to the omission of quantitative site counts and some risk context, but no factual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 413,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Both the 2023 filing (see page 57) and the 2024 filing (see page 58) describe Google Marketing Platform as one of the primary channels through which advertisers buy Google‑Ads inventory. The company’s accounting for ads on Google Network properties also remains unchanged – it evaluates whether it is the principal or an agent and, when acting as principal, records the billed amount as gross revenue and the payments to network partners as cost of revenue. Thus, between 2023 and 2024 the platform’s role in generating ad revenue and the way network‑property ads are recognized and managed have stayed essentially the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly identifies that Google Marketing Platform is a channel for ad inventory and references the principal vs. agent evaluation, it asserts that the role and revenue recognition practices 'have stayed essentially the same' between 2023 and 2024. This directly contradicts the ground truth, which states that the platform's role evolved in 2024 to include a more nuanced evaluation of principal vs. agent status with an emphasis on control over inventory, and introduced a more detailed explanation of its central function in managing advertising across Google Network properties. The LLM incorrectly minimizes or ignores this evolution. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in narrative and emphasis between the two years, incorrectly concluding stability when the ground truth describes evolution in both revenue recognition rationale and platform management role. (4) Contextual relevance is moderate—the answer addresses advertising revenue recognition and mentions Google Network properties, but misses the key evolution in the platform’s role. Correctness and qualitative accuracy are low due to the central factual inaccuracy in the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 397,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Bank of America’s “Federal funds purchased & securities‑loaned” line grew sharply – the notional amount rose from roughly **$481.9 billion in 2023** (Level 2 amount) to about **$570.2 billion in 2024**, an increase of ≈ $88 billion (≈ 18 %).  At the same time the fair‑value of the liability climbed from **$178.6 billion** to **$192.9 billion**, up about **$14 billion (≈ 8 %)**【page_156†L31-L34】【page_155†L31-L34】.  The higher volume and higher fair‑value indicate that BAC leaned more heavily on Federal‑funds and repo‑style securities‑loan transactions in 2024, expanding its short‑term funding toolkit to support liquidity and take advantage of market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the trend of increasing volume and fair value in Federal Funds Purchased & Sec Loaned from 2023 to 2024, and accurately infers that BAC expanded its use of short-term funding, which aligns with the ground truth's interpretation. However, there are significant discrepancies in the quantitative details. 2) The ground truth states a net change in volume of $16,466 million (i.e., $16.5 billion) in 2023, but the LLM reports a notional increase from $481.9B to $570.2B (an $88.3B increase), which contradicts the ground truth. Additionally, the fair value increase is reported as $14B (from $178.6B to $192.9B), while the ground truth only provides the 2024 fair value ($192,859M ≈ $192.9B) without a 2023 baseline, making full verification impossible. The $14B delta cannot be confirmed, but the 2024 fair value matches. The LLM introduces a 2023 fair value ($178.6B) not present in the original answer, which may be accurate but is not supported by the provided ground truth. 3) The multi-hop reasoning is sound in linking volume and fair value increases to short-term funding strategy, and the entities (BAC, Federal Funds Purchased & Sec Loaned, 2023–2024) are correct. 4) The contextual relevance is perfect—directly addresses both parts of the question with appropriate interpretation. However, the quantitative accuracy is reduced due to unverified and conflicting volume figures. The LLM may be pulling correct data from the source, but it diverges from the ground truth provided, which only reports a $16.5B net change in volume in 2023, not an $88B year-over-year increase. Thus, while the direction and qualitative conclusion are correct, the magnitude of change is inconsistent with the ground truth, leading to a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 483,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "PepsiCo’s 2022 Form 10‑K only gave a brief pointer in the Market‑Risks section, stating that “the exposure of our **pension and retiree medical plan assets and liabilities** to risks related to market fluctuations” can be found in the “Our Critical Accounting Policies and Estimates” note【page_40】. By the 2024 filing, the company placed that same exposure within a broader discussion of indefinite‑life intangible assets and goodwill, again referring readers to the Critical Accounting Policies note but now framing the pension/medical‑plan sensitivity as part of a more comprehensive analysis of market‑risk impacts on intangible assets【page_42】. This reflects an evolution from a simple reference to a more integrated, detailed disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in that it identifies the evolution of PepsiCo's disclosure between 2022 and 2024 regarding pension and retiree medical plan liabilities. It correctly notes that in 2022, the company referred readers to 'Our Critical Accounting Policies and Estimates' for details on market risk exposure (page 40), and that by 2024, the discussion was more integrated (page 42). However, the core factual claim in the LLM answer — that the 2024 disclosure framed pension/medical plan sensitivity as part of a discussion on indefinite-life intangible assets and goodwill — is incorrect and contradicts the ground truth. The original answer states that by 2024, PepsiCo expanded the disclosure to include sensitivity to inflationary, deflationary, and recessionary conditions, not intangible assets. This mischaracterization represents a significant error in entity and conceptual accuracy. While the LLM recognizes an evolution in disclosure depth, it misattributes the nature of that evolution. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound in identifying a shift in disclosure integration, but the multi-hop synthesis fails because it draws on incorrect or misaligned information. Contextually, the answer is relevant to the question but misdirects the focus to intangible assets, which were not part of the actual evolution in pension liability disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 401,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "In the 2024 filing Adobe now spotlights Adobe Scan as a free mobile app that captures paper documents, applies OCR and instantly creates searchable PDFs that are stored and shared through Adobe Document Cloud – and it is listed alongside Acrobat and Acrobat Sign as a core Document Cloud component (see 2024 p. 12‑13). The 2023 filing’s disclosed sections contain no specific mention of Adobe Scan or its integration, indicating that between 2023 and 2024 Adobe elevated Scan from a peripheral offering to an integrated piece of its broader document‑management ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. It accurately identifies that Adobe Scan was more prominently featured in the 2024 filing as a core component of Adobe Document Cloud, integrated alongside Acrobat and Acrobat Sign, and highlights its functionality (OCR, PDF creation, cloud storage). The claim that Adobe Scan was not specifically mentioned in the 2023 filing is consistent with the ground truth implication that it was less emphasized, supporting the conclusion that its positioning was elevated by 2024. However, the LLM answer does not fully capture the qualitative evolution emphasized in the original answer—specifically, the shift toward AI-driven features (e.g., Firefly, Content Credentials) and enterprise workflow integration, which are key aspects of Adobe’s 2024 strategic direction. While the LLM correctly infers increased integration, it omits these advanced capabilities that define the broader ecosystem evolution. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign, 2023 vs 2024) are correctly identified. The reasoning is sound but slightly incomplete in synthesizing the full scope of multi-hop information regarding technological enhancements. Contextual relevance is strong as it directly addresses the question’s focus on positioning within the document management ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 404,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini debuted in December 2023 as a ground‑up multimodal model that can “generalize and seamlessly understand, operate across, and combine different types of information, including text, code, audio, images, and video” and was positioned for use across Alphabet’s businesses 【page_6】. By 2024 the upgraded Gemini 2.0 model had become the engine behind AI features in all seven of Google’s flagship consumer products—Android, Chrome, Gmail, Maps, Play Store, Search and YouTube—as well as Google Cloud and Workspace, and it added new multimodal functions such as native image‑generation, video‑background creation, richer coding assistance and broader app‑integration capabilities 【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini launched in December 2023 as a multimodal model capable of handling text, code, audio, images, and video, and by 2024, Gemini 2.0 was integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. The mention of Google Cloud and Workspace, while not in the original answer, does not contradict it and may reflect expanded integration beyond the core seven. (2) Quantitative accuracy is perfect: the timeline (2023 launch, 2024 upgrade), product count (seven), and capabilities are correctly stated. Format variations (e.g., '2023' vs 'December 2023') are acceptable and even add precision. (3) Multi-hop reasoning is sound: the answer synthesizes evolution over time and advancement in capabilities, correctly linking Gemini 2.0 to broader integration and enhanced multimodal functions like image generation and video-background creation—specific advancements not explicitly detailed in the original but plausibly inferred as part of 'more advanced applications' and consistent with the direction of Gemini's development. (4) The only minor shortcoming is that the original mentions experimental prototypes (Project Astra and Project Mariner), which the LLM omits. This is a small gap in completeness but does not detract significantly from the core answer. Overall, the LLM conveys semantic equivalence with strong factual and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 418,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "In the 2022 filing Linde’s global helium wholesale was bundled in the “Other” segment, which recorded about $2.0 billion of sales but an operating loss of $56 million (a loss‑making component)【page_31】. By the 2024 filing helium was still in “Other,” but sales fell roughly 2% (≈$32 million) as helium volumes dropped, while operating profit jumped 44% to about $62 million – the gain came from an insurance recovery that was only partially offset by higher helium‑related costs【page_28】. Thus, helium moved from being a loss‑driving element in 2022 to a volume‑driven sales drag and cost pressure in 2024, even as the segment’s overall profitability improved.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the evolution of Linde's relationship with helium from 2022 to 2024 and correctly identifies that helium negatively impacted sales and operating profit in 2024. However, there are significant quantitative inaccuracies. The ground truth does not state that the 'Other' segment had an operating loss of $56 million in 2022 or that it reached $62 million in profit in 2024; these specific figures are not present in the original answer and appear to be fabricated or inferred incorrectly. The 2% sales decrease (≈$32M) is plausible if the 'Other' segment was ~$1.6B, but this total segment size is not confirmed in the ground truth, making the calculation speculative. (2) The original answer states that the 'Other' segment had a 44% increase in operating profit, which the LLM correctly notes, but ties it to a specific dollar figure ($62M) not present in the ground truth, reducing quantitative accuracy. The claim that helium was a 'loss-driving element' in 2022 is an overinterpretation—the original only says helium was a supply, not that it caused losses. (3) The multi-hop reasoning is generally sound: the model connects helium to the 'Other' segment, tracks changes in sales and profit impact from 2022 to 2024, and notes the insurance recovery being offset by helium costs. This shows good synthesis across time and segments. (4) Contextual relevance is high—the answer directly addresses the question’s focus on helium’s evolving impact on sales and profit. Despite strong qualitative reasoning and relevance, the inclusion of unsupported dollar figures and loss attribution lowers the correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 458,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net carrying amount of acquired franchise rights fell from $626 million in 2022 to $598 million in 2024, a decline of $28 million (about a 4½ % drop)【page_83†L13-L20】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. The ground truth states the 2022 net value was $789 million, but the LLM reports $626 million—a major discrepancy of $163 million. The 2024 value is correctly reported as $598 million in both answers. (2) The calculation of the decline is therefore incorrect: the LLM computes a $28 million drop (from $626M to $598M), but the actual decline is $191 million ($789M to $598M). The claimed 4.5% drop is also wrong; the true percentage decrease is approximately 24.2%. (3) The reasoning is partially sound in structure—recognizing a decline over time and attempting to quantify the change—but fails due to incorrect input data. The multi-hop aspect (comparing two years) is addressed, but based on incorrect figures. (4) Contextual relevance is high as the answer addresses the right metric, time frame, and direction of change. However, the quantitative inaccuracy severely undermines the correctness, warranting a low score overall. Minor phrasing like 'net carrying amount' vs 'net value' is semantically acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 317,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "In the 2023 filing Chevron disclosed a U.S. natural‑gas delivery commitment of roughly **746 billion cubic feet per year** (for 2024‑2026), and the 2024 filing increased that commitment to about **813 billion cubic feet per year** (for 2025‑2027). By contrast, the natural‑gas production attributed to its Tengizchevroil joint‑venture in Kazakhstan was essentially unchanged, remaining at **≈ 113 million cubic feet per day** in both 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in several critical ways. (1) Quantitative Accuracy: The numbers provided are factually wrong. The LLM claims Chevron's U.S. natural gas delivery commitment is 746 billion cubic feet per year in 2023 and 813 billion in 2024, which is off by orders of magnitude—these figures are not supported by the ground truth. Additionally, the LLM states Tengizchevroil production was ~113 million cubic feet per day in both years, but the ground truth reports Chevron's total sold volumes (including its share from Tengizchevroil) as 7,148 million cubic feet per day in 2023 and 7,569 million in 2024—over 60 times larger than the LLM's figure. The LLM also misrepresents the data as being solely from Tengizchevroil when it is actually Chevron’s total natural gas volumes including its share from that joint venture. (2) Completeness: The question asks about how Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolved from 2023 to 2024. The LLM does not address the actual evolution of volumes tied to Tengizchevroil as reported in the filings; instead, it introduces unrelated U.S. delivery commitments and falsely claims no change in Tengizchevroil volumes. (3) Entity Accuracy: While Chevron and Tengizchevroil are correctly identified, the time periods and metrics are misattributed. The LLM confuses total company-level natural gas volumes with joint-venture-specific production and mislabels delivery commitments. (4) Reasoning: The multi-hop synthesis is flawed. The model fails to connect Chevron’s reported total natural gas volumes (consumed and sold) to its share from Tengizchevroil as presented in the ground truth. Instead, it fabricates or misinterprets unrelated data points. (5) Semantic Equivalence: The meaning is not equivalent—the LLM suggests stability in Tengizchevroil volumes and focuses on U.S. commitments, while the ground truth shows significant growth in both consumed and sold volumes linked to Tengizchevroil. Overall, the answer contains major factual and conceptual errors, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 574,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "In the 2023 Form 10‑K, Google Network partners were referenced only as a line‑item cash outflow – “payments to distribution and Google Network partners” – without detail on how those payments fit into the revenue model. By the 2024 filing, the company explicitly states that amounts paid to Google Network partners are recorded as **cost of revenues** and that it evaluates whether it is a principal or agent on network ads, generally reporting the ad revenue on a gross basis and the partner payments as a cost (see 2023 p. 42; 2024 p. 58‑59). This change reflects a more precise accounting of the partners’ role in Google’s advertising ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in how Google treats payments to Network partners between 2023 and 2024. In 2023, the payment was described as a general cash outflow under operating activities without detailed linkage to revenue accounting. By 2024, the answer correctly notes that these payments are now explicitly recorded as cost of revenues and tied to the gross reporting of ad revenue, reflecting a more refined accounting treatment. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying a shift in accounting language and classification. The citation of specific page numbers (2023 p. 42; 2024 p. 58–59) adds credibility and reflects accurate sourcing. (4) While the ground truth emphasizes the reclassification under Traffic Acquisition Costs (TAC), the LLM answer captures the same economic substance by stating these payments are now part of cost of revenues and directly linked to network ad revenue, which is consistent with TAC being a component of cost of revenue. The only minor gap is the absence of the explicit term 'Traffic Acquisition Costs', but the functional and accounting implications are correctly conveyed. Thus, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 426,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "In the 2023 10‑K the bank warned that a “increasing global regulatory focus, including state, federal and non‑U.S. jurisdictions, on climate change” was spawning new or heightened requirements and that “potential jurisdictional divergence” would raise its legal, compliance and public‑disclosure costs (2023 Form 10‑K p. 24). By the 2024 10‑K the discussion was updated to stress that public‑policy pressures and divergent stakeholder views are further amplifying those jurisdictional differences, increasing the risk of non‑compliance, legal exposure and reputational harm (2024 Form 10‑K p. 24). Thus, the impact of public policies on climate‑related regulatory requirements has grown, with greater jurisdictional divergence and heightened compliance risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: the 2023 10-K notes increasing global regulatory focus and potential jurisdictional divergence leading to higher legal, compliance, and disclosure costs (p.24), and the 2024 10-K confirms that these pressures have intensified, with divergent policies amplifying compliance risks, legal exposure, and reputational harm (p.24). The shift from anticipated to actual impact is correctly inferred. (2) There are no numerical values requiring calculation, but the years (2023, 2024), document types (10-K), and page references (p.24) are accurately cited—quantitative accuracy is perfect. (3) Multi-hop reasoning is sound: the model synthesizes information across two years of filings and correctly identifies the evolution from expectation to experienced impact, particularly around jurisdictional divergence. The mention of 'divergent stakeholder views' adds contextual nuance present in the 2024 filing. (4) The only minor shortcoming is that the LLM slightly reframes the 2024 risk as including 'reputational harm'—while plausible and consistent with the filing, the original answer emphasizes 'actively impacting legal, compliance, and public disclosure risks,' focusing more on operational than reputational effects. This does not make the answer incorrect but introduces a slight shift in emphasis. Overall, the response is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 414,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "In the 2022 filing GM listed “the success of our current line of full‑size SUVs and **full‑size pickup trucks**” as a key risk factor, underscoring the segment’s strategic importance (2022 p. 48). By 2024 the company is reporting concrete upside: North‑American net sales rose $16.1 billion (‑ 11.4 % YoY) and EBIT‑adjusted grew $2.2 billion (‑ 18.1 % YoY), driven largely by “increased net wholesale volumes … **full‑size pickup trucks**” and a “favorable mix … **full‑size pickup trucks**” that added $12.8 billion of volume and $2.5 billion of mix to sales (2024 p. 34). The 317‑thousand‑unit (10.1 %) rise in wholesale vehicle sales further quantifies the stronger market positioning of the full‑size pickup line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. While it correctly identifies that full-size pickup trucks were a key risk factor in 2022 and became a performance driver in 2024, the financial figures cited are incorrect or misrepresented. For example, the LLM claims North American net sales rose by $16.1 billion but then adds '(-11.4% YoY)', which is contradictory—sales cannot rise in dollar terms while declining by 11.4%. Similarly, EBIT-adjusted grew by $2.2 billion but is paired with '(-18.1% YoY)', another logical inconsistency. These errors suggest flawed data interpretation. The $12.8 billion volume and $2.5 billion mix contributions may be misattributed or inaccurately extracted. (2) The ground truth highlights a variable profit of approximately 160% for full-size trucks on a weighted-average basis in 2024, which is a critical profitability metric that the LLM completely omits. Instead, the LLM invents or misquotes figures not present in the original answer, such as the 317,000-unit (10.1%) rise in wholesale sales—this specific number is not mentioned in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly traces the evolution from risk factor (2022) to performance contributor (2024), showing awareness of strategic shift. However, it fails to accurately synthesize the correct quantitative indicators—especially the 160% variable profit—which is central to the 2024 performance assessment. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution of strategy and 2024 performance indicators. However, due to major quantitative inaccuracies and omission of key metrics, the correctness score is low. The qualitative accuracy is moderate because the conceptual framework is correct, but execution is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 507,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "In the 2022 filing the nuclear‑decommissioning trusts held $21 million of U.S. Treasury and government‑agency securities at Alabama Power and $293 million at Georgia Power (about $314 million in total) 【page_311】. By the 2024 filing those balances were $20 million at Alabama Power and $349 million at Georgia Power (about $369 million combined) 【page_277】. The increase—particularly the jump at Georgia Power—shows the trusts are being tilted toward more low‑risk, government‑backed securities, reflecting a more conservative investment strategy for future decommissioning costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and years from the ground truth: $21M and $293M in 2022 for Alabama Power and Georgia Power respectively, and $20M and $349M in 2024. These figures match the original answer exactly, and the total calculations ($314M in 2022, $369M in 2024) are accurate. (2) Quantitative accuracy is perfect—no errors in numbers, formatting, or arithmetic. (3) However, the reasoning and interpretation differ significantly from the ground truth. The original answer emphasizes a shift in allocation focus toward Georgia Power’s portfolio, suggesting internal reallocation within the company’s subsidiaries. In contrast, the LLM interprets the change as a broad move toward a more conservative investment strategy due to increased government-backed securities overall. While the total allocation did increase, the decrease in Alabama Power’s holdings suggests a reallocation between subsidiaries, not a company-wide shift to conservatism. This mischaracterizes the strategic implication, missing the nuance of internal portfolio rebalancing. (4) Therefore, while the facts and numbers are fully correct (justifying a high quantitative and contextual score), the qualitative reasoning is partially flawed, leading to a correctness score of 7—core data is right, but the synthesized conclusion is not fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 385,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "In the 2022 filing PepsiCo described independent bottlers mainly as customers that receive “bottler funding” – sales‑incentive and advertising support tied to annual targets and accrued as a reduction of revenue 【page_60】. By the 2024 filing the relationship is framed as an exclusive franchise arrangement in which bottlers pay for concentrate, finished‑goods and royalty fees, while still receiving annually‑negotiated bottler‑funding for advertising, new‑product and equipment programs 【page_9】. This shows the partnership has become more formalized and strategically dependent, with financial incentives now embedded in a structured franchise model.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PepsiCo's relationship with independent bottlers from 2022 to 2024 in terms of financial incentives and strategic dependency. It accurately notes that in 2022, bottler funding was provided as sales incentives and advertising support tied to annual targets, accrued as a reduction of revenue, which aligns with the ground truth. In 2024, it correctly identifies that funding remained but within a more structured, annually negotiated framework involving advertising, new product, and equipment programs. The characterization of the relationship as an 'exclusive franchise arrangement' is consistent with increased formalization. However, the LLM answer omits a key quantitative element from the original answer: that Walmart alone accounted for approximately 14% of consolidated net revenue in 2024, highlighting strategic dependency. This omission reduces completeness and weakens the support for the claim of increased strategic dependency. (2) There are no numerical inaccuracies—no incorrect numbers, dates, or percentages are stated. The LLM does not introduce false quantitative data, but it fails to include the 14% figure, which is central to the ground truth’s argument about strategic dependency. (3) The multi-hop reasoning is partially sound: the model synthesizes information across 2022 and 2024 filings and correctly infers increased formalization and dependency. However, it does not fully connect the revenue concentration (Walmart’s 14%) to the conclusion of strategic dependency, missing a critical link in the evidence chain. (4) The correctness score is 7 because core facts and reasoning are accurate, but a significant contextual detail (the 14% revenue contribution) is missing. Quantitative accuracy is 10 because no stated numbers are wrong. Qualitative accuracy is 7 due to incomplete synthesis and missing evidence for strategic dependency. Contextual relevance is 9 as the answer directly addresses the question and uses appropriate terminology and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 551,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "In the 2023 filing Adobe Firefly appears only as one entry in the “Summary of Trademarks” list, showing it was a registered brand but not highlighted in the narrative (see 2023 page 99). By the 2024 filing the company is explicitly calling out Firefly in its risk‑factor discussion, noting it as a newly released generative‑AI product whose success, regulatory exposure and reputational impact are material to Adobe’s innovation agenda (see 2024 page 23). This shift from a simple trademark listing to a prominent risk‑disclosure signal marks Firefly’s evolution from a peripheral brand to a central pillar of Adobe’s AI‑driven product strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects that in 2023, Adobe Firefly was listed only in the trademarks section (page 99), indicating it was a registered brand but not emphasized in narrative disclosures. In 2024, it was explicitly mentioned in the risk factors (page 23) as a newly released generative AI product, signaling strategic importance. (2) There are no numerical values requiring calculation, but the years (2023, 2024) and page references (99, 23) are correctly cited and consistent with the evidence. Format and referencing are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, contrasting trademark listing versus risk disclosure to infer strategic evolution. It draws the correct conclusion that Firefly moved from a peripheral brand to a central component of Adobe’s AI strategy. (4) The answer is semantically equivalent to the original, with enhanced detail (e.g., page numbers, 'regulatory exposure', 'reputational impact') that enrich understanding without introducing error. All aspects of the question—evolution, trademark positioning, risk disclosure, strategic implications—are addressed thoroughly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 354,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "In 2022 the MD&A listed “contractual rent escalations on existing tenant leases, net of churn” as one of the primary drivers of tenant‑billing growth, but gave no dollar amount, implying that escalations were a stable, positive contributor with little offset from churn. In 2023 the filing quantifies that escalations added only $12.5 million to tenant‑billing growth (net of churn) while churn rose to roughly 3 % of billings—largely from T‑Mobile lease cancellations—so the net impact of escalations was modest and partially offset by the higher churn (see 2023 MD&A, pages 39 and 35).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the original answer, most notably that 'escalations added only $12.5 million to tenant-billing growth (net of churn)' in 2023. This figure is not mentioned in the ground truth and cannot be verified from the provided information, making it factually unsupported. The original answer does not provide any dollar amounts for the impact of rent escalations in either 2022 or 2023, so this addition represents a significant factual overreach. Additionally, while the 3% churn rate is correctly attributed to 2023 and linked to T-Mobile, the original does not specify that this 3% is 'of billings'—a detail the LLM adds without confirmation. (2) The calculation of net escalation impact as $12.5M is entirely absent from the ground truth, introducing a false sense of precision. No dollar figures were provided in the original, so including one here undermines quantitative accuracy. (3) The qualitative reasoning is strong: the LLM correctly identifies the shift in narrative from 2022 to 2023, noting that rent escalations remained a driver but faced headwinds from increased churn, particularly due to T-Mobile lease cancellations. It also correctly infers that the context changed, with escalations being more offset by churn in 2023. This shows sound multi-hop reasoning in interpreting the evolving impact of escalations despite not having explicit numerical data. (4) Contextual relevance is high—the response directly addresses the question about how the role of rent escalations changed amid rising churn. However, the inclusion of unverified numbers reduces overall correctness. While the direction of reasoning aligns with the ground truth, the unsupported quantification leads to a correctness score of 6, reflecting partial accuracy with significant factual embellishment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 505,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "In 2023 Chevron reported $3.5 billion of affiliate‑capex, with “nearly half of Affiliate Capex … for Tengizchevroil’s FGP/WPMP Project in Kazakhstan” (≈$1.7 billion) 【page_50】.  For 2024 the company expects $3 billion of affiliate‑capex, again “nearly half … for Tengizchevroil” (≈$1.5 billion) and a separate $1.3 billion equity‑affiliate spend “primarily related to development projects for TCO in Kazakhstan” 【page_11】.  Production from the Kazakhstan affiliate (which includes TCO) was essentially flat at about 45 k barrels of oil‑equivalent per day in both 2023 and 2024 【page_9】, and 2024 saw “329 million BOE in Kazakhstan, primarily at TCO” transferred to proved developed reserves 【page_111】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and misrepresents the timeline. The original answer states that the $3 billion affiliate capex was *expected in 2024*, with nearly half allocated to Tengizchevroil's FGP/WPMP project. However, the LLM claims Chevron *reported $3.5 billion* in affiliate capex for 2023, which contradicts the ground truth (which does not specify the exact 2023 capex amount, only the 2024 expectation). The ≈$1.7 billion and ≈$1.5 billion allocations are estimates based on 'nearly half' but are not explicitly confirmed in the original answer, making their precision misleading. Additionally, the LLM introduces a $1.3 billion equity-affiliate spend in 2024 'primarily related to development projects for TCO'—a detail absent from the original answer and unsupported by the ground truth. (2) The production volume of ~45k BOE/day and 329 million BOE in reserve additions are not mentioned in the original answer, making them extraneous and unverified details that undermine quantitative accuracy. (3) The qualitative reasoning correctly identifies a shift from capital investment to production involvement, aligning with the original answer’s theme of transition from development to operational phase. It attempts multi-hop synthesis by connecting capex trends and production/reserve data across years and entities. However, it overreaches by introducing unsupported specifics. (4) Contextual relevance is high because the response focuses on Chevron’s evolving relationship with Tengizchevroil, addressing both capex and production across 2023–2024. Despite factual inaccuracies, the structure and intent match the question’s requirements. Overall, the answer is partially correct but contains significant quantitative errors and unsupported details, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 500,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "UPS’s description of the bond‑matching method did not change – the 2023 filing says the company “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments” (page_84), and the 2024 filing repeats the same language verbatim (page_88). Thus, the specificity of the approach remained consistent between the two years, with no added detail or alteration.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the language was repeated verbatim between 2023 and 2024. The ground truth states that while the mechanics of the bond matching approach did not change, the 2024 disclosure evolved to use more precise language, stating that the approach 'guides' the bond selection process—indicating a subtle but meaningful shift in operational framing. The LLM incorrectly asserts that the wording was identical across years, which contradicts the original answer and suggests a failure to detect nuanced changes in disclosure language. There are no numerical figures in this question, so quantitative accuracy is not applicable beyond correct referencing of page numbers (which the LLM did correctly cite as page_84 and page_88), earning full marks there. However, the qualitative accuracy is low because the model failed to recognize the evolution in specificity and framing, misrepresenting consistency as verbatim repetition. The answer is contextually relevant—addressing the right topic and documents—but fundamentally wrong in its conclusion. This constitutes a significant error in multi-hop reasoning, as the question requires comparing subtle shifts in language and policy articulation across two years, which the model did not perform accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 362,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde went from mainly buying helium as a raw‑material input in 2022 – the 2022 filing notes that “helium … are largely purchased from outside sources” (see page 6) – to operating a dedicated global helium‑wholesale business that is now grouped in its “Other” segment (page 28).  In 2024 the lower helium volumes cut “Other” sales by $32 million (about 2 %) while operating profit in that segment rose $19 million (≈44 %) as insurance recoveries partially offset the higher helium‑related costs (page 28).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a significant discrepancy in the operating profit impact. The ground truth states that helium had a negative impact on operating profit, with costs putting downward pressure on profits, partially offset by insurance recovery. However, the LLM claims operating profit in the 'Other' segment rose $19 million (≈44%), which implies a net positive outcome, contradicting the negative impact described in the original answer. This misrepresents the financial impact on profitability. Quantitatively, the $32 million sales decrease (2%) is accurately reported, and the reference to insurance recovery is correct. The evolution of Linde’s relationship with helium—from a purchased input in 2022 to a dedicated wholesale business by 2024—is well captured and reflects accurate multi-hop reasoning across years and segments. The entity identification (Linde, 'Other' segment, helium, LAMT) and time frame (2022 to 2024) are correct. The answer is contextually relevant and addresses both parts of the question: the evolution of the relationship and the financial impact. However, due to the incorrect characterization of operating profit as increasing rather than being under pressure, the qualitative and overall correctness scores are reduced. Semantic equivalence fails on the profit impact, which is a core part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 378,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America’s unfunded capital contributions for renewable‑energy equity projects fell from **$6.2 billion at year‑end 2023 to $4.6 billion at year‑end 2024** – a drop of roughly **$1.6 billion**【page_132】.  In the same span, the tax credits it recognized on those renewable‑energy investments slipped from **$4.0 billion in 2023 to $3.9 billion in 2024**, a decline of about **$0.1 billion**【page_132】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculated differences ($1.6 billion and $0.1 billion) are correct. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entities are correctly identified—Bank of America, the correct years (2023 to 2024), and the relevant financial metrics (unfunded capital contributions and recognized tax credits). (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly extracted and compared data across two years for two related financial metrics. (5) The semantic meaning is equivalent to the original answer, with slightly more emphasis on numerical changes but without altering factual content. Minor formatting differences (e.g., en-dashes, bolding) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 322,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "In the 2022 Form 10‑K GM explained that it sells fleet vehicles “directly or through our dealer network” and warned that “certain fleet transactions, particularly sales to daily rental‑car companies, are generally less profitable than retail sales to end customers” (2022 p. 8). By the 2024 filing the company still uses its dealer network for fleet sales but adds that “fleet sales are completed through the dealer network and in some cases directly with fleet customers” and frames profitability in terms of broader “vehicle‑level profitability metrics” rather than singling out fleet sales as less profitable (2024 p. 103).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, GM acknowledged that fleet sales—especially to rental companies—were less profitable than retail and used direct or dealer-based channels. By 2024, GM continued using the dealer network but clarified that some fleet sales were completed directly with fleet customers, indicating a more structured approach. The LLM correctly notes the shift in tone regarding profitability, from explicitly stating fleet sales were less profitable in 2022 to discussing them within broader vehicle-level profitability metrics in 2024. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) and page references (p. 8, p. 103) are correctly cited and consistent with the source structure, though exact page numbers are not part of the ground truth evaluation; their inclusion does not detract from accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two different disclosures, correctly identifying the evolution in sales channels and the nuanced shift in how profitability is discussed. (4) Semantic equivalence is strong—the LLM captures the strategic shift without overstating it, and wording differences (e.g., 'in some cases directly' vs 'directly or through dealer network') reflect accurate paraphrasing. The only minor limitation is that the LLM does not explicitly state that this reflects a 'strategic shift toward balancing fleet sales with profitability,' which is a key interpretive point in the original answer, but this concept is implied through the comparison. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 502,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "In 2022 PepsiCo said that its Food & Beverage North America (FLNA) segment “makes, markets, distributes and sells Sabra refrigerated dips and spreads through a joint venture with Strauss Group,” reflecting a 50 % equity ownership in Sabra 【page_42】. By 2024 PepsiCo had re‑measured that 50 % stake at fair value, recognizing a pre‑tax gain of $122 million (about $92 million after‑tax) in SG&A for the FLNA division, indicating the joint‑venture interest was being accounted for differently (and likely reduced or sold) 【page_73】. The change turned the Sabra investment into a one‑time accounting gain of roughly $122 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $122 million pre-tax gain and $92 million after-tax figure match expectations (implied tax rate ~24.6%, reasonable and consistent). The 50% equity stake is correctly stated for both 2022 and 2024. Dates (2022 and 2024) are accurate. (2) The answer correctly identifies that PepsiCo held a 50% stake in Sabra in 2022 via a joint venture with Strauss Group, and that by 2024, the stake was remeasured at fair value, resulting in a $122M pre-tax gain. This matches the ground truth that PepsiCo no longer had full ownership and recognized a gain due to remeasurement. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a change in accounting treatment reflecting a strategic shift, even if the exact phrase 'divested a portion' isn't used. The mention of SG&A and FLNA adds contextual detail from the source. (4) Minor deduction in qualitative accuracy because the original answer notes PepsiCo previously had 'full ownership' before 2022, implying a change to 50% stake, while the LLM states PepsiCo already had 50% in 2022 — this may suggest a timing nuance (whether the divestment occurred before or during 2022). However, since the ground truth states 'by 2024' PepsiCo held 50%, and the LLM confirms 50% in 2022, the core evolution (continued 50% stake, remeasurement for gain) is correctly conveyed. Wording differences do not undermine factual correctness. Overall, the answer is complete, relevant, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 439,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "In the 2023 Form 10‑K, Adobe Scan is mentioned only in the trademark list (see 2023 page 99) and is not described as part of any product suite. By the 2024 filing, Adobe Scan is specifically called out as one of the apps that make up Adobe Document Cloud—alongside Acrobat and Acrobat Sign—showing that Adobe now positions Scan as an integrated component of its cloud‑based document‑workflow ecosystem (see 2024 page 12).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects that in 2023, Adobe Scan was only listed in the trademark section (page 99 of the 2023 10-K) and not described as part of any product suite, which matches the original answer's claim about trademark recognition. In 2024, it correctly states that Adobe Scan was explicitly included in Adobe Document Cloud alongside Acrobat and Acrobat Sign (page 12 of the 2024 10-K), demonstrating integration into a strategic product ecosystem. (2) There are no numerical values requiring calculation, but the cited page numbers (99 for 2023, 12 for 2024) are factually accurate and support the claims, enhancing verifiability. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings, identifying a shift in product positioning from passive trademark listing to active inclusion in a defined cloud suite. (4) The answer is semantically equivalent to the original, with added value from specific document citations. All entities—Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign, and the correct years—are accurately identified. The response is highly relevant, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 348,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "In the 2022 Form 10‑K GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had a broad indemnification commitment to Stellantis for any losses arising from inaccurate representations, breaches of covenants, emissions‑related claims, product‑liability and recall costs, and it could not estimate a material loss – the obligations were subject to time limits, thresholds and caps (see 2022 p. 90‑94). By the 2024 filing the same indemnification framework remains, but GM now states it has already paid an immaterial amount for specific Takata‑related recalls and views any further Stellantis indemnification risk as remote, while still being unable to quantify a material exposure (see 2024 p. 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the ongoing indemnification obligations from the 2017 Opel/Vauxhall sale, specifying key liability areas such as emissions-related claims, product liability, recalls (including Takata), and representations and warranties — all consistent with the original answer. The evolution from 2022 to 2024 is accurately portrayed: in 2022, GM had broad indemnification commitments with no material loss estimated; by 2024, it reports having paid an immaterial amount for Takata-related recalls and views further risk as remote. (2) There are no numeric inaccuracies — the term 'immaterial amount' matches the ground truth's 'accrued an immaterial amount as of December 31, 2024', and no specific dollar figures are misstated. Format and terminology are consistent with SEC disclosure language. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), entities (GM and Stellantis), and legal/financial concepts (indemnifications, remote risk, materiality). It captures the shift from operational to indemnification-based exposure, though it does not explicitly mention the 2022 supply-related transactions (a minor omission). (4) Despite this, the core transformation in the nature of obligations is clearly conveyed. The LLM cites specific page numbers (2022 p. 90–94, 2024 p. 93–94), enhancing verifiability. The only reason for not scoring a 10 is the slight lack of emphasis on the earlier operational supply relationship in 2022, which the original answer highlights as context for the evolution. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 464,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo disclosed that, beyond its own owned or leased facilities, it “utilizes a highly distributed network of plants, warehouses and distribution centers that are owned or leased by our contract manufacturers, **co‑packers**, strategic alliances or joint ventures in which we have an equity interest” (2022 p. 27). The 2024 Form 10‑K repeats the same language, confirming that the company still depends on co‑packers for production capacity while maintaining equity stakes and joint‑venture arrangements that give it strategic influence over those operations (2024 p. 30). Thus, between 2022 and 2024 PepsiCo’s operational dependency on co‑packers remained steady, and its strategic involvement—through equity interests and partnerships—continued unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the language in the 2024 Form 10-K is the same as in 2022, directly contradicting the ground truth which identifies a meaningful shift in wording and strategic emphasis. The original answer notes that in 2022, co-packers were described as part of a 'highly distributed network' owned by third parties, indicating operational dependency, while in 2024 the language evolved to emphasize 'strategic alliances or joint ventures in which we have an equity interest,' signaling deeper strategic involvement. The LLM fails to detect this evolution and instead asserts no change occurred. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is flawed: the task required comparing PepsiCo’s disclosures across two years to identify a shift in relationship characterization. The LLM incorrectly concludes the language is identical, when in fact the ground truth (based on actual filings) shows a shift in emphasis and wording that reflects strategic evolution. This represents a failure in document comparison and synthesis. (4) While the LLM answer is relevant to the topic and cites correct document types (Form 10-K) and page numbers, its core factual claim—that nothing changed—is false per the ground truth. Hence, despite good formatting and apparent sourcing, the answer is substantively incorrect, warranting a low correctness and qualitative accuracy score. Contextual relevance is higher because the response addresses the right companies, time frame, and general theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 452,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "In 2023 Simon & Schuster’s (SPG) relationship with Authentic Brands Group (ABG) was marked by a series of capital‑transaction‑driven dilutions that cut its ownership from roughly 12 % to about 9.6 % and generated several non‑cash gains – a $145.8 million deemed‑disposal gain from the SPARC equity issuance, a $59.1 million deemed‑disposal gain from ABG’s capital moves, and a $157.1 million share‑of‑gain on the sale of a portion of its ABG interest (all disclosed on page 65 of the 2023 filing). By contrast, in 2024 SPG fully exited the partnership, selling its remaining ABG stake for $1.2 billion and recognizing a pretax cash gain of $414.8 million (page 73 of the 2024 filing), effectively monetizing the investment and ending the strategic relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2023 gains of $145.8 million (from SPARC dilution), $59.1 million (from ABG's capital transactions), and $157.1 million (from sale of ABG interest), it misrepresents the 2024 developments. The ground truth states that in 2024, SPG recognized a $18.8 million gain from the sale of a portion of its ABG interest that occurred in December 2021 (disclosed in 2024), not a full exit. In contrast, the LLM claims SPG 'fully exited the partnership' in 2024, selling its remaining stake for $1.2 billion and recognizing a $414.8 million gain—information not present in the original answer and factually incorrect based on the provided truth. (2) The quantitative accuracy is partially correct for 2023 numbers but entirely wrong for 2024: the $1.2 billion sale and $414.8 million gain are fabricated. The $18.8 million gain mentioned in the truth is omitted. (3) The multi-hop reasoning fails: instead of recognizing that 2024 marked a shift toward strategic operational collaboration (Reebok partnership), the model incorrectly infers a full exit, reversing the actual evolution of the relationship. It also misattributes the timing of the 2021 sale being disclosed in 2024 as if the transaction occurred in 2024. (4) Scores are low due to major factual and directional errors in both quantitative and qualitative dimensions. Contextual relevance is moderate because the answer addresses the right companies and general theme of financial evolution, but the conclusion is fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 436,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin said that higher RMS product costs were “primarily attributable to … higher production volume on various Sikorsky helicopter programs” (2022 p. 43), but it did not detail which airframes were involved. By the 2024 filing the company’s RMS segment is described as supporting a broader set of Sikorsky platforms—Black Hawk, Seahawk, CH‑53K King Stallion, the Combat Rescue Helicopter and the VH‑92A Marine One—and notes that the final VH‑92A aircraft was delivered in 2024 (2024 p. 4‑5), showing continued high‑volume production plus an expanded program scope that now includes the Marine One transport mission.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or percentages are misstated—the original answer notes a $560 million increase in product costs in 2022 due in part to higher Sikorsky production volume, and the LLM correctly avoids quantifying the production volume itself, instead citing the cost impact contextually. No numerical inaccuracies are present. (2) The LLM correctly identifies the evolution from 2022 to 2024: in 2022, Sikorsky programs contributed to higher production volume (linked to cost increases), and by 2024, specific platforms (Black Hawk, Seahawk, CH-53K, Combat Rescue Helicopter, VH-92A) are explicitly named as part of RMS’s portfolio, including the completion of the VH-92A program in 2024. This reflects an expanded program scope as stated in the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across the 2022 and 2024 10-K filings to show an evolution in both production volume and program scope. The LLM adds slightly more detail (e.g., VH-92A delivery completion) than the original answer, which is supported by the source but not included in the ground truth summary; this is a minor enhancement, not an error. (4) The only reason for not scoring a perfect 10 is that the LLM answer frames the 2022 cost increase as 'primarily attributable' to higher production volume, while the original answer states it was 'partly due to'—a slight overstatement of causality. However, the LLM accurately quotes the document, so this is justified. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 452,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023 Walmart bought Alert Innovation for about $0.4 billion, converting the former variable‑interest entity into a wholly‑owned subsidiary (≈100 % ownership)【page_45】. The 2024 filing shows no further purchase or sale of Alert Innovation, so Walmart kept the 100 % stake and made no additional cash investment in the company during fiscal 2024【page_65】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and increased ownership to approximately 100%, which matches the ground truth. However, it incorrectly concludes that Walmart retained the 100% stake in fiscal 2024, directly contradicting the ground truth, which states there was no mention of Walmart retaining ownership, indicating a full exit. This is a critical factual error in the core conclusion of the answer. (2) Quantitatively, the $0.4 billion figure is accurate and correctly attributed to fiscal 2023. There are no calculation errors in the numbers presented. (3) The multi-hop reasoning is flawed: while the LLM correctly interprets the 2023 acquisition, it misinterprets the absence of mention in the 2024 filing as evidence of continued ownership, whereas the ground truth treats this absence as evidence of divestiture. This reflects a failure in correct inference from the data, especially in the context of tracking ownership changes over time. (4) The answer is contextually relevant and addresses the evolution of ownership and investment, but due to the major error in the 2024 conclusion, the overall correctness is severely compromised. The qualitative accuracy is low because the reasoning and synthesis across years are incorrect, despite accurate entity and number identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 380,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "In 2023 Simon Property Group used its €750 million borrowing under the €3.5 billion Supplemental Facility, hedged that Euro‑denominated debt with a 3.81% fixed‑rate swap, and then fully repaid the facility on Nov 14‑17 2023 with proceeds from a €750 million senior unsecured bond issuance 【page_70】. By 2024 the Supplemental Facility remained available with a $3.5‑$4.5 billion borrowing capacity but no outstanding balance, showing that the company shifted from drawing on the facility to preserving it as a liquidity source 【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SPG's borrowing of €750 million under the Supplemental Facility in 2023 and its full repayment in November 2023, aligning with the ground truth. The repayment date is slightly off—Nov 14–17 vs. Nov 17—but this narrow range likely reflects interpretation of reporting language and does not materially misrepresent the event. The 2024 status of zero outstanding balance is accurately reported, as is the continued availability of the facility. The shift in strategy toward using long-term unsecured notes is implied by referencing the bond issuance as the repayment source, though the $1.0 billion September 2024 issuance mentioned in the ground truth is not explicitly included, representing a minor omission. (2) All numeric values—€750 million, €3.5 billion facility size, 3.81% swap rate—are factually accurate and contextually appropriate. The date range (Nov 14–17) is close to the exact date (Nov 17) and may reflect document phrasing; no calculation errors are present. (3) The multi-hop reasoning is sound: the model connects the borrowing, hedging, repayment, and refinancing activity across time, correctly inferring a strategic shift from active use to precautionary availability. The synthesis of refinancing via bond proceeds demonstrates valid reasoning. (4) The answer is highly relevant, directly addressing borrowing activity and repayment strategy evolution. The omission of the specific $1B 2024 unsecured note weakens completeness slightly, but the core strategic shift is accurately conveyed. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth with only minor detail gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 463,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "In the 2023 filing Linde explicitly listed helium as one of its core “process gases” and described its merchant‑supply model – typically 3‑ to 7‑year contracts that carry no minimum‑purchase or volume commitments (2023 10‑K, page 100). By contrast, the 2024 filing no longer calls out helium as a primary product; it only presents aggregate sales by distribution method (merchant, on‑site, packaged) without a separate helium discussion (2024 10‑K, page 89), suggesting helium has been subsumed into the broader process‑gas portfolio and is no longer highlighted with a distinct supply‑strategy narrative.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that in 2023, helium was explicitly listed as a core product (referred to as 'process gases') with a detailed supply strategy involving 3- to 7-year contracts without minimum purchase requirements, citing the correct page (100) of the 2023 10-K. (2) For 2024, it accurately notes that helium is no longer called out as a distinct product and is instead included in aggregate sales by distribution method (merchant, on-site, packaged), citing page 89 of the 2024 10-K. (3) The reasoning is sound: the shift from explicit mention to aggregation supports the conclusion that helium has been subsumed into the broader gas portfolio, indicating a strategic repositioning. (4) All entities (Linde, helium, industrial gases, 2023 vs 2024 filings) are correct, and the multi-hop synthesis across years and documents is accurate. Minor wording differences (e.g., 'process gases' vs 'primary products') do not affect factual equivalence. No calculation errors. Full contextual relevance to the question on positioning and supply strategies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 323,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan held $182 million in fixed‑income securities and cash equivalents (Level 1 $7 m + Other $175 m) and $98 million in equity securities, for total assets of $280 million【TXN_10k_2022.pdf page_48】. By year‑end 2023 fixed‑income holdings had risen to $210 million (Level 1 $4 m + Other $206 m) while equity securities fell to $54 million, leaving total assets of $264 million and shifting the mix from roughly 65%/35% fixed‑income‑to‑equity to about 80%/20%【TXN_10k_2023.pdf page_47】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 figures. According to the ground truth, in 2022 the plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. However, the LLM reports $182 million in fixed income and $98 million in equity, totaling $280 million—these numbers are incorrect. In contrast, the 2023 figures ($210 in fixed income and $54 in equity, totaling $264) match the ground truth exactly. (2) Calculations: The LLM correctly calculates the 2023 total and the shift in allocation percentages (from 65%/35% to 80%/20%), but these are based on incorrect 2022 baselines. The actual 2022 split was ~64.4% fixed income and ~35.6% equity (248/385 and 137/385), so the percentage characterization is approximately correct, but derived from wrong inputs. (3) Multi-hop reasoning: The model attempts to synthesize data across two years and two filings (2022 and 2023 10-Ks), which shows correct intent and structure. However, due to erroneous 2022 data extraction, the comparative analysis is flawed. The conclusion that equity securities decreased significantly is correct, but the claim that fixed income 'rose' to $210 million is false—the ground truth shows a decrease from $248 to $210. (4) Justification: The correctness score is low due to major quantitative errors in 2022 data. Quantitative accuracy is poor (3/10) because key dollar amounts are wrong. Qualitative accuracy is moderate (5/10) as the reasoning framework and use of sources are sound, but entity values are incorrect. Contextual relevance is high (8/10) because the answer addresses the right plan, years, and asset classes with proper citation and comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 473,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "In 2023 Trodelvy’s sales rose to $777 million in the U.S., $217 million in Europe and $68 million elsewhere – $1.06 billion total – up from $525 million, $143 million and $12 million (‑$680 million total) in 2022, a 56 % increase year‑over‑year【page_40†L31-L38】.  The year also brought new regulatory wins: Gilead obtained FDA approval and European Commission (EC) approval for Trodelvy as a monotherapy in HR⁺/HER2‑ metastatic breast cancer【page_39†L13-L19】, expanding the product’s label beyond the earlier accelerated FDA approval for urothelial cancer (April 2021) that was highlighted in the Immunomedics acquisition notes【page_79†L13-L20】.  Together, higher sales and broader approvals show Trodelvy’s stronger financial performance and strategic positioning in 2023 versus 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. The ground truth states that Trodelvy generated $380 million in 2022, but the LLM claims $680 million (sum of $525M US, $143M Europe, $12M elsewhere), which is significantly higher and incorrect. For 2023, the LLM reports $1.06 billion in total sales, but the original answer explicitly states that 'specific revenue figures for 2023 are not provided,' making the LLM's detailed breakdown ($777M US, $217M Europe, $68M elsewhere) entirely fabricated. The 56% year-over-year increase is therefore also incorrect. (2) Calculations are internally consistent in the LLM answer (e.g., $525M + $143M + $12M = $680M; $777M + $217M + $68M = $1.062B), but since the inputs are false, the outputs are invalid. (3) On qualitative aspects, the LLM correctly identifies key regulatory milestones: FDA and EC approval for HR+/HER2- metastatic breast cancer in 2023, which aligns with the ground truth. It also correctly references prior accelerated approval for urothelial cancer in 2021, adding contextual background. This shows sound multi-hop reasoning in synthesizing regulatory developments across time and regions. (4) Contextually, the answer addresses both financial performance and strategic positioning as asked, and draws a reasonable conclusion about improved market potential based on approvals. However, the complete fabrication of revenue data severely undermines factual correctness. While the reasoning structure is logical and relevant, the core quantitative claims are false, warranting a low correctness score despite accurate qualitative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 449,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron’s downstream earnings from affiliated companies—including GS Caltex—declined modestly, falling from $16.3 billion in 2022 to $13.9 billion in 2024 (page 85).  Yet Chevron kept its 50 % stake in GS Caltex, with the investment balance still around $3.6 billion (page 78) and net loans to affiliates rising from $4.3 billion at year‑end 2022 to $4.7 billion at year‑end 2024 (page 85).  The stable ownership and continued earnings contribution show the joint venture remains a strategically important source of downstream revenue and a key foothold in the Asian market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly reports the decline in sales and other operating revenues from affiliated companies, including GS Caltex, from $16.3 billion in 2022 to $13.9 billion in 2024, which matches the ground truth values of $16,286 million and $13,850 million (rounded appropriately). The 50% ownership stake is correctly stated. The investment balance and net loans to affiliates are additional details not in the original answer but do not contradict it and may come from deeper document analysis; they enhance rather than detract from accuracy. (2) The minor discrepancy is the lack of explicit mention that downstream earnings were higher in 2022 (though implied by revenue decline), and the original answer notes improved income from equity affiliates, which the LLM omits. However, the core financial trend is correct. (3) The reasoning is sound: the LLM correctly infers that despite lower revenues, the stable ownership and continued financial involvement indicate strategic importance, which is consistent with the original answer’s conclusion. (4) The answer addresses all parts of the question—evolution of earnings and investment (2022 to 2024) and strategic implications—with accurate multi-hop synthesis across years and entities (Chevron, GS Caltex, affiliated revenues). Wording differs but meaning is semantically equivalent. One point deducted only because the LLM does not explicitly mention the 2022 'higher downstream earnings' phrasing from the original, though it is implied by the revenue comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 439,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "In the 2022 filing the CH‑53K’s improved profit‑booking rates (risk retirements) were a key driver of RMS operating profit, adding roughly $140 million of profit from the Sikorsky helicopter line [page_50]. By the 2024 filing the focus had shifted to a production ramp‑up, with higher CH‑53K build rates cited as a primary contributor to the rise in RMS product sales [page_34].",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly identifies the $140 million profit increase in 2022 tied to risk retirements and improved booking rates for the CH-53K program, aligning with the ground truth. It also accurately notes the production ramp-up in 2024 as a contributor to higher product sales. However, it omits a critical part of the ground truth: the 73% decline in RMS operating profit by 2024 and the explanation that lower profit booking rate adjustments across the portfolio (including likely diminished gains from CH-53K risk retirements) contributed to this decline. This omission significantly affects completeness and qualitative accuracy. (2) Quantitatively, the $140 million figure is correct and properly attributed to 2022. No incorrect numbers are presented. (3) The reasoning is partially sound—while the model correctly links risk retirements to profit in 2022 and production volume to sales in 2024, it fails to synthesize the multi-hop insight that despite higher production, overall profitability declined, suggesting a maturation of risk retirement benefits. This missing synthesis weakens the qualitative accuracy. (4) Contextually, the answer is relevant and addresses both financial performance and production status, but the lack of reference to the broader profit decline in RMS in 2024 results in an incomplete picture, reducing correctness and qualitative scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 382,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "In the 2022 filing PayPal framed its seller‑protection program mainly as a source of financial risk, noting that “the risk of losses from our buyer and seller protection programs… transaction loss rates have ranged between 0.09 % and 0.15 % of TPV” and warning that merchant bankruptcies or regulatory changes could increase those losses (2022 p. 51). By the 2023 filing the tone had shifted to a strategic emphasis – seller protection is highlighted as a core part of the merchant value proposition and a differentiator, tied to “risk management and seller protection programs” and supported by ongoing platform investment to build trust (2023 p. 9; 2023 p. 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the transaction loss rates of 0.09% to 0.15% of TPV in 2022 are accurately cited, and the years (2022 and 2023) are correctly attributed. No calculations were required, but the cited percentage range matches the original answer exactly. (2) The answer addresses both parts of the question—evolution in risk exposure and strategic emphasis—across the two years. It correctly identifies that in 2022, seller protection was framed as a financial risk with specific exposure, while in 2023, the focus shifted to strategic value and merchant trust. (3) Entity accuracy is strong: PayPal is correctly identified, and the references to TPV (Total Payment Volume), risk exposure, and merchant services are contextually accurate. The mention of specific page numbers (2022 p. 51; 2023 pp. 9, 10) adds precision, though not required, and does not detract from accuracy. (4) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts the risk-focused narrative in 2022 with the strategic, value-driven framing in 2023, correctly interpreting the evolution in tone and business logic. The only minor shortcoming is that the LLM answer does not explicitly mention the integration of seller protection with analytics and other merchant services as part of the broader value proposition—a detail present in the original answer. However, the core evolution in strategic emphasis and risk framing is well captured, making the answer semantically equivalent in intent and substance. Hence, a score of 9 is justified for correctness, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 466,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "In the 2023 filing Starbucks said that sales of ready‑to‑drink beverages (included in “Other revenues”) are recognized when the product is shipped to the customer, i.e., upon transfer of control (page 65). By the 2024 filing the company still treats those sales as “Other revenues,” but it now emphasizes that the drinks are purchased from several specialty suppliers under long‑term supply contracts, making its ready‑to‑drink portfolio explicitly dependent on external suppliers (page 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2023, revenue from ready-to-drink beverages was recognized upon shipment (transfer of control), which matches the original answer's description of revenue recognition under 'Other Revenues' upon shipment. The 2024 update correctly highlights the dependency on specialty suppliers under long-term contracts, accurately reflecting the shift toward supply chain resilience. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly identifying the evolution from revenue recognition treatment (2023) to increased focus on supplier dependency (2024). The use of page references (65 and 13) adds verifiability and suggests accurate sourcing. (4) The only minor shortcoming is that the LLM answer does not explicitly articulate the broader strategic shift 'from revenue-centric reporting to supply-chain risk management' as emphasized in the original answer. While the facts are all present, the interpretive synthesis is slightly less developed. However, the core facts, entities (Starbucks, ready-to-drink beverages, 'Other Revenues', specialty suppliers, long-term contracts), years (2023 vs 2024), and reasoning are correct and relevant. Thus, the answer is semantically equivalent with only slight omission of interpretive depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 428,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "In 2022 Trodelvy was already approved in the United States (FDA), the European Union (EC) and Canada (Health Canada) – covering the U.S., Europe and a handful of other Project Orbis markets – and generated $525 M in U.S. sales, $143 M in Europe and $12 M elsewhere【page_39】. By 2023 its geographic footprint had broadened, with sales rising to $777 M in the U.S., $217 M in Europe and $68 M in other international markets【page_40】, but the filing reported no new regulatory approvals, only a negative Phase 3 NSCLC trial result, leaving the set of approvals unchanged from the prior year【page_38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims Trodelvy had approvals in the U.S., EU, and Canada in 2022 and that no new approvals occurred in 2023, directly contradicting the original answer, which states that in 2023 Trodelvy received FDA and EC approvals for new indications (HR+/HER2- metastatic breast cancer). These approvals are key regulatory developments that the LLM incorrectly denies. (2) Quantitatively, the LLM reports $525M U.S. sales in 2022 and $777M in 2023, while the ground truth states $370M in 2022 and does not provide 2023 sales figures—making the LLM's numbers unsupported. Similarly, the LLM claims $143M in European sales in 2022 and $217M in 2023, whereas the ground truth reports only $10M in Europe in 2022 with no other international sales. The LLM also cites $12M and $68M in other markets, which are absent in the ground truth. These figures are not only different but suggest a much broader geographic reach in 2022 than supported. (3) The multi-hop reasoning is flawed: the question asks about evolution in geographic reach and regulatory approvals between 2022 and 2023. The ground truth infers expanded market access in 2023 based on new FDA and EC approvals, while the LLM incorrectly asserts no new approvals occurred, missing the core development. The LLM appears to conflate prior approvals with new ones and misrepresents the expansion as purely commercial (via sales growth) rather than regulatory. (4) Despite addressing the general topic—geographic reach and approvals—the LLM's answer is factually misaligned on both quantitative and qualitative dimensions. The contextual relevance is moderate because it discusses the right drug and timeframe, but the substance is incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 495,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "In 2023 Simon’s stake in ABG was gradually diluted from roughly 12 % at the start of the year to about 9.6 % by year‑end, as a series of capital‑transaction dilutions produced non‑cash pre‑tax gains of $36.4 million in Q2, $12.4 million in Q3 and $10.3 million in Q4, and a cash pre‑tax gain of $157.1 million when a portion was sold (2023 10‑K p. 114; 2024 10‑K p. 73). In the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, recording a $414.8 million pretax gain and ending its ABG ownership (2024 10‑K p. 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced dilution of its ownership stake in ABG in 2023 from 12.3% to 9.6% through non-cash, capital-related transactions, resulting in non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M. However, the LLM incorrectly claims a $157.1 million cash pre-tax gain from a sale in 2023, which is not supported by the original answer. Furthermore, the LLM states that in Q1 2024, SPG sold its remaining ABG interest for $1.2 billion and recorded a $414.8 million pretax gain—this is entirely false per the ground truth, which explicitly states that SPG did not report any new transactions or changes in ownership stake in 2024 and only referenced a prior 2021 transaction. (2) Quantitative accuracy is severely compromised: the $157.1M cash gain and $414.8M gain in 2024 are fabricated; the $1.2 billion sale figure has no basis in the original answer. The only correct numbers are the 2023 non-cash gains ($36.4M, $12.4M, $10.3M) and the approximate stake reduction from ~12% to 9.6%, though even the starting percentage is rounded and slightly off from the precise 12.3%. (3) Multi-hop reasoning failed: instead of recognizing that 2024 involved no new stake changes and only a reference to a 2021 transaction, the model invented a major 2024 divestiture. This shows a failure to synthesize correctly across years and documents. (4) The contextual relevance is moderate because the answer addresses ownership evolution and financial gains, but the incorrect data and invented transactions severely undermine correctness. Due to major factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 471,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "In the 2023 Form 10‑K Meta only reported the 2012 Equity Incentive Plan “as amended” (exhibit 10.2(A)) and its **third amendment** (exhibit 10.2(B)), together with a series of award‑agreement forms through exhibit 10.2(J) (the most recent of those filed in April 2023). The 2024 filing adds a **fourth amendment** to the plan (exhibit 10.2(C), filed August 1 2024) and expands the award‑agreement disclosures with a new exhibit 10.2(K) (filed April 25 2024), showing that the plan has been further amended and its documentation updated since the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Third Amendment in the 2023 filing and the Fourth Amendment dated August 1, 2024, in the 2024 filing—matching the original answer. It also accurately notes the inclusion of new award agreement forms in April 2024 (exhibit 10.2(K)), which corresponds to the 'additional forms of award agreements from April 2024' in the ground truth. (2) All dates and amendment numbers are correct: 'Third Amendment' (2023), 'Fourth Amendment' (August 1, 2024), and new exhibit filed April 25, 2024—this is consistent with the ground truth’s timeline. The mention of April 2023 forms in the 2023 filing adds minor contextual detail not contradicted by the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes between two years’ filings, identifying both plan amendments and evolution in award agreement disclosures. (4) The only minor shortcoming is that the original answer emphasizes the 2017 forms as part of the 2023 disclosure, while the LLM answer does not explicitly mention 2017 forms, instead referring to forms up to April 2023. However, this does not make the answer incorrect—just slightly less specific on prior-year forms—while still correctly capturing the evolution. Overall, the answer is factually correct, well-structured, and contextually complete, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 391,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The company’s accounting for software licenses did not change – they are capitalized as intangible assets and amortized on a straight‑line basis over the license term (see the 2022 note on capitalized software licenses)【page_36】. However, the balance‑sheet amount grew from $152 million at year‑end 2022 to $223 million at year‑end 2023, and the related amortization expense rose from $54 million to $63 million, showing that Texas Instruments increased its spending and investment in software licensing during the year【page_27】【page_28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the unchanged amortization policy (straight-line basis) from 2022 to 2023 and accurately reports the carrying value of capitalized software licenses increasing from $152 million in 2022 to $223 million in 2023, matching the ground truth. It also adds new correct detail not in the original answer — the rise in amortization expense from $54 million to $63 million — which strengthens the conclusion about increased investment. All numeric values are factually accurate and properly attributed to fiscal year-ends. (2) Quantitative accuracy is perfect: $152M → $223M increase is correctly stated, and the additional amortization figures are consistent with increased capitalization and ongoing usage. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes accounting policy (from 2022) with balance sheet values and expense data (from 2023) to infer increased investment, which aligns with and even enriches the ground truth’s conclusion. The only minor gap is that the original answer emphasizes the evolution from policy disclosure (2022) to quantified asset (2023) as a shift in transparency, which the LLM touches on implicitly but does not explicitly highlight. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to strong reasoning and correct entity identification (Texas Instruments, capitalized software licenses, correct years). Contextual relevance is complete as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 437,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "In 2022 PayPal had $3.8 billion of European customer balances approved for use in credit activities – about 37 % of the balances it could draw on for corporate purposes. By year‑end 2023 that approved amount fell to $3.0 billion, but it now covered roughly 39 % of the available European balances【page_49】. The reduction in absolute funding while the share of the balance‑sheet pool rose shows PayPal is tightening its internal funding of credit products, using a larger proportion of its European balances more prudently and leaning on external sources to support its credit growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.8 billion approved in 2022 (37%), decreasing to $3.0 billion in 2023 (39%). These figures match the ground truth exactly, with acceptable formatting variations. (2) All numbers, percentages, and years are accurate. The calculation of relative proportions (37% vs 39%) is correctly interpreted as an increase in utilization rate despite a drop in absolute value. (3) The reasoning is sound: the model correctly infers that a higher percentage utilization on a lower absolute base suggests more prudent or efficient internal funding. It also correctly identifies a strategic shift toward external funding, though it omits the specific detail about the €40 billion receivables sale agreement and the $5.5 billion sold during the year, which is a minor gap in completeness. (4) Despite this omission, the core multi-hop synthesis—linking changes in approved balances to strategic funding behavior—is logically and factually supported. The answer captures the essence of PayPal’s strategic approach, even if it lacks one key external funding detail. Thus, the answer is highly accurate with only a slight reduction in completeness affecting the top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 346,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks’ stake in the Valor Siren private‑equity funds grew sharply – the 2023 10‑K listed the “Other investments” line (which includes the Valor Siren interests) at $24.2 million【page_75】, while the 2024 filing disclosed a combined carrying value of $211.9 million for its limited‑partnership interests in Valor Siren Ventures I L.P. (and II L.P.) as of September 29, 2024【page_76】.  Income (or loss) from these funds is reported only in “interest income and other, net” on the consolidated earnings statement, and the activity was described as not material to the consolidated financial results【page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2023 carrying value. The original answer (ground truth) states that the carrying value for Valor Siren Ventures I L.P. in fiscal 2023 was not specifically disclosed. However, the LLM claims it was $24.2 million based on a reference to 'Other investments' on page 75, which is not supported by the ground truth. This is a critical quantitative inaccuracy. The 2024 combined carrying value of $211.9 million for Valor Siren Ventures I and II L.P. is correctly reported and matches the ground truth. (2) The date (September 29, 2024) is correctly cited. The financial impact being reported in 'interest income and other, net' and described as not material is accurately conveyed in both years, which aligns with the original answer. (3) The multi-hop reasoning is partially sound: the model attempts to compare 2023 and 2024 data and correctly identifies the evolution in disclosure from unspecified to quantified value. However, the reasoning is flawed because it infers a specific value for 2023 that the ground truth explicitly states was not disclosed, undermining the validity of the comparison. (4) The LLM adds a detail (page 75 reference to $24.2 million under 'Other investments') not present in the ground truth, which may reflect overinterpretation or incorrect extraction. While the overall structure and intent of the answer are relevant and address the question’s focus on evolution, materiality, and reporting, the incorrect 2023 figure severely impacts factual correctness. Hence, the correctness score is reduced to 6 due to this major quantitative error, despite correct qualitative trends and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 464,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "TI’s analog business continues to be framed around the same four sustainable competitive advantages—low‑cost, high‑control manufacturing; a broad analog portfolio; extensive market‑channel reach; and diversified, long‑lived products—highlighted in both filings 【page_18†L2-L9】【page_3†L1-L5】.  Financially, the segment remained the dominant revenue driver but slipped modestly: it produced $14.05 billion in 2021 (about 77 % of total revenue) 【page_22†L9-L14】 and $13.04 billion in 2023 (about 74 % of revenue) 【page_3†L1-L6】, indicating a slight decline in absolute sales while still accounting for roughly three‑quarters of TI’s overall revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of the ground truth. While it correctly identifies that Analog Products remain central to TI's strategy and mentions the four sustainable competitive advantages, it fails to capture the evolution in strategic framing between 2022 and 2023. The ground truth emphasizes a shift in 2023 toward explicitly linking Analog Products to TI's competitive advantages—especially cost and supply chain control—and highlights a renewed focus on long-term free cash flow per share as the key performance metric. The LLM answer does not mention gross margin (67.5% in 2022) or any margin data, which is a critical financial contribution metric in the original answer. Instead, it introduces revenue figures ($14.05B in 2021, $13.04B in 2023) that are not in the ground truth and misaligns the timeline (the question asks about 2022–2023, but the LLM cites 2021 data). (2) Quantitative accuracy is low: the dollar amounts and percentages (77%, 74%) are not supported by the ground truth, which does not provide revenue figures but focuses on gross margin and strategic framing. There is no mention of 2022 revenue or margin beyond the 67.5% gross margin, so the LLM’s comparative revenue analysis is factually incorrect and based on unsupported data. (3) The reasoning is partially sound in recognizing that Analog Products are a dominant segment and tied to competitive advantages, but it fails the multi-hop requirement: it does not synthesize how the strategic positioning evolved from 2022 to 2023 in terms of both competitive advantages and financial contribution. The use of 2021 data instead of 2022 undermines the comparison. (4) Contextual relevance is moderate because the answer discusses Analog Products and TI’s strategy, but it substitutes revenue trends for the actual financial metric emphasized in the ground truth (gross margin and free cash flow). The qualitative accuracy is limited by incorrect data and missing strategic evolution. Overall, the answer is partially on topic but factually and quantitatively flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 567,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "In 2023 Chevron recorded $5.73 billion of depreciation, depletion, amortization and impairments (DD&A) for its Lower 48 segment, up from $4.85 billion in 2022 – an increase of about $875 million【page_133】. The higher DD&A implies Chevron is allocating more capital to the Lower 48, expanding its asset base (and/or taking larger impairment charges), indicating a more aggressive investment focus in that region compared with the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in depreciation, depletion, amortization, and impairments (DD&A) from $4.85 billion in 2022 to $5.73 billion in 2023, which aligns with the ground truth values of $4,854 million and $5,729 million (rounded appropriately). The calculated increase of $875 million is accurate ($5,729M - $4,854M = $875M). (2) All numeric values are correct and presented in consistent formats (billion vs. million), with acceptable rounding ($5.73 billion ≈ $5,729 million; $4.85 billion ≈ $4,854 million). (3) The reasoning correctly infers that higher DD&A indicates increased capital allocation and asset development in the Lower 48 region, demonstrating sound multi-hop logic by linking financial metrics to strategic intent. It also appropriately notes the implication of potential impairment charges. (4) While the LLM answer captures the core evolution in capital allocation strategy and supports it with accurate data and logical interpretation, it omits the comparative context provided in the original answer—specifically, that other regions like Europe, Middle East, and North Africa showed stable or declining trends, which strengthens the contrast. This minor omission slightly affects completeness and qualitative depth but does not detract from the central factual accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 408,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "In 2023 Verizon presented Fixed Wireless Access (FWA) as a supplemental broadband option that sat alongside its traditional land‑line services in both the Consumer and Business segments, leveraging its 5G and 4G LTE networks to serve roughly 3.1 million residential and business customers as an alternative to wired internet (page 5; page 4; page 7; page 8). By 2024 the company had elevated FWA to a “growing” business line, tying it to its wireless‑mobility investments and fiber‑expansion strategy and positioning it as a core element of an integrated wireless‑and‑wireline portfolio that appeals to customers who want both types of broadband—still targeting both consumer and business users but with a stronger focus on cross‑selling and combined service offerings (page 24; page 25; page 100).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 3.1 million FWA connections in 2023 are accurately reported, and the use of both 5G and LTE networks is correctly noted. No numerical inaccuracies or miscalculations are present. (2) The answer fully addresses the evolution in positioning and target segments. It correctly identifies that FWA was initially a supplemental option in 2023 but became a 'growing' and more integrated part of the portfolio in 2024, aligned with wireless, fiber, and cross-selling strategies. This reflects the shift from 'provides' to 'produces' as a more strategic posture. (3) The multi-hop reasoning is sound—information is synthesized across time (2023 vs 2024) and business segments (Consumer and Business), and the strategic repositioning is logically inferred from contextual cues in the filings. (4) The only minor shortcoming is that the LLM does not explicitly mention the shift in terminology from 'provides' to 'produces' as an indicator of strategic intent, which is a subtle but relevant point in the ground truth. However, the semantic meaning—that FWA became more product-centric and strategically important—is effectively conveyed. Wording differs but meaning is equivalent. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 380,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson turned its AspenTech relationship from a 55 % equity‑joint‑venture created in fiscal 2022—when it contributed two stand‑alone software businesses and cash to form “New AspenTech” (see p. 26)—to a larger 57 % stake in fiscal 2024 and a November 2024 proposal to buy the remaining shares, effectively moving toward full ownership (see p. 25).  The Heritage‑AspenTech acquisition helped lift Emerson’s gross margin, adding about 0.6 percentage‑points in 2023 and contributing to the rise from 45.7 % in 2022 to 49.0 % in 2023 and 50.8 % in 2024 (see p. 22 & p. 26).  Thus, the evolving AspenTech ownership boosted margins and increased Emerson’s equity exposure from 55 % to 57 % (with a pending move to 100 %).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies that deviate from the ground truth. First, it incorrectly states that Emerson formed a 55% joint venture in fiscal 2022, whereas the original answer indicates that the partnership in 2022 was a collaboration, not an ownership stake; the 55% ownership was acquired later as part of the 'New AspenTech' transaction, not in 2022. The LLM also claims Emerson increased its stake to 57% in 2024 and proposed full acquisition in November 2024—details not present in the ground truth, which only confirms the 55% stake and strategic transaction without specifying a 57% increase or buyout proposal. (2) The quantitative claims are partially correct: the 0.6 percentage point gross margin benefit in 2023 aligns with the original answer. However, the LLM fabricates specific gross margin figures—45.7% in 2022, 49.0% in 2023, and 50.8% in 2024—which are not in the ground truth and cannot be verified. These numbers imply a level of precision and attribution (entire margin increase due to AspenTech) that the original answer does not support; it only states the 0.6 pp contribution without claiming total margin levels. (3) The multi-hop reasoning is partially sound—linking ownership evolution to financial impact—but flawed in timeline and causality. The LLM incorrectly frames the relationship evolution as beginning with a 55% stake in 2022, when the ground truth describes a non-ownership partnership that matured into majority control by 2024. The equity structure impact is oversimplified, focusing only on ownership percentage changes and omitting the original answer’s key point about gains/losses from AspenTech stock plans and software asset restructuring. (4) Despite these issues, the LLM captures the core idea of deepening involvement with AspenTech and a positive margin impact, earning moderate scores for qualitative accuracy and high relevance. However, the invented percentages and timeline errors significantly reduce factual correctness, warranting a 6/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 548,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "In the 2022 Form 10‑K the relationship was largely a guarantee‑type one – NEE (through its subsidiary FPL Group) entered into a Guarantee Agreement with FPL Group Capital Inc (dated Oct 14 1998) and acted as guarantor on a series of older unsecured subordinated‑debt indentures (e.g., the 2004 and 2006 indentures) 【page_124】, 【page_120】. By the 2023 filing the focus had shifted to direct capital‑structure participation: new officer‑certificates and letters created floating‑rate notes, a 4.45 % note, and Series K and L debentures that name NEE as a party or obligor, reflecting ongoing covenant and financing obligations rather than just a guarantee 【page_118】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of the financial relationship between NEE and FPL Group Capital Inc from a guarantee-based arrangement in 2022 to a more direct capital structure involvement in 2023, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. (1) The LLM incorrectly states that NEE acted as guarantor through its subsidiary FPL Group — in fact, the original guarantee was between FPL Group, Inc. and FPL Group Capital Inc., and NEE (NextEra Energy) is the parent entity post-restructuring; the corporate hierarchy and naming are misrepresented. (2) The LLM mentions 'Series K and L debentures' in 2023, but the ground truth specifies Series B, C, L, M, N, O, and P — Series K is not mentioned in the truth, and the omission of multiple series (B, C, M, N, O, P) reduces completeness. (3) The LLM references 'floating-rate notes' and a '4.45%' note, which are not present in the original answer and may be hallucinated or misattributed details from the filing; these specific instruments are not part of the documented evolution in the ground truth. (4) The original answer emphasizes a strategic shift to long-term financing via junior subordinated debentures with maturities from 2057–2082, a key point about duration and structure that the LLM omits. (5) While the LLM correctly identifies the 1998 Guarantee Agreement and its relevance in 2022, it mischaracterizes the nature of the obligations by referencing '2004 and 2006 indentures' not mentioned in the ground truth, introducing unsupported detail. Quantitative accuracy is low due to incorrect series, percentages, and missing maturity dates. Qualitative accuracy is moderate — the reasoning framework (shift from guarantee to direct obligation) is sound and contextually relevant, but entity relationships and instrument specifics are flawed. Contextual relevance is high as the answer addresses the core evolution asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 531,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic described InterStim II as one of the three InterStim neurostimulators (InterStim II, InterStim Micro and InterStim X) that together drive “continued acceptance and growth” of its Pelvic Health therapies 【page_42】. By the 2024 filing the company still highlights InterStim II – now specifically called a “recharge‑free” neurostimulator – alongside the rechargeable InterStim Micro and the also‑recharge‑free InterStim X, and again stresses “continued acceptance and growth” of Pelvic Health therapies 【page_39】. Thus, between 2022 and 2024 InterStim II has retained its core position in the InterStim suite, its market acceptance has remained strong, and its differentiation as a recharge‑free option has been emphasized within an expanding portfolio of InterStim devices and broader Pelvic Health offerings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: InterStim II is correctly positioned in 2022 as part of a suite with InterStim Micro and InterStim X, contributing to continued acceptance and growth in Pelvic Health therapies. By 2024, it is accurately described as being highlighted as a 'recharge-free' device, alongside the rechargeable InterStim Micro and the recharge-free InterStim X. (2) There are no numeric values requiring calculation, but the years (2022 and 2024) are correctly referenced and aligned with the evolution of product positioning. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and three devices, correctly identifying the shift in emphasis from general portfolio growth to device-specific attributes like recharge status. (4) The answer fully addresses the question by explaining how InterStim II’s positioning evolved—retaining market acceptance while gaining clearer differentiation within an expanded product lineup. Wording differs slightly but meaning is preserved, and all entities (device names, therapy area, time periods) are accurate. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 341,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "In the 2022 filing the Supplemental Facility was described as a $3.5 billion revolving line (expandable to $4.5 billion) that matures on January 31 2026 and carries interest at SOFR + 72.5 bps (plus a spread‑adjustment) with a margin set by the company’s credit rating. By the 2024 filing the capacity range remained $3.5‑$4.5 billion but the maturity was extended to January 31 2029 (optionally to 2030), and the same SOFR‑plus‑72.5 bps pricing is still used; however, Simon actively hedged the facility’s Euro‑denominated borrowings with a €750 million interest‑rate swap that fixed the rate at 3.81% and then used proceeds from a €750 million, 3.50% senior bond issuance to repay those Euro borrowings on Nov 17 2023, effectively reducing the outstanding balance of the Supplemental Facility. This reflects a shift from simply having the facility available in 2022 to actively managing its interest‑rate exposure and repaying a sizable portion of its debt by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the initial borrowing capacity of $3.5 billion (expandable to $4.5 billion), the SOFR-based interest rate structure, the €750 million borrowing, its repayment on November 17, 2023, and the 3.81% fixed rate via interest rate swaps. However, it introduces significant inaccuracies: the maturity date is incorrectly stated as extended to January 31, 2029 (optionally 2030), while the ground truth states the original maturity was January 31, 2026, with no mention of extension. Additionally, the LLM specifies a margin of SOFR + 72.5 bps, which is not present in the ground truth—only that the margin depends on credit rating without a specific number. The bond issued is described as a 3.50% senior bond, but the ground truth does not specify the coupon rate or exact instrument type. (2) Quantitative accuracy is partially compromised: while €750 million, 3.81%, and Nov 17, 2023 are correct, the 72.5 bps spread and maturity extension to 2029/2030 are unsupported by the original answer and likely incorrect. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic shift from passive availability in 2022 to active utilization and hedging in 2024, synthesizing borrowing, hedging, and repayment actions. It correctly links the bond proceeds to repayment of the facility. (4) Contextual relevance is perfect—the answer directly addresses evolution in borrowing capacity, interest rate strategy, and repayment. Due to the introduction of unsupported specifics (maturity extension, exact margin, bond rate), the quantitative accuracy is reduced, but core facts and reasoning remain strong, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 461,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "In 2023 Verizon’s device‑payment plans were described simply as installment arrangements that let consumers pay for a handset over a typical 36‑month, non‑interest‑bearing note while keeping a month‑to‑month service contract, and the company had already stopped offering new consumer‑focused fixed‑term subsidized plans, limiting subsidies to business customers【page_5】. By 2024 the financing structure remains the same, but the filing now spells out that the plans can include explicit promotional incentives—billing credits tied to continued service and optional upgrade/trade‑in rights— which are accounted for as consideration payable and guarantee liabilities, reflecting a more formalized incentive component within the device‑payment offering【page_60】【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Verizon offered non-interest-bearing installment plans over a 36-month term, consistent with the original answer’s description of installment payments over time. The LLM adds contextual detail (e.g., month-to-month service contracts, discontinuation of fixed-term subsidized plans for consumers) not in the ground truth but not contradicted by it. (2) For 2024, the LLM accurately notes the formalization of promotional incentives such as billing credits and upgrade/trade-in rights, which matches the ground truth’s claim of a defined promotional upgrade feature. It further enriches the answer by specifying accounting treatment (consideration payable and guarantee liabilities), which is consistent with a more structured incentive model. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in financing structure and promotional elements across two years, correctly identifying evolution from a basic installment plan to a more structured, incentive-driven model. (4) Minor difference: the ground truth emphasizes the upgrade after 'paying a specified portion' and trading in the device, while the LLM describes it more broadly as 'optional upgrade/trade-in rights'—slightly less specific but semantically aligned. No numeric or date inaccuracies; all financial and temporal references are correct. The answer is fully relevant and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 407,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings Coca‑Cola continues to press a declaratory‑judgment suit asserting that it “has no obligation … for any past, present or future liabilities … in connection with any claims or lawsuits against Aqua‑Chem” and that it is not responsible for Aqua‑Chem’s asbestos‑related claims (2024 Item 3, p. 30; 2023 Item 3, p. 30). The company’s position has not changed – the Wisconsin case was dismissed, the Georgia case remains stayed, and Coca‑Cola still relies on the 1981 sale agreement and its insurance coverage to shield itself from liability (2023 Item 3, p. 31).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, case references (Georgia and Wisconsin), and contractual basis (1981 sale agreement), and correctly cites the declaratory judgment stance from both the 2023 and 2024 10-K filings. Quantitative accuracy is perfect—no numerical or date errors, and document locations (Item 3, page 30/31) are correctly referenced. However, the LLM fails to capture the key nuance highlighted in the ground truth: while Coca-Cola maintains its legal position of no direct liability, its 2024 disclosure includes a more detailed discussion of insurance policies and ongoing coverage litigation, signaling a shift in emphasis toward insurance dynamics and shared insurer responsibility. The LLM interprets this as 'no change in position,' which contradicts the ground truth’s assertion of a nuanced evolution in stance—shifting from outright denial to a more detailed focus on insurance coverage. This represents a failure in qualitative accuracy and multi-hop reasoning, as the model does not synthesize the subtle but important evolution in disclosure strategy between years. Contextually, the answer is highly relevant and well-structured, but misses the core analytical point of the question: the evolution in tone and emphasis, not just legal posture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 358,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel’s 2024 filing shows long‑term income taxes payable of **$1.6 billion**, down from the **$4.3 billion** reported in the 2022 filing, with both figures “reduced by the associated deduction for state taxes and **non‑US tax credits**”【page_83】 and【page_92】. The roughly $2.7 billion drop reflects Intel’s growing use of foreign tax credits to offset its U.S. transition‑tax liability, indicating a deliberate international tax strategy that leverages overseas credits to lower its overall effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key financial figures: long-term income taxes payable of $4.3 billion in 2022 and $1.6 billion in 2024, matching the ground truth exactly. The calculated decrease of $2.7 billion ($4.3B - $1.6B) is accurate. The mention of non-US tax credits as a reducing factor is consistent with the original answer.\n\n2) Quantitative accuracy is perfect: both dollar amounts and the implied difference are correct. The years (2022 and 2024) are accurately referenced, and no calculation errors are present.\n\n3) The reasoning is sound and reflects proper multi-hop synthesis across the two years and filings. The conclusion about Intel’s growing use of foreign (non-US) tax credits to offset U.S. tax liabilities aligns with the ground truth’s interpretation of a strategic shift. The only minor shortcoming is the slight rewording of 'non-US tax credits' as 'foreign tax credits'—while semantically equivalent, the original terminology is slightly more precise per the source. However, this does not affect factual accuracy.\n\n4) The answer is contextually fully relevant, addressing both the quantitative change and the implication for Intel’s international tax strategy. It correctly infers a deliberate strategy to lower the effective tax rate through overseas credits, which is consistent with the original answer’s conclusion about increased effectiveness and strategic leverage.\n\nOverall, the LLM answer is factually correct, well-supported, and logically sound—meriting a high score with only negligible room for terminological precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 431,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "In the 2022 Form 10‑K MetLife simply listed pension‑risk‑transfer contracts as part of its “Retirement and Income Solutions” segment – a mix of short‑ and long‑duration capital‑market products that are exposed to interest‑rate movements in the company’s hypothetical rate‑scenario analysis, but without any specific regulatory commentary (see 2022 p. 61). By the 2024 filing the company is flagging regulatory risk: rules on defined‑benefit pension‑plan funding may delay or reduce plan terminations and therefore change the mix of its pension‑risk‑transfer business, potentially increasing exposure to non‑guaranteed funding products, while still acknowledging that these long‑duration transfers remain interest‑rate‑sensitive (see 2024 p. 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: in 2022, pension risk transfers were part of the 'Retirement and Income Solutions' segment, which included both short- and long-duration products and was exposed to interest rate scenarios (as confirmed on page 61 of the 2022 10-K). By 2024, regulatory changes—specifically around defined benefit pension plan funding—were identified as potentially delaying or reducing plan terminations, thereby affecting the mix of pension risk transfer products, with a noted shift toward non-guaranteed funding products (per 2024 10-K, p. 32). The continued interest rate sensitivity is correctly acknowledged. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) and document references (page numbers) are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of filings, identifies the evolution in risk exposure, and links regulatory influence to strategic shifts in product mix. (4) The only minor shortcoming is that the LLM slightly emphasizes MetLife’s disclosure practices (e.g., 'MetLife simply listed...') rather than stating the more neutral 'the treatment of pension risk transfers,' which slightly reduces qualitative precision. However, this does not affect factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 425,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic highlighted the InterStim Micro as a **newly launched** neurostimulator that was driving growth in its Pelvic‑Health franchise, targeting overactive bladder, urinary retention and bowel incontinence 【page_41】. By the 2024 filing the company is positioning InterStim Micro as a **rechargeable** member of an expanded InterStim family that now also includes recharge‑free InterStim II and InterStim X devices, emphasizing continued acceptance and broader growth of Pelvic‑Health therapies for the same indications 【page_39】【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, InterStim Micro was newly launched and part of Medtronic's Pelvic Health offerings for overactive bladder, urinary retention, and bowel incontinence, which matches the original answer's description of it being part of a growing product line. By 2024, the LLM correctly notes the shift in positioning to emphasize InterStim Micro as a 'rechargeable' device, differentiating it from the recharge-free InterStim II and InterStim X models—this reflects the more targeted marketing strategy described in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers an evolution in product strategy—moving from general inclusion in a product line to explicit differentiation based on rechargeability. The only minor omission is that the original answer notes InterStim Micro was not necessarily 'newly launched' in 2022 (it may have been launched slightly earlier), so 'newly launched' is a slight overstatement not present in the ground truth. However, this does not materially distort the strategic evolution. (4) The answer is contextually relevant, directly addressing how Medtronic's positioning and product strategy evolved. Overall, the LLM captures the core factual and strategic progression accurately, warranting a high correctness score with only a minor deduction for the slight overstatement about launch timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 461,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "In the 2022 filing Simon’s Supplemental Facility was still a major source of liquidity – it provided a $3.5 billion borrowing capacity that could be increased to $4.5 billion and, together with the other credit facilities, supported a $2.1 billion aggregate outstanding balance during the prior year 【page_124】. By the 2024 filing the company had largely paid down that facility – it used the proceeds of a €750 million senior bond issued in November 2023 to retire the same‑currency borrowing on the Supplemental Facility 【page_70】, and the total amount outstanding under all credit facilities had fallen to $325.1 million at year‑end 2024 【page_69】. This reflects a shift from active borrowing on the Supplemental Facility in 2022 to a near‑complete repayment by the end of 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trend of reduced borrowing and repayment actions related to Simon Property Group's Supplemental Facility between 2022 and 2024. It accurately notes the €750 million repayment in November 2023 using bond proceeds, aligning with the ground truth. However, there are minor quantitative discrepancies: the LLM states the year-end 2024 outstanding balance under all credit facilities was $325.1 million, while the ground truth reports a weighted average outstanding balance of $311.1 million in 2024. Though close, this is not the same metric (year-end vs. weighted average), and the values differ by ~$14 million. Additionally, the ground truth specifies the $519.9 million weighted average balance in 2022, which the LLM does not mention, instead citing the $2.1 billion maximum aggregate balance (which is correct but less precise for assessing average usage). (2) The date of the repayment (November 2023) is correctly identified, and the €750 million amount matches, though the U.S. dollar equivalent ($815.4 million) is omitted in the LLM answer—this is a minor omission, not an error. (3) The multi-hop reasoning is sound: the LLM synthesizes data from 2022 and 2024 filings, connects the bond issuance to the repayment of the Supplemental Facility, and infers a strategic shift in debt management. It correctly interprets the reduction in outstanding balances as evidence of repayment, demonstrating strong qualitative understanding. (4) The contextual relevance is excellent—the answer directly addresses the evolution of the Supplemental Facility’s use, focusing on borrowings and repayments. The qualitative accuracy is high due to correct entity identification (Simon Property Group, Supplemental Facility, correct years), proper synthesis, and logical conclusion. The correctness score is 8 due to the mix of accurate core facts and minor quantitative imprecision in metrics and timing (year-end vs. average).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 533,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP’s Lower 48 segment’s depreciation, depletion, amortization and impairments rose from **$4,854 million in 2022 to $5,729 million in 2023** – an increase of roughly **$875 million (≈18 %)**【page_133】. The higher DDAI expense signals that the company’s investment activity and asset base in the Lower 48 grew year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $4,854 million in 2022 and $5,729 million in 2023 are accurately reported. The increase of $875 million is correctly calculated (5,729 - 4,854 = 875), and the approximate percentage increase of 18% is reasonable (875 / 4,854 ≈ 0.1803 or 18.03%). Minor rounding to 18% is acceptable. (2) The answer is complete, addressing both the numerical change and the qualitative implication regarding investment activity. (3) Entities are accurate: COP (ConocoPhillips), Lower 48 region, correct years (2022 to 2023), and the correct financial metric (depreciation, depletion, amortization, and impairments — DDAI) are all correctly identified. (4) The reasoning is sound: an increase in DDAI expenses typically reflects higher asset utilization or increased investment in productive assets, so concluding that investment activity grew is logically and financially valid. The multi-hop synthesis — connecting expense changes to investment trends — is correctly executed. (5) The semantic meaning fully aligns with the original answer, with added clarity via percentage change and concise terminology (DDAI). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 351,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "In the 2023 filing Verizon presented corporate networking solutions as one element of a broad Business‑segment suite that includes data, video, conferencing, security, managed‑network and IoT services, and it detailed the “Enterprise and Public Sector” unit as offering private‑networking, private‑cloud connectivity, virtual and software‑defined networking (VZ 2023 10‑K, p. 5). By the 2024 filing the same corporate networking services are still listed under the Business segment, but the company now reports Business revenue in distinct “Enterprise and Public Sector” ($14.2 bn) and “Business Markets and Other” ($13.1 bn) lines, signalling a sharper focus on enterprise customers and the monetization of its networking platforms (VZ 2024 10‑K, p. 100 & 25).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2023, Enterprise and Public Sector revenues were $15.1 billion, making up about 50% of the Business segment's total revenue. However, the LLM claims that in 2024, Verizon reported 'Enterprise and Public Sector' at $14.2 billion and 'Business Markets and Other' at $13.1 billion, implying a total Business segment revenue of $27.3 billion. This level of detail and segmentation is not supported by the original answer, which explicitly states that in 2024, Verizon no longer provided the same level of detail in offerings or segment revenue. Thus, the LLM fabricates precise 2024 revenue breakdowns that are not present in the ground truth. (2) The calculation of $14.2B + $13.1B = $27.3B is mathematically correct but based on false premises. The original answer does not mention 'Business Markets and Other' or any such revenue split in 2024, nor does it provide updated revenue figures for Enterprise and Public Sector beyond 2023. The LLM incorrectly asserts that such data exists in the 2024 filing. (3) The multi-hop reasoning is partially sound in that it attempts to compare service descriptions across years and infer strategic emphasis. However, it draws an incorrect conclusion: while the ground truth describes a *streamlining* and *reduction in detail*, the LLM interprets this as a *sharper focus* and *new monetization signaling*, supported by non-existent revenue segmentation. This misrepresents the evolution as more granular in 2024 when it was actually more generalized. (4) The contextual relevance is high because the answer addresses service description changes and business segment emphasis as asked. However, the correctness score is low due to major factual and quantitative errors. The qualitative accuracy is moderate because the general direction of change (from detailed to less detailed) is somewhat acknowledged, but the interpretation is inverted. Quantitative accuracy is poor due to invented figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 559,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "In the 2022 filing MetLife said its FVO securities are measured as Level 3 assets and are valued using the income‑approach (present‑value or option‑pricing models) with significant unobservable inputs; a 10 % appreciation of the U.S. dollar was projected to reduce the $1.6 billion fair‑value of those securities by about $54 million (2022 p.151). The 2024 filing still classifies FVO securities as Level 3 and applies the same valuation methodology (income‑approach/option‑pricing with unobservable inputs) but no longer provides a separate dollar‑impact for a 10 % dollar appreciation, stating only that the sensitivity of FVO securities is similar to that of other Level 3 assets (2024 p.247‑250).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in quantitative terms: it accurately reports the 2022 fair value of $1.6 billion and the $54 million decrease from a 10% U.S. dollar appreciation, with correct citation to the 2022 filing. The entity (MetLife), metric (FVO securities), and years (2022, 2024) are correctly identified, and the classification as Level 3 assets and use of the income approach are factually accurate. However, the qualitative analysis of the evolution in valuation approach is incomplete. The original answer notes a shift to a 'more nuanced and dynamic valuation methodology' in 2024 involving duration- and currency-dependent sensitivity, particularly around nonperformance risk spreads and unobservable inputs. The LLM answer acknowledges the continued use of the income approach and lack of specific dollar impact in 2024 but fails to capture this key evolution toward a more structured, multi-dimensional sensitivity framework. Instead, it states only that sensitivity is 'similar to that of other Level 3 assets,' which is less precise and misses the core advancement in methodology. This omission affects the depth of the multi-hop reasoning—while the LLM correctly identifies continuity in valuation technique, it underrepresents the progression in sensitivity modeling. The answer remains contextually relevant and factually sound on surface-level details, but lacks the full synthesis required to reflect the nuanced evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 406,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "In 2022 the company already described its power‑marketing business – NEER “provides full energy and capacity‑requirements services… and engages in power and fuel marketing and trading activities” (2022 p. 77). By 2023 those trading activities had turned from a drag on earnings to a boost: non‑qualifying hedge activity moved from a $696 million loss in 2022 to a $1.5 billion gain in 2023 (2023 p. 37), and commodity‑hedge gains of about $2.53 billion in 2023 replaced $2.67 billion of losses in 2022, lifting operating revenue by $5.95 billion (2023 p. 40). Thus, NEER’s power‑marketing and energy‑trading function shifted from a loss‑making component in 2022 to a major positive contributor to earnings and revenue in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NextEra Energy's power marketing activities from 2022 to 2023, noting a shift from loss-making to a significant earnings contributor, which aligns with the ground truth's emphasis on increased profitability. The subsidiary NEER is correctly identified as central to these activities. (2) However, there are discrepancies in the quantitative details. The ground truth states that net income for NEER rose from $285 million in 2022 to $3,558 million in 2023. The LLM answer does not mention this net income progression directly. Instead, it cites a $696 million loss in non-qualifying hedge activity in 2022 turning into a $1.5 billion gain in 2023, and commodity-hedge gains of $2.53 billion replacing $2.67 billion in losses, lifting operating revenue by $5.95 billion. While these figures may be derived from the same financial statements, they do not directly support the net income change stated in the ground truth. The LLM’s numbers, though plausible and consistent with a turnaround narrative, are not the same metric (net income) and thus introduce a mismatch in key financial performance indicators. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, identifies a shift in financial performance, and attributes it to power marketing and trading activities. It correctly infers that these activities evolved positively from being a drag to a boost. However, it substitutes net income with other line items (hedge gains/losses), which, while related, are not equivalent. This affects quantitative accuracy but not the overall qualitative conclusion. (4) The contextual relevance is excellent—the answer directly addresses the evolution in engagement and financial performance. The qualitative accuracy is high due to correct entity identification (NEER, power marketing, trading services) and logical reasoning. The correctness score is 8 because the core conclusion (significant growth and turnaround in profitability) is supported, but the key financial metric (net income) cited in the ground truth is not accurately reflected in the LLM answer, replaced instead with other, less directly relevant figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 594,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca‑Cola Company continued to hold roughly a 28 % equity stake in Coca‑Cola FEMSA at year‑end 2024 (Note 6, page 87 of the 2024 filing – the same percentage reported for year‑end 2023 on page 87 of the 2023 filing).  At the same time, its equity‑method income fell sharply, dropping from $159 million in 2023 to $92 million in 2024 (page 116), reflecting a lower proportionate share of earnings from FEMSA and its other equity‑method investees.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that The Coca-Cola Company held a 28% stake in Coca-Cola FEMSA in both 2023 and 2024, which aligns with the ground truth's assertion of a 28% ownership stake in 2024 and implies consistency from 2023. It also accurately reports the decline in equity-method income from $159 million in 2023 to $92 million in 2024, with correct page references. These numbers are factually accurate and properly formatted. (2) Quantitatively, all figures—28%, $159M, $92M—are correct and consistent with the knowledge graph's expectations. The calculation of a decline in income is implied and accurate. (3) However, the qualitative reasoning diverges from the ground truth: while the LLM focuses on the drop in equity income and stake stability, it misses the key multi-hop insight about the *evolution* of the financial relationship—from indirect dependency (credit rating influence in 2023) to direct strategic ownership with material income implications in 2024. This shift in relationship nature is central to the original answer but absent in the LLM response. (4) The answer is contextually relevant and factually precise on numbers, earning high marks for quantitative and contextual accuracy. However, it lacks the synthesis of strategic evolution, which is critical to fully addressing the question’s intent, thus reducing the qualitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 391,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "In 2023 the Lower 48 segment’s depreciation, depletion and amortization rose to **$5.7 billion**, up from **$4.9 billion in 2022**【page_133】, while the company’s capital outlay to affiliates in that area fell to **$118 million**, down from **$235 million a year earlier**【page_134】.  At the same time, Lower 48 sales – a close proxy for production – dropped sharply to **$38.2 billion** from **$52.9 billion** in 2022【page_133】, indicating lower production volumes.  Together, these data show a shift away from new financial investment toward a higher‑cost, lower‑volume operating focus in the Lower 48 region.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the depreciation, depletion, and amortization (DD&A) figures are approximately correct—$5.7 billion in 2023 vs $4.9 billion in 2022 (ground truth: $5,729M vs $4,854M)—the claim that 'sales dropped sharply' from $52.9B to $38.2B is misleading and incorrect as a proxy for production volumes. The original answer emphasizes actual production volumes (447 kbbl/d crude oil, 1,340 MMcf/d gas in 2022), which the LLM fails to mention. Sales revenue is not a valid proxy for production volume due to price volatility, especially given the large drop in energy prices post-2022. The LLM incorrectly infers declining production from lower sales, which contradicts the ground truth indicating stable or moderate production levels. Additionally, the LLM introduces 'capital outlay to affiliates' falling from $235M to $118M, which is not mentioned in the original answer and is used to support a narrative of reduced investment—this is unsupported and distracts from the actual trend of increasing financial investment via rising DD&A. (2) Quantitatively, the DD&A numbers are close but rounded ($4.9B ≈ $4,854M; $5.7B ≈ $5,729M), so acceptable. However, using sales as a proxy for production is a critical error in interpretation. (3) The multi-hop reasoning is flawed: instead of linking rising DD&A to increased financial investment despite stable production (as in the original), the LLM incorrectly infers a 'shift away from new financial investment'—the opposite of the ground truth. This reflects a failure in logical synthesis. (4) Correctness is low due to major factual and interpretive errors, despite partial number accuracy. Quantitative accuracy is moderate due to acceptable rounding. Qualitative accuracy is poor due to incorrect reasoning and entity usage (e.g., sales ≠ production). Contextual relevance is moderate as it discusses the Lower 48 and relevant metrics, but misinterprets them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 533,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "In the 2023 filing Verizon’s 4G LTE network was described mainly as a delivery platform for Fixed‑Wireless Access (FWA) broadband – “We also provide FWA broadband through our 5G or 4G LTE networks as an alternative to traditional landline internet access”【page_97】. By the 2024 filing the LTE network had been elevated to a strategic pillar of the company’s core infrastructure: it is listed alongside C‑Band, millimeter‑wave spectrum and fiber as the foundation that will “drive innovative products and services and fuel our growth”【page_23】, and it continues to support FWA broadband in the same way【page_24】【page_100】. This shows the LTE network moving from a supporting role for broadband to a central element of Verizon’s network strategy and growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2023, Verizon used 4G LTE primarily for FWA broadband as an alternative to landline internet; by 2024, it became part of a broader integrated network strategy including C-Band, millimeter wave, and fiber to drive innovation and growth. The LLM correctly identifies the evolution from a service delivery role to a strategic infrastructure component. (2) There are no numeric values requiring calculation (e.g., dates like 2023 and 2024 are used appropriately), so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects proper multi-hop synthesis across the two years’ filings, correctly identifying the shift in strategic positioning. The only minor shortcoming is that the LLM does not explicitly use the phrase 'multi-technology ecosystem' or 'foundational component' as in the original, but the meaning is semantically equivalent. (4) The answer is fully relevant to the question about strategic evolution, directly addressing changes in role within infrastructure and growth initiatives. Overall, this is a strong response with only negligible differences in phrasing, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 358,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it paid about $6 billion in cash and contributed its own industrial‑software businesses to acquire a 55 % controlling stake in the software firm; the deal lifted AspenTech’s order backlog to $1.0 billion (up from $328 million in 2021) and added roughly 0.6 percentage‑points to Emerson’s gross‑margin, which rose to 49.0 % that year【page_3†L15-L22】【page_10†L31-L38】【page_26†L5-L9】. By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer for the remaining shares, valuing AspenTech at about $15.3 billion【page_25†L1-L5】, while Emerson’s overall gross‑margin continued to improve to 50.8 % (up from 45.7 % in 2022) and its consolidated backlog grew to $8.1 billion (up from $6.5 billion in 2021)【page_22†L1-L9】【page_10†L31-L38】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative details. The ground truth states that in 2022, Emerson held a stake in AspenTech with a backlog of $1,042 million, but the LLM claims a $1.0 billion backlog resulting from a $6 billion transaction in 2022, which is not supported by the original answer. The original does not mention the $6 billion cash payment or contribution of software businesses in 2022, nor does it state that the deal occurred then—instead, the 55% ownership and 'New AspenTech' were realized by 2024. The LLM incorrectly places the 55% (actually 57%) ownership and deal rationale in 2022, misaligning the timeline. (2) The LLM reports a 0.6 percentage-point margin boost in 2022 and a gross margin of 49.0%, but the ground truth states a 3.3 percentage-point increase in gross margin in 2023 due to the acquisition. The LLM’s margin figures (49.0% in 2022, 50.8% in 2024) are unsupported; the original does not provide Emerson’s overall gross margin values. The backlog growth is partially correct: LLM says $8.1 billion in 2024 (close to the true $8,053 million), and correctly notes growth from $6.5 billion in 2021, but incorrectly attributes the 2022 backlog to a jump from $328 million in 2021 to $1.0 billion, whereas the ground truth reports $1,042 million in 2022 and $6,533 million in 2021—indicating confusion in data sourcing. (3) The multi-hop reasoning is partially sound—LLM connects ownership, financial metrics, and timeline—but misattributes events and figures to incorrect years and overstates transaction details not in the original. The evolution of ownership from 55% to 57% by 2024 is plausible but slightly diverges from the original’s 55% ownership in 'New AspenTech' without mention of increase. The $240-per-share offer and $15.3 billion valuation are not in the ground truth, making them hallucinated details. (4) Despite these issues, the LLM captures the strategic evolution direction—increased ownership, impact on backlog and margins—and maintains contextual relevance. However, major quantitative and temporal inaccuracies reduce correctness. Scores reflect partial credit for correct directional trends and metric types, but significant deductions for incorrect numbers, timing, and unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 616,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "In the 2022 filing NEE disclosed that it recorded a full‑write‑off impairment on its Mountain Valley Pipeline investment in the first quarter of 2022, effectively eliminating the asset from its books (2022 10‑K, Note 8, p. 97). By the 2023 filing, NEE’s commitment schedule shows a planned equity contribution in 2024 for the pipeline’s construction and a 20‑year natural‑gas transportation agreement of roughly $70 million per year (2023 10‑K, Commitments table, p. 108; Contracts note, p. 109). This move from a write‑off to new capital commitments indicates that NEE has shifted back to actively investing in the project, reflecting a strategic decision to retain a long‑term stake in the pipeline’s value‑creation potential.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that NEE recorded a full write-off impairment of its Mountain Valley Pipeline investment in Q1 2022 is incorrect and contradicts the ground truth, which states NEE maintained an equity stake between 32% and 55% in 2022 and did not write off the investment. There is no evidence in the provided ground truth of an impairment or write-off. (2) The LLM asserts that NEE had a 'planned equity contribution in 2024' based on the 2023 filing, but the ground truth only confirms a 32.8% equity investment by 2023 and a 20-year transportation agreement worth ~$70M/year — it does not mention future contributions in 2024. While the $70 million per year figure matches the ground truth and is correctly cited, the narrative of a 'write-off followed by re-investment' is factually wrong. (3) The qualitative reasoning is flawed: the model infers a strategic reversal (from exit to re-entry), whereas the ground truth describes a progression from a variable ownership range (32%-55%) to a more precisely defined 32.8% stake — indicating clarification, not a write-off and return. This misrepresents NEE's investment strategy. (4) Contextually, the answer addresses the evolution of commitment and attempts to interpret strategy, so relevance is moderate. However, due to major errors in entity accuracy (mischaracterizing NEE’s financial actions) and reasoning (false narrative of write-off and return), the overall correctness is low. Minor positive: correct citation of contractual value (~$70M/year) and recognition of long-term agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 444,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "In the 2023 filing, Costa Limited was described only as a retail‑store operator that sells directly to consumers, with those sales “included in our Global Ventures operating segment” (page 6). By the 2024 filing, Costa is named as a distinct reporting unit whose results are part of the Global Ventures segment—grouped with other consumer‑focused businesses (innocent, doğadan) and distribution‑coordination fees—showing that Costa has been more tightly integrated and positioned as a strategic component of Global Ventures (page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costa Limited was part of the Global Ventures segment in 2023 as a retail-store operator, and by 2024, it was more deeply integrated as a named reporting unit alongside innocent and doğadan, with inclusion of distribution-coordination fees. There are no numeric inaccuracies—dates (2023 to 2024), entities (Costa Limited, innocent, doğadan), and segment name (Global Ventures) are all correctly identified. (2) Quantitative accuracy is perfect: no calculations are required, but the temporal progression (2023 vs 2024) is correctly referenced, and the contextual details (e.g., page numbers cited) support fidelity. (3) Multi-hop reasoning is sound: the model correctly infers increased strategic integration by comparing the evolution of reporting language and grouping of businesses across filings. (4) The only minor shortcoming is that the LLM does not explicitly state the *implication* of this integration—'a broader strategic role within Coca-Cola’s diversified beverage portfolio'—which is present in the original answer. However, the conclusion that Costa is 'more tightly integrated and positioned as a strategic component' captures the same essence. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 396,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel’s short‑term portfolio of marketable debt – which includes financial‑institution instruments – has been shrinking.  The company recorded a net loss of $748 million on its economically hedged marketable‑debt holdings in 2022, posted a net gain of $534 million in 2023 and a net loss of $464 million in 2024, with the fair‑value of those hedged investments falling from $17.1 billion at the end of 2023 to $13.5 billion at year‑end 2024 – a decline of about $3.6 billion over the period【page_83】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value decline from $17.1 billion in 2023 to $13.5 billion in 2024 and the $748 million net loss in 2022 and $464 million net loss in 2024, which aligns with the ground truth. However, it introduces a net gain of $534 million in 2023, which is not mentioned in the original answer and is extraneous to the question. While this detail may be factually correct from the source (page_83), it was not part of the ground truth summary and introduces information beyond what was verified in the knowledge graph, potentially affecting quantitative accuracy. (2) The key numbers for 2022 and 2024 losses and the fair value drop are accurate: $748M (2022 loss), $464M (2024 loss), and the $3.6B decline ($17.1B to $13.5B) is correctly calculated. The 2023 gain is the only unverified addition. (3) The multi-hop reasoning is sound—linking changes in fair value and losses across years for hedged marketable debt investments—and correctly synthesizes the trend of portfolio contraction and reduced losses. (4) The answer is contextually relevant and complete regarding the evolution from 2022 to 2024, though the inclusion of 2023 performance, while consistent with a shrinking portfolio, slightly deviates from the ground truth's focus. The core facts are correct, but the extra detail without confirmation in the ground truth justifies a slight deduction in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 396,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "In 2023 AMT’s MD&A was centered on property‑lease revenue growth (total property revenue ≈ $7.8 bn) and it disclosed asset‑retirement obligations of $2.08 bn on the balance sheet【page_41】【page_86】. By 2024 the company’s emphasis had shifted to the recurring nature of communications‑site cash flows—stating that most property‑operation revenue now comes from multiyear leases that must be maintained—and it reported that asset‑retirement obligations had risen to $2.39 bn on the balance sheet (with an undiscounted cash‑outlay estimate of $4.5 bn)【page_56】【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMT's evolving financial focus from 2023 to 2024: in 2023, emphasis was on recurring lease revenue (≈$7.8B in property revenue), and by 2024, the focus expanded to include growing asset retirement obligations (AROs). (2) Quantitatively, the LLM reports AROs of $2.08B in 2023 and $2.39B in 2024 on the balance sheet, with a $4.5B undiscounted future cash outlay estimate as of 2024—this matches the ground truth's $4.5B figure. While the original answer does not specify the 2023 ARO balance, the LLM’s inclusion of $2.08B and $2.39B appears consistent with typical reporting trends and does not contradict the ground truth; the $4.5B undiscounted liability is correctly attributed to 2024. (3) The reasoning is sound: it captures the multi-hop evolution from revenue focus to inclusion of long-term liabilities, synthesizing across years and financial concepts. (4) Minor point: the original answer emphasizes that 99% of revenue came from property operations, while the LLM focuses on the $7.8B figure and lease structure—this is a slight difference in emphasis but not in substance, as both highlight recurring revenue from site leasing. Overall, the LLM provides a factually correct, complete, and contextually appropriate response with only negligible variation in framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 381,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "In the 2023 Form 10‑K the company’s discussion of Guyana is limited to the legal framework – the Petroleum Activities Act 2023, which authorizes the Government of Guyana to grant petroleum agreements with exploration periods of up to 10 years and production periods of 20 years for oil (30 years for gas) with renewal rights of up to 10 years (2023 p. 25). By the 2024 filing, Guyana is no longer described mainly in legal terms but is highlighted as an “Advantaged Asset” in the earnings‑driver definitions, grouped with Permian and LNG as a core growth project that drives volume and value (2024 p. 37). This shows a shift from emphasizing the regulatory basis to positioning Guyana as a strategic growth engine for the business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Petroleum Activities Act 2023 is accurately described, including the 10-year exploration period, 20-year production period for oil (with up to 10-year renewal), and the shift in 2024 to 'Advantaged Asset' status under volume growth. The mention of gas having a 30-year production period is an additional detail not in the original answer but is plausible and does not contradict the ground truth. (2) Quantitative accuracy is perfect: all years (2023, 2024), timeframes (10, 20, 30 years), and document references (p. 25, p. 37) are correctly cited. Format and precision match expectations. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying a shift from legal framework discussion to strategic business emphasis. It infers the evolution in strategic positioning based on contextual changes in disclosure tone and categorization. (4) Semantic equivalence is strong—though wording differs, the core message (transition from regulatory basis to core growth asset) is preserved. The only minor gap is that the LLM answer does not explicitly name 'Advantaged Volume Growth' as the earnings driver (referring more generally to 'earnings-driver definitions'), slightly reducing qualitative precision. However, this does not undermine the overall correctness. Contextual relevance is excellent, directly addressing both legal framework and business growth emphasis as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 426,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar continues to place its diesel‑electric locomotive and other rail‑related products inside the Machinery, Energy & Transportation (ME&T) segment, where it remains responsible for design, manufacturing, marketing, remanufacturing, leasing and product‑support functions (2023 p. 116; 2024 p. 39). The 2024 filing notes that rail‑service sales – which include diesel‑electric locomotives – rose modestly, but the segment’s strategic positioning and operational duties are essentially unchanged from 2023 (2024 p. 37).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Caterpillar's strategic evolution between 2023 and 2024, directly contradicting the ground truth. While it correctly identifies the ME&T segment and references operational functions (design, manufacturing, etc.) with citations, it asserts that Caterpillar's strategic positioning and operational duties are 'essentially unchanged'—which conflicts with the original answer stating a clear evolution in 2024 toward integrated systems, electrified powertrains, and zero-emission technologies. This misrepresents the key multi-hop insight: Caterpillar’s locomotive business shifted focus from traditional remanufacturing and support to advanced, environmentally focused solutions. There are no numeric values to verify, so quantitative accuracy is not applicable beyond the absence of errors in cited page numbers. The reasoning is flawed because the model fails to synthesize the strategic shift indicated in the 2024 filing, instead downplaying changes despite evidence of a broader technological repositioning. Contextually, the answer addresses the right segment and timeframes, but misses the central theme of strategic evolution, making it partially relevant but factually inadequate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 348,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "In 2022 the company’s securitized‑debt program held about $15 billion of obligations, which accounted for roughly 4 % of total funding sources (see page 67). By year‑end 2024 the outstanding securitized debt had slipped to about $14.3 billion (see page 219), a modest decline that shows Capital One is marginally scaling back its reliance on securitization and continuing to lean more on deposits and other funding sources while still maintaining a diversified funding mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company did not disclose a specific amount for securitized debt obligations, but the LLM claims it was $15 billion, which is unsupported. The 2024 figure of $14.3 billion is close to the ground truth carrying value of $14,264 million (i.e., $14.264 billion), so this part is approximately correct with acceptable rounding. However, the 4% of total funding and page references (67, 219) are not present in the ground truth and appear fabricated. (2) Quantitative accuracy is low because the 2022 figure is invented, and the percentage (4%) lacks support. The 2024 number is reasonably accurate ($14.3B vs $14.264B), but the comparison implies a decline that cannot be confirmed due to lack of 2022 data. (3) The reasoning is flawed: the conclusion that Capital One is 'marginally scaling back' its reliance on securitization assumes a decrease from $15B to $14.3B, but the original answer does not provide a 2022 figure, making this trend inference invalid. The multi-hop synthesis fails because the model invents data rather than acknowledging absence of 2022 figures. (4) Contextual relevance is high—the answer addresses the evolution of securitized debt and funding strategy—but correctness is undermined by hallucinated numbers and unsupported conclusions. The qualitative reasoning would be stronger if based on actual disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 401,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "In 2023 McDonald’s accounted for developmental licensees as non‑consolidated licensees, recognizing the royalty and initial‑fee payments they make as non‑lease revenue and regularly evaluating those relationships for variable‑interest‑entity scope exceptions (2023 p.45). By 2024 the company still uses the same licensing model, but it now reports the developmental‑licensed segment explicitly (International Developmental Licensed Markets & Corporate) with expanded segment disclosures under the newly adopted ASU 2023‑07, and the count of developmental‑licensed restaurants grew to 9,247 (2024 p.18; 2024 p.46).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key areas. (1) Correctly identifies that developmental licensees paid royalties and initial fees in 2023, aligning with the original answer’s description of revenue recognition. However, it introduces segment reporting under ASU 2023-07 and an explicit segment name (International Developmental Licensed Markets & Corporate), which are not mentioned in the ground truth and represent a factual overreach. (2) The claim that McDonald's reported a specific count of 9,247 developmental-licensed restaurants in 2024 is unsupported by the original answer, which does not provide any numerical data about restaurant counts—this is a major quantitative inaccuracy. (3) The original answer emphasizes a change in rounding policy (to nearest whole number) in 2024 and ongoing VIE evaluations, while the LLM answer incorrectly frames the evolution as being about segment disclosure under new accounting standards, missing the actual financial reporting change. (4) The LLM answer correctly notes that relationships are evaluated for variable interest entities, but misattributes the timing and context—ground truth states this became a focus in 2024, not 2023. (5) Multi-hop reasoning is partially sound—linking financial treatment and relationship management across years—but synthesizes incorrect details from potentially plausible but unverified sources. Overall, the answer is contextually relevant and attempts the right scope, but contains significant factual and qualitative errors, especially regarding financial reporting changes and numerical disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 449,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company disclosed that, of the 131 million shares reserved for equity‑based compensation, 26.9 million shares were available for awards under its Equity and Incentive Compensation Plan at December 31, 2023. The 2024 filing still references the same 2021 plan but adds a specific exhibit that spells out the terms of equity awards granted to named executive officers, shifting the focus from a simple pool‑size disclosure to a more detailed executive‑award disclosure (the share‑availability number is no longer restated in the excerpt).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 26.9 million shares available as of December 31, 2023, and the reference to the 131 million shares reserved under the plan is consistent with typical disclosures (though not in the original answer, it is contextually valid and does not contradict). The 2021 plan's effective date (May 26, 2021) is implied via reference to the same plan, and the absence of a restated share availability in 2024 is correctly noted. (2) The LLM correctly identifies the evolution: from disclosing share availability in 2023 to providing detailed exhibit-level terms of executive awards in 2024, which reflects increased transparency. (3) The multi-hop reasoning is sound—linking the 2023 availability data to the 2024 shift in disclosure depth shows synthesis across years and reporting formats. (4) The only minor shortcoming is that the LLM does not explicitly characterize the evolution as a shift toward 'more formalized and transparent governance' as in the original answer, slightly reducing qualitative completeness. However, the factual and contextual core—increased disclosure specificity in 2024—is clearly conveyed. Wording differs but semantic meaning is equivalent. No calculation errors. All entities (Southern Company, Equity and Incentive Compensation Plan, Named Executive Officers, 2021 plan) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 400,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "In 2023 Pfizer reported that Inlyta’s worldwide revenue rose to **$1,036 million** from **$1,003 million** in 2022 – a **≈3 % increase** (U.S. sales grew from $618 million to $642 million, ≈4 %; international sales from $385 million to $394 million, ≈3 %)【page_44】.  The modest upside was **driven by stronger U.S. uptake of Inlyta in first‑line combination regimens with immune‑checkpoint inhibitors for advanced renal‑cell carcinoma**, while **lower volumes and reduced net price in some European markets dampened growth**; the international gain reflected **continued expansion in emerging markets**【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Inlyta's 2023 global revenue as $1,036 million and implies 2022 revenue of $1,003 million, which aligns with a 3% total increase as stated in the ground truth. U.S. and international breakdowns ($618M to $642M and $385M to $394M) are consistent with ≈4% and ≈3% growth, respectively, supporting the overall 3% total and 5% operational growth mentioned in the original (operational growth adjusts for price/volume and currency effects; the LLM does not contradict this). The key qualitative driver — increased U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC — is accurately identified. The dampening effect from lower volumes and net prices in Europe is also correctly noted, along with growth in emerging markets. (2) All numeric values and percentages are accurate and internally consistent. $1,003M in 2022 growing to $1,036M in 2023 is indeed ≈3.3% growth, which rounds to the reported ≈3%, and sub-segment calculations are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes global revenue, regional performance, and causal factors across markets, correctly attributing growth dynamics to specific clinical and market-level developments. (4) The only minor gap is that the original answer notes Inlyta's role in Pfizer’s 2022 growth alongside Comirnaty, Eliquis, and Vyndaqel — a contextual point about 2022 performance that the LLM omits. However, the LLM still adequately addresses the evolution from 2022 to 2023. Thus, while highly accurate, it misses a small element of completeness regarding 2022 context, justifying a 9 instead of 10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 464,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "In the 2023 filing the company described franchisee fees for technology platforms only as “Other revenues…fees paid by franchisees to recover a portion of costs incurred by the Company for various technology platforms” and stressed that most cash flow comes from rent, royalties and minimum payments (2023 10‑K p. 4). By the 2024 filing McDonald’s says it is the **principal** in those technology‑platform arrangements, now presenting the fees on a **gross basis** and recognizing revenue as the goods or services are transferred (2024 10‑K p. 46), and it also details **cost‑sharing** of certain restaurant improvements—up‑front funding by the Company with later allocation of costs between property‑and‑equipment and receivables (2024 10‑K p. 46). Thus the financial structure has become more explicit—gross‑basis revenue and formal cost‑sharing—while the overall reliance on franchisees for the bulk of revenue remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2023 to 2024, particularly around revenue recognition for technology platforms. In 2023, the company treated fees as a recovery of costs (pass-through), while in 2024 it became the principal, recognizing revenue on a gross basis—this is factually correct and supported by the cited 10-K pages. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2023, 2024) and document locations (p. 4, p. 46) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting treatment (gross vs. net revenue recognition) and links it to deeper financial interdependence, including cost-sharing for technology and infrastructure. The mention of 'up-front funding by the Company with later allocation' adds nuance consistent with increased integration. (4) The only minor gap is that the LLM does not explicitly state that this shift reflects a 'stronger dependency' or 'operational interdependence' in the same conceptual terms as the original answer, though it implies it through 'formal cost-sharing' and gross revenue recognition. This slight omission in framing prevents a perfect 10, but the factual and logical core is intact. Overall, the answer is contextually precise, semantically equivalent, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 419,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The subsidiaries’ fair‑value of energy‑related derivatives dropped sharply – assets fell from $123 million in 2022 (Alabama Power $15 m, Georgia Power $13 m, Mississippi Power $59 m, Southern Power $8 m, Southern Company Gas $28 m) to $55 million in 2023 (Alabama Power $15 m, Georgia Power $13 m, Mississippi Power $15 m, Southern Power $3 m, Southern Company Gas $9 m)【page_283】【page_285】—while liabilities rose modestly from $343 million to $358 million (Alabama Power $110 m/Georgia Power $124 m/Mississippi Power $32 m→$61 m/Southern Power $12 m→$5 m/Southern Company Gas $65 m→$58 m)【page_277】【page_282】. The net derivative position shifted from a $220 million net liability to roughly $303 million, indicating a larger net exposure to energy‑price volatility and a greater potential impact from market fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both asset and liability values for 2022 and 2023, and incorrectly identifies which subsidiaries reported derivative positions in each year. According to the ground truth, in 2022, the subsidiaries with reported values were Mississippi Power, Southern Power, and Southern Company Gas — not Alabama Power or Georgia Power, which the LLM incorrectly includes. The LLM fabricates asset values for Alabama Power ($15M) and Georgia Power ($13M) in 2022, which are not present in the original answer. Similarly, in 2023, the ground truth only reports Alabama Power and Georgia Power — but the LLM adds values for Mississippi Power ($15M), Southern Power ($3M), and Southern Company Gas ($9M), which are not in the original. (2) Calculations are therefore incorrect: the LLM reports 2022 total assets as $123M (summing $15+$13+$59+$8+$28), but the correct total is $95M ($59+$8+$28). Liabilities are reported as $343M in 2022 by the LLM, but the correct sum is $109M ($32+$12+$65). The net liability in 2022 is thus incorrectly stated as $220M instead of the correct $14M net asset ($95M - $109M = -$14M) or more precisely, a net liability of $54M as stated in the original (likely after intercompany adjustments or different classification). The LLM’s 2023 net liability of $303M is also wrong — correct net liability is $219M. (3) Multi-hop reasoning is flawed: the model fails to correctly identify which subsidiaries reported in which year, introduces false data points, and performs calculations on fabricated inputs. It does not reflect the actual shift in reporting entities from 2022 to 2023. (4) Despite these major errors, the answer is contextually relevant — it attempts to address the evolution of fair value and exposure to market fluctuations, and correctly infers increased exposure, though based on incorrect data. However, due to severe quantitative and qualitative inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 537,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was merely listed among the company’s equity‑compensation plans and incorporated by reference (see Exhibit 10‑27 and Exhibit 10‑28) 【page_72】, indicating its existence but without quantitative detail. By the 2024 filing the plan is highlighted in Item 12’s security‑ownership table, where the company notes that it is the only plan that permits future grants and specifies a maximum grant size of 187 million shares with 77 million shares still available for issuance 【page_68】, underscoring its ongoing significance and potential dilution impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption on October 8, 2019, indicating formal establishment. However, the LLM claims that in 2022, the plan was 'merely listed' and 'incorporated by reference' without detail, which contradicts the ground truth that it was newly introduced and detailed. Conversely, the LLM claims that by 2024, the plan is highlighted as the only one allowing future grants with 187 million shares authorized and 77 million available. However, the original answer does not mention any quantitative details (such as 187M or 77M shares), nor does it state that it is the only plan permitting future grants. These specific numbers and assertions are not supported by the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is low because the numbers (187 million, 77 million) are not present in the original answer and cannot be verified; thus, they are incorrect in this context. There are no calculations in the original or LLM answer, but the introduction of precise figures without basis undermines accuracy. (3) The multi-hop reasoning is partially sound in that the LLM attempts to compare the plan’s treatment across 2022 and 2024 filings, but the synthesis is flawed due to incorrect characterization of both years. The evolution described—moving from minimal mention to central role—is opposite to the ground truth, which describes the plan as newly detailed in 2022 and later becoming a standard part of disclosures by 2024. The LLM inverts the trajectory. (4) Contextual relevance is fair because the answer addresses the right document type (10-K), the right plan, and the right time frame, and attempts to show evolution. However, due to factual and directional errors, the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 534,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company’s 2023 filing (see 2023 10‑K p. 263) already stressed that it “minimizes the risk of large losses primarily through diversification but also monitors and manages other aspects of risk,” relying on a diversified asset mix, formal rebalancing and written guidelines for external managers. In the 2024 filing (see 2024 10‑K p. 255) the language is unchanged on diversification, but the company now highlights the use of derivative instruments as hedging tools (and shows a $‑8 million derivative position in the fair‑value table on p. 258) and provides a more detailed discussion of the asset‑allocation process and rebalancing program. Thus, while the overall reliance on diversification remains, 2024 adds an explicit emphasis on hedging with derivatives and a more granular, active risk‑management framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects of risk management emphasis. (1) Correctly identifies Southern Company and the relevant years (2023 and 2024), and accurately references diversification, rebalancing, and external manager oversight as part of the 2023 framework. The mention of derivative instruments in the 2024 filing with a $-8 million position is factually supported by the cited page (p.258), contributing to quantitative accuracy. (2) However, the ground truth indicates a *reduction* in emphasis on external manager oversight and a shift toward market-driven risks (volatility, interest rates), whereas the LLM claims an 'explicit emphasis on hedging with derivatives' and a 'more granular, active risk-management framework'—a characterization not present in the original answer. This represents a qualitative misinterpretation of the shift in risk management focus. (3) The multi-hop reasoning is partially sound—comparing language across two years’ filings—but draws an incorrect conclusion about the nature of the evolution. The original answer highlights a move *away* from active oversight toward market-exposure awareness, while the LLM suggests increased active management via derivatives and process detail, which contradicts the ground truth. (4) Despite accurate page references and some correct details, the core claim about evolving risk emphasis is misaligned, warranting a mid-range correctness score. Quantitative accuracy is high due to correct dollar amounts and page citations. Contextual relevance is strong as it addresses the question’s scope, but qualitative accuracy is reduced due to flawed synthesis and incorrect inference about risk management evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 477,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "In the 2022 filing, NVIDIA’s discussion is limited to hardware‑focused financial results (e.g., the revenue breakdown in page 100) and does not call out CUDA as a distinct product or revenue driver. By the 2023 filing, the company explicitly positions CUDA as a core software layer of its full‑stack platform—highlighting the “CUDA parallel programming model” and the broader CUDA‑X libraries, SDKs and paid AI‑Enterprise licenses (page 6) and noting it as the “foundational CUDA programming model that runs on all NVIDIA GPUs” (page 4). This change signals a strategic shift from a primarily hardware‑centric business to a broader software‑and‑services‑driven AI and data‑center strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies NVIDIA's evolving role from 2022 to 2023: in 2022, CUDA was not emphasized as a distinct product or revenue driver (hardware-focused), while in 2023, it was explicitly positioned as a core software layer, including references to CUDA-X, SDKs, and AI-Enterprise licenses. These details are consistent with the ground truth's claim of a shift from supplier to developer. (2) There are no numeric values, dates, or calculations in the original or LLM answer beyond years (2022, 2023), which are correct. Page references (e.g., page 6, page 4) are specific and plausible within SEC filing context, though not part of the ground truth; they do not contradict it and support the reasoning. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, infers strategic evolution based on changing language and emphasis, and correctly concludes a shift toward a full-stack, software-and-services-driven strategy—directly reflecting the ground truth’s conclusion about strengthening a full-stack computing platform. (4) The LLM adds contextual detail (e.g., AI-Enterprise licenses, page citations) not in the ground truth but derived from actual filings, enhancing precision without introducing error. The only minor gap is that the ground truth emphasizes 'developer' vs 'supplier' roles more explicitly, while the LLM frames it as hardware- vs software-centric—semantically equivalent but slightly less precise in role terminology. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 449,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "In 2022 Pfizer’s PC 1 segment still generated revenue from “manufacturing of legacy Upjohn products for Viatris under manufacturing and supply agreements” (2022 10‑K p. 41). By 2023 those same MSAs and an interim agency operating model remained in place, but the net amount Pfizer owed Viatris fell dramatically – from $94 million at 12/31/2022 to $33 million at 12/31/2023 (2023 10‑K p. 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $94 million balance as of December 31, 2022, and the $33 million as of December 31, 2023, are accurately reported, with proper directional change (decrease) noted. The reference to PC1 revenue in 2022 from manufacturing legacy Upjohn products for Viatris under supply agreements matches the original answer. (2) The LLM correctly cites the 2022 and 2023 10-Ks as sources, demonstrating proper grounding. (3) The multi-hop reasoning is sound: it connects Pfizer’s 2022 supply agreement revenue with the evolving financial balance due to Viatris in 2023, showing a clear evolution in the financial relationship. (4) The only minor omission is that the LLM does not explicitly mention the completion of most transitional services under the TSAs by end of 2023, which is part of the original answer and adds context about reduced operational interdependence. However, the dramatic reduction in the payable balance implies this trend. The use of 'MSAs' and 'interim agency operating model' adds detail not in the original but does not contradict it. Overall, the answer is factually correct, well-supported, and contextually appropriate, missing only a small element of completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 364,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "In the 2023 filing the company described its communications sites almost exclusively as collateral for securitized debt – the cash flows from those sites were pledged to service the Series 2015‑2 and other secured revenue notes and were not available for any other obligations (see 2023 Note on securitizations, p. 112). By the 2024 filing the same securitization cash‑flow restrictions are still disclosed, but the company also places the sites in a broader context: the material‑cash‑requirements table and its footnote tie operating‑lease obligations to the need to renew leases “because failure to do so could result in a loss of the applicable communications sites and related revenues” (2024 p. 56‑57). Thus, disclosure has evolved from a narrow focus on sites as securitization collateral to a more integrated view that links the sites to both debt service and lease commitments, emphasizing their importance for covenant compliance and revenue retention.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in disclosure practices between 2023 and 2024, identifying the shift from communications sites being explicitly tied to securitized debt (e.g., Series 2015-2 Notes) to a broader financial context involving lease obligations and revenue retention. The qualitative reasoning is sound: it notes the continued presence of securitization cash-flow restrictions in 2024 while highlighting an expanded disclosure linking site lease renewals to financial risk, which aligns with the ground truth's theme of moving toward a more integrated view. However, the LLM omits key quantitative details present in the original answer: the specific reference to 3,343 communications sites securing debt in 2023 and the $1.3 billion repayment funded by the 2023 Securitization are not mentioned, weakening completeness. Additionally, the $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024 — a central quantitative point in the ground truth — is entirely absent. While the LLM introduces relevant new context about lease renewals and covenant compliance (supported by cited page numbers), this does not compensate for missing the core numerical disclosures. Entity accuracy is strong: correct years (2023, 2024), correct debt instruments (Series 2015-2), and accurate framing of securitization. The reasoning is logically structured and multi-hop, connecting collateral treatment, cash flow restrictions, and operational dependencies. Contextual relevance is excellent — the answer directly addresses how treatment and disclosure evolved. Overall, the answer is factually plausible and well-reasoned but lacks critical numerical data required for full factual equivalence, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 485,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "In the 2022 filing Comcast said that the fees it receives under NBC and Telemundo retransmission‑consent agreements are part of its distribution revenue, accounted as licenses of functional intellectual property and recognized on a monthly basis as the programming is provided to multichannel video providers【page_94】. By the 2023 filing the company still records those per‑subscriber and fixed‑fee revenues on a monthly basis, but it also notes that it now pays local broadcast stations for consent and expects higher concession payments, showing a shift to a more balanced cost‑and‑revenue approach within its multi‑year, subscriber‑based distribution contracts【page_10】【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Comcast's retransmission consent approach between 2022 and 2023, particularly regarding distribution models. (1) What was correct: The answer accurately states that in 2022, Comcast recognized revenue monthly as programming was provided, tied to subscribers, which aligns with the ground truth. It also correctly notes that in 2023, the company continued monthly recognition and mentioned subscriber-based fees, supporting quantitative and entity accuracy. (2) Number/calculation verification: No explicit numbers (e.g., dollar amounts, percentages) are present in either answer, so no calculation errors exist—this aspect is accurate by default. (3) Multi-hop reasoning assessment: The LLM fails to capture the core evolution highlighted in the ground truth—the strategic shift toward a combined linear and streaming distribution model, including virtual MVPDs and integration with Peacock. Instead, it introduces new information not in the original (i.e., Comcast paying local stations for consent and expecting higher concession payments), which may be factually present in the filing but distorts the focus of the evolution. This reflects a reasoning gap: while cost dynamics are relevant, they do not substitute for the structural shift in distribution models. (4) Justification for scores: Correctness is scored 6 because key facts about revenue recognition timing are correct, but the answer omits the critical 2023 shift to hybrid distribution and Peacock integration, which are central to the question. Qualitative accuracy is 6 due to incomplete synthesis and potential misdirection in reasoning. Quantitative accuracy is 10 as no numerical inaccuracies exist. Contextual relevance is 8 because the response stays on topic but emphasizes less relevant cost aspects over strategic distribution changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 508,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "In the 2023 filing Caterpillar described diesel‑electric locomotives and related rail products simply as a line of the Energy & Transportation segment – a production, component‑supply, remanufacturing and leasing business that supported its broader rail‑related responsibilities. By the 2024 filing the same locomotive business is still part of the segment, but the company now highlights it as a growth engine – transportation sales (which include rail services) rose 4% to $5.36 billion – and positions diesel‑electric locomotives alongside electrified power‑train and zero‑emission initiatives, indicating a more strategic focus on rail and locomotive offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Caterpillar's strategic positioning in diesel-electric locomotives from 2023 to 2024, noting a shift toward greater strategic emphasis and integration with broader transportation and emissions initiatives. However, it introduces significant factual inaccuracies that undermine its correctness. (1) The claim that 'transportation sales (which include rail services) rose 4% to $5.36 billion' is not supported by the ground truth and introduces a specific dollar amount and percentage not present in the original answer; no such financial data was provided in the ground truth, making this a fabrication or misattribution. (2) The original answer emphasizes a structural and descriptive shift in segment reporting—from ME&T in 2023 to Energy & Transportation in 2024 with an explicit 'produces' designation—but the LLM incorrectly states that locomotives were already part of Energy & Transportation in 2023, contradicting the ground truth which states they were under ME&T in 2023. (3) The LLM mentions 'leasing' and 'zero-emission initiatives' as part of the 2024 positioning, which are not mentioned in the ground truth and represent added details not supported by the source. (4) The competitive landscape mention (Wabtec, Siemens Mobility) in 2024, a key differentiator in the original answer, is entirely omitted in the LLM response, missing a critical multi-hop element. While the LLM correctly infers a strategic elevation in focus, the quantitative inaccuracy and misrepresentation of segment classification and missing competitive context reduce its correctness. The reasoning is partially sound but based on incorrect or invented data. Contextual relevance is high as it addresses the evolution question directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 478,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "In the 2023 filing McDonald’s described franchise‑related revenue simply as “rent and royalties based on a percent of sales with minimum rent payments, and initial fees,” plus “other revenues…fees paid by franchisees to recover a portion of costs incurred by the Company for various technology platforms” 【page_43】. By the 2024 filing the company added that it is the **principal** in those technology‑platform arrangements and therefore presents the fees on a **gross basis** as the goods or services are transferred, and it now explicitly discloses **cost‑sharing of restaurant‑improvement projects**—funding the projects up‑front, estimating each party’s share, and allocating the costs between property‑and‑equipment and accounts receivable 【page_46】. Thus, the franchise relationship has become more transparent: revenue from technology services is now gross‑reported, and cost‑sharing of capital improvements is formally described.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key elements from the ground truth are present: in 2023, revenue from franchisees included rent, royalties, initial fees, and cost-recovery fees for technology platforms; in 2024, the company clarified its role as principal in technology platform arrangements, resulting in gross reporting of those fees, and introduced detailed disclosures on cost-sharing for restaurant improvements, including upfront funding and cost allocation between Property and Equipment and Accounts Receivable. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the qualitative financial reporting changes—such as gross vs. net presentation and cost allocation methodology—are correctly described. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and two types of financial arrangements (revenue recognition and cost-sharing), identifying both continuity (core rent/royalty model unchanged) and evolution (increased transparency and accounting detail). (4) The LLM uses precise terminology (e.g., 'principal', 'gross basis', 'accounts receivable', 'property and equipment') and cites specific page numbers, enhancing credibility. Wording differs slightly from the original answer but conveys the same meaning with high fidelity. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 397,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company only gave a high‑level overview of its equity‑compensation program – noting that PSUs and RSUs are granted under the 2021 Equity and Incentive Compensation Plan and that most awards vest immediately upon retirement, with expense recognized accordingly (see 2023 p. 276). By the 2024 filing the company had added a dedicated exhibit that spells out the actual award agreement language for named executive officers – “Form of Terms for Named Executive Officer Equity Awards Granted under the Southern Company 2021 Equity and Incentive Compensation Plan” – thereby providing a more detailed, formalized documentation of the plan and its award terms (see 2024 p. 316). This shift reflects a move from a general description to explicit, disclosed award‑term documentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Southern Company provided a general overview of its equity compensation under the 2021 Equity and Incentive Compensation Plan, with PSUs and RSUs awarded across employee levels, and notes retirement-related vesting and expense recognition (citing p.276 of the 2023 filing). This matches the original answer’s description of a less formalized, high-level disclosure. (2) For 2024, the LLM accurately states the introduction of a dedicated exhibit—'Form of Terms for Named Executive Officer Equity Awards'—which formalizes award terms for executives, citing p.316. This reflects the ground truth’s point about increased specificity and transparency in documentation. (3) The reasoning is sound: the LLM correctly infers a shift from general program description to explicit, standardized executive award documentation, demonstrating proper multi-hop synthesis across years and disclosure practices. (4) Minor difference: the original answer emphasizes the evolution in 'approach' to executive compensation, while the LLM focuses more on documentation changes. However, the core factual evolution—greater formalization and transparency in 2024—is correctly captured. All entities (Southern Company, PSUs, RSUs, 2021 Equity and Incentive Compensation Plan, Named Executive Officers) and years (2023 vs 2024) are accurate. Page references and plan name (2021 version) are precise. No calculation errors. The answer is semantically equivalent and contextually fully relevant. One point deducted from qualitative accuracy only because the LLM slightly underemphasizes the broader 'structured approach' to executive compensation beyond just documentation, but the key evolution is correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 489,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K, P&G explicitly listed “membership club stores” among its key retail customers, showing that the company still counted club‑store traffic as an important sales channel [page_4]. By the 2024 filing, the company no longer calls out membership clubs and instead highlights “evolving sales channels… e‑commerce… hard discounter channels” as central to its growth strategy [page_7]. This omission signals a deliberate shift away from reliance on club‑store partners toward a more diversified, digitally‑focused retail mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim and directly contradicts the ground truth. According to the original answer, P&G's reliance on membership club stores increased from 2022 to 2024, with the company shifting language to emphasize greater dependency on this channel. However, the LLM claims that P&G omitted membership club stores in the 2024 filing and shifted away from them, which is false based on the provided ground truth. There are no numeric values in the question or answers requiring quantitative verification, so quantitative accuracy is scored as 10 due to absence of numerical errors. Qualitative accuracy is very low because the model misidentifies the direction of strategic evolution—claiming a shift away from club stores when the truth indicates increased reliance. This reflects a failure in multi-hop reasoning: the model either misread or misinterpreted the source documents, leading to an incorrect synthesis. Contextual relevance is low because the answer addresses the general topic of retail channel strategy but with the wrong conclusion, making it misleading despite referencing appropriate document types (Form 10-K) and other channels. The semantic meaning is not equivalent to the ground truth; it conveys the opposite strategic movement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 358,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "In the 2023 Form 10‑K, AMT disclosed that it had drawn Nigeria Letters of Credit amounting to about **$3.4 million** (recorded as variable‑rate debt with interest at SOFR + spread and payable 270 days after each draw). By the 2024 filing the line shows a **$0 carrying value**, meaning the letters of credit were fully repaid or otherwise extinguished, eliminating that short‑term financial obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.4 million obligation in 2023 and $0 carrying value in 2024 are accurately reported, with acceptable formatting (bolded, spaced currency). (2) The answer addresses both parts of the question: the evolution (from $3.4M to $0) and the implication (obligation eliminated). (3) Entities are correct—AMT, Nigeria Letters of Credit, 2023 and 2024 time frame, variable-rate debt context. (4) The reasoning is sound: the drop to zero carrying value logically indicates full repayment or extinguishment, which correctly infers the settlement of financial obligations. The LLM adds minor contextual detail (SOFR + spread, 270-day term) not in the ground truth but consistent with typical LOC structures and not contradictory. These enhancements improve clarity without compromising accuracy. All multi-hop elements—comparing two years’ disclosures and inferring financial implication—are correctly executed. Semantic equivalence is strong, with no factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 302,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "GD continues to classify its retirement‑annuity contracts as Level 3 assets measured at fair value using significant unobservable inputs, consistent with its fair‑value hierarchy (see Note P, page 93).  The contracts’ fair‑value balance fell from roughly $35 million in the 2022 filing (Level 3 amount shown in the “Changes in our Level 3 defined‑benefit plan assets” table, page 96) to $22 million in the 2024 filing (Level 3 amount in the plan‑asset hierarchy table, page 94), indicating a smaller composition of these contracts while maintaining the same reporting methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that GD maintained the same valuation methodology (Level 3 with unobservable inputs), but the ground truth states that by 2024, GD shifted to using NAV as a practical expedient, which removes these assets from the formal fair value hierarchy—this is a major change in reporting approach that the LLM completely misses. Additionally, the LLM incorrectly reports the 2024 value as $22 million, which is not supported by the original answer (the ground truth does not provide a 2024 dollar value at all). The 2022 reference to $35 million is accurate as it reflects the value as of December 31, 2021, but the LLM misattributes timing by calling it the '2022 filing' value without clarifying it's for the prior year. (2) Quantitative accuracy is partially correct: the $35 million figure for 2021 (reported in 2022) is accurate, but the $22 million figure for 2024 is unsupported and likely incorrect. No calculation is performed in the original answer, so no calculation error applies, but the introduction of a new number without basis reduces accuracy. (3) Multi-hop reasoning fails: the question asks about changes in both methodology and composition between 2022 and 2024. The LLM only addresses composition (with incorrect data) and entirely misses the key methodological shift to NAV as a practical expedient, which is the central point of the original answer. This indicates a failure to synthesize the correct disclosures across years. (4) Contextual relevance is moderate—the answer discusses Level 3 assets and fair value, which are relevant, but misrepresents the evolution of the reporting approach. The conclusion that the methodology remained consistent is directly contradicted by the ground truth, undermining the qualitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 502,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "In the 2022 filing the company only noted that the cash held for securitization investors appears as the “restricted cash for securitization investors” component of its consolidated VIE assets, without giving a dollar amount or a fair‑value hierarchy breakdown【page_179】. By the 2024 filing that line item is quantified at $441 million (carrying and fair‑value) and is shown to be entirely Level 1 in the fair‑value hierarchy, with no Level 2 or Level 3 portions【page_219】. Thus the composition (cash for securitization investors) remains the same, but the amount is now disclosed and is classified as Level 1 fair‑value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $441 million value for 2024 is accurately reported, and the absence of a dollar amount in 2022 is correctly noted. The classification as Level 1 in 2024 with no Level 2 or Level 3 components aligns with the ground truth. (2) The answer is complete, addressing both years, the change in disclosure (from no breakdown to full fair value hierarchy classification), and the composition remaining consistent. (3) Entity accuracy is correct: 'restricted cash for securitization investors' and 'consolidated VIEs' are properly identified, and the years 2022 and 2024 are correctly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: it contrasts the lack of fair value hierarchy detail in 2022 with the explicit Level 1 classification in 2024, concluding a shift toward more transparent valuation—exactly as stated in the original answer. Minor wording differences (e.g., 'carrying and fair-value') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 309,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "In 2024 McDonald’s recognized more franchised‑restaurant revenue ($15.7 bn versus $15.4 bn in 2023) and a smaller loss on sales of restaurant businesses to franchisees (a $94 m loss versus a $103 m loss in 2023), while asset dispositions moved from a $7 m net loss in 2023 to a $100 m net gain in 2024, indicating tighter asset‑management of franchise‑related properties (see 2024 p. 40 and 2024 p. 18). The company still does not consolidate franchisee advertising cooperatives because it lacks voting control, and goodwill—generated from purchases of franchisee restaurants—remains a key asset, showing a modestly improved financial recognition of franchisee activity while maintaining the same non‑consolidation stance (see 2023 p. 45, 2024 p. 48).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several specific financial figures (e.g., $15.7B vs $15.4B franchised-restaurant revenue, $94M vs $103M loss on sales, $7M net loss to $100M net gain in asset dispositions) that are not present in the original ground truth and cannot be verified against it. While these numbers may come from actual filings, the ground truth does not mention them, and thus their inclusion introduces unverified quantitative claims. The original answer focuses on a qualitative shift in McDonald's relationship with franchisees—from asset acquisition and goodwill management in 2023 to a service-based, technology-driven model in 2024 with gross revenue recognition for tech services. The LLM answer misses this core conceptual evolution entirely. Instead, it emphasizes asset dispositions and financial metrics without addressing the shift to technology platform services or the change in revenue recognition methodology. It correctly notes that McDonald's does not consolidate franchisee advertising cooperatives due to lack of voting control and mentions goodwill from purchasing franchisee restaurants, which aligns partially with the 2023 context. However, it fails to recognize the fundamental transformation in the business relationship described in the original answer. The reasoning is factually inconsistent with the ground truth’s narrative, showing poor multi-hop synthesis. While some elements (e.g., goodwill, non-consolidation) are contextually relevant, the central theme of a shift from asset ownership to service dependency is absent. Therefore, despite some accurate peripheral details, the answer is largely incorrect in its representation of the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 462,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan is presented simply as another stock‑and‑incentive plan – it is listed with its own regulations and additional terms and is mentioned alongside the 2014 Plan and earlier plans. By the 2024 Form 10‑K the company singles out the 2019 Plan as the **only** equity‑compensation plan that can issue future grants, stating a 187 million‑share ceiling and that 77 million shares remain available, thereby emphasizing its unique role in equity compensation relative to the other plans.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in disclosure focus—from listing the 2019 Plan among others in 2022 to highlighting its exclusive role in future grants by 2024—which aligns with the ground truth's theme of shifting from procedural governance to strategic equity structure. However, the LLM introduces specific quantitative details (187 million-share ceiling, 77 million shares remaining) that are not present in the original answer and cannot be verified against the provided ground truth, raising concerns about factual accuracy. These numbers may be correct in actual filings, but since they are absent from the ground truth derived from the knowledge graph, they represent unverified additions. (2) The original answer does not include any numerical data, so the inclusion of precise share counts in the LLM response constitutes a deviation rather than a confirmation. This affects quantitative accuracy despite plausible formatting tolerance. (3) The multi-hop reasoning is sound: the model correctly identifies a shift in disclosure emphasis between 2022 and 2024 and synthesizes the changing relationship between the 2019 Plan and other compensation plans. It correctly infers that the 2019 Plan becomes the primary (or only) active plan for future grants, which is consistent with the original answer’s claim about its evolving strategic role. (4) The contextual relevance is high because the response directly addresses the question about the evolution of disclosures, particularly regarding the plan’s relationship with other plans and its role in equity compensation. The qualitative reasoning is strong, but the unsupported numbers reduce confidence in factual correctness, warranting a score of 7 for overall correctness—core facts are right, but with significant unverified additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 494,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "In the 2022 Form 10‑K, Salvatore Ferragamo is listed as a tenant at eight international premium‑outlet sites – four in Japan (Gotemba, Kobe‑Sanda, Rinku and Sano) and one each in Mexico (Punta Norte), South Korea (Yeoju and Siehung), Malaysia (Johor) and Canada (Montreal)【page_42】【page_43】. The 2023 filing excerpts do not include the international‑outlet tenant tables, so no new locations or removals are disclosed; based on the available pages, there is no evidence that Ferragamo’s international presence changed between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Salvatore Ferragamo was present in three Japanese outlets in 2022 (Gotemba, Kobe-Sanda, Sano), but the LLM claims eight locations across multiple countries including four in Japan (adding Rinku), plus sites in Mexico, South Korea, Malaysia, and Canada—none of which appear in the ground truth. This overstatement of locations and incorrect geographic spread represents a major factual error. Furthermore, the ground truth states that in 2023, Ferragamo was present only at Las Vegas Outlets North in the U.S., indicating a reduction. However, the LLM claims that no change can be determined because the 2023 filing 'does not include the international-outlet tenant tables,' concluding there is 'no evidence of change.' This misrepresents the situation—the absence of data in the 2023 filing does not imply no change; the ground truth affirms a documented shift based on available disclosures. (2) Quantitative accuracy is poor: the LLM reports 8 locations in 2022 (vs. 3 in ground truth), and fails to report the 2023 presence in one U.S. location. The calculation of change (from 3 to 1) is entirely missed due to incorrect data and flawed reasoning. (3) Multi-hop reasoning is unsound: the model fails to synthesize the correct tenant list from 2022 and incorrectly infers stability due to missing tables in 2023, rather than acknowledging the documented presence in a single U.S. location as per the ground truth. It does not recognize that the shift from Japan to the U.S. is a meaningful evolution. (4) Contextual relevance is moderate—the response addresses the question's intent and cites document sections, but the factual foundation is wrong, undermining usefulness. The reliance on incorrect source interpretation invalidates the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 508,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East slipped slightly in 2024.  The developed gas base fell from 312 billion cubic feet (BCF) in 2023 to 296 BCF in 2024, while equity‑affiliate reserves dropped from 3,558 BCF to 3,189 BCF, and undeveloped gas stayed flat at 7 BCF (COP 2024 10‑K, p. 145).  This modest decline and stagnant undeveloped inventory suggest the company is not pursuing new gas growth in the region, but is instead focusing on maintaining and optimizing its existing gas assets there.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. While it correctly states the 2023 (312 BCF) and 2024 (296 BCF) developed natural gas reserves for COP in the Asia Pacific/Middle East region, it introduces additional data points—equity-affiliate reserves (3,558 BCF to 3,189 BCF) and undeveloped gas (7 BCF)—that are not mentioned in the original answer and cannot be verified from the provided ground truth. These additions suggest fabrication or misattribution of data, severely impacting quantitative accuracy. (2) The core calculation of the developed gas decline (312 to 296 BCF) is accurate and matches the ground truth, but the inclusion of unsupported figures for equity-affiliate and undeveloped reserves introduces significant error. The ground truth makes no mention of these categories or values, so their inclusion is unjustified. (3) The reasoning about operational focus—suggesting a lack of aggressive growth and a shift toward optimization of existing assets—is a reasonable qualitative interpretation and aligns semantically with the ground truth’s conclusion about 'stabilization' rather than growth. However, the reasoning is based partly on fabricated data, weakening the multi-hop logic. (4) The contextual relevance is high because the answer addresses the evolution of COP’s gas position and infers operational focus. However, the correctness score is reduced to 6 due to major quantitative inaccuracies, despite the correct core trend and plausible interpretation. The qualitative accuracy is moderate because the conclusion is sound but based on partially incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 452,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "In the 2022 Form 10‑K Comcast described wireless gateways as a broadband‑service offering and noted that “customer premise equipment, including wireless gateways” saw **decreased spending** as part of its $6.9 billion capital‑expenditure program (see 2022 p. 7, 8 and 42). By the 2024 filing the company had shifted to a **strategic focus** on expanding those devices, stating that future capex will be “focused on … the continued deployment of wireless gateways” as a core part of its Connectivity & Platforms business (2024 p. 51). This reflects a move from a lower‑priority, cost‑cutting stance in 2022 to an explicit, investment‑driven emphasis on wireless gateways in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Comcast's approach: in 2022, wireless gateways were part of broadband offerings with decreased spending noted ($6.9 billion capex program, pages 7, 8, 42), and by 2024, the company shifted to strategic emphasis on deployment (page 51). The characterization of a shift from cost-cutting to investment-driven strategy is factually supported. (2) Quantitative details are accurate: the $6.9 billion capital expenditure figure is correctly cited from the 2022 10-K, and the shift in capex focus is properly attributed to the 2024 filing. No calculations were required, but references to specific pages and filings enhance credibility. (3) Multi-hop reasoning is sound—synthesizing information across two years’ filings to show a strategic pivot. The LLM correctly infers a change in strategic emphasis based on contrasting language and investment patterns. (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of 2022 as a 'cost-cutting stance,' which is implied but not explicitly framed as such in the original; otherwise, the reasoning and synthesis are excellent. Semantic equivalence is maintained, and all entities (Comcast, wireless gateways, 2022–2024, capex) are correct. The answer fully addresses strategic emphasis and investment, satisfying completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 390,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "The 2022 Form 10‑K notes that by year‑end 2021 the G500/G600 family had delivered “almost 150” aircraft 【page_6】, while the 2024 Form 10‑K reports that by year‑end 2024 cumulative deliveries of the G500 and G600 together “totaled more than 300” 【page_5】—roughly doubling the G600’s delivery volume over the period.  The G600, which entered service in 2019 as a clean‑sheet replacement for the G550, is highlighted as a core large‑cabin, high‑performance jet in Gulfstream’s product lineup, complementing the G500 and underpinning the newer models such as the G800 and G400 【page_5】【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that cumulative deliveries for the G500 and G600 were 'almost 150' by year-end 2021 (per 2022 10-K) and 'more than 300' by year-end 2024 (per 2024 10-K), accurately reflecting the doubling trend. These numbers match the ground truth exactly in substance, though the LLM refers to 'G600’s delivery volume' doubling, which is slightly imprecise since the data is for G500 and G600 combined. However, the overall quantitative interpretation is sound. (2) All dates and figures are correct: 'almost 150' by end of 2021 and 'more than 300' by end of 2024 aligns with the original answer. The calculation that deliveries roughly doubled is accurate and supported. (3) The multi-hop reasoning is strong—information is correctly synthesized across the 2022 and 2024 10-K filings. The LLM correctly infers increased market presence via delivery growth and evolution in product role. It accurately notes the G600's transition to a core model and mentions the shift in focus to newer models like G800 and G400, which matches the ground truth's point about the G600 no longer being framed as a new introduction. (4) Minor wording issue: the LLM says 'doubling the G600’s delivery volume', which could mislead as the data is for G500 and G600 combined. However, this does not invalidate the overall correctness, as the combined fleet growth is correctly attributed and the qualitative evolution is well captured. Hence, a score of 9 is justified—excellent accuracy with a small imprecision in attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 424,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "In 2023 AIG still owned a controlling stake in Corebridge – 52.2 % of its common stock as of December 31, 2023【page_27】. By 2024 AIG had sold down most of that interest, retaining only 294.2 million Corebridge shares (valued at about $8.5 billion) and reclassifying Corebridge as a discontinued operation【page_110】. As a result, AIG’s earnings from Corebridge shifted to an equity‑method gain of $601 million for the June‑December 2024 period (plus Corebridge’s pre‑tax profit of $1.574 billion) and a $4.754 billion after‑tax loss on the de‑consolidation of Corebridge【page_109】【page_110】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant quantitative inaccuracies despite capturing the general trend of AIG's evolving relationship with Corebridge. (1) Correct elements: It correctly states that AIG held 52.2% of Corebridge as of December 31, 2023, and that it began selling down its stake, reclassifying Corebridge as a discontinued operation. It also correctly identifies the shift to equity method accounting and mentions income recognition under that method. (2) Quantitative errors: The claim that AIG retained 294.2 million shares valued at $8.5 billion is not supported by the ground truth and introduces specific figures not present in the original answer. The $601 million equity-method gain and $1.574 billion pre-tax profit are specific numbers not mentioned in the ground truth, which only states that AIG recognizes income based on dividends and stock price changes from June 9, 2024. The $4.754 billion after-tax loss on de-consolidation is also not in the original and appears to be fabricated or misattributed. (3) Multi-hop reasoning: The model correctly infers a shift from control to passive investment but overreaches by introducing detailed financials not present in the ground truth, undermining factual reliability. (4) The answer is contextually relevant and addresses both equity ownership and income recognition, but the inclusion of unsupported numbers reduces correctness. While the qualitative shift is understood, the quantitative accuracy is low due to unverified figures, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 430,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "In 2022 Tesla’s Solar Roof was tied to a single manufacturing hub – Gigafactory New York in Buffalo – where the company “uses … for the development and production of our Solar Roof and other solar products and components” and relied on its in‑house design, software and mounting‑hardware expertise to build the system【page_9】. By the 2024 filing Tesla no longer emphasizes a dedicated factory; instead it warns that “we have experienced … delays in launching and/or ramping production of … Solar Roof” and cites “supply chain constraints, regulatory or other approvals … and the pace of bringing production equipment and processes online” as key operational hurdles, reflecting a shift from a location‑specific dependency to broader production‑ramp challenges【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Tesla produced the Solar Roof at Gigafactory New York, which was explicitly dedicated to solar products, and by 2024, the company reported delays in ramping production, citing supply chain constraints and production ramp challenges. These points match the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, units) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2024) and references to specific filings are correct, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two time points and two different 10-K filings, identifying the shift from a dedicated manufacturing site to broader operational and ramp-up challenges. It captures the evolution in Tesla’s disclosures—from location-specific production to systemic production risks. (4) The only minor shortcoming is that the LLM does not explicitly mention the financing options or integration into the broader energy ecosystem noted in the 2022 context, nor does it reference the specific challenges around 'design tolerances, high quality and output rates' or 'localized procurement' from the 2024 filing. While the core evolution in strategy and challenges is accurately conveyed, these omissions slightly reduce completeness in qualitative synthesis. However, the central thesis of shifting from a focused, location-based strategy to a more complex, risk-laden ramp-up is preserved. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as it directly addresses manufacturing dependencies and operational challenges across the specified timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 495,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "In 2023 Qualcomm presented on‑device AI as a core pillar of its technology platform – it built dedicated AI‑engine hardware (the Hexagon NPU and Snapdragon AI Engine) and a unified AI‑Stack to run complex AI workloads on phones, PCs and emerging edge devices, and it projected that generative‑AI‑capable handsets would grow rapidly 【page_9】. By 2024 the company still invests in that foundational AI engine, but it has broadened its business focus to apply on‑device AI across new product areas such as automotive and IoT and is now using acquisitions and other strategic transactions to accelerate those AI‑related expansions 【page_20】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of Qualcomm's strategy from 2023 to 2024. (1) It accurately captures that in 2023, Qualcomm focused on building foundational on-device AI technologies like the Hexagon NPU and Snapdragon AI Engine, positioning AI as a core part of its platform across devices — consistent with the original answer’s description of on-device AI as a core product offering. In 2024, the LLM correctly notes a broadening into automotive and IoT and increased use of acquisitions and strategic transactions, which matches the ground truth’s emphasis on a shift toward investment-centric growth and ecosystem development. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are used correctly, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and strategic focus areas, correctly identifying the shift from product-centric to investment- and expansion-focused strategy. However, the LLM slightly underemphasizes the conceptual shift described in the original answer — from 'core product offering' to a 'more investment-centric strategy' focused on long-term ecosystem enablement and third-party integration. While the mention of acquisitions supports this, the deeper strategic reframing (e.g., reduced emphasis on direct product commercialization) is implied but not explicitly articulated. (4) Despite this nuance, the LLM answer remains contextually rich, relevant, and factually aligned. Minor deduction in qualitative accuracy for incomplete articulation of the strategic pivot’s depth, but overall correctness is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 485,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "In the 2022 filing Dolce & Gabbana was listed as a tenant at several premium‑outlet sites – the Las Vegas Outlets in Nevada and a handful of overseas locations, including Gotemba, Kobe‑Sanda and Rinku Premium Outlets in Japan and Punta Norte Premium Outlets in Mexico City (2022 ‑ p. 34; 2022 ‑ p. 42; 2022 ‑ p. 43). By the 2023 filing the only outlet still showing the brand is Las Vegas Outlets (2023 ‑ p. 32; 2023 ‑ p. 34). This contraction to a single, high‑traffic flagship suggests SPG is concentrating its luxury‑brand mix in marquee locations, using Dolce & Gabbana to reinforce a premium positioning at its most visible outlets while streamlining the tenant mix elsewhere.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but includes an inaccuracy regarding Dolce & Gabbana's 2022 presence at Las Vegas Outlets and Punta Norte Premium Outlets. The ground truth states that in 2022, the brand was present in Japan (Gotemba, Kobe-Sanda, Rinku), but does not mention Las Vegas or Mexico City. The LLM incorrectly adds Las Vegas as a 2022 location, which contradicts the ground truth that shows Dolce & Gabbana only appearing there in 2023. This affects quantitative and factual accuracy. (2) There are no numerical values requiring calculation, but the presence/absence of locations across years is a key factual element. The LLM correctly identifies the 2023 presence at Las Vegas Outlets, aligning with the ground truth, but misrepresents the 2022 footprint by including U.S. and Mexican locations not cited in the original. (3) The multi-hop reasoning is sound: the model correctly infers a strategic contraction and repositioning from multiple locations to a single flagship, which aligns with the ground truth's interpretation of a shift toward exclusive U.S. placement. The logic about SPG streamlining luxury tenants in marquee locations is a reasonable and contextually appropriate interpretation. (4) The contextual relevance is perfect—the answer directly addresses the evolution and strategic implication. Qualitative accuracy is high due to strong reasoning, but quantitative accuracy is reduced due to incorrect entity mapping in 2022. Correctness score is 7 because core facts about the 2023 shift and strategic interpretation are correct, but the 2022 tenant list contains significant inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 448,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "In 2023 ConocoPhillips reported $44 million of exploration expenses for its Asia Pacific/Middle East operations (see the “Exploration expenses” line for that region in the 2023 segment table)【page_148】.  The 2024 reserve table shows a dash for “Extensions and discoveries” in the Asia Pacific/Middle East column, indicating no new discoveries or exploration activity for the year 2024【page_145】.  The drop from a measurable outlay in 2023 to essentially zero in 2024 signals that the company has pulled back its exploration investment and is de‑emphasizing new development in the Asia Pacific/Middle East region.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the drop in exploration activity from 2023 to 2024 and interprets it as a strategic pullback, which aligns with the ground truth. However, the 2023 exploration expenditure is reported as $44 million in the LLM answer, whereas the ground truth states $49 million—a material discrepancy. The 2024 value is correctly interpreted as $0 (via a dash in the 'Extensions and discoveries' line), which supports the conclusion of no new activity. (2) The quantitative inaccuracy in the 2023 figure reduces confidence in data extraction precision. While the dash in the 2024 reserve table can reasonably be interpreted as $0 in new activity, the absence of an explicit 'exploration expenses' line for 2024 in the region introduces some ambiguity, though the inference is logical. (3) The multi-hop reasoning is sound: the model connects 2023 segment-level expense data with the 2024 reserve table’s lack of extensions/discoveries to infer a halt in exploration. This synthesis supports the correct strategic interpretation. (4) Despite the numerical error, the overall conclusion about strategic de-emphasis is valid and well-supported. The answer is fully relevant and addresses both parts of the question—evolution of investment and strategic implication—earning high marks for qualitative reasoning and relevance, but the incorrect dollar amount limits the correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 400,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast’s ownership of the Beijing park has not changed – it still holds a 30 % equity interest in Universal Beijing Resort.  The resort’s financing has been trimmed modestly, falling from roughly $3.5 billion of total debt (about $3.1 billion of term‑loan principal) at year‑end 2022 [2022 10‑K, p. 15] to $3.4 billion of total debt (about $3.0 billion of term‑loan principal) at year‑end 2024 [2024 10‑K, p. 86].",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership interest in Universal Beijing Resort, which aligns with the ground truth for 2024. However, it incorrectly states that the ownership 'has not changed' from 2022, while the original answer clarifies that no specific stake was disclosed in 2022 — only that the resort was newly mentioned. This is a significant omission, as the 30% figure was not confirmed in 2022 filings, making the claim of stability inaccurate. (2) Quantitatively, the LLM claims $3.5 billion debt at year-end 2022, but the ground truth states $3.5 billion was the 2023 figure, with no specific debt number provided for 2022 in the original answer. The $3.4 billion debt figure for 2024 is correct. The reference to term-loan principal ($3.1B in 2022, $3.0B in 2024) introduces granular detail not present in the ground truth, which cannot be verified against the provided knowledge and may be extraneous or incorrect. (3) The reasoning partially supports the multi-hop requirement by comparing 2022 and 2024 disclosures, but fails to acknowledge that 2022 lacked explicit stake and debt data, leading to flawed synthesis. The evolution is misrepresented as stable when in fact it reflects increased disclosure clarity over time. (4) Despite these issues, the answer is contextually relevant and captures the core direction of debt reduction and ownership level by 2024. The quantitative accuracy is reduced due to unsupported figures for 2022, while qualitative reasoning and completeness are partially sound but miss key nuances in disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 437,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy’s net derivative position shrank sharply – the net balance fell from $29 million at 12/31/2022 to $13 million at 12/31/2023.  At the same time, the company settled far more contracts in 2023 (‑$68 million) than in 2022 (‑$32 million) and reduced purchases (‑$42 million vs. ‑$74 million), turning a $35 million loss on derivatives in 2022 into a $10 million gain in 2023【page_192】.  This pattern shows Duke Energy actively reduced its net exposure to derivatives, using larger settlements and fewer new purchases to lower its derivative footprint and capture gains.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net derivatives balance at the end of 2022 ($29 million) and 2023 ($13 million), which matches the ground truth. It also correctly states that settlements in 2022 were $32 million and increased to $68 million in 2023. However, the LLM introduces additional data not present in the original answer—specifically, 'reduced purchases (‑$42 million vs. ‑$74 million)' and 'a $35 million loss on derivatives in 2022 into a $10 million gain in 2023'—which are not part of the ground truth and cannot be verified from the provided information. These additions introduce factual inaccuracies or unverified details. (2) While the core numbers for net balances and settlements are accurate, the inclusion of unverified figures (purchases, gains/losses) undermines quantitative accuracy. There are no calculation errors in the numbers cited from the ground truth, but the extra data points are unsupported. (3) The reasoning about reduced exposure and active management of derivatives aligns with the original conclusion about a shift in management strategy due to lower net balance despite higher settlements. This shows sound qualitative reasoning based on correct trends, though it extends beyond the evidence with speculative financial details. (4) The answer is contextually relevant and addresses the evolution of the net derivatives balance and settlement activity, drawing a reasonable inference about exposure/management. However, the addition of unverified metrics reduces overall correctness. The core multi-hop synthesis (comparing balances and settlements across years) is done correctly, but the answer goes beyond the source data in key areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 464,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "In the 2022 Form 10‑K SPG only listed LTIP units as a line‑item in equity (showing a $17.8 million credit) and noted in the per‑share footnote that LTIP units were “potentially dilutive” but had no material dilutive effect for the prior years (2021, 2020, 2019) — without describing how their value is measured (see 2022 p. 95; 2022 p. 115). By the 2023 filing, SPG still treats LTIP units as participating securities under the two‑class EPS method and again confirms they had no material dilutive impact for 2023‑2021, but now adds that the grant‑date fair value of market‑based LTIP units is estimated using a Monte Carlo model (see 2023 p. 111; 2023 p. 127).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, SPG disclosed LTIP units as potentially dilutive with no material effect for 2021–2019, and that by 2023, SPG added more detailed disclosures including the use of a Monte Carlo model for grant-date fair value of market-based LTIP units and confirmed their treatment as participating securities under the two-class EPS method. (2) The dollar amount ($17.8 million credit) is specific and matches the filing (allowing for format variation), and all years (2022, 2023, and referenced prior years) are correct. No calculations were required, but temporal references are accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts the level of disclosure between 2022 and 2023, identifying both the continuity (treatment as participating securities, no material dilution) and the evolution (addition of Monte Carlo valuation methodology). (4) The only minor shortcoming is that the LLM does not explicitly mention the shift 'from a general statement about dilution to a more granular and valuation-focused disclosure'—a synthesis emphasized in the original answer—but this conceptual framing is implied through the factual details provided. Thus, the answer is factually complete and semantically equivalent, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 402,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "In the 2022 filing Comcast only noted that it had amended its November 2020 agreement with Atairos – extending the investment term and allowing capital to be recycled – but did not disclose the specific funding limits (see CMCSA 2022 10‑K p. 105). By the 2024 filing Comcast clarified that the amendment reduced its aggregate funding commitment from up to $5 billion to $4.5 billion, capped annual capital calls at $400 million, and confirmed a separate $40 million‑per‑year management‑fee commitment (see CMCSA 2024 10‑K p. 84). This shows a tightening of the capital exposure while keeping the management‑fee arrangement unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the management fee. Quantitatively, the reduction in capital commitment from $5 billion to $4.5 billion is accurate, and the $40 million annual management fee is correctly stated. However, the LLM incorrectly states that the management-fee arrangement was 'unchanged'—the original answer notes it was 'introduced' or newly confirmed in 2024, implying it was not previously in place or disclosed, which contradicts the claim of being 'unchanged.' Additionally, the LLM mentions a 'cap on annual capital calls at $400 million,' which is not present in the ground truth and may be extraneous or misinterpreted information. This affects qualitative accuracy slightly, as the reasoning implies continuity in the fee structure when the original answer suggests a strategic recalibration. The answer is contextually relevant and addresses both capital funding and management fee commitments over the 2022–2024 period. Multi-hop reasoning is sound in comparing disclosures across filings, but the synthesis includes an unsupported inference about the management fee's continuity. Overall, core facts and numbers are correct, but minor errors in interpretation prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 358,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP’s combined developed + undeveloped natural‑gas reserves in the Asia Pacific/Middle East fell from **312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024** – a drop of roughly 5 % (≈ 16 BCF)【page_145】. This modest decline indicates that the company’s own gas resource base in that region is contracting, suggesting a relatively limited or de‑emphasized operational focus on expanding natural‑gas assets there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024, matching the ground truth exactly. The calculated decrease of approximately 16 billion cubic feet (5%) is accurate and appropriately contextualized. (2) All numeric values, years, and calculations are correct. The difference (312 - 296 = 16 BCF) and percentage drop (~5.1%) are precise. The use of 'BCF' and 'billion cubic feet' is consistent and acceptable. (3) The reasoning is sound: the model correctly infers that a decline in reserves may indicate a reduced or de-emphasized operational focus in the region, which aligns with the original answer’s interpretation of a 'potential shift in operational focus or resource allocation.' The addition of 'contracting resource base' adds slight interpretive depth without overreaching. (4) The answer fully addresses both parts of the question—evolution of reserves and implications for operational focus—and maintains semantic equivalence with the ground truth. The only minor point preventing a perfect 10 is the slight interpretive extension of 'de-emphasized operational focus,' which is reasonable but slightly stronger than the original's more cautious 'suggesting a potential shift.' However, this does not constitute an inaccuracy. All entities (COP, geographic region, years, metric) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 400,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022 Comcast’s wireless‑gateway strategy was to source the devices from a **limited number of suppliers** as part of its broader purchase of customer‑premise equipment (see 2022 10‑K pages 7‑8). By 2024 the company’s capital‑expenditure plan had shifted to **network‑deployment spending**, with higher outlays for scalable infrastructure and line extensions and a reduction in spending on customer‑premise equipment such as wireless gateways (see 2024 10‑K pages 42 and 51).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its qualitative reasoning. While it correctly states that in 2022 Comcast sourced wireless gateways from a limited number of suppliers (supported by 2022 10-K pages 7-8), it incorrectly claims that by 2024 the company reduced spending on customer-premise equipment like wireless gateways. This contradicts the ground truth, which states that wireless gateways became a *key component* of 2024 capital expenditures as part of network deployment and multigigabit upgrades. The LLM misinterprets the 2024 10-K (pages 42 and 51), likely confusing a relative shift in spending mix with an absolute reduction. The ground truth indicates a strategic *integration* of gateways into infrastructure, not a reduction. (2) There are no explicit numbers (dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—references to document pages are accurate, supporting sourcing. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution from procurement to strategic deployment. Instead, it infers a decrease in importance based on a reallocation of capital, missing the core point that gateways became more strategically central in 2024 despite potential shifts in spending categories. (4) Correctness is low due to the reversal of the key trend (reduction vs. increased strategic focus). Quantitative accuracy is high because no numbers are misstated. Qualitative accuracy is low due to flawed reasoning and incorrect conclusion. Contextual relevance is moderate as the answer addresses the right documents and general topic, but misrepresents the strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 462,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "In the 2022 filing Tesla presented Solar Roof as a key growth driver – it helped lift energy‑generation and storage revenue by $795 million (a 40 % jump) and was described as a “significant expansion opportunity” for its solar business【page_39】. By the 2024 filing the product is still viewed as strategically important within the solar‑energy portfolio, but Tesla now flags Solar Roof among the products that could face launch and production‑ramp delays, citing ongoing bottlenecks and manufacturing challenges【page_17】【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tesla's evolving stance on the Solar Roof between 2022 and 2024: from a growth driver in 2022 to a product with potential production delays in 2024. The strategic importance is maintained, but the emphasis shifts to manufacturing risks, which matches the original answer. (2) Quantitatively, the LLM adds specific figures—$795 million revenue increase and 40% growth—which are not present in the ground truth but are plausible and consistent with Tesla’s reported trends; since the ground truth does not contradict these numbers and the question does not ask for specific metrics, their inclusion enhances detail without introducing inaccuracy. Format and calculations are sound. (3) The multi-hop reasoning is strong: the model synthesizes information across two years (2022 and 2024), correctly attributes shifts in tone and strategic framing, and supports claims with document citations (e.g., page references). (4) Semantic equivalence is achieved—while the LLM provides more granular detail, the core message about shifting emphasis from deployment success to production challenges is preserved. One minor point preventing a perfect 10 is that the ground truth emphasizes the comparison of Solar Roof’s production risks to past vehicle and energy storage launches, a nuance slightly underemphasized in the LLM response. Otherwise, entity accuracy (Tesla, Solar Roof, correct years), reasoning, and relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 418,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy’s “Net pending transactions and other investments” rose from **$14 million at year‑end 2022** to **$54 million at year‑end 2023** – a **$40 million increase** (see the table on page 219 of the 2023 Form 10‑K, which lists $14 million for 2022 and $54 million for 2023). This sizable jump shows the company is deliberately expanding its exposure to these assets, indicating a strategic move to grow and diversify its retirement‑trust investment portfolio and capture additional return opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, whereas the LLM claims it increased from $14 million in 2022 to $54 million in 2023—reversing the trend and misstating both values. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $39 million ($14M vs $53M), the 2023 figure is off by $40 million ($54M vs $14M), and the calculated $40M increase is entirely wrong (actual change is a $39M decrease). The cited source (page 219 of the 2023 10-K) may exist, but the data extracted is either misread or misrepresented. (3) The multi-hop reasoning fails because the model incorrectly identifies the direction of change, leading to an opposite and unsupported conclusion about strategic positioning—claiming expansion when the truth indicates retrenchment or completion of initiatives. (4) The contextual relevance is partially maintained as the answer addresses the right metric and attempts strategic interpretation, but due to fundamental factual errors, the conclusion is misleading. Scores reflect near-total failure in accuracy despite correct mention of the metric and document source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 356,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company kept the same liability‑driven investment (LDI) framework – a 20 % equity/80 % fixed‑income target – but in its 2024 filing it disclosed that the actual mix of plan assets had shifted toward more equity (pension equity ≈ 21 % versus 18 % in 2023; post‑retirement equity ≈ 57 % versus 53 % in 2023) and away from Treasury/other holdings (pension Treasury/other ≈ 16 % versus 25 % in 2023; post‑retirement Treasury/other ≈ 13 % versus 16 % in 2023)【page_89†L1-L9】【page_86†L1-L9】.  At the same time, expense for its tax‑qualified defined‑contribution plans rose modestly, to $112 million in 2024 from $109 million in 2023【page_89†L10-L12】【page_85†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the defined contribution plan expenses ($109M in 2023, $112M in 2024) and the 20%/80% target allocation, it incorrectly claims that the actual asset composition shifted toward more equity and away from Treasury/other holdings, with specific percentages for pension and post-retirement plans. The original answer does not mention any such shifts in actual asset composition or provide breakdowns by pension vs. post-retirement plans. Instead, the ground truth states that the 2024 filing introduced a new disclosure indicating that the actual composition would be characterized, implying a forward-looking transparency enhancement, not a reported shift in allocations. (2) The quantitative inaccuracies are severe: the LLM fabricates specific percentages (e.g., pension equity ≈21% vs 18% in 2023, Treasury/other 16% vs 25%) that are not present in the original answer and contradict its more general statement about disclosure practices. These numbers appear to be hallucinated or misattributed from another context. (3) The multi-hop reasoning is partially sound in linking expense changes and investment framework continuity, but fails in synthesizing the correct evolution of disclosures. Instead of focusing on the introduction of a new disclosure about future characterization of asset composition, the model incorrectly infers that detailed actual allocations were reported and changed materially. (4) The contextual relevance is high because the answer addresses both parts of the question—defined contribution expenses and asset composition disclosure—but the factual inaccuracies severely undermine correctness. The qualitative accuracy is moderate because the framework and expense figures are correct, but the core claim about asset shifts is unsupported. Quantitative accuracy is low due to fabricated percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 520,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "In the 2023 filing Qualcomm only mentioned AI in a broad regulatory‑compliance context (“AI technologies” in Item 1A, page 31) and did not highlight on‑device AI as a distinct strategic priority. By fiscal 2024 the MD&A makes on‑device artificial intelligence a headline growth pillar – the company says it is “investing significant resources” in high‑performance, low‑power computing and on‑device AI alongside 5G (page 20) and adds that “5G combined with high‑performance, low‑power computing and on‑device artificial intelligence will continue to drive adoption” in new markets such as automotive and IoT (page 45). This shows a shift from a generic AI reference in 2023 to a focused, resource‑intensive on‑device AI strategy in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its assessment of Qualcomm's evolving strategic focus on On-Device AI between fiscal 2023 and 2024, with accurate qualitative insights and strong contextual relevance. It correctly identifies that in fiscal 2023, Qualcomm did not emphasize On-Device AI as a distinct strategic priority but mentioned AI in a broader context, while in fiscal 2024, the company elevated it to a headline growth pillar with explicit investment. The page references (e.g., page 20, 45) and quotes are consistent with disclosure patterns, though the ground truth does not specify exact page numbers or Item 1A details—this is acceptable as long as the overall message aligns. The LLM accurately captures the shift from a general mention to a focused, resource-intensive strategy. However, the original answer emphasizes a key nuance: Qualcomm’s 2024 strategy includes pursuing acquisitions or strategic transactions as part of its investment approach, which the LLM answer omits. This is a meaningful detail in the evolution from vision to active expansion, making the LLM response slightly less complete in multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Qualcomm, fiscal years, 5G, on-device AI, automotive, IoT) are correctly identified. The reasoning is sound and the answer is highly relevant to the question. The omission of acquisitions/strategic transactions prevents a top score, but the core facts and evolution are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 417,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the Simon family voting arrangement as an exhibit – Exhibit 9.1 (and 9.2) – and describe it in the same way as the “Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy” between Melvin Simon & Associates, Inc. and the Simon family members (see 2023 page 140 and 2022 page 144). The unchanged classification and identical presentation across the two years signal that the voting‑trust mechanism, a cornerstone of Simon Property’s governance, has remained stable and unaltered.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the 2022 10-K refers to the agreement as 'Second Amended and Restated,' while the 2023 10-K drops this modifier and refers to it simply as the Voting Trust Agreement dated March 1, 2004. The LLM incorrectly asserts that both years use the same 'Second Amended and Restated' language, which contradicts the ground truth. This misrepresentation undermines the entire analysis. (2) While the date 'March 1, 2004' is correctly referenced in the context of the agreement, the key qualitative change in classification between years is entirely missed. There are no numeric calculations in this question, but the presentation of the document title is a factual detail that must be accurate—this is where the LLM fails. (3) The multi-hop reasoning is flawed because the model fails to detect the change in terminology between the two filings. Instead, it assumes consistency without evidence, leading to an incorrect conclusion about stability based on false premises. The actual reasoning in the ground truth hinges on the *removal* of the 'Second Amended and Restated' label, implying no new amendments—this nuance is lost. (4) Contextual relevance is fair because the answer addresses the right topic (governance stability via voting trust), cites correct exhibit numbers (9.1/9.2), and attempts to reason about implications. However, due to the central factual error, the correctness, quantitative, and qualitative accuracy scores are low. Minor formatting differences are acceptable, but claiming identical presentation when there is a documented change is a major factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 458,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East fell between year‑end 2023 and year‑end 2024. The 2024 10‑K shows the region’s total gas reserves dropped from 312 billion cubic feet (305 BCF developed + 7 BCF undeveloped) in 2023 to 296 BCF (289 BCF developed + 7 BCF undeveloped) in 2024 – a decline of about 5 % (≈ 16 BCF)【page_145】. During the same period the company’s overall gas reserve base grew from 9,399 BCF to 10,580 BCF, so the Asia Pacific/Middle East share fell from roughly 3.3 % to 2.8 % of total reserves, indicating the region’s relative strategic importance to COP’s global reserves portfolio is diminishing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: 312 BCF in 2023 and 296 BCF in 2024, a decrease of 16 BCF (~5.1%), which the LLM correctly rounds to ~5%. The breakdown into developed and undeveloped reserves (305+7 and 289+7) is consistent with the source data. (2) The LLM adds contextual detail not in the original answer—specifically, the split between developed and undeveloped reserves and the change in the region’s share of total global reserves (from 3.3% to 2.8%) based on overall reserves growing from 9,399 to 10,580 BCF. These calculations are accurate and enhance the analysis. (3) The reasoning is sound: the LLM correctly infers that despite absolute reserves declining only slightly, the region’s relative strategic importance is diminishing due to slower growth compared to COP’s global portfolio. This is a valid interpretation and represents strong multi-hop synthesis across regional and global reserve data. (4) The only minor difference from the original answer is that the LLM does not mention equity affiliates holding an additional 5,870 BCF in 2024—a detail present in the ground truth. While this omission slightly reduces completeness, it does not undermine the core factual accuracy or the logical conclusion about declining relative strategic importance. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 400,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s debt on its balance sheet – about $9.4 billion of Corebridge notes, bonds and a DDTL facility (e.g., $6.45 billion of senior unsecured notes, $989 million of junior subordinated debt, $200 million of CRBGLH notes, etc.) and had a guarantee‑reimbursement and collateral agreement with Corebridge – and the equity‑method result from that investment was modest (roughly $29 million)【page_112】【page_107】. By 2024 Corebridge was classified as a discontinued operation and de‑consolidated, so its debt no longer appears in AIG’s debt roll‑forward, while AIG recognized a much larger equity‑method gain of $601 million from Corebridge based on fair‑value changes【page_109】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's financial relationship with Corebridge from 2023 to 2024, noting the deconsolidation and shift to equity method accounting under discontinued operations. It accurately identifies that Corebridge debt was removed from AIG’s balance sheet in 2024 and that equity method income increased significantly. However, the $29 million equity-method income figure for 2023 and $601 million gain in 2024 are not present in the original answer (ground truth), which only states that equity method income in 2024 included dividends and stock price changes since June 9, 2024, without specifying a total amount. These specific figures may be factually correct based on source pages cited, but since they contradict or add precision not in the ground truth (which emphasizes structural change over specific income amounts), this introduces a quantitative discrepancy. (2) The original answer reports $9,368 million total Corebridge debt in 2023, broken into $6,452 million senior unsecured notes and $989 million junior subordinated debt. The LLM adds $200 million of CRBGLH notes and a DDTL facility, which sum to more than the total in the ground truth. While these may be components of the total, presenting them as additional line items without clarifying they are included in the $9.368 billion misrepresents the structure and inflates the total, leading to a partial quantitative inaccuracy. (3) The multi-hop reasoning is strong: the model correctly synthesizes the shift from consolidation to equity method, ties it to discontinued operations, and explains the implications for debt and income reporting. This reflects sound understanding of financial statement transformations. (4) The contextual relevance is perfect—the answer directly addresses debt structure and equity method income evolution. Due to the addition of unverified specific income figures and potential double-counting of debt components not reflected in the ground truth, the quantitative accuracy is reduced to 7, pulling the overall correctness to 8. The core narrative and qualitative accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 574,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "In the 2022 Form 10‑K (covering Dec 31 2021) NextEra’s special‑use funds were made up of roughly **$5.5 bn of equity securities and $2.5 bn of fixed‑income securities** – about **69 % equity and 31 % fixed‑income**【page_55】. By the 2024 filing the composition had shifted to about **$6.2 bn of equity securities and $2.3 bn of fixed‑income securities**, or **≈73 % equity and 27 % fixed‑income**【page_89】. The modest increase in the equity share (and corresponding dip in bond holdings) indicates a slight tilt toward higher‑return, higher‑risk assets while still keeping a sizable fixed‑income base for liquidity and regulatory‑required safety.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, in 2022, NextEra Energy's Special Use Funds were entirely composed of fixed income securities with a carrying amount of $2,505 million — there were no equity securities. However, the LLM claims that in 2022, NEE had $5.5 billion in equity and $2.5 billion in fixed income, which is completely inconsistent with the ground truth. This misrepresents both the total amount and the allocation. In 2024, the LLM reports $6.2 billion in equity and $2.3 billion in fixed income, which partially aligns with the ground truth equity figure ($6,164 million ≈ $6.2 billion), but the fixed-income total is inaccurate: the ground truth lists $722M (U.S. Gov/municipal) + $685M (corporate debt) + $873M (asset-backed) = $2,280 million ($2.28 billion), which the LLM rounds to $2.3 billion — this part is acceptable. However, the starting point (2022) is entirely wrong. (2) The LLM incorrectly references the 2022 Form 10-K as covering Dec 31, 2021, which may reflect a misunderstanding of fiscal reporting timelines, though this is a secondary issue. More critically, the core numbers for 2022 are fabricated or misread. (3) The multi-hop reasoning is flawed because the LLM fails to recognize that the 2022 portfolio was 100% fixed income, making the claimed 69% equity allocation impossible. Therefore, the conclusion about a 'modest increase' in equity share is based on false premises. The actual shift is from 0% equity to a majority-equity portfolio, indicating a dramatic strategic change, not a slight tilt. (4) Despite incorrect numbers, the LLM attempts to address the question’s components — allocation changes, risk appetite, liquidity — and correctly interprets the directional shift toward equities by 2024. Hence, contextual relevance is moderate. However, due to severe quantitative inaccuracies and flawed reasoning, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 530,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "In the 2022 Form 10‑K the company warned that “extensive sharing of site infrastructure…including due to increases in advanced network technology such as 5G…may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the de‑commissioning of equipment on certain existing sites”【page_16】. The 2024 filing no longer contains a comparable discussion of 5G‑driven site‑sharing risk in its risk‑factor sections (see the risk‑factor pages 15, 44, 49, 92 and 95, which omit any reference to this issue), suggesting the company now views the risk as less material or has subsumed it under broader technology‑competition concerns.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly cites the 2022 risk description and quotes the filing accurately, it falsely claims that the 2024 filing no longer discusses 5G-driven site-sharing risk. The ground truth states that by 2024, the risk evolved to focus more specifically on RAN sharing, roaming, or resale arrangements with explicit concern over lack of compensation—indicating a refinement and intensification of the risk, not its disappearance. The LLM incorrectly interprets the absence of identical wording as evidence the risk is no longer material, which reflects a failure in multi-hop reasoning and qualitative synthesis. There are no numeric values to assess, so quantitative accuracy is neutral (scored 10 by default for absence of error). Contextual relevance is moderate because the answer addresses the right topic and cites relevant sections, but the conclusion is fundamentally wrong. The model failed to recognize that evolution of risk language—rather than deletion—signifies a maturation of the risk, especially in the context of 5G adoption and its financial implications on leasing activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 335,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron’s 36.4 % equity interest in Angola LNG Limited is accounted for using the equity method. The carrying amount of the investment fell from $1.96 billion at year‑end 2022 to $1.76 billion at year‑end 2023, and the equity‑method share of earnings dropped sharply from $1.86 billion in 2022 to $513 million in 2023【page_82†L13-L20】. This reflects a reduction in both the investment balance and the affiliate’s reported profit contribution while the ownership percentage remained unchanged【page_78†L13-L20】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Chevron's 36.4% ownership interest in Angola LNG Limited for both years, which matches the ground truth. It also accurately states that the investment is accounted for using the equity method. However, it introduces specific financial figures—carrying amount ($1.96B to $1.76B) and equity-method earnings ($1.86B to $513M)—that are not present in the original answer and were not part of the ground truth derived from the knowledge graph. These numbers may be factually correct in an absolute sense (hence a decent quantitative accuracy score), but since they are absent from the verified truth, their inclusion represents a deviation rather than confirmation. (2) The quantitative values themselves appear consistent in format and plausible in trend (decline in carrying amount and earnings), but without corroboration in the ground truth, they cannot be considered accurate per the evaluation criteria. The percentage (36.4%) is correctly repeated. (3) The multi-hop reasoning is partially flawed: while the LLM focuses on financial performance changes (value and earnings), the original answer emphasizes a structural and relational shift—from 'Depends_On' to 'Invests_In'—indicating a change in the nature of the investment relationship, not just its financial outcome. This key qualitative evolution in Chevron’s strategic posture is entirely missing in the LLM response. (4) As a result, while the LLM provides numerically rich and contextually relevant information about the investment’s performance, it fails to capture the core conceptual evolution described in the ground truth—the reclassification of the investment type. Thus, the correctness and qualitative accuracy scores are moderate to low, despite good contextual relevance and acceptable number formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 494,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "In the 2022 filing Gulfstream described the G600 as a clean‑sheet, large‑cabin jet that entered service in 2019 and, like the G500, is “faster, more fuel‑efficient, has greater cabin volume, more range and improved flight controls” than the models it replaces, with cumulative deliveries of “almost 150” aircraft by year‑end 2021【page_6】. The 2023 filing still highlights those same performance advantages for the G600 and notes that “cumulative deliveries for the aircraft totaled over 250” at year‑end 2023, showing that the G600 has moved from a newly‑introduced model with modest deliveries to a core, high‑volume product in Gulfstream’s lineup【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: 'almost 150' cumulative deliveries by end of 2021 (implied in 2022 filing) and 'over 250' by end of 2023 are consistent with the knowledge graph. The entry into service in 2019 is correctly stated. (2) The answer captures the evolution from a recently introduced model to a mature, high-volume product, which matches the ground truth's characterization of the G600 transitioning from 'new' to 'core' in the lineup. (3) The LLM correctly identifies performance metrics (speed, fuel efficiency, range, cabin volume, flight controls) and notes continuity in these advantages from 2022 to 2023. (4) While the LLM does not explicitly mention the Symmetry Flight Deck being extended to newer models (G700, G800, G400), this is a minor omission. The core evolution—shift from new to established product with growing delivery volume and foundational role—is clearly conveyed. The reasoning is sound, and the synthesis across years is accurate. The answer is contextually relevant and factually correct, warranting a high score despite the slight incompleteness on technology transfer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 337,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "In the 2022 filing McDonald’s said the franchise system “relies to a large degree on the financial success and cooperation of our franchisees” and that franchisees must fund major initiatives on their own, with the company’s role limited to collecting rent, royalties and initial fees (2022 p. 30). By the 2024 filing the company adds that it now “may co‑invest with franchisees to fund improvements to their restaurants or operating systems,” developing these projects collaboratively to modernise and grow revenue while still requiring franchisees to reinvest capital and meet rigorous standards (2024 p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in McDonald's relationship with franchisees: in 2022, the model was passive, with franchisees bearing full financial responsibility for major initiatives, and by 2024, McDonald's began co-investing in restaurant and operating system improvements. The key factual elements—shift from passive franchising to active co-investment, continued franchisee reinvestment, and strategic goals of modernization and revenue growth—are all present. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct and properly attributed to the respective filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years and two different strategic stances, correctly identifying a shift in financial involvement and strategic collaboration. It references specific page numbers (2022 p. 30, 2024 p. 4), which adds credibility and shows document grounding. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'developmental licenses' context from 2022 or the broader strategic intent (e.g., 'catering to consumer preferences, improving local performance') emphasized in the original, but it does convey the essence of modernization and growth. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for slight incompleteness in motivational context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 453,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The smokeable‑products segment’s net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (a drop of about $720 million, or roughly 3 %).  Operating income (OCI) for the same segment slipped from **$10,688 million in 2022 to $10,670 million in 2023**, a modest $18 million decline【page_29】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. The calculated differences—$720 million decline in revenue and $18 million in operating income—are correct. The approximate 3% revenue decline is also accurately derived (720 / 22,476 ≈ 3.2%). (2) The answer is complete, addressing both net revenues and operating income across both years as required by the question. (3) Entities—'smokeable products', financial metrics, and years—are correctly identified and consistently applied. (4) The reasoning is sound: the LLM correctly synthesizes year-over-year performance, computes changes, and characterizes the trend as a modest decline, which aligns with the ground truth's interpretation. Minor wording differences (e.g., 'slipped', 'fell') do not affect semantic equivalence. The citation [page_29] suggests proper grounding. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 308,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "In the 2022 filing Opdivo was described mainly as a product that BMS co‑develops and co‑commercializes with Ono in Japan, South Korea and Taiwan, with BMS supplying the drug and the parties sharing development costs, profits and losses. By the 2024 filing Opdivo has moved to the center of BMS’s immuno‑oncology platform – the company now leads its global launch, lists Opdivo (and the Opdivo + Yervoy combo) as a foundational IO asset, and has added a string of new approvals (e.g., FDA approval for Opdivo + cisplatin/gemcitabine in urothelial carcinoma, the sub‑cutaneous Opdivo Qvantig formulation, EU and Japan approvals for additional indications), reflecting a shift from a regional partnership model to a flagship, globally‑commercialized therapy driving BMS’s product development and commercialization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Opdivo's 2022 co-development and co-commercialization arrangement with Ono in specific Asian markets, cost and profit sharing, and the shift by 2024 to a central role in BMS's immuno-oncology strategy are accurately described. The March 2024 FDA approval for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma is correctly noted, though the LLM slightly generalizes the timing as 'by the 2024 filing' rather than specifying March 2024. (2) Quantitative accuracy is excellent: no incorrect numbers, dates, or percentages are presented. The mention of the FDA approval date is semantically accurate even if not exact to the month, and other approvals (EU, Japan, subcutaneous formulation) are plausible extensions consistent with BMS's trajectory, though the ground truth only explicitly confirms the March 2024 FDA approval. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from a collaborative regional model to a globally led commercialization strategy, inferring a strategic shift supported by new approvals. (4) The answer is contextually relevant and comprehensive, addressing both the collaborative framework changes and new therapeutic approvals. The only minor shortcoming is the inclusion of additional approvals (e.g., EU, Japan, subcutaneous formulation) not explicitly confirmed in the ground truth, which slightly exceeds the provided information but does not contradict it. Overall, the answer demonstrates strong factual grounding and logical synthesis, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 466,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "In the 2022 Form 10‑K AMT disclosed that its revolving credit facilities and delayed‑draw term loans were priced as a spread over LIBOR (for USD borrowings) or EURIBOR (for euro borrowings) or a defined base rate, with the loan agreements containing financial covenants that limited total debt to EBITDA, subsidiary indebtedness and required a minimum debt‑service‑coverage ratio (see pages 49, 51 and 52). By the 2024 filing the company had moved away from LIBOR/EURIBOR – the only benchmark mentioned is SOFR for the Nigeria letters of credit (page 117) and the new senior notes are issued at fixed rates (page 53) – and the covenants now focus on DSCR and cash‑trap reserve‑account requirements under the securitization loan and 2015 Indenture, along with pre‑payment and reserve‑account provisions (page 116).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift from LIBOR/EURIBOR in 2022 to SOFR in 2024 for Nigeria letters of credit, and notes the use of fixed rates for new senior notes—consistent with the transition away from LIBOR-based instruments. The mention of base rate pricing in 2022 matches the original answer’s reference to a 'defined base rate.' (2) There are no numeric values (percentages, fees, dates) in the original answer that are contradicted; the LLM does not introduce any incorrect figures, and where specifics like commitment fees (0.080%–0.300%) are omitted, they were not explicitly required to answer the evolution of referenced rates and covenants. The absence of these percentages does not detract from core correctness. (3) The multi-hop reasoning is sound: the model synthesizes changes in benchmark rates across years (2022 vs 2024), identifies specific instruments (letters of credit in Nigeria, senior notes), and traces covenant evolution from detailed financial ratios (debt/EBITDA, DSCR) to more focused cash-trap and reserve requirements. (4) The LLM enhances the original answer with additional context (e.g., fixed-rate senior notes, specific covenant types under securitization loan and 2015 Indenture), which are consistent with a more granular reading of the filings and do not contradict the ground truth. The only minor shortcoming is that the original answer emphasizes a shift in *disclosure focus* (from detailed covenants to consequences of non-compliance), while the LLM focuses more on the *content* of current covenants. This is a nuance in emphasis, not a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 484,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "In the 2022 filing McDonald’s explained that for a conventional franchise it “generally owns or secures a long‑term lease on the land and building for the restaurant location” and that “ownership of real estate, combined with the co‑investment by franchisees, enables it to achieve restaurant performance levels that are among the highest in the industry” (2022 10‑K pp. 34‑35). The 2024 filing repeats the same ownership model (2024 10‑K p. 3) but adds that “the Company may co‑invest with franchisees to fund improvements to their restaurants or operating systems,” describing a more active partnership that goes beyond initial real‑estate ownership to joint funding of upgrades and system initiatives (2024 10‑K p. 4). This reflects an evolution from a basic co‑investment tied to property ownership toward a broader, collaborative co‑investment strategy for restaurant improvements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, McDonald's already had a model where it owns or secures long-term leases on land and buildings, with franchisee co-investment, citing the 2022 10-K (pp. 34–35). This matches the ground truth’s description of the conventional franchise model, though the LLM attributes more specificity to 2022 than the ground truth suggests—where 2022 was characterized as focusing on ESG coordination without detailing real estate roles. However, the LLM’s citation of the 2022 filing is factually correct, so this is a nuance rather than an error. (2) For 2024, the LLM accurately notes the continuation of the real estate ownership model and adds the new element of co-investment for improvements and operating systems, citing the 2024 10-K (p. 4), which reflects the evolution toward a more structured partnership. This aligns with the ground truth’s claim of a shift to a more clearly defined and strategic co-investment approach. (3) The multi-hop reasoning is sound: the model compares two years’ filings, identifies continuity in real estate ownership, and detects an expansion in co-investment scope. The conclusion about evolving toward a broader collaborative strategy is logically supported. (4) All entities (McDonald's, franchisees), years (2022, 2024), and financial concepts (co-investment, real estate ownership) are correct. No numerical inaccuracies; dates and citations are precise. The only minor gap is that the ground truth emphasizes a shift from general ESG collaboration in 2022 to specific real estate/co-investment clarity in 2024, while the LLM implies the co-investment model was already clearly articulated in 2022. This slightly overstates the 2022 clarity but does not contradict factual content. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 517,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors was only mentioned as an approved equity‑compensation plan with 703,256 shares available for future issuance (see page 114). In the 2023 Form 10‑K the plan is shown as having been **amended and restated** (effective Oct. 26 2022) and is listed as Exhibit 10.22, with the share pool reduced to 589,927 shares (see pages 107 & 110). This shift—from a simple reference to a formally amended, documented plan with updated share limits—demonstrates Altria’s practice of regularly reviewing and formally codifying director compensation, enhancing transparency and governance oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 703,256 shares available in 2022 is accurately reported; the amendment effective October 26, 2022, is correctly stated; and the updated share count of 589,927 in 2023 is factually consistent with the knowledge graph (though the original answer did not include this number, its presence in the LLM answer reflects additional precision from the source document). (2) The LLM correctly identifies the evolution: from a plan merely referenced in 2022 to a formally amended and restated plan in 2023, incorporated via Exhibit 10.22 and referencing the September 30, 2022, 10-Q. (3) The reasoning is sound: the shift to formal amendment and restatement, with updated share limits, supports the conclusion that Altria is actively managing and codifying its director compensation framework, indicating stronger governance and transparency—this aligns semantically with the original answer’s interpretation. (4) The only minor gap is that the original answer emphasizes the incorporation by reference from the 10-Q, while the LLM mentions the exhibit but does not explicitly note the incorporation mechanism, which slightly reduces qualitative completeness. However, this does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates proper multi-hop synthesis across years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 404,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The 2022 Form 10‑K warned that “extensive sharing of site infrastructure through RAN sharing, **roaming or resale arrangements** among wireless service providers… may cause new lease activity to slow” and could even lead to equipment de‑commissioning【page_15】. The 2024 filing repeats the same risk – now stressing that “the extensive sharing of site infrastructure, **roaming or resale arrangements**… especially with 5G, … may cause new lease activity to slow”【page_16】. The unchanged (and slightly sharpened) language shows that carrier‑level sharing and resale arrangements remain a persistent competitive pressure that continues to curb AMT’s ability to generate new leases.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of the 10-K language from 2022 and 2024, correctly identifying that roaming and resale arrangements were cited as risks to new lease activity in both years. The quantitative accuracy is perfect: no numerical errors, correct years (2022 and 2024), correct referencing of risk factors, and proper use of terminology (RAN sharing, roaming, resale). Contextual relevance is high—the response directly addresses the evolution of the risk and its implication for competitive pressures on lease growth. However, the qualitative accuracy is slightly lower because the LLM fails to fully capture the evolution described in the ground truth. While it notes that the language is 'unchanged (and slightly sharpened)', the ground truth emphasizes a meaningful shift: by 2024, the risk expanded beyond slowing new leases to include decommissioning of existing equipment due to redundancy. This indicates a deepening competitive pressure that the LLM answer underrepresents. Additionally, the ground truth explicitly links 5G to the rise of these arrangements in 2022, whereas the LLM incorrectly attributes the emphasis on 5G to the 2024 filing (when it was already present in 2022). Thus, while the core facts are correct, the synthesis of how the risk evolved over time is incomplete and slightly misattributed, reducing the correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 383,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "In the 2022 filing McDonald’s described franchisees as independent operators who must fund and execute major initiatives and meet rigorous standards, with the company’s growth hinging on their willingness and ability to invest (2022 p. 28‑30). By the 2024 filing the relationship had become more collaborative: McDonald’s now co‑invests with franchisees to modernize restaurants and accelerate system‑wide initiatives, while still requiring franchisees to reinvest capital and adhere to strict operational standards (2024 p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in McDonald's relationship with franchisees from 2022 to 2024: in 2022, franchisees were expected to independently fund and execute initiatives under operational pressures (linked to pandemic-related challenges in the original answer), while by 2024, McDonald's had shifted to a co-investment model to support modernization and system-wide growth. The key themes—franchisee investment responsibility in 2022 and increased collaboration through co-investment in 2024—are factually correct and semantically equivalent to the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct and properly attributed. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers a strategic shift in the franchisee relationship, moving from independent execution to collaborative investment. The citation of specific page numbers (2022 p. 28–30; 2024 p. 4) suggests accurate sourcing, though not required for correctness. (4) The only minor shortcoming is that the LLM answer omits explicit mention of the 'Accelerating the Arches' strategy and the pandemic-driven context (labor, supply chain) emphasized in 2022, which slightly reduces qualitative completeness. However, the core evolution in strategic investment and operational expectations is accurately conveyed. Thus, the answer is contextually relevant and factually strong, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 468,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K the company said its nuclear‑decommissioning reserve (special‑use) funds were “invested in marketable equity securities … broadly diversified,” with the bulk of the holdings measured at Level 1 fair value 【page_55】.  \nBy the 2024 filing the equity portion of those funds had grown to $6.2 billion for NEE and $4.2 billion for FPL, and the composition now includes a sizable amount of Level 2 commingled‑fund securities (and a modest Level 3 amount), showing a shift toward a larger, more diversified mix of fund‑based equity investments while still adhering to regulatory guidelines 【page_89】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that in 2022, NextEra Energy held $8,922 million in Special Use Funds with no explicit breakdown of equity securities. However, the LLM claims that in 2022, the company disclosed investments in marketable equity securities and a Level 1 fair value breakdown, which contradicts the original answer stating no explicit equity breakdown was provided. This is a significant factual error. In 2024, the ground truth reports $6,164 million in equity securities for NextEra Energy, but the LLM states $6.2 billion for NEE and $4.2 billion for FPL (a subsidiary), introducing a figure ($4.2B for FPL) not present in the original answer and inflating the total. While $6.2 billion is close to $6,164 million (~$6.16B), the addition of FPL’s separate amount misrepresents the data and suggests a multi-entity breakdown not supported in the ground truth. (2) Quantitative accuracy is partially correct for the 2024 NEE equity figure (rounding $6,164M to $6.2B is acceptable), but the introduction of $4.2B for FPL is unsupported and incorrect. The 2022 equity allocation is falsely quantified when the original answer states no such breakdown was given. (3) The reasoning is flawed in multi-hop synthesis: the LLM incorrectly infers that because equity investments were described as diversified in 2022, a detailed allocation existed, when the ground truth emphasizes the lack of such detail. It also introduces FPL-specific data not mentioned in the original answer, suggesting a conflation of corporate and subsidiary levels without evidence. The conclusion about increased diversification and fund-based investments goes beyond the ground truth, which only infers greater transparency and possibly more emphasis on equities. (4) Contextual relevance is high—the answer addresses investment strategy evolution in Special Use Funds over time and attempts to analyze shifts. However, due to significant factual and quantitative errors, especially the unsupported FPL figure and misrepresentation of 2022 disclosures, the correctness score is low. The qualitative reasoning is partially sound but based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 590,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "In the smokeable‑products segment, net revenues fell from $22.476 billion in 2022 to $21.756 billion in 2023 – a drop of roughly $720 million (about 3%).  Operating income (OCI) slipped from $10.688 billion to $10.670 billion, a modest $18 million decline (≈0.2%)【page_29】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and factually aligned with the ground truth. (1) All key financial figures are accurate: net revenues of $22,476 million (reported as $22.476 billion) in 2022 and $21,756 million ($21.756 billion) in 2023; operating income of $10,688 million ($10.688 billion) in 2022 and $10,670 million ($10.670 billion) in 2023. (2) Calculations are correct: the revenue drop is accurately computed as ~$720 million (3%) and operating income decline as $18 million (~0.2%). (3) The reasoning is sound and synthesizes year-over-year performance correctly, capturing the marginal decrease in both revenue and profitability. (4) The answer addresses all parts of the question—evolution of net revenues and operating income from 2022 to 2023—with precise, semantically equivalent data. Minor formatting differences (billion vs. million) are acceptable and do not affect accuracy. The citation [page_29] adds contextual support. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 287,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "In fiscal 2022 Accenture’s board authorized $3.13 million for its publicly announced open‑market repurchase and related share‑purchase programs and actually bought 12.18 million Class A ordinary shares (9.64 million via open‑market purchases and 2.55 million through other programs) that were held as treasury shares to fund employee equity awards and payroll‑tax withholding 【page_93†L1-L4】【page_94†L1-L9】. In fiscal 2023 the company kept using Class A shares for employee compensation, issuing 5.71 million shares under the 2010 Employee Share Purchase Plan (up from 4.37 million in 2022) while its total repurchase authority fell to $2.69 million, indicating a shift toward greater employee‑plan utilization with a modest reduction in repurchase capacity 【page_99†L1-L7】【page_100†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer states that in 2022, Accenture had an aggregate available authorization of $3,129,296 (approximately $3.13 million), which the LLM incorrectly reports as $3.13 million—this appears close but misrepresents the amount by three orders of magnitude (it should be ~$3.13 billion, not million). This is a critical error in financial context. Additionally, the LLM claims Accenture bought 12.18 million shares in 2022 with a breakdown of 9.64 million and 2.55 million, but this data is not present in the ground truth and cannot be verified from the provided information. The ground truth does not mention actual purchases or volumes in 2022, only the authorization amount. (2) The LLM introduces specific figures for share issuances under the Employee Share Purchase Plan (5.71 million in 2023 vs 4.37 million in 2022), which are not mentioned in the original answer and appear to be hallucinated or extracted from unsupported sources. The reduction in repurchase authority to $2.69 million is also incorrect—the original does not state this figure, and again, the scale is off by orders of magnitude. (3) While the LLM correctly identifies the intended usage of shares for employee benefits and payroll tax withholding, it misattributes the source of this activity to the publicly announced buyback programs, whereas the original clarifies that share withholding for payroll taxes in fiscal 2024 was separate from the buyback authorization. The reasoning around a 'shift toward greater employee-plan utilization' is partially aligned with the ground truth’s observation of increased focus on internal compensation mechanisms, but the conclusion is based on flawed data. (4) Despite these issues, the LLM captures the general theme of evolving utilization toward employee compensation, which maintains contextual relevance. However, due to severe quantitative inaccuracies and unsupported specifics, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 564,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "In the 2022 filing AMT’s operating covenants were attached to its 2021 credit facilities and delayed‑draw term loans, which imposed standard financial‑covenant limits and used floating‑rate benchmarks—LIBOR for the USD facilities and EURIBOR for the EUR facilities, each with a 1.125 % spread (see pages 113‑114). By the 2024 filing the covenant framework had moved to the supplemental indentures for the newly issued senior notes and the securitization loan agreement, which now contain cash‑flow‑based tests (DSCR thresholds, cash‑trap and amortization triggers) and the debt carries fixed coupons (e.g., 5.200 %, 5.450 %, 3.900 % EUR, 4.100 % EUR) rather than LIBOR/EURIBOR (see pages 53, 117‑118).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the LLM introduces specific spreads (1.125%) and fixed coupon rates (e.g., 5.200%, 5.450%) not present in the original answer, which does not mention exact spreads or fixed rates. These numbers are unverified against the ground truth and appear to be fabricated or misattributed. (2) The original answer emphasizes a benchmark transition from LIBOR/EURIBOR to SOFR, particularly for Nigerian letters of credit, which the LLM answer omits entirely. Instead, the LLM claims a shift to fixed-rate senior notes and securitization loans with cash-flow tests (DSCR, cash-trap triggers), which is not supported by the ground truth. (3) Entity accuracy is partially correct: AMT, 2021 credit facilities, LIBOR, and EURIBOR are correctly identified for 2022. However, the 2024 evolution is misrepresented—no mention of SOFR in the LLM answer, despite it being central to the ground truth. (4) Reasoning is flawed: the LLM infers a structural shift to fixed-rate instruments and new covenant types (e.g., DSCR), but the ground truth describes a benchmark transition (LIBOR → SOFR) within existing covenant frameworks, not a shift to different debt instruments or covenant types. (5) Contextual relevance is moderate—the answer addresses covenant evolution and benchmarks but mischaracterizes the nature of the change. The core multi-hop synthesis (comparing 2022 vs 2024 debt benchmarks and covenant structures) fails because the LLM invents new instruments and omits the SOFR transition. Thus, while the answer shows understanding of financial terminology, it lacks factual alignment with the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 477,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Disney+ Hotstar was reported to have about **36 million paid subscribers** as of September 28, 2024 (DIS 2024 10‑K, p. 7) — the FY 2023 filing did not disclose a separate Hotstar subscriber count, so the new figure reflects both growth and more explicit reporting of the service’s base. In June 2024 Disney merged Star+ into Disney+ in Latin America, creating a single Disney+ product offering (DIS 2024 10‑K, p. 7), which streamlines the international streaming portfolio, reduces brand fragmentation and strengthens Disney’s global streaming strategy by delivering a unified, broader‑content platform to the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Disney+ Hotstar's 36 million paid subscribers as of September 28, 2024, matching the ground truth. However, it incorrectly states that the FY2023 filing did not disclose a separate Hotstar subscriber count — the original answer does not make this claim, and the question only asks about evolution between 2023 and 2024 filings, not absence of data. Despite this minor misstatement, the core numeric and strategic facts are accurate. (2) Quantitatively, the subscriber number (36 million) and date (September 28, 2024) are correct. The consolidation timing (by end of June 2024) is accurately reflected as occurring in June 2024. No calculations were required, and all dates/numbers align with the ground truth. (3) The reasoning is sound: the LLM correctly identifies the merger of Star+ into Disney+ in Latin America and interprets its strategic impact — streamlining offerings, reducing fragmentation, and strengthening global strategy — which aligns with the ground truth’s interpretation of a strategic shift toward unified branding and operational efficiency. (4) The answer is contextually fully relevant, addressing both the subscriber base and the strategic impact of the Star+ consolidation. The only minor flaw is the unsupported claim about the 2023 filing not disclosing Hotstar subscribers, which slightly affects qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 406,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The filings show that the share of the workforce under collective bargaining has stayed essentially unchanged – roughly one‑fifth of the subsidiaries’ employees were covered by collective agreements in both years, with the company still managing about 62 agreements 【page_79】.  This consistency indicates that General Dynamics is pursuing a stable labor‑agreement strategy, maintaining the same proportion of union‑covered workers and renegotiating a similar number of agreements each year without a material shift in its workforce composition 【page_77】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The ground truth states that the number of employees expected to be covered under collective labor agreement negotiations decreased from approximately 3,000 in 2022 to 2,100 in 2023. However, the LLM claims that the share of the workforce under collective bargaining has 'stayed essentially unchanged' and emphasizes stability, which directly contradicts the documented reduction in employees subject to upcoming negotiations. (2) The numbers cited in the LLM response (e.g., 'one-fifth of the subsidiaries’ employees', '62 agreements') are not present in the original answer and are not corroborated by the ground truth, making them unsupported and potentially misleading. There is no mention of total workforce size or percentages in the ground truth, so asserting proportional stability is an unjustified inference. (3) The multi-hop reasoning is flawed: while the question asks about changes in the number of employees covered under agreements from 2022 to 2023 and the strategic implication, the LLM fails to recognize the downward trend and instead asserts continuity. The conclusion about a 'stable labor-agreement strategy' contradicts the ground truth's indication of a strategic shift due to fewer renegotiations. (4) The contextual relevance is moderate because the answer addresses labor agreements and strategy, but it misrepresents the core data and draws an opposite conclusion. Quantitative accuracy is very low due to fabricated metrics and incorrect interpretation of trends. Qualitative accuracy is low because of incorrect entity synthesis and flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 458,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "In the 2022 filing NextEra Energy reported $137 million of U.S. Government and municipal bonds (Level 1 $131 m + Level 2 $6 m)【page_101】. By year‑end 2024 the combined NEE/FPL portfolio held $1,283 million ($722 m for NEE and $561 m for FPL)【page_89】—an increase of about $1.15 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states the 2022 value of $137 million for NextEra Energy's U.S. Government and municipal bonds, it incorrectly reports the 2024 value as $1,283 million (attributing $722 million to NEE and $561 million to FPL). The ground truth states that in 2024, the investment was $161 million for NEE alone under 'Other investments'. The LLM conflates NEE and FPL (a subsidiary) portfolio totals and misrepresents the 2024 figure by over 10x. The claimed increase of $1.15 billion is therefore grossly inaccurate; the actual increase is $24 million. (2) Quantitative accuracy fails: the 2024 number is wrong, the calculation of change is wrong, and the percentage increase (implied ~840%) is nowhere near the correct 17.5%. Only the 2022 value is accurate. (3) Multi-hop reasoning is flawed: the model fails to isolate NEE's bond investment over time and incorrectly combines entity-level data (NEE and FPL), violating the question's focus on NextEra Energy (NEE). It also does not support the claim that the $722 million is for U.S. Government and municipal bonds specifically—this breakdown is not provided in the citation. (4) Contextual relevance is moderate because it addresses bond investments and time evolution, but the incorrect entity scope and numbers undermine the response. The citations reference specific pages but do not validate the erroneous synthesis. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 419,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "In the 2022 Form 10‑K BMS noted that Opdivo was an established immuno‑oncology product for which the company “has the capability to manufacture Opdivo internally and have arrangements with third‑party manufacturers to meet demand” (2022 p. 27). By the 2024 filing Opdivo had become a cornerstone of BMS’s IO platform, receiving a suite of new approvals—including the sub‑cutaneous Opdivo Qvantig formulation, neoadjuvant NSCLC, urothelial carcinoma, and the Opdivo + Yervoy combination (2024 p. 44‑46)—and the company’s manufacturing strategy shifted toward using third‑party manufacturers for mature products while retaining internal capacity for Opdivo as part of its broader productivity initiative (2024 p. 46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Opdivo was manufactured both internally and through third-party arrangements, citing the correct context from the 2022 10-K (p. 27). (2) For 2024, it accurately notes the expansion of therapeutic approvals, including the key new indication for urothelial carcinoma (though it goes slightly beyond the ground truth by listing additional approvals like sub-cutaneous formulation and neoadjuvant NSCLC, which are plausible but not specified in the original answer). The March 2024 FDA approval for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma is correctly implied as part of the 'suite of new approvals'. (3) Regarding manufacturing strategy, the LLM adds a nuanced detail not in the original answer — that BMS shifted toward third-party manufacturing for mature products while retaining internal capacity for Opdivo — which is consistent with the ground truth's emphasis on continued manufacturing investment and may reflect deeper insight from the 2024 filing (p. 46). This does not contradict the original answer and enhances it contextually. (4) All entities (Bristol-Myers Squibb/Opdivo, FDA, therapeutic areas, years) are correct. Dates and references to filing pages are accurate. No calculation errors. The answer fully addresses both parts of the question: evolution in manufacturing strategy and therapeutic approvals. The only reason for not scoring a 10 is that the LLM includes extra approvals not confirmed in the ground truth, which, while likely correct, go beyond the verified scope. Overall, the reasoning is sound, multi-hop synthesis across years and documents is effective, and the semantic meaning matches and enriches the original answer without factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 507,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "In Disney’s 2023 Form 10‑K the company said it owned 73 % of National Geographic magazine (and its online business) and that the asset was reported under the Content Sales/Licensing line of the Entertainment segment【page_78】. The 2024 filing still includes National Geographic magazine in the Content Sales/Licensing category but does not restate the ownership percentage, indicating the 73 % stake remains unchanged while the magazine continues to be positioned as a licensed‑content asset within Disney’s broader Entertainment portfolio【page_7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that in 2023, Disney owned 73% of National Geographic magazine and that it was reported under Content Sales/Licensing in the Entertainment segment, which matches the ground truth. It also correctly notes that in 2024, the magazine remained in the same reporting category. However, the LLM misinterprets the removal of the ownership percentage in the 2024 filing as merely an omission, stating 'indicating the 73% stake remains unchanged.' This contradicts the ground truth, which interprets the change in language—from ownership ('73% owned') to operational ('published')—as a strategic shift toward a more operational rather than ownership-focused relationship. The LLM fails to recognize this nuanced but important evolution in business structure and strategic positioning. (2) All numbers and dates are accurate: 73%, 2023, 2024, Content Sales/Licensing, Entertainment segment—all factually correct. No calculation errors. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across two years and identifies the consistent placement in Content Sales/Licensing. However, it fails to infer the strategic implication of the changed disclosure language, which is central to the question about evolution in business structure and positioning. This represents a failure in qualitative synthesis despite correct data retrieval. (4) Correctness score is 6 due to accurate data but significant error in interpretation. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 5 due to flawed reasoning about the strategic shift. Contextual relevance is 9 because the answer addresses the right documents and entities and stays focused on the question, despite the misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 485,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings PayPal describes its “transaction management databases” as part of a platform that lets customers use its suite of products and services worldwide. The 2023 filing (page 10) says the platform can send payments in roughly 200 markets and ≈150 currencies, withdraw funds in 56 currencies and hold balances in 24 currencies, whereas the 2024 filing (page 9) updates those figures to ≈140 currencies for sending payments, 57 currencies for withdrawals and still 24 currencies for balances. Thus the core description of the databases is unchanged, but the reported currency coverage was modestly revised – a slight reduction in supported send‑currency count and a one‑currency increase for withdrawals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While the ground truth states PayPal emphasized withdrawal capabilities in 56 currencies (2023) and 57 currencies (2024), the LLM correctly identifies this one-currency increase. However, it introduces unsupported figures about 'sending payments in ≈150 currencies (2023)' and '≈140 currencies (2024)' and 'hold balances in 24 currencies'—none of which appear in the ground truth and contradict the original answer, which does not mention sending or balance-holding currencies at all. These additions are factually unverified and distort the actual evolution described in the original answer. The qualitative analysis partially aligns: noting a modest change in currency count for withdrawals is correct, but the claim of a 'reduction' in send-currency coverage is unsupported and incorrect per the ground truth. The LLM also misses the key qualitative shift in 2024’s language—placing 'consumers' ahead of 'merchants'—which is a central point in the original answer about consumer-centric reframing. This omission weakens the reasoning and synthesis. While the answer addresses the general topic of currency evolution and is contextually relevant, the inclusion of fabricated metrics and missing core narrative elements from the ground truth results in a partially correct but significantly flawed response. Quantitative accuracy is low due to invented numbers; qualitative accuracy is moderate due to partial reasoning but missed key framing shifts; contextual relevance is high as it attempts the right question scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 439,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The 2023 filing notes that NEECH remarketed its Series K Debentures (due Mar 1 2025) and reset the interest rate to **6.051 % per year**, with interest payable semi‑annually on March 1 and September 1【page_104】. The 2024 filing still lists the same Series K Debentures and the March 2023 letter as the governing document, with no further amendment, indicating the **6.051 % rate remained unchanged**【page_120】. This reflects NEE’s strategy of using remarketing to align debt costs with market conditions and then locking in a stable, market‑based fixed rate to manage its financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the interest rate reset to 6.051% in March 2023 as part of the remarketing, which matches the ground truth. It also accurately notes that the 2024 filing references the same rate and the March 1, 2023 letter, indicating no further change—this aligns with the original answer’s claim of continued terms. The only minor omission is that the LLM does not explicitly mention the letter was dated March 1, 2023, though it does reference it as the governing document, implying awareness. (2) All numeric values—6.051%, semi-annual payment dates (March 1 and September 1), and maturity (March 1, 2025)—are factually correct and match the source. No calculations were required, but the consistency of the rate across years is accurately reported. (3) The multi-hop reasoning is sound: the model synthesizes information from both the 2023 and 2024 filings to infer that the rate remained unchanged, demonstrating correct cross-document analysis. It correctly attributes the remarketing to NEECH (a subsidiary of NEE), and ties the action to NEE’s broader financing strategy. (4) The conclusion about NEE using remarketing to align with market conditions and then locking in a stable rate is semantically equivalent to the ground truth’s interpretation that NEE adjusted its strategy to lock in a higher rate in response to market conditions. The LLM slightly reframes 'higher interest rate' as 'market-based fixed rate' but retains the correct strategic implication. Overall, the answer is factually complete, precise, and contextually appropriate, warranting a high score with only a minor deduction for not explicitly stating the letter's date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 459,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil’s 2023 filing repeats the same unit‑of‑production depreciation policy that was disclosed in its 2022 filing. In both years the company calculates depreciation by dividing an asset’s cost by total proved (or proved‑developed) reserves and applying that rate to actual production; it switches to straight‑line only when the asset’s economic life does not reasonably match the reserve life, and it re‑computes the unit‑of‑production rate using the most recent SEC price when proved reserves are substantially de‑booked (2022 CR Estimates p. 77 & Audit Report p. 85; 2023 CR Estimates p. 73). Thus, between 2022 and 2023 there was no substantive change—ExxonMobil simply reaffirmed its existing approach of adjusting depreciation in response to updated reserve estimates and asset‑life assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing ExxonMobil's Unit-of-Production Depreciation method as consistent between 2022 and 2023, correctly identifying the core methodology: using proved or proved-developed reserves, switching to straight-line when asset life doesn't match reserve life, and re-computing rates using the most recent SEC price when reserves are substantially de-booked. It accurately cites the relevant pages from both years' filings (2022 CR Estimates p. 77 & Audit Report p. 85; 2023 CR Estimates p. 73), supporting its claims. There are no numeric inaccuracies—this is a qualitative policy question without specific numbers, so quantitative accuracy is scored as 10. However, the LLM concludes there was 'no substantive change' and that the company 'simply reaffirmed its existing approach,' which understates the evolution noted in the ground truth: in 2023, ExxonMobil placed 'greater emphasis' on using the most recent SEC price in cases of significant reserve reductions, reflecting a refinement in response to economic conditions. This nuance—a shift in emphasis and intent to better align depreciation with updated economic realities—is missing in the LLM answer, representing a moderate gap in qualitative accuracy. The answer is contextually relevant and addresses the core of the question, but fails to fully capture the subtle yet meaningful evolution in application, not just policy repetition. Thus, while the facts are correct, the reasoning synthesis across years lacks the depth needed to reflect a true multi-hop understanding of policy refinement versus static application.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 441,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "In 2023 Netflix stressed that original programming was a core growth driver but that it still “contracts with third parties related to the development, production, marketing and distribution of our original programming” while beginning to “scale our own studio operations…through acquisitions such as Scanline and Animal Logic” (2023 10‑K p. 7). By 2024 the filing still acknowledges the use of third‑party partners, yet it places a stronger spotlight on “scaling our own studio operations to produce original content” and “building out expertise” in creative, marketing, legal, finance and other disciplines, signaling a shift toward more internal‑studio production alongside the continued partner model (2024 10‑K p. 7).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and cited acquisitions (Scanline and Animal Logic), and correctly references the shift in Netflix's strategic language between 2023 and 2024. It accurately notes that in 2023, Netflix acknowledged reliance on third-party partners while beginning to scale internal studios through acquisitions. In 2024, it correctly identifies the increased emphasis on internal studio scaling and building internal expertise across functions. The answer cites correct page numbers and filing years, and there are no numerical inaccuracies (quantitative accuracy is perfect, as no numbers are misstated). However, the LLM answer does not fully capture a key nuance present in the original answer: the explicit omission in 2024 of the 2023 risk language regarding third-party partners (e.g., legal, insolvency, fraud risks), which is a critical indicator of reduced dependency and strategic shift. While the LLM implies a move toward internal control, it stops short of stating that the removal of risk disclosures suggests a reduced reliance on external partners—a key inferential point in the ground truth. This omission slightly weakens the qualitative accuracy and completeness of the multi-hop reasoning, though the core facts and direction of the strategy are correctly conveyed. Contextual relevance is strong, as the response directly addresses the evolution in strategy and balances both years' perspectives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 402,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "In the 2022 filing, cyber‑and‑intelligence solutions were described only as a line‑item under “Other revenues,” a fee‑based, value‑added product that “prevent[s], detect[s] and respond[s] to fraud and ensure the safety of transactions made primarily on Mastercard products” (page 80). By the 2023 filing, Mastercard is positioning those solutions as a core pillar of its value‑added services—“designed to allow all parties to transact securely, easily and with confidence”—and tying them to a broader, multi‑layered security strategy that supports new network investments such as open‑banking and digital‑identity capabilities (page 49). This shift reflects a move from a peripheral revenue source to a strategic, integrated security offering central to Mastercard’s growth agenda.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of Mastercard's Cyber and Intelligence Solutions between 2022 and 2023: in 2022, the solutions were a component of 'Other revenues' focused on fraud prevention for Mastercard transactions; by 2023, they were elevated to a strategic, value-added service integral to the broader payments ecosystem. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022 and 2023) are correctly referenced and aligned with the filings. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years of filings, identifying both the structural change (from a line item to a core pillar) and the strategic expansion (linking to open banking, digital identity, and network investments). (4) The LLM adds contextual detail (e.g., 'multi-layered security strategy', 'open-banking and digital-identity capabilities') that is consistent with and enriches the ground truth without introducing inaccuracies. Wording differs but meaning is preserved, and the answer fully addresses the question of strategic positioning evolution. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 354,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "In 2023 Tesla highlighted a modular, vehicle‑derived design for its Powerwall and Megapack and relied on its existing U.S., China and Germany factories to scale energy‑storage production (see page_7, page_9, page_13). By 2024 the company is confronting delays in ramping production at new factories, stressing the need to establish its own proprietary cell and pack lines while still depending heavily on external cell suppliers such as Panasonic and CATL (see page_17, page_18).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of timeline (2023 vs 2024 evolution) and key themes: modular design in 2023 and production/supply chain challenges in 2024. It correctly identifies Tesla's reliance on internal manufacturing expertise and external suppliers like Panasonic and CATL. The mention of new factory ramp delays and the push for proprietary cell and pack lines aligns with the 2024 strategic focus on production bottlenecks and supplier dependencies. However, the LLM introduces specific details not present in the original answer—such as Tesla using factories in China and Germany, references to Powerwall, and page citations (e.g., page_7, page_17)—which were not part of the ground truth. While these may be contextually plausible, they represent unverified additions that go beyond the provided knowledge. The original answer does not mention Powerwall, specific countries, or proprietary cell lines, focusing instead on general risks around supplier reliability and scaling. Thus, while the core evolution in strategy and challenges is accurately captured (supporting a high contextual relevance and solid qualitative accuracy), the inclusion of unsupported specifics slightly undermines the qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Overall, the answer captures the essence but adds granularity not confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 400,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "In 2023 NEECH’s debt activity was confined to remarketing existing fixed‑rate Series J, K and L debentures and the filing makes no mention of a new floating‑rate issuance【page_104】. By 2024 the company added a floating‑rate program, selling $600 million of floating‑rate debentures that all mature in early 2026 (the “Floating Rate Debentures, Series due January 29, 2026”)【page_105】【page_121】. This marks a shift from no floating‑rate issuance in 2023 to a $600 million issuance in 2024 with a single short‑term maturity.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timing of the floating rate debenture issuance. The original answer (ground truth) states that NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026 in 2023, while the LLM claims no floating-rate issuance occurred in 2023 and that the $600 million issuance happened in 2024. This reverses the actual sequence of events and misrepresents the evolution of the issuance strategy. The principal amount ($600 million) and maturity date (January 29, 2026) are correctly stated in the 2024 context, but their attribution to a 'new' 2024 program is incorrect since the ground truth indicates the 2024 Officer's Certificate formalized a prior commitment. (2) Quantitatively, the dollar amount and maturity date are accurate, earning partial credit. However, the incorrect assignment of the issuance to 2024 instead of 2023 undermines the temporal accuracy critical to the question. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the continuity between 2023 disclosure and 2024 formalization, instead interpreting it as a shift from no program to a new program. This mischaracterizes the strategic evolution, missing the nuance that the 2024 action was a specification of terms for an already-disclosed issuance. (4) Despite these errors, the answer remains contextually relevant by addressing the key elements of principal amount and maturity structure, and citing appropriate document sections. However, the core factual inversion on timing severely limits correctness, warranting a low-to-mid score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 454,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "In the 2023 filing (page 20) Intel described a broad, supplier‑centric program that combined direct audits, capability‑building for both direct and indirect suppliers, an expanding pool of engaged vendors, greenhouse‑gas‑footprint work and diversity‑spending targets, while also noting collaboration on climate‑water transparency and responsible‑minerals sourcing. By the 2024 filing (page 13) the language shifts to a tighter focus on leading industry‑wide initiatives—especially improving climate‑water transparency and responsible‑minerals sourcing—and on setting industry standards, audit processes and training, while still referencing robust supplier education and engagement but without the detailed expansion of direct/indirect‑supplier activities. Thus Intel’s approach moved from a wide‑ranging, supplier‑focused engagement model in 2023 to a more collaboration‑driven, industry‑standard‑setting emphasis in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's 2023 focus on expanding supplier engagement under RISE, inclusion of sustainability and compliance programs, and the net-zero Scope 3 goal by 2050 are accurately reflected, though the specific mention of 'net-zero upstream Scope 3 emissions by 2050' is implied through 'greenhouse-gas-footprint work' rather than stated verbatim. The 2024 shift toward deeper collaboration on responsible minerals, climate-water transparency, and industry standards is correctly identified. (2) There are no numerical inaccuracies—no specific numbers (e.g., dollar amounts, percentages) are misstated, and the years (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in focus across two years, correctly infers a strategic shift from broad supplier expansion to industry-wide collaboration and standard-setting, and supports this with specific thematic evidence (audits, training, transparency). (4) The answer is contextually excellent, directly addressing both collaboration focus and supplier engagement scope as asked. The only minor shortcoming is the omission of the explicit 'net-zero upstream Scope 3 by 2050' goal, which slightly reduces qualitative completeness, but the reference to greenhouse gas footprint work preserves substantial accuracy. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 403,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Both the 2022 and 2023 10‑K footnotes describe the standardized measure as “prepared on the basis of certain prescribed assumptions … including first‑day‑of‑the‑month average prices, which represent discrete points in time and therefore may cause significant variability in cash flows from year to year as prices change.” In each year the company also reiterates that the measure “does not provide a reliable estimate of the Corporation’s expected future cash flows.” Thus, the framing of the reliance on first‑day‑of‑the‑month prices—and the warning about its variability—remains essentially unchanged between the 2022 and 2023 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly citing some consistent language between the years. (1) The original answer (ground truth) identifies a clear evolution in tone and framing: from 'prepared on the basis of' in 2022 to 'depends on' in 2023, signaling a stronger emphasis on dependency and sensitivity to assumptions, particularly first-day-of-the-month prices. The LLM incorrectly asserts that the framing 'remains essentially unchanged,' which directly contradicts the ground truth. (2) Quantitatively, there are no numbers, percentages, or dates in the question or answers that are incorrect—both filings reference the same discount rate, costs, and tax assumptions, and the LLM does not introduce false data. (3) The multi-hop reasoning fails: the model does not recognize that while some language is repeated, the shift in verb choice ('prepared on' vs. 'depends on') represents a meaningful change in emphasis and disclosure strategy, which is the central point of the question. The LLM overlooks this nuance and incorrectly concludes no change occurred. (4) Contextual relevance is moderate—the response addresses the right document (10-K), company (XOM), and metric (standardized measure), and includes relevant caveats about variability and reliability. However, it misses the key interpretive shift the question asks about, leading to a substantially incorrect overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 394,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "In its 2022 filing, Mastercard described digital‑identity offerings as part of a broader identity, biometric and cyber‑services portfolio—highlighting device intelligence, behavioral biometrics, document‑proofing and related tools—but did not tie them to an open‑banking platform or give any coverage metrics【page_14】. By 2023, those identity capabilities were embedded in an open‑banking platform that provides permissioned API access and now reaches > 95 % of U.S. deposit accounts and roughly 3,000 European banks, dramatically expanding its reach across financial institutions【page_17】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments between 2022 and 2023. (1) Quantitatively, all numbers are accurate: the claim that MA's open banking platform reached >95% of U.S. deposit accounts and approximately 3,000 European banks in 2023 matches the original answer exactly. No calculations were required, and the figures are presented with acceptable formatting (e.g., '> 95 %' equivalent to 'over 95%'). (2) Entity accuracy is strong—Mastercard (MA) is correctly identified, and the years 2022 and 2023 are properly attributed to the respective stages of development. (3) The reasoning correctly captures the evolution: in 2022, digital identity tools were present but not integrated with open banking; by 2023, they were embedded within an open banking platform with expanded reach. This reflects sound multi-hop synthesis across years and capabilities. (4) However, the LLM omits a key qualitative detail from the original answer: the 2023 partnership with financial institutions to launch an ACH payment solution using open banking infrastructure, which demonstrates deeper integration of digital identity into financial services. While the core evolution and reach are accurately described, this missing element slightly weakens completeness and qualitative depth. (5) Contextual relevance is excellent—the response directly addresses the question about evolution, integration with open banking, and reach across financial institutions. Overall, the answer is factually sound and well-aligned, meriting a high score with minor deduction for incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 441,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "In 2023 Tesla presented Solar Roof as a market‑ready product it was actively selling and improving – it highlighted ongoing work to boost installation efficiency, collaborations with developers, and a multi‑source component strategy to secure supply and keep pricing competitive【page_6】. By the 2024 filing the tone had shifted: the company now admits it has experienced, and may continue to experience, launch and ramp‑up delays for Solar Roof and stresses that its ability to scale the product depends on overcoming supplier‑related component constraints and other production‑ramp challenges【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Tesla's Solar Roof approach between 2023 and 2024: in 2023, Tesla positioned the product as market-ready with improvements in installation efficiency and supply chain strategy; by 2024, the company acknowledged production ramp delays and supplier-related constraints. These points match the original answer’s emphasis on design maturity in 2023 and ramp-up challenges in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the LLM or original answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years and correctly infers a shift in tone and strategic emphasis, though it does not explicitly mention the 'depends in large part' quote about mass-market vehicle production that implies strategic prioritization. This omission slightly weakens the qualitative score, as it misses a key indirect signal about potential resource allocation trade-offs affecting Solar Roof. However, the core factual progression—improvement efforts in 2023 to acknowledged delays in 2024—is well-supported. (4) Contextual relevance is excellent: the response directly addresses production challenges and strategic dependencies, even referencing supplier constraints and ramp-up difficulties. Overall, the answer is factually correct and semantically equivalent to the ground truth with only minor omission of the strategic prioritization nuance, justifying a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 438,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "In the 2023 Form 10‑K the only pledge arrangement disclosed was a **Pledge Agreement dated September 1 2022** between NextEra Energy, Inc., Deutsche Bank Trust Company Americas (as collateral, custodial and securities intermediary) and The Bank of New York Mellon (as purchase‑contract agent)【page_121】. By the 2024 filing the same 2022 agreement remains, but **two additional pledge agreements were added – one dated June 1 2024 and another dated October 1 2024** – and both also name Deutsche Bank Trust Company Americas and The Bank of New York Mellon as the counterparties【page_123】. Thus, NextEra’s use of pledge agreements expanded in 2024 to include newer agreements while retaining the original 2022 counterparties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates are accurate: the original Pledge Agreement is correctly identified as dated September 1, 2022, and the two new agreements in 2024 are correctly dated June 1, 2024, and October 1, 2024. There are no numerical calculations required, and all dates match exactly. (2) The counterparties—Deutsche Bank Trust Company Americas and The Bank of New York Mellon—are correctly identified with their respective roles, and it is accurately noted that the same counterparties appear in both the original and new agreements. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: the LLM correctly infers evolution by comparing the 2023 and 2024 disclosures, noting the retention of the original agreement and the addition of two new ones, which shows an expansion in the use of pledge agreements over time. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., specifying agent roles) that enhances clarity without introducing error. All parts of the question—evolution between 2023 and 2024, dates, and counterparties—are fully addressed. No factual inaccuracies, omissions, or reasoning flaws are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 352,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "In 2023 Intel’s Edge‑AI story centered on an “edge‑native” software platform that provided modular building blocks, tools such as the OpenVINO 2023.1 toolkit, and a set of named ecosystem partners—including Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft—to help developers bring AI‑enabled compute to the edge【page_30】【page_31】. By 2024 the company has broadened that positioning into a fully integrated edge‑AI solution that runs on its Xeon, Core and Atom silicon, offers AI‑optimized compute and connectivity through open software frameworks, and is backed by a much larger ecosystem of over 500 network‑builder and vertical partners, while also showing growth in AI‑related DCAI revenue【page_18】【page_25】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Intel's Edge AI strategy from 2023 to 2024 with accurate qualitative details. In 2023, it correctly identifies Intel's edge-native software platform, modular building blocks, developer tools like OpenVINO 2023.1, and key ecosystem partners (Ericsson, Nokia, Cisco, etc.), aligning with the ground truth. For 2024, it accurately reflects a broader ecosystem (over 500 partners) and integration across Intel's silicon portfolio (Xeon, Core, Atom), which corresponds to the NEX initiative’s focus on general-purpose, cloud-native compute. The mention of AI-optimized compute, open software frameworks, and growth in DCAI revenue adds relevant context supported by the filings. However, the LLM does not explicitly mention the NEX initiative by name or the strategic shift from fixed-function hardware to programmable, cloud-native systems—a key conceptual evolution in the original answer. While the expansion of partnerships is correctly emphasized, the deeper technical transformation (e.g., cloud-native software on programmable hardware) is under-articulated. All named partners and tools are accurate, and there are no incorrect numbers; the reference to 'over 500 partners' is consistent with the knowledge graph. No calculations were required. The answer is contextually rich and directly addresses both software platform offerings and ecosystem partnerships across the two years. Minor omission of the NEX branding and its architectural implications prevents a perfect score, but core facts and reasoning remain sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 433,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "In the 2023 filing CVS listed three series of senior notes that mature in 2030 – $1.5 billion of 5.125% notes due February 2030, $1.5 billion of 3.75% notes due April 2030 and $1.25 billion of 1.75% notes due August 2030, for a total 2030 portfolio of $4.25 billion【page_168】. The 2024 filing shows the same three series with identical balances, including the 1.75% August 2030 notes still at $1.25 billion, indicating no change in composition or value of the 2030 senior‑note debt between 2023 and 2024【page_161】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the value of the 1.75% senior notes due August 2030 as $1.25 billion in both 2023 and 2024, matching the ground truth. It also accurately notes that the composition and value remained unchanged, which aligns with the original answer. However, the ground truth mentions that the 3.75% senior notes due April 2030 remained at $1,500 million (i.e., no change), but the original answer incorrectly states 'decreased from $1,500 million in 2023 to $1,500 million in 2024'—a contradiction in wording but no actual decrease. The LLM correctly interprets that there was no change and includes additional context (e.g., the 5.125% notes due February 2030) not mentioned in the ground truth, which is accurate per the cited filing pages and improves completeness. (2) All numeric values—$1.25 billion for the 1.75% notes, $1.5 billion for the other two series—are correct and consistently reported across years. Total portfolio sum of $4.25 billion is accurate ($1.5B + $1.5B + $1.25B). Dates (February, April, August 2030) and interest rates match. (3) The multi-hop reasoning is sound: the model compares the 2023 and 2024 filings, identifies the relevant debt instruments, tracks their values over time, and correctly concludes no change in composition or value. It synthesizes information across years and instruments appropriately. (4) The LLM answer is semantically equivalent to and in fact more complete than the ground truth, though the ground truth contains a minor error in implying a decrease when the value is unchanged. The LLM avoids this error. The only reason for not scoring a perfect 10 is that the question specifically focuses on the 1.75% notes and the broader 2030 debt context, while the original answer omits mention of the February 2030 notes—however, including them is an enhancement, not a flaw. Thus, the LLM answer is factually superior, but the score reflects strict alignment with the original answer's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 534,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "In the 2023 filing Netflix said it was **adding a new, lower‑priced ad‑supported subscription tier** as a fresh pricing option – a “new ad‑supported subscription plan” introduced to broaden its pricing model and help attract and retain members (2023 10‑K p. 7; also noted as a “new, lower‑priced ad‑supported subscription plan” in the risk‑factors discussion, p. 6). By the 2024 filing the tier is no longer a pilot but is presented as a **regular component of its pricing portfolio**, one of the range of plans the company offers “to meet a variety of consumer needs” and to drive global membership growth while staying within its operating‑margin targets (2024 10‑K p. 3).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies that Netflix introduced a lower-priced ad-supported plan in 2023 as a new pricing option to broaden its membership base, citing the 2023 10-K. In 2024, it accurately notes the plan evolved from a pilot to a core part of the pricing portfolio, now presented as a standard offering to meet diverse consumer needs and support global membership growth, citing the 2024 10-K. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, showing the evolution from introduction (2023) to integration (2024) within Netflix’s pricing strategy. (4) All entities—Netflix, the ad-supported subscription plan, 2023 and 2024 timeframes, and the strategic objectives of membership growth and pricing diversification—are accurately identified and contextualized. The answer matches the original in both factual content and conceptual depth, with only minor wording differences that do not affect meaning. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 351,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "In the 2023 filing Tesla said it had only just moved into early production and deliveries of the Tesla Semi (the commercial truck began early production in 2022)【page_5】. By the 2024 filing the Semi is shown as being in “pilot production” at the Nevada facility【page_36】 and is referenced as one of the new‑product, next‑generation vehicle platform initiatives that underpin Tesla’s broader manufacturing‑capacity expansion and growth strategy【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Tesla began early production and deliveries of the Tesla Semi in 2023, with early production starting in 2022, which is consistent with the timeline in the original answer. By 2024, it accurately reports the status as 'pilot production' at the Nevada facility, matching the ground truth. (2) There are no numeric values requiring calculation, but all dates and production phases are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years and two different production stages, correctly identifying the evolution in production status and linking it to Tesla's broader strategic initiatives, such as next-generation vehicle platforms and capacity expansion. (4) The answer adds contextual detail not in the ground truth (e.g., referencing the Semi as part of Tesla’s growth strategy on page 35), which enhances completeness without introducing error. The only minor shortcoming is that it doesn't explicitly frame the evolution as a 'strategic progression' in the same synthesized way as the original answer, but the implication is clearly present. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 352,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The 2024 filing adds new Executive Retention Employment Agreements – a continuation of Nicole Daggs’ agreement (dated Jan 1 2024) and a brand‑new agreement for Brian Bolster (dated May 6 2024) (see Exhibit list on page 125), whereas the 2023 filing only listed agreements through early‑2023 (see Exhibit list on page 123). This expansion shows that NextEra Energy is deliberately bolstering leadership continuity by locking in additional senior executives, underscoring a strategic focus on retaining top talent to support its long‑term goals.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Executive Retention Employment Agreements from 2023 to 2024, noting the addition of Brian Bolster in 2024 with a correct date (May 6, 2024). However, it incorrectly states that Nicole Daggs had a continuation agreement dated January 1, 2024, which is not mentioned in the ground truth. The original answer only references Mark Lemasney and Armando Pimentel, Jr. as having agreements in 2023, with no mention of Nicole Daggs in either year. This is a factual error in entity identification. (2) All other dates and references to filing pages (e.g., Exhibit list on page 125 for 2024, page 123 for 2023) are consistent with the structure of SEC filings and do not contradict the ground truth; however, the inclusion of Nicole Daggs introduces an unverified entity and date. There are no numerical calculations in this question, so quantitative accuracy pertains to dates and document references, which are mostly correct except for the erroneous Daggs reference. (3) The multi-hop reasoning is sound: the model correctly infers that expanding the number of agreements from 2023 to 2024 indicates a strategic emphasis on leadership continuity and talent retention. It synthesizes information across two years of filings and draws a logical conclusion aligned with the original answer. (4) Despite the incorrect mention of Nicole Daggs, the core insight about strategic expansion in executive retention is preserved, and the Brian Bolster addition is accurately cited. Hence, the answer is mostly correct with a minor but notable factual inaccuracy affecting entity and date accuracy, warranting a score of 8 for correctness and quantitative accuracy, 9 for qualitative reasoning, and full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 485,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "In the 2023 filing Intel said that its xPU products were one of several R&D focus areas – “our xPU products and features” were grouped with process‑and‑packaging, AI and software development (2023 10‑K p. 51). By the 2024 filing the company had made xPU a central strategic pillar, describing a distinct family of client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators and pledging to “develop and offer leading products across each of these architectural categories” to meet AI, data‑center and edge workloads (2024 10‑K p. 5). This shows a shift from a broad research emphasis in 2023 to a focused product‑development priority and market‑driven roadmap for xPU in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Intel's xPU strategy from a broad R&D focus in 2023 to a more structured, product-centric priority in 2024. The key elements—grouping xPU with process/packaging, AI, and software in 2023, and the shift to a strategic product development focus in 2024—are factually correct and well-supported by the cited 10-K pages. (2) There are no numeric values in the LLM answer, but the ground truth includes $16.0 billion in R&D spending for 2023, which the LLM omits. This is a minor omission but does not detract significantly from the core answer, as the question emphasizes strategic focus and product priorities rather than financial figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies the shift in strategic framing, and supports it with direct quotes and page references. (4) The LLM uses slightly different phrasing (e.g., 'central strategic pillar' vs. 'product competitiveness') but conveys the same semantic meaning. The mention of 'advisory group to expand the x86 ecosystem' from the ground truth is missing, but the core strategic shift is accurately represented. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 387,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "In the 2023 filing Netflix warned that its ability to grow ad revenue depended on “develop[ing] and expand[ing] an advertising sales organization team” and on “develop[ing] the technology and related infrastructure to support advertising” (2023 10‑K p. 10). By the 2024 filing the language was sharpened to a dedicated “advertising sales and advertising technology organization team” and to “develop the technology and related infrastructure to support advertising and drive value to advertisers,” showing a move toward a formalized team and a stronger commitment to infrastructure investment (2024 10‑K p. 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Netflix's approach from 2023 to 2024, noting the shift from developing advertising capabilities as a dependency to a more formalized and committed effort in 2024. The key phrases from both years are accurately quoted and cited (2023 and 2024 10-K, p.10), and the semantic meaning matches the original answer. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, compares the language changes, and infers a strategic shift toward internal development and infrastructure investment. The only minor shortcoming is that the LLM does not explicitly mention the 'reliance on third-party providers' or 'risks' highlighted in 2023, which is a small omission in completeness. However, the core evolution in organizational development and infrastructure investment is clearly and correctly conveyed. (4) The answer is fully contextually relevant, directly addressing both organizational development and infrastructure investment as asked. The slight deduction in qualitative accuracy reflects the omission of the third-party reliance context, but the overall reasoning and factual correctness remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 401,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "In 2023 Tesla described its unlimited free‑Supercharging benefit as part of a “stand‑ready” service bundle (including internet connectivity and OTA updates) that was provisioned at delivery and recognized on a straight‑line basis over the expected vehicle‑ownership life, with any limited free‑Supercharging incentives accounted for when actually used or when they expired【page_37】. By 2024 the company has formalized the offering as a “free Supercharging program” within a broader services bundle, tracking a specific deferred‑revenue liability for it and recognizing revenue from that liability over the performance period – the deferred balance grew to $3.6 bn and revenue recognized rose to $1.19 bn in 2024 versus $595 m in 2023【page_57】【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in Tesla's revenue recognition for free Supercharging: in 2023, it was part of a bundled 'stand-ready' service with straight-line recognition over ownership life, and in 2024, it shifted to a formalized program with specific deferred revenue liability tracking. This matches the ground truth's description of deferring revenue and amortizing over time. (2) Quantitatively, the LLM provides specific figures: deferred revenue balance of $3.6B and recognized revenue of $1.19B in 2024 vs. $595M in 2023. While the ground truth does not include these exact numbers, they are consistent with the described shift in accounting treatment and plausible within the context. The absence of these figures in the original answer does not make them incorrect, as they may come from the cited pages (57, 58) of the filing. (3) The multi-hop reasoning is sound—linking changes in program structure to revenue recognition policy across two years, synthesizing accounting treatment, bundling, and financial impact. (4) Minor deduction in quantitative accuracy due to the introduction of specific dollar amounts not present in the ground truth, though they are likely correct given the citation. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 382,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "In the 2023 filing the exhibit list for junior‑subordinated debt stops at Series P and all of the listed issues carry a fixed coupon (e.g., a 4.45 % Series N due Feb 28, 2030) and very long maturities【page_120】—there is no Series O shown. By the 2024 filing the company has added a new Series O Junior Subordinated Debenture that will mature on Nov 1, 2029, and the exhibit does not disclose a fixed coupon, implying a different (likely floating‑rate or lower‑rate) structure【page_121】. This shift suggests NextEra is moving toward shorter‑dated, potentially more flexible financing to diversify its capital structure and take advantage of current market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, Series O was not present in the filing and that only Series up to P were listed, whereas the ground truth confirms a Series O was issued in 2023 with a maturity of May 1, 2079. The LLM also misrepresents the coupon structure: it claims no coupon was disclosed in 2024 and implies a floating rate, while the ground truth states that the 2024 issuance had a defined 5.55% coupon. Conversely, it was the 2023 issuance that had no explicit coupon disclosed. The maturity date for 2024 is correctly identified as November 1, 2029. (2) Quantitative accuracy is low: the 5.55% coupon rate in 2024 is entirely omitted in the LLM answer, and the 2023 maturity date (May 1, 2079) is not mentioned. Instead, the LLM references a Series N with a 4.45% coupon due 2030, which is irrelevant to the question about Series O. These are critical omissions and misattributions. (3) The multi-hop reasoning is partially sound—the LLM attempts to infer strategic intent from maturity and coupon changes—but it is based on incorrect data. The conclusion about shorter-dated, flexible financing has some alignment with the ground truth, but the reasoning is undermined by factual errors. (4) Contextual relevance is high because the answer addresses the evolution of debenture terms and infers strategic intent, which matches the question’s focus. However, due to major factual and quantitative errors, especially the inversion of coupon disclosures between years and omission of key data, the correctness score is low at 4—partially correct on directionality but flawed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 456,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "In the 2022 Form 10‑K (see page 94), ExxonMobil’s impairment‑assessment discussion already noted that “OPEC investment activities and production policies also have an impact on world oil supplies” as part of the supply‑side factors that shape its long‑term price and cash‑flow assumptions. The 2023 Form 10‑K (see page 88) repeats the same language, still treating OPEC activity as one of the supply‑side drivers that influence the long‑term oil‑supply outlook used in its recoverability tests. Thus, the company’s consideration of OPEC has not materially changed – it remains a consistent element of the long‑term supply dynamics in the impairment framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing correct document locations and repeating accurate language from the filings. While it correctly notes that ExxonMobil mentioned OPEC's impact on oil supplies in both 2022 and 2023 10-Ks, it fails to recognize the qualitative evolution described in the ground truth: a shift from direct emphasis on OPEC to a broader, integrated framework including environmental and macroeconomic factors like greenhouse gas costs and net-zero targets. The LLM incorrectly asserts that 'the company’s consideration of OPEC has not materially changed,' which directly contradicts the ground truth indicating a strategic shift in how OPEC is contextualized within impairment assessments. There are no numerical errors (hence high quantitative accuracy), but the qualitative analysis and multi-hop reasoning are flawed—failing to synthesize the evolution in framing despite consistent terminology. The answer is contextually relevant but misses the key conceptual change, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 302,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "In the 2023 Form 10‑K the ad‑supported tier appears only in a risk‑factor discussion (Item 1A, p. 18), where Netflix notes that it has “no operating history” with the plan and that forecasting member adoption or advertising revenue is uncertain. By the 2024 filing, the same plan is described in the Business overview (Item 1, p. 3) as a core part of its pricing portfolio—“We aim to offer a range of pricing plans, including our ad‑supported subscription plan”—signaling that the offering has moved from a tentative, risk‑focused mention to an established, strategically emphasized component of its growth strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) It accurately reflects the evolution of Netflix's ad-supported plan from 2023 to 2024: in 2023, it was mentioned only in the risk factors (Item 1A, p. 18) with emphasis on uncertainty and lack of operating history; by 2024, it was integrated into the Business overview (Item 1, p. 3) as a core part of the pricing strategy. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2023, 2024), document sections (Item 1A, Item 1), and page numbers are correctly cited and consistent with the knowledge graph. (3) The multi-hop reasoning is sound—comparing the same offering across two years and different sections of the 10-K filings to infer a strategic shift—and the conclusion that the plan moved from a risk-focused mention to a strategically emphasized offering is logically and factually supported. (4) The answer is semantically equivalent to the original, with added precision (specific filing sections and page numbers), enhancing clarity without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 335,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping‑offer strategy has remained a low‑price marketing tool, but the cost base has shifted. In the 2022 filing the company said shipping costs rose because of “increased product and shipping costs… increased carrier rates, wage rates and incentives, and fulfillment‑network inefficiencies” and that it would “mitigate … through higher sales volumes, optimizing our fulfillment network, negotiating better terms with our suppliers, and achieving better operating efficiencies” (2022 p. 25‑26). By 2024 the drivers are still higher shipping rates and faster, more expensive delivery methods, but the rise is now partly offset by “fulfillment‑network efficiencies” and foreign‑exchange gains, with Amazon emphasizing continued investment in and optimization of its fulfillment network to absorb the higher shipping costs while keeping offers cheap (2024 p. 25‑27).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Amazon's shipping strategy between 2022 and 2024, identifying key cost drivers and strategic shifts. It accurately reflects that in 2022, rising shipping costs were driven by carrier rates, wages, incentives, and network inefficiencies, and that mitigation strategies included higher sales volumes, network optimization, supplier negotiations, and operational efficiencies—consistent with the ground truth. By 2024, the emphasis on fulfillment-network efficiencies as an offset is correctly noted, along with continued investment in the network. However, the LLM omits the specific $76.7 billion shipping cost figure from 2021 mentioned in the original answer, which provides important quantitative context for the cost trajectory. (2) No incorrect numbers are presented, but the absence of the $76.7B figure results in a partial loss of quantitative completeness. All other qualitative cost drivers and strategic responses are accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings, compares cost drivers, and identifies a shift toward efficiency gains as a countermeasure. The mention of foreign-exchange gains in 2024 adds detail not in the ground truth, but this does not contradict it and may reflect additional reporting; however, it slightly deviates from the core narrative focused on fulfillment efficiency. (4) The correctness score is 8 due to accurate reasoning and entity identification (Amazon, 2022 vs 2024, fulfillment costs, network optimization), but docked for missing the key 2021 cost figure. Quantitative accuracy is 9 because no numbers are wrong—just one major one missing. Qualitative accuracy is 8 due to strong synthesis but minor overemphasis on foreign exchange not highlighted in ground truth. Contextual relevance is 10 as all content directly addresses the question’s focus on cost drivers and strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 534,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "In the 2023 filing Duke Energy said the Master Retirement Trust held roughly 98 % of its assets for qualified pension plans and 2 % for other post‑retirement plans, with explicit class‑by‑class targets – e.g., 45 % global equity, 35 % debt, 7 % return‑seeking debt, 4 % hedge funds, etc., for the RC‑BP portfolio and 14 % equity, 80 % debt, 2 % return‑seeking debt, etc., for the DELPP portfolio – and it disclosed the asset mix by fair‑value hierarchy (Level 1, 2, 3) (2023 p.217‑p.219). By the 2024 filing the company had moved to a risk‑based split (35 % liability‑hedging/65 % return‑seeking for RC‑BP assets and 80 % liability‑hedging/20 % return‑seeking for DELPP assets), noted the discontinuation of securities‑lending, and provided a more granular quantitative disclosure of the trust’s holdings—including dollar amounts for each asset class, a Level‑3 reconciliation, and subsidiary‑level allocation percentages (2024 p.217, p.228).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Duke Energy's reporting between 2023 and 2024, noting a shift from class-by-class asset allocation targets in 2023 (e.g., global equity, debt, hedge funds) to a risk-based framework (liability-hedging vs. return-seeking) in 2024. This matches the ground truth's emphasis on more granular and transparent reporting in 2024. (2) Quantitatively, the percentages cited (e.g., 45% global equity, 35% debt for RC-BP; 14% equity, 80% debt for DELPP in 2023; 35/65 and 80/20 splits in 2024) are consistent with typical pension asset allocation disclosures and plausibly reflect the actual filing content. The mention of Level 3 fair value reconciliation and subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18% — though not repeated in the LLM answer) is partially accurate; the LLM correctly notes the introduction of subsidiary-level allocation percentages and Level 3 reconciliation in 2024, even if it omits the specific 15% and 18% figures. (3) The reasoning is sound: it captures the multi-hop synthesis across years and reporting changes, correctly identifying discontinuation of securities lending and increased granularity in dollar amounts and risk categorization. (4) The answer is contextually excellent, directly addressing utilization and reporting evolution, asset allocation changes, and disclosure practices. The only minor shortcoming is the omission of specific subsidiary percentages (15%, 18%) mentioned in the ground truth, which slightly reduces completeness. However, the core factual and conceptual content is correct, warranting a high score but not perfect due to this omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 475,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "In 2022 the 10‑K explained that a large portion of Google’s cost of revenues was “TAC … amounts paid to Google Network partners primarily for ads displayed on their properties,” and that the cost‑of‑revenues percentage on network‑property ads was “significantly higher” than on Search ads (2022 10‑K p.32). By 2024 TAC is still a major cost, but the overall TAC rate fell from 21.4% to 20.7% as more revenue came from higher‑margin Search & other properties, while the TAC rate on Google Network revenues remained essentially flat—so payments to network partners stay sizable but now represent a slightly smaller share of total cost of revenues (2024 10‑K p.39; cash‑flow uses p.42).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Traffic Acquisition Costs (TAC) paid to Google Network Partners in 2022 and 2024, and accurately references the higher cost-of-revenues percentage for network properties compared to Search. It also correctly notes a decline in the overall TAC rate from 21.4% to 20.7% between years, with the TAC rate on Network revenues remaining flat—this quantitative detail aligns with typical disclosures in Google's 10-Ks. (2) Quantitatively, the percentages cited (21.4% to 20.7%) are plausible and consistent with historical trends, though the ground truth does not mention these specific figures or an overall TAC rate change, so their inclusion introduces unverified precision. The core financial mechanism—TAC as a major cost—is correct. (3) However, the LLM misses the key qualitative shift emphasized in the original answer: the evolution from TAC as a cost-of-revenue item to being a primary operating cash outflow in 2024, indicating a structural change in financial obligations. Instead, it focuses on margin shifts and rate changes, which were not part of the ground truth. This reflects a failure in multi-hop reasoning—while both years are addressed, the synthesis of a transformation in the nature of the financial relationship (from income statement cost to cash flow obligation) is absent. (4) The answer is contextually relevant and well-structured, using correct entities (Google, Network Partners, TAC, 10-K references), but the qualitative inaccuracy in interpreting the evolution of the financial relationship significantly undermines the correctness. Hence, a score of 6 is justified—partially correct with key omissions in reasoning and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 467,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "UPS continues to treat offsetting interest‑rate swaps and foreign‑currency forward contracts that are not designated as hedges as non‑designated derivatives, measuring them at fair value and recognizing any gains or losses directly in earnings.  In 2022 the net loss from foreign‑currency exchange contracts recorded in the statement of consolidated income was $‑69 million, whereas in 2023 the same line item showed only a $‑7 million loss, indicating a much smaller adverse impact while the accounting treatment remained unchanged (page 132).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$-69 million net loss in 2022 and $-7 million in 2023 for foreign currency exchange contracts—that are not present in the original answer (ground truth). The ground truth does not provide any 2022 or 2023 financial impacts for derivatives, explicitly stating that 'the financial impact in 2023 was not quantified in the excerpt.' Therefore, the LLM fabricates precise numbers not supported by the source, severely undermining factual accuracy. (2) The quantitative accuracy is low because the dollar amounts and implied comparisons (e.g., reduction from $69M to $7M loss) are not corroborated by the ground truth, which only references data for 2021 ($163M gain) and 2020 ($124M gain), with no mention of 2022 or 2023 figures. There is no basis for the LLM’s claim of a 'much smaller adverse impact' due to lack of disclosed data. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that UPS treats certain derivatives (interest rate swaps, foreign exchange forwards) as non-designated, marks them to fair value, and recognizes gains/losses in earnings—consistent with the original answer’s description of accounting treatment. It also correctly notes that offsetting or terminating positions are mentioned consistently. However, it fails the multi-hop synthesis by asserting current-year impacts that the source explicitly says are not disclosed, indicating a failure to recognize the key nuance about reduced transparency in 2023. (4) Contextual relevance is high because the LLM addresses the core topic—accounting treatment and financial impact of offsetting swaps—and attempts to compare years and assess evolution. However, the introduction of unsupported numbers significantly reduces correctness. The answer would score higher if it had acknowledged the absence of 2023 quantification, as in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 517,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 filing now lists the Directors’ Savings Plan in the equity‑compensation summary (showing shares that could be payable under the plan and describing its mechanics) 【page_239】, whereas the 2023 filing only referenced an amendment to the plan in the exhibit index and did not highlight it in the compensation tables 【page_245】. This shift signals that Duke Energy is making the Directors’ Savings Plan a more central, performance‑linked component of director pay, moving toward greater use of deferred equity compensation compared with 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2023, the Directors' Savings Plan was only referenced in the exhibit index (e.g., as an amendment) without detailed discussion in compensation tables or narrative sections, while in 2024, it is now included in the equity-compensation plan summary with a description of mechanics and share availability. The page references (239 and 245) are consistent with typical 10-K structures, though exact page numbers may vary slightly by filing format—this does not affect factual accuracy. The conclusion that the plan has become a more central component of director compensation is supported and reflects the shift toward deferred compensation and transparency. The only minor shortcoming is the addition of 'performance-linked' in the LLM answer, which is not explicitly stated in the ground truth; the original answer emphasizes deferral flexibility and phantom investment options but does not tie the plan directly to performance metrics. This slight overinterpretation prevents a perfect 10 on qualitative accuracy, but the core reasoning, entity identification (Duke Energy, Directors' Savings Plan, 2023 vs 2024), and multi-hop synthesis across years are sound. All non-numeric elements are semantically equivalent, and the answer fully addresses the question about strategic shifts in director compensation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 391,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "In the 2022 filing, American Express warned that “intensifying competition” required it to “differentiate ourselves… develop compelling value propositions” and that rivals could offer richer programs, making the evolution of its offers a cost‑driven, defensive necessity (2022 10‑K Risk Factors). By the 2024 filing, the company had shifted to a proactive, multi‑pronged plan—targeting Millennials/Gen‑Z, expanding merchant and B2B acceptance, investing in digital channels, AI, new partnerships and a multiproduct digital ecosystem—to continuously refresh and broaden its value propositions in response to competitive pressure and changing customer behaviors (2024 10‑K MD&A).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. (1) It correctly identifies the defensive, cost-driven stance in 2022 due to intensifying competition, particularly from alternative payment providers, and the need to develop compelling value propositions as a necessity. This aligns with the original answer's emphasis on competitive threats and rising rewards costs. In 2024, the LLM correctly notes the shift to a proactive strategy targeting Millennials and Gen-Z, expanding digital capabilities (AI, digital ecosystem), merchant acceptance, and partnerships—matching key elements in the ground truth including AI, app enhancements, Tock/Rooam (implied in 'partnerships'), and global merchant growth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the years 2022 and 2024 are correctly attributed to their respective strategic contexts, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two filings (2022 Risk Factors, 2024 MD&A), correctly inferring a strategic shift from reactive to proactive. The only minor omission is the lack of explicit mention of 'dining platform expansion' (Tock, Rooam) and 'B2B payments leadership', which are specific components in the original answer. While 'B2B acceptance' is mentioned, 'leadership in premium commercial payments' is slightly more precise. These omissions are minor and do not distort the overall accuracy. (4) The answer is contextually excellent—directly addressing competitive pressures and changing customer behaviors, and explaining how Amex's approach evolved in response. Wording differs but semantic meaning is equivalent. A score of 9 is justified due to high factual fidelity with only slight incompleteness on specific program names and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 532,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil’s 2022 10‑K listed four series of senior notes – a 0.142 % note maturing in 2024 together with 0.524 % notes due 2028, 0.835 % notes due 2032 and 1.408 % notes due 2039【page_1†L9-L15】. The 2024 filing no longer shows the 0.142 % 2024 note; its outstanding long‑term notes are now only the 0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039 series【page_1†L9-L15】. This reflects a shift from holding a short‑dated, ultra‑low‑coupon issue to relying on longer‑dated notes with modestly higher rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all debt instruments disclosed by Exxon Mobil in 2022 and 2024, including exact interest rates and maturity years (0.142% due 2024, 0.524% due 2028, 0.835% due 2032, 1.408% due 2039), matching the ground truth. The observation that the 0.142% note is absent in the 2024 filing is accurate and correctly interpreted as retirement or maturity of that obligation. (2) All numeric values—interest rates and maturity dates—are factually correct with no calculation errors. Format variations (e.g., spacing in percentages) do not affect accuracy. (3) The reasoning correctly synthesizes multi-hop information across two years’ filings, infers strategic evolution in debt composition, and supports the conclusion that Exxon shifted toward longer-term debt. The LLM slightly understates the broader strategic emphasis on long-term financing by focusing on 'modestly higher rates'—a nuance not contradicted but not fully aligned with the ground truth’s emphasis on structural capital strategy. (4) The answer is contextually precise, directly addressing the evolution in long-term debt composition. Scores reflect full quantitative accuracy, near-perfect qualitative reasoning, and complete relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 350,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express’s 10‑K shows that the corporate‑card agenda has stayed anchored in its commercial‑payments pillar, but the emphasis has sharpened. In both the 2022 and 2024 filings the company says it will “evolve our card value propositions” and “further differentiate our corporate card and accounts‑payable expense‑management solutions” (2022 p. 8; 2024 p. 8). The 2024 filing adds that this differentiation will be driven by “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating a deeper focus on integrated financing and new product innovation beyond the broader differentiation language used in 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and quoted language from the 10-K filings, and correctly identifies the continuity in American Express's strategic focus on evolving card value propositions and differentiating corporate card and accounts payable solutions between 2022 and 2024. It accurately cites page numbers and uses direct quotes, showing strong grounding in the source material. However, the LLM misses a key evolution highlighted in the ground truth: the shift toward an integrated global network strategy in 2024 focused on increasing merchant acceptance and delivering fraud protection and marketing insights. Instead, the LLM emphasizes 'innovative products and features, including financing, banking and payment solutions' as evidence of deeper product innovation—but this nuance does not fully capture the external, ecosystem-driven strategic pivot (e.g., merchant network expansion) that distinguishes the 2024 approach. While the LLM correctly notes increased emphasis on product innovation, it fails to synthesize the multi-hop insight that the strategic emphasis shifted from internal differentiation (2022) to external integration and ecosystem value (2024). There are no numerical inaccuracies, and all references to years and strategic themes are contextually relevant. Thus, the answer is partially correct with solid qualitative grounding but lacks completeness in capturing the full strategic evolution, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 417,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "In the 2022 Form 10‑K Amazon already highlighted AWS as a distinct, high‑growth business – it lists Adam Selipsky as CEO of Amazon Web Services (page 5, 2022) – signaling its strategic importance. By the 2024 filing the company stresses that it is “investing in AWS” and expanding its on‑demand compute, storage, database, analytics and machine‑learning services (page 21, 2024), and it reports a sharp rise in operating cash flow to $115.9 billion in 2024 from $84.9 billion in 2023 (page 22, 2024), reflecting that AWS’s growing enterprise and developer customer base has become an even larger source of cash generation for Amazon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $115.9 billion operating cash flow in 2024 and $84.9 billion in 2023 are accurately reported, matching the original answer. There are no calculation errors. (2) The answer correctly identifies the strategic evolution of AWS from a high-growth, strategically important segment in 2022 to a major cash flow engine by 2024. It references AWS's expanding service offerings and growing customer base as drivers of cash flow, which is consistent with the shift from risk-focused to revenue-focused narrative. (3) Multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), connects strategic emphasis (leadership, investment focus) with financial outcomes (cash flow growth), and correctly attributes the financial performance to AWS’s enterprise role. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the 'competitive pressures and risks' framing from 2022 that is central to the original answer’s contrast; instead, it emphasizes AWS’s strategic importance early on. However, this does not invalidate the overall trajectory described. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—directly addresses cash flow generation and strategic emphasis as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 385,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Both the 2023 and 2024 audit reports state that the auditors “utilized trend analyses to evaluate the historical consistency of regulatory asset balances” (2023 Report – page 102; 2024 Report – page 81). The language and purpose are unchanged, indicating that the trend‑analysis scope remained focused on assessing the historical consistency of those balances, with no new dimensions added in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly citing that trend analyses were used in both years to evaluate historical consistency of regulatory asset balances. The ground truth states that while the general scope remained the same, in 2024 there was an expansion of audit procedures to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash—indicating a shift in focus toward more specialized compliance areas. The LLM incorrectly asserts that 'no new dimensions were added in 2024,' which directly contradicts the ground truth. This represents a failure in multi-hop reasoning, as the model did not recognize or report the nuanced evolution in focus even if the high-level language appeared similar. There are no numeric values to assess, so quantitative accuracy is not applicable but assumed correct. Contextual relevance is moderate because the answer addresses the right topic and years, but misses the key qualitative shift. The answer lacks completeness and semantic equivalence with the original, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 322,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "In the 2022 filing Costco said that, to offset higher costs and pricing pressures, it would “adjust…our pricing and merchandise mix, including increasing the penetration of our private‑label items” (2022 MD&A, p. 22). By the 2023 filing the company was still pursuing that lever and noted that its Kirkland Signature private‑label brand “represents a growing portion of our overall sales,” showing that the private‑label push had moved from a planned increase to an expanding share of sales as a key tool against cost pressures (2023 MD&A, p. 23; Kirkland discussion, p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Costco's strategy in 2022 as including an intention to increase private-label penetration in response to cost pressures, citing the 2022 MD&A. In 2023, it notes the continued emphasis and observes that Kirkland Signature now represents a growing portion of sales, indicating execution and expansion of the strategy. This matches the ground truth's characterization of a shift from reactive to strategic emphasis. (2) There are no numerical figures in this question, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022, 2023) and references (MD&A pages) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly infers evolution in strategy (from planning to observable growth), and ties it to cost pressures. The use of direct quotes strengthens accuracy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Costco's 2022 tactics like absorbing costs or bulk purchasing, which were part of the broader context in the original answer. However, the focus of the question is on the evolution of private-label strategy, which the LLM captures accurately. Thus, while slightly less comprehensive, it remains semantically equivalent in scope and correct in reasoning and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 408,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Pfizer said that the contract revenue still to be recognized for Paxlovid fell to about **$1 billion** at year‑end 2024 (the “remaining performance obligations” for Paxlovid)【page_109】.  By contrast, the total deferred‑revenue balance for Paxlovid + Comirnaty was **$5.1 billion** at the end of 2023 (down to $2.2 billion in 2024)【page_110】, implying that the Paxlovid‑specific portion of future contractual revenue was materially larger in 2023.  The drop to $1 billion of remaining obligations signals a noticeably weaker financial outlook for Paxlovid in 2024 versus the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that contradict the ground truth. (1) Quantitatively, while the $1 billion remaining performance obligations for Paxlovid as of December 31, 2024 is correct (matching the ground truth), the claim that the 'Paxlovid-specific portion of future contractual revenue was materially larger in 2023' is unsupported. The ground truth explicitly states that Pfizer did not disclose Paxlovid-specific remaining performance obligations in 2023. The LLM incorrectly infers this from the combined deferred revenue for Paxlovid + Comirnaty ($5.1 billion in 2023), which is a different metric and does not allow for a valid comparison. (2) The reasoning is flawed: the LLM interprets a decline in total deferred revenue (Paxlovid + Comirnaty) as evidence of a 'weaker financial outlook' for Paxlovid in 2024, but the ground truth interprets the $1 billion in specific Paxlovid obligations in 2024 as a sign of *increased* contractual certainty—directly opposite conclusions. (3) The multi-hop synthesis fails: the question asks how the financial outlook evolved based on remaining performance obligations, but the LLM conflates deferred revenue with remaining performance obligations and draws incorrect inferences from aggregated data. (4) Contextually, the answer addresses the right company and drug, and cites plausible document pages, but misinterprets key financial concepts and misrepresents the trend. Minor formatting of numbers ($1 billion) is acceptable, but the core conclusion is factually incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 435,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "In the 2022 filing (p. 95) American Express explained that it estimates lifetime credit losses by applying statistically‑based models over a “reasonable and supportable” (R&S) period that incorporates historical loss experience and current‑and‑future economic conditions, then reverts to long‑term average loss rates for any period beyond the R&S horizon. The 2024 filing (p. 98) still relies on that same R&S‑period framework, but the disclosure is framed around the auditor’s review of the reasonableness of the R&S period and the loss‑rate assumptions used after it, indicating that the company continues to use a forward‑looking, model‑driven approach while subjecting those key assumptions to heightened validation. This evolution shows a consistent, proactive credit‑risk methodology that balances near‑term economic forecasts with long‑term averages and underscores robust governance over its loss‑reserve assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the use of the Reasonable and Supportable (R&S) Period in both 2022 and 2024 is accurately described, including its role in estimating credit loss reserves using forward-looking economic conditions and reverting to long-term averages beyond the R&S horizon. The reference to auditor review in 2024 adds contextual depth not in the original answer but does not contradict it—rather, it enhances the narrative around governance and validation, which is consistent with a maturing framework. (2) There are no numeric inaccuracies; while the original answer mentions the $3.3 billion reserve as of December 31, 2021 (relevant context for 2022 filing), the LLM does not mention this figure. However, this omission is minor because the focus of the question is on the evolution of the R&S Period assumption, not the reserve amount itself, and the LLM still correctly frames the methodology used in both years. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, identifies continuity in the R&S framework, and infers increased scrutiny/validation in 2024, which logically supports the conclusion that the approach has matured. (4) The semantic meaning matches the original: while the LLM emphasizes 'auditor review' and 'governance' more than the original, this reflects a valid interpretive extension that aligns with the idea of the R&S Period becoming embedded in a more established process. The core evolution—from explicit explanation in 2022 to assumed, validated practice in 2024—is correctly captured. Minor deduction in qualitative accuracy due to added emphasis on audit review not present in ground truth, but this does not undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 488,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "In the 2022 Form 10‑K Amazon’s debt schedule was dominated by a series of fixed‑rate senior notes, including a low‑cost 0.800 % note that matures in 2025 (listed in Exhibit 4.5). By the 2024 filing the same 0.800 % note due 2025 is still on the books (Exhibit 4.6), but Amazon has broadened its financing mix with new revolving‑credit facilities (a five‑year and a 364‑day line) and higher‑coupon senior notes issued in 2022, showing a shift toward more flexible, diversified debt financing while retaining the low‑interest long‑term note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 0.800% Note due 2025 is accurately referenced in both 2022 and 2024 filings, and the mention of new debt instruments in 2022 (e.g., higher-coupon senior notes) is consistent with the introduction of new financing tools like the 4.600% Note due 2025 in the original answer. While the LLM does not explicitly name the 4.600% Note, it correctly infers the issuance of higher-interest debt. (2) The LLM correctly identifies the continuity of the 0.800% Note from 2022 to 2024 and notes the addition of new financing structures, including revolving credit facilities, which supports the conclusion of a more diversified debt strategy. (3) The multi-hop reasoning is sound: it synthesizes information across years (2022 to 2024), identifies the persistence of a specific debt instrument, and infers strategic evolution based on new instruments. (4) The only minor shortcoming is the lack of explicit mention of the 4.600% Note due 2025, which is a specific example in the ground truth. However, the reference to 'higher-coupon senior notes issued in 2022' captures the same concept, making the answer semantically equivalent with slight abstraction. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 386,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "In the 2022 Form 10‑K the Twenty‑third Supplemental Indenture is listed under the Duke Energy Progress mortgage‑and‑deed‑of‑trust series (4.4.19) as a June 1 1978 instrument incorporated by reference to Exhibit 2(c) (File 2‑61611)【page_249†L19-L22】. The 2024 filing still discloses that same indenture in the same schedule and also shows a Twenty‑third Supplemental Indenture for Duke Energy Indiana (4.14.2) dated January 1 1977 (File 2‑57828)【page_252†L13-L16】, indicating that the historic instrument remains incorporated by reference across subsidiaries and continues to be considered a relevant, ongoing component of the company’s debt documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that the Twenty-third Supplemental Indenture is still disclosed in the 2024 filing, when the ground truth explicitly states there is no direct mention or continued reference to it in DUK_10k_2024.pdf. Instead, the LLM invents a reference to a 'Twenty-third Supplemental Indenture for Duke Energy Indiana (4.14.2) dated January 1 1977' which does not appear in the ground truth and contradicts the absence of any such mention in 2024. (2) The date of the original indenture (June 1, 1978) is correctly cited from the 2022 filing, but the LLM introduces an additional, unverified date (January 1, 1977) and file number (2-57828) not present in the ground truth, making the quantitative accuracy partially correct at best. (3) The multi-hop reasoning is fundamentally flawed: the question asks how the treatment evolved, implying a comparison across years. The ground truth notes a disappearance of the indenture in 2024, signaling diminished relevance. The LLM instead asserts ongoing relevance by claiming continued disclosure, which is factually wrong. (4) Contextual relevance is moderate because the answer addresses the right topic (disclosure of the indenture over time) and cites document structure (schedules, exhibit references), but the core factual claim is false. The conclusion about 'ongoing component' is unsupported and incorrect based on the evidence. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 420,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "Alphabet’s share‑repurchase program for its Class C capital stock (combined with Class A) rose from $59.3 billion in 2022 to $62.2 billion in 2023 and was $62.0 billion in 2024, indicating a modest increase in 2023 and a slight dip in 2024【page_82†L9-L12】.  The Class C portion of those repurchases was 450 million shares for $52.9 billion in 2023 and 306 million shares for $50.2 billion in 2024 (the 2022 Class C amount is included in the $59.3 billion total)【page_82†L15-L22】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total repurchase amounts for 2022 ($59.3B), 2023 ($62.2B), and 2024 ($62.0B), which matches the ground truth and addresses the evolution of repurchase activity. However, the question specifically asks for the total value of Class C shares repurchased in each year, but the LLM introduces a breakdown by share class that is not fully aligned with the original answer. The original answer states that the $59.3B in 2022 includes both Class A and Class C repurchases without specifying the Class C portion, which the LLM correctly acknowledges. However, the LLM then provides specific Class C values for 2023 ($52.9B) and 2024 ($50.2B), which are not present in the original answer and represent a level of detail not supported by the ground truth. (2) The numbers cited for total repurchases are accurate and correctly formatted. However, the attribution of $52.9B and $50.2B specifically to Class C in 2023 and 2024 is not confirmed in the original answer, which only gives combined totals. This introduces potentially incorrect quantitative claims. (3) The reasoning partially fails the multi-hop requirement: while it correctly tracks the overall trend, it incorrectly assumes that the Class C breakdown is available for 2023 and 2024 but not 2022, which may reflect a misinterpretation of the source. The original answer does not provide annual Class C-specific values, so this breakdown undermines factual accuracy. (4) The contextual relevance is high because the answer addresses repurchase trends and cites specific figures with citations. However, the correctness score is reduced due to unsupported specificity in Class C values, which misrepresents the data. Quantitative and qualitative accuracy are moderately impacted by these over-specified figures, though core totals are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 500,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "In the 2022 Form 10‑K the Salary/Bonus Deferral Plan was listed as Exhibit 10.16, its 1994 amendment as Exhibit 10.17 and the 1997 amendment as Exhibit 10.19. In the 2024 filing the same plan is now Exhibit 10.13, the 1994 amendment is Exhibit 10.14 and the 1997 amendment is Exhibit 10.16, reflecting a re‑ordering and renumbering of the exhibit schedule while still incorporating the same historic documents.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the exhibit numbers and their associated years, which undermines the quantitative and qualitative accuracy. According to the ground truth, in the 2022 filing, the Salary/Bonus Deferral Plan was referenced as Exhibit 10.16 (1988 plan) and the 1994 amendment as Exhibit 10.17 — this part is partially correct. However, the LLM incorrectly states that the 1997 amendment was listed as Exhibit 10.19 in 2022; the ground truth does not mention Exhibit 10.19 at all in either year, and specifically notes that the 1997 amendment first appears in the 2024 filing as Exhibit 10.16. This is a critical error: the 1997 amendment was not present in the 2022 filing at all, but the LLM implies it was. In the 2024 filing, the LLM correctly identifies the renumbering (Exhibit 10.13 for the 1988 plan, 10.14 for 1994), and 10.16 for 1997 — this matches the ground truth. However, the reasoning that this reflects only a 're-ordering and renumbering' is incorrect, because the 2024 filing actually introduces a new amendment (1997) not previously disclosed, which represents a substantive expansion of documentation, not just renumbering. Thus, the core conclusion of the LLM is flawed. While the answer addresses the question's focus on changes between filings and attempts multi-hop synthesis, it fails on key facts and reasoning. The contextual relevance is high because it discusses exhibit changes and historical documentation appropriately, but the factual foundation is partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 421,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks’ interest‑rate‑swap exposure has shrunk. In the 2022 filing the company recorded an interest‑rate‑swap liability of **$34 million** in the “Other long‑term liabilities” line (with an additional $12 million of accrued‑liability for interest‑rate items) 【page_68】. By fiscal 2024 the swap liability fell to **$19.2 million**, still classified under “Other long‑term liabilities,” and only a small **$3.6 million** derivative liability appears in accrued liabilities 【page_72】【page_74】, showing a clear reduction in both magnitude and short‑term exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34.0 million liability in 2022 and the $19.2 million liability in 2024, both under 'Other long-term liabilities', which matches the ground truth. However, it introduces a $12 million 'accrued liability for interest-rate items' in 2022 and a $3.6 million derivative liability in 2024 that are not mentioned in the original answer and appear to be misinterpretations or extractions from unrelated line items. The ground truth states that in 2024, there was a $19.2 million liability and references a prior-year (2023) liability of $41.4 million — this key point is entirely missing in the LLM answer. Instead of showing a comparison to a higher prior-year liability (implying a reduction), the LLM fabricates short-term accrued liabilities not present in the original. (2) The core numbers ($34M and $19.2M) are accurate, but the additional $12M and $3.6M figures are unsupported by the ground truth and introduce quantitative inaccuracy. The absence of the $41.4M 2023 liability — critical for the 'evolution' narrative — undermines the quantitative and temporal analysis. (3) The reasoning is partially sound in noting a reduction in long-term liability, but fails the multi-hop requirement by not incorporating the 2023 liability data needed to show the trajectory from 2022 → 2023 → 2024. The conclusion of 'reduction' is directionally correct but lacks proper support from the full time-series. (4) The answer remains contextually relevant, addressing balance sheet classification and magnitude changes, but omits and distorts key financial data, reducing its factual reliability. The classification detail is correct, and the trend direction is right, but the supporting data is incomplete and partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 480,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Savings Plan is simply listed as an existing plan that was amended effective December 16 2021 (see the “Amended and Restated Duke Energy Corporation Directors’ Savings Plan” and the “Amendment to Duke Energy Corporation Directors’ Savings Plan” referenced on page 258). By the 2024 filing the same plan is described as a non‑qualified deferred‑compensation vehicle whose deferred amounts are credited to an unfunded account and may generate future share issuances, with the company noting that the number of shares that could be issued under the plan cannot be determined because it depends on future voluntary deferrals (Item 12, footnote 4 – page 239). This shift shows Duke Energy’s continued use of a deferral mechanism for director pay while increasing disclosure of its equity‑impact, reflecting a governance stance that ties director compensation to long‑term performance and maintains flexibility in how deferred amounts are ultimately settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 reference to the Directors' Savings Plan with the December 16, 2021 amendment is accurately cited, including document titles and page numbers. The 2024 description correctly identifies the plan as a non-qualified deferred-compensation vehicle with unfunded accounts and potential future share issuances, also citing the correct filing location (Item 12, footnote 4, page 239). (2) Quantitative accuracy is perfect: dates (December 16, 2021), years (2022 and 2024 filings), and structural details (unfunded, phantom investment, share issuance uncertainty) are all factually correct. Format and citation details match the source material. (3) Reasoning is sound: the LLM correctly infers a shift from policy documentation in 2022 to operational and disclosure transparency in 2024, and logically concludes that this reflects governance efforts to tie director compensation to long-term performance and equity impact. The mention of flexibility in settlement mechanisms adds nuance not in the original but is consistent with the data. (4) The only minor gap is that the LLM does not explicitly mention 'phantom investment options' or 'Duke Energy Common Stock Fund'—specific terms in the ground truth—which slightly reduces qualitative completeness. However, the concept is conveyed through 'deferred amounts credited to an unfunded account' and 'future share issuances.' Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong multi-hop reasoning across years and document sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 446,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "In the 2022 Form 10‑K Costco described its Kirkland Signature private‑label as a “high‑quality” offering that is “generally lower than national brands,” helping to lower costs, differentiate the merchandise mix and earn higher margins, and the company said it expected to increase the brand’s sales penetration【page_7】. The 2023 filing (pages 14, 16, 45, 50, 67) contains no new discussion of Kirkland Signature, indicating that the company has not altered the brand’s positioning or identified any additional material risks – its risk profile and strategic role appear unchanged from the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly citing some content from the 2022 filing. (1) It claims that the 2023 filing contains 'no new discussion of Kirkland Signature' and that the brand's positioning and risk profile are unchanged. This directly contradicts the ground truth, which states that while the 2022 filing emphasized growth and brand strength, the 2023 filing expanded risk disclosures to include supply chain disruptions, foreign exchange fluctuations, and catastrophic events affecting private-label brands like Kirkland Signature—indicating a shift toward a more risk-focused lens. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable beyond correct referencing of page numbers, which the LLM did accurately. (3) The multi-hop reasoning failed: the model should have compared the strategic emphasis in 2022 with the expanded risk disclosures in 2023, but instead concluded no change due to lack of explicit mention, which is a reasoning error. (4) Contextual relevance is low because the answer misses the evolution in risk profile, which is the central point of the question. The LLM’s assertion that no new discussion implies no change is unsupported and incorrect, as risk disclosures in 2023 implicitly but significantly altered the risk context for Kirkland Signature.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 381,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves fell from **326 billion cubic feet (BCF) at year‑end 2022** to **312 BCF at year‑end 2023** and then to **296 BCF at year‑end 2024** – a total decline of about 30 BCF【page_145】. The drop was driven mainly by production drawdowns (‑24 BCF in 2022 and ‑25 BCF in 2023) while only modest additions came from upward revisions (+6 BCF in 2022, +9 BCF in 2023) and a single extension/discovery of 1 BCF in 2022; no purchases were recorded and undeveloped reserves stayed flat at 4‑7 BCF【page_145】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 and 2024 reserve volumes (326 BCF and 296 BCF), matching the ground truth. However, it introduces an intermediate 2023 figure (312 BCF) that is not present in the original answer, which only compares 2022 to 2024. While this may be accurate based on the cited source (page_145), the original ground truth does not mention 2023, so the addition of this data point introduces detail beyond the verified truth. The production and revision numbers (e.g., -24 BCF production in 2022, +6 BCF revisions) are not in the original answer and cannot be verified against the ground truth, which only states 'revisions and production activities' without quantification. (2) The total decline of 30 BCF (326 to 296) is correct, but the breakdown across years with specific additions and subtractions is more granular than the original and not fully corroborated. The claim of '1 BCF extension/discovery in 2022' and 'no purchases' adds specificity absent in the original, which only notes 'minimal extensions and discoveries' and 'no sales or significant additions in 2024'. (3) The reasoning is sound and reflects multi-hop synthesis—likely from a detailed table across years—and the conclusion of declining reserves due to production outpacing modest additions aligns with the original. The model infers a trend and attributes it correctly, even if with more detail. (4) The answer is contextually excellent, addressing evolution over time and sources of change. However, the quantitative accuracy is reduced because the original answer does not support the specific yearly flows; thus, while plausible, they introduce unverified precision. The core facts (start/end volumes, overall decline, minimal additions, no sales in 2024) are correct, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 496,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "In 2022 FedEx’s Boeing 767‑300F fleet was entirely owned – 114 aircraft with no leased units – and the company had already pledged to buy more 767Fs (14 in 2023 and another 14 in 2024)【page_40】. By 2024 the fleet remains overwhelmingly owned (less than 1 % of all aircraft is leased) and the 767‑300F is now singled out as a cornerstone of FedEx’s aircraft‑modernization program, together with new B777Fs, underscoring a shift from simply expanding ownership to using the 767F as a key element of its modernization and efficiency strategy【page_98】【page_116】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that FedEx owned 114 Boeing 767F aircraft in 2022 with no leased units, which aligns with the ground truth. It also accurately reflects the shift in strategic focus by 2024, where the 767F is emphasized as a key part of modernization and efficiency efforts. While the original answer does not specify lease percentages or exact future purchase commitments (14 in 2023 and 14 in 2024), these details are plausible extensions from disclosed procurement plans and do not contradict the ground truth. The claim of 'less than 1% leased' in 2024 is consistent with an overwhelmingly owned fleet, though not explicitly confirmed in the ground truth. (2) All numeric values (114 aircraft, 14 in 2023, 14 in 2024) are presented accurately and plausibly, though the original answer does not provide 2024 ownership numbers or lease breakdowns. These additions in the LLM response enhance detail without introducing factual errors. (3) The multi-hop reasoning is sound—correctly connecting 2022 ownership data with 2024 strategic modernization focus, synthesizing across time and strategy dimensions. The evolution from expansion to modernization is logically inferred and well-supported. (4) The LLM answer conveys the same core information as the ground truth with added contextual precision (e.g., lease percentage, specific order years), maintaining semantic equivalence. Minor score deduction due to inclusion of specific future order numbers not present in the original answer, though they do not appear inaccurate. Overall, the response is factually strong, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 447,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "In fiscal 2022 Starbucks held $310.3 million of roasted‑coffee inventory (Note 5, Inventories)【page_71】. By fiscal 2024 the company’s roasted‑coffee business was anchored by a network of four major roasting plants – York, PA (1.96 M sq ft), Minden, NV (1.08 M sq ft), Kunshan, China (0.63 M sq ft) and Kent, WA (0.51 M sq ft) – together providing roughly 4.2 million sq ft of roasting, warehousing and distribution capacity【page_33】. This reflects a shift from emphasizing inventory levels in 2022 to operating a sizable, geographically diversified roasting infrastructure by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the inventory value of $310.3 million in 2022 is accurately reported. The infrastructure details for 2024 are also correct, listing the four roasting facilities in York, PA; Minden, NV; Kunshan, China; and Kent, WA. While the original answer does not include square footage, the LLM provides additional precise capacity data (1.96M, 1.08M, 0.63M, 0.51M sq ft) that sum to approximately 4.2 million sq ft, which is a valid aggregation and enhances accuracy without contradicting the ground truth. (2) The answer addresses both parts of the question: inventory value in 2022 and production infrastructure evolution by 2024. (3) Entities are correct—Starbucks, fiscal years 2022 and 2024, roasted coffee inventory, and correct geographic locations of facilities. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers a strategic shift from holding inventory to building production scale, based on the contrast between 2022 (inventory focus) and 2024 (infrastructure expansion). The added detail about facility sizes strengthens the conclusion without introducing errors. (5) Semantic equivalence is maintained—the core message about evolving involvement in roasting, from inventory holder to large-scale operator, is preserved and even enriched with contextual detail. No factual inaccuracies or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 397,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo’s filing the 2.750 % Senior Notes due 2025 are listed as a specific debt instrument (Item 4.7) and the Board of Directors’ resolutions expressly authorized the terms for issuing those notes (see Exhibit 4.65 on page 129). The 2024 Form 10‑K repeats that same Board‑resolution language (Exhibit 4.64 on page 130), indicating the company continues to have the 2.750 % Senior Notes due 2025 authorized and available, with no disclosed retirement or new issuance – i.e., its utilization of this instrument remained essentially unchanged from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the 2.750% Senior Notes due 2025 being authorized in both 2023 and 2024 filings, with correct references to exhibit numbers and document locations (e.g., Exhibit 4.65 in 2023 and Exhibit 4.64 in 2024), satisfying quantitative and entity accuracy. The percentages, dates, and document citations are correct, earning a perfect quantitative accuracy score. However, the LLM fails to capture the key evolution highlighted in the ground truth: the introduction of a new 2.750% Senior Notes due 2030 in 2024, which signals a strategic extension of the same interest rate to a longer-term instrument. This omission represents a critical gap in multi-hop reasoning and qualitative understanding. While the LLM correctly notes that the 2025 notes remained authorized, it concludes that utilization 'remained essentially unchanged,' which contradicts the ground truth interpretation that PepsiCo evolved its debt strategy by reusing the 2.750% rate for a new long-term note. Thus, despite accurate data points, the synthesis and strategic inference are incorrect, leading to a low qualitative accuracy and overall correctness score. The answer is contextually relevant but misses the core analytical insight required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 356,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "In the 2022 filing FedEx had committed to eight B777F freighters – 2 slated for 2023, 4 for 2024 and 2 for 2025 (see page 114). By the 2024 filing that commitment had been trimmed to just two B777F aircraft, scheduled for delivery in 2025 (see page 117). The cut‑back shows FedEx is scaling the B777F down to a limited, niche role rather than a core workhorse of its fleet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timelines. According to the ground truth, in 2022, FedEx planned for 4 B777F aircraft in 2024 and 2 in 2025 — not 8 total as claimed. The LLM incorrectly states that 2 were slated for 2023, 4 for 2024, and 2 for 2025, which misrepresents the original plan. The 2024 filing update correctly notes only 2 B777Fs planned for 2025 with no further plans, aligning with the phase-out indication. However, the LLM’s characterization of an 'eight' aircraft commitment is unsupported and exaggerates the original scope. (2) Quantitative accuracy is low: the numbers per year are wrong, and the total (8 vs actual 6 planned over years) is incorrect. The 2023 delivery is not mentioned in the ground truth, introducing a false data point. (3) The reasoning partially captures the strategic shift — the reduction and niche role interpretation is plausible and aligns with the phase-out idea — but fails to accurately reflect the earlier plan's scale and timing, weakening the multi-hop comparison. (4) Contextual relevance is high because the answer addresses both the change in utilization and strategic implications, and cites appropriate pages. However, due to major numerical errors and introduction of unsupported details (e.g., 2023 deliveries), the overall correctness score is reduced to 4, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 397,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks’ “foreign‑currency – other” cash‑flow hedge moved from a $55.3 million net gain (loss) recorded in AOCI for the fiscal year ended Oct 2 2022 (with $32.5 million slated for reclassification) to $39.6 million (and $23.6 million to be re‑classified) for Oct 1 2023, and then to just $11.5 million (with $9.5 million to be re‑classified) as of Sep 29 2024【page_66】【page_70】. The sharp decline in both the AOCI balance and the amount expected to flow to earnings signals that the company’s exposure to foreign‑currency fluctuations has been shrinking – likely because the underlying foreign‑currency risk has lessened or the firm’s hedging program has become more effective.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents the data from the ground truth. The original answer states that in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million (not a gain/loss in AOCI), while in 2024, the net gains included in AOCI were $11.5 million. However, the LLM claims a $55.3 million net gain (loss) in AOCI for 2022, which contradicts the ground truth that no such AOCI gain existed in 2022—only a liability of $0.3 million. The $11.5 million figure for 2024 is correct and matches the ground truth, but the earlier figures for 2022 and 2023 are not supported by the original answer. (2) The LLM introduces numbers not present in the ground truth: $55.3M (2022), $32.5M (reclassification), $39.6M (2023), and $23.6M (reclassification), which are entirely absent from the verified data. These values cannot be reconciled with the original answer, indicating fabrication or misattribution. (3) The multi-hop reasoning is flawed because the LLM incorrectly frames the evolution as a decline in AOCI gains from $55.3M to $11.5M, implying decreasing exposure, while the ground truth shows a shift from a negligible liability ($0.3M) in 2022 to a significant unrealized gain ($11.5M) in 2024—indicating increased exposure or hedging activity, not reduced. Thus, the conclusion about shrinking exposure contradicts the original interpretation. (4) Despite incorrect numbers and reasoning, the LLM does address the right topic (foreign currency derivative liabilities and AOCI), references the correct company and metric, and attempts to analyze trends over time, earning moderate points for contextual relevance and partial qualitative accuracy. However, the core quantitative inaccuracies severely undermine the correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 493,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo’s debt‑instrument schedule does not call out a 2.625 % Senior Note due 2026 – the only 2.625 % note listed is the 2041 issue (see page 129) and there is no board‑resolution reference to a 2026 issuance. By the 2024 filing the company explicitly authorizes and discloses the 2.625 % Senior Notes due 2026 in its board resolutions (see page 130) and lists the note’s form among its senior‑note schedules (see page 126), indicating a more detailed and prominent inclusion of this instrument in its broader debt disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, the 2.625% Senior Notes due 2026 were already listed in 2023 in a section involving Board of Directors Resolutions authorizing officers to establish terms for senior notes. However, the LLM claims that in the 2023 10-K, PepsiCo does not list this note and even asserts that the only 2.625% note is the 2041 issue — this directly conflicts with the ground truth. (2) The LLM incorrectly states there is no board-resolution reference to a 2026 issuance in 2023, while the ground truth confirms such a reference exists. This is a critical factual error in both entity and qualitative accuracy. (3) The LLM correctly notes that by 2024, the 2.625% Senior Notes due 2026 are explicitly disclosed and included in schedules, which aligns with the ground truth’s claim of continued disclosure. However, it fails to mention the broader context of an expanded and more diversified set of senior notes (e.g., 3.000% due 2027, 2.625% due 2029), missing a key multi-hop insight about PepsiCo’s capital markets strategy. (4) The reasoning is flawed because it misrepresents the 2023 disclosure status, leading to an incorrect evolution narrative — instead of showing continuity and expansion, it falsely suggests the note was introduced in 2024. While the percentages and years mentioned (2.625%, 2026, etc.) are numerically accurate, their contextual placement is wrong, dragging down quantitative and qualitative scores. The answer is relevant to the question’s domain but factually inverted on the core timeline, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 447,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco has long warned that its growth hinges on successfully developing new products, and that technical hurdles or delays in product planning could undermine its strategic alliances and market share (2022 10‑K pp. 24‑25). By 2024 the company still flags technical hurdles as a core risk, but it now ties them explicitly to its larger strategic investments—particularly in AI, cloud, security and software‑as‑a‑service (including the Splunk acquisition)—and stresses that timely resolution of these challenges is critical to realize the expected benefits of those investments and meet product‑development timelines (2024 10‑K pp. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Cisco's 2022 risk disclosures mention technical hurdles affecting product planning, timing, and market share, and by 2024, the focus shifts to strategic investments in AI, cloud, security, and SaaS, including the Splunk acquisition. The LLM correctly identifies the evolution in risk framing and the increased strategic stakes. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable beyond correct year references (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes information across two years of 10-K filings, connects technical hurdles to strategic investments, and highlights the increased importance of timely resolution for product timelines and ROI on investments. The mention of Splunk is consistent with Cisco’s 2024 strategic moves. (4) The only minor gap is that the LLM answer does not explicitly mention the expanded consequences in 2024 such as reputational damage, legal liability, and reduced customer retention, which are part of the broader risk profile in the original answer. This omission slightly affects completeness but does not undermine the core accuracy. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 387,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "In the 2022 Form 10‑K the company said that the rise in Google Network revenues was “primarily driven by strength in AdMob, **Google Ad Manager**, and AdSense” (2022 p. 35). By contrast, the 2023 filing only lists Google Ad Manager as one of the network platforms – “Google Network properties … participating in AdMob, AdSense, and **Google Ad Manager**” – without singling it out as a growth catalyst (2023 p. 57). Thus, Google Ad Manager moved from being highlighted as a key growth driver in 2022 to being mentioned merely as part of the broader network mix in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Google Ad Manager was explicitly named as a key driver of Google Network revenue growth alongside AdMob and AdSense, citing the 2022 10-K (p. 35). In 2023, it accurately notes that Google Ad Manager was mentioned only as part of the broader platform mix (AdMob, AdSense, GAM) without being highlighted as a growth driver, referencing the 2023 10-K (p. 57). (2) There are no numerical figures in the question or answer that require verification (e.g., $8.6B increase is mentioned in the ground truth but not in the LLM answer); however, the absence of this specific dollar amount does not detract from correctness, as the LLM focuses on the qualitative shift in narrative, which is fully supported. (3) The multi-hop reasoning—comparing the change in emphasis across two years and drawing a conclusion about the evolving role of Google Ad Manager—is sound and logically derived from the source statements. (4) The LLM conveys the same core insight as the ground truth: a shift from being a standout growth contributor in 2022 to a less emphasized, integrated platform in 2023. The only minor shortcoming is the omission of the broader context that in 2023, Google Ad Manager was grouped with other platforms like Google Ads and Display & Video 360 in marketing materials, which slightly enriches the 'integrated suite' point. However, the LLM’s characterization as part of the 'broader network mix' captures the essence. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 473,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks’ designated derivative liabilities for “foreign‑currency‑other” were only $0.3 million in accrued liabilities in FY 2022【page_68】. By FY 2024 they had grown to $4.7 million in accrued liabilities plus $4.1 million in other long‑term liabilities, or $8.8 million total【page_72】. That is an increase of roughly $8.5 million from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2022 derivative liability amount ($0.3 million) and the 2024 amount under accrued liabilities ($4.7 million), it incorrectly adds $4.1 million from other long-term liabilities, claiming a total of $8.8 million in 2024. The ground truth specifies only $4.7 million under accrued liabilities with no mention of additional liabilities in long-term categories. This leads to a grossly inflated total and incorrect magnitude of change. (2) The calculation of the increase as $8.5 million is therefore wrong; the correct increase is $4.4 million ($4.7M - $0.3M). The inclusion of $4.1 million from another liability category not referenced in the original answer is unsupported and distorts the result. (3) The multi-hop reasoning fails because the model synthesizes data from different liability categories without justification, conflating 'accrued liabilities' with 'other long-term liabilities' despite the ground truth specifying only the former. It does correctly identify the evolution across years and the relevant metric, showing some understanding of the required comparison. (4) The contextual relevance is high because the answer addresses the right company, metric, and time frame, and attempts a quantitative comparison. However, the quantitative accuracy is low due to incorrect figures and miscalculations. The qualitative accuracy is moderate because the core concept of tracking derivative liabilities over time is correct, but the reasoning and synthesis are flawed. Correctness score is 4 due to partial factual correctness but major errors in data aggregation and calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 462,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo’s 2023 Form 10‑K shows the Board authorizing the terms of a new 4.600 % senior note series that matures in 2045 (see page 129). The 2024 filing again lists that same 4.600 % senior note due 2045 in the Board‑resolution table (page 130) and includes it among the outstanding senior‑note series (page 126), indicating the series remains active and has been reaffirmed. This continuity reflects PepsiCo’s strategy of using long‑dated, fixed‑rate senior notes to lock in low borrowing costs and diversify its debt‑maturity profile, emphasizing a stable, long‑term capital‑structure approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance and continuation of the 4.600% Senior Notes due 2045 in both 2023 and 2024, accurately reflecting the Board authorization in 2023 and reaffirmation in 2024. All numeric values—interest rate (4.600%), maturity year (2045)—are correct, and the references to specific pages in the 10-K filings (page 129 in 2023, pages 126 and 130 in 2024) align with expected disclosure locations, supporting factual accuracy. (2) Quantitatively, there are no errors: percentages and years match the ground truth exactly, and no incorrect figures are introduced. (3) Regarding reasoning and multi-hop synthesis: the LLM correctly infers continuity of the 4.600% note as part of PepsiCo’s long-term debt strategy, which is valid. However, it omits a key element from the ground truth—namely, that in 2024 PepsiCo expanded its debt portfolio to include new instruments like the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This omission limits the completeness of the strategic analysis. While the conclusion about using long-dated, fixed-rate notes is sound, the failure to mention the broadening or diversification of the debt portfolio means the answer does not fully capture the evolution toward a more diversified financing strategy as indicated in the original answer. (4) The answer remains highly contextually relevant and well-reasoned, with only a partial gap in completeness. Hence, a score of 8 is justified—core facts and numbers are correct, but a meaningful qualitative detail about strategic expansion is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 435,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East region shifted from a largely direct base in 2022 to a greater reliance on equity‑affiliate interests by 2024.  The consolidated (operated) gas reserve fell from 326 BCF at year‑end 2022 to 296 BCF at year‑end 2024, while equity‑affiliate gas reserves rose from 5,753 BCF to 5,870 BCF, producing a modest net increase of about 87 BCF overall【page_145】.  This pattern shows COP is scaling back its own operated gas assets in the region and emphasizing growth through equity‑affiliate partnerships and joint‑ventures, indicating a strategic focus on leveraging affiliate exposure rather than expanding direct operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that COP's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased from 326 BCF in 2022 to 296 BCF in 2024—matching the ground truth—it fabricates the existence of equity-affiliate reserves increasing from 5,753 BCF to 5,870 BCF, which are not mentioned or supported in the original answer. These numbers are orders of magnitude larger than the direct reserves and completely change the interpretation. There is no mention in the ground truth of a 'net increase of 87 BCF overall' or a strategic pivot to equity-affiliate partnerships. (2) The quantitative accuracy is partially correct for the direct reserves (326 → 296 BCF is accurate), but the fabricated equity-affiliate figures (5,753 → 5,870 BCF) and the claimed net increase (87 BCF) are unsupported and incorrect. No such calculation is possible from the original data. (3) The multi-hop reasoning is flawed: the original answer draws a cautious conclusion about a minor reduction possibly indicating a strategic shift due to market dynamics. The LLM overinterprets and invents a detailed strategic pivot to equity-affiliate models without evidence, introducing entities and trends not present in the source. (4) Contextual relevance is moderate—the answer addresses COP’s natural gas position and strategic focus in the correct region and timeframe—but the invented data and erroneous synthesis undermine the validity. The conclusion is not supported by the ground truth, leading to a low correctness score despite some accurate base numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 445,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "In the 2022 10‑K, Google Play was highlighted as a standalone non‑advertising revenue pillar – “Google Play generates revenues from sales of apps and in‑app purchases and digital content sold in the Google Play store.” By the 2023 filing, Google Play is no longer listed separately; it is described as the primary source of revenue within the broader “platforms” category of non‑advertising revenue, still driven by app and in‑app sales, showing that its role has shifted from an isolated revenue line to an integrated part of a wider platform‑based growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Google Play was a standalone non-advertising revenue source with revenues from 'sales of apps and in-app purchases and digital content'—matching the original wording and meaning. In 2023, it accurately notes the shift: Google Play is no longer listed separately but is instead described as part of a broader 'platforms' category, primarily driven by 'apps and in-app purchases.' This reflects the correct evolution in strategic emphasis. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) and document references (10-K filings) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure structure and narrative focus across two years, correctly inferring a strategic shift from isolation to integration. (4) The only minor shortcoming is that the LLM says Google Play is 'no longer listed separately,' which slightly overstates the case—it may still be referenced within the broader category without being a top-level line item. The original answer more precisely says it was 'grouped under' the broader category. This nuance is minor and does not undermine the overall correctness. Hence, a score of 9 is justified—excellent accuracy with a small loss in precision on phrasing of structural changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 397,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed a commitment to 49 Cessna SkyCourier 408s – 11 slated for 2023, 12 for 2024, another 12 for 2025 and 14 for 2026 (page 114). By the 2024 filing the earlier deliveries had been fulfilled and the remaining order was 31 aircraft, now scheduled for 17 deliveries in 2025 and 14 in 2026 (page 117), reflecting a higher concentration of new SkyCouriers in 2025. This shift shows FedEx is still heavily counting on the SkyCourier to expand its regional feeder network, with an even greater reliance on the type for the near‑term fleet build‑out.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but introduces details not present in the ground truth. The 2022 projection of 49 aircraft is correct, and the 2024 update reducing the total to 31 is also accurate. However, the LLM adds specific yearly delivery breakdowns (11 in 2023, 12 in 2024, etc.) and claims these are from page 114 and 117 of the 10-K, which are not mentioned or verifiable in the ground truth. These granular delivery schedules are not part of the original answer and may be fabricated or misattributed. (2) The calculation of 11+12+12+14=49 is numerically correct, and 17+14=31 matches the reduced total, so the arithmetic is sound, but the source data for these splits is not supported by the ground truth. The ground truth does not specify annual delivery numbers, only total projected aircraft over time periods. (3) The reasoning about increased near-term reliance due to concentration in 2025 contradicts the ground truth, which notes a strategic shift from 'Increases' to 'Depends_On', indicating moderated reliance, not increased. The LLM fails to mention this key qualitative shift in strategic relationship, which is central to the question about FedEx's strategic reliance. (4) While the LLM captures the reduction from 49 to 31 aircraft, it misinterprets the implication—portraying continued heavy reliance instead of a more nuanced, moderated dependence. The contextual relevance is high as it addresses the evolution and strategic implication, but the qualitative inaccuracy in interpreting strategic intent significantly undermines correctness. Thus, the answer is partially factually accurate but flawed in key reasoning and unsupported in specific numeric details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 469,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "In the 2022 filing AIG explained that it “generally use a combination of loss‑development methods and expected‑loss‑ratio methods for excess‑casualty product lines” and that it “segments our analysis between automobile‑related claims and non‑automobile claims, further segmenting the non‑automobile claims for certain latent exposures such as construction defects and mass‑torts and also by attachment‑point bands” (see page 263). By the 2023 filing the expected‑loss‑ratio approach is described more generically – it “multiplies premiums by an expected loss ratio… for business written in excess of a deductible” and is applied to both long‑tail and short‑tail exposures without the same detailed casualty‑line segmentation (see page 200). Thus, AIG moved from a highly segmented, casualty‑line‑specific use of expected‑loss‑ratio methods in 2022 to a broader, less granular application across lines in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the use of expected loss ratio methods in both 2022 and 2023 and the segmentation by automobile vs. non-automobile claims and attachment points in 2022, which aligns with the original answer. It also correctly cites page numbers and quotes from the filings. However, the core evolution described in the LLM answer is factually incorrect: it claims that in 2023, AIG applied the expected loss ratio method more broadly and generically across lines without detailed segmentation, whereas the ground truth states that in 2023, AIG shifted focus to U.S. Workers' Compensation and introduced new, detailed segmentation by state, industry, claim handling entity, and risk-sharing features like high deductibles and retrospective rating. This represents a change in casualty line and segmentation type, not a reduction in granularity. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the years (2022, 2023) and page references (263, 200) are correctly cited, supporting a higher score in this category. (3) The multi-hop reasoning is flawed: the LLM incorrectly interprets the 2023 filing as a move toward less granular application, when in fact it reflects a shift in the context of application (from U.S. Excess Casualty to U.S. Workers' Compensation) with different but still detailed segmentation. The model fails to recognize that the method evolved in terms of *where* and *how* it was applied, not in becoming less segmented. (4) The correctness score is 4 due to significant factual inaccuracy in the core claim about the evolution of the method. While the answer is well-structured and cites sources, it misrepresents the strategic shift. Qualitative accuracy is low due to incorrect synthesis. Contextual relevance is moderate because the answer addresses the right topic and time frame but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 543,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "In FY 2022 Nike introduced a new consumer construct of Men’s, Women’s, Kids’ and Jordan Brand, and any product that could not be placed in one of those segments was reported in the “Others (5)” line item, described as “products not allocated to Men’s, Women’s, Nike Kids’ and Jordan Brand, as well as certain adjustments that are not allocated to products designated by consumer”【page_35†L31-L38】. By FY 2024 the same unallocated items continued to be shown in the “Others (4)” line, defined in the same way – “products not allocated to Men’s, Women’s, Kids’ and Jordan Brand, as well as certain adjustments that are not allocated to products designated by consumer”【page_37†L31-L38】. Thus the classification of unallocated products remained within the “Others” bucket of Nike’s consumer construct, with only a footnote renumbering and no substantive re‑categorization between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entity names, and the definition of the 'Others' category in both fiscal years 2022 and 2024, correctly citing the consistent classification of unallocated products and referencing the footnote renumbering (from (5) to (4)). The quantitative accuracy is perfect: fiscal years, segment names (Men’s, Women’s, Kids’, Jordan Brand), and the textual definitions from the filings are correctly quoted and attributed to specific pages. Contextual relevance is strong, as the response directly addresses the evolution (or lack thereof) in reporting unallocated products. However, the original answer highlights a key nuance: in FY2022, unisex products were explicitly classified within Men's, but by FY2024 there was no mention of this, suggesting a potential shift in how unisex products were handled. The LLM answer omits this important detail about unisex product classification, which is central to the question’s focus on 'evolution' in categorization. While the LLM correctly notes stability in the 'Others' category definition, it fails to acknowledge the potential change in treatment of unisex products, which weakens the qualitative accuracy and reasoning. This omission prevents a higher score despite strong performance on other dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 361,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo only disclosed the 3.500 % Senior Note due 2025 as an existing instrument (Form of 3.500 % Senior Note due 2025, Exhibit 4.4)【page_129】. By the 2024 Form 10‑K the Board had approved new issuances of the same 3.500 % Senior Notes due 2025, and the note appears again in the schedule of senior notes the company may issue【page_129】【page_126】【page_130】. This shift from passive listing to active authorization shows PepsiCo is using the 3.500 % 2025 notes to refinance or expand its borrowing at a low fixed rate, reflecting a proactive debt‑management strategy aimed at maintaining liquidity and optimizing its cost of capital.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.500% Senior Notes due 2025 in both 2023 and 2024, with accurate percentages and maturity dates, satisfying quantitative accuracy. The references to Form 10-K pages (e.g., page_129, page_126) suggest document support. However, the LLM claims that in 2024, the Board 'approved new issuances' of the same 3.500% Senior Notes due 2025, which is not supported by the ground truth. The original answer indicates that PepsiCo introduced new long-term notes (e.g., due 2034, 2040), not additional issuances of the 2025 notes. This misrepresents the evolution of the debt instrument. (2) All numeric values (3.500%, 2025 maturity) are correct; no calculations were required. (3) The multi-hop reasoning is flawed: while the LLM correctly tracks the presence of the 2025 notes over time, it fails to synthesize the key strategic shift—issuance of longer-term debt to diversify maturities—as stated in the ground truth. Instead, it invents a narrative about reissuing the same note, which contradicts the evidence of portfolio expansion. (4) The contextual relevance is high because the answer addresses debt management and uses appropriate financial reasoning, but the core qualitative inaccuracy—misidentifying the nature of new issuances—reduces correctness and qualitative accuracy significantly. The conclusion about proactive strategy has some merit but is based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 396,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "In the 2022 Form 10‑K ConocoPhillips reported only $3.1 billion of capital expenditures for its Lower 48 assets (see the “Capital Expenditures and Investments” table, 2022 Lower 48 $3,129 mm)【page_149】. By the 2024 filing the company disclosed a much larger outlay – $29.95 billion of total capital spending in the Lower 48 (including unproved and proved property acquisitions, exploration and development)【page_157】. At the same time, the company’s outlook for cash generation in that region was revised downward, with projected future cash inflows falling from $195.6 billion in 2022 to $164.3 billion in 2024 (discounted net cash flows dropping from $55.9 billion to $38.7 billion)【page_158】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, COP reported $3,129 million (i.e., $3.129 billion) in capital expenditures for the Lower 48, which the LLM correctly identifies as $3.1 billion (rounded). However, the LLM incorrectly claims that in 2024, COP disclosed $29.95 billion in capital spending for the Lower 48 — this figure is not supported by the ground truth, which explicitly states that no new capital expenditure figure was provided for 2024. This is a critical error. Additionally, the LLM introduces specific projected future cash inflow numbers — $195.6 billion in 2022 falling to $164.3 billion in 2024, and discounted cash flows from $55.9B to $38.7B — none of which appear in the original answer or are implied by it. The ground truth only states that 'certain amounts... had been revised to reflect additional future cash inflows and future production costs,' indicating an upward revision, not a downward one as the LLM claims. (2) The quantitative inaccuracies are severe: the $29.95B capex figure is fabricated in context, and the cash flow projections are entirely invented. Even allowing for format variation, these numbers do not match the ground truth in magnitude or direction (e.g., 'additional future cash inflows' contradicts 'downward revision'). (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes non-existent trends, asserting a narrative of declining outlook when the ground truth suggests a shift toward revised projections due to updated production and cost expectations — possibly positive. It fails to recognize that the absence of a new capex number is meaningful. (4) The contextual relevance is moderate because the answer addresses capital expenditures and future cash inflows in the Lower 48 across 2022–2024, which aligns with the question’s scope, but the factual foundation is incorrect. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 538,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "In the 2023 filing Comcast’s relationship with Atairos was set out in the “Fourth Amended and Restated Shareholders Agreement” (and its June 2 2023 amendment) that defined the parties’ voting and ownership rights 【page_100】. By the 2024 filing Comcast disclosed that the November 2020 amendment to the Atairos agreement reduced its funding commitment from up to $5 billion to $4.5 billion (with a $400 million annual capital‑call limit and a $40 million annual management‑fee commitment) and clarified that Atairos is controlled by management companies led by its former CFO, giving Comcast no voting rights but obligating it to absorb about 99 % of losses and receive roughly 86 % of residual returns 【page_84】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key financial and governance changes between 2023 and 2024. (1) Quantitatively, all numbers are accurate: the reduction in capital commitment from $5 billion to $4.5 billion, $400 million annual capital-call limit, $40 million annual management fee, 99% loss absorption, and 86% residual returns are all correctly reported. Dates are mostly correct, though there is a minor issue: the LLM attributes the amendment that reduced the commitment to November 2020, while the ground truth states the framework evolved by 2024 with no mention of a November 2020 amendment being responsible for the $4.5B reduction—this is a factual misattribution that affects reasoning. (2) The answer addresses both parts of the question—financial commitments (capital obligations) and governance (control structures)—and correctly notes Comcast’s lack of voting rights despite financial exposure. (3) Entities are accurate: Comcast, Atairos Group, and the involvement of Comcast’s former CFO are correctly identified. (4) The multi-hop reasoning is mostly sound, linking governance and financial terms across years, but the incorrect dating of the amendment weakens the causal logic. Despite this, the core evolution is accurately conveyed. Wording differs but meaning is semantically equivalent. Minor deduction for the date/amendment error, but overall a strong, relevant response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 389,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx’s 2022 10‑K showed a commitment to acquire **49 Cessna SkyCourier 408s** (including 11 slated for 2023) 【page_40】. By the 2023 filing the outlook had been trimmed to **31 SkyCourier 408s** (17 in 2025 and 14 in 2026) 【page_117】. The reduction signals that FedEx now views the SkyCourier as a niche, feeder‑type aircraft rather than a core capacity platform, especially when compared with the far larger fleets of B777F, B767F and other main‑line jets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in projected utilization of the Cessna SkyCourier 408 from 49 in the 2022 filing to 31 in the 2023 filing, matching the ground truth. It accurately reflects the reduction and provides specific years (2025 and 2026) for deliveries, which aligns with the updated timeline extending to 2029 in the 2023 filing. (2) All numeric values are correct: 49 and 31 aircraft are accurately reported. The mention of 11 for 2023 in the 2022 plan and 17+14 split in 2025–2026 is consistent with known filing data, and no calculation errors are present. (3) The reasoning is sound: the model correctly infers that the reduction indicates a strategic downgrading of the SkyCourier’s role, positioning it as a 'niche, feeder-type aircraft' rather than a core platform. The comparison to B777F and B767F fleets, though slightly more interpretive, is logically supported by the context and aligns with the ground truth’s implication of relative strategic importance. (4) The answer is semantically equivalent to the original, with slightly more interpretive language ('niche, feeder-type') but no factual deviation. The only minor point preventing a perfect 10 is that the ground truth emphasizes the extension of the timeline to 2029 (vs. 2027), which the LLM mentions implicitly via delivery years but does not explicitly contrast. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 402,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "In Nike’s 2022 Form 10‑K the Air Max line was not singled out – revenue was only broken out by broad footwear, apparel and equipment categories (see the disaggregated revenue tables in the 2022 filing, e.g., Note 16 on pages 88‑89) with no specific Air Max disclosure. By the 2024 Form 10‑K the company explicitly lists Air Max among its flagship technologies (product‑research section, page 6) and even details the Air Manufacturing Innovation subsidiary that supplies Air‑Sole cushioning for the line (page 7), showing a shift toward greater transparency about the Air Max platform and a stronger emphasis on its technological innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that in 2022, Air Max was not specifically called out in revenue disclosures, consistent with the original answer noting it was only included in a general list of technologies without specific revenue figures. In 2024, the LLM correctly identifies that Nike highlighted Air Max as a flagship technology and mentioned the Air Manufacturing Innovation subsidiary, reflecting increased emphasis on technological innovation. (2) There are no numeric values to verify (e.g., revenue amounts), but the years (2022, 2024) and document references (Form 10-K, page numbers) are factually consistent with typical SEC filing structures, and no incorrect numbers are present—thus quantitative accuracy is high. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring a shift from no specific disclosure to active promotion of Air Max as an innovation driver. However, the LLM slightly overstates 'greater transparency' by implying structural financial transparency improved, while the ground truth clarifies that no standalone revenue metrics were provided even in 2024—transparency increased in narrative but not financial terms. This nuance is missed, slightly reducing qualitative accuracy. (4) The response is highly relevant, directly addressing both revenue transparency and technological innovation across the specified time frame. Overall, the answer captures the core evolution accurately but lacks the precise caveat about continued absence of financial metrics, warranting a score of 8/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 453,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In the 2023 filing Comcast highlighted a **specific increase in capital spending to build Epic Universe in Orlando** – the 10‑K notes that “capital expenditures increased related to the development of Epic Universe in Orlando” (page 37). By the 2024 filing the language had shifted to a **broader, ongoing commitment**: the company says it “expects to continue investment in existing and new attractions at our Universal theme parks, including Epic Universe” (page 51), but it does not break out a separate dollar amount for the project, indicating a move from a targeted cap‑ex boost in 2023 to a continued, less‑quantified investment priority in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, Comcast explicitly mentioned increased capital expenditures for Epic Universe, citing the exact qualitative language from the filing. While the LLM does not include the $8.2 billion figure allocated to Connectivity & Platforms (which included Epic Universe investments), this omission slightly affects completeness but not core correctness, as the focus is on the strategic shift rather than full financial breakdown. (2) In 2024, the LLM accurately notes the absence of a specific dollar amount and correctly quotes the broader investment language, reflecting the shift to sustained, less-quantified investment. The lack of explicit mention of $8.2B is a minor gap in quantitative detail but does not misrepresent the data. (3) The reasoning is sound: it correctly synthesizes the evolution from targeted 2023 spending to ongoing 2024 commitment, capturing the multi-hop nuance of changing disclosure and strategic emphasis. (4) Entities (Comcast, Epic Universe, Universal theme parks, years) are correct, and the answer is fully contextually relevant, directly addressing the evolution in cap-ex strategy. The minor omission of the $8.2B figure prevents a perfect 10, but the core factual and qualitative analysis is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 371,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "In the 2022 filing FedEx reported operating six ATR‑72‑600F aircraft and had a purchase commitment of six for delivery in 2025 and one for 2026 – seven in total for those planning periods (see page 40). The 2023 filing raised that future commitment to seven ATR‑72‑600F aircraft in 2025 and three in 2026 – ten in total (see page 117), showing an increased projected utilization of the type for the same future periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both numbers and interpretation. According to the ground truth, in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections changed to 7 aircraft in 2025 and 3 in 2026 — indicating a reduction in planned utilization over time. However, the LLM incorrectly states that in 2022, FedEx reported operating six aircraft and had a purchase commitment of six for 2025 and one for 2026. This misrepresents the original projection data: the 2022 filing projected 11 for 2023, not current operations, and did not commit to six for 2025 and one for 2026 as stated. Furthermore, the LLM claims the 2023 filing increased commitments to seven in 2025 and three in 2026, interpreting this as an increase in utilization. While the numbers for 2025 and 2026 in the 2023 filing are correct (7 and 3), the interpretation is flawed: the overall trend from earlier projections (11 in 2023 down to 1 in 2026) versus later (7 in 2025, 3 in 2026) reflects a reduction in long-term plans, not an increase. The LLM incorrectly frames this as 'increased projected utilization,' which contradicts the ground truth's conclusion of reduced usage. Additionally, the LLM introduces 'purchase commitment' and 'operating six' in 2022, which are not supported by the original answer. The multi-hop reasoning fails because it misidentifies the nature of the data (projections vs. commitments/operations) and draws the opposite conclusion from the evidence. Quantitative accuracy is partially present for the 2025 and 2026 numbers in the 2023 projection but missing earlier years and misstated in context. Contextual relevance is moderate as it addresses fleet projections but with incorrect framing and data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 488,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "In FY 2022 Nike disclosed a single “sales‑related reserve” that bundled product returns, post‑invoice discounts and other claims, estimating the most likely amount and recording a contra‑revenue reduction with an accrued‑liability offset while the expected cost of returned inventory was booked in prepaid expenses (see 2022 10‑K p. 89‑66). By FY 2024 the company broke the reserve out into discretionary authorized returns, discounts and claims and described a three‑step estimation process—historical rates, specific identification of outstanding returns, and projected but not yet finalized returns—still adjusting revenue when actual returns differ (see 2024 10‑K p. 66‑67). This shift to a more granular, continuously‑updated reserve reflects a refined ASC 606‑aligned revenue‑recognition approach that emphasizes greater transparency and precision in estimating and adjusting for product returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. Most critically, it incorrectly states that in FY2022 Nike used a 'most likely amount' estimation method and had a 'single sales-related reserve' that bundled returns and discounts. The ground truth indicates that in FY2022, Nike disclosed a specific $269 million reserve for product returns (recorded in Prepaid expenses), but does not mention bundling with discounts or using the 'most likely amount' methodology at that time. The 'most likely amount' approach is explicitly attributed to FY2024 in the original answer, not FY2022. The LLM also fabricates a 'three-step estimation process' (historical rates, specific identification, projected returns) not mentioned in the ground truth. Additionally, the LLM cites page numbers (e.g., p. 89-66, p. 66-67) and document sections not verifiable from the provided data. (2) Quantitatively, the LLM omits the key $269 million figure from FY2022 and fails to note that FY2024 did not disclose a specific dollar amount—both central facts in the original answer. No calculations are made, but the omission of disclosed figures reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a shift toward more granular, ASC 606-aligned estimation practices by FY2024, which aligns with the ground truth’s conclusion about a more formalized, probabilistic approach. However, the reasoning is based on incorrect premises about FY2022 practices, weakening the comparison. (4) Despite factual inaccuracies, the answer is contextually relevant and addresses the evolution in Nike’s methodology and its implications for revenue recognition. The conclusion about increased transparency and ASC 606 alignment is consistent in spirit with the original, though supported by incorrect details. Thus, correctness is reduced due to significant factual and descriptive errors, particularly around the timing and nature of methodology changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 539,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The 2022 filing showed FedEx had 12 Cessna SkyCourier 408s slated for delivery in 2025 and 14 in 2026, with no further deliveries thereafter (see page 114). The 2023 filing raised the 2025 commitment to 17 aircraft while keeping the 2026 figure at 14 and still showing no deliveries beyond 2026 (see page 117). This increase for 2025 indicates FedEx is leaning more heavily on the SkyCourier 408 for its near‑term capacity expansion, while its longer‑term (post‑2026) reliance on the model remains unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the 2022 plan for 2026: the ground truth states that in 2022, FedEx planned 12 aircraft for both 2025 and 2026, but the LLM claims 14 in 2026. This is incorrect and contradicts the original answer. The 2023 update correctly notes an increase to 17 for 2025 and a reduction to 14 for 2026, which the LLM accurately reflects for 2025 but misrepresents for 2022. (2) Quantitative accuracy is compromised because of this misstatement: the 2022 2026 figure is wrong (14 vs correct 12), though the 2023 numbers (17 for 2025, 14 for 2026) are correctly reported. The calculation of change over time is partially flawed due to incorrect baseline. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies the shift from 2022 to 2023 filings and draws a logical inference about increased near-term reliance. However, it fails to note the reduction from 2025 to 2026 in the 2023 plan, which the original answer highlights as a 'moderate decline' and 'recalibration.' The LLM instead claims long-term reliance remains unchanged due to no deliveries beyond 2026, which is contextually relevant but overlooks the strategic implication of reducing from 17 to 14. (4) Contextual relevance is high—the answer addresses fleet composition changes and strategic reliance directly. Qualitative reasoning is strong despite missing nuance in the forward-looking strategy. Correctness score is 7 due to core factual error in 2022 plan, but key trends and entities are mostly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 424,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "In 2023 Mastercard’s real‑time account‑based payments were operating or being rolled out in 13 markets, and the service was protected by a multi‑layered security framework that includes network protection, fraud‑scoring and digital‑identity tools (page_11). By 2024 the filing stresses an expanded, globally integrated payments network that now embeds advanced digital‑identity and open‑banking capabilities within the same multi‑layered security architecture, indicating both a broader operational footprint and tighter security integration (page_17; page_11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of 13 markets in 2023 is correctly reported, and the years (2023–2024) are accurate. No calculations were required. (2) The LLM correctly identifies the evolution in operational scale—expansion of the global network—and enhanced security integration, including fraud scoring, digital identity, and multi-layered security. It adds specific details like 'open-banking capabilities' and 'network protection' that are consistent with the ground truth’s emphasis on intelligent routing, tokenization, and partnerships. (3) The reasoning is sound: it synthesizes information across two time points and infers a strategic expansion in both scale and security, correctly characterizing the evolution as broader footprint and tighter integration. (4) While the original answer mentions ACH enhancements and value-added services explicitly, the LLM captures the essence through 'advanced digital-identity' and 'globally integrated payments network.' Minor omission of 'ACH' and 'tokenization' by name does not detract significantly from the overall correctness, as tokenization may fall under digital identity tools. Semantic equivalence is maintained. Contextual relevance is excellent—directly addresses both operational scale and security evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 374,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "In 2022 Nike’s foreign‑exchange forwards and options were largely booked as cash‑flow hedges, producing only a modest $19 million before‑tax gain (about $8 million after tax) that was recorded in OCI and then re‑classified to earnings; the filing does not itemize a specific liability balance for those contracts. By 2024 the program had grown substantially – the company reported $313 million of designated forward‑ and option‑asset balances and $146 million of designated liability balances (including $110 million of accrued liabilities) – and the hedges generated a $270 million loss in OCI but a $468 million gain when re‑classified to income, showing a much larger, more active hedging strategy and a far greater impact on both the balance sheet and earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the $8 million after-tax gain in 2022 (matching the ground truth), it introduces a $19 million before-tax gain not present in the original answer, which may be an inference but is not supported by the provided ground truth. More critically, the 2024 figures are substantially incorrect: the LLM claims $146 million in liability balances (including $110 million in accrued liabilities), but the ground truth only specifies $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities—totaling $115 million, not $146 million. Additionally, the LLM introduces large asset balances ($313 million) and P&L impacts ($270 million loss in OCI, $468 million gain reclassified) that are not mentioned in the ground truth, making these unsupported additions. The qualitative reasoning about a strategic shift toward a more active hedging strategy is plausible and aligns with the increased liabilities, but the conclusion is based on fabricated data. The entity (Nike), years (2022, 2024), and general concept of evolving hedging strategy are accurate, and the answer addresses the question's focus on evolution and impact. However, the extensive incorrect numerical details and unsupported financial figures severely reduce factual reliability. The contextual relevance is high as it directly addresses the evolution of hedging strategy and balance sheet impact, but the multi-hop synthesis fails due to reliance on non-grounded data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 433,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In the 2022 Form 10‑K, Puffs is listed as a major brand under the **Family Care** sub‑category (paper towels, tissues, toilet‑paper) of the Baby, Feminine & Family Care segment【page_19】. The 2023 Form 10‑K shows the same placement – Puffs appears again under **Family Care** (paper towels, tissues, toilet‑paper) within the Baby, Feminine & Family Care segment【page_18】. Thus, the product‑category classification of Puffs did not change between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its conclusion despite citing correct document locations. The ground truth states that while Puffs remained in the Family Care category, the 2023 reporting simplified the sub-category details by removing the explicit mention of 'Tissues' and不再 providing a breakdown, indicating a change in reporting structure. However, the LLM claims there was 'no change' in classification and even reproduces the same sub-category list (paper towels, tissues, toilet-paper) for 2023, contradicting the ground truth which notes a consolidation or simplification in how the segment was reported. There are no numeric values to verify, so quantitative accuracy is满分. The reasoning is flawed because it fails to recognize the evolution in disclosure granularity as a meaningful change in classification reporting, which is the core of the question. While the answer correctly identifies Puffs' segment and general category, it misses the key nuance about the shift in sub-category detail presentation between years, resulting in a partially correct but ultimately misleading response. Contextual relevance is high as the answer addresses the right segment and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 334,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "In the 2022 Form 10‑K, Tampax was shown under the **Baby, Feminine & Family Care** segment as a brand in the **Feminine‑Care** sub‑category (which grouped adult incontinence and generic feminine‑care products) and was listed together with baby‑care brands such as Luvs and Pampers Bounty【page_19】.  \nIn the 2023 filing the segment was streamlined to **Feminine Care (Adult Incontinence, Menstrual Care)** and **Family Care**, dropping the baby‑care sub‑category; Tampax (still listed as “Tampax Bounty”) is now positioned explicitly as a menstrual‑care brand within the Feminine‑Care sub‑category of the same segment【page_18】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Tampax's categorization between 2022 and 2023, noting the shift from a broader 'Feminine Care' category to a more specific menstrual care focus. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Tampax was grouped with 'adult incontinence' in 2022 is not supported by the ground truth, which only mentions 'Feminine Care' without specifying adult incontinence as a sub-component. Second, the LLM incorrectly states that Tampax was listed as 'Tampax Bounty' in both years — this is false; 'Bounty' is a separate P&G brand (paper towels) and not part of the Tampax brand name. The mention of 'Bounty' appears to be a confusion with other brands listed in the same segment. Additionally, the 2023 reorganization is misrepresented: the ground truth states that 'Menstrual Care' became a distinct sub-category, whereas the LLM implies that 'Feminine Care (Adult Incontinence, Menstrual Care)' was a new combined sub-category, which alters the intended meaning. While the broader segment 'Baby, Feminine & Family Care' is correctly identified for both years, and the directional shift toward more focused positioning is acknowledged, the incorrect brand naming, misrepresentation of sub-categories, and erroneous grouping with adult incontinence undermine the qualitative accuracy. Quantitative accuracy is scored higher because there are no numerical values to assess, and the years (2022, 2023) are correct. Contextual relevance is fair because the response addresses the question’s focus on categorization changes, but the inaccuracies limit its usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 449,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "In fiscal 2022 Oracle’s filing notes that the hardware segment – which includes Oracle Engineered Systems – produced $3.2 billion of revenue (a 5 % decline year‑over‑year) as the company de‑emphasized non‑strategic hardware in favor of cloud‑based infrastructure (2022 p.51). By fiscal 2023 the company says the hardware business (including Engineered Systems) accounted for about 6 % of total revenue and explicitly re‑affirms its plan to keep investing in research‑and‑development to improve existing hardware and create new products (2023 p.43). This marks a shift from a modest, declining hardware contribution in 2022 to a stable‑share positioning with a clear R&D commitment in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in Oracle's positioning of Oracle Engineered Systems from fiscal 2022 to 2023, noting the increased emphasis on R&D investment and the clarification of hardware's revenue share at 6% in fiscal 2023. However, the ground truth does not mention the $3.2 billion revenue figure or the 5% year-over-year decline cited by the LLM, which introduces unsupported quantitative details. These specific numbers and the claim of de-emphasis in 2022 are not present in the original answer, making them factually unverifiable based on the provided ground truth. (2) The 6% revenue contribution in fiscal 2023 is correctly reported and aligns with the original answer. However, the $3.2 billion and 5% decline are extraneous and not corroborated, reducing quantitative accuracy. (3) The multi-hop reasoning is sound in comparing the evolution of strategy across years—highlighting the shift from indirect channel focus and point-of-sale recognition in 2022 to a clearer strategic commitment with R&D plans and revenue share disclosure in 2023. The synthesis of strategic emphasis and investment intent is accurate and well-reasoned. (4) While the qualitative and contextual elements are strong—correct entities (Oracle, Engineered Systems, fiscal years), accurate description of strategic evolution, and relevance to revenue contribution and R&D—the inclusion of unverified financial figures lowers the quantitative and overall correctness scores. The core conclusion about strategic repositioning remains valid, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 438,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "In 2022 Honeywell’s non‑U.S. pension plans held about **$90 million** in private‑fund assets, all measured at fair value with **$54 million classified as Level 2** and **$36 million as Level 3** (no Level 1). By year‑end 2023 the allocation grew to **$115 million**, still with **no Level 1** exposure, but the mix shifted to **$41 million in Level 2** and **$74 million in Level 3**, indicating a larger share of the private‑fund holdings moved into the higher‑uncertainty Level 3 category.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and misattributes data to the wrong pension plan. The original answer states that in 2022, Honeywell reported $1,105 million in private fund investments—but this was for its *U.S.* pension plans, not Non-U.S. The LLM incorrectly claims $90 million in Non-U.S. private fund investments in 2022 with $54M Level 2 and $36M Level 3, which contradicts the ground truth. The ground truth does not provide 2022 data for Non-U.S. plans, so the LLM fabricated or misattributed figures. In contrast, the 2023 data in the LLM answer is correct: $115M total, $41M Level 2, $74M Level 3 for Non-U.S. plans. (2) Quantitative accuracy fails on the 2022 numbers—$90M vs. no stated Non-U.S. amount in ground truth (but $1,105M mentioned for U.S.)—and the breakdown is unsupported. The 2023 numbers are accurate and sum correctly ($41M + $74M = $115M). However, the comparison over time is flawed because the LLM compares Non-U.S. 2022 (invented) to Non-U.S. 2023 (correct), while the ground truth compares a shift from U.S. to Non-U.S. plans. (3) Multi-hop reasoning is partially sound in noting a shift toward Level 3 in 2023, but the analysis is based on incorrect prior-year data. The ground truth emphasizes a significant *decrease* in overall private fund allocation (from $1,105M to $115M) and a shift in geography (U.S. to Non-U.S.), which the LLM completely misses. Instead, it suggests growth from $90M to $115M, which is factually wrong. (4) Scores reflect partial credit for correct 2023 figures and relevant discussion of fair value hierarchy shifts, but major deductions for incorrect 2022 data, misclassification of plan type (U.S. vs. Non-U.S.), and failure to capture the core trend of overall reduction and geographic shift. Contextual relevance is high because the answer addresses allocation and classification across hierarchy levels as asked, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 528,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 USD Notes (3.375 % senior notes due April 2024) were still on the balance sheet – $1 billion of principal was listed and, per the footnote, they were classified as short‑term debt as of December 31, 2023【page_55】.  In the 2024 filing the company reports that the notes matured in April 2024 and the full $1 billion principal was paid, eliminating that tranche from its debt portfolio【page_58】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2014 USD Notes had a $1 billion principal, were classified as short-term debt as of December 31, 2023, carried a 3.375% interest rate, and matured in April 2024. The answer correctly states that the full $1 billion was paid in April 2024, eliminating the debt. (2) Quantitative elements—$1 billion principal, April 2024 maturity—are precisely aligned with the original answer; the addition of the interest rate (3.375%) is a minor enhancement not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from the 2023 and 2024 filings to show the transition from short-term liability to full repayment. (4) The answer addresses both parts of the question: the status in 2023 (still on balance sheet, short-term classification) and the 2024 action (maturity and full repayment). Wording differs slightly but meaning is identical. All scores are 10 due to complete factual accuracy, correct synthesis, and full responsiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 314,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "In the 2022 Form 10‑K the Officer Indemnification Agreement is disclosed as Exhibit 10.31 (incorporated by reference, filed April 2 2019)【page_90】. In the 2024 Form 10‑K the same agreement is still incorporated by reference, now listed as Exhibit 10.23 (with the identical filing date of April 2 2019)【page_79】. The unchanged filing date and continued reliance on incorporation‑by‑reference—despite a renumbering of the exhibit—show that Lowe’s has not altered the core indemnification terms, underscoring a stable executive risk‑management framework and continuity in its governance practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately identifies that the Officer Indemnification Agreement was originally filed on April 2, 2019, and was refiled without amendment in both the 2022 and 2024 10-Ks, despite exhibit number changes (10.31 in 2022, 10.23 in 2024). The date and incorporation-by-reference are correctly noted, supporting the conclusion of no substantive changes. This aligns with the ground truth, which confirms the same form (originally Exhibit 10.43) was reused without modification. The minor discrepancy is in the exhibit number cited: the ground truth references Exhibit 10.43 as the original, while the LLM reports 10.31 and 10.23. However, exhibit renumbering across filings is common and the LLM correctly infers that the unchanged filing date and incorporation method imply no content changes. Thus, the core quantitative facts (dates, exhibit status) are accurate, and the reasoning about governance continuity and stable risk management is sound and contextually appropriate. The answer fully addresses both parts of the question—evolution (or lack thereof) and implications for governance—making it semantically equivalent to the original answer despite slightly different exhibit numbers, likely due to variations in exhibit indexing across filing years. No calculation errors; multi-hop synthesis across years and filings is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 384,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "The 2022 filing said P&G “compete … behind Always Discreet, with over 10 % market share in the key markets” for adult incontinence【page_19】. The 2023 filing still notes P&G is “behind Always Discreet” but its share has risen to “about 15 % market share in the markets in which we compete”【page_18】. Thus, Always Discreet remained the category leader, while P&G’s share grew from just over 10 % to roughly 15 % between the two reports.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in several key aspects. The original answer states that in the 2022 filing, Always Discreet had over 10% market share, but in the 2023 filing, no specific market share figure is provided. However, the LLM claims that in 2023, the market share rose to 'about 15%,' which is not supported by the ground truth. This is a major factual error. Additionally, the LLM incorrectly attributes the market share to P&G as if P&G's share grew from 10% to 15%, but the filings refer to Always Discreet (a brand) having over 10% share, not P&G as a company—this confuses entity-level performance. (2) Quantitatively, the 10% figure is correctly cited from 2022, but the 15% figure in 2023 is fabricated and not present in the original answer or implied by the data. There is no numerical support for growth to 15%. (3) The multi-hop reasoning is flawed: instead of recognizing that the 2023 filing omitted a specific market share (indicating a change in disclosure, not performance), the model incorrectly infers an increase in market share. It also fails to note the shift from quantified disclosure to general category mention, which is the actual change in positioning. (4) Contextual relevance is moderate because the answer addresses the right documents and brand, and attempts to compare across years, but the core conclusion about market share growth is false. Due to severe factual and quantitative inaccuracies, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 412,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "In the 2022 filing Oracle portrayed Engineered Systems as “core to our cloud‑based and on‑premise data‑center infrastructure offerings,” emphasizing their pre‑integrated design and flexible deployment (on‑premise, OCI, hybrid) as a primary driver for moving customers onto Oracle Cloud (see 2022 p. 13). By the 2023 filing the same products are grouped under the broader hardware segment, which now accounts for only about 6 % of total revenue, indicating that Engineered Systems are positioned as a supporting hardware line rather than the centerpiece of the cloud‑transformation narrative (see 2023 p. 43). This evolution reflects a shift from a central, cloud‑enabling role to a more peripheral hardware‑business role as Oracle’s growth story focuses increasingly on software, services and OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misinterpretation of Oracle's strategic positioning of Engineered Systems between 2022 and 2023. (1) Quantitatively, the answer correctly states that hardware revenues, including Engineered Systems, represented about 6% of total revenue in 2023, which aligns with the ground truth (6% in both fiscal 2023 and 2024). The citation of the 2022 and 2023 filings is plausible and contextually appropriate. (2) However, the qualitative interpretation diverges from the ground truth: while the LLM claims Engineered Systems shifted to a 'peripheral' role, the original answer indicates they were *elevated* strategically as part of a broader, integrated hardware business (including servers, storage, OS) and positioned as foundational to hybrid cloud and on-premise strategies. The LLM incorrectly infers that reduced revenue share implies reduced strategic importance, whereas the ground truth emphasizes increased integration and R&D investment, signaling continued strategic relevance. (3) The multi-hop reasoning is flawed: the model fails to synthesize that grouping Engineered Systems into a broader hardware segment reflects an expansion of scope and integration, not a demotion. It also overlooks the narrative continuity in using these systems to support cloud transformation via hybrid deployments. (4) Despite accurate numbers and relevant context, the conclusion contradicts the ground truth’s emphasis on strategic elevation, warranting a moderate correctness score. Wording differences are acceptable, but the semantic meaning here is divergent on a key point—strategic importance—leading to a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 458,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 Form 10‑K the filing explicitly said that the 2020 Stock Plan “is the successor to the 2011 Stock Plan” and that the 5,530,106 shares that were still available under the 2011 Plan “are available for award grants under the 2020 Stock Plan”【page_59】. By the 2023 Form 10‑K the company had removed that language – the 2023 disclosure only notes that the 2020 Stock Plan was approved in June 2020 and describes its grant provisions, with no reference to the 2011 Plan or the transferred shares【page_61】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports that in the 2022 10-K, 5,530,106 shares from the 2011 Stock Plan were carried forward under the 2020 Stock Plan, with the exact number and correct plan names. (2) It correctly states that this specific reference was omitted in the 2023 10-K, which now only describes the 2020 Stock Plan without linking to the 2011 plan. (3) The multi-hop reasoning—comparing disclosures across two years and identifying the removal of specific language about the predecessor plan and share transfer—is sound and well-supported. (4) The answer includes semantic equivalents of the original answer (e.g., 'successor to the 2011 Stock Plan' conveys the same relationship as 'carried forward'), and the cited page numbers add precision. All entities (2020 and 2011 Stock Plans, correct years, share count) are accurate. No factual, quantitative, or reasoning errors are present, and the response directly addresses the evolution in disclosure between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 299,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s pension assets show a higher commitment to private‑fund investments in 2023.  In the non‑U.S. plan, private‑fund holdings rose from $90 million in 2022 (Level 2 $54 m, Level 3 $36 m) to $115 million in 2023 (Level 2 $41 m, Level 3 $74 m)【page_110】, and in the U.S. plan the assets measured at NAV increased from $1,258 million to $1,265 million with direct private investments climbing from $1,284 million to $1,293 million【page_109】.  The overall increase and the shift toward more Level 3 (illiquid) private‑equity exposure indicate that Honeywell is prioritizing higher‑return, longer‑term private‑fund investments as a key part of its capital‑deployment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and entity breakdowns. The ground truth states that Honeywell's total investment in private funds was $1,244 million in 2022 and $1,265 million in 2023, representing a 1.7% increase. However, the LLM claims U.S. plan assets measured at NAV increased from $1,258M to $1,265M and direct private investments rose from $1,284M to $1,293M, which contradicts the ground truth. Additionally, the LLM introduces a non-U.S. plan increase from $90M to $115M, a detail not present in the original answer and unsupported by the provided truth. These figures suggest a misattribution or confusion between different components of pension assets, possibly conflating U.S. and non-U.S. plans or different asset categories. (2) The only correct number is the 2023 $1,265 million figure; the 2022 figure is wrong ($1,258M vs. correct $1,244M), leading to an incorrect basis for comparison. The claimed increases and allocations to Level 2/Level 3 assets are not reflected in the ground truth, which does not break down private fund investments by fair value hierarchy levels. (3) The multi-hop reasoning is flawed because the model fails to correctly identify and synthesize the total private fund investments across years. Instead, it introduces granular subcategories (e.g., Level 2/Level 3, U.S. vs. non-U.S.) that were not part of the original data, leading to an overcomplicated and factually incorrect narrative. The conclusion about increasing illiquid exposure and strategic prioritization of higher-return investments is speculative and not fully supported by the ground truth, which only notes a modest increase consistent with stability. (4) Despite the factual errors, the answer is contextually relevant—addressing the evolution of allocation strategy and inferring capital deployment priorities—and attempts qualitative interpretation correctly in direction (slight increase suggesting continued emphasis). However, the quantitative inaccuracies severely undermine the correctness score, placing it in the partially correct range with major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 570,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "In the 2023 filing Visa reported that **no Class B‑2 common shares were outstanding** – the note to the equity table states that “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer” (2023 10‑K, p. 87). By the 2024 filing, Visa disclosed that the exchange offer had created **≈120 million Class B‑2 shares (186 million as‑converted Class A shares) with a conversion rate of 1.5430** and that these shares are convertible into Class A common stock, with conversion‑rate adjustments that have double the impact of those for Class B‑1 shares (2024 10‑K, p. 87; 2024 10‑K, p. 89).  Thus, the stock moved from non‑existent in 2023 to an issued, convertible class in 2024, linked directly to the Class B‑1 exchange offer and to Class A common stock.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Class B-2 Common Stock was not newly issued in 2024; rather, it was already part of the capital structure in 2023 with disclosures about its conversion mechanics and dilution effects tied to the U.S. litigation escrow. The claim that 'no Class B-2 common shares were outstanding' in 2023 is misrepresented—the original answer clarifies that no shares were outstanding *prior to* the Class B-1 exchange offer, not that they didn’t exist or weren’t disclosed. (2) The LLM introduces specific quantitative figures (≈120 million Class B-2 shares, 186 million as-converted Class A shares, conversion rate of 1.5430) that are not present in the ground truth and are factually unsupported by the provided information. These numbers appear fabricated or misattributed. (3) The reasoning is flawed: the LLM claims Class B-2 moved from 'non-existent' in 2023 to 'issued' in 2024, which directly contradicts the ground truth stating that Class B-2 was actively discussed in 2023 regarding conversion adjustments and dilution. Instead, the 2024 filing showed a *reduction* in disclosure, not an introduction of new issuance. (4) The entity and year references are correct (Class B-2, Class B-1 exchange offer, 2023 and 2024 filings), but the synthesis is incorrect. The LLM fails the multi-hop reasoning by reversing the narrative: it should have noted that disclosures about conversion mechanics were present in 2023 but absent or reduced in 2024, suggesting diminished relevance—not that the stock was created in 2024. Overall, the answer inverts the factual timeline and introduces false quantitative data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 471,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle liability – recorded as deferred revenue – rose from **$89 million in fiscal 2022** (as of January 29, 2022) to **$117 million in fiscal 2024** (as of February 3, 2024)【page_46】【page_50】. That $28 million increase shows the loyalty program has grown, with more rewards being earned (and thus a larger future‑redemption obligation), indicating expanding member participation and program value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the deferred revenue amounts for 2022 ($89 million as of January 29, 2022) and 2024 ($117 million as of February 3, 2024), and accurately calculates the $28 million increase. These numbers match the ground truth exactly, and date formatting is consistent with the source. (2) Quantitative accuracy is perfect—both values are correct, the difference is accurate, and fiscal year references align with the original answer. (3) However, the LLM answer is incomplete in its qualitative reasoning: it fails to mention the sharp drop in deferred revenue to $19 million by February 1, 2025, which is a critical part of the program's evolution and indicates a significant shift (e.g., increased redemptions or accounting changes). This omission affects the completeness and depth of the multi-hop reasoning, as the full trajectory—growth followed by a steep decline—is necessary to fully assess the program’s evolution. (4) While the reasoning provided about growing participation and program value is logically sound based on the increase, it presents only half the story. The conclusion lacks balance without acknowledging the subsequent drop, which changes the interpretation. Thus, while contextually relevant and factually accurate on the data it includes, the answer is partially incomplete on a key aspect of the question about the program’s evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 390,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The Level 2 fair‑value of the 4.375 % Senior Notes rose from **$980 million** at December 31 2022 to **$996 million** at December 31 2023 – an increase of about **$16 million (≈1.6 %)**【page_56】. The higher price indicates that investors were willing to pay more for the notes, suggesting either a more favorable perception of Netflix’s credit standing or a broader market environment of lower interest rates that made the fixed‑rate debt more attractive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the fair value of Netflix's 4.375% Senior Notes *increased* from $980 million to $996 million, while the ground truth states it *decreased* from $980 million to $996 million. This is a direct contradiction — an increase cannot be correct if the value decreased. Despite using the same numbers, the direction of change is reversed, which fundamentally undermines the answer's correctness. (2) Quantitatively, the dollar amounts ($980M and $996M) and dates (December 31, 2022, and December 31, 2023) are accurate, and the $16M difference is correctly calculated. However, the percentage change is mischaracterized: a rise from $980M to $996M would be about a 1.6% increase, but since the ground truth describes a *decrease* to $996M from $980M, this would actually imply the value went *up*, which contradicts the stated decrease. Thus, the calculation is mathematically correct but applied to an incorrect directional claim. (3) The multi-hop reasoning is partially sound — the model attempts to interpret the change in fair value in terms of investor perception and market conditions. However, because the direction of change is wrong, the conclusion (that investors are more willing to pay more due to improved credit or lower rates) is based on a false premise. The ground truth interprets the movement *toward par* as stabilization, which aligns with a *decrease* in fair value if the notes were previously below par — but the LLM incorrectly frames an *increase* in value as improvement. (4) Contextual relevance is high — the answer addresses both parts of the question (change in fair value and its implication), uses appropriate financial reasoning, and cites a source. However, the reversal of the change direction results in a fundamentally incorrect conclusion, warranting a low correctness and quantitative accuracy score despite otherwise strong structure and relevant logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 530,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "In 2023 the balance sheet listed only 10 shares of Class C common stock as issued and outstanding, a non‑marketable class that is convertible into Class A common stock and carries limited voting rights【page_58】. In 2024 the company’s May exchange offer added roughly 48 million new Class C shares (issued in exchange for Class B‑1 shares), expanding the Class C pool while the shares remained classified as non‑marketable, convertible common stock with limited voting rights【page_40】【page_34】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that in 2023, only 10 shares of Class C common stock were listed as issued and outstanding. However, the ground truth indicates that in 2023, approximately 48 million Class C shares were issued as part of an exchange offer involving 241 million Class B-1 shares. The 10-share figure is accurate for 2024, not 2023. The LLM reverses the timeline: it claims the 48 million shares were issued in a May 2024 exchange, but the ground truth states this occurred in 2023. (2) COMPLETENESS: The answer addresses share issuance and classification but misrepresents the direction and timing of the equity evolution. It fails to note that the 2024 balance reflects a stabilization after 2023 activity, which is central to the original answer. (3) ENTITY & TEMPORAL ACCURACY: The company (Visa) and stock classes (Class B-1, Class C) are correctly identified, but the years associated with the exchange offer and resulting share balances are swapped, which is a critical error. (4) REASONING: The multi-hop synthesis is flawed—the model incorrectly infers that the exchange happened in 2024 and that the 10-share balance was in 2023, contradicting the chronological evolution. This reversal breaks the logical flow of equity restructuring. (5) SEMANTIC EQUIVALENCE: Despite using similar terms (e.g., 'convertible', 'limited voting rights'), the core timeline and quantitative facts are inverted, leading to a substantively different and incorrect narrative. The contextual relevance is moderate because it discusses the right topic and stock classes, but the factual backbone is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "In the 2022 filing, Rough Plumbing was listed only as a product line – it was grouped under the “Building Products” merchandise category 【page_55】. By the 2024 filing, Rough Plumbing is highlighted as one of the categories that generate the bulk of Lowe’s installed‑sales, meaning the company now sells and installs Rough Plumbing items through its independent‑contractor installation service 【page_7】. This shift moves Rough Plumbing from a pure product classification to a service‑oriented offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Rough Plumbing was classified under 'Building Products' as a product-only offering, and by 2024 evolved into a service-oriented model through installation services. The shift from product to service is accurately captured. (2) There are no numeric inaccuracies; while the LLM does not mention the 'approximately 5% of total sales attributed to installed sales in 2024' figure, it correctly references the increase in installed sales and Rough Plumbing's role in driving them. This omission is minor and does not affect core correctness. (3) The multi-hop reasoning—linking classification changes across years and inferring strategic evolution—is sound and supported by the filings. The use of independent-contractor installation service adds contextual detail consistent with service integration. (4) The answer is contextually complete and relevant, addressing both business classification and service offering changes. The only minor gap is the missing 5% installed sales metric, which slightly reduces completeness but doesn't undermine the factual or qualitative accuracy of the main evolution described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 342,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "In 2023 Visa reported **no Class B‑2 shares outstanding** – the capital structure listed only Class A, Class B‑1 and Class C common stock. In 2024, after the January‑23 charter amendment and the May‑6 2024 exchange offer, Visa **issued a new Class B‑2 series** (about 120 million shares, 49 million weighted‑average for the year) in exchange for retired Class B‑1 shares, and the class now appears in EPS tables and the as‑converted share count. This shows that Class B‑2 was created as a transitional class to replace the restricted Class B‑1 shares, acting as an intermediate step in moving those shares toward freely tradable stock and thereby expanding the company’s equity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and timing of events. (1) According to the original answer, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims no Class B-2 shares existed in 2023 and that they were instead created in 2024—reversing the timeline. (2) The LLM states that about 120 million Class B-2 shares were issued in 2024 with a weighted average of 49 million, but the ground truth reports 77 million shares outstanding in 2023 and zero in 2024, making the LLM's numbers factually wrong. (3) The LLM incorrectly attributes the creation of Class B-2 as a result of a January 23 charter amendment and May 6, 2024 exchange offer, while the ground truth indicates that by 2024, no Class B-2 shares were outstanding prior to the Class B-1 exchange, suggesting retirement or replacement—not introduction—of Class B-2. (4) The reasoning is flawed: the LLM suggests Class B-2 was created to replace Class B-1, while the ground truth implies Class B-2 may have been replaced or restructured. This misrepresents the multi-hop evolution across years. (5) Entity accuracy fails—while 'Class B-1' and 'Class B-2' are correctly named, the years, share counts, and corporate actions are inverted. (6) Despite incorrect facts, the answer attempts to address the question’s intent regarding capital structure evolution, giving it moderate contextual relevance. However, the core factual inversion (introduction vs. elimination) results in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 425,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The 2022 filing only describes the Target Circle loyalty program and does not show a separate liability for it (the 2022 Business section contains no Target Circle liability figure)【page_5】. By February 3 2024 the company reported a $117 million deferred‑revenue liability for Target Circle in Accrued and Other Current Liabilities【page_50】. The rise from an undisclosed (or negligible) amount in 2022 to $117 million in 2024 signals that the program has grown markedly, with more members earning rewards and a larger outstanding obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitatively, it correctly states that no liability was disclosed in 2022 and that the deferred revenue liability was $117 million as of February 3, 2024—matching the original answer exactly in both amount and date. The format '$117 million' is consistent with acceptable variations. (2) The answer addresses all parts of the question: it identifies the change in financial liability (from no disclosed amount to $117M) and interprets this as a sign of program growth, citing increased membership and obligations. (3) Entity accuracy is correct: 'Target Circle program', 'deferred revenue', 'Accrued and Other Current Liabilities', and the correct fiscal date (February 3, 2024) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model infers increased program scale from the emergence and size of a previously unreported liability, which aligns with the original answer’s conclusion. Minor wording differences (e.g., 'undisclosed (or negligible)' vs. 'no specific liability figure') do not affect factual equivalence. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 333,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "In the 2023 Form 10‑K, NVIDIA warned that new carbon‑tax, fuel‑tax and **pollution‑limit** regulations could raise direct costs, force changes to its manufacturing processes and product design, and that rules limiting energy, water **or land** use could curb customers’ ability to expand data‑center capacity. The 2024 filing repeats the same exposure – noting that pollution‑limit rules may increase expenses and require operational adjustments – but now focuses the data‑center risk on energy‑ and water‑availability constraints (dropping the land‑availability language), indicating a continued but slightly refined concern about regulatory impacts on both NVIDIA’s operations and its customers’ data‑center growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its characterization of the evolution between 2023 and 2024. While it correctly identifies that in 2023, NVDA highlighted pollution limits as a risk that could increase costs and affect manufacturing and customer data center expansion (including land use), it incorrectly states that the 2024 filing *dropped* the land-availability concern and instead focused only on energy and water constraints. The ground truth indicates the opposite: in 2024, NVDA *expanded* its concern to include land and permitting constraints as new risks that could impair customer data center expansion. This reversal misrepresents the direction of the company's evolving risk assessment. There are no numerical values in the question, so quantitative accuracy is not applicable in a traditional sense, but all referenced regulatory areas and years are otherwise correctly attributed. The answer addresses the question's focus on regulatory impact on operations and customer expansion, so it is contextually relevant. However, the flawed synthesis of the multi-hop change over time—especially the incorrect claim about removing land constraints from the risk discussion—undermines the qualitative accuracy. The reasoning fails to correctly track the progression of risk disclosure, leading to an incorrect conclusion about NVDA's evolving concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 389,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "In November 2023 the Company’s Japanese subsidiary issued four Guaranteed Senior Notes for roughly $500, bearing fixed rates of 1.40 %‑2.12 % and maturing between Nov 7 2033 and Nov 7 2043, and these notes are measured at fair value using Level 3 inputs【COST_10k_2023.pdf page_52】. In July 2024 the subsidiary repaid $77 of those notes, leaving about $423 outstanding, and the fair‑value of the Company’s long‑term debt (which includes the Guaranteed Senior Notes) fell from about $5.74 billion at year‑end 2023 to $5.41 billion at year‑end 2024, still based on Level 3 inputs【COST_10k_2024.pdf page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the $500 issuance of four Guaranteed Senior Notes by the Japanese subsidiary in November 2023 at fixed interest rates of 1.40%–2.12%, consistent with the ground truth (rates range from 1.400% to 2.120%). The use of Level 3 inputs for fair value measurement is correctly stated. In 2024, the $77 repayment is accurately reported (July 2024), and the resulting outstanding amount (~$423) is a correct inference. The fair value of total long-term debt decreased from $5.738 billion (rounded to $5.74 billion) in 2023 to $5.412 billion (rounded to $5.41 billion) in 2024—these figures are quantitatively accurate with acceptable rounding. (2) All numbers, dates, and calculations are correct: $500 issuance, $77 repayment, $5.74B and $5.41B debt values (rounded appropriately), and interest rate range match within acceptable formatting. The maturity dates (Nov 7, 2033–2043) are additional but consistent details not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data from both the 2023 and 2024 10-Ks, correctly linking the issuance, repayment, and change in overall debt fair value. It infers the remaining principal ($423M) logically, though this is not explicitly required in the ground truth. The conclusion about the reduction in fair value being partially driven by repayments is implied correctly. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (maturity dates, exact months), but no factual deviation. The only minor point preventing a perfect 10 is that the ground truth emphasizes the reduction in fair value is 'partially driven' by repayments, while the LLM implies causality more directly—though not incorrectly. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 510,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "In 2022 Netflix’s filing highlighted a $384 million jump in technology‑and‑development personnel costs – the bulk of which was “to support the increase in average headcount to support the increase in our production activity and continued improvements in our streaming service”【page_26】. By 2024 the company was not only scaling the platform with new features such as games, an ad‑supported tier and live programming【page_7】, but also formalized its cyber‑risk program by appointing a Vice President of Security and Privacy Engineering, expanding a dedicated security team, and placing cybersecurity oversight with the Board and Audit Committee【page_17】 (and noting that new features and AI “increase our exposure to vulnerabilities”【page_11】). Thus, the investment shifted from primarily adding engineering headcount in 2022 to a broader focus on dedicated security leadership and governance in 2024, reflecting higher risk exposure as the service grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $384 million increase in personnel costs in 2022 related to headcount growth for production and streaming improvements, matching the ground truth. In 2024, it accurately captures the shift toward cybersecurity with specific organizational changes (e.g., appointing a VP of Security and Privacy Engineering, expanding security teams, board-level oversight), which aligns with the disclosed risk exposure evolution. While the original answer emphasizes enterprise-wide security programs and third-party risk management, the LLM answer conveys equivalent concepts through governance and oversight mechanisms. (2) Quantitatively, the $384 million figure is correct and properly attributed to 2022 personnel costs. No other numerical data is required, and all dates (2022, 2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across years and domains (personnel investment → cybersecurity governance), correctly inferring a strategic shift as Netflix’s service matured. It connects new features (games, ads, live) to increased risk exposure, which is consistent with the 2024 filing’s mention of AI and new features expanding vulnerabilities. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'digital content theft' or 'unauthorized data releases' as specific risks highlighted in 2024, which are key elements in the ground truth. However, it does reference increased exposure to vulnerabilities and formalized cyber-risk programs, capturing the essence. Thus, the answer is highly accurate with only slight omission of specific risk examples, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 470,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "In the 2023 Form 10‑K the company only described a flat “award of 10 restricted stock units (‘RSUs’) or BK Shares” to eligible employees and merely attached the upcoming 2024 RSU template as an exhibit (see page 8 and Exhibit 10.29 on page 20). By the 2024 filing the firm had filed both the prior 2023 RSU agreement and a revised 2024 Form of Restricted Stock Unit Agreement (see page 19), signalling that BNY Mellon has updated the grant‑vesting‑forfeiture mechanics to more actively manage the RSU lifecycle and to use the awards as a flexible, strategic component of its executive compensation program.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes significant inaccuracies and misrepresentations that undermine its correctness. (1) Quantitatively, the mention of '10 restricted stock units' is not supported by the ground truth and appears to be a fabrication or misreading of the document; no such specific award size is mentioned in the original answer or implied in the context. The years referenced (2023 and 2024 filings, 2024 and 2025 forms) are mostly correct, but the LLM incorrectly states that the 2023 RSU agreement was filed in 2024 — the ground truth indicates the 2024 form was introduced in 2023 and then referenced as 'previously filed' in 2024, while the 2025 form was newly filed in 2024. The LLM reverses or misstates this progression. (2) The answer incorrectly claims that both the '2023 RSU agreement' and a 'revised 2024 Form' were filed in the 2024 filing, which contradicts the ground truth: the 2024 form was already filed in 2023, and the 2025 form was the new one in 2024. This breaks the lifecycle narrative. (3) The qualitative reasoning is flawed: while the LLM correctly infers strategic lifecycle management and executive compensation alignment, it bases this on incorrect document filing timelines and fabricated details (e.g., 'grant-vesting-forfeiture mechanics' being updated), which are not mentioned in the original answer. The ground truth emphasizes the annual introduction of forward-looking forms (2024 form in 2023, 2025 form in 2024) as evidence of iterative strategy, not changes in mechanics. (4) Contextual relevance is moderate — the answer addresses executive compensation strategy and lifecycle management, which are relevant, but does so using incorrect evidence. Overall, the answer captures the general direction of strategic evolution but fails on key facts and multi-hop synthesis, warranting a low-to-mid score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 506,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "In the 2023 filing Home Depot disclosed that it had just issued a new $750 million tranche of 4.90 % senior notes in November 2023, maturing in April 2029, and because the issuance occurred after the fiscal‑year‑end the notes showed no carrying amount on the January 29, 2023 balance sheet (the line for the 4.90 % notes is blank)【page_60】. By the 2024 filing the tranche is recorded on the balance sheet with a carrying amount of $743 million and the maturity date remains April 2029, reflecting the amortization of the issuance discount and its inclusion in long‑term debt【page_59】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $750 million principal amount, issuance in November 2023, maturity date of April 2029, carrying amount of $743 million as of January 28, 2024, and the presence of an issuance discount. It accurately notes that the notes were not reflected on the January 29, 2023 balance sheet due to post-year-end issuance. (2) Quantitatively, all numbers match the ground truth: $750 million principal, $743 million carrying amount (reflecting $3.4 million discount and amortization), and correct dates. The slight discrepancy in fiscal year-end dates (Jan 29 vs Jan 28) is immaterial and reflects actual reporting differences between years. (3) The reasoning is sound: the model correctly infers that because the notes were issued after the 2023 fiscal year-end, they had no carrying amount on that year’s balance sheet, and by 2024 they appear with a carrying value reflecting discount amortization. This demonstrates proper multi-hop synthesis across filings. (4) The only minor shortcoming is that the LLM does not explicitly mention the semi-annual interest payment schedule starting April 15, 2024, which was included in the original answer. However, this detail is secondary to the core focus on carrying amount and maturity timeline. All other elements are semantically equivalent and factually accurate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 387,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Costco’s Japan subsidiary first raised the notes in November 2023, issuing four Guaranteed Senior Notes that together provided about $500 million of financing at fixed rates of 1.40%‑2.12% and maturing between 2033 and 2043【page_52】. In July 2024 the subsidiary repaid $77 million of those notes, lowering the outstanding balance, while the 2024 cash‑flow statement still shows the original issuance proceeds as a financing inflow【page_30】【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: four Guaranteed Senior Notes were issued in 2023 totaling approximately $500 million at fixed interest rates between 1.400% and 2.120%, and $77 million was repaid in 2024. The LLM adds specific months (November 2023 and July 2024) and maturity ranges (2033–2043), which are not in the original answer but do not contradict it and may reflect additional context from the filing. (2) Quantitative accuracy is perfect: $500 million and $77 million match the original (with acceptable formatting), rates are correctly reported (1.40%–2.12% ≈ 1.400%–2.120%), and the repayment amount is exact. (3) The reasoning is sound—correctly linking the 2023 issuance to the 2024 repayment and noting that the issuance proceeds appear in the 2024 cash flow statement as a financing inflow, which reflects proper multi-hop synthesis across time and financial statements. (4) The only minor gap is that the original emphasizes the 'continued financial engagement' with the instrument, a qualitative point slightly underdeveloped in the LLM response, though implied by referencing the cash flow statement. No factual errors, excellent contextual relevance, and strong qualitative reasoning justify a 9/10 overall, with full marks for quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 371,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "In the 2022 10‑K Danaher warned that “competitors may also develop after‑market services and parts for our products which may detract from our sales,” and that this competition could “adversely impact our business and financial statements” (see 2022 p. 23). The 2023 10‑K repeats the same concern—again noting that “competitors may also develop after‑market services and parts for our products which may detract from our sales” (2023 p. 20)—so the risk has not materially changed; it remains identified as a factor that could reduce sales and negatively affect Danaher’s business and financial results.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in quoting the 2022 and 2023 10-K filings and correctly identifies that the same language about competitors developing after-market parts was used in both years, which supports the claim that the risk was still recognized. However, it fails to capture the nuanced evolution in risk framing described in the ground truth. While the exact wording may be similar, the original answer highlights a qualitative shift in how the risk is contextualized: in 2022 it was presented as a direct threat to sales and competitive position, whereas in 2023 it was reframed as one of several external pressures, 'Impacted By' broader industry trends like cost containment and reimbursement policies—indicating a relative de-emphasis or strategic recalibration. The LLM answer incorrectly concludes that 'the risk has not materially changed' based on verbatim repetition, missing this important contextual and strategic shift evident in the risk's placement and framing within the broader risk factor discussion. This reflects a failure in multi-hop qualitative reasoning: while the textual content is accurately reported, the evolution in tone, emphasis, and integration with other risks is overlooked. Quantitative accuracy is perfect—no numbers, dates, or entities are incorrect. Contextual relevance is fair, as the answer addresses the core risk and its financial implications, but misses the deeper analytical point about how the company's perception or presentation of the risk evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 414,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "Netflix has widened and tiered its pricing: in 2022 the core paid plans ranged from $2 to $27 per month and the company began testing a lower‑priced ad‑supported tier while adding games and live‑programming features (page_24; page_6; page_7). By 2024 the price band had stretched to $1 to $32 for core plans (with extra‑member sub‑accounts at $2‑$8) and the ad‑supported tier became a permanent offering, alongside continued expansion of games, live events and other non‑subscription revenue sources (page_22; page_7). These pricing and feature changes were intended to lift average revenue per paying member, counteract slowing subscriber growth, inflationary pressure and high fixed content costs, and protect the business against intensifying competition (page_6; page_7).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The claim that Netflix's core paid plans ranged from $2 to $27 in 2022 and expanded to $1 to $32 by 2024 is not supported by the ground truth and appears fabricated. The ground truth does not specify exact price ranges or mention games, live programming, or non-subscription revenue features as part of the 2022–2024 plan evolution. While the introduction of the ad-supported tier is correctly identified, the LLM incorrectly states it was 'tested' in 2022 and became permanent by 2024 — the ground truth confirms the ad-supported plan was launched to address membership challenges but does not specify a testing phase or exact timeline. (2) The dollar amounts ($1, $2, $8, $27, $32) are not present in the original answer and contradict known public pricing (e.g., Netflix did not offer a $1/month plan in 2024). The ground truth emphasizes average monthly revenue per membership increased 7% and average paying memberships grew 11% in 2022, but the LLM omits these correct metrics entirely. (3) The reasoning is partially sound: the LLM correctly infers that pricing and feature changes were intended to address slowing subscriber growth and competition, aligning with the ground truth’s mention of retention pressures and intensifying competition. It also correctly identifies broader business challenges like inflation and content costs, though these are not explicitly detailed in the original. (4) Despite incorrect numbers, the answer captures the strategic intent behind Netflix’s plan evolution — introducing tiered pricing (especially ad-supported) to combat slowing growth and competition — which maintains contextual relevance and qualitative logic. However, the made-up price points severely undermine quantitative accuracy, warranting a low score there, while overall correctness is reduced due to unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 525,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "In 2022 Boeing treated satellite‑in‑orbit incentive fees mainly as a contingent exposure – noting that a failure to meet performance could trigger the loss of those payments as a financial risk 【page_45】. By 2023 the company had refined its accounting, now recognizing the net‑present‑value of the incentive fees as revenue in the construction period, while still warning that the payments remain at risk for up to 15 years and could require refunds or charge‑offs if the satellite does not meet contractual performance 【page_15】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Boeing's approach to in-orbit incentive payments between 2022 and 2023, noting the shift from general risk acknowledgment to a more specific accounting treatment involving revenue recognition during construction. It accurately identifies the contingent nature of the payments in 2022 and the recognition of net present value of fees as revenue during construction in 2023, with ongoing risk over up to 15 years. However, it omits the key quantitative detail from the ground truth: the $1,585 million in additional losses recorded in 2023 on Boeing’s five major fixed-price development programs. This is a significant omission because the question specifically asks about financial recognition and risk exposure, and the dollar amount is central to the 2023 update. While the qualitative reasoning and entity accuracy (Boeing, in-orbit incentives, fixed-price programs, revenue recognition timing, performance risk) are sound and contextually relevant, the absence of this specific financial figure reduces quantitative accuracy. The multi-hop synthesis across years and accounting practices is well-executed, and the answer remains semantically aligned with the core evolution described in the original answer, just lacking full completeness on the financial impact. Hence, a score of 8 is appropriate for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 380,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the filing pointed investors to a **specific PDF link** for the Directors’ Code of Conduct ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and said the company would post any amendments or waivers on its website 【page_13】. By the 2024 filing, the code is no longer singled out with a URL; instead it is listed together with other governance documents (Corporate Governance Guidelines, By‑laws, committee charters, etc.) as material that is freely available on the company’s website 【page_3】. This shift shows the disclosure moving from a stand‑alone, explicit link in 2023 to a more consolidated, integrated presentation of the Directors’ Code of Conduct within a broader set of governance resources in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurately reported: in 2023, the Directors' Code of Conduct was disclosed with a specific URL and a commitment to post amendments or waivers online; in 2024, it was no longer given a standalone link but included in a broader list of governance documents. (2) There are no numeric values requiring calculation, but the years (2023 and 2024) and document references (URL, governance materials) are correct and consistent with the ground truth. (3) The multi-hop reasoning—comparing disclosure practices across two years and interpreting the shift from explicit to consolidated referencing—is sound and well-articulated. (4) The answer addresses all parts of the question, maintains contextual relevance, and conveys the same conclusion as the original: a shift toward a more integrated but less direct disclosure approach in 2024. Minor formatting differences in the URL (e.g., line breaks, hyphens) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 310,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "In 2022 Mobileye Drive was described as Mobileye’s Level‑4 self‑driving system that formed the core of its Robotaxi and Vehicle‑as‑a‑Service models – Mobileye acted as an end‑to‑end service provider (often together with Moovit) for public‑transport, cargo‑delivery and other mobility‑provider customers. By 2023 the company repositioned Mobileye Drive as a fleet‑deployment platform, targeting transportation‑network companies, public‑transit operators and suppliers of AV‑ready vehicle platforms, and presenting it as the “eyes‑off/hands‑off” solution that will feed into the future Mobileye Chauffeur consumer‑AV product and can be bundled with Moovit services. This marks a shift from a broad service‑provider role to a more focused go‑to‑market strategy centered on fleet operators and the next‑generation consumer AV roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mobileye Drive™ was launched as an SAE L4 system in 2022, targeted robotaxi and mobility-as-a-service models, and involved collaborations with Moovit. By 2023, the strategy shifted to focus on fleet deployment for transportation network companies, public transit operators, and AV platform suppliers, with bundling of Moovit services. The mention of the connection to Mobileye Chauffeur and the consumer AV roadmap is an accurate contextual addition not contradicted by the original. (2) There are no numeric values, dates, or financial figures in dispute—both years (2022, 2023) are correctly used. (3) Multi-hop reasoning is sound: the answer synthesizes Mobileye’s shift from end-to-end service provider to a platform supplier, correctly identifying the strategic pivot and target customers. (4) The only reason for not scoring a 10 is minor: the original answer specifically mentions Udelv, Transdev, and Geely as 2022 collaborators/design wins, which the LLM omits. While not strictly necessary for the core evolution narrative, their absence slightly reduces completeness. However, the semantic meaning and strategic evolution are fully preserved. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 368,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "In the 2022 Form 10‑K the Tower Holdings preferred interests were described as two series – a September Class A‑1 series of $1.5 billion that paid an initial 5.0% preferred distribution and a December Class A‑2 series of $4.5 billion that paid 4.75%, with the rates resetting every five years【page_130】. By the 2024 filing, AT&T had amended the interests (effective Nov 2024) so that all of the 2019 Tower preferred interests are now re‑classified as Fixed‑Rate Class A Limited Membership Interests paying 5.90% and a portion will become Floating‑Rate Class A Limited Membership Interests paying SOFR + 250 bps, with the floating portion transitioning over a five‑year period【page_87】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two series of Tower Preferred Interests in 2022 with their respective amounts and distribution rates. However, it incorrectly states the amounts as $1.5 billion and $4.5 billion, whereas the ground truth specifies $1,500 and $4,500 — a significant discrepancy in magnitude (off by a factor of one million). This is a critical quantitative error. The 5.0% and 4.75% rates are correct, as is the five-year reset clause. (2) Regarding the 2024 changes, the LLM correctly captures the reclassification into Fixed-Rate Class A Interests at 5.90% and the transition to Floating-Rate Interests at SOFR + 250 bps. However, it incorrectly states the amendment effective date as November 2024, while the ground truth specifies August 2024. Additionally, the LLM mentions a 'five-year transition period' for the floating portion, which is not explicitly stated in the ground truth (which says 'annually' without specifying duration). (3) The multi-hop reasoning is largely sound: the model synthesizes information from 2022 and 2024 filings and correctly identifies the structural evolution from two fixed series to a hybrid fixed/floating structure. The core transformation is accurately described despite timing and scale inaccuracies. (4) The contextual relevance is perfect — the answer directly addresses the evolution in structure and distribution rates. Due to major quantitative errors in dollar amounts and a date error, the correctness score is reduced to 7, with quantitative accuracy at 6. Qualitative accuracy is higher because the conceptual evolution is well-explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 444,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The OPB plan assets are invested in a balanced‑index fund (about 60 % equities, 40 % debt) that is valued using a market approach based on the quoted price of an identical Level 1 instrument. Unrealized gains on the fund’s Level 3 holdings swung from a net loss of roughly $41 million in 2022 (driven by $16 m loss on corporate, $11 m on mortgage‑backed, $14 m on municipal and $1 m on real‑asset securities) to a net gain of about $11 million in 2023 (with $2 m gain on corporate, $6 m on mortgage‑backed and $3 m on other fixed‑income securities).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies in numbers and misrepresents the total unrealized gains/losses. While it correctly identifies the $16M loss on corporate and $11M loss on mortgage-backed securities in 2022, it adds $14M (municipal) and $1M (real-asset) not mentioned in the original answer, inflating the total 2022 loss to $41M — which is unsupported by the ground truth. Similarly, for 2023, it reports $11M total gains with $3M in 'other fixed-income securities' not present in the original, which only lists $2M (corporate) and $6M (mortgage-backed/asset-backed). These fabricated numbers significantly reduce quantitative accuracy. (2) The original answer does not mention municipal, real-asset, or 'other fixed-income' securities at all, so their inclusion is factually incorrect. The core correct numbers — $16M loss → $2M gain (corporate) and $11M loss → $6M gain (mortgage-backed/asset-backed) — are present, preserving partial correctness. However, the net totals are wrong due to unsupported additions. (3) The reasoning partially captures the turnaround in performance but fails on precise multi-hop synthesis — it conflates or invents categories of Level 3 assets. The mention of the Balanced Index Fund’s 60/40 allocation is correct and consistent across years. The LLM incorrectly attributes the Level 1 valuation approach to the entire fund without noting that this shift in disclosure specifically applied to the valuation methodology in 2023 for Level 3 assets, per the original. It oversimplifies by stating the fund is valued entirely via Level 1, contradicting the nuance that Level 3 assets were involved. (4) Despite these flaws, the answer addresses the evolution of unrealized gains and investment approach, showing directional understanding. Hence, correctness is mid-range: partially accurate but with significant factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 508,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K forward‑looking sections list “accounting developments” together with regulatory, technology, market and economic developments as a factor that could affect BNY Mellon’s business (2023 forward‑looking statements – page 3; 2024 forward‑looking statements – page 3). The language is essentially unchanged, showing that accounting standards remain a steady, acknowledged consideration but have not become a more prominent driver of the firm’s strategic priorities over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of BNY Mellon's language regarding accounting developments between 2023 and 2024. While it correctly identifies that both years mention 'accounting developments' among other factors, it asserts that 'the language is essentially unchanged,' which directly contradicts the ground truth. The original answer shows a clear evolution: in 2024, BNY Mellon expanded its forward-looking statement to explicitly include 'the impacts of such developments on our businesses,' indicating a more integrated and strategic consideration of accounting changes. Furthermore, the 2024 filing links these developments to specific business decisions like 'capital plans including dividends and repurchases' and 'efficiency savings,' which were not present in 2023. The LLM answer fails to detect this meaningful shift in emphasis and thus misrepresents the changing influence of accounting standards on strategic priorities. There are no numeric values to evaluate, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is flawed due to incorrect textual comparison, resulting in poor qualitative accuracy. The response is contextually relevant in that it addresses the right document sections and topic, but the conclusion is substantively wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 379,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In the 2023 filing Home Depot warned that a failure to keep stores safe and secure – including rising shrink‑theft, physical‑safety incidents and increasingly sophisticated cyber‑attacks – could erode trust, raise stress and turnover, and therefore diminish the overall associate experience (2023 p.20‑19). By contrast, its 2022 filing highlighted a suite of engagement‑focused initiatives – annual Voice‑of‑the‑Associate surveys, a digital engagement platform, recognition programs, DEI priorities and enhanced compensation – that were designed to boost associate commitment and satisfaction (2022 p.13‑12). Thus, while 2022 emphasized proactive engagement to improve the associate experience, 2023 introduced new safety and cybersecurity risks that could undermine that experience if not effectively managed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Home Depot (HD) emphasized engagement initiatives such as Voice-of-the-Associate surveys, digital platforms, recognition programs, DEI, and compensation—consistent with the original answer’s mention of engagement surveys and recognition programs. In 2023, HD highlighted risks including store shrink (especially from theft), physical safety, and cybersecurity threats, which could erode trust, increase stress, and harm retention—directly matching the original answer’s emphasis on organized retail crime and cybersecurity compromising associate data and morale. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense, but all referenced years (2022, 2023) and page citations (p.20-19, p.13-12) are correctly attributed and consistent with document sources. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and two sets of disclosures—shifting from internal engagement efforts in 2022 to external risk factors in 2023—and draws a logical contrast regarding their potential impact on the associate experience. (4) The LLM adds slightly more detail (e.g., mentioning DEI and compensation, citing specific page numbers) not in the original answer, but this enhances completeness without introducing inaccuracies. The only minor gap is that the original answer notes 'four out of five associates were emotionally committed' as a historical benchmark, which the LLM omits. This is a small but relevant point about the baseline success of 2022 initiatives, so full perfection is not achieved. However, the core contrast and implications are preserved. Thus, the answer is semantically equivalent and factually correct, warranting a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 538,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "In the 2022 filing the learning‑curve is called out as a **risk factor** – one of the items that “could result in lower margins (or a material charge …) if the curve does not improve,” signaling that insufficient learning could erode program profitability (page 42). By the 2023 filing the learning‑curve is treated as a **standard input** to the quarterly cost‑and‑production‑estimate process, listed alongside production rates, supply‑chain and rework factors, showing it is now integrated into the routine estimation and risk‑management framework for program profitability (page 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution described in the ground truth. (1) It correctly identifies that in 2022, the learning curve was framed as a risk factor affecting margins and profitability—specifically citing the potential for material charges if improvement did not occur—aligning with the original answer's emphasis on risk due to rework, delays, and losses. In 2023, it accurately states the learning curve became a 'standard input' in cost estimation, integrated with production rates, supply chain, and rework factors, reflecting the shift toward treating it as a predictable, managed element. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; the years 2022 and 2023 are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly contrasting the framing of the learning curve from risk to integrated planning component. It references specific page numbers (42 and 49), which supports fidelity to source material, though these are not part of the ground truth evaluation. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Boeing or specific programs like the 787, which are present in the original answer and provide contextual grounding. However, given that the question implies a company-specific context (likely Boeing based on knowledge graph), and the LLM still captures the conceptual shift accurately, this omission does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 480,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings contain the same Item 9B disclosure that “certain of our officers or directors have made elections to participate in, and are participating in, our dividend reinvestment plan … and have made, and may from time to time make, elections to have shares … withheld to cover withholding taxes or pay the exercise price of stock awards, which may be designed to satisfy the affirmative‑defense conditions of Rule 10b5‑1 … or may constitute non‑Rule 10b5‑1 trading arrangements”【BK_10k_2023.pdf page_12】. The 2024 filing repeats this language with only a minor wording change—replacing “shares withhold” with “shares withheld”—but otherwise the treatment and disclosure of officer/director participation and the related trading‑arrangement caveat remain unchanged【BK_10k_2024.pdf page_12】.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, directly contradicting the ground truth. The original answer states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, indicating a simplification of disclosure. However, the LLM asserts that the language was 'repeated' with only a minor wording change, implying no substantive change in disclosure—this is false. While the LLM correctly identifies the context of officer/director participation in the Dividend Reinvestment Plan and references the correct item (Item 9B) and page numbers, it fails to detect the critical omission in the 2024 filing. There are no numerical values in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default for absence of error. Qualitative accuracy is very low because the reasoning is flawed: the model did not correctly synthesize the evolution between the two filings, which is the central requirement of the multi-hop question. Contextual relevance is moderate since the answer discusses the right topic and cites appropriate sections, but it draws the wrong conclusion about the evolution of disclosure. The answer would have been acceptable if it had noted the presence of similar language but also acknowledged the absence of the detailed Rule 10b5-1 framework explanation in 2024; instead, it affirms continuity, which is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 392,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot raised its capital outlay for the interconnected shopping experience from **$2.6 billion in fiscal 2021** to **$3.2 billion in fiscal 2023**【page_6】【page_5】.  While FY 2021 focused on data‑driven merchandising tools and supplier collaboration to “build an interconnected shopping experience that is **tailored to our customers’ shopping intent and location**”【page_8】, by FY 2023 the company deepened that personalization with new digital features—mobile‑app store maps, self‑service lockers, curbside pickup, electronic shelf‑labeling, re‑designed front‑end areas, and integrated, location‑specific marketing messages—so the experience is more customized across online and in‑store channels【page_7】【page_8】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that The Home Depot increased its capital expenditures from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. The ground truth only confirms the $2.6 billion investment in fiscal 2021 and does not provide any capital expenditure figure for fiscal 2023. Therefore, the $3.2 billion figure is unsupported and incorrect, representing a major factual error. (2) While the LLM correctly identifies the fiscal 2021 investment amount and the strategic focus on tailoring the shopping experience to customer intent and location, it fabricates specific fiscal 2023 enhancements such as mobile-app store maps, self-service lockers, curbside pickup, electronic shelf-labeling, and re-designed front-end areas. The ground truth mentions enhanced merchandising IT tools but does not list these specific features. (3) The multi-hop reasoning is partially sound in that it attempts to compare two fiscal years and describe an evolution in strategy, but it fails because it invents data not present in the source. The original answer emphasizes a shift from general investment to a more refined, data-driven personalization strategy—this conceptual evolution is somewhat reflected, but with incorrect supporting details. (4) Despite the incorrect numbers and fabricated initiatives, the LLM captures the general direction of strategic evolution toward personalization based on intent and location, which keeps the answer contextually relevant. However, due to the critical errors in quantitative claims and unsupported specifics, the correctness score is low. Quantitative accuracy is penalized heavily due to the made-up $3.2 billion figure. Qualitative accuracy is moderate because the core idea of enhanced personalization is present but poorly substantiated. Contextual relevance remains high as the response stays on-topic and attempts a valid comparison across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 533,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "In 2022 Danaher still treated the Aldevron deal as a major capital‑intensive event – it projected roughly $1.5 billion of capital spending that year, much of it tied to expanding capacity after the $9.6 billion cash purchase, and it recorded about $6.1 billion of goodwill and $28 million of transaction‑related costs for the Aldevron acquisition (2022 10‑K p. 59; 2022 10‑K p. 82‑83). By 2023 the filing only mentions Aldevron’s acquisition costs as a historical $28 million charge incurred in 2021 and provides no new capital‑investment or acquisition‑related outlays for Aldevron, showing the relationship has shifted from an acquisition‑integration phase to a routine operating phase (2023 10‑K p. 74).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $9.6 billion cash purchase of Aldevron occurred in 2022, while the ground truth indicates that the net cash consideration of $9,561 million was paid in 2023. This misplacement of the acquisition payment year is a critical error. Additionally, the LLM claims $6.1 billion of goodwill and $28 million in transaction costs were recorded in 2022, but the ground truth does not support these specific figures or their attribution to Aldevron alone. The $28 million transaction cost is said to be from 2021 in the 2023 filing, which contradicts the evolution narrative in the original answer. (2) Quantitatively, the $1.5 billion capital expenditure projection for 2022 is correctly cited, but the $9.6 billion acquisition cost is misrepresented as occurring in 2022 rather than 2023. The $9,561 million (i.e., $9.561 billion) cash consideration in 2023 is omitted entirely in the LLM's narrative of that year, and instead, the answer incorrectly focuses on past costs. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the major financial outflow (acquisition payment) happened in 2023, not earlier, and thus mischaracterizes the evolution. It concludes that 2023 shows no new outlays and represents a shift to 'routine operating phase,' whereas the ground truth emphasizes 2023 as the year of full integration via a $9.561 billion cash payment, marking the culmination of the acquisition, not its aftermath. This reverses the correct timeline and financial significance. (4) Despite these errors, the answer is contextually relevant, addressing capital investment and acquisition expenditures and attempting to compare 2022 and 2023. The qualitative reasoning shows an attempt at synthesis, but with incorrect data inputs, leading to an inaccurate conclusion about the nature of the financial relationship's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 523,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "In the 2022 filing AT&T disclosed that Telco LLC held only a single $2 billion (‑$2,000 million) non‑convertible cumulative preferred series (Telco Class A‑1) that paid a 4.25% annual distribution and reset every seven years (2022‑10K p.130). By the 2024 filing the pool had expanded to $7.25 billion after a $5.25 billion issuance of Class A‑2 and A‑3 interests in April 2023; the new series carry a 6.85% initial distribution and will reset on Nov 1 2027 and every seven years thereafter, while the original Class A‑1 retains its 4.25% rate and seven‑year reset (2024‑10K p.87).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in 2022, Telco LLC had $2,000 million ($2 billion) in preferred interests (Class A-1) with a 4.25% distribution rate and seven-year reset; in April 2023, $5,250 million ($5.25 billion) of new preferred interests (Class A-2 and A-3) were issued at a 6.85% rate, resetting first on November 1, 2027, and every seven years thereafter; total preferred interests reached $7,250 million ($7.25 billion) by 2024. (2) Quantitative accuracy is perfect: $2,000 + $5,250 = $7,250, and all percentages and dates match exactly. Format variations (e.g., $2 billion vs $2,000 million) are acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the model correctly synthesized data from two different years (2022 and 2024 filings), identified the structural change in the capital stack, and contrasted the distribution rates and reset schedules across tranches. (4) The answer addresses all parts of the question: evolution of structure and total value, changes in distribution rates, and reset schedules. Entity names (Telco LLC, Class A-1/A-2/A-3), years, and financial terms are accurate. The inclusion of source citations (10-K page numbers) adds contextual support. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 374,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "In the 2022 filing AIG said it relied on expected‑loss‑ratio techniques mainly for short‑tail lines (e.g., U.S. Property) and for aviation exposures, using them to set reserves for the latest accident year when loss‑development data are limited and to complement frequency‑severity analyses【page_273】. By the 2024 filing the company had broadened that approach to its long‑tail U.S. Workers’ Compensation business, now applying a mix of loss‑development, frequency‑severity and expected‑loss‑ratio methods to capture the slow emergence of claims and the impact of risk‑sharing features such as high deductibles and self‑insured retentions【page_151】. This evolution shows AIG moving from using expected‑loss‑ratio methods primarily on short‑tail or early‑year reserves to also employing them on complex, long‑tail lines to improve reserve adequacy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and for aviation exposures, especially where loss development data were limited; by 2024, the method was expanded to U.S. Workers' Compensation, a long-tail line. The rationale—limited data in early years and complementing other methods—is accurately conveyed. (2) There are no numeric values to verify (e.g., percentages or dollar amounts), but the years (2022, 2024) and business lines (aviation, U.S. Workers’ Compensation) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time across different insurance lines and explains the evolving rationale. The addition of 'short-tail lines like U.S. Property' in 2022 is not in the original answer but is contextually plausible and does not contradict the ground truth; it adds minor detail without inaccuracy. (4) The semantic meaning fully matches the original: the evolution from narrow to broader application, especially into long-tail lines with complex features, is clearly and correctly articulated. The only minor point is that the original emphasizes 'high-severity nature' for aviation, while the LLM focuses on data limitations—both are valid aspects, but the LLM slightly shifts emphasis. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 400,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "In 2023 Target already treated its owned and exclusive labels as a core growth engine – about one‑third of merchandise sales came from those brands and the corporate strategy explicitly called for “strengthening our owned brands portfolio” (2023 10‑K, p. 6; p. 3). By 2024 the focus shifted to actively expanding and launching new owned lines, adding a low‑price “dealworthy” range and growing brands such as Auden, Cat & Jack, Gigglescape and up&up, with an explicit emphasis on newness, differentiation and scaling high‑performing brands (11 now exceed $1 billion in annual sales) (2024 10‑K, p. 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Target's strategic emphasis on owned brands in 2023 as a core growth driver, citing the 2023 10-K, and notes the shift in 2024 toward active expansion and new product development, consistent with the original answer’s 'more concrete execution phase.' The mention of specific brands (Auden, Cat & Jack, Gigglescape, up&up) and the low-price 'dealworthy' line adds detail not in the ground truth but does not contradict it and reflects accurate portfolio development. (2) Quantitatively, the claim that '11 now exceed $1 billion in annual sales' in 2024 is a precise figure that matches public disclosures and enhances the answer; no incorrect numbers are present. The 'one-third of merchandise sales' from owned brands in 2023 is also accurate per Target’s reporting. All citations to 10-K pages are plausible. (3) The multi-hop reasoning is sound: the model synthesizes strategic language from two years’ filings, infers evolution in strategy from 'strengthening' to 'expanding and launching,' and supports it with product-level evidence. (4) While the original answer mentions 'over 40 distinct brands' and the LLM answer does not, this is a minor omission rather than an error—the LLM compensates with richer qualitative and quantitative detail on brand performance. Wording differs but semantic meaning is equivalent or superior. No factual inaccuracies; minor completeness gap on total brand count does not detract from core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 421,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM’s 2024 securities list still includes the legacy 0.875 % Notes due 2030 (IBM 30A) that were on the 2023 list, and it adds a new 2.900 % Notes due 2030 (IBM 30C) 【IBM_10k_2024.pdf page_1】. This shows IBM is keeping its ultra‑low‑cost debt on the books while simultaneously issuing fresh long‑dated paper at a higher, but still modest, yield—indicating a strategy of layering new financing onto existing cheap debt and that the market remains receptive to long‑term borrowing even as rates have risen since the original issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: IBM maintained the 0.875% Notes due 2030 (IBM30A) from 2023 into 2024 and issued a new 2.900% Notes due 2030 (IBM30C) in 2024. The percentages (0.875%, 2.900%), maturity year (2030), and trading symbols (IBM30A, IBM30C) are accurately reported. (2) Quantitative accuracy is perfect—no calculations required, but the interest rates and years are correctly cited. (3) The reasoning is sound: the LLM correctly infers that IBM is retaining low-cost debt while issuing new debt at higher rates, suggesting a strategy of layering financing. It also correctly notes that the market remains receptive to long-term borrowing despite higher rates, which is a reasonable interpretation of continued investor demand. (4) The LLM captures the core strategic implication—using both cheap legacy debt and new higher-cost debt—but slightly underemphasizes the potential reasons such as refinancing risk management or targeting different investor segments, which are mentioned in the ground truth. However, this does not detract significantly from the overall correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 346,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "The 2022 10‑K already listed a portfolio of AT&T global notes that included the 4.000 % Global Notes due June 1 2049. In the 2024 10‑K the same 4.000 % notes are still shown, but the debt schedule has been broadened with additional long‑term issuances – for example, new 4.250 % Global Notes due June 1 2044 and March 1 2050 (and other later‑dated series) appear in the list 【page_2】. Thus, while the 4.000 % 2049 notes remained a core component, AT&T added new higher‑coupon, longer‑dated notes to diversify and extend its long‑term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies regarding the specific debt instruments added. According to the ground truth, AT&T added the 4.300% Global Notes due November 18, 2034 (T 34C) by 2024. However, the LLM incorrectly states that AT&T added 4.250% Global Notes due June 1, 2044 and March 1, 2050, which are not mentioned in the original answer and contradict the specific new instrument (2034 maturity). The 4.000% Global Notes due 2049 are correctly identified as present in both years, which is accurate. (2) Quantitative accuracy is low: the coupon rate (4.250% vs 4.300%), maturity dates (2044/2050 vs 2034), and instrument symbols (not mentioned but implied by dates) are incorrect. These are critical financial attributes and their inaccuracy undermines the answer’s reliability. (3) The reasoning is partially sound—recognizing that AT&T expanded its debt portfolio while maintaining long-dated obligations reflects correct multi-hop synthesis. However, the failure to identify the correct new note (2034 maturity) breaks the chain of accurate inference. The conclusion about diversifying and extending debt is plausible but misaligned with the actual addition of a nearer-term note (2034), which contradicts the 'longer-dated' claim. (4) Contextual relevance is high—the response addresses the evolution of debt composition and focuses on the right company and time frame. However, due to key factual errors in the newly added instruments, the correctness score is limited to 4, reflecting partial accuracy with major omissions and errors in critical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 433,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech deal added $258 million of intangible‑asset amortization in 2023 (part of the $482 million total) and restructuring costs were modest at $72 million; in 2024 total amortization jumped to $1,077 million, but the $560 million portion was tied to the National Instruments acquisition, so the AspenTech‑related amortization ceased to be a new driver, while restructuring expenses rose sharply to $228 million (up from $72 million) as integration and other restructuring activity increased【page_55】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, AspenTech-related intangibles amortization decreased from $258 million in 2023 to $97 million in 2024. However, the LLM claims that AspenTech-related amortization 'ceased to be a new driver' and implies it dropped to zero or is no longer relevant, which contradicts the ground truth value of $97 million in 2024. Additionally, the LLM incorrectly states that total amortization in 2024 was $1,077 million with $560 million tied to National Instruments, information not present in the original answer and irrelevant to the question. While restructuring costs are correctly reported as $72 million in 2023 and $228 million in 2024, matching the ground truth, the core error in amortization figures undermines the quantitative accuracy. (2) The numbers for 2023 amortization ($258M) and restructuring ($72M) are correct, but the 2024 amortization figure for AspenTech is wrong—the LLM fails to report the actual $97M and instead suggests it is subsumed or negligible due to another acquisition, which is unsupported by the ground truth. There is no mention of National Instruments in the original answer, making that a hallucination. (3) The multi-hop reasoning is partially sound in that it attempts to disentangle acquisition-related amortization and link rising restructuring costs to integration activity. However, it fails to correctly synthesize the actual evolution of AspenTech-specific amortization between 2023 and 2024, which is the central focus of the question. The introduction of an unrelated acquisition (National Instruments) breaks the logical chain and misrepresents the financial impact. (4) The contextual relevance is high because the answer addresses the right topic, time frame, and types of costs, and even cites a plausible page reference. However, due to major quantitative errors and the inclusion of irrelevant information, the overall correctness score is low. The qualitative accuracy is moderate because the reasoning structure is logical, but based on incorrect data. Quantitative accuracy is poor due to the incorrect reporting of the 2024 amortization figure and the omission of the correct $97M value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 602,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG still relies on a mix of loss‑development, frequency‑severity and Expected Loss Ratio (ELR) techniques for workers’ compensation, but its ELR application has become more granular. In the 2022 filing ELR was weighted heavily only for the most recent accident year on guaranteed‑cost business and for the most recent five years on excess‑of‑deductible business (with tail‑factor tweaks for non‑NY/CA states); by the 2024 filing the company emphasizes separate grouping of guaranteed‑cost and excess‑deductible lines by state, industry and deductible size, noting that the rising proportion of large‑deductible accounts—often administered by third parties—has slowed claim reporting and therefore increases reliance on ELR estimates for those high‑deductible segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in AIG's use of expected loss ratio (ELR) methods between 2022 and 2024. (1) It correctly identifies that in 2022, ELR was applied primarily to the most recent accident year for guaranteed-cost business and to the most recent five accident years for excess-of-deductible business, with a mention of tail-factor adjustments for non-NY/CA states—this aligns with the ground truth, even adding a detail (state-specific tail factors) not contradicted by the original. (2) For 2024, the LLM accurately notes increased segmentation by state, industry, and deductible size, and correctly highlights the growing influence of large-deductible accounts administered by third parties on slower claim reporting, which increases reliance on ELR—this matches the ground truth's emphasis on segmentation by deductible size and administrator type. (3) The LLM correctly infers that slower claim emergence due to large deductible accounts increases reliance on ELR, which is logically sound and implied in the original answer. (4) One minor omission: the 2024 ground truth explicitly mentions limitations in claim count data due to aggregation and reinsurance exclusions, which the LLM does not include. This is a small but notable qualitative detail affecting completeness. However, all entities (AIG, workers' compensation, guaranteed cost, excess-of-deductible, large deductible accounts), years (2022, 2024), and financial actuarial methods are correctly identified and synthesized. (5) No numerical or date inaccuracies; all references to time periods (most recent year, five years) are correct. The answer is semantically equivalent and contextually fully relevant. The omission prevents a perfect 10, but the response is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 484,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "In 2023 Target’s filing described its cyber‑fusion center simply as the hub that “investigates and responds to threats” and noted that the company “shares threat intelligence and collaborates with organizations across different industries” to fight cybercrime and exchange best practices (2023 Form 10‑K, p. 17). By 2024 the center is embedded in a more formal “proactive threat‑intelligence program” and a “coordinated escalation model” that routes incidents to senior management and the Board and is integrated with the company’s enterprise‑risk‑management framework (2024 Form 10‑K, p. 20‑21), while still maintaining the same external‑partner collaboration for intelligence sharing and best‑practice development (2024 Form 10‑K, p. 21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Target's Cyber Fusion Center was described as investigating and responding to threats, with collaboration across industries for threat intelligence and best practices—consistent with the original answer. In 2024, it accurately notes the evolution toward a more structured approach, including a coordinated escalation model to senior management and the Board, which matches the ground truth. The mention of integration with enterprise risk management and proactive threat intelligence reflects the increased formality and maturity described. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financials. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two filings, correctly identifying continuity (external collaboration) and evolution (formal escalation, integration with risk framework). The only minor omission is that the LLM does not explicitly mention the 2024 expansion into regular training/compliance activities for team members or third-party assessments, which are part of the enhanced external engagement in the ground truth. This limits completeness slightly but does not invalidate the core correctness. (4) The answer is contextually relevant, directly addressing the evolution in Cyber Fusion Center operations and external collaboration. Wording differs but semantic meaning is equivalent. Overall, this is a strong, factually correct response with only a small detail missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 464,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "In 2023 Lilly treated Baqsimi as a rights‑sale transaction, recognizing a one‑time $579 million revenue (the “net gain on the sale of rights”) and receiving $500 million cash that year with a further $125 million cash payment scheduled for 2024, both of which were included in the 2023 transaction price【page_47】. By 2024 the arrangement had shifted to a supply agreement with Amphastar that obligates Amphastar to purchase the drug Lilly manufactures; under this agreement Lilly now records net product revenue over time as the product is produced, while the $125 million cash is already accounted for and the company remains eligible for up to $450 million in sales‑based milestones that have not yet been recognized【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $579 million in revenue from the sale of Baqsimi rights in 2023, $500 million cash received in 2023, $125 million scheduled for 2024, and up to $450 million in potential sales-based milestones—all match the source data. (2) The qualitative description captures the evolution: from a one-time rights sale in 2023 to a supply agreement in 2024 under which Eli Lilly recognizes ongoing net product revenue as goods are delivered. This reflects the shift from direct revenue to a collaborative supply model, consistent with the original answer’s emphasis on changing revenue recognition. (3) The multi-hop reasoning is sound—linking the 2023 transaction structure to the 2024 supply arrangement and future milestone eligibility shows synthesis across time and contractual layers. (4) The only minor gap is that the original answer emphasizes Baqsimi being folded into broader 'collaboration and other revenue' disclosures in 2024, while the LLM focuses more on the supply agreement mechanics. However, the LLM’s characterization is factually supported and semantically aligned, just more operationally detailed. No factual errors; excellent contextual relevance and numerical precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 362,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "In 2023 AT&T used cash from its April 2023 issuance of new Telco LLC preferred interests to retire the remaining 213 million Mobility Preferred Interests (repurchased for $5.4 billion) and simultaneously enlarged its Telco LLC capital by issuing an additional $5.25 billion of non‑convertible cumulative preferred interests (the “April preferreds”)【page_38】. By 2024 the company’s focus shifted to reshaping its Tower Holdings preferred structure—resetting the 2019 Tower preferred series into Fixed‑Rate (5.90% distribution) and Floating‑Rate classes—while leaving the Telco LLC preferred interests at $7.25 billion and not pursuing further Mobility repurchases【page_87】. This reflects a move from eliminating a legacy preferred series to restructuring existing preferred interests to better manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) All key facts are correct: in 2023, AT&T repurchased 213 million Mobility Preferred Interests for $5.4 billion (matches $5,414 in ground truth, acceptable rounding), funded by $5.25 billion in new Telco LLC preferred interests issuance. The Telco LLC total reached $7.25 billion by 2024, consistent with the original $2,000 plus 2023 additions. In 2024, the focus shifted to restructuring the 2019 Tower preferred interests into fixed (5.90%) and floating (SOFR + 250 bps) rate classes. (2) Quantitative accuracy is excellent: all dollar amounts ($5.4B, $5.25B, $7.25B), percentages (5.90%, 6.85% implied via context), and share count (213 million) are correct or appropriately rounded. The funding mechanism and capital structure shift are accurately represented. (3) Multi-hop reasoning is sound—correctly linking the 2023 repurchase to the Telco issuance and identifying the strategic pivot in 2024 toward Tower Holdings restructuring. The answer synthesizes information across years and entities (Mobility, Telco LLC, Tower Holdings). (4) Minor omission: the LLM does not explicitly mention the $2,650 and $2,670 liability reductions from 'Accounts payable and accrued liabilities' and 'Other noncurrent liabilities', nor the 6.85% distribution rate on the new Telco preferreds, which are present in the ground truth. However, these are secondary details that do not undermine the overall correctness. The strategic pivot is clearly and accurately conveyed. Hence, a score of 9 is justified—excellent accuracy with near-complete coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 452,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson’s tie‑up with AspenTech moved from a 55 % ownership stake after the Heritage AspenTech transaction (the basis of the 2023 results) to roughly 57 % in 2024 and a November‑2024 proposal to buy the remaining shares (see EMR 10‑K 2024 p. 26 and p. 23).  That ownership change, together with the AspenTech contribution, helped raise Emerson’s gross‑margin from 49.0 % of sales in 2023 to 50.8 % in 2024 – a 1.8‑percentage‑point increase (see EMR 10‑K 2024 p. 22).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson acquired a 55% stake in 'New AspenTech' in 2024 as part of a transaction involving $6.0 billion in cash, transitioning from a prior business relationship in 2023. However, the LLM incorrectly states that Emerson already had a 55% ownership stake in 2023 (the basis of 2023 results), which contradicts the ground truth that the relationship in 2023 was a business partnership, not ownership. The LLM further claims ownership increased to 57% in 2024 and mentions a November 2024 proposal to buy remaining shares, none of which is supported by the original answer or implied in the knowledge graph. (2) Quantitative inaccuracies include the misattribution of the gross margin increase: the original answer specifies that AspenTech contributed a 3.3 percentage point increase in 2023 and a 1.8 percentage point increase in 2024 as part of broader changes. The LLM incorrectly attributes the entire 1.8-point increase in gross margin from 49.0% to 50.8% in 2024 solely to AspenTech, while the ground truth states it was 'part of broader changes.' Additionally, the LLM fabricates specific gross margin percentages (49.0%, 50.8%) not present in the original answer. (3) Multi-hop reasoning is partially sound in linking ownership change to financial impact, but the synthesis is flawed due to incorrect timeline and ownership details. The model fails to correctly represent the evolution from partnership to majority ownership as a 2024 event, instead backdating the 55% stake to 2023. (4) Contextual relevance is high as the answer addresses the relationship evolution and financial impacts on gross margin and ownership, but correctness is severely compromised by false numbers and timeline errors, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 506,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG’s Japan pension plans made up roughly 61 % of the company’s total non‑U.S. pension‑plan assets in the most recent data shown in the 2022 filing (page 311), but by year‑end 2024 they accounted for only about 50 % of the total projected‑benefit obligations for all non‑U.S. plans (page 183).  Over the same span the weighted‑average discount rate used for the Japan plans rose from about 1.09 % in 2022 (page 183) to 1.81 % at December 31 2024 (page 183).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in Japan pension plans' share from 61% in 2022 to 50% in 2024, aligning with the ground truth. However, it misstates the 2022 weighted average discount rate for Japan plans as 1.09%, while the ground truth does not provide the 2022 discount rate but states that the rate increased from 1.48% in 2023 to 1.81% in 2024. The LLM incorrectly introduces a 2022 rate not present in the original answer, leading to a factual inaccuracy. Additionally, the original answer notes a drop from 54% in 2023 to 50% in 2024 in terms of projected benefit obligations, which the LLM omits, thus missing a key intermediate data point. (2) The 61% and 50% figures are correct and properly contextualized. The 1.81% discount rate in 2024 is accurate. However, the 1.09% figure for 2022 is unsupported by the ground truth, which only provides 2023 and 2024 rates. This introduces a significant quantitative error. (3) The LLM performs adequate multi-hop reasoning by connecting Japan's share of non-U.S. pension assets in 2022 to its share of projected benefit obligations in 2024 and tracking the discount rate change. However, it fails to accurately report the evolution across all years (missing 2023 PBO percentage) and introduces an incorrect earlier discount rate, undermining the full trend analysis. (4) The contextual relevance is high as the answer addresses both parts of the question—evolution of contribution and change in discount rate—with appropriate sourcing. The qualitative reasoning is mostly sound but weakened by the incorrect numerical input. The correctness score is 6 due to partial accuracy in numbers and incomplete trend data, despite correct directional conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 471,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "In the 2022 Form 10‑K Amazon mentioned competitive stores only in a risk‑factor list – “the introduction of competitive stores, websites, products, services, price decreases, or improvements” – as one of many items that could cause sales and operating‑result fluctuations (2022 p. 9). By the 2023 filing the company not only repeats that risk‑factor (2023 p. 9) but also adds a dedicated “Competition” discussion that frames the threat of competitive stores within a rapidly evolving, intensely competitive worldwide marketplace and ties it to broader external market conditions such as general economic, business and geopolitical trends (2023 p. 4).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and accurately identifies the presence of the phrase about competitive stores in both the 2022 and 2023 10-K filings, with correct page references (p. 9 for both years), which aligns with the ground truth. The quantitative accuracy is perfect: no numerical errors, and the years (2022, 2023) and document types (Form 10-K) are correct. However, the LLM introduces a claim not present in the original answer: that the 2023 filing includes a 'dedicated Competition discussion' on page 4 that ties competitive stores to broader external conditions. The ground truth does not mention a new or expanded 'Competition' section or a page 4 discussion; instead, it specifies that the same core language was embedded within a broader context emphasizing external economic and geopolitical conditions—without stating this occurred in a new or separate section. This overinterpretation misrepresents the nature and location of the framing shift. While the general idea of a shift toward contextualizing competition within broader external risks is correctly identified (supporting a high contextual relevance), the LLM adds structural details (dedicated section, page 4) not found in the ground truth, weakening the qualitative accuracy. The multi-hop reasoning is partially sound—comparing language across years—but the synthesis includes an unsupported inference about document structure. Thus, the answer captures the core evolution in framing but does so with an inaccurate detail that affects completeness and reasoning fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 431,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "In the 2023 filing Target flagged port‑security risk mainly at “California ports where we receive a significant portion of the products we source from outside the U.S.” (page_13). By the 2024 filing the language was broadened to “major U.S. ports where we receive a significant portion of the products we source from outside the U.S.” (page_15), indicating a wider geographic exposure. In both years the company warns that port closures, ship diversions or congestion can raise costs and disrupt the flow of inventory, so the operational impact – higher expenses and potential inventory shortages – remains unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the shift in geographic focus from 'California ports' in 2023 to 'major U.S. ports' in 2024, correctly identifying the broadening of risk exposure. The operational impact—increased costs and inventory disruptions—is correctly noted as consistent across both years. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to years (2023, 2024) and document locations (page_13, page_15) are factually consistent with the expected data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two filings to show an evolution in risk language and scope. However, the LLM omits a key detail from the original answer: in 2023, Target stated it had already made alternative arrangements due to past disruptions, whereas in 2024 the focus shifted to potential future impacts due to global conflicts and labor disputes. This nuance in temporal emphasis (past mitigation vs. future risk) is missing, slightly weakening the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and factually accurate on the core elements—geographic evolution and operational impact—justifying high scores in contextual relevance and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 384,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "In 2023 Emerson recorded $258 million of amortization of intangible assets that were directly tied to the Heritage AspenTech acquisition; the 2024 filing shows no AspenTech‑related amortization (the $560 million amortization reported for 2024 relates to the National Instruments acquisition)【page_55】.  At the same time, AspenTech‑segment restructuring costs rose from roughly $1 million in 2023 (part of a total $72 million) to about $8 million in 2024 (part of a total $228 million), indicating higher integration‑related expenses in the later year【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly states the $258 million AspenTech-related amortization in 2023 and the absence of AspenTech-specific amortization in 2024, which aligns with the ground truth. However, it incorrectly claims that AspenTech-segment restructuring costs rose from $1 million in 2023 to $8 million in 2024. The original answer states total restructuring costs increased from $72 million in 2023 to $228 million in 2024, with no breakdown by segment—thus, the $1M and $8M figures for AspenTech are unsupported and likely incorrect. (2) Quantitative accuracy is compromised due to these fabricated segment-specific restructuring numbers. While the $258M amortization and total restructuring totals ($72M and $228M) are mentioned correctly, the LLM introduces false precision by attributing only $1M and $8M to AspenTech, which is not in the ground truth. The mention of $560 million amortization related to National Instruments in 2024 adds detail not in the original but may be contextually accurate; however, it distracts from the core question about AspenTech. (3) The multi-hop reasoning is partially sound: the model correctly infers that the absence of AspenTech amortization in 2024 suggests it is no longer treated as a recent acquisition. However, the reasoning about restructuring costs is flawed due to incorrect data attribution. The model assumes AspenTech’s share of restructuring costs increased, but the ground truth does not provide segment-level restructuring data. (4) Contextual relevance is high—the answer focuses on the right companies, time frame, and financial metrics. Qualitative accuracy is moderate because the logic is reasonable where data permits, but the introduction of unsupported figures reduces reliability. Correctness score is 6 due to significant error in restructuring cost allocation despite correct handling of amortization trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 524,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "In the 2022 Form 10‑K AIG explained that expected‑loss‑ratio (ELR) estimates were **given significant weight for the most recent accident years** – for guaranteed‑cost workers’ compensation only the latest accident year, for excess‑deductible workers’ compensation the latest five accident years, and for D&O, E&O, EPLI and professional‑liability lines ELR was “given more weight in the more recent accident years” while older years relied more on loss‑development methods【page_260】【page_270】.  \n\nThe 2024 filing still notes that ELR is one of the techniques used for workers’ compensation, but it no longer quantifies the weighting, merely stating that a “combination of loss development, frequency/severity and expected loss ratio methods” is employed, indicating a shift toward a more balanced, case‑by‑case use of ELR rather than the explicit heavy emphasis on recent years seen in 2022【page_151】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects, resulting in a partially correct evaluation. (1) On correctness: The LLM correctly identifies that in 2022, AIG gave significant weight to Expected Loss Ratio (ELR) methods for recent accident years in D&O, E&O, EPLI, and professional liability lines, aligning with the original answer. It also correctly notes the use of ELR in workers’ compensation for recent accident years. However, it incorrectly claims that in 2024, AIG moved toward a 'more balanced, case-by-case use' and reduced emphasis on ELR, which contradicts the ground truth stating that AIG *expanded* the use of ELR to include U.S. Workers’ Compensation — a long-tail line — indicating broader, not reduced, application. (2) Quantitative accuracy: The specific details about 'latest accident year' for guaranteed-cost and 'latest five accident years' for excess-deductible workers’ comp are not present in the original answer and appear to be over-specified or inferred from sources not reflected in the ground truth. These numbers cannot be verified as correct per the provided truth, so they introduce unverified precision. The absence of such details in the ground truth suggests they may be extraneous or misaligned. (3) Reasoning: The multi-hop synthesis is flawed. The LLM interprets the 2024 shift in language (from 'more weight' to 'combination of methods') as a reduction in ELR use, whereas the ground truth interprets it as an expansion into more complex lines (like Workers’ Comp), implying integration rather than de-emphasis. This misreads the evolution of the method’s application. (4) Contextual relevance is high because the answer addresses the question’s focus on ELR evolution, lines of business, and accident years, and cites appropriate sections. However, the conclusion about reduced weighting in 2024 contradicts the ground truth’s assertion of expanded use. Thus, while contextually relevant and containing accurate fragments, the overall factual correctness and reasoning are compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 559,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Amazon still monetizes its produced and licensed video and music together as a single “film group” in each Prime market, but the scale of that model grew. The capitalized cost of video‑and‑music content rose from $16.7 billion in 2022 to $17.4 billion in 2023, while the related expense climbed from $16.6 billion to $18.9 billion, indicating a larger investment in content and higher amortization as the company leans more heavily on film‑group revenue generation【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: capitalized video and music content costs increased from $16.7B in 2022 to $17.4B in 2023, and associated expenses rose from $16.6B to $18.9B—these figures match the original answer exactly. (2) Quantitative accuracy is perfect; all dollar amounts and years are correctly reported with no calculation errors. (3) The reasoning is sound: the increase in capitalized costs and expenses is correctly interpreted as evidence of greater investment and intensified monetization efforts, which reflects valid multi-hop synthesis across financial metrics and strategic implications. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'monetization strategy evolved' or directly state that this reflects an evolution in strategy to the same degree as the original answer, though it implies it by referencing increased investment and revenue generation. This slight omission in framing—not in facts—prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 333,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "In the 2022 Form 10‑K, PMI’s equity investment in Rothmans, Benson & Hedges (RBH) was disclosed with no mention of a write‑down, implying the stake was carried at cost (see 2022 pages 34‑42)【page_34】. By the 2024 filing, PMI still owned the RBH investment but, because of uncertainty over the allocation of a CAD 32.5 billion settlement, it recorded a non‑cash impairment of $2.316 billion to reflect the reduced fair value of that stake (Item 8, Note 6)【page_30】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2.316 billion impairment (expressed as $2.316 billion, equivalent to $2,316 million) and the CAD 32.5 billion settlement amount are accurately reported, with acceptable format variation. The years (2022 and 2024) and entities (PMI, RBH) are correctly identified. (2) The answer correctly notes that in 2022, PMI had an equity investment in RBH with no impairment mentioned, consistent with the ground truth's implication of a pre-existing financial relationship evolving from trademark licensing to equity ownership. However, the original answer emphasizes a shift from a trademark and brand licensing relationship in 2022 to an equity investment in 2024, while the LLM answer assumes the equity stake existed in 2022. This is a minor discrepancy in narrative emphasis but not outright incorrect, as PMI may have held both types of relationships concurrently. (3) The multi-hop reasoning is sound: the LLM connects the lack of impairment in 2022 to the presence of a significant impairment in 2024 due to litigation uncertainty, correctly attributing the cause to the unresolved allocation of the Canadian settlement. (4) The answer is contextually relevant, directly addressing the evolution of the financial relationship, stake status, and impairment. The only slight shortfall is in fully capturing the nature of the 2022 relationship as primarily trademark/licensing-focused before evolving into a financially impaired equity stake, but the core facts and synthesis remain strong. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 470,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The 2023 Form 10‑K disclosed that a 5 % swing in the company’s sales‑return, rebate and discount liability would change net product revenue by roughly **$615 million**. The 2024 Form 10‑K does not provide a new estimate – it references the same $615 million figure (or omits an updated number), indicating that the sensitivity of net product revenue to those liabilities did not materially change from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 sensitivity figure of $615 million for a 5% change in sales return, rebate, and discount liabilities, which matches the ground truth exactly—this satisfies quantitative accuracy. The entity (LLY), metric (sensitivity of net product revenue to liabilities), and year (2023) are all accurate. However, the qualitative reasoning is flawed: the LLM states or implies that the 2024 10-K 'references the same $615 million figure' or 'did not materially change,' suggesting the number was either reused or implicitly confirmed. In reality, the ground truth states that the 2024 filing did *not provide an updated estimate* and *did not disclose a revised figure*, which is not the same as affirming the prior number or implying stability. The omission of a new sensitivity figure does not equate to the sensitivity remaining unchanged—it only indicates a lack of updated disclosure. The LLM incorrectly infers a conclusion (no material change in sensitivity) that is not supported by the available data, introducing a significant logical error in multi-hop reasoning. While the answer is contextually relevant and addresses the evolution question, it misrepresents the nature of the 2024 disclosure, leading to an incorrect interpretation of the situation. Hence, correctness is partially compromised despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 377,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "In 2022 Bulk shipments were a core commodity, delivering $6.656 billion – about 33 % of total freight revenue of $20.2 billion (2022 10‑K table)【page_35】. By 2024 Bulk still accounted for roughly a third of the business, generating 32 % of the $22.8 billion freight revenue, which translates to about $7.3 billion (2024 10‑K discussion)【page_6】. Thus, Bulk’s share of total freight revenue slipped only slightly (from ~33 % to 32 %) while its absolute contribution grew as overall freight revenue increased.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage contribution of Bulk shipments to total freight revenue in 2022 (~33%) and 2024 (32%), and notes the slight decline in share while absolute revenue grew. However, it introduces specific dollar figures ($6.656 billion in 2022, $7.3 billion in 2024) and total freight revenues ($20.2 billion in 2022, $22.8 billion in 2024) that are not present in the original answer or supported by the ground truth from the knowledge graph. These numbers may be accurate in the actual filings, but since the ground truth does not include them, their inclusion represents a deviation from the verified data. Additionally, the original answer emphasizes a shift in strategic importance and operational scope (grain, fertilizer, coal, international connections), which the LLM answer omits entirely. (2) While the percentages (33%, 32%) align reasonably with the original’s 32% in 2024 and implied prior share, the original does not state the 2022 percentage or provide revenue totals—thus the quantitative precision claimed by the LLM cannot be verified against the ground truth and appears over-specified. The calculation of $7.3 billion from 32% of $22.8 billion is mathematically correct, but again, these totals are not in the original answer. (3) The LLM performs sound multi-hop reasoning by comparing revenue shares across years and interpreting stability in contribution despite revenue growth. However, it fails to capture the qualitative evolution emphasized in the original—namely the increased strategic embedding in supply chains and international linkages—which is a key part of how the role of Bulk shipments evolved. (4) The contextual relevance is high because the answer directly addresses the evolution of revenue contribution over time. Qualitative accuracy is good but not perfect due to missing strategic context. Quantitative accuracy is moderate: while percentages are close and logically consistent, the specific dollar amounts are unverified additions not present in the ground truth, lowering confidence in strict factual alignment. Correctness score is 7 because core trends are accurately captured (stable % share, growing absolute role), but key strategic dimensions are missing and unverified numbers are introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 612,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "IBM’s 2028 notes kept the same coupons – the 0.300 % “IBM 28B” and the 1.750 % “IBM 28A” rates appear in the 2023 filing and are unchanged in the 2024 filing【IBM_10k_2023.pdf page_1】【IBM_10k_2024.pdf page_1】. The flat rates show IBM is preserving low‑cost, long‑dated financing rather than refinancing at higher yields, reflecting a strategy of maintaining a stable, inexpensive debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by introducing a '0.300% IBM 28B' note that is not present in the ground truth. The original answer only references the 1.750% Notes due 2028 (IBM 28A) in both 2023 and 2024. There is no mention of an 'IBM 28B' or a 0.300% note in the ground truth, making this a clear hallucination or misidentification. This undermines the quantitative accuracy. However, the correct 1.750% rate for IBM 28A is accurately reported and correctly stated as unchanged between 2023 and 2024. (2) The calculation aspect is minimal here (no math required), but the inclusion of an incorrect financial instrument (0.300% note) introduces a major quantitative inaccuracy. The core fact about the 1.750% note being stable is correct. (3) The reasoning about IBM preserving low-cost financing is plausible and aligns with the ground truth's implication of stability. However, the LLM fails to mention IBM’s broader strategy of issuing new debt at higher rates for longer maturities (e.g., 2.900% Notes due 2030 and 3.150% due 2033), which is a key part of the original answer and essential to fully addressing the question about IBM's overall debt strategy. Thus, the multi-hop synthesis is incomplete—while it correctly infers stability from unchanged rates, it misses the strategic expansion into higher-cost, longer-term debt. (4) The contextual relevance is high because the answer addresses the evolution of the 2028 notes and attempts to interpret IBM's debt strategy. However, due to the incorrect entity (IBM 28B) and omission of new debt issuances, the qualitative and quantitative accuracy scores are reduced. Correctness is partially achieved but compromised by critical factual and completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 477,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "In 2023 AT&T eliminated its Mobility Preferred Interests by repurchasing all 213 million of those securities in April 2023, removing them from the capital structure and reflecting the buy‑back in the EPS reconciliation (Note 16)【page_55】. By 2024 the Mobility interests are gone, but the company’s capital structure now includes other preferred securities – the Tower Holdings Preferred Interests, which were reset and re‑structured into Fixed‑Rate and Floating‑Rate series in late 2024, and the Telco LLC Preferred Interests, expanded to $7.25 billion of cumulative preferred interests as of year‑end 2024【page_87】. This marks a shift from eliminating a specific preferred class to managing and restructuring new preferred instruments within AT&T’s equity mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the answer correctly states the 2023 repurchase of Mobility Preferred Interests and the 2024 restructuring of Tower Holdings into fixed and floating rate series, as well as the expansion of Telco LLC Preferred Interests to $7.25 billion (equivalent to $7,250 million in the original answer). The mention of April 2023 for the repurchase adds precision not in the original but does not contradict it. The only minor omission is the specific redemption value ($5,340 million) and annual distributions ($373 million), which were present in the original answer but not included in the LLM response—this affects completeness but not core correctness. (2) The numbers that are provided are accurate and correctly formatted (e.g., $7.25 billion = $7,250 million). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2023 vs 2024), entities (Mobility, Tower Holdings, Telco LLC), and strategic implications, showing a pivot from eliminating one class to restructuring others. (4) The answer is contextually fully relevant, directly addressing the evolution of AT&T’s capital structure strategy regarding preferred interests. Wording differs but semantic meaning matches. The omission of specific dollar figures for the Mobility interests prevents a perfect score, but all other key facts and strategic interpretation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 401,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "In the 2022 Form 10‑K Amazon treated “websites” as a generic part of the competitive landscape, listing them together with other rivals in a catch‑all risk factor – “the introduction of competitive stores, **websites**, products, services, price decreases, or improvements” (2022 p. 9). By the 2023 filing the company broke this out into a detailed taxonomy, calling out “**web search engines, comparison‑shopping websites, social networks, web portals, and other online and app‑based means** of discovering, using, or acquiring goods and services” (2023 p. 4). The change from a broad, undifferentiated reference to a specific enumeration of digital platforms and apps signals that Amazon now views competition from websites as a more nuanced, platform‑driven threat rather than just another generic store entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Amazon's competitive threat characterization between 2022 and 2023. In 2022, websites were mentioned as part of a general list—'competitive stores, websites, products, services, price decreases, or improvements'—which the LLM accurately quotes and contextualizes. In 2023, the language shifted to a more detailed breakdown including 'web search engines, comparison-shopping websites, social networks, web portals, and other online and app-based means,' which the LLM correctly cites with specificity. (2) There are no numeric values to verify, but the years (2022 and 2023) and document references (p. 9 and p. 4) are correctly attributed, meeting quantitative accuracy standards. (3) The multi-hop reasoning is sound: the model synthesizes language changes across two filings and infers a strategic shift in how Amazon perceives digital competition. The conclusion—that the threat is now seen as more nuanced and platform-driven—matches the ground truth's assertion of a shift from general to strategic competitive concern. (4) The only minor shortcoming is that the LLM emphasizes 'taxonomy' and 'platform-driven threat' more than the original answer, slightly reframing the insight without contradicting it. However, this interpretation is reasonable and supported by the evidence. Semantic equivalence is maintained, with accurate entity, year, and context alignment. Thus, the answer is factually correct, complete, and contextually precise, warranting a 9/10 due to slight rephrasing emphasis but no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 447,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "In the 2022 Form 10‑K PMI reported that it had entered a three‑year “global collaboration agreement” with KT&G, granting PMI exclusive rights to distribute KT&G’s heat‑not‑burn, hybrid and vapor smoke‑free products outside South Korea and noting that commercial initiatives for those licensed products began in Q3 2020【PM_10k_2022.pdf page_51】. By the 2024 filing, KT&G‑licensed heat‑not‑burn brands (e.g., Fiit and Miix) are listed as part of PMI’s heated‑tobacco unit (HTU) portfolio and the company explicitly states that its heat‑not‑burn offerings now include licensed KT&G products, which are contributing to the strong growth of its smoke‑free revenue segment【PM_10k_2024.pdf page_40】【PM_10k_2024.pdf page_41】. This reflects a shift from a collaborative distribution agreement to a deeper strategic reliance on KT&G’s heat‑not‑burn products within PMI’s overall smoke‑free portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 global collaboration agreement with KT&G, its three-year term, PMI's exclusive distribution rights outside South Korea, and the inclusion of KT&G's heat-not-burn products in PMI's portfolio by 2024. The LLM correctly identifies that commercialization began in Q3 2020, which is consistent with the source. (2) Quantitative accuracy is perfect: no numerical errors; dates (2022, 2024, Q3 2020) and document references (page numbers, filing years) are correctly cited. Format variations (e.g., 'Fiit' and 'Miix' vs. 'LIL Mini' and 'LIL Plus' in the original) do not affect factual correctness—these are different brand names under the same KT&G product line, and the LLM accurately reflects that licensed KT&G brands are part of PMI's HTU portfolio. (3) Multi-hop reasoning is sound: the LLM synthesizes information from both the 2022 and 2024 10-Ks to show evolution from distribution to integration, correctly inferring a deeper strategic reliance. (4) The only minor shortcoming is that the original answer emphasizes a shift from 'distribution partnership' to 'embedded supplier or technology partner,' while the LLM describes it as a shift to 'deeper strategic reliance'—semantically very close but slightly less precise in characterizing the nature of the evolved relationship. However, this does not detract significantly from the overall correctness. The answer is fully contextually relevant and addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 425,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "In the 2022 Form 10‑K IBM noted that the PWCC Acquisition Long‑Term Performance Plan is **administered by the Executive Compensation and Management Resources Committee of the Board (with authority that may be delegated to officers)** and is used **solely to fund awards for employees who joined IBM through the PwCC acquisition, excluding senior executives**【page_28】. The 2024 filing repeats that the PWCC Plan “has been and will continue to be used solely to fund awards for employees of PwCC … Awards for senior executives … will not be funded from the PWCC Plan” and that its terms are identical to the 2001 Plan, but it no longer restates the Committee’s administration, implying the same oversight remains unchanged while the scope stays the same【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the PWCC Plan was used solely for former PwCC employees, excluding senior executives, and its terms remained substantively identical to the 2001 Plan. The administration by the Executive Compensation Committee in 2022 and its omission in 2024 are correctly noted, with a reasonable inference that oversight likely remains unchanged. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct handling of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound—comparing the 2022 and 2024 disclosures to assess evolution in administration and scope. The LLM correctly infers that while administrative details were omitted in 2024, the scope was reaffirmed with stronger language. (4) The only minor shortcoming is that the LLM does not explicitly note the shift in tone from 2022 to 2024 ('will continue to be used' vs. 'has been and will continue to be') as a sign of reaffirmation and stronger commitment, which was highlighted in the ground truth. However, the core conclusion about unchanged scope and likely unchanged administration is correct. Thus, the answer is semantically equivalent with only a slight omission in nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 390,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "In 2023 AT&T still carried the Mobility Preferred Interests as a liability – interest expense included the re‑classification of those distributions and the interests were recorded as a Level 3 liability until the company repurchased the remaining 213 million interests in April 2023 (see 2023 10‑K p. 25). The 2024 filing notes that all Mobility Preferred Interests were fully repurchased as of April 2023, leaving no amounts outstanding at year‑end (see 2024 10‑K p. 90/87). This elimination of a non‑controlling, equity‑type obligation shows AT&T is simplifying its capital structure, removing a source of interest expense and reducing financing complexity to improve balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AT&T repurchased all remaining Mobility Preferred Interests in April 2023, eliminating the obligation by year-end 2023, with no amounts outstanding in 2024—this matches the original answer’s timeline and outcome. (2) The only minor omission is the exact total repurchase cost of $5,414 million, which is not mentioned in the LLM answer; otherwise, all dates (April 2023), quantities (213 million interests), and financial treatment (Level 3 liability, reclassification of distributions) are accurately reported. (3) The reasoning is sound: the elimination of this liability is correctly interpreted as a move to simplify the capital structure, reduce interest expense, and improve balance sheet flexibility—consistent with the ground truth’s conclusion about selective capital structure management. The LLM also correctly contrasts the treatment of Mobility Preferred Interests with other preferred instruments implicitly by noting its complete removal, though it does not explicitly mention the continued existence of Tower Holdings or Telco LLC interests as in the original. (4) Despite this slight lack of comparative detail, the core facts, multi-hop synthesis (across 2023 and 2024 filings), and strategic interpretation are correct. Quantitative accuracy is high—only the total dollar amount is missing, but the event timing and scale (213 million interests) are right. Qualitative reasoning and contextual relevance are excellent, fully addressing the evolution and strategic implication of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 439,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM’s 2022 Form 10‑K already warned that the value of its debt securities can be affected by “governmental and stock‑exchange regulations” (2022 p. 22). The 2024 filing repeats the same risk‑factor language, again citing “governmental and stock‑exchange regulations” as an external factor beyond its control (2024 p. 11), showing that IBM’s regulatory exposure to stock‑exchange rules for its debt securities has remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its conclusion despite citing accurate document sources and page numbers. While it correctly identifies that IBM mentioned 'governmental and stock-exchange regulations' in both 2022 and 2024 filings, it fails to detect the evolution in language and tone described in the ground truth. The original answer highlights a shift from viewing stock exchange regulations as one of several external factors influencing debt security value (2022) to being 'subject to' such regulations (2024), indicating a stronger, more direct regulatory exposure. The LLM incorrectly asserts that 'regulatory exposure has remained essentially unchanged,' which contradicts the ground truth's central claim of heightened recognition. There are no numerical errors (hence high quantitative accuracy), but the qualitative reasoning is flawed—missing the semantic shift in regulatory stance across years. This is a multi-hop requirement: comparing language evolution across filings to infer changing exposure. The answer is contextually relevant but draws an incorrect inference from the cited text, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 323,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "In 2022 Disney reported that it owned a 50 % equity stake in A+E and recognized equity‑income from that investment (the filing notes the 50 % ownership but does not give a dollar amount)【page_12】. By fiscal 2024 the equity‑in‑investees line, which is driven largely by A+E earnings, fell to $575 million – a $207 million decline from the prior year – showing that Disney’s equity‑income contribution from A+E had dropped sharply over the period【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's 50% equity stake in A&E (A+E) in 2022 and the $207 million decline in equity income by 2024, aligning with the ground truth. The dollar amount for 2024 equity income ($575 million) is accurately reported, and the $207 million decrease is consistent with the knowledge graph. (2) All numeric values—50%, $575 million, $207 million, and the years 2022 and 2024—are factually correct and properly contextualized. The calculation implied (a $207M drop leading to $575M in 2024) suggests a 2023 figure of $782M, which is not contradicted by the ground truth and aligns with the stated decline. (3) The multi-hop reasoning is sound: the model connects Disney’s ownership stake to equity income recognition and tracks the change over time, correctly attributing the decline to A+E. The only minor limitation is that the original answer emphasizes the comparative significance of A&E among Disney’s equity investees (alongside CTV Specialty Television), which the LLM omits. However, this does not detract from the core financial evolution described. (4) The answer is semantically equivalent to the ground truth in terms of financial trend and magnitude, with high contextual relevance and precise quantitative accuracy. The qualitative score is slightly reduced only for the omission of A&E’s relative importance among Disney’s investees in 2022, but all key facts and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 400,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The balance‑sheet line for securitized debt obligations rose from **$16.973 billion at December 31 2022** to **$18.043 billion at December 31 2023** – an increase of roughly **$1.07 billion** (see 2022 table on page 211 and 2023 table on page 210). This upward move signals that Capital One is expanding its securitization program, using securitized debt as a growing component of its long‑term funding mix to diversify capital sources and support balance‑sheet growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level of $42.3 billion (as of December 31, 2021), with no direct 2022 figure provided in the original answer. However, the LLM claims an increase from $16.973 billion in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the ground truth. The LLM’s reported numbers do not align with the original answer, and the implied growth narrative is the opposite of the actual strategic reduction described. (2) The quantitative values ($16.973B and $18.043B) may reflect actual figures from filings, but the comparison is invalid because the ground truth indicates a significant decline from $42.3B in 2021 to $18.043B in 2023, suggesting the $16.973B figure for 2022 is either incorrect or misaligned with the knowledge graph’s data. The calculation of a $1.07B increase is therefore based on incorrect inputs. (3) The multi-hop reasoning fails: the original answer emphasizes a reduction in securitized debt obligations as part of a strategic shift away from this funding source, while the LLM interprets the same metric as increasing, leading to an opposite conclusion about the company's long-term funding strategy. This reflects a fundamental error in synthesis. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts to interpret strategic implications, but the factual inaccuracies render the conclusion invalid. Due to major errors in numbers, direction of change, and resulting interpretation, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 479,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "In 2022 Disney’s scripted series were still anchored to a massive international linear footprint – roughly 220 general‑entertainment channels (primarily Fox, National Geographic and Star) that aired scripted, reality and documentary programming worldwide – and the company warned that its growing direct‑to‑consumer (DTC) focus would erode that licensing‑based channel model (2022 p. 11, 24‑26). By 2024 Disney has moved the bulk of new scripted content onto its streaming services, merging Star+ into Disney+, adding a Star‑branded general‑entertainment tile and stating that most new series will debut on Disney+ or Disney+ Hotstar rather than on the international linear channels (2024 p. 7‑8), marking a clear shift from channel‑centric to DTC‑centric scripted distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the figure of 'approximately 220 general entertainment channels' in 2022 is correctly reported, and the timeline (2022 to 2024) is accurately framed. No calculations are required, and all cited page references (e.g., 2022 p. 11, 24–26; 2024 p. 7–8) are consistent with source documentation. (2) The answer correctly identifies the key brands (Fox, National Geographic, Star) and the shift from linear to DTC platforms. (3) The reasoning is sound: it traces the evolution from a licensing-based linear model in 2022 to a DTC-centric strategy by 2024, including the integration of Star+ into Disney+ and the prioritization of Disney+ and Disney+ Hotstar for new scripted content. This reflects accurate multi-hop synthesis across years and business units. (4) While the LLM omits mention of the Venu Sports joint venture and the 2025 ESPN+ live streaming plan—specific initiatives highlighted in the original answer—these are contextual enhancements rather than core to the scripted programming shift. The LLM focuses tightly on scripted content distribution, which is the central thrust of the question, and correctly identifies the strategic pivot. Thus, the omission slightly affects completeness but not overall correctness. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 385,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "In the 2022 filing Tesla noted that accounts‑receivable tied to its energy‑generation and storage sales were highly volatile because payments from financing partners and long‑duration government rebates could take weeks or even a year to clear, and that scaling its storage output was dependent on a lease‑based partnership with Panasonic that required purchasing the full output of Panasonic’s Gigafactory Nevada equipment (2022 p. 64; 2022 p. 74). By the 2023 filing the company still referenced receivables from financing arrangements, but the emphasis shifted to broader operational risk – warning that delays in ramping energy‑storage production and supply‑chain constraints, even with a modular design meant to boost capacity, could hinder scaling and affect financial results (2023 p. 16; 2023 p. 7; 2023 p. 9).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution from financial to operational challenges in Tesla's energy storage business from 2022 to 2023. It accurately notes the volatility of accounts receivable due to government rebates and financing partner payments in 2022 and the shift in 2023 toward production scaling risks and supply chain constraints. However, it omits the specific $627 million receivable balance as of December 31, 2021, which is a key quantitative detail from the original answer. While it references 'long-duration government rebates' and timing issues, the absence of this exact figure reduces quantitative accuracy. (2) The LLM does not include any incorrect numbers but fails to report the $627 million receivable amount, which is central to the 2022 financial challenge. This omission affects precision, though no numbers provided are wrong. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2023 filings, correctly identifying a shift in emphasis from financial exposure (receivables) to operational dependencies (production bottlenecks, supplier constraints, facility ramps). It appropriately references dependencies like the Panasonic partnership and modular design limitations, aligning with the broader operational risks highlighted in 2023. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: evolution of financial challenges (accounts receivable) and operational scaling dependencies. The qualitative accuracy is high due to correct entity identification (Tesla, energy storage, Panasonic, Nevada factory), accurate use of risk categories, and logical progression over time. The main deduction is for missing the specific $627M figure, which is a material data point in the ground truth, hence the 8/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 501,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "In the 2022 filing, syrups were grouped with concentrates and sold to bottling partners, with revenue recognized either when the partner shipped the finished product (for consolidated bottlers) or when the syrup itself was sold (for unconsolidated bottlers); the filing did not call out a separate fountain‑syrup channel. By the 2023 filing, Coca‑Cola describes syrups—especially fountain syrups—as a distinct product line that it manufactures and sells not only to its bottling partners but also directly to fountain retailers (or through fountain wholesalers), highlighting a broader, more direct role for syrups in the fountain‑service segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in Coca-Cola's syrup business model between 2022 and 2023. (1) It correctly identifies the revenue recognition differences between consolidated and unconsolidated bottling partners in 2022, aligning with the ground truth. It also accurately notes that in 2023, fountain syrups were described as a distinct product line sold directly to fountain retailers or through wholesalers, which reflects the shift toward a more integrated operational role. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or figures; however, the years (2022 and 2023) are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure and business emphasis across two years and different partner types (bottlers vs. fountain retailers), correctly inferring a strategic shift even without explicit financial metrics. The only minor shortcoming is that the LLM does not explicitly mention the 'dependency within a broader operational framework' language from the original answer, slightly reducing qualitative completeness. (4) The answer is fully contextually relevant, directly addressing the evolution of syrups in relation to bottling partners and fountain retailers. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight omissions in descriptive nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 413,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney’s “Other mortgage‑ and asset‑backed securities” holding rose from $84 million in FY 2022 (Level 2) to $166 million in FY 2024 (Level 2), roughly doubling the dollar amount【page_104】.  Despite the increase, its share of the overall fair‑value hierarchy stayed flat at about 1 % of plan assets in both years【page_107】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the dollar amounts. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in FY 2022 and $120 million in FY 2024. However, the LLM reports $84 million in FY 2022 and $166 million in FY 2024, both of which are incorrect. While the proportional share (1%) is correctly reported as stable, the absolute values are not. (2) The quantitative inaccuracies are substantial: the reported FY 2022 value is off by $12 million (12.5% error), and FY 2024 is off by $46 million (38.3% error). The claim that the investment 'roughly doubled' is therefore misleading, as the actual increase was from $96M to $120M (25% increase), not from $84M to $166M. (3) The qualitative reasoning is partially sound: the model correctly identifies that the proportion within the fair value hierarchy remained constant at 1%, which addresses the trend relative to total plan assets. It also correctly attributes the securities to Level 2 of the fair value hierarchy, though this detail was not required in the original answer. The multi-hop synthesis—comparing two fiscal years and assessing both absolute and relative changes—is logically structured. (4) Contextual relevance is high, as the answer addresses both parts of the question: evolution in investment value and trend in proportion. However, due to major errors in core financial figures, the correctness and quantitative accuracy scores are low. Minor flexibility is allowed for wording (e.g., 'about 1%' vs exactly '1%'), but the dollar amounts must match. The incorrect numbers undermine the factual reliability of the response despite correct reasoning structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 465,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "In the 2022 Form 10‑K Lockheed Martin described Skunk Works (its Advanced Development Programs) as targeting future unmanned and manned aerial systems and “next‑generation capabilities for **air dominance**, hypersonics, intelligence, surveillance, reconnaissance, situational awareness and air mobility”【page_4】. By the 2023 filing the language was trimmed to the same unmanned/manned aerial‑system focus and next‑generation hypersonics, ISR, situational‑awareness and air‑mobility capabilities, but the explicit “air dominance” phrase was omitted, indicating a shift toward a broader technology‑insertion and network‑enabled approach【page_6】.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of Skunk Works' focus areas between 2022 and 2023, directly contradicting the ground truth. According to the original answer, the 2022 focus included air dominance (though not explicitly listed in the initial summary), and by 2023 there was an increased emphasis on air dominance. However, the LLM claims that 'air dominance' was explicitly mentioned in 2022 but omitted in 2023, interpreting this omission as a shift away from air dominance—this is the opposite of the truth. The ground truth states that the 2023 focus evolved to emphasize air dominance more, representing a refinement with increased prioritization, not a de-emphasis. There are no numeric values in the question, so quantitative accuracy is not applicable—however, the years (2022, 2023) and entities (Skunk Works, Lockheed Martin, hypersonics, ISR, etc.) are correctly identified. The reasoning is flawed due to misinterpretation of the source language changes: trimming of wording does not imply removal of focus, yet the LLM infers a strategic shift based on phrasing differences without supporting evidence. The answer is contextually relevant—addressing the right topic and citing appropriate focus areas—but the conclusion is fundamentally wrong. Thus, while the answer contains accurate entities and correct dates, the qualitative reasoning and final conclusion are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 402,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "In 2022 Tesla’s Powerwall strategy was centered on **cross‑selling the home‑battery with its residential solar products and expanding its output** – the filing notes that “for Powerwall … we are emphasizing cross‑selling with our residential solar energy products” and that the company was “continuing to increase the production of our energy storage products … including beginning construction of our Megafactory”【page_34】.  \n\nBy 2023 the focus shifted to **tighter integration of Powerwall with the Solar Roof system**, with the 2023 filing stating that “we designed both products to integrate with Powerwall” and that customers can purchase an “integrated solar and Powerwall system”【page_7】【page_9】, while still leveraging a modular, vehicle‑derived battery architecture to scale production efficiently【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tesla's 2022 strategy of cross-selling Powerwall with residential solar products and increasing production, including the construction of the Megafactory, which matches the original emphasis on availability and production scaling. In 2023, it accurately notes the shift toward tighter integration with Solar Roof, citing that both products were 'designed to integrate'—this reflects the ground truth's point about a more deliberate, engineered synergy. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all referenced details (e.g., Megafactory construction, modular architecture) are factually consistent with the filings. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two product lines (Powerwall and Solar Roof), correctly identifying the evolution from sales-driven cross-promotion to technical integration. (4) The only minor shortcoming is that the LLM does not explicitly mention 'installation capabilities' or 'price efficiencies for Solar Roof' from the 2022 context, which slightly reduces completeness in qualitative nuance. However, the core evolution in strategy—shift from cross-selling to engineered integration—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 422,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "In the 2022 Form 10‑K Gilead presented Biktarvy as a flagship HIV product – a once‑daily, single‑tablet regimen of bictegravir, emtricitabine and tenofovir alafenamide (TAF) that was listed among its primary revenue‑generating HIV medicines【page_5】. By the 2024 filing the company no longer calls out Biktarvy by name, instead grouping it with its other TAF‑based HIV drugs and warning that “many of our HIV products contain tenofovir alafenamide (‘TAF’)…If there are any changes to the treatment or prevention paradigm for HIV, and nucleoside‑based therapeutics do not remain the preferred regimen, our HIV product sales would be adversely impacted,” and noting broader competitive, generic and pricing pressures as commercial risks【page_18】. This shift reflects a move from highlighting Biktarvy as a core growth driver to treating it as part of a broader, risk‑exposed HIV portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Biktarvy is correctly identified as a single-tablet regimen with bictegravir, emtricitabine, and TAF in 2022, and its role as a revenue-generating flagship product is accurately described. By 2024, the shift in disclosure—where Biktarvy is no longer individually highlighted and instead grouped with other TAF-based products—is correctly noted, along with the associated commercial risk related to dependence on nucleoside-based therapies. (2) There are no numeric values (e.g., sales figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly inferring a strategic shift from product-specific promotion to portfolio-level risk disclosure. The conclusion that Gilead has transitioned from innovation-focused positioning to increased vulnerability due to overreliance on TAF is logically supported and semantically equivalent to the ground truth. (4) The only minor shortcoming is that the LLM slightly underemphasizes the continuity of Biktarvy as a 'core product' in 2024—while it's true the company groups it with other TAF drugs, it remains central to the portfolio. However, this nuance does not materially distort the overall accuracy. Wording differs but meaning is preserved. Scores reflect high correctness, perfect quantitative alignment, strong qualitative reasoning, and full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 441,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "In the 2022 filing the U.S. Retrospective Responsibility Plan was described as consisting of six mechanisms – a U.S. litigation‑escrow agreement, the conversion feature of the company’s class B common stock, Visa U.S.A. members’ indemnification obligations, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement 【page_71】. The 2023 filing lists the same six items but adds a seventh mechanism – “the make‑whole agreements relating to the class B‑1 common‑stock exchange offer” – to the plan’s composition 【page_72】.  Thus, the only change between 2022 and 2023 was the inclusion of the make‑whole agreements alongside the existing escrow‑related mechanisms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the six original mechanisms in the 2022 U.S. Retrospective Responsibility Plan: U.S. Litigation Escrow Agreement, conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement. (2) It correctly states that in 2023, a seventh mechanism — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — was added, with no removals, indicating an expansion. (3) The multi-hop reasoning is sound: the model correctly compares the composition across two years and synthesizes the change as the addition of one element while retaining prior components. (4) All entities, years, and mechanisms are accurately named and contextualized. Minor formatting differences (e.g., 'make-whole' vs 'makewhole', use of em dashes) do not affect factual accuracy. The answer directly addresses the question about changes in composition and the role of the U.S. Litigation Escrow Agreement (retained). No factual, quantitative, or qualitative errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 333,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Gilead reported that Biktarvy’s primary compound patents run until 2033 in both the United States and the EU, giving the drug roughly a decade of protected market exclusivity (see the patent‑expiration table on page 11). By the 2024 filing, the company’s risk‑factor section explicitly warns that a substantial portion of its revenue comes from HIV products and that any loss of sales could force a reduction in R&D, underscoring that Biktarvy remains a core, protected revenue driver (see the HIV‑dependency risk disclosure on page 18). This shows that while the patent horizon for Biktarvy has not changed, Gilead now emphasizes its strategic reliance on the drug’s protected sales more prominently.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2033 U.S. patent expiration for Biktarvy from the 2022 filing, which matches the ground truth. However, it incorrectly states that the EU patent also expires in 2033, whereas the ground truth explicitly notes that no EU expiration was listed in 2022, indicating potentially longer or undetermined protection. This is a factual error affecting entity and quantitative accuracy. (2) The 2024 analysis correctly identifies Gilead's increased risk disclosure around HIV product dependency, aligning with the ground truth’s emphasis on heightened risk due to market competition and treatment shifts. However, the LLM interprets this as evidence of continued strategic reliance due to patent protection, while the ground truth suggests the opposite: that despite long-term patents, the strategic position has become more vulnerable. This misrepresents the reasoning and conclusion. (3) The multi-hop reasoning is partially sound—linking patent data from 2022 and risk disclosures from 2024—but fails to correctly synthesize the implication: the increasing risk disclosures signal vulnerability, not reinforced strength. The model misses the nuance that patent protection remains, but external pressures are eroding strategic confidence. (4) Quantitative accuracy is high (patent year 2033 is correct for U.S.), but the erroneous EU claim reduces the score. Qualitative accuracy is moderate due to correct identification of documents and sections but flawed interpretation. Contextual relevance is high as the answer addresses both patent timelines and risk disclosures as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 443,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "No. In both the 2022 and 2023 Form 10‑K filings AT&T’s guarantee for Illinois Bell Telephone Company appears unchanged – it is still listed under Item 4‑c as a “Guaranty of certain obligations … Illinois Bell Telephone Company” and is referenced to Exhibit 4‑d to the Form 10‑K for the period ending December 31, 2011【page_141】. The 2023 filing repeats the same description and reference (Item 4‑c) with no new amendment or different exhibit cited【page_103】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that there were no modifications to the financial guarantee provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The guarantee is correctly referenced under Exhibit 4-d to the Form 10-K for the period ending December 31, 2011, in both years. The LLM correctly identifies the exhibit number and filing history, confirming structural consistency. The only minor discrepancy is the reference to 'Item 4-c' in the LLM answer, whereas the ground truth refers to 'Exhibit 4-d' without mentioning an 'Item' designation. However, this appears to be a difference in document labeling convention rather than a factual error, and the exhibit citation (4-d) is correct. All dates and exhibit references match exactly. The reasoning is sound, demonstrating accurate synthesis across the 2022 and 2023 filings. The answer addresses both parts of the question: guarantee structure (unchanged) and documentation (same exhibit). Quantitative accuracy is perfect—correct years, exhibit numbers, and company names. Contextual relevance is strong, directly answering the question with precise evidence. The answer is semantically equivalent to the ground truth despite slight wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 361,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The conversion rate for Class C common stock into Class A common stock stayed at 4.0 : 1 in both 2022 and 2023 (Note 15, page 87). Because the rate did not change, any conversion of Class C shares would add the same proportion of Class A shares as before, so the potential voting‑power dilution for existing Class A shareholders in a merger or other significant transaction remains predictable and limited to the already‑known 4‑to‑1 ratio (see discussion of voting dilution, page 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the conversion rate of 4.0:1 (equivalent to 4.0000 in the original) is correctly stated for both 2022 and 2023, and no incorrect numbers are introduced. The slight increase in as-converted Class A value from 38M to 39M is omitted, but this does not affect the core conclusion about voting power stability. (2) The entity identification—Class C to Class A conversion, years 2022 and 2023—is correct. (3) The reasoning is sound: the unchanged conversion rate implies consistent voting dilution impact, which directly addresses the question about Class A stockholders' voting power in significant transactions. The LLM correctly infers that the stable ratio limits unpredictability in dilution. (4) While the original answer emphasizes the 'no structural change' in influence, the LLM captures the same semantic meaning by highlighting predictability and the fixed 4-to-1 ratio. The only minor gap is the lack of explicit mention of the increasing as-converted share value (38M to 39M), which slightly enriches the context but does not alter the conclusion. Overall, the answer is factually correct, contextually relevant, and logically sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 351,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "In 2022 Tesla treated the Solar Roof as an in‑house product, developing it internally and producing it at Gigafactory New York (2022 p. 9). By 2023 the emphasis shifted to ongoing engineering iterations, integration with Powerwall and new financing options, while the filing warned of production‑ramp delays and disclosed a strategic reliance on external research partners (SUNY / Silevo) for solar‑technology development (2023 p. 7, 9, 16, 110).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's in-house production of the Solar Roof at Gigafactory New York in 2022, aligning with the ground truth. It also accurately reflects the 2023 shift toward caution regarding production ramp delays and strategic dependencies. However, it introduces factually unsupported details not present in the ground truth: specifically, the claim that Tesla disclosed reliance on external research partners 'SUNY / Silevo' for solar-technology development. No such entities or partnerships are mentioned in the original answer or implied by the knowledge graph, making this a significant factual error. Additionally, while the LLM mentions 'engineering iterations', 'integration with Powerwall', and 'new financing options' as 2023 developments, these specifics are absent from the ground truth, which focuses solely on risk disclosures around scaling and production challenges. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift from production focus to risk disclosure between years. However, it fails to base its synthesis strictly on the provided ground truth and instead adds unverified details, undermining the qualitative accuracy. The introduction of external partners like Silevo (which was actually a defunct solar startup acquired by Tesla years earlier and not an active 2023 partner) reflects a potential hallucination or outdated inference. (4) The correctness score is 6 because the core idea—a shift from active production to strategic caution—is correct, but the inclusion of unsupported specifics reduces accuracy. Contextual relevance remains high (8) as the answer addresses the evolution in focus and dependencies, even if some details are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 511,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "In the 2022 filing Coca‑Cola described syrups as “intermediate products” produced in its concentrate operations that are sold to authorized bottling partners, which then combine the syrups (or concentrates) with water and sweeteners to create finished beverages [KO_10k_2022.pdf p 5‑6]. By the 2023 filing the company still treats syrups as the feed‑stock for finished‑beverage production, but it adds that fountain syrups are now sold directly to fountain retailers, authorized wholesalers and bottling partners and are reported in specific operating‑segment disclosures (e.g., North America) [KO_10k_2023.pdf p 5‑6]. Thus, syrups have moved from a purely bottler‑supply role in 2022 to a more explicit, stand‑alone distribution channel in 2023 while continuing to underpin finished‑product manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: syrups are correctly described as intermediate products used in concentrate operations and sold to bottling partners for finished beverage production in 2022. In 2023, the expansion to direct sales to fountain retailers, wholesalers, and bottling partners is accurately noted, as is the inclusion in the North America operating segment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years and two filings to show an evolution in distribution strategy and reporting structure. The conclusion that syrups moved from a 'purely bottler-supply role' to a 'stand-alone distribution channel' captures the strategic shift described in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the comparative financial characteristics (lower revenues but higher margins) of syrup/concentrate operations versus finished product operations, which is a detail included in the ground truth. However, this omission does not undermine the core accuracy of the response. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 404,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The company’s geographic reporting for Africa/Eurasia has not changed – it is still listed as one of the five reportable operating segments of the Oral, Personal and Home Care business (2024 Note 13, p. 114). In the most recent pre‑2022 data the segment generated about $200 million of operating profit (≈$203 m in 2021) and modest capital spending (≈$33 m) (2022 segment table, p. 117), and by 2024 it remains part of the emerging‑market group that accounts for roughly 45 % of total net sales, indicating a steady but relatively small contribution to overall results.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but includes notable inaccuracies and omissions. It correctly identifies that Africa/Eurasia remained a reportable segment within Oral, Personal and Home Care in 2024, aligning with the ground truth. However, it incorrectly references 2021 data (≈$203M operating profit) as 'pre-2022' and attributes it to 2022 without confirming the 2022 figure directly, despite the ground truth stating the $203M was for 2022. The mention of 'modest capital spending (≈$33M)' is not present in the original answer and introduces unverified data, reducing quantitative accuracy. The claim that Africa/Eurasia is part of an 'emerging-market group' accounting for 45% of net sales is not supported in the ground truth and represents an unsupported inference. (2) The operating profit figure of $203M is correctly cited in value but misattributed in timing (linked to 2021 instead of confirmed 2022), and the 45% sales contribution is extraneous and unverified. (3) The multi-hop reasoning is weak: the LLM fails to address the key 2024 realignment of the skin health business from Europe to North America, which is a critical part of the operational focus evolution. This omission significantly undermines the qualitative accuracy and completeness. Additionally, the answer does not contrast the relative financial contribution over time or note any strategic refinement in reporting structure beyond continuity. (4) The contextual relevance is fair because the response stays on topic regarding geographic reporting and financial contribution, but it misses key strategic changes and introduces unsupported data, leading to a moderate correctness score of 5. The answer is partially correct in structure but flawed in key details and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 488,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "In the 2023 Form 10‑K Johnson & Johnson presented its Orthopaedics business chiefly with a quantitative sales table, showing $8.9 billion of worldwide Orthopaedics revenue (U.S. $5.5 bn + International $3.4 bn) and a 4.1 % increase versus 2022 (page 90). In the 2024 filing the focus shifted to a strategic narrative, describing the Orthopaedics portfolio as “products and enabling technologies that support hips, knees, trauma, spine, sports, and others,” emphasizing technology enablement rather than detailed sales figures (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 2023 global Orthopaedics revenue of $8.9 billion (matching $8,942 million), 4.1% growth, U.S. revenue of $5.5 billion (~$5,525 million), and international $3.4 billion (~$3,417 million) are correctly rounded and presented. The shift in 2024 from quantitative to qualitative framing is accurately described. (2) Quantitative accuracy is excellent—minor rounding ($8.9B vs $8,942M) is acceptable and common in reporting; the sum of $5.5B + $3.4B ≈ $8.9B is logically consistent. Percentages (4.1%, 3.8%, 4.6%) are not all listed in the LLM answer but the overall 4.1% growth is correctly cited. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across two years and filings, identifying the shift from financial reporting to strategic narrative. The mention of 'enabling technologies' and the product areas (hips, knees, trauma, spine, sports) matches the ground truth. (4) The only minor omission is the lack of explicit mention of the 3.8% U.S. and 4.6% international growth rates from 2023, which slightly reduces completeness but does not undermine the core correctness. The answer remains semantically equivalent and contextually precise, earning high marks across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 364,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Visa’s loss‑sharing framework continued to be governed by the 2015 amendment that broadened the definition of “U.S. covered litigation” to include any opt‑out actions from the Rule 23(b)(3) settlement class in MDL 1720 [2022 p.73]. The 2023 filing repeats that the loss‑sharing agreement indemnifies Visa U.S.A., Visa International and, in certain circumstances, Visa itself, and that each participating bank’s “several” obligation equals its proportionate share of any final judgment or settlement – the same allocation mechanism described in the 2022 filing [2022 p.71; 2023 p.71]. No new amendment or change in scope or allocation is disclosed for 2023, indicating the approach remained essentially unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in terms of factual content but fails to capture the key evolution in Visa's approach between 2022 and 2023, which is the central focus of the question. Quantitatively, the answer correctly references the 2015 amendment and the 66.6667%/33.3333% liability split (implied via description of Visa's indemnification and bank obligations), and accurately cites page numbers and MDL 1720 context. However, it incorrectly concludes that 'no new amendment or change in scope or allocation is disclosed for 2023' and that the approach 'remained essentially unchanged,' which directly contradicts the ground truth. The original answer highlights a significant strategic shift in 2023: the consolidation of the loss sharing agreement under the U.S. Retrospective Responsibility Plan and the inclusion of 'settled or otherwise fully or substantially resolved' matters, indicating a pivot toward resolving legacy liabilities. This evolution is entirely missed by the LLM, which instead asserts continuity. The reasoning is flawed because it fails to synthesize the broader strategic context in the 2023 filing, reducing the answer to a narrow, static interpretation of liability mechanics. While entity names (Visa, MDL 1720), years (2022, 2023), and legal terms are accurate, the qualitative analysis lacks depth and misrepresents the directional change in Visa's strategy. The answer is contextually relevant and addresses the topic, but omits the critical forward-looking shift in liability management, resulting in a substantively incomplete and misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 435,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "CL cut its guaranteed‑investment‑contract holdings sharply – the 2022 filing shows $1 million of U.S. GICs and $55 million of international GICs (​page 101​), while the 2024 filing reports no U.S. GICs and $30 million of international GICs (​page 99​). The roughly $25 million reduction reflects a strategic shift away from insurance‑linked contracts toward a more diversified, primarily fixed‑income and other asset mix in its pension plans.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend of reducing Guaranteed Investment Contracts (GICs) in both U.S. and international pension plans between 2022 and 2024, which aligns with the ground truth. However, there is a quantitative inaccuracy in the international GIC amount for 2024: the LLM reports $30 million, while the ground truth states $34 million. This $4 million discrepancy affects the accuracy of the claimed 'roughly $25 million reduction'—the actual reduction internationally is $21 million ($55M - $34M), and with the $1M U.S. elimination, total reduction is $22M, not $25M. (2) The U.S. GIC values are correct: $1M in 2022 and $0 in 2024. The international 2022 value is correctly cited as $55M, but 2024 is misstated. Calculations based on incorrect figures reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across two years and two pension plan types (U.S. and international), correctly infers a strategic shift, and links it to broader asset allocation changes. The conclusion about moving toward a more diversified, fixed-income-focused strategy is a reasonable interpretation, though slightly more specific than the original answer, which only states 'strategic reallocation.' (4) Despite the numerical error, the answer addresses both parts of the question—evolution of investment and strategic implication—and uses correct entities (CL, GICs, pension plans, correct years). Wording differences are acceptable under semantic equivalence, but the incorrect figure prevents a higher score. Hence, correctness is 7 due to core accuracy with a significant but not critical numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 456,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "In 2022 the Mastercard Developer Platform was presented mainly as a single‑point API hub that “simplifies access to, and integration of, our digital assets” by giving customers a unified gateway to find and use Mastercard APIs (2022 ‑ page 14). By 2024 the platform had been elevated to a strategic gateway for emerging tech – it now supports blockchain‑based business models, the Multi‑Token Network for programmable payments, and crypto‑card purchases, expanding its role from basic API access to a broader enabler of digital‑asset and new‑technology integration (2024 ‑ page 14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the platform was described as a single access point/API hub for digital assets (correctly cited from 2022, page 14); by 2024, it evolved to support blockchain, the Multi-Token Network, and programmable payments (consistent with 2024, page 14). The mention of 'crypto-card purchases' is a minor addition not explicitly in the ground truth but is contextually plausible and does not contradict it. (2) There are no numeric values, dates, or calculations to verify—years (2022, 2024) are correct and consistently referenced. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years and correctly infers an evolution in strategic positioning—from a general integration platform to one enabling advanced digital asset technologies. The reference to the Mastercard Multi-Token Network™ and programmable payments matches the ground truth’s emphasis. (4) Semantic equivalence is strong; the LLM conveys the same core evolution using slightly different but accurate phrasing (e.g., 'elevated to a strategic gateway' vs. 'expanded its strategic positioning'). The only reason for not scoring a 10 is the slight expansion with 'crypto-card purchases,' which, while reasonable, is not explicitly confirmed in the ground truth and adds a detail beyond the provided evidence. Otherwise, the answer is complete, relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 406,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "In the 2022 filing the company reported **no U.S. common‑stock holdings** in its U.S. defined‑benefit pension plan (the “U.S. common stocks” line is shown as “‑”)【page_100】. By December 31 2024 that line reflects a **$1 million Level 1 investment** in U.S. common stocks【page_99】. This modest addition moves the plan a step closer to its stated target of roughly 21 % equity exposure for U.S. plans, indicating a gradual shift toward greater equity weighting in the pension portfolio as part of its strategic asset‑allocation plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. The ground truth states that there were no investments in U.S. common stocks in the U.S. pension plan in both 2022 and 2024, but the LLM claims a $1 million investment in 2024, which contradicts the original answer. Additionally, the LLM introduces a 'Level 1 investment' and a 'target of roughly 21% equity exposure' that are not present in the ground truth and cannot be verified from the provided information. (2) Quantitatively, the $1 million figure is incorrect—ground truth confirms zero allocation in the U.S. plan for both years. The international plan maintained a $2 million investment in both years, which the LLM completely omits. No calculations are required in this question, but the reported numbers are factually wrong. (3) The multi-hop reasoning is flawed: the LLM fails to distinguish between U.S. and international pension plans and incorrectly infers a strategic shift toward equity based on non-existent data. The original answer emphasizes a continued avoidance of U.S. common stocks in the domestic plan, while the LLM suggests a new strategic move, which is unsupported. (4) Contextual relevance is moderate—the answer addresses asset allocation and pension investments, and attempts to interpret strategic intent, but due to factual inaccuracies and missing key distinctions (U.S. vs. international plans), the response misrepresents the situation. The omission of the $2 million stable international investment further reduces completeness and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 426,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships as a line‑item of its broader Parks & Experiences capital program, saying that a “majority of the Company’s capital spend… is principally for … cruise ships” and that future investment plans were based on management’s expectations (page 17). By the 2023 filing the company moved to a more explicit growth strategy – announcing plans to expand its cruise‑ship fleet (page 22) – while also flagging heightened operational risks, from pandemic‑related sailings suspensions and weather events to insurance coverage limits and potential asset write‑downs (e.g., the Star Wars: Galactic Starcruiser closure) (page 21).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in its characterization of Disney's strategic shift. While the original answer states that Disney shifted from a growth-oriented investment focus in 2022 to a risk-mitigation focus in 2023, the LLM claims the opposite — that Disney moved toward a 'more explicit growth strategy' in 2023. This misrepresents the core evolution of strategic focus and is a major contradiction. Additionally, the LLM cites the closure of Star Wars: Galactic Starcruiser as an example of operational risk related to cruise ships, but this was a land-based immersive hotel experience, not a cruise ship, indicating a significant entity confusion. (2) Quantitatively, the LLM accurately references the 'majority of capital spend' language from 2022 and correctly cites page numbers and general risk categories (weather, pandemic), so numerical and textual references are mostly accurate, though no specific dollar amounts or percentages are involved. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the directional shift in strategy (from investment to risk) and incorrectly links unrelated assets (Starcruiser) to cruise operations. It also omits the key point that hurricanes and external disruptions reframed cruise ships as operational exposures. (4) The contextual relevance is moderate — the answer discusses capital investment and operational risks as requested, but due to the reversed strategic narrative and incorrect examples, the qualitative accuracy is low. The answer appears plausible but conveys the opposite of the ground truth on the central point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 448,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard’s practice of using short‑duration foreign‑exchange derivatives has remained essentially unchanged – the 2022 10‑K explains that the company “may enter into short‑duration foreign‑exchange derivative contracts … to manage … the risk that typically exists for a few days between a payment transaction and its subsequent settlement” and that gains or losses on those contracts are recorded in general‑and‑administrative expense【page_111】. The 2024 filing repeats the same description of the contracts’ purpose and accounting treatment【page_106】, but now also quantifies the exposure, reporting about $2.7 billion of non‑designated FX contract notional at year‑end 2024 (down from $5.4 billion in 2023), indicating that the role in daily settlement risk management persists while the scale of the contracts has shifted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $2.7 billion notional amount in 2024 and $5.4 billion in 2023 are accurately reported, with proper directional change (down from 2023 to 2024), and these figures are consistent with typical disclosures in 10-K filings. (2) The LLM correctly identifies that the use of short-duration FX derivatives for managing daily settlement risk remained consistent between 2022 and 2024, citing identical language from both years’ filings regarding purpose and accounting treatment, which supports the continuity claim in the ground truth. (3) The qualitative reasoning is strong: it captures the persistent role of these contracts in managing short-term FX risk during settlement, while implicitly acknowledging a more dynamic broader FX strategy through the mention of changing notional amounts. However, the LLM does not explicitly mention the de-designation and re-designation of euro-denominated debt hedging activities in 2023 and 2024—a key nuance in the evolution of Mastercard’s broader FX risk management strategy noted in the original answer. This omission slightly weakens the synthesis of multi-hop information across financial instruments and years, though the focus of the question was primarily on short-duration contracts. (4) Despite this minor gap, the answer remains factually correct, contextually relevant, and semantically equivalent in conveying the core evolution (or stability) of short-duration FX derivative usage. Wording differences do not detract from accuracy, and number formats are appropriately handled.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 448,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "In the 2023 filing Salesforce framed its ties to enterprise‑cloud firms mainly as a **strategic‑investment portfolio** that “focuses primarily on enterprise cloud companies, technology startups and system integrators” and is used to “expand our solution ecosystem” and support AI‑related initiatives (2023 p.23; 2023 p.32). By the 2024 filing the company still stresses those investments but adds that it is **deepening ecosystem integration**, noting that it is “increasing our reliance on third‑party cloud computing platforms” and moving data and workloads to them while planning to reinvest proceeds into new enterprise‑cloud investments that target specific technologies and geographies (2024 p.8; 2024 p.15). Thus, the relationship has evolved from a primarily investment‑focused strategy to a dual approach that couples continued strategic investing with greater operational integration of external cloud platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution from a primarily investment-focused strategy in 2023 to a dual approach in 2024 that includes both strategic investments and deeper operational integration with enterprise cloud companies. The key elements—expansion of the solution ecosystem, focus on AI-related initiatives (mentioned in LLM but not in ground truth), and increased reliance on third-party platforms—are consistent with the original answer’s emphasis on ecosystem integration and dependency beyond investment. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly identifying a shift in strategic emphasis. The only minor deviation is that the ground truth emphasizes the role of the Salesforce Platform and AppExchange for ISVs, while the LLM highlights reliance on third-party cloud computing platforms and data migration—slightly different aspects of integration, but semantically related and not contradictory. This represents a nuanced interpretation rather than an error. (4) The answer is contextually relevant, directly addressing both investment focus and ecosystem integration as asked. The inclusion of specific page citations (e.g., 2023 p.23) adds precision, though not required. Overall, the LLM captures the core evolution accurately, earning a 9 due to slight differences in emphasis but no factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 443,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s method for accruing vendor‑funding did not change – in both FY 2023 and FY 2024 it “develop[s] accrual rates based on the provisions of the agreements…review[s] historical purchase trends and volumes throughout the year, adjust[es] accrual rates as appropriate, and confirm[es] amounts with select vendors.” In each year it notes that the accrued amounts “could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met,” and it confirms that no material changes to the methodology were made. 【page_33】【page_34】",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing the company's consistent methodology for accruing vendor funding across fiscal 2023 and 2024, correctly citing the lack of material changes and the ongoing use of historical trends, projected volumes, and vendor confirmations. It accurately quotes language from the filings (e.g., 'could be impacted if actual purchase volumes differ') and correctly references the continuity in approach. However, it fails to capture a key qualitative distinction highlighted in the ground truth: the explicit mention of 'graduated purchase volumes' in FY2023 that was omitted in FY2024. The LLM incorrectly implies that both years included the same detailed reference to graduated volumes, stating that 'in each year it notes...' this sensitivity—this is not accurate. The removal of that specific language in FY2024 is a critical nuance indicating a potential shift in emphasis or simplification, which the LLM overlooks. While all cited numbers and dates are correct (quantitative accuracy is high), the reasoning is flawed in its synthesis across years, leading to a misleading conclusion about consistency in disclosure. The answer is contextually relevant and well-supported with citations, but the failure to identify the change in disclosure language undermines the qualitative accuracy, particularly in addressing the evolution of sensitivity to projected volumes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 388,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "In the 2022 filing, Lilly’s partnership with Boehringer Ingelheim on Jardiance was described mainly as a co‑marketing and development arrangement in which BI—not Lilly—initiated a separate patent suit (Lilly was not a party) and, under the collaboration agreement, agreed to defend and indemnify Lilly in the five pending Jardiance product‑liability lawsuits. By the 2024 filing the relationship had become a broader global joint‑development and commercialization agreement that equally shares R&D and marketing costs, pays and receives royalties and performance‑based payments, and was recently amended (including a $300 million one‑time payment and a shift of some smaller‑market commercialization responsibilities), showing a deeper financial interdependence and a move away from the earlier litigation‑focused description.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the evolution of the LLY-BI relationship and correctly notes that LLY was not a party to the 2022 patent litigation, which aligns with the ground truth. It also identifies increased collaboration depth by 2024, mentioning financial interdependence and agreement amendments. However, it introduces a $300 million one-time payment and specific structural changes (e.g., shift in commercialization responsibilities) that are not present in the original answer or supported by the provided ground truth. These additions are unverified and likely incorrect, undermining factual accuracy. (2) Quantitative inaccuracies include the fabricated $300 million payment; the ground truth mentions a 66% discount under the IRA but no such payment. The LLM omits this key pricing fact entirely, which is central to the strategic dependency in 2024. While dates (2022, 2024) are correct, the absence of the 66% discount—a critical quantitative element—represents a major omission. (3) The multi-hop reasoning is partially sound: the model infers deeper collaboration over time and correctly distinguishes legal roles in 2022. However, it fails to connect Jardiance’s IRA pricing designation to LLY’s revenue dependency, which is the core of the 2024 strategic shift. Instead, it substitutes speculative financial terms, indicating flawed synthesis. (4) Despite incorrect specifics, the answer remains contextually relevant, addressing legal involvement and collaborative evolution. The qualitative reasoning about deepening ties is directionally correct, but lacks grounding in the actual regulatory (IRA) driver. Hence, correctness is partially compromised by invention of details and omission of key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 471,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "In the 2022 filing Disney stressed that investing in new cruise ships was a sizable, upfront outlay made before the market’s response was known, treating the ships as a higher‑risk, stand‑alone asset. By the 2023 filing, cruise‑ship spending was folded into the Parks & Experiences capital plan – the company said most of its capital is now directed to park‑ and resort‑related expansion, new attractions and cruise ships, indicating a more integrated strategy that aligns cruise‑ship investment with its broader park‑and‑resort growth agenda.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the shift in Disney's capital investment strategy toward cruise ships from 2022 to 2023 and contextualizes it within the broader Parks & Experiences business, which aligns with the ground truth. It accurately reflects that in 2023, cruise ships were explicitly included in capital spending plans alongside parks and attractions, indicating a more integrated strategy. However, the LLM introduces a claim not present in the original answer or supported by the cited filings: that in 2022, Disney treated cruise ships as a 'higher-risk, stand-alone asset' and emphasized 'sizable, upfront outlay before market response was known.' The original 2022 10-K did not single out cruise ships for such risk characterization; instead, it discussed macroeconomic risks (inflation, supply chain, currency) affecting the broader Experiences segment. This misrepresents the 2022 stance and adds unsupported qualitative framing. There are no numerical figures in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numeric errors. The reasoning is mostly sound in identifying a strategic shift, but the incorrect attribution of 2022 risk language to cruise ships specifically undermines full qualitative accuracy. The answer remains contextually relevant and captures the core evolution in strategy, hence a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 388,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "In the 2022 filing Mastercard Foundry is portrayed as the company’s dedicated innovation arm that runs hands‑on programs—such as the five‑day Launchpad prototyping workshop, in‑lab usability testing and concept‑design services—to give customers and early‑stage fintechs access to thought‑leadership, new technologies and innovation methodologies (2022 p.14‑16). By the 2024 filing its role has shifted to a continuous, strategic engine that actively scouts, tests and integrates emerging technologies and start‑ups, providing ongoing access to innovation tools, fintech partnerships and digital‑asset services through the broader Mastercard Developer ecosystem (2024 p.14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mastercard Foundry's evolution from a thought leadership and prototyping hub in 2022 to a more active, continuous innovation engine in 2024 is accurately described. The mention of hands-on programs like the Launchpad workshop and usability testing in 2022 (citing p.14–16) matches the source context. In 2024, the shift toward ongoing scouting, testing, and integration of emerging technologies and fintech partnerships via the Mastercard Developer ecosystem (p.14) reflects the expanded role. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all timeframes (2022, 2024) are correct. (3) The multi-hop reasoning—comparing Foundry’s role across two years and synthesizing changes in engagement with emerging tech and fintechs—is sound. The LLM correctly infers a strategic deepening of innovation activities. (4) The only minor omission is that the original answer specifies Foundry’s role in enabling blockchain-based business models and the Mastercard Multi-Token Network™, which the LLM answer does not explicitly mention, though 'digital-asset services' likely encompasses this. This slight lack of specificity prevents a perfect 10 on qualitative accuracy, but the core evolution is correctly captured. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with minor abstraction on the technical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 413,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "In 2022 the Boehringer Ingelheim partnership was presented as a joint‑development and commercialization arrangement for Jardiance and Basaglar, with its strategic value anchored in FDA Breakthrough‑Therapy, Fast‑Track and priority‑review designations for new Jardiance indications (e.g., HFpEF and CKD) and revenue derived from shared development/commercialization costs and royalties (Jardiance $2.1 bn)【page_39】. By 2024 the collaboration generated higher sales, a $300 million one‑time amendment payment and a re‑allocation of commercialization responsibilities, but it now faces steep pricing pressure after Jardiance was selected for government‑set pricing under the Inflation Reduction Act, resulting in a 66 % discount and significant revenue erosion【page_73】【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Breakthrough Therapy and Fast Track designations in 2022 for Jardiance indications (HFpEF, CKD), the 66% discount under the Inflation Reduction Act in 2024, and the effective 2026 pricing are all factually consistent. The $2.1 billion Jardiance revenue and $300 million one-time payment are correctly cited. (2) Quantitative accuracy is perfect: all numbers (66%, $2.1B, $300M) match or are consistent with the knowledge graph; format variations are acceptable. (3) Multi-hop reasoning is sound—correctly synthesizes evolution from regulatory facilitation (2022) to pricing pressure (2024), linking Boehringer Ingelheim collaboration, FDA designations, and IRA impact. The addition of Basaglar and priority review is extra context not in the ground truth but not incorrect. (4) The only minor gap is that the original answer emphasizes a strategic shift from regulatory support to financial constraint, which the LLM captures implicitly but could have articulated more explicitly. However, the core evolution is accurately conveyed. Semantic equivalence is maintained with strong contextual and factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 340,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "In the 2023 filing the CH‑53K King Stallion was presented as a **program‑of‑record in the Rotary and Mission Systems segment that was just entering a growth stage**, and the filing noted a recent international contract – Israel’s purchase of 12 helicopters, with the first four awarded in 2022 and the remainder in 2023【page_29】【page_31】.  \nBy the 2024 filing the helicopter is described as a **well‑established, growth‑driving program within RMS**, emphasizing that it now sits as a mature, core platform that continues to expand production and sales【page_3】.  \n\nThus, the CH‑53K’s strategic positioning has shifted from an emerging growth program with new foreign orders in 2023 to a confirmed, core growth engine in the RMS segment by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the strategic evolution of the CH-53K within Lockheed Martin's RMS segment from 2023 to 2024, and includes additional specific details (e.g., Israel’s purchase of 12 helicopters, with four awarded in 2022 and the remainder in 2023) that are plausible and cited with page references. There are no numeric inaccuracies—dates and contract details are presented clearly and do not contradict the ground truth. However, the original answer emphasizes a shift in framing the CH-53K within broader technological advancements (AI/ML, autonomy, all-domain solutions, interoperability), which the LLM answer omits. Instead, the LLM focuses on maturity and production growth, which is valid but represents a narrower interpretation of the strategic shift. While the core idea—that the CH-53K evolved from an emerging to a core growth program—is aligned with the ground truth, the LLM misses the qualitative evolution toward integration with digital and multi-domain mission systems, which is a key nuance in the original answer. Thus, the quantitative accuracy is perfect (10), and contextual relevance is high because it directly addresses the question, but qualitative accuracy is slightly reduced due to incomplete synthesis of the multi-hop concept of 'strategic positioning' involving technological integration. The correctness score reflects that the answer is substantially correct but lacks a key dimension of the strategic repositioning described in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 419,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The 2022 filing lists a broad joint portfolio – Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar – co‑commercialized with Boehringer Ingelheim【page_7】. By 2024 the collaboration is limited to just Jardiance, Glyxambi, Synjardy and Trijardy XR, dropping Trajenta, Jentadueto and Basaglar【page_8】. This narrowing signals that both companies are refocusing the partnership on the high‑growth SGLT2‑inhibitor and fixed‑dose combination segment of diabetes care, while moving other products (e.g., the insulin Basaglar and the DPP‑4 inhibitor/Jentadueto) to separate, company‑specific strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—LLY, Boehringer Ingelheim, product names (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar), and years (2022, 2024)—are correctly identified. The list of products in both years matches the original answer exactly. (2) There are no numerical values requiring calculation, but the temporal comparison across 2022 and 2024 is handled accurately. (3) The multi-hop reasoning—comparing the portfolio composition across years and inferring strategic refocusing—is sound. The LLM correctly identifies the narrowing of the portfolio and attributes it to a strategic shift toward SGLT2 inhibitors and fixed-dose combinations, which is consistent with the ground truth’s implication of prioritizing higher-growth or more differentiated products. (4) The LLM adds interpretive value by categorizing the dropped products (e.g., Basaglar as insulin, Jentadueto as DPP-4 inhibitor) and suggesting they were moved to company-specific strategies, which is a reasonable inference though not explicitly stated in the ground truth. This slightly exceeds the original answer but does not introduce inaccuracy. The only reason for not scoring a 10 is that the original answer includes additional nuance about potential drivers like patent protection and generic competition, which the LLM omits. Overall, the answer is semantically equivalent, contextually precise, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 408,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "In 2023 JASSM was a steady‑state missile in Lockheed Martin’s Missiles‑and‑Fire‑Control (MFC) line, contributing to $11.3 billion of net sales and a year‑end backlog of $32.2 billion. In 2024 the program entered a production ramp‑up, accounting for most of the $1.2 billion of tactical‑missile sales that lifted MFC net sales to $12.7 billion and helped grow the segment’s backlog to $38.8 billion—showing a markedly higher production activity and strategic importance despite a sharp drop in MFC operating profit (see pages 34 & 40).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$11.3 billion in net sales and $32.2 billion backlog for MFC in 2023, rising to $12.7 billion and $38.8 billion in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, as the ground truth does not specify MFC’s total net sales or backlog values. The only quantitative figure confirmed in the ground truth is the $1.2 billion increase in tactical and strike missile programs in 2024, which the LLM correctly attributes to JASSM and related programs. However, claiming JASSM 'accounted for most' of this increase overreaches, as the original answer states JASSM was 'a key contributor' alongside PAC-3 and GMLRS, not the dominant one. (2) The calculation of a $1.4 billion increase in MFC net sales ($12.7B - $11.3B) and $6.6 billion backlog growth is unsupported by the ground truth, which does not provide segment-level financial aggregates. These precise figures undermine quantitative accuracy. (3) The qualitative reasoning correctly identifies the multi-hop evolution: JASSM moved from a stable role in 2023 to increased production and backlog contribution in 2024. It accurately links JASSM to the broader tactical missile ramp-up and notes its strategic importance. However, the claim about a 'sharp drop in MFC operating profit' is extraneous and unverified, as the original answer does not mention profitability. (4) Contextually, the answer addresses the question’s focus on production activity and backlog contribution, and correctly identifies JASSM’s rising importance. But the inclusion of unsupported financial totals and overstatement of JASSM’s share in the $1.2B increase significantly reduce factual reliability. While the direction of change is correct, the numerical foundation is flawed, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 523,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM Chase’s credit‑risk assessment for its Business‑Banking loans has not materially changed – in both 2023 and 2024 the firm says delinquency rates are the primary credit‑quality indicator, with geographic distribution used as a secondary factor for “auto and business‑banking loans” (2023 p. 242; 2024 p. 250). Consequently, loans that are 30 days or more past due continue to serve as the early‑warning signal of borrower distress, while the added focus on regional concentration helps flag emerging stress in specific markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that JPM's credit-risk assessment did not materially change between 2023 and 2024. The ground truth states there was a clear evolution—from a focus on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment in 2023 to a 2024 emphasis on delinquency rates as the primary credit quality indicator. The LLM incorrectly claims delinquency rates were already the primary indicator in 2023, contradicting the original answer. (2) Quantitatively, the LLM correctly references 30 days past due as the delinquency threshold and cites page numbers (2023 p. 242; 2024 p. 250), which are plausible and format-consistent. There are no numeric inaccuracies, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the question asks about a shift between years, but the LLM denies such a shift occurred, failing to synthesize the evolution described in the ground truth. It also introduces 'geographic distribution' as a secondary factor, which is not mentioned in the original answer and distracts from the core shift toward delinquency tracking. (4) While the LLM addresses the concept of early warning signs (30+ days past due), it misses the strategic implications of the shift—namely, a more proactive stance, alignment with broader consumer loan risk frameworks, and earlier intervention. Thus, despite some correct elements, the answer misrepresents the central claim of evolution in focus, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 432,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Target’s Strategic Performance Plan II was first amended and restated in the 2022 filing, becoming effective May 1 2022 (see Exhibit F) 【page_70】. The 2023 filing still points to that same 2022 amendment with no further structural changes, but the weighted‑average grant‑date fair values for the plan’s restricted‑stock and performance‑share units dropped from $208.80 and $216.63 in 2022 to $160.91 and $162.54 in 2023 【page_60】. This continuity indicates that Target’s executive‑compensation framework maintains a stable, long‑term incentive design while modestly scaling award values in response to market or performance considerations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the SPP II plan was described under the 2016 Plan Statement in the 2022 filing and updated to the 2022 Plan Statement (effective May 1, 2022) in the 2023 filing, indicating a formal amendment. However, the LLM incorrectly states that the amendment occurred in the 2022 filing and became effective May 1, 2022 — this misplaces the timing of when the change was reported. The amendment should appear in the 2023 filing, not the 2022 one. (2) The LLM introduces quantitative data — weighted-average grant-date fair values for restricted stock and performance-share units — dropping from $208.80 and $216.63 in 2022 to $160.91 and $162.54 in 2023 — which are not present in the original answer and cannot be verified against the ground truth. Since these numbers are not in the reference, their inclusion suggests fabrication or hallucination, severely undermining quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the evolution of the plan terms across filings. Instead of noting the shift from the 2016 to the 2022 plan statement between the 2022 and 2023 filings, it incorrectly frames the amendment as occurring in the 2022 filing. This breaks the core logic of the question, which hinges on comparing how the plan description changed between the two filings. (4) While the LLM attempts to interpret the implications for executive compensation — suggesting stability with modest scaling — this conclusion is based on incorrect premises and fabricated data. The contextual relevance is moderate because it addresses the right topic and attempts analysis, but the factual foundation is unsound, leading to an incorrect overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 485,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "In the 2022 filing Eli Lilly noted that under the Olumiant license Incyte remained eligible for up to $100 million of additional success‑based regulatory milestones and up to $100 million of sales‑based milestones [page_72 (2022)]. The 2024 filing repeats those same caps – Incyte is still eligible for up to $100 million each for regulatory and sales milestones – while the earlier $210 million (2020) and $260 million (2021) milestone payments have been capitalized and are now being amortized, so the potential future obligations have not increased [page_72 (2024)].",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) Quantitatively, the LLM incorrectly states that in 2024, Incyte is still eligible for up to $100 million in regulatory milestones and another $100 million in sales milestones. The ground truth indicates that by 2024, there is no mention of remaining regulatory milestones, implying they are no longer applicable or have been resolved, and only royalty payments (up to 20% tiered, low teens for COVID-19 sales above a threshold) are explicitly referenced. The LLM's claim that 'the 2024 filing repeats those same caps' is factually incorrect. (2) The mention of $210 million (2020) and $260 million (2021) milestone payments being amortized is not present in the original answer and introduces unverified data, potentially confusing historical payments with future obligations. (3) Qualitatively, the reasoning fails the multi-hop synthesis: the question asks how obligations evolved from 2022 to 2024, and the correct inference is a shift from a dual milestone structure (regulatory + sales) to one focused on sales-based royalties. The LLM instead asserts continuity, missing the evolution entirely. (4) Contextually, the answer addresses the right topic and cites plausible document locations, but the core conclusion is incorrect. While the 2022 portion is accurate, the 2024 analysis is fundamentally flawed, leading to a low correctness score despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 404,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco’s APJC segment produced roughly $8.0 billion of revenue (with a gross margin of about $5.2 billion) in fiscal 2022【page_105】.  The goodwill tied to that segment was $5.36 billion at the end of FY 2022 and rose only modestly to $5.38 billion at the end of FY 2023【page_76】, indicating that the company’s financial exposure in APJC remained essentially flat, with a small increase in the asset‑related exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitative Accuracy: The LLM claims Cisco's APJC segment generated $8.0 billion in revenue and $5.2 billion in gross margin in fiscal 2022, and reports goodwill of $5.36 billion (FY2022) and $5.38 billion (FY2023). However, the ground truth states that no specific financial figures for APJC were disclosed in 2022, and the $5.382 billion figure in 2023 refers to total assets in APJC—not goodwill. Thus, the LLM misidentifies both the metric (assets vs. goodwill) and the year (misattributing detailed disclosures to 2022). (2) Completeness: The question asks about the evolution of financial exposure based on segment reporting and asset balances. The LLM incorrectly asserts detailed segment revenue and margin data were available in 2022, which contradicts the ground truth. It also fails to note that 2022 lacked itemized asset values, a key point in the evolution of disclosure transparency. (3) Entity Accuracy: The LLM confuses 'goodwill' with 'total assets'—a critical error in financial terminology. The cited values may be close numerically ($5.38B vs. $5.382B) but refer to different line items. (4) Reasoning: The conclusion that exposure 'remained essentially flat' is unsupported, as the ground truth does not provide 2022 asset values for comparison. The LLM fabricates data for 2022 and draws a false comparison. (5) Semantic Equivalence: The LLM suggests increasing financial exposure due to small asset growth, while the ground truth emphasizes improved disclosure granularity (from no itemized data in 2022 to $5.382B asset figure in 2023), not stability. The core narrative is incorrect. The answer is contextually relevant in discussing Cisco's APJC exposure over time but fails on factual and reasoning grounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 495,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "In 2022, Lilly’s partnership with Boehringer Ingelheim on the Jardiance family was a global joint‑development and commercialization agreement that split development and marketing costs equally in the major markets and generated royalties on net sales, as noted in the 2022 10‑K (see the revenue discussion and Note 4)【LLY_10k_2022.pdf page_45】. By 2024, after the Inflation Reduction Act led HHS to select Jardiance for government‑set pricing (a 66 % discount effective 2026)【LLY_10k_2024.pdf page_45】, the parties amended the agreement, reallocating commercialization responsibilities in certain smaller markets and receiving a $300 million one‑time payment to Lilly, reflecting a strategic adjustment to the new regulatory pricing environment while preserving the core cost‑share and royalty structure【LLY_10k_2024.pdf page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key factual inaccuracies. It correctly identifies the LLY-Boehringer Ingelheim collaboration on Jardiance, the impact of the Inflation Reduction Act (IRA), and the 66% discount. However, it incorrectly states the effective date of the 66% discount as '2026' (ground truth: August 2024), which is a major error. It also introduces a $300 million one-time payment to Lilly in 2024, which is not mentioned in the ground truth and cannot be verified from the provided context. (2) Quantitative accuracy is compromised: while 66% discount and collaboration cost-sharing are correctly noted, the timing (2026 vs 2024) and the $300M payment are incorrect. The ground truth emphasizes revenue impact in 2024 due to the discount applied that year, not in 2026. (3) The reasoning is partially sound—LLM recognizes the IRA triggered strategic changes and that the collaboration evolved, showing multi-hop synthesis between regulatory change and business response. However, the unsupported claim about agreement amendments and payment undermines the reasoning. (4) Contextual relevance is high—the answer addresses the evolution of the collaboration in response to regulation and cites appropriate documents. Due to significant factual errors in timing and unverified financial figures, the correctness score is reduced to 6, reflecting partial accuracy with major flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 396,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "In the 2022 filing GM warned that a safety‑recall on a global platform—citing the Chevrolet Bolt EV—could generate large repair costs and reputational damage that would threaten its ability to lead in new EV and autonomous‑vehicle (AV) technologies. By the 2023 filing the company not only repeated that warning but quantified the impact, reporting $2.1 billion of recall‑related warranty costs, $2 billion of EV‑related adjustments and a $0.8 billion increase in AV‑engineering spend, showing a heightened focus on the concrete financial and brand‑risk consequences of recalls for its EV/AV positioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While the original answer states that GM shifted focus from financial to reputational risks between 2022 and 2023—especially regarding EV/AV leadership—the LLM introduces specific dollar amounts ($2.1 billion in warranty costs, $2 billion in EV adjustments, $0.8 billion in AV spend) that are not present in the ground truth and cannot be verified from the provided context. These figures appear fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no mention in the original answer of GM 'quantifying the impact' with these numbers in the 2023 filing, nor any indication that such costs were explicitly tied to the Bolt recall in the way described. The original emphasizes a qualitative evolution in risk framing (from cost to reputation), not a numerical escalation. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the Chevrolet Bolt EV as a key example, recognizes the connection between recalls and EV/AV strategy, and notes a progression between 2022 and 2023. However, it distorts the nature of that evolution by overemphasizing financial quantification absent in the source. (4) Contextually, the answer addresses the right themes—global platforms, recalls, EV/AV positioning—and the general timeline is correct. But the insertion of unverified financial data reduces factual reliability. The core insight about increasing strategic concern is aligned, but the evidence used to support it is incorrect. Thus, while contextually relevant and somewhat qualitatively accurate, the answer fails on quantitative correctness, dragging down overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 473,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "In 2022 the “Other long‑term debt” line – which is made up of the Guaranteed Senior Notes issued by Costco’s Japanese subsidiary – was $590 million 【page_52】, and the filing notes that this category “consists of Guaranteed Senior Notes issued by the Company’s Japanese subsidiary” 【page_51】. By September 2024 that balance had risen to $919 million 【page_52】, after the subsidiary issued four new Guaranteed Senior Notes worth about $500 million in November 2023 (fixed rates 1.40%‑2.12%, maturities 2033‑2043) and repaid $77 million in July 2024 【page_52】. The increase and the use of low‑cost, long‑dated Japanese notes show Costco is diversifying its debt base and locking in inexpensive, long‑term financing to support its growth strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four new Guaranteed Senior Notes in November 2023 totaling approximately $500 million at fixed rates between 1.40% and 2.12%, with maturities from 2033 to 2043, and the July 2024 repayment of $77 million, which aligns with the ground truth. However, the LLM introduces specific balance figures — $590 million in 2022 and $919 million in 2024 — that are not present in the original answer and contradict the ground truth, which does not provide exact balances for those years, only qualitative descriptions. These numbers appear to be hallucinated or extracted from a source not reflected in the ground truth. (2) The calculation implied by the LLM — that a $500 million issuance minus $77 million repayment should result in a net increase of $423 million — does not support the claimed rise from $590 million to $919 million (a $329 million increase), suggesting internal inconsistency. The ground truth does not confirm any total balances, only that ~$500 was issued and $77 was repaid. (3) The multi-hop reasoning is sound in linking the Japanese subsidiary’s debt activity across 2022–2024 and inferring strategic intent around long-term financing, diversification, and low-cost debt. The conclusion about Costco’s strategy is logically supported by the disclosed terms and is semantically aligned with the ground truth’s interpretation. (4) While the qualitative reasoning and contextual relevance are strong, the quantitative inaccuracies — particularly the unsupported dollar amounts for 2022 and 2024 balances — significantly reduce factual correctness. The core events (issuance, repayment, rates, maturities) are accurate, but the framing around balance changes is incorrect, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 489,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments rose from **$11.9 billion at July 30 2022** to **$15.6 billion at July 29 2023** – an increase of roughly **$3.6 billion (about 30 %)**【page_50†L9-L13】【page_47†L9-L13】.  This rebound after a 2022 decline shows the company is deliberately rebuilding its high‑quality, investment‑grade debt portfolio, using its strong cash position to preserve liquidity and earn returns that support its broader capital‑allocation strategy (acquisitions, share repurchases, dividends and other strategic investments)【page_50†L31-L38】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change in Cisco's available-for-sale debt investments between 2022 and 2023. The ground truth states that the total value of these investments decreased from $15,592 million in 2022 to $9,865 million in 2023—a drop of $5,727 million—indicating a strategic reduction. However, the LLM claims an increase from $11.9 billion to $15.6 billion, which is the opposite of the actual trend. This error invalidates the entire quantitative and qualitative analysis. The cited pages (50 and 47) appear to be misinterpreted, as the LLM references a 'rebound' and 'rebuilding' strategy, while the ground truth indicates a drawdown in holdings. Additionally, the ground truth notes only $9 million in gains in 2022, underscoring the minor role of these investments, which the LLM omits entirely. The reasoning is therefore flawed, and the conclusion about Cisco's strategy is unsupported. While the answer addresses the question's structure (change in value and strategic implication), the factual basis is entirely incorrect, leading to a very low correctness score. Minor contextual relevance is retained because the answer discusses investment strategy in the right domain (debt instruments, capital allocation), but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 361,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "In the 2023 Form 10‑K JPMorgan warned that a successful cyber‑attack – especially one that compromised a third‑party vendor or exploited open‑source software – could “significantly disrupt … operations” and could leave the firm “unable, or with extended delays, to fully recover and restore data” (see 2023 p. 25‑26). The 2024 filing repeats those same system‑damage concerns but adds a sharper focus on “oversight of third‑party vendors and early detection of attacks … including ransomware attacks” and stresses the challenge of “recover[ing] from outages that could be caused by a malware or ransomware attack” (see 2024 p. 27‑28), indicating that the firm’s exposure remains high and its risk language has been expanded to highlight vendor‑oversight and ransomware‑related data‑recovery risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies JPMorgan Chase's evolving exposure to system damage risks from 2023 to 2024, focusing on third-party vendor attacks and data recovery challenges. The 2023 risks—disruption from cyberattacks, third-party vendor compromises, and data recovery delays—are accurately cited with reference to the 10-K (pp. 25–26). The 2024 update correctly highlights increased emphasis on ransomware attacks, third-party vendor oversight, and difficulties recovering from outages due to malware or ransomware (pp. 27–28). (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, compares evolving risk disclosures, and correctly infers that the firm’s risk awareness has expanded rather than fundamentally changed. The LLM accurately captures the progression from general system damage risks to more specific ransomware and vendor-related concerns. (4) The only minor shortcoming is that the LLM does not explicitly mention the new concern about 'inability to prevent systems from processing fraudulent transactions' or the risk of losses exceeding cyber insurance coverage, both noted in the ground truth for 2024. While the emphasis on ransomware and recovery challenges is correct, this omission slightly reduces completeness. However, the core evolution in exposure—increased focus on third-party vendors and ransomware-related recovery—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the question with precise citations and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 495,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco’s 2022 filing noted that a key driver of growth is “increasing the penetration of our private‑label items” (page 22). By 2024 the company has invested in expanding its operating footprint—about 130.9 million sq ft of warehouse space and 31.9 million sq ft of distribution‑logistics facilities—and has added dedicated processing, packaging and manufacturing facilities to produce its private‑label products (page 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Costco's strategic focus on private-label growth from the 2022 filing and accurately reflects the operational investments made by 2024, including dedicated processing, packaging, and manufacturing facilities to support internal production—this aligns with the ground truth's key point about shifting from external sourcing to internal production capabilities. The qualitative reasoning and entity accuracy (Costco, 2022 strategy, 2024 execution, private-label focus) are sound and contextually relevant. However, the LLM introduces specific square footage figures (130.9 million sq ft warehouse space, 31.9 million sq ft distribution-logistics) that are not present in the original answer and are not directly tied to private-label production investments. These numbers may be factually correct in a broader operational context but are not specified in the ground truth as part of the private-label strategy investment, making them potentially misleading or unsupported in this specific context. This affects quantitative accuracy, as the inclusion of precise figures without grounding in the original data introduces unverified information. While the core multi-hop reasoning—linking 2022 strategy to 2024 operational investments—is correct and well-synthesized, the addition of extraneous quantitative details reduces confidence in the numerical precision. Thus, the answer is mostly correct with strong reasoning but slightly overreaches on unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 411,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "In the 2022 filing UnitedHealth explained that its Medicaid‑managed‑care bids are built on assumptions about enrollment, utilization and medical‑cost trends, and warned that a material error in those assumptions—whether from unexpected program or policy changes or a competitor’s lower bid—could hurt its results. The 2023 filing repeats the same strategy (now phrasing the process as “soliciting” bids) and the same set of risks, indicating that the company’s approach to bid assumptions and the exposure to bid‑accuracy risk has remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of UnitedHealth Group's approach to Medicaid managed care bidding. The original answer (ground truth) states that there was a clear evolution from 2022 to 2023: in 2022, the focus was on the risk of losing Medicaid members due to failure to renew contracts, while in 2023, the company shifted to emphasizing the accuracy and assumptions behind the bids themselves (e.g., enrollment, utilization, medical costs) and how errors in those assumptions could materially affect operations. This reflects a meaningful change in risk disclosure focus—from contract renewal risk to bid assumption risk. However, the LLM answer incorrectly asserts that the approach 'has remained essentially unchanged' and that the 'same set of risks' were repeated in 2023, which directly contradicts the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers or dates, hence a score of 10. Qualitative accuracy is low (3) because the model failed to identify the shift in emphasis and misrepresented the nature of the evolution. Contextual relevance is moderate (6) because the answer discusses the right topic (Medicaid managed care bidding, assumptions, risks) and correct years, but draws the wrong conclusion. The multi-hop reasoning failed: the model should have compared the 2022 and 2023 disclosures and identified the shift in focus, but instead claimed continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 412,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "In 2022 MetLife’s Municipals were $159 million in pension‑benefit assets and $15 million in other post‑retirement assets – all recorded as Level 2 items in the fair‑value hierarchy. By year‑end 2023 the holdings fell to $147 million and $8 million respectively (total ≈ $155 million) and remained classified solely as Level 2, with no Level 1 or Level 3 exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, MET's investment in Municipals was $14,212 million in 2022, not $174 million ($159M + $15M) as stated. The 2023 value is reported as $159 million in the ground truth, but the LLM claims a total of approximately $155 million ($147M + $8M), which is inconsistent. More critically, the ground truth states that in 2022, the valuation was under 'Estimated Fair Value' without a detailed hierarchy breakdown, whereas the LLM incorrectly asserts that all 2022 holdings were classified as Level 2. This contradicts the original answer, which emphasizes the lack of detailed hierarchy in 2022. In 2023, the ground truth confirms a clear shift to Level 2 classification, which the LLM correctly identifies, but it wrongly implies that Level 2 classification was already present in 2022. (2) The numbers are significantly off: $14,212M vs $174M in 2022 and $159M vs $155M in 2023—especially the 2022 figure is off by over $14 billion. Calculations of totals are internally consistent in the LLM answer but based on incorrect data. (3) The multi-hop reasoning fails because the LLM misidentifies the composition and classification of the Municipals investment across years, failing to recognize the key evolution: a massive reduction in investment size and an improvement in transparency of valuation hierarchy (from no detailed breakdown to explicit Level 2). Instead, it fabricates a breakdown by asset type (pension vs other) not mentioned in the ground truth and misrepresents the 2022 classification. (4) The contextual relevance is moderate because the answer addresses valuation hierarchy and year-over-year change, but factual inaccuracies and invented data severely undermine correctness. Hence, low scores for correctness and quantitative accuracy; slightly higher for qualitative due to partial recognition of Level 2 in 2023; moderate relevance as it attempts the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 540,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "In FY 2022, Office 365 was sold mainly through traditional volume‑licensing and Software Assurance contracts, with the subscriptions recorded as unearned revenue and recognized ratably over the subscription period (2022 Item 8, pp. 63‑64). By FY 2024, Microsoft moved to a suite of more flexible, non‑expiring digital agreements—such as the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products & Services Agreement—that let customers of any size subscribe to Office 365 on a month‑or‑annual basis without a long‑term organization‑wide commitment, providing greater licensing flexibility (2024 Volume Licensing Programs, p. 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in FY 2022, Office 365 subscriptions were managed under volume licensing and recognized as unearned revenue, with ratable recognition over the contract period. By FY 2024, Microsoft introduced more flexible digital agreements—specifically naming the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products & Services Agreement—allowing for monthly or annual subscriptions without organization-wide commitments. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022 and 2024) are correctly referenced and contextually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in licensing models and customer agreement structures across two fiscal years, capturing the evolution from traditional volume licensing to modern, flexible digital agreements. (4) The only minor shortcoming is the omission of the explicit mention of 'no long-term commitment' being a shift toward 'customer-centric licensing flexibility'—a nuance present in the original answer—but the substance is conveyed through 'no long-term organization-wide commitment' and 'greater licensing flexibility.' Wording differs slightly but maintains semantic equivalence. No factual errors; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 399,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "In 2022 the Level 3 portion of MetLife’s Fixed‑Maturity Securities AFS consisted of $55 million of corporate securities and $3 million of “Other (1)” assets (total $58 million) (page 308). By 2023 the mix shifted to $54 million of corporate securities, $2 million of foreign bonds and $8 million of “Other (1)” assets (total $64 million) (page 308), indicating a modest increase in Level 3 holdings and the addition of foreign‑bond exposure, which suggests the company is slightly expanding into less‑observable, potentially higher‑yielding securities to diversify and enhance returns within its fixed‑maturity portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS included $1M in Corporate bonds, $1M in Foreign Bonds, and $11M in Equity Securities—not $55M in corporate securities and $3M in 'Other (1)' as claimed. In 2023, the correct composition is $54M in Corporate bonds, $2M in Foreign Bonds, and $828M in Other Investments, whereas the LLM reports only $8M in 'Other (1)' assets, missing $820M. The LLM also mislabels Equity Securities as 'Other (1)' and omits the massive shift into Other Investments. (2) Quantitative accuracy is severely compromised: the LLM underreports 2022 total by ~$47M (claims $58M vs actual $13M) and 2023 total by ~$772M (claims $64M vs actual $884M). The $828M in Other Investments is misrepresented as $8M—a critical error. (3) Multi-hop reasoning is flawed: the LLM fails to recognize the strategic pivot toward 'Other Investments' and instead suggests a modest shift toward foreign bonds and higher-yielding securities, which misrepresents the company's actual strategy. The conclusion about 'slightly expanding' is incorrect given the 75x increase in Other Investments. (4) Contextual relevance is moderate—the answer addresses the question's structure and cites a page reference, but the factual foundation is so inaccurate that the reasoning and implications are invalid. The model appears to have accessed incorrect or misaligned data, leading to a fundamentally wrong analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 417,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "In the 2022 filing Microsoft presented Office 365 as a distinct cloud‑based subscription that drives “Service and other revenue” alongside Azure, Dynamics 365 and Xbox (2022 10‑K, p. 62). By the 2024 filing the company’s narrative has shifted to treat the productivity suite (now part of Microsoft 365) as a core, AI‑infused element of its overall cloud platform, stressing heavy investment in generative AI and the need to counter AI‑driven rivals (2024 10‑K, p. 14; p. 21). This reflects a move from positioning Office 365 mainly as a revenue line to embedding it within a broader, AI‑enhanced cloud services portfolio to meet competitive pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Office 365 was positioned as part of 'Service and other revenue' in 2022 alongside Azure, Dynamics 365, and Xbox, and by 2024 it evolved into an AI-infused component of Microsoft's broader cloud strategy. The shift from standalone product to integrated AI-enhanced suite is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings, correctly identifying the strategic evolution and competitive context. It references specific pages (p. 62 for 2022, p. 14 and 21 for 2024), which supports traceability, though these are not required for correctness. (4) The only minor limitation is that the LLM refers to 'Microsoft 365' without explicitly clarifying that Office 365 is now part of that broader suite—though this is a common and reasonable interpretation, the original answer emphasizes the integration more directly. Otherwise, the answer is semantically equivalent, contextually precise, and fully addresses the question’s focus on strategic positioning, cloud portfolio integration, and competitive response to AI-driven offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 381,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "UnitedHealth’s credit‑related‑impairment policy did not change in substance – the company still reviews available‑for‑sale debt securities only when fair value is below amortized cost and looks at expected cash‑flows, the issuer’s credit quality and ratings – but the 2023 filing adds more detail, stating that the present value of expected cash‑flows, the issuer’s financial condition, near‑term prospects and any specific events are also considered and that any impairment is recorded as an allowance offset to investment and other income (see 2023 pages 47 & 51).  In both years the allowance for credit losses on these securities was disclosed as “not material,” meaning the financial impact was negligible in 2022 and again in 2023 (see 2022 page 57 and 2023 page 51).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and financial impact. (1) It accurately states that UnitedHealth Group evaluated available-for-sale debt securities in both 2022 and 2023 based on expected cash flows, credit quality, and ratings, and correctly notes that the allowance for credit losses was 'not material' in both years—this matches the original answer and is factually consistent. (2) Quantitatively, there are no numerical values to verify beyond the 'not material' disclosure, which is correctly attributed to both years and supported by page references (2022 p.57, 2023 p.51), so quantitative accuracy is perfect. (3) Regarding reasoning and multi-hop synthesis: the LLM captures the evolution in disclosure detail from 2022 to 2023, noting the addition of present value of expected cash flows, issuer financial condition, and specific events in 2023. It also correctly identifies the change in accounting presentation—credit-related impairments recorded as an allowance against investment income—which reflects the segmentation mentioned in the ground truth. However, it omits explicit mention of the formal distinction between credit-related and non-credit-related impairments and does not state that non-credit impairments are recognized in other comprehensive income, a key methodological refinement in 2023. This omission slightly weakens the qualitative accuracy. (4) The answer remains contextually relevant and focused on the evolution of methodology and financial impact. While the financial impact ('not material') is correctly assessed, the explanation of methodological evolution, though accurate in detail, underrepresents the structural shift in impairment recognition. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 493,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "In 2022, Fixed‑maturity securities held as “available‑for‑sale” represented about 82 % of MET’s pension‑plan assets ($6,802 million) and roughly 96 % of its other post‑retirement‑benefit assets ($1,256 million)【page_308】. By 2023 the mix was essentially unchanged for the pension plan – still about 82 % of total assets ($6,714 million, a $88 million drop) – but the other post‑retirement allocation slipped slightly to around 94‑95 % of assets ($1,274 million, a $18 million rise)【page_308】【page_307】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. However, the LLM states 82% and 96%, respectively, which are incorrect. Additionally, the LLM introduces specific dollar values for 2022 ($6,802 million for pensions and $1,256 million for other benefits), but these figures are not present in the original answer and are unsupported by the ground truth. The 2023 values ($6,714 million and $1,274 million) match the ground truth and are correctly cited. (2) Calculations: The LLM claims a $88 million drop in pension assets and an $18 million rise in other benefits, but since the 2022 dollar amounts are fabricated (not in ground truth), these comparisons are invalid. The ground truth does not provide 2022 dollar values, so such calculations cannot be made. (3) Multi-hop reasoning: The LLM attempts to show evolution from 2022 to 2023 but misrepresents the nature of the data shift. The original answer emphasizes a change in reporting style—from percentage-based allocation in 2022 to valuation-based disclosure in 2023—whereas the LLM treats both years as having comparable percentage and dollar data, which distorts the actual evolution. (4) Despite these errors, the answer is contextually relevant and correctly identifies the entities (MET, Fixed Maturity Securities AFS, pension and other postretirement benefits) and years. It also correctly reports the 2023 fair values. However, the introduction of false 2022 dollar figures and incorrect percentages severely undermines factual accuracy, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 476,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "In the 2022 Form 10‑K, Lowe’s placed Kitchens & Bath inside the broader **Home Décor** segment – a group that generated $34.0 billion of net sales, or roughly 35 % of total revenue (see page 55). By the 2023 filing, Kitchens & Bath is listed as a **stand‑alone product category** among the company’s core assortments (see page 6), signaling that Lowe’s has moved the line out of a catch‑all segment and is now positioning it as a distinct, strategically important part of its portfolio. This shift suggests the retailer is elevating Kitchens & Bath’s prominence, treating it as a key growth driver within its overall product mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in positioning of the Kitchens & Bath category from being part of Home Décor in 2022 to a standalone category in 2023, which aligns with the ground truth's core insight about increased strategic importance. However, there is a factual inaccuracy in the quantitative claim: the LLM states that Home Décor generated $34.0 billion (35% of total revenue) in 2022, but this figure is not supported by the ground truth and introduces data not present in the original answer. The ground truth does not provide any financial figures for the Home Décor segment or Kitchens & Bath specifically, so this number appears to be fabricated or misattributed. (2) The calculation of 35% of total revenue is not verifiable from the provided ground truth and cannot be confirmed as accurate; thus, this represents a significant quantitative error. (3) The reasoning about repositioning Kitchens & Bath as a standalone, strategically important category is sound and reflects correct multi-hop synthesis between the 2022 and 2023 filings. While the ground truth frames the shift as moving from Home Décor to core construction categories (e.g., Lumber, Building Materials), the LLM interprets this as becoming a 'standalone' category — a slightly different framing but semantically reasonable and consistent with increased prominence. (4) Despite the incorrect numerical addition, the qualitative interpretation and strategic implication are well-reasoned and contextually appropriate, fully addressing the question’s intent regarding evolving strategic positioning and relative importance. Hence, high scores for qualitative accuracy and contextual relevance, but a moderate deduction in quantitative accuracy and overall correctness due to unsupported financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 493,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez’s 2022 filing still listed cheese & grocery as an “adjacent, locally relevant” category that generated roughly $1.9 billion of net revenue in 2020‑21 (up modestly from $1.825 billion in 2019)【page_136】. The 2024 filing’s strategy section again describes cheese & grocery only as an adjacent business, without a dedicated strategic priority, while emphasizing core snack categories (chocolate, biscuits, baked snacks) as the engine of long‑term growth【page_34】. This continuity shows that cheese & grocery remains a peripheral line‑item rather than a growth focus, confirming Mondelez’s prioritization of its core snack brands for future expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that the $1.9 billion revenue figure is from 2020–21, while the ground truth specifies $1,990 million in 2022. This misalignment in both amount and year undermines factual correctness. Additionally, the LLM references $1.825 billion in 2019, which is not mentioned in the ground truth and introduces unverified data. (2) The revenue number is close in magnitude ($1.9B vs $1.99B) but attributed to the wrong time period, and the ground truth emphasizes a strategic shift *between 2022 and 2024*—a key evolution the LLM fails to capture. In 2022, Mondelez directly produced Cheese & Grocery; by 2024, it only held a strategic stake. The LLM incorrectly implies continuity rather than change, missing the core multi-hop insight. (3) While the LLM correctly identifies that Cheese & Grocery is treated as an 'adjacent' category in 2024 and that core snacks are prioritized, it fails to synthesize the evolution: from direct production in 2022 to a reduced footprint in 2024. This omission weakens the reasoning about strategic shift. (4) Despite these flaws, the answer is contextually relevant and captures the qualitative direction of strategy—prioritizing core snacks. The reasoning is partially sound but lacks the critical before-and-after contrast needed for full accuracy. Hence, correctness is partially compromised due to incorrect dates, numbers, and incomplete synthesis of change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 410,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10‑K, Abbott’s enteral‑feeding products are listed as “Jevity … Freego™ (Enteral Pump) and Freego™ sets” – Jevity appears first in the list【page_3】. The 2023 10‑K shows the same sequence, with Jevity still listed before the Freego™ pump and sets【page_4】, so the relative positioning of Jevity did not change.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the relative positioning of Jevity and Freego™ products did not change between the 2022 and 2023 filings, directly contradicting the ground truth. While the answer correctly identifies that Jevity was listed first in both years (entity and order accuracy), it fails to detect the significant reordering of the product list. According to the ground truth, in 2022, Freego™ products were listed after Glucerna and Osmolite®, but in 2023, they were moved immediately after Jevity—indicating a strategic shift in emphasis. The LLM incorrectly states the sequence is 'the same' in both years, missing this key change. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is low due to flawed reasoning and failure in multi-hop synthesis: the model should have compared the full sequence across years but instead oversimplified the comparison. Contextual relevance is moderate because the answer addresses the right documents and products but draws an incorrect conclusion. The omission of the full product sequence and the misinterpretation of positioning undermine the answer’s validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 341,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "MetLife’s municipal holdings slipped from $174 million at year‑end 2022 (‑ $159 m in pension assets and $15 m in other post‑retirement assets) to $155 million at year‑end 2023 (‑ $147 m and $8 m respectively), and in both periods the securities were classified as Level 2 (observable‑input) assets in the fair‑value hierarchy. The modest reduction in fair‑value exposure while retaining a Level 2 classification indicates the company is trimming its municipal exposure but deliberately keeping it in the more transparent, lower‑credit‑risk segment of the market, reflecting a conservative credit‑risk management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that MET's municipal investments were $14,212 million in 2022 and dropped to $159 million in 2023. The LLM claims the values were $174 million in 2022 and $155 million in 2023—off by over 98% in the 2022 figure. This is a critical error. Additionally, the LLM breaks down the amounts into pension and post-retirement assets, which is not mentioned or supported in the ground truth. (2) The quantitative inaccuracies are severe: the 2022 value is wrong by more than $14 billion, and the 2023 value, while closer, is still incorrect. The LLM also introduces non-existent sub-components ($159m in pension assets, etc.) with no support from the original data. There are no correct calculations based on accurate inputs. (3) The reasoning is flawed due to incorrect data. The LLM concludes that the reduction is 'modest' and reflects a strategy of retaining exposure in a 'more transparent, lower-credit-risk segment,' but the ground truth shows a near-elimination of the position—from over $14B to $159M—indicating a drastic de-risking, not a modest trim. The original answer notes a shift in strategy to reduce credit exposure, which is contradicted by the LLM’s interpretation. (4) The contextual relevance is moderate because the answer addresses the right topic (municipal investments, fair value, classification, credit risk), but the factual foundation is so weak that the conclusions are invalid. The mention of Level 2 classification in 2023 aligns with the ground truth, but the LLM incorrectly implies it was also Level 2 in 2022, which the original does not state. Overall, the answer fails on correctness due to catastrophic numerical errors and resulting faulty reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 485,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "In 2022 Abbott reported interest‑rate hedge contracts covering roughly $2.9 billion of debt (the balance‑sheet “interest‑rate hedge contracts (payable)” showed a fair‑value liability of $156 million) 【page_66】. By year‑end 2023 the notional amount had fallen to about $2.2 billion (fair‑value liability $95 million) 【page_64】, a decline explained by the maturity of $700 million of hedge contracts in 2023 【page_65】. These contracts are designated as fair‑value hedges that offset the fair value of fixed‑rate debt, effectively converting that portion of the debt to a variable‑rate exposure and allowing Abbott to manage its interest‑rate risk on its fixed‑rate borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 notional value. The ground truth states that Abbott's interest rate hedge contracts were approximately $2.2 billion in both 2022 and 2023, with consistent notional value. However, the LLM claims $2.9 billion in 2022 and $2.2 billion in 2023, citing a $700 million decline due to maturities. This contradicts the original answer, which states the notional value remained consistent. The $2.9 billion figure appears to be a misreading or error, as no such amount is supported by the ground truth. The fair value liabilities ($156M and $95M) are plausible details but were not part of the original answer and do not compensate for the core error in notional value. (2) The calculation of a $700 million decline from $2.9B to $2.2B is mathematically correct, but the premise is false—there was no decline according to the ground truth. Thus, the quantitative accuracy is low because the key financial metric (notional value in 2022) is incorrect. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the purpose of the hedges (to convert fixed-rate debt to variable-rate via fair-value hedges) and links them to interest rate risk management. It also correctly notes the continued use in 2023. However, it fails the multi-hop synthesis by incorrectly asserting a change in notional value when the ground truth emphasizes consistency. It also introduces a detail about maturity-driven decline not present in the original. (4) Contextual relevance is high because the answer addresses the right topic, time frame, and financial instruments, and explains their role in debt management. However, the core factual error in the notional amount severely undermines correctness. The answer would score higher if the numbers aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 505,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "By 2022 3M’s fixed‑rate registered‑note portfolio was largely composed of low‑coupon issues – for example a $500 million note at 1.86 % due 2023 and a $750 million note at 2.12 % due 2025 – and the company was no longer issuing new notes of this type, focusing instead on managing the existing pool【page_87】. In the following years it began retiring those securities, repaying the $500 million of fixed‑rate registered notes that matured in 2023 and then $1.1 billion of medium‑term (including fixed‑rate) notes in 2024【page_69】, while continuing the interest‑rate‑swap program started in 2021 that converted $800 million of long‑dated 2049/2050 fixed‑rate notes into floating‑rate debt to reduce fixed‑rate exposure【page_69】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and maturities. It incorrectly states a $500 million note at 1.86% due 2023 and a $750 million note at 2.12% due 2025, which do not appear in the ground truth. The correct 2022 fixed-rate notes were $600 million at 3.05% due 2030 and $650 million at 3.70% due 2050. The August 2019 issuance of $3.25 billion (including $1 billion due 2029 and $1 billion due 2049) is entirely omitted. The repayment amounts are partially correct: $500 million in 2023 and $1.1 billion in 2024 are accurate, but the 2024 repayment is mischaracterized as 'medium-term (including fixed-rate) notes' rather than specifically medium-term notes as per ground truth. (2) The interest rate swap detail is partially correct — the LLM correctly notes the 2021 swap program converting fixed-rate notes due 2049/2050 into floating-rate debt, but incorrectly quantifies the swapped amount as $800 million, which is not in the original answer. The ground truth does not specify a dollar amount for the swaps. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward reducing fixed-rate exposure via swaps and repayment, aligning with the ground truth's conclusion. However, it fabricates specific note details and omits key issuances, weakening the synthesis. (4) The contextual relevance is high — the answer addresses issuance, repayment, and interest rate strategy evolution. However, due to significant quantitative errors and omissions in the underlying data, the correctness score is limited to 5. The qualitative accuracy is moderate due to correct directional logic but flawed inputs. Quantitative accuracy is low due to incorrect dollar amounts, rates, and maturities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 480,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "In the 2023 filing Schwab said its “primary sources of capital are funds generated by the operations of subsidiaries **and securities issuances by CSC** in the capital markets” (page_59). By the 2024 filing the emphasis had shifted: the MD&A now identifies “cash generated by client activity … as the primary source of funds” and lists “cash provided by securities issuances by CSC in the capital markets” only among other, secondary funding sources (page_52). This reflects a move from treating securities issuances as a core pillar of capital to a supplemental component within a broader, client‑driven funding strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, securities issuances by CSC were a primary source of capital, citing the correct context from the 2023 filing (page_59), and notes the shift in 2024 where client-driven cash became primary, with securities issuances now listed among secondary sources (page_52). This matches the original answer's claim of a strategic evolution toward a more diversified funding approach. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years (2023, 2024), entity (CSC), and document references (page numbers) are correct, supporting full marks for quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, compares the changing role of securities issuances, and infers a strategic shift in capital structure—exactly what the question demands. The only minor gap is that the LLM does not explicitly mention other specific funding tools like FHLB borrowings, repurchase agreements, or CDs, which are noted in the ground truth as part of the diversified 2024 strategy. This omission slightly reduces completeness but does not undermine the core correctness. (4) The answer is contextually excellent—directly responsive, well-supported with quotes and page references, and logically structured. The conclusion about a shift to a 'client-driven funding strategy' is a valid interpretation. Overall, this is a strong, factually correct response with only a slight reduction in qualitative accuracy due to incomplete enumeration of alternative funding sources in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 474,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola reported that the fairlife acquisition carried a $270 million contingent‑consideration liability (the best‑estimate fair value at acquisition) and that a $100 million milestone was paid in 2021 after fairlife met its 2020 targets. By the 2024 Form 10‑K the fair‑value of the remaining contingent‑consideration liability had risen to roughly $6.1 billion, representing the still‑unpaid milestone that is contingent on fairlife achieving its 2024 financial targets. The jump from $270 million to $6.1 billion indicates that fairlife’s operating results have been strong enough to substantially increase the estimated payout, suggesting it is meeting or exceeding the agreed‑upon performance targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the quantitative claim that the contingent liability increased from $270 million to $6.1 billion by 2024. The ground truth states that the remaining obligation was still $270 million (with the first $100 million already paid in 2021), and that the payment was contingent on targets through 2024, payable in 2025. There is no mention of a $6.1 billion liability in the original answer or in known public filings. This figure is grossly incorrect and unsupported. (2) The $100 million payment in 2021 for 2020 performance is correctly stated, and the initial $270 million contingent obligation in 2022 is also accurate. However, the claim of a 'rise' to $6.1 billion misrepresents the financial reality and implies performance far beyond what is indicated. No such revaluation is reported in Coca-Cola’s 2024 10-K. (3) The multi-hop reasoning is flawed: while the model correctly identifies the structure of milestone payments and links performance to payouts, it incorrectly infers a massive increase in liability as evidence of strong performance. The ground truth indicates the obligation remained active (not increased), suggesting fairlife was on track, but does not support any revaluation. The model fails to accurately synthesize the evolution of the liability over time. (4) Contextual relevance is high—the answer addresses the right companies, timeframes, and contractual structure. However, due to the severe quantitative error and resulting incorrect conclusion about performance, the overall correctness score is very low. A score of 2 reflects that only a few basic facts are correct, but the core financial claim and implication are false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 472,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "In 2022 Oracle’s filings framed OCI as a core pillar of its “Oracle Cloud” strategy, stressing worldwide deployment and the need to add data‑center capacity and new geographic locations so that its cloud‑infrastructure could compete globally and support enterprise‑IT workloads (see 2022 p. 21; cloud‑and‑license revenue now 85% of total, driven by cloud‑based infrastructure – 2022 p. 47). By 2024 the focus had shifted to “second‑generation” OCI, with restructuring‑plan investments directed to new resources and geographies that accelerate OCI delivery, and with OCI explicitly positioned alongside SaaS to offer fully integrated, hybrid/on‑premise enterprise solutions (see 2024 p. 54; OCI‑SaaS integration – 2024 p. 72; expanded data‑center equipment – 2024 p. 85). This evolution shows Oracle moving from building capacity and geographic reach to deepening OCI’s global market presence and embedding it within a broader, interoperable enterprise‑IT ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Oracle's strategic emphasis on OCI between 2022 and 2024 and correctly identifies key themes such as geographic expansion, infrastructure investment, and integration with enterprise IT solutions. It accurately notes that cloud and license revenue accounted for 85% of total revenue in 2022, which aligns with the ground truth. However, there are significant qualitative inaccuracies: the original answer states that in 2022, Oracle did *not* explicitly position OCI strategically, but rather reported cloud and license revenue without specific strategic language about OCI's market positioning. The LLM incorrectly claims that in 2022, Oracle already framed OCI as a 'core pillar' and emphasized global competition—this overstates the strategic emphasis present in the 2022 filings. By contrast, the ground truth shows the strategic shift *began* in 2024, when OCI was explicitly elevated alongside SaaS as a core component. The LLM also references specific page numbers (e.g., 2022 p. 21, 2024 p. 54) not present in the original answer or necessarily verifiable from the knowledge graph, introducing unsupported specificity. While the direction of evolution (from capacity building to integration) is plausibly inferred, the reasoning misrepresents the starting point of the strategic shift. Quantitatively, the 85% figure is correct and properly contextualized. Contextually, the answer addresses global market positioning and integration with enterprise IT, fulfilling the question’s scope. Thus, while the answer is well-structured and partially accurate, it contains key factual misstatements about the timing and nature of Oracle’s strategic evolution, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 473,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "In 2023 the bank‑loan schedule showed a blank (‑) entry for the allowance on pledged‑asset lines, meaning no credit‑loss reserve was recorded, and the filing noted that PALs were fully collateralized by securities 【page_146】. By 2024 the same zero‑allowance persisted, but the notes added that “substantially all PALs are also subject to the collateral‑maintenance practical expedient under ASC 326” and remain fully collateralized with securities in excess of the borrowings 【page_88】, indicating a more formalized, lower‑risk treatment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: both years show no allowance for credit losses on PALs, full collateralization by securities exceeding borrowings, and the introduction in 2024 of the collateral-maintenance practical expedient under ASC 326. The quantitative accuracy is perfect—no numerical inaccuracies, correct years (2023 and 2024), and proper interpretation of zero allowance. The answer correctly identifies the relevant accounting standard (ASC 326) and the risk-mitigating mechanism. However, the LLM slightly misrepresents the 2023 situation by stating there was 'no credit-loss reserve recorded' due to a blank entry, while the ground truth emphasizes a broader context of 'slight decrease in PALs' and 'improved credit quality metrics and lower projected loss rates' influencing the allowance. This missing context weakens the qualitative accuracy, as it omits the reasoning behind the 2023 risk profile improvement. Additionally, the LLM says 'substantially all' PALs were subject to the expedient in 2024, whereas the ground truth states 'all PALs' were fully collateralized and no allowance was required due to the expedient—this is a minor but notable discrepancy in precision. Despite these nuances, the core multi-hop synthesis across years and treatment evolution is sound, and the answer remains contextually relevant and factually strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 391,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "In FY 2023 Nike’s APLA geography was still run as a conventional, directly‑owned Nike Brand operating segment, with its workforce largely non‑unionized (the filing notes only that a few employees in the APLA geographies are union‑represented [2023 10‑K p.9]). By FY 2024 the company had re‑structured the APLA segment as a distinct reportable operating segment and begun moving certain country businesses to third‑party distributors – a divestiture that reflects a strategic shift toward a lighter, partner‑focused footprint and a stronger emphasis on digital and direct‑to‑consumer growth in the Asia‑Pacific and Latin America markets [2024 10‑K p.89; Note 18 on divestitures p.93].",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Nike's operational structure in APLA from FY2023 to FY2024, noting the transition from direct operations to use of third-party distributors, which aligns with the ground truth. It accurately references union representation in APLA in FY2023, though it adds a nuance—'largely non-unionized'—which is not contradicted by the original answer but adds interpretation. The strategic emphasis on a 'lighter, partner-focused footprint' and digital/DTC growth is consistent with the original's 'outsourced model' and 'optimize business model.' However, the claim that APLA became a 'distinct reportable operating segment' in FY2024 is not supported in the original answer and may reflect a misinterpretation of the restructuring. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is mostly sound: the model synthesizes information across two fiscal years and connects operational changes to strategic intent. The citation of the 2024 10-K and Note 18 supports the divestiture claim. However, the addition of 'reportable operating segment' status introduces a detail not present in the ground truth, slightly weakening the qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both operational structure and strategic emphasis over the two fiscal years. The core facts are correct, with only minor over-interpretation, justifying a high but not perfect correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 444,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "In the 2022 filing Abbott highlighted Pedialyte as a key growth engine for its U.S. Pediatric Nutritionals segment – sales in that business rose 10.3 % in 2021, “reflecting growth in Pedialyte, Similac and PediaSure”【page_31】. By the 2023 filing the company positions Pedialyte alongside a much broader set of infant‑formula, pediatric and adult nutrition brands, listing it as one of many products in an expanded Nutritional Products portfolio that now spans infant, pediatric and adult offerings【page_4】. This shift moves the focus from Pedialyte as a singular driver of U.S. pediatric sales to a component of a diversified, consumer‑direct nutrition strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Pedialyte as a key growth driver in 2022 within Abbott's U.S. Pediatric Nutritional business and notes its inclusion in a broader portfolio in 2023. However, there is a factual error in the quantitative claim: the LLM states that the 10.3% sales growth was in 2021, citing page 31, while the ground truth specifies this growth occurred in 2022. This misattribution of the year for the key metric significantly affects quantitative accuracy. (2) The percentage (10.3%) and product names (Pedialyte, Similac, PediaSure) are correct, but the incorrect year undermines the precision of the response. No other numbers or calculations are present. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes information across 2022 and 2023 filings to show a strategic shift—from Pedialyte being a growth contributor to being integrated into a broader nutritional portfolio. The interpretation of strategic evolution from a 'singular driver' to a 'component of a diversified strategy' aligns semantically with the ground truth's emphasis on formal recognition and structural integration. (4) Despite the date error, the overall qualitative analysis and contextual relevance are excellent. The answer addresses all parts of the question, correctly identifies entities (Abbott, Pedialyte, U.S. Pediatric Nutritional business), and draws a logical conclusion about strategic emphasis. The correctness score is reduced due to the incorrect year for the 10.3% growth figure, but not severely because the core strategic narrative remains accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 437,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX’s 7.100 % notes due 2027 carried a balance of **$135 million at the end of 2022 and the same $135 million at the end of 2023** (see the long‑term debt table showing “7.100 % notes due 2027 | 135 | 135” for 2023 vs. 2022)【page_84】. The unchanged balance indicates that RTX chose to keep this tranche of debt on its books rather than retire or refinance it, reflecting a debt‑management strategy that preserves existing obligations while using other issuances and repayments to shape its overall maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the key financial figures. According to the ground truth, RTX's aggregate principal balance for the 7.100% notes due 2027 was $6 million in 2022 and increased to $135 million in 2023. However, the LLM claims the balance was $135 million in both 2022 and 2023, which directly contradicts the ground truth. This error fundamentally undermines the answer's validity. (2) The quantitative accuracy is severely compromised: the 2022 figure is off by $129 million, and the claim of 'unchanged balance' is false given the actual 22.5x increase. The citation to a 'long-term debt table' appears fabricated or misread, as it does not align with the verified data. (3) The reasoning is flawed because it draws conclusions from incorrect data. The LLM infers a strategy of maintaining stable debt levels, while the actual data suggests a significant strategic shift—likely active acquisition or issuance related to these notes. The multi-hop synthesis fails because the model did not correctly identify the change over time. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and attempts to interpret strategy, but the incorrect numbers lead to an invalid conclusion. The mention of debt management strategy is appropriate, but the basis for the interpretation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 381,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Converse’s total revenues slipped from $2.427 billion in fiscal 2023 to $2.082 billion in fiscal 2024 (‑14% overall, ‑15% on a currency‑neutral basis) and its earnings before interest and taxes fell 30% to $474 million, reflecting weaker sales in North America and Western Europe (page 46). Nonetheless, Converse remains a wholly‑owned subsidiary that designs, distributes and licenses casual sneakers, apparel and accessories, with its results reported on a stand‑alone basis and incorporated into Nike’s corporate revenue and foreign‑exchange risk‑management framework, underscoring its continued strategic positioning within Nike’s brand portfolio (page 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the revenue decline is correctly reported as -15% on a currency-neutral basis, matching the original answer. The absolute revenue figures ($2.427B in FY2023 and $2.082B in FY2024) imply a ~14% drop, which the model correctly notes as -14% overall and -15% currency-neutral—this is consistent with the knowledge graph. The EBIT decline of 30% to $474M is an additional detail not in the original answer but does not contradict it and may come from the same source (page 46), so it adds precision without error. (2) The qualitative assessment of Converse as a 'wholly-owned subsidiary operating on a stand-alone basis' is accurately reflected in the LLM’s description of it being 'reported on a stand-alone basis' and 'incorporated into Nike’s corporate revenue and foreign-exchange risk-management framework,' indicating correct multi-hop synthesis of strategic positioning. (3) The reasoning correctly connects financial performance (revenue and EBIT decline due to weak sales in key regions) with strategic continuity (stand-alone brand within Nike), capturing the evolution from financial struggle to strategic reaffirmation. (4) Minor deduction in quantitative and qualitative scores due to the introduction of EBIT data not in the ground truth, which, while likely accurate, slightly exceeds the scope of the original answer without explicit need. However, this does not detract from correctness. Contextual relevance is perfect—the response directly addresses revenue performance and strategic positioning across both fiscal years as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 445,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola warned that the “digital evolution” was reshaping shopping habits and, if the company failed to keep pace, it could lose share of sales and hurt revenue growth (2022 risk discussion, page 17). By the 2024 filing the language had sharpened: the company now says that an unsuccessful digital‑transformation could not only curb sales growth but also impede margin improvement and add cost pressures, making the financial risk more pronounced (2024 risk discussion, page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift in Coca-Cola's risk assessment from 2022 to 2024: in 2022, digital evolution was a risk to sales and revenue growth if not addressed; by 2024, failure in digital transformation is linked more strongly to both sales growth and margin improvement, as well as cost pressures. This matches the original answer’s core claim of a strategic shift from risk to dependency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024), correctly attributes evolving language in risk disclosures, and captures the deepening financial linkage (from sales risk to margin and cost impacts). The only minor gap is that the LLM does not explicitly state that digital evolution became a 'strategic dependency'—a key phrase in the original answer—but it effectively conveys the same meaning by stating the financial risks are now more pronounced and tied to margins and costs. (4) The answer is fully contextually relevant, directly addressing how the financial risk assessment evolved and its implications for sales and margins. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; only a slight omission of the 'strategic dependency' framing prevents a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 415,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "In fiscal 2022 Oracle said it spent **$7.2 billion on research and development** to enhance its portfolio and build new technologies, positioning Oracle Cloud Services as a growth engine that works alongside on‑premise and hybrid deployments 【page_6】. By fiscal 2024 the company’s strategy had sharpened its cloud focus – the 2024 restructuring plan redirected cost‑savings into resources for “developing, marketing, selling and delivering our cloud‑based offerings” and a second‑generation cloud infrastructure, and Oracle’s disclosures now describe Oracle Cloud Services (SaaS + OCI) as the core integrated solution with on‑premise licenses and hybrid options presented as complementary 【page_54】【page_72】【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $7.2 billion R&D investment in fiscal year 2022, matching the ground truth exactly. While the fiscal 2024 R&D amount is not specified in the LLM answer—consistent with the original answer, which notes that the 2024 report does not specify the R&D figure—the LLM accurately reflects the strategic shift without inventing data. (2) All numeric values and fiscal years are correct. There are no calculations required beyond accurate reporting of figures, and the LLM correctly states the $7.2 billion for 2022. (3) The multi-hop reasoning is sound: the LLM synthesizes information across fiscal years 2022 and 2024, correctly tracing the evolution from cloud as a growth engine alongside on-premise to cloud as the core solution with on-premise and hybrid options as complementary. It references Oracle Cloud SaaS and OCI as central, aligning with the ground truth’s emphasis on cloud-first positioning. The use of restructuring cost savings to fund cloud development is an additional detail supported by the source (e.g., page 54, 72, 73) that enriches the answer without contradicting the original. (4) The answer is semantically equivalent to the ground truth, with slightly more detail on the 2024 restructuring but without introducing inaccuracies. The only minor gap is a slightly less explicit mention of 'interoperable deployment models' or 'security' as differentiators in 2022, though the core strategic emphasis is preserved. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 440,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors’ Formula Stock Award Plan remained a non‑shareholder‑approved plan that does not allow any new stock awards or deferrals in either year. The only shares that could still be issued were those already earmarked for distribution, and that residual pool fell from 509 shares in the 2023 filing (2023 10‑K, page 11) to 391 shares in the 2024 filing (2024 10‑K, page 15).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative evolution of the Norwest Corporation Directors' Formula Stock Award Plan — that no new awards or deferrals were allowed in either 2023 or 2024, and only existing obligations remained. It correctly identifies that the plan was inactive for new grants and that only residual shares were left for distribution. However, there is a critical quantitative inaccuracy: the LLM states that the number of shares was 509 in 2023, but the ground truth does not specify this number — it only mentions that 391 shares remained in 2024. The 509 figure is not present in the original answer and appears to be fabricated or misattributed from a source not reflected in the ground truth. This undermines the quantitative accuracy significantly. Additionally, the original answer emphasizes that in 2024, the filing clarified that column (a) of the equity compensation table reflected all remaining shares, reinforcing the finality of the plan’s closure — a nuance missing in the LLM response. While the direction of decline (509 to 391) might align with external data, the ground truth does not confirm the 2023 share count, making the inclusion of specific numbers unsupported. The reasoning is otherwise sound, and the entity (Norwest Corporation Directors' Formula Stock Award Plan) and years (2023–2024) are correct. The answer is contextually relevant and addresses the evolution question, but the unsupported numerical claim reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 408,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "In the 2022 Form 10‑K, food‑safety was presented mainly as a risk factor – the filing warned that contamination, tampering or recalls “in the supply chain, restaurants or delivery” could damage the brand and that commodity‑price volatility for beef, chicken and pork is partly driven by food‑safety concerns, product recalls and regulation (2022 p.31‑33). By the 2023 filing the disclosure had shifted to a dedicated “Supply Chain, Food Safety and Quality” discussion that outlines a Food‑Safety Advisory Council, a Supplier Code of Conduct and systematic risk‑assessment processes, and it pairs this with an inflation/commodity‑cost section that stresses inventory turnover, menu‑price adjustments and fixed‑cost real‑estate to mitigate cost volatility (2023 p.6, p.25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution in McDonald's disclosure between 2022 and 2023 regarding food safety, supply chain risks, and cost volatility. In 2022, the LLM correctly notes that food safety was framed as a reputational risk due to contamination or recalls, with an acknowledgment that such issues contribute to commodity price volatility for beef, chicken, and pork—consistent with the original answer’s emphasis on brand impact and financial exposure. The citation of pages 31–33 in the 2022 10-K adds precision. For 2023, the LLM accurately captures the shift toward integrating food safety into supply chain management, highlighting structural changes like the Food Safety Advisory Council and Supplier Code of Conduct, and linking food safety more directly to cost volatility through supply chain mechanisms. It also correctly references the discussion of mitigation strategies like menu pricing and inventory turnover (2023 pp.6, 25). While the original answer emphasizes the conceptual shift from reputational to financial/supply chain risk, the LLM conveys this through concrete examples and structural disclosures, achieving semantic equivalence. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (McDonald's, 2022/2023 filings, supply chain, commodity costs) are correct. The reasoning is sound and reflects multi-hop synthesis across years and topics. The only minor shortcoming is that the LLM does not explicitly state the 'shift in emphasis' as clearly as the original, instead implying it through descriptive detail—hence a 9 on qualitative accuracy. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 477,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "In 2023 the 1.750 % 7‑Year Senior Notes (due 10/15/2028) were carried at **$700 million** and had an **effective interest rate of 1.89 %**【page_62】.  By December 31 2024 the same notes were still carried at **$700 million** with an **effective interest rate unchanged at 1.89 %**【page_47】.  Thus, both the carrying value and the effective rate remained the same from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of $700 million and effective interest rate of 1.89% for both 2023 and 2024 are correctly reported. The maturity date (October 15, 2028) is also accurately included. Minor formatting differences (e.g., spacing in percentages, use of em-dash in dates) do not affect meaning and are acceptable. (2) The answer is complete, addressing both the carrying value and interest rate for both years as required by the question. (3) Entity accuracy is correct: TMO’s 1.750% 7-Year Senior Notes are properly identified with the correct ticker, instrument name, and due date. (4) The reasoning is sound—by noting that both metrics remained unchanged and citing specific pages (62 for 2023, 47 for 2024), the model demonstrates correct multi-hop synthesis across years and documents. (5) The semantic meaning is equivalent to the original answer, clearly conveying that no change occurred in either metric between 2023 and 2024. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 312,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX’s balance of the 7.000 % notes due 2038 was $148 million at year‑end 2022 and remained $148 million at year‑end 2023, showing no change in exposure【page_85】. Maintaining the same amount suggests RTX is keeping a steady, diversified long‑term debt profile rather than accelerating repayment or adding new issuance of that tranche, reflecting a measured approach to managing its future maturities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's balance of 7.000% notes due 2038 was $148 million in 2022 and remained unchanged in 2023. The ground truth shows that the balance was $11 million in 2022 and increased to $148 million in 2023. This misstatement completely reverses the trend and invalidates the conclusion. (2) Quantitative accuracy is severely compromised: the LLM reports $148 million for both years, while the correct values are $11 million (2022) and $148 million (2023). The increase of $137 million is entirely missed. (3) The reasoning is flawed due to incorrect data input—claiming 'no change' leads to an incorrect interpretation of RTX’s debt strategy as 'steady' and 'measured,' whereas the actual significant increase suggests a strategic decision to issue more long-term debt or restructure maturities. The multi-hop synthesis failed because the model did not correctly retrieve or apply the year-over-year change. (4) Contextual relevance is partially maintained as the answer addresses the right topic (RTX's long-term debt management), but the incorrect numbers and resulting flawed interpretation severely undermine the qualitative and quantitative accuracy, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 353,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "In the 2022 filing McDonald’s explained that its franchise agreements generate rent and royalty revenue – both calculated as a percent of franchisee sales with a minimum‑rent floor – and that, after having deferred roughly $1 billion of rent and royalty cash collections during the height of COVID‑19, the company had “collected substantially all of these deferrals as of December 31, 2021”【page_51】. The 2023 filing still describes rent and royalties as separate revenue components from franchised restaurants, but makes no mention of any deferrals, indicating that the company now receives these payments on a regular, ongoing basis under the same percent‑of‑sales/minimum‑rent structure【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that McDonald's deferred approximately $1 billion in rent and royalties during the height of the pandemic and had collected substantially all of these deferrals by December 31, 2021, which aligns with the original answer's claim that the collection was completed by the end of 2021. The 2022 filing correctly references the prior deferral and its resolution, and the 2023 filing accurately notes the absence of ongoing deferrals, indicating a return to normal operations. (2) Quantitative accuracy is perfect: the $1 billion figure is correctly cited, and the dates (December 31, 2021) match the ground truth. No calculations are required, but the temporal references are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring that the absence of deferral mentions in 2023 implies a return to standard payment practices. It connects the structural details of rent and royalty collection (percent of sales with minimum rent) to show continuity in the business model. The only minor shortcoming is that the original answer explicitly mentions the deferrals occurred primarily in the first half of 2020 due to government restrictions, which the LLM omits, though it does reference the pandemic context. (4) The answer is highly relevant, directly addressing the evolution of McDonald's financial relationship with franchisees regarding rent and royalties between 2022 and 2023. The omission of the specific timing (first half of 2020) and the reason (government restrictions) slightly reduces completeness but does not affect the core factual correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 493,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "In the 2022 filing the Company said it still “account[s] for our remaining ownership interest in Andina as an equity‑method investment” after having sold a portion of the stake in 2019 (see page 76). By 31 December 2024 the Andina investment was recorded at a $90 million carrying value with a $168 million fair‑value, indicating a smaller, minority equity‑method holding (see page 87). This shift shows Coca‑Cola has trimmed its direct ownership but retains a strategic, influential minority position—preserving board representation and upside potential while limiting capital exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $90 million carrying value and $168 million fair value of Coca-Cola's stake in Embotelladora Andina S.A. as of 2024, matching the ground truth. It also accurately reflects that Coca-Cola retained an equity stake and accounts for it using the equity method. However, it references a partial sale in 2019 rather than 2022, which contradicts the ground truth stating a $39 million gain was recognized in 2022 from a partial sale. This is a factual error in timing, though the overall narrative of partial divestiture is consistent. (2) All numeric values—$90 million carrying value and $168 million fair value—are correct and match the ground truth exactly. No calculations are required beyond accurate reporting, which is done properly. (3) The multi-hop reasoning is largely sound: the model connects Coca-Cola’s ongoing equity-method accounting with reduced ownership and interprets the strategic implications (retained influence, reduced exposure) appropriately. The only flaw is the incorrect year for the partial sale (2019 vs. 2022), which affects the timeline but not the overall conclusion about continued strategic positioning. (4) The answer is highly relevant, complete in addressing both the evolution and strategic implication, and semantically equivalent to the ground truth except for the misdated sale. The qualitative reasoning is strong, hence a 9/10. Quantitative accuracy is perfect, earning a 10. Contextual relevance is full, as all parts of the question are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 430,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle’s 2022 filing stressed that most of its offerings—including Oracle Cloud Infrastructure—are built internally, with OCI described as a core element of its cloud‑services portfolio and the company investing to add features, capacity and hybrid‑cloud capabilities (2022 R&D discussion page 16; OCI description page 11). By the 2024 filing, Oracle’s restructuring plan earmarked resources for “the development and delivery of our second‑generation cloud infrastructure” (page 54) and now positions OCI alongside SaaS as part of an integrated “Oracle Cloud Services” suite that delivers both applications and infrastructure (notes page 72; revenue‑recognition page 73), indicating a shift to a next‑gen, centrally‑aligned cloud infrastructure offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Oracle emphasized internal development in 2022, with OCI already a core part of its cloud portfolio, and by 2024, OCI was further elevated as part of an integrated 'Oracle Cloud Services' suite alongside SaaS. The mention of 'second-generation cloud infrastructure' in 2024 reflects an evolution in strategic emphasis consistent with the ground truth's description of a more structured, product-specific approach. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022 and 2024 filings, identifying the shift from general internal R&D focus to a more defined, integrated product strategy centered on OCI. The use of specific page references (e.g., page 54, 72, 73) suggests precise grounding in source documents. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'second-generation cloud infrastructure' not explicitly in ground truth), this does not contradict but rather adds specificity that is contextually consistent. The only minor gap is that the LLM does not explicitly mention the 'global R&D workforce' or 'innovation in response to market demands' from 2022, but it captures the essence of internal development. Thus, qualitative accuracy is 9. Contextual relevance is perfect—the answer directly addresses the evolution of Oracle's cloud strategy, internal development, and OCI's positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 452,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "In 2023 Thermo Fisher disclosed that it bought The Binding Site Group – a U.K. specialty‑diagnostics provider – for $2.7 billion, placing the business in the Specialty Diagnostics segment (Note 12 and investing‑activities discussion)【page_65】【page_24】. By the 2024 filing the only acquisitions highlighted are Olink and CorEvitas, with no further mention of The Binding Site Group, indicating that the company has moved the acquisition into the “steady‑state” of its Specialty Diagnostics segment and is now focused on integrating that capability while pursuing new growth opportunities elsewhere.【page_65】",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 acquisition of The Binding Site Group by TMO (Thermo Fisher) for $2.7 billion and places it within the Specialty Diagnostics segment, which matches the ground truth. The dollar amount is accurate (allowing for formatting variation: $2.7B vs $2.70B), and the year is correct. However, the LLM fails to mention the key 2024 development — that The Binding Site Group was integrated into the amortization schedule with a 19-year weighted-average amortization period for customer relationships, a critical indicator of post-acquisition integration. This omission significantly weakens the answer’s completeness and qualitative accuracy. (2) Quantitatively, all numbers and dates are correct: $2.7 billion in 2023 is consistent with the ground truth (minor rounding acceptable). No calculations were required, but the factual figures are accurately reported. (3) The multi-hop reasoning is partially sound — the model infers from the absence of mention in 2024 filings (except for Olink and CorEvitas) that The Binding Site Group has entered a 'steady-state', which is a reasonable interpretation. However, this is speculative and does not reflect the actual evidence in the ground truth (i.e., the amortization data), which provides direct proof of integration. The model misses the opportunity to cite concrete financial integration metrics, weakening the reasoning. (4) The contextual relevance is high — the answer addresses the evolution and strategic focus — but the lack of specific integration evidence from 2024 reduces its factual depth. The conclusion about shifting focus to new growth opportunities is plausible but not directly supported by the ground truth, which emphasizes long-term value creation through integration, not strategic pivot. Thus, while the answer is factually sound on acquisition details, it lacks key post-acquisition integration data, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 528,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was disclosed with a full, direct URL – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf – and the filing explicitly noted that it “applies to all directors of BNY Mellon”【page_11】. By the 2024 filing the company still says the code “applies to all directors of BNY,” but the link has been moved to a different path (bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf) and is shown without the full domain, reflecting a change in how the document is accessed online【page_13】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: in 2022, the Directors' Code of Conduct was accessible via a full URL and applied to all directors; by 2024, the scope remained the same but the URL changed. However, there are minor inaccuracies and omissions. The 2022 URL in the LLM answer has a typo ('in relations' instead of 'investor-relations') and is inconsistently formatted (uses en-dashes and spaces). The 2024 URL is only partially provided (missing the domain 'https://www.bny.com'), which reduces quantitative accuracy. While the LLM notes the scope still applies to all directors, it does not explicitly recognize the rebranding from 'BNY Mellon' to 'BNY' as a likely reason for the URL change, which was part of the original answer’s qualitative insight. The reasoning is sound but incomplete—multi-hop synthesis is partially achieved (link change + consistent scope), but the deeper implication of corporate rebranding is missed. The answer remains contextually relevant and captures the core evolution in disclosure and accessibility. Minor formatting issues and incomplete URL presentation prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 319,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "In the 2022 filing McDonald’s framed its franchisees mainly as a risk factor and reported franchise‑related items such as deferred revenue from initial franchise fees, stressing that the company’s growth depended on franchisees’ ability to fund and adopt major initiatives 【page_30】. By the 2023 filing the relationship is reflected in the financial statements themselves – a $103 million gain from restaurants sold to franchisees, goodwill that largely stems from those purchases, and a comment that operating‑income growth was driven by strong franchised‑margin performance 【page_18】【page_45】, indicating a shift toward more concrete, performance‑linked reporting and a strategic emphasis on leveraging franchisee‑driven growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures such as a '$103 million gain from restaurants sold to franchisees' and attributes goodwill and operating-income growth to franchisee-related activities in 2023. However, these quantitative details are not present in the original ground truth answer, which states only that transactions with franchisees were 'not material' to the consolidated financial statements in 2022 and notes a strategic shift in emphasis in 2023. There is no mention in the ground truth of a $103M gain, goodwill from franchisee purchases, or franchised-margin-driven operating income. Thus, the LLM fabricates or misrepresents specific financial data not supported by the source. (2) The quantitative accuracy is low because the dollar amount ($103M), the claim about goodwill, and the assertion about operating-income drivers are not corroborated by the original answer and contradict the 'not material' characterization from 2022. Even if the direction of the trend (increased emphasis) is correct, the specific numbers and financial impacts are incorrect or unsubstantiated. (3) The qualitative reasoning shows partial multi-hop understanding: the LLM correctly infers a shift in strategic tone from 2022 to 2023, moving from framing franchisees as a risk/funding dependency to highlighting their performance impact. This aligns with the ground truth’s observation of increased strategic emphasis and transparency in 2023. However, it overreaches by injecting unsupported financial metrics instead of relying on the documented 'not material' impact. (4) Contextual relevance is high because the answer addresses the evolution of the franchisee relationship in financial reporting and strategy across the two years. While the direction of the narrative is consistent with the ground truth, the inclusion of false quantitative claims significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 534,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "In the 2023 Form 10‑K Mondelēz recorded a distinct contingent‑consideration liability for the Clif Bar acquisition of **$548 million** (long‑term) that was measured at fair value using **Level 3 Monte‑Carlo inputs**. In the 2024 filing the liability is no longer shown separately; instead the company reports **purchase‑price‑allocation adjustments for Clif Bar** that are reflected in the indefinite‑life intangible‑asset balance, indicating the contingent‑consideration has been re‑measured and absorbed into the allocation (still using a Level 3 fair‑value approach).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $548 million contingent consideration liability in 2023 is correctly stated, and the use of Monte Carlo simulation (specified as Level 3 inputs) matches the original answer's description of fair value measurement using Monte Carlo. (2) The 2024 update correctly notes the absence of a separate contingent consideration liability and instead references purchase price allocation adjustments related to Clif Bar, which is consistent with the ground truth. The inference that the liability was 're-measured and absorbed into the allocation' is a reasonable interpretation given the lack of updated disclosures, though the original answer is more cautious in stating that the 2024 filing does not provide updated figures or methods. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2023 and 2024 filings, identifying the shift from active fair value reporting to integration into purchase price adjustments. (4) Minor deduction in qualitative accuracy due to slightly stronger assertion ('absorbed into the allocation') compared to the original's more tentative 'may have been finalized or reclassified,' but this does not materially misrepresent the situation. All entities (Mondelēz, Clif Bar, 2023/2024 filings), metrics (contingent consideration, fair value, purchase price allocation), and years are correct. The answer is fully contextually relevant and addresses both fair value measurement and purchase price allocation adjustments as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 433,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "In the 2022 Form 10‑K AMD highlighted that its Radeon RX 6000‑series (RDNA 2) discrete GPUs “support current‑generation application programming interfaces (APIs) like DirectX 12 Ultimate and Vulkan” (2022 p.8). The 2024 filing makes the same claim for the newer Radeon RX 7000‑series (RDNA 3) GPUs, again stressing Vulkan support alongside DirectX 12 Ultimate (2024 p.8). This consistent emphasis across two product generations shows AMD treats Vulkan compatibility as a core pillar of its GPU strategy, using it to ensure its discrete GPUs stay competitive by meeting the latest developer and gamer API requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's Vulkan API support in both 2022 and 2024, referencing the correct GPU series (Radeon RX 6000 and 7000) and architectures (RDNA 2 and RDNA 3), which matches the original answer. The citations to the 10-K filings (2022 p.8 and 2024 p.8) add precision and are consistent with the expected source documentation. (2) There are no numerical values requiring calculation, but the years (2022, 2024), product names, and API references (Vulkan, DirectX 12 Ultimate) are all factually correct—no quantitative errors. (3) The reasoning correctly synthesizes information across two years of filings to infer a strategic continuity in API support, which is the core insight in the ground truth. The LLM concludes that Vulkan is a 'core pillar' of AMD's strategy, which is a valid interpretation of the sustained emphasis. The only minor gap is that the original answer adds context about AI/ML computing and 'backward compatibility,' which the LLM omits—this slightly reduces completeness but does not detract from the central argument. (4) The answer is fully relevant, directly addressing AMD's evolving strategic emphasis and competitiveness in the discrete GPU market. Overall, the LLM demonstrates strong multi-hop reasoning by connecting product generations, architectures, and API support over time to infer strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 393,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX’s operating profit rose modestly in 2022, increasing by about $0.4 billion to $5.5 billion as integration‑related costs were limited (see page 39). In 2023, operating profit fell sharply by $1.9 billion to $3.6 billion, driven primarily by a new $2.9 billion Powder Metal Matter charge at Pratt & Whitney—a significant integration‑related expense that pulled the operating margin down from 8.2% to 5.2% (see page 39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial trends and the $2.9 billion Powder Metal Matter charge in 2023, which aligns with the ground truth. It accurately states the $1.9 billion decrease in operating profit from 2022 to 2023, matching the original answer. The operating profit figures of $5.5 billion in 2022 and $3.6 billion in 2023 are consistent with a $1.9 billion decline. The mention of operating margin dropping from 8.2% to 5.2% adds contextual detail not in the original answer but does not contradict it and is likely supported by source data. (2) All numeric values—$0.4 billion increase in 2022, $1.9 billion decrease, $2.9 billion charge, and margin percentages—are quantitatively accurate and internally consistent. The calculation of the profit drop is correct. (3) The multi-hop reasoning is sound: the model connects the introduction of a major integration-related charge in 2023 (Powder Metal Matter) to the reversal of prior-year trends, contrasting limited integration costs in 2022 with the large 2023 charge. While the original answer emphasizes the decline in Acquisition Accounting Adjustments in 2022, the LLM infers a modest profit increase due to limited integration costs, which is a reasonable interpretation. The entity names (RTX, Pratt & Whitney), metric (operating profit), and years (2022, 2023) are correct. (4) The answer is semantically equivalent and highly relevant, capturing the core causal relationship between integration charges and profit trends. The only minor gap is that it does not explicitly reference the decrease in Acquisition Accounting Adjustments in 2022 as a positive contributor, instead summarizing the outcome as a modest profit rise. This is a slight omission but does not detract significantly from overall accuracy. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 520,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "In 2023 Mondelēz still carried the post‑acquisition accounting for Clif Bar – a contingent‑consideration liability that rose to $548 million (up from $452 million in 2022) and acquisition‑related costs were essentially nil (see page 99 and page 42). By 2024 the Clif Bar brand is shown as part of indefinite‑life intangible assets (with the 2023 purchase‑price‑allocation adjustments noted on page 87) and no new acquisition‑related expenses or additional contingent‑consideration are disclosed, indicating the transaction has moved from settlement to steady integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MDLZ's relationship with Clif Bar in 2023 involved post-acquisition accounting, specifically contingent consideration that increased from $452M in 2022 to $548M in 2023, which matches the financial impacts noted in the 2023 10-K. By 2024, the absence of new acquisition-related expenses and the inclusion of Clif Bar in indefinite-life intangible assets reflect the transition to integration and consolidation, consistent with the 2024 10-K's mention of purchase price allocation adjustments. (2) The quantitative figures ($542M → $548M increase in contingent consideration) are correctly cited, and while the exact source years (2022 vs 2023 reporting of prior-year events) are slightly nuanced, they are contextually accurate as the 2023 filing reports the August 1, 2022 acquisition and its ongoing impacts. The lack of new costs in 2024 is correctly noted. (3) The multi-hop reasoning—linking 2023 accounting treatment (contingent liability, integration costs) to 2024 treatment (intangibles, no new costs)—demonstrates sound synthesis across filings and years. (4) The answer captures the evolution from acquisition to integration phase, matching the ground truth’s emphasis on financial recalibration. One minor point: the original answer emphasizes the 2023 filing notes the August 1, 2022 acquisition, while the LLM focuses on 2023 financials without reiterating the 2022 acquisition date, but this does not detract from correctness. Overall, the answer is factually solid, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 451,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "In the 2023 filing Gulfstream highlighted its role as the industry leader in using sustainable aviation fuel and energy‑efficient engines as a core part of its R&D strategy【page_4】. By the 2024 filing that strategy had moved to concrete product integration, with all‑new, high‑efficiency engines fitted to its newest models – the ultra‑long‑range G700 (certified March 2024) and the newly launched G800 and G400 families – demonstrating a shift from a broad leadership claim to tangible aircraft improvements【page_4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution from strategic emphasis in 2023 to product integration in 2024, which aligns with the ground truth. It correctly identifies Gulfstream's focus on sustainable aviation fuel and energy-efficient engines in 2023 and the shift to actual implementation in 2024. However, it introduces significant factual inaccuracies: the G800 and G400 families are not mentioned in the original answer, and the ground truth specifies only the G700 as featuring the new engines in 2024. Additionally, while the G700 certification date (March 2024) is plausible and consistent, the original answer does not mention certification timing, so including it adds unverified detail. The claim about 'all-new, high-efficiency engines fitted to its newest models' overgeneralizes to multiple aircraft not cited in the ground truth, suggesting a broader rollout than supported. This reflects a failure in entity accuracy and overextension of the multi-hop synthesis. Quantitatively, there are no explicit numerical errors, but the inclusion of unsupported aircraft models undermines completeness and correctness. The reasoning is partially sound but extends beyond the evidence. Contextually, the answer remains highly relevant and addresses both parts of the question, just with inflated scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 363,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "In 2022 AMD said that revenue from its semi‑custom SoC products came mainly from one‑time engineering fees and product sales that were “directly related to sales of the third‑party’s products” and therefore depended on the customer’s product success and marketing – a non‑recurring, highly contingent stream (AMD 2022 10‑K, p. 25). By 2024 the company lists semi‑custom SoCs alongside its AI accelerators, CPUs and GPUs as a core part of its portfolio (AMD 2024 10‑K, p. 62) and now recognizes revenue for custom orders over the production period using a cost‑based input method (AMD 2024 10‑K, p. 63), with the Embedded segment (which houses these SoCs) still contributing several billion dollars of revenue (AMD 2024 10‑K, p. 70). This reflects a shift from a largely opportunistic, non‑recurring revenue model to a more integrated, strategically positioned and structured revenue stream within AMD’s broader product lineup.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of AMD's relationship with semi-custom SoCs from 2022 to 2024, noting the shift from dependency on third-party product success and non-recurring revenue (2022) to strategic integration within a diversified portfolio (2024). (2) No explicit numerical values (e.g., exact revenue figures) are present in the original answer, but the LLM correctly references 'several billion dollars' from the 2024 10-K (p.70), which aligns with known revenue levels and is consistent with the ground truth’s emphasis on continued significance. There are no calculations required, and all dates (2022, 2024) and financial terms (non-recurring engineering fees, cost-based input method) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of 10-K filings, correctly inferring a strategic shift based on changes in revenue recognition (from one-time fees to production-period revenue) and product categorization (from isolated offerings to core portfolio components). (4) The answer enhances the original with specific citations (page numbers, accounting methods) without introducing errors, demonstrating strong qualitative and contextual accuracy. All aspects of the question—revenue structure and strategic positioning—are addressed with precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 391,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The Shareholders’ Equity section shows that Medtronic’s authorized preferred‑share capital was the same in both years – 127.5 million Preferred Shares (par $0.20) and 500 k “A” Preferred Shares (par $1.00), and no preferred shares were issued or outstanding in FY 2023 or FY 2024【page_81】. The unchanged authorization indicates the company is not using preferred equity as a financing source, instead relying on ordinary‑share repurchases and debt, reflecting a capital strategy focused on returning cash to shareholders while preserving balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the preferred share authorization remained unchanged between FY 2023 and FY 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. It also accurately notes that no preferred shares were issued or outstanding in either year, matching the ground truth exactly. (2) All numeric values are correct and match the original answer; format variations (e.g., '500 k' vs '500 thousand') are acceptable and semantically equivalent. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the lack of change in authorization and zero issuance indicates preferred shares are not being used as a financing tool. It goes a step further by inferring a broader capital strategy—reliance on share repurchases and debt, and focus on shareholder returns and balance-sheet flexibility—which is a reasonable qualitative extension supported by typical financial interpretation, though not explicitly stated in the ground truth. This adds insight without contradicting facts. (4) The answer is fully contextually relevant, addressing both parts of the question: evolution of structure (no change) and implication for capital strategy. The only reason for not scoring a 10 is that the original answer takes a more conservative stance, stating only that the company has not utilized or pursued changes, while the LLM infers additional strategic intent. While logical, this inference slightly exceeds the data provided in the ground truth, warranting a 9 instead of 10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 457,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "In the 2022 filing (see page 4) the company warned that “our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm,” and linked that risk mainly to climate‑change concerns that could damage its reputation. By the 2024 filing (see page 5) the same phrasing is retained, but the disclosure broadens the context—adding sustainability issues such as climate change **and** diversity, the possibility of extra regulatory requirements, and a wider array of geopolitical and environmental shocks—so that adverse publicity is now framed as part of a larger reputational‑risk nexus that could affect client activity, regulatory exposure, and overall business performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in structure and captures the evolution of BK's risk disclosure framing between 2022 and 2024, with accurate page references and correct identification of years and company (BK). Quantitatively, there are no numeric inaccuracies since the question does not involve figures like dollar amounts or percentages—dates (2022, 2024) are correct. Contextual relevance is high: the answer addresses how adverse publicity is framed over time and links it to broader reputational concerns. However, there is a factual inaccuracy in the LLM answer: it incorrectly states that in 2022, BK linked adverse publicity 'mainly to climate-change concerns.' The ground truth indicates that in 2022, adverse publicity was linked to government scrutiny and general reputational harm—not specifically or mainly to climate change. Climate change and diversity were introduced as expanded elements in 2024, not 2022. This misattribution affects the qualitative accuracy, as it misrepresents the initial scope of the risk in 2022. The 2024 expansion is correctly described, including the addition of sustainability issues (climate change and diversity), regulatory expectations, and geopolitical/environmental shocks, as well as the connection to operational models like the platforms operating model transition—though the latter is omitted in the LLM answer. While the broader 'nexus' idea is well-phrased, the failure to mention the platforms operating model transition as a new linkage in 2024 is a minor omission. Overall, core facts about the broadening of reputational risk are correct, but the incorrect attribution of climate change as a primary concern in 2022 and the missing operational model context in 2024 prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 474,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "In 2023 Amazon disclosed that its $1.25 billion convertible note from Anthropic, PBC was recorded as an **available‑for‑sale Level 3 asset**, measured at fair value with unrealized gains and losses reported in accumulated other‑comprehensive income, and that it retained an option to invest up to a further $2.75 billion in a second note. By the 2024 filing the investment remained an **available‑for‑sale convertible‑debt holding** measured at fair value, but Amazon now stresses that valuing Anthropic is more complex because of the lack of observable market data and heightened global‑economic uncertainty, so market‑price sensitivities are deemed impracticable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.25 billion 2023 investment, its classification as an available-for-sale Level 3 asset, fair value measurement with unrealized gains/losses in accumulated other comprehensive income, and the $2.75 billion commitment for a second note. In 2024, it accurately states the classification remained the same but emphasizes increased valuation complexity due to lack of observable market data and global economic uncertainty. (2) Quantitative accuracy is perfect: both dollar amounts ($1.25B and $2.75B) are correct, no calculations are required, and timeframes (2023 to 2024) align with the ground truth. Format variations (e.g., using 'up to' vs. 'agreement to invest') are semantically acceptable. (3) The multi-hop reasoning is sound—correctly synthesizing changes in disclosure emphasis from investment mechanics in 2023 to valuation challenges in 2024. The only minor shortcoming is that the LLM slightly softens the certainty of the $2.75 billion commitment by saying 'option to invest up to,' whereas the original specifies a binding agreement to invest $2.75 billion by Q1 2024. This slightly understates the contractual nature but does not materially misrepresent the intent. (4) Contextual relevance is excellent—the answer directly addresses the evolution in investment classification and valuation factors. Overall, the answer is factually accurate, well-reasoned, and conveys the same core information as the ground truth with only a minor nuance missing on the binding nature of the second investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 434,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Both the 2023 and 2024 filings list the same core IP‑protection risks – the need to safeguard trademarks, patents, copyrights, registered designs, trade‑secrets, recipes, technology, **know‑how** and licensing agreements, and the exposure to third‑party infringement claims that could lead to costly litigation, injunctions or licence fees, especially as AI‑related developments evolve【page_26 (2023)】【page_27 (2023)】. The 2024 filing repeats this language without adding new categories, showing that the nature of the IP‑related risks has remained essentially unchanged year‑over‑year【page_26 (2024)】【page_27 (2024)】.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in identifying that MDLZ continues to emphasize protection of intellectual property, including know-how, in both 2023 and 2024. It correctly notes the persistence of risks related to third-party infringement and litigation. However, it fundamentally misrepresents the evolution of the risk by claiming the nature of the risks has 'remained essentially unchanged,' which contradicts the ground truth. The original answer highlights a key shift: in 2023, MDLZ specifically flagged artificial intelligence as a factor that could undermine intellectual property protections, whereas in 2024, this AI-specific concern was omitted and replaced with a broader focus on legal and regulatory non-compliance, enforcement actions, and reputational damage. This evolution—from a technologically specific risk (AI) to a more generalized compliance and enforcement risk—is central to the question and was missed entirely by the LLM. The LLM incorrectly asserts continuity and even cites the same page numbers across years to support its claim, failing to detect the nuanced but important change in risk framing. While entity accuracy (MDLZ, know-how, years) and contextual relevance are acceptable, the qualitative inaccuracy in reasoning and failure to capture the shift in risk nature severely undermines the answer. There are no numerical elements, so quantitative accuracy is scored as 10 by default.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 392,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "In the 2023 Form 10‑K the exhibits list “Amendments to Certain Non‑Employee Director Equity Award Agreements” (Exhibit 10.69 covering the fiscal year ended Nov 28 2008) and a “Form of Non‑Employee Director RSU Award Agreement (pre‑2015)” (Exhibit 10.21 for the FY 2014) together with a cash‑settled version 【page_6†L17-L18】【page_5†L8-L9】.  \n\nThe 2024 Form 10‑K keeps the same amendment reference to Exhibit 10.69 (still tied to the 2008 fiscal year) but drops the “pre‑2015” label, instead showing a generic “Form of Non‑Employee Director RSU Award Agreement” (and a cash‑settled version) and adds a one‑time/year‑end RSU award form, reflecting a more current set of director equity‑award documents 【page_246†L18-L19】【page_247†L32-L34】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in exhibit numbering and misrepresents the evolution described in the ground truth. (1) The original answer states that in 2023, the agreement was referenced as Exhibit 10.17, pointing to the November 28, 2008 amendment. However, the LLM claims it was Exhibit 10.69 in 2023, which contradicts the ground truth—Exhibit 10.69 is cited in the 2024 filing as the source, not in 2023 under that number. This is a critical error in entity accuracy. (2) The LLM incorrectly states that Exhibit 10.69 was listed in the 2023 10-K as covering the 2008 amendment, but according to the ground truth, 2023 used Exhibit 10.17 to reference that amendment. The shift to citing Exhibit 10.69 (from the 2008 Annual Report) occurred in 2024, which the LLM gets partially right but misattributes the timeline. (3) The LLM introduces Exhibit 10.21 (Form of RSU Agreement pre-2015) in 2023 and notes its removal in 2024, replacing it with a generic version and adding a one-time/year-end form. While this may reflect actual changes, it is not mentioned in the ground truth and thus introduces unverified details, detracting from factual accuracy. (4) The core evolution—continuation under a new exhibit number with deeper historical documentation being emphasized—is partially captured in the LLM’s observation about referencing Exhibit 10.69 and updating forms, but the incorrect exhibit numbers and added details reduce correctness. Quantitative accuracy is moderate: dates like 'Nov 28, 2008' are correct, but exhibit numbers (10.17 vs 10.69) are misassigned. Qualitative accuracy suffers due to flawed multi-hop reasoning—failing to correctly trace the exhibit number transition. Contextual relevance is high as the response stays focused on director equity awards and filing changes. Overall, the answer shows understanding of the topic but fails on key factual details essential to the multi-hop comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 529,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "In 2022 Booking Holdings began moving more of its business onto a **merchant‑processing model**, actually handling payments for travel‑service providers and recording “merchant revenues” (and the associated payment‑processing, charge‑back and personnel costs) as it facilitated those transactions 【page_50】. By 2023 the company’s contracts with providers were framed as giving the providers the right to market inventory while **retaining delivery responsibility**, and the firm now presents revenue on a **net basis**—recognizing it at the point post‑booking services are completed and travelers begin using the service, based on the commission or margin specified in the contract 【page_83】. This reflects a shift from taking on more payment‑processing duties to a clearer facilitator role with net‑basis revenue recognition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of BKNG's evolving relationship with travel service providers between 2022 and 2023, particularly regarding revenue recognition on a net basis and timing of revenue recognition when services are used. It correctly identifies the shift toward clearer contractual framing where providers retain delivery responsibility and BKNG acts as an agent, aligning with the ground truth. The mention of net-basis revenue recognition and recognition timing matches the original answer. However, the LLM introduces the claim that in 2022 BKNG was moving to a 'merchant-processing model' and recording 'merchant revenues,' which is not present in the original answer and contradicts the ground truth that emphasizes BKNG’s intermediary/agent role and net revenue recognition by 2023. The original answer does not mention a shift away from a merchant model, but rather a clarification of accounting treatment. This introduces a potential misrepresentation of the direction of change—portraying a shift from merchant to agent model, whereas the ground truth describes a refinement in disclosure and accounting clarity, not necessarily a business model reversal. There are no numerical figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all referenced years (2022, 2023) and page citations are contextually appropriate and do not conflict. The reasoning is partially sound but contains an unsupported inference about a merchant model shift, weakening the multi-hop synthesis. The answer remains contextually relevant and captures the core evolution in contractual and revenue recognition practices, but with an overinterpretation of model transition not substantiated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 484,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "In the 2023 Form 10‑K the two executive‑life‑insurance policies appeared as items 10.11 (Metropolitan Life) and 10.12 (Pacific Life) 【page_5†L31-L38】. In the 2024 Form 10‑K a General Guarantee Agreement was added as item 10.11, which moved the Metropolitan‑Life policy to 10.12 and the Pacific‑Life policy to 10.13 【page_246†L1-L7】. The change therefore renumbered and reordered the life‑insurance disclosures, shifting them down one slot in the exhibit list.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies the exhibit numbers for the executive life insurance policies in both the 2023 and 2024 10-K filings: 10.11 (Metropolitan Life) and 10.12 (Pacific Life) in 2023, renumbered to 10.12 and 10.13 respectively in 2024. The explanation that a new exhibit (General Guarantee Agreement) was added as 10.11, causing the shift, is consistent with the structural reorganization described in the original answer. All entities (Metropolitan Life Insurance Company, Pacific Life & Annuity Company), exhibit numbers, and the nature of the change (renumbering due to insertion, not substantive policy changes) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis between the two filings. The only minor omission is not explicitly stating that the policies were 'retained' in substance, which slightly weakens the qualitative emphasis on 'structural vs. substantive' change, but the conclusion about renumbering and reordering effectively conveys the same idea. No numerical or date inaccuracies are present, and formatting (e.g., page references) is appropriately used. Semantic equivalence is high, and the answer fully addresses the question about structural changes in disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 363,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Broadcom continues to treat its FBAR filters as a strategic, proprietary technology that commands a sizable share of the cellular handset market and differentiates it from rivals. The company still manufactures FBAR filters in‑house—using its U.S. and Singapore III‑V wafer fabs—to protect IP and accelerate time‑to‑market, while outsourcing commodity processes, a stance reiterated in the 2022 filing and emphasized in 2024 as a core competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: FBAR filters are confirmed as strategically important and manufactured internally in both 2022 and 2024, with the purpose of protecting IP and accelerating time to market. The use of U.S. and Singapore III-V fabs is consistent with Broadcom's disclosed manufacturing approach. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that internal fabrication remained a consistent strategy across years, which matches the ground truth. It also correctly infers that this in-house approach is a competitive differentiator. (4) The only minor omission is that the 2024 context includes heightened competition from Qorvo, Qualcomm, and Skyworks, which the LLM does not explicitly mention. While it refers to differentiation from 'rivals,' it misses the expansion and specificity of the competitive landscape detailed in the original answer. This limits qualitative accuracy slightly but does not undermine the core correctness. Overall, the answer is semantically equivalent and contextually precise, addressing both strategic importance and manufacturing evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 380,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "In 2023 BMS listed Krazati only as a Mirati pipeline candidate, running three registrational trials—KRYSTAL‑12 in 2 L+ NSCLC, KRYSTAL‑10 in 2 L colorectal cancer and KRYSTAL‑17 in 1 L NSCLC—with no approvals (2023 10‑K p. 14)【page_14】. By 2024 BMS had completed the Mirati acquisition for a total consideration of $4.8 billion (net $4.1 billion) and moved Krazati into a commercial role, obtaining FDA accelerated approval for KRAS‑mutated colorectal cancer (June 2024) and reporting positive Phase III NSCLC data (KRYSTAL‑12) (2024 10‑K p. 71; p. 93)【page_71】【page_93】, shifting the focus from pure development to market launch and assigning the asset a multi‑billion‑dollar valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $4.8 billion acquisition cost (with $4.1 billion net) matches the original answer, and the June 2024 FDA approval for KRAS-mutated colorectal cancer is consistent with the timeline. The reference to 2024 10-K pages 71 and 93 supports the approval and Phase III data. (2) The clinical trials listed—KRYSTAL-12, KRYSTAL-10, KRYSTAL-17—are correctly identified with their respective indications and lines of therapy, matching the 2023 positioning. (3) The qualitative reasoning is sound: the acquisition of Mirati by BMY (BMS) is correctly framed as a strategic move to gain full control of Krazati, transitioning it from a pipeline asset to a commercial product. The shift in focus from development to market launch is well-articulated. (4) The only minor omission is that the original answer notes EMA approval in addition to FDA approval for second-line NSCLC, which the LLM answer does not explicitly mention. Additionally, while the LLM mentions positive Phase III data in NSCLC, it does not explicitly state that Krazati is now being developed in combination with a PD-1 inhibitor for first-line NSCLC—a key expansion in clinical strategy. These omissions are minor and do not undermine the core accuracy. Semantic equivalence is largely preserved, with appropriate use of terms and correct multi-hop synthesis across years, companies, and regulatory milestones.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 411,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "In the 2022 filing BKNG emphasized that travel‑service providers (hotels, airlines, car‑rental firms, etc.) are core partners but warned that integrations or divestitures could cause “loss of travel service providers” and other partner disruptions (see page_6, page_8, page_23‑28). By the 2023 filing the company had moved to a more operational view: it now records cash received from travelers as “Deferred Merchant Bookings” that represent amounts payable to travel‑service providers and it explicitly accounts for incentive programs (referral bonuses, rebates, credits, loyalty points) as revenue reductions, while also noting exposure to chargebacks or pre‑payment losses if a major provider files for bankruptcy (see page_25, page_84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the shift in BKNG's relationship with travel service providers from 2022 to 2023: from a competitive stance to a more dependent, partnership-oriented model. The mention of 'Deferred Merchant Bookings' as a liability representing amounts payable to providers aligns with the original answer and reflects the correct financial treatment. The inclusion of incentive programs (referral bonuses, rebates, loyalty points) being recognized as revenue reductions matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all references to financial concepts are correctly described. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years (2022 and 2023 filings), correctly contrasting the strategic framing of provider relationships and linking it to accounting practices (liabilities and revenue recognition). It also appropriately cites risk factors like provider bankruptcy and chargebacks, which adds context. (4) The only minor shortcoming is that the LLM does not explicitly state the *strategic intent* behind the shift (i.e., 'enhancing partnerships and incentivizing collaboration rather than competing'), though this is implied through the description of incentives and liabilities. This slight omission in framing prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually rich, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 439,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "In the 2022 filing Broadcom simply listed **custom touch controllers** as a product line within its wireless semiconductor portfolio, indicating they were offered as a component in its broader suite of solutions【page_5】. By the 2024 filing the company describes its touch controllers as devices that **process signals from touch‑screens in mobile handsets and tablets**, highlighting a more specific, functional role that directly supports the end‑device’s user‑interface and thus reflects deeper involvement in the later stages of the product lifecycle【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), entities (Broadcom), and the evolution of its role in Custom Touch Controllers. It correctly identifies that in 2022, Broadcom listed custom touch controllers as part of its wireless semiconductor portfolio, and by 2024, provided more functional detail about their role in processing touch-screen signals in mobile devices. This aligns with the ground truth's assertion of a shift toward deeper involvement. The answer captures the core evolution—increased specificity and functional integration—as evidence of broader lifecycle engagement. However, it stops short of explicitly stating the strategic shift from 'component supplier' to 'active producer involved in design and creation,' which is central to the original answer. While the implication is present through the description of functional detail, the synthesis of Broadcom’s role evolving into custom silicon solutions and active development is not fully articulated. There are no numerical inaccuracies (quantitative accuracy is perfect), and all referenced information is contextually relevant. The reasoning is sound but slightly less comprehensive in strategic interpretation, warranting a high but not perfect qualitative and overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 358,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "In 2023 Union Pacific relied primarily on leasing freight cars – it reported $1.6 billion of operating‑lease assets and added $241 million of freight‑car capacity through operating‑lease liabilities (see the 2023 lease tables [page 68, page 69]). By 2024 the company shifted toward ownership, allocating $788 million to locomotives and freight cars and using $143 million of that amount for lease buyouts, indicating a strategic move to acquire and retain more freight‑car assets rather than depend on leases (see the 2024 capital‑investment table [page 33]).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Union Pacific's shift from leasing in 2023 to acquiring freight cars in 2024. The $143 million lease buyout in 2024 matches the ground truth exactly. While the ground truth mentions $57 million in lease buyouts in 2023, the LLM does not contradict this but instead provides additional context—$1.6 billion in operating lease assets and $241 million in new lease liabilities—which is consistent with a leasing strategy and adds depth without inaccuracy. (2) The $788 million capital allocation in 2024 for locomotives and freight cars is correctly cited, and the $143 million portion for lease buyouts is accurately broken out. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes data across 2023 and 2024 filings, correctly infers a strategic shift from leasing to ownership, and supports it with specific financial figures from appropriate sections (lease tables, capital investment). (4) The answer is semantically equivalent to the ground truth, with enhanced detail that improves clarity without introducing errors. The only minor limitation is the absence of the explicit 2023 $57 million buyout figure, but this omission does not detract from the core conclusion. All entities (Union Pacific, freight cars, 2023–2024 timeframe) and metrics are correct. Thus, the answer earns a 9/10 for correctness—excellent, with near-perfect quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 415,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike’s FY‑2023 restructuring of its Asia‑Pacific‑Latin‑America (APLA) segment centered on the sale of its Argentina and Uruguay businesses to a third‑party distributor.  The divestiture generated a net loss of about $550 million – $389 million of which reflected the release of cumulative foreign‑currency translation losses and the remainder from local‑currency devaluation – and the cash proceeds from the sale were recorded in “Other investing activities” (the loss was classified within Corporate).  Operationally, Nike exited direct operations in those two markets, moving the businesses to a distributor model and thereby reducing APLA’s direct assets, inventories and on‑ground presence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structural change in APLA involving the transition of certain businesses (specifically Argentina and Uruguay) to third-party distributors, aligning with the ground truth's description of a shift from direct operations to a distributor model. It also correctly notes operational impacts such as reduced direct assets, inventories, and on-ground presence. However, the $550 million net loss and its breakdown ($389 million from foreign currency translation losses and the rest from devaluation) are not present in the original answer and appear to be fabricated or misattributed; the ground truth mentions non-recurring impairment charges due to anticipated release of cumulative foreign currency translation losses but does not specify a dollar amount. (2) Quantitative accuracy is compromised because the original answer contains no numerical figures, yet the LLM introduces precise numbers like $550 million and $389 million without support from the provided ground truth. These figures may exist in actual filings but are absent in the knowledge graph's verified answer, making them unsupported in this evaluation context. (3) The reasoning is logically sound and reflects multi-hop synthesis: the LLM infers financial impact (losses tied to currency translation), operational changes (exit from direct operations), and reporting implications (classification in Corporate, cash flows). It correctly links the transition to reduced operational footprint and financial consequences, demonstrating good qualitative understanding. (4) Contextual relevance is high as the answer directly addresses the financial and operational impacts of Nike’s APLA restructuring. While it adds unsupported specifics, the overall direction and structure of the response match the question’s intent. The score is reduced primarily due to the introduction of unverified quantitative claims not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 528,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "In the 2022 Form 10‑K Broadcom’s filing makes no reference to fabricating InP‑based lasers – the discussion focuses on its overall product portfolio and lists competitors such as Lumentum, MACOM, etc., without highlighting any proprietary InP‑laser capability【page_17】. By the 2024 Form 10‑K the company says it now uses its own U.S. and Singapore III‑V fabs to produce vertical‑cavity surface‑emitting and side‑emitting lasers built on GaAs and InP for fiber‑optic communications, a move meant to protect its IP, speed time‑to‑market and compete more directly with other integrated‑device and fabless laser suppliers【page_13】. This reflects a shift from no disclosed internal InP‑laser production in 2022 to an explicit internal‑fabrication strategy and stronger competitive positioning in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding Broadcom's 2022 disclosure. The original answer (ground truth) states that in 2022, Broadcom *did* disclose using internal fabrication for products based on proprietary processes, including InP lasers. However, the LLM claims that the 2022 Form 10-K 'makes no reference to fabricating InP-based lasers,' which directly contradicts the ground truth. This undermines the core reasoning of the answer, which frames the evolution as a shift from no internal InP-laser production in 2022 to explicit strategy in 2024. In reality, the strategy existed in 2022 and was continued and re-emphasized in 2024 with more competitive context. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2024) and locations (U.S., Singapore) are consistent and plausible. The mention of GaAs and InP materials and laser types (VCSELs, side-emitting) aligns with the ground truth. (3) The multi-hop reasoning is flawed because it misrepresents the 2022 state of affairs, leading to an incorrect conclusion about strategic evolution. The LLM incorrectly infers a change in fabrication strategy when the ground truth indicates continuity with increased competitive framing. (4) Despite accurate mention of competitors (Lumentum, MACOM) and correct 2024 details, the fundamental mischaracterization of 2022 information results in a partially correct but misleading narrative. The contextual relevance is high as it addresses internal fabrication and competitive positioning, but the qualitative accuracy is low due to the incorrect premise. Correctness score is 4 due to major factual error in entity-state synthesis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 475,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K Nike disclosed that Swoosh, LLC owned about 77 % of the company’s Class A common stock – a stake that would translate to roughly 16 % of the Class B stock if all of those shares were converted 【page_25】. The 2023 filing reports the same ownership level – Swoosh, LLC still held about 77 % of the Class A shares (≈ 16 % of Class B on a full conversion) 【page_26】. Because Class A shareholders elect three‑quarters of Nike’s board, Swoosh’s dominant Class A position gives the Knight family outsized voting power and control over corporate decisions; only a conversion to Class B would substantially dilute that influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 77% ownership of Class A Common Stock and approximately 16% of Class B Common Stock if converted, for both 2022 and 2023. These figures match the original answer exactly, and the citation of page numbers from the 10-K filings adds verifiability. (2) The answer is complete, addressing both the evolution (consistency across years) and implications (influence over shareholder decisions). It correctly identifies that ownership percentages did not change, fulfilling the multi-hop requirement of comparing across years. (3) Entity accuracy is strong: Swoosh, LLC, NIKE’s Class A and Class B stock, and the correct time periods (2022 and 2023) are all properly referenced. (4) Reasoning is sound and even enhances the original answer by explicitly noting that Class A shareholders elect three-quarters of the board, which strengthens the explanation of voting control. The only minor shortcoming is that the LLM does not explicitly name Travis Knight as having a management role in Swoosh, LLC—though it refers to the 'Knight family,' which is semantically close and contextually accurate. This slight omission prevents a perfect 10 on qualitative accuracy, but the core implications for shareholder influence are correctly and thoroughly explained. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 400,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "In 2022 PMI described its reduced‑risk products mainly as a growing revenue segment—$9.1 bn of net revenue in 2021 versus $6.8 bn in 2020—covering heated‑tobacco, e‑vapor and oral‑nicotine offerings (page 97). By 2023, after acquiring Swedish Match in 2022, PMI repositioned RRPs as an integrated “smoke‑free” portfolio that combines its IQOS heat‑not‑burn platform with ZYN oral‑nicotine, and it reported that these smoke‑free products were now available in 84 markets worldwide (pages 29 & 28). This reflects a shift from a standalone RRP revenue focus to a unified, globally‑available smoke‑free product suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of PMI's strategic positioning of Reduced-Risk Products (RRPs) from 2022 to 2023, noting the shift from RRPs as a standalone category to integration into a broader 'smoke-free' portfolio. The mention of heated tobacco, e-vapor, and oral nicotine products in 2022 matches the original answer. (2) Quantitatively, the LLM provides revenue figures ($9.1B in 2021 vs $6.8B in 2020), which are not contradicted by the ground truth—though the ground truth does not include these specific numbers, they are plausible and do not conflict. The key quantitative fact from the ground truth—availability in 84 markets by end of 2023—is correctly reported. The acquisition of Swedish Match in 2022 is accurately cited as a driver for the repositioning, explaining the integration of ZYN into the portfolio. (3) The reasoning is sound: the LLM correctly synthesizes the strategic shift (from separate RRP reporting to unified smoke-free products) and links it to expanded market availability and portfolio integration post-acquisition. The only minor gap is that the ground truth specifies wellness and healthcare offerings were added to the new Smoke-Free Products category, which the LLM omits—instead focusing on IQOS and ZYN. This is a small omission in completeness but does not distort the core message. (4) The answer is fully relevant to the question, addressing both portfolio integration and market availability. Overall, the LLM conveys semantically equivalent information with strong multi-hop reasoning across time, product categories, and corporate strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 455,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "By 2022 Caterpillar’s reciprocating‑engine business was essentially a sales‑focused platform – the engines were sold “principally through the dealer network and to other manufacturers…through subsidiaries such as Perkins, FG Wilson and MaK”【page_9】. By 2024 the company had repositioned the business as a strategic solutions hub, adding drivetrain, electrified‑power‑train and zero‑emission offerings and a dedicated remanufacturing operation for its own and third‑party engines【page_39】. That broader role coincided with a shift in the revenue mix – flat oil‑and‑gas sales but a drop in well‑servicing engine sales offset by growth in gas‑compression and large power‑generation engines – which, together with stronger price realization, lifted Energy & Transportation profit and created higher gross‑margin potential【page_37】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Caterpillar's strategic role from a sales-focused model in 2022 to a broader solutions and remanufacturing provider by 2024, aligning with the ground truth. It accurately notes the expansion into remanufacturing for both Caterpillar and third-party engines, which is a key qualitative shift. However, the LLM adds details not present in the ground truth—specifically 'drivetrain, electrified-power-train and zero-emission offerings'—which, while plausible, are not mentioned in the original answer and represent an overextension. (2) There are no explicit numerical values (e.g., revenue figures, percentages) in either the ground truth or LLM answer, so quantitative accuracy is high by default; the LLM references 'flat oil-and-gas sales', 'drop in well-servicing engine sales', and 'growth in gas-compression and large power-generation engines' with a mention of 'stronger price realization'—these are qualitative trends, not hard numbers, and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM connects the strategic evolution to changes in revenue composition and gross margin potential, correctly inferring that the shift toward services and remanufacturing improves margins due to lower material costs, even if it frames the reasoning around additional product lines not in the original. The synthesis across time (2022 to 2024) and business model (sales to lifecycle services) is logically coherent. (4) The correctness score is 8 because the core facts—expansion into remanufacturing, shift in revenue mix, and improved margin potential—are accurate and well-supported. The addition of unverified offerings (e.g., zero-emission) prevents a 9 or 10. Qualitative accuracy is 8 due to these extrapolations, but contextual relevance is 10 as the answer directly and thoroughly addresses the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 516,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon said it would “disclose on our website any amendments to or waivers of … the Directors’ Code of Conduct,” linking to a PDF at https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf【page_11】. The 2023 filing repeats the same commitment but updates the web address (now https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf and a revised “csr code‑of‑conduct.pdf” link)【page_13】, indicating a refined, more specific online posting while maintaining the website‑based disclosure mechanism. This shows continuity in transparency—posting changes online—but with a modest evolution in how the documents are organized and accessed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that BNY Mellon committed to disclosing amendments to the Directors' Code of Conduct on its website in both 2022 and 2023, which aligns with the ground truth. It accurately cites the disclosure language and provides specific URLs from both years, demonstrating attention to source details. However, the LLM introduces a claim not supported by the ground truth: that there was a 'refined, more specific online posting' and a 'modest evolution in how the documents are organized and accessed.' The original answer explicitly states there was no change in the mechanism or transparency commitment, indicating a stable approach. The LLM interprets URL updates as a meaningful evolution in transparency or mechanism, but the ground truth treats these as immaterial changes consistent with ongoing practice. This mischaracterizes the nature of the change and overstates evolution where none was deemed significant by the company. While the factual elements (dates, URLs, disclosure commitments) are accurate, the reasoning and synthesis incorrectly infer a shift in approach. Thus, quantitative accuracy is perfect, but qualitative accuracy is reduced due to flawed interpretation. Contextual relevance remains high as the response directly addresses the question's focus on mechanisms and transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 369,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "In FY 22 Nike’s APLA market was largely run through its own NIKE Direct business—owned stores, digital platforms and a mix of independent distributors—fueling double‑digit growth in the region (see FY 22 MD&A, p. 31). By FY 23 the company began reshaping that model, completing the sale of its Argentina and Uruguay entities and moving those operations to third‑party distributors, signalling a shift to a lighter, more outsourced operating structure while still reporting APLA as a distinct geographic segment (see FY 23 operating‑segment note, p. 89, and Divestitures note, p. 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Nike's direct operation in APLA in FY22 through NIKE Direct and distributors, matching the original answer's description of significant direct presence and contribution to 14% growth (though the exact percentage is not repeated, the 'double-digit growth' phrasing is consistent with 14%). In FY23, it accurately notes the shift to third-party distributors, specifically citing the sale of Argentina and Uruguay entities, which is a precise detail supporting the strategic transition. (2) There are no numeric inaccuracies—while the 14% growth figure from the original answer is not explicitly repeated, the LLM's 'double-digit growth' is semantically equivalent and supported by the cited FY22 MD&A. No calculations are required, and fiscal years (FY22, FY23) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes information across operational structure (NIKE Direct, distributors) and market participation changes (divestitures in Argentina/Uruguay), correctly inferring a strategic pivot. The citations (MD&A p.31, operating segment note p.89, Divestitures note p.93) suggest proper grounding in document evidence. (4) The answer is contextually complete and relevant, addressing both operational structure and market participation evolution. The only minor shortcoming is the omission of the explicit '14%' growth figure, which slightly reduces qualitative precision, but the core strategic evolution is accurately and thoroughly conveyed. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 436,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "In the 2022 filing (covering FY 2021), Caterpillar said that **favorable price realization was a primary driver of growth**, helping lift total sales and revenues by $9.2 billion (a 22 % increase) and boosting operating profit by $2.3 billion (a 51 % rise)【page_34】【page_36】. By FY 2024, the company noted that **lower sales volume reduced revenue, but favorable price realization now acted as a mitigating factor**, partially offsetting the volume decline and contributing positively to profit, essentially cushioning the drop rather than driving growth【page_30】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies that favorable price realization contributed $9.2 billion to sales in 2022 (matching the ground truth $9.223 billion, acceptable rounding). However, it incorrectly states this was from the '2022 filing (covering FY 2021)', which misaligns the fiscal year — the $9.2B figure pertains to 2022 performance, not 2021. The LLM also introduces an unsupported $2.3 billion increase in operating profit in 2022, which is not present in the original answer and cannot be verified from the context provided. In the 2024 analysis, the LLM correctly notes that favorable price realization offset declining sales volume, aligning with the original answer. However, it omits key quantitative details: the $2.251 billion sales volume decrease and the rise in profit from $10.335B to $10.792B — critical for assessing evolution in profitability. (2) Quantitative accuracy is compromised: while the $9.2B figure is approximately correct, the $2.3B operating profit increase is extraneous and unsupported by the ground truth, which focuses on total profit increasing from 2023 to 2024 due to pricing. The absence of the exact 2024 profit figures and volume decline weakens the response. (3) The multi-hop reasoning is partially sound — the model connects pricing effects across years and recognizes a shift from growth driver to mitigator. However, it fails to synthesize the full trajectory by missing the actual profit numbers in 2023 and 2024, which are essential for evaluating profitability evolution. (4) Contextual relevance is high — the answer addresses the core theme of how price realization evolved in impact. Qualitative accuracy is moderate due to correct conceptual framing but flawed or missing financial data. Correctness score is 6 due to partial factual alignment but significant omissions and one major factual misstatement (profit increase in 2022).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 532,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "In the 2023 filing GM stressed that expanding EV output would be driven by concrete capital projects – a $0.7 bn investment in Ultium Cells, a $0.3 bn stake in Lithium Americas, and other plant spend – and that a “more resilient, scalable and sustainable North‑American‑focused EV supply chain” built through strategic sourcing and multi‑year raw‑material agreements was essential to that capacity growth (2023 p.40; 2023 p.18). By the 2024 filing the narrative had broadened: the company now frames EV capacity as part of a holistic strategy to “scale our EV manufacturing capabilities, reduce battery‑cell costs, license and monetize platforms, and leverage synergies with ICE vehicles,” while still committing to a resilient, North‑American supply chain and long‑term supplier contracts (2024 p.15‑16; 2024 p.18).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in GM's EV manufacturing strategy from 2023 to 2024: in 2023, the focus was on capital investments (e.g., Ultium Cells, Lithium Americas) and building a North American-focused supply chain through strategic sourcing and long-term agreements. By 2024, the strategy expanded to include broader goals like reducing battery costs, monetizing platforms, and leveraging ICE synergies—details not in the original answer but consistent with a more holistic approach. (2) Quantitatively, the $0.7B Ultium and $0.3B Lithium Americas investments are correctly cited (though the original answer does not include these figures, they are plausible and do not contradict it). No calculations are required, and the dollar amounts are presented accurately. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifies shifts in strategic language, and correctly infers an evolution in focus. (4) The LLM adds slightly more detail than the original (e.g., specific project names and page references), but this enhances rather than distorts the answer. The core factual content—shift toward a resilient, scalable, North American supply chain and strategic sourcing—matches the ground truth. One minor point preventing a perfect 10 is that the original emphasizes 'sustainable' in the supply chain, which the LLM mentions only implicitly. Otherwise, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 430,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "The 2022 Form 10‑K does not give a specific dollar amount for Paxlovid’s remaining performance‑obligation balance (the filing only references the product and its forecasted revenue contribution, but no RPO figure is disclosed)【page_9】. By contrast, the 2024 Form 10‑K states that the remaining performance obligations for Paxlovid were about **$1 billion** as of December 31 2024【page_110】. Thus, Pfizer’s disclosed future contractual commitment for Paxlovid has been quantified at $1 billion in 2024, down from an unspecified (and presumably larger) amount in 2022, reflecting a reduction in the outstanding revenue obligations as the product moved from government‑sponsored contracts to commercial sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Pfizer's 2022 10-K did not disclose a specific remaining performance obligation (RPO) for Paxlovid, and accurately reports the $1 billion RPO as of December 31, 2024, from the 2024 10-K. These quantitative facts match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the LLM introduces an incorrect inference that the obligation in 2022 was 'presumably larger' and that the $1 billion reflects a 'reduction' in obligations. The ground truth does not support this interpretation — the absence of a disclosed figure in 2022 does not imply a larger obligation; it simply means the obligation was not quantified at that time. This misrepresents the evolution and reflects flawed reasoning. (3) The multi-hop synthesis correctly connects Paxlovid RPOs across two years using the appropriate filings, but the conclusion about a reduction in commitment is not supported by the data and introduces a logical error. The shift from government to commercial sales is not mentioned in the ground truth and is speculative. (4) Despite this, the core facts are correct and the answer addresses the evolution in disclosure practice, so the overall correctness score is 7 — the key data points are accurate, but the interpretation contains significant qualitative inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 375,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Both the 2022 filing (page 9) and the 2023 filing (page 9) state that Caterpillar “uses a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks…including supplier financial viability, the ability to increase or decrease production levels, business continuity, quality and delivery.” The 2023 filing repeats this language verbatim, showing that the company’s risk‑mitigation strategy and the contractual framework for monitoring supplier financial health have remained essentially unchanged from 2022 to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in quoting the verbatim language from both the 2022 and 2023 filings regarding Caterpillar's use of supplier agreements and risk monitoring processes, including supplier financial viability. The page numbers (page 9) and quoted text are consistent with the source, satisfying quantitative and entity accuracy. However, the answer fails to capture the nuanced evolution highlighted in the ground truth: while the exact wording may be repeated, Caterpillar in 2023 placed a more explicit emphasis on 'supplier financial viability' by listing it as the first risk in its supply chain disclosures, signaling a prioritization shift. Additionally, the 2023 filing included new language about reinforcing global strategic sourcing models to build long-term relationships and leverage enterprise spend—indicative of a more structured approach to supplier risk management. The LLM incorrectly concludes that the strategy 'remained essentially unchanged,' missing this qualitative evolution in emphasis and strategic framing. This constitutes a failure in multi-hop reasoning and qualitative synthesis, as the model did not interpret the significance of reordering risk factors or the addition of strategic sourcing enhancements. While the quoted content is accurate, the interpretation of 'no change' overlooks key contextual developments, leading to a partially correct but misleading conclusion. Hence, correctness and qualitative accuracy are significantly penalized despite strong performance on literal accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 426,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "In the 2022 filing Visa only listed Risk and Identity Solutions as one of its five value‑added‑service categories (alongside issuing, acceptance, open‑banking and advisory services) without detailing specific offerings (see 2022 p. 5). By 2024 the group has become a strategic pillar of the value‑added‑services platform, highlighted as a distinct category within a portfolio of >200 products and described as “transforming data into insights for near‑real‑time decisions” and “facilitating account‑holder authentication” – now featuring AI/ML‑driven tools such as Visa Deep Authorization, Visa Protect for A2A Payments and Visa Risk Manager that are integrated across both Visa and non‑Visa transactions (see 2024 p. 11‑12). This reflects a shift from a simple service label to a core, integrated fraud‑prevention engine embedded throughout Visa’s broader suite of solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Risk and Identity Solutions were listed as one of several value-added services without detailed elaboration, matching the original answer's claim of minimal strategic detail. By 2024, it accurately reflects the evolution into a more structured and strategic component of Visa’s offerings. The mention of >200 products is consistent with the expanded scope implied in the ground truth. (2) There are no numeric inaccuracies—dates (2022, 2024), page references (p. 5, p. 11–12), and product names (Visa Deep Authorization, Visa Protect for A2A Payments, Visa Risk Manager) are correctly cited. The absence of exact dollar amounts or percentages means quantitative precision is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 → 2024), compares strategic positioning, and infers increased integration through specific product examples and AI/ML capabilities. It correctly identifies the shift from a categorical label to a core, technology-driven function. The only minor gap is that the LLM does not explicitly mention the 'three-pillar strategy' framework (Visa transactions, non-Visa transactions, beyond payments) from the ground truth, which slightly reduces completeness in structural detail. However, the description of services covering both Visa and non-Visa transactions implies awareness of the second pillar, and the reference to 'beyond payments' is partially captured in 'facilitating account-holder authentication' and 'near-real-time decisions'. (4) The answer is contextually excellent—directly addressing strategic positioning and integration within value-added services, using precise evidence from filings. Overall, this is a semantically equivalent, well-supported response with only a slight omission of the explicit three-pillar framing, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 526,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "In the 2022 filing the company warned that “changes in the policies or practices of our retail trade customers… inventory de‑stocking, fulfillment requirements, **limitations on access to shelf space**, delisting of our products” together with the early growth of e‑commerce and alternative channels could hurt sales【page_11】. The 2023 filing repeats the shelf‑space limitation risk but adds that “the rapid growth of e‑commerce and the emergence of alternative retail channels… have created pricing pressures and may adversely affect our relationships with our key retailers,” indicating that the exposure to shelf‑space constraints has become more pronounced as digital and direct‑to‑consumer channels expand【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, shelf space limitations were presented as a potential risk tied to retail customer policies, and in 2023, this evolved into a more pronounced challenge due to the growth of e-commerce and alternative retail channels. The use of direct quotes from the filings (e.g., 'limitations on access to shelf space') supports factual fidelity. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2023) are correct, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly infers an escalation from 'potential risk' to 'more pronounced' impact, and links it to expanding digital and direct-to-consumer channels. The only minor shortcoming is that the LLM does not explicitly mention the company’s planned response—investing in digital and analytics capabilities—which is included in the original answer and represents a small omission in completeness. (4) Despite this, the answer remains semantically equivalent in conveying the evolution of the risk. Contextual relevance is excellent, directly addressing changes in shelf space exposure in relation to retail policies and alternative channels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 370,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "In FY 2023 Oracle’s hybrid‑deployment story was framed as a portfolio of flexible options – on‑premise, cloud‑based and hybrid – highlighted by offerings such as Exadata Cloud@Customer, Dedicated Region and multicloud capabilities (Item 1 Business, FY 2023 10‑K, p. 6). By FY 2024 the focus shifted to making cloud‑centric growth a strategic priority: the restructuring plan and investment agenda were tied to “developing, marketing, selling and delivering our cloud‑based offerings,” including the rollout of a second‑generation cloud infrastructure that deepens and expands hybrid services (Restructuring Plan, FY 2024 10‑K, p. 54; Item 1 Business, FY 2024 10‑K, p. 6).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Oracle's hybrid deployment offerings in FY2023, including Exadata Cloud@Customer and Dedicated Region, and correctly notes the emphasis on flexibility and deployment choice. In FY2024, it correctly observes a strategic shift toward cloud-centric growth while still enhancing hybrid services through second-generation cloud infrastructure. The mention of the restructuring plan and investment priorities in FY2024 is supported by the cited 10-K references. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct fiscal year references (FY2023 and FY2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two fiscal years and connects strategic emphasis with product evolution. However, the LLM slightly reframes the FY2024 evolution as a 'shift to cloud-centric growth' rather than a deepening of hybrid integration, which downplays Oracle’s continued strategic investment in hybrid interoperability emphasized in the ground truth. While not incorrect, it shifts focus away from the 'tailored integrations and services for hybrid environments' highlighted in the original answer. (4) Despite this nuance, the answer remains factually accurate, contextually relevant, and well-supported by citations. The minor omission of explicit mention of 'interoperability' and 'customer-managed environments' prevents a perfect score, but core facts and strategic trajectory are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 452,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer’s 2022 Form 10‑K does not provide a disclosed remaining‑performance‑obligation balance for Paxlovid – the filing discusses the product’s revenue and government‑contract context but gives no specific RPO figure (see 2022 pages 21‑26). By the end of 2024, however, the company reported about **$1 billion** of contracted revenue still to be recognized from remaining performance obligations for Paxlovid (see 2024 page 109), showing a quantified future commitment that was not disclosed in the 2022 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, the $1 billion remaining performance obligation (RPO) for Paxlovid as of December 31, 2024, is correctly reported, matching the original answer. The absence of a specific RPO figure in the 2022 filing is also accurately noted—this is consistent with the knowledge graph, which states that Pfizer discussed potential ongoing revenue but did not quantify future obligations at that time. (2) The LLM correctly identifies that while 2022 acknowledged future revenue potential, no specific RPO was disclosed, and by 2024, a concrete $1 billion RPO was reported, expected to be recognized from 2025 through 2028 (implied in the LLM’s reference to future recognition, though exact years are omitted). (3) The multi-hop reasoning is sound: the model contrasts the lack of quantified commitment in 2022 with the explicit $1B figure in 2024, correctly inferring an evolution in disclosure and financial commitment. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2025–2028 revenue recognition timeline, which is part of the original answer and adds context to the multi-year horizon. However, stating that the $1B is 'still to be recognized' implies future recognition, capturing the essence. Wording differs but semantic meaning is preserved. All entities (Pfizer, Paxlovid, RPO, years) are correct. Thus, high scores across all dimensions with a slight deduction in qualitative accuracy for partial omission of the time horizon.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 423,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "In the 2022 filing Caterpillar simply noted that it sells its products through a “global network of independent dealers” to build long‑term customer relationships, without detailing the contractual framework. By the 2023 filing the company explains that each dealer is bound by standard sales‑and‑service agreements that grant selling rights, require active promotion, inventory and record‑keeping, and can be terminated by either party with 90‑day notice—signaling a shift toward more formal, performance‑driven contracts and a strategic emphasis on dealers’ inventory and sourcing decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Caterpillar's dealer relationships between 2022 and 2023. It correctly identifies that in 2022, the relationship was described generally as a 'global network of independent dealers' without detailed contractual terms, while in 2023, standardized sales-and-service agreements were introduced. The key contractual obligations—selling rights, promotion, inventory, record-keeping, and 90-day termination clause—are accurately reported. The strategic emphasis on formalization, performance, and control through inventory and sourcing is correctly inferred. The only minor omission is that the original answer specifies dealers must maintain 'adequate sales and support personnel' and that financial records must be accessible to Caterpillar—details not explicitly mentioned in the LLM response. However, these are secondary to the main shift toward formal contracts. All entities (Caterpillar, independent dealers, 2022 vs 2023), years, and contractual terms are correct. No numerical inaccuracies; dates and notice periods (90-day) are precise. The reasoning correctly synthesizes multi-hop information across two years of filings to infer a strategic shift. The answer is contextually fully relevant and conveys semantically equivalent information with only slight compression of detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 375,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "In 2023 the company sharply scaled back its Africa/Eurasia spending – capital‑expenditure for the region fell to **$10 million**, down from **$30 million in 2022** (Colgate‑Palmolive 2023 10‑K, p. 117).  Likewise, the Global Productivity Initiative restructuring program – which the company expects to allocate roughly **10 % of its total charges to Africa/Eurasia** – saw its overall pretax charge drop from **$110 million in 2022 to $32 million in 2023** (Corporate segment discussion, p. 46‑47), meaning the region’s share of restructuring costs fell from about $11 million to roughly $3 million.  Together, these figures show a clear reduction in both investment and restructuring focus on Africa/Eurasia from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, capital expenditures for Africa/Eurasia were $33 million in 2022, not $30 million as stated, and there is no mention of $10 million in 2023 in the original answer—this figure is entirely fabricated. The original answer does not provide 2023 capital expenditure figures at all, instead noting a shift in focus toward restructuring. The LLM incorrectly claims that restructuring charges for Africa/Eurasia fell from $11 million to $3 million based on a 10% allocation of total charges ($110M in 2022, $32M in 2023), but the original answer does not state total charges or regional dollar amounts for restructuring—only that approximately 10% of cumulative pretax charges from the 2022 Global Productivity Initiative relate to Africa/Eurasia. This calculation is speculative and not supported by the ground truth. (2) Number verification: $33M (actual 2022 capex) vs $30M (claimed) is incorrect; $10M 2023 capex is unsupported; total restructuring charges and derived regional costs are not in the original answer and are thus invalid. (3) Multi-hop reasoning is flawed: the model infers a reduction in focus based on fabricated or misinterpreted numbers, whereas the original answer describes a strategic shift from capital investment to restructuring—without asserting a reduction in overall activity. The LLM mischaracterizes the evolution as a 'scaling back' and 'reduction in focus,' while the truth reflects a reallocation from capital spending to restructuring, not necessarily a decrease. (4) Correctness score is low due to major factual and numerical errors. Quantitative accuracy is very poor. Qualitative accuracy is partially acceptable in identifying a strategic shift but fails in correct synthesis. Contextual relevance is fair as it addresses the region and time frame and attempts to compare capex and restructuring, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 528,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "In its 2022 filing Qualcomm emphasized that it was pouring “significant resources toward advancements primarily in support 5G‑based technologies” and expanding 5G through early‑stage strategic investments via Qualcomm Ventures, with most 5G‑related revenue still coming from licensing multimode device sales【page_21】【page_13】. By the 2024 filing the emphasis had shifted to commercializing integrated 5G products—Snapdragon 5G modem‑RF platforms, RFFE front‑end modules for sub‑6 GHz and mmWave, and broader automotive, IoT and other deployments—signalling a move from pure R&D and venture bets to tangible 5G product roll‑outs and diversified revenue streams【page_11】【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Qualcomm's strategic evolution from 2022 to 2024: in 2022, the focus was on R&D and early-stage investments in 5G, particularly through Qualcomm Ventures, with revenue still largely tied to licensing multimode devices. By 2024, the emphasis shifted to commercialization of integrated 5G products across multiple platforms (modem-RF, RFFE, automotive, IoT), indicating a transition to monetization and product deployment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and strategic domains (investment → commercialization, mobile → automotive/IoT), correctly identifying the shift from development to market leadership. (4) The LLM omits explicit mention of the 'leading patent portfolio in 5G NR' and 'majority of QTL revenues from OFDMA-based products' from the 2024 filing, which are key indicators of monetization in the ground truth. However, it effectively conveys the same overall trajectory through references to product rollouts and diversified revenue. Wording differs but semantic meaning is equivalent. Minor omission prevents a perfect 10, but the core facts, entities, timeline, and strategic logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 397,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer’s Paxlovid shifted from a government‑driven, high‑revenue product in 2022 to a commercially‑focused offering by 2024: it generated $18.9 billion (≈19 % of total revenue) in 2022, with the U.S. government accounting for 23 % of total sales, but fell to $5.7 billion (≈9 % of total revenue) in 2024 and the government’s share dropped to 6 % after an amended U.S. agreement moved the drug into the commercial market (page_108).  At the same time, advance‑payment liabilities tied to Paxlovid fell from over $5 billion of deferred revenue in 2023 to $2.2 billion at year‑end 2024, and remaining long‑term Paxlovid contracts now represent about $1 billion of future revenue, reflecting a transition from large government bulk‑supply contracts to smaller commercial and pandemic‑preparedness commitments (pages_108, 110, 109).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key financial figures. The ground truth states Paxlovid generated $76 million in revenue in 2022, but the LLM claims $18.9 billion, which is off by two orders of magnitude. Similarly, the LLM reports $5.7 billion in 2024 revenue, while the original answer does not provide a 2024 revenue figure—only $1 billion in remaining performance obligations (RPO), which is not equivalent to revenue. These numbers are fundamentally incorrect and misrepresent Pfizer's financials. (2) The quantitative inaccuracies extend to percentages: claiming Paxlovid was 19% of total revenue in 2022 and 9% in 2024 cannot be validated due to the incorrect base revenue figures. Additionally, deferred revenue falling from over $5 billion to $2.2 billion is not mentioned in the ground truth, making it unsupported. Only the $1 billion in remaining performance obligations for future Paxlovid deliveries matches the original answer. (3) The qualitative reasoning shows an understanding of a strategic shift—from government to commercial markets and longer-term contracts—but this is built on false numerical premises. The mention of an amended U.S. agreement moving Paxlovid into the commercial market adds context not contradicted by the ground truth, and the concept of transitioning from bulk government purchases to smaller commitments aligns thematically. However, the multi-hop synthesis fails because it relies on fabricated or misattributed data. (4) Contextual relevance is moderate: the answer addresses revenue trends and contractual evolution as asked, but due to severe numerical errors, the overall correctness score is low. The model appears to confuse Paxlovid with another product or misread the source data entirely. While some structural elements of the response are logically sound, the factual foundation is unsound, warranting a correctness score of 3 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 521,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "In the 2022 filing the company called out “the impact on our suppliers of tighter credit or capital markets” and warned that “disruptions in the credit markets… could adversely affect our business” (2022 p. 16, 20). In the 2023 filing the same supply‑chain risk is still mentioned (2023 p. 15) but the company now emphasizes strong cash generation, lower debt and ample undrawn credit facilities that give it broad access to global credit markets (2023 p. 52), indicating that its exposure to credit‑market tightness has lessened even though the risk remains.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing page numbers and some accurate excerpts. The ground truth states that the company's framing evolved from credit market tightness negatively impacting suppliers in 2022 to the company itself being 'impacted by' these conditions in 2023—indicating an increased or more direct recognition of vulnerability. However, the LLM incorrectly interprets the 2023 filing as showing reduced exposure due to strong cash flow, lower debt, and credit access, which contradicts the ground truth. While the mention of ongoing risk is correct, the inference that exposure has 'lessened' is unsupported by the provided ground truth and misrepresents the evolution of risk perception. There are no numerical errors (hence high quantitative accuracy), but the qualitative reasoning is flawed in synthesizing the multi-hop change over time. The context of supply chain risk is addressed, but the conclusion about decreasing vulnerability runs counter to the documented shift toward broader operational impact, reducing both qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 317,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "In 2022 Paxlovid generated $18.9 billion of revenue almost entirely from government and government‑sponsored contracts, creating $5.1 billion of deferred revenue (about $2.6 billion current and $2.5 billion non‑current) and large performance‑obligation balances. After an amended U.S. agreement in late‑2023 that moved Paxlovid to commercial markets – resulting in a $3.5 billion non‑cash revenue reversal, a $771 million favorable adjustment and a $442 million revenue recognition for a U.S. SNS – the 2024 filing shows deferred revenue for Paxlovid/Comirnaty fell to $2.2 billion, remaining contracted revenue for Paxlovid is about $1 billion, and a $0.5 billion charge for excess raw‑material inventory was recorded. This reflects a shift from heavy government‑backed supply commitments in 2022 to a smaller, commercial‑focused contract portfolio and reduced financial commitments by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a detailed and largely accurate evolution of Pfizer's financial commitment and contractual obligations related to Paxlovid from 2022 to 2024, with strong multi-hop reasoning and contextual relevance. However, there are some quantitative discrepancies that prevent a perfect score. (1) The $18.9 billion revenue figure for Paxlovid in 2022 is factually correct and aligns with Pfizer's disclosures, as is the $5.1 billion deferred revenue breakdown. However, the $3.5 billion non-cash revenue reversal is not explicitly confirmed in public 10-K filings as being solely tied to Paxlovid; it may be conflated with broader adjustments. (2) The $771 million favorable adjustment is correctly cited from the 2024 disclosures and matches the ground truth, which references this amount as a final adjustment related to returned EUA-labeled treatment courses. (3) The remaining performance obligations of $1 billion in 2024 are accurately reported and consistent with the original answer. (4) The $0.5 billion charge for excess raw-material inventory is mentioned in Pfizer’s 2023 10-K but is not directly tied to Paxlovid in all disclosures—this linkage may be inferential. (5) The drop in deferred revenue to $2.2 billion (Paxlovid/Comirnaty combined) is accurate but combines two products, potentially overstating specificity about Paxlovid alone. (6) The shift from government to commercial markets post-2023 agreement is well-reasoned and supported by Pfizer’s transition from EUA to commercial supply. While the original answer emphasizes forward-looking delivery commitments (2025–2028) and renegotiation risk, the LLM captures this implicitly through 'remaining contracted revenue.' Overall, the LLM synthesizes across years and contractual changes soundly, but minor inaccuracies in attribution and one potentially incorrect reversal figure reduce quantitative precision. Semantic equivalence is strong, and the answer fully addresses the question’s scope with excellent contextual and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 544,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "In 2023 3M recorded a $62 million accrual for Aearo’s respirator‑mask/asbestos product liabilities and defense costs; by December 31 2024 that accrual had fallen to $51 million, an $11 million reduction (2023 $62 M → 2024 $51 M)【page_83】【page_87】. The company still notes that Aearo’s exposure is limited by its 1995 Cabot indemnity agreement but could increase if the arrangement changes or other developments arise, and it cannot estimate any amount that might exceed the accrued liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that in 2023, 3M recorded a $62 million accrual for Aearo’s liabilities, but the ground truth indicates that in 2023, MMM had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy with no specific accrual mentioned for Aearo itself at that time. The $62 million figure does not appear in the ground truth and is incorrect. The only correct number is the $51 million accrual in 2024 for Aearo-related claims, which matches the original answer. (2) The calculation of an $11 million reduction from $62M to $51M is based on incorrect input data and therefore invalid. The actual evolution from 2023 to 2024 cannot be quantified as a simple reduction because the 2023 figure cited in the LLM answer does not correspond to Aearo-specific liabilities. (3) The qualitative reasoning partially captures the multi-hop nature of the question by referencing the Cabot indemnity agreement and noting potential changes in liability, which aligns with the original answer’s mention of the agreement limiting Aearo’s liability. However, it fails to mention the key context that Aearo was in bankruptcy in 2023 with a stay of litigation, and that the 2024 framework represents a shift to active management of liability through cost-sharing and contractual arrangements. The LLM answer also omits the $100,000 quarterly fee detail, which is a material term of the agreement. (4) The contextual relevance is high because the answer addresses the evolution of liability and risk exposure over time and references key contractual elements. However, due to major quantitative errors and incomplete synthesis of the 2023 situation, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 504,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of about 1.7 percentage points【page_48】.  Over the earlier period, its shipment volume also fell, dropping from 208.5 million cans/packs in 2020 to 197.4 million in 2021 – a reduction of roughly 11 million units (about a 5 % decline)【page_46】.  Thus, both the share and the volume of Skoal moved lower, with the share loss expressed in points and the volume loss in absolute units.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: retail share decreased from 9.3% in 2023 to 7.6% in 2024; shipment volume dropped from 208.5 million to 197.4 million between 2020 and 2021. The LLM correctly calculates the 1.7 percentage point decline in share and approximates the volume decline as ~11 million units (~5%), which aligns with the actual 5.3% drop (11.1 million units). Minor rounding is acceptable. (2) The answer is complete, addressing both sub-questions: the 2023–2024 retail share trend and the 2020–2021 shipment volume trend. (3) Entities are accurate—Skoal, MO (implied), correct time periods, and correct metrics (retail share, shipment volume). (4) The reasoning is sound: it correctly synthesizes data across time periods and metrics, noting that both indicators declined, which reflects consistent downward performance. The comparison logic is valid and matches the original conclusion of a long-term challenge. (5) Semantic equivalence is strong—though the LLM does not explicitly state 'long-term challenge,' it conveys the same factual trajectory and implication through parallel declines. All citations (page references) are consistent with source data. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 364,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm described multimedia (camera, video, display and computer‑vision) as a distinct R&D focus, allocating engineers to develop new modem‑and‑multimedia technologies and protecting related video/audio‑codec patents 【page_14】. By the 2024 filing the same expertise is still highlighted, but it is now presented as a core component of the Snapdragon family—mobile, compute, sound and automotive platforms—tightly coupled with AI/NPU and computer‑vision engines and delivered as integrated SoC and platform solutions for phones, automotive, IoT and XR 【page_11】【page_14】. This reflects a shift from developing multimedia as a separate technology area to embedding it directly into Qualcomm’s flagship product platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's 2022 focus on multimedia technologies—camera, video, display, and computer vision—as a distinct R&D area, consistent with the original answer. By 2024, it accurately captures the shift toward deeper integration of these capabilities into Snapdragon platforms across mobile, automotive, IoT, and XR, which reflects the platform-oriented evolution described in the ground truth. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and identifies a strategic shift—from standalone multimedia R&D to integrated, platform-based delivery—supported by references to specific pages. The mention of AI/NPU coupling aligns with the ground truth’s emphasis on generative AI and AI-enhanced R&D, though the LLM does not explicitly mention 'generative AI' or 'developer enablement,' which are key nuances in the original answer. (4) Despite this minor omission, the core evolution in engineering focus and product integration is correctly conveyed, making the answer semantically equivalent in substance. The LLM emphasizes hardware-software integration and platform delivery, capturing the essence of the shift. Only a slight deduction in qualitative accuracy due to missing explicit reference to generative AI and developer ecosystem focus, but the overall reasoning and contextual relevance remain excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 433,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "In 2023, after the Aearo Entities were reconsolidated, 3M’s balance sheet still reflected a $0.7 billion equity‑investment interest in those entities and a $0.6 billion net inter‑company liability (the gross amounts appeared as $0.9 billion in other liabilities and $0.3 billion in other assets)【page_101】. By 2024, the parties amended the CAE Settlement so that 3M elected to settle the $1 billion equity component in cash, effectively removing the equity‑investment asset and the related inter‑company balances from 3M’s consolidated statements【page_101】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, 3M reconsolidated the Aearo Entities, which led to the *removal* of a $0.7 billion equity investment and $0.6 billion net liability from its balance sheet. However, the LLM incorrectly states that these balances were *still reflected* on the balance sheet after reconsolidation, which contradicts the actual event. Furthermore, the LLM claims that in 2024, a CAE Settlement amendment occurred where 3M settled a $1 billion equity component in cash, removing the balances. This $1 billion figure and the settlement event are not present in the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is low: while $0.7 billion and $0.6 billion are correctly cited in magnitude, their context is reversed—these amounts were removed due to reconsolidation in 2023, not retained. The introduction of a $1 billion equity component and gross breakdowns ($0.9B liability, $0.3B asset) lacks support in the original answer and introduces unsupported data. (3) Multi-hop reasoning is flawed: the model fails to correctly trace the evolution from reconsolidation in 2023 (which brought the entities back into 3M’s financials temporarily) to deconsolidation and a retained stake in 2024. Instead, it invents a 2024 settlement event not mentioned in the ground truth, breaking the logical chain. (4) Contextual relevance is moderate—the response addresses equity investment and intercompany balances and attempts to describe a timeline, but the underlying facts and causality are incorrect, undermining the overall correctness. The shift from consolidation to a retained stake in 2024 is partially aligned, but the explanation is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 484,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "In the 2022 filing Visa’s Risk and Identity Solutions were described as a set of fraud‑prevention tools that “transform data into insights for near‑real‑time decisions” and relied on card‑centric products such as Visa Advanced Authorization, Visa Secure, Visa Advanced Identity Score and the Visa Consumer Authentication Service 【page_12】. By the 2024 filing the offering had been rebranded as the Visa Protect suite and expanded with AI‑driven products—including Visa Deep Authorization, Visa Protect for A2A Payments, and a scheme‑agnostic Visa Risk Manager with Advanced Authorization—extending fraud protection to real‑time non‑card flows 【page_12】. This evolution positions Risk and Identity Solutions as a core, AI‑enabled pillar of Visa’s five‑category value‑added services portfolio (Issuing, Acceptance, Risk and Identity, Open Banking, Advisory) 【page_11】, broadening its strategic role from a card‑focused safeguard to a comprehensive, cross‑channel fraud‑prevention engine.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), correct product names, and strategic positioning within Visa's value-added services. It correctly identifies the evolution from fraud-prevention tools to a broader role and accurately references the five-category portfolio (Risk and Identity, Open Banking, etc.), aligning with the ground truth. Quantitatively, there are no numbers, percentages, or dollar amounts to verify, so accuracy is scored as 10. Contextual relevance is strong—the response directly addresses the evolution and strategic positioning as asked. However, the LLM introduces details not present in the ground truth: (1) the rebranding to 'Visa Protect suite' is not mentioned in the original answer; (2) specific new products like 'Visa Deep Authorization' and 'Visa Protect for A2A Payments' are not referenced in the ground truth; (3) the claim about 'scheme-agnostic Visa Risk Manager' and extension to 'real-time non-card flows' goes beyond the original information. While these may be plausible inferences or based on external knowledge, they are not supported by the provided ground truth, which only states that Risk and Identity Solutions became one of five core categories and that over 200 services existed as of September 30, 2024. The qualitative accuracy is reduced because the LLM overreaches in product-level detail and implies a rebranding and AI-driven expansion not confirmed in the original answer. The core evolution—strategic elevation within a broader services portfolio—is correctly captured, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 434,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "In the 2023 Form 10‑K RTX disclosed a line‑item “Acquisition accounting adjustments” that reduced operating profit by **$(1,998) million** (see 2023 10‑K, p. 109). In the 2024 Form 10‑K the same line‑item was presented, but the adjustment grew to **$(2,058) million**, a **$60 million** larger negative impact, and the filing noted that the adjustments were “relatively consistent” with prior‑year amounts (see 2024 10‑K, p. 54).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims that in 2024, RTX disclosed a negative impact of $(2,058) million due to Acquisition Accounting Adjustments, but the ground truth states that RTX did *not* provide updated quantitative figures for 2024. This number is false and contradicts the original answer. The claimed $60 million increase and citation of page 54 of the 2024 10-K are unsupported by the ground truth. (2) The original answer explicitly states that RTX *shifted away* from quantitative disclosure in 2024 and only provided qualitative policy context, making the LLM’s assertion of a specific 2024 dollar figure a critical factual error. (3) Qualitatively, the LLM fails to recognize the shift in disclosure strategy from numerical to conceptual, which is the core of the question. Instead, it asserts continuity in quantification, directly contradicting the ground truth. (4) Contextually, while the 2023 figure of $(1,998) million is correctly cited, the overall response misrepresents the evolution of disclosure by implying consistent quantification, when in fact the key development was the *discontinuation* of such detailed numerical reporting in 2024. This represents a complete failure in multi-hop reasoning and synthesis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 370,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "In FY 2022 Office 365 Commercial (reported within “Office products and cloud services”) generated about $45 billion of the $91.4 billion Microsoft Cloud revenue – roughly 49 % of the cloud business. By FY 2023 that line grew to about $48.8 billion, but the total Microsoft Cloud revenue rose faster to $111.6 billion, pulling the share down to roughly 44 % (Office 365 Commercial contribution ≈ $48.8 bn / $111.6 bn)【page_93】. Thus, Office 365 Commercial is still expanding in absolute terms, but its growth is outpaced by Azure and other cloud services, indicating a solid but comparatively slower trajectory within Microsoft’s broader cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific figures for Office 365 Commercial revenue ($45B in FY2022 and $48.8B in FY2023) that are not present in the original ground truth and cannot be verified from the provided knowledge. The original answer does not break out Office 365 Commercial revenue as a standalone dollar amount within Microsoft Cloud revenue, nor does it state that it constituted 49% or 44% of the total. These precise numbers and percentages are fabrications or unsupported inferences. (2) While the total Microsoft Cloud revenue figures are correct—$91.4B in FY2022 and $111.6B in FY2023—the LLM performs a calculation (48.8/111.6 ≈ 44%) based on an unverified numerator. This undermines quantitative accuracy. The growth trajectory conclusion relies on this faulty calculation. (3) The reasoning partially aligns with the original: the shift from segment-level reporting to consolidated cloud disclosure and the idea that other services (like Azure) are growing faster than Office 365 Commercial is a reasonable inference. However, the original answer does not support a comparative growth analysis or state that Office 365’s share declined. The multi-hop synthesis is partially sound but overreaches by quantifying unreported revenue splits. (4) Contextual relevance is high because the answer addresses the evolution of Office 365’s role and growth trajectory within Microsoft Cloud. However, the inclusion of fabricated quantitative breakdowns significantly reduces factual correctness, warranting a low-to-mid correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 434,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck’s alliance revenue from the Lynparza collaboration was $1,199 million in 2023 (U.S. $607 m + Intl $592 m)【page_126】. In 2024 the revenue grew about 9%, taking it to roughly $1.3 billion, driven largely by higher demand in most international markets under the AstraZeneca partnership【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in Lynparza alliance revenue from 2023 to 2024 and attributes it to higher international demand, which aligns with the ground truth. The 2023 revenue figure of $1,199 million is accurately broken down into U.S. ($607M) and international ($592M) components, and the 2024 figure is correctly estimated as approximately $1.3 billion (which is consistent with a ~9% increase: $1,199M * 1.09 ≈ $1,307M). (2) Quantitative accuracy is high: the sum $607M + $592M = $1,199M is correct, and the ~9% growth leading to ~$1.3B is a reasonable approximation. The use of 'about 9%' and 'roughly $1.3 billion' is acceptable given typical reporting rounding. (3) The multi-hop reasoning is sound—LLM synthesizes data from two different pages (2023 revenue breakdown and 2024 growth trend), correctly linking them to show evolution over time and attributing the change to international demand, consistent with the AstraZeneca partnership context. (4) The only minor limitation is that the original answer notes Lynparza was part of broader alliance revenue reporting in 2023, which the LLM omits, slightly reducing completeness. However, the LLM provides more precise figures than the ground truth, enhancing rather than detracting from accuracy. All entities (Merck, Lynparza, AstraZeneca partnership, international markets) are correctly identified. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 410,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 Stock and Incentive Compensation Plan was disclosed only by reference to earlier exhibits (e.g., Exhibit 10‑25 and 10‑26) and to the Compensation and Leadership Development Committee’s regulations, without appearing in the equity‑compensation summary. By the 2024 Form 10‑K the plan is listed in Item 12’s table of equity‑compensation plans, showing the securities issuable and remaining under the plan and pointing to the 2024 Proxy Statement for further detail—signaling a move from simple exhibit incorporation to the SEC‑required equity‑compensation reporting format.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of the 2014 Stock and Incentive Compensation Plan's disclosure between 2023 and 2024. In 2023, the plan was referenced via exhibits and committee regulations without inclusion in the equity-compensation summary, matching the original answer’s point about regulatory context. By 2024, it appears in Item 12’s equity-compensation plans table with details on securities issuable and remaining availability, which reflects the shift toward formal equity compensation reporting—consistent with the ground truth’s claim of integration into broader equity reporting. (2) There are no numeric values to verify, but all dates (2023, 2024), document types (Form 10-K, Proxy Statement), and exhibit references (Exhibit 10-25, 10-26) are factually accurate and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure format across two years, connects them to regulatory requirements (e.g., SEC Item 12), and infers a meaningful shift in reporting practice. (4) While the LLM uses more specific terminology (e.g., 'Item 12’s table', 'SEC-required format') than the original answer, this adds precision rather than contradicting it. The only minor gap is that the LLM does not explicitly mention the coexistence with other plans like the 2009 and 2019 plans, which the original answer notes as evidence of integration into the overall framework. However, referencing the 2024 Proxy Statement implies broader context. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth with only slight omission of comparative plan context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 470,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 1992 Stock Plan is only referenced as an exhibit (Exhibit 10‑2) – a historical document listed among the company’s filings【page_69】. By the 2024 Form 10‑K the plan is listed alongside the newer plans in the equity‑compensation summary table that shows the securities that may be issued on exercise of options, warrants and rights, indicating that the 1992 Stock Plan still exists for outstanding awards but now functions as a legacy, closed‑grant component of the equity‑compensation structure (only the 2019 Plan can issue new grants)【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1992 Stock Plan was referenced in the 2023 10-K as an exhibit (Exhibit 10-2), and in the 2024 10-K it appears in the equity-compensation summary table, indicating its transition to a legacy status. The LLM correctly identifies that only the 2019 Plan can issue new grants, which is consistent with the plan being closed to new awards. (2) There are no numeric values to verify (e.g., share counts or dollar amounts), so quantitative accuracy is not compromised—dates (1992, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring the shift from standalone reference to inclusion in a consolidated table, and interprets the implication—that the plan is now a legacy component. (4) The LLM adds value by specifying that the 1992 Plan remains active only for outstanding awards and that new grants are limited to the 2019 Plan, which is a reasonable inference not explicitly stated in the ground truth but consistent with typical SEC disclosures. This enhances completeness without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the 'passive stake' framing, while the LLM uses 'legacy, closed-grant component'—slightly different phrasing with equivalent meaning—so the semantic match is very strong but not perfectly mirrored. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 435,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings note that macro‑economic volatility has slowed client spending on smaller, short‑duration contracts and consulting services, but “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period.” The company’s messaging therefore remains consistent – it is leaning more heavily on longer‑term transformation engagements as a stable revenue source while overall client spend shifts toward fewer, smaller deals (page_21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures that in both 2023 and 2024, clients reduced spending on smaller, short-duration contracts and consulting services due to macroeconomic volatility, while continuing to prioritize large-scale transformations with longer revenue conversion timelines. This matches the original answer's core message. (2) There are no numeric values or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across both years’ filings and correctly identifies the consistency in client behavior and company emphasis. It accurately reflects that there is no new quantitative metric provided and relies on qualitative repetition as evidence of strategic reinforcement. (4) The only minor shortcoming is that the LLM slightly condenses the nuance in the 2023 filing, which explicitly notes a 'slowdown in client spending' and 'deferring' of smaller contracts, whereas the 2024 filing 'reiterates' the trend. The LLM treats both years as equally emphatic, slightly underrepresenting the evolution from observation to reaffirmation. However, this does not undermine the overall correctness. The inclusion of a citation (page_21) is extraneous but not factually incorrect. Semantic equivalence is maintained, and the answer fully addresses the question on client spending patterns and revenue conversion timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 414,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture’s employee‑share issuances fell in 2024 – the company issued 4,904,718 Class A ordinary shares under its 2010 ESPP, versus 5,710,542 shares in fiscal 2023, a drop of roughly 806 k shares (about 14 %).  The 2024 issuances (including other share‑based awards) added roughly $1.94 billion to additional paid‑in capital, reduced treasury‑share balances by about $842 million and lifted total shareholders’ equity by approximately $1.35 billion, expanding the equity base despite the lower share count【page_99】【page_70】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude. The ground truth states that Accenture *issued* 7,970 Class A Ordinary Shares in fiscal 2024 for employee programs, indicating a net issuance, while the LLM claims a *reduction* in share issuances from 5.7M to 4.9M shares, which contradicts the truth. The numbers cited (4.9M and 5.7M shares) do not appear in the ground truth and are factually wrong. The dollar amounts mentioned—$1.94B added to paid-in capital, $842M reduction in treasury shares, $1.35B increase in equity—are not supported by the original answer and appear fabricated or misattributed. (2) The ground truth reports a net *increase* of 7,970 shares issued in 2024 (from 15,656,591 to 15,664,561), while the LLM reports a decrease in share-based compensation activity, which is the opposite of the correct trend. The treasury share value decreased from $(3,408,491) million to $(6,678,037) million (i.e., more negative, meaning more shares were repurchased), but the LLM interprets this as a reduction in treasury balances by $842M, which does not align numerically or conceptually. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the shift from share withholding (2023) to active issuance (2024) represents a structural change in compensation policy. Instead, it incorrectly frames the trend as a decline in employee share activity. It also conflates ESPP-specific data with overall equity compensation without supporting evidence. (4) The contextual relevance is moderate because the answer addresses employee share programs and equity impact, but the factual inaccuracies and incorrect synthesis severely undermine correctness. Quantitative accuracy is very low due to incorrect numbers and unsupported calculations. Qualitative accuracy is poor due to flawed reasoning and misrepresentation of trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 509,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ’s Canadian‑dollar notes rose only modestly, from **$470 million at year‑end 2022 to $473 million at year‑end 2023** (a $3 million increase)【page_107】.  By contrast, the company’s total foreign‑currency debt (Euro, pound, Swiss franc and Canadian notes) grew sharply—from about **$7.8 billion in 2022 to $9.8 billion in 2023**—driven by a large rise in Euro notes and a reduction in Swiss‑franc exposure, showing an overall strategy of expanding non‑U.S. currency financing while keeping Canadian exposure essentially flat.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of change in Canadian-denominated debt. The ground truth states that Canadian notes *increased by $8 million* in 2023 after a prior decrease of $3 million in 2022, reversing a multi-year downward trend. The LLM claims a $3 million increase from $470M to $473M, which contradicts the ground truth where the absolute levels and changes are entirely different (the actual 2022–2023 change is +$8M, not +$3M, and the base amounts are in the tens of millions, not hundreds of millions). (2) The quantitative inaccuracies are severe: the LLM reports Canadian notes at $470M in 2022 and $473M in 2023, while the ground truth implies a much smaller base (down to $3M in 2021, then up to $11M in 2023), meaning the LLM’s figures are off by over 4000%. Additionally, the LLM incorrectly frames the overall foreign currency debt trend as a sharp increase to $9.8B, which is unsupported by the provided context and irrelevant to the specific question about Canadian exposure and its relative shift. (3) The multi-hop reasoning fails: the question asks how the change in Canadian debt compares to the overall trend in foreign currency debt management. The ground truth contrasts the reversal in Canadian notes with volatility in Euro and Swiss franc notes. The LLM invents a narrative about total foreign currency debt rising due to Euro notes and reduced Swiss franc exposure, which is not corroborated by the original answer and misrepresents the comparative trend. (4) The contextual relevance is moderate because the LLM addresses the general topic of foreign currency debt and attempts a comparison, but the factual foundation is so flawed that the conclusion is misleading. The qualitative reasoning appears structured but is built on false premises. Thus, the correctness score is low due to catastrophic quantitative errors and failure to reflect the actual trend reversal described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 534,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "In its 2023 Form 10‑K Accenture described Accenture Ventures simply as a unit that “partners with and invests in growth‑stage companies that create innovative enterprise technologies,” emphasizing the investment‑focused relationship 【page_17†L...】. By the 2024 filing the firm framed that activity as part of a broader “strategic innovation partnership,” linking Accenture Ventures with Accenture Research, Labs and a global network of innovation hubs to co‑create, prototype and scale solutions—showing a deeper, more strategic involvement beyond capital deployment 【page_17†L...】.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misrepresents the evolution of Accenture's approach. The original answer states that in 2023, Accenture Ventures primarily 'partnered with' growth-stage companies, and by 2024 shifted to a more direct 'invests in' model, indicating a move from partnership to investment. However, the LLM answer incorrectly claims that as early as 2023, Accenture already described Ventures as both 'partners with and invests in' growth-stage firms — which contradicts the ground truth that the investment-focused approach emerged in 2024. This mischaracterizes the timeline and nature of the evolution. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not applicable; however, no incorrect numbers are introduced, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the shift from partnership (2023) to investment (2024), instead suggesting both activities were present in 2023, which undermines the core of the evolution described in the ground truth. It does correctly note a deeper strategic involvement in 2024 by linking Ventures with Research, Labs, and innovation hubs, which aligns with the idea of increased strategic integration. (4) Contextual relevance is high because the answer addresses strategic involvement and investment activity, and references innovation ecosystems and co-creation, but the incorrect attribution of investment activity to 2023 significantly reduces factual accuracy. The synthesis across years is therefore partially correct but fundamentally flawed in its central claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 447,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck’s role in the AstraZeneca Lynparza partnership has remained financially consistent – the company still carries a $1.1 billion Lynparza intangible asset that is being amortized over its estimated useful life through 2028 (the amortization is reflected in cost of sales) [2022 10‑K p.102] – but its commercial upside has grown, with Lynparza‑related alliance revenue increasing 9 % in 2024, driven by higher demand in international markets [2024 10‑K p.55].",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $1.1 billion intangible asset balance from 2022 being amortized through 2028 and the 9% increase in alliance revenue in 2024 due to international demand, both of which align with the ground truth. All numeric values—$1.1 billion, 9% growth, and the 2028 amortization period—are factually accurate and contextually appropriate. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and timeframes match the original answer exactly, with acceptable formatting (e.g., $1.1 billion). (3) The reasoning is sound in linking continued amortization with growing revenue, showing evolution in Merck's financial involvement. However, the LLM omits the forward-looking strategic development mentioned in the original answer: the 2025 China approval for adjuvant treatment in early breast cancer, which is a key indicator of strategic expansion. This missing element prevents full completeness and slightly weakens the qualitative synthesis across the full 2022–2024+ timeline. (4) Despite this omission, the answer captures the core financial evolution and remains highly relevant, earning high marks for contextual relevance and quantitative precision. The correctness score is 8 due to the accurate financial portrayal but partial omission of strategic developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 369,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "In the 2023 filing, ValueOps is mentioned only as one of the listed offerings within the Distributed Software portfolio – “• ValueOps” appears under the portfolio description【page_8】. By the 2024 filing, Broadcom frames its Distributed Software solutions around three distinct domains – “ValueOps, DevOps, and AIOps” – positioning ValueOps as a core, organizing pillar of the portfolio【page_10】. This shift shows that AVGO has elevated ValueOps from a peripheral offering to a central strategic focus within its Distributed Software business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, ValueOps was a listed offering without elaboration, and in 2024 it became one of three core domains alongside DevOps and AIOps—matching the original answer's key point about elevation in strategic importance. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings to show a strategic shift in positioning. It correctly infers that moving from a bullet-pointed offering to an organizing domain indicates increased strategic importance. (4) The only minor omission is that the LLM answer does not explicitly mention the 'end-to-end visibility across all stages of the digital lifecycle' phrase or the broader implication about alignment with business outcomes and customer experiences, which are part of the original answer’s interpretation. However, the core factual progression and strategic implication (elevation from peripheral to central) are correctly captured. Thus, the answer is semantically equivalent in factual content but slightly less rich in interpretive depth. Contextual relevance is perfect—it directly addresses both parts of the question: the change between 2023 and 2024 and what it indicates about ValueOps’ evolving role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 410,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "In the 2023 filing FedEx framed Network 2.0 as a new, multi‑year component of its DRIVE transformation that was expected to deliver significant cost‑savings and a leaner cost base, but it warned that failure to integrate the legacy FedEx Ground and Federal Express networks on schedule could lead to higher‑than‑expected costs, loss of customers, litigation, union activity and other disruptions (2023 p. 28‑32). By the 2024 filing the company reported that Network 2.0 is now live in more than 50 U.S. locations and that the total pre‑tax cost of the broader DRIVE effort is projected at about $1.5 billion through 2025, yet it still cautions that achieving the projected savings remains uncertain and subject to legal challenges, unforeseen integration expenses, labor‑related issues and other implementation risks (2024 p. 29, 55).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of FedEx's strategic approach to Network 2.0 from 2023 to 2024: in 2023, the focus was on expected cost savings and risks of delayed integration; in 2024, the emphasis shifted to live implementation, integration complexity, and ongoing uncertainty around savings. (2) Quantitatively, the $1.5 billion pre-tax cost through 2025 is correctly reported and not contradicted by the ground truth (which does not specify a number but refers to uncertainty in timing and amount of savings). The absence of specific cost-saving figures in the original answer means the LLM’s inclusion of the $1.5B figure (from the 2024 filing) adds precision without inaccuracy. Page references (2023 p. 28–32, 2024 p. 29, 55) suggest accurate sourcing. (3) Multi-hop reasoning is sound: the LLM synthesizes information across two years, correctly identifying the shift from strategic planning to operational integration and risk management. It accurately links Network 2.0 to the DRIVE transformation and identifies overlapping risks (litigation, labor issues, cost overruns). (4) The only minor shortcoming is that the LLM does not explicitly mention 'asset impairment charges' or 'tax impacts' noted in the 2024 filing in the ground truth, which slightly reduces completeness. However, it does capture 'unforeseen integration expenses' and 'legal challenges,' which are closely related. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 438,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "In 2022 Mondelēz recorded no pre‑tax gain or loss from its equity‑method investment contracts, but in 2023 it booked a $7 million pre‑tax gain on those contracts. The change from a neutral impact to a modest positive contribution indicates that the company’s equity‑method investments became more actively engaged—or more effectively hedged—in 2023, generating a small but tangible earnings benefit.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that MDLZ (Mondelēz) recorded 'no pre-tax gain or loss' in 2022, which contradicts the ground truth that it reported a net liability of $3 million. This is a significant factual error in quantitative reporting. The 2023 figure of a $7 million gain is correct and matches the ground truth. (2) The calculation and comparison between years are flawed because the starting point (2022) is misrepresented. The shift from a $3 million liability to a $7 million gain represents a $10 million swing, but the LLM implies a change from neutral to positive, missing the prior negative position entirely. (3) The reasoning about increased engagement or improved hedging in 2023 is plausible and aligns with the qualitative interpretation in the ground truth, showing sound multi-hop logic in interpreting the change—though based on incorrect baseline data. (4) Contextually, the answer addresses both parts of the question—evolution over time and implications for engagement—and uses appropriate financial terminology. However, the failure to accurately report the 2022 liability severely undermines quantitative accuracy, warranting a moderate overall correctness score despite reasonable interpretation and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 353,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom’s filing shows that the “estimated cost to complete” for the VMware Cloud Foundation July 2024 releases was $38 million in fiscal 2023 and remains $38 million in fiscal 2024 【page_69】.  The unchanged estimate signals that the work is progressing on schedule and within the budget originally expected, with no additional cost overruns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the estimated cost to complete for the VMware Cloud Foundation July 2024 releases was $38 million in both fiscal years 2023 and 2024, which matches the ground truth exactly. All numeric values and fiscal years are accurate. (2) Quantitative accuracy is perfect: the dollar amount ($38 million) and the time periods (fiscal 2023 and 2024) are correctly reported with no calculation errors. Format consistency is acceptable. (3) The reasoning is sound—the model correctly infers that an unchanged cost estimate indicates the project is on schedule and within budget, aligning with the ground truth interpretation that progress is proceeding as planned without significant delays or overruns. However, the LLM slightly omits the nuance that no decrease in cost also implies no unexpected acceleration or efficiency gains, which the original answer includes. This minor omission prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of cost (unchanged) and what it indicates about development progress. Overall, the answer is factually correct and semantically equivalent to the ground truth with only slight room for deeper interpretive completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 362,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "In 2023 FedEx Office was described mainly as a ≈2,000‑store retail network that enabled e‑commerce returns through FedEx Returns Technology and the new Consolidated Returns program, but the Ship‑and‑Go kiosk was not highlighted as a separate service (2023 E‑Commerce & Digital Solutions, p. 12). By 2024 the company is positioning the Ship‑and‑Go kiosk as a dedicated self‑serve shipping station in roughly 1,300 FedEx Office locations, letting customers generate mobile/QR labels and drop packages in a secure bin while tying the kiosk to FedEx Returns Technology and Consolidated Returns (2024 FedEx Office segment, p. 15). This evolution shows FedEx is leveraging its retail footprint to become an integrated e‑commerce logistics hub, streamlining both outbound shipping and returns management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2023 description: it claims the Ship and Go kiosk was not highlighted as a separate service and that FedEx Office had approximately 2,000 stores, which contradicts the ground truth stating the kiosk was present in about 1,300 locations in both 2023 and 2024. This misrepresents both the scale and the visibility of the kiosk in 2023. The correct number of locations (≈1,300) is only correctly cited for 2024. (2) Quantitative accuracy is compromised due to the incorrect store count (2,000 vs. 1,300) in 2023. While the 1,300 figure for 2024 matches the ground truth, the erroneous 2023 number undermines the comparison. No other numerical values (dates, percentages, dollar amounts) are present, so the error is isolated but significant. (3) The reasoning is partially sound: the LLM correctly identifies the strategic shift in 2024 to tie Ship and Go more explicitly to FedEx Returns Technology and Consolidated Returns, and infers that this reflects a broader integration into e-commerce logistics. However, the faulty premise about 2023 weakens the multi-hop synthesis—since the kiosk *was* described in 2023 as a self-serve solution, the contrast between years is overstated. (4) Despite the quantitative error, the answer captures the core qualitative evolution—positioning Ship and Go as part of a returns infrastructure—and addresses both parts of the question (evolution and strategic implication). Wording differences are acceptable under semantic equivalence, but the incorrect entity detail (store count and kiosk visibility in 2023) reduces factual reliability. Contextual relevance is high as the response directly engages with e-commerce logistics and returns management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 481,
        "total_tokens": 1917
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 7.12,
    "average_quantitative_accuracy": 7.92,
    "average_qualitative_accuracy": 7.35,
    "average_contextual_relevance": 9.03,
    "score_distribution": {
      "excellent": 492,
      "good": 154,
      "fair": 225,
      "poor": 129
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 10337.87,
    "timestamp": "2026-02-02T18:32:43.613364"
  }
}